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The Armadillo Family Protein p0071 is a Cadherin and Desmoplakin Binding Protein
A.P. Kowalczyk,* C.C. Calkins,* B. Hoepner,* C.M. Law,* M. Hatzfeld, and M.R. Novak*
The Medical Faculty, University of Halle, Halle, Saale, Germany; *Dermatology, Emory University,
Atlanta, Georgia, U.S.A.
VE-cadherin is an endothelial adhesion molecule that plays a central role in vascular barrier
function and angiogenesis. VE-cadherin function is regulated by cytoplasmic interactions with
beta-catenin and p120, members of the armadillo gene family. The unique junctional complexes in
endothelial cells are thought to couple VE-cadherin to both actin and intermediate ®lament
networks. p0071, a member of the armadillo gene family, localizes to both adherens junctions and
desmosomes in epithelial cells, and exhibits homology to p120 and to the desmosomal protein
plakophilin-1. We have found that p0071 is also present at dermal microvascular endothelial
junctions and colocalizes with VE-cadherin. To de®ne the role of p0071 in junction assembly, we
tested p0071 for interactions with other intercellular junction proteins. In transient expression
assays, p0071 colocalized with and formed complexes with both VE-cadherin and desmoplakin.
Deletion analysis using the yeast two hybrid system revealed that the armadillo repeat domain of
p0071 binds to the cytoplasmic tail of VE-cadherin. p0071 expressed in COS cells displaced p120
from intercellular junctions, and site directed mutagenesis experiments demonstrated that p0071
and p120 bind the same region of the VE-cadherin tail. In contrast to VE-cadherin, desmoplakin
was found to associate with the nonarmadillo head domain of p0071. Co-transfections and triple
label immuno¯uorescence analysis revealed that VE-cadherin colocalization with desmoplakin in
transfected COS cells required p0071, suggesting that p0071 may couple VE-cadherin to
desmoplakin. These ®ndings suggest that p0071 associates with both adherens junction and
desmosomal components, and that p0071 speci®cally binds to both cadherins and desmoplakin.
These data suggest that p0071 may play a role in endothelial intercellular junction assembly and in
the morphogenic events associated with vascular remodeling.
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Constitutive Activation of MAP Kinase Kinase Signaling Results in Malignant
Transformation of Melanocytes to Melanoma
B. Govindarajan, X. Bai, C. Cohen,* M. Moses,² and J.L. Arbiser
Dermatology, Emory University, Atlanta, Georgia, U.S.A.; *Departments of Dermatology, Cutaneous
Biology Research Center, Harvard Medical School, Boston, Massachusetts, U.S.A.; ²Department of Surgery,
Childrens Hospital,Harvard Medical School, Boston, Massachusetts, U.S.A.
Malignant melanoma (MM) is the leading cause of skin cancer death. While activation of ras and
loss of PTEN have been shown in melanoma, the precise signal transduction events leading to
melanoma are not known. We have hypothesized that synergy exists between loss of the tumor
suppressor gene p16ink4a and activation of MAP kinase. Since most melanomas exhibit loss of
p16ink4a, we hypothesized that activation of MAP kinase would lead to transformation.
Examination of atypical nevi and melanomas with an antibody speci®c for phospho-MAP kinase
showed activation of MAP kinase in melanomas but not nevi. In order to determine whether MAP
kinase was functionally important in melanoma transformation, we expressed a constitutively active
MAP kinase kinase (MAPKK) in immortalized L10BIOBR murine melanocytes. Increased
activation of MAP kinase was observed in MAPKK expressing melanocytes compared with GFP
vector controls. Overexpression of MAPKK lead to increased production of matrix
metalloproteinase 2 (MMP-2) in vitro by zymography and lead to tumorigenesis in nude mice.
GFP expressing melanocytes produced dormant tumor nodules in nude mice. Our results show
that activation of MAP kinase is suf®cient to convert melanocytes into vertical growth melanoma
cells. In addition, we provide further evidence that synergy exists between MAP kinase activation
and p16ink4a loss, and that MAP kinase inhibition may be a powerful strategy for the prevention
and treatment of malignant melanoma.
003
Tyrosine Kinase Inhibitor Pro®ling: Analysis and Therapeutic Implications of Platelet-
Derived Growth Factor Signal Transduction in Tuberous Sclerosis-Related Lesions
J.L. Arbiser, B. Govindarajan, X. Bai, H. Onda,* A. Kazlauskas,* S.D. Lim, M.B. Amin, and L.
Clasesson-Welsh²
Departments of Dermatology and Pathology, Emory University, Atlanta, Georgia, U.S.A.; *Schepens Eye
Institute and Department of Adult Oncology, Harvard Medical School, Boston, Massachusetts, U.S.A.;
²Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
Tuberous sclerosis (TS) is a common autosomal dominant disorder due to loss of one of two genes,
hamartin (tsc1) and tuberin (tsc2). The primary cause for morbidity and mortality from TS are
neoplasms of the brain, kidney, and skin. No medical treatment exists for the neoplasms of TS. In
order to determine whether TS cells are susceptible to tyrosine kinase inhibitors, we subjected a
human angiomyolipoma cell line and a murine tumor cell line derived from a tsc2+/± mouse to a
battery of small molecular weight tyrosine kinase inhibitors. Both human and murine cell lines
showed increased susceptibility to PDGFRb tyrosine kinase inhibition. Immunohistochemistry
reveals high levels of phosphorylated (active) PDGFRb expression in angiomyolipomas in vivo.
Western blot and immunoprecipitation reveals presence and activation of PDGFRb in vitro. The
grb7 molecule, which serves as an adaptor molecule for PDGFRb mediated signal transduction is
also present in high levels in angiomyolipomas, but is not expressed in other human renal tumors.
Subsequently, we have found that these cells are sensitive to the FDA approved tyrosine kinase
inhibitor STI 571 (Gleevec), which inhibits PDGFRb mediated signal transduction in addition to
that of bcr-abl and c-kit tyrosine kinases. These ®ndings suggest a novel potential use of tyrosine
kinase inhibitors in the treatment of benign and malignant neoplasms in tuberous sclerosis. This
approach also has general utility in determining potential contributions of tyrosine kinases to
neoplastic processes through a rapid screen of tyrosine kinase inhibitors.
004
Dimethylfumarate Inhibits TNF-Induced Nuclear Entry of NF-kB/p65 in Human
Endothelial Cells
R. Loewe, W. Holnthoner, M. Gro
È
ger, M. Pillinger, F. Gruber,* E. Hofer,* K. Wolff, and P.
Petzelbauer
Department of Dermatology, Section of General Dermatology, University of Vienna Medical School, Vienna,
Austria; *Institute for Vascular Biology and Thrombosis Research, University of Vienna Medical School,
Vienna, Austria
Fumaric acid esters, mainly dimethylfumarate (DMF), have been successfully used to treat psoriasis.
Based on previous observations that DMF inhibited expression of several TNF-induced genes in
endothelial cells, we wished to explore the molecular basis of DMF function in greater detail. To
determine the speci®city of DMF to inhibit TNF-induced activation, we analyzed DMF effects on
tissue factor expression in human endothelial cells in culture, because tissue factor is expressed by
two independent sets of transcription factors, by TNF via NF-kB and by VEGF via EGR-1. We
show that DMF inhibits TNF-induced tissue factor mRNA and protein expression, as well as
TNF-induced DNA binding of NF-kB proteins. In contrast, DMF does not inhibit VEGF-
induced tissue factor protein and mRNA expression as well as VEGF-induced EGR-1 ± DNA
binding. To determine the site where DMF interferes with the TNF/NF-kB signaling cascade, we
analyzed DMF effects on IkB and on the subcellular distribution of NF-kB. DMF does not inhibit
TNF-induced IkBa phosphorylation and IkBa degradation, thus NF-kB is properly released from
IkB complexes even in the presence of DMF. Importantly, DMF inhibits the TNF-induced
nuclear entry of NF-kB proteins and this effect appears selective for activated NF-kB, because the
constitutive shuttling of inactive NF-kB/IkB complexes into and out from the nucleus is not
blocked by DMF. Moreover, DMF does not block NF-kB/DNA binding. In conclusion, DMF
appears to selectively block the nuclear entry of activated NF-kB and this may be the basis of its
bene®cial effect in psoriasis.
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The Endogenous Angiogenesis Inhibitor Thrombospondin-1 Plays a Critical Role in the
Induction of Hair Follicle Involution and Vascular Regression During Catagen
K. Yano, L.F. Brown,* J. Lawler,* and M. Detmar
Dermatology, CBRC/MGH, Charlestown, Massachusetts, U.S.A.; *Pathology, Harvard Medical School,
Boston, Massachusetts, U.S.A.
Hair follicle growth during the anagen phase is associated with pronounced perifollicular
angiogenesis, whereas the catagen regression phase is characterized by apoptosis-driven blood
vessel regression. Previously, we have shown that follicle growth during anagen is dependent on
vascular expansion induced by cyclic up-regulation of the angiogenesis factor VEGF. In the present
study, we investigated the expression of the endogenous inhibitor of angiogenesis, thrombos-
pondin-1 (TSP-1), during the murine hair cycle, using in situ hybridization. In addition, we
studied the biological importance of TSP-1 by comparative studies of induced hair cycling in
wildtype, TSP-1 de®cient and TSP-1 overexpressing transgenic mice (K14/TSP-1). Moderate
TSP-1 mRNA and protein expression was detected in outer root sheath keratinocytes throughout
the hair cycle. However, TSP-1 expression was virtually absent from the dermal papilla during
early to mid-anagen, but was highly up-regulated in dermal papilla cells at the late anagen stage and
throughout catagen and telogen, suggesting a potential role in the induction of catagen and follicle
involution. Indeed, the anagen growth phase was extended and the onset of catagen involution was
delayed by several days in TSP-1 de®cient mice, associated with signi®cantly increased
perifollicular vascularization and vascular proliferation, as evaluated by computer-assisted
morphometric analysis of CD31 and/or anti-BrdU-stained sections. In contrast, anagen hair
follicle growth was reduced in K14/TSP-1 transgenic mice that expressed high levels of TSP-1 in
outer root sheath keratinocytes, associated with a signi®cant reduction of perifollicular
vascularization. Our results suggest a critical role of TSP-1-induced vessel regression in the
control of follicle involution during the catagen phase.
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Epidermal Stem Cells Accelerate the Restoration of the Blood Flow in Ischemic Limbs
M. Dunnwald, C. Jiao,* K.L. Mercer, and G.C. Schatteman*
Dermatology, The University of Iowa, Iowa City, Iowa, U.S.A.; *Exercise Science, The University of Iowa,
Iowa City, Iowa, U.S.A.
Until recently, epidermal and hair follicle stem cells were thought to be unipotent, giving rise only
to other keratinocytes, consistent with the conventional wisdom that the lineage potential of adult
stem cells was restricted to the tissue of origin. Here, we investigated whether mouse epidermal
stem cells could adopt a novel fate in phenotype as well as in function. To test our hypothesis we
used a well-established mouse model of ischemia. We injected freshly isolated and cultured
epidermal stem and transient amplifying (TA) cells into a mouse ischemic limb and followed the
cells' fate and the recovery of the mouse ischemic limb blood ¯ow over time. Both stem and TA
cells had incorporated into the vasculature of the ischemic limb 2 and 5 weeks postinjection, and
some had acquired an endothelial cell phenotype. This was true whether the cells were freshly
isolated or grown in culture. However, only the injected stem cells accelerated the restoration of
the blood ¯ow; the TA did not. This is the ®rst time that epidermal cells were found incorporated
into adult tissues other than skin (i.e. vasculature) and exert functions other than the ones expected
from epidermal cells (i.e. acceleration of the restoration of blood ¯ow) strongly suggesting that
epidermal stem cells are pluripotent. Since epidermal stem cells are a readily accessible and
expandable population of stem cells, and have been found incorporate into the vasculature, they
constitute an ideal candidate for nonviral gene delivery system as well as for constant systemic
delivery of proteins like insulin in diabetes.
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The Helix-Loop-Helix Protein Id-1 Delays Onset of Replicative Senescence in Human
Endothelial Cells
J. Tang, G.M. Gordon, B.J. Nickoloff, and K.E. Foreman
Pathology, Loyola University Medical Center, Maywood, Illinois, U.S.A.
Id proteins are negative regulators of basic helix-loop-helix transcription factors, which are critical
for expression of genes associated with cellular proliferation and differentiation. Previous studies
have shown that overexpression of Id-1 delays cellular senescence in several cell types including
®broblasts, mammary epithelial cells and keratinocytes. Although studies have demonstrated the
expression of Id-1 in endothelium, the regulation of Id-1 has not been studied in these cells. In this
report, a retroviral vector was utilized to overexpress Id-1 in human endothelial cells. Sustained
expression of Id-1 resulted in a 2±3-fold increase in the total number of population doublings
(replicative capacity) of the cells; compared to vector-treated controls, which correlated with low
levels of p16, p21 and p27 expression. The cells, however, were not immortalized, and did
eventually undergo senescence despite elevated Id-1 levels. Senescence was characterized by a
dramatic increase in p16, but not p21 and p27. Under these experimental conditions, telomerase
activity was not detected and the telomeres became progressively shorter with time. These results
demonstrate the importance of Id-1 in endothelial cell proliferation and indicate that Id-1 represses
p16 expression resulting in delayed senescence. These ®ndings may have implications in the
development of endothelial cell-related tumors.
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Overexpression of Bcl-2, Akt, or PDGF-BB in HUVEC Produces Unique Vascular
Phenotypes In Vivo
D.R. Enis,* A.L. Bothwell,² W.C. Sessa,³ J.S. Pober,*§ and J.S. Schechner§
*Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.; ²Section
of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.; ³Department of
Pharmacology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.; §Department of
Dermatology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.
Human umbilical vein endothelial cells (HUVEC) that have been retrovirally transduced to
overexpress Bcl-2 and implanted into CB.17 SCID/beige mice form mouse smooth muscle/
pericyte invested, human EC-lined complex vascular networks that contain elements resembling
true arterioles, venules, and capillaries. In contrast, control EGFP-transduced HUVEC form
simple, undifferentiated EC tubes uninvested by mesenchymal cells. To determine if increased
survival was responsible for these Bcl-2-induced changes, we compared the Bcl-2 phenotype to
that produced by overexpression of a different survival gene, Akt/PKB. Bcl-2 and Akt both
protected HUVEC from apoptosis stimulated by C6-ceramide or serum starvation, and both genes
prolonged the survival of HUVEC tubelike structures in 3D collagen/®bronectin gels in vitro.
However, when implanted in vivo, Akt-transduced HUVEC formed hemangioma-like structures
that were dilated, highly branched, thin-walled, and invested by a poorly organized smooth
muscle/pericyte layer. To determine if mesenchymal cell investment could replicate the Bcl-2
effect, we prepared HUVEC that overexpress a smooth muscle cell chemoattractant, PDGF-BB. In
vitro PDGF-BB expression and secretion by the PDGF-transduced HUVEC was con®rmed by
ELISA. In vivo, PDGF-BB-transduced HUVEC formed small, capillary-like structures invested by
a single layer of mesenchymal cells. Therefore, these different phenotypes demonstrate that the
complex effects of Bcl-2 cannot be replicated by either a different survival gene (Akt) or by
mesenchymal cell recruitment (by PDGF-BB) alone. Furthermore, the varied patterns of vascular
differentiation suggest that this model can be used to analyze the roles of various genes in vascular
remodeling in vivo. Finally, the hemangioma-like phenotype produced by Akt may implicate this
gene product in vascular malformations/tumors.
009
Engraftment of a Vascularized Human Skin Equivalent
S.K. Crane, F. Wang, A.L. Bothwell,* J.S. Pober,² and J.S. Schechner
Interdepartmental Program in Vascular Biology and Transplantation, Department of Dermatology, Yale
University, New Haven, Connecticut, U.S.A.; *Interdepartmental Program in Vascular Biology and
Transplantation, Section of Immunobiology, Yale University, New Haven, Connecticut, U.S.A.;
²Interdepartmental Program in Vascular Biology and Transplantation, Section of Immunobiology,
Departments of Dermatology and Pathology, Yale University, New Haven, Connecticut, U.S.A.
Clinical performance of current human skin equivalents is probably limited by inadequate
vascularization and perfusion. We have developed an engineered human skin equivalent
containing endothelial cells that becomes perfused in vivo after engraftment on an immunode®cient
(SCID/beige CB.17) mouse. The constructs were prepared by ®rst seeding human neonatal
keratinocytes on devitalized acellular cadaveric dermis. Epidermal differentiation into a strati®ed
squamous epithelium was induced by culture in increased calcium (1.2 mM) and the withdrawal of
epidermal growth factor. Endothelial cell invasion of the construct was achieved by addition of
Bcl-2-transduced human umbilical vein endothelial cells (HUVEC) to the underside of the dermis
24 h prior to transplantation of the grafts on the backs of SCID/beige mice. Bcl-2 overexpression
was utilized because this modi®cation enhanced in vivo vascularization of devitalized acellular
dermis compared to untransduced HUVEC. At 2 weeks, the grafts showed morphologic similarity
to human skin, having a continuous and corni®ed strati®ed epidermis as well as a vascularized
dermis with evidence of perfusion (i.e. intravascular erythrocytes). Immunohistochemical analysis
of the grafts using human-speci®c involucrin and type 4 collagen antibodies and the lectin UEA-1
con®rmed that the epidermis and the endothelial lining of many of the dermal vessels were of
human origin. To our knowledge, this is the ®rst report of successful transplantation of a perfused
vascularized engineered human skin equivalent. This methodology may enhance the clinical utility
of skin equivalents, especially in recipients with impaired angiogenesis (e.g. diabetes and the
elderly).
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Transgenes Expressed Under the Control of the VEGFR-3 Promoter are Selectively
Expressed by Lymphatic Endothelial Cells of Transgenic Mice
M. Sugaya, T. Watanabe, A. Atkins, E. Aquilino, D. Borris, E. Jaffe,* L. Feigenbaum,² and A.
Blauvelt
Dermatology Branch, National Cancer Institute, Bethesda, Maryland, U.S.A.; *Pathology Branch,
National Cancer Institute, Bethesda, Maryland, U.S.A.; ²SAIC, National Cancer Institute, Bethesda,
Maryland, U.S.A.
Vascular endothelial growth factor receptor 3 (VEGFR-3) is expressed almost exclusively in
lymphatic endothelial cells in adults and it is one of the key markers that distinguish lymphatics
from blood vessels. In an attempt to selectively express genes of interest within lymphatic
endothelial cells, we cloned, sequenced, and characterized the murine VEGFR-3 promoter and the
exon-intron organization of the 5¢ end of the murine VEGFR-3 gene. We then created
recombinant DNA constructs composed of the following: 4 kB of VEGFR-3 promoter; the genes
encoding for either Lac-Z, LANA, or v-cyclin (the latter two are viral genes expressed in Kaposi's
sarcoma [KS] VEGFR-3 + spindle cells) in place of VEGFR-3 exon 1; 5 kB of VEGFR-3 intron 1;
and SV40 polyA sequence. Next, transgenic (Tg) mice were created using these same constructs.
Importantly, adult Lac-Z Tg mice selectively expressed Lac-Z within dermal lymphatics as shown
by beta-gal staining. Interestingly, adult LANA Tg mice were noted to be signi®cantly heavier than
Lac-Z and v-cyclin Tg mice. Two of these overweight LANA Tg mice died prematurely, and
autopsy of one revealed severe peritoneal ascites and histologic evidence of congestion/edema in
many tissues, including skin, heart, lungs, thymus, and spleen. In summary, we cloned and
sequenced the murine VEGFR-3 promoter and used this promoter to selectively express
transgenes in lymphatic endothelial cells of mice; of particular importance, expression of the KS-
associated gene LANA in vivo created lymphatic dysfunction. These results suggest that mice that
express transgenes under the control of the VEGFR-3 promoter may be useful for understanding
KS pathogenesis, as well as for elucidating underlying mechanisms of normal lymphatic function.
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Sialomucin Expression on Human Dermal Microvascular Endothelial Cells in Psoriasis
In Vitro and In Vivo
Y. Okubo,* U. Nagavarapu,² P.J. Yang,* K. Relloma,² A. Soleiman,³ S. Breiteneder-Gellef,³ and
G.S. Herron*²
*Dermatology, Stanford University, Stanford, California, U.S.A.; ²Cutaneous Biology, Molecular Medicine
Research Institute, Sunnyvale, California, U.S.A.; ³Clinical Pathology, University of Vienna, Vienna,
Austria
The cell surface sialomucins are expressed on vascular endothelium in multiple tissues. CD34 and
podpcalyxin are involved in leukocyte-endothelial adhesion and podoplanin is a speci®c marker of
lymphatic endothelium. To characterize the expression of these mucins in skin microvasculature
and explore their potential contribution to the angiogenic phenotype observed in psoriatic skin, we
used Western blots of human dermal microvasucular endothelial cells (HDMEC) grown in vitro
and immuno¯uorescent staining of HDMEC implanted with Matrigel in SCID mice for two
weeks in vivo. Primary adult HDMEC were isolated from lesional skin and nonlesional skin in
psorisis (n = 4) and puri®ed using anti-PECAM-1 af®nity besds. As controls, we implanted
telomerized lymphatic (LEC) and blood (BEC) HDMEC lines, as well as, primary HDMEC from
neonatal foreskin. Whereas LEC expressed high constant podoplanin in vitro and on LEC-derived
microvasculature in vivo, BEC expressed none. Psoriatic HDMEC had variable podoplanin; 75%
from nonlesional skin and 50% from lesional skin were positive both in vitro and in vivo. All cells
expressed podocalyxin in vivo but processing of podocalyxin was different in LEC vs. BEC where a
130-kDa band was absent in LEC. All psoriatic and neonatal HDMEC expressed BEC-like
processed forms of podocalyxin. CD34 expression by QBEnd10 was faint or negative in all
HDMEC in vivo. Our results show that some HDMEC derived from psoriatic skin coexpress both
LEC and BEC sialomucins but that processing of podocalyxin in psoriatic HDMEC is different
from our LEC lines. We speculate that abnormal angiogenesis and chronic in¯ammation in
psoriasis may involve lymphatic microvasculature.
012
Increased Expression of Platelet-Derived Growth Factor A and Pleiotrophin in
Tuberous Sclerosis Skin Tumors
T. Lei, D. Nguyen, J. Nguyen, J. Moss,* and T. Darling
Department of Dermatology, Uniformed Services University, Bethesda, Maryland, U.S.A.; *Pulmonary-
Critical Care Medicine Branch, NHLBI, Bethesda, Maryland, U.S.A.
Facial angio®bromas and periungual ®bromas observed in tuberous sclerosis (TSC) show increased
vascularity, while collagenomas do not. Since inhibiting angiogenesis offers potential for treatment
of TSC tumors, the aim of our study was to identify angiogenic cytokines up-regulated in
angio®bromas and periungual ®bromas, but not in collagenomas. Using a cDNA ®lter array,
differences in the expression of 268 cytokine genes and receptors were assessed in total RNA
extracted from paired samples of skin tumor and normal-appearing skin from 3 TSC patients.
Levels of mRNA more than twice higher than those in normal-appearing skin were observed for 7
genes in the angio®broma and the periungual ®broma. The genes up-regulated, listed with the
mean level relative to that in normal-appearing skin (1X), were S100A8 (36), S100A9 (28),
PDGFA (9), SCYB5 (8), IL1R2 (6), PTN (4), and WNT5A (2.5). These mRNAs were not
increased in the collagenoma and no gene tested was up-regulated 2-fold or more in all three
tumors. To demonstrate increased protein production as well as tissue localization, cryosections
obtained from 3 angio®bromas, 1 periungual ®broma, and normal-appearing skin from 4 TSC
patients were studied using immunohistochemistry, focusing on platelet derived growth factor A
(PDGFA) and pleiotrophin (PTN) because of their reported role in angiogenesis. PDGFA and
PTN staining was usually more intense in the epidermis of tumors than in normal-appearing skin.
Notably, there was scattered positive staining in the dermis of tumors that was not observed in
normal-appearing skin. In contrast, staining for calgranulin A (S100A8, not known to play a role in
angiogenesis) was increased in the epidermis of tumors but negative in the dermis of both tumors
and normal. Increased expression of PDGFA and PTN in TSC angio®bromas and periungual
®bromas suggests that these cytokines may be important for the development of these tumors.
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The Cutaneous Neuropeptide Substance P is Chemotactic for Human Dermal
Microvascular Endothelial Cells
F.I. Ramos-Ceballos, R.M. Campbell, A. Kowalczyk, C.A. Armstrong,* and J.C. Ansel*
Dermatology, Emory University, Atlanta, Georgia, U.S.A.; *Dermatology, North-western University,
Chicago, Illinois, U.S.A.
Substance P (SP) and calcitonin gene-related peptide (CGRP), both synthesized and released by
cutaneous sensory nerves, can modulate key aspects of normal angiogenesis and wound healing.
The purpose of these studies is to better understand the relationship between the cutaneous
nervous system and angiogenesis. Injury to the cutaneous nervous system releases neuropeptides
from peripheral nerves that may play a signi®cant role in subsequent wound healing, particularly
initial steps of angiogenesis. The present study examines whether neuropeptides SP, substance
(SK), and CGRP have chemotactic activity for human dermal microvascular endothelial cell
(HDMEC). There is in vitro evidence that substance P (SP) induces the proliferation and migration
of large vessel endothelial cells (HUVEC) and is capable of modulating differentiation of HUVEC
into capillary-like structures. Such a relationship between substance P and the microvasculature of
the skin has never been demonstrated. Chemotaxis was assessed in triplicate using a modi®ed
Boyden chamber assay by quantitating the numbers of HDMEC that migrate across a
polycarbonate ®lter with 8 mm pore diameter against a concentration gradient of SP (1 nM-
1000 nM), SK (1 nM-1000 nM), or CGRP (1 nM-1000 nM). PBS and VEGF (40 mg/ml) were
used as negative and positive controls, respectively. Our results indicate that there was a SP-
dependent chemotactic dose±response in the HDMEC. A synergistic effect between SP and
neuropeptides SK or CGRP was not observed. Our results failed to demonstrate chemotactic
activity of SK and CGRP for HDMEC. Thus, SP but not SK or CGRP has chemotactic activity
for HDMEC. These studies may have important implications for our understanding of the
relationship between the cutaneous nervous system and angiogenesis.
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Interleukin-18 Inhibits Angiogenesis Induced by Human Tumor Cells In Vivo and
Mediates Antiangiogenic Effect of Imiquimod
S. Jablonska, S. Majewski, M. Marczak, B. Mlynarczyk, and B. Benninghoff*
Department of Dermatology and Venereology, Warsaw School of Medicine, Warsaw, Poland; *Medical
Affairs, 3M Medica, Borken, Germany
Interleukin-18 (IL-18) was reported to enhance survival of experimental animals bearing malignant
tumors and these effects were related to its capability to inhibit angiogenesis. Therefore our aim
was to ®nd out whether this cytokine is also capable of inhibiting angiogenesis induced by human
tumor cells in a murine model of angiogenesis in vivo. Angiogenesis was induced by i.d. injection
into X-ray immunosuppressed Balb/c mice of human keratinocytes harboring HPV16 DNA (Skv
cells) and, for comparison, L1 mouse sarcoma cells. We found that i.p. administration of mrIL-18
signi®cantly (p < 0.001) in a dose-dependent manner decreased the number of newly formed blood
vessels induced by both Skv and L1 cells. Pretreatment in vitro of Skv cells with hrIL-18 or L1 cells
with mrIL-18 resulted in inhibition of their angiogenic capability when tested in the in vivo
angiogenesis assay suggesting that this cytokine directly in¯uences generation of angiokines by
tumor cells. Since imiquimod, a potent stimulator of a variety of proim¯ammatory cytokines, was
found to be effective in inhibiting tumor progression, we studied whether this effect is related to
modulation of tumor cell-induced angiogenesis. We found that topically applied imiquimod 5%
cream strongly inhibited angiogenesis induced in the mice by both human and murine tumor cells.
Using a panel of speci®c monoclonal antibodies we found that the antiangiogenic effect of topical
imiquimod is mediated by IL-18 and IL-12, and only partially by TNFa. Thus imiquimod, in
addition to its proin¯ammatory activity, has an important inhibitory effect on tumor angiogenesis
which depends on induction of antiangiogenic cytokine IL-18, similarly as we found previously for
IL-12. This effect of imiquimod could be of importance for treatment of HPV-associated benign or
premalignant angiogenesis-dependent proliferative tumors.
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Suppression of Thymidine Phosphorylase-Mediated Angiogenesis by 2-Deoxy-L-Ribose
H. Uchimiya,*² T. Furukawa,* M. Okamoto,³ Y. Nakajima,* S. Matsushita,² R. Ikeda,* T.
Gotanda,* M. Haraguchi,* T. Sumizawa,* M. Ono,³ M. Kuwano,³ T. Kanzaki,² and S.
Akiyama*
*Cancer Chemotherapy,Institute for Cancer Reseach, Faculty of Medicine,Kagoshima University,
Kagoshima, Japan; ²Dermatology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan;
³Medical Biochemistry, Graduate School of Medical Science,Kyushu University, Fukuoka, Japan
Thymidine phosphorylase (TP), an enzyme involved in the reversible conversion of thymidine to
thymine, is identical to an angiogenic factor, platelet-derived endothelial cell growth factor (PD-
ECGF). Both TP, and one of the TP-degradation products of thymidine 2-deoxy-D-ribose
(dRib), display endothelial cell chemotactic activity in vitro and angiogenic activity in vivo.
Recently, we demonstrated that 2-deoxy-L-ribose (lRib) could abolish the inhibitory effect of
dRib on hypoxia-induced apoptosis. This suggested that lRib may be a useful inhibitor of dRib
and thereby of TP functions. We therefore investigated the ability of lRib to inhibit the range of
biological activities of TP and dRib. lRib suppressed both dRib-induced endothelial cell migration
in a chemotaxis assay and endothelial tube formation induced by dRib in a collagen gel. lRib could
also suppress the biological effects of TP in vivo assays of angiogenesis. Thus in a corneal assay of
angiogenesis lRib inhibited angiogenesis induced by the implantation of recombinant TP. In a
dorsal air sac assay of angiogensis lRib inhibited angiogenesis induced by the implantation of KB
cells overexpressing TP (KB/TP). These ®ndings demonstrate that TP and dRib play an important
role in angiogenesis that its effect can be inhibited by lRib. Thus lRib is a potentially useful agent
for the suppression of TP-dependent angiogenesis.
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A New Role for the Human Vascular Endothelial Growth Factor Receptor-1: Direct
Involvement in Endothelial Cell Adhesion and Migration
G. Zambruno, A. Orecchia, P.M. Lacal,* C. Schietroma, V. Morea,² and C.M. Failla
Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome, Italy; *Pharmacology Laboratory, IDI-
IRCCS, Rome, Italy; ²Laboratory of Molecular Biology, MRC Centre, Cambridge, U.K.
Human vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine kinase receptor for
several growth factors of the VEGF family. Endothelial cells express the membrane-spanning form
of VEGFR-1 and secrete a soluble variant of the receptor comprising only the extracellular region.
In this study, we investigate whether the extracellular domain of VEGFR-1 could be involved in
endothelial cell adhesion and migration. A chimeric VEGFR-1 bound to a solid support reveals
that the molecule speci®cally promotes endothelial cell attachment and spreading. VEGFR-1
mediated cell-adhesion is divalent cation-dependent and inhibited by antibodies directed against
the a5b1 integrin complex. Direct binding of VEGFR-1 to a5b1 integrin is also seen. Moreover,
the VEGFR-1 secreted by endothelial cells in the culture medium is present within the
extracellular matrix deposited by these cells. Like other extracellular matrix proteins, VEGFR-1
acts as a chemotactic factor for endothelial cells. Altogether these results indicate that in addition to
and independently of its classic role as a growth factor receptor, VEGFR-1 is directly involved in
endothelial cell adhesion and migration. Soluble VEGFR-1 might thus behave as an extracellular
matrix protein by binding to a5b1 integrin.
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The a1b1 and a2b1 Integrins Provide Critical Support for VEGF Signaling, Endothelial
Cell Migration, and Tumor Angiogenesis
M. Detmar, M. Streit, C.A. Perruzzi,* V.E. Koteliansky,² A.A. de Fougerolles,² and D.R.
Senger*
CBRC/Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.;
*Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, U.S.A.; ²Biogen,
Inc., Cambridge, Massachusetts, U.S.A.
Angiogenesis is a complex process, involving functional cooperativity between cytokines and
endothelial cell (EC) surface integrins. In this study, we investigated the mechanisms through
which the a1b1 and a2b1 integrins support angiogenesis driven by vascular endothelial growth
factor (VEGF), using blocking anti-a1b1 and a2b1 integrin antibodies, either alone or in
combination, in attachment and migration assays in vitro and in angiogenesis and tumor models in
vivo. Human dermal microvascular EC attachment through either a1b1 or a2b1 supported robust
VEGF-activation of the Erk1/Erk2 (p44/42) MAPK signal transduction pathway which drives EC
proliferation. Haptotactic EC migration towards collagen I was dependent on a1b1 and a2b1 as
was VEGF-stimulated chemotaxis of EC in a uniform collagen matrix. Consistent with the
functions of a1b1 and a2b1 in supporting signal transduction and EC migration, antibody
antagonism of either integrin resulted in potent inhibition of VEGF-driven angiogenesis in mouse
skin. Moreover, combined antagonism of a1b1 and a2b1 substantially reduced tumor growth and
angiogenesis of human squamous cell carcinoma xenografts. These studies identify critical
collaborative functions for the a1b1 and a2b1 integrins in supporting VEGF signal transduction,
EC migration, and tumor angiogenesis.
018
Up-Regulation of the Hypoxia Inducible Factor 1a in Keratinocytes by Hypoxia and
UVB
C. Miller, R. Agnello, and W. Bowers
Dermatology, University of Rochester, Rochester, New York, U.S.A.
To better understand factors relating to tumorigenesis in cutaneous malignancies, we have
attempted to further de®ne the regulation of hypoxia inducible factor 1a (HIF1a) in keratinocytes.
Unlike other cell types in which HIF1a is constitutively expressed, keratinocytes have low basal
expression of this transcription factor which mediates cellular responses to hypoxia. We have
demonstrated for the ®rst time that both hypoxia and ultraviolet B (UVB) irradiation can induce
expression of the HIF1a gene in normal human keratinocyte cultures. Primary human
keratinocyte cultures were prepared from mammoplasty specimens and grown to ~80%
con¯uence. The cells were then exposed to UVB irradiation (Westinghouse FS20 bulbs with
UVC cutoff ®lter, total dose 45 mJ/cm
2
) or sham-irradiated. Sham-irradiated cultures were
exposed to a hypoxic environment (2% O
2
) or housed in a normoxic (21% O
2
) incubator along
with the UVB-irradiated cultures. After 24 h, the cells were harvested, total RNA was isolated, and
cDNA was prepared via reverse transcriptase. The cDNAs were subjected to real time quantitative
PCR with multiplexing using speci®c primers for HIF1a and 36B4, a ribosome-associated protein
whose gene product was used for normalization. Results show that both hypoxia (4.6±11.0-fold)
and ultraviolet B irradiation (3.5±5.9-fold) markedly elevated expression of the HIF1a gene when
compared to normoxic sham-irradiated controls. As both hypoxia and UVB may have important
roles in cutaneous tumorigenesis, these results suggest that there is a unique site of HIF1a
regulation in keratinocytes that represents a potential target for therapeutic intervention.
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A Critical Role of Placental Growth Factor in the Induction and Maintenance of
Cutaneous In¯ammation and Edema Formation
H. Oura, P. Velasco, J. Silva, L. Janes, B. Lange-Asschenfeldt, P. Carmeliet,* and M. Detmar
Cutaneous Biology Research Center, MGH, Charlestown, Massachusetts, U.S.A.; *Center for Transgene
Technology and Gene Therapy, Flanders Interuniversity Insititute for Biotechnology, Leuven, Belgium
The biological function of placental growth factor (PlGF), a member of the vascular endothelial
growth factor (VEGF) family of angiogenesis factors, in the skin has remained unclear. Therefore,
we generated transgenic mice with targeted overexpression of PlGF in basal epidermal
keratinocytes, using a keratin 14 expression cassette, and studied cutaneous delayed-type
hypersensitivity (DTH) reactions in PlGF transgenic mice, as compared with wild-type and with
PlGF de®cient mice. DTH reactions were elicited in the ears by topical sensitization and challenge
with oxazolone. Ear thickness was measured daily and skin angiogenesis was evaluated by
quantitative, computer-assisted image analysis of CD 31 stained sections. Ef®cient PlGF expression
in the skin of PlGF transgenic mice was con®rmed by in situ hybridization and by Northern and
Western blot analysis of keratinocyte lysates. In wild-type mice, PlGF mRNA and protein
expression was strongly up-regulated in acute DTH reactions elicited in ear skin. In PlGF
transgenic mice, up-regulation of transgene expression was observed in acutely in¯amed ear skin,
associated with increased redness, ear swelling, edema formation, in¯ammation, and average size of
blood vessels, as compared with wild-type mice. No major differences in the levels of VEGF
expression were detected between the two genotypes. The critical role of PlGF in mediating
cutaneous in¯ammation was con®rmed by DTH studies in PlGF de®cient mice that showed
signi®cantly reduced ear swelling, less pronounced edema formation and in¯ammation, and
reduced average vessel size, as compared with wild-type mice. These results reveal that PlGF
expression is up-regulated during cutaneous in¯ammation and that PlGF plays an important role in
the induction and maintenance of skin in¯ammation, vascular hyperpermeability, in¯ammatory
in®ltration, and vascular remodeling.
020
Chronic Transgenic Delivery of VEGF to the Skin Leads to the Development of a
Psoriasis-Like Phenotype
A.Y. Xia, B. Li, M. Detmar,* G.D. Yancopoulos, and J.S. Rudge
Angiogenesis, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, U.S.A.; *Cutaneous Biology
Research Center, Harvard Medical School, Charlestown, Massachusetts, U.S.A.
Psoriasis is a common skin disorder affecting approximately 2% of the human population. Because
this disease is characterized by epidermal thickening and prominent cutaneous in¯ammation,
efforts to understand its etiology have focused on molecular mediators of epidermal keratinocyte
growth or of in¯ammation. However, transgenic delivery of such mediators to the skin has not led
to a complete replication of the psoriatic phenotype. A vascular basis for psoriasis has not been
extensively explored, although it has long been known that the reddened appearance of psoriatic
skin is due to hyperplastic dermal vessels, that vascular changes occur early in this disease, and that
levels of vascular endothelial growth factor (VEGF) are elevated in psoriatic skin. Here we make
the surprising observation that chronic transgenic delivery of VEGF to the skin is suf®cient to
induce many features of psoriasis, including the characteristic epidermal alterations and
in¯ammatory in®ltrates, suggesting a new etiology for this disease. In addition, a high af®nity
VEGF antagonist signi®cantly ameliorated the psoriasis-like phenotype. Therefore, the use of a
speci®c VEGF antagonist to eliminate the hyperplastic vascular phenotype and suppress the
associated in¯ammatory state in human may provide a novel therapeutic strategy.
021
Lymphatic, but Not Blood, Microvascular Endothelial Cells Chemoattract Epidermal
Langerhans Cells
E. Kriehuber,²* B. Ko
È
nigshofer,* N. Kraut,³ T. Schweighoffer,³ G. Stingl,* and D. Maurer²*
*DIAID, University of Vienna Medical School, Vienna, Austria; ²CEMM, Center of Molecular Medicine
of the Austrian Academy of Sciences, Vienna, Austria; ³BI, Boehringer Ingelheim, Vienna, Austria
The entry of epidermal Langerhans cells (LCs) into lymphatic vessels is a prerequisite for the
initiation of T cell-mediated immunity via the skin. It is still undecided whether and, if so, how
LCs are recruited by lymphatic endothelial cells (LECs). Progress in the understanding of the
molecular events operative in LC egress from the skin has been hampered by the lack of suitable
culture systems for LECs. By the use of LEC-speci®c markers, we succeeded recently in the
isolation and propagation of this cell type. Our studies revealed that microvascular LECs and blood
vessel ECs (BECs) belong to stable and antigenically distinguishable EC lineages. Among other
LEC-restricted proteins, we identi®ed the CC chemokine receptor 7 ligand SLC/CCL21 and
osteopontin (OPN), both implicated in LC emigration previously. To test for contributions of
LEC-secreted moieties, puri®ed LCs were assayed for their migratory response to supernatants of
LEC and BEC cultures. We found that LCs migrate to LEC- but not to BEC-conditioned
medium. LCs responded to LEC-derived factors in a chemotactic, i.e. gradient-dependent fashion.
The migratory response was maximal in the early phase and gradually down-regulated in the late
phase of LC maturation. Surprisingly, anti-CCL21/SLC and -OPN immunodepletion did not
abolish LC migration. In search for novel candidate factors, we performed cDNA expression
pro®ling of isolated LECs and BECs. We identi®ed further moieties expressed selectively by one or
by the other EC subtype, among them chemokines, chemokine receptors, adhesion molecules, and
extracellular matrix molecules. In conclusion, we show that LECs but not BECs chemoattract LCs
in a maturation-dependent fashion. While the LEC-restricted secretion of CCL21 and OPN might
still contribute to LC migration in vivo, our data argue for a more complex situation than previously
anticipated with yet not fully characterized factors being critically involved in this migratory event.
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An N-Terminal 80-kDa Recombinant Fragment of Human Thrombospondin-2 Inhibits
Dermal Endothelial Cell Migration In Vitro and Tumor Growth and Angiogenesis In Vivo
Y.H. Noh, Y. Hong, L. Riccardi, H. Oura, M. Streit, and M. Detmar
Cutaneous Biology Research Center, MGH, Charlestown, Massachusetts, U.S.A.
We have previously reported that stable overexpression of thrombospondin-2 (TSP-2) inhibited
tumor growth and angiogenesis of squamous cell carcinomas (SCC). Because large-scale extraction
of TSP-2 from tissues has not been possible, and because of dif®culties with the production of full
length recombinant TSP-2, the molecular mechanisms of TSP-2-mediated angiogenesis inhibition
have remained largely unknown. We cloned a 1.67-kbp human TSP-2 cDNA (nt 213±1883),
ampli®ed by PCR from a human placenta cDNA library, into a modi®ed pCEP 4 His expression
vector. The N-terminal 80-kDa fragment of human TSP-2 (TSP-2/NTF), encompassing the N-
terminal globular region through the type I repeats, was then expressed in mammalian 293 cells and
was puri®ed using ammonium sulfate precipitation, gelatin- and heparin-sepharose columns. The
sequence of the puri®ed protein was con®rmed by N-terminal peptide sequencing. Recombinant
TSP-2/NTF inhibited both haptotactic migration towards ®bronectin and VEGF-directed
chemotactic migration of human dermal microvascular endothelial cells in vitro. Daily
intraperitoneal injection of recombinant TSP-2/NTF into tumor-bearing nude mice dose-
dependently inhibited tumor growth of intradermally injected A431 squamous cell carcinomas,
associated with reduced tumor angiogenesis. These results con®rm the bioactivity of recombinant
TSP-2/NTF in vitro and identify a potent antiangiogenic fragment of TSP-2. Recombinant TSP-
2/NTF will now allow more detailed studies of the mechanisms that mediate the antitumoral and
antiangiogenic activity of TSP-2 in vitro and in vivo.
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Ly294002 Inhibits Vascular Cell Adhesion Molecule 1 Expression in Human Dermal
Microvascular Endothelial Cells via a PI-3 Kinase-Independent Mechanism
S.W. Koo, K. Casper, and R.A. Swerlick
Dermatology, Emory University, Atlanta, Georgia, U.S.A.
Activation of the PI-3 kinase pathway by tumor necrosis factor a (TNFa) in endothelial cells has
been suggested as an important pathway for induction of adhesion molecule expression. To
investigate a possible role of TNFa mediated PI-3 kinase activation in vascular cell adhesion
molecule 1 (VCAM-1) expression, human dermal microvascular endothelial cells (HDMEC) were
stimulated with TNFa in the presence or absence of the PI-3 kinase inhibitors Ly294002 (Ly) or
wortmannin (Wm). Expression of cell-surface VCAM-1 protein was determined by ELISA. Ly
pretreatment inhibited TNFa mediated induction of cell-surface VCAM-1 in a dose-dependent
manner with maximal inhibition noted 25±50 mM. In contrast, pretreatment of HDMEC with
Wm failed to inhibit TNFa-mediated VCAM-1 induction, even at doses as high as 1 mM. Both
agents completely inhibited Akt phosphorylation in HDMEC, suggesting a target for Ly effect
distinct from PI-3 kinase, potentially via Ly effects on casein kinase II (CKII) activity. In order to
address whether Ly pretreatment blocked VCAM-1 expression by inhibiting gene transcription,
we examined steady-state levels of VCAM-1 mRNA and induction of heterogeneous nuclear
RNA (hnRNA) using real-time PCR. VCAM-1 RNA hnRNA was analyzed using PCR primers
that recognzed intronic sequences present only in unspliced hnRNA. Ly pretreatment had no
effect on TNFa mediated increases in steady state VCAM-1 mRNA or hnRNA, suggesting that
Ly blocked VCAM-1 expression at a post-transcriptional level. In order to address whether Ly
blocked induction of cell surface VCAM-1 by targeting protein translation or protein traf®cking,
we measured total cellular VCAM-1 expression by Western blot. Pretreatment of HDMEC with
LY prior to TNFa stimulation blocked the appearance of VCAM-1 protein despite having no
effect on TNFa mediated increases in VCAM-1 mRNA expression. These data demonstrate that
Ly inhibits cytokine mediated VCAM-1 protein up-regulation at the translational level via a PI-3
kinase independent mechanism, possibly via effects on CKII.
024
17b-Estradiol Enhances Vascular Endothelial Growth Factor Production and
Dihydrotestosterone Antagonizes the Enhancement Via the Regulation of Adenylate
Cyclase in Differentiated THP-1 Cells
N. Kanda and S. Watanabe
Department of Dermatology, Teikyo University, School of Medicine, Teikyo University, School of Medicine,
Tokyo, Itabashi-Ku, Japan
We studied in vitro effects of sex hormones on vascular endothelial growth factor (VEGF)
production in differentiated THP-1 monocytic cells. Phorbol-12-myristate-13-acetate differ-
entiated THP-1 into macrophage-like cell. 17b-estradiol increased VEGF secretion in
differentiated THP-1, which was antagonized by dihydrotestosterone though dihydrotestosterone
alone did not alter VEGF secretion. 17b-estradiol increased mRNA level of VEGF in
differentiated THP-1 and the increase was counteracted by dihydrotestosterone though
dihydrotestosterone alone did not alter VEGF mRNA level. 17b-estradiol enhanced VEGF
promoter activity, which was antagonized by dihydrotestosterone. The region between ±88 and ±
66 bp on VEGF promoter may be involved in the transcriptional regulation by each hormone. The
mutation within AP-2 element in this region abrogated the transcriptional regulation by each
hormone. 17b-estradiol activated transcription from AP-2-responsive reporter which was
antagonized by dihydrotestosterone. Adenylate cyclase inhibitor suppressed 17b-estradiol-induced
enhancement of VEGF production while dihydrotestosterone-induced suppression on the effects
of 17b-estradiol was counteracted by cAMP analog. 17b-estradiol increased intracellular cAMP
level by activating adenylate cyclase while dihydrotestosterone reduced the 17b-estradiol-increased
cAMP level by inhibiting adenylate cyclase. These results suggest that 17b-estradiol enhances
VEGF production while dihydrotestosterone antagonizes the effect of 17b-estradiol via up- or
down-regulation of adenylate cyclase in differentiated THP-1.
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Basic Fibroblast Growth Factor is Involved in IL-6 Induced Angiogenesis in Basal Cell
Carcinoma Cells
S. Jee, H. Chiu, Y. Huang, C. Chu, and M. Kuo*
Department of Dermatology, National Taiwan University, Taipei, Taiwan; *Institute of Toxicology,
National Taiwan University, Taipei, Taiwan
We have previously demonstrated the xenograft of IL-6 over-expressing basal cell carcinoma cells
mixture (BCC/IL-6) into nude mice developed tumor with vasculature. Here, we studied which
proangiogenic factor may be induced in BCC/IL-6 cells and in BCC cells stimulated with IL-6.
First, parental BCC cells (BCC), vector control BCC cells (BCC/Neo), BCC/IL-6 cells and BCC
cells stimulated with IL-6 were examined by RT-PCR and by Western blotting for the expression
of several growth factors involved in angiogenesis process. bFGF and IL-8 were up-regulated by
IL-6, however, VEGF and PDGF were not up-regulated. The functional implication of such a
®nding was tested by in vivo chorioallantoic membrane (CAM) assay and Matrigel plug assay, and,
in vitro tube formation assay of human umbilical vein endothelial cells. Comparing among the IL-6
highly expressing BCC cell clone (BCC/IL-6/8D), BCC/IL-6, BCC/Neo and BCC, the
condition media of BCC/IL-6/8D and BCC/IL-6 increased vasculization. The plug formation
and tube formation were abolished by preneutralization of the condition media of BCC/IL-6/8D
and BCC/IL-6 with antibFGF antibody but not anti-VEGF antibody. Together, the results
indicate bFGF is a key angiogenc factor up-regulated by IL-6 in BCC cells. Thus, blockage of IL-6
induced bFGF may be a feasible strategy to inhibit BCC-associated angiogenesis and to treatment
of tumor aggression.
026
Decreased Expression of FLT-4 mRNA in Scleroderma Skin Tissue
T. Ohtsuka and S. Yamazaki
Dermatology, Dokkyo University School of Medicine, Mibu, Tochigi, Japan
Systemic sclerosis (SSc) is a connective tissue disease of unknown etiology, in which development
of ®brosis, vascular insuf®ciency and in¯ammatory processes are prominent in the skin as well as in
other organs. Possible involvement of vascular endothelial growht factor (VEGF) family and their
receptors in the formation of SSc skin tissue abnormality was studied. The expressions fo VEGD,
VEGF-A, VEGF-B VEGF-C, VEGF-D, Neuropilin, FLT-1, FLT-4, FLK-4 CD34 and KDR
mRNA'S were studied in SSc andnormal controls with reverse transcription-polymerase chain
reastion (RT-PCR) method. The intensity of RT-PCR results was digitized normalizing with the
intensity of G3PDH. In SSc skin tissue, the expression of FLT-4 mRNA'S were signi®canty
decreased than those of normal controls (p < 0.02). In SSc skin derived ®broblasts, all the mRNA
expressions showed no signi®cant difference between SSc andnormal controls. In SSc blood cells,
the expressions of CD34 mRNA'S were signi®cantly decreased than those of normal controls
(p < 0.05). The results showed that FLT-4 are involved in the formation of SSc skin tissue
abnormality, though CD34 are down regulated in blood cells
027
Retinoic Acid Differentially Modulates the Microvascular Alterations Associated with
Intrinsic Aging vs. Photoaging of the Skin
J. Chung, K. Yano,* M. Lee, J. Seo, K. Kim, K. Cho, H. Eun, and M. Detmar*
Dermatology, Seoul National University College of Medicine, Seoul, South Korea; *Dermatology,
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, U.S.A.
With aging, cutaneous blood vessels undergo pronounced alterations. To investigate the effects of
aging and photoaging of human skin on cutaneous vessel density and size sequentially over decades,
and to characterize the effects of topical retinoic acid on aging- and photoaging-induced
microvascular alterations, quantitative image analysis of CD31-stained tissue sections was
performed. Both intrinsically aged and photoaged skin showed an age-dependent reduction of
vascularity. However, photoaged skin showed a much more pronounced decrease of cutaneous
vascularity than intrinsically aged skin, with a prominent reduction of vessel size, vascular density
and cutaneous area covered by vessels. In sun-protected skin, we detected a selective decrease of
vessel size with age, whereas the density of vessels remained unchanged. Importantly, topical
application of retinoic acid speci®cally reversed the alterations of cutaneous vessels in intrinsically
aged and photoaged skin. These results indicate that topical treatment with retinoic acid exerts
bene®cial effects on aged skin by restoring the physiological vascularity in the papillary dermis of
the elderly.
028
Selective Isolation and Characterization of Cultured Human Dermal Lymphatic
Endothelial Cells
S. Hirakawa, V. Schacht, Y. Hong, and M. Detmar
Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School,
Charlestown, Massachusetts, U.S.A.
Lymphatic vessels play crucial roles in ¯uid transportation, in¯ammatory responses and tumor
metastasis. However, little is known about the distinct molecular and functional characteristics of
lymphatic endothelial cells (LEC). Therefore, we aimed to develop a new technique for the
selective isolation and in vitro propagation of human dermal LEC, using a multistep
immunomagnetic protocol. LEC were isolated from neonatal human foreskins by several negative
selection steps for blood vascular endothelial cell (BVEC) and other surface markers, followed by
positive selection for CD31 expression. Northern blot and quantitative real-time RT-PCR
analyses revealed highly increased expression levels of several known lymphatic markers, including
the transcription factor Prox1, the hyaluronan receptor LYVE-1, the glycoprotein podoplanin, and
secondary lymphoid chemokine, as compared with BVEC. All cultured LEC were stained by an
antibody to LYVE-1, whereas no immunoreactivity was observed on BVEC. LEC ef®ciently
formed tubes in matrigel and in collagen overlay assays in vitro, con®rming their functional
characteristics as endothelial cells. The selective in vitro propagation of LEC provides a valuable
new tool for basic studies of the molecular regulation of LEC function in in¯ammation, tumor
progression, and lymphedema formation in the skin.
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Techniques for the Selective Detection of Lymphatic and Blood Vessels
V. Schacht, S. Hirakawa, D. Berens von Rautenfeld,* and M. Detmar
Cutaneous Biology Research Center, Harvard Medical School, Boston, Massachusetts, U.S.A.; *Institute of
Anatomy, Medical School of Hannover, Hannover, Germany
Whereas the development and function of the blood vascular system have been studied in detail,
the understanding of the biology of the lymphatic system has remained limited, partly due to the
lack of reliable markers for lymphatic vessels. The purpose of our study was to evaluate different
methods for the selective visualization of lymphatics vs. blood vessels. The lymph collectors of the
legs of human corpses were injected with a solution of Berlin Blue. After ®xation lymphatic vessels
were prepared from the dorsum of the foot up to the super®cial draining lymph nodes. In addition,
enzymatic and immuno¯uorescence studies were performed on human and murine tissues to
analyze the 5'-nucleotidase activity and the expression of vascular and lymphatic markers. After
injection of Berlin blue into lymph collectors, the network of the super®cial lymphatic system of
the human leg was visualized. Interestingly, we found a large interindividual variability regarding
the architecture of the lymphatic vasculature. A highly increased activity of 5'-nucleotidase was
found in small lymphatic capillaries, as compared with blood vascular capillaries, whereas larger
vessels could not be distinguished by this technique. The most reliable visualization of cutaneous
lymphatic vessels was achieved by immuno¯uorescence staining for the lymphatic-speci®c LYVE-
1 receptor or the transcription factor Prox1 in combination with the pan-vascular marker CD31.
VEGFR-3 was also selectively expressed on lymphatic, but not on blood vascular endothelium.
Double staining for LYVE-1 and CD34 or PAL-E was mutually exclusive, with selective
expression of CD34 and PAL-E on blood vessels. These results demonstrate that recently identi®ed
lymphatic markers allow the speci®c identi®cation of cutaneous lymphatic and blood vessels by
immuno¯uorescence, providing new tools for future studies on the biological role of lymphatics in
the immune response and tumor progression.
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Anti-Tumor Effect of Thalidomide and Dacarbazine in Melanoma SCID Mouse Model
E. Heere-Ress,*² J. Boehm,² C. Hoeller,* C. Thallinger,*² K. Wolff,* H. Pehamberger,* and B.
Jansen*²
*Department of Dermatology; Division of General Dermatology, University of Vienna, Vienna, Austria;
²Department of Clinical Pharmacology; Section of Experimental Oncology/Molecular Pharmacology,
University of Vienna, Vienna, Austria
Malignant melanoma is a chemotherapy refractory tumor and commonly used anticancer drugs are
unable to signi®cantly modify the prognosis of metastatic disease. New therapies for malignant
melanoma are clearly needed. Tumor angiogenesis, the formation of new blood vessels, is a critical
requirement for tumor growth and is a prerequisite for tumor cell dissemination and metastasis. It
has been demonstrated recently that thalidomide has antiangiogenic properties translating into
antitumor activity in certain human malignancies like multiple myeloma. Little is known about the
therapeutic potential thalidomide may have in melanoma. In this study, our objective was to
investigate the in¯uence of thalidomide on melanoma xenotransplants in a SCID mouse model.
Furthermore, we combined thalidomide with dacarbazine (DTIC), still the single most effective
agent used in melanoma therapy. We could demonstrate that intraperitoneally administered
thalidomide (400 mg/kg/d for 21 days) led to a clear inhibition of melanoma growth in SCID mice
compared to solvent treated controls. A signi®cantly lower microvessel density was encountered in
the thalidomide group which highlights the antiangiogenic effect of thalidomide in this model.
Thalidomide combined with dacarbazine treatment (80 mg/kg/d for 5d) markedly enhanced the
antitumor effect and showed a signi®cant tumor reduction (70.01% 6 SD 15.51%) relative to the
dacarbazine-only group (24.09% 6 SD 25.46%). The ability to achieve better antitumor responses
by combining dacarbazine ± a cytotoxic agent ± and thalidomide ± an antiangiogenic cytostatic
agent ± may qualify as a rational treatment approach to improve the outcome of malignant
melanoma.
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Antitumor Effects of Bosentan, a Novel Endothelin Receptor Inhibitor, on Melanoma
Cells
A. Sekulic, M.R. Pittelkow, and S. Markovic*
Dermatology, Mayo Clinic/Foundation, Rochester, Minnesota, U.S.A.; *Oncology, Mayo Clinic/
Foundation, Rochester, Minnesota, U.S.A.
The incidence of malignant melanoma continues to rise, and, despite intensive research, advanced
melanoma remains fatal. New treatment modalities are urgently needed. Endothelin 1 (ET-1) and
Endothelin Receptor A (ETRA) are important mediators in endothelial biology and cardiovascular
disease as well as tumor angiogenesis. The ET-Endothelin Receptor B (ETRB) system, on the
other hand, is required for normal development and function of melanocytes. Limited previous
investigation also suggests a potential role of the ET system in pathogenesis of malignant
melanoma. Here we studied effects of Bosentan, a novel dual ETRA and ETRB inhibitor, on
proliferation and survival of melanoma cell lines. Bosentan inhibited proliferation of 6
characterized melanoma cell lines with 50% inhibition of growth detected between 5 and
40 mg/ml, as measured by 3H-thymidine proliferation assays. A speci®c inhibitor of ETRB,
BQ788, also inhibited growth of these cells whereas a speci®c ETRA inhibitor BQ123 had no
apparent effect. To further elucidate the nature of Bosentan-induced growth inhibition, we
evaluated effects of Bosentan on apoptosis of selected melanoma cells. Even at concentrations
inducing complete inhibition of growth, Bosentan did not promote signi®cant cell death, as judged
by Caspase 3 and 7 apoptosis assays as well as Annexin V and propidum iodide staining. In contrast,
treatment of melanoma cells with camptothecin resulted in signi®cantly enhanced apoptosis. To
assess antitumor effects of Bosentan on growth of melanoma cells in vivo, female NOD Scid mice
were injected with A375 melanoma cell and treated with oral Bosentan or water vehicle alone. In
preliminary experiments, tumors grew signi®cantly slower in animals treated with Bosentan
compared to controls. These results suggest a novel therapeutic role for dual ETR inhibition in
management of melanoma. Inhibition of ETRA and ETRB concurrently could modulate ET-
mediated angiogenesis and melanoma cell growth, respectively.
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Expression of Psoriasis-Associated Fatty Acid-Binding Protein in Senescent Human
Dermal Microvascular Endothelial Cells
K. Chung,* M. Ha,*² D. Bang,* Y. Park,* and K. Lee*
*Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul,
South Korea; ²Brain Korea 2Project for Medical Sciences, Yonsei University College of Medicine, Seoul,
South Korea
Gradual pathophysiologic changes in endothelial cells are known to be closely related to the aging
process. In vitro senescence of endothelial cells is manifested by loss of replicative ability as well as
change in the expression of genes and proteins. We have utilized 2-D gel electrophoresis, which is
one of the important tools of proteomics, to observe the changing pattern of protein expression in
aging human dermal microvascular endothelial cells (HDMEC). Senescence-associated beta-
galactosidase activity staining was done to detect senescent cells in in vitro cultured HDMEC and 2-
D gel electrophoresis was performed. Protein spots of interest were digested and identi®ed by using
Maldi-Mass and protein sequence database. Interestingly, expression of psoriasis-associated fatty
acid-binding protein (PA-FABP) was found to be increased in aged HDMEC. Anti-PA-FABP
antibody was synthesized using a 13 amino acid peptide and the expression of PA-FABP was
studied in cells and tissues.
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Tie2 Receptor Activation by Angiopoietin-1 Enhances Vessel Maturation and
Suppresses Squamous Cell Carcinoma Growth
T. Hawighorst, M. Skobe, M. Streit, Y. Hong, L. Riccardi, L.F. Brown,* and M. Detmar
CBRC, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts,
U.S.A.; *Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston,
Massachusetts, U.S.A.
The distinct roles of angiopoietin-1 (Ang1) and Ang2, counteracting ligands for the endothelium-
speci®c Tie2 receptor, in tumor development and progression have remained poorly understood.
We investigated the expression of Ang1 and Ang2 during multistep mouse skin carcinogenesis by
in situ hybridization and studied the in vivo tumor growth of intradermally injected human A431
squamous cell carcinoma cells, stably transfected to overexpress either Ang1 or Ang2. Expression of
Ang2, but not of Ang1, was strongly up-regulated in angiogenic tumor vessels during the
consecutive stages of mouse skin carcinogenesis. Enhanced Tie2 receptor phosphorylation was
found in Ang1 overexpressing A431 squamous cell carcinomas, resulting in a more than 70%
inhibition of tumor growth. In contrast, overexpression of Ang2 did not modulate Tie2
phosphorylation and failed to affect tumor growth and angiogenesis. No major changes in vascular
density, VEGF mRNA and protein expression, or VEGFR-2 phosphorylation levels were
observed in Ang1 expressing tumors. However, the fraction of tumor blood vessels with coverage
by alpha-smooth muscle actin-positive periendothelial cells was signi®cantly increased, indicative
of an increased vascular maturation status. In summary, our data provide evidence for an inhibitory
role of Ang1 mediated Tie2 receptor activation in squamous cell carcinoma growth and suggest an
important function of the maturation status of the tumor vasculature in tumor progression.
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Detection of TCRg Sequences in Patients with Primary Cutaneous CD30+ Large T-Cell
Lymphomas by Micromanipulation and Single-Cell PCR
S. Gellrich, A. Wilks, M. Wernicke, A. Mu
È
ller, J. Muche, K. Jasch, A. Lukowsky, H. Audring, and
W. Sterry
Department of Dermatology, Charite Humboldt University, Berlin, Germany
To evaluate the hypothesis that the large lymphoid CD30+ cells in primary cutaneous CD30+
large T-cell lymphomas belong to the tumor cell population and to investigate if they form a
unique cell population. We investigated CD30+ single cells of three patients with CD30+ CTCLs.
A total of 212 CD30+ single cells was acquired by hydraulic micromanipulation. 185 of the cells
were picked from the epidermis of tumor lesions and 27 from a cytospin slide of peripheral blood
lymphocytes. In order to identify clonal cell populations, which are thought to represent the tumor
cells, we employed single cell PCR of the T-cell receptor (TCR)g gene followed by direct
sequencing. In 119 of the 212 separated cells we succeeded in analysing a rearrangement for the
TCRg. In all three cases a clonal population with a biallelic rearrangement of the TCRg was
detected. Beside these clonal populations which comprise the majority of the isolated cells, all
samples showed the existence of CD30+ cells with polyclonal rearrangements. Our study con®rms
that the tumor cell population in CD30+ CTCLs is to be found within the group of CD30+ large
lymphoid cells. According to our results we conclude that the CD30+ large T-lymphocytes do not
represent a uniform tumor cell population, although the morphological and phenotypical
occurrence is equalbetween clonal and other T-lymphocytes. With regard to the varying but not
insigni®cant amount of polyclonal CD30+ T-cells within the tumor lesions their possible role in
the pathogenesis of CD30+ CTCL should be considered.
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Role of p53 and p21Waf-1 in Cell Cycle Control and DNA Repair in UV-Damaged
Keratinocytes
T. Maeda, M.T. Chong, R.A. Espino, P.P. Chua, J.Q. Cao, and V.A. Tron
Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada
We have previously shown that the p53 tumor suppressor protein plays a crucial role in nucleotide
excision repair. The role of p21Waf-1, a p53-regulated cyclin-dependent kinase inhibitor, in DNA
repair and cell cycle control after UV irradiation in keratinocytes is now examined. Keratinocytes
from p21Waf-1 or p53-transgenic mice were irradiated with UVB, and the removal of thymine
dimers, cell cycle progression, and cell death were assessed. Both p21Waf-1-de®cient and p53-
de®cient cells failed to maintain G2 arrest. p21Waf-1-de®cient cells showed a lack of G1 arrest.
p53-de®cient cells demonstrated larger sub-G0/G1 population (22.5%) than p53-pro®cient cells
(12.5%), starting at 48 h after UV irradiation. On the other hand, the sub-G0/G1 population of
p21Waf-1-def®cient cells was not different from the wild type controls. At 48 h after UV
irradiation, the TUNEL assay showed DNA fragmentation in wild type cells, p53-de®cient cells
but not in p21Waf-1-de®cient cells. In addition, a morphological nuclear abnormality was
frequently detected in p21-de®cient cells. These results suggest that cells lacking p21 preferentially
undergo mitotic cell death (catastrophe), rather than classic apoptotic death. p21Waf-1 protein was
up-regulated in both p53-pro®cient and de®cient cells. Finally, DNA repair ef®ciency was
compared between p21Waf-1-pro®cient and de®cient cells, indicating that p21Waf-1-de®cient
cells have slightly less ef®cient nucleotide excision repair. In summary, p21Waf-1 regulates the G2/
M checkpoint via p53 and the G1 checkpoint is controlled by p21Waf-1 in both a p53-dependent
and independent manner. Our study also suggests that cell death is p53-independent in basal
keratinocytes. p21Waf-1 functions to regulate the cell cycle in UV irradiated keratinocytes, and
may contribute to skin cancer prevention.
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Serial Tyrosinase RT-PCR as Prognostic Factor in Follow-Up of Stage II and III
Melanoma Patients
C. Voit, M. Kron,* M. Schwu
È
rzer-Voit, L. Weber,² W. Sterry, A. Schoengen,² and T. Proebstle³
Dermatology, Charite, Berlin, Germany; *Medical Documentation, University Ulm, Ulm, Germany;
²Dermatology, University Ulm, Ulm, Germany; ³Dermatology, University Mainz, Mainz, Germany
Detection of melanoma cells with sentinel lymph node biopsy proved to be the most important
prognostic marker for survival. Whether early detection of circulating melanoma cells in peripheral
blood has similar consequences is still under discussion. N = 66 stage II and N = 34 stage III (AJCC)
melanoma patients received serial testing for tyrosinase transcripts in peripheral blood as they
presented for routine follow-up. A total of 248 blood samples were analyzed during the test
interval of 2 years using a RT-PCR assay. Median follow-up time from the ®rst blood sample was
3.5 years (range 0.9±5.4). The disease-speci®c survival time was calculated as time from ®rst blood
sampling to time of death from melanoma. Survival curves using the method of Kaplan and Meier
were calculated. The 4 years disease-speci®c survival probability was 97% for patients always
showing negative RT-PCR results and 69% for patients tested at least once positive. In a Cox
proportional hazard model sex, site of the primary tumor, histological subtype, tumor thickness,
and the time dependent variable PCR outcome were selected as important prognostic factors.
Patients with a positive RT-PCR test had a distinctly higher risk to die from melanoma with a
hazard ratio of 48.7 (95% con®dence interval 5.0±474.0, p < 0001). Our study showed a strong
association between PCR and disease speci®c survival. Detection of circulating tumor cells in
peripheral blood of melanoma patients might have similar impact on the course of melanoma
disease as detection of micrometastatic disease within sentinel lymph node biopsy.
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Ganglioside Gene Modulation Leads to Increased Tumorigenicity in a Mouse Squamous
Carcinoma Model
K. Lopatka, T.E. Reddick, A. Irvine, S. Bangash, J. Guitart, and A.S. Paller
Dermatology, North-western University, Chicago, Illinois, U.S.A.
Gangliosides are sialylated glycosphingolipids of the keratinocyte membrane that have been shown
in vitro to affect cell proliferation, differentiation, adhesion and migration on ®bronectin, and
survival. The role of cutaneous gangliosides in vivo is unknown, although altered ganglioside
expression has been found in neoplastic and psoriatic cells. We hypothesized that modulation of
ganglioside content endogenously by overexpression of genes that direct ganglioside synthesis and
metabolism would affect the proliferative and morphologic characteristics of squamous carcinoma
cells (SCCs) in vivo. SCC12 cells were stably transfected with genes for sialidase, GD3 synthase, or
GM2/GD2 synthase by lipofection. Transgene expression was veri®ed by Northern assays and
changes in ganglioside content by ganglioside ELISA. Transfected cells and controls were injected
subcutaneously into SCID mice. Tumors were measured serially for 40 days, then resected for
histologic and immunohistochemical analyses. Tumor characteristics correlated well with the
known in vitro effects of depletion or increase in speci®c gangliosides. Volumes of GD3 synthase
and sialidase transfected tumors were 10-fold greater than those of control SCC12 cells and GM2/
GD2 synthase cells. Histologic examination of tumors from the parental SCC12 tumor showed a
small, poorly differentiated SCC. In contrast, GM2/GD2 synthase expression led to well-
differentiated, minimally proliferative SCCs with squamous eddies and keratoacanthomatous
changes. GD3 synthase tumors showed proliferation at the periphery with extensive mitosis but
marked terminal differentiation and necrosis centrally. Sialidase expressing tumors looked highly
malignant and less differentiated with anaplasia and high mitotic activity. Alterations in
proliferation and apoptosis were documented immunohistochemically. These studies show that
endogenous alteration of ganglioside content markedly in¯uences the morphology and
proliferation of SCCs, suggesting a role for ganglioside modi®cation in cutaneous neoplasia.
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A Dual Role for E2F in Squamous Neoplasia
N.A. Saunders, C.F. Wong, A.J. Dicker, D. Liaskou, C. Popa, M.M. Serewko, L. Smith, and A.L.
Dahler
Centre for Immunology & Cancer Research, University of Queensland, Brisbane, Queensland, Australia
E2F is a transcription factor complex involved in promoting proliferation and tumourogenesis. We
now show that the overexpression of E2Fs are able to suppress the expression of squamous
differentiation-speci®c marker genes in normal human keratinocytes. Examination of E2F1
constructs mutated in the DNA binding domain or the pocket protein binding/trans-activation
domains revealed that the ability to suppress squamous differentiation required the E2F to be
bound to the DNA and also required an active trans-activation domain. In addition, analysis of
squamous differentiation-speci®c promoters in normal keratinocytes indicates that the E2F-
dependent suppression localizes to a site normally regulated by the Sp1/KLF transcription factor
family. These data indicate that the deregulation of E2F activity in cancer cells may serve two
functionally distinct purposes. In the ®rst instance E2F promotes deregulated proliferation. In the
second instance, the deregulated E2F also actively suppresses terminal differentiation.
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Green Tea Polyphenol (±)-Epigallocatechin-3-Gallate Inhibits Ultraviolet B-Mediated
Activation of NF-kB in Normal Human Epidermal Keratinocytes
H. Mukhtar, N. Ahmad, V.M. Adhami, and F. Afaq
Dermatology, Case Western Reserve University, Cleveland, Ohio, U.S.A.
Solar ultraviolet (UV) radiation, particularly its UVB (290±320 nm) component, is the major cause
of skin cancers and a variety of other cutaneous disorders. We have earlier shown that (±)-
epigallocatechin-3-gallate (EGCG), the major polyphenol present in green tea, provide signi®cant
protection from UV-mediated damages in mouse and human skin. The mechanism(s) of
photochemoprotective effects of EGCG is not well understood. Nuclear transcription factor
`nuclear factor kappa B (NF-kB)' is a nuclear transcription factor, which plays key role in many
physiological processes including in¯ammation, immune-modulation, apoptosis, and cellular
proliferation. In this study, we investigated the involvement of NF-kB pathway in
photochemoprotective effect of EGCG. Employing normal human epidermal keratinocytes
(NHEKs), we evaluated the effect of EGCG on UVB-mediated modulations in NF-kB pathway.
Immunoblot analysis demonstrated that the treatment of NHEK with EGCG (10±40 mM) for 24 h
prior to UVB (40 mJ/cm
2
) exposure dose-dependently inhibited UVB-mediated (i) degradation
and phosphorylation of IkBa, and (ii) activation of IKKa. In time-dependent study, we observed
that EGCG (10 mM) inhibited UVB-mediated degradation and phosphorylation of IkBa and
activation of IKKa in a time dependent manner at 1, 2, 3, 6, 12 h post UVB-exposure. Employing
immunoblot analysis, enzyme linked immunosorbent assay and gel shift assay, we found that
EGCG treatment to the cells resulted in signi®cant dose- and time-dependent inhibition of UVB-
mediated activation and nuclear translocation of NF-kB/p65. Based on our data, we suggest that
EGCG protects against the adverse effects of UV radiation via modulations in NF-kB pathway.
These results provide molecular basis for the photochemopreventive effect of EGCG and suggest
that green tea may be a useful agent against UVB-mediated adverse effects in human skin.
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Green Tea Polyphenol Inhibits UVB-Induced Mitogen Activated Protein Kinase and
NF-kB Signaling Pathways in Mouse Skin
F. Afaq and H. Mukhtar
Dermatology, Case Western Reserve University, Cleveland, Ohio, U.S.A.
Solar ultraviolet (UV) radiation elicits a variety of adverse effects in the skin including
pigmentation, photoaging, and cancer. UV radiation results in oxidative stress via an increased
generation of reactive oxygen species. The UVB component of UV radiation is believed to be a
major cause of the variety of cutaneous disorders including skin cancers. Green tea polyphenol
(GTP) has been shown to possess antioxidant, anticarcinogenic, anti-in¯ammatory and
photochemoprotective properties. Previous studies from our laboratory have shown that
epigallocatechin-3-gallate, the major polyphenol present in green tea inhibits UVB-mediated
activation of mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-kB)
pathways in normal human epidermal keratinocytes. This study was designed to investigate, the
relevance of these ®ndings to the in vivo situations in SKH-1 hairless mouse. The SKH-1 hairless
mice were topically treated with GTP followed by an exposure with UVB (180 mJ/cm
2
) every
alternate day for seven exposures. The topical application of GTP (5 mg/0.2 ml acetone/mouse) to
SKH-1 hairless mice 30 min prior to UVB radiation resulted in signi®cant decrease in bifold-skin
thickness, skin edema and in®ltration of leukocytes. Employing Western blot analysis and
immunohistochemical studies, we found that topical application of GTP to mouse skin prior to
UVB irradiation resulted in inhibition of UVB-induced: (i) phosphorylation of extracellular signal
regulated kinases (ERK1/2) (ii) c-Jun N-terminal kinases (JNK), and (iii) p38 protein expressions.
Further employing Western blot analysis, we also studied the effect of GTP on UVB-mediated
NF-kB pathway. Our data demonstrated that GTP signi®cantly inhibited UVB-induced: (i)
activation of NF-kB (ii) activation of IKKa, and (iii) phosphorylation and degradation of IkBa.
Taken together, our data provides molecular basis for photochemopreventive effects of green tea in
an in vivo animal model system.
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Role of p33ING1 in UV-Induced Apoptosis
K. Cheung,* V. Ho,*² and G. Li*²
*Medicine, University of British Columbia, Vancouver, British Columbia, Canada; ²Dermatology,
Vancouver Hospital and Health Sciences Center, Vancouver, British Columbia, Canada
The biological functions of the tumor suppressor, ING1, have been studied extensively in the last
®ve years since it was cloned. It shares many biological functions with those of p53 and has been
reported to mediate growth arrest, senescence, apoptosis, anchorage-dependent growth,
chemosensitivity, and DNA repair. Some of these functions, such as cell cycle arrest and
apoptosis, have been shown to be dependent on the activity of both ING1 and p53 proteins. Two
recent reports demonstrate that p33ING1 (one of ING1 isoforms) translocates to nucleus and binds
to PCNA upon UV irradiation. Here we report that p33ING1 is involved in enhancing UV-
induced cell death in melanoma cells in cooperation with p53. We found that overexpression of
p33ING1 enhanced the frequency of cell death in melanoma cells after UVB irradiation and that
p53 appeared to complement such enhancement. We also observed a change in mitochondrial
membrane potential in UV-irradiated p33ING1-overexpressing cells, an indication that UV-
induced p33ING1-mediated cell death is dependent on the mitochondrial pathway. Taken
together, these observations strongly suggest that p33ING1 cooperates with p53 in UV-induced
cell death via the mitochondrial cell death pathway in melanoma cells.
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The Role and Regulation of the Human Damage-Speci®c DNA Binding Protein that is
Defective in Xeroderma Pigmentosum Group E
T. Itoh and S. Linn
Molecular and Cell Biology, University of California, Berkeley, California, U.S.A.
Human damage-speci®c DNA binding protein (DDB) is a hetrodimer, comprised of DDB1/p127
and DDB2/p48. DDB activity was found to be defective in cell strains from some xeroderma
pigmenosum group E (XP-E) patients. In those cases, mutations in the DDB2 gene, not in the
DDB1 gene have been found. After reinvestigation of 3 XP-E strains with DDB activity, we have
shown that they should be reclassi®ed to other XP groups or ultraviolet (UV)±sensitive syndrome.
These ®ndings strongly suggest that only the DDB2 gene be related to XP-E. We have recently
studied the regulation of the DDB2 gene after UV irradiation of normal and XP-E strains. In a
normal cell strain, the DDB2 mRNA was 3±4 fold increase 38 h after 12 J/m
2
of UV irradiation,
and p48 and DDB activity reached a similar elevation 48 h after UV irradiation. In four XP-E cell
strains, p48 was detectable and both DDB2 mRNA and p48 levels were more up-regulated after
UV-irradiation than in a normal primary strain. Moreover, DDB activity also became apparent
after irradiation. The regulation in XP-E strains of other genes responding to UV-irradiation is
currently being studied.
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Allelic Deletion of the TSC2 Gene in Tuberous Sclerosis Skin Tumors and Cultured
Stromal Cells
T.N. Darling, J. Wang, F. Takeuchi, T. Lei, S. Pack,* Z. Zhuang,* and J. Moss²
Department of Dermatology, Uniformed Services University, Bethesda, Maryland, U.S.A.; *Molecular
Pathogenesis Unit, SNB, NINDS, Bethesda, Maryland, U.S.A.; ²Pulmonary-Critical Care Medicine
Branch, NHLBI, Bethesda, Maryland, U.S.A.
Tuberous sclerosis (TSC) skin tumors are benign but dis®guring hamartomatous lesions without an
obvious neoplastic cell population. The aim of our study was to examine these tumors for the
presence of a neoplastic cell population that might be studied in vitro and targeted by new
treatments. Touch preparations and cultured stromal cells from TSC skin tumors were studied by
¯uorescence in situ hybridization (FISH), probing for loss of either the TSC1 or TSC2 tumor
suppressor gene mutated in TSC. In contrast to 16 samples of normal-appearing skin, touch
preparations of 23/24 angio®bromas, 5/7 collagenomas, and 11/11 periungual ®bromas from 17
patients showed allelic deletion of the TSC2 gene. The percentage nuclei showing allelic deletion
ranged from 18 to 51%, consistent with the mixture of cell lineages in these tumors. No sample
showed deletion of the TSC1 gene. An 18th patient had a germline deletion of TSC2. Since a
neoplastic cell population could be identi®ed, stromal cells from 6 angio®bromas, 3 collagenomas,
2 periungual ®bromas, and 4 samples of normal-appearing skin were cultured to test for
propagation of neoplastic cells in vitro. FISH analysis of cultured cells showed deletion of the TSC2
gene in proportions similar to the parent tissue, with up to 30% neoplastic cells at passage 5. The
cell cultures were studied for levels of TSC2 mRNA and protein (tuberin), using real-time
quantitative RT-PCR and Western blot, respectively. Cultured stromal cells from one
angio®broma showed levels of TSC2 mRNA (95 + 17%, n = 3) unchanged but levels of tuberin
(32 + 7%, n = 3) signi®cantly lower than those in cultured normal adult human ®broblasts. These
results demonstrate that TSC skin tumors contain a clonal `two-hit' neoplastic cell population in a
minority of cells, and support a potential role for loss of tuberin function in the development of
TSC skin tumors.
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Successive Roles of UVB in Skin Carcinogenesis: P53 Mutations, Colonization, and
Breaking the Stem Cell Barrier
N.M. Wikonkal, W. Zhang,* E. Remenyik,³ D. Zelterman,§ and D. Brash*²
Department of Dermatology, Semmelweis University School of Medicine, Budapest, n/a, Hungary;
*Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, U.S.A.;
²Department of Genetics, Yale School of Medicine, New Haven, Connecticut, U.S.A.; ³Department of
Dermatology, University Medical School of Debrecen, Debrecen, n/a, Hungary; §Division of Biostatistics,
Yale Cancer Center Yale School of Medicine, New Haven, Connecticut, U.S.A.
Once mutated, a single cell must expand into a clone to become signi®cant in carcinogenesis. The
forces driving clonal expansion are poorly understood. In a genetic mechanism, acquiring a second
mutation enables the cell to expand autonomously. If carcinogen exposure instead induced a
physiological change, clonal expansion requires the carcinogen's continued presence. To address
this question, we studied microscopic p53 immunopositive clones of keratinocytes in epidermal
sheets of mouse skin. To control the carcinogen exposure, we irradiated mice with UVB and
observed the expansion of p53-mutated cells into clones in the epidermis. p53-mutant clones only
grew during chronic UVB exposure and regressed after the cessation of UVB. Therefore, clonal
expansion was not triggered by a proliferative mutation, but was instead continually driven by
UVB. Unexpectedly, the clone size distribution showed periodicity with maxima at estimated
intervals of 16 6 6 cells, the size of the epidermal proliferating unit in murine dorsal skin. In the
absence of UVB, rare `imprisoned clones' increased in cell number without increasing in area. We
conclude that UV acts on two levels of skin carcinogenesis: (1) by driving clonal expansion of such
p53-mutated cells and (2) allowing mutated cells to break into an adjacent stem cell compartment,
a barrier to clonal expansion. Colonization is the rate-limiting step in early clonal expansion;
sustained UVB enables this process without incurring an additional mutation.
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Apoptosis Resistance in Human Melanocytes Associated with Expression of Multiple
Inhibitors of Apoptosis
A.R. Bowen, S. Allen, A. Alexander, M.Y. Diedrich, A. Hanks, and D. Grossman
Department of Dermatology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah,
U.S.A.
Malignant melanoma is notoriously resistant to chemotherapeutic agents and ionizing radiation,
which are thought to act by inducing apoptosis in malignant cells. Animal models have further
demonstrated a correlation between resistance to apoptosis and tumor metastasis. To investigate the
basis for this apoptosis resistance in melanoma cells, we have characterized responses to apoptotic
stimuli and the expression of a panel of apoptosis inhibitors in both human melanoma cell lines and
primary foreskin melanocytes. In contrast to human keratinocytes, foreskin melanocytes were
resistant to etoposide-induced (up to 100 mM) apoptosis, as assessed by propidium iodide staining
and ¯ow cytometry. Melanocytes were also markedly resistant to ultraviolet-B (UVB) radiation-
induced apoptosis, requiring a dose of 800 J/m
2
to achieve 18% (6 6) apoptosis at 48 h. By contrast,
4 cell lines (LOX, YUSIT1, YUSAC2, YUGEN8) derived from lesions of metastatic melanoma
were more sensitive, with a dose of 320 J/m
2
suf®cient to induce 30% (6 7) apoptosis at 24 h. This
dose±response was comparable to that observed with foreskin keratinocytes and the keratinocyte
cell line HaCat. Foreskin melanocytes were also relatively resistant to the tyrosine analog 4-tert-
butylphenol (4-TBP), achieving only 10% (6 5) apoptosis at 48 h in response to 0.3 mM 4-TBP,
while the same concentration 4-TBP induced 26% (6 7) apoptosis at 24 h in the melanoma lines.
These cell types were examined for expression of FLIP and other known apoptosis inhibitors from
the Bcl-2 and IAP families by Western blotting. Bcl-2, Bcl-xL, Mcl-1, FLIP, cIAP-1, cIAP-2 and
XIAP at med. to high levels in three independently derived melanocyte cultures, and at variable
levels in the melanoma cell lines. Thus expression of a wide array of apoptosis inhibitors may
account for the resistance to apoptosis in melanocytes, and the apoptosis resistance in melanoma
cells primarily re¯ects the intrinsic apoptosis resistance of melanocytes from which they are
derived.
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Different Expression of Mucin Core Proteins in Three Lesions of Extramammary
Paget's Disease
N. Yoshii, S. Kitajima,² S. Yonezawa,* M. Setoyama,³ and T. Kanzaki
Dermatology, Faculty of Medicine, Kagoshima University, Kaoghima, Japan; *Pathology, Faculty of
Medicine, Kagoshima University, Kaoghima, Japan; ²Research and Examination, National Sanatorium
Hoshizuka Keiaien, Kaoghima, Japan; ³Dermatology, School of Medicine, Miyazaki Medical College,
Miyazaki, Japan
Extramammary Paget's disease (EPD) is relatively common skin cancer and tumor cells have mucin
in their cytoplasm. However, little is known about mucin expression in EPD. In the present study,
we examined the expression of mucin core proteins immunohistochemically in 37 cases of EPD
and found different patterns of expression in intraepithelial lesions (n = 37), microinvasive lesions
(n = 14) and invasive lesions (n = 6). We investigated expression of MUC1, MUC2, MUC5AC
and MUC6. For MUC1 mucin expression, different glycoforms of MUC1 were examined using
®ve antibodies (NCL-MUC-1-GP, NCL-MUC-1-CORE, DF3, MY.1E12, and HMFG-1). In
normal skin, all MUC1s were expressed in sebaceous, eccrine and apocrine glands, but MUC2,
MUC5AC and MUC6 were not expressed in any of these parts. MUC1s and MUC5AC expressed
in intraepithelial lesions. MUC1s were also expressed in microinvasive and invasive lesions,
however, MUC5AC expression is decreased or lost in the invasive lesions. MUC2 and MUC6
were not expressed in any of the examined EPD lesions. Expressions of defferent glycoforms of
MUC1s were almost same patterns, although the expression rates of MUC1 detected by HMFG1
(fully glycosylated MUC1) expressed rate were lower than other four MUC1s. In conclusion, the
combination of immunohistochemical staining for MUC1 and MUC5AC was useful for
identifying invasive Paget cells. The decrease or loss of MUC5AC expression may have an
important role in the invasive growth of Paget cells.
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Metastasis-Associated Protein 1 Enhances Migration, Invasion, and Anchorage-
Independent Survival of Immortalized Human Keratinocytes
M. Mahoney, A. Simpson, M. Jost, M. NoeÁ, C. Kari, D. Pepe, Y. Choi, J. Uitto, and U. Rodeck
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.
The metastasis-associated protein (MTA1) is a member of the nucleosome-remodeling complex
with histone deacetylase activity. Recent evidence has implicated MTA1 in regulation of gene
expression by covalent modi®cation of histone proteins. Although the mechanism by which
MTA1 contributes to the transformed phenotype of cancer cells is still poorly understood MTA1 is
frequently overexpressed in biologically aggressive epithelial neoplasms. Here, we extend this
observation to squamous carcinoma cells, which express high levels of MTA1 relative to normal or
immortalized keratinocytes. To address functional aspects of MTA1 expression, we established
variants of human immortalized keratinocytes (HaCaT cells) by expressing MTA1 cDNA in both
the sense and antisense orientations. We demonstrate that (1) forced MTA1 expression enhances
migration and invasion of immortalized keratinocytes through Matrigel coated surfaces; (2)
overexpression of MTA1 slightly increased cellular proliferation while depletion of MTA1 had a
marginal inhibitory effect on cellular proliferation; (3) MTA1 expression is necessary but not
suf®cient for cell survival in the anchorage independent state (depletion of MTA1 drastically
reduced cell survival in forced suspension culture); (4) MTA1 contributes to expression of the
antiapoptotic Bcl-2 family member Bcl-xL; (5) MTA1 expression in immortalized keratinocytes
depends, in part, on activation of the epidermal growth factor receptor (EGFR). These results
establish that, in epithelial keratinocytes, modulation of the state of histone acetylation/deactylation
through MTA1 contributes to several aspects of the metastatic phenotype including EGFR-
dependent survival in the anchorage independent state, migration, and invasion.
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Survivin Expression in Mouse Skin In¯uences Multiple Steps in Experimental
Carcinogenesis
D. Grossman, S. Allen, S. Florell, A. Hanks, A. Alexander, and M. Diedrich
Dermatology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, U.S.A.
Induction of cutaneous squamous cell carcinoma (SCC) in mice, either by chemical [9,10-
dimethylbenzanthracene (DMBA) and phorbol 12-myristate 13-acetate (PMA)] application or
ultraviolet-B (UVB) irradiation, is a multistep process involving papilloma formation and
progression to carcinoma. We have generated a transgenic (Tg) mouse (keratin14-survivin) with
skin expression of survivin, a newly recognized inhibitor of apoptosis found in most skin cancers.
To investigate the role of survivin and apoptosis in cutaneous carcinogenesis, we subjected these
mice to established chemical and UVB carcinogenesis regimens. First, 50 mice were treated once
topically with 200 nmol DMBA followed by twice weekly with 6.8 nmol PMA for 32 weeks.
Surprisingly, tumor formation was less frequent (31% vs. 43%) and signi®cantly delayed (p = 0.01)
in Tg compared to non-Tg littermates. On the other hand, papilloma regression was not observed
in Tg mice, while 20% of papillomas regressed in non-Tgs; one SCC was generated in Tg mice,
while none was seen in non-Tgs. To increase tumor formation and SCC in particular, a second
experiment was performed with 59 mice on a p53 6 background. Again, tumor formation was less
(71% vs. 89%) and signi®cantly delayed (p = 0.02) in Tg p53 6 animals compared to p53 6 non-
Tgs. Papilloma regression was also not observed in Tg p53 6 mice, while 10% of papillomas
regressed in p53 6 non-Tgs; SCCs represented 21% of tumors in Tg p53 6 mice compared to 12%
of tumors in p53 6 non-Tgs. In a third experiment, 79 mice on a hairless background were UVB-
irradiated 3 times weekly for 20 weeks. Although Tg mice formed less tumors (222 vs. 328) than
non-Tgs, tumor formation was not signi®cantly delayed (p = 0.18); a higher percentage of tumors
in Tg mice were SCC (5% vs. 3%). These results indicate that survivin exerts a paradoxical negative
effect on tumor formation, while its effects on papilloma regression and conversion to SCC are
consistent with its expression in most human skin cancers.
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Functional Purinergic Receptors Suggest New Treatment Modalities for Nonmelanoma
Skin Cancer
A. Greig, M. Rustin,* D.A. McGrouther,² C. Linge,³ and G. Burnstock
Autonomic Neuroscience Institute, Royal Free and University College Medical School, London, U.K.;
*Department of Dermatology, Royal Free and University College Medical School, London, U.K.;
²Department of Plastic Surgery, Wythenshaw Hospital, Manchester, U.K.; ³The RAFT Institute, Mount
Vernon Hospital, Northwood, U.K.
Topical drug treatments for nonmelanoma skin cancer are indicated for multiple, large, super®cial
cutaneous neoplasms which are dif®cult to treat with other methods. This study aimed to
investigate possible new treatment modalities for nonmelanoma skin cancers using purinergic
receptors. Purinergic receptors, which bind ATP, are expressed on human cutaneous
keratinocytes. Previous work in rat epidermis suggested functional roles for purinergic receptors
in the regulation of proliferation, differentiation and apoptosis, for example P2X5 receptors were
expressed on keratinocytes undergoing proliferation and differentiation, while P2X7 receptors
were associated with apoptosis. In our study immunohistochemical analysis of human basal cell
carcinomas and squamous cell carcinomas for P2X5 and P2X7 receptors was performed. A human
cutaneous squamous cell carcinoma cell line (A431) was grown in culture. Speci®c agonists and
antagonists to purinergic receptors were applied to cells and changes in cell number were
quanti®ed via a colorimetric assay and read using a spectrophotometric plate reader. In basal cell
and squamous cell carcinoma there was up-regulation of the expression of P2X5 receptors within
the tumour cells. P2X7 receptors were expressed in the necrotic centre of basal cell carcinomas, in
mast cells, macrophages and swollen ®broblasts. The P2X7 receptor agonist benzoylbenzoyl-ATP
caused a signi®cant reduction in cell number (p < 0.001) in the cultured squamous cell carcinoma
cell line, A431. The P2X5 receptor agonist ATP-g-S did not cause a signi®cant amount of
proliferation. We have demonstrated that nonmelanoma skin cancers contain some functional
purinergic receptors and speci®c agonists can signi®cantly reduce cell numbers. This opens the
pathway for new treatment modalities in these important skin cancers.
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Innovative Model for Accelerated Induction of Cutaneous Basal Cell Carcinomas:
ptch+/± Heterozygous Knockout Mice Over-Expressing Ornithine Decarboxylase
M. Athar, J. Russo, A.L. Kim, H. Zhang, X. Tang, M. Aszterbaum,² L. Kopelovich,* E.H.
Epstein,² and D.R. Bickers
Dermatology, College of Physicians & Surgeons, Columbia University, New York, New York, U.S.A.;
*Division of Chemoprevention, NCI, Bethesda, Maryland, U.S.A.; ²Dermatology, UCSF, San Francisco,
California, U.S.A.
Skin BCCs are the most common type of human cancer. Based upon discoveries in patients with
the dominantly inherited nevoid BCC syndrome (NBCCS), mutations in sonic hedgehog (shh)
signaling genes including patched (ptch) are known to underlie BCCs development. Ptch+/± mice
develop BCCs and trichoblastomas after chronic UVB exposure. UVB is a potent inducer of ODC
activity, which drives the continued proliferation and clonal expansion of intiated cells leading to
tumor development. We reasoned that overexpressing ODC in ptch+/± mice might accelerate
BCCs development. We generated ptch+/± mice over-expressing the ODC trangene (ptch+/±/
ODC TgN). The parent ptch+/± mice are heterozygous for deletions of exons 1 and 2 and
insertions of lacZ and neo genes. UVB induction of BCCs in ptch+/±/ODC TgN mice results in
derepressed transcription of the lacZ genes inserted in the inactivated ptch locus. Untreated skin at
the age of seven months is grossly normal; however, histologic examination shows small basaloid
tumors. Immunohistochemical studies reveal positive staining for b-galactosidase (b-Gal), gli-1 and
shh. Wild-type or ptch+/± littermates manifest no such lesions nor b-Gal staining. Positive b-Gal
staining veri®es activation of shh signaling in BCCs-like lesions. Chronic UVB irradiation (180
mJ/cm
2
twice a week) for 10 weeks resulted in multiple small visible tumors, which increased both
in number and size after another 20 weeks of irradiation. Tumor incidence was 100% by week 20.
Histologically, these lesions are indistinguishable from human BCCS and show strong positive
staining for b-gal, gli-1 and shh indicating enhanced shh signaling, a hallmark of human BCCs.
Our results indicate that ptch+/±/ODC TgN mice provide a uniquely sensitive model for
accelerated BCCs induction by UVB.
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Precursor Cells as the Origin for Melanoma
J.M. Grichnik, J.A. Burch, and F.H. Lin
Medicine/Dermatology, Duke University Medical Center, Durham, North Carolina, U.S.A.
We hypothesize that melanocytic precursor cells, not differentiated melanocytes, are the cell of
origin for the majority of melanomas (and nevi). In an effort to investigate this process, we
evaluated melanoma cells isolated from patients' lymph nodes. Melanoma cells from nodal
metastasis were found to be phenotypically heterogeneous in culture. Immunohistologic staining
for KIT (an early marker present on melanoblasts) revealed a subpopulation of markedly positive
cells. We clonally puri®ed this `precursor' cell population from one of the tumors. In culture these
cells gave rise to a number of different daughter cell phenotypes (spindle and polygonal forms). The
daughter cells demonstrated increased adherence, size, and pigmentation. KIT was down-
regulated, TRP-1 was up-regulated, and melanosomes were found to be increased in number and
stage. The daughter cells also exhibited a marked increase in proliferation, and with prolonged
culture, these cells displaced the precursor cell phenotype. Similar ®ndings could also be
demonstrated in the other metastatic melanoma isolates. The existence of small, poorly adherent,
slow cycling cells that can differentiate into a larger, more pigmented cells with increased
proliferative rate in metastatic melanoma lesions supports the hypothesis that the melanocytic
precursor cell is involved in melanoma tumorgenesis. These ®ndings impact our current concepts
of melanoma development, dormancy, heterogeneity, ``dedifferentiation'', and metastasis.
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Regulation of Human Malignant Melanoma Growth and Metastasis by AGE±AGE
Receptor Interaction
R. Abe, T. Shimizu, H. Watanabe, H. Nakamura, H. Choei,* N. Sasaki,* S. Yamagishi,² M.
Takeuchi,³ and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; *Neuropsychiatry,
Sapporo Medical University, Sapporo, Japan; ²Medicine, Kurume University School of Medicine, Kurume,
Japan; ³Pharmaceutical Science, Hokuriku University, Kanazawa, Japan
Advanced glycation end products (AGEs) are nonenzymatically glycated protein derivatives that
have been implicated in the development and progression of diabetic angiopathies, including skin
dermopathy. However, the involvement of AGEs in the development and progression of
melanoma has yet not to be fully elucidated. In this study we investigated the expression levels of
AGEs and their receptor for AGE (RAGE) in human malignant melanoma, and then studied the
effects of AGEs on melanoma growth and migration. Various types of immunochemically distinct
AGEs were detected and were colocalized with RAGE in the cytoplasm of human malignant
melanoma cells. Among different types of AGEs, glyceraldehyde- and glycolaldehyde-derived
AGEs signi®cantly stimulated the growth and migration of human melanoma cells. Furthermore,
tumor formation of melanoma cells xenografts in athymic mice were found to be prevented by the
treatment of anti-RAGE neutralizing antibodies. These results suggest that AGEs might be
involved in the growth and invasion of malignant melanoma through the interaction with RAGE
and are good candidates for assessing the full therapeutic ef®ciency of treatments in patients with
malignant melanoma.
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Mutational Analysis of the Novel ING1 Tumor Suppressor Gene in Human Melanoma
E. Campos, M. Martinka,* P. Lin, and G. Li
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada;
*Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada
Epidemiological evidence indicates that ultraviolet radiation exposure is directly linked to the
evident increase in the incidence of melanoma observed in the past decades. However, the genetic
changes caused by ultraviolet radiation that lead to melanoma formation remain unclear. Although
the p53 tumor suppressor gene has been shown to be mutated in over 90% of nonmelanoma skin
cancers, its mutation is only observed in 15±25% of melanoma biopsies suggesting that p53
mutation may not be an early step in melanoma development. Recently, a potential tumor
suppressor gene ING1 was shown to inhibit cell growth and induce apoptosis in the presence of
p53. Overexpression of this gene leads to a G0/G1 cell cycle arrest and dramatically enhances the
repair of ultraviolet-damaged DNA. To investigate if ING1 plays a role in melanoma formation,
we examined the ING1 protein levels in 14 melanoma cell lines and found ING1 to be
overexpressed in all cell lines compared to normal melanocytes. Since the ING1 gene was further
found to be mutated in 2 of the 14 cell lines, we have examined the mutational status of ING1 in
54 human melanoma biopsies. Immunohistochemical staining showed that as in melanoma cell
lines, ING1 is overexpressed in most human cutaneous melanomas. However, single-strand
conformation polymorphism (SSCP) analysis showed small percentage of the melanoma biopsies
has band shifting. Furthermore, few alterations were found to be potential ultraviolet transitions
suggesting that like p53, ING1 mutations may not play a causative role in human melanoma.
However, most mutations concentrated within exon 2 of the ING1 gene potentially interfering
with the nucleolar targeting and PHD zinc ®nger sequences of this tumor suppressor.
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Newcastle Disease Virus Oncolysate Induces a Signi®cant and Speci®c Antimelanoma
Effect in a Preclinical Murine Model System
R.M. Campbell, A. Pham, R. Compans,* J.C. Ansel,² and C.A. Armstrong²
Dermatology, Emory University, Atlanta, Georgia, U.S.A.; *Microbiology, Emory University, Atlanta,
Georgia, U.S.A.; ²Dermatology, North-western University, Chicago, Illinois, U.S.A.
It has been previously demonstrated in preclinical and clinical studies that Newcastle disease virus
(NDV) is an oncolytic virus with signi®cant antitumor biological activities when delivered as an
oncolysate with lysed melanoma cells. In this study we wanted to determine whether the antitumor
activity of NDV in the inhibition of melanoma development and progression is speci®c to NDV,
or if this virus acts as a nonspeci®c viral danger. Like NDV, Simian virus 5 (SV5) also is a member
of the paramyxovirus family. NDV and SV5 are similar viruses which share common mechanisms
of infection; both have hemagglutinin-neuraminidase (HN) protein and fusion (F) proteins and
both induce the production of interferon g after infection. In this study the antimelanoma effects of
NDV melanoma oncolysate and SV5 melanoma oncolysate were compared in a murine model to
determine whether the antimelanoma effect is unique to NDV or is also characteristic of other
RNA viruses of this family. Three groups of mice were injected intravenously with 3 x 10
5
cells of
HFH18 murine melanoma cells and subsequently treated by intraperitoneal injection of DMEM,
SV5 oncolysate, or NDV oncolysate on days 3, 10, and 14. On day 26, mice were euthanized and
the number of grossly visible metastatic melanoma tumors in the lungs were counted. Our results
demonstrate a signi®cant reduction in lung metastases in mice treated with NDV melanoma
oncolysate whereas no reduction in metastasis was observed in the SV5 melanoma oncolysate
treated group. These results indicate that the antimelanoma effects are speci®c for NDV and not
merely a nonspeci®c general response to a viral danger signal. These results provide further
evidence that NDV oncolysate is an effective and speci®c antitumor therapy therefore supporting
the rationale for its use as a single treatment or adjuvant treatment for high-risk melanoma patients.
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Role of Mitochondrial Death Pathway in Fas-Mediated Apoptosis of Melanoma
J.L. Urquhart, D. Marr, Y. Shellman, and D. Norris
Dermatology, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.
Two different pathways following Fas receptor activation have been described. Type I cells require
DISC formation and caspase-8 activation to activate death effector caspases. Type II cells do not
require DISC formation and involve changes in mitochondrial membrane potential and
cytochrome c release to induce cell death. Studies have shown decreased susceptibility to Fas-
mediated apoptosis in melanoma but it is unclear which Fas receptor pathway is utilized.
Immuno¯uorescent staining studies have shown that WM35, a human radial growth phase
melanoma cell line, express surface Fas receptor. Chromium release cytotoxicity assays have shown
that these cells are susceptible to Fas-mediated cell death but are more resistant compared to the
positive control cell line. To determine which Fas pathway is activated in melanoma, we studied
the effects of caspase-8 and caspase-9 inhibitors, z-IETD-FMK and z-LEHD-FMK, respectively,
on Fas-mediated cell death. Caspase-9 inhibition decreased susceptibility to Fas-mediated apoptosis
but caspase-8 inhibition had no effect. These results suggest that melanoma cells utilize
mitochondrial pathways in Fas-mediated apoptosis. We have successfully transfected WM35 cells
with antisense oligonucleotide bcl-2 to down-regulate bcl-2 protein expression. We are in the
process of conducting cytotoxicity experiments to determine the effects of bcl-2 down-regulation
on Fas-mediated cell death. In the future, we would like to study the role of other bcl-2 family
members in Fas-mediated apoptosis of WM35 and other melanoma cell lines. Elucidation of the
mechanism by which melanoma cells are resistant to Fas-mediated apoptosis may be helpful in
determining therapeutic strategies to induce cell death in melanoma.
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The Lipid-Lowering Drug, Lovastatin, Induces Bax-Dependent Cell Death in
Aggressive Melanoma Cell Lines
D.A. Norris, J.P. Gendall, M. Draznin, L. Schilling,*² and R.P. Dellavalle
Dermatology, University of Colorado School of Medicine, Denver, Colorado, U.S.A.; *Medicine, University
of Colorado School of Medicine, Denver, Colorado, U.S.A.; ²Preventive Medicine and Biometrics,
University of Colorado School of Medicine, Denver, Colorado, U.S.A.
Large, randomized, placebo-controlled coronary artery disease prevention trials have associated the
use of lipid-lowering medication with lower melanoma incidence. To investigate a potential
molecular mechanism to explain how lipid-lowering medications may work as chemopreventive
agents for melanoma, this in vitro study examined the effect of HMG-CoA (3-hydroxy-
3methylglutaryl-coenzyme A) reductase inhibitors, lovastatin and mevastatin, on the regulation of
apoptosis in keratinocyte and melanoma cell lines. Incubation with lovastatin preferentially
decreased the survival of aggressive melanoma cell lines as measured by an assay with MTT (3-(45-
dimethylthiazol-2 L-yl)-dephenyltetrazoleum bromide). Statins did not trigger apoptosis in the
transformed keratinocyte cell line A431; after a 72- h incubation in lovastatin (4 mM), 95% of A431
cells were viable. The same treatment, however, proved highly cytotoxic to B16 murine
melanoma and A375 human metastatic melanoma cell lines, where viability was reduced to 35%
and 55%, respectively. Similar results were obtained in experiments using mevastatin. Western blot
analysis revealed that induction of apoptosis by statins is accompanied by a 66% increase in Bax
expression. Further analysis indicates that this effect is Bcl-2-independent. These results lend
promise to the novel concept that lipid-lowering drugs may prevent melanoma or serve as adjuvant
chemotherapy to prevent melanoma metastasis.
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Functional Fas ligand is Expressed on Human Cutaneous T Cell Lymphoma Cells and
Inhibited by Bexarotene
X. Ni, C. Zhang, P. Hazarika, and M. Duvic
Department of Dermatology, MD Anderson Cancer Center, Houston, Texas, U.S.A.
Fas-Fas ligand (FasL) is an important mechanism by which some tumors can evade the immune
system. Bexarotene is an RXR selective synthetic retinoid that is active in treating cutaneous T-
cell lymphoma (CTCL). CTCL cells express FasL with an inverse correlation between distribution
of FasL and CD8+ T lymphocytes within CTCL lesions [Ni, X et al Clin. Cancer Res. 7:2682,
2001]. To further study the role of FasL in CTCL immune evasion, a JAM assay for Fas-FasL
induced-cell death was used to demonstrate functional FasL expression on cell surface of CTCL
cells. Three CTCL cell lines (HUT78, MJ and HH) and peripheral blood lymphocytes (PBLs)
from a SeÁzary Syndrome (SS) patient were coincubated with Fas-sensitive Jurkat T-cells at ratios of
1:1, 1:5, 1:10 and 1:20 Jurkat (target) to CTCL cells (effectors). The Jurkat cells were killed at
9.1%, 28.1%, 49.2% and 71.6% when increasing numbers of HUT78 cells were added.
Neutralizing antibody to FasL and antagonistic antibody to Fas inhibited the killing signi®cantly.
Bexarotene incubation at an optimal dose of 10 mm decreased Jurkat cell death induced by
HUT78 by 9.4% (p = 0.28), 46.4% (p = 0.0007), 40.4% (p = 0.005) and 52.5% (p = 5.64E-5) at
ratios above, respectively. The MJ cell line could only induce T cell death of 22.4% at a 1:10 ratio
and of 35.2% at 1:20. The HH cell line killed 10.3% of Jurkat cells only at a ratio of 1:20. The
degree of cell death induced by three CTCL cell lines correlated with the levels of membrane
bound FasL (r = 0.961, Pearson correlation). Lymphocytes from a patient with 57% circulating
SeÁzary cells, but not from a normal donor, were able to kill 23.1%, 50.4%, 48.1% and 79.9% of
Jurkat cells at ratios above and were inhibited by pretreatment with 5 mm bexarotene. These data
suggest that CTCL cells are capable of killing Fas-sensitive lymphocytes to a different degree and
that bexarotene may be effective in blocking loss of tumor mediated T-cell immunity which
appears to be a key factor in patient prognosis.
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Thrombospondin-2 Overexpression in the Skin of Transgenic Mice Reduces the
Susceptibility to Chemically Induced Multistep Carcinogenesis
Y. Hong, M. Streit, H. Oura, L. Janes, L. Riccard, M. Detmar, and T. Hawighorst
Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts,
U.S.A.
We have recently reported stromal up-regulation of the endogenous angiogenesis inhibitor
thrombospondin-2 (TSP-2) during multistep skin carcinogenesis, and we found accelerated and
enhanced skin carcinogenesis and angiogenesis in TSP-2 de®cient mice. To investigate whether
enhanced levels of TSP-2 might protect from skin cancer development, we generated transgenic
FVB mice overexpressing TSP-2 under the control of the keratin K14 promoter. Twenty-®ve
TSP-2 transgenic mice and wild-type littermates were subjected to a standard two-step skin
carcinogenesis regimen. For initiation, mice were treated once with 50 mg DMBA, applied to the
dorsal skin, followed by 20 weekly topical applications of 5 mg of the tumor promoter PMA.
Ef®cient transgene expression by epidermal keratinocytes was con®rmed by in situ hybridization.
TSP-2 transgenic mice showed a delayed onset of tumor formation with an average latency period
of 18 weeks, as compared to 14 weeks in wild-type mice. At 18 weeks after initiation of PMA
promotion, the percentage of tumor-bearing mice was 100% in wild-type, as compared to 52% in
TSP-2 transgenic mice. Moreover, TSP-2 transgenic mice developed signi®cantly less papillomas
compared with the control group. After 20 weeks of PMA promotion, TSP-2 transgenic mice
averaged less then 3 papillomas per mouse as compared to more than 7 papillomas per wild-type
mouse. Furthermore, the incidence of tumors larger than 3 mm was signi®cantly lower in TSP-2
transgenic mice when compared to wild-type littermates. These results demonstrate that enhanced
levels of TSP-2 in the skin result in reduced susceptibility to chemically induced skin
carcinogenesis, and they identify TSP-2 as a potential new target for the prevention of skin cancer.
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The Expression of P-Selectin Ligand Glycoprotein Ligand-1 was Up-Regulated in
Metastatic Malignant Melanoma
T. Hoashi, K. Kikuchi, and K. Tamaki
Dermatology, Tokyo University, Tokyo, Japan
P-selectin is expressed on endothelial cells. P-selectin ligand glycoprotein ligand-1 (PSGL-1),
which was ®rst identi®ed on myeloid cells, is a homodimer of two about 120 Kd subunits. CD24,
which was also identi®ed on neutrophils, is mucin like glycosylphosphatidylinositol-linked cell
surface glycoprotein bound to the membrane via phosphatidyl inositol anchor. PSGL-1 and CD24
play a crucial role on leukocyte rolling. We studied the expression of PSGL-1 and CD24 on
human malignant melanoma cell lines. Primary melanoma (PM-WK, KHm-4 and WM-115),
recurrent primary melanoma (r.p.m.-EP and r.p.m.-MC), lymphnode metastatic melanoma (MM-
AN, MM-BP, MM-LH and MM-RU) and visceral metastatic melanoma (MM-LH) cell lines
were used. Reverse transcriptase-coupled polymerase chain reaction revealed that all expressed
PSGL-1 and only r.p.m.-MC, MM-AN and MM-LH expressed CD24. Western blot revealed that
r.p.m.-EP, MM-BP, MM-RU and MM-LH expressed PSGL-1 protein, although primary
melanoma cell lines did not. No cell line expressed CD24 protein. Moreover, eight pairs of
primary melanomas and their metastatic lesions were studied by immunohistochemical technique.
CD24 expression was not detected on all specimen. Our study revealed that PSGL-1 expression
was enhanced during progression (2 out of 8 cases). And nodular melanoma expressed PSGL-1 on
both primary and metastatic melanomas. We thought the expression of PSGL-1 might enhance
metastatic capacity in the progression of malignant melanoma.
060
The Epidermal Platelet-Activating Factor Receptor Augments Chemotherapy-
Induced Apoptosis in Human Carcinoma Cell Lines
T. Li, Y. Pei, M.D. Southall, Q. Yi, and J.B. Travers
Dermatology, Indiana University, Indianapolis, Indiana, U.S.A.
The mechanism of action of many chemotherapeutic agents involves the induction of apoptosis
on malignant target cells. Recent studies suggest that chemotherapeutic agents such as etoposide
and mitomycin C can have pro-oxidative effects upon target cells. Inasmuch as oxidative stress
is a potent stimulus for the production of the lipid mediator platelet-activating factor (1-alkyl-2-
acetyl-glycerophosphocholine; PAF), and our previous studies have shown that the PAF
receptor can augment ultraviolet B radiation-induced apoptosis (JBC 273:18891±18897, 1998),
the objective of the present study was to de®ne whether the epidermal PAF receptor could
augment apoptosis induced by a variety of chemotherapeutic drugs. Using a novel model
system created by retroviral-mediated transduction of the PAF receptor-negative human
epidermal cell line KB with the human PAF receptor, we tested whether the PAF-R could
modulate toxicity induced by two chemotherapeutic agents that could induce oxidative stress
(etoposide, mitomycin C), and tumor necrosis factor related apoptosis-inducing ligand
(TRAIL), an agent that is not a pro-oxidative stressor. Treatment of vector control or PAF
receptor-expressing KB cells with etoposide, mitomycin C and TRAIL resulted in time-
dependent and dose-dependent increase in apoptosis (as assessed by caspase-3, DNA
fragmentation and enrichment of nucleosomes into the cytoplasm). Treatment with etoposide
and mitomycin C resulted in enhanced apoptosis in PAF receptor-expressing KB over vector
control cells. However, TRAIL-induced apoptosis was similar amongst the cell types. Ablation
of the endogenous PAF-R with a retroviral-based antisense strategy in the cell line HaCaT also
resulted in protection against mitomycin C and etoposide-induced apoptosis. These studies
suggest that the epidermal PAF receptor on carcinoma cells can augment pro-apoptotic stimuli
such as pro-oxidative chemotherapeutic agents.
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Effect of Ultraviolet B Irradiation and Tyrosinase Expression on the Growth of
Fibroblasts from Patients of Familial Dysplastic Nevus Syndrome
A. Yoneta, H. Jin, T. Yamashita, S. Kondo, and K. Jimbow
Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
Patients of familial dysplastic nevus syndrome (FDNS) have high incidence of malignant
melanoma. Fibroblasts (FBs) derived from FDNS patients show higher sensitivity to UVC and
mutagens, e.g. 4-nitoquinoline 1-oxide. This study examines if the development of malignant
melanoma in FDNS is related to the combination of inherent sensitivity to UV iradiation and
abnormal melanin synthesis. FBs from FDNS patients, 3012T and 3072T and normal human FBs
were irradiated by UV. 3012T and 3072T showed higher sensitivity to the toxicity of UVB than
normal ones. 3072T was more sensitive to UVB than 3012T. We introduced and expressed human
tyrosinase in 3072T and normal human FBs by adenovirus vector, and after UVB irradiation, the
number of cells was counted three days after virus infection. 3072T revealed increased human
tyrosinase expression and melanin synthesis by UVB, and tyrosinase expression was much higher
than those of normal FBs. Only FDNS FBs, not normal FBs, showed a marked synergistic increase
of cell death compared to FBs with UVB or tyrosinase expression alone. We suggest that UVB
exposure and increased melanin synthesis may synergistically affect the increased cytotoxicity to
FDNS ®broblasts, which may be related to the genomic instability of FDNS FBs.
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Lack of Vascular Endothelial Cell Growth Factor in Epidermal Keratinocytes Prevents
Dimethyl Benzanthracene-Induced Tumor Formation in C57Bl6/129 Mice
H. Rossiter,* C. Barresi,* C. Wu,* J. Pammer,* E. Wagner,² and E. Tschachler*³
*Dermatology, University Vienna Medical School, Vienna, Austria; ²Dermatology, I.M.P., Vienna,
Austria; ³Dermatology, CE.R.I.E.S., Neuilly, France
We have previously shown that Cre/lox-p mediated deletion of the ¯oxed VEGF A gene in
C57Bl6/129 epidermal keratinocytes results in retarded healing of punch biopsy wounds, and that
depilation-induced hair regrowth is compromised. VEGF is also associated with tumor growth.
Since, in our hands, this mouse strain was resistant to two-stage chemical carcinogenesis, we have
now used dimethyl benzanthracene (DMBA) as both tumor initiator and promotor in neonatal
mice. 50 micrograms of DMBA were applied to mice aged day 1 to day 4, then once/week for
17 weeks. All VEGF f/f male mice that had been 1-day-old at ®rst application, displayed proli®c
papilloma formation (16 6 3 papillomas/mouse), but no carcinomas, and all tumors arose at the site
of DMBA application. Males aged 2±4 days at ®rst treatment, developed far fewer papillomas (3 6
3 papillomas/mouse), and many of these converted to squamous cell carcinomas (14% conversion
for 3-day-old-male mice). Moreover, many of these appeared at body sites distant from the DMBA
application area. Female VEGF f/f littermates developed few papillomas (2±4/mouse), with a
conversion rate to carcinomas of roughly 14%, and some of these were at body sites distant from
the application area. Most notably, no overt tumors at all appeared in VEGF f/f K5-Cre+
littermates of both sexes. On histological examination however, VEGF f/f K5-Cre+ mice showed
evidence of severe hyperplasia, with the formation of rete ridges deep into the dermis. Although
CD31 staining suggested an adequate supply of dermal capillaries between these rete ridges, large
blood vessels were missing. We conclude that the frequency and type of epidermal tumor
induction with DMBA in this mouse strain depends strongly on the age of the mice at ®rst
treatment, and that, in the absence of keratinocyte-derived VEGF, only epidermal hyperplasia, but
no three-dimesional squamous papillomas can be induced by this method.
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Melanoma, but Not Nonmelanoma, Skin Cancer Exhibits an Up-Regulated Antioxidant
Network and Increased Lipid Peroxidation
J.J. Thiele, F. Hamm, C.S. Sander, and P. Elsner
Department of Dermatology, Friedrich Schiller University, Jena, Germany
Solar UV radiation is considered a major etiological factor in melanoma and nonmelanoma skin
cancer. A growing body of evidence indicates that oxidative stress is involved in the etiology of
photocarcinogenesis, however, in vivo data of human skin are still lacking. ROS participate in a
number of pathophysiological processes including DNA damage as well as lipid peroxidation
(LPO) and are a key factor in tumor progression. We hypothesized, that in human skin cancer the
natural redox balance is disturbed and results in accumulation of LPO-products. To test this, skin
biopsies of super®cial spreading melanoma were compared to age-matched benign melanocytic
naevi and young healthy controls. Additionally, the nonmelanoma skin cancers basal cell
carcinoma, squamous cell carcinoma (SCC) and aktinic keratosis were investigated (n = 18 each).
Expression of the antioxidant enzymes copper-zinc SOD, manganese SOD and catalase was
analyzed by immunohistochemical techniques. To detect lipid peroxidation products, protein-
bound malondialdehyde (MDA) was visualized. In human melanoma biopsies, a signi®cant
overexpression of all antioxidant enzymes was found when compared to surrounding nontumor
tissue as well as to benign melanocytic naevi, and young controls. Intriguingly, the lipid
peroxidation marker MDA was signi®cantly increased in melanoma tissue. MDA was found not
only in typical melanoma cells, but also occurred in surrounding keratinocytes. In contrast, a
severely disturbed antioxidant balance with diminished antioxidant enzymes was found in
nonmelanoma tumors, whereas MDA was signi®cantly elevated in SCC only when compared to
controls. These ®ndings indicate that oxidative stress may play different roles in the pathogenesis of
human skin cancers: In nonmelanoma skin cancer, a diminished antioxidant defense caused by
chronic UV-exposure might contribute to multistep carcinogenesis, whereas melanoma cells
exhibit increased oxidative stress which could damage surrounding tissue and thus support the
progression of metastasis.
064
Deregulation of the PTCH Pathway in Linear Unilateral Basal Cell Nevus
S.S. Fakharzadeh, X. Cha, P. Williams,* R. Oakey,* G. Militello, and J. Seykora
Dermatology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, U.S.A.; *Genetics,
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.
We have identi®ed a patient with features most consistent with linear unilateral basal cell nevus
(LUBCN). Findings include a congenital streak of pitting at the right sole and a narrow band of
¯esh-colored 1±2 mm papules at the right ¯exor forearm. The histopathology of these papules is
consistent with basaloid follicular hamartoma (BFH). Later in life, basal cell carcinomas (BCC)
started developing within a narrow strip along the dorsal right foot and lateral right leg, as well as in
a more diffuse distribution limited to the right shoulder, chest and neck. Based on these ®ndings,
we predict that this patient harbors a mosaic gene defect suf®cient to cause congenital pitting and
BFH in some regions, yet predispose to BCC in others. Presumably acquisition of a second
mutation in susceptible cells is required to give rise to BCC. Patients with basal cell nevus
syndrome develop multiple BCCs and commonly display palmar and plantar pitting. This disorder
is caused mutations in the PTCH tumor suppressor gene. Moreover, the majority of sporadic
BCCs harbor either acquired PTCH defects or activating mutations in the target of PTCH
suppression, SMO. However, induction of PTCH message is a consistent feature of BCC and
correlates with deregulation of the PTCH pathway. To determine whether deregulation of the
PTCH pathway could be implicated in LUBCN, we examined PTCH expression in lesions from
our patient. We observed up-regulation of PTCH message in both BFH and BCC by RT-PCR
and in situ hybridization, although PTCH message was more abundant in BCC. Using genomic
DNA from BCC we sequenced all coding exons for the PTCH and SMO genes. No mutations
were detected. These ®ndings indicate that there is perturbation of the PTCH pathway in lesions
from our patient, however, the genetic defect underlying this case of LUBCN appears to not
involve genes commonly associated with BCC. We are examining additional candidate genes and
exploring other genome-based approaches for elucidating the gene defect in this case.
065
The NFkB Inhibitor PG490 Signi®cantly Potentiates Cisplatin-Induced Apoptosis in
Melanoma
J.P. Gendall, J.L. Urquhart, D.A. Norris, and Y.G. Shellman
Dermatology, University of Colorado School of Medicine, Denver, Colorado, U.S.A.
In this study we seek to maximize the cytotoxic effects of cisplatin by inhibiting NFkB, a
transcription factor which is frequently recruited during a cytotoxic assault that works to enhance
survival signaling. Because these survival signals abrogate the ef®ciency of chemotherapy, it is
important to develop a system whereby melanoma cells can undergo unhindered drug-induced
apoptosis. We have found that PG490, a novel NFkB inhibitor, signi®cantly potentiates cisplatin-
induced apoptosis in the radial growth phase WM35 cell line. At a low dose of cisplatin (25 mM) to
which this RGP melanoma cell line has been highly resistant, a preincubation with PG490 renders
these cells highly susceptible to apoptosis. Without PG490, cells treated with 25 mM cisplatin show
no evidence of cell death. However, with a pretreatment of PG490, cisplatin causes a signi®cant
cytotoxic stress such that viability is reduced to 60% of the baseline, as determined by an objective
MTT viability assay. We have compelling support to this data using both an ethidium bromide/
acridine orange morphological assay and Flow Cytometry using an Annexin Assay. The results
from the morphological assay indicate that the decrease in viability is largely the result of apoptosis,
and not of necrosis. We show by luciferase assay that PG490, in causing a marked enhancement of
apoptosis, also inhibits NFkB activation in our system. Furthermore, we have preliminary results
that show this increase in apoptosis is Bcl-2-independent, and is abetted by a signi®cant decrease in
p21 expression. By inhibiting NFkB, which triggers survival signals and in¯ammation, PG490 is an
attractive compound that could potentially maximize the ef®ciency of current chemotherapy
treatments.
066
Loss of the Melanoma Suppressor Gene Locus CDKN2a Confers De®cient Repair of
DNA Photoproducts and UVB-Hypersensitivity to Cells
P. Sarkar, I. Vergilis, and T.M. Ru
È
nger
Dermatology, Boston University, Boston, Massachusetts, U.S.A.
The melanoma suppressor gene locus CDKN2a encodes two cell cycle inhibitors, p16INK4a and
p19ARF, which act through Rb and p53, respectively. While p53 has been shown to directly alter
DNA repair, no such link has been established for p16. In order to investigate a possible link
between p16 and/or p19 and DNA repair, we compared the repair of DNA photoproducts in
mouse embryonal ®broblasts (MEF) from CDKN2a-knockout mice and their CDKN2a+/+
littermates. We used the shuttle vector plasmid pYZ289, damaged with 10±50 mJ/cm
2
UVB, and
transfected into CDKN2a-knockout and CDKN2a-intact MEF. We saw a 3.7- to 10.5-fold
reduced plasmid survival and a 7.1- to 8.9-fold increased mutation frequency in the CDKN2a-
de®cient cells (n = 5, p < 0.01). This indicates a profoundly reduced repair ef®ciency and a reduced
repair ®delity, and is consistent with our recent report of hypermutable DNA repair in p16-
de®cient melanoma lines. Since in this DNA repair assay, only the plasmids are irradiated prior to
transfection, but not the cells themselves, the in¯uence of CDKN2a on DNA repair is independent
of its effect on cell cycle regulation. A possibly different cell cycle regulation after the trauma of
transfection during the repair assay was excluded by FACS analysis. 24 h after irradiation with 50
mJ/cm
2
UVB, pronounced apoptosis was only seen with CDKN2a-de®cient cells. This UVB-
hypersensitivity of the CDKN2a-de®cient cells can be the result of an uncontrolled cell cycle
progression with unrepaired DNA damage. Here we suggest that the impaired DNA repair might
also contribute. DNA repair of photoproducts was mildly reduced in both MEF from selective
p16- and selective p19-knockout mice (n = 2±4), indicating that both pathways contribute to the
more pronounced DNA repair de®cient phenotype of the CDKN2a double knockout MEF. Loss
of CDKN2a with subsequent DNA repair de®ciency might confer a mutator phenotype and
possibly explain why CDKN2a germ-line mutations predispose particularly to UV-induced
tumors.
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Telomere 3¢ Overhang Speci®c DNA Induces Apoptosis and Differentiation in Human
Melanoma Cells In Vitro and Reduces their Tumorigenicity In Vivo
N. Puri, M. Eller, H. Byers, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
The 3¢ end of mammalian telomeres consists of a single-stranded overhang that has been proposed
to stabilize a loop structure at chromosome ends. Experimental disruption of this loop structure
induces DNA damage responses including apoptosis and cell cycle arrest. We have shown that
treatment of cells with oligonucleotides homologous to the telomere overhang (T-oligos) induces
these responses in the absence of telomere disruption. Because apoptosis is an important
mechanism of action for chemotherapeutic agents, we explored using T-oligos to induce apoptosis
in melanoma cells. We found that treatment with an 11-base T-oligo induces apoptosis in human
melanoma MM-AN cells preceeded by induction of the E2F1 trancription factor and p73, known
to cooperate with E2F1 in apoptosis. To further explore the mechanism of this T-oligo-induced
apoptosis, MM-AN cells were stably transfected to ectopically express a dominant-negative mutant
form of p73 (p73DN). Transfection with p73DN vs. empty vector reduced T-oligo-induced
apoptosis by 50%, demonstrating a major role for p73 in this apoptotic response. Furthermore, by
Western blot, the differentiation markers Mart-1, tyrosinase, TRP-1 and gp-100 were up-
regulated 48±72 h after T-oligo treatment of MM-AN cells. We then studied the effect of the T-
oligo on tumorigenicity of MM-AN cells in SCID mice. Mice were injected in the right scapular
region with 106 cells that had been pretreated for 48 h with either T-oligo or diluent alone.
Tumors were palpable at the site injected with diluent-treated cells by day 10. On day 18, animals
were sacri®ced and all tumors were removed and measured. Mean tumor volume in the diluent-
treated group was 322 6 45 mm
3
vs. 56 6 13 mm
3
in the T-oligo-treated group (p = 0.04). These
data demonstrate the potential therapeutic use of DNA oligonucleotides homologous to the
telomere 3¢ overhang to induce apoptosis and/or differentiation of melanoma cells.
070
p16INK4A Induction is Activated as a Senescence Mechanism and Immortalization
Barrier in Keratinocytes in Culture and in Dysplastic Epithelium In Vivo as a Potential
Barrier to Malignant Progression
J. Rheinwald, M. Ramsey, E. Natarajan,² M. Saeb,* Z. Guo, N. Radoja, S. Woo,² and P.
McKee*
Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts,
U.S.A.; *Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts,
U.S.A.; ²Oral Pathology, Harvard School of Dental Medicine, Boston, Massachusetts, U.S.A.
We have sought to identify conditions under which the cell cycle inhibitor p16INK4A is up-
regulated in keratinocytes. p16 has been implicated in limiting replicative lifespan of keratinocytes
in culture and interfering with immortalization by TERT. A recent study, however, tentatively
concluded that p16 senescence is an artifact and that, under suitable conditions, TERT expression
can immortalize keratinocytes and bypass p16 arrest. Other studies have found that p16 protein is
not detectable in normal strati®ed epithelium and yet potential expression is typically lost by
genetic changes in squamous cell carcinomas. We compared p16 expression, lifespan (LS), and
TERT-immortalization for primary epidermal (strain N), oral (OKF4), and corneal limbal (KL5)
keratinocytes cultured in Gibco ker-sfm medium (G) and in the serum/DMEM/F12 3T3 feeder
(a.k.a. Rheinwald/Green) system (F). OKF4 had a longer LS in F than G, but the others had
similar LS in F and G. Cells double-immunostained for p16 and for BUdR incorporation showed
that most cells senescing after growth in either media were p16-positive. We transduced OKF4 and
KL5 to express TERT and then compared their fates in G vs. F. Immortalization occurred more
readily, but not always, when TERT cells were maintained in F. TERT cells cultured in G could
also produce immortalized lines if transduced early in their LS. Many TERT-immortalized lines in
G or F initially grew slowly but evolved more rapid growth, apparently by selection of variants
de®cient in p16 expression. We found that epidermal and oral dysplastic and CIS lesions in vivo
contain many p16-positive cells. These results suggest that p16 up-regulation is a natural tumor-
suppressor mechanism, activated in response to abnormal growth in vivo and in culture. In both
settings, selection pressure favors growth of variants that can evade this mechanism.
072
Bypassing CDK4 Suppression by Oncogenic Ras Leads to Invasive Human Epidermal
Carcinoma Capable of Visceral Dissemination
M. Lazarov, Y. Kubo, M. Dajee, T. Cai, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Ras acts with other proteins to induce neoplasia. By itself, however, strong Ras signaling arrests
growth of normal cells. In keratinocytes, we found that Ras suppresses CDK4 levels and that
CDK4 coexpression bypasses Ras growth inhibition. Ras-CDK4 expressing primary human
keratinocytes grafted on immune de®cient mice generate an invasive neoplasia resembling
squamous cell carcinoma (SCC) [n = 12]. These neoplasms display features of human SCC,
including invasiveness as well as decreased E-cadherin expression along with augmented MMP2/3
and VEGF levels. Ras-CDK4 expressing primary human keratinocytes rapidly generate tumors
upon subcutaneous injection and are capable of visceral dissemination, producing multiple
pulmonary tumor nodules within 3 weeks. Re-isolated tumor cells displayed are diploid and lack
chromosomal recombination as assayed by SKY-FISH analysis, arguing against additional genetic
changes from genomic instability. Of interest, 4 SCC excised from human patients displayed levels
of CDK4 and Ras protein expression comparable to induced Ras-CDK4 neoplasia. Ras-CDK4
epidermal neoplasia is dependent on CDK4 kinase function as coexpression of kinase-inactive
CDK4 N158 point mutant with Ras failed to generate tumors. Cyclin D1 coexpression with Ras
in the absence of CDK4 failed to induce neoplasia and cyclin D1 antisense vector blocked Ras-
CDK4 tumorigenesis, indicating that cyclin D1 is necessary but not suf®cient for this process. Ras
and CDK4 alter the composition of cyclin D and cyclin E complexes and promote resistance to
growth inhibition by INK4 CKIs, including p15INK4B and p16INK4A. Thus CDK4's principal
role in Ras-driven neoplasia appears to center on promoting escape from G1 growth restraints to
permit uncontrolled proliferation. These data identify a new role for oncogenic Ras in CDK4
regulation, describe the ®rst instance of human neoplasia induced from only 2 genetic elements and
highlight the functional importance of CDK4 suppression in preventing uncontrolled growth.
069
The Kaposi's Sarcoma-Associated Herpesvirus Gene LANA Immortalizes Primary
Human Umbilical Vein Endothelial Cells
T. Watanabe, M. Sugaya, A. Atkins, E. Aquilino, and A. Blauvelt
Dermatology Branch, National Cancer Institute, Bethesda, Maryland, U.S.A.
Although more than 80 ORFs are present in the genome of Kaposi's sarcoma-associated
herpesvirus (KSHV), only a small subset (~5) of these genes is highly expressed in KS tumor spindle
cells. To better understand KS pathogenesis, we stably transduced NIH3T3 cells and primary
human umbilical vein endothelial cells (HUVEC) using retroviral constructs containing LANA or
v-cyclin, two of the ®ve KSHV genes expressed in KS tumors. KSHV gene-transduced cells were
directly compared with untransduced cells and cells transduced with retroviral vector alone
(negative controls), as well as with cells transduced with the known viral oncogene SV40 large T
antigen (positive control). We discovered the following: (1) LANA-transduced NIH3T3 cells and
HUVEC assumed a spindle cell morphology; (2) cellular proliferation was increased 4±10 fold in
cells transduced with LANA or v-cyclin (more prominent in the former), but not as high as in
SV40-transduced cells; (3) LANA- and v-cyclin-transduced HUVEC, but not SV40-transduced
HUVEC, retained the ability to form tubular structures in an in vitro angiogenesis assay; (4) most
interestingly, transduction of HUVEC with LANA greatly extended cellular life span (25+
passages) when compared to untransduced, retroviral vector-transduced, or v-cyclin-transduced
HUVEC (<10 passages); and (5) unlike SV40-transduced cells, LANA- and v-cyclin-transduced
cells demonstrated neither clonogenicity in soft agar assays nor tumorigenicity in nude mice. Taken
together, these results suggest that KSHV LANA induces cellular immortalization, but not cellular
transformation (like SV40 large T antigen). These ®ndings add insight into how KSHV may cause
KS, providing a possible explanation for the increased proliferation of KS spindle cells and for the
relative lack of true malignant conversion (i.e. transformation) of KS tumors. Finally, HUVEC
immortalized by KSHV LANA should prove useful as a model system for elucidating molecular
mechanisms of cellular immortalization and for testing of potential therapeutic strategies for KS.
071
Familial Basaloid Follicular Hamartoma: Comparison and Contrast with Basal Cell
Carcinoma
D. Jih, M. Shapiro, W. James, M. Levin, P. Williams,* R. Oakey,* S. Fakharzadeh,* and J.
Seykora
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; *Department
of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.
Deregulation of the patched signaling pathway plays a key role in the tumorigenesis of basaloid
epithelial neoplasms such as basal cell carcinoma (BCC) and tricoepitheliomas. In this report, we
characterize a familial case of basaloid follicular hamartoma (BFH), a rare indolent basaloid
epithelial tumor, and compare it with BCC. A father and daughter presented with multiple 1±
2 mm ¯esh colored papules on the face which exhibited a stable clinical course; the daughter also
demonstrated palmar pits but no other features of basal cell nevus syndrome. Histiologically, BFH
differs from BCC in that the lesional cells appear more differentiated and emanate from the
follicular infundibulum. BFH does not demonstrate signi®cant single cell necrosis, mucinous
stroma, cytologic atypia, peripheral palisading of tumor cells as is characteristic of BCC. Given
these differences we also characterized the staining pattern of various immunohistochemical
markers in a series of 6 BFHs and 8 BCCs with follicular differentiation. In BFH, the proliferation
markers, PCNA and Ki-67, stained positively in less than 10% of lesional cells whereas the BCCs
demonstrated more prominent staining for both molecules. By mRNA in situ hybridization, both
BFH and BCCs demonstrated increased expression of the patched gene; however, in BFH patched
was overexpressed in lesion cells contacting the dermis while in BCC, patched was diffusely up-
regulated. Our results support the idea that BFH is a distinct basaloid epithelial neoplams, differing
from BCC, but both BFH and BCC exhibit deregulation of the patched pathway. This is
important as basaloid follicular hamaratomas are often misclassi®ed as basal cell carcinomas often
resulting in unnecessary surgical therapy.
067
12-O-Tetradecanoylphorbol 13-Acetate Induces Keratinocyte Differentiation Through
Phospholipase D Activation
W.B. Bollag,*² W.T. Allred², and D.M. Hardy²
*Department of Medicine (Dermatology), Medical College of Georgia, Augusta, Georgia, U.S.A.; ²Institute
of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia, U.S.A.
We have previously demonstrated that the protein kinase C (PKC)-activating phorbol ester, 12-O-
tetradecanoylphorbol 13-acetate (TPA) activates phospholipase D (PLD) in primary mouse
epidermal keratinocytes. We investigated the potential role of this PLD activation in TPA-induced
keratinocyte differentiation. The effect of PKC inhibitors on TPA-stimulated PLD and
transglutaminase (TGase) activities was determined by incubating keratinocytes with 100 nM




6983. PLD activation and TGase activity, as a measure of keratinocyte differentiation, were then
measured after 30 min and 6 h, respectively. Go
È
6983 more effectively inhibited both TPA-





PLD activation by approximately 36% and TGase activity by 35%, whereas Go
È
6983 decreased
PLD activity by 80% and TGase activity by 96%. PLD catalyzes the hydrolysis of phosphatidylcho-
line to yield phosphatidic acid, which can be dephosphorylated to produce diacylglycerol. In the
presence of small amounts of a primary alcohol, PLD can also catalyze a transphosphatidylation
reaction that results in the formation of novel phosphatidylalcohols, which are generally not
metabolized well in cells. Inhibiting PLD signal generation with 1-butanol inhibited TPA-induced
TGase activity. On the other hand, the structurally related tertiary alcohol, tert-butyl alcohol,
which cannot be utilized by PLD, had no signi®cant effect on the activity of the late differentiation
marker, TGase. TPA activates all conventional and novel PKC isoforms, yet cannot circumvent
the 1-butanol-mediated inhibition resulting from decreased PLD signal generation. This result
suggests that PLD mediates its differentiative effects in keratinocytes, at least in part, through an
effector enzyme system distinct from the conventional or novel PKC isoenzymes.
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Role of c-Myc in Sebaceous Gland Development and Carcinogenesis
K.A. Huntzinger,* R.L. Waikel,* and D.R. Roop*²
*Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, U.S.A.;
²Department of Dermatology, Baylor College of Medicine, Houston, Texas, U.S.A.
c-Myc, is an oncoprotein known to induce proliferation, transformation and apoptosis in
mammalian cells. To analyze the role of c- Myc in vivo, we previously targeted the overexpression
of c-Myc to the hair follicles and basal layer of the mouse epidermis. These mice (K14.myc2) when
homozygous, exhibit a hyperplastic phenotype at postnatal day 3, are signi®cantly smaller than
wild-type littermates, and die before 21 days of age. K14.myc2 heterozygous mice do not exhibit
an obvious phenotype as neonates, but as adults develop spontaneous ulcerated lesions, which
become so severe they must be euthanized at 5 months. We have previously documented that this
phenotype occurs due to a severe impairment in wound healing and accelerated depletion of
epidermal stem cells. These mice also exhibit an increase in the number and size of sebaceous
glands and exposure to a chemical carcinogenesis protocol results in development of sebaceous
gland tumors with a frequency of 100%. Taken together, these results suggest that deregulated
expression of c-Myc may alter the fate of multipotent stem cells, diverting them to a sebaceous
gland lineage. The short life span of the K14.myc2 mice limits their use in further testing this
hypothesis. To bypass the premature lethality of K14.myc2 mice, we have generated an inducible
mouse model in which c-Myc expression can be regulated by topical application of RU486.
Topical treatment of these neonatal mice to induce c-Myc expression results in an accelerated rate
of sebaceous gland development. Current studies are using the inducible model to determine the
molecular mechanisms by which c-Myc overexpression in¯uences stem cell fate decisions and
transformation.
076
Immunohistochemical Analysis of Biomarkers for DNA Adducts and DNA Damage in
Carcinogenesis
R.N. Saladi, L.M. Austin, M.G. Lebwohl, and H. Wei
Dermatology, Mount Sinai School of Medicine at NYU, New York, New York, U.S.A.
Sunlight (UV radiation) alone or in combination with the model environmental carcinogen
Benzo(a)pyrene (BaP) induces DNA adducts (6±4 dipyrimidines and BPDE ± DNA, respectively)
and oxidative DNA damage (8-hydroxy-2'-deoxygunosine (8-OHdG)) which are measured in
carcinogenic risk assessment studies. DNA adduct formation and oxidative DNA damage plays an
important role in many pathological conditions including carcinogenesis and photo-aging. The
purpose of this study was to establish experimental protocols for immunohistochemical evaluation
of UV induced DNA-photoproducts, carcinogen induced DNA-adducts and oxidative DNA
damage for future studies on carcinogenic induction and prevention. Tumor-prone SKH-1 mice
were treated with either UVA, UVB, BaP, combination UVA/BaP, or left untreated for negative
controls in order to induce signi®cant levels of speci®c types of DNA adducts and oxidative DNA
damage on dorsal areas of skin. Following treatment, adjacent samples of excised skin were turned
into formalin-®xed paraf®n sections or acetone-®xed frozen sections for immunohistochemical
evaluation of speci®c monoclonal antibodies. Our UVA and UVB treatments induced staining
with the anti-UVssDNA antibody indicative of 6±4 dipyrimidine photoproducts. Equivalent
staining was detected both in paraf®n and frozen sections. Skin samples taken from BaP and BaP/
UVA treated mice shown staining for anti-BPDE-DNA. The staining patterns were consistent for
each of these types of treatments in paraf®n and frozen sections. Oxidative DNA damage was
detected following UVB treatments using an anti8-OHdG monoclonal antibody on frozen
sections. For all of these antibodies, no staining was observed within untreated skin nor with
duplicate sections stained with the isotype controls. Therefore, these DNA damage biomarkers
should provide speci®c, sensitive, and direct identi®cation of potential precancerous cells for future
carcinogenic research in Dermatology.
078
Benzo(a)pyrene Plus Ultraviolet A Exposures Cause a Time-Related Accumulation of
DNA Damage
R.N. Saladi, L.M. Austin, D. Gao, Y. Lu, Z. Fazekas, M.G. Lebwohl, and H. Wei
Dermatolgy, Mount Sinai School of Medicine at NYU, New York, New York, U.S.A.
Polycyclic aromatic hydrocarbons (PAH) including Benzo(a)pyrene (BaP) are ubiquitous
environmental carcinogens. BaP is metabolized in vivo to reactive intermediates that become
covalently bound to DNA and form BaP±DNA adducts, an initial event in carcinogenesis. UVA
synergies with BaP to signi®cantly accelerate carcinogenesis and tumor formation. This study was
initiated to investigate in vivo cellular changes related to carcinogenesis induced by repeated
exposures to BaP plus UVA. This simulated chronic exposure to an environmental carcinogen and
sunlight was done through biweekly topical BaP treatments (20 nmol/mouse) followed one hour
later by a single UVA dose (40 KJ/m
2
) to dorsal mouse skin over a 10-week period. BaP diol
epoxide (BPDE)±DNA adducts were measured in vivo by immunohistochemistry using an anti-
BPDE±DNA monoclonal antibody. Oxidative damage was measured using HPLC detection of 8-
hydroxy-2'-deoxygunosine (8-OHdG) formation in equivalent samples of epidermis. Alterations
in cell cycle physiology relevant to carcinogenesis were revealed by changes in p53 as identi®ed in
vivo using an anti-p53 polyclonal antibody. We found that cells containing BPDE±DNA adducts
and nuclear p53 expression increase between 2 and 10 weeks of treatment while no damage nor
signi®cant amounts of p53 were observed in untreated skin. Using regression analysis, oxidative 8-
OHdG damage also showed a parallel increase over 2±10 weeks (r = 0.80). We previously reported
in vitro experiments showing that BaP in combination with UVA substantially enhanced the
formation of 8-OHdG. In this study, we extended these observations to show that over time
multiple treatments proportionally increased formation of 8-OHdG. Overall these results indicate
that genetic damage due to exposures to BaP plus UVA accumulates with time and increases the
potential for inductive events leading to carcinogenesis and tumor formation.
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NF-kB Blockade and Oncogenic Ras Induce Invasive Human Epidermal Neoplasia by
Circumventing Cell Cycle Arrest
M. Dajee, M. Lazarov, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
While more dif®cult to transform than mouse, human skin tissue represents a more faithful setting
in which to study contributions of these regulators to neoplasia. Both NF-kB and Ras are proto-
oncogenes that regulate epidermal growth. Ras can stimulate epidermal proliferation, however,
strong constitutive Ras signaling triggers keratinocyte growth arrest. When expressed in primary
human epidermal cells via high ef®ciency retroviral transduction, oncogenic H-Ras causes growth
arrest. Because NF-kB subunits also inhibit epidermal growth, we coexpressed the NF-kB
inhibitor, IkBaM, to examine effects of simultaneous NF-kB blockade on Ras-induced growth
arrest. IkBaM bypassed Ras growth arrest but failed to block Ras induction of CDK inhibitors.
However, IkBaM reversed the suppression of CDK4 protein expression mediated by oncogenic
Ras. When regenerated upon human dermis xenografted to immune de®cient mice, unselected
human epidermal tissue expressing Ras and IkBaM produced large tumors resembling human
SCC within 3 weeks in all cases [n = 8], indicating that NF-kB blockade not only circumvents
oncogenic Ras growth arrest but also supports Ras-driven tumorigenesis. In contrast, expression of
Ras alone led to cell growth arrest with poor graft take while IkBaM alone grafts demonstrate only
moderate epidermal hyperplasia [n = 4 each]. Ras-IkBaM tumors display hallmark histologic and
protein expression features of human SCC, including induction of VEGF and MMP2/3 as well as
suppression of E-cadherin and a > 50-fold boost in mitotic index. Ras-IkBaM expressing primary
human keratinocytes produced subcutaneous tumors on injection into nude mice and were capable
of visceral dissemination, producing > 20 visceral tumor nodules/mouse within 3 weeks.
Functional studies indicate that Ras and IkBaM make distinct contributions to this process: Ras
induces key targets such as VEGF and MMPs and IkBaM ± acting via CDK4 ± helps bypass G1
growth arrest induced by Ras.
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Analysis of Genetic Instability in Cutaneous T-Cell Lymphomas by Microallelotyping
A.F. Ru
È
bben,*³ W. Kempf,³ M. Kadin,² and G. Burg³
*Dermatology, RWTH-Aachen, Aachen, Germany; ²Pathology, Harvard Medical School, Boston,
Massachusetts, U.S.A.; ³Dermatology, UniversitaÈtsspital ZuÈrich, ZuÈrich, Switzerland
Analysis of microsatellite DNA enables detection of microsatellite instability (MSI) as well as of
gross chromosomal rearrangements (GCR) within malignant tumors but identi®cation of genetic
instability may be obscured by the presence of normal cells in the biopsy specimen. Thus, we have
performed microsatellite analysis on microdissected tissue sections from six patients with mycosis
fungoides and one patient with anaplastic large cell T-cell lymphoma originating from
lymphomatoid papulosis. We extracted DNA from 253 microdissected regions from 28 lesions
and performed PCR at markers: D6S260, D6S261, D9S162, D9S171, D10S215, P53, D18S65.
Loss of heterozygosity (LOH) as indicator of GCR as well as MSI could be demonstrated in tumor
tissues of all patients. LOH was found at 55 out of 87 PCR-ampli®cations of heterozygote
microsatellite markers (63%). The frequency of LOH varied from 30% to 81% between the
analysed patients. Microsatellite instability was identi®ed at 121 out of 379 analysed PCR
ampli®cations of microsatellite markers (32%, range: 18%-51%). Our results con®rm that genetic
instability is a driving force of tumorigenesis and tumor progression in cutaneous T-cell
lymphomas. Moreover, the data suggest that both forms of genetic instability, MSI as well as GCR,
play a signi®cant role in this process.
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Expression of CD117 (c-kit) in Dermato®brosarcoma Protuberans: An
Immunohistochemical Study of 25 Cases
A.Y. Moore, T. Moore,* P. Sinkre,² and R. Ashfaq²
Dermatology, The University of Texas South-western Medical Center, Dallas, Texas, U.S.A.; *Surgery,
Baylor University Medical Center, Dallas, Texas, U.S.A.; ²Pathology, The University of Texas South-
western Medical Center, Dallas, Texas, U.S.A.
CD34, the de®ning antigen of dermato®brosarcoma protuberans (DFSP), is also expressed in a
wide variety of tumors including, solitary ®brous tumor, Kaposi's sarcoma, various lipomatous
tumors and the most common mesenchymal tumor of the gastrointestinal tract, i.e. gastrointestinal
stromal tumors (GISTs). In the GISTs, the signi®cance of CD34 expression has been superseded by
CD117 as the more sensitive, more speci®c and therapeutically signi®cant antigen. CD117, the c-
kit proto-oncogene product, de®nes the transmembrane receptor tyrosine kinase KIT. C-kit
mutations constitutively activate the KIT tyrosine kinase and thereby confer a positive growth
potential. Imatinib mesylate, an inhibitor of the tyrosine kinase, has found successful therapeutic
applications both in preclinical experiments and in clinical trials and forms a key anticancer drug for
GISTs. Although occasional CD117 reactivity has been described in DFSPs, there have been no
studies to our knowledge that have studied this marker exclusively in DFSPs. We studied the
expression of CD117 in 25 cases of DFSPs retrieved over a two year period. The diagnosis of
DFSP in all 25 cases was supported by immunoreactivity for the CD34 antigen. In 21 cases the
degree of reactivity was negative. In 2 cases the degree of reactivity was rare positive cells, 2% and
in 2 cases the degree of reactivity was 2±3+, > 50% of the cells. CD117 is expressed in a minority
(4/25, 16%) of DFSPs. Unlike CD34, CD117 does not de®ne the immunohistochemical pro®le of
DFSP. Whether Imatinib mesylate has a role in the therapy of those rare cases of DFSP that show
distinct immunoreactivity for CD117 remains to be studied.
220 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
080
Chemokine Receptors Alter Metastastic Pathways in B16 Murine Melanoma
S.T. Hwang, W. Maki, H. Fang, and T. Murakami
Dermatology Branch, NCI, Bethesda, Maryland, U.S.A.
The chemokine receptors CCR7 and CXCR4 are up-regulated in some human breast cancer and
melanoma lines, suggesting that these receptors may play a role in the localization of cancer
metastases. Herein, we determined if regional (lymphatic) lymph node (LN) metastasis and distant
(vascular) lung metastases could be in¯uenced by the expression of these receptors.
CCR7(lo)CXCR4(lo) murine B16 melanoma were retrovirally transduced with either the
cDNA for CCR7 or CXCR4. CXCR4-B16 cells were also transduced with cDNA for luciferase.
Functional CCR7 expression was con®rmed with calcium ¯ux assays, and anti-CXCR4 mAb
were used to select B16 with high levels of CXCR4. Regional LN metastases were assayed by ®rst
injecting tumor cells into the footpad of mice, followed by extraction of the draining popliteal LN
7±10 days later and quanti®cation by RT-PCR for tyrosinase-related protein-1. Vascular
metastases were assayed by counting visible metastases and measuring luciferase activity in lung
tissue. Metastasis of CCR7-B16 cells to regional LN was 700-fold greater compared to vector-B16
cells and could be inhibited by neutralizing anti-SLC (a CCR7 ligand) antibodies. 58% of mice
injected with CCR7-B16 (vs. 5% of vector-B16-injected mice, p = 0.005) showed gross LN
metastases 3 weeks after footpad injection. Compared to vector-B16, CCR7-B16 showed no
enhancement of metastases to lung when injected i.v. By contrast, CXCR4-B16 showed little
enhanced regional LN metastasis although pulmonary metastases were increased 9-fold compared
to vector-B16. Strikingly, pulmonary metastases in CXCR4-B16 injected mice were inhibited
by > 70% with daily injections of T22, an 18 amino acid, speci®c inhibitor of CXCR4 function.
Thus, the chemokine receptors CXCR4 and CCR7 demonstrated differential increases in
metastases at speci®c sites. Anti-SLC antibodies and a novel small peptide inhibitor of CXCR4
demonstrated ef®cacy in reducing metastases in draining LN and in the lung, respectively,
suggesting that targeting of speci®c chemokines or their receptors may reduce metastatic
dissemination.
082
Immunohistochemical Staining of RhoC in Human Melanoma
G. Weichert, E. Achilli,* N. Ball, and Y. Zhou
Division of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada;
*Department of Kinesiology, Simon Fraser University, Vancouver, British Columbia, Canada
Rho is a cellular enzyme of the Rho-GTPase family. In a study of melanoma cell lines RhoC
expression was increased in cells with high metastatic potential. Ampli®cation of RhoC expression
resulted in increased migration and invasion by melanoma cells. These studies suggest that RhoC
may be a key alteration in the genetic machinery of melanoma cells leading to metastatic potential.
RhoC has thus far been studied only within experimental melanoma cell lines. The status of RhoC
in human melanoma has not been studied. Our hypothesis was that RhoC immunohistochemical
staining would be enhanced in melanomas of greater thickness, thereby representing a greater
metastatic potential. We examined 13 primary melanomas (0.35±6.0 mm). Four benign
melanocytic nevi were used as controls. Sections of tissue were incubated with the human
RhoC antibody (Santa Cruz Biotechnology), counterstained with a secondary antibody and
processed with an avidin-biotin immunoperoxidase stain. Examination revealed positive staining in
control lesions and in the melanomas. Deeper melanomas had an enhanced degree of staining
compared to thinner melanomas. However, when these thicker melanomas were compared to
benign melanocytic lesions of similar thickness, the degree of staining was not signi®cantly
different. In summary, this is the ®rst study to examine human melanoma tissue for the presence of
RhoC. Although this protein has been implicated in enhanced metastatic potential in melanoma
models, the presence of RhoC as assessed by immunohistochemistry in human melanoma tumours
does not appear to be increased compared to benign melanocytic lesions of large bulk.
084
Novel Approach to Cancer Chemoprevention: Inhibition of Sonic Hedgehog (shh)
Signaling by Cyclopamine (CPN) Abrogates Ultraviolet B-Induced Basal Cell
Carcinomas (BCCs) in ptch+/± Heterozygous Mice
X. Tang, M. Athar, A.L. Kim, L. Kopelovich,* E.H. Epstein,² and D.R. Bickers
Dermatology, College of Physicians & Surgeons, Columbia University, New York, New York, U.S.A.;
*Division of Chemoprevention, NCI, Bethesda, Maryland, U.S.A.; ²Dermatology, UCSF, San Francisco,
California, U.S.A.
Cancer chemoprevention at the gene level is a major challenge. UVB-induced BCCs are the most
common form of human cancer. Mutations in shh signaling genes including patched (ptch) and
smoothened activate transcription factors of the GLI family that regulate target genes leading to
BCCs development. Ptch+/± knockout mice develop BCCs and trichoblastomas following
chronic exposure to UVB and manifest activated shh signaling. To explore the possibility that
inhibition of shh signaling could provide an innovative approach to chemoprevention of BCCs,
CPN, which blocks shh signaling, was assessed for its effect on UVB-induced BCCs development.
For this experiment, ptch+/± mice were irradiated with UVB (240mJ/cm
2
, three times a week) for
35 weeks at which time 50% of the mice had one or more visible tumors. UVB was then stopped
and mice were divided into two groups of 30each with ~equal tumor numbers. Group-1 received
vehicle whereas group-2 received 0.1 mg% CPN in drinking water. Mice treated with CPN
developed 30% fewer visible tumors compared to controls by week 52. However, the number of
BCCs in CPN-treated mice was reduced by more than 50%. In addition, microscopic lesions





tissue area). To further explore the mechanism of action of CPN its effect on the expression
of cell cycle regulatory proteins was assessed. Over-expression of cyclin D1, A2 and B1 occured in
UVB-irradiated skin; CPN signi®cantly reduced the expression of these proteins. These results
indicate that chemical blockade of shh signaling by CPN substantially diminished UVB-induced
BCCs development in ptch+/± mice and that this compound also diminished UVB-induced
aberrant cyclin overexpression that occurs in UVB-irradiated skin.
079
Gamma Delta T Cells: A Novel Marker Associated with Decreased Survival in
Cutaneous Peripheral T Cell Lymphoma
J.R. Toro, D. Liewehr, L. Sorbara, M. Raffeld, S. Steinberg, and E. Jaffe
Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, U.S.A.
The exact function of gamma delta T-cells is still unclear, particularly with respect to their role in
lymphomas. The objective of this study was to investigate the prognostic value of TCRd1
expression in primary cutaneous peripheral T-cell lymphoma. TCRd1 cellular expression was
assessed in skin biopsy specimens of 104 individuals with Peripheral T-cell lymphoma by
immunohistochemistry. Both univariate (Kaplan-Meier) and multivariate (Cox regression) analyses
were conducted to determine which variables (T-cell type, hemophagocytosis, histologic pro®le,
age, sex, and adenopathy) were signi®cantly associated with survival. Univariate analysis indicated
that there was a statistically signi®cant difference in survival between the patients with alpha beta
cutaneous T-cell lymphoma and patients with gamma delta cutaneous T-cell lymphoma
(p < 0.0001). There was also a statistically signi®cant decrease in survival among patients who
had subcutaneous involvement compared with patients who had epidermotropic and/or dermal
involvement (p < 0.0001). A Cox model analysis was also done to evaluate factors simultaneously,
and prognostic factors considered in the Cox analysis included: T-cell type, histologic pro®le, and
sex. This analysis indicated that TCRd1 expression was the factor that was most well associated
with decreased survival (p < 0.0001). Among those patients with cutaneous gd T-cell lymphoma
(n = 33), there was a trend for decreased survival for patients who had histologically subcutaneous
fat involvement in comparison to patients who had epidermotropic and/or dermal involvement
(p = 0.067). No other prognostic factors were identi®ed as having a notable association with
outcome in this subgroup. TCRd1 expression in cutaneous lymphomas is an independent
prognostic factor associated with decreased survival.
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Selective Inhibition of Tumor-Angiogenesis by CD4+ T Cells
H. Braumu
È
ller, B.J. Pichler,* A.K. Sakrauski, N. Mu
È
ller-Hermelink, M. Kneilling, K. Ghoreschi,
M. Schwaiger,* W.A. Weber,* and M. Ro
È
cken
Dermatology, Ludwig-Maximilians University, Munich, Germany; *Nuclear Medicine, Technical
University, Munich, Germany
We and others recently showed that tumor-speci®c Th1 cells are ef®cient in the treatment of
MHC class II+ and MHC class II± tumors. To investigate the underlying antitumor mechanism we
studied tumor-speci®c Th1 cells in RIP1-Tag2 mice that express SV40 T antigen (Tag) in all
insulin-producing beta cells of the pancreas; 30% of the islets develop into adenomas and 1±2% into
carcinomas. At 14 weeks mice die from hypoglycemia. Tumor-speci®c Th1 cells were generated
by stimulating CD4+ cells from T cell receptor (TCR) transgenic C3H mice bearing a TCR
speci®c for Tag peptide. Mice recieved 107 Th1 cells weekly. At various times part of the animals
were sacri®ced for further investigations. Th1 treatment prevented hypoglycemia and prolonged
life of mice by a factor of two. Surprisingly, Th1-treated mice never developed diabetes. These
data suggested that Th1 cells did not destroy Tag+ cells but arrested tumor development at early
stages. This hypothesis was underlined by histology, showing large, vascularized tumors in sham-
treated mice, but only small poorly vascularized adenomas in Th1-treated animals at 13 weeks. To
objectify this ®nding, we injected mice with an I125-labelled RGD-peptide binding to the
biologically active con®guration of aV-b3 integrin that is preferentially expressed during tumor-
angiogenesis. Sham-treated mice had 8-fold increased aV-b3 expression in their pancreas, while
this integrin remained almost normal in Th1-treated mice. Transfer of tumor-speci®c Th1 cells did
not affect any other organ. In contrast to CD8+ T cells, tumor-specifc Th1 cells seem to prevent
tumor development by selective inhibition of tumor angiogenesis and possibly even malignant
transformation. Thus, adoptive transfer of tumor-speci®c Th1 cells establishes not only highly
ef®cient and safe tumor therapies, but may raveal new insights into the interaction between tumor-
development and host immune system.
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Alteration of Mast Cell Proliferation/Apoptosis and Expression of Stem Cell Factor in
the Regression of Mastocytoma
T. Inoue, M. Kakurai,* M. Manabe, and T. Demitsu²
Department of Dermatology, Akita University School of Medicine, Akita, Japan; *Department of
Dermatology, Jichi Medical School, Tochigi, Japan; ²Omiya Medical Center, Jichi Medical School, Saitama,
Japan
Spontaneous regression of solitary mastocytoma is a well-described phenomenon, but its
mechanism is unknown. The present study was performed to elucidate mechanisms responsible
for the clearance of cutaneous mast cells from the lesional skin during the regression of
mastocytoma. We have examined serial-section immunohistochemical analyses on biopsies of a
mastocytoma from a Japanese child during the proliferation stage (PS, 7 months of age) and the
regression stage (RS, 5 years old). Mast cell density in RS was markedly decreased (406 cells/mm
2
)
compared to that in PS (3554 cells/mm
2
). Mast cells in RS were larger than those in PS. With
proliferative cell nuclear antigen (PCNA) staining, 1.7% Mast cells were positive in PS, whereas
none of positive mast cells was seen in RS. TUNEL-labeling index (LI) in RS (2.8%) increased 1.5
fold in PS (1.9%). With stem cell factor (SCF) staining, 57% of lesional mast cells in RS revealed
strong cytoplasmic immunoreactivity, whereas only 9% of mast cells were positive in PS.
Epidermal SCF reactivity was found as intracellular and intercellular patterns in both PS and RS.
We conclude that loss of mast cell proliferating activity, an increase in apoptotic mast cells, and
increased expression of SCF in remaining mast cells in RS may play a role in the involution of
mastocytomas.
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Over-Expression of RhoC in Human Melanomas
Y.G. Shellman, Y. Xu, I. Maxwell, and D.A. Norris
Dermatology, University of Colorado Health Science Center, Dever, Colorado, U.S.A.
RhoC GTPase is a member of Ras homologous (= Rho) small GTPases. Rho family members are
involved in regulation of a variety of cellular processes, such as the organization of the
micro®lamental network, cell-cell contact and malignant transformation. RhoC GTPase has been
shown involved in tumor metastasis in human tumors including breast cancer and melanoma.
Over-expression of RhoC up-regulates angiogenic factors such as vascular endothelial growth
factor (VEGF), basic ®broblast growth factor (bFGF), interleukin-6 (IL-6), and interleukin-8 (IL-
8) in breast cells (van Golen et al 2000, Neoplasia). It has also been shown that RhoC over-
expression could enhance the migratory and invasive capacity of a nonmetastatic melanoma cell
line (Clark et al 2000, Nature). To study the contribution of RhoC GTPase in metastasis in
melanoma, we are generating stable transfectants of several human melanoma cell lines over-
expressing the RhoC protein. Retroviral vectors carrying either a full-length human RhoC gene
or a dominant-negative Rho mutant (DN-Rho), together with a green ¯uorescent protein (GFP)
gene, were used to transduce three different human melanoma cell lines, and cells potentially
expressing high levels of RhoC were selected by ¯uorescence-activated cell sorting (FACS) for
GFP. The cell lines we used are: WM35, WM278, and WM1617, and they are radial growth
phase, vertical growth phase and metastatic melanoma cells, respectively. We have obtained stable
transfectants of WM35 cells with RhoC and DN-Rho, and con®rmed by quantitative RT-PCR a
6±12 increased RhoC expression. We are in the process of obtaining other stable transfectants. We
are using these cells to study the roles of RhoC in regulation of secretion of angiogenic factors, cell
migration, invasiveness, and apoptosis. These experiments should clarify the role of RhoC GTPase
in metastasis in melanoma, and might point to means for preventing the metastasis.
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Mismatch Repair Gene Mutations in Radial Growth Phase Cutaneous Malignant
Melanoma Cell Lines
M.R. Hussein and G.S. Wood
Medicine: Dermatology, University of Wisconsin Madison and Veteran Affairs Medical Center, Madison,
Wisconsin, U.S.A.
Although microsatellite instability and reduced expression of the mismatch repair (MMR) proteins
have been reported in melanoma, little is known about MMR gene mutations in these lesions. To
investigate these changes, radial growth phase Wistar melanoma cell lines were established and
UVB irradiated (10 mJ/cm
2
). Mutational analysis for exons 13,16 and 19 (hMSH2) and 6,7 and 12
(hMLH1) was performed both before and after irradiation by ®rst amplifying the individual exon
fragments and then directly sequencing the PCR products. Transition (T to C, G to A) and
transversion (G to T, A to T) mutations in exons 6,16,19 were found, some in the irradiated cells
only and some in both non irradiated and irradiated cells. Our data suggest that hMLH1 and
hMSH2 gene mutations occur early in melanoma tumorigenesis and can be induced further by
UVB irradiation. Further investigation is warranted to determine whether these mutations
contribute to the microsatellite instability that has been documented previously in melanomas.
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Beta-Catenin Expression in Pilomatricomas and Hair Follicle-Related Tumours
J. Xia, K. Urabe, H. Duan, T. Koga, and M. Furue
Dermatology, Kyushu university, Fukuoka, Fukuokaken, Japan
Beta-Catenin, a participant in the Wnt pathway, has been shown to play an important role in the
morphogenesis of hair follicles and the formation of hair follicle-related tumours, including
pilomatricomas. It has been reported that at least 75% of human pilomatricomas possess activating
mutations in beta-catenin. However, whether or not beta-catenin localizes in the nucleus of the
cells of pilomaticomas is controversial. To study the expression and the localization of beta-catenin
in pilomatricomas and other hair follicle-related tumours, we immunohistochemically stained beta-
catenin on 67 cases of human pilomatricomas and 43 cases of other human hair follicle-related
tumours. All transitional cells of pilomatricomas strongly expressed beta-catenin and most of the
basophilic cells also expressed beta-catenin strongly. Concerning the localization, beta-catenin was
stained in the nucleous of basophilic cells on 26 cases (53.2%) out of the 49 cases. On the contrary,
trichofolliculomas, trichillemmomas, trichilemmmal cysts and hidradenmas weakly expressed beta-
catenin just in the cytoplasmic region. Our results suggest tumorigenesis of pilomatricomas are
related to nuclear localization of beta-catenin.
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Spectrum of Mutations in 25 Xeroderma Pigmentosum Complementation Group C
Patients from the United States, Turkey and Israel
K.H. Kraemer,* S.G. Khan,* T. Shahlavi,* D.B. Busch,² T. Ueda,* H. Inui,* S. Emmert,* V.
Muniz-Medina,* C.C. Baker,* E. Gozukara,** H. Slor,³ A. Metin,§ R.B. Albert,² D.W. Ziffer,²
D.M. Coleman,² and J.J. DiGiovanna*¶
*BRL, NCI, Bethesda, Maryland, U.S.A.; ²Toxicology, AFIP, Washington, District of Columbia,
U.S.A.; ³Genetics, Tel Aviv U, Tel Aviv, Israel; §Derm, Yuzuncu Y'l U, Van, Turkey; ¶Derm, Brown
Medical School, Providence, Rhode Island, U.S.A.; **Biochem, Inonu U, Malatya, Turkey
Xeroderma pigmentosum (XP) patients have sun sensitivity with a 1000-fold increased risk of skin
cancers. XP complementation group A to G proteins function in DNA nucleotide excision repair.
The 940 amino acid XPC protein recognizes UV damaged DNA. Because XP cells exhibit
decreased survival after UV exposure, cells from suspected XP patients were screened for
hypersensitivity to killing by UVC. We then used a plasmid host cell reactivation assay to assign
hypersensitive cells to XP complementation groups. UV-treated luciferase containing plasmid was
transfected into XP cells along with wild type XP cDNA expression vectors of different
complementation groups. These studies identi®ed cell lines as XP-C in families from US, Turkey
and Israel. We developed methods to clone full length 3.5kb XPC cDNA and primers to amplify
each of the 16 XPC exons separately. 29 mutations in XP-C cell lines from 25 different families
were found: 20 mutations in exons 1 through 11, and 9 mutations in introns 1 through 11. There
were no large mutation hotspots. 19 of the exon mutations were deletions or single nucleotide
changes resulting in premature termination. One mutation interrupted the ATG initiation codon.
There were 2 splice donor, 4 splice acceptor and 3 lariat mutations. These intron mutations led to
exon skipping or insertion of portions of introns with consequent premature termination. We
developed a real time quantitative reverse-transcriptase polymerase chain reaction assay to measure
XPC mRNA levels in the cells. We found reduced XPC mRNA in 14 of 16 XP-C cell lines
which was consistent with nonsense mediated message decay anticipated from the premature
termination sequence data. These studies discovered a broad spectrum of mutations in the XPC
gene. Most lead to premature termination or exon skipping with low XPC mRNA levels.
087
p53 and Bcl2 Expression in Radial Growth Phase Wistar Melanoma Cell Lines Following
Ultraviolet Irradiation
M.R. Hussein, A.K. Midtling, and G.S. Wood
Medicine: Dermatology, University of Wisconsin Madison and Veteran Affairs Medical Center, Madison,
Wisconsin, U.S.A.
To investigate the underlying mechanisms of apoptotic changes in radial growth phase melanoma
following ultraviolet irradiation, an in vitro system consisting of Wistar melanoma cell lines was
established. Cells were UV irradiated (10 mJ/cm
2
for UVB and 6 J/cm
2
for UVA) and evaluated
for apoptosis, p53 and Bcl-2 protein expression using TUNEL assay and Western blot,
respectively. Ultraviolet irradiation caused an increase in the apoptotic activity in the irradiated cell
lines. The UVA irradiation induced more apoptotic effects than UVB. In UVB irradiated cells,
there was up-regulation of p53 and Bcl-2. In contrast, UVA irradiation down-regulated Bcl-2 and
had no effect on p53 expression. Further studies are needed to determine if the differential effects
of UVA and UVB on melanoma cell apoptosis are related directly to their differential effects on the
expression of p53 and Bcl-2. These alterations also suggest a potential role for UV radiation in
melanoma cell selection during tumor progression.
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Morphological Changes in Radial Growth Phase Wistar Melanoma Cell Lines Following
Ultraviolet-B Irradiation
M.R. Hussein, M.O. Hassan,* and G.S. Wood
Medicine: Dermatology, University of Wisconsin Madison and Veteran Affairs Medical Center, Madison,
Wisconsin, U.S.A.; *Pathology, Case Western Reserve University, Cleveland, Ohio, U.S.A.
Although ultraviolet irradiation (UVR) is potentially involved in melanoma tumorigenesis, in vitro
studies investigating the morphological changes in the early stages of this neoplasm following UVR
are still lacking. Thus, we used an in vitro system consisting of three radial growth phase Wistar
melanoma cell lines (WM35, WM3211 and WM1650) to investigate these changes. Cells were
UVB irradiated (10 mJ/cm
2
), harvested after UVB exposure and evaluated for morphological
changes using inverted light microscopy and transmission electron microscopy. As compared to the
nonirradiated cells, exposure to UVB produced: (1) progressive cell death associated with marked
apoptosis; (2) morphological changes including increased branching, cytoplasmic size, and number
of binucleated and multinucleated cells (phase contrast microscopy); and (3) increased nuclear to
cytoplasmic ratio and irregularity of nuclear contour, increased numbers of cytoplasmic organelles,
including mitochondria and prominent nucleoli, and appearance of apoptotic bodies (transmission
electron microscopy). The ability of UVB to induce these morphological changes in radial growth
phase melanoma cell lines is consistent with a role in melanoma apoptosis and possibly also
melanoma cell select Bcl-2 ion during tumor progression.
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Over-Expression of a Novel Caveolae Associated Protein, Flotillin-2, is Associated with
Melanoma Progression
P. Hazarika, S. George, V. Prieto,* X. Ni, M. Bar-Eli,² and M. Duvic
Dermatology, MDAnderson Cancer Center, Houston, Texas, U.S.A.; *Pathology, MDAnderson Cancer
Center, Houston, Texas, U.S.A.; ²Cancer biology, MDAnderson Cancer Center, Houston, Texas,
U.S.A.
Caveolae are blebs on the inner cell membrane containing caveolins and ¯otillin proteins forming
homo and heterodimers that tether growth factor receptors initiating signal transduction pathways.
Flotillin-2 (Flot-2) is a novel 41.7 kDa, highly conserved protein ®rst cloned from keratinocytes.
We ®rst studied the expression of ¯otillin-2 in tumor lines and found highest ¯ot-2 levels in highly
metastatic melanoma cell lines, inversely correlated with caveolin-1 isoforms. Flot-2 was next
transfected into a nonmetastatic melanoma line (SB2) creating two separate transformed clones that
were highly tumorigenic and metastatic with properties of vasculogenesis on matrigel and
angiogenesis in mice. To further study whether over-expression of Flot-2 protein was found in
progression of melanoma, we stained a tissue array composed of patient specimens from 19 benign
nevi, 21 dysplastic nevi, 25 primary melanoma lesions, and 19 nodal metastases using a mouse
monoclonal antibody to ¯ot-2 detected by immunohistochemistry with tyramide ampli®cation.
Flot-2 staining intensity was graded by 2 blinded observers on a semi quantitative scale (0 none to 5
strongest). Fisher's exact test was used to compare random samplings among patient groups. To
avoid reporting bias from the multiple comparisions, adjusted p-values using the step down
Bonferroni method of Holm are reported. There was a highly signi®cant difference between the
overall comparison of patients with nevi, primary melanoma, and metastatic melanomas
(p < 0.0001). Visceral and nodal melanomas were signi®cantly higher in ¯ot-2 staining intensity
than nevi or primary melanomas (p < 0.0001 and p = 0.02, respectively). Primary melanomas were
also signi®cantly higher than nevi (p = 0.02). These data suggest that over-expression of Flot-2 is
associated with melanoma progression.
094
Re®nement of the Locus for Multiple Cutaneous Leiomyoma and Uterine Fibroids,
MCUL1
A. Martinez-Mir,* D. Gordon,³ L. Horev,§ A. Panteleyev,* J. Ott,³ A. Zlotogorski,§ and A.M.
Christiano*²
*Department of Dermatology, Columbia University, New York, New York, U.S.A.; ²Department of
Genetics and Development, Columbia University, New York, New York, U.S.A.; ³Laboratory of Statistical
Genetics, Rockefeller University, New York, New York, U.S.A.; §Department of Dermatology, Hadassah
University Medecal Center, Jerusalem, Israel
The association of cutaneous and uterine leiomyomas in the autosomal dominant syndrome called
multiple cutaneous leiomyoma (MCL [MIM 150800]) facilitates the study of the genetic causes
underlying the more common uterine leiomyomas, a leading cause of hysterectomy. Very recently,
the locus responsible for MCL has been mapped to a ~14 cM region on chromosome 1q42.3±43.
The same locus has been identi®ed in a separate study as the susceptibility locus for a hereditary
cancer syndrome including renal cell cancer, as well as uterine and cutaneous leiomyoma. The aim
of our study is the genetic ®ne-mapping of the MCUL1 locus, to facilitate the identi®cation of the
underlying gene. We report the clinical and genetic ®ndings of an extended pedigree with MCL,
with an emphasis on the particular timing and speci®c pattern in the appearance of the skin lesions.
Using linkage analysis, we have narrowed the interval of the MCUL1 locus to a region of 4±7 cM
on chromosome 1. We have collected additional families with several affected family members
displaying the same combination of skin and uterine involvement and will proceed with the further
re®nement of the MCUL1 locus. Our results have signi®cantly narrowed the disease locus, already
excluding several positional candidate genes. According to the data gathered in the different linkage
studies, MCL exhibits genetic homogeneity with all families mapping to the same locus thus far.
Based on this, we predict that the use of newly identi®ed families with MCL such as this one will
be valuable in the search of the MCL gene.
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Antigen Peptide Mimics Coupled to Tetanus Toxoid are Recognized by the
Antimelanoma Monoclonal Antibody 225.28S
S. Wagner,* H. Christine, J. Erika,* C. Zielinski,² O. Scheiner,* K. Wolff, H. Breiteneder,* and
H. Pehamberger
Department of Dermatology, University of Vienna, Vienna, Austria; *Department of Pathophysiology,
University of Vienna, Vienna, Austria; ²Department of Internal Medicine I, University of Vienna, Vienna,
Austria
Tumor-associated antigens (TAA) are useful markers for the development of immunodiagnostic
and immunotherapeutic approaches. For melanoma the human high molecular weight-melanoma-
associated antigen (HMW-MAA) has been described as a TAA. Like most of the TAAs the HMW-
MAA represents a self-antigen. One approach to apply speci®c immunotherapy for malignant
melanoma is breaking the tolerance to this self-antigen. We used the anti-HMW-MAA
monoclonal antibody 225.28S for screening a linear and a circular pVIII-9aa phage peptide library
to develop peptide mimics of the HMW-MAA. After three rounds of panning speci®c phages were
enriched and the DNA coding for the displayed peptides was sequenced. The deduced amino acid
sequences of the peptides showed no homology to the amino acid sequence of HMW-MAA. In
ELISA experiments seven phages, four containing linear peptides and three containing circular
peptides, were recognized speci®cally by the 225.28S antibody. Two of the seven peptide mimics
were synthetically synthesized and coupled to tetanus toxoid. These conjugates were also
recognized speci®cally by the antibody. Competitive ELISA experiments showed that the 225.28S
antibody can be speci®cally prevented from binding to melanoma cells expressing the antigen
HMW-MAA by the conjugates. Our results clearly indicate that the phage displayed peptides are
structural equivalents of the 225.28S epitope of HMW-MAA. Furthermore, the peptides keep
their speci®city when coupled to tetanus toxoid. Therefore, the obtained immunogenic conjugates
represent useful tools to induce an immune response directed against the self-antigen HMW-
MAA.
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Identi®cation of Two Keratinocyte Stem Cell Regulatory Loci Implicated in Skin
Carcinogenesis
R.J. Morris, N.V. Popova, K.A. Teti,* and K.Q. Wu*
Dermatology, Columbia University College of Physicians and Surgeons, New York, New York, U.S.A.;
*Epithelial biology, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, U.S.A.
Several converging lines of evidence suggest that keratinocyte stem cells, including those capable of
colony formation in vitro, are the target cells in cutaneous carcinogenesis. To provide further
evidence and to look towards the identi®cation of important new regulatory genes, we have
recently demonstrated that the number of keratinocyte stem cells from mice, including the colony-
forming cells, is a genetically de®ned and quantitative complex trait. In this investigation, we
analyzed the size of the colonies in BALB/c, C57BL/6, and their (BALB/cxC57BL/6)F1 hybrid
mice. We found that the size of the colonies is also genetically regulated. We determined there are
at least two types of clonogenic keratinocytes that form either small or large colonies. We
performed a genome wide scan of the two backcross [BALB/cx(BALB/cxC57BL/6)F1]; C57BL/
6x(BALB/cxC57BL/6)F1]; and [(BALB/cxC57BL/6x(BALB/cxC57BL/6)F1] intercross mice.
We report here that loci on chromosomes 4 and 9 play a role in the regulation of large and small
colony number, respectively. We conclude that the epidermis of mice has at least two major types
of stem cells with different proliferative potentials and regulated by different genes. Moreover, the
loci (one major and several minor) linked to the subpopulation of keratinocytes forming small
colonies were related, if not identical to, the loci associated with susceptibility/resistance to skin
tumor promotion and skin tumor development.
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Trichothiodystrophy With and Without Xeroderma Pigmentosum
J.J. DiGiovanna,*² T. Ueda,* H. Inui,* D.B. Busch,³ M.R. Pittelkow,§ E. Sanders,¶ V. Price,**
A.R. Lehmann,²² and K.H. Kraemer*
*BRL, NCI, Bethesda, Maryland, U.S.A.; ²Derm, Brown Medical School, Prov, Rhode Island,
U.S.A.; ³Toxicology, AFIP, Washington, District of Columbia, U.S.A.; §Derm, Mayo Clinic, Rochester,
Minnesota, U.S.A.; ¶Derm, University of Alabama, Birmingham, Alabama, U.S.A.; **Derm, University
of CA, SF, San Francisco, California, U.S.A.; ²²GDSC, University of Sussex, Brighton, U.K.
Trichothiodystrophy (TTD) manifests as short brittle hair with a ``tiger tail'' appearance on
polarizing microscope and low sulphur content and may show photosensitivity, ichthyosis,
intellectual impairment, decreased fertility, and short stature (PIBIDS). Increased skin cancer
frequency is not a typical feature of TTD. The phenotype of xeroderma pigmentosum (XP) is
markedly different with early onset of sunlight induced skin changes including acute sun sensitivity,
lentiginous pigmentation, poikiloderma, and a 1000-fold increase of skin cancers. Remarkably,
most TTD patients have defective DNA repair with mutations in the XPD or XPB genes. We
report 2 unrelated patients with clinical features both TTD and XP and 2 siblings who have TTD
without XP. Patient XP/TTD268BE is a 17 y/o male with sulphur de®cient brittle hair with
``tiger tail'' appearance, sun sensitivity, ichthyosis, short stature, congenital cataracts, multiple sino-
pulmonary infections, and developmental delay. Brain MRI showed generalized leukodystrophy.
His sun exposed skin had the typical pigmentary changes of XP. Two different mutations in the
XPD gene were found in his cultured cells. Patient XP/TTD306BE is an 8 y/o male with brittle
hair with ``tiger tail'' appearance, sun sensitivity, ichthyosis, short stature, multiple sino-pulmonary
infections, developmental delay, and dysmyelinating changes on brain MRI. He had pigmented
lesions in a photodistribution indicative of mild XP. DNA repair studies are in progress. Siblings
TTD124BE, a 6 y/o boy, and TTD125BE, a 1.5 y/o girl, both had sulphur de®cient brittle hair
with ``tiger tail'' appearance. TTD124BE had short stature, with mild developmental delay but no
sun sensitivity ichthyosis, or infections. His skin was free of pigmented lesions with no features of
XP. DNA repair studies are in progress. In conclusion, TTD may occur alone or in combination
with XP. Those TTD patients who also have XP may have a greatly increased skin cancer risk.
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The Blockade of Epidermal Growth Factor Signaling in Human Cutaneous SCC Cell
Lines Suppresses the Cell Proliferation Associated with the Down-Regulation of
Constitutive Stat3 Activation
T. Bito, M. Ashida, A. Budiyanto, M. Ueda, and M. Ichihashi
Dermatology, Kobe University Graduate School of Medicine, Kobe, Japan
Recent study demonstrated that Stat3 activation in squamous cell carcinoma (SCC) abrogated
apoptosis in vivo. Stat3 has been recognized as an oncogene, thus the inhibition of Stat3 protein can
be a target of cancer therapies. To elucidate the role of Stat3 in cutaneous SCC, Stat3 activation
was investigated in human cutaneous SCC cell lines and skin SCC lesions using electrophoretic
mobility shift assay. Constitutive Stat3 activation was observed in 3 SCC cell lines (HSC1, HSC3,
and HSC4) and 3of 4 skin SCC tissues examined, but not in HaCaT cells nor in human primary
keratinocytes. Immunoprecipitation analysis revealed overexpression of epidermal growth factor
receptor (EGF-R) in the SCC cell lines. EGF-R inhibitor (AG1478) inhibited Stat3 activation of
HSC1 dose-dependently. As well. AG1478 suppressed the cell proliferation of HSC1 in a dose-
dependent manner. These data indicate that Stat3 activation in cutaneous SCC is associated with
overexpression of EGF-R, which may contribute to the cell growth.
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Overexpression of Smad7 Cooperates with a ras Oncogene to Cause Hyperproliferation
and Malignant Conversion of Primary Mouse Keratinocytes
X. Liu, M. Cooley, S. Hartley, E. Bhogte, and A. Glick
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda,
Maryland, U.S.A.
Smad7 is an inhibitory Smad which can block TGFb mediated signal transduction and is itself
induced by TGFb both in vitro and in vivo. Overexpression of Smad7 has been detected in some
human and experimental cancers. To address the role of Smad7 in squamous tumor development,
we have generated a retrovirus expressing a ¯ag-tagged Smad7 and used it along with a v-rasHa
expressing retrovirus to coinfect primary mouse keratinocytes. In doubly infected keratinocytes,
Smad7 blocked TGFb1 mediated induction of gene expression from a 3TP-lux reporter, cell cycle
arrest, and phosphorylation and nuclear translocation of Smad2. Skin grafts of the v-rasHa and
Smad7 infected keratinocytes formed squamous cell carcinomas within 3 weeks, while the control
v-ras and pBabepuro infected cells only formed benign papillomas. In the Smad7 tumors, the
percentage of BrdU labeled cells was 2-fold higher than controls, even in regions that showed no
evidence of malignancy. Smad7 tumors expressed keratin 8, a marker of malignant progression, and
had reduced or absent expression of keratins 1 and 10. Thus, these data demonstrate for the ®rst
time that inactivation of TGFb signaling through overexpression of Smad7 can cooperate with v-
rasHa to cause malignant conversion of primary mouse keratinocytes, and strongly suggest that
overexpression of endogenous Smad7 could be important for human cancer development.
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Suppression of Multistage Skin Carcinogenesis in Mice De®cient for Placental Growth
Factor
J. Silva,* H. Oura, K. Yano, T. Hawighorst, P. Carmeliet, and M. Detmar
*CBRC, Mass General Hospital, Charlestown, Massachusetts, U.S.A.; *Center for Transgene Technology
and Gene Therapy, University Ziekenhuis Leuven, KU Leuven, Belgium
Placental growth factor (PlGF), a member of the vascular endothelial growth factor (VEGF) family
of angiogenesis factors, activates VEGFR-1, but not VEGFR-2, generally thought to be the
predominant mediator of the pro-angiogenic effects of VEGF during tumor angiogenesis.
Accordingly, the biological importance of PlGF has remained unclear, in particular with regard to
tumor growth and angiogenesis. We subjected PlGF de®cient (n = 19) and age-matched wild-type
mice (n = 20) to a standard two-step chemical skin carcinogenesis regimen, using topical
application of 50 mg DMBA for tumor initiation and 20 weekly applications of 5 mg PMA for
tumor promotion. PlGF de®cient mice were healthy and fertile and did not display any
macroscopic abnormalities. PlGF de®cient mice showed a delayed onset of tumor formation with a
3-weeks longer average latency period than wild-type mice. At 20 weeks after initiation of tumor
promotion, PlGF de®cient mice had developed 3-times less papillomas per mouse than wild-type
mice. The vascularity of epithelial tumors that were induced in PlGF de®cient mice was reduced,
as compared with tumors induced in wild-type mice. However, PlGF de®ciency did not directly
affect the differentiation of normal or neoplastic epidermal keratinocytes. These results reveal an
important role of PlGF in the promotion of autochthonous epithelial tumor growth and associated
angiogenesis, and they suggest that PlGF, in addition to the established tumor angiogenesis factor
VEGF, might serve as a new target for antiangiogenic tumor therapy.
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Expression of Cyclooxygenase in the EpiDerm
TM
Human Skin Model: Regulation by
Ultraviolet Radiation and Cytokines
P.J. Hayden, T.J. Last, B. Burnham, and M. Klausner
R & D, MatTek Corporation, Ashland, Massachusetts, U.S.A.
Cyclooxygenase-2 (COX-2) appears to play an important role in skin carcinogenesis caused by
solar ultraviolet radiation (UVR): UVR induces COX-2 expression in human skin, COX-2
activity is up-regulated in skin cancers and COX inhibitors reduce UVR-induced tumor
formation. In this report, we use RT-PCR, Western blotting and ELISA to study the effect of
UVR on COX message, protein and metabolites, respectively, in the EpiDerm in vitro human skin
equivalent. There are two isoforms of COX, COX-1 (constitutive) and COX-2 (inducible). COX
enzymes metabolize arachadonic acid (AA) to eicosanoid products including prostaglandin E2
(PGE2) thromboxane A2 and PGI2, which are thought to contribute to skin carcinogenesis. COX
may also metabolize AA to 8-isoprostane (8IP), a novel mitogenic prostaglandin previously
thought to be formed only via free radical pathways. EpiDerm tissues expressed COX-1 message
and protein constitutively, and secreted PGE2 and 8IP into the culture medium. COX-2 message
and protein were also detectable. UVR enhanced COX-2 expression without effecting COX-1,
and increased production of both PGE2 and 8IP. COX inhibitors reduced production of PGE2
and 8IP to below baseline levels, indicating a metabolic rather than free radical mechanism of
formation. Additional experiments were conducted to study regulation of COX expression by
cytokines in the absence of UVR. IL-1a, IL-1b or TNFa induced expression of COX-2 without
effect on COX-1, and increased production of PGE2 and 8IP. Combinations of IL-1a or IL-1b
with TNFa produced additive PGE2 and 8IP production. Thus, EpiDerm tissues behave similarly
to in vivo human skin with respect to regulation of COX-2 by solar UVR and cytokines. COX-
dependent production of 8IP by human skin equivalents is demonstrated for the ®rst time,
suggesting a potential role for this mitogenic metabolite in skin carcinogenesis. Finally, the results
indicate that in vitro human skin equivalents are useful models for study of COX regulation by
UVR, and related aspects of human skin carcinogenesis.
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Chemopreventive Potential of Lycopene Against Photocarcinogenesis
Z. Fazekas, D. Gao, Y. Lu, R.N. Saladi, L.M. Austin, M. Lebwohl, and H. Wei
Dermatology, Mount Sinai School of Medicine, New York, New York, U.S.A.
Lycopene is a carotenoid found in tomato-based products and represents 50% of the carotenoids
found in human serum. It is a powerful antioxidant with the highest oxygen quenching ability
among the carotenoids. It is able to protect against oxidation of DNA, proteins and lipids. Oral
lycopene can decrease UV light-induced erythema in humans. The purpose of this investigation is
to determine lycopene's potential role against UV light-induced photocarcinogenesis. To begin
these studies the lack of lycopene's cytotoxicity for SVK-14 keratinocytes was established after
incubation in up to 50 mmol of lycopene. 100% cell viability was maintained after 2 and 24 h as
measured by neutral red uptake assay. Next, we examined lycopene's ability to protect SVK-14
keratinocytes from UVB-induced cell death. Lycopene maintained 70% cell viability of SVK-14
keratinocytes at 24 h following cytotoxic levels of UVB treatment (155 mJ/cm
2
). Since UVB
induces oxidative DNA damage that leads to photocarcinogenesis, lycopene's protective ability was
examined by measuring the reduction of oxidative 8-OHdG DNA adduct formation. In vitro,
10 mmol lycopene inhibited 30% of 8-OHdG formation following UVB irradiation of calf thymus
DNA. In vivo, lycopene treated SKH-1 mouse skin showed signi®cant reduction of UVB-induced
edema and in¯ammation. Thus lycopene has potential chemoprotective effects against UVB-
induced damage both at the level of initiation (8-OHdG) and subsequent in¯ammatory reactions
associated with carcinogenesis. In conclusion, these studies indicate that lycopene has potential
chemopreventive effects against photocarcinogenesis.
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Genetic and Immunophenotypic Analysis of p53 in Nonmelanoma Skin Cancer
A.J. Stratigos, N. Kapranos,* E. Petrakou,* G. Voutsinas,² A. Anastasiadou,* A. Pagouni, E.
Christo®dou, E. Kokka,* C. Antoniou, and A. Katsambas
Dermatology, University of Athens, Athens, Greece; *Molecular Pathology, A. Fleming Hospital, Athens,
Greece; ²Institute of Biology, NCSR Democritos, Athens, Greece
The p53 tumor suppressor gene is frequently found mutated in basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC) of the skin. We aimed to study the mutation pattern of the p53
gene in nonmelanoma skin cancers and to correlate the p53 protein expression with apoptotic and
cell proliferation markers in these tumors. Thirty-®ve nonmelanoma skin tumors (19 BCCs and 16
SCCs) from sun-exposed skin areas were analyzed. p53 protein expression was studied
immunohistochemically using the DO7 monoclonal antibody against wild type and mutant p53
forms. The percentage of immunopositive nuclei was measured by image analysis. Cell
proliferation and apoptosis were assessed by image analysis following Ki-67 and TUNEL
immunostaining, respectively. Gene analysis was performed in 30 cases by direct sequencing using
fresh tumor genomic DNA and the big-dye terminator technology. The percentage of p53-
expressing cells varied from 3.5 to 90 in BCC (median value 55%) and from 0 to 94 in SCC
(median value 40.4%). p53 expression was positively correlated with cell proliferation (r = 0.75,
p = 0.000001) and negatively with apoptosis (r = ±0.23, p = 0.05). Mutation detection was carried
out in exons 5±8. One G to A transition was detected affecting codon 280 (exon 8) in a BCC with
76.1% protein expression. Additionally, two C to T transitions were detected in exon 5 including
one in codon 179 and another in codon 167 in two SCCs with 77.8 and 64.1% protein expression,
respectively. In conclusion, the high p53 expression, observed in the majority of the examined
carcinomas, appears to be related to a nonfunctional protein which is unable to exert its regulatory
function on cell proliferation and apoptosis. Protein accumulation may be partly attributed to
missense point mutations of the p53 gene, such as the three detected in the exons analyzed. The
transitions in codons 280 and 179 have been already detected in skin cancer, whereas the transition
in codon 167 has not been previously reported.
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Mitochondrial DNA in Aging Skin and in Nonmelanoma Skin Cancer
J.E. Sligh, A. Eshaghian, A.C. Musiek, R. Vleugels, S. Stokes, and A. Slater
Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, U.S.A.
The potential role of mitochondrial DNA (mtDNA) changes in cutaneous photoaging and in
nonmelanoma skin cancer (NMSC) was explored using a genetic approach. NMSC tumors and
adjacent tumor-free margin skin were obtained from Mohs surgical excisions in our Dermatology
clinic. DNA was isolated from the specimens and portions of the mtDNA were ampli®ed by the
polymerase chain reaction (PCR). A screen for mtDNA deletions was performed using
oligonucleotide primers spaced distantly from one another, but ampli®ed using extension times
that permitted only shorter mtDNA molecules containing deletions to amplify. Several new
mtDNA deletions have been discovered in aging skin including a novel 6278 bp deletion with a
frequency approaching that of the previously well characterized 4977 bp common deletion. The
observed mtDNA deletions were typically ¯anked by 3 bp to 15 bp direct or indirect repeats. More
complex mtDNA rearrangements such as single mtDNAs with multiple deletions have also been
characterized. Long extension PCR was also used to amplify 98% of the mtDNA in a single
reaction. The PCR products were visualized using ®eld inversion gel electrophoresis. mtDNA
deletions were abundant in margin tissue specimens from older patients and were often the only
forms detected in this assay. However, full length mtDNA was always detected in the tumors
suggesting a genetic selection for speci®c mtDNAs in the process of tumorigenesis. The full length
mtDNA from the tumors as well as from NMSC cell lines is currently being analyzed at the single
base level for point mutations. In conclusion, we have characterized many new mtDNA deletions
from aging skin which support the use of mtDNA mutations as biomarkers of photoaging in the
skin. There also appears to be a genetic selection for speci®c mtDNA species in the development of
NMSC.
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¿5 in Scleroderma Fibroblasts
Y. Asano, H. Ihn, K. Yamane, M. Kubo, and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Tokyo, Japan
Extracellular matrix (ECM) metabolism of ®broblasts is tightly regulated by multiple
environmental in¯uences, including adhesion to the ECM and soluble factors. Cell±ECM
interaction is mediated through distinct receptors on the cell surface, mainly belonging to the




¿5, and its ligand, vitronectin.
Vitronectin is a plasma protein that is also found distributed in ECM of various tissues in vivo,
including dermal ®bers in the skin. Matrix vitronectin binds various kinds of protease inhibitor,
including plasnimogen activator inhibitor type-1, and controls their activities. The conformation of









¿5 might regulate matrix turnover and
remodeling through vitronectin related pericellular proteolysis. In the present study, we compared




¿5 on dermal ®broblasts and the deposition levels of vitronectin
in dermal tissue between scleroderma and healthy controls. Immunoblotting and Northern blot
analysis showed that E
Â





¿5 on cell surface of scleroderma ®broblasts was also demonstrated by immunopre-





®broblasts as well as vitronectin in dermal tissue was elevated in scleroderma skin sections. These
results indicate that vitronectin dependent inhibition of pericellular proteolytic cascade may





¿5 serves to transduce a signal related to activation of lesional ®broblasts. Our
data strengthen the concept that an important pathogenetic mechanism in scleroderma may be the
abberant expression of ECM receptors.
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T-Cadherin is Expressed Speci®cally in Basal Keratinocytes
S. Zhou, N. Matsuyoshi, S. Liang,* T. Takeuchi,* Y. Ohtsuki,* and Y. Miyachi
Department of Dermatology, Kyoto University, Kyoto, Kyoto, Japan; *Department of Pathology, Kochi
Medical University, Nankoku, Kochi, Japan
T-Cadherin is a unique member of the cadherin superfamily that shares the ectodomain
organization with classical cadherins, but lacks both transmembrane and cytoplasmic regions and is
instead anchored to the plasma membrane through a glycosyl-phosphatidylinositol moiety. To test
whether the unusual truncated T-cadherin is expressed in keratinocytes and investigate its
distribution pattern on cultured keratinocytes and skin tissue, RT-PCR, Western blotting,
immunocytochemistry and immunohistochemistry staining were performed on human and mouse
keratinocytes and skin tissues. The result of RT-PCR indicated that keratinocytes expressed the
mRNA of T-cadherin apart from classical cadherins, E- and P-cadherin. The immunostaining on
Pam212 cells con®rmed that mouse keratinocytes expressed T-cadherin. In order to compare the
distribution pattern of T-cadherin with classical cadherins on keratinocytes, the Z- and XZ-
sections were made from the 3D scanning by confocal microscope. The Z- and XZ-sections
clearly demonstrated that T-cadherin was distributed diffusely on the whole cell surface, while E-
and P-cadherin were concentrated on the cell-cell contacts. The immunostaining and Western
blotting of T-cadherin on DJM-1 cells further con®rmed the expression of T-cadherin in human
keratinocytes. The immunohistochemistry staining strikingly showed that T-cadherin was
intensively expressed only on the basal cell layer of the mouse and human skin. It was for the
®rst time found and veri®ed that T-cadherin was expressed on the mouse and human keratinocytes
and speci®cally localized on the basal cell layer of skin. The nature of T-cadherin function and its
mechanism of localization at the basal cell layer of skin are important issues to be addressed
concerning this unique member of the cadherin family and its physiological and pathological roles
in the skin.
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Molecular Mechanisms of Stimulatory Effect of M4 Muscarinic Acetylcholine Receptor
on Keratinocyte Migration
A. Chernyavsky, J. Arredondo, V. Nguyen, A. Ndoye, S. Zia, J. Wess,* and S. Grando
Dermatology, University of California, Davis, California, U.S.A.; *Molecular Signaling, NIH, NIDDK,
Bethesda, Maryland, U.S.A.
Human epidermal keratinocytes (KC) express several muscarinic acetylcholine receptor (mAChR)
subtypes. Early results suggested that M4 is the predominant mAChR regulating cell motility. To
determine muscarinic effects on lateral migration of KC, we used agarose gel keratinocyte
outgrowth assay. Muscarine, 10 nM, produced a dose-dependent stimulatory effect on cell
migration (p < 0.05). This was abolished by atropine, which decreased migration distance. To
identify the mAChR subtype(s) mediating these muscarinic effects, we substituted atropine with
subtype-selective antagonists. Tropicamide (M4-selective) was more effective at decreasing the
migration distance than pirenzepine and 4-DAMP at nanomolar concentrations. In keeping with
these pharmacologic results, actively moving KC displayed mainly M4. Terminally differentiated
KC lacked M4 mAChR. In epidermis, M4 mAChR was predominantly localized to the
lowermost prickle cells that continuously migrate upward. To determine the molecular mechanism
of M4-mediated regulation of keratinocyte migration, we used 6 week-old M4 mAChR knockout
(KO) and wild-type (WT) mice. The mice were anesthetized, the hair of the back was removed,
and 2 mm in diameter full thickness circle incisions were made through the panniculus carnosus.
After 72 h, a 6-mm area surrounding the wound was excised, and used to quantify a2, a3, a5, aV,
and b5 integrins using quantitative RT-PCR, immunoblot and immuno¯uorescence assays. The
expression of integrins was reduced in the intact epidermis of M4 KO mice at both the mRNA and
protein levels. Wounding stimulated integrin expression in both WT and KO mice. Compared to
WT mice, wound integrin expression was higher in M4 KO mice. These results indicate that M4
plays a central role in mediating cholinergic control of keratinocyte migration by regulating
integrin expression. Compensatory changes in integrin expression of wound KC in M4 KO mice
may be attributed to engagement of compensatory regulatory pathways in the absence of M4
mAChR.
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Association of HHV-8 with Kaposi's Sarcoma and Some Other Skin Tumours in Russia
E. Kadyrova, L. Yakovleva, V. Chernova,* A. Molochkov,* V. Molochkov,* and V. Gurtsevich
Laboratory of Viral Carcinogenesis, Cancer Research Center, Moscow, Russian Federation; *Skin tumours
Department, Regional Institute of Clinical Investigations, Moscow, Russian Federation
The purpose of this investigation was to study the level of the herpesvirus-8 (HHV±8) association
with different forms of Kaposi's sarcoma (KS) and some other skin malignancies in Russia-
nonendemic for KS huge geographical region with HHV-8 prevalence in general population
around 1±2%. Sera and tumour DNAs obtained from the same KS patients (Pts) as well as Pts with
melanoma and T- and B-cell skin lymphomas have been tested for HHV-8-speci®c markers by
indirect immuno¯uorescence (iIF) and PCR (to orf 26 and/or K1) assays, respectively. A wide
range of positive results has been obtained in iIF and PCR studies for KS Pts of different clinical
forms. In group of Pts with classic KS the percentage of sero- and PCR-positive cases was 71%
(44/62) and 74% (39/53), respectively. In Pts with other forms of the disease above meanings were
as follows: 75% (6/8) and 100% (9/9) for AIDS-associated KS; 71% (5/7) and 57% (4/7) for
immunosuppressive KS; 20% (2/10) and 62,5% (5/8) for post-transplantant KS, respectively. In
melanoma Pts both tests were completely negative while 60% (6/10) of Pts with B- and T-cell skin
lymphomas were found to be seropositive with negative, however, PCR ®ndings in their tumour
DNAs. Percentage of HHV-8 seropositive individuals among HIV-infected homosexuals and renal
recipients (risk groups) was 44,4% (4/9) and 12,3% (8/65), respectively. The data obtained
demonstrated a quite strong HHV±8 association with different forms of KS in Russia, however,
less strong than that observed by other investigators. Our observation could be, probably, explained
by either a small number of tested Pts in 3 of 4 Ks groups or in¯uence of genetic, environmental or
some other factors on KS development in Russia. We also speculate that high HHV-8 prevalence
rate in 2 risk groups may correlate with high KS occurrence in these groups.
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Expression of a VE-Cadherin Mutant Induces Endocytosis of Endogenous VE-Cadherin
in Microvascular Endothelial Cells
M.D. Kottke, K. Xiao, D.F. Allison, S. Summers, G.P. Sorescu, V. Faundez,* and A.P. Kowalczyk
Dermatology and Cell Biology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.; *Cell
Biology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.
VE-cadherin is an adhesion molecule with a central role in angiogenesis and growth control. The
cytoplasmic tail of VE-cadherin binds directly to b-catenin, which in turn interacts with a-catenin
to link VE-cadherin to the actin cytoskeleton. Although signi®cant progress has been made in
elucidating how VE-cadherin is coupled to the cytoskeleton, less is known about how VE-
cadherin cell surface levels are regulated. To address this issue, a VE-cadherin mutant comprising
the nonadhesive IL-2 receptor extracellular domain and the VE-cadherin cytoplasmic tail (IL-2R-
VE-cadcyto) was expressed in primary dermal microvascular endothelial cells using an adenoviral
delivery system. Western blot analysis showed that expression of this mutant caused a dramatic,
rapid down-regulation of endogenous VE-cadherin. Dual label immuno¯uorescence analysis
demonstrated that the mutant cadherin triggered internalization of cell surface VE-cadherin, and
that the internalized VE-cadherin colocalized with early endosomes. The lysosomal inhibitor
chloroquine dramatically inhibited the degradation of endogenous VE-cadherin, indicating that
internalized VE-cadherin was sorted to a lysosomal compartment for degradation. Interestingly, the
region of the VE-cadherin cytoplasmic tail that binds to b-catenin also contains a conserved motif
involved in endocytic traf®cking, suggesting that disruption of the cadherin-b-catenin complex
might expose an internalization signal on the cadherin tail. Indeed, although the cell surface pool of
VE-cadherin exhibited extensive colocalization with b-catenin, the internalized pool of VE-
cadherin showed no such colocalization. These data indicate that endothelial cells use endocytosis
to regulate cell surface levels of VE-cadherin. Furthermore, catenins may regulate the availability of
internalization motifs present on the cadherin cytoplasmic tail.
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Mechanisms of Pharmacologic Regulation of Keratinocyte Adhesion by Cholinergic
Drugs
S.A. Grando, J. Arredondo, A. Chernyavsky, Y. Kitajima,* and V.T. Nguyen
Dermatology, University of California, Davis, California, U.S.A.; *Dermatology, Gifu University, Gifu
City, Japan
Acetylcholine receptors expressed by keratinocytes (KC) have been shown to regulate cell
adhesion. Receptor agonists stimulate adhesion whereas antagonists cause acantholysis. The
mechanism remained unknown. To elucidate the mechanism responsible, we investigated
cholinergic effects on both the expression and postranslational modi®cation of adhesion molecules
in KC. The 95% con¯uent monolayers of human KC were incubated for 14 h with the agonist
carbachol (CCh), 0.25 mM, which can activate both muscarinic and nicotinic receptors and inhibit
acetylcholinesterase, or the acetylcholinesterase inhibitor pyridostigmine bromide (Mestinon;
Mes), 0.25 mM, and used in semiquantitative immuno¯uorescence (IF) and Western blot (WB)
assays. By IF, CCh increased the intensity of speci®c staining of KC by antibody to pan-cadherin
(Cad) by 90%, E-Cad by 50%, pan-desmoglein (Dsg) by 180%, Dsg1 by 20%, Dsg3 by 110%, and
b-catenin (b-Cat) by 170%. By WB, CCh increased E-Cad by 14%, Dsg1 by 47% and Dsg3 by
11%. Mes produced similar results. Neither drug changed g-Cat (plakoglobin) expression. Since
phosphorylation of adhesion molecules has been shown to play an important role in assembly/
disassembly of intercellular junctions by KC, we also measured cholinergic effects on
phosphorylation of keratinocyte adhesion molecules using an assay that combines measurements
of the amount and the radioactivity of each immunoprecipitated molecule. Exposure of con¯uent
DJM-1 cell cultures to the muscarinic antagonist atropine, 0.02 mM, for 15 min increased
phosphorylation of E-Cad by 55%, Dsg3 by 33%, b-Cat by 37%, and g-Cat by 20%, but not of
Dsg1 or Dsg2. In the presence of CCh, 0.5 mM, atropine-dependent phosphorylation of adhesion
molecules was suppressed. We conclude that cholinergic control of keratinocyte adhesion is
exerted through receptor-mediated modi®cations of both expression and phosphorylation of
adhesion molecules.
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Pemphigus Sera, Expressing High Levels of Fas Ligand, Induces Keratinocyte Apoptosis
M. Puviani, A. Marconi, C. Fila, E. Cozzani,* A. Giannetti, and C. Pincelli
Dermatology, University of Modena and Reggio Emilia, Modena, Italy; *Dermatology, University of
Genova, Genova, Italy
Apoptosis (anoikis) can follow cell to cell detachment and apoptotic keratinocytes are abundantly
present in vivo in pemphigus lesional skin. In the present study, we asked whether pemphigus sera
are capable of inducing apoptosis in normal human keratinocytes. Therefore, we cultured second
passage keratinocytes in serum-free medium up to precon¯uency and provided sera from patients
with either pemphigus vulgaris (N = 4) or pemphigus foliaceous (N = 5), before or after
corticosteroid treatment (N = 5). Sera from both types of pemphigus but not from healthy subjects
or from patients undergoing steroid treatment (37.8 6 4.8%, 2 6 0.05%, 5.2 6 4.5%, respectively,
p < 0.01) induced apoptosis in human keratinocytes, as shown by the TUNEL method. In
addition, cell yields was signi®cantly higher in keratinocytes treated with sera from healthy subjects
or from patients on steroid treatment than from untreated pemphigus sera (p < 0.01). We next
asked which factor in patient sera could be responsible for cell death. Anoikis is inhibited by Fas-
ligand (L) blocking antibodies and FasL levels are increased in sera from patients with toxic
epidermal necrolysis. We therefore measured FasL concentrations in sera from the same patients
used for the apoptosis experiments by ELISA. FasL levels (ng/ml) were very high in sera from
untreated patients and below the limit of detection in sera from patients treated with
corticosteroids, similarly to healthy controls. Pemphigus sera pretreated with anti-FasL neutralizing
antibodies failed to induce keratinocyte apoptosis and cell yields in keratinocytes pretreated with
anti-FasL were similar to those in sera from healthy controls. Our results suggest that high levels of
FasL in pemphigus sera induce apoptosis in human keratinocytes.
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Lipoid Proteinosis Maps to 1q21 and is Caused by Mutations in the Extracellular Matrix
Protein 1 Gene
T. Hamada,*² I. McLean,³ M. Ramsay,§ G. Ashton,* A. Nanda,¶ T. Jenkins,§ O. Bleck,* A.
South,* G. Orchard,* T. Hashimoto,² R. Eady,* and J. McGrath*
*Cell and Molecular Pathology, GKT Medical School, London, U.K.; ²Department of Dermatology,
Kurume University School of Medicine, Kurume, Japan; ³Epithelial Genetics Group, University of Dundee,
Dundee, U.K.; §Department of Human Genetics, University of Witwatersrand, Johannesburg, South Africa;
¶Department of Dermatology, Asad A-Hamad Dermatology Center, Kuwait, Kuwait
Lipoid proteinosis (LP; OMIM 247100) is a rare, autosomal recessive disorder with generalized
thickening of skin, mucosae and certain viscera, the etiology of which is currently unknown. Using
DNA from 3 affected siblings in a consanguineous Saudi Arabian family we performed genome-
wide linkage and mapped the disorder to 1q21 (marker D1S498) with a two-point lod score of
3.45 at q = 0. A further 28 affected individuals from 5 other unrelated consanguineous family
groups from different geographical regions also showed complete linkage and resulted in a
maximum two-point lod score of 21.85 at q = 0. Using available markers in the interval between
D1S442 and D1S305 and observed recombinants placed the gene in a 2.3-cM critical interval
between D1S2344 and D1S2343 (Marsh®eld genetic map) corresponding to a ~6.5 Mb region on
the UCSC physical map. Using a candidate gene approach (comparison of control vs. LP gene
expression in cultured ®broblasts) and direct sequencing of genomic DNA, we identi®ed six
different homozygous loss-of-function mutations (Q276X, Q346X, W359X, 501insC, 1019delA,
1163del) in the extracellular matrix protein 1 gene (ECM1). Although the precise function of
ECM1 is not known, our ®ndings demonstrate its relevance to skin adhesion, epidermal
differentiation, scarring, angiogenesis/angiopathy and basement membrane physiology, as well as
de®ning the molecular basis of LP.
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Loss of Cell Adhesion in Dsg3bal-Pas Mice with Homozygous Deletion Mutation
(2079del14) in the Desmoglein 3 Gene
Y. Choi, L. Pulkkinen, A. Simpson, X. Montagutelli,* J. Sundberg,² J. Uitto, and M. Mahoney
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.;
*Unite de Genetique des Mammiferes, Institut Pasteur, Paris, France; ²Dermatology, The Jackson
Laboratory, Bar Harbor, Maine, U.S.A.
Pemphigus encompasses a group of autoimmune blistering diseases with circulating autoantibodies
recognizing proteins including the desmosomal cadherin, desmoglein 3 (Dsg3). Targeted
disruption of the Dsg3 gene by homologous recombination (Dsg3tm1Stan) or a single base-pair
insertion (Dsg3bal-2 J) in mouse results in fragility of the skin and oral mucous membranes,
analogues to the human disease. We now report an allelic mutation, Dsg3bal-Pas, with clinical
features similar to those in Dsg3bal-2 J. We have identi®ed a 14-bp deletion in exon 13 of the Dsg3
gene resulting in a frameshift and premature termination codon 7 bp downstream from the site of
deletion and causing a truncation of the Dsg3 polypeptide by 199 amino acids, eliminating the
intracellular domain. We demonstrate that although a Dsg3 mRNA transcript was detectable in
Dsg3bal-Pas skin, the corresponding protein for Dsg3 was absent in the oral mucosal epithelium of
homozygous Dsg3bal-Pas compared with that of +/Dsg3bal-Pas mice. To elucidate a potential
mechanism causing loss of cell adhesion in the Dsg3bal-Pas mice, we generated a myc-tagged
truncated Dsg3bal-Pas Dsg3 protein (Dsg3T.myc) and expressed it in keratinocytes. Dsg3T.myc
was found predominantly in the cytoplasm possibly due to increased proteolytic degradation. Cell
surface staining was also detected but was jagged, not linear along cell-cell border as observed for
the full-length Dsg3. The expression of Dsg3T.myc resulted in reduction in staining of other
desmosomal proteins including Dsg1 & 2, plakophilin 2, and plakoglobin. In addition, the cells
expressing Dsg3T.myc underwent dramatic changes in cell morphology and exhibited striking
extensive ®lopodia. Collectively, these data showed that the truncation of Dsg3 found in Dsg3bal-
Pas mice can disturb desmosome formation in and adhesion of keratinocytes resulting in
phenotypic changes in the epithelium.
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Lack of Plakophilin-1 Reduces Calcium Stability of Membrane Bound Desmosomal
Components
A. South, H. Wan, M. Stone,* P. Dopping-Hepenstal, P. Purkis,² I. Leigh,² R. Eady, I. Hart,*
and J. McGrath
Department of Cell and Molecular Pathology, GKT Medical School, London, U.K.; *Richard Dimbleby/
ICRF Department of Cancer Research, GKT Medical School, London, U.K.; ²ICRF Skin Tumour
Biology Unit, The Royal London Hospital, London, U.K.
Ablation of the desmosomal plaque component Plakophilin 1 (PP1) underlies the autosomal
recessive genodermatosis, skin fragility±ectodermal dysplasia syndrome (OMIM 604536). To
further investigate the role of PP1 in keratinocyte adhesion, we compared the effects of different
extracellular concentrations of calcium on desmosome stability and protein composition in three
sets of cultured keratinocyte cell lines comprising: PP1-null keratinocytes stably expressing
retrovirally delivered full-length recombinant PP1, PP1-de®cient cells expressing appropriate
vector controls, and normal keratinocyte cell lines expressing vector controls. Cells were grown in
physiological concentrations of calcium (1.2 mM) for 72 h and then switched to low concentration
(0.09 mM) for 24 h before comparison using time-lapse phase-contrast microscopy and
immuno¯uoresence microscopy. Keratinocytes lacking PP1 became more refractile in response
to a calcium switch as judged by image analysis from time-lapse phase-contrast microscopy. This
difference was evident as early as 48 min after introduction of low calcium media. Immunolabeling
using antibodies to desmoplakin, plakoglobin, desmoglein-3 and desmocollin-3 showed that in
cells lacking PP1 there was a marked reduction of membrane bound staining when compared to
cells expressing PP1. This reduction was most evident for desmoplakin. Membrane bound
desmoplakin was markedly reduced in cells lacking PP1 1 h after calcium switching, while changes
in plakoglobin, desmoglein-3 and desmocollin-3 were only apparent after 24 h. From these data we
conclude that lack of PP1 reduces the proportion of membrane bound desmosomal components
and therefore desmosome stability in response to low calcium concentrations, observations that
give further insight into the mechanisms of keratinocyte dysadhesion in the inherited syndrome.
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Exfoliative Toxin B and Newly Identi®ed Exfoliative Toxin D Speci®cally Target
Desmoglein 1
K. Nishifuji, T. Yamaguchi,* Y. Hanakawa,² Y. Fudaba,* M. Sugai,* J.R. Stanley,² and M.
Amagai
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; *Department of
Microbiology, Hiroshima University Faculty of Dentistry, Hiroshima, Japan; ²Department of Dermatology,
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A.
Exfoliative toxin A (ETA) and B (ETB), two major serotypes of ETs produced by Staphylococcus
aureus, cause epidermal separation in bullous impetigo and Staphylococcal scaled skin syndrome.
We have shown that ETA speci®cally cleaves desmoglein (Dsg) 1, a desmosomal cell-cell adhesion
molecule. The purpose of this study was to determine if there are additional ET family members
produced by S. aureus, and to determine whether all members cleave Dsg1. We ®rst screened ET
genes in S. aureus isolated from disease patients and found a strain whose DNA fragment was faintly
hybridized with probes for the ETA and ETB genes. Nucleotide sequencing of chromosomal
DNA from this strain revealed an open reading frame that codes a protein with signi®cant
homology with ETA and ETB. This new ET was termed ETD. To clarify the function of ETB
and ETD, we transformed S. aureus RN4220 with either the ETB or ETD gene to obtain
recombinant toxins. Western blotting analysis revealed that ETD was serologically distinct from
ETA and ETB. Neonatal mice injected with ETB or ETD showed extensive super®cial epidermal
blisters. Immuno¯uorescence of the injected skin showed that cell surface staining of Dsg1 was
largely diminished before appearance of blister formation, while the staining of Dsg3 was not
affected at all. Furthermore, in vitro incubation of the recombinant extracellular domains of human
and mouse Dsg1 and Dsg3 with ETB or ETD demonstrated that Dsg1, but not Dsg3, was directly
cleaved by ETB and ETD in a dose dependent fashion. These ®ndings indicate that all three
known serotypes of ET, ETA, ETB and ETD, can cause blister formation by identical
pathophysiologic mechanisms.
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Molecular Mechanisms for Speci®c Cleavage of Desmoglein 1 by Exfoliative Toxins
Y. Hanakawa, N.M. Schechter, C. Lin, L. Garza, H. Li, M. Sugai,² T. Yamaguchi,² Y. Fudaba,²
K. Nishifuji,* M. Amagai,* and J.R. Stanley
Dermatology, U. of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; *Dermatology, Keio U., Tokyo,
Japan; ²Microbiolology, Hiroshima U., Hiroshima, Japan
In bullous impetigo and staphylococcal scalded skin syndrome (SSSS), three homologous
exfoliative toxins (ETA, ETB, ETD) from S. aureus blister the super®cial epidermis. The structure
of ETA suggests it is a serine protease that is predicted to cleave after a glutamic acid (Glu). To
demonstrate such cleavage, we incubated ETA with the 84-kDa recombinant extracellular domain
of human (h)Dsg1 with a carboxy (C)-terminal E epitope tag, and showed two major products by
SDS-PAGE of 50-kDa and 35-kDa, suggesting one major cleavage site. Anti-E-tag immunoblot-
ting (IB) demonstrated that the C-terminus was the 35-kDa band, peptide sequencing of which
demonstrated cleavage of hDsg1 after the Glu at position 381. Similar studies showed ETB and
ETD cleaved hDsg1, and ETA cleaved mouse(m) Dsg1, at the same site. Around this site m and h
Dsg1 are highly homologous, but diverge from Dsg3 which is not cleaved. To show that ETA
cleavage of Dsg1 was dependent on the predicted active serine at position 195, we mutated it to an
alanine (ETm). ETm no longer cleaved Dsg1, however, it did bind to Dsg1 and block its cleavage
by active ETA. The dissociation constant (Kd) was 1±10 mM (i.e. 50% of Dsg1 was free to be
cleaved at this concentration of ETm). ETm was used to de®ne speci®city of potential substrates.
Anti-ETm immuno¯uorescence of epidermis incubated with ETm showed identical staining to
that of anti-Dsg1. Furthermore, immunoprecipitation followed by IB showed ETm and Dsg1, but
not Dsg3, were coprecipitated. ETA also bound Dsg1, but only in short incubations, before
cleavage, consistent with enzyme recycling. Similar studies showed binding of ETB, ETD and
their enzymatically inactive mutants to Dsg1. These studies show that ETs are functional serine
proteases that target Dsg1 and hydrolyze it at a speci®c site. The blisters in bullous impetigo and
SSSS, which are due to inactivation of Dsg1, presumably follow from this molecular lesion.
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Pemphigus Vulgaris IgG and a Corticosteroid Exhibit Reciprocal Effects on
Keratinocyte Adhesion Molecules
V.T. Nguyen, J. Arredondo, A. Chernyavsky, M.R. Pittelkow,* Y. Kitajima,² and S.A. Grando
Dermatology, University of California, Davis, California, U.S.A.; *Dermatology, Mayo Clinic, Rochester,
Minnesota, U.S.A.; ²Dermatology, Gifu University, Gifu City, Japan
Previous studies convincingly demonstrated that corticosteroids could block acantholytic effects of
PVIgG on cultured keratinocytes (KC). To elucidate the mechanism responsible, we compared
effects of 8 h treatments of KC with PVIgG (0.5 mg/ml), normal IgG (0.5 mg/ml), and 0.25 mM
methylprednisolone (MP) on transcription, translation and phosphorylation of adhesion molecules.
Changes in gene expression were investigated by DNA microarray assay. Compared to normal
IgG, PVIgG decreased transcription of 198 genes, including one coding for desmoglein (Dsg) 3,
and increased transcription of 236 genes including the plasminogen activator inhibitor gene. MP
decreased transcription of 26 genes, and increased transcription of 819 genes. MP up-regulated
transcription of the genes encoding adhesion molecules Dsg3, desmocollins, plakophilin, E-
cadherin (E-Cad), P-Cad, a-catenin (a-Cat), several protein phosphatases, protease inhibitors, and
lipocortins. At the protein level, pharmacologic effects of MP were investigated using
semiquantitative Western blot (WB) and immuno¯uorescence (IF) assays. By WB, MP increased
E-Cad by 15%, Dsg1 by 16% and Dsg3 by 42%. By IF, MP increased the intensity of speci®c
staining of KC for pan-Cad by 30%, E-Cad by 50%, pan-Dsg by 170%, Dsg3 by 80%, and b-Cat
by 210%. Since PVIgG has been shown to cause phosphorylation of Dsg3, we assayed
phosphorylation status of adhesion molecules in DJM-1 cells exposed for 1 h to PVIgG containing
both anti-Dsg1 and anti-Dsg3 autoantibodies, or normal IgG in the presence or absence of MP.
Given alone, PVIgG increased phosphorylation of E-Cad by 83%, Dsg3 by 300%, b-Cat by 128%,
and plakoglobin by 60%, but not of Dsg1 or Dsg2. In the presence of MP, the PVIgG-induced
phosphorylation of adhesion molecules was suppressed. We conclude that PVIgG induces
acantholysis via a complex of intracellular genomic and nongenomic events some of which can be
antagonized by MP at the transcription, translational or postranslational level.
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The a3b1 Integrin Plays a role in Organizing Arrays of Laminin-5 in the Basement
Membrane
G.W. deHart and J.C. Jones
Cell and Molecular Biology, North-western University Medical School, Chicago, Illinois, U.S.A.
Laminin-5 is a major component of the basement membrane of skin and plays an important role in
mediating strong attachment of keratinocytes to the extracellular matrix. The two main receptors
via which cells bind laminin-5 are the a6b4 and a3b1 integrins. Evidence from mice with targeted
deletions in the genes for a3 and b1 integrin suggests that the a3b1 integrin receptor determines
the organization and assembly of the basement membrane of skin. In this study, we tested a
hypothesis that the a3b1 integrin speci®cally regulates the supramolecular organization of laminin-
5, using wild type keratinocytes and keratinocytes derived from a3 integrin-null mice. We ®rst
compared the organizational state of laminin-5 in the matrix of a3-null cells with that of laminin-5
in the matrix of wild type keratinocytes. Laminin-5 distributes in diffuse arcs and circles in the
matrix of normal mouse keratinocytes and a6b4 integrin shows colocalization with the deposited
laminin-5. In contrast, laminin-5 is organized into multiple linear, spike-like arrays in the matrix of
the a3-null cells. Moreover, the a3-null keratinocytes fail to organize laminin-5 arrays when
plated onto surfaces coated with puri®ed laminin-5 protein, and show decreased strength of
adhesion to such surfaces when compared with their normal counterparts in a radial ¯ow assay. On
the other hand, both the normal and a3-null keratinocytes adhere equally strongly to laminin-5
that has been organized into arrays by other epithelial cells, including the rat bladder line 804G.
The a3 integrin-null cells are more motile than wild type cells. HEK 293 epithelial cells show
increased motility when plated onto matrix derived from a3-null cells compared to matrix from
wild type keratinocytes. In summary, these data suggest that a3b1 integrin plays a role in
determining the proper incorporation of laminin-5 into basement membranes, and that the
organizational state of laminin-5 regulates the motile behavior and ®rm adhesion of keratinocytes
to matrix.
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Inhibition of Collagen Production Inphotodamage: Collagen Fragments Generated by
Matrix Metalloproteinase-1 and Cleared by MMP-9 Inhibit Procollagen Synthesis by
Skin Fibroblasts
J. Varani, P. Perone, S.E. Fligiel, G.J. Fisher,* and J.J. Voorhees*
Pathology, University of Michigan, Ann Arbor, Michigan, U.S.A.; *Dermatology, University of Michigan,
Ann Arbor, Michigan, U.S.A.
Three-dimensional lattices of reconstituted, polymerized type I collagen were subjected to partial
hydrolysis by organ culture ¯uid from ultraviolet-irradiated human skin or by various matrix
metalloproteinases (MMPs) including MMP-1 (interstitial collagenase), MMP-2 (72-kDa
gelatinase A), MMP-8 (neutrophil collagenase), MMP-9 (92-kDa gelatinase B) or MMP-13
(collagenase-3). Following partial digestion, human dermal ®broblasts were incubated on the
enzyme-treated or control lattices and examined for ability to contract the collagen lattice and
synthesize type I procollagen. Collagen lattices partially degraded by organ culture ¯uid were
contracted by ®broblasts under conditions in which control collagen lattices were not. On the
partially degraded collagen, ®broblasts synthesized reduced amounts of type I procollagen
(approximately 70% reduction). Puri®ed MMPs with collagenolytic activity duplicated the effects
of the human skin organ culture ¯uid, although MMP-8 and MMP-13 were less ef®cient than
MMP-1 (65% vs. 40% and 18% reduction in type I procollagen production for MMP-1, MMP-8
and MMP-13, respectively). MMP-2 and MMP-9 were without effect on intact collagen.
However, when collagen lattices were subjected to digestion by a combination of MMP-1 and
MMP-9, fragments produced by MMP-1 were further degraded by the gelatinase. Collagen
contraction and inhibition of procollagen synthesis were both reduced. MMP-2 was less effective
than MMP-9 in clearing MMP-1-generated fragments. MMP-2 was also less effective in
preventing contraction and inhibiting the down-regulation of type I procollagen synthesis. These
observations suggest that in the presence of high molecular weight fragments of type I collagen,
type I procollagen synthesis is inhibited. As these fragments are processed further, there is less
inhibition of type I procollagen production.
115
Targeted Ablation of the Murine LAMC2 Gene Recapitulates Human Herlitz Junctional
Epidermolysis Bullosa Phenotype
X. Meng, J. Klement, J. Uitto, and L. Pulkkinen
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.
The Herlitz junctional epidermolysis bullosa (H-JEB) is an autosomal recessive blistering disorder
with poor prognosis. The underlying mutations reside in the genes encoding laminin 5 subunit
polypeptides, most of them in LAMB3 (b3 chain) while some have been described in LAMA3 and
LAMC2 (a3 and g2 chains). To evaluate the pathomechanisms and tissue involvement of H-JEB in
further detail, and to provide an animal model for development of gene therapy approaches, we
have developed a LAMC2 null mouse (±/±) by targeted ablation of exon 8 of the g2 chain gene of
laminin 5, which results in out-of-frame deletion of 115 bp and creates a downstream premature
termination codon for translation. Heterozygous mice were clinically normal, while homozygotes
manifested with extensive blistering of the skin and mucous membranes and died within 1±2 day of
birth. Histopathology revealed tissue separation at the cutaneous basement membrane zone.
Immunohistochemistry of the skin and tongue at the dermal-epidermal junction (DEJ) was
essentially negative for g2 chain expression, and a3 chain expression was concomitantly reduced.
The expression of other DEJ components (type VII and XVII collagens, a6 integrin, and plectin)
appeared normal. RT-PCR clearly detected the shortened mRNA transcript in ±/± mice, but
Western analysis was unable to detect g2 chains. PCR genotyping revealed that in 21 litters, 41
(24.4%), 96 (57.1%), and 31 (18.5%) mice were ±/±, +/±, and +/+, respectively, consistent with
autosomal recessive inheritance and no evidence for embryonic lethality. Collectively, these data,
together with previously developed LAMA3 ±/± mice and a naturally occurring LAMB3 null
mouse, attest to the critical importance of each laminin 5 polypeptide subunit in epithelial-
mesenchymal adhesion.
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Characterization of Hemidesmosome Protein Dynamics in Live Cells
D. Tsuruta, S.B. Hopkinson, and J.C. Jones
Cell and Molecular Biology, North-western University Medical School, Chicago, Illinois, U.S.A.
Hemidesmosomes mediate anchorage of epithelial cells to laminin-5 in the basement membrane
and are assumed to be stable adhesion complexes. To assess their dynamic properties we have
generated a construct encoding a GFP-tagged human b4 protein. When expressed in cultured cells,
GFP human b4 binds laminin-5 ligand in the extracellular matrix and both bullous pemphigoid
antigens BP180 and BP230. By following the fate of GFP-tagged protein in live cells, we show that
hemidesmosome protein clusters are dynamic not only in migrating cells but also in stationary cells.
In addition, we have characterized the behavior of protein components within assembled
hemidesomosomes using the ¯uorescent recovery after photobleaching (FRAP) technique. In this
assay, a broad stripe of ¯uorescence is bleached across a labeled cell and recovery of ¯uorescence is
monitored over time. Remarkably, recovery of ¯uorescence of areas of bleached GFP-tagged
human b4 protein occurs in as little as 5 min and is almost complete by 30 min. Quanti®cation of
these results indicates that there is relatively rapid turnover of integrin subunits in assembled
hemidesmosomes. In summary, these data indicate that hemidesmosomes are not merely stable
adhesions structures but are dynamic. We hypothesize that b4 dynamics re¯ect the ability of
hemidesmosome to respond rapidly to cues that are triggered during times of skin remodeling in
development and wound healing.
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Caspase-8-Activated Signal Predominates in Keratinocyte Anoikis
C. Fila, A. Marconi, S. Krajewski,* J.C. Reed,* A. Giannetti, and C. Pincelli
Dermatology, University of Modena and Reggio Emilia, Modena, Italy; *Cancer Research Center, The
Burnham Institute, La Jolla, California, U.S.A.
We have previously shown that keratinocyte stem cells, rapidly adhering to the extracellular matrix
(ECM) are protected from apoptosis (``anoikis'') via an integrin signaling pathway, while cells
slowly adhering to the ECM undergo anoikis. The aim of the study was to elucidate the molecular
mechanisms involved in keratinocyte anoikis. Western blot analysis revealed that caspase-8 and Bid
are activated in ``young'' TA and TA but not in stem cells, suggesting a cascade similar to that of
death receptor-mediated anoikis. To con®rm this pathway, we treated keratinocyte stem cells and
``young'' TA cells with disintegrins and evaluated the activation of both long (``initiator'')- and
short (``executioner'') prodomain caspases. First, caspases-8, ±9, ±3, and ±6 were activated at 3 h in
``young'' TA cells, and at 6±9 h in stem cells. Loss of cell-matrix adherence, in absence of
disintegrins and at high cell density, induced caspase activation later than in presence of
disintegrins, possibly due to cell-cell contact. Secondly, the caspase-8 inhibitor zIETD-fmk
inhibited the activation of caspase-9, whereas caspase-9 inhibitor zLEHD-fmk failed to block the
activation of caspase-8. Thirdly, the inhibitor of apoptosis XIAP is inactivated at 6 h. Finally,
PARP cleavage was inhibited by caspase-8 inhibitor, but not by caspase-9 inhibitor up to 9 h.
These results con®rm that keratinocyte stem cells are more resistant to anoikis as comapred to
``young'' TA cells. In addition, this work suggests that the death receptor-activated caspase-8
pathway prevails in keratinocyte anoikis.
VOL. 119, NO. 1 JULY 2002 ABSTRACTS 227
122
In Vivo Restoration of Type VII Collagen Expression and Function in Dystrophic
Epidermolysis Bullosa
M. Chen, L. Chan,* W.K. Hoef¯er,² D. Finlay,² D.R. Keene,³ and D.T. Woodley
Dermatology, University of Southern California, Los Angeles, California, U.S.A.; *Dermatology, North-
western University, Chicago, Illinois, U.S.A.; ²Dermatology, Xgene Corporation, San Carlos, California,
U.S.A.; ³Portland Imaging Center, Shriners Hospital for Children, Portland, Oregon, U.S.A.
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders caused
by mutations in the type VII collagen (COL VII) gene and subsequent perturbations in anchoring
®brils. The lack of therapy for DEB provides an impetus to develop gene therapy strategies. We
previously used a lentiviral vector to express both full-length COL VII and type VII minicollagen
in RDEB keratinocytes (KCs) and ®broblasts (FBs) and demonstrated the correction of the RDEB
cellular phenotype in vitro. To determine if such gene-corrected RDEB cells could restore COL
VII expression and anchoring ®bril formation in vivo. We reconstituted full-thickness human skin
by the addition of a mixed cell slurry of KCs and dermal FBs into an inert silicon chamber grafted
onto the back of SCID mice. We used both minigene or full-length COL VII corrected RDEB
cells and recombined the cells in the following con®gurations: 1. Normal KCs & normal FBs, 2.
RDEB KCs & RDEB FBs, 3. Gene corrected RDEB KCs & gene corrected RDEB FBs, 4. Gene
corrected RDEB KCs & RDEB FBs, and 5. RDEB KCs & gene corrected RDEB FBs.
Composite skin regenerated on SCID mice using gene-corrected RDEB KCs & gene-corrected
RDEB FBs displayed normally localized COL VII in the basement membrane zone (BMZ) at
amounts similar to skin regenerated from normal human KCs and FBs. In contrast, skin
regenerated from parental RDEB KCs & RDEB FBs entirely lacked COL VII expression.
Surprisingly, expression of COL VII in the BMZ was also observed in the skin regenerated from
parental RDEB KCs & gene-corrected RDEB FBs. In addition, transmission electron microscopy
detected anchoring ®bril structures in skin regenerated from RDEB cells corrected with either
minicollagen or full length COL VII. Our studies provide the ®rst evidence for the restoration of
COL VII gene expression in DEB skin in vivo and thus represent an advance in efforts to develop ex
vivo gene therapy for DEB.
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Site-Speci®c Cleavage of Desmoglein 1 by Caspase-3 and its Fate During Apoptosis
R.L. Dusek,* F. Chen,³ S. Getsios,* J.K. Park,* V.L. Cryns³, and K.J. Green*²
*Pathology, North-western University Medical School, Chicago, Illinois, U.S.A.; ²Dermatology, North-
western University Medical School, Chicago, Illinois, U.S.A.; ³Medicine, North-western University Medical
School, Chicago, Illinois, U.S.A.
Human genetic or autoimmune skin diseases occur when the intercellular adhesive properties of
the differentiation-dependent desmosomal cadherin desmoglein 1 (Dsg1) are compromised.
Recent studies suggest that desmogleins may also have nonadhesive roles in epithelial cells.
Although desmoglein 2 is widely expressed in cultured cells and its ectopic expression is easily
tolerated in stable cell lines, we have observed that cultured cells do not tolerate ectopic expression
of Dsg1 in a stable and homogenous fashion. In addition, we showed that among a panel of
desmosomal molecules screened in vitro, Dsg1 was the most ef®ciently cleaved by caspase-3. Thus,
we sought to investigate the potential role of Dsg1 during epithelial cell apoptosis. In vitro cleavage
assays showed that of caspases-2,-3,-6,-7, and ±8, the Dsg1 tail was preferentially cleaved by
caspase-3 to produce a 17-kDa fragment. Mutational analysis showed that cleavage occurs at a
caspase-3 consensus site, DLRD, encompassing amino acids 885±888 of the full-length Dsg1
protein. To test whether this cleavage event occurs in vivo, a stable A431 cell line inducibly
expressing a full-length Dsg1 construct ¯ag-tagged at the C-terminus was generated. A 17-kDa C-
terminal Dsg1 fragment was detected by 3 h after TRAIL/cycloheximide treatment and 6 h
following treatment with UV radiation, but not in cells treated with the peptide caspase inhibitor
ZVAD-fmk. The appearance of the soluble 17 kDa fragment correlated with an enrichment of the
remaining full-length Dsg1 in the triton-insoluble fraction. In addition, immuno¯uorescence
analysis demonstrated a decrease in Dsg1 immunoreactivity over time following treatment with the
various death stimuli. Our results suggest that, in addition to its role in cell-cell adhesion, Dsg1 is
also a caspase substrate that may play an active role in epithelial cell survival and proliferation or
contribute to other caspase-dependent processes such as epidermal differentiation.
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Elevated Expression and Retinoid Regulation of Cyr61 in Chronologically Aged,
Photoaged, and UV-Irradiated Human Skin In Vivo
T.H. Quan, T. He, Y. Shao, J.J. Voorhees, and G.J. Fisher
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Damage to dermal collagen is a prominent feature of both photoaging and chronological aging. In
both photoaging and chronological aging, matrix-degrading matrix metalloproteinases (MMPs) are
increased and types I and III procollagen are decreased. These abnormalities are normalized by
topical retinoic acid treatment, suggesting a common molecular basis. Recently, Cyr61, a member
of the connective tissue growth factor family, has been shown to inhibit procollagen synthesis and
induce MMPs upon addition to cultured human skin ®broblasts. We report here that Cyr61
mRNA levels (measured by quantitative real-time RT/PCR) are increased 3.9 fold in sun-
protected aged (80+ years) human skin, compared to young human skin (20±30 years, n = 5, p
< 0.05). Cyr61 mRNA levels were increased 2.9 fold in photoaged forearm skin, compared to
subject-matched sun-protected hip skin (n = 3, p < 0.05). UV-irradiation (2MED solar-simulated
UV) induced Cyr61 mRNA within four hours, with maximal induction (6.6 fold) 8 h post UV
(n = 3, p < 0.05). Cry61 gene expression returned to its initial basal level 24 h post UV.
Immunohistology revealed that Cyr61 protein was expressed mainly in dermal cells in human skin.
Topical treatment of human skin in vivo with retinol (1%) for seven days reduced Cyr61 mRNA
expression in aged skin and photoaged skin by 65% (n = 6, p < 0.05) and 70% (n = 3, p < 0.05),
respectively, compared to vehicle-treated skin. These data demonstrate, for the ®rst time, Cyr61
expression in human skin in vivo. Given the ability of Cyr61 to inhibit procollagen and induce
MMPs, it is likely that overexpression of Cyr61 is a key mediator of aberrant collagen homeostasis
observed in aged and photoaged human skin. Suppression of Cyr61 expression by retinol or other
agents represents a novel therapeutic mechanism by which to improve the health of aged and
photoaged human skin.
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Syndecan-4 Modulates Focal Adhesion Kinase Phosphorylation
S.A. Wilcox-Adelman, F. Denhez, and P.F. Goetinck
Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown,
Massachusetts, U.S.A.
Cell migration is important in normal biological processes such as development, wound healing,
in¯ammation and angiogenesis. Migration results from a delicate balance between adhesion of cells
to an underlying substrate and the highly regulated dissolution of those focal adhesions. Fibroblasts
seeded on ®bronectin (FN) will generate actin stress ®bers and focal adhesions. Cell seeded onto
the cell-binding domain (CBD) fragment of FN will attach but not form stress ®bers or focal
adhesions. Treatment with either LPA, to activate Rho, or PMA, to activate PKC, or antibodies to
induce the clustering of the cell-surface heparan sulfate proteoglycan syndecan-4 will stimulate
stress ®ber and focal adhesion formation in CBD-adherent cells. The morphological differences
between cells adherent to CBD and to FN suggest that syndecan-4 may in¯uence the organization
of the focal adhesion or activation state of focal adhesion associated proteins. FN-null cells (which
express syndecan-4) exhibit diminished phosphorylation of focal adhesion kinase (FAK) tyrosine-
397(Y397) when adherent to CBD compared with FN as analyzed by Western blotting
techniques. Treating CBD-adherent ®broblasts with LPA or the tyrosine phosphatase inhibitor
sodium vanadate increases the phosphorylation of FAK Y397 to that of cells seeded on FN,
although treatment with PMA does not. To con®rm that this regulatory pathway involves
syndecan-4 speci®cally we utilized ®broblasts derived from mice lacking syndecan-4. The
phosphorylation levels of FAK Y397 were lower in FN-adherent syndecan-4-null ®broblasts
compared with wildtype cells and these levels were rescued by addition of LPA. These results
demonstrate that syndecan-4 ligation regulates the phosphorylation of FAK Y397 and that this
mechanism is dependent on Rho and not PKC. In addition, the data suggest that this pathway is
negatively regulated by a tyrosine phosphatase. Our results implicate syndecan-4 activation in focal
adhesion regulation.
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Different Responsiveness to TGF-b1 and TNF-a in Protein Synthesis of Type IV and
VII Collagens Among Dermal Fibroblasts
S. Amano, N. Akutsu, Y. Ogura, and T. Nishiyama
Skin Biology Research Laboratories, Shiseido Life Science Research Center, Yokohama, Japan
Type IV and VII collagens are major components of epidermal basement membrane and play
important roles in the adhesion between the epidermis and the dermis. The syntheses of both
collagens have been examined by immunostaining or Northern blotting, but rarely at the protein
level. To examine the protein synthesis of both collagens by human keratinocytes and human
®broblasts, sensitive sandwich ELISAs speci®c to each collagen were developed by using two kinds
of speci®c antibodies against triple helical domain of type IV collagen or NC1 domain of type VII
collagen. Ascorbic acid or its derivatives were essential for the extracellular secretion of both
collagens in both keratinocytes and ®broblasts. Protein syntheses of both collagens were stimulated
by IL-1a, TNFa, TGFb1, and PDGF in ®broblasts and by TGFb1 in keratinocytes. The protein
syntheses of type IV and VII collagens were compared among skin ®broblasts derived from 24
persons (fetal ± 91 years old). There was no correlation between the age of the donors and the
synthesis of each collagen. The responsiveness of type IV collagen synthesis to TNFa (1 ng/ml) and
TGFb1 (1 ng/ml) was different among ®broblasts and was very low in ®broblasts from 41-year-old
and older donors, except for those from an 89-year-old donor, whereas all ®broblasts were more
responsive to TGFb1 than TNFa in terms of type VII collagen synthesis. Type IV collagen
synthesis by ®broblasts from papillary dermis showed more responsiveness to TNFa than TGFb1,
although ®broblasts from middle and reticular dermis responded much more strongly to TGFb1
than TNFa. These results suggest that the responsiveness to cytokines of type IV collagen and type
VII collagen protein syntheses is different among ®broblasts, especially between ®broblasts from
papillary dermis and reticular dermis.
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A Pathogenic Antidesmoglein3 Monoclonal Antibody Recognizes the N-Terminal
Adhesive Region of Desmoglein3
K. Tsunoda,*³ M. Aoki,² T. Ota,*² T. Nagai,³ T. Yamada,§ S. Koyasu,² T. Nishikawa,* and M.
Amagai*
*Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; ²Department of
Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan; ³Department of Dentistry
and Oral Surgery, Keio University School of Medicine, Tokyo, Japan; §Department of Pathology, Keio
University School of Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by antidesmoglein 3 (Dsg3)
IgG autoantibodies. We have recently succeeded in developing an active disease mouse model for
PV by adoptive transfer of Dsg3±/± splenocytes to Rag-2±/± immunode®cient mice. The purpose
of this study is to generate a pathogenic anti-Dsg3 monoclonal mouse IgG using PV model mice
and to characterize its epitope on Dsg3. AK23 is an anti-Dsg3 IgG1 monoclonal antibody
established from splenocytes of PV model mice. AK23 was found to bind to both mouse and
human Dsg3, but not to Dsg1, as determined by immuno¯uorescence and ELISA. When AK23
alone was injected into neonatal mice, the mice developed microscopic blisters with suprabasilar
acantholysis in histology. When AK23 was coinjected with a small amount of PF sera or exfoliative
toxin A whose amount was insuf®cient to induce blisters by itself, the mice developed extensive
blisters. More convincingly, when hybridoma cells producing AK23 were inoculated in
intraperitoneum of Rag-2±/± mice, the mice showed weight loss and patchy hair loss at day 7±
10, which were virtually identical to the phenotype of PV model mice or Dsg3±/± mice. Oral
mucosa of these mice showed suprabasilar acantholysis with IgG deposition on keratinocyte cell
surfaces. Thus, AK23 is a pathogenic monoclonal antibody which can induce the phenotype of PV
in mice by itself. Furthermore, we characterized the epitope of AK23 by immunoprecipitation and
competition ELISA using domain-swapped as well as point-mutated Dsg3/Dsg1 recombinant
proteins. AK23 was considered to recognize an epitope which involves the Dsg3-speci®c residues
of 25T, 28Y, and 29Q, which are located in the N-terminal adhesive region of cadherins. AK23
will be a valuable tool to dissect the molecular mechanism of blister formation in pemphigus.
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Changes in Expression Patterns of Tight Junction Proteins in Malignant Melanoma and
Adjacent Epidermis Compared to Melanocytic Nevi
N.K. Haass, J.M. Brandner, P. von den Driesch, E. Wladykowski, S. Kief, P. Houdek, and I. Moll
Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Despite the dogma, that the barrier function of the skin is held upright mainly by corneocytes and
lipids, it is much discussed, if tight junctions are involved in this function as well. In simple
epithelia and endothelia tight junctions are responsible for the formation and maintenance of the
tissue barrier between distinct compartments. They are composed of various transmembrane
(Claudin 1±20, Occludin, junctional adhesion molecule (JAM)) and plaque proteins (Zonula
occludens proteins 1±3 (ZO-1±3), Symplekin). We focus on the occurrence of Occludin, Claudin
1 and ZO-1 in malignant melanoma (MM) compared to melanocytic nevi, angioma and normal
interfollicular epidermis. Investigations were performed by immuno¯uorescence microscopy of
frozen sections and of cultured cells. As previously shown by us and others in normal interfollicular
epidermis Occludin and ZO-1 are expressed in the stratum granulosum and the transition layer,
while Claudin 1 occurs in all layers. Now we demonstrate a strong expression of ZO-1 in MM, in
contrast to melanocytes, known to be negative for ZO-1. In contrast to normal epidermis there is
no expression of ZO-1 in epidermis adjacent to MM. ZO-1 is also seen in melanocytic nevi and in
the endothelia of angioma, but with a normal expression in the adjacent epidermis to these lesions.
On the other hand Occludin and Claudin 1 are absent from MM cells. They occur in interfollicular
epidermis adjacent to MM, but Occludin is present in all layers and is no more restricted to the
stratum granulosum and the transition layer. Occludin is not expressed in melanocytic nevi,
whereas Claudin 1 is negative for basal cells of melanocytic nevi, but positve in their suprabasal
cells. These results clearly show a down-regulation of ZO-1 in interfollicular epidermis adjacent to
MM and an induction of ZO-1 in MM cells. Ongoing investigations will elucidate the function of
ZO-1 and other tight junction proteins in the genesis of MM.
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p120ctn Isoforms in Epithelial Cell Biology
S. Aho, T. Pajunen, S. Kazerounian, and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.
P120 catenin has been implicated as a regulatory molecule in adherens junction formation. Due to
alternative splicing and multiple translation initiation codons, several p120ctn isoforms can be
expressed from a single gene. We have examined the distribution of p120ctn isoforms in mouse
and human tissues, as well as the consequences of their over-expression in cultured cells of
epidermal origin. While the isoform 3A, the epithelial isoform, was prominent in tissues with E-
cadherin, the long isoform 1A primarily localized with VE- and N-cadherins. In cultured cells the
induction of prominent protrusions, ®lopodia and lamellopodia, collectively called as the branching
phenotype, was dependent on the nuclear localization of p120ctn isoforms 1A, 2A and 3A, while
the isoforms 4A and 1AB, which were excluded from the nucleus, and often lost from tumor cells,
did not induce the branching phenotype. The branching phenotype has been connected with the
disruption of actin ®laments. However, we observed that the over-expression of both isoforms 1A
and 1AB was able to disrupt the keratin intermediate ®laments. The over-expression of p120ctn
deletion constructs revealed that the N-terminal sequences containing seven tyrosine residues,
recently characterized as potential candidates for phosphorylation by Src kinase, are required for
the nuclear localization and for the branching phenotype. The expression of the p120ctn isoforms,
which caused the branching phenotype, also resulted in subcellular relocalization of E-cadherin
from the cell-cell junctions in HaCaT cells. We have shown that this region of p120ctn is also
responsible for binding to the intracellular domain of BP180/type XVII collagen. Collectively,
distinct domains of p120ctn are responsible for its biological functions. The interactions of p120ctn
with various soluble cytoplasmic and nuclear proteins, with the components of cell-cell and cell-
matrix adhesion structures, as well as the interference with the cytoskeletal structures indicates
multiple regulatory functions for p120ctn in cell adhesion and motility.
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Laminin 5 Integrin b4 are Required for Ras-Driven Human Epidermal Tumorigenesis
M. Dajee, M. Lazarov, A. Russell, P. Marinkovich, J. Reuter, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
The expression of matrix molecules and their cellular receptors are altered in human cancers, as
seen in the case of increased expression of laminin 5 and a6/b4 integrin in certain epithelial
neoplasms. The bulk of work studying genes involved in carcinogenesis, however, has been carried
out in murine models where cells are vastly more susceptible to transformation than human and
where, in skin, major tissue architectural differences exist. To study the role of matrix factors in a
setting more relevant to human tumorigenesis, we have used the following elements; (1) primary
human keratinocytes from genetically characterized patients with epidermolysis bullosa (EB) that
are de®cient in LAMB3 (Laminin 5 b3) or ITGb4 (b4 integrin) (2) a new human tumor induction
approach using expression of Ras and IkBaM which directly transforms normal human epidermal
cells into those displaying cardinal features of human squamous cell carcinoma (SCC), including
tissue invasion and visceral dissemination in immune de®cient mice. Ras and IkBaM epidermal
tumors generated from wild-type human cells are lethally aggressive and display high levels of
laminin 5 and b4 integrin [n = 8]. Both laminin 5 b3±/± and b4 integrin±/± cells expressing Ras
and IkBaM failed to form tumors in all cases [n = 4 each]. Re-introduction of wild-type LAMB3
and ITGb4 into these cells, however, restored their tumor forming capability kinetics to those of
wild-type cells, con®rming that the previously missing genes rather than the general health of these
EB patient cells was responsible for the lack of tumor formation. Consistent with these genetic
studies, injection of blocking antibodies directed at laminin 5 and b4 integrin, but not control IgG
or antilaminin 10 antibodies, blocked tumor formation in wild-type human cells. These data
indicate that laminin 5 and its ligand b4 integrin are necessary for Ras-driven human epidermal
tumorigenesis and provide a new general genetic approach to study the matrix factors involved in
human epidermal neoplasia.
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Retinoid Induction of Transforming Growth Factor-b1 and Connective Tissue Growth
Factor: Major Regulators of Collagen Synthesis, in Aged and Photoaged Human Skin In
Vivo
T. He, T.H. Quan, G.J. Fisher, and J.J. Voorhees
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Synthesis of type I procollagen and its conversion to collagen (COL), the major structural protein
of dermis, is reduced in aged human skin and photoaged human skin. This reduction impairs the
skin's structure, function, and appearance. Topical treatment of aged or photoaged human skin
with retinoids increases COL production, thereby improving its function and appearance. We have
investigated molecular basis for reduced COL synthesis and its induction by retinoids in aged skin
and photoaged human skin. In situ hybridization revealed that dermal mRNA expression of the
two major regulators of COL production, transforming growth factor-b1 (TGF-b1) and its
downstream effector connective tissue growth factor (CTGF), was reduced in aged (80+ years) and
photoaged skin, compared to young (20±30 years) skin and sun-protected skin, respectively.
Quantitative real-time RT-PCR analysis demonstrated that TGF-b1 and CTGF mRNA levels,
normalized to total RNA or housekeeping gene 36B4, were reduced in aged skin by 65% and 45%,
respectively (n = 5±6, p < 0.05), and in photoaged skin by 60% and 50%, respectively (n = 5±6, p
< 0.05). In contrast, levels of TGF-b2 and TGF-b3 mRNA were not altered in aged or photoaged
skin, demonstrating that gene expression was not generally repressed in aged or photoaged skin.
Topical application of retinol (0.1%) for seven days markedly increased TGF-b1, CTGF, and COL
gene expression in aged (2.3-fold, 2.6-fold, and 2.6-fold, respectively, n = 4±6, p < 0.05) and
photoaged skin (2.1-fold, 2.2-fold, and 3.0-fold, respectively, n = 4±6, p < 0.05), compared to
vehicle-treated skin. In situ hybridization revealed increased TGF-b1 and CTGF mRNA in the
dermis and epidermis. These data indicate that reduced TGF-b1 and CTGF expression mediates, at
least in part, loss of procollagen synthesis in aged and photoaged human skin. Understanding
mechanisms by which retinoids up-regulate TGF-b1 and CTGF will advance discovery of new
therapeutic modalities to treat aged and photoaged human skin.
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Matrix Metalloproteinase-9 Activation in Human Skin
Y. Han, Y. Nien, and W.L. Garner
Surgery, University of Southern California, Los Angeles, California, U.S.A.
Compelling evidence has demonstrated an association between in¯ammation and increased MMP
activity in chronic wounds. Among the wide spectrum of proteases over expressed in chronic
tissue, MMP-9 is thought to be of particular importance since its essential role in remodeling of
basement membrane zone, resulting in changes in epithelialization. The cellular factors to promote
MMP-9 expression and activation in human tissue have not been identi®ed. The purpose of this
prospective study was to determine the factors that induce and activate MMP-9 in human tissue.
We utilized intact human skin to measure MMP-9 induction and activation in response to various
cytokines. We found that TGF-b is a strong inducer of pro-MMP-9 and that TNF-a/IL-1
promotes pro-MMP-9 activation by conversion of the 92-kDa latent proteinase into 82-kDa active
enzyme. This cytokine-mediated activation of MMP-9 is mediated by unidenti®ed skin tissue
associated proteinase. We also found the TNF-a mediated activation of pro-MMP-9 is linked to
down regulation of TIMP-1, the proteinase inhibitor. Further, we isolated dermal ®broblasts and
epidermal keratinocytes and tested their response to these cytokines. Our results showed that either
TGF-b or TNF-a can individually induce pro-MMP-9 by keratinocytes. However, signals from
TGF-b and TNF-a are both required for the induction in dermal ®broblasts. This induction is
mediated, at least in part, by activation of the 5'-¯anking promoter of the mmp-9 gene. In
summary, we identi®ed TGF-b, IL-1 and TNF-a as potential cellular factors in regulation of the
expression and activation of MMP-9 in human tissue. Given the facts that these cytokines are
present in chronic wound we believe they could be the causative factors to induce and activate
MMP-9 in abnormal healing.
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Activation of the Small GTPase Rac1 Alters Localization of Integrin a3b1 Leading to
Disruption of Hemidesmosome Formation
J. Chu, A.J. Russell, and M.P. Marinkovich
Program in Epithelial Biology, Stanford University School of Medicine, Stanford, California, U.S.A.
The small GTPase Rac1 is an important mediator of epithelial polarity and cell migration. We have
previously shown that a6b4 integrin ampli®es Rac1 activation through the EGF receptor, leading
to enhanced keratinocyte migration. We sought to investigate whether Rac1 activation also plays a
role in hemidesmosome (HD) disassembly, an integral part of epithelial migration. Primary human
keratinocytes were infected with a retrovirus expressing constitutively activated V12 Rac1 or LacZ
control. Transduced cells expressing V12Rac had increased surface levels of a3b1 and a6b4
integrin (147% and 142% of LacZ control) by ¯ow cytometry and were 129 6 6% more adhesive
to puri®ed laminin 5 than LacZ cells. Immuno¯uorescence microscopy revealed that Rac1 did not
overtly compromise the clustering of a6b4 integrin with HD components plectin/HD1, BP180
and laminin 5. However, we did observe a relocation of a3b1 integrin from HD-associated focal
adhesions to vinculin containing structures at the cell periphery. Focal adhesions containing a3b1
integrin have been proposed as early nucleating factors for HD formation, prior to a6b4 integrin
ligation. We therefore examined the in¯uence of Rac1 upon HD formation when attachment of
a6b4 integrin was prevented. Treatment of V12Rac1 keratinocytes with an inhibitory antibody
against b4 integrin completely inhibited HD formation, while HD formation was unaffected in
LacZ cells. Additionally, b4 integrin de®cient keratinocytes expressing an attachment defective
form of the b4 integrin subunit were unable to cluster HD components under conditions of
activated Rac1. These studies directly link HD-associated a3b1 integrin with the nucleation of
HD complexes. We also show that Rac1 speci®cally disrupts this pathway and may antagonize the
formation of new HD complexes during wound healing. Experiments are currently underway to
understand the in vivo consequences of this inhibition using SCID mice grafted with V12Rac
expressing keratinocytes.
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Laminin 10/11 Restores the Intrinsically Poor Tissue Regenerative Capacity of
Differentiating Keratinocytes
P. Kaur, A. Li, and N. Pouliot
Epithelial Stem Cell Biology Laboratory, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia
The aim of this study was to investigate factors affecting proliferation and tissue regeneration
capacity of keratinocyte stem cells (KSC) and their progeny. We used a FACS method to
distinguish between subpopulations of basal keratinocytes as reported by us previously (1), and the
organotypic culture model system as an assay for tissue regenerative capacity of KSCs, transit
amplifying (TA) cells and differentiating cells (PMD) distinguished by their differential expression
of the cell surface markers CD59f (a6 integrin) and CD71 (transferrin receptor). Our data
demonstrate that (a) KSCs have an intrinsic epithelial regeneration capacity and an ability to
achieve homeostasis; (b) TA cells regenerate a hyperplastic epithelium; and (c) PMD cells have a
limited capacity to regenerate a multilayered epithelium. Importantly, we observed that this limited
tissue regenerative ability of PMDs could be overcome by exogenous supply of the basement
membrane proteins laminin 10/11, and the epithelium regenerated was similar to that obtained
from KSCs. Consistent with this result, we demonstrate that laminin 10/11 is a potent adhesive and
proliferative substrate for cultured keratinocytes (2) and more importantly stimulates the
proliferation of PMD cells in monolayer culture. We conclude that laminin 10/11 is an important
regulator of epidermal proliferation and its ability to promote tissue regeneration has important
implications for wound healing.
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Defective Cell-to-Cell Adhesion in Hailey-Hailey Disease is Aggravated by
Environmental Factors Associated with Increased IL-1 and TNF Levels
I. Aronchik,* M.J. Behne,*² D. Crumrine,*² G. Bench,³ P.M. Elias,*² E. Epstein,²§ and T.M.
Mauro*²
*Dermatology, VA Medical Ctr, San Francisco, California, U.S.A.; ²Dermatology, UCSF, San Francisco,
California, U.S.A.; ³Ctr Acc Mass Spec, Lawrence Livermore Natl Laboratories, Livermore, California,
U.S.A.; §Dermatology, SF General Hosp, San Francisco, California, U.S.A.
Hailey-Hailey disease (HHD, MIM 16960) is a blistering skin disease caused by mutations in the
Golgi Ca
2+
ATP'ase ATP2C1. Affected individuals develop blisters and erosions in characteristic
intertriginous locations, although the ATP2C1 mutations are equally present in unaffected skin.
We found that cell-to-cell adhesion is impaired when HHD keratinocytes are treated with IL-1a
and TNF-a, in concentrations similar to that found in skin disturbed by scratching, maceration, or
exposed to sweat; all conditions more likely to occur in the locations where lesions are found in
HHD. Normal keratinocyte cell adhesion was not affected under these conditions. E-cadherin as
an essential component of desmosomal cell-to-cell adhesion is processed through the ER/Golgi.
Addition of IL-1a or TNF-a perturbed its processing in HHD keratinocytes. These treatments
raised intracellular Ca
2+
from intracellular stores in both normal and HHD keratinocytes,
suggesting they may act to further deplete Golgi Ca
2+
. In addition, we found that ATP levels in
undifferentiated HHD keratinocytes were much lower than in normal controls. Since actin is
required for cell-to-cell adhesion, and ATP controls actin polymerization, the low levels of ATP in
HHD keratinocytes we observed may be an additional pathologic mechanism. Consistent with this
®nding were alterations in actin structure in HHD cells seen by light and electron microscopy.
Overall decreased levels of cellular p in HHD skin as compared to healthy skin con®rm these
results. These studies emphasize the importance of calcium stores for strati®ed squamous
epithelium, demonstrate that additional environmental factors may worsen the HHD lesions in
individuals carrying the ATP2C1 mutations, and suggest possible therapeutic interventions that
may prevent the development of skin lesions.
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The Noncollagenous (NC2) Domain of Type VII Collagen Initiates Triple-Helical
Assembly
D.T. Woodley, J. Wang, K.R. Lipman, T.M. Atha, and M. Chen
Dermatology, University of Southern California, Los Angeles, California, U.S.A.
Type VII (anchoring ®bril) collagen, consists of a central collagenous triple helical domain (TH)
¯anked by noncollagenous domains NC1 and NC2 at the N- and C-terminus, respectively. We
previously showed that NC2 and 186 amino acids (AAs) of the adjacent TH domain (NC2
+ 186TH) initiated triple helical assemble and antiparallel dimer formation of type VII collagen.
However, the exact mechanism of triple helical formation and sequences governing it are
unknown. In this study, we produced recombinant subdomains within NC2 + 186TH in human
293 cells. The ®rst construct, 186TH + 38NC2, contained the entire 186 AAs of the TH domain
plus only 38 AAs of the NC2 domain. The second construct, 186TH, contained 186 AAs of the
TH domain. The third construct, NC2, contained the entire NC2 domain. The fourth construct,
C7-NC2 contained the entire type VII collagen except for the NC2 domain. 186TH + 38NC2
was secreted as correctly folded, disul®de-bonded, helical trimers resistant to protease digestion.
However prevention of hydroxylation abolished trimer formation. The C7-NC2 was secreted
mostly as monomers and a small amount of trimers that were sensitive to protease degradation,
suggesting a nonhelical conformation. In contrast, the pure NC2 and 186TH were secreted only as
monomers. To identify the critical cysteine residues for disul®de bonds that stabilize the trimers,
we analyzed the effects of substituting serine for the cysteine residues within the NC2 and TH
domains. Mutation of either cysteine 2802 or cysteine 2804 alone within the NC2 domain reduced
trimer formation while a double substitution mutation completely abolished trimer formation. In
contrast, a single cysteine mutation, 2634, within the TH domain had no effect. Further, a
generated methionine to lysine substitutions, M2798K, that is associated with recessive dystrophic
epidermolysis bullosa, had reduced ability to form trimers. We conclude that triple helix formation
of type VII collagen proceeds from C to the N terminus and the 38 AAs within the NC2
subdomain are critical for the initiation of triple-helical assembly.
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Transposase-Based Stable Nonviral Laminin 5 Gene Delivery in Junctional
Epidermolysis Bullosa
S. Ortiz-Urda, S. Yant, F. Scholl, Z. Siprashvili, P. Chen, M. Kay, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Recent genetic correction of human junctional epidermolysis bullosa (JEB) skin tissue used
amphotropic MLV-based retrovirus. While ef®cient, durable and capable of restoring normal
laminin 5 gene expression and tissue cohesion, this approach suffers from limitations that include
biosafety concerns as well as the expense and regulatory hurdles of viral gene transfer. Non-viral
plasmid-based vectors represent a logical next step free of many of these disadvantages.
Conventional plasmids exist as episomes, however, and thus achieve only transient gene transfer
because such extra-genomic DNA is unstable. To achieve stable plasmid-based nonviral gene
transfer in JEB, we used a newly developed nonviral approach to permanent gene integration based
on the Sleeping Beauty (SB) ancestral ®sh transposase, a member of the Tc1/mariner superfamily.
SB and other mariner family transposases integrate incoming DNA into the genome using a ``cut-
and-paste'' mechanism requiring short inverted repeat (IR) sequences ¯anking the insert. An IR-
¯anked laminin 5 b3 expression plasmid was constructed in which gene expression is directed by
the CMV IE promoter driving both laminin 5 expression and the blastocidin resistance gene.
Primary keratinocytes from genetically characterized laminin 5 b3-de®cient JEB patients were
transfected with this construct along with either wild-type SB or its inactive point mutant (mSB).
While mSB failed to support durable laminin 5 restoration, as measured by Western blot and
immuno¯uorescence, wild-type SB led to stable, retained gene expression through > 20 cell
divisions. Addition of a 10-day course of blastocidin selection enriched the percentage of
keratinocytes stably expressing laminin 5 in transfected bulk populations of primary JEB cells to
100%. Further studies are underway to extend these ®ndings to JEB in vivo tissue models.
Transposase-based plasmid integration thus provides the ability to achieve stable nonviral gene
transfer integrated into host cell genomes and may replace current viral approaches.
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Human ATP2C1 Localizes to the Golgi in Keratinocytes and Controls Golgi Ca
2+
Stores
M.J. Behne,*² I. Aronchik,² G. Bench,§ E. Epstein,*³ T. Pozzan,¶ and T.M. Mauro*²
*Dermatology, UCSF, San Francisco, California, U.S.A.; ²Dermatology, VA Medical Ctr, San Francisco,
California, U.S.A.; ³Dermatology, SF General Hosp, San Francisco, California, U.S.A.; §Ctr Acc Mass
Spec, Lawrence Livermore Natl Laboratories, Livermore, California, U.S.A.; ¶Biomed Sci, U Padova,
Padova, Italy
Hailey-Hailey disease (HHD, MIM16960) is a blistering skin disease caused by mutations in the
Ca
2+
ATP'ase ATP2C1. Using an antibody raised speci®cally against the human ATP2C1, we
localized the ATP2C1 to the Golgi apparatus in human keratinocytes, similar to its localization in
yeast and C elegans. Further, we found that the protein levels of ATP2C1 are decreased in HHD.
To test whether the ATP2C1 controls Golgi Ca
2+
stores, we measured intraorganelle Ca
2+
concentrations using aequorins speci®cally targeted to the Golgi apparatus. While normal
keratinocytes display Golgi Ca
2+
levels comparable to other epithelial cells, HHD keratinocyte
Golgi Ca
2+
re®ll is slower and the maximum Ca
2+
concentration reached is signi®cantly lower.
These ®ndings were replicated in vivo, as clinically normal HHD epidermis, but not dermis,
contains lower Ca
2+
stores than does normal skin. Previously, we have shown that HHD
keratinocytes do not respond to extracellular Ca
2+
to the same degree as normal keratinocytes (Hu
et al 2000). These data suggest that the inability of HHD keratinocytes to release intracellular
Ca
2+
in response to raised extracellular Ca
2+
stems from a decrease in intraorganelle ATP2C1 Ca
2+
stores and imply that keratinocyte Ca
2+
stores controlled by the ATP2C1 may be mobilized during
normal keratinocyte Ca
2+
signalling. This is the ®rst report to localize the ATP2C1 and





Wound-Inducible Expression of Rat Stromelysin-1/Matrix Metalloproteinase-3
Targeted to Keratinocytes Alters Early Events During Wound Healing in Transgenic
Mice
L.J. McCawley, J. Wright, and L.M. Matrisian
Cancer Biology, Vanderbilt University, Nashville, Tennessee, U.S.A.
Stromelysin-1/Matrix Metalloproteinase-3 (MMP-3) is detected in skin during wounding, in
nonhealing skin diseases and during tumorigenesis. MMP-3 is expressed by a variety of cell types;
however, keratinocyte expression of MMP-3 is restricted to the basal population during wound
repair and during carcinogenesis upon conversion to the metastatic, spindle phenotype. Mice
which are null for MMP-3 have delayed closure of excisional wounds. MMP-3 displays broad
speci®city for a number of matrix and nonmatrix substrates suggesting that induction of MMP-3
could have widespread consequences. In order to examine the biological role of MMP-3
expression in keratinocytes, transgenic mice were generated with targeted expression of an
autoactivated MMP-3 construct to basal keratinocytes under the control of keratin 5 and keratin 6
promoter regions. These mice display induced expression of MMP-3 in keratinocytes upon
wounding. K5/6-MMP-3 mice displayed a modest but signi®cant earlier time to excisional wound
closure as compared to control animals. Elevation of mRNA expression of MMP-3 is reported as
being localized to proliferating basal keratinocytes during wounding; however, the number of
proliferating keratinocytes as measured by BrdU incorporation in transgenic and wildtype
counterparts did not signi®cantly differ postwounding. Histological and immunohistochemical
analysis revealed that wounded areas from K5/6-MMP-3 displayed reduced thickness of
hypertrophic epidermis. Wounded dermis of K5/K6-MMP-3 did have signi®cantly increased
areas of blood vessel density as detected by immunohistochemical analysis and enhanced blood
perfusion as measured by laser Doppler in the early days postwounding. These results are consistent
with a role for MMP-3 in modulation of existing vasculature during wound healing and suggest
that induction of MMP-3 in the wound environment in¯uences early stages of excisional wound
repair.
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New Laminin-Peptide Promotes Extracellular Matrix Production and Modulates Cell
Adhesion
C. Dal Farra, E. Bauza, K. Cucumel, J. Botto, F. Portolan, J. Sabatier,* and N. Domloge
Research Center, Vincience, Sophia Antipolis, France; *CNRS UMR6560, Faculte de Medecine Nord,
Marseille, France
Laminin is a very important component of extra cellular matrix (ECM) and is an essential
constituent of basement membrane. Laminin plays a critical role in cell behavior, is a potent cell
adhesion molecule, and is involved in some skin pathologies. We have developed a synthetic oligo
laminin-peptide and studied its stability, degradation, and effect on cell adhesion and synthesis of
some ECM molecules. Analytical reverse-phase HPLC showed that the peptide exhibited total
stability in water and only a low degradation (less than 30%) was observed when the peptide was
incubated with culture medium taken from human ®broblasts cultured for 36 h. Moreover, the
peptide exhibited a low surface adsorption when stored in plasticware. Cell adhesion assay using
HaCat cells showed that pretreatment of microplates with 10±6 M of peptide, a few hours prior to
cell seeding, enhanced cell adhesion. Immuno¯uorescence studies on subcon¯uent cells revealed
an increased expression of ECM molecules (such as ®bronectin and laminin 5) in cells treated with
10±6 M of peptide. Since B1 integrins include receptors implicated in the adhesion of
keratinocytes to ECM (collagen, laminin and ®bronectin), we studied B1 integrin expression in
subcon¯uent HaCat keratinocytes cultured in the presence of 10±6 M of peptide. These studies
showed that B1 expression is increased in these cells. These results suggest an interesting role for
Laminin-peptide in stimulating ECM biosynthesis and promoting cell adhesion, which is of great
interest in tissue regeneration.
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Development of a Reconstructed Dermis for Assessment of Factors In¯uencing
Cutaneous Nerve Regeneration





pital du Saint-Sacrament, Universite
Á
Laval,
Quebec, Quebec, Canada; *Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
During regeneration of cutaneous innervation, many factors in¯uence axon guidance and
lengthening. Key factors include cell interactions, neurotrophic factors and extracellular matrix
molecules. Our aim was to produce a dermal model, which could allow neurite outgrowth and
facilitate the study of factors that could favour or inhibit this process. We created a reconstructed
dermis made of a collagen and chitosan sponge seeded with human ®broblasts and grown in vitro
for 14 days. We extracted sensory neurons from dorsal root ganglions of mice embryos and added
them on the reconstructed dermis, which was lift at the air±liquid interface and cultured 14
additional days. We used this reconstructed dermis to study the effects of nerve growth factor and
endothelial cells coculture on the lengthening of nerve ®bres by adding nerve growth factor in the
culture medium of the dermis with neurons and by seeding human umbilical vein endothelial cells
with human ®broblasts. The axon migration was analysed with the immunohistochemical marker
protein gene product 9.5, which is widely used for the labelling of cutaneous nerves. The addition
of nerve growth factor with human endothelial cells grown in coculture with ®broblasts was the
best combination to enhance neurite outgrowth within the reconstructed dermis. This model
could easily be modi®ed to analyse the in¯uence of other type of cells such as keratinocytes and
Schwann cells and molecules like glycosaminoglycans and neurotrophins on axonal migration.
Therefore, this reconstructed dermis is a useful model to study the mechanism of neural
regeneration in skin.
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The Amount of Desmoglein in Hair Root Sheath has Relation to the Intensity to Pluck
Anagen Hair
M. Hotta, M. Sasajima, E. Wakisaka, T. Nomura, and Y. Takema
Biological Science Laboratories, Kao Corporation, Haga, Tochigi, Japan
Many kinds of cell adhesion molecules are related to anchoring a hair follicle to the skin. In
telogen, desmoglein 3 is involved in anchoring hair. On the other hand, little is known about cell
adhesion molecules concerned with anchoring hair in anagen. We examined which adhesion
molecule contributed to the strength to pluck anagen hair. In this study, we measured the force to
pluck hair and the amount of desmogleins in hair root sheath of each anagen hair of beard. We
veri®ed the strength to pluck hair had signi®cant correlation with the amount of both desmoglein 1
and desmoglein 3. While, no signi®cant correlation was observed between the amount of
desmoglein 2 and the strength to pluck hair. We found that trans-3, 4?f-dimethyl-3-
hydroxy¯avanone increased the amount of desmoglein 1 and/or 2 in human keratinocyte and
in rat hair follicle. Therefore, we measured the force to pluck anagen hair in the scalp of the
subjects who applied trans-3, 4?f-dimethyl-3-hydroxy¯avanone (treatment A) or placebo
(treatment B) for six months. In result, the strength to pluck hair was signi®cantly increased in
treatment A compared with in treatment B. These observations suggest that desmoglein 1 and
desmoglein 3 contribute to anchor anagen hair to the skin.
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CD44 and Hyaluronate Expression in Follicular Mucinosis
G. Kaya, E. Augsburger, P. Chavaz, and J.H. Saurat
Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland
CD44 is a membrane glycoprotein and serves as the major cell surface receptor for hyaluronate
(HA). In a recent study we have demonstrated that the lack of CD44 expression in murine
keratinocytes leads to an abnormal HA accumulation in the super®cial dermis, indicating an
important role of CD44 in local HA metabolism in the mouse skin. We have also observed a
decrease in the expression of epidermal CD44 in patients of lichen sclerosus et atrophicus which is
potentially responsable for the dermal deposition of HA in this disease. Recently we have also
shown that HA accumulation was associated with decreased expression of CD44 in
trichofolliculoma-like epithelial proliferations in perifollicular solitary cutaneous myxoma. In this
study we examined the follicular expression of CD44 and HA in the skin biopsy specimens of
seven patients with follicular mucinosis by using CD44-speci®c monoclonal antibodies and
biotinylated HA-binding protein (HABP), respectively. No difference of CD44 expression was
observed in the follicular keratinocytes when compared with those of unaffected interfollicular
epidermis. The follicular zones of mucin deposition were strongly positive for HA. A weak
interkeratinocyte staining pattern for HA was also observed in the interfollicular epidermis.
However, HABP staining revealed a stronger reactivity in the follicular keratinocytes surrounding
the mucin-accumulated areas compared to the interfollicular keratinocytes, indicating an active
secretion of HA by follicle cells in follicular mucinosis.
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A Nonsense Mutation in the Desmoglein 1 Gene Underlies Striate Keratoderma
A. Kljuic,* L. Gilead,³ J. Frank,§ R.F. O'Shaughnessy,² A. Zlotogorski,³ and A.M. Christiano²*
*Genetics and Development, Columbia University, New York, New York, U.S.A.; ²Dermatology,
Columbia University, New York, New York, U.S.A.; ³Dermatology, Hadassah University Medical Center,
Jerusalem, Israel; §Dermatology and Allergology, University Clinic of the RWTH Aachen, Aachen,
Germany
Striate keratodermas (PPKS) (OMIM 148700) comprise a rare group of autosomal dominant
genodermatoses characterized by palmoplantar keratoderma typi®ed by streaking hyperkeratosis
along each ®nger and extending onto the palm of the hand. We report a four-generation kindred
originating from Iran-Syria in which three members were affected with PPKS. Clinically, these
patients present with hyperkeratotic palms and plantar plaques. Direct DNA sequencing analysis
revealed a heterozygous C-to-A transversion at nt 395 of DSG1 gene. This mutation converted a
serine residue (TCA) in exon 5 to a nonsense mutation (TAA) designated S132X. The mutation
identi®ed in this study is a novel mutation in DSG1 gene and extends the body of evidence
implicating the desmoglein gene family in the pathogenesis of human skin disorders.
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Heat Accelerates UV-Induced Skin Wrinkling
I. Bae, K. Cho, M. Lee, K. Kim, H. Eun, and J. Chung
Dermatology, Seoul National University, Seoul, South Korea
Sunlight damages human skin, resulting in an old and wrinkled appearance. Ultraviolet (UV)
radiation is responsible for the dermal connective tissue destruction observed in photoaged skin. By
infrared radiation exposed to human skin, the skin temperature can become high (up to 400C).
Heat delivered by infrared light may contribute signi®cantly to photoaging. Therefore, we
investigated the effects of heat on the expression of MMPs and procollagen, and UV-induced skin
wrinkling. Exposure of human skin or cultured dermal ®broblasts to heat activated EGF receptors,
and stimulated extracellular signal-regulated kinase (ERK), c-Jun amino-terminal kinase (JNK),
and p38. Heat phosphorylated, and thereby activated transcription factors c-Jun Heat stimulated
DNA binding activity of transcription factor activator protein (AP) 1, leading to increased
transcription of matrix metalloproteinases such as collagenase and a 92-kDa gelatinase. On the
other hand, heat decreased procollagen mRNA and protein synthesis. We also demonstrated that
heat accelerate UV-induced skin wrinkling in hairless mice. These results indicate that heat as well
as UV contained in the sunlight may play an important role in the development of photoaging.
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Fibrinogen Inhibits Fibroblast-Mediated Contraction of Collagen Gels
Y. Nien, Y. Han, B. Tawil,* and W.L. Garner
Surgery, University of Southern California, Los Angeles, California, U.S.A.; *Baxter BioScience, Global
Biosurgery R & D, Duarte, California, U.S.A.
After an injury, reorganization of the newly synthesized matrix into a functional tissue is a necessary
process that involves several proteins. The manner in which they interact is not completely clear.
Clinically, the initial ®brin clot appears to remain stable in size while the later synthesized collagen
contracts. We studied the interactions of these two important components of early wounds using
®broblast populated matrix lattices. We use 3 different preparations of ®brinogen, which varies in
their purity and additional components. (1) Lattices were fabricated using type 1 collagen (1.7 mg/
ml), three ®brinogen sources, Tisseel from Baxter BioScience, Calbiochem and Enzyme Research
Laboratories, at 0, 0.5, 1, 2, 3, mg/ml with and without serum, using three distinct human
®broblast cell strains (100 000 cells/ml) and DMEM. Reorganization was measured by change in
lattice diameter. Data were compared using analysis of covariance with repeat measures. (2) (96 h/
5% serum) Collagen: 55.27% original area; Collagen + Thrombin 0.2 U/ml: 56.69%;
Collagen + Fibrinogen 0.5 mg/ml: 32.25%; Collagen + Fibrinogen 1 mg/ml: 61.33%;
Collagen + Fibrinogen 2 mg/ml: 81.80%; Collagen + Fibrinogen 3 mg/ml: 91.15%. (3)
Fibrinogen signi®cantly decreased the contraction of collagen lattices (p < 0.0001). Further this
effect was dose dependent (p < 0.001). Polymerization of ®brinogen with thrombin has no effect
on this inhibition. Fibronectin, a component of some ®brinogen preparations had not inhibitory
effect on contraction. These data suggest that ®brinogen has a stabilizing effect on matrix,
inhibiting its contraction. This may be important in the early phases of wound healing when ®brin
clot is important to prevent hemorrhage. After ®brinolysis occurs and the ®brin is gone, the
remaining collagen matrix contracts. The stability of ®brin containing matrixes may contribute to
their usefulness as frameworks for bioengineering purposes.
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A Novel Lipoxygenase Product, 8-Hydroxy Eicosatetraenoic Acid, Stimulates Wound
Closure in Cultured Neonatal Human Keratinocytes
J.C. Ojingwa, V.A. Ziboh, and R.R. Isseroff
Dermatology, University of California, Davis, Davis, California, U.S.A.
Re-epithelialization of a skin wound by the migration of keratinocytes from the wound edge is an
important and necessary component of wound healing. The major eicosanoids in normal human
skin or keratinocytes are 15- hydroxy- and 12- hydroxy eicosatetraenoic acid (15-HETE and 12-
HETE) which are derived from the lipoxygenase (LOX) pathways of arachidonic acid (AA)
metabolism. These metabolites have been implicated in chemotaxis, cell adhesion and cell motility
in various cell types. There is compelling evidence to suggest that they play an essential role in
wound healing. The present study was undertaken to evaluate the level of LOX metabolites in
wounded cultured neonatal human keratinocytes (NHK) and their role in wound closure. Using
reversed-phase and straight-phase high performance liquid chromatography separation, we
determined that wounding results in minor up-regulation of the 12-HETE product. More
interestingly, we identi®ed a major peak, 8-HETE in wounded cultured NHK. Interestingly, very
low 8-LOX activity has been determined in normal mouse epidermis and none have been
expressed in normal human skin or keratinocytes, indicating that the enzyme is not constitutively
expressed. Pre-incubation of con¯uent monolayer keratinocyte cultures with nor-dihydroguaiare-
tic acid (NDGA, a selective inhibitor of LOX) before wounding, inhibited cell migration into the
wound and delayed wound closure. Exogenous addition of 8-HETE to the wounded NHK totally
reversed the inhibitory effect of NDGA and complete wound closure was achieved early. 12-
HETE partially reversed the inhibitory effect of NDGA and there was delay in wound closure
compared to control. 15-HETE had no effect on wound closure. These results suggest important
physiological role of 8- and 12-HETE in cell migration and wound healing.
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Sphingosine Kinase Activity is Up-Regulated by TGF-b in Dermal Fibroblasts and May
be Involved in Elevated Collagen Production by Scleroderma Fibroblasts
M. Yamanaka, E.A. Smith, R.M. Silver, A. Bielawska,* L.M. Obeid,* Y.A. Hannun,* and M.
Trojanowska
Rheumatology & Immunology, Medical University of South Carolina, Charleston, South Carolina, U.S.A.;
*Biochemistry & Molecular Biology, Medical University of South Carolina, Cherleston, South Carolina,
U.S.A.
Abnormal TGF-b signaling has been implicated in dysregulated collagen synthesis by scleroderma
®broblasts, but the underlying mechanism is not well understood. The present study was
undertaken to examine a possible role for sphingolipid signaling in TGF-b regulation of collagen in
SSc and healthy dermal ®broblasts. For this study ®ve matched pairs of SSc and normal ®broblasts
were obtained from skin and one pair was obtained from lung biopsies. SPHK activity was
measured by a standard in vitro kinase assay using cell extracts from control and TGF-b stimulated
cells. SPHK mRNA levels were determined using RT-PCR. Adenoviral vector expressing human
SPHK was generated to ensure ef®cient gene delivery into dermal ®broblasts. Secreted collagenous
proteins were measured by 3H-proline labeling of ®broblasts followed by SDS-PAGE and
autoradiography. Stimulation of dermal ®broblasts with TGF-b resulted in a prolonged increase of
SPHK activity with maximum stimulation observed after 24 h and persisting for up to 48 h.
Increases in SPHK mRNA were observed after 3 h with a maximum increase after 24 h post TGF-
b addition. The basal level of SPHK activity was signi®cantly lower in SSc than in control
®broblasts (72% vs. 100%, p < 0.03). While both control and SSc ®broblasts responded to TGF-b
with an increase in SPHK activity, there were signi®cantly lower levels of SPHK in SSc ®broblasts
after TGF-b stimulation (124% vs. 222%, p < 0.0011). To test the in vivo role of SPHK, dermal
®broblast were transduced with adenovirus expressing SPHK or with control adenovirus and
stimulated with TGF-b. Expression of SPHK blocked collagen stimulation by TGF-b. Together,
these data suggest that SPHK is regulated by TGF-b, and that the elevated basal expression of
collagen in SSc ®broblasts may result from the lower levels of SPHK in these cells.
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Effects of Vegetable Extract from Lupinus Albus (Lu105) on the Degradation by Human
Leucocyte Elastase and Bacterial Collagenase of Gingival Collagen and Elastic Fibers
B. Gogly, N. Piccardi,* P. Msika,* and G. Godeau






de Chirurgie Dentaire-paris V,
Montrouge, 81, France; *R & D, Laboratoires Pharmascience, Epernon, 81, France
Human gingiva contains the macromolecules present in most connective tissues. Among the
macromolecules, collagen and elastic ®bers play a key role in its architecture. Chronic gingival
in¯ammation as observed during periodontitis is mainly characterized by proteolysis of extracellular
matrix molecules. the enzymes responsible for tissue destruction may originate from several cellular
sources including: resident cells (®broblasts, epithelial cells,¼) and pathogenic oral bacteria.
Compounds able to in¯uence ®broblasts function and to interfere with leukocyte elastase and
bacterial collagenase activities could exhibit major impact in gingival remodelling. This work
investigates wether vegetable extract derived from seeds of Lupinus albus (LU105) could ihnibit
leukocyte elastase (HLE) and bacterial collagenase activities. These inhibitory capacities were
experimented ex vivo using human gingival tissue sections and automated image analysis. Effects of
LU105 on cell proliferation were also approached using cell cultures. Finding from the present
study demonstrated that LU105: (1) protects gingival elastic ®bers from degradation by HLE; (2)
inhibits partially HLE activity; (3) protects gingival collagen ®bers from degradation by bacterial
collagenase (Clostridium histolyticum); (4) does not inhibits collagenase activity directely. At low
doses (0.01 and 0.1%) LU105 does not modify the proliferation and the cell phenotype of gingival
®broblasts in culture. In conclusion, the use of LU105 for inhibiting gingival matrix molecules
degradation by in¯ammatory and bacterial enzymes may offer a good opportunity for the treatment
of gingival in¯ammation and periodontitis in man
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Basement Membrane Components in Genetically Diabetic Mice Wounds
Y. Miyashita, N.S. Gibran,* M.L. Usui, P.D. Zook, R.O. Sigle,²³ W.G. Carter,²³ and J.E.
Olerud
Medicine (Dermatology), University of Washington, Seattle, Washington, U.S.A.; *Surgery, University of
Washington, Seattle, Washington, U.S.A.; ²Pathobiology, University of Washington, Seattle, Washington,
U.S.A.; ³Basic Sciences, Fred Hutchinson Cancer Reseach Center, Seattle, Washington, U.S.A.
Failure of wound healing of foot and leg ulcers is the most common cause of lower extremity
amputation in the patients with diabetes mellitus. The genetically diabetic mouse (db/db; BKS Cg-
m+/+Leprdb) has a phenotype resembling human type 2 diabetes mellitus and has been used
extensively as a model of delayed wound healing. We have observed greater incidence of blistering
of new wound epithelium in db/db mice as compared to their nondiabetic heterozygous
littermates (db/±). Therefore, we evaluated BM components, especially laminin 5 (Lam 5). Lam 5
is known to be important in epithelial migration and expressed initially as a precursor form with an
uncleaved a3 chain (pLam5) which quickly undergoes cleavage. This uncleaved form is involved
in keratinocyte (KC) migration via integrin a3b1 following wounding. The cleaved form of Lam 5
acts to anchor the BM via integrin a6b4. Four, full-thickness, 6 mm punch biopsies were created
in dorsal skin of 12 week old male db/db and db/± mice and covered with occlusive dressing.
Wound tissue was harvested at 1, 3, 7, 10 and 14 days after wounding (12 wounds/time point).
Wounds were ®xed in 10% neutral buffered formalin for H&E staining or frozen for
immunohistochemistry (IHC). IHC of BM components included pLam 5, BP230, and integrins
a6 and b4. The db/db wounds healed more slowly than db/± as determined by measurements of
H&E sections. IHC of pLam 5 showed no differences between db/db and db/± in 1 and 3-day
wounds, however, by day 7 postwounding, pLam 5 in the leading edge KCs was markedly reduced
in db/db compared to db/±. There were no appreciable differences between db/db and db/± for
BP230 and integrins a6, b4. The reduction in IHC of pLam 5 is possibly due to a reduction in
production or increase in cleavage. Since Lam 5 plays an important role not only in cell attachment
and migration but cell signaling, impaired migration of KC in diabetic wounds may be directly
related to the reduction of pLam 5.
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Diminished Expression of NF2 (Merlin) in Metastatic Malignant Melanoma
R. Edwards, D. Altomare,* S. Lessin,² K. Skele,* and J. Testa*
Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, U.S.A.; *Human Genetics, Fox Chase
Cancer Center, Philadelphia, Pennsylvania, U.S.A.; ²Medical Oncology, Fox Chase Cancer Center,
Philadelphia, Pennsylvania, U.S.A.
Germline mutations in the NF2 gene residing in chromosome 22q12.1 are associated with the
inherited tumor predisposition syndrome neuro®bromatosis-2 (NF2). The NF2 syndrome is
characterized by development of intracranial and intraspinal tumors, most commonly bilateral
acoustic schwannomas, meningiomas and ependymomas. NF2 mutations are also found in the
sporadic counterparts of these tumors, and have additionally been described in malignant
mesothelioma, a tumor of mesodermal origin, and in a subset of malignant melanomas, although
the data in melanoma is con¯icting. The protein product of the NF2 gene, merlin, shows
homology to members of the protein 4.1 superfamily (ezrin, radixin, moesin) that function as links
between cell membrane-associated proteins and the cytoskeleton. Merlin is distinct from these
other family members in ful®lling criteria for a tumor suppressor, both through its genetic and
functional features. In this study, we have examined the potential role of merlin in the pathogenesis
of malignant melanoma by determining levels of protein expression of merlin in 10 cryopreserved
metastatic melanomas. Merlin was immunoprecipitated from frozen tissue protein lysates using an
antimerlin antibody (A-19). The immunoprecipitates were electrophoresed, Western blotted onto
Hybond membranes, and incubated with a different merlin antibody (C-18) followed by
horseradish peroxidase-conjugated secondary antibody. Chemiluminescent detection identi®ed
immunoprecipitated merlin. Markedly diminished or absent detection of merlin was noted in 5 of
10 metastatic melanomas analyzed. These results indicate that loss of expression of merlin
characterizes a subset of metastatic melanomas and suggests that the NF2 gene locus may play a role
in the pathogenesis of some melanomas. Further studies are required to address the mechanism/s by
which merlin/NF2 is inactivated, and the stage of melanoma tumor progression at which this
occurs.
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Mononuclear Cells Migration into Normal and Psoriatic Skin Equivalent
N.V. Konstantinova
Research, Nioxin Research Laboratory, Atlanta, Georgia, U.S.A.; Dermatology, UT Houston, Houston,
Texas, U.S.A.
To investigate the role of mononuclear cells (MNC) in pathogenesis of psoriasis and normal
wound healing we created 5 triplicates of psoriasis and 5 triplicates of normal skin equivalent (SE)
using 5 different ®broblast lines from psoriatic patients and 5 from healthy donors. MNC were
obtained from blood of young healthy donors by standard technique. Only adhesive cells were
used in our experiment. MNC were added in SE at day 3. Control group was a triplicate of normal
SE without MNC for every experiment. We found (a) there exists a possibility of MNC migration
into normal and psoriatic SE with different ability and pattern of migration through dermis. (b)
The epidermis in the case of MNC looked thicker, more differentiated and proliferated earlier than
in the control case. Adding MNC into the model may facilitate the regeneration of SE. MNC play
an important part in the whole process of skin regeneration.
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Laminin 10 in Wound Re-Epithelialization and Angiogenesis
J. Li, R.S. Kirsner, M.P. Marinkovich,* J.H. Miner,² and Y. Zhang
Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida, U.S.A.; *Dermatology,
Stanford University, Stanford, California, U.S.A.; ²Renal Division, Washington University, St Louis,
Missouri, U.S.A.
Laminins are the major noncollagenous glycoproteins of the extracellular matrix components in
basement membrane and in¯uence a variety of important biological processes including cell
attachment, migration, angiogenesis, wound healing and tissue development. The objective of this
study is to examine the role of newly identi®ed laminin 10 (a5, b1 and g1) in cutaneous wound
repair. Laminin 10 has been recently detected in human epidermal keratinocytes and basement
membrane of the dermal-epidermal junction. Laminin 10 expression is also found in human dermal
microvascular endothelial cells and underlying basement membrane of blood vessels by immuno-
¯uorescent staining. Using an in vitro cell attachment assay, we found that puri®ed laminin 10
protein promoted human keratinocyte spreading and attachment. Blocking antibodies directed
speci®cally to integrin b1 and b4 subunits blocked this attachment, indicating that laminin 10-
induced keratinocyte attachment is mediated by integrin receptors. By immuno-peroxidase
staining, newly formed microvascular blood vessels in human wound lesions also stained strongly
positive for laminin 10. A laminin a5 chain knockout animal wound model revealed that
de®ciency of laminin 10 is associated with decreased granulation tissue formation as well as
abnormal reepithelialization. These preliminary data suggest that laminin 10 may play important
roles in wound repair process including reepithelialization, restoration of basement membrane and
wound angiogenesis.
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Treatment with a Cream Containing a Thyroid Hormone Analogue Restores
Corticosteroid Down-Regulated Collagen Synthesis
J. Faergemann, P. Yasdanparast, A. Oikarinen, B. Carlsson, and J. Risteli
Dermatology, Sahlgrenska University Hosp, Gothenburg, Alabama, U.S.A.
Objective of this randomized, double-blind, clinical trial was to compare the change in collagen
synthesis between topical treatments with two doses of a thyroid hormone analogue (KB2611) or a
placebo after pretreatment with topical bethamethasone 17-valerate (BM). Test products were
administered twice daily during two weeks on abdominal skin. Treatment was preceeded by
administration of BM on the same area for 3 days. Ef®cacy was evaluated by measurements of
collagen Type I and type III propeptides (PINP and PIIINP) in suction blister ¯uid (SBF) and by
histology and immunhistochemistry on punch biopsies. Skin thickness was measured with
sonography. 15 healthy volunteers were evaluated for ef®cacy; 4 treated with placebo (Pgroup), 6
treated with 0.03% (T003 group) and 5 treated with 0.1% (T01 group) KB2611. Non-parametric
statistical analysis was performed and p-values compare change between the active and placebo-
treated groups are given in parenthesis. After 3 days of BM-treatment median concentrations of
PINP and PIIINP in SBF were 5 and 9 mg/gram total protein (mg/gtp), respectively.
Corresponding values for SBF from untreated bilateral skin were 21 and 14 mg/gtp. After 7 days
of treatment median percentage increase of PINP was 5% and PIIINP ± 12% in Pgroup. In T003
group PINP was 230% (p = 0.038) and PIIINP 24% (p = 0.6).In T01 group PINP was 148%
(p = 0.29) and PIIINP 23% (p = 0.6). After 14 days of treatment median percentage increase of
PINP was 55% and PIIINP 58% in Pgroup. In T003-group PINP was 521% (p = 0.067) and
PIIINP 137% (p = 1.0). In T01-group PINP was 339% (p = 0.28) and PIIINP 230% (p = 0.9).
Structure of collagen-®bers was more often classi®ed as ``thickened'' and the number of cells
staining for PINP was more pronounced in the T groups as compared to Pgroup. Sonography
showed no clinically relevant effects on either dermal or epidermal thickness. Treatment was safe,
well tolerated. Results encourage further trials to con®rm that KB2611 is a treatment option for
cortico steroid induced skin atrophy.
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Modulation of Hemidesmosomes During Epidermal Differentation: the Role of
Interferon-g
C. Lanschuetzer, A. Huber-Wechselberger, A. Klausegger, K.B. Yancey,* and J.W. Bauer
Dermatology, General Hospital, Salzburg, Austria; *Dermatology, Medical College of Wisconsin,
Milwaukee, Wisconsin, U.S.A.
Adhesion structures like hemidesmosomes mediate adherence to surrounding elements of the
dermis. Accordingly, these structures anchor the cell via cytoskeletal proteins to the extracellular
matrix. The assembly and disassembly of these HD is a dynamic process which is of crucial
importance in cutaneous development, morphogenesis, wound healing and tumor invasion. To
evaluate the coordinate regulation of proteins involved in formation of these structures we
investigated plectin, bullous pemphigoid antigen 1 (BPAG1), bullous pemphigoid antigen 2,
integrins a6 and ¯4 by immuno¯uorescence and mRNA quanti®cation in response to interferon
gamma (IF-g), which is an important mediator of in¯ammation and differentation. Treatment of
cultured human keratinocytes with 250 U/ml IF-g for 24 h induced a redistribution of plectin from
a diffuse staining pattern to an increased granular and cell membrane staining-pattern consistent
with a desmosomal distribution. BPAG1 did not show a redistribution upon treatment with IF-g;
however, the mRNA level was decreased up to 4-fold. BPAG2 was redistributed from a granular
pattern to a diffuse pattern without reduction of the mRNA level. Both integrins a6 and ¯4 were
redistributed from a granular, hemidesmosomal-like pattern to a diffuse distribution after treatment
with IF-g. Thus, these adhesion molecules exhibit a distinct pattern of reaction following
stimulation of KC with IF-g although they are initially situated at the same structure, the
hemidesmosome.
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T Domain of this Polypeptide
C. Matsui, A. Utani,* and M. Morohashi
Dermatology, Toyama medical Pharmaceutical University, Toyama, Toyama, Japan; *Dermatology, Chiba
University, Chiba, Chiba, Japan
CP is autoimmune bullous disease that primarily affects mucosal tissues. Recent studies have
identi®ed that CP patients have IgG autoantibodies recognize several basement membrane proteins
including laminin5 (LAM). To further understand the pathophysiology of blister formation in these
patient, we have sought to identify the speci®c epitope(s) targeted by their autoantibodies. Since
bacterial fusion proteins that contain LAM a3 amino acid sequence do not react with patient sera
in immunoblotting study, we used recombinant peptides made by in vitro transcription/translation
reaction for immunoprecipitation. The peptides that contain aÂU/aÂT domain of LAM a3 were
precipitated by patient sera and conformational epitope seems to be necessary for Antigen-
Antibody bindings. Though aÂW domain of LAM a3 has be reported crucial for keratinocyte
attachment, aÂU/aÂT domain also might be imperative.
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Recombinant Antigen (IC3.4) in the Development of ELISA to Detect Ocular
Cicatricial Pemphigoid Autoantibody
A. Ahmed, S. Kumari, and C. Foster*
Department of Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts, U.S.A.; *Mass.
Eye Ear and In®rmary, Harvard Medical School, Boston, Massachusetts, U.S.A.
Ocular Cicatricial Pemphigoid (OCP) is an acquired autoimmune, subepithelial blistering disease
that predominates mucous membrane of conjunctiva. Sera of OCP patients bind to target antigens
in the basement membrane zone (BMZ). In our earlier studies, we have demonstrated that in
OCP, the target antigen is human b4 integrin molecule. The OCP autoantibody has been
demonstrated to bind to an 83 aa acid stretch fragment (IC3.4) in the cytoplasmic domain of the C-
terminus of the b4 molecule. Antibody to this fragment (IC3.4) produced in rabbit, resulted in
BMZ separation, histologically identical to that observed when normal human conjunctiva was
cultured with OCP sera thereby suggesting a possible role for it in blister formation. In the present
study we show that IC3.4 exhibits strong speci®city and sensitivity to sera from patients with active
OCP, in an enzyme-linked immunosorbent assay. The titer of the autoantibody in OCP patients
correlates with the severity of disease activity. This ELISA assay can be used to detect autoantibody
in OCP and will facilitate to study the serological response during treatment in OCP.
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Management with Topical Nitrogen Mustard in Mycosis Fungoides: Update of the
Stanford Experience
Y.H. Kim and R.T. Hoppe*
Dermatology, Stanford University, Stanford, California, U.S.A.; *Radiation Oncology, Stanford
University, Stanford, California, U.S.A.
Clinical ef®cacy, toxicity and survival outcomes in patients with mycosis fungoides (MF) treated
with topical nitrogen mustard (HN2) as primary therapy were studied. This was a single, academic
referral center retrospective cohort analysis of 203 patients with clinical stage I-III MF treated with
HN2. Long-term actuarial survival, freedom-from-relapse, and freedom-from-progression (FFP)
results were calculated by the Kaplan Meier method. The overall response rate for 203 patients was
83%; CR rate of 50%. Median time to achieve CR was 12 month (T1 10 month, T2 19 month);
median time to relapse was 12 month. The duration of CR increased with longer maintenance
therapy; however, upon treatment completion, the respone duration or relapse rate was similar
regardless of maintenance regimen. Patients with T1 disease had superior response and survival
outcomes than those of T2 disease with overall and CR rates of 93% and 65% in T1, 72% and 34%
in T2. A similar clinical response was seen in patients with stage IIA vs. IB. Sixty-eight percent of
patients received HN2-only throughout their follow-up, including most patients who achieved an
initial CR. Clinical response to topical HN2 as salvage therapy was similar to initial response rates.
Ef®cacy results were similar in patients who were treated with aqueous vs. ointment preparations.
FFP rates at 5 and 10 year were 92% and 85% in T1, 83% at 5 and 10 year in T2. Less than 10% of
patients experienced contact hypersensitivity reaction when HN2 was used as an ointment
preparation. Only 8 patients (4%) developed secondary cutaneous malignancy, none attributable to
topical HN2 monotherapy. Pediatric patients experienced no signi®cant toxicity with HN2
therapy. Topical HN2 remains as effective primary initial or salvage therapy in MF for patients
with T1 and T2 disease. Long-term follow-up results con®rm the safety of topical HN2.
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Application of Cultured Epidermis in Surgical Treatment of Buruli Ulcer Patients
K. Sakai, K. Ebisawa,* K. Toriyama,* T. Hasegawa,* Y. Hibino,² K. Kubo,§ K. Takamura,§ K.
Hata,² S. Torii,² F. Mork,³ and M. Ueda
Oral Surgery, Nagoya University, Nagoya, Aichi, Japan; *Plastic Surgery, Nagoya University, Nagoya,
Aichi, Japan; ²Tissue Engineering, Nagoya University, Nagoya, Aichi, Japan; ³Plastic Surgery, Korle-Bu
Teaching Hospital, Accra, Accra, Ghana; §J-TEC, Japan Tissue Engineering Company, Gamago-ri, Aichi,
Japan
Buruli ulcer (BU), caused by mycobacterium ulcerans, is a disease of subcutaneous tissue that has
been reported in many countries in Africa. The infection appears as a painless, erythematous
nodule that develops central necrosis and ulceration. Medical treatment of BU is usually
disappointing, leaving wide surgical excision followed by skin grafting the only alternative. We
have developed a technique for cultured epidermis and cultured oral epithelium, which it has
applied clinically in over a hundred cases. Allogenic epidermis has been used successfully for some
kinds of skin defect. WHO has taken the lead in coordinating BU control and research efforts
worldwide. WHO invited us to apply this treatment to BU, and a treatment team was organized
and sent to Ghana. The objective of our study is to conduct a preliminary investigation to assess the
therapeutic applicability of allogenic cultured epidermis transplantation in healing of BU, and its
possibility in replacing the standard method using standard split thickness skin graft. Cultured
epidermis was prepared by J-TEC, and transported by containers with liquid nitrogen from Japan.
Transplantation of the allogenic cultured epidermis and meshed skin was carried out two weeks
after the initial surgical excision for 7 patients at Korle-Bu Teaching Hospital in Ghana. Re-
epithelialization of lesion was examined at 1 and 2 weeks post-transplantation, and the lesion
healing was examined at 3, 6 and 12 months after transplantation. It was recognized that the mean
rate of epithelialization at 1 week post-transplantation was 88%, and 100% at 2 weeks. Three
months after transplantation, the recipient sites of all seven patients healed without any problem.
These results suggest that this method could well serve as one of the standard methods for BU. The
procedure and results of the treatment for BU, and the 6-month follow-up data will be presented.
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Histologic Features in Squamous Cell Carcinomas in Immune-Compromised Patients
Including Transplant Patients
K.J. Smith, A. Bussian, H. Diwan, and H. Skelton
Dermatology/Pathology, University of Alabama, Birmingham, Alabama, U.S.A.
In immune compromised patients cutaneous squamous cell carcinomas (SCC)s show a more
marked increase incidence, which increases with the duration of immune suppression. We wanted
to determine if any histologic features were more characteristic of SCCs arising in immune
compromised patients: We evaluated 250 cutaneous SCCs from immune competent and immune
suppressed patients including patients with transplants and immune suppressed patients secondary
to other mechanisms. In all patient populations their cutaneous SCCs occurred dominantly in
chronically ultraviolet (UV) exposed skin. However, in transplant patients a greater percentage
occurred on the extremity. SCCs arising in SCC-in-situ was more common in immune
compromised patients, and SCC with acantholytic features was more common in transplant
patients. In transplant patients, some SCCs arose from the basal layer of the epidermis with
overlying epidermal maturation. This histologic pattern was seen in only one immue competent
patient. Clinical size was not consistently reported; however, histologically the tumors in immune
compromised patients were consistently larger and deeper. Marked epidermal hyperkeratosis was
more common overlying SCCs in transplant patients, and features suggestive of HPV effect and
pleomorphism were more common in SCCs in all immune compromised patients. Our ®ndings
con®rmed that chronic UV exposure is a cocarcinogen for the development of cutaneous SCCs in
immune compromised patients. Although features suggestive of HPV effect were seen more
commonly in immune compromised patients, other histologic features were more predictive of
immune suppression, particularly of immune suppression associated with transplantation. These
features included loss of cell-cell adhesion and early dermal invasion. The medications used in
transplant patients, including calcineurin inhibitors, may play a role separate from their immune
suppressive effects in the development of these histologic features, as well as the greater size and
depth of SCCs in these patients at presentation.
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In¯uence of IVIg Therapy on Antibody Titers to Human a6 Integrin
N. Sami, K. Bhol, and A.R. Ahmed
Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts, U.S.A.
Oral pemphigoid (OP) is a chronic autoimmune disease, involving the oral cavity. The junction of
the epithelium with the basement membrane zone consists of the interaction between various
protein molecules that are required for the normal integrity of this structural interface. The a6/b4
heterodimer within the hemidesmosome complex is a member of the integrin family of adhesion
receptors. Recent studies have demonstrated that sera from OP patients, and monoclonal and
polyclonal antibodies to a6 integrin, bind to a 120-kDa protein, in bovine gingival lysate. The use
of intravenous immunoglobulin (IVIg) in the treatment of pemphigoid has been recently described.
In this study, we present the use of IVIg, in a group of seven patients, with severe OP, in whom
systemic conventional treatment were contraindicated. To determine the in¯uence of treatment on
antibodies to human a6 integrin in OP, seven patients with OP treated with IVIg therapy and a
comparable control group of seven patients with OP, treated with conventional therapy, were
evaluated at monthly intervals, for a 12-month treatment period. An effective clinical response was
observed in all seven patients treated with IVIg therapy, after a mean treatment period of
4.5 months.² A statistically signi®cant difference was observed in the quality of life pre- and post-
IVIg therapy (p < 0.001).² A statistically signi®cant reduction in the antibody titers to a6 was
observed after four months of treatment, in both groups (p = 0.015).² Thereafter, patients treated
with IVIg therapy had a faster rate of decline in the antibody titers. This difference in the rate of
decline between the study and control groups became statistically signi®cant after six months of
treatment (p = 0.03). IVIg therapy seems be an effective alternative treatment modality in OP
patients. The use of IVIg therapy resulted in reduction of anti-a6 antibody titers and in inducing
and maintaining both a sustained, clinical and serological remission.
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Ef®cacy of Enbrel in Patients with Psoriasis
A.B. Gottlieb, R.T. Matheson,* N.J. Lowe,² and R.J. Zitnik³
Clinical Research Center, UMDNJ, Robert Wood Johnson Medical Center, New Brunswick, New Jersey,
U.S.A.; *Department of Dermatology, Oregon Medical Research Center, Portland, Oregon, U.S.A.;
²Department of Dermatology, Clinical Research Specialists, Santa Monica, California, U.S.A.; ³Clinical
Research, Immunex Corporation, Seattle, Washington, U.S.A.
In previous studies of patients with psoriatic arthritis, etanercept (Enbrelq) produced signi®cant
improvement in psoriatic skin disease. This study examines the ef®cacy of etanercept as
monotherapy in patients with psoriasis. In a 24-week, multicenter, blinded, randomized study,
patients received etanercept 25 mg or placebo by SC injection twice weekly. The primary
endpoint was the 75% improvement in psoriasis area and severity index (PASI) at 12 weeks. One
hundred 12 patients enrolled in the study. Groups (n = 57 for etanercept; n = 55 for placebo) were
well-matched for patient age, psoriasis duration, and disease intensity. The percent of patients
achieving PASI 75 at 12 weeks was signi®cantly higher in the etanercept group vs. the placebo
group (30% vs. 2%, respectively; p < 0.0001). Ef®cacy continued to improve with longer
treatment, with 56% of etanercept-treated patients and 5% of placebo-treated patients reaching the
PASI 75 at 24 weeks (p < 0.0001). Statistically signi®cant improvements in patient global, physician
global, and target lesion assessments and DLQI, con®rmed ef®cacy of etanercept therapy.
Etanercept was well-tolerated. Numbers of patients reporting adverse events were similar between
groups (70% for etanercept, 67% for placebo), as were the rates of adverse events (4.49 per patient
year for etanercept, 5.66 per patient year for the placebo group). Etanercept as monotherapy was
ef®cacious, safe, and well-tolerated in the treatment of psoriasis.
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Image Analysis of Color Information from Dermoscopic Findings in Melanocytic
Lesions
M. Tanaka, S. Kobayashi, H. Mizutani,* T. Tanaka,* and T. Nishikawa
Dermatology, Keio University School of Medicine, Tokyo, Japan; *Applied Physics and Physico-Informatics,
Keio University Faculty of Science and Technology, Yokohama, Japan
The purpose of the present study is to compare RGB color information from dermoscopic ®ndings
in melanoma and nevus using a method of image analysis. A diagnosis of melanoma or nevus is
sometimes very dif®cult even together with pathological examination. Dermoscopy has been
shown to be very useful for the correct diagnosis of melanocytic skin lesions. However, a high level
of skill in dermoscopy is needed to obtain a proper diagnosis. Irregular shape and distribution are
the most important dermoscopic ®ndings to distinguish melanoma from nevus. Especially,
irregularly broad dark pigment network, irregular streaks, and wide and irregular distribution of
blue-whitish veil are found almost exclusively in melanoma. We have elaborated a method to
quantify dermoscopic ®ndings such as color variegation or structural asymmetry using image
analysis. First, a dermoscopic image of melanocytic lesion was digitized and the size of pixels was
reduced to approximately 10000 pixels by a photo-retouching software. Second, the image was
divided into RGB component and each component was further subdivided into 9±11 levels with
different intensities (0±255), depending on the cases. Comparison between three melanomas and
three nevi revealed that irregular distribution of low intensity area of blue component could be
most important to distinguish melanomas from nevi. Comparison of these dark blue areas by total
amount of distance from each pixel to the center of the lesion was performed using a computer
program. Divided 12 areas were graphically shown with these total distances and compared
between melanomas and nevi. Melanomas showed one-sided, asymmetrical pattern of distribution,
whereas nevi showed relatively symmetrical distribution. Analyzing many dermoscopic images of
pigmented skin lesion by the use of this novel methodology would enable us to estimate the
possibility of melanoma in a percentage for any pigmented melanocytic lesions.
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Human b-Defensin-2 Expression is Up-Regulated after Injury in Bioengineered Skin
and Normal Human Skin and is Constitutively Elevated in Chronic Wounds
J. Butmarc,² T. Yu®t,² and V. Falanga*²
*Dermatology and Biochemistry, Boston University, Boston, Massachusetts, U.S.A.; ²Dermatology, Roger
Williams Medical Center, Providence, Rhode Island, U.S.A.
First identi®ed in psoriatic epidermis and subsequently in other in¯ammatory cutaneous lesions,
human b-defensin 2 (HBD-2) is one of two endogenous antimicrobial peptides related to defensins
in plants and animals. The purpose of this study was to determine the presence and cutaneous
distribution of HBD-2 after skin injury. We hypothesized that HBD-2 expression is increased after
injury and with bacterial colonization. Biopsies of normal ipsilateral thigh skin and wound edges
were taken from 9 consecutive patients with venous leg ulcers on Day 1 and from the same biopsy
sites on Day 3. We also took sequential samples from intact or meshed bilayered bioengineered
skin, consisting of neonatal human keratinocytes and dermal ®broblasts in a collagen matrix.
Specimens were processed and immunostained for HBD-2 using a polyclonal rabbit antibody. In
both human tissues and bioengineered skin, staining for HBD-2 spared the basal cells, and was
con®ned to the upper epidermal layers. Analysis of 26 tissue samples from patients showed that
normal skin had no HBD-2 expression, but that marked up-regulation occurred after wounding
(Day 3). Conversely, all chronic ulcers showed moderate to strong immunostaining for HBD-2 at
baseline (Day 1), with little or no increase in intensity after wounding (Day 3). Bioengineered skin
showed a similar pattern and disbribution of cytoplasmic HBD-2 immunostaining, which increased
with time (Day 1±4) in unwounded specimens but with increased intensity after meshing. We
conclude that in normal human skin and in bioengineered skin the expression of HBD-2 is up-
regulated after injury. Chronic wounds uniformly show a constitutively high baseline expression of
HBD, possibly due to ongoing tissue injury and bacterial colonization.
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The Response of Skin Disease to Stress; Changes in the Severity of Acne Vulgaris as
Affected by Examination Stress
A. Chiu and A.B. Kimball
Dermatology, Stanford University, Stanford, California, U.S.A.
Although emotional stress has long been suspected to exacerbate acne vulgaris, previous reports
addressing the in¯uence of perceived stress on acne severity have been mainly anecdotal. To
further elucidate the possible relationship of stress and the exacerbation of acne, a prospective
cohort study was conducted with university students utilizing previously validated scales measuring
acne severity and perceived stress. To evaluate changes in acne severity during nonexam periods
and midterm and ®nal examination periods, and to explore the possible relationship of these
changes in severity with perceived examination stress. 15 women and 7 men, ages 18±29, with
baseline Leeds acne scores of 0.5±1.75 were enrolled. Clinical grading of acne severity utilizing the
photonumeric Leeds scale and assessment of subjects' perceived stress with the Perceived Stress
Scale questionnaire were conducted on students during both nonexam and exam periods. The
grader was not aware of the subjects' stress scores. Subjects were found to have a higher mean grade
of acne severity (p < 0.001) and a higher mean perceived stress score (p < 0.001) during exams.
Using correlation analysis, increased acne severity was associated with increased stress levels
(Pearson correlation = 0.068, p = 0.003). The effects of confounding variables such as, changes in
sleep hours, sleep quality, diet quality, and number of meals/day were assessed with logistic
regression. Worsening of stress remained most tightly associated with acne change (p = 0.004),
while change in diet quality was the only other signi®cant association (p = 0.01). This study
suggests that patients with acne experience worsening of disease during examinations. Further,
changes in acne severity correlate highly with increasing stress experienced during examination
periods, suggesting emotional stress from external sources may have a signi®cant in¯uence on acne
vulgaris.
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NF-kB is Activated and Proin¯ammatory Cytokines and Matrix Degrading Enzymes are
Induced in In¯ammatory Acne Lesions In Vivo
S. Kang, S. Cho, J. Burger, Y. Shao, J. Chung, G.J. Fisher, and J.J. Voorhees
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Scarring is the most undesirable sequela of in¯ammatory acne. Mechanisms by which in¯ammation
leads to acne scarring are not well characterized. It is proposed that activation of cell surface
cytokine receptors induces transcription factors NF-kB and AP-1, leading to in¯ammation, matrix
degradation (by matrix metalloproteinases [MMPs]) and eventual scarring. We examined this
proposed mechanism by characterizing involved and uninvolved facial skin of in¯ammatory acne.
Antibody to p65 or p50 components of NF-kB, were used to identify nuclear localization (i.e.
activation) of NF-kB. Compared to uninvolved skin, nuclear localization of p65 and p50 was
evident in involved follicular epidermis of acne. Consistent with this, IL-1b (16-fold; p < 0.007),
TNFa (2.6-fold; p < 0.08), IL-8 (3015-fold; p < 0.001), and IL-10 (46-fold; p < 0.001) mRNA
levels, measured by quantitative real-time RT-PCR, were signi®cantly elevated in involved vs.
uninvolved skin (n = 8). Prominent in®ltration of neutrophils in acne lesions was accompanied by a
striking increase in neutrophil collagenase (MMP-8) protein levels (Western blot). AP-1-regulated
collagenase (MMP-1, 506-fold; p < 0.008), stromelysin (MMP-3, 829-fold; p < 0.008), and
gelatinase B (MMP-9, 12-fold; p < 0.003) mRNA levels were signi®cantly elevated in involved vs.
uninvolved skin (n = 6). In situ zymograms revealed lysis of ¯uoresceinated-collagen in involved,
but not in uninvolved skin sections, indicating the presence of functional matrix-degrading MMP
activities in in¯ammatory acne. These data demonstrate that activation of NF-kB and AP-1
signaling cascades induce in¯ammation and degradation of collagen in acne lesions in vivo.
Initiation of these signaling cascades may involve activation of toll-like receptors on intrafollicular
keratinocytes by products from Propionibacterium acnes. Knowledge that these signaling cascades
are activated in acne will enable identi®cation of new pharmacologic agents that target both the
in¯ammation and scarring seen in acne.
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Hypoxia Up-Regulates COL1A1 Transcription and TGF-b1 Signaling in Human
Dermal Fibroblasts
T. Yu®t,² C. Paiva,² and V. Falanga*²
*Dermatology and Biochemistry, Boston University, Boston, Massachusetts, U.S.A.; ²Dermatology, Roger
Williams Medical Center, Providence, Rhode Island, U.S.A.
Hypoxia stimulates the proliferation of ®broblasts and endothelial cells and the production of
certain cytokines and growth factors, including TGF-b1, PDGF, VEGF, endothelin, and
erythropoietin. We have previously shown that short-term exposure of human dermal ®broblasts
to low oxygen tension increases overall collagen synthesis and mRNA levels of a1(I) procollagen
(COL1A1), and that this effect is largely due to TGF-b1. In this report, we determined the
transcriptional activity of the COL1A1 promoter in hypoxic dermal ®broblasts and whether
hypoxia has an effect on TGF-b1 signaling. Human dermal ®broblasts were exposed to either
standard (20% oxygen) conditions or hypoxia (2% oxygen) for up to 72 h. COL1A1 promoter
luciferase and CAT constructs were used, having 5¢ endpoints between ±804 and ±72 bp. We
found that the transcriptional activity of COL1A1 in hypoxic dermal ®broblasts is up-regulated in
promoter-luciferase and CAT constructs from ±804 to ±107 bp (but not ±84 or ±72 bp). These
®ndings indicate that the increased up-regulation of COL1A1 in hypoxia resides between ±107 and
±84 bp from the transcriptional start site. Smads proteins are a critical set of proteins transmitting
TGF-b1 signaling. Immunostaining was performed for Smad 4 with and without TGF-b1 (5 ng/
ml) in standard and hypoxic conditions. Nuclear localization of Smad 4 protein was increased by
TGF-b1 in both control and hypoxic cells, but with marked differences over time. Compared to
control, hypoxic ®broblasts showed Smad 4 immunostaining that was increased at 15 min, equal at
1 h, and decreased at 24 h. These results point to an effect of hypoxia on TGF-b1 signaling. In
addition, strategies aimed at blocking the hypoxia-responsive promoter regions of COL1A1 may
be of therapeutic value in decreasing collagen deposition.
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Rapid Healing of Chronic Foot and Leg Ulcers by The Exposure of Bone Marrow Cells
and Epidermal Grafting
Y. Yamaguchi, T. Kubo,* K. Ozawa, H. Asada, Y. Hakamada,² T. Murakami,² M. Takahashi,²
E. Kobayashi,² K. Yoshikawa, and S. Itami
Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan;
*Department of Plastic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan;
²Center for Molecular Medicine, Jichi Medical School, Tochigi, Tochigi, Japan
The impacts of bone marrow cells on chronic wounds are not examined inspite of increasing
evidence that marrow stromal cells have multipotency to differentiate into a variety of cell type
under a certain niche. Thirteen deep chronic ulcers with necrotic bone involvement, including
ischemic ulcers, diabetic foot ulcers, venous ulcers, and wounds caused by collagen diseases were
sharply debrided until fresh bleeding is observed with the use of bone scraper, followed by
occlusive dressing therapy. After this procedure, epidermal sheets obtained from suction blisters
were grafted onto the healthy granulation tissue in 10 out of 13 cases. To investigate the
multipotentiality of marrow stromal cells, those derived from green-¯uorescent protein (GFP)
tansgenic rats were topically administered onto the calvarian bone exposed wounds of nude rats,
followed by the biopsy at 2 weeks postgrafting. The simply combined treatment of marrow
exposure and occlusive dressing therapy healed all the chronic ulcers, which were intractable for
the period from 3 months to 3 years, within 2 month without the recurrence or occurrence of
osteomyelitis. Epidermal sheet grafts accelerated wound healing and achieved site-speci®c
differentiation. GFP-positive marrow cells, transplanted onto nude rat wound, differentiated to
myo®broblasts expressing alpha-smooth muscle actin. These results suggest that bone marrow cells
accelerate wound healing at least partly through transdifferentiation of marrow stromal cells into
myo®broblasts. This is the ®rst translational clinical research with the use of stem cell plasticity from
bone marrow cells to dermal cells.
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Mechanisms of Epiboly in Bioengineered Skin: A Model for Investigating Keratinocyte
Migration
V. Falanga*² and J. Butmarc²
*Dermatology and Biochemistry, Boston University, Boston, Massachusetts, U.S.A.; ²Dermatology, Roger
Williams Medical Center, Providence, Rhode Island, U.S.A.
There are few models for studying epithelial migration in vitro, and their relevance is compromised
by reliance on simple cell monolayers and the choice of a suitable matrix. In this study, the process
of keratinocyte migration and epiboly was investigated by using a bilayered bioengineered skin
construct, consisting of human foreskin keratinocytes and dermal ®broblasts. This construct closely
resembles human skin in its dermal matrix and cytokine pro®le. Six-mm punch biopsies of the
construct were placed in serum-free medium (AIM-V) or in DMEM with or without 10% FBS. At
various time points, the bioengineered skin specimens were processed and analyzed by histology
and immunohistochemistry. Time-dependent migration of the epidemis over the dermis, which by
72 h enveloped the entire construct (epiboly), was observed in AIM-V and DMEM but was
blocked by the presence of serum. In a dose-dependent manner, the process of epiboly was
blocked by neutralizing antibodies to IL-1a, partially blocked by EGF antibodies, but unaffected
by antibodies to TNF-a, PDGF-BB, or TGF-b1. Increasing concentrations of TGF-b1 peptide
(up to 30 ng/ml) completely blocked epiboly. We then determined the proliferative activity of the
epidermal edge and whether vitronectin (epibolin) plays a role in this process of epithelialization of
the construct. At the edge of the migrating epidermis, there was diminished immunostaining for
the proliferative marker Ki67 and increased immunostaining for vitronectin. Increasing
concentrations of antibodies to vitronectin blocked epiboly, as did antibodies to the a(v) b(5)
integrin receptor, which is known to mediate vitronectin-driven keratinocyte locomotion. In
conclusion, we propose that the process of epiboly in this model of wounded bioengineered skin
can be used to better understand and assess the mechanisms involved in keratinocyte migration and
in determining the critical components required for epidermal resurfacing.
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Topical Retinol Prevents Acute UV Irradiation-Induced Collagen Degradation and
Increases Procollagen I in Photoaged Human Skin In Vivo
R. Ka®, T.H. Quan, G.J. Fisher, S. Kang, and J.J. Voorhees
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Repetitive exposure to solar ultraviolet (UV) irradiation causes premature skin aging by damaging
skin connective tissue. This damage is mediated by matrix-degrading metalloproteinases (MMP),
which are induced by UV through up-regulation of transcription factor cJun. Accumulation of
collagen damage results in disorganization of the extracellular matrix, which impairs synthesis of
procollagen by dermal ®broblasts. Topical retinoic acid (RA), which effectively treats photoaging,
stimulates procollagen synthesis. Furthermore, pretreatment of human skin with RA blocks UV-
induction of cJun and MMP expression. Therefore, RA not only treats photoaging by partially
restoring collagen, but also is expected to prevent photoaging by blocking collagen degradation.
Topical retinol (ROL) is metabolically converted to RA in human skin, and causes less skin
irritation than RA. We investigated whether ROL can induce procollagen synthesis in photoaged
skin and prevent UV-induced matrix degradation. Subjects with moderate to severe photoaging
were treated for 7 days with 1% ROL and its vehicle. Compared to vehicle, ROL signi®cantly
increased procollagen I mRNA levels (3-fold; p < 0.05; n = 4), as measured by real time RT-PCR.
This increase was accompanied by 2-fold increase in TGF-b1 (p < 0.05; n = 6). Topical
pretreatment with 0.1% ROL for 2 days inhibited UV (2 MED) induction of cJun protein by 71%
(p < 0.05; n = 19). Consistent with these data, ROL signi®cantly prevented UV induction of
collagen breakdown by 59% (p < 0.05; n = 5). Inhibition of UV-induced cJun and collagen
breakdown by 0.1% ROL was equivalent to that of 0.1% RA. ROL, like RA, induces formation
of dermal collagen in photoaged skin, and inhibits UV induction of cJun and collagen breakdown.
Thus, we conclude that ROL can treat and most likely prevent photoaging. However, with less
potential for skin irritation, ROL is expected to be better tolerated than RA.
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Enbrel Improves the Clinical and Pathologic Features of Psoriasis
A. Gaspari, A.B. Gottlieb,* S. Kang,² K. Gordon,³ A. Feng,§ and R.J. Zitnik§
Dermatology Department, University Maryland, Baltimore, Maryland, U.S.A.; *CRC, UMDNJ, New
Brunswick, New Jersey, U.S.A.; ²Dermatology Department, University of Michigan, Ann Arbor, Michigan,
U.S.A.; ³Dermatology Department, North-western University, Chicago, Illinois, U.S.A.; §Clinical
Research, Immunex, Seattle, Washington, U.S.A.
Etanercept (Enbrelq), a TNF receptor p75-IgG Fc fusion protein, potently inhibits TNF effects.
This report summarizes clinical and pathologic improvements following Enbrel therapy in a
subgroup of patients from a multicenter safety and ef®cacy study who underwent skin biopsy. In
this 24-week double-blind study, patients were randomized to Enbrel 25 mg or placebo by SC
injection twice weekly. The primary endpoint was the proportion of patients achieving a 75%
improvement in psoriasis area and severity index (PASI) at 12 weeks. 112 patients enrolled in the
study (55 placebo, 57 Enbrel). Skin biopsy specimens were taken in a subgroup of 31 patients (14
placebo, 17 Enbrel) at baseline and week 12. Biopsies were evaluated for epidermal Ki67 and
keratin 16 expression, and epidermal thickness. In addition, biopsies from 11 patients (5 placebo, 6
Enbrel) were evaluated for total CD3 count and keratinocyte ICAM-1 expression. Baseline disease
severity and response to Enbrel were similar in the biopsied patients compared with those in the
study as a whole. The proportion of biopsied patients achieving PASI 75 at 12 weeks was
signi®cantly higher in the Enbrel group vs. the placebo group (41% vs. 7%, respectively, p < 0.05).
Clinical ef®cacy was mirrored by improvements in biopsy parameters at week 12 compared to
baseline. Mean percent reduction in epidermal thickness was signi®cantly greater in the Enbrel
group vs. the placebo group (44% vs. 7%, respectively; p = 0.0099). Reduction in Ki67 and CD3
positive cells, and keratinocyte ICAM-1 and keratin 16 expression was also observed. Enbrel
monotherapy was ef®cacious in the treatment of psoriasis. The clinical ef®cacy was associated with
reduction in keratinocyte adhesion protein expression and epidermal T cell in®ltration, a decrease
in epidermal thickness, and diminished expression of keratinocyte activation and proliferation
markers. Taken together, our data clearly indicate that TNF plays an important role in the
pathogenesis of psoriasis.
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A Disintegrin and Metalloprotease Family Expression in the Psoriatic Epidermis
K. Yamasaki, Y. Shirakata, S. Tokumaru, E. Nishiwaki,* Y. Maeda,* K. Sayama, and K.
Hashimoto
Dermatology, Ehime University School of Medicine, Onsen-gun, Ehime, Japan; *Research and Development
Division, Nippon Organon K.K., Osaka, Osaka, Japan
The ADAM, a disintegrin and metalloprotease, family is a group of newly identi®ed
metalloproteases, and more than 30 ADAMs have been identi®ed. Each ADAM contains
disintegrin, metalloprotease, and transmembrane domains, and therefore has both cell adhesion and
protease activity. For example, ADAM17 is a TNF-a-converting enzyme (TACE) that sheds
transmembrane type TNF-a to release the mature form of TNF-a. ADAM17 also sheds TGF-a, a
member of EGF family which is abundant in psoriatic epidermis. In psoriasis, there is hypertrophy
of the epidermis and a rapid turnover of keratinocytes. Overexpression of metalloproteases is
reported in psoriatic epidermis, but there are no reports on ADAM expression in both normal and
psoriatic epidermis. Therefore, we examined the expression of ADAM mRNA in normal and
psoriatic epidermis using a quantitative real-time PCR system. Total RNA was extracted from
psoriatic (n = 8) and normal (n = 8) epidermis. We performed quantitative RT-PCR using an ABI
PRISM 7700 sequencer detection system. To quantify ADAM mRNA expression, the results
were given as relative intensities using GAPDH as an internal reference, and compared with the
relative value of samples from normal skin as an overall reference. ADAM10 (Kuzbanian),
ADAM15 (metargidin), ADAM28, and ADAMTS1 were decreased in the psoriatic epidermis,
while ADAM19, ADAMTS4, and ADAMTS7 were increased. Although the difference was not
signi®cant, there was more ADAM17 (TACE) expression in the psoriatic epidermis. These results
suggest that ADAMs have a pathological role in psoriatic epidermis, and they might modulate the
motility and mobility of the epidermis.
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The Possible Involvement of Dectin-1 in Pathogenesis of Atopic Dermatitis
A. Maeda,* Y. Aragane,* K. Matsushita,* A. Kawada,* T. Yudate,*² T. Tezuka,* K. Ariizumi,²
and T. Schwarz³
*Dermatology, Kinki University School of Medicine, Osakasayama, Japan; ²Dermatology, South-western
Medical Center, University of Texas, Dallas, Texas, U.S.A.; ³Dermatology, University of Muenster,
Muenster, Germany
Atopic dermatitis (AD) is an allergic condition, which may be regarded as an unusual type of
contact hypersensitivity (CHS) due to chronic exposure to environmental allergens. This, in turn,
may be implicated that AD is a condition, in which tolerance to those antigens is hardly established.
Dectin (Dec)-1 is a recently identi®ed costimulatory molecule, which is selectively expressed on
dendritic cells (DC). Therefore, we were ®rst interested how Dec±1 is modulated in AD. Biopsy
specimens obtained from skin of patients with AD (n = 15) or of healthy individuals (n = 10) were
analyzed for expression of Dec±1 by double immunostaining using antibodies against human Dec±
1 and CD1a, respectively. Only Dec±1+CD1a+DC were seen in healthy skin. Interestingly,
while, in AD, CD1a was vigorously expressed on DC, only marginal expression of this molecule
was detected, indicating that Dec±1 is down-modulated in AD. To examine the biological
relevance of these ®ndings, we next examined whether tolerance is dependent on Dec±1. To do
so, C3H/HeN mice were exposed to ultraviolet B light (UV), sensitized with dinitro¯uorobenzen,
challenged 5 days later, and CHS monitored. As expected, CHS was signi®cantly suppressed by
UV, and subsequently tolerance was induced. However, while injection of soluble Dec±1, a
competitive inhibitor of cognate Dec±1, before sensitization failed to affect UV-induced
immunosuppression upon challenge, a pronounced ear swelling response was observed upon
rechallenge in those animals, indicating that Dec±1 selectively is involved in the induction of
tolerance. Together, our present study strongly suggests that in vivo down-modulation of Dec±1,
by highering the threshold of the induction of tolerance, may lead to cutaneous hypersensitivity
conditions, and that it may contribute to the onset of allergic skin disorders, such as AD.
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Intravenous Micellar Paclitaxel Improves Severe Psoriasis
A. Ehrlich, D. Borris, K. Tejura, S. Steinberg,* T. Fojo,² W. Figg,² M. Detmar,³ M. Turner, and
A. Blauvelt
Dermatology Branch, NCI, Bethesda, Maryland, U.S.A.; *Biostatistics and Data Manangement Section,
NCI, Bethesda, Maryland, U.S.A.; ²Medicine Branch, NCI, Bethesda, Maryland, U.S.A.; ³Department
of Dermatology, Harvard Medical School, Boston, Massachusetts, U.S.A.
Paclitaxel is a chemotherapeutic agent that is frequently used to treat many different types of
cancers. This drug inhibits neutrophil and lymphocyte function, angiogenesis, cellular
proliferation, and matrix metalloproteinase production. Given these effects, we hypothesized that
paclitaxel would also be an effective therapy for psoriasis. To test this hypothesis, we designed a
pilot phase I/II study for patients with severe psoriasis using micellar paclitaxel (Paxceed
TM
), a
novel Cremophorá-free formulation of paclitaxel. Five patients with a baseline Psoriasis Area
Severity Index (PASI) of greater than 20 were treated with 75 mg/m
2
intravenously every 4 weeks
for 6 months. The primary endpoint to determine potential clinical ef®cacy was the percentage
change in PASI from week 0 to week 24. Using this endpoint, all 5 patients experienced 50±75%
improvement. Total RNA extracted from serial punch biopsies of lesional and nonlesional skin and
analyzed by quantitative real-time PCR revealed progressive declines in pro-in¯ammatory and
type 1 cytokine (e.g. TNF-a, IL-1a, IL-2) cDNA levels within psoriatic lesions. In addition,
histologic and immunohistochemical studies of serially biopsied lesional skin demonstrated
normalization of pathologic and immunophenotypic markers associated with psoriasis. We also
characterized the pharmacokinetics of micellar paclitaxel and found the clearance to be similar to
paclitaxel. Of note, three patients experienced mild diffuse alopecia and two experienced mild
worsening of arthralgia. Otherwise, the drug proved safe and was well tolerated, without
occurrence of toxicities normally associated with higher doses of paclitaxel (e.g. neutropenia,
mucositis). The results from this pilot study suggest that micellar paclitaxel is a potential therapeutic
option for patients with severe psoriasis that warrants further study.
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Long-Term Outcome of 525 Patients with Mycosis Fungoides and Sezary Syndrome at
Stanford: Clinical Prognostic Factors and Risks of Disease Progression and Second
Cancer
Y.H. Kim, H.L. Liu, S. Mraz-Gernhard, and R.T. Hoppe*
Dermatology, Stanford University, Stanford, California, U.S.A.; *Rad Oncology, Stanford University,
Stanford, California, U.S.A.
Clinical characteristics and long-term outcome of 525 pts with MF/SS were studied by a single-
center retrospective cohort analysis. Actuarial overall and disease-speci®c (DS) survivals, FFR and
dz progression were calculated by Kaplan Meier meth. Relative risks (RR) of survival and second
cancers were calculated using expected survivals and second cancers in control pop. T classi®cation
at dx was T1 30%, T2 37%, T3 18%, T4 15%. Seven percent presented with extracutaneous dz.
Relative inc in prevalence of MF was identi®ed in males and white race. Median symptom
duration was 4.2 year. Forty-three percent of deaths were attributable to MF, primarily in T3 or
T4. Pts with more advanced T classi®cation and clin stage had worse survival. Except in T1 or
stage IA dz, RR of death was greater in MF pts than in control pop (RRs: IB/IIA 2.2, IIB/III 3.9,
IV 12.8). Despite similar overall survival in stage IB vs. IIA, IIB vs. III, the DS survivals were sig
different. Most sig clin prognostic factors in univariate analysis were pt age, TNMB classi®cation,
clin stage groupings, and presence of extracutaneous dz. Multivariate analysis revealed pt age, T
classi®cation, and presence of extracutaneous dz as the most sig independent factors. Risk of dz
progression to more advanced TNMB or clin stage, or death due to MF correlated with the
severity of initial T classi®cation. Pts who did not achieve CR to initial tx were at greater risk for
progression. Risk of development of extracutaneous dz also correlated with T classi®cation; none
of these pts had T1 when extracutaneous dz was detected. No overall inc incidence of second
cancers in MF pts was found; however, risk of developing other lymphomas was greater than in
control pop. Thus, pts with MF/SS have varying risk of dz progression or death. Pt age, T
classi®cation, presence of extracutaneous dz are independent clinical prognostic factors. Sig DS
survival differences between clin stages validate the usefulness of current (NCI) MF clin staging
system.
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Clinical Classi®cation System of Bioengineered Skin Use and its Correlation for Healing
of Diabetic Foot and Venous Ulcers
L. Saap, K. Donohue, and V. Falanga
Dermatology, Boston University SM/RWMC, Providence, Rhode Island, U.S.A.
Increasingly, chronic wounds are being treated with bioengineering skin constructs (BSC).
However, there is no standard way of assessing wounds treated with a BSC and determine whether
they will heal. Recently, we have developed and published a classi®cation system to evaluate
wounds after construct application. The goal of the present study was to determine if this
classi®cation system has validity and predictive value for ultimate wound closure. To accomplish
this goal, we evaluated serial wound photographs in 83 and 79 patients with diabetic foot ulcers
(DFU), and 85 and 84 patients with venous ulcers (VU) at Week 1 and 2, respectively, after
treatment with a BSC. We then applied the following two parameters of our classi®cation system.
Early clinical effect of the BSC (A = full resurfacing; B = edge effect only; C = wound bed
stimulation only; and D = no bene®t) and early construct appearance (1 = intact construct;
2 = altered construct; 3 = residual construct; and 4 = no construct visible). The two parameters
were then combined to give a total score (i.e. A1, B2). Percentages of healed patients for each score
were determined. In some cases, we combined the results from certain scores to obtain a statistically
meaningful size. The following results were obtained for the DFU patients. At day 7, we found the
following correlations between score and percentage of patients healed: A1 = 82%, B2 = 70%,
B3 = 39%, and C (C1 thru C4) = 29%. At day 14, the following associations were found:
A1 = 85%, A2 = 80%, B2 = 56%, and B3 = 40%. In VU patients, early epithelial coverage seems to
be more predictive of ultimate wound closure. Thus, we found the following correlations: at week
1 A1 = 81%, A2 and A3 combined = 58%, B1 and B2 combined = 62%, B3 and B4
combined = 33%, and C1,C2,C3 and D1 combined = 33%; at week 2 A1 = 86%, A2 and A3
combined = 65%, B1 and B2 combined = 48%, B3 and B4 combined = 53%, and C2 and C3
combined = 29%. Our conclusions are that early clinical effect and early construct persistence are
important parameters for predicting ultimate wound closure after BSC application in diabetic and
venous ulcer.
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The Largest Single-Center U.S. Study of Cutaneous CD30+ Lymphoproliferative
Disorders
H. Liu, S. Kohler, J. Harvell, R. Hoppe,* and Y. Kim
Dermatology, Stanford University, Stanford, California, U.S.A.; *Rad Onc, Stanford University, Stanford,
California, U.S.A.
Retrospective cohort analysis of 56 pts at Stanford w/primary cutaneous anaplastic large cell
lymphoma (PCALCL) &/or lymphomatoid papulosis (LyP) was performed. Diagnosis was
con®rmed by tissue and clinical features. Cases presenting w/extracutaneous (EC) dz and
CD30+ LC transformation of mycosis fungoides were excluded. A borderline dx was given if the
histopath features were indistinguishable from Type C LyP vs. PCALCL and clinicopath
correlation was not possible. Thirty-one LyP (16 Type A, 9 Type B, 5 Type C, 1 Unspecif), 23
PCALCL (20 T-cell, 3 Null-cell), & 2 borderline cases were studied. Median age for LyP was 41
and PCALCL was 50. Male to female ratio for LyP was 20:11 and PCLACL was 16:7. Skin
involvement in LyP was limited in 15 pts (48%) & extensive in 16 (51%) pts and in PCALCL was
solitary/regional (stg Ie) in 17 pts (74%) & generalized (stg IVd) in 6 pts (26%). All LyP & 3
PCALCL (13%) demonstrated spontaneous regression of lesions. PCALCL tested for Alk-1 were
neg (n = 10). Nineteen LyP pts (61%) & 6 (35%) PCALCL pts had concurrent hematolymphoid
malignancy. None w/LyP died of dz. Three pts w/LyP (9.7%) developed PCALCL (2 Type B; 1
Unspec); none have progressed to EC dz. In PCALCL, 5-, 10- year dz speci®c survivals (DSS)
were 82%. Age, gender, & initial response to tx did not affect DSS. Five-year DSS of stg Ie vs. stg
IVd was 89% vs. 50%; this was not statistically sig (p = 0.39). Treatments for PCALCL were
excision (EXC, n = 3), radiation (XRT, n = 7), chemotx (CTX, n = 4), CTX/XRT (n = 5), other
(n = 2), & none (n = 2). CR rates by tx were 100% EXC, 86% XRT, 100% CTX, 80% CTX/
XRT. Of pts w/CR, overall relapse rate (RR) was 62% w/94% occurring in skin only; RR by tx
were similar w/50% EXC, 60% XRT, 75% CTX, & 50% CTX/XRT. Three of 23 (13%)
PCALCL pts progressed to EC dz. In summary, pts w/LyP and PCALCL have an overall excellent
outcome. Histo type of LyP did not predict progression to PCALCL. In PCALCL, there was no
DSS difference btwn stg Ie vs. stg IVd, risk of relapse was not affected by tx type, and majority of
relapse occurred in skin.
180
Detection and Sequences of Human Papillomavirus DNA in Nongenital Seborrhoeic
Keratosis of Healthy People
A. Gushi, T. Kanzaki, and Y. Eizuru*
dermatology, Kagoshima University Faculity of Medicine, Kagoshima, Kagoshima, Japan; *Division of
Persistent and Oncogenic virus, Center For Chronic Viral Diseases, Kagoshima University, Kagoshima,
Kagoshima, Japan
The etiology of seborrhoeic keratosis (SK) is unknown, but its clinical and histopathological
similarities to verruca vulgaris and condylomata acuminata prompted us to examine the possibility
that human papillomavirus (HPV) is present in SK. A total of 104 SK specimens, diagnosed by
clinical and histopathological examinations, were analyzed for HPV DNA by in situ hybridization,
polymerase chain reaction (PCR), Southern blot hybridization and by sequencing viral DNA of
the ampli®ed fragments. We determined 8 mucosal type HPVs (HPV6/11/16/18/31/33/52/58)
and 2 cutaneous type HPVs (HPV1/2). By in situ hybridization 30 of 104 (28.8%) SK contained
HPV DNA. By PCR 86 (82.6%) cases contained HPV18 and 79 (76.0%) cases contained HPV6.
Both HPV18 and 6 were detected in 65 cases (61.5%). There was a relatively low incidence of
HPV1 and 2, 10 (9.7%) and 14 (13.5%) cases, respectively. All 20 controls were negative for HPV
DNA by in situ hybridization but 7 were positive by PCR sequencng. No HPV mutations were
detected by sequence analysis. These results suggest that HPVs, possibly coinfection with more
than two types of HPVs may play an important role in the pathogenesis of SK.
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Profound Loss of T Cell Receptor Repertoire Complexity in Cutaneous T Cell
Lymphoma
N. Yawalkar, D. Jones, K. Ferenczi, and T.S. Kupper
Dermatology, BWH/Harvard/DFCI, Boston, Massachusetts, U.S.A.
Patients with CTCL can develop global immunosuppression that is comparable to that seen in
patients with AIDS. As a result of loss of multiple CD4+ T cells and activation of other T cells,
HIV infected patients suffer a demonstrable decline in the diversity of their T cell repertoire, as
measured by Tcr CDR3 spectratyping. We decided to explore the diversity of the Tcr repertoire
in the peripheral blood of patients with early and advanced CTCL using spectratyping to measure
the number of Tcr CDR3 segments in 24 distinct Vb (BV) families. We examined peripheral
blood T cells from 6 normal volunteers and 12 patients with CTCL. Complexity scores (the sum of
all BV spectratype peaks) for normal volunteers averaged 188, consistent with published values.
Strikingly, Tcr repertoire complexity scores of CTCL patients averaged 130 (range 95±168). This
degree of T cell dysregulation and loss of T cell repertoire complexity is comparable in magnitude
and degree to that seen in patients infected with HIV-1. This profound reduction in complexity of
the Tcr repertoire was most signi®cant in patients with stage III disease, but was also readily
apparent in patients with stage IA disease. In CTCL patient samples, within individual BV families
there were multiple apparent monoclonal and oligoclonal Tcr expansions in both CD4 and CD8
populations, as well apparent deletion of one or more individual BV families in the majority of
patients. Individual patients showed multiple clonal expansions across several BV families. In 5/12
patients, at least one of these multiple expansions could be con®rmed with BV speci®c antibodies.
We conclude that there is a profound dysregulation of the T cell repertoire in the blood of CTCL
patients, which is apparent even in very early and limited disease (stage IA). While the etiology of
this phenomenon in CTCL patients is obscure, the apparent expansion and/or deletion of multiple
T cells suggests a systemic disease and is consistent with the hypothesis that a presently unidenti®ed
T lymphotropic infectious agent may be involved in disease pathogenesis.
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Clinical Classi®cation of Wound Bed Preparation and its Correlation for Healing of
Venous Ulcers
K. Donohue, L. Saap, and V. Falanga
Dermatology, Boston University SM/RWMC, Providence, Rhode Island, U.S.A.
There is a great need to be able to evaluate chronic wounds with respect to their healing potential.
Recently, we have developed (Falanga V, Wound Rep Regen, 2000) a classi®cation system to
evaluate venous ulcer (VU) wound bed preparation. The goal of the present study was to
determine if this classi®cation system has validity and predictive value for ultimate wound closure.
To accomplish this goal, we used this classi®cation system to assign a score to photographs of 168
VU patients at baseline (Day 0). Eighty of the 168 patients were treated with standard compression
therapy and the other 88 patients were treated with applications of a bioengineered skin construct
(BSC, Apligraf). The patients were followed for a total of 12 months, and healing was determined
as complete epithelialization with no wound drainage. The classi®cations system evaluates these
key parameters: wound bed appearance score (A = 100% granulation tissue, B = 50±100%
granulation tissue, + ®brin, C = < 50% granulation tissue, + ®brin, and D = any amount of
granulation tissue, + ®brin, + eschar) and wound exudate score (1 = none/minimal, 2 + moderate,
3 + very exudative wound). The two parameters are then combined to give each wound a total
score (i.e. A1, B2, etc.). Using this scoring system, we determined the percentages of healed
patients for each score. In some cases, we combined the results from certain scores to obtain a
statistically meaningful sample size. The following correlation was found for all 168 patients
(Control and BSC groups): A1 and A2 combined = 73%, B1 = 67%, B2 and B3 combined = 36%,
C1 = 70%, C2 and C3 combined = 61%, and D1 and D2 combined = 39%. Similar correlations
were found both in the control and BSC groups. Our conclusions are that minimal wound
exudate, increased granulation tissue and lack of an eschar seem to be important factors for
predicting ultimate wound closure in both control and BSC treated VU. Ultimately, this scoring
system may help clinicians in venous ulcer wound bed preparation and in optimizing the wound
bed prior to treatment with bioengineered skin and other therapeutic modalities.
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Change in Induration of Target Plaques in the First 4±6Weeks of Systemic Treatment is
Predictive of the Final Response to Treatment of Psoriasis: A Comparison of the PASI
and National Psoriasis Foundation Psoriasis Score
S.E. Zone, K.P. Callis, and G.G. Krueger
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.
Although the Psoriasis Assessment Severity Index (PASI) has become a standard assessment tool for
clinical trials of systemic treatment for psoriasis, practicing dermatologists, investigators, and
regulatory agencies ®nd it cumbersome and not re¯ective of what occurs in the clinic. The NPF
has recently developed the NPF Psoriasis Score (NPFPS), a composite score consisting of 5 primary
endpoints, including assessment of induration of 2 target lesions; affected body surface area,
physician's static global assessment, patient's global assessment, and patient's assessment of itch.
Assessment of induration is felt to be the most reliable indicator of psoriasis improvement. The
intent of this study was to compare the PASI to the NPFPS and to determine if the change in NPF
induration scores in the ®rst 4±6 weeks of systemic treatment is predictive of the ultimate response
of psoriasis to treatment. A meta-analysis of the PASI and NPFPS from 60 subjects enrolled in 5
different clinical psoriasis trials was performed. The correlation coef®cient between the PASI and
NPF scores at all time points was 0.75. The best ®t line slope for the PASI and the NPFPS were ±
0.31 and ±0.45, respectively. The correlation coef®cient between the induration and PASI at all
time points was 0.67. The initial change in induration for each subject was de®ned as the slope of
line between the baseline and week 4 or 6 induration scores. The correlation coef®cients between
the initial change in induration and the percent change from baseline of PASI and NPFPS for all
patients were 0.54 and 0.74, respectively. We conclude that the NPFPS highly correlates to the
PASI and may be a more robust measure of psoriasis improvement given its greater change of
slope. Furthermore, early change in induration of the target plaques may predict whether the
subject will be a responder at the primary endpoint of treatment.
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Diagnostic of Patch Tests in Rosacea with Laser Doppler Perfusion Imager
M. Rone, D. Petzoldt, and U. Jappe
Department of Dermatology and Venereology, University Heidelberg, Heidelberg, Germany
Rosacea patients generally suffer from an extreme sensitivity to topically applied formulations.
Therefore, diagnostic allergy tests sometimes are dif®cult to interprete. In order to determine,
whether the evaluation of the skin blood perfusion can improve the differentiation between
positive, marginal and irritant patch test reactions four rosacea patients (1 male, 3 female) and a
control-group of 4 patients (1 male, 3 female) with hand and face dermatitis were patch tested with
standart allergens, constituents of topical formulations and external medications. Readings were
evaluated visually and with the patch-test-program of a 2-dimensional laser Doppler perfusion
imager PIM 1,0 (LDPI) and 2,5 software (Lisca Development AB, Linkoping, Sweden). In all 8
patients a total of 20 positive result were detected. Six marginal ``+/±`` reactions to different
constituents of topical formulations were obtained only in rosacea patients. The grade of perfusion
in positive patch test reaction was comparable to the level obtained by visual score and no LDPI-
differences were seen between rosacea patients and control-group. The maximal perfusion-
intensity observed in positive tests was more than twice as high than in marginal reactions in
rosacea patients. LDPI of marginal test reactions showed variable low-grade skin perfusion close to
negative test reactions and therefore differentiation between irritant and allergic results was
impossible, whereas continuous LDPI-monitoring of marginal reactions over a period of 96 h led
to a pro®le of perfusion: in 4/6 reactions maximal perfusion decreased (1.2,20 V to 0,72 V, 2.2,51
V to 0,90 V, 3.2,61 V to 1,99 V, 4.2,48 V to 1,83 V), in 2/6 it slightly increased (1.2,03 V to
2,11 V, 2.1,17 V to 1,33 V). The pro®le seems to be more useful for differentiation between
marginal and clear positive reactions than visual evaluation. Although encouraging, these results
have to be reproduced with higher numbers of patients in order to obtain an objective assessment
of marginal reactions.
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Patient Satisfaction and Longevity of Cosmetic Result After Facial Injection of Human
Collagen (Cymetra)
M. Alam, N.E. Omura,*² and M.S. Kaminer*²
Dermatology, DermSurgery Associates, Houston, Texas, U.S.A.; *Department of Medicine (Dermatology),
Dartmouth Medical School, Hanover, New Hampshire, U.S.A.; ²Dermatology, SkinCare Physicians,
Chestnut Hill, Massachusetts, U.S.A.
Soft tissue augmentation materials that can improve rhytides and depressions of the face are in
widespread use. Although cosmetically elegant, many of these substances have limited longevity.
The purpose of this study was to investigate the longevity and patient bene®t of Cymetra, an
injectable soft-tissue augmentation material derived from cadaveric human collagen. A follow-up
study was performed of 30 patients receiving Cymetraá injections to the face during the period
from March 2000 to December 2000 in a urban/suburban dermatology practice. The primary
outcome measure was patient satisfaction and the secondary outcome measure was investigator
assessment. Patients responded to a survey on average 4.9 months after their last Cymetra
treatment. Using a scale from 1 (minimum) to 5 (maximum), patients rated overall ease of
treatment 3.2, immediate cosmetic result 4.2, long-term cosmetic result 2.4, and overall
satisfaction, 2.8. Patients receiving 3 treatments had much greater overall satisfaction (4.3/5) than
patients receiving 1 (2.7) or 2 (2.4) treatments. A small proportion of the Cymetra injected at each
treatment may persist for a year or longer. As a consequence, the cumulative residual material from
successive treatments may better ®ll a cosmetic defect than a single treatment. Further research is
necessary to con®rm this result.
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Accuracy of the Clinical Diagnosis for Melanoma With and Without Dermoscopy
H. Kittler, H. Pehamberger, K. Wolff, and M. Binder
Department of Dermatology, University of Vienna Medical School, Vienna, Austria
Our objective is to review the contemporary literature and to determine the accuracy of the
clinical diagnosis for melanoma with and without dermoscopy. We performed a meta-analysis of
studies reporting the accuracy of the clinical diagnosis for melanoma with and/or without
dermoscopy. We identi®ed 27 eligible studies. The diagnostic accuracy for melanoma achieved
with dermoscopy (log odds ratio: 4.0, 95% CI: 3.0±5.1) was signi®cantly higher than the diagnostic
accuracy achieved without dermoscopy (log odds ratio: 2.7, 95% CI: 1.9±3.4), which is an
improvement of 49% (p = 0.001). The diagnostic accuracy of dermoscopy depended on the level of
experience of the examiners. Dermoscopy performed by untrained examiners was not better than
clinical inspection without dermoscopy. The diagnostic performance of dermoscopy improved
when the diagnosis was made by a group of examiners in consensus and diminished when the
prevalence of melanoma increased. A comparison of diagnostic algorithms for dermoscopy showed
no signi®cant differences in their diagnostic performances. Critical appraisal of the study
characteristics showed that the majority of studies is potentially in¯uenced by veri®cation bias.
Dermoscopy improves the diagnostic accuracy for melanoma in comparison to inspection with the
unaided eye. The diagnostic accuracy of dermoscopy depends on the level of experience of the
examiners and whether or not the diagnosis was made in consensus.
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Removal of Streptococcal Antigen Deposited at the Skin Basement Membrane in a
Patient with Streptococcal Associated Psoriasis Following the Use of Topical 25%
Isopropyl Myristate
P.W. Noah, E.W. Rosenberg, R.B. Skinner Jr, C.R. Handorf, T.D. Mandrell, and T. Glenn
Pathology,Medicine-Dermatology, University of Tennessee, Memphis, Tennessee, U.S.A.;
*Pathology,Medicine-Dermatology, University of Tennessee, Memphis, Tennessee, U.S.A.
The purpose of this study is to determine if topical 25%isopropyl myristate is effective in removing
microbial products deposited in the skin of psoriasis patients. A psoriasis patient whose disease was
known to ¯are following streptococcal infection and whose antibody levels to streptoccal
exoenzymes, deoxyribonuclease B, hyaluronidase, streptolysin O, and Streptozyme-Wampole
were elevated, was treated with topical 25% isopropyl myristate. Biopsies were taken of the
involved area on her thigh prior to and after her treatment. Stains for streptococcal deposition were
performed using a primary rabbit polyclonal antibody to Streptozyme-Wampole with the DAKO
linked streptavidin biotin alkaline phosphatase ampli®cation stain. A prominent red stain was
observed in the lesional skin prior to treatment indicating deposition of streptococcal exoantigen in
the lesion. Following treatment with the 25% isopropyl myristate the lesion cleared clinically and
repeated stains of this cleared area showed an abscense of the red staining indicating that removal of
streptococcal antigen had occurred. We conclude that the use of topical 25% isopropyl myristate in
streptococcal associated psoriasis aids in clinically clearing lesions and that removal of microbial
debris occurs in association with this clearing.
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A Comparative Evaluation of Paraf®n and Frozen Tissue Reactive T-Cell Deletion
Markers (CD7, CD5) in Stage 1 Mycosis Fungoides
H.S. Qureshi, C.K. Ma, M.W. Lee, H.W. Lim, D.P. Fivenson, and A.H. Ormsby
Pathology, Henry Ford Hospital, Detroit, Michigan, U.S.A.
The diagnosis of early MF can be dif®cult, requiring adjunctive diagnostic modalities such as T-cell
deletion markers (CD7/CD5 most commonly deleted) and T-cell gene rearrangements. To date,
the utility of CD7/CD5 deletion in the diagnosis of early MF using paraf®n (P) antibodies has not
been assessed. All cases of clinically and histologically identi®ed stage I MF at Henry Ford Hospital
from January 2000-December 2001 were prospectively evaluated for P-CD7 (n = 27) (Novacastra;
clone: DK24; dilut: 1:50; HIER: 10min, EDTA pH 8.0). P-CD3 (n = 27), P-CD5 (n = 21), P-
CD4 (n = 22) and P-CD8 (n = 22) immunostaining was also performed. CD7/CD5 immunostain-
ing was performed on a set of benign (lichenoid dermatoses = 5; chronic dermatitis n = 7) and early
MF frozen tissue control cases (n = 10). The histological diagnosis of early MF was con®rmed by 3
dermatopathologists. T-cell marker deletion was de®ned as > 50% loss in immunoreactive atypical
T-cells as compared to matching CD3 stains. Mean age was 62 year (range: 16±85) and 56.5% were
male. P-CD7/P-CD5 deletion was present in 24/27 (89%) and 3/21 (14%) stage I MF cases,
respectively. CD7/CD5 deletion in the control frozen tissue group was present in 7/10 (70%) and
1/10 (10%) cases, respectively. CD7/CD5 deletion was not identi®ed in any benign control case.
CD4:CD8 ratio was > 8:1 in 2/22 (9%) stage I MF cases. Excellent concordance is seen between
frozen and paraf®n-reactive CD7/CD5 deletion antibodies in early MF. A high proportion of
CD7 (89%) deletion is present in early MF cases, however, is not seen in benign controls (0%)
using paraf®n-reactive antibodies. CD5 deletion and increased CD4:8 ratio occur at such low
frequencies (10% and 9%, respectively) as to make their routine use impractical. These results
suggest that paraf®n-reactive CD7 deletion can be successfully used on routine biopsy material in
the diagnosis of early MF.
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Abnormal Itch Processing in Atopic Dermatitis Patients
A. Ikoma, M. Fartasch,* and M. Schmelz
Department Physiology 1, University Erlangen, Erlangen, Germany; *Department Dermatology, University
Erlangen, Erlangen, Germany
Electrical, mechanical and chemical stimuli eliciting pain in healthy subjects were applied in
visually healthy and affected skin of atopic dermatitis (AD) patients to investigate mechanisms of
itch and pain processing. In 8 AD patients and 8 healthy subjects the following stimuli were
applied: Pinpricks by a 27 G needle with ®ve different loads (1.0±14.8 g), electric stimulation
(50 Hz, 2 ms, 0.02±1.79 mA) via newly developed intraepidermal electrodes (diameter: 0.1 mm),
and acidic solution (citrate buffer, pH 3) given for 10 min via intradermal microdialysis ®bers
inserted at a length of 5 mm. Intensity of itch or pain evoked by these stimuli was evaluated on a
numerical scale from 0 (no sensation) to 10 (worst imaginable sensation). The mechanical and
electrical stimuli dose-dependently evoked pain in healthy subjects. Similar results were obtained in
visually healthy skin of the patients. However, when applied in affected skin, pure itch was evoked
in all of the patients. At higher stimulus intensities, patients felt a combination of itch and pain. The
chemical stimuli evoked itch in the patients, predominantly in their affected skin, although they
exclusively evoked pain in healthy subjects. Mechanically and chemically induced itch could be
attributed to sensitization of itch-specialized ®bers in the periphery or to spinal sensitization.
However, electrical activation of skin nerves is independent of possible sensitization of the
receptive endings, and thus electrically induced itch provides evidence for spinal sensitization. The
lack of pain-induced inhibition of itch in the patients further substantiates this assumption. Our
results emphasize the role of spinal processing in chronic itch patients and provide a rational basis
for the antipruritic treatment with opiate-antagonists. Moreover, the newly developed model for
electrically induced itch is being used in functional imaging to locate cerebral areas involved in
chronic itch patients.
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ABX-IL8 in the Treatment of Psoriasis: Clinical Results
M.H. Horowitz, G.G. Krueger,* G.M. Bell, S. Huang, M. Wyres, and F. Chen
Clinical Development, Abgenix, Inc., Fremont, California, U.S.A.; *Department of Dermatology,
University of Utah, Salt Lake City, Utah, U.S.A.
Interleukin-8, a member of the CXC chemokine family, is implicated in many in¯ammatory
diseases including psoriasis. ABX-IL8 is a fully human monoclonal antibody recognizing human
interleukin-8 that was generated in transgenic XenoMouseq animals. To assess the ef®cacy of
ABX-IL8 in the treatment of plague psoriasis, 94 patients were randomized to either placebo,
3 mg/kg or 6 mg/kg of ABX-IL8 administered every 3 weeks over 12 weeks for a total of 5 doses.
Psoriasis area severity index (PASI) scores were obtained at Baseline, Week 9 and every 3 weeks
thereafter. The primary analysis included all randomized patients who received at least one dose of
study medication. The proportion of patients achieving >= 75% improvement in their PASI scores
at Week 15 compared to Baseline was 0%, 18% and 3% of the placebo, ABX-IL8 3 mg/kg, and
ABX-IL8 6 mg/kg treated patients, respectively (p = 0.033 for comparision of ABX-IL8 3 mg/kg
with placebo). In an analysis of patients who completed through Week 18, the proportion of
patients achieving >= 75% improvement in their PASI scores was 0%, 24% and 4% of the placebo,
ABX-IL8 3 mg/kg, and ABX-IL8 6 mg/kg treated patients, respectively (p = 0.024 for comparison
of ABX-IL8 3 mg/kg with placebo). The bene®t of ABX-IL8 was more pronounced in patients
with more severe disease at Baseline (PASI >= 12). In this population 0% of placebo patients and
33% of ABX-IL8 3 mg/kg treated patients achieved >= 75% improvement in their PASI scores at
Week 15 compared to Baseline (p = 0.0057). To assess the durability of the clinical response, PASI
scores were monitored for 24 weeks after the 12-week treatment period. All ABX-IL8 responders
(>= 75% improvement in PASI at Week 15) remained at least 50% improved at the end of the 24-
week follow-up. Based on these results, an additional safety and ef®cacy trial evaluating two dose
levels of ABX-IL8 (200 mg and 300 mg) in 276 patients with moderate to severe plague psoriasis
was initiated in 2001. The results of this trial, where appropriate, will be compared and contrasted
with those of the forgoing trial.
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The Response of Skin Disease to Stress: Changes in the Severity of Acne Vulgaris as
Affected by Examination Stress
A. Chiu and A.B. Kimball
Dermatology, Stanford University, Stanford, California, U.S.A.
Although emotional stress has long been suspected to exacerbate acne vulgaris, previous reports
addressing the in¯uence of perceived stress on acne severity have been mainly anecdotal. To
further elucidate the possible relationship of stress and the exacerbation of acne, a prospective
cohort study was conducted with university students utilizing previously validated scales measuring
acne severity and perceived stress. Our objective is to evaluate changes in acne severity during
nonexam periods and midterm and ®nal examination periods, and to explore the possible
relationship of these changes in severity with perceived examination stress. 15 women and 7 men,
ages 18±29, with baseline Leeds acne scores of 0.5±1.75 were enrolled. Clinical grading of acne
severity utilizing the photonumeric Leeds scale and assessment of subjects' perceived stress with the
Perceived Stress Scale questionnaire were conducted on students during both nonexam and exam
periods. The grader was unaware of the subjects' stress scores. Subjects were found to have a higher
mean grade of acne severity (p < 0.001) and a higher mean perceived stress score (p < 0.001) during
exams. Using correlation analysis, increased acne severity was associated with increased stress levels
(Pearson correlation = 0.068, p = 0.003). The effects of confounding variables such as, changes in
sleep hours, sleep quality, diet quality, and number of meals/day were assessed with logistic
regression. Worsening of stress remained most tightly associated with acne change (p = 0.004),
while change in diet quality was the only other signi®cant association (p = 0.01). This study
suggests that patients with acne experience worsening of disease during examinations. Further,
changes in acne severity correlate highly with increasing stress experienced during examination
periods, suggesting emotional stress from external sources may have a signi®cant in¯uence on acne
vulgaris.
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Photoaging: Clinical and Biometrological Results of a Double-Blind Randomized Trial
Evaluating a New Cosmetic Product Containing Avocadofurane+Pentapeptides and
Retinol
H. Philippe,² P. Creidi,² H. Zahouani,* B. Chadoutaud,³ J. Choulot, and P. Msika
R & D, Laboratoires Pharmascience, Epernon, *UMR, CNRS 5513, Lyon, 81, France; ²Dermatology
unit, CHU Besanaon, Besanaon, 81, France; ³Clinical Research Consultant, BC Consulting, Toulouse,
81, France
The role of Metallo Matricial Proteinases (MMPs) in cutaneous aging is now well established.
Moreover the decrease of TGF beta has been more recently discovered. Two new molecules have
been developed in this ®eld: A biotechnologic Pentapeptide which inhibits the production of
MMP1,3,9 by UV exposure on ®broblast cultures and pure heptadecadienylfurane
(Avocadofurane) which increases the collagen synthesis via a speci®c stimulation of TGF beta.
Associated to retinol palmitate, they have been clinically evaluated in photoaging. A 6-months,
hemiface, randomized double-blind comparative study (daily application of the emulsion vs.
placebo), has been conducted in 30 nonsmoker women (age 40±50) presenting with a marked
photoaging. At each visit (Week0, W8, W16, W24), volunteers had a clinical examination on
several items with a visual scale, and biometrological measurements: cutometer evaluation
(Cutometer SEM 575) and skin relief evaluation with silicon replicas analyzed with a defocused
laser device. Compared with placebo, the tested product was superior for all clinical items: +17%
hydration, ±8% lentigines, ±12% telangiectasiae, ±13% open comedons, +15% brightness, +15%
smoothness, +8% radiance and ±7% wrinkles. The ratio Ur/Ue (recovery/extensibility) (which
decreases with age) signi®cantly increased (+18.2%). Both parameters of depth, length and volume
of the wrinkles signi®cantly improved (p < 0.05). The association of Pentapeptides and
Avocadofurane to retinol demonstrated antiageing effects both on clinical assessment and
biometrological measurements.
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Sensitivity and Speci®city of Near Infrared Re¯ectance Confocal Scanning Laser
Microscopy for In Vivo Diagnosis of Basal Cell Carcinoma
S. Nori, K. Swindells, F. Rius Diaz, J. Valderrama, S. Hicks, M. Huzaira, R. Tachihara, Z.
Tannous, M.H. Goldgeier,* and S. Gonzalez
Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
*Dermatology, Dermatology and Dermatologic Surgery, Rochester, New York, U.S.A.
This pilot study was aimed at de®ning the sensitivity and speci®city of confocal microscopy criteria
for in vivo diagnosis of Basal Cell Carcinoma. 81 lesions, from 75 patients ages 30±97, were imaged
with confocal microscopy. All 81 lesions had con®rmed diagnoses based on the gold standards of
either biopsy or clinical exam; 33 of the lesions were BCC. Near infrared confocal scanning laser
microscopy was used to visualize the histological features of each lesion in vivo. Based on a previous
study (Gonzalez & Tannous, J.A.A.D 2002), a set of 5 confocal imaging criteria for diagnosing
BCC was formulated by analyzing biopsy-correlated confocal images. These criteria were presence
of elongated nuclei, polarization and monomorphism of these nuclei, in¯ammatory in®ltrate,
increased vasculature and pleomorphic epidermis indicative of actinic changes. These confocal
imaging criteria were then retrospectively applied in a blinded fashion to the database of images
from all 81 lesions to determine their sensitivity and speci®city for diagnosing BCC. The sensitivity
of the presence of 4 or more confocal imaging criteria for diagnosing BCC in vivo was 90.3% with a
speci®city of 77%, and con®dence intervals of 80±100% (J.Jouden test). As the number of criteria
that were present increased, the sensitivity decreased, but the speci®city increased so that with all 5
criteria present, the speci®city was 92%. Amongst the individual criteria, the most sensitive was the
presence of elongated nuclei at 94%. The presence of 4 or more confocal imaging criteria is
sensitive for the in vivo microscopic diagnosis of BCC, and the more criteria that are present, the
higher the speci®city.
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Assessment of Skin Lesions Using Image Analysis in Patients with Pemphigus Vulgaris
in Relation to ELISA Scores for Desmoglein 1 and 3
S. Kobayashi, M. Tanaka, and T. Nishikawa
Dermatology, Keio University School of Medicine, Tokyo, Japan
The assessment of disease severity in bullous disorders has been performed usually with subjective
scoring methods. The purpose of the present study is to evaluate disease activities in relation to
ELISA scores in patients with pemphigus vulgaris by use of a computer-assisted method for
measurement of the involved area. Patients with pemphigus vulgaris have various types of skin
lesions including bulla, crust, erosion and pigmentation. Moreover, because of shadow and various
colors, it is not easy to extract lesions with a simple method. We have tried to extract skin lesions





g. Color slides from three patients with pemphigus vulgaris at several different
times were scanned and digitized using a ®lm scanner. We only used photographs of the back
because they would represent the main lesions of the patients and the assessment of the area would
be relatively easy. The area of involvement were then extracted using L*a*b* color measurement
method. Gauss ®lter was used to eliminate noise information on the digital images. The extraction
of erythema and erosion was quite ef®ciently completed and seemed to depict active areas of
involvement, if they were compared with original images. Area of involvement seemed to change a
few days after ELISA scores changed depending on the cases. This method would enable us to
assess the disease severity accurately and objectively. Disease activity seemed to ¯uctuate, with
several days delay, in relation to the ELISA score of desmoglein 1 and 3. Further investigation in
patients with pemphigus foliaceus and evaluation of mucosal involvement in patients with
pemphigus vulgaris would be needed.
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Avocadofurane, Pentapeptides and Soy Iso¯avones: A Clinical Study Against Hormonal
Aging
M. Philippe, F. Perin,* P. Beau,* G. Georgesco,² J. Pittet,* B. Chadoutaud,³ J. Choulot, and L.
Vaillant²
R & D, Laboratoires Pharmascience, Epernon, France; *R & D, Spincontrol, Tours, France; ²Dermatology,
CHRU Trousseau, Tours, France; ³Clinical Research Consultant, BC Consulting, Toulouse, France
Post-menopausal aging is characterized by a dermal atrophy and collagen loss. A patented
association has been studied in this ®eld: Avocadofurane limits the decrease of collagen synthesis via
the stimulation of TGF-b. Pentapeptides inhibit the destruction of collagen ®bers by MMPs. Soy
iso¯avones have a positive effect on collagen synthesis. In 2 clinical studies, 30 women (age > 50,
with no hormonal replacement therapy) have applied twice daily the product during one year.
First, in a randomised double-blind placebo-controlled study, products were applied on the
internal face of each forearm. We performed at 6 and 12 months (M): clinical parameters, hydration
(Corneometer CM825 PC), biomechanical properties (Cutometer SEM 575), microrelief (replica
analysed using topometry by fringes projection), skin thickness (high resolution ultrasound
20 MHz) and energy metabolism status (31P MR spectroscopy of the skin). The 2nd open study
concerned the face. We investigated clinical parameters, hydration and biomechanical properties at
the temporal zone and the relief of the crow's foot by replica. In the 1-st study, signi®cant
improvements were observed on verum side from 6M to 12M. For example, the cutometric
parameters (6M): elasticity (+52.5%), extensibility (+44%) and tonicity (+28.5%); the skin
thickness (12M): +19% with a restoration of the super®cial dermis echogenicity; the hydration
level (+40%). The energy status was also improved.
In the 2nd study, these performances were con®rmed on the face at 6 and 12M: by the clinical
parameters, by ultrasound (12M: thickness +9%, nonechogenic layer ±36%), and even in the
wrinkles of the crow's-foot (±19% of roughness). The association of 3 patented synergic antiage
molecules is able to reverse the main cutaneous alterations of hormonal aging: atrophy, atony,
dryness and loss of energy.
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Re¯ectance Confocal Microscopy may Differentiate Acute Allergic and Irritant Contact
Dermatitis In Vivo
K. Swindells, N. Burnett, F. Rius-Diaz, B. Raju,* M.A. Srinivasan,* E. Gonzalez², and S.
Gonz´lez
Wellman Laboratories of Photomedicine, Department of Dermatology, Massachusetts General Hospital,
Boston, Massachusetts, U.S.A.; *Laboratory for Human and Machine Haptics, Massachusetts Institute of
Technology, Cambridge, Massachusetts, U.S.A.; ²Contact Dermatitis Unit, Department of Dermatology,
Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
Acute irritant and allergic contact dermatitis (ICD and ACD, respectively) are common conditions
but may not be easy to differentiate by clinical or histological assessment. In vivo re¯ectance
confocal scanning laser microscopy (RCM) enables real-time high resolution skin imaging to a
depth of 200±350 microns. We hypothesize that noninvasive microscopic evaluation at high
resolution by RCM may differentiate ACD and ICD. Volunteer subjects with ACD were
recruited and patch tested with an allergen and the irritant, sodium lauryl sulphate. RCM imaging
as well as other noninvasive techniques: transepidermal water loss (TEWL) and high frequency
(50 MHz) ultrasound (HFUS), were performed 24 and 72 h after patch testing. Biopsies were
obtained and correlated with RCM images. RCM enabled dynamic evaluation of cutaneous
responses to allergens and irritants. Histological features including stratum corneum disruption,
spongiosis, microvesicle formation, in¯ammatory cell in®ltrate and vasodilatation were visualized,
in real time. In comparison with ACD, ICD resulted in greater disruption of the stratum corneum
(p < 0.04), more super®cial in¯ammatory in®ltration (p = 0.003) and more but not signi®cant
epidermal thickening. In contrast, marked vesicle formation was more often apparent in ACD. As
expected, there was a signi®cantly greater increase in TEWL in ICD than in ACD (p < 0.02).
HFUS of ACD and ICD enabled assessment of dermal thickening and changes to dermal
echogenicity. We conclude that noninvasive techniques may help to evaluate cutaneous events
occurring in acute CD. CRM is a promising in vivo tool for dynamic, high resolution assessment
and may help to differentiate acute ACD and SLS-induced ICD.
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Presence of Mab 465.12 De®ned Cytoplasmic Melanoma-Associated Antigen in Sera of
Patients with Melanoma and Relation to Prognosis
D. Levy, S.R. Reynolds, S. Ferrone,² R.L. Shapiro,* M.N. Harris,* D.F. Roses,* and J. Bystryn
The Ronald O Perelman Department of Dermatology, NYU School of Medicine, New York, New York,
U.S.A.; *Department of Surgery, NYU School of Medicine, New York, New York, U.S.A. ²Dermatology,
Roswell Park Institute, Buffalo, New York, U.S.A.
Antigens associated with melanoma can be present in the circulation of patients with this cancer.
Among them is a cytoplasmic antigen (CYTMAA) de®ned by Mab 465.12. This antigen is present
in the sera of normal individuals and may be present in higher levels in pts with melanoma. This
study was conducted to examine whether the presence of this antigen in pts with melanoma
correlates with clinical outcome. We measured serum levels of CYTMAA in 95 pts with resected
AJCC stage IIb or IIIa melanoma using a double-sandwich ELISA. The normal range of
CYTMAA was determined utilizing sera of 30 normal individuals. The results of the assay were
reproducible and quantitative. Elevated levels of CYTMAA were present in 19 (20%) of melanoma
pts. There was a trend for poorer clinical outcome in patients with this antigen in their circulation.
By Kaplan-Meier analysis the median 75% recurrence-free survival of the positive pts was
8.1 month compared to > 24 month for negative pts (p = 0.06). These results suggest that
measuring CYTMAA in serum of pts with melanoma may provide clinically useful information.
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Long-Term Survival of Stage IV Melanoma Patients Treated with a Polyvalent, Shed
Antigen, Melanoma Vaccine
D. Laky, R.L. Shapiro,* M.N. Harris,* D.F. Roses,* A.Z. Jacquotte, S.R. Reynolds, and J.
Bystryn
Kaplamn Comprehensive Cancer Center, NYU School of Medicine, New York, New York, U.S.A.;
*Department of Surgery, NYU School of Medicine, New York, New York, U.S.A.
The long-term survival of patients with AJCC stage IV melanoma is poor, with approximately 10%
surviving 5 year. Recently, we showed that immunization to a polyvalent, shed antigen, melanoma
vaccine appears to prolong recurrence-free survival in stage III melanoma. Here, we examine the
survival of 94 pts with stage IV melanoma treated with the same vaccine; and compare the results
to those of 10 large historical studies of survival in stage IV melanoma. The 94 pts were immunized
to 40 mg of vaccine adjuvanted with alum or IL-2 liposomes; administered q2±3 week x 4,
monthly x 3, q3 month x 2, and then q6 month for 2 year or to disease progression. Twenty-six pts
were also treated with a low dose (1±10 M units sc 3x/ week) of interferon alfa-2b. By Kaplan-
Meier analysis, median overall survival of vaccine treated pts was 28.6 month compared to 8 month
(range 6.4±19 month) for historical controls; survival at 2 year was 60% vs. 15% (range 11±20%)
and at 5 year was 26% vs. 7% (range 4±22%), respectively. Similar results were obtained when pts
were strati®ed by site of metastatic disease, the strongest predictor of survival in stage IV disease.
Median survival of vaccine treated pts with distant skin, subcutaneous, and lymph node metastasis
(n = 39) was 35 month vs. 15 month (range 10±29 month) for historical controls; survival at 2 year
was 69% vs. 23% (range 15±29%); and at 5 year were 35% vs. 12% (range 5±33%). For pts with lung
metastases (n = 27) median survival was 20 month vs. 8 month (range 7±14 month), 2 year survival
was 44% vs. 12% (range11±27%) and at 5 year 8% vs. 4% (range 1.2±16%). For pts with liver, bone,
or other visceral metastasis (n = 28) median survival was 28 month vs. 5 month (range 5±6 month),
survival at 2 year was 61% vs. 8% (range 6±11%) and at 5 year 28% vs. 5% (range 2±4%). These
results suggest that treatment with a polyvalent shed antigen; melanoma vaccine may prolong long-
term survival in pts with stage IV melanoma.
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Addition of Pentoxifylline Reduces the Side-Effects of Fumaric Acid Esters in
Treatment of Psoriasis




cke,² W. Sterry,* and K.
Asadullah*³
*Dermatology, University Hospital Charite, Berlin, Berlin, Germany; ²Immunology, University Hospital
Charite, Berlin, Berlin, Germany; ³RBA Dermatol., Schering- AG, Berlin, Berlin, Germany
The ef®cacy of fumaric acid esters (FAE) for treatment of psoriasis is well proven, however,
patients often discontinue the FAE-treatment due to gastrointestinal side-effects and ¯ush, which
are supposed to be mediated by TNF-a release from monocytes. We speculated that a reduction of
FAE-induced TNF-a secretion should improve the tolerability of the compound. Therefore, we
compared FAE therapy and the combination of FAE plus pentoxifylline (PTX), a potent
suppressor of TNF-a release. 44 patients with moderate to severe psoriasis vulgaris were included
in this open-label prospective trial. In group A (FAE monotherapy), 16 out of 21 patients showed
adverse effects, 4 patients ceased the FAE treatment. The incidence was slightly lower in group B
(combination therapy FAE plus PTX) where 12 patients out of 23 reported adverse effects leading
to withdrawal from the study in 4 cases. Each of the adverse effects, were less frequently reported in
the patients receiving PTX coapplication. Concerning the severity of all side-effects a signi®cant
reduction was found in the patients with combination therapy. Our data supports the hypothesis
that the FAE-associated side-effects are TNF-a-mediated and indicates that adding PTX seems to
increase the tolerability of this therapy regime.
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Electron Microscopy of Skin Biopsy as a Diagnostic Tool in CADASIL
S. Borelli, M. Moschopulos,* U.W. Buettner,² and P. Itin
Dermatology, Kanton Hospital, Aarau, Switzerland; *Pathology, Kanton Hospital, Aarau, Switzerland;
²Neurology, Kanton Hospital, Aarau, Alabama
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
(CADASIL) is a hereditary vascular disease caused by NOTCH3 mutations associated with
migraine, recurrent ischemic strokes, and early onset multiinfarct dementia. Since Cadasil has a
broad and unspeci®c clinical phenotype the diagnosis should be con®rmed by genetic testing,
electron microscopy or immunostainig with NOTCH3 monoclonal antibodies. Diagnostic
ultrastructural changes are found not only in the brain, but also in skin vessels. The increasing
awareness of this diagnosis and the consecutively increasing consultation of dermatologists for skin
biopsies necessitates the knowledge of the disease and the diagnostic tools. We present two
patients, a 52-year-old-woman and a 65-year-old-man, in which the diagnosis CADASIL could be
made by demonstrating the characteristic granular, electron-dense, osmiophilic material attached to
vascular smooth muscle cells in the ultrastructural examination of skin biopsies. As the skin is easily
accessible to biopsy and an ultrastructural diagnosis is usually available within one week, the
electron microscopic examination of skin biopsies is a simple, fast and effective diagnostic approach
to CADASIL preceding de®nite genetic diagnosis.
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Pharmacokinetics and Pharmacodynamics of ABX-Il8 in Patients with Psoriasis
G.G. Krueger, M. Tabrizi,* S. Huang,* L. Roskos,* N. Raie,* H. Lu,* and G. Bell*
Department of Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; *Clinical Development,
Abgenix, Inc., Fremont, California, U.S.A.
ABX-IL8 is a fully human, high af®nity monoclonal antibody generated in transgenic
XenoMouseq animals, which neutralized human interleukin-8 (IL-8). In a recent Phase II study,
94 patients with plague psoriasis were randomized and treated with placebo, 3 or 6 mg/kg of ABX-
IL8 administered every three weeks over a 12-week treatment period for a total of 5 doses. The
initial dose was a 2x loading dose. Serum samples were collected pre- and postinfusion at each
treatment visit. Average steady state serum concentrations (Cave) of ABX-IL8 for each dosing
interval was calculated using the equation: Cave = (Cmax ± Cmin)/1n(Cmax/Cmin), where Cmax
and Cmin represent the maximum and minimum concentrations measured in serum samples over
each dosing interval. Dose proportional increases in steady state serum concentrations were
observed at all intervals throughout the study. The Cave values obtained for cohort 1 (3 mg/kg)
and cohort 2 (6 mg/kg) during the last dosing interval were 52 6 16 and 117 6 31 mg/ml,
respectively. IL-8 concentrations were determined in serum and in target plagues at Baseline.
Serum IL-8 levels did not correlate with Baseline PASI scores and skin IL-8 levels did not correlate
with serum IL-8 levels. However, a linear association between Baseline skin IL-8 levels and
Baseline induration score for the target plague was observed (R < 0.05). The effect of ABX-IL8 on
plague induration was evaluated by determining the proportion of patients whose target plague had
the most induration (Psoriasis Severity Score = 4) at Baseline and achieved >= 2 point
improvement in induration score at Week 15. 9% (1/11) of placebo treated patients achieved
this level of improvement compared with 40% (9/23) of ABX-IL8 treated patients. This analysis
indicates that IL-8 is a key cytokine in the pathogenesis of induration, the most sensitive indicator
of disease activity of psoriasis, and that ABX-IL8 therapy can reduce induration scores.
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Clinical Effects of Gamma-Linolenic Acid Coated Undershirts on Children with Atopic
Dermatitis
S. Kanehara, T. Kishi, T. Ohtani, A. Aioi, K. Uede, and F. Furukawa
Department of Dermatology, Wakayama Medical University, Wakayama, Wakayama, Japan
It has been reported that gamma-linolenic acid is effective to improve the symptom of atopic
dermatitis. We studied clinical effects of undershirts coated borage oil containing gamma-linolenic
acid on children with atopic dermatitis. Twenty-six children, aged 2±7 years, with mild to
moderate atopic dermatitis, were studied. They wore cotton undershirts coated borage oil
containing 69.3 mg of gamma-linolenic acid per 100 g of cotton daily for 4 weeks. On 1, 2 and
4 weeks after the start, itch, dryness and eczema were evaluated. Transepidermal water loss
(TEWL) and water content of the stratum corneum were measured at the back skin before and
after the clinical trial. After 4 weeks eczema improved in 15 patients (57.5%) and dryness improved
in 17 patients (65.4%) by dermatological examination. In parents' questionnaire, eczema improved
in 16 patients (61.5%) and itch improved in 17 patients (65.4%) and dryness improved in 15
patients (57.7%). After 4 weeks, TEWL decreased slightly, but water content of the stratum
corneum was constant. Normally dietary linoleic acid is converted to gamma-linolenic acid by the
enzyme delta-6-desaturase. Subsequently, gamma-linolenic acid is converted to dihomogamma-
linolenic acid and arachidonic acid. In the patients with atopic dermatitis the level of gamma-
linolenic acid, dihonogammalinolenic acid, and arachidonic acid are decreased, whereas the level of
linoleic acid are higher than normal; this suggests defective activity of delta-6-desaturase. In this
study, we suggested that gamma-linolenic acid coated undershirts were useful for atopic dermatitis
along with the standard therapy.
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Effect of Botulinum Toxin Type A on Quality of Life Measures in Patients with
Excessive Axillary Sweating: A Randomized Controlled Trial
N. J. Lowe,* M. K. Naumann, and H. Hamm
Department of Neurology, University of Wurzburg, Wurzburg, Germany; *Dermatology, Cranley Clinic for
Dermatology, London, U.K.
The purpose of this multicenter, randomized, placebo-controlled study was to provide a
quantitative assessment of how treatment with BTX-A affects quality of life (QOL) in patients with
chronic axillary hyperhidrosis. Patients (n = 320) exhibiting persistent, bilateral, primary axillary
hyperhidrosis suf®cient to interfere with daily activities were randomly assigned to receive either
50 U BTX-A (BOTOX, Allergan, Inc.) or placebo in each axilla. QOL was assessed using the
Hyperhidrosis Impact Questionnaire (HIQ(c)) and the Medical Outcomes Trust SF-12 health
surveyoÃ (SF-12) at baseline and at 1, 4, 8, 12, and 16 weeks post-treatment. At baseline, participants
reported a marked negative impact of their hyperhidrosis on various measures, including state of
mind, emotional status, comfort in social situations, productivity at work, number of clothing
changes needed per day, and their ability to engage in sex or participate in athletic activities. After
treatment, signi®cantly greater improvements were observed in all these measures in the BTX-A
group than in the placebo group (p < 0.01). Patients treated with BTX-A also exhibited
signi®cantly greater improvement in the physical component summary score of the SF-12 at
16 weeks than did placebo-treated patients (p < 0.019). In conclusion, BTX-A treatment markedly
improves the qol of patients af¯icted with hyperhidrosis.
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In¯uence of Aircraft Cabin Environment on Skin Hydration in Healthy Women
I. Le Fur, F. Morizot, and E. Tschachler*
Skin Bioengineering, C.E.R.I.E.S, Neuilly Sur Seine, France; *Department of Dermatology, University of
Vienna, Vienna, Austria
Airline passengers often complain about sensations of skin and mucous membrane dryness and
discomfort due to the dry atmosphere in aircraft cabins. Despite the fact that very low humidity is
routinely encountered, no study of its effects on the skin has been reported in the cabin
environment. The aim of our study was to study the changes in skin hydration in healthy women
during long distance ¯ights. The study was performed on three healthy women having not applied
skin care products for at least 12 h. They traveled on east to west ¯ights lasting eight hours. The
inside air cabin temperature and relative humidity were registered at each measurement time point
with a thermohygrometer HM 34 (Vaisala Sensor Systems, Helsinki) and skin capacitance,
re¯ecting stratum corneum hydration, was assessed with a miniature Corneometer CM 825
(Courage and Khazaka electronic GmbH, Ko
È
ln) on the forehead, the cheek and the volar forearm
with three measurements on each site for each time point. Measurements were performed 30 min
after take-off (T0) and every two hours (T2, T4, T6). Results for skin capacitance were expressed
in percentages of variation compared to T0. Mean air cabin relative humidity decreased from
20.7 6 5.0% (mean 6 SEM) at T0±9.4 6 0.8% at T2 and remained between 5 and 10% until the
end of the study. The air cabin mean temperature of 24.4 6 1.1°C at T0 increased at T2 and T4
with a maximum of 29.5 6 0.6°C at T4. Skin capacitance showed signi®cant changes on the three
investigated areas, with higher variations for the cheek where it decreased by 34.2% (6 8.7) six
hours after the ®rst measurements, compared to the volar forearm and the forehead with variations
of 17.9% (6 7.2) and 7.2% (6 3.0), respectively, at the same measurement time point. Our results
demonstrate that variations in stratum corneum hydration occur rapidly during long distance
¯ights.
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Low Dose Bexarotene (Targretinq) Capsules and Phototherapy for Early Stage
Cutaneous T-Cell Lymphoma
J. Guitart, R. Tucker, and V. Stevens*
Dermatology, North-western University, Chicago, Illinois, U.S.A.; *Medical Research, Ligand
Pharmaceuticals, San Diego, California, U.S.A.
Targretinq (bexarotene) capsules are approved as a safe and effective treatment for CTCL. PUVA
therapy is also ef®cacious in treating this disorder. A multicenter study is evaluating the safety and
ef®cacy of combining bexarotene capsules and PUVA with the objective of maximizing patient
response. Patients with histopathologically con®rmed Stage IB±IIA CTCL were randomized to
receive 150 or 300 mg bexarotene (QD) and PUVA therapy (3x/ week) for 24 week. Patients
started bexarotene 1 week prior to initiating PUVA treatments. Monthly ef®cacy determinations
are based on a Physician's Global Assessment and percentage BSA involvement. Complete
responders receive con®rmatory biopsy. Serum lipids are prophylactically stabilized with lipid
lowering agents before bexarotene treatment and monitored monthly. Four patients with Stage IB-
IIA CTCL (M = 3, F = 1, Mean age = 60) have been enrolled. Two patients have been randomized
to each of the 2 dose regimens of bexarotene. These patients have received 6±18 week of
combination therapy and all patients have shown a complete (CCR) or partial clinical response
(PR) (2/4 CCR, 2/4 PR). The patients with CCR showed remission after 6±7 week of
combination therapy. One is randomized to receive 150 mg bexarotene QD and has received a
total of 65 J/cm
2
in 17 sessions over 6 week. The other is receiving 150 mg bexarotene QD, after a
dose reduction from 300 mg due to elevated triglycerides. This patient cleared of CTCL lesions
after receiving a total of 76 J/cm
2
in 17 sessions over 7 week. Mild elevations in triglycerides (up to
2.5 x ULN, Grade 1) were observed in all patients and were controlled by a reduction in
bexarotene dose or an increase in lipid-lowering drug. One patient had Grade 2 elevation of
triglycerides. No serious adverse events have been reported other than a single case of cholelithiasis.
Preliminary data suggests that safe and rapid clearing of early stage CTCL is attainable with this
combination therapy, with a substantial reduction in time to clearing and Joules required for
clearing.
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Video-Correlated In Vivo Real-Time Optical Coherence Tomography as Applied to
Mohs Micrographic Surgery
A. Peng, A. M. Rollins, K. D. Cooper, S. W. Jeon, V. Westphal, and L. J. Li
Dermatology, University Hospitals of Cleveland, U.S.A.; Case Western Reserve University, Cleveland,
Ohio, U.S.A.
Optical coherence tomography (OCT) was used to image, in vivo, normal skin and also basal cell
carcinoma (BCC) in the context of Mohs micrographic surgery (MMS). OCT is a noninvasive
imaging technique enabling microscopic sectioning of biological tissues. OCT can image up to
1.5 mm in depth into skin, but skin is a dif®cult medium for imaging due to its highly scattering
properties. Real-time image acquisition with a hand held probe greatly improves the ®nal image
and correlated video imaging allows for localization of the scanned images with reference to the
skin surface in an in vivo and ex vivo setting. This newly developed OCT system was used to
examine, in vivo, normal skin and basal cell carcinoma. Ex vivo skin samples were also imaged and
correlated to histological images with hematoxylin and eosin (H&E) staining. 5 patients
undergoing MMS had in vivo baseline imaging of the BCC and also imaging performed with each
subsequent Mohs surgical stage. The images were compared with the gold standard H&E frozen
sections. The in vivo OCT images correlate well with the H&E frozen sections with positive BCC
Mohs stage and can allow differentiation of tumor from normal tissue. This state of the art OCT
system can directly image the skin and discern nodular BCC from grossly uninvolved tissue
margins. It also has the advantages of recording the video images for later evaluation, contributing
great time-savings during Mohs surgery in delineating the surgical margins.
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Betamethasone Valerate Foam vs. Fluocinolone Acetonide Topical Oil in the Treatment
of Scalp Psoriasis: Quantitative Assessment of Patients' Preference and Ef®cacy
T. S. Housman, A. J. McMichael, B. G. Mellen,* A. E. Derrow, M. A. McCarty, and S. R.
Feldman
Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.;
*Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina,
U.S.A.
Delivering topical agents to patients with scalp psoriasis is a challenge because of hair acting as a
natural barrier. The vehicle chosen in this setting must achieve patient acceptance to assure
compliance with treatment. The primary objective was to compare psoriasis patients' preference
for the physical characteristics of two topical corticosteroid treatments formulated with foam vs. oil
vehicles. A secondary aim was to examine the ef®cacy of treatment. In this randomized, single-
blind trial of 25 patients with scalp psoriasis, each subject was randomized to crossover between 14-
days of 0.12% betamethasone valerate foam and 14 days of 0.01% ¯uocinolone acetonide topical
oil. T-tests were used to analyze results, when appropriate; otherwise, nonparametric tests were
used. For the primary outcome measure, a previously validated treatment preference measure was
used to assess subject preference for the two topical therapies. Other clinical ef®cacy measures
included assessing the signs of psoriasis (plaque thickness, scaling, erythema), pruritus, as well as the
global response to treatment (as judged by investigator and the subject). 24 subjects completed the
trial, and one was lost to follow-up. Mean treatment preference scores (6 SD) were 14.2 (6 6.5)
for foam and ± 2.1 (6 8.7) for oil after 2 weeks of therapy (p < 0.0001). After 2 weeks of therapy,
the sum of erythema, scaling, and plaque thickness was improved in both treatment groups
(p = 0.001 for foam; p = 0.0005 for oil; p = 0.4 for the difference between foam and oil). Patients
with scalp psoriasis prefer the use of foam vehicle compared to an oil. While in the clinical study
both agents achieved similar ef®cacy, in clinical practice better compliance with a preferred vehicle
may be important for ef®cacy.
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Prognostic Signi®cance of the High Molecular Weight-Melanoma Associated Antigen in
Sera of Patients with Melanoma
B. D. Wainwright, S. R. Reynolds, S. Ferrone,² R. L. Harris,* M. N. Harris,* D. F. Roses,* and
J. Bystryn
The Ronald O Perelman Department of Dermatology, NYU School of Medicine, New York, New York,
U.S.A.; *Department of Surgery, NYU School of Medicine, New York, New York, U.S.A.;
²Dermatology, Roswell Park Institute, Buffalo, New York, U.S.A.
Melanoma-associated antigens can be detected in the circulation of patients with melanoma.
Among them is the HMW-MAA whose levels may be elevated in pts with melanoma compared to
normal persons. This study was conducted to examine whether there is a correlation between the
presence of this antigen in the circulation of pts with melanoma and clinical outcome. We
measured serum levels of the HMW-MAA in 84 pts with resected AJCC stage IIb or IIIa
melanoma using a double-sandwich ELISA. The normal range was determined utilizing sera of 33
healthy individuals. The results of the assay were reproducible (mean intra-assay CV 10.5%) and
quantitative. Elevated levels of HMW-MAA were present in 33 (39%) of melanoma pts and in 7
(21%) of normal persons (p = 0.057). There was a correlation between presence of this antigen in
the circulation and poorer clinical outcome. By Kaplan-Meier analysis the median 75% recurrence-
free survival of the positive pts was shorter (10.4 month) than that of negative patients
(> 29 month). The difference was signi®cant (p = 0.02). These results suggest that measuring
HMW-MAA in serum of pts with melanoma may provide clinically useful information.
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Efalizumab (Anti-CD11a) is Safe and Effective in the Treatment of Psoriasis: Pooled
Results of the 12-Week First Treatment Period from 2 Phase III Trials
K. B. Gordon, C. Leonardi,* S. Tyring,² A. Gottlieb,³ P. Walicke,§ W. Dummer,§ and K. Papp¶
Dermatology, North-western University, Chicago, Illinois, U.S.A.; *Clinical Research, Radiant Research,
St. Louis, Missouri, U.S.A.; ²UTMB Center for Clinical Studies, University Texas Medical Branch,
Houston, Texas, U.S.A.; ³Clinical Research Center, UMDNJ, Robert Wood Johnson Medical School,
New Brunswick, New Jersey, U.S.A.; §Medical Affairs, Genentech, Inc., So. San Francisco, California,
U.S.A.; ¶Clinical Research, Probity Medical Research, Waterloo, Ontario, Canada
The ef®cacy and safety of efalizumab, a nonlymphocyte depleting humanized monoclonal IgG1
antibody that binds to CD11a, the a chain of lymphocyte function-associated antigen-1 (LFA-1),
was evaluated. Efalizumab, a targeted T-cell modulator, acts by inhibiting T-cell binding to
endothelium, traf®cking, and activation. Patients (pt) (n=1095) with moderate/severe plaque
psoriasis were randomized to treatment with 1.0 or 2.0 mg/kg/wk subcutaneous efalizumab or
placebo. After 12 weeks, 29.2% and 27.6% in the 1.0- and 2.0-mg/kg groups of efalizumab-treated
pt, resp., had =75% improvement in Psoriasis Area and Severity Index (PASI), the 18 ef®cacy
endpoint (3.4% of placebo, both studies). Signi®cant PASI improvement for both efalizumab doses
occurred as early as Day 14 (P´0.005). Efalizumab-treated pt demonstrated marked improvement
on 28 ef®cacy endpoints: Overall Lesion Severity (OLS) score of Minimal/Clear in 24.6% and
22.5% of pt in the 1.0- and 2.0-mg/kg groups, resp. (3.1%, placebo); Physician's Global Assessment
(PGA) score of Excellent/Clear, Z29% of efalizumab-treated pt (4.1%, placebo). Efalizumab-
treated pt reported improvement in Dermatology Life Quality Index (DLQI): mean 5.4 and 5.8 in
1.0- and 2.0-mg/kg groups, resp. (1.9, placebo). The most frequent adverse events (AE) were
headache, nausea, chills, nonspeci®c infection, pain, fever, asthenia. Acute AE (fever, chills, nausea
within 48 hrs of injection) occurred in 39.0% of all pt (efalizumab, 43.2%; placebo, 27.4%), were
most frequent after Dose 1, and decreased with subsequent doses. There was no evidence of T-cell
depletion or increased risk of end-organ toxicity, malignancy, or infection. Pooled data indicate
that efalizumab is effective and safe in the treatment of moderate/severe plaque psoriasis.
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Growth Failure in Severe Ichthyosis: A Major Cause is Attributable to Calories Lost
Through Evaporation Across Defective Skin Barrier
A. Fowler, J. Fluhr, A. Wong, M. Heyman, and M. Williams
Dermatology, UCSF, San Francisco, California, U.S.A.
Some infants and children with ichthyosis may have severe growth failure. Although its cause is not
known, it has been attributed to a hypercatabolic state. While epidermal hyperproliferation and
skin in¯ammation may constitute a caloric drain, heat lost through water evaporation from a
defective permeability barrier may also be important, as well as a primary or secondary enteropathy
with subsequent malabsorption and/or nutritional de®ciencies. This study intended to determine
the role of some of these factors in children with severe ichthyosis and growth failure. Four
children (F: 9 y,16 kg; M: 13.6 y, 24.2 kg; M: 10 y, 24.8 kg; M: 7.4 y, 20 kg) with ichthyosis
(Netherton syndrome:3; ichthyosis en confetti:1) and severe growth failure were studied. Nutrient
intake (2155*174.90 (SD) kcal/day; 104.3*17.63 kcal/kg/day) exceeded the RDA for age. A
complete blood and GI work-up revealed a few de®ciencies, including low levels of vitamins A &
D and iron, or esophageal re¯ux in a few, but did not reveal evidence of signi®cant GI
malabsorption to account for their growth failure. Transepidermal water loss (TEWL)
measurements determined at multiple body sites by Tewameter, and then normalized to total
body surface area, revealed a marked caloric drain from evaporative skin losses (631*269.8 kcal/
day), roughly 8 times that of a normal adult and about 29% of their energy intake. If water loss from
body sites varied by greater than 5%, we used the ``rule of 9s'' to determine total TEWL. Two of
the 4 children were grossly infected on admission and after oral antibiotic treatment, their baseline
water loss improved without a change in emollient routine. These results reveal signi®cant caloric
de®cits can result from cutaneous energy loss through heat of evaporation alone and are likely to be
a major contributor to cumulative caloric de®ciency and consequent growth failure in these
children. Further studies are indicated to determine whether appropriate nutrition support and/or
barrier repair strategies will be able to reverse these de®cits and normalize growth in these children.
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The Relationship of Rosacea Phenotype and Extrafacial Lesions
J.T. Bamford,*² B.A. Elliott,*² and I.V. Haller³
*Dermatology, SMDC, Duluth, Minnesota, U.S.A.; ²Medicine, University of Minnesota-Duluth Medical
School, Duluth, Minnesota, U.S.A.; ³Research and Medical Education, SMDC, Duluth, Minnesota,
U.S.A.
Our purpose was to study extrafacial signs of rosacea and relate their prevalence to rosacea
phenotype. Sixty-three subjects with active, currently untreated rosacea were evaluated for
extrafacial signs using the Walsgrave method (Henderson, CA Charles-Holmes, S, McSween, R,
Ilchyshyn, A. A system for Grading Roscaea Severity. BJ Derm, July 1995 supplement). The
subjects were then divided into two groups based on their frontal facial digital photograph. They
were placed in either the Papules/Pustules (PP) (N = 33) or the Erythema/Telangiectasia (ET)
(N = 30) based on the predominant sign observed. The association between facial rosacea
phenotype and signs of erythema, telangiectasia, papules, pustules, oedema, or scaling at each
extrafacial site (neck, ears, scalp, or trunk) was tested using Chi-square or Fisher's Exact Test, when
appropriate (p-values are 2-tailed). Only erythema on trunk (p < 0.001) and telangiectasia on the
neck (p < 0.035) showed a signi®cant increase with more signs in cases of ET phenotype. In our
study, these two extrafacial signs were associated with the ET phenotype of rosacea.
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Immunophenotype of Conjunctival and Caruncular Melanomas
S. Iwamoto, R. Burrows, J. Orcutt, R. E. Kalina, M. Boehm, M. A. Bothwell, and R. Schmidt
We sought to determine the immunophenotypic expression patterns of conjunctival and
caruncular melanomas. Four conjunctival melanomas and one caruncular melanoma were
immunolabeled with a panel of antibodies including S100, HMB45, tyrosinase, Melan-A,
Microphthalmia transcription factor (MiTF), and p75 neurotrophin receptor (p75NTR). The low
sample number re¯ects the rarity of these tumors. Results were analyzed by the intensity and
pervasiveness of the antibody labeling. All four specimens of conjunctival melanomas and the single
caruncular melanoma expressed high levels of S100, tyrosinase, Melan-A, HMB45 and MiTF.
P75NTR was expressed at minimal levels in both the conjunctival and the caruncular melanoma.
The pattern is similar to that found in cutaneous epithelioid melanomas, but differs from the
immunophenotypic patterns of cutaneous spindle melanomas and of uveal melanomas. This is the
®rst report of the immunophenotypic expression levels of tyrosinase, MiTF, and p75NTR in
conjunctival melanomas, and is the ®rst immunophenotypic characterization of a caruncular
melanoma.
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In the Treatment of Mild to Moderate Psoriasis, the Ef®cacy of Clobetasol Propionate
Foam, 0.05%, is Not Enhanced by the Addition of Zinc Pyrithione Spray, 0.25%
T. S. Housman,* B. G. Mellen, M. A. McCarty, A. B. Fleischer Jr, and S. R. Feldman
Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.;
*Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina,
U.S.A.
Discovery that a well-liked OTC psoriasis therapy, called Skin Cap, actually contained clobetasol
propionate (CP) in addition to zinc pyrithione (ZP), led the FDA to withdraw it from the market.
The purpose of this study was to compare the ef®cacy of CP foam, 0.05%, to foam plus topical
0.25% ZP spray in treating psoriasis. The design was randomized and double-blind, with subjects
having mild to moderate, symmetrical, plaque-type psoriasis. All subjects received CP foam for use
on all lesions; half were randomly assigned to ZP spray on the left, and half to the right side; vehicle
spray was assigned to the opposite side. Treatments were applied twice daily for 2 weeks. The
primary outcome measure was ef®cacy, evaluated as the change from baseline to week 2 in left and
right target-lesion score for erythema, scaling, and plaque thickness severity (0±4 scale). Other
outcomes included measurement of pruritus (100 mm visual analogue scale) and global assessment
(GA) of treatment response evaluated by both investigator and subject. 25 patients were enrolled;
24 completed the trial; one was lost to follow-up. 63% (15/24) were men, and mean and SD for
age were 50 6 12.2. After 2 weeks of therapy, the average decline in the composite score was 3.5
(6 1.8) for single therapy (CP foam and vehicle) and, similarly, 3.3 (6 1.8) for CP foam plus ZP
spray (p = 0.5). Pruritus scores were signi®cantly improved (p = 0.0002), and both investigator and
subject GA scores demonstrated signi®cant clearance as compared to a score of `3¢ representing
moderate/about 50% improvement (p = 0.0003, and p < 0.0001, respectively). In conclusion, zinc
pyrithione spray does not appear to enhance the ef®cacy of clobetasol propionate foam after
2 weeks of therapy. Treatment of psoriasis with CP foam, with or without the addition of ZP, is
well tolerated.
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Immunohistochemistry and Flow Cytometry of Psoriatic Skin Before and After Oral
Bexarotene Treatment
J. Smit, M. Franssen, E. de Jong, V. Stevens,* and P. van de Kerkhof
Dermatology, University Medical Center, Nijmegen, Netherlands; *Medical Research, Ligand
Pharmaceuticals Inc., San Diego, California, U.S.A.
Patients with moderate to severe psoriasis were treated with bexarotene, an RXR-selective
retinoid, at doses of 0.5, 1, 2, and 3 mg/kg/day for 12 week. Baseline and post-treatment
evaluations were made on 30 pts for severity of clinical signs and symptoms (mPASI),
immunohistochemistry (IHC) markers of the epidermis, and for ¯ow cytometry of epidermal cells
dispersed from biopsies. Lesion biopsies before and after 12 week of treatment were embedded in
paraf®n, sectioned and stained for IHC analysis for the following markers: Ki67 associated
proliferation, keratin 10, keratin 13, keratin 16, keratin 19, transglutaminase, dermal T-cells,
CD4+ and CD8+. Lesional epidermis was also analyzed by ¯ow cytometry using thermolysin split
skin dispersed into single epidermal cell suspensions for assessment of keratin 10 and keratin 6. The
overall response was a reduction in the mean PASI score of 28% from 16.3 to 11.8 (p < 0.001). A
dose±response trend was not observed. Analysis by IHC indicated that bexarotene decreased the
number of proliferating keratinocytes (p < 0.001) and hyperproliferation-associated keratin 16
expression (p < 0.01). Signi®cant improvements were observed in keratin 10 expression (p < 0.01),
transglutaminase (p = 0.01), dermal in®ltrate (p < 0.001), and CD4+ T-cells (p = 0.001). Retinoid
stimulated keratins 13 and 19 were not expressed. Flow cytometry demonstrated a signi®cant
increase of 43% in the keratin 10+ keratinocytes without a signi®cant change in either keratin
6 + keratinocytes or the number of epidermal cells in the SG2M-phase. Analysis of keratin 6 and 10
coexpressing cells indicated an increase of 77% of K10+K6- (p < 0.05) and a 33% decrease in K10-
K6+ cells (p < 0.01), but K10+K6+ cells were unchanged. The data suggest that bexarotene
treatment affects keratinocyte compartments to increase cells in normal keratinization at the
expense of proliferation-associated keratinization. IHC data also indicate a reduction in
proliferating keratinocytes and dermal CD4+ T-cells.
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Comparison of the Pharmacokinetics of In¯iximab in Patients with Psoriasis or Crohn's
Disease Not Receiving Concomitant Immunosuppressants or Corticosteroids
A.A. Fasanmade, C. Wagner, H. Davis, M. Graham, D. Everitt, and A. Gottlieb*
Clinical Pharmacology, Centocor, Inc, Malvern, Pennsylvania, U.S.A.; *Clinical Pharmacology, RWJ
Medical School, New Brunswick, New Jersey, U.S.A.
In¯iximab (IFX), a monoclonal antibody capable of neutralizing TNF-a, is approved for the
treatment of rheumatoid arthritis and Crohn's disease (CD), and has also been evaluated in a pilot
study for the treatment of plaque-type psoriasis. This report compares the pharmacokinetics (PK)
of IFX in patients with psoriasis or CD. In a double-blind, placebo-controlled trial, 33 patients
with plaque-type psoriasis not being treated with corticosteroids (CST) or immunomodulators
were administered placebo, 5 or 10 mg/kg of IFX intravenously at weeks 0, 2 and 6. ACCENT I
was a trial of 573 patients with active CD. In ACCCENT I, 133 patients not being treated with
CST or immunomodulators received 5 mg/kg of IFX at Weeks 0, 2 and 6. Pharmacokinetic
analyses were performed using the software WinNonlin (Pharsight, Inc). The median values (and
interquartile ranges [IQR]) of IFX PK parameters; maximum concentration (Cmax), volume of
distribution, clearance, mean residence time, and half-life were: 116 (95.3±136) ug/ml after the
®rst dose, 39.2 (36.6±55.0) ml/kg, 3.73 (3.07±5.43) ml/day/kg, 11.0 (9.55±14.6) days, and 7.62
(6.62±10.2) days, respectively, in the psoriasis patients. These values were 89.4 (78.0±108) ug/ml,
50.4 (38.1±58.0) ml/kg, 4.65 (1.57±13.1) ml/day/kg, 9.47 (7.05±18.9) days, and 6.56 (4.89±13.1)
days, respectively, for the CD patients that were on the same 5 mg/kg dosage regimen. The PK
parameters have similar IQR for both studies. The concentration (Cmin) 8 weeks after the last
induction dose (week 14 into the study) appears to be slightly different between the two studies
(0.671 [.012±4.11] for psoriasis and 2.53 [0.525±5.82] for CD patients); this might be due to the
small number of patients in the psoriatic study. The PK of IFX, based on the ®rst 14 weeks of
treatment, were similar for the CD and psoriasis patients studied. These results indicate that there is
a comparable exposure to IFX in both patient populations.
216
Tazarotene Effectively Removes ``Clogged Pores'' of the Photoaged Face
Y. Zhen, M. J. Stoudemayer, and A. M. Kligman
Research, S.K.I.N., Incorporated, Conshohocken, Pennsylvania, U.S.A.
Photodamaged facial skin often shows the presence of prominent dark, dilated follicular ori®ces,
especially on the cheeks. These are actually horn ®lled follicles or horny casts to open comedones,
representing an early stage of false comedones. Women call these ``clogged pores'' and regard them
as ugly cosmetic defects. These horny impactions are deeply embedded and dif®cult to remove
with a comedo extractor. Since topical retinoids are known to be comedolytic, we assessed the
capacity of Tazarotene, a new potent receptor speci®c retinoid, to eliminate clogged pores. 0.05%
Tazorac gel (Allergan) was applied to the face of 10 women showing many clogged pores twice
daily for 4 weeks. The usual signs of photoaging were present, namely, wrinkles and laxity.
Treatment was well tolerated, causing only moderate stinging and mild erythema in a few subjects,
resolving after the ®rst week. Weekly global assessments by a dermatologist showed marked
clearing of the horny impactions by the end of the fourth week. The elimination of ``clogged
pores'' was quanti®ed by the follicular biopsy technique using cyanoacrylate glue (Krazy Glue).
The results showed almost a 75% reduction in the density of horny casts per sq. cm. accompanied
by a marked reduction in the sizes of horny casts that were not completed removed.Using the same





. 3 mm punch biopsies of some larger casts were sectioned for histologic
study. These were typical of solar comedones containing a dense mass of horny material and the
presence of budding yeasts (P. ovale) in the upper portion and gram positive rods (P. acnes) below.
Luna and Hale stained specimens showed a marked degree of elastosis and a great increase in
GAG's, signs of extreme photodamage of the dermis surrounding the horn-®lled follicles. Post-
treatment biopsies showed nearly complete elimination of the horny material without any effect on
the degree of elastosis or GAG's. High-resolution photos con®rmed the nearly complete
elimination of dark, dilated follicles after Tazorac treatment.
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Clinical and Pathological Spectrum of Post-Transplant Lymphoproliferative Disorders
with Skin Involvement
S. Wee,* S. Horowitz,² S. Kohler,*³ and Y. H. Kim*
*Dermatology, Stanford University, Stanford, California, U.S.A.; ²Medical Oncology, Stanford University,
Stanford, California, U.S.A.; ²Pathology, Stanford University, Stanford, California, U.S.A.
Within the ®rst year after transplant, solid organ transplant recipients have an increased risk of
developing post-transplant lymphoproliferative disorders (PTLD). Skin involvement is rare.
Approximately 16 cases of PTLD with skin involvement have been reported, 5 of which were
limited to skin. We conducted a retrospective review of 4 patients with cutaneous manifestations of
PTLD to study their clinico-pathological features and therapeutic outcomes. Clinical features and
tissue biopsy con®rmed diagnoses. Median age was 54. Two patients were male, and 2 patients
were female. Two patients received renal allografts, and 2 others received combined cardiac-renal
or cardiac-lung transplants. All patients developed late-onset PTLD (> 1 years after transplant) with
mean time between organ allograft and tumor diagnosis of 5.9 years. The extent, number, and
anatomic location of skin lesions were variable, ranging from a localized patch to widespread
nodules. No patients showed systemic symptoms at time of PTLD diagnosis, and Karnofsky status
of all patients was > 80%. One patient had extracutaneous involvement of PTLD. Histopathologic
features ranged from plasmacytic hyperplasia to diffuse large cell lymphoma. In situ hybridization
detected EBV-genomic DNA in 3 out of 4 patients. Treatment consisted of reduction in
immunosuppression and adjuvent therapy including anti-CD20 monoclonal antibody therapy,
localized radiation therapy, or surgical resection. Clinical outcome in all patients was favorable.
With a median follow-up period of 11 months, 2 patients are alive and in remission, 1 patient is
alive with disease, and 1 patient is alive with unknown disease status. We conclude that PTLD with
skin involvement varies widely in clinical presentation. Pathology of most lesions were B-cell in
origin and EBV+. These patients show a prolonged time to diagnosis and may have more favorable
outcomes than cases of PTLD arising in other organ systems.
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Investigations on Cytokines/Growth Factors in Blister Fluids of Patients with
Hereditary Epidermolysis Bullosa
R. W. Hametner, A. Klausegger, J. W. Bauer, G. Pohla-Gubo, and H. Hintner
Department of Dermatology, General Hospital, Salzburg, Austria
In all three major groups of epidermolysis bullosa (EB) ± EB simplex-EBS, juntional EB-JEB,
dystrophic EB-DEB ± large melanocytic nevi may occur that clinically resemble malignant
melanoma. Histopathology of such -EB-nevi¢ which regularly exhibit the outlines of former
blisters may show free ¯oating melanocytes/nevus cells (or groups of) in the blister cavity. In order
to get more insight into the pathogenesis of EB nevi we evaluated the concentrations of various
cytokines and growth factors (known to stimulate melanocyte growth) in the blister ¯uid of 14 EB
patients (EBS, n = 7; JEB, n = 2; DEB, n = 5) and in control samples (¯uid from blisters of patients
with burns, Stephens Johnson syndrome ± SJS, bullous pemphigoid ± BP or a supernatant of a
keratinocyte culture ± KGM). ELISAs for human interleukin-8 (IL-8), human ®broblast growth
factor (FGF), human hepatocyte growth factor (HGF), human granulocyte macrophage colony
stimulating factor (GM-CSF), leucotriene B4 (LTB4) and prostaglandine E2 (PGE2) were used.
IL-8: 600 pg/ml to 2100 pg/ml (burn blister 1100 pg/ml). FGF: 2pg/ml - 11,5pg/ml (burn blister
3pg/ml, BP 0pg/ml). HGF: 5000pg/ml to 9100pg/ml (burn blister 5000pg/ml). GM-CSF: 10pg/
ml to 400pg/ml (BP 40pg/ml, SJS 2pg/ml, burn blister 4pg/ml, KGM 3pg/ml). LTB4: 100pg/ml
to 450pg/ml; in one EBJ-patient: 35.000pg/ml (SJS 200pg/ml, KGM 20pg/ml). PGE2: 1000pg/
ml to 4300pg/ml (SJS 400pg/ml, KGM 390pg/ml). The partly high concentrations of cytokines/
growth factors in the blister ¯uid of patients with EB were comparable to their content in
in¯ammatory blisters. These factors may promote the rapid proliferation of melanocytes/nevus
cells after they detached for the basement membrane (BM) (caused by an inherited defect of a
structural BM-protein) and ¯oated free in the blister cavity to form the typical large -blister
shaped'' EB nevi.
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Treatment of Photodamaged Skin with Bioengineered Growth Factors and
Antioxidants
G. Naughton, L. Rheins,* R. Harper,* and R. Fitzpatrick²
Executive, Advanced Tissue Sciences, La Jolla, California, U.S.A.; *Executive, DermTech International,
La Jolla, California, U.S.A.; ²Executive, DermTech International, La Jolla, California, U.S.A.;
³Executive, Skin Medica, La Jolla, California, U.S.A.
Double-blinded clinicals were conducted to assess the effects of topically applied growth factors
(gfs) and antioxidants (aos) on photodamaged skin. Formulations consisted of various
concentrations of NouriCel (1x,6.5x in oil, 10xgel), a by-product of neonatal ®broblasts grown
in three dimensions. NouriCel contains gfs, including TGF-B, VEGF, KGF, Il6 and IL8, and low
m.w. aos, including cysteine, superoxide dismutase, glutathione peroxidase and reductase. 29
female subjects (37±75 years of age) applied 1 3 test material and control 2x/day for 12 week.
Changes in skin were assessed at each visit with silicon replicas, and NOVA and Cutometer
measurements and at 0 and 12 week with photographs. At 12 week the treatment group showed an
overall 22% increase in skin moisturization, 12% increase in ®rmness (p = 0.0007), and a signi®cant
improvement in wrinkle smoothing from baseline. In 2 of 3 biopsies the treatment group showed
an increase in Ki-67 positive cells, a ®nding not seen with the control. Similar results were noted in
a test with 50 female patients (36±72 years of age) where 12 week of treatment with the 6.5x
formulation showed an increase in moisture content (p = 0.0003) and decrease in the ratio of
viscoelastic/elastic deformation from baseline to ®nal visit (p < 0.0001). No signi®cant difference
was seen in these parameters when comparing test article and control. A 200 patient 8 center trial is
underway to test the 10x concentration vs. placebo. Information on the ®rst 20 subjects has shown
a signi®cant increase in epidermal thickness (p = 0.047), Grenz zone collagen (p = 0.004) and
improvement in skin texture (p = 0.039, smoothness (p = 0.031) and decrease in wrinkle depth
(p = 0.033)as measured by optical pro®lometry. Silicon casts showed improvement in the depth
(p = 0.028) and length (p = 0.037) of wrinkles in treatment vs. control. All statistics utilized a 2-
sided t test. Data indicate that topical application of gfs and aos from ®broblast cultures can be
effective in reversing several photodamage-associated skin problems.
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Identi®cation of a Novel R223Q Missense Mutation in the Flavin-Containing
Monooxygenase 3 Gene in Trimethylaminuria
G. Preti,* R. Ubriani, J. Kim,* H. Lawley,* S. Tjoa,² P. Fennessey,² and S. S. Fakharzadeh
,
Dermatology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, U.S.A.; *Chemical
Senses Center, Monell, Philadelphia, Pennsylvania, U.S.A.; ²Pediatrics and Pharmacology, University of
Colorado Health Sciences Center, Denver, Colorado, U.S.A.
Trimethylaminuria (TMAU) is a metabolic disorder that results from de®ciency of the ¯avin-
containing monooxygenase 3 (FMO3) enzyme. This leads to an inability to metabolize
trimethylamine, which accumulates and may impart a strong smell. Affected individuals frequently
present to dermatologists complaining of skin malodor. An autosomal recessive inheritance pattern
has been observed and mutations in the FMO3 gene that reduce or ablate its product's function
have been identi®ed. Milder forms of the disease that result from mutation of one FMO3 allele or
even homozygosity for certain polymorphisms that may reduce FMO3 activity have been
described. Factors such as diet, gut ¯ora, and menstruation may in¯uence expression of milder
forms. We have performed mutation screenings on subjects that presented with malodor and
displayed reduced capacity to generate trimethylamine-N-oxide after choline challenge. Coding
exons 2±9 of the FMO3 gene were ampli®ed from genomic DNA and subjected to direct
sequencing. We have identi®ed a Japanese-American proband with severe disease who has a novel
R223Q alteration in exon 6. A `g' to `a' change at nucleotide 41 of exon 6 is responsible for this
amino acid substitution. The patient also carries a R492W mutation in exon 9 indicating that he is
a compound heterozygote. The arginine at position 223 in FMO3 is conserved across animal
species and among human FMO family members, suggesting that the R223Q mutation contributes
to reduced FMO3 activity in this individual. The nucleotide substitution removes a HPAII
restriction site from exon 6. Thus far, we have tested 44 control subjects, of which 17 are Japanese
or East Asian. All maintain the HPAII site, indicating that this alteration likely is not a
polymorphism. In sum, we have identi®ed a novel R223Q missense mutation in the FMO3 gene
in an individual with TMAU.
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Reduction of CD45RO+ Effector T Lymphocytes is Not Observed in the Treatment of
Psoriasis with Methotrexate
K. P. Callis, A. Chadha, A. Vaishnaw,* and G. G. Krueger
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; *Clinical Studies, Biogen, Cambridge,
Massachusetts, U.S.A.
The intent of this study is to determine if the treatment of psoriasis with methotrexate is associated
with a reduction in CD4+ and CD8+ CD45RO+ memory T effector lymphocytes. An open
study of 25 subjects with moderate-to-severe psoriasis was conducted. 16 men and 9 women were
treated with oral methotrexate over 24 weeks. Doses were initiated at 15 mg weekly and were
increased if clinically indicated to a maximum of 30 mg. Clinical response was measured utilizing
the Psoriasis Assessment Severity Index (PASI) and the National Psoriasis Foundation Psoriasis
Score (NPFPS). Lymphocyte subsets including CD4 and CD8 CD45RO+ T lymphocytes were
measured at baseline, 2, 4, 8, 12, 16, 20, and 24 weeks and correlation to PASI score performed.
CBC, hepatic and renal function were monitored throughout the study. At this time we have an
interim analysis of 19 of the 25 subjects. 15 of 25 subjects have completed 24 weeks of treatment, 1
cleared at 8 weeks, 1 nearly cleared at 16 weeks and discontinued treatment, and 2 discontinued at
5 and 9 weeks due to adverse events. The mean dose of methotrexate was 19.0 mg/week. The
mean baseline PASI and NPFPS were 14.1 (range 5.3±32.0) and 19.6 (range 13±25), and the mean
reduction of 24 weeks or study withdrawal in PASI and NPFPS were 49.5% and 50.0%. the
correlation coef®cient between PASI to the CD4+ and CD8+ CD45RO+ counts for the 10
patients who achieved greater than a 50% response in PASI was 0.23 and 0.46, compared to ±0.17
and 0.11 for the 9 subjects who achieved less than a 50% response. We are undertaking further
analyses to determine whether the correlation between changes in CD45RO+ subsets and PASI
reduction is speci®c, as for alefacept, or whether it is part of a more nonspeci®c action of
methotrexate on various lymphocyte subsets.
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Extracutaneous Lesions of Porphyria Cutanea Tarda
N. P. Kuznetsova, I. Afanasyeva, and A. Chaschin
Dermatology, Medical University, Irkutsk, Russia, Russian Federation
We examined 202 patients with porphyria cutanea tarda (PCT) who were treated during 20 years
in dermatological clinic. There were 89.11% men (48.8 6 0.64) and 10.89% (49.37 6 1.86)
women among our patients. Hepatomegaly was among all these patients with extracutaneous
lesions at ®rst then the functional hepar disturbances apeared and the outcome of two patients was
fatal from the cirrhosis of the liver. Decreasing or absence of corneal and conjunctival re¯exes,
hyposthesia of the face, hands and development of polyneurotic syndrome characterizes the
damage of the nervous system. At the last stage 11.1% of patients revealed scleroderma-like form.
These subjects had craniocerebral trauma in the past history. During ophthalmologic examinations
it was revelaed the steady dilatation of the conjunctival vessels and pinguicula formation. In acute
cases the phlyctenular keratitis was shown and after this the multiple cornea opacity was developed.
All these changes are asymptomatic and diagnosis can be made only during ophthalmologic
examination. These data permit to see PCT as polyorganiz or systemic diseases.
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The Ef®cacy of a Formulation (Acnomel) Containing Sulfur and Resorcinol for a
Treatment of Rosacea
M. Stoudemayer, T. Stoudemayer, and A. M. Kligman
Research, S.K.I.N., Incorporated, Conshohocken, Pennsylvania, U.S.A.
Preparations containing elemental sulfur have long been used for the treatment of rosacea.
Evidence of ef®cacy rests mainly upon empirical reports by experienced clinicians. Our object was
to use more objective quanti®able measurements to assess the bene®cial effects of treatments. We
selected Acnomel as a test agent since it contains two components which have been judged to be
helpful in the treatment of rosacea, namely sulfur and resorcinol. Ten adult women with long-
standing classical centro-facial rosacea were treated two times daily for three months with
Acnomel. Non-invasive measurements were used to assess ef®cacy. Papulo-pustules in the three
patients who presented with these lesions rapidly regressed, none were present after two months.
As regards overall global estimates, two were deemed to have achieved a good result, seven were
fair and one showed no improvement. Surface clarity and texture, especially in those who were
dry-scaly were notably improved in all subjects. The density of p.acnes was determined by the
detergent scrub method. The pretreatment count decreased 10-fold after treatment. Cyanoacrylate
follicular biopsies were taken to extract horny material from sebaceous follicles. The density of
horny casts per sq. cm substantially decreased after treatment. Horny casts are variably colonized by
Demodex folliculorum. Not unexpectedly, the Demodex count fell signi®cantly after treatment.
This uncontrolled pilot study shows that b.i.d. applications of Acnomel were bene®cial for the
treatment of rosacea, probably re¯ecting the capacity of the preparation to eliminate
microcomedones by the comedolytic effect of resorcinol and the anti-P.acnes effect of sulfur.
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Terbina®ne-Induced Subacute Cutaneous Lupus Erythematosus: Cytochrome P450 and
Tumor Necrosis Factor-´ in Disease Pathogenesis
K. Mehrany, L. Drage, and M. R. Pittelkow
Dermatology, Mayo Clinic/Foundation, Rochester, Minnesota, U.S.A.
A strong association exists between subacute cutaneous lupus erythematosus (SCLE) and the ±308
A polymorphism of the human tumor necrosis factor-´ (TNF-´) promoter. Induction or
exacerbation of SCLE and systemic lupus erythematosus by terbina®ne have recently been
reported. The P450 enzyme, CYP2D6 is a major target of inhibition by terbina®ne. We describe
two cases of SCLE associated with terbina®ne therapy and propose possible mechanisms mediating
this drug-induced eruption. Detailed medical histories and examinations were performed. Genetic,
serologic, histologic and follow-up ®ndings were also obtained. CYP2D6 function and toxic
metabolites regulated by terbina®ne and involved in development of drug-induced lupus
erythematosus were characterized. One patient with chronic polymorphous light eruption and a
second with long standing photosensitivity developed positive antinuclear antibodies (ANA) and
anti±Ro antibodies in association with histologic and clinical ®ndings documenting SCLE.
Genotyping demonstrated ±308 A locus heterozygosity (G/A) in each individual. The ±308 A
polymorphism enhances TNF?; expression. CYP2D6 inhibition by terbina®ne modi®es
metabolism of various endogenous substrates and xenobiotics. Patients with a known history of
photosensitivity, connective tissue disease or those with a genetic predisposition may be at
increased risk for terbina®ne-induced SCLE. CYP2D6 inhibition by terbina®ne may unmask
SCLE in predisposed individuals harboring the ±308 A polymorphism.
221
Bexarotene and T Cell Compartmentalization in CTCL
S. A. Bouwhuis, R. A. El-Azhary, M. T. McEvoy, L. E. Gibson, and M. R. Pittelkow
Dermatology, Mayo Clinic/Foundation, Rochester, Minnesota, U.S.A.
Bexarotene is a novel retinoid drug for the treatment of Cutaneous T-cell lymphoma (CTCL).
Effects of bexarotene alone or in combination with extracorporeal photopheresis (ECP) on T-cell
tissue localization are reported. Oral bexarotene 300 mg daily was added to monthly ECP
treatment for 8 patients with CTCL (7 Sezary syndrome (SS), 1 CD30+ large cell lymphoma
(ALCL)/mycosis fungoides (MF)/lymphomatoid papulosis). 5 patients (4 MF, 1 SS) received only
oral bexarotene 650 mg daily. Two patients developed lymphoma of solid organs (lung, liver)
despite skin improvement and a decrease in peripheral blood Sezary cell counts. Histology and
gene-rearrangement of the lung tumor were similar to the skin pathology. CT imaging of chest and
pelvis was negative prior to bexarotene initiation. One patient developed lymphoma involving
lymph nodes though the Sezary cell count decreased. A SS patient receiving bexarotene only was
noted to have cyclic tumor burden measured by skin symptoms and lymph node size that was
inversely related to peripheral Sezary cell counts. Two patients developed new skin tumors despite
decreases in Sezary cell counts. In this study group bexarotene is associated with the development
of internal organ lymphomas, increased involvement of lymph nodes or development of new skin
tumors in 5 of 8 patients treated with the combination of bexarotene and ECP. Tumors developed
within 1±9 months of initiation of therapy. These results suggest that bexarotene alters
compartmentalization of the malignant T-cells within skin, blood, lymph nodes and internal
organs in some patients with CTCL. Regular CT imaging and monitoring of patients treated with
bexarotene is recommended. Further studies to examine lymphocyte and malignant T-cell
traf®cking and sequestration in lymph nodes and other organs of CTCL patients treated with
bexarotene is warranted.
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Diabetic Neuropathic Foot Ulcer: Risk Factors for Not Healing
D.J. Margolis,*² O. Hofstad,² La. Taylor,² and J. Berlin²
*Dermatology and Biostatistics and Epidemiology, University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania, U.S.A.; ²Biostatistics and Epidemiology, University of Pennsylvania School of
Medicine, Philadelphia, Pennsylvania, U.S.A.
Lower extremity ulcers are a serious complication of diabetes mellitus. More than 16 million
people in the US have diabetes and 15% of them can expect to develop a foot ulcer at some point
in their life. The annual incidence of foot ulcers in community-based studies on individuals with
diabetes is between 2 and 3%, with a prevalence of 4±10%. The goal of this study was to evaluate
whether risk factors can be identi®ed that can be used to differentiate successfully between those
patients with a diabetic neuropathic foot ulcer who will heal and those patients who will not heal.
This was a cohort study using the Curative Health Services patient database. We evaluated 31 172
individuals who had a total of 71 937 diabetic neuropathic foot ulcers. All patients received
standard therapy consisting of moist wound dressing, wound debridement, and wound off loading.
We used both ®xed effects and random effects multivariable logistic regression models. We showed
that wounds were less likely to heal on men (OR = 1.09; 95% CI = 1.07, 1.10), as they increased in
size (log mm2) (OR = 1.33; CI = 1.32, 1.35), the older the wound (log months) (OR = 1.23;
CI = 1.21, 1.25), and higher the grade (exposed bone or tendon with infection or gangrene)
(OR = 2.08; CI = 2.00, 2.17). All p-values were less than 0.0001. These effects did not change if
the patient's care included an adjuvant therapy such as rhPDGF. We conclude that several risk
factors that are clinically accessible and part of the patient's original work-up can be used to help a
physician determine who is likely to heal by the 20th week of care.
226
Effects of Photographic Feedback on Treatment Satisfaction in Men with Androgenetic
Alopecia
R. L. Hornung, T. Rhodes,² S. Aasi,* M. Horn,* T. G. Rodgers,* D. P. West,* and C. J.
Girman²
Medicine and Pediatrics, University of Washington School of Medicine, Seattle, Washington, U.S.A.;
*Dermatology, North-western University Medical School, Chicago, Illinois, U.S.A.; ²Epidemiology, Merck
Research Laboratories, West Point, Pennsylvania, U.S.A.
This study investigated the effects of photographic feedback on patient treatment satisfaction in
men with androgenetic alopecia and the differences related to feedback using a Nikon vs. Polaroid
camera system. This was a usual care study of 106 adult men with androgenetic alopecia (baseline
Norwood-Hamilton hair loss pattern of II-v, III-v, IV, V). All subjects were treated with 1 mg
®nasteride daily for 12 months and randomized to one of two groups: (1) patients received
immediate photographic feedback and comparison to baseline hair loss at 6 and 12 months (2)
patients received no photographic feedback at 6 and 12 months. To measure treatment satisfaction,
patients completed the men's hair growth quality questionnaire (MHGQ) at 0, 6, and 12 months
prior to being photographed by both camera systems. Patients who were randomized to receive
photographic feedback also completed the MHGQ after receiving feedback. At the conclusion of
the study period, patients who were initially randomized to receive no photographic feedback
were then randomized to receive delayed Nikon photographic feedback or immediate Polaroid
photographic feedback, followed by completion of the MHGQ. Subjects who received
photographic feedback had statistically signi®cant increases in MHGQ scores in four areas (bald
spot getting smaller, growth of hair, satisfaction with frontal hairline, and satisfaction with top of
head) after comparing pre- and post-treatment photographs. No differences were observed
between Nikon and Polaroid camera systems. In conclusion, photographic feedback may have
positive implications for patient treatment satisfaction of androgenetic alopecia. In addition,
immediate photographic feedback may be more effective in increasing patient satisfaction levels.
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Increased Proportion of Lentigo Maligna and Lentigo Maligna Melanoma Subtypes in
the Veterans Affairs Palo Alto Health Care System and Stanford University Medical
Center
S. Swetter,* S. Jung,* J. Harvell,*² and B. Egbert*²
*Dermatology, Stanford University Medical Center/VA Palo Alto Health Care System, Palo Alto,
California, U.S.A.; ²Pathology, Stanford University Medical Center/VA Palo Alto Health Care System,
Palo Alto, California, U.S.A.
This study was designed to assess the incidence of melanoma subtypes observed in the Veterans
Affairs Palo Alto Health Care System (VAPAHCS) and Stanford University Medical Center
(SUMC) compared to worldwide melanoma data. A retrospective review of dermatopathology
records and tumor registry information at VAPAHCS (1990±2000) and SUMC (1995±2000) was
performed. Ninety-eight In situ and 61 invasive primary cutaneous melanomas were diagnosed at
VAPAHCS and classi®ed into histologic growth patterns as follows: 86/98 (88%) lentigo maligna,
11 (11%) super®cial spreading melanoma In situ, and 1 (1%) acral lentiginous melanoma In situ; 22/
61 (36%) (invasive) lentigo maligna melanoma, 22 (36%) super®cial spreading melanoma, 14 (23%)
nodular melanoma, and 3 (5%) acral lentiginous melanoma. Over 95% of melanomas at
VAPAHCS occurred in Caucasians (mean age 73), and 65% were located on sun exposed sites
(head, neck or arms). The Stanford melanoma population consisted of 1009 patients.
Intraepidermal melanoma subtypes included 270/420 (64%) lentigo maligna, 145 (35%) super®cial
spreading melanoma In situ, and 5 (1%) acral lentiginous melanoma In situ. Invasive melanomas
included 494/589 (84%) super®cial spreading melanoma, 55 (9%) lentigo maligna melanoma, 25
(4%) nodular melanoma, and 15 (2.5%) acral lentiginous melanoma. Worldwide, lentigo maligna
melanoma comprises 4±15% of cutaneous melanoma and occurs less commonly than super®cial
spreading or nodular subtypes. However, our data revealed a signi®cantly higher proportion of
lentigo maligna (melanoma In situ) at both institutions. Lentigo maligna melanoma was as prevalent
as invasive super®cial spreading melanoma in the Veterans Affairs population and more prevalent
than nodular melanoma at Stanford. This data may serve to direct site-speci®c physical examination
and screening for melanoma detection in similar demographic settings.
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Relationship Between Uveal and Cutaneous Malignant Melanomas in Persons with
Multiple Primary Tumors
A. R. Shors, S. Iwamoto, D. R. Doody,* and N. S. Weiss²
Medicine/Dermatology, University of Washington, Seattle, Washington, U.S.A.; *Biostatistics, Fred
Hutchinson Cancer Research Center, Seattle, Washington, U.S.A.; ²Epidemiology, University of
Washington School of Public Health, Seattle, Washington, U.S.A.
Uveal and cutaneous melanoma differ in tumor biology, immunophenotypes, and the
demographic correlates of their occurrence. As a means to examine the possibility of some shared
etiologic factors, we wished to learn if the two cancers occurred in the same individual more often
than would be expected by chance. Data from the Surveillance, Epidemiology, and End Results
(SEER) program from 1973 to 1998 were utilized for this purpose. The number of persons who
went on to develop a second melanoma was compared to that expected based on the incidence of
each type of melanoma in the general population, after adjusting for age, sex, calendar year, and
residence. Given an initial cutaneous melanoma, there was a 10-fold increased risk of developing a
second cutaneous melanoma (95% con®dence interval (95% CI) = 9.4±10.6). Persons with uveal
melanoma went on to develop cutaneous melanoma 4.8 times (95% CI = 2.9±6.8) more often than
the population at large. In contrast, persons with cutaneous melanoma were not subsequently
diagnosed with uveal melanoma at an appreciably elevated rate (observed/expected = 1.4, 95%
CI = 0.5±3.0). While these data offer some support for the hypothesis that uveal and cutaneous
melanoma have one or more etiologies in common, the lack of symmetry in the pattern of second
uveal and second cutaneous melanomas remains unexplained.
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The Proportion of Melanomas Diagnosed In Situ as a Function of Year of Birth
J. A. Lee
Public Health Sciences, Fred Hutchinson Cancer Reseaarch Center, Seattle, Washington, U.S.A.
It is well known that lifetime risks of invasive or fatal melanoma are determined by year of birth.
Rates for melanoma diagnosed In situ (not penetrating the dermis) are tightly linked to the rates for
invasive (coef®cients of In situ melanoma rates on log invasive are about 3, R squared > 0.9)
(Melanoma Research 2001,11,1±7). This appears to imply a simple link. The current study takes
this statistical relationship closer to a biologic interpretation by showing the in¯uence of cohort of
birth. Data were from the US SEER program of population based cancer registration. Standard
cross-sectional and cohort analyses were made. The birth cohorts 1915±65 were followed from
1975 to 1998. The incidence rates for invasive melanoma showed the expected decrease in cohort
difference with later year of birth. The rates for In situ melanoma showed large differences by birth
cohort, increasing regularly with each successive cohort. Thus the proportion of melanomas
diagnosed In situ showed large cohort effects, increasing with each quinquennium from 1915 to
1965. As exposure to sunlight in youth increases birth-cohort to birth-cohort, melanoma incidence
increases in consequence. If they are exposed at all, the most vulnerable develop melanomas
whenever born in the late twentieth century. The increments from cohort to cohort of the
increasing melanoma incidence are derived from people who are progressively more capable of
resisting the disease. The disease must change in presentation and prognosis with time. So probably
has the patient's phenotype and the history of exposure that they give.
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Atopic Dermatitis is Associated with Increased Numbers of Melanocytic Nevi in
Children at Age Three
R. P. Dellavalle,*³ D. L. Stegner,* A. M. Deas,² T. R. Pacheco,* S. Mokrohisky,§ J. G. Morelli,*
and L. A. Crane²
*Dermatology, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.; ²Preventive
Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.;
³Dermatology, Veterans Affairs Medical Center, Denver, Colorado, U.S.A.; §Pediatrics, Kaiser Permanente
of Colorado, Denver, Colorado, U.S.A.
Moles are commonly used as intermediate biomarkers for melanoma risk. Since Broberg and
Augustsson have recently reported that adults with severe atopic dermatitis have signi®cantly fewer
nevi than matched controls (mean 9, median 5 vs. mean 67, median 53 (p < 0.0001), we
investigated the relationship between melanocytic nevi and atopic dermatitis in children. Our study
employed a cohort of children born in a large Colorado Health Maintenance Organization in
1998. Mole counts were performed on 281 children during the summer of 2001. Eczema status
was determined by calling parents on the telephone in November and December 2001 and asking
whether the child was ever diagnosed with eczema or atopic dermatitis by a health care
professional. If so, the parents were asked to estimate the total number of months their child had
eczema. Twelve children were lost to follow-up prior to the determination of their eczema status.
Forty-four of the 269 children (16%) were reported to have eczema. Children reported to have
eczema had signi®cantly more moles (mean 7.55, median 7.5 vs. mean 5.61, median 5.0
(p = 0.005)). Subgroup analysis yielded similar statistically signi®cant increased mole numbers for
children reported with eczema for < 2 years, or > 2 years, as compared to children without eczema
(mean + sd = 7.5 + 3.8; 7.6 + 5.5; 5.7 + 3.7, respectively, p = 0.02, ANOVA). Hence, preliminary
analysis of this cohort study ®nds eczema associated with increased number of melanocytic nevi in
three-year-old-children, the opposite of the association reported in Broberg and Augustsson's case-
control study in adults. The potential role of atopic dermatitis or other cutaneous in¯ammatory
diseases modifying melanoma biomarkers and/or melanoma risk will be discussed.
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Investigating Attitudes in the Management of Atopic Dermatitis: A Survey Among
Dermatologists in Japan, the United States and the United Kingdom
E. Baron, D. Barzilai,* M. Kawashima,² M. Takigawa,³ H. Nakagawa,§ G. Johnston,¶ R.
Graham-Brown,¶ S. Green,* and S. Stevens
Dermatology, Case Western Reserve University, Cleveland, Ohio, U.S.A.; *Epidemiology and Biostatistics,
Case Western Reserve University, Cleveland, Ohio, U.S.A.; ²Dermatology, Tokyo Women's Medical
University, Tokyo, Japan; ³Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan;
§Dermatology, Jichi Medical School, Tochigi-Prefecture, Japan; ¶Dermatology, Leicester Royal In®rmary,
Leicester, U.K.
To compare attitudes and practices of dermatologists in Japan, US and UK regarding AD, we sent a
questionnaire focusing on utilization of speci®c therapies to all members of the American Academy
of Dermatology, British Association of Dermatology, and Japanese Dermatological Society.
Statistical analysis was performed via Chi-square, Mantel-Haenzsel, and Breslow heterogeneity
tests was performed. 3668 completed surveys were returned. Response rates were: Japan=49%,
US=14%, UK=48%. All 3 ranked proper skin care as the most important lifestyle factor. Use of
moisturizing agents was universal. US and UK were similar in prescribing systemic steroids (84%)
and antibiotics (98%), in contrast to 49% and 69%, in Japan. UK used systemic immunosuppressants
most (96%), followed by US (40%), then Japan (15%). All prescribed topical steroids but whereas
72% in US and UK use them on infants, only 38% in Japan do so. The level of comfort increased
with patient age but even for adult patients, only 73% in Japan, versus 92% in UK and 93% in US,
use them. Alternative therapy use was 27% in Japan, 14% in UK and 9% in US. This was
signi®cantly more common among those aged 45 and above in US and UK. There was a tendency
for younger Japanese dermatologists to use alternative therapy. Optimism for newer systemic
immunosuppressants was 45% in UK, 29% in US and 17% in Japan; and for topical
immunosuppressants: 81% in US, 75% in Japan and 59% in UK. In all 3, optimism for topical
immunosuppressants was signi®cantly more common among younger physicians. We conclude
that whereas, all dermatologists agreed on the need for good skin care practices, there was
heterogeneity in the use of speci®c therapies. These observations may re¯ect diversity in AD
patient populations or cultural differences.
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Is Melanoma Screening Cost-Effective? A Decision Analysis
F.C. Bedding®eld III
Division of Dermatology, UCLA, Los Angeles, California, U.S.A.; The Rand Graduate School of Policy
Analysis, The Rand Corporation, Santa Monica, California, U.S.A.
The purpose of this study was to estimate the cost-effectiveness of melanoma screening from the
available data on this subject. A decision analysis model was used to estimate the cost-effectiveness
of a melanoma screening program by dermatologists in 1998 in a self-selected, higher-than-
average-risk population by incorporating data from the American Academy of Dermatology
(AAD) screenings and SEER with estimates from the literature. The (AAD) screening results were
compared to the usual care (SEER) from the societal perspective and the results were reported as
cost per year-of-life-saved (YLS). A sensitivity analysis was performed to determine the in¯uence
of varying key estimates on the cost per YLS. The results showed that melanoma screening in this
setting costs $48 001.00 per YLS. If the additional induced costs of evaluating and treating
nonmelanoma skin cancers are included in the analysis, the cost increases to $61 081.00 per YLS,
but there would also be additional nonlife-saving bene®ts of early diagnosis and treatment of
nonmelanoma skin cancers. Patients with a melanoma detected by screening had a 5% greater
chance of survival and on average an additional 0.55 more life years than patients with melanomas
detected without screening. Screening resulted in an expected bene®t of 7.76 lives not lost to
melanoma, per 100 000 patients. The cost-effectiveness ratio varied linearly with the cost of the
providing the initial screen itself, and was a major determinant of the cost-effectiveness ratio. The
cost-effectiveness of melanoma screening calculated in this decision analysis falls within the range of
other currently funded cancer screening programs. A trial of melanoma screening with prospective
data collection on cost effectiveness should be considered.
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Effect of Lipid-Lowering Drugs on the Development of Melanoma
M. E. Ming,* R. M. Levy,* M. S. Lehrer,* O. J. Hoffstad,² P. A. Gimotty,² and D. J. Margolis*²
*Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.;
²Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania,
U.S.A.
Recently, two clinical trials investigating the effects of lovastatin and gem®brozil on cardiovascular
events demonstrated a decreased incidence of melanoma in subjects taking the medication
compared to those taking placebo, raising the possibility that lipid-lowering agents may have a
chemopreventive effect. We performed a nested case-control study to estimate the association
between lipid-lowering agents and melanoma through use of the General Practice Research
Database, which contains information compiled on 2.7 million patients seen in the United
Kingdom from 1987 to 2000. Our cases were 5199 patients over 55-year-old-who had been
assigned the diagnosis of melanoma, while our control group was 1262 patients over 55-year-old-
who had been assigned the diagnosis of nevus. We evaluated whether these patients had been given
prescriptions for lipid-lowering agents (speci®cally HMG-CoA reductase inhibitors [`statins'] or
®bric acid derivatives), beta-blockers, calcium-channel blockers, and diuretics. Odds ratios (OR)
and 95% con®dence intervals (CI) were estimated using univariate and multivariate logistic
regression. We found that the odds of having been prescribed a lipid-lowering agent were
signi®cantly lower in patients who had had a melanoma as compared to those who had been
assigned the diagnosis of a nevus (OR = 0.72; 95% CI: 0.53, 0.98). A similar relationship was found
when evaluating statins alone (OR = 0.66; 95% CI: 0.48, 0.93), but not for ®bric acid derivatives
(OR = 1.11; 95% CI: 0.62, 1.98). In contrast, the OR for beta-blockers and calcium-channel
blockers were not signi®cant (OR = 1.02 and 1.14, respectively). The OR for diuretics was 1.24
(95% CI: 1.09, 1.42), but after controlling for age, the resulting adjusted OR for diuretics was not
signi®cant (OR = 0.96; 95% CI: 0.84, 1.10). Our ®ndings may provide additional evidence that
lipid-lowering agents, and statins in particular, may be useful chemopreventive agents for inhibiting
the development of melanoma.
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Potential Impact of Multidisciplinary Melanoma Clinic to Reduce Mortality by
Increasing the Rate of Optimal Excision Margins
D. A. Barzilai*² and M. E. Singer*
*Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, U.S.A.; ²Skin
Diseases Research Center, Case Western Reserve University, Cleveland, Ohio, U.S.A.
We estimated the potential impact of Multidisciplinary Melanoma Clinic (MDMC) to reduce rates
of inadequate excision margins in the treatment of localized invasive melanoma for a hypothetical
cohort of 55 years old Caucasians, newly diagnosed in the community setting with localized
invasive melanoma. A Markov decision analytic model was created to follow patients from
diagnosis of invasive melanoma until death under two scenarios: usual care, and MDMC to
improve rates of optimal excision margins. Markov states included local recurrence, no local
recurrence, cured, and dead. Published population-based data was used for rates of optimal excision
margins, local recurrence and mortality. Two outcome measures were employed: melanoma-
related mortality and life expectancy. Major assumptions included: (1) local recurrence only occurs
within ten years of diagnosis, and (2) patients revert to general population mortality rates 10 years
following melanoma excision or subsequent local recurrence. For usual care, the model estimated
8.17% melanoma-related mortality. Modeling MDMC with 100% optimal excision margins
reduced this rate to 6.15% Ð a 25% decrease in mortality Ð resulting in an increase in life
expectancy of 0.437 years in our 55 year-old reference group. Increasing the percentage of optimal
excision margins to merely 80% would still yield substantial improvement, with a 6.83%
melanoma-related mortality rate, which would save .29 life-years compared to baseline. Results
were not sensitive to moderate changes in the parameter values. These ®ndings suggest that
suboptimal excision margins may account for approximately one fourth of all melanoma-related
mortality for localized invasive melanoma. If MDMC can achieve even modest (80%) adherence to
optimal excision margins, it could yield a substantial reduction in mortality.
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Employment Opportunities Experienced by Recent Dermatology Training Program
Graduates
A. B. Kimball, C. R. Lorenzo, H. Kruger,² S. S. Loevy,* and B. Lowery²
Dermatology, Stanford University, Stanford, California, U.S.A.; *The, Loevy Consulting Group, Chicago,
Illinois, U.S.A.; ²Workforce Taskforce, American Academy of Dermatology, Schaumburg, Illinois, U.S.A.
Despite decades of concern about a pending oversupply of U.S. dermatologists, new evidence
suggests that a shortage may be developing. The purpose of this study was to assess employment
opportunities of recent dermatology residency and fellowship training program graduates as a
measure of workforce supply and demand and to develop data for future comparisons. An
anonymous survey was distributed to dermatologists taking a board exam review course in 1999
and 2000. We obtained responses from 223/273 (82%) in 1999 and 204/267 (76%) in 2000
representing 63% of the total 295 US. training program graduates in 1999 and 53% in 2000. The
rest of the participants were mostly fellows (15 and 20% of the respondents, respectively). Slightly
over 50% of the respondents were women in both years. In 1999, 91% of respondents had more
than one job offer, and 50% had more than four offers. In 2000, 81% of respondents had more than
one job offer, and 37% had more than four offers. On average, each dermatologist had more than
six job offers in 1999 and four job offers in 2000. In both years over 75% were satis®ed with their
current jobs, around 10% were neutral and about 10% were dissatis®ed. Only 9.8% and 6.9%
reported trouble ®nding a preferred position in 1999 and 2000, respectively. In 1999, 36% and
worked in private dermatology groups and 10% in academia. 42% were in private groups and 14%
in academia in 2000. 8% were in solo practice both years. Average debt was $83 693 in 1999 and
$77 947 in 2000. Interestingly, those with no debt had higher levels of job dissatisfaction (15% and
12%, respectively) than those with debt. The factors considered most important in job selection for
both years, in order of importance, were location, autonomy, hours, and income. Despite the
importance of location, there were no speci®c geographic areas with limited job opportunities.
Unlike some other specialists, recent dermatology residency and fellowship graduates currently face
excellent employment opportunities.
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Mohs Surgery vs. Standard Excision: A Cost Comparison Analysis
T. L. Bialy, J. Whalen,* D. Lafreniere,² J. Spiro,² and S. C. Chen
Dermatology, Emory University, Atlanta, Georgia, U.S.A.; *Dermatology, University of Connecticut,
Farmington, Connecticut, U.S.A.; ²Otolaryngology, University of Connecticut, Farmington, Connecticut,
U.S.A.
Nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell
carcinoma (SCC), is the most common cancer in the United States, resulting in more than 800 000
cases per year, 65% of which affect facial sites, thus having functional and cosmetic signi®cance.
Two ef®cacious treatments for facial NMSC are standard surgical excision and Mohs surgery.
Because the cost of these procedures is signi®cant and the incidence of NMSC is high,
determination of the most cost-effective treatment is essential for health policy design. The purpose
of this study is to determine which treatment modality, Mohs surgery or standard excision,
provides the best outcome in terms of tissue preservation, residual tumor burden, and total cost. In
a prospective study, 94 consecutive patients referred for Mohs surgery for facial NMSC were
evaluated by an otolaryngologist for surgical excision size, frozen or permanent pathology, site of
surgical procedure, and reconstruction. A Mohs surgeon performed the surgery and a comparison
was made for the relevant outcomes. Costs were determined by the 2000 RBRVS of Medicare
reimbursements. There was no signi®cant difference between Mohs and standard excision in terms
of tissue preservation, mean area (mm
2
6 SD) 250 6 272 vs. 215 6 204.7 or total cost $838 6 $255
vs. $798 6 $543, respectively. However, of the 63 surgical excision cases that were sent for
permanent sections, 19 (30%) demonstrated residual tumor, and of the 31 cases sent for frozen
section, 13 (42%) showed residual tumor in the ®rst analysis; (p < 0.001) for both. Given that the
standard of care to remove residual tumor in permanent section cases is with Mohs surgery, the
additional procedural cost would increase the total cost for each case of standard excision by $169,
making standard excision $130 more expensive than Mohs surgery (p = 0.014). There is a
signi®cant bene®t to the use of Mohs surgery compared to standard excision in terms of
minimizing residual tumor burden and cost outcome for facial NMSC.
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Effect of Antibiotics on the Oro-Pharyngeal Flora of Individuals with Acne
R. M. Levy,* E. Y. Huang,* D. Roling,* J. J. Leyden,* and D. J. Margolis*²
*Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.;
²Department of Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
Antibiotics have revolutionized the practice of medicine but injudicious use has resulted in
alterations in microbial colonization and resistance. Streptococcus pyogenes and Staphylococcus
aureus are pathologic bacteria not normally found in the human oro-pharynx. The purpose of this
cross-sectional study was to examine the point prevalence of colonization and resistance of these
two organisms in the oro-pharynx of a convenience sample of individuals with acne who were on
antibiotics and those who were not. Using established techniques, organisms were cultured and
tetracycline antibiotic resistance was determined. Relative risks with 95% con®dence intervals
were estimated using 2 3 2 tables and Mantel-Haenszel techniques. We evaluated 105 individuals
with an average age of 24.6 of which 68.5% were females; 41 were using an oral or topical
antibiotic and 64 were not. S. pyogenes was cultured from the oro-pharynx of 10.9% of those not
on antibiotics and 31.6% of those on antibiotics (RR = 2.88 [1.24, 6.70], p = 0.01). The relative
risk was similar when examining those only on oral and those only on topical antibiotics. Among
women, S. pyogenes was cultured from 9.43% of those not on oral antibiotics and 33.3% of those
on oral antibiotics (RR = 3.53 [1.22, 10.2], p = 0.02). No signi®cant difference was found among
men. S. aureus was cultured from the oro-pharynx of 28.6% of those not on antibiotics and 22.5%
of those on antibiotics (RR = 0.78 [0.39, 1.58], p = 0.49). Topical benzoyl peroxide and topical
retinoid use was not associated with any difference in bacterial colonization. 83.3% of S. pyogenes
cultures were resistant to tetracycline in those on antibiotics compared to 33.3% in those not on
antibiotics (p = 0.03). Our ®ndings indicate that oral and topical antibiotic use in acne patients is
associated with increased colonization and resistance of S. pyogenes in the oro-pharynx. Future
studies with larger sample sizes are needed to determine the clinical and long-term signi®cance of
these ®ndings in patients and their close contacts.
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Prognostic Factors and Survival in Familial Melanoma
S. Leachman,*² J. Astle,² K. Boucher,²³ R. Kerber,²³ G. Mineau,²³ C. Wiggins,²³ and A.
Tsodikov²³
*Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah, U.S.A.; ²Huntsman
Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, U.S.A.; ³Oncological
Sciences, University of Utah Health Sciences Center, Salt Lake City, Utah, U.S.A.
Familial melanoma patients are reported to be younger at the time of diagnosis, and to present with
thinner lesions. However, published studies on this topic have typically relied on patient reports of
familial melanoma occurrence. The Utah Population Database (UPDB) overcomes problems
associated with self-reporting. UPDB contains 6 million genealogical records from the Church of
Jesus Christ of Latter Day Saints (Mormon Church) that have been linked with Utah Cancer
Registry pathology records. UPDB therefore facilitates identi®cation of familial melanoma cases. A
mathematical formula called the familial standardized incidence ratio (FSIR) has been developed
that assesses the likelihood that a given cancer is familial. An FSIR score has been assigned to 3291
UPDB-linked melanoma cases. Cases with an FSIR score greater than 1 (the top 8th percentile)
were assigned a `familial' status and the remaining 92% were considered `nonfamilial.' Multivariate
logistic regression analysis found no association between age, sex, Breslow's depth, or Clark's level
and the familial status. A survival analysis of these data were also performed with respect to
Breslow's depth categories of 0±1 mm, > 1±2 mm, > 2±4 mm or > 4 mm. Only tumors with
Breslow's depth > 4 mm showed a signi®cant effect of familial status on overall survival. The
similarities in prognosis and survival between familial and nonfamilial melanoma suggest that
melanomas occuring in the context of an underlying inherited susceptibility do not have a
signi®cantly different biologic behavior, unless > 4 mm in depth.
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Non-Melanoma Skin Cancer: An Episode of Care Management Approach
T. S. Housman, P. M. Williford, S. R. Feldman, H. V. Teuschler,* A. B. Fleischer Jr, N. D.
Goldman,² R. Balkrishnan,* and G. J. Chen*
Bristol-Myers Squib Center for Dermatology Research, Dermatology, Wake Forest University School of
Medicine, Winston-Salem, North Carolina, U.S.A.; *Public Health Sciences, Wake Forest University
School of Medicine, Winston-Salem, North Carolina, U.S.A.; ²Otolaryngology, Wake Forest University
School of Medicine, Winston-Salem, North Carolina, U.S.A.
The incidence of nonmelanoma skin cancers (NMSC) is estimated at 1.3 million cases for the year
2000 and is on the rise. It is the most common form of cancer in the U.S., more common than all
other cancers combined. To determine the contributors to the cost of NMSC care, an episode of
care of NMSC needs to be de®ned. To de®ne and validate an episode of NMSC care. Using
survey and Medicare Part A & Part B claims data of the Medicare Current Bene®ciary Survey
(MCBS), 1992±95, an algorithm was created to de®ne an episode of care for the diagnosis and
treatment of a NMSC. MCBS estimates of the number of episodes occurring in three service
settings (physician's of®ce, outpatient/ambulatory surgical center, or hospital) and demographics
were compared to data from independent datasets, including the National Ambulatory Medical
Care Survey (NAMCS, 1995), the National Survey of Ambulatory Surgery (NSAS, 1994±96), and
the National Hospital Discharge Survey (NHDS, 1992±97). Pathology claims for NMSC diagnosis
served as the indicator of NMSC episodes. The procedures, of®ce visits, and tests that resulted in
and from the pathology specimen were identi®ed. The sum of the associated charges to Medicare
or Medicare payments for all identi®ed claims equals the total cost of the episode of NMSC care.
This study de®nes and validates a model of an episode of NMSC care. Use of this model will allow
identi®cation of factors that determine the cost of NMSC treatment and are associated with higher
cost of care.
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Recurrent Nonmelanoma Skin Cancers: Variation in Performance Rates of Therapies
M. Chren,*² A. Sahay,³ L. Sands,³ L. Maddock,* and K. Lindquist³
*Dermatology, San Francisco Veterans Affairs Medical Center, San Francisco, California, U.S.A.;
²Dermatology, University of California at San Francisco, San Francisco, California, U.S.A.; ³Medicine,
University of California at San Francisco, San Francisco, California, U.S.A.
The criteria physicians use to choose therapies for nonmelanoma skin cancer (NMSC) are not
clear. We have shown that wide variation exists in different practice settings in the treatment of
nonrecurrent NMSC. For recurrent tumors, Mohs micrographic surgery is recommended by some
as ®rst-line therapy. To learn if variation exists in the treatment of recurrent tumors, we studied all
patients seen over 2 years who were newly diagnosed with recurrent NMSC at a Veterans Affairs
Medical Center (VA) and its af®liated departmental private practice (PRIVATE). All treatment
modalities were available at both sites. Overall, 190 patients (mean age 66 years, 75% male) were
diagnosed with 210 recurrent NMSCs [72% basal cell carcinomas (BCC), 28% squamous cell
carcinomas (SCC)]. Compared with patients in the PRIVATE setting, the 81 VA patients (43%)
were older (70 vs. 64 years, p < 0.01), less educated (percent with more than high school
education, 38% vs. 75%, p < 0.01), poorer (percent with annual income less than $30 000 90% vs.
22%, p < 0.01), and had more comorbid illnesses (modi®ed Charlson index 2.9 vs. 1.6, p < 0.01).
Tumors of VA patients were similar to those of PRIVATE patients, however, in size and location
on the body. Treatments varied widely (p < 0.01) between the VA and PRIVATE sites. The
proportions of tumors treated in the VA and PRIVATE sites were 9% and 10%, respectively, for
electrodessication and curettage; 64% and 15%, respectively, for excisional surgery; and 26% and
64%, respectively, for Mohs surgery. In multivariable analyses controlling for patient age, gender,
and comorbidity, and tumor type, size, and location on the body, tumors treated in the PRIVATE
site were signi®cantly more likely to be treated with Mohs surgery (OR 7.4 [2.4±22.5],
p = 0.0001). We conclude that wide variation exists in the treatment of recurrent NMSC in
different practice settings. This variation cannot be explained by clinical characteristics of the
patients or tumors.
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Imaging-Centered Intervention For Enhancing Skin Self-Examination For the Early
Detection of Melanoma
M. A. Weinstock,*² F. Q. Nguyen,*² and R. A. Martin³
*Dermatoepidemiology Unit, V A Medical Center, Providence, Rhode Island, U.S.A.; ²Department of
Dermatology, Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island,
U.S.A.; ³Center for Alcohol and Addiction Studies, Brown University School of Medicine, Providence,
Rhode Island, U.S.A.
Prior research has documented that a key impediment to early detection of melanoma is the
infrequency and inconsistency of skin examination. We sought to evaluate, in a high risk
population, the impact of a mole-mapping program centered on skin imaging in enhancing
participant performance of thorough skin self-examination. Sixty-four randomly selected enrollees
completed a brief telephone interview (7% refused) with study personnel not connected to the
mole-mapping program. Impact of the program was assessed by (retrospective) self-report.
Participants were generally satis®ed and found the program useful and effective; 97% would
recommend it. All had retained the images at the time of interview, 1±34 months (mean
14.3 months) after receiving the images. Almost half (45%) of those who were not performing
thorough skin self-examination before participation reported performing it after receiving their
images; none of those already performing this practice ceased to do so (p < 0.0001). After
participation, a partner such as a spouse (77%) or friend (12%) was more commonly assisting in
these examinations (39% before vs. 67% after). We also noted a correlation between sun protection
and performance of self-examination, and differences among different de®nitions of thorough skin
self-examination. Key limitations of inference from these data include the selected nature of the
study population and the reliance on retrospective self-reports. Also, the imaging was combined
with other components of the intervention. We nevertheless infer that interventions centered
around imaging have the potential to substantially enhance and encourage the performance of
thorough skin self-examination for the early detection of melanoma, and we encourage their
further evaluation.
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Predicting Pressure Ulcers at Home
J.M. Gelfand,*² D.J. Margolis,*² J. Knauss,² and W. Bilker²
*Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; ²Center for Clinical
Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
In the current health care environment sick patients are increasingly more likely to be cared for at
home. While many tools exist to predict the occurrence of pressure ulcers in acute care and
chronic care facilities, no tools currently exist for predicting pressure ulcers in the elderly
ambulatory care population. We used a 10% random sample of elderly patients (individuals > 65 -
years of age, N = 70 461) from the General Practice Research Database, a patient-record database
from the UK. As predictors, we evaluated several medical conditions that were noted in a patient's
medical record during at least one of®ce visit prior to the onset of a pressure ulcer. A very well-
calibrated and highly discriminatory complex logistic regression model was created (Brier
score = 0.01 and area ROC = 0.78, respectively). Age, gender and the following medical
conditions were contained in this model: angina congestive heart failure, stroke, dementia,
diabetes, limb edema, Parkinson's disease, anemia, malignancy, rheumatoid arthritis, malnutrition,
history of hip fracture, and beta-blocker use. Further, a simple well-calibrated count model with
good discrimination was established (Brier = 0.01, area ROC = 0.72), assigning points for
increasing age (categorized by 5- year groups), and a physician diagnosis of dementia,
Parkinson's disease, malignancy, malnutrition, rheumatoid arthritis, and history of hip fracture.
Since elderly patients are being more frequently cared for at home, we feel that it is important to
institute therapies to prevent pressure ulcers at home. The simple count model that we describe can
be used in ambulatory practice to help guide the use of these therapies in the home care
environment.
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Evaluation of Risk Factors for Malignant Melanoma in 210 Marathon Runners
C. M. Rudolph, M. Fu
È
rstner, E. Richtig, R. Hofmann-Wellenhof, and H. Kerl
Department of Dermatology, Karl-Franzens-University School of Medicine, Graz, Austria
Between 1987 and 2001, we observed 7 marathon runners (m:f, 6 : 1; age range, 35±56 y; median
50y) among our patients with MM. Immunosupression due to long-term intensive exercise or to
accumulated sun exposure were discussed as trigger. To assess possible risk factors for MM in
marathon runners, we conducted a screening campaign using a representative control group. In
summer 2001, 210 participants of the Graz marathon (marathon group = MG; m:f, 166 : 44; age
range, 9±71 y; median 37y) and 220 visitors of a recreation center in Graz (control group = CG;
m:f, 83 : 137; age range, 2±80 y; median 28y) were examined for skin cancer and clinical risk
factors (> 50 nevi, > 10 atypical nevi, numerous solar lentigines). In addition, data were collected
on anamnestic (changes in skin lesions, history of skin cancer), phenotypic (blonde/red hair, blue/
grey/green eyes, ephelides, high sun sensitivity/skin type I or II), and sun-related (> 10 sunburns,
at least 1 sunburn with blisters) risk factors using a standardized questionnaire. Results of both
groups were statistically correlated by the Chi square test. Signi®cant differences were as follows:
Phenotypically, the CG exhibited a higher sun sensitivity [CG 156/220 (70.9%), MG 104/210
(49.5%)] and lighter eye colour [CG 166/220 (75.5%), MG 118/210 (56.2%)]. Clinically, more
atypical nevi [MG 13/210 (6.2%), CG 4/220 (1.8%)] and more solar lentigines [MG 64/210
(30.5%), CG 23/220 (10.5%)] were found in the MG. MG individuals also reported more
sunburns [MG 82/210 (39%), CG 38/220 (17.3%)]. In the MG 19 individuals were referred for
surgical excision of lesions suggestive of skin cancer or precursor lesions compared to 2 CG
individuals. Compared to the CG, the MG presented with more atypical nevi, more UV-induced
skin lesions and a history of more sunburns. This accumulation of risk factors may put marathon
runners at a higher risk to develop skin cancer in general and MM in particular.
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Prevalence of Tanning Bed Usage and the Associated Behavioral Patterns
C. Vest, W. Ting, and R. Sontheimer
Dermatology, University of Iowa Hospitals & Clinics, Iowa City, Iowa, U.S.A.
The objective of this study is to characterize the prevalence and associated behavioral pattern of
tanning bed usage in the general population. 433 anonymous written surveys were collected during
a two-day general public skin cancer screening sponsored by the University of Iowa Hospitals and
Clinics in May 2001. Prevalence of tanning bed use is inversely proportional to age among the
women surveyed. Of the 74 women surveyed that were 34 years or younger, 52 had utilized
tanning beds in the past (70.3% prevalence). Bimodal distribution was observed in the men
surveyed. Of these men, the prevalence of tanning bed use peaked in the 23 years-old and younger
age group and also in the 45±49 years-old age group, with prevalence of 25% and 33%,
respectively. Of the admitted tanning bed users, 17% have had greater that 50 tanning bed
exposures. Among the tanning bed users, 40% indicated that they spent, on average, 15 min or
greater during each tanning bed session, and 30% of the users patronized a tanning bed at least once
every other month. Furthermore, 65 out of the 158 tanning bed users (41%), reported to have
never or only occasionally been informed, by the tanning bed facility operators, about the possible
risk of developing sunburn with the use of a tanning bed. Of the 158 tanning bed users, 12% have
either never or only occasionally had protective eye goggles made available to them during tanning
bed exposure. We conclude that there is an alarmingly high prevalence of tanning bed exposure
among young women in this surveyed cohort. This study con®rms inadequate safety measures to
protect users from the deleterious effects of tanning bed exposure. Further studies are needed to
bolster public health efforts to educate the public regarding the danger of tanning bed exposures.
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Use of the Self-Administered Eczema Area and Severity Index by Parent Caregivers:
Results of a Validation Study
T. S. Housman, M. J. Patel, F. Camacho,* S. R. Feldman, A. B. Fleischer Jr, and R. Balkrishnan*
Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.;
*Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina,
U.S.A.
The Eczema Area and Severity Index (EASI) is used by dermatologic investigators world wide to
assess eczema disease severity. EASI measures are however, time-consuming and require trained
personnel, thereby limiting its application to large-scale epidemiologic studies. Additionally, the
use of self-assessed severity indices in dermatology is restricted to adult subjects and conditions,
thereby not addressing the needs of pediatric patients. Our purpose was to develop and validate an
instrument for a caregiver's self-assessment of the severity of his/her child's atopic dermatitis (AD),
the Self-Assessment Eczema Area and Severity Index (SA-EASI). Trained investigators performed a
modi®ed EASI assessment on the same day a SA-EASI was obtained from 47 caregivers of children
with AD. Results: The SA-EASI is a valid measure of the severity of AD. Total, acute, and chronic
SA-EASI scores predict total, acute, and chronic modi®ed EASI scores (p<0.0001). SA-EASI body
surface area (BSA) scores predict EASI BSA scores (p<0.0001). SA-EASI pruritus scores correlate
with the acute, chronic and total EASI scores (p=0.0001). The SA-EASI may provide caregivers
the means to objectively report the severity of their child's skin disease. The high correlation with
the EASI score observed in this sample does imply that statistical inferences with the SA-EASI will
be valid for large populations. In future studies, this will permit analysis of the relationship of skin
disease severity to such measures as quality of life, disability, patient satisfaction, and the costs of
various therapies. Moreover, this SA-EASI instrument may allow older patients, over 12 years old,
to assess the severity of their AD.
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Skin Cancer is Among the Most Costly of All Cancers to Treat for the Medicare
Population
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Bristol-Myers Squibb Center for Dermatology Research, Dermatology, Wake Forest University School of
Medicine, Winston-Salem, North Carolina, U.S.A.; *Otolaryngology, Wake Forest University School of
Medicine, Winston-Salem, North Carolina, U.S.A.; ²Internal Medicine-Section on Hematology/Oncology,
Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.; ³Public Health
Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.
Compared with other malignancies, nonmelanoma skin cancer (NMSC) is associated with much
less morbidity or mortality. NMSC is, however, far more common than other malignancies. The
cost of managing NMSC has not been assessed. The purpose is to determine where the cost of
NMSC management ranks among other cancers in the Medicare population. Representative
Medicare Part A and Part B claims data were obtained from the Medicare Current Bene®ciary
Survey 1992±95 (MCBS). Claims associated with cancer costs were identi®ed using the
International Classi®cation of Diseases, 9th Revision, Clinical Modi®cation (ICD-9-CM) codes.
Weights were applied to obtain nationally representative estimates. Average Medicare expenditure
on cancer management was $13 billion per year. The ®ve most costly cancers to Medicare were
lung & bronchus, prostate, colon & rectum, breast, and NMSC. The mean annual cost per
Medicare patient for all cancers was $17 094. Malignancies of lung & bronchus, colon & rectum,
breast, and prostate were 11±19 times more costly per affected patient as NMSC. In addition to
classifying cancers by number of cases and number of deaths, the ®nancial impact of treatment can
also be used to prioritize different malignancies. Such a scheme ranks NMSC far higher than would
death statistics. In light of its already high and rising incidence, the cost of NMSC care to Medicare
is likely to increase. However, to maintain the cost-effective management of NMSC, it is essential
to preserve the current low per patient cost of its management.
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Mortality Rates by Melanoma and Ultraviolet Radiation
P.R. Figueroa
Dermatology, World Dermatology Institute, Santiago, Chile; School of Public Health, University of Chile,
Santiago, Chile
The purpose of the study is to assess if there is any impact in the mortality rates by malignant
melanoma according to the level of ultraviolet radiation. Mortality rates in Chile by malignant
melanoma were calculated per geographic distribution. Two extreme regions were chosen
(extreme North and extreme South) and the Metropolitan Region (Center of the country).
Measurements of Ultra Violet radiation periodically assessed by an of®cial institution were
compared between the three regions and a correlation was done with the mortality rate by
malignant melanoma. The region with most ultraviolet radiation, in the northern part of the
country as well in the center of the country, showed a lower mortality rate by melanoma (0.8 per
100 000 vs. 1.3 per 100 000). This discrepancy may be in part to genetic factors. In the Northern
region there is a higher percentage of population with darker skin types than in the Southern and
central part of Chile. In addition, we were comparing current levels of ultraviolet radiation. This
study may point out the importance of assessing longer trends of ultraviolet radiation and the
inclusion of genetic markers of predisposition to melanoma.
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Ethnic Differences in the Utilization of Dermatologic Health Care: A Pilot Study
A. M. Cheng and H. W. Lim
Dermatology, Henry Ford Health System, Detroit, Michigan, U.S.A.
This pilot study evaluates differences in dermatologic health care utilization between African-
Americans and Caucasians in a predominantly open-access, HMO-payer environment. A
retrospective chart review was performed for all visits from 4/1/2001 to 4/7/2001 at a general
dermatology hospital-based clinic and two of®ce-based satellite clinics. Of all visits, 502 charts
(95%) were available for review. African-Americans accounted for 221 visits, Caucasians made 251
visits, and other ethnic groups made 30 visits. Acne, verruca, and cutaneous fungal infections were
common to both ethnic groups, and this is consistent with prior studies. However, psoriasis,
reported to have a Caucasian predominance, was also seen comparably in African Americans (4% in
both groups). The top diagnosis for African-Americans was dermatitis (all types; 48%); for
Caucasians, dermatitis was the second most common diagnosis (22%). The top diagnosis for
Caucasians was benign neoplasm (all types; 41%) as opposed to 15% for their African-American
counterparts. In African-Americans, alopecia/hair and pigmentary complaints were present in 8%
and 14% of visits, respectively, as opposed to only 2% and 5% in Caucasians. Cutaneous malignancy
was present in 10% of Caucasian visits and 1% of African-Americans. The differing rates of
cutaneous malignancy may partly explain the ®nding that procedures were performed in 42% of
Caucasian visits compared to 17% of African-American visits. A larger study based on this pilot data
would be warranted to help determine if, given an equal access environment, certain dermatologic
conditions would have a higher prevalence in African-Americans than previously reported. Health
utilization data can also provide a picture on what different ethnic groups value in dermatologic
health care, and how we can better provide those services.
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Central Role for a7 Nicotinic Acetylcholine Receptor in Terminal Differentiation of
Keratinocytes
J. Arredondo, V. Nguyen, A. Chernyavsky, A. Orr-Urtreger,* D. Bercovich,* D. E. Vetter,² A.
L. Beaudet,* and S. A. Grando
Dermatology, University of California, Davis, California, U.S.A.; *Molecular and Human Genetics, Baylor
College of Medicine, Houston, Texas, U.S.A.; ²Neuroscience, Tufts University, Boston, Massachusetts,
U.S.A.
Several nicotinic acetylcholine receptor (nAChR) types are abundantly expressed in non-neuronal
locations but their functions remain unknown. We found that keratinocyte a7 nAChR controls
homeostasis and terminal differentiation of epidermal keratinocytes required for formation of the
skin barrier. In the present study, the effects of functional inactivation of a7 nAChR on
keratinocyte cell cycle, differentiation and apoptosis were studied in cell monolayers treated with
abungarotoxin or antisense oligonucleotides and in the skin of Acra7 homozygous mice lacking a7
nAChR. Elimination of the a7 pathway of autocrine and paracrine control of keratinocytes with
ACh blocked both nicotine-induced in¯ux of radioactive calcium, and also inhibited terminal
differentiation of these cells at the transcriptional and/or translational level. On the other hand,
inhibition of the a7 nAChR pathway favored cell-cycle progression. Lack of a7 was associated
with up-regulated expression of the a3 containing nAChR channels that lack a5 subunit, and both
homomeric a9- and heteromeric a9a10-made nAChR channels. The shifts in the repertoire of
keratinocyte nAChRs suggested that engagement of alternative nicotinergic pathways coupled to
maintenance of the immature cell phenotype led to reciprocal changes in cell cycle regulation,
including proliferation-inducing effects and antiapoptotic gene activation in a7 knockout mice.
Thus, the obtained results indicate that ACh signaling through a7 nAChR channels controls late
stages of keratinocyte development in the epidermis by regulating expression of the cell cycle
progression, apoptosis and terminal differentiation genes, and that these effects are mediated, at least
in part, by alterations in cell calcium metabolism.
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Uptake and Traf®cking of Naked Plasmid DNA in Human Keratinocytes
E. Basner-Tschakarjan, A. Mirmohammadsadegh, J. Maschke, and U. R. Hengge
Department of Dermatology, Venerology and Allergology, University of Essen, Essen, Germany
The skin is an interesting organ for human gene therapy due to its easy accessibility, immunologic
potential and synthesis capabilities. Therefore, it is important to understand the uptake and
transport mechanisms of DNA in keratinocytes with the goal to optimize therapeutic approaches in
skin gene therapy. In previous work we have shown that naked plasmid DNA is taken up and
expressed by human keratinocytes upon in vivo intradermal injection. Yet, the mechanism by
which plasmids surmount the cell membrane and enter keratinocytes as well as their intracellular
traf®cking still remain unknown. We measured uptake of FITC-labeled plasmid by FACS analysis
after 24 h incubation detecting 5±10% internalization in a dose- and time-dependent manner.
Furthermore, we demonstrate that cycloheximide treatment inhibited uptake by > 90%, suggesting
a protein-mediated uptake. Next, we attempted to inhibit selected alternative internalization
pathways such as macropinocytosis, clathrin-coated pits and caveolae. Most prominently, blocking
macropinocytosis reduced the uptake by > 85%. Finally, colocalization studies by confocal laser
microscopy revealed a time-dependent accumulation of plasmid DNA in endosomes (FITC-
dextran) and lysosomes (LysoTracker Green). To detect potential DNA receptors on the
keratinocyte surface, two DNA-binding proteins, ezrin and moesin, were identi®ed in 2-D South-
Western blots and MALDI-mass spectrometry using linearized calf thymus and phage DNA.
Although these actin-membrane linker proteins are localized intracellularly, they are functionally
associated with a number of transmembrane receptors such as the EGF- or ICAM-1-receptor.
Taken together, naked plasmid DNA seems to enter human keratinocytes through different
pathways. Compared with linear calf thymus DNA, plasmid DNA seems to be less abundant in
endosomes and lysosomes, making it particularly suitable for skin gene therapy.
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Keratinocyte Differentiation Imparts Resistance to UVB-Irradiation and Ceramide-
Induced Cell Death
Y. Uchida,* M. Behne,* A. DiNardo,* P. M. Elias,* and W. M. Holleran*²
*Dermatology, UCSF & V.A. Medical Center, San Francisco, California, U.S.A.; ²Pharmaceutical
Chemistry, UCSF, San Francisco, California, U.S.A.
Multiple pathways are involved in UV-induced keratinocyte apoptosis, many of which are
associated with caspase activation. We previously reported that induction of de novo Cer synthesis
also is involved in UVB-induced apoptosis of cultured normal human keratinocytes (CHK), and
that this Cer-dependent apoptotic pathway is independent from classical caspase-dependent
mechanism(s). Since sphingolipid synthesis, including de novo Cer synthesis, is up-regulated by
keratinocyte differentiation, we investigated here whether sensitivity to UVB-induced apoptosis
varies with CHK differentiation. CHK, maintained in either 0.03 mM Ca
2+
(undifferentiated
CHK) or 1.2 mM Ca
2+
(differentiated CHK), were irradiated with UVB (60 mJ/cm
2
). Cell
viability, assessed by MTT assay, remained unchanged in differentiated CHK, but decreased 27.5%
in undifferentiated CHK 27 h after irradiation. In addition, differentiated CHK were more resistant
than undifferentiated CHK to the cytotoxic effects of UVB; i.e. LDH increased 27.3% vs. 12.9% in
undifferentiated vs. differentiated CHK, respectively (p < 0.01). Cer synthesis, assessed by [3H]-
palmitate incorporation, was signi®cantly elevated in undifferentiated CHK over that in
differentiated CHK in response to UVB; i.e. 3.7-fold vs. 1.7-fold over sham irradiated controls,
respectively. Finally, differentiated CHK were signi®cantly more resistant than their undiffer-
entiated counterparts to direct Cer-induced cell death; i.e. addition of both exogenous Cer and
PDMP, an inhibitor of GlcCer synthase. These results reveal that differentiated CHK are less
susceptible to UVB-induced cell death, an effect correlated with diminished Cer accumulation/
sensitivity. Thus, differentiated human keratinocytes appear to have a mechanism(s) to maintain/
control Cer levels, and to protect against the Cer-mediated cell death induced by UVB irradiation.
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Tobacco Aging: The Relation Between Smoking and Skin Aging is Different Among
Men and Women
J. Bouwes Bavinck and K. Kennedy
Dermatology, Leiden University Medical Center, Leiden, NL, Netherlands
Smoking and ultraviolet radiation are known to have an aging effect on human skin. Elastosis and
telangiectasia are characteristics of skin aging. The purpose of the study was to assess the relative
importance of intrinsic aging, tobacco aging and photo-aging on the development of elastosis and
telangiectasia in a well-de®ned group. We made use of a cohort of 966 individuals who
participated in a study to investigate environmental and genetic risk factors for skin cancer.
Exposure measurements for sunlight and smoking were collected and the degree of elastosis and
telangiectasia in the face and neck was recorded according to a four-graded score varying from
none to severe. Relative risks were estimated using exposure odds ratios from cross tabulation and
logistic regression. Multivariate logistic regression was used to adjust for potential confounders. A
strong association was observed between increasing age and severity of elastosis and telangiectasia.
Both smoking and sun exposure were also associated with elastosis and telangiectasia. Smoking,
however, was much stronger associated with elastosis among men, with an odds ratio adjusted for
age, skin type, and sun exposure of 3.15 (1.61; 6.16) compared with the adjusted odds ratio among
women of 1.55 (0.83; 2.88). Duration of smoking and number of cigarettes smoked were
signi®cantly associated with elastosis. Smoking was also associated with telangiectasia among men,
with an adjusted odds ratio of 2.53 (1.25; 5.13). No such association was apparent among women
with an adjusted odds ratio of 0.69 (0.38; 1.22). Tobacco aging was more prominent among men
than women. Intrinsic differences between men and women (e.g. hormones) or behavior
differences (e.g. more frequent use of creams and cosmetics among women) could account for this
apparent difference.
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Stratum Corneum Acidi®cation in Neonates: Impact on Permeability Barrier
Homeostasis and Integrity/Cohesion
J. W. Fluhr,* A. J. Fowler,* J. Hachem,* D. Crumrine,* P. M. Elias,* and K. R. Feingold*²
*Dermatology, VAMC and University of California, San Francisco, California, U.S.A.; ²Medicine,
VAMC and University of California, San Francisco, California, U.S.A.
Mammalian newborn stratum corneum (SC) displays a near-neutral surface pH, which declines
during the early postnatal period to adult levels. We developed a model to study the mechanisms
and consequences of SC acidi®cation in the neonatal period. In newborn rats the surface pH,
measured with a ¯at glass electrode (pH-Meter, Courage & Khazaka) declined from an almost
neutral pH (6.8) after birth to physiologic levels (5.6) over 5 days. The SC acidi®cation was not
related to bacterial colonization. Enzyme activity of secretory phospholipase A2 (sPLA2), measured
with a ¯uorometric assay, increased over 5 days after birth by 66%. Moreover, inhibition of sPLA2
resulted in a delay of the acid mantle formation. Under basal conditions the permeability barrier of
newborn rats is competent. However, barrier repair after acute barrier disruption (acetone or tape
stripping) is delayed on day 1 compared to day 5. Electron microscopy revealed abnormal lipid
processing leading to abnormal bilayer formation during barrier repair on day 1. Beta-
glucocerebrosidase activity, as assessed by In situ zymography, was decreased which could account
for the lipid processing abnormality. Furthermore, SC integrity/cohesion was altered at birth. The
abnormality in SC integrity (number of tape strippings required to achieve barrier disruption) and
SC cohesion (mg protein removed/stripping) was associated with a reduced density of
corneodesmosomes and decreased desmoglein 1 in the SC. These results indicate that sPLA2
plays an important role in the neonatal formation of the acid mantle. The near neutral pH at birth
adversely impacts permeability barrier homeostasis and SC integrity/cohesion, which could
increase the susceptibility of newborn skin to environmental insults.
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N-Methyl-D-Aspartate Receptor Expression is Regulated by Calcium in Human
Keratinocytes
V. Morhenn, C. Brandt, and R. L. Gallo
Medicine/Dermatology, UCSD, San Diego, California, U.S.A.
In the skin, calcium regulates the growth and differentiation of keratinocytes (KC). Recently, the
N-methyl-D-aspartate (NMDA) receptor has been found on cultured KC. NMDA controls entry
of calcium into neurons and therefore may play a role in KC differentiation. To explore this, we
asked where in human skin this receptor is expressed and if its expression on KC is regulated by
calcium. Normal and diseased skin was stained for NMDA receptor using immunohistochemistry.
In normal skin, the stratum corneum, basal cell layer the stratum granulosum were stained. By
contrast, in psoriasis, weak staining of the basal cell layer and weak staining of the granular cell layer
were found. In lichen planus, prominent staining of the granular cell layer was seen. To determine
if calcium regulates the expression of the NMDA-R1 in KC, normal human KC were grown
overnight with 0.02 mM calcium on coverslips then changed in some cultures to 1.8 mM calcium.
After 3 d the cells were washed with PBS, ®xed with 100% methanol and stained with an antibody
against NMDA-R1. KC grown in low calcium medium demonstrated no staining. However,
select subpopulations of cells in 1.8 mM calcium expressed NMDA-R1 at the surface. Treatment
with 0.1 mM MK-801, a noncompetitive antagonist of the NMDA receptor, inhibited expression
of NMDA-R1. We conclude that the NMDA receptor is expressed in normal human skin and to a
lesser extent in psoriasis and lichen planus, and that the expression of this receptor by KC is
regulated by calcuim.
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SV40 Immortalized Human Sebocytes Express Peroxisome Proliferator Activated
Receptors and Respond to Adipogenic Stimuli
D. Thiboutot, K. Gilliland, A. Sivarajah, and Z. Cong
Dermatology, Penn State University, Hershey, Pennsylvania, U.S.A.
The study of the factors regulating sebum production and hence the development of acne has been
limited by the availability of a model system. The establishment of SV40 large T antigen transfected
human sebocytes has led to tremendous progress in this regard (Zouboulis et al). Although SV40
transfection promotes cellular proliferation it simultaneously impairs differentiation through
binding to Retinoblastoma proteins. Sebum production is a marker for terminal differentiation of
sebocytes. The goal of this study was to determine the effects of adipogenic stimuli on the
differentiation of a newly development immortalized human sebocyte cell line (SEB-1). Secondary
human sebocytes from a 55-year-old-male were transfected with a plasmid containing SV40 large
T antigen. Colonies were selected following clonal dilution. Transfection was con®rmed with an
antibody to SV40 large T antigen and by continued passage in culture. SEB-1 cells have been
subcultured greater than 84 times. They express cytokeratins 4,13,7, androgen receptor, OM-
1(sebaceous gland antigen), type 1 5a-reductase and predominantly PPARs b and g. When treated
with adipogenic stimuli including isobutyrlmethylxanthine, dexamethasone and insulin, an
increase in uptake of 14C-oleate and incorporation of 14C-acetate into sebaceous lipids is noted.
Further examination of the factors regulating the differentiation of human sebocytes may lead to
the identi®cation of novel therapeutic target sites in the treatment of acne.
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Reviewing the Structure of the Stratum Corneum: Corneocytes Embrace Each Other
R. Wepf, T. Richter,* K. Dunckelmann, M. Sattler, S. Biel, U. Hintze, and K. Wittern
Analytical Microscopy, R & D cosmed Beiersdorf AG, Hamburg, HH, Germany; *Department of Applied
Physics, University of Hamburg, Hamburg, HH, Germany
In the `brick and mortar' model the penetration barrier of the skin is generally associated with
lateral variations of lamellar lipid arrangements within the `mortar' phase. This model reduces the
skin barrier mainly to a lipid barrier in a protein environment and explains the enormously reduced
water exchange rates by a prolonged penetration pathway through the different lamellar lipid
phases. However, this model does not explain the strong cohesive resistance of the 5±10 mm thick
outermost layer of the human body against mechanical stress. Improvements in structure
preservation combined with cryo-processing of human skin biopsies for TEM and Cryo-SEM have
revealed a much more complex structural organization of the stratum corneum (SC) and hence of
the penetration pathway. The corneocytes are densely packed, showing an average overlap with
their neighbors of up to 15%. In addition, extra interdigitating `corneocyte-cell-extensions' are
found on the apical side, forming a special rim around the entire corneocyte surface. This `hook-
like' rim reinforces the lateral stability of the entire SC. Desmosomal structures were found to be
much better preserved after cryo-processing, exposing the typical `5-layer like' morphology
throughout the whole SC. CLSM, Cryo-SEM and AFM measurements have proven that the SC
and even single corneocytes can swell up to 60±100% in thickness but less than 8% in laterally
dimension upon treatment with different salt solutions. This combination of static and dynamic
®ndings makes it necessary to rethink the skin barrier and consider different potential penetration
pathways as well as new structure-based mechanical features of corneocyte packing in the SC. In
addition, the hook-like structure may help us understand the enhanced skin ¯akiness found even in
conditions where cohesion through corneodesmosomes is known to be reduced enzymatically.
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Integrin-Linked Kinase is the Key Regulator of Early Phase Keratinocyte Differentiation
in Collaboration with PI3 Kinase
K. Sayama, K. Yamasaki, Y. Shirakata, S. Dedhar,* and K.Hashimoto
Dermatology, Ehime University School of Medicine, Shigenobucho, Ehime, Japan; *Biochemistry, University
of British Columbia, Vancouver, British Columbia, Canada
Intracellular signaling mechanisms of keratinocyte differentiation are not fully understood.
Previously, we showed that phosphatidyl inositol (PI) 3 kinase regulates early phase keratinocyte
differentiation. The dominant negative form of PI3 kinase initiates keratinocyte differentiation, and
the active form of PI3 kinase prevents differentiation. This indicates that signals of keratinocyte
adhesion to the basement membrane determine the initiation of differentiation. Integrin-linked
kinase (ILK) binds to the cytoplasmic domain of b-integrin and regulates cell adhesion to the
extracellular matrix and its downstream signal transduction. Since, signal transduction via integrins
through ILK is PI3 kinase-dependent, we hypothesized that ILK is involved in the mechanisms
regulating differentiation in collaboration with PI3 kinase. Using a ribonuclease protection assay,
we analyzed suspension cultures using poly HEMA-coated dishes, which disrupt cell adhesion to
the extracellular matrix, inducing keratinocyte differentiation, which results in the expression of
differentiation markers such as involucrin, loricrin, K1, and K10. Transfection of wild-type ILK
into keratinocytes using adenoviral vector at an MOI of 10 almost completely abolished the
induction of K1 and K10 mRNA, early phase differentiation markers. This indicates that ILK
prevents early phase differentiation. Furthermore, cotransfection of the the wild type ILK with the
dominant negative form of PI3 kinase induced differentiation, indicating that ILK function is
dependent on PI3 kinase activity. Since Akt is an ILK target molecule, it is possible that Akt is
involved in ILK-PI3 kinase-regulated differentiation as a downstream signal. However,
transfection of the constitutively active or the dominant negative forms of Akt using adenovirus
vectors had no effect on the expression of K1 and K10 mRNA. This is the ®rst report that ILK is
the key regulator of early phase keratinocyte differentiation in collaboration with PI3 kinase.
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An Increase in Severe Atopic Dermatitis Patients Due to Protein Oxidative Damage in
the Stratum Corneum Induced by Environmental Pollution
Y. Niwa
Dermatology, Niwa Institute for Immunology, Tosashimizu, Japan
We have reported a recent change in the features of atopic dermatitis (AD) in Japan, with a marked
increase in the incidence of AD, and in the number of patients with severe and treatment-resistant
AD, especially in urban and industrial areas. We have ascribed this to increased oxygen radicals
(OR) generated from environmental pollution and solar radiation (Niwa et al Arch. Dermatol. 130:
1387, 1994). Increased exposure to high concentrations of environmental OR produces excessive
epidermal lipid peroxides by reacting with unsaturated fatty acids, promoting loss of skin
moisturization, which is one of the hallmarks of AD. This study demonstrates direct oxidative
protein damage of stratum corneum of the biopsied skin from AD patients. Carbonyl moieties in
skin biopsies from 75 patients with AD was assessed using both spectrophotometric and immuno-
histochemical detection of the formation of dinitrophenylhydrazone (DNP) from dinitrophe-
nylhydrazine (DNPH). Lipid peroxidation was also assessed by staining with antibody to 4-
hydroxy-2-nonenal (4-HNE), an aldehyde product of oxidized omega-6-fatty acids. The activity
of superoxide dismutase (SOD), an effective scavenger of OR, was also assessed. The level of
protein carbonyl moieties in patients' skin was elevated and correlated directly with the severity of
the disease. SOD activity was increased except for those with extra-severe disease. Positive staining
with anti-DNP antibody and anti4-HNE-antibody were found in the most super®cial layers of the
stratum corneum. Similar results were found for 4-HNE. Atmospheric NOx concentration for the
top ®ve cities of origin of the AD patients seen in the past 4 years directly paralleled the number of
patients from those cities who had severe AD requiring hospitalization. This supports the
hypothesis that environmentally generated OR induce oxidative protein damage in stratum
corneum, leading to the disruption of barrier function with resultant loss of moisturization and
enhancement of antigen presentation, hallmarks of AD.
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Adult Somatic Epidermal Stem Cells can Transdifferentiate into Several Cell Lineages
J. R. Bickenbach and L. Liang
Anatomy and Cell Biology, and Dermatology, The University of Iowa, Iowa City, Iowa, U.S.A.
It has been demonstrated that several types of somatic stem cells have the remarkable capacity to
differentiate into other types of tissues. We have shown that stem cells from the skin, the largest
organ of the body, have the capacity to form multiple cell lineages during development. Using our
recently developed sorting technique, we isolated viable homogenous populations of somatic
epidermal stem and transient amplifying (TA) cells from the skin of 3-day-old-transgenic mice,
who carried the eGFP (enhanced green ¯uorescent protein) transgene, and injected stem or TA
basal epidermal cells into 3.5-day C57BL/6 blastocysts. Only the stem-injected blastocysts
produced mice with GFP+ cells in their tissues. We found GFP+ cells in ectodermal,
mesenchymal, and neural crest derived tissues in E13.5 embryos, 13-day-old-neonates, and 60-
day-old-adult mice. Thus epidermal stem cells survived the blastocyst injection and multiplied
during development. These injected stem cells altered their epidermal phenotype and expressed the
appropriate proteins for the tissues into which they developed, demonstrating that somatic
epidermal stem cells have the ability to produce cells of different lineages during development.
These data suggest that somatic epidermal stem cells may show a generalized plasticity expected
only of embryonic stem cells and that environmental (extrinsic) factors may in¯uence the lineage
pathway for somatic stem cells. To test this hypothesis, we have added inductive factors to cultured
adult epidermal stem and TA cells and found that, depending on the factor, either the stem cells
altered their phenotype or the TA cells did, but not both. This suggests that we could reprogram
adult epidermal cells to form short-lived cell types from the TA cells and long-lived cell types from
the stem cells.
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Regulation of Glucosylceramide Synthase Expression Through Sp1-Mediated Promoter
Activation
S. Murata,*² Y. Uchida,* J. D. Lee,* S. Ichikawa,³ P. M. Elias,* Y. Hirabayashi,³ and W. M.
Holleran*§
*Dermatology, UCSF & V.A. Medical Center, San Francisco, California, U.S.A.; ²Dermatology, Jichi
Medical School, Tochigi, Japan; ³Brain Science Institute, RIKEN, Saitama, Japan and §Pharm. Chem.,
UCSF, S.F., California, U.S.A.
The enzyme glucosyceramide synthase is responsible for generating glucosylceramides (GlcCer) in
all mammalian tissues, including the epidermis. Although GlcCer represent critical precursors for
epidermal barrier ceramides (Cer), the Cer-to-GlcCer conversion also is important for regulating/
maintaining cellular Cer levels to attenuate apoptotic stressors. Prior studies have shown that
epidermal GlcCer synthase activity increases in a differentiation-dependent fashion, a process that is
regulated by PKC. However, the mechanisms responsible for transcriptional regulation of GlcCer
synthase gene expression have not been de®ned in any tissue. Using cultured human keratinocytes
(CHK), phorbol ester (TPA 10 nM) induced signi®cant increases in: GlcCer synthesis; GlcCer
synthase activity; and mRNA and protein levels. Promoter-deletion constructs revealed a putative
Sp1 site to be critical for promoter activation by TPA. Using an oligodeoxynucleotide (ODN)
decoy strategy, CHK were transduced with phosphorothioated double stranded ODN for the Sp1
consensus domain (Sp1-decoy). Mock-ODN transfected CHK retained responsiveness to TPA, as
de novo GlcCer synthesis was signi®cantly increased (2.3-fold; p < 0.001) at 24 h after treatment.
Sp1-decoy ODN did not reduce baseline GlcCer synthesis, but signi®cantly attenuated the TPA-
induced increase in this parameter (> 70% attenuation; p < 0.001). RT-PCR analysis also revealed
that Sp1-decoy transduction signi®cantly reduced the TPA-mediated increases in GlcCer synthase
mRNA at both 8 and 24 h. Finally, mithromycin, an inhibitor of Sp1 binding to DNA, had no
effect on baseline, but completely eliminated the TPA-induced increase in GlcCer synthesis in
CHK. These results demonstrate that an Sp1-mediated promoter mechanism is operative in the
activation of GlcCer synthase in response to the differentiation-inducing agent TPA, and further
suggest a critical role for Sp1 in regulating epidermal GlcCer production.
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Aging of Human Epidermis: the Role of Apoptosis, Fas, and Telomerase
R. S. Kalish,² Y. Ullman, R. Karry,* R. Shalaginov, B. Assy, S. Sera®movich, and A. Gilhar
Skin Research Laboratory, Technion-Israel Institute of Technology & Flieman Medical Center, Haifa, Israel;
*Department Psychiatry Rambam Medical Ctr, Technion-Israel Institute of Technology Center, Haifa,
Israel; ²Dermatology, SUNY @ Stony Brook, Stony Brook, New York, U.S.A.
Aged human epidermis is characterized by decreased thickness and proliferation. We have
previously demonstrated these changes are reversible upon grafting of human skin to
immunode®cient mice. Aged (N = 14; mean 70.7 years), and young (N = 14; mean 23.4 years)
sun protected human skin was grafted onto beige-SCID mice. Prior to grafting, aged skin
demonstrated an increase in apoptosis below the granular layer of the epidermis, as well as increased
epidermal Fas, and FasL expression. Telomerase activity was similar in aged, and young skin.
Engraftment of aged skin to beige-SCID mice reversed thinning of the epidermis, as well as the
decrease in epidermal proliferation (Ki-67). Reversal of aging changes was associated with a
decrease in both apoptosis, and Fas expression. The apoptotic index, and levels of Fas expression of
aged skin after grafting were equivalent to those of grafted young skin, and similar to young skin
prior to grafting. All the above changes were signi®cant at (p < 0.001). Telomerase activity did not
differentiate young vs. old epidermis, suggesting that in a self renewing tissue with slowly cycling
stem cells, telomerase is not a limiting factor in aging. It is postulated that Fas/FasL mediated
apoptosis, along with decreased proliferation, mediate aging changes of human epidemris.
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Striking Phenotypes of Keratinocyte-Speci®c Ceramide Knockout Mice
S. Sano, S. Osuka,*³ T. Kobayashi, F. Sakamoto,² S. Itami, M. Ito,² K. Yoshikawa, Y.
Hirabayashi,³ and J. Takeda*
Department of Dermatology, Osaka University Graduate School, Suita, Osaka, Japan; *Department of
Social and Environmental Medicine, Osaka University Graduate School, Suita, Osaka, Japan; ²Department
of Dermatology, Niigata University School of Medicine, Niigata, Niigata, Japan; ³Laboratory of Neuronal
Circuit Mechanism, RIKEN, Wako, Saitama, Japan
Ceramides, the major lipids in the stratum corneum, have been thought to be required for
epidermal barrier function and water retention. Also, recent studies suggest that intracellular
ceramides participate in cell signaling as second messengers for apoptosis. To address the role of
ceramides in the skin, we have generated sphingolipids knockout mice by disruption of Sptlc-2
gene, which encodes serine palmitoyl transferase, the ®rst enzyme for sphingolipid biosynthesis
upstream of ceramides. Since germline targeting of the gene resulted in embryonic lethality, we
ablated it speci®cally in keratinocytes using the Cre-loxP technology behind the keratin 5
promoter. Skin of newborn K5.Sptlc±/± mice appeared shiny and xerotic, although no histological
abnormalities in the epidermis and appendages were found by HE stain. The mutant mice
exhibited decreased water retention, while barrier function was not affected. Keratinocytes from
K5.Sptlc±/± mice were as well susceptible to apoptotic stimuli as wild-type. Electron microscopic
examination of new born mutant mice revealed that the lamellar structure was missing in the
lamellar bodies (LB) in granular cells. From two weeks of age, K5.Sptlc±/± mice developed
hyperkeratosis and aberracy in their hair texture with prominent histological changes. Strikingly,
electron micrograph of 3 week-old K5.Sptlc±/± mice exhibited disappearance of LB, poor
formation of corni®ed envelopes. Results from the present study suggested that ceramides play a
pivotal role in the structural integrity of stratum corneum, not in signaling to apoptosis in
keratinocytes.
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The Consequences of Conditional b-Catenin Gene Ablation on Epidermal Keratinocyte
Proliferation, Adhesion and Differentiation In Vitro
H. Posthaus, L. Williamson, D. Baumann, R. Caldelari, M. Suter, R. Kemler,* and E. Mu
È
ller
Institute of Animal Pathology, University of Bern, Bern, BE, Switzerland; *Immunobiology, Max-Planck
Institute, Freiburg, Germany
The armadillo protein b-catenin serves a dual function. It is present in adherens junctions and acts
as a signaling molecule with the capacity to transactivate transcription in the nucleus. It has been
suggested that b-catenin signaling has to be shut off to allow renewal and differentiation of the
embryonic and adult mouse interfollicular epidermis. In this study we established long-term
epidermal keratinocyte cultures from transgenic mouse embryos, engineered to allow conditional
b-catenin gene ablation by exogenous expression of adenovirus-encoded Cre-recombinase (Cre/
loxP system). This enabled us to compare b-catenin+/+ with b-catenin+/± and b-catenin±/±
keratinocytes. We addressed the consequences of b-catenin deletion on the keratinocyte
proliferation and differentiation capacity, as well as on intercellular adhesion structure formation.
Our results desmonstrate that plakoglobin substitutes for the loss of b-catenin in adherens junctions
which otherwise remain biochemically and ultrastructurally unaffected. b-catenin deletion had no
effect on the expression and assembly of desmosomal components nor on the in vitro proliferation
capacity of these epidermal keratinocytes. Moreover, calcium-induced differentiation proceeded
normally with the exception that some late terminal differentiation markers were aberrantly
expressed. Most interestingly, we also found that Tcf/Lef1 dependent transcriptional activity was
suppressed in the proliferating epidermal keratinocytes but that this effect was independent of the
presence or absence of b-catenin. Our results extend the current knowledge about b-catenin's
involvement in the differentiation process of epidermal keratinocytes and show that b-catenin
signaling is not essential for proliferation and commitment to terminal differentiation of these cells
in vitro.
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Angiotensin Enhances Keratinocyte Migration via EGF Receptor Transactivation
Mediated by HB-EGF SheddingÐA Novel Function of Angiotensin II in the Skin
Y. Yahata, Y. Shirakata, K. Yamasaki, K. Sayama, and K. Hashimoto
Dermatology, Ehime University School of Medicine, Shigenobucho, Ehime, Japan
Angiotensin II (Ang II) has a well-de®ned role in the control of systemic blood pressure and
volume homeostasis. Recently, Ang II has been reported to accelerate wound healing in animal
models. Therefore, we compared wound-healing rates in Ang II type 1a (AT1R)-de®cient mice
and wild-type mice. A cutaneous wound was made using an 8-mm punch biopsy and the wound
area was measured on day 8. The wound areas were 28.6 and 14.1 mm
2
in AT1R-de®cient mice
and wild-type mice, respectively. Therefore, AT1R-de®cient mice showed signi®cant retardation
of wound healing. This led us to examine the effect of Ang II on the growth and migration of
normal human keratinocytes (NHK). The presence of AT1R in NHK was con®rmed by RT-
PCR and a binding assay. Ang II induced NHK migration in a dose-dependent manner, with a
2.4-fold optimum at 10±7 M, while Ang II had no effect on NHK growth. Several groups have
reported that binding of ligands to the G-protein-coupled receptor (GPCR) induced EGF receptor
(EGFR) transactivation by HB-EGF shedding (the proteolytic conversion of membrane-anchored
HB-EGF to the soluble form). Since AT1R is a GPCR, we hypothesized that Ang II-induced
NHK migration is mediated by an EGFR transactivation mechanism. The addition of Ang II
induced the phosphorylation of EGFR, with a maximum at 15 min, and this was prevented by the
presence of valsartan, an AT1R antagonist. Furthermore, valsartan also inhibited Ang II-induced
NHK migration by 80%. Anti-HB-EGF neutralizing antibody (5 mg/ml) inhibited Ang II -
induced NHK migration by 50%. CRM197, a nontoxic mutant of diphtheria toxin, speci®cally
inhibits HB-EGF by binding to its EGF-like domain. CRM197 inhibited Ang II-induced NHK
migration by 30% at 1 mg/ml. In conclusion, we demonstrated a new biological function of Ang II
in the skin, namely the acceleration of wound healing by enhancing NHK migration;
Furthermore, this was mediated by EGFR transactivation through HB-EGF shedding via the
Ang II/AT1R signaling pathway.
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Disruption of Suprabasal Keratin Network by Mutation M150T in the Helix Initiation
Motif of Keratin 10 Does Not Affect Corni®ed Cell Envelope Formation in Human
Epidermis
M, Akiyama, Y. Takizawa,* I. Matsuo,² and H. Shimizu
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan;
*Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; ²Department of
Dermatology, Teikyo University School of Medicine, Ichihara Hospital, Ichihara, Japan
Binding of keratin 10 (K10) to the corni®ed cell envelope (CCE) is thought to play an important
role in interaction between the keratin ®lament network and CCE and to enhance the structural
integrity of the corni®ed cells. Bullous congenital ichthyosiform erythroderma (BCIE) is a genetic
disorder of keratinization caused by gene mutations for conserved sequences of keratin 1 or K10,
which leads to abnormal suprabasal keratin network formation. To date, the exact
pathomechanisim of hyperkeratosis in BCIE is unknown and there is a possibility that abnormal
suprabasal keratin network disturbs the CCE formation, resulting in hyperkeratosis. In order to
clarify whether abnormal K10 and malformed keratin network affect CCE formation in vivo, the
formation of CCE was studied in the epidermis of patients with BCIE with disturbed keratin
®lament network by an identical mutation of K10 gene. We studied skin specimens from two
Japanese BCIE patients from two independent families carrying an identical novel missense
mutation M150T in the helix initiation motif of K10. Ultrastructurally, 15 nm-thick, dense normal
CCE was formed in the cell periphery of the keratinized epidermal cells in the patients' skin. Light
and electron microscopic immunolabelings revealed that major CCE precursor proteins, involucrin
and loricrin, were normally distributed in the patients' epidermis restricted to CCE.
Immuno¯uorescent labeling showed that epidermal TGases, TGase 1, TGase 2 and TGase 3,
were expressed normally in the patients' epidermis. These ®ndings suggested that CCE could be
normally formed during the human epidermal keratinization in the condition that the suprabasal
keratin ®lament network was disturbed by the dominant negative effect of K10 mutation M150T
in the helix initiation motif.
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A Canine Genodermatosis Provides Novel Insights into Features of Darier Disease
E. Mu
È
ller, R. Caldelari, D. Baumann,* G. Richard,² P. Jensen, P. Girling, L. Williamson,³ F.
Delprincipe, and M. Suter
Institute of Animal Pathology, University of Bern, Bern, Switzerland; *Department of Dermatology and
Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.; ²School of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; ³Department of Physiology, University of
Bern, Bern, Switzerland
We addressed the molecular mechanisms underlying an inherited acantholytic skin disorder in a
dog family. Confocal microscopy of Fluo-3AM-loaded keratinocytes from lesional and nonlesional
epidermis (treated with or without thapsigargin) revealed that the affected dogs suffered from
altered calcium homeostasis due to defective SERCA2 calcium pumps. A comprehensive analysis
of intercellular junctions, proliferation and differentiation abilities of nonlesional vs. normal
keratinocytes in vivo and in vitro revealed altered cell cycle control as the remarkable consequence of
faulty SERCA2 function. This effect was even more pronounced in cells of lesional origin, which
in addition demonstrated impaired formation of intercellular adhesion junctions and profoundly
altered expression of differentiation markers. This distinct phenotype and its persistence during
several cycles of keratinocyte subculture is suggestive for the accumulation of additional somatic
mutations. Based on our ®ndings we propose a model that might also apply for human Darier
disease. We suggest that faulty SERCA2-gated calcium pumps deplete intracellular calcium stores
and thereby hamper cell cycle control. Whereas epidermal keratinocytes can adapt to these
alterations under normal conditions, faulty SERCA2 function compromises re-entry of cells into
the cell cycle during wound healing and favors accumulation of secondary somatic mutations
resulting in chronic lesions.
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Differentiation-Dependent Mobilization and Export of Psoriatic Marker Proteins,
S100A8 and S100A9, in Human Keratinocytes
A. Broome* and R. L. Eckert*²
*Physiology & Biophysics, CWRU, School of Medicine, Cleveland, Ohio, U.S.A.; ²Dermatology,
CWRU, School of Medicine, Cleveland, Ohio, U.S.A.; ³Biochemistry, CWRU, School of Medicine,
Cleveland, Ohio, U.S.A.; §Oncology, CWRU, School of Medicine, Cleveland, Ohio, U.S.A.
Calcium acts as an intracellular second messenger to regulate keratinocyte shape, secretion,
contraction, proliferation, and differentiation. Calcium signaling is mediated, in part, via calcium
interaction with S100 calcium binding proteins. S100 proteins are thought to be important in
epidermal differentiation, as they are expressed in epidermis, clustered in the epidermal
differentiation complex at 1q21, differentially expressed during differentiation, and activated by
calcium. Moreover, selected members of this family are overexpressed in epidermal disease.
S100A8 and S100A9 form a hetero-complex, and are particularly important, since they are
markedly overexpressed in psoriasis. In the present study, we map S100A8 and S100A9 expression
in normal and psoriatic epidermis. In normal human epidermis, S100A8 and S100A9 are expressed
in the granular layer. In contrast, in psoriasis, S100A8 and S100A9 expression is markedly elevated
and aberrant expression is detected in the epidermal basal and spinous layers. We also used green
and red ¯uorescent protein-tagged fusion proteins and video-confocal microscopy to study the
intracellular behavior of S100A8 and S100A9 in cultured human keratinocytes. In untreated
keratinocytes, S100A8 is localized in the nucleus and cytoplasm, while S100A9 is present only in
the cytoplasm. The distribution of these proteins is not changed following treatment with the
differentiating agents, calcium, thapsigargin or phorbol ester. However, okadaic acid treatment
causes both S100A8 and S100A9 to migrate to the cell periphery and localize in membrane-
associated vesicles. This result implies that selected differentiating agents cause mobilization of an
S100A8/A9 complex to the trans-Golgi network and into plasma membrane vesicles for eventual
export, suggesting that the S100A8/A9 complex acts in the extracellular environment to modulate
keratinocyte function.
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Estrogen Stimulates Epidermal Keratinocytes
S. Sevrain, M. Yaar, N. Wang, A. Traish,* and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; *Biochemistry, Boston
University School of Medicine, Boston, Massachusetts, U.S.A.
Estrogens induce their effects by binding two nuclear receptor isoforms that belong to the steroid
hormone receptor superfamily: estrogen receptor a and b (ERa and b). These nuclear receptors act
as ligand regulated transcription factors. Estrogens are believed to affect cutaneous functions like
elasticity, vascular dilation and pigmentation but their effect on keratinocytes (Kc) is not well
elucidated. To determine the estrogen effect on Kc proliferation, normal human Kc were placed in
serum-free, phenol-free medium and stimulated with estradiol at a physiologic concentration (10
±
10
M). Within 72 h, estradiol increased 3H-thymidine incorporation by 42 6 2% compared to
diluent treated control cultures, demonstrating that estradiol enhances Kc proliferation. Western
blot analysis showed constitutive low level expression of the 66 kDa-ERa and 59 kDa- ERb bands
in Kc maintained in medium lacking estradiol. Interestingly, estradiol concentrations within the




M) increased the levels of both ERa and










M) induced expression of the EGF receptor and the high af®nity nerve growth factor
receptor-trkA, both implicated in Kc proliferation. EGF receptor transcripts were maximally
increased 5 fold with 10
±9









M) also induced the level of ERa in these
cells by > 2 fold. Our results demonstrate that in vitro physiologic concentrations of estradiol
enhance Kc proliferation, induce its own receptors and receptors for at least two known Kc
mitogens. The data suggest that estrogen may affect epidermal turnover and wound healing in vivo,
at least in part by inducing the level of receptors in Kc and that estrogen de®ciency
postmenopausally may impair these functions.
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Do Tight Junctions Play a Role in the Barrier Function of the Skin?
J. M. Brandner, E. Proksch,* P. Von den Driesch, S. Kief, E. Wladykowski, N. K. Haass, and I.
Moll
Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Germany;
*Department of Dermatology, University of Kiel, Kiel, Germany
The epidermis is known to play an important role in the barrier function of the skin, protecting the
human body from the entry of noxious agents and from excessive water loss. Tight junctions (TJ)
ful®l important barrier functions in simple epithelia and endothelia, thereby supporting, e.g. the
generation of the blood-brain or blood±testis barrier. TJ are also present in strati®ed epithelia, e.g.
the epidermis, as we and others have shown lately, but their function is still unknown. To elucidate
their possible role in barrier function we investigated the synthesis of TJ proteins during epidermal
differentiation in diseases characterized by an impaired barrier function of the skin. In psoriasis,
lichen ruber, and eczema we studied the localization of TJ proteins, notably claudins, by using
speci®c antibodies. In addition, we investigated TJ protein synthesis and localization in hairless skin
of mice at different time points after barrier disruption by tape-stripping. We found a down-
regulation of the synthesis of some TJ proteins in severely diseased skin of psoriasis, lichen rubber
and eczema, especially in areas which histologicaly showed an epidermal invasion of neutrophil
granulocytes. However we could also show that the restriction of the TJ protein occludin to the
stratum granulosum and the transition layer of normal skin is abolished in some areas of diseased
skin as well as after tape-stripping. The distribution of protein ZO-1 is heterogeneously. In
summary, these results show a regulation of TJ proteins during epidermal differentiation and a
putative participation of TJs in the barrier-function of the skin.
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Transporter Proteins and Xenobiotica Metabolizing Enzymes in Proliferating Human
Epidermal Keratinocytes
J. M. Baron, R. Schiffer,* G. Zwadlo-Klarwasser,* D. Hoeller, H. F. Merk, and F. Jugert
Department of Dermatology, RWTH Aachen, Aachen, Germany; *Interdisciplinary Center for Clinical
Research BIOMAT, RWTH Aachen, Aachen, Germany
The aim of this study was to analyze the expression pattern of polyspeci®c membrane transporters
such as OATP A-E, p-gp and MRP1-7, and CYP-enzymes in human epidermal keratinocytes
under constitutive conditions and after induction with various inducers. RT-PCR analysis of
transport proteins revealed the constitutive expression of MRP1, MRP3, MRP4, MRP5, MRP6
and MRP7, as well as OATP-B, -D and -E and CYP1A1, 1B1, 2B6, 2E1 and 3A5 in human
epithelial keratinocytes and was negative for MDR1, MRP2, OATP-A and OATP-C. Expression
of MDR1 and CYP3A4 was seen after induction with dexamethasone. RT-PCR results were
con®rmed by immunoblots and immunohistology. The localization of all CYP-enzymes was
restricted to the cytoplasm of the keratinocytes and transport proteins were expressed in the cell
membrane. Constitutive activity of CYP 1A1, 2B, 2E1 and 3A enzymes was measured by catalytic
assays. Active in¯ux and ef¯ux of xenobiotics was demonstrated by functional assays such as
calcein-acetoxymethylester transport assay. These results show that keratinocytes of the human skin
express various transport associated- and detoxifying metabolic enzymes. This is extremely
interesting, because previous studies have revealed, that CYP enzymes and transport-associated
proteins play complementary roles in drug disposition by uptake (phase 0), biotransformation
(phase I) and antitransport (phase III). Especially the discovery of the expression of organic anion
transporting polypeptides seems to be a complete new factor in human skin barrier.
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Ultrastructural Localization of Steroid Sulfatase and Cholesterol Sulfate: Basis for
Abnormal Desquamation and Barrier Dysfunction in Recessive X-Linked Ichthyosis
P.M. Elias, M. Schmuth,* F. Kenneth,* U. Rassner, and D. Crumrine
Dermatology, UC San Francisco, San Francisco, California, U.S.A.; *Metabolism, UC San Francisco, San
Francisco, California, U.S.A.
Deletions or mutations of the gene for steroid sulfatase (SSase), leading to loss of enzyme activity,
are responsible for recessive x-linked ichthyosis (RXLI). As a consequence of SSase de®ciency, its
substrate, cholesterol sulfate (CSO4), accumulates in the epidermis and other tissues. Accumulation
of this amphipathic lipid in the outer epidermis provokes both a typical ichthyosiform scaling
phenotype, and a mild abnormality in permeability barrier function. We report here new studies
that shed further light on the pathogenesis of RXLI using a new ultrastructural cytochemical
method that employs either barium or lead to capture sites of SSase activity. SSase normally is
concentrated in lamellar bodies (LB), and secreted into the stratum corneum (SC) interstices, along
with other LB-derived lipid hydrolases, where it is positioned to degrade CSO4, generating a
portion of the free cholesterol pool for the barrier, and mediating desquamation. Although
multiple molecular pathways have been proposed to contribute to disease pathogenesis in RXLI,
we show here further that Ca++ levels persist into the lower SC RXLI, but not in normal SC.
Retention of Ca++ in this location could bind excess CSO4, thereby contributing to increased
corneocyte retention. In summary, the localization of SSase to the SC interstices, and the In situ
persistence of Ca++ into the lower SC of RXLI, provide new insights not only into normal SC
function, but also into the pathogenesis of RXLI.
269
Side Population Cells in the Human Epidermis: A Novel Candidate for Keratinocyte
Stem Cells
A. Terunuma, K. L. Jackson, V. Kapoor,* W. G. Telford,* and J. C. Vogel
Dermatology Branch, National Cancer Institute, NIH, Bethesda, Maryland, U.S.A.; *Medicine Branch,
National Cancer Institute, NIH, Bethesda, Maryland, U.S.A.
Epidermis, as a renewing tissue, is maintained by keratinocyte stem cells (KSC). KSC are attractive
targets for skin gene therapy in order to achieve long-term expression of therapeutic genes in a
high percentage of keratinocytes. However, unique cell surface markers for KSC that allow their
identi®cation and manipulation are not known. In the bone marrow, side population cells (SP) that
represent a very primitive population of hematopoietic stem cells (HSC) have recently been
described. Bone marrow SP are detected by FACS analysis for their ability to exclude Hoechst
33342 dye (dye-low) after staining cell suspensions. Surprisingly, we found that SP are also present
in epidermal suspensions: SP represented a small population in epidermal suspensions (0.3% of the
total); SP consisted of keratinocytes (89%) and increased percentage of melanocytes (10%); and SP
were enriched for cells in G0/G1 phase of cell cycle. Additionally, the epdidermal SP phenotype
disappears following verapamil treatment, similar to bone marrow SP, suggesting that the dye-low
phenotype can be attributed to cellular pump activity. Although a membrane pump in the ABC
transporter family, ABCG2, has been reported to be responsible for the SP phenotype in bone
marrow SP, our quantitative RT-PCR and FACS analysis did not demonstrate ABCG2 up-
regulation in epidermal SP. We next addressed if SP contain markers used to enrich for KSC and/
or represent a population of KSC. Integrin molecules, such as a6 or b1, which we found to be up-
regulated on label retaining keratinocytes, were only expressed at low levels on epidermal SP.
Thus, epidermal SP have a distinct phenotype compared to both bone marrow SP and putative
KSC, and represent a biologically unique population of cells. The possibility that SP represent KSC
will have to be determined by an in vivo biological assay.
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Functional Characterization of Glutamate `Neurotransmission' in Keratinocytes
S. J. Max®eld,*² E. J. Wood,² J. Watson,³ and P. G. Genever*
*Department of Biology, University of York, York, U.K.; ²School of Biochemistry, University of Leeds,
Leeds, U.K.; ³Group Research Centre, Smith & Nephew, York, U.K.
Glutamate (Glu) is the major excitatory neurotransmitter in the central nervous system and
functions via ionotropic (NMDA, AMPA, kainate) and metabotropic receptors, whilst speci®c
transporters including EAAT1, EAAT2 and EAAT3 recycle Glu for re-release. We have previously
immunolocalised Glu signaling proteins in epidermal keratinocytes. The purpose of this work was
to determine the pharmacological and physiological activities of Glu receptors and transporters in
these cells. mRNA and protein expression pro®les were determined by RT-PCR, immunohis-
tochemistry and Western blot analyses and we used speci®c radio- and ¯uorimetric assays to
quantitate Glu binding, uptake and release in HaCaT cells and primary human/rat keratinocytes.
We con®rmed that these cells expressed a range of NMDA receptor subunits, associated clustering
molecules and transporters. In human epidermis, intense immunoreactivity for NMDA receptors,
EAAT1 and EAAT3 was detected on basal keratinocytes, whereas EAAT2 expression was
restricted to suprabasal cells. Speci®c binding of [3H]L-Glu to keratinocytes in vitro was reduced by
the competitive NMDA antagonist DAP5 and excess cold Glu. Keratinocytes displayed high
af®nity, sodium dependent Glu uptake, which was signi®cantly inhibited by the speci®c transporter
antagonists PDC and DHK and the Glu analogues D- and L-aspartate. Keratinocytes also released
Glu (8±30 nmoles/mg protein) via a calcium dependent mechanism and Glu binding, uptake and
release were markedly reduced following induction of differentiation. Exposure of keratinocytes to
the NMDA receptor antagonist MK801 increased expression of involucrin and keratin 10, without
affecting cell numbers, whilst PDC and DHK dramatically reduced adhesion to all substrates tested.
These ®ndings demonstrate that pharmacological manipulation of Glu signalling proteins has
profound effects on keratinocyte behaviour and may represent novel targets for the treatment of
skin disease characterised by an aberrant programme of differentiation.
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Defective Epidermal Barrier Function in gd T cell De®cient Mice
M. Girardi, R. Filler, and R. Tigelaar
Dermatology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.
To investigate the role of gd + dendritic epidermal T cells (DETC) in the maintenance of
epidermal barrier function, we measured the skin surface electrical capitance (SSEC) of T cell
receptor (TCR)d±/± mice, and age- and strain-matched controls using a NOVA Dermaphase
Meter 9003. Skin surface hydration (SSH) was determined as instantaneous (t = 0 s) SSEC, and
transepidermal water loss (TEWL) was measured as the change in SSEC over time (1±10 s interval).
The ear skin of TCRd±/± mice demonstrated a 40% greater mean SSH [209.4 6 19.1 picoFarads
(pF)] compared to controls (147.6 6 2.1 pF; p = 0.009). In addition, mean TEWL was increased
(> 4-fold) in the ear skin of TCRd±/± mice (11.68 6 1.36 vs. 2.75 6 0.23 pF/ s; p < 0.00005). To
examine differences in SSEC on a hair-bearing site, abdominal skin was shaved and assayed. Again,
TCRd±/± mice demonstrated increased SSH (150.4 6 3.6 vs. 129.2 6 1.6 pF, p < 0.007) and
TEWL (3.64 6 0.53 vs. 2.20 6 0.37 pF/ s; p < 0.03). In addition, following topical application of
acetone to deplete the lipid envelope, the SSH of TCRd±/± mice remained markedly elevated at
120 h (338.7 6 19.4) while it began to normalize in controls (156.8 6 14.1 pF; p < 0.00001). To
determine the degree to which increased SSH and TEWL in TCRd±/± mice is reversible and
dependent on the environment, two groups of TCRd±/± mice were housed under different
conditions: conventional nonventilated housing (CNVH), and individually ventilated housing
(IVH). Compared with CNVH, TCRd±/± mice in IVH showed markedly lower SSM
(156.8 6 17.1 vs. 309.8 6 34.6 pF; p < 0.005) and TEWL (5.0 6 0.4 vs. 12.8 6 1.0; p < 0.00001).
To determine whether Vg5 + DETC could abrogate the defect in TCRd±/± mice, day 17
Vg5 + fetal thymocytes were transferred to neonatal TCRd±/± mice and compared to
unmanipulated TCRd±/± littermates. Recipient mice demonstrated lower SSH (112.4 6 1.4 vs.
150.4 6 3.6; p < 0.0003) and TEWL (1.04 6 0.2 vs. 2.20 6 0.37; p < 0.03). These results indicate
that gd T cells, and speci®cally intraepithelial Vg5 + DETC, are critical to maintaining the integrity
of the epidermal water barrier.
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The Developmental Transcription Factor Slug Participates in Re-Epithelialization
During Cutaneous Wound Healing
L. G. Hudson, P. Savagner,* and D. F. Kusewitt²
Pharmacy, University of New Mexico, Albuquerque, New Mexico; *Equipe Genome et Cancer, Batiment de
Recherche en Cancerologie, Montpellier, 117, France; ²Veterinary Biosciences, Ohio State University,
Columbus, Ohio, U.S.A.
Epithelial-mesenchymal transformation (EMT) occurs during normal embryonic development and
tumor metastasis. Keratinocytes recapitulate some features of EMT during wound re-
epithelialization, including loss of intercellular junctions, keratin cytoskeleton reorganization,
increased protease production, and enhanced migration. Because members of the Snail/Slug family
of transcription factors are recognized modulators of EMT during development, we assessed the
possible role of Slug in cutaneous wound repair. We found that transient or stable overexpression
of Slug in cultured human keratinocytes led to EMT-like alterations in cell morphology and
behavior, including increased cell spreading, partial dissociation of desmosomes, disruption of
cytokeratin intermediate ®laments and accelerated in vitro re-epithelialization. Additional evidence
for a role of Slug in wound repair was obtained by detection of Slug at wound margins in human
keratinocyte monolayers in vitro and in mouse skin in vivo. Slug expression appeared within 24 h
after in vitro wounding, remained elevated at 48 and 72 h after wounding, and began to diminish by
96 h. Slug expression was particularly prominent in cells with lamellipodia actively migrating across
the gap in the cell layer. In mouse skin in vivo, the pattern of Slug expression was similar. Within
2 days after wounding Slug was detected in scattered keratinocytes at the wound margin and by
3 days Slug was expressed in the keratinocytes that constituted the migrating front of the wound.
The related transcription factor Snail, however, was expressed at very low levels in adult
keratinocytes, and its expression was not increased at wound margins. These ®ndings suggest that
the developmental factor Slug may play an important role in modulating EMT during wound
healing in adult skin.
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Characterization of a Novel Gene with Filaggrin-Like Repeats that is Expressed Late in
Epidermal Differentiation
J. A. Rothnagel,*² P. Listwan,* S. Karunaratne,* and D. Zhang*
*Department of Biochemistry and Molecular Biology, University of Queensland, Brisbane, Queensland,
Australia; ²The Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland,
Australia
One of the most prominent markers of late epidermal differentiation is ®laggrin, which is
synthesized as a large short-lived polyprotein (pro®laggrin). Filaggrin interacts with keratin
®laments in the corni®ed layer to form highly ordered structures known as macro®brils. We have
identi®ed a gene in both human and mouse genomes that has homology with ®laggrin and the
same structural organization as pro®laggrin. A search of the genomic and protein databases revealed
that this gene encodes a hitherto uncharacterized protein. The conceptually translated protein
contains a calcium-binding domain, followed by a unique sequence and then several repetitive
units that vary between 76 and 82 residues. Each repeating unit has a pI of 11.6 and is rich in
proline, glycine, serine, glutamine and arginine. Northern blot analysis revealed a single transcript
(> 12 kb) that is expressed in high levels in the epidermis and is not found in any other epithelia. It
is ®rst detected at day 16dpc of embryonic mouse development and precedes the appearance of
pro®laggrin by 12±24 h. A polyclonal antibody produced using a synthetic peptide derived from
the conceptually translated ORF, detects both high and low molecular weight products consistent
with processing of a polypeptide precursor. Double-label immuno¯uorescence localized the novel
protein to the granular and corni®ed layers of the epidermis. Staining of the granular layer was
localized to small keratohyalin granules that could be distinguished from the larger ®laggrin (F)
granules. Analysis of the recombinant protein expressed in bacteria revealed that the calcium-
binding domain is functional and that the repetitive ®laggrin-like subunits are able to align keratin
®laments into macro®brils. The identi®cation of this novel protein that is structurally and
functionally related to (pro)®laggrin as well as the recently identi®ed ®laggrin-like protein,
hornerin, suggests a high degree of redundancy in this class of protein.
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Cathepsin D Regulates Transglutaminase 1-Mediated Expression of Involucrin and
Loricrin During Epidermal Differentiation
E. Proksch, F. Rosin, M. Heinrich,* S. Winoto-Morbach,* P. Saftig,² and S. Schuetze*
Dermatology, University of Kiel, Kiel, Germany; *Immunology, University of Kiel, Kiel, Germany and
²Biochemistry, University of Kiel, Kiel, Germany
Increased expression of the lysosomal aspartat protease cathepsin D (CTSD) in early melanoma, in
metastatic squamous cell carcinoma, in psoriasis, during epidermal differentiation and during
wound healing has been reported. We recently described that CTSD is targeted by acid
sphingomyelinase derived ceramide. Here, we explored speci®c functions of CTSD during
epidermal differentiation in wild type and CTSD-de®cient mice. After experimental injury to the
skin in wild type mice we found an increased epidermal expression and an increased activity of
CTSD by immunoblotting and by speci®c enzyme assays, respectively. Topical application of the
CTSD inhibitor pepstatin A signi®cantly delayed permeability barrier repair. The inhibitor
suppressed the expression of the corni®ed envelope proteins involucrin and loricrin, which are
early and late markers in differentiation. Application of imipramine, an inhibitor of acid
sphingomyelinase, also signi®cantly diminished involucrin and loricrin expression in the skin.
CTSD±/± mice revealed dryness of the skin and epidermal hyperkeratosis. The activity of
keratinocyte transglutaminase 1 (TG1) was reduced by 50% in the epidermis of CTSD+/± mice
compared to wild-type mice and almost diminished in CTSD±/± mice. The protein pattern of
TG1, involucrin and loricrin was dramatically altered in the CTSD de®cient mice, suggesting
defects in processing of the respective precursor proteins. Similarly, dry skin and hyperkeratosis are
signs of human lamellar ichthyosis. In this disease mutations in the TG1 gene, resulting in
decreased enzyme activity and decreased involucrin expression are known. In summary, it was
found that CTSD is crucially involved in the regulation of TG1 activity, involucrin and loricrin
expression during epidermal differentiation. We propose a signal transduction pathway regulating
epidermal differentiation by acid sphingomyelinase-derived ceramide, involving CTSD and TG1
for the processing of the corni®ed envelope proteins involucrin and loricrin.
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Epidermal Prostanoid Receptor EP1 Expression and Regulation of Keratinocyte
Differentiation
P. LaCelle and R. Konger
Dermatology, University of Rochester, Rochester, New York, U.S.A.
The inducible form of cyclooxygenase, COX-2, which produces prostaglandin E2 is elevated in
numerous human neoplasms. Message for all 4 PGE2 receptor types, EP1 ± EP4, has been
identi®ed in keratinocytes. Since EP1 in other cell types is associated with mobilization of calcium,
a primary signal for keratinocyte differentiation, we investigated the potential role of EP1 in
keratinocyte differentiation. We identi®ed the EP1 message in cell lysates by RT-PCR. In
addition, we characterized a new mouse monoclonal anti-EP1 antibody, 5F12. COS-7 cells
transfected with EP1 showed perinuclear immunolocalization. Detection by Western blot revealed
extensive multimerization of this highly hydrophobic protein (188 hydrophobic amino acids out of
402). Heat denaturation shifted the antigen to an even higher molecular weight range, as reported
elsewhere for G-protein-coupled receptors, and detection was blocked by competition with the
antigenic peptide. Treating cells with tunicamycin yielded the expected 42 kDa band, indicating
glycosylation, which contributes to its anomalously low electrophoretic mobility. The EP1
receptor was immunolocalized to the granular layer in normal skin sections, suggesting a role in
terminal differentiation. Basal cell tumor sections exhibited no staining, as might be expected, but
none of the squamous cell carcinomas tested showed signi®cant EP1 staining, in spite of the more
differentiated character of the cells. Treatment of normal keratinocytes in culture with the selective
EP1 receptor antagonist SC51322 (300 nM) partially blocked calcium-induced activation of the
differentiation-associated genes keratin 10 and transglutaminase 1. These results suggest that EP1
activation may contribute to the expression of differentiation-speci®c genes, but that its main role
may be to trigger the rise in intracellular calcium that engenders the ®nal stages of differentiation.
Further research is needed to de®ne the role of EP1 in normal keratinocyte differentiation, and the
relationship between loss of its expression in SCC, and the uncoupling of differentiation from the
cessation of growth.
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Caspase 14 is Cleaved by Human Keratinocyte Membrane Fraction
M.K. Kuechle,* A. Chien,* and R.B. Presland*²
*Medicine (Dermatology), University of Washington, Seattle, Washington, U.S.A.; ²Oral Biology,
University of Washington, Seattle, Washington, U.S.A.
Caspase 14 is a skin speci®c caspase expressed in the upper differentiating layers of strati®ed,
corni®ed epithelium. Caspase 14 is detected as a processed peptide in human skin extracts and
organotypic cultures, but is not processed to its large and small subunits in submerged con¯uent
keratinocytes. To characterize the conditions and factors that are required for caspase 14 activation,
we ®rst expressed recombinant human caspase 14 in both mammalian cells and in a bacterial
system. Despite ample levels of recombinant protein expression, no processing of caspase 14 was
detected. Fractionation of human foreskin reveals that the large and small subunits of caspase 14 are
predominantly cytosolic, although unprocessed procaspase 14 is detected in the membrane
fraction. However, activity against a putative caspase 14 substrate, LGGD-AFC, was seen with the
human foreskin membrane fraction, and not the cytosolic fraction. Incubation of puri®ed
recombinant caspase 14 with membrane isolates of cultured human keratinocytes resulted in
processing of caspase 14 into large and small subunits. These data suggest the presence of an as yet
unidenti®ed cofactor in the membrane fraction of keratinocytes required for caspase 14 cleavage as
well as the possibility of cytosolic caspase 14 inhibitor(s). Together, these studies may lend new
insight into the complex mechanisms involved in regulation of caspase 14 as well as the potential
role of these processes in epidermal terminal differentiation.
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Impaired Stratum Corneum Hydration in Mice Lacking Epidermal Water Channel
Aquaporin-3
T. Ma,* M. Hara,*² R. Sougrat,³ J. Verbavatz,³ and A. S. Verkman*
*Departments of Medicine and Physiology, UCSF, San Francisco, California, U.S.A.; ²Basic Research
Laboratory, Kanebo, Ltd, Odawara, Kanagawa, Japan; ³Service de Biologie Cellulaire, CEA, Saley, France
The water and solute transporting properties of the epidermis have been proposed to be important
determinants of skin moisture content and barrier properties. The water/small solute transporting
protein aquaporin-3 (AQP3) was found by immuno¯uorescence and immunogold electron
microscopy to be expressed at the plasma membrane of epidermal keratinocytes in mouse skin. We
studied the role of AQP3 in stratum corneum (SC) hydration by comparative measurements in
wildtype and AQP3 null mice generated in a hairless SKH1 genetic background. The hairless
AQP3 null mice had normal perinatal survival, growth and serum chemistries, but were polyuric
because of defective urinary concentrating ability. AQP3 deletion resulted in > 4-fold reduced
osmotic water permeability and > 2-fold reduced glycerol permeability in epidermis. Epidermal,
dermal and SC thickness and morphology were not grossly affected by AQP3 deletion. Surface
conductance measurements showed remarkably reduced SC water content in AQP3 null mice in
the hairless genetic background (165 6 10 vs. 269 6 12 mS, p < 0.001), as well as in a CD1 genetic
background (209 6 21 vs. 469 6 11 mS). Reduced SC hydration was seen from 3 days after birth.
SC hydration in hairless wildtype and AQP3 null mice was reduced to comparable levels (90±
100 mS) after 24 h exposure to a dry atmosphere, but the difference was increased when surface
evaporation was prevented by occlusion or exposure to a humidi®ed atmosphere (179 6 13 vs.
441 6 34 mS). Conductance measurements after serial tape stripping suggested reduced water
content throughout the SC in AQP3 null mice. Water sorption-desorption experiments indicated
reduced water holding capacity in SC of AQP3 null mice. The impaired skin hydration in AQP3
null mice provides the ®rst functional evidence for the involvement of AQP3 in skin physiology.
Modulation of AQP3 expression or function may thus alter epidermal moisture content and water
loss in skin diseases.
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CRH is an Autocrine Hormone for Human Sebocytes Promoting Lipogenesis
C.C. Zouboulis, H. Seltmann, N. Hiroi,*² W. Chen,³ M. Young,² W.A. Scherbaum,* C.E.
Orfanos, S.M. McCann,³ and S.R. Bornstein*²
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
Berlin, Germany; *Department of Endocrinology, University Medical Center, Heinrich Heine University,
Duesseldorf, Germany; ²Pediatric and Reproductive Endocrinology Branch, National Institute of Child
Health and Development, National Institutes of Health, Bethesda, Maryland, U.S.A.; ³Department of
Dermatology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; §Pennington
Biomedical Research Center, Baton Rouge, Louisiana, U.S.A.
Sebaceous glands seem to be involved in the hypothalamic-pituitary-adrenal (HPA) axis equivalent
pathway in skin as they express neuropeptide receptors. Corticotropin-releasing hormone (CRH)
is the most proximal element of the HPA axis. Recent work has shown the presence of the CRH
system in human skin and lately in human sebaceous glands therefore we investigated the
expression of CRH, CRH-binding protein (CRH-BP) and CRH receptors (CRH-R) in SZ95
sebocytes in vitro and their regulation. CRH, CRH-BP, CRH-R1 and CRH-R2 were detectable
in SZ95 sebocytes at the mRNA and protein levels. CRH-R1 was the predominant type (CRH-
R1/CRH-R
2
= 2). CRH was biologically active on human sebocytes: It induced biphasic
regulation of sebaceous lipids with a maximum stimulation at 10
±7
M and up-regulated mRNA
levels of 3b-hydroxysteroid dehydrogenase/D5-4 isomerase. It did not affect cell viability,
proliferation or IL1b-induced IL-8 release. CRH, dehydroepiandrosterone and 17b-estradiol did
not regulate CRH-R expression. Testosterone at 10
±7
M down-regulated CRH-R1 and CRH-
R2 mRNA expression at 6±24 h, GH switched CRH-R1 mRNA expression to CRH-R2 at 24 h.
Therefore, CRH is a autocrine hormone for human sebocytes with a homeostatic lipogenic
activity. Testosterone and GH induce CRH feedback mechanisms. The ®ndings implicate a
possible involvement of CRH in the clinical development of acne, seborrhea, androgenetic
alopecia, skin aging, and xerosis.
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Regulated Ras Function in Transgenic Skin Demonstrates Potent and Reversible Ras
Effects on Epidermal Growth and Differentiation
M. Tarutani, M. Dajee, T. Cai, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
In many tissues, Ras GTPases regulate key processes of relevance to carcinogenesis, including
cellular proliferation and differentiation. In epidermal cells, the role of Ras has been controversial.
Some studies have demonstrated that Ras promotes cell division and inhibits differentiation while
other work reports the opposite. A major limitation of this prior work is that it was performed in
cultured cells subjected to constitutive Ras signaling. To avoid these potentially confounding
issues, we have generated 3 independent lines of transgenic mice expressing an inducible Ras N-
terminal fusion to a hydroxytamoxifen (OHT)-responsive mutant estrogen receptor ligand binding
domain (K14-ER:Ras mice). OHT-inducible epidermal Ras function in vivo was con®rmed by
up-regulation of levels of active GTP-bound Ras within epidermal tissue and by enhanced
phosphorylation of the Ras target MAP kinase (MAPKs ERK1 and ERK2). Ras induction rapidly
stimulated epidermal proliferation, increasing the epidermal mitotic index and boosting the
number of cells per 100 mm of basement membrane zone by > 5-fold within one week. Con¯uent
papillomatosis appeared by 7±10 days of OHT treatment. Ras induction disrupted differentiation,
with loss of normal granular layer formation, induction of keratin 6 and development of prominent
parakeratosis. Control mice treated with OHT or ethanol diluent displayed none of these changes.
Ras-induced effects were entirely reversible upon cessation of OHT, indicating a central role for
Ras in sustaining enhancement of growth and abnormal differentiation. This in vivo approach to
regulated Ras induction within epidermis indicates that Ras promotes cellular proliferation and
inhibits normal terminal differentiation.
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Caspase-14 Auto-Processes In Vitro, Generating Active Recombinant Enzyme
T. R. Hathaway, M. K. Kuechle, R. B. Presland, and B. A. Dale
Medicine, Division of Dermatology, University of Washington, Seattle, Washington, U.S.A.
Caspase-14 is a recently described member of the caspase family of cysteine proteases, which is
expressed and activated in the upper living cell layers and adnexal structures of the epidermis. All
caspases, including caspase-14, are expressed as inactive proenzymes which are cleaved at internal
aspartate residues to generate the active enzyme, consisting of large and small subunits. Caspase
family proteins function as key effectors of apoptosis and in¯ammation by cleaving a wide variety
of cellular substrates. Both in-vivo and in-vitro data suggest there is a great deal of overlap between
epidermal terminal differentiation and apoptosis. Based on its location and structure, caspase-14 is
likely to function in the terminal differentiation of epidermal keratinocytes. To prepare caspase-14
for in-vitro studies, we have successfully expressed recombinant mouse caspase-14 in E. coli.
Puri®ed recombinant caspase-14 exhibits evidence of auto-processing in-vitro, with generation of
large and small subunits. At this time, we are employing numerous approaches to identify
substrate(s) of caspase-14 using our puri®ed active recombinant enzyme.
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FLIM for Measurement and Localization of Stratum Corneum pH
M.J. Behne,*² K.M. Hanson,³ N.P. Barry,³ R.M. Clegg,³ K. Feingold,* WM. Holleran,*² P.M.
Elias,*² and T.M. Mauro*²
*Dermatology, UCSF, San Francisco, California, U.S.A.; ²Dermatology, VA Medical Ctr, San Francisco,
California, U.S.A.; ³LFD, Department of Phys, UI, Urbana, Illinois, U.S.A.
We previously reported the importance of an acidic stratum corneum (SC) pH for optimal barrier
recovery (Arch. Derm. Res. 290: 215, 1998). However, investigations into the mechanisms
responsible for SC acidi®cation and the putative SC-pH gradient have been limited by current
methodology. Here we apply ¯uorescence-lifetime imaging (FLIM) to simultaneously capture and
localize pH within intact epidermis. Topical applications of the ¯uorescent dye BCECF allow
concentration independent pH measurements throughout the epidermis without the necessity for
tape-stripping, accessing deeper tissue layers only optically. We ®rst correlated FLIM pH
measurements with a biochemical pH-surrogate, b-Glucocerebrosidase (GlcCer'ase) activity,
which in vitro and in vivo is activated by acidic pH (J Lip. Res. 40: 861, 1999). FLIM reveals areas of
acidic pH at the surface, throughout the SC, and at the SG/SC interface, where conventional
methods measure only an average neutral pH. These acidic `microdomains' coincide with
increased GlcCer'ase acitivty. Next we compared SC pH in NHE1 knockout vs. wild-type animals
by FLIM, and have found alterations consistent with antiporter SC pH regulation. A functional
NHE1 is essential for barrier homeostasis, because both pharmacologic inhibition and transgenic
knockout of NHE1 impair lipid processing and delay barrier repair. Finally, in newborn rats, we
studied the postnatal development of SC acidity. Our initial results suggest a two-component
development of SC acidi®cation during the ®rst postnatal week, partly from extrinsic acidity,
possibly supplied by breakdown products of the periderm, and an intrinsic contribution, possibly
due to increasing NHE1 activity. In summary, FLIM visualizes pH in intact tissue with great detail,
and will allow to elucidate the origin and role of the SC pH gradient, as well as other ionic
gradients.
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Defective Epidermal Barrier Recovery and Reduced Skin Elasticity in Aquaporin-3 Null
Mice
M. Hara,*² T. Ma,* S. Inoue,² and A. S. Verkman*
*Departments of Medicine and Physiology, Cardiovascular Research Institute, University of California, San
Francisco, San Francisco, California, U.S.A.; ²Basic Research laboratory, Kanebo Ltd, Odawara,
Kanagawa, Japan
Aquaporin-3 (AQP3) is a water/solute transporting protein expressed in epidermal keratinocytes.
In an accompanying abstract, we report impaired stratum corneum hydration and decreased
epidermal water and glycerol permeability in AQP3 null mice in the hairless SKH1 genetic
background. To investigate whether AQP3 plays a role in epidermal barrier function and skin
mechanical elasticity, comparative measurements were made on wildtype and AQP3 null mice.
Stratum corneum morphology, transepidermal water loss and lipid composition were not affected
by AQP3 deletion, suggesting normal epidermal barrier function in unperturbed AQP3 null mice.
However, transepidermal water loss measurements showed that barrier recovery after removal of
the stratum corneum by tape-stripping was delayed signi®cantly at 2 and 6 h in AQP3 null mice (54
6 2% vs. 75 6 4% recovery at 6 h, p < 0.01). Further measurements of epidermal biosynthetic
function and stratum corneum composition are needed to determine the mechanism for delayed
barrier recovery in the AQP3 null mice. Skin elasticity was measured by cutometry using a 2-mm
diameter suction probe and 50 mbar pressure transients. The parameters Uv/Ue (viscosity, 0.53 6
0.07 vs. 0.31 6 0.05, p < 0.05) and Ur/Uf (biological elasticity, 0.56 6 0.05 vs. 0.73 6 0.04, p
< 0.05) were changed in AQP3 null mice, indicating reduced viscoelasticity. These parameters
became similar after removal of the stratum corneum by tape stripping or by exposure to a dry
atmosphere for 24 h, indicating that differences in stratum corneum mechanical properties account
for the difference in mechanical properties. These results indicate that AQP3 is an important
determinant of epidermal barrier recovery and skin elasticity.
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The Cell Sorted Skin Equivalent as a Model for Basement Membrane Formation
D. R. Finlay, J. M. Lievers, S. D. Purdy, and W. K. Hoef¯er
CeSSE Skin Program, Xgene Corporation, San Carlos, California, U.S.A.
Human skin can be accurately modeled by use of the Cell Sorted Skin Equivalent (CeSSE) that
relies on the inherent cell adhesive properties of keratinocytes and dermal ®broblasts to sort-out
into distinct layers from the mixed cell slurry when transplanted onto SCID mice (J Invest Derm
2000, 114 : 674). This in vivo method results in formation of a skin equivalent with a clearly de®ned
dermis, epidermis, and basement membrane zone. Electron microscopy has revealed that this in
vivo CeSSE has normal architecture along the dermal/epidermal junction. We have recently
extended this cell sorting method to an in vitro system. As with the in vivo method the keratinocytes
and ®broblasts sort out into separate dermal and epidermal layers separated by a de®ned basement
membrane zone. Here we characterize this in vitro BMZ using antibodies against junctional
antigens. The in vitro CeSSE stained with anti-Collagen IV showed a sharp demarcation of signal at
the dermal epidermal junction extending down into the dermis. Staining with an antilaminin
antibody which reacts with the 400 kDa fragment (B1 portion) of intact laminin results in a ®ne
linear signal at the junction. We believe this indicates that the in vitro CeSSE forms a BMZ similar
to that found in normal human skin and should provide an excellent format in which to further
pursue the formation of the basement membrane zone. Proper junction formation at the BMZ is
important in wound healing and skin grafting where blister formation is a problem. In addition the
BMZ also plays an important role in the bioavailability of topically applied substances to the dermis
and dermal vessels. For this reason the presence of a properly formed BMZ is an important step in




P.M. Steinert, L. Marekov, M. Raghunath,* H. Traupe,* K. Boeshans, and B. Ahvazi
Laboratory of Skin Biology, NIAMS NIH, Bethesda, Maryland, U.S.A.; *Department of Dermatology,
University of Munster, Munster, Germany
Several transglutaminase (TGase) isoforms are expressed in the epidermis and are important for
formation of the corni®ed cell envelope barrier structure. TGases are normally assayed in the
laboratory undernon-physiological conditions. Here we have performed enzyme reactions in
altered pressure conditions that more closely mimic those encountered in intact tissues. Human
TGases 1, 2 and 3 were expressed in and puri®ed from baculovirus. Membrane-bound TGase 1
was recovered and used in two ways: bound to insect membranes, or freed of membranes. All four
enzyme samples were then assayed in standard solution assays but under conditions of increased
pressure (up to + 120 mmHg). The rates of reaction of TGases 2 and 3 and the soluble form of
TGase 1 decreased by 20±30% in the range of 100±120 mm of pressure. However, with TGase 1
on membranes, activity decreased by 50% at > 80 mm of pressure. Examination of the three-
dimensional structures of TGases reveal two unusual nonproline and one proline cis peptide bonds
in the vicinity of the active site. One of the nonproline cis bonds stabilizes the proline cis bond, so
together, these unusual bonds cooperate to stabilize enzyme structure. In addition, the proline cis
bond undergoes rapid cis-trans isomerization. When in the cis form, the enzymes are active. In the
trans form, temporarily stabilized by insertion of additional water molecules, the enzymes are
inactive. We speculate that pressure ¯uctuations can affect the water content around these bonds,
the cis-trans isomerization equilibrium, and thus the resulting amount of active and inactive forms.
Membrane-bound TGase 1 activity is especially sensitive to these pressure differences and this may
be of physiological signi®cance during fetal development vs. life in dry air.
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The Keratinocyte-Speci®c Protein, KCS-1, is a New Marker of Epidermal
Differentiation
S. Tsuchida, M. Bonkobara, J. McMillan,² Y. Aragane,* J. Takao, T. Tezuka,* H. Shimizu Jr,² P.
Cruz, and K. Ariizumi
Dermatology, The University of Texas South-western Medical Center, Dallas, Texas, U.S.A.;
*Dermatology, Kinki University School of Medicine, Osaka, Japan; ²Dermatology, Hokkaido University
School of Medicine, Sapporo, Japan
To identify novel genes encoding proteins secreted by KC, we conducted a signal sequence (SS)
trap of a human KC cDNA library. We identi®ed KCS-1, which encodes a polypeptide of 99 a.a.
with SS, has no signi®cant homology to known proteins, contains no cysteine residues, but has
several leucine residues at sites of hydrophobic interaction. KCS 3 1 mRNA is expressed
abundantly in skin and mucosae, minimally in thymus, and not in other organs, indicating
epithelial restriction. To study biochemical properties, we transfected COS-1 cells or dermal
®broblasts with KCS-1 gene and examined protein expression by Western blotting. We detected a
single band of 10.5 KD in supernatants, but not in cell extracts, con®rming KCS-1 secretion. By
contrast, transfected KC or HaCaT cells produced large amounts of proteins intracellularly, with
little detected in supernatants, indicating a KC mechanism preventing secretion. Immunoelectron
microscopy showed accumulation of KCS-1 protein in intracellular vesicles of KC. To study
effects of KC differentiation, we examined 1o cultured KC shifted from low to high [Ca++]
media. mRNA was barely detectable in low [Ca++] KC, but up-regulated 60-fold after exposure
to high [Ca++]. In situ hybridization of normal skin showed no mRNA expression in basal KC,
but abundant expression in suprabasal KC. By contrast, immunohistochemistry revealed protein
expression in normal skin limited to the granular layer in a pattern mimicking that of ®laggrin.
Finally, we examined KCS-1 protein in psoriatic skin and found it overexpressed in suprabasal KC.
We conclude that KCS-1 is a novel, small protein expressed by KC during differentiation, trapped
intracellularly preventing secretion, and incorporated into the corni®ed envelop. Finally, because
KCS-1 properties simulate those of ela®n and cystatin-a, we are testing the possibility that KCS-1 is
a protease inhibitor.
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The GTPase Rho Mantains Keratinocytes in an Undifferentiated State Through a
Speci®c Effector: Citron-Kinase
M. Grossi, E. Calautti, A. Lyubimova, S. Cabodi, and G. Dotto
CBRC, MGH East, Massachusetts General hospital, Charlestown, Massachusetts, U.S.A.
The Rho family of small GTPases has been shown to be involved in the organization of the actin
cytoskeleton as well as control of cell adhesion, cell cycle progression and, further downstream,
transcription. In our study we have explored the role of RhoA in differentiation of primary mouse
keratinocytes. We used an adenoviral vector expressing an activated form of Rho (Rho-V14) or
we blocked the function of the endogenous protein with the C3 toxin, which speci®cally
inactivates this GTPase. We have found that Rho activation exerts a negative role on keratinocytes
differentiation marker expression, while it has no effect on keratinocyte growth control. This is an
unexpected result in view of our recent ®nding that the activity of Rho increases during
keratinocyte differentiation and is required for the establishment of cell-cell adhesion, an event
which is associated with the differentiation process (Calautti et al JCB 2002 January 7; 156(1): 137±
48). However analysis of different effectors of the Rho GTPase revealed that the Ser-Thr kinase
CRIK (Citron-kinase) is speci®cally down-modulated after differentiation. Like activated Rho,
over-expression of the activated form of CRIK by adenoviral vector infection inhibits
differentiation markers expression, while no such inhibition is caused by over-expression of
PRK2, the effector of Rho which is required for the establishment of cell-cell adhesion. Our
results suggest that the Rho/CRIK pathway is important for the maintenance of keratinocytes in
an undifferentiated state and that this pathway is switched-off during differentiation by down-
modulation of CRIK expression.
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Human Serum (But Not Plasma) Promotes Keratinocyte Migration Via MAP Kinase
Pathway and MMP Production
G. Henry, W. Li, W. Garner, and D. Woodley
Medicine/Surgery, University of Southern California, Los Angeles, California, U.S.A.
A critical step in healing skin wounds is the lateral migration of human keratinocytes (HKs) over
the wound bed. HKs in the unwounded state are programmed to differentiate into a strati®ed
squamous epithelium, but when the skin is wounded, these cells enter a highly migratory mode.
The process that initiates re-epithelialziation is not known. In acute wounds HKs at the disrupted
edge are exposed to serum, rather than plasma, for the ®rst time. In this study, we examined the
capacity of human serum and human plasma to drive HK migration. Two well-established,
independent, HK migration assays were used to assess HK migration on collagen I, a component of
the wound bed. Assays were performed with HKs in the presence of human serum, human plasma
or medium without plasma, serum or growth factors. We analyzed three biological parameters
related to wound healing and HK migration: (1) formation of lamellipodia/®lopodia; (2)
expression of matrix metalloproteinases and (3) activation of the p38 MAP kinase signal
transduction pathway. We found that human serum signi®cantly promoted HK migration on
collagen, whereas human plasma did not (MI = 35% vs.15%), similar to the lack of migration
enhancement seen in the growth factor absent condition. Serum, but not plasma, altered the
morphology of the HKs towards a migratory phenotype with polarized lamellipodia and ®lopodia.
Human serum-activated the p38 MAP kinase signal transduction pathway which is critical for HK
motility. Finally, we found that serum, but not plasma, signi®cantly increased the expression of
HK-derived MMP-9, a major metalloproteinase associated with HK motility. We conclude that
human serum, but not human plasma, promotes HK migration. Serum promotes HK migration by
altering the HK phenotype, by activating the p38 MAP kinase pathway and by increasing
expression of MMP-9. These ®ndings provide an explanation for how human serum in acute
wounds promotes the re-epithelialization of skin wounds.
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First Evidences For the Involvement of E-Cadherins in Stretch Stimulated Cell
Proliferation
A. Bernd, F. Kauer, R. Kaufmann, and S. Kippenberger
Dermatology, JW Goethe University School of Medicine, Frankfurt/M., Germany
Cadherins mediate calcium dependent homophilic cell-cell adhesions and are thought to be
involved in cell migration and proliferation with implications to tumor invasion. Adhesion
molecules can mediate mechanical impulses and cause mitogen cell reactions in different cell
species as demonstrated for ?1 integrins. In this study we investigated the hypothesis that E-
cadherins might be involved in the mechano transduction of human epidermal cells. For this
purpose A-431 cells were stably transfected with an inducible E-cadherin construct lacking the
extracellular domain (kindly provided by K.R. Johnson, Toledo, USA). These Cells were
cultivated in ¯exibl silicon dishes and consecutively stretched twice for 5 min each with a time
interval of two hours. After 24 h the incorporation rate of BrdU was determined using a cell
proliferation assay (Roche, Mannheim, Germany). Stretching of A-431 cells containing vectors
without the truncated cadherin construct enhanced the BrdU incorporation rate by about 3±5
times. Cells expressing the E-cadherin mutant showed an attenuated response to cell stretch. These
results indicate an involvement of E-cadherins in the stretch induced growth stimulation in A-431
cells.
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Characterization of the Stratum Corneum of Streptozotocin-Induced Diabetic Hairless
Mice
S. Sakai, Y. Endo, T. Sugawara, N. Ozawa, A. Kusaka, T. Sayo, S. Inoue, and H. Tagami*
Basic Research Laboratory, KANEBO.LTD., Odawara, Kanagawa, Japan; *Department of Dermatology,
Tohoku University School of Medicine, Sendai, Japan
Diabetes is a major lifestyle disease, and insulin has been reported to play an important role in the
proliferation and differentiation of keratinocytes. In this study, we evaluate the effects of diabetes
on the functions of the stratum corneum (SC). We measured the TEWL, high-frequency
conductance, and water-holding capacity of the SC of streptozotocin (STZ)-induced diabetic
hairless mice, and then we analyzed the intercellular lipid and amino acid contents in the SC. We
also analyzed the epidermal DNA content, PCNA-positive keratinocytes, and epidermal
(pro)®laggrin using corresponding antibodies. In the STZ-group, the epidermal DNA content
and PCNA-positive keratinocytes showed suppressed proliferation of keratinocytes. Compared
with the control animals, the STZ-group also exhibited signi®cantly lower high-frequency
conductance, as well as a lower water-holding capacity of the SC, although the TEWL remained
normal. The amino acid content in the SC was slightly higher in the STZ group, whereas
epidermal (pro)®laggrin, a precursor protein of SC amino acids, was unchanged. The triglyceride
content (per unit area) was signi®cantly lower in the STZ-group than in the control, while the
ceramide, cholesterol, and free fatty acid contents were all higher. Thus, the STZ-induced diabetes
in mice apparently impaired the moisture characteristics of the SC without affecting the barrier
function or SC amino acid content. These ®ndings suggest that the moisture conditions of the SC
in a hyperglycemic condition are regulated by factors other than the intercellular lipid and amino
acid contents in the SC.
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NMDA Type Glutamate Receptor is Associated with Cutaneous Barrier Homeostasis
S. Fuziwara, K. Inoue, and M. Denda
Skin Biology Research Laboratories, Shiseido Life Science Research Centre, yokohama-shi, Kanagawa-ken,
Japan
Previous reports suggested that calcium ¯ux on epidermal keratinocytes played a crucial role in skin
barrier homeostasis. To clarify the mechanism of ion dynamics in the epidermis, we studied the
role of the glutamate-gated ion channel on keratinocytes. Effects of glutamate receptor agonists and
antagonists on skin barrier homeostasis were studied using hairless mouse. Topical application of L-
glutamate, L-aspartate, and N-methyl-D-aspartate (NMDA) delayed barrier recovery rate after
barrier disruption with tape stripping. The non-NMDA type receptor agonist, a-amino-3-
hydroxy-5-methyl-4-isoxazole propionate (AMPA), did not affect the barrier recovery. On the
other hand, topical application of MK801, an NMDA type receptor antagonist, accelerated the
barrier repair. Topical application of MK801 also improved the epidermal hyperplasia induced by
acetone treatment under low environmental humidity. Immediately after barrier disruption on skin
organ culture, secretion of glutamate from skin was signi®cantly increased. Furthermore we
elucidated the translocation of glutamate to basal keratinocytes from stratum granulosum after tape
stripping on isolated skin organ culture. Immunohistochemistry and RT-PCR assay showed an
expression of an NMDA type receptor-like protein on hairless mouse epidermis. We also
demonstrated that calcium in¯ux in human normal keratinocyte culture was induced by NMDA
and it was prevented by pretreatment with MK801. These results suggest that glutamate plays an
important role as a signal of cutaneous barrier homeostasis via NMDA receptor and that regulation
of glutamate receptors is potentially useful novel therapeutic strategy for skin diseases, which show
barrier abnormalities and epidermal hyperplasia.
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Overexpression of GlucosylCeramide Synthase Protects Keratinocytes Against
Ceramide-Induced Stress
W. M. Holleran,*² Y. Uchida,* S. Murata,* M. Behne,* J. D. Lee,* S. Ichikawa,³ Y.
Hirabayashi,³ and P. M. Elias*
*Dermatology, UCSF & V.A. Medical Center, San Francisco, California, U.S.A.; ²Pharmaceutical
Chemistry, UCSF, San Francisco, California, U.S.A.; ³Brain Science Institute, RIKEN, Wako, Japan
Ceramides (Cer) are not only critical for epidermal barrier function, but also inhibit keratinocyte
proliferation and induce apoptosis, while glucosylceramides (GlcCer) exert pro-mitogenic effects.
Since alterations in Cer-to-GlcCer ratios appear to modulate cellular growth vs. apoptosis, we
assessed whether overexpression of GlcCer synthase, responsible for GlcCer synthesis, in cultured
human keratinocytes (CHK) attenuates the adverse effects of increased cellular Cer levels.
Treatment of control CHK with exogenous sphingomyelinase (SM?ase), a standard model for
induction of endogenous Cer levels, causes an initial (0±8 h) marked decrease in both
sphingomyelin content and cell proliferation. Proliferation recovered thereafter, reaching normal
rates by 24 h, in parallel with signi®cant increases in both GlcCer synthesis ([3H]-L-serine
incorporation) and GlcCer synthase activity, changes attributed to antecedent increases in GlcCer
synthase mRNA and protein levels. Overexpression of GlcCer synthase in immortalized,
nontransformed HaCaT keratinocytes, resulted in a two-fold increase in GlcCer synthesis, and a
corresponding increase in GlcCer content (i.e. 2.6-fold), over control (mock-transfected) cells.
Although baseline proliferation was not altered between the GlcCer synthase-overexpressing and
mock-tranfected cells, SM'ase treatment only diminished proliferation in mock-transfected HaCaT
cells similar to that seen in CHK; i.e. HaCaT cells that overexpress GlcCer synthase were resistant
to this antiproliferative effect. These results demonstrate that SM'ase-induced stress initiates a
response in keratinocytes, which includes the up-regulation of GlcCer synthesis to protect against
the deleterious effects of excess Cer. Given that a variety of stressors, including ultraviolet light,
increase keratinocyte Cer levels, the production of GlcCer may represent a general protective
mechanism against membrane-initiated cell death in keratinocytes.
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The Effects of Multilamella Emulsion on Corticosteroid-Induced Skin Atrophy and
Barrier Impairment
S. Jeong,*² Y. Kim,* E. Lee,² J. Youm,³ B. Park,³ and S. Lee²
*Department of Dermatology, Yonsei University College of Medicine, Seoul, South Korea; ²Central
Research Laboratory, Aekyung Co., Ltd, Daejon, South Korea; ³Laboratory, Neopharm Co., Ltd, Daejon,
South Korea
Skin atropy is one of the most frequent side-effects of topical and systemic application of
corticosteroid and skin barrier impairment is also reported as a steroid induced adverse effect.
Although there have been various studies about preventing or minimizing the atrophogenic effect
of steroid, little has been reported about the prevention of barrier impairment. In a previous study,
lipid mixtures expressing multilamellar emulsion structure (MLE) were shown to be able to
attribute to the recovery of the skin barrier recovery. In this study, we have tested the effects of
MLE, used as a vehicle, on the barrier impairment and skin atrophy induced by topical application
of corticosteroids. For the experiments, two kinds of corticosteroids, hydrocortisone (HC) and
clobetasol-17-propionate (CP), with conventional formulation and MLE formulation (M/H and
M/C, respectively) were topically applied at each ¯ank of hairless mouse for 4 weeks. And the
functional study for barrier impairment evaluation and histologic study for epidermal thickness
measurement were conducted. Measurement of the trans-epidermal water loss (TEWL) value
showed that M/H and M/C treated skin had signi®cantly less (p < 0.05) increase in TEWL value
compared with HC and CP treated, respectively. And the skin surface capacitance value showed
less (p < 0.05) decrease for the M/H treated skin compared with the HC treated skin, whereas the
M/C and CP treated skin showed nearly same pro®les. These results suggest that the MLE
formulation with steroids should be effective in preventing the barrier impairment induced by
corticosteroid. As for the epidermal thickness measurement using light microscopy, the M/H and
M/C treated skin showed slightly less decrease than HC and CP treated skin, but it was not
statistically signi®cant (p > 0.05).
293
The Characterization of Lamellar Structure of Arti®cial Stratum Corneum Lipids
Emulsion
B. Park, J. Youm, E. Choi,* and S. Lee²
Laboratory, Neopharm Co., Ltd, Dae Jeon, South Korea; *Dermatology, Yonsei University Wonju College
of Medicine, Wonju, South Korea; ²Dermatology, Yonsei University College of Medicine, Seoul, South
Korea
Recently, atopic dermatitis patients use a variety of moisturizers containing ceramide and
pseudoceramide. There have been several research results which pointed out the importance of
optimum composition and the lamellar structure on the recovery of the damaged skin. The
purpose of this study was to investigate the structural similarity of the lamellar structure between
natural ceramide multilamellar emulsion (MLE) and pseudoceramide mulsion MLE. The lamellar
structure of them have been investigated by DSC, TEM and XRD. The arti®cial stratum corneum
lipids composed of pseudo-intercellular lipid components, ceramide III as a natural ceramide or
myristyl/palmityl-oxo-stearamide/arachidamide MEA as a pseudoceramide, fatty acid and
cholesterol in combination with amphiphillic molecule. These arti®cial stratum corneum lipids
were emulsi®ed by phase transition emulsi®cation method resulted in multilamellar emulsions in
which each emulsion droplet showed concentric lamellar structure under the cross polarized
microscope (3400). The lamellar structure of the emulsions were studied by TEM after RuO4
post®xation. TEM results showed that the arti®cial stratum corneum lipids of MLEs were all self-
assembled with well ordered lamellar structure. There was not sigini®cant difference between
natural ceramide MLE and pseudoceramide MLE in the microscopic obserbation. The small angle
XRD showed that main distance of lamellar layers was 5.808 nm (2q = 1.520) and the wide angle
XRD showed the distance of alkyl chain was 0.411 nm (2q = 21.615). With these results, we
concluded that the alkyl chains of arti®cial stratum corneum emulsion are hexagonally packed
within well ordered lamellar planes and rotated similar with the intercelluar lipids in stratum
corneum.
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Artemia Extract `Compensates' for Age-Related Decrease of Hsp70 in Skin
K. Cucumel, C. Dal Farra, and N. Domloge
Research Center, Vincience, Sophia Antipolis, France
Heat shock proteins play an essential role in protecting cells from various types of stress. It is known
that aged skin has less defense against stress such as UV. At the same time, prior studies have shown
that aged skin may exhibit a normal constitutive level of Hsp70. Our prior studies have shown that
treatment of human skin with Artemia extract `AE' induces Hsp70 in skin cells in a stress-free
manner. In these studies, we investigated Hsp70 level in aged skin stressed with UVB, with and
without Hsp induction by Artemia extract. Punch biopsies from 10 volunteers, between the ages of
50 and 70, were cultured for 24 h. AE was administered in half of the samples. Then, Hsp70
expression was studied in all skin samples by immunostaining, before and 24 h after their exposure
to UVB (100 mJ/cm
2
). Parallel studies were conducted on skin samples from ®ve younger
volunteers (between the ages of 31 and 40). Our results showed that in stress-free conditions, both
aged and younger skin exhibit similar levels of constitutive Hsp70 in the epidermis and super®cial
dermis. After UV stress, aged skin failed to produce more Hsp70 and exhibited a strong decrease in
Hsp70 level. In contrast, the Hsp70 level of younger skin increased signi®cantly. Interestingly, aged
skin where Hsp70 was induced by AE prior to UV stress, exhibited a higher level of Hsp70, similar
to younger skin. Moreover, H&E staining studies showed that this induction of Hsp70 by AE,
enhanced aged skin defense from UV damage. These skin samples showed a decrease in UV-
damage signs, such as apoptotic `sun burn' cells, compared to the untreated aged skin. These studies
con®rm the fragility of aged skin toward UV stress and offer a very interesting application of AE for
increasing Hsp70 in aged skin and therefore for protecting aged skin from stress.
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Treatment of Human Cells with Artemia Extract Helps to Restore the Decrease in
Hsp70 Level Caused by Cell Treatment with `All Trans Retinoic Acid'
E. Bauza, K. Cucumel, C. Dal Farra, and N. Domloge
Research Center, Vincience, Sophia Antipolis, France
Earlier data have shown that long-term treatment with Retinoids induces a post-transcriptional
decrease of constitutive Hsp70 level. Hsp70 is critical for skin protection from different types of
stress, and is particularly critical for protection from UV stress. In the focus on mechanisms of cell
defense, our prior studies have shown that Artemia extract (AE) induces Hsp70 in human cells and
enhances cell protection from UV stress. In these studies, through immunoblotting, we
investigated Hsp70 protein level after the administration of AE to human ®broblasts treated with
`All trans Retinoic Acid' (ATRA) for a prolonged time (up to 7 weeks). These studies con®rmed
that ATRA administration into the cells decreases Hsp70 protein level. Surprisingly, this effect was
seen within the ®rst week of ATRA administration. Moreover, a general decrease in constitutive
Hsp70 accompanies this in vitro aging of the cells. Interestingly, long-term treatment of cells with
ATRA (for 3±7 weeks) seemed to maintain more than a minimal Hsp70 level in these `in vitro-
aged' cells, but not to the physiological control level. At the same time, AE administration
signi®cantly restored Hsp70 to a level which approached the control constitutive level. Moreover,
as IL-1 represents another important mechanism of cell defense, and as our prior studies have
shown that AE reduces in¯ammatory cytokines, we performed ELISA studies that showed that AE
modulates IL-1 in ATRA-treated cells to approach the physiological level. These results propose
an interesting role for Artemia extract in ATRA-treated cells, which may help skin defense and
comfort during therapy with Retinoids.
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Multiple Keratinocyte Subpopulations Occur During Wound Re-Epithelialisation
G. K. Patel, C. Wilson,² D. Grif®ths,* A. Y. Finlay, K. G. Harding,² and P. E. Bowden
Dermatology, UWCM, Cardiff, U.K.; *Pathology, UWCM, Cardiff, U.K.; ²Wound Healing Unit,
UWCM, Cardiff, U.K.
Keratinocytes involved in wound re-epithelialisation have altered keratin ®lament composition,
reduced cell-cell adhesion, altered integrin expression and form both lamellapodia and focal
contacts to allow migration. Suprabasal keratinocytes become `activated' within 36 h of injury and
reduce differentiation-speci®c keratin (K1, K2e, K10) expression and increase expression of
inducible keratins (K6, K16 and K17). However, it remains unclear if these `activated'
keratinocytes form a single population of cells and if all of them are involved in migration across
the wound bed. In a study of 10 individuals, biopsies were taken from the wound edge at 1, 2, 3, 4,
6 and 8 days after initial wounding (`polo' biopsy technique). Immuno¯uorescence and
immunohistochemistry with speci®c antibodies against keratins (K5, K6, K10, K14, K16, K17),
integrins (a3, a5, a6, aV) and Ki67 were used to characterise keratinocyte populations. We
identi®ed 4 distinct keratinocyte phenotypes during re-epithelialisation of acute and chronic
wounds, characterised by differential expression of keratins (K5-K14 positive, K6-K17 positive,
K6-K16-K17 positive and K1-K10 positive). Only the K5-K14 subgroup display integrin
expression characteristic of migrating keratinocytes (a3, a5) and these remain in a basal position as
they migrate over the wound bed. The leading suprabasal keratinocytes express K6-K17 while cells
further back express K6-K16-K17. Furthermore, the activated keratinocytes at the wound edge
(K6-K16-K17 positive) form a different cell population from the differentiating cells (K1-K10
positive). Thus, the cell and molecular biology of wound re-epithelialisation is more complex than
perceived to date.
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Het-Cam Test Combined with Histological Studies for Active Ingredient Innocuity
Evaluation
N. Domloge, Z. Djabari, and C. Dal Farra
Skin Research, Vincience, Sophia Antipolis, France
In the search for alternative methods to animal testing, Het-Cam test (Hen's egg test on
chorioallantoic membrane) takes a central place in evaluating the innocuity of active ingredients.
Therefore, we combined in the following studies Het-Cam test with histological evaluation, in
order to push further sensitivity of the evaluation. Twenty active ingredients from four different
categories of origin of active ingredients (vegetal, marine, biotechnological and chemical synthetic)
were subjects for innocuity evaluation at two different concentrations (pure and 10%). We
performed Het-Cam test and histological evaluation after H&E staining of the chorioallantoic
membrane, in order to microscopically evaluate cellular and vascular aspect and state of damage.
These studies showed that when the active ingredient was diluted (10%), no discrepancy was seen
between classical Het-Cam evaluation and the histological reading of the membrane. The
histological ®ndings corresponded with the visual observation of the membrane. When the active
ingredients were tested pure, 7 out of 20 tested products demonstrated discrepancy between the
two tests. The histological exam revealed in 6 cases histological signs of irritation, such as slight
hyperaemia, while visual Het-Cam evaluation was negative. In another case, the histological exam
revealed a slight haemorrhage while visual evaluation showed only hyperaemia. These results
suggest that combining histological and visual chorioallantoic membrane evaluation (Het-Cam) is
of interest for evaluating more sensitively the innocuity of cosmetic active ingredients, which may
help in avoiding some cases of in vivo intolerance reactions.
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Biosynthesis of Cathepsin D in Human Epidermal Keratinocytes
R. Jans, M. Jadot,* S. Marcoux, M. HeÁrin, and Y. Poumay
Histology-Embryology, University of Namur, Namur, Belgium; *Physiological Chemistry, University of
Namur, Namur, Belgium
The lysosomal protease cathepsin D has been suggested to contribute to keratinocyte
desquamation. In order to investigate possible involvement of cathepsin D during epidermal
differentiation, the enzyme biosynthesis was studied in cultured keratinocytes using autocrine
conditions that de®ne precise proliferation and differentiation stages. Metabolic labeling
experiments followed by immunoprecipitation demonstrate that keratinocytes synthesize cathepsin
D as 52 kDa proenzyme which is processed into 48 kDa intermediate and 31 kDa mature forms,
respectively, detected after 2 and 4 h of chase time lapse. Keratinocytes secrete variable amounts of
52 kDa procathepsin D in any culture condition, from approximately 20% to 70% of newly
synthesized enzyme. Incubation of keratinocytes with ammonium chloride, which perturbs the
mannose 6-phosphate (M6P)-dependent lysosomal targeting pathway, has no signi®cant effect on
procathepsin D secretion, suggesting that its targeting does not solely rely on the M6P-mediated
pathway. Northern blot analysis demonstrates that keratinocytes express cathepsin D mRNAs
without major variation at the analyzed culture conditions. However, Western blot analysis reveals
that the relative amount of mature cathepsin D detected in subcon¯uent cells seems to be up-
regulated after con¯uence, suggesting that cathepsin D expression is regulated at protein level.
Cathepsin D immunolabelings show vesicular lysosomal localization around the nuclei of
subcon¯uent keratinocytes, then progressively distributed in the cytoplasm at con¯uence and
postcon¯uence. In epidermis reconstructed in vitro and in normal tissue, cathepsin D-labeled
organelles are present in living cell layers, but prominent in granular cells. Localization of cathepsin
D in stratum granulosum/corneum transitional keratinocytes suggests involvement of cathepsin D
at the cell periphery. In conclusion, proliferating and differentiating keratinocytes secrete
procathepsin D, suggesting a possible extracellular involvement of this lysosomal protease during
epidermal differentiation.
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Comparative Studies on Different Cell Lines for the Evaluation of Different Classes of
Cosmetic Active Ingredient Innocuity
Z. Djabari, C. Dal Farra, and N. Domloge
Research Center, Vincience, Sophia Antipolis, France
in vitro alternative methods to animal testing have become the priority in the evaluation of the
innocuity of active ingredients for topical use. Among these in vitro methods, the evaluation of the
IC50 (the concentration-inducing 50% inhibition of growth) takes a central place. However, many
discrepancies in ®ndings have been reported in the screening and determination of active
ingredient toxic dose. In order to deepen this point further, we performed the following
comparative studies, using four different cell lines and 12 active ingredients from four different
categories of origin of active ingredients (vegetal, marine, biotechnological and chemical
synthetic). We used 3 samples from each category. The IC50 of viability was determined by
standard MTT and NR methods. Comparison of the results of the different cell lines (human
epidermal HaCat, A431cells, mouse 3T3, and rabbit corneal ®broblasts SIRC cells) showed that
HaCat cells exhibited the highest IC50 for most tested samples. Interestingly, 3T3 and A431 cells
revealed very similar IC50, that were close to the IC50 of SIRC cells in most tests (10/12).
However, a critical difference between the two methods (MTT and NR) was found in 2 products
of marine and biotechnological origin. Considering the origin of the active ingredients, our results
showed that the products of chemical synthetic origin exhibit the lowest IC50. Our studies show
that these four cell lines can be used to determine the IC50 of an active ingredient. However, the
SIRC cells are slightly more sensitive than the others. Moreover, it is helpful to consider both
MTT and NR tests in order to double-check the IC50 for some categories of ingredients, and to
con®rm their toxic dose.
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Interaction of Envoplakin and Periplakin with Cytoskeletal Proteins
A. E. Kalinin, W. W. Idler, and P. M. Steinert
Laboratory of Skin Biology, NIAMS, NIH, Bethesda, Maryland, U.S.A.
Envoplakin and periplakin are members of the family of plakins ± proteins that have been shown to
interconnect components of cytoskeleton: microtubules (MT), actin ®laments (F-actin), and
intermediate ®laments (IF), as well to connect cytoskeletal elements to cell junctional complexes.
Interaction partners of several family members such as desmoplakin, bullous pemphigoid antigen 1,
plectin, and microtubule-actin crosslinking factor (MACF) have been characterized both in vivo
and in vitro, and the domains responsible for these interactions have been identi®ed in most cases.
Nevertheless, there is very limited data yet on cellular interactions of envoplakin and periplakin.
Here we report results of in vitro studies of their interactions with separate cytoskeletal components.
We expressed and puri®ed from bacteria full-length and various domains of human envoplakin and
periplakin, and tested their ability to interact with in vitro assembled F-actin, MT and vimentin IF.
We found that soluble envoplakin/periplakin oligomers bind strongly to F-actin. Head domains of
periplakin, and especially envoplakin, most likely mediated this interaction. In experiments with
MT, we found interaction only with the C domain motif of envoplakin. In the case of IF, notable
binding occurred only with a construct containing the last 232 residues of the periplakin rod and
the whole tail domain. The tail domain itself did not bind to vimentin IF in vitro. This observation
suggests that oligomerization is required for binding of the plakins to the IF.
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Origin of the Epidermal Calcium Gradient: Regulation by Barrier Status and Role of
Active vs. Passive Mechanisms
S. K. Ahn, B. Brown, K. R. Feingold,* and P. M. Elias
Dermatology, VA Medical Center, San Francisco, California, U.S.A.; *Metabolism, VA Medical Center,
San Francisco, California, U.S.A.
Mammalian epidermis displays a characteristic calcium (Ca) gradient, with low Ca levels in the
lower, basal and spinous epidermal layers, while Ca levels increase progressively towards the outer
stratum granulosum (SG), and declining again in the stratum corneum (SC). Since the Ca gradient
disappears after acute permeability barrier disruption, and returns by 5±6 h in parallel with barrier
recovery, barrier function (through restriction of transcutaneous water movement) could regulate
the formation of the epidermal Ca gradient. Two types of experiments con®rmed the role of
barrier status in regulating the Ca gradient: (1) Either a vapor-permeable membrane (GoreTexá)
or an emollient (Vaselineá), applied after acute barrier disruption, immediately restored barrier
function, while accelerating the return of the Ca gradient. (2) In contrast, applications of lovastatin,
a cholesterol synthesis inhibitor, which delayed barrier recovery, retarded the return of the Ca
gradient. We next asked whether the Ca gradient is formed/maintained by passive and/or active
mechanisms. Previous studies have demonstrated that cold exposure (4°C) blocks permeability
barrier recovery after acute disruption. Here, we abrogated the barrier with tape-stripping, and
then compared barrier recovery and restoration of the calcium gradient in hairless mice exposed to
4°C external temperatures, with and without occlusion with GoreTexá. Acutely disrupted,
unoccluded, and cold-exposed sites showed neither barrier recovery nor reappearance of the Ca
gradient at 5 h. Similarly, acutely disrupted, cold-exposed sites, covered with GoreTexá, likewise
displayed little barrier recovery. Yet, in contrast to unoccluded, cold-exposed sites, the Ca gradient
largely returned in cold-exposed epidermis under the GoreTexá dressing by 3 h. These results
show ®rst, that barrier status regulates formation of the Ca gradient, and second, that passive
processes alone can account for formation/maintenance of the Ca gradient.
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Increased Stratum Corneum pH Promotes Activation and Release of Primary Cytokines
from the Stratum Corneum Attributable to Activation of Serine Proteases
J. A. Hachem, A. J. Fowler, M. Behne, J. W. Fluhr, R. Feingold,* and P. M. Elias
Dermatology, VA med center, San Francisco, California, U.S.A.; *Metabolism, VA med center, San
Francisco, California, U.S.A.
The `acid mantle' of the stratum corneum (SC) is crucial for cutaneous permeability homeostasis as
well as SC integrity and cohesion. In response to acute barrier disruption or SC injury, a preformed
pool of primary cytokines (IL-1a) is released from the SC and synthesis of primary cytokine also
increases dramatically. This phenomenon is followed by a downstream cytokine cascade, which
results in in¯ammation. The surface pH of in¯ammatory skin disorders increases in many skin
diseases, such as atopic dermatitis, seborrheic dermatitis and acute eczema. To address the
hypothesis that these pH changes could be critical determinants in initiating cutaneous
in¯ammation, we assessed here: (1) whether increased pH alone stimulates IL-1a and TNFa
activation and release in vivo, and (2) whether these changes are linked to coactivation of serine
proteases in murine epidermis. Exposure of intact murine SC to a neutral pH buffer solution
for < 3 h produced an increase in the level of both IL-1a and TNFa in the SC and stratum
granulosum, as determined by immuno¯uorescence staining and confocal microscopy. Similarly,
applications of a superbase 1% (1,1,3,3-tetramethylguanidine, TMG) in propylene glycol:ethanol,
increase skin surface pH (7.7±8.0) and in parallel increased immunostaining for IL-1a and TNFa
in comparison to a neutralized form of the superbase. Furthermore, as in sites exposed to neutral
pH buffers, abnormalities in both permeability barrier homeostasis and SC integrity/cohesion
occurred in the TMG-treated site. Finally, serine protease activity in mouse epidermis was assessed
using in-situ zymography, and found to be increased in response to SC alkalization with TMG.
These results support the hypothesis that an increase in SC pH initiates the activation/release of
primary cytokines, the earliest initiation of cutaneous in¯ammation and that cytokine activation/
release is associated with pH-related increase in serine protease activation.
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Intracellular Biosynthesis of Ascorbic Acid by Human Keratinocytes and Fibroblasts:
Introduction of Gulonolactone Oxidase
p, Schwartz,*² G. Menon,³ and H. John*²
*Dermatology, VA Connecticut, West Haven, Connecticut, U.S.A.; ²Dermatology, Yale University, New
Haven, Connecticut, U.S.A.; ³Advanced Technologies, Avon Products, Inc., Suffern, New York, U.S.A.
Vitamin C (L-ascorbic acid) is an essential vitamin in man and other primates. Mutations in the
gene for gulonolactone oxidase (GLO) are responsible for the inability of human cells to synthesize
an intracellular supply of ascorbic acid. The tissue concentration of ascorbic acid is particularly
relevant to skin where elevated levels may be useful for minimizing photodamage, preventing skin
cancer and reducing the signs of aging. Increasing the daily oral administration of ascorbic acid does
not increase intracellular levels of the vitamin; at higher daily doses there is decreased bioavailability
due to renal excretion. Topical application of ascorbic acid is limited by problems with formulation
and absorption. To increase intracellular ascorbic acid, we have introduced a functioning GLO
gene into human keratinocytes and dermal ®broblasts. The rat GLO gene, obtained from M.
Nisikimi (Wakayama, Japan), was cloned into a retroviral expression vector and expressed in
primary human keratinocytes, HaCaT cells and human dermal ®broblasts. GLO activity in cell
extracts was measured by a colorimetric assay for synthesis of ascorbic acid from gulonolactone.
Whereas control cells had no GLO activity, transformed cells had GLO activity ranging from 20 to
40 mg ascorbic acid formed/mg protein. These cells will be used to determine if the GLO+ human
cells have gained the capacity to synthesize an intracellular supply of ascorbic acid and to investigate
the activity and morphology of the GLO+ human skin cells.
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Modulations in Epidermal Calcium Regulate the Expression of Differentiation-Speci®c
Proteins
K. Feingold, P. M. Elias,* S. K. Ahn,² B. Brown,* and D. Crumrine*
Metabolism, VA Medical Center, San Francisco, California, U.S.A.; *Dermatology, VA Medical Center,
San Francisco, California, U.S.A.; ²Dermatology, Yonsei University College of Medicine, Seoul, South
Korea
Mammalian epidermis normally displays a distinctive calcium (Ca) gradient, with low levels in the
basal/spinous layers, and high levels in the stratum granulosum (SG). Whereas changes in SG Ca
regulate the lamellar body (LB) secretory response to permeability barrier alterations, whether
modulations in Ca also regulate the expression of differentiation-speci®c proteins in vivo remains
unknown. Since acute barrier perturbations reduce Ca levels in SG, we studied the regulation of
murine epidermal differentiation after loss of Ca accompanying acute barrier disruption and by
exposure of such acutely perturbed skin sites to either low (0.03 mM) or high (1.8 mM) Ca. Three
hours after acute barrier disruption, coincident with reduced Ca and ultrastructural evidence of
accelerated LB secretion, both Northern analyses and In situ hybridization revealed decreased
mRNA levels for loricrin, pro®laggrin, and involucrin in the outer epidermis. Moreover, exposure
of acutely disrupted skin sites to low Ca solutions sustained the reduction in mRNA levels, while
exposure to high Ca solutions restored normal mRNA levels, which was blocked by the L-type
Ca-channel inhibitor, nifedipine. Finally, with prolonged exposure to a low (< 10% RH) or high
(> 80% RH) humidity, Ca levels in the outer epidermis increased and declined, respectively.
Accordingly, with these sustained changes in the epidermal Ca gradient, mRNA and protein levels
of the differentiation-speci®c proteins increased and decreased at low and high RH, respectively.
These results provide direct evidence that acute and sustained ¯uctuations in epidermal Ca regulate
expression of differentiation-speci®c proteins in vivo, and demonstrate that modulations in
epidermal Ca coordinately regulate events late in epidermal differentiation that together form the
barrier.
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Altered Ultrastructure in a Mouse Model for Epidermolytic Hyperkeratosis
M. J. Arin, X. Wang,* T. Krieg, and D. Roop*
Dermatology, University of Cologne, Koeln, Germany; *Molecular and Cellular Biology and Dermatology,
Baylor College of Medicine, Houston, Texas, U.S.A.
Epidermolytic hyperkeratosis (EHK) is an autosomal-dominant disorder of corni®cation due to
point mutations in the suprabasal keratins K1 and K10. We recently generated a mouse model for
EHK by introducing a K10 point mutation, which is found in the majority of human cases of
EHK, into the mouse germline. To investigate the nature and location of the cyto-architectural
changes associated with the observed phenotype, we performed electron microscopic analysis.
Tono®lament clumps were observed in keratinocytes of the spinous layer in a perinuclear
distribution, whereas basal cells, hair follicle cells and dermis were ultrastructurally normal. Keratins
K1 and K10 were present in bundles and densly packed aggregates in spinous cells, highlighting the
dominant negative effect of the K10 point mutation on the entire keratin ®lament network in the
suprabasal layer of the epidermis. In the granular layer, keratohyalin granules were found attached
to dense aggregates of clumped keratin ®laments, as seen in the human disease. This is the ®rst
animal model for EHK that recapitulates the human disease at the genetic, phenotypic and
ultrastructural level.
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Effect of Protein Kinase C on the Skin Barrier Recovery
H. Kim, Y. Kim, E. Lee, W. Lew, J. Sohn,* H. Jeong,* J. Seo,* K. Park,* and S. Lee
Department of Dermatology, Yonsei University College of Medicine, Seoul, South Korea; *Department of
Oralbiology, Yonsei University College of Dentistry, Seoul, South Korea
The permeability barrier of skin is mainly exerted by the outermost part of skin, stratum corneum
(SC) and the lamellar bodies located between the corneocytes seems to regulate the barrier. The
lamellar bodies originate from polar lipid precursors provided by the cells of the stratum
granulosum (SG) through the exocytosis of their lamellar body contents. Calcium ions act as a
major regulator in corneocytes differentiation and proliferation, and epidermal calcium ions are
main signaling factor for skin barrier homeostasis. Protein kinase C (PKC) is closely related with
calcium ion and important protein for signal transduction pathway. Recently, it has been reported
that, in cultured human keratinocytes, glucosylceramide synthase and serine palmitoyl transferase
activity are regulated through PKC-dependent manner. In this study, we investigated the effects of
PKC inhibitor on the barrier recovery of hairless mice skin, after disrupted by tape-stripping
method. The expression and localization of PKC was studied using Western blotting and reverse-
transcription polymerase chain reaction (RT±PCR), and barrier recovery was determined by
measuring transepidermal water loss (TEWL) and electron microscopy (EM) detection method.
Western blotting results showed that all the tested PKC subtypes, PKC-a, b, d, h are expressed in
hairless mouse skin and RT-PCR showed that the amount of mRNA decreased at 0.5 h, slightly
increased at 1 h and decreased at 3, 6 and 24 h after barrier disruption. Topical application of
Calphostin C and Chelerythrine, both broad type PKC inhibitors, inhibited the recovery of barrier
at 3, 6 h after barrier disruption. Finally, EM ®ndings showed immature lamellar bodies in
Calphostin C treated skin compared with control site. In conclusion, these ®ndings suggest that
PKC is related with the barrier recovery and a further investigation about the detailed role of PKC
in barrier recovery is needed.
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cDNA Array Based Analysis of Gene Expression Pro®le in Three Different Models of
Reconstructed Human Epidermis
F. Bernerd and B. Mehul
Life Sciences, L Oreal Recherche, Clichy, France
Organotypic skin models allowing epidermal differentiation can be performed on different
substrates. The aim of this study was to compare the pro®le of gene expression of three
reconstructed epidermis obtained on different substrates, i.e. (i) the de-epidermized dermis (DED)
(RE
Á
gnier et al 1981) (ii) a dermal equivalent containing ®broblasts embedded in a collagen gel
(Lattice) (Asselineau et al 1985) and (iii) an amorphous polymerized collagen I substrate covered by
a thin layer of collagen IV (Episkin) (Tinois et al 1991). The study also included normal human
subcon¯uent keratinocytes (NHK) cultured on plastic. Total RNA from epidermal keratinocytes
were reversed transcribed and hybridized to membranes composed of 504 known genes related to
cutaneous biology. Results were analysed for minimal expression level (> 1000 counts), or for
differential expression ratio (> 3 fold). Correlation coef®cient between the models indicate
stricking similarities. Only 81 genes out of the 504 were not expressed in the three models, and
among the remaining 423 genes, 368 were expressed in all the three. Analysis of expression ratio
revealed that 36 genes were over-expressed in one or two models compared to the third.
Moreover, gene expression pro®le of the three models was compared to that of NHK. 22 genes
were identi®ed to be over-expressed at least in one of the three organotypic models. Six were
drastically over-expressed in all the 3D models (keratin 1, loricrin, ®laggrin, caspase 14,
corneodesmosin and CLSP), therefore representing a set of irrefutable markers of epidermal
differentiating conditions. In contrast 18 genes were over-expressed in KHN compared to at least
one 3D model, but none of them were common for all the three models. These results allow a
better characterization of three reconstructed epidermis models, i.e. DED, LATTICE or EPISKIN
and illustrate their usefulness for relevant investigations in the biology of epidermis.
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Biophysical Properties of Loricrin Provide New Information on its Utilization in the
Epidermal Corni®ed Cell Envelope
L. N. Marekov, P. M. Steinert, S. Jang, and H. Zhao
Laboratory of Skin Biology, NIAMS, NIH, Bethesda, Maryland, U.S.A.
Loricrin is the major protein constituent of the corni®ed cell envelope (CE) of ortho-keratinizing
epithelia and it is cross-linked to the CE by the action of multiple transglutaminases (TGases).
Previous scanning transmission electron microscope data have shown that the epidermal CE is
uniformly 10 nm thick, 80% loricrin and has a net density of 0.7 g/cc. In loricrin cross-linking
assays, TGase 3 inserts intrachain links to form a monomer of faster mobility on SDS gels, as well as
interchain linked dimers and trimers. TGase 1 alone forms only intrachain monomers, but
following a prior reaction with TGase 3, large polymers are formed. Thus, we conclude that in
vivo, loricrin is cross-linked sequentially by TGase 3 followed by TGase 1. However, it is not clear
how poorly soluble loricrin (40 mg/ml) is mobilized to the CE, and how many layers of loricrin
become attached to the CE. Here, we report that the TGase 3 cross-linked monomer and
oligomers are notably more soluble (100±140 mg/ml). Thus the act of cross-linking may facilitate
dispersal to the CE. By ultracentrifugation analyses, we found that all species act nearly ideally in
solution, despite the unusual amino acid composition. Uncross-linked loricrin in solution (26 kDa)
has a net axial ratio of about 1.3, whereas the cross-linked monomer is 1.0, the dimer is 1.8, and
trimer is 2.0. Thus cross-linking of loricrin forms a nearly spherical monomer, an elongated dimer,
and compact planar trimer. Together with established microscopy data, each cross-linked loricrin
monomer could occupy a cube about 3.5±3.7 nm on a side. Thus we conclude that there is a net of
two layers of loricrin on the CE, formed by accretion of more soluble cross-linked monomers,
dimers and trimers.
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Synthetic Pseudo-Ceramide Containing Atocopherol (Tocomide
TM
) Showed
Antioxidative Effect and Improved Barrier Recovery Rate in Disrupted Hairless Mice
Skin
G. Nam, E. Son, S. Ahn, J. Kim, H. Rho,* C. Lee, B. Lee, and I. Chang
Skin research team, Amore Paci®c R & D center, Yongin-si, Kyounggi-do, South Korea; *Fine &
Biochemical research team, Amore Paci®c R & D center, Yongin-si, Kyounggi-do, South Korea
The skin, the largest body organ, is strategically located as a barrier between the external and
internal environments, being permanently exposed to noxious stress such as UV, organic solvent
and chemical detergent. The epidermal layer, outermost skin must have multiple barrier function
to protect skin from environmental stress. To develop skin barrier improving agent, we synthesized
TocomideTM from synthetic N,N¢-bis(2-hydroxyethyl)-2-hydroxy-1,3-propanediamine which
was reported to comprise epidermal lipid components and alpha-tocopherylsuccinoyl chloride,
widely known to have antioxidative effect. In this study, we evaluated the effects of Tocomide
TM
as an antioxidant and barrier recovery agent. We examined the protective effects of Tocomide
TM
on UVB-induced oxdative damage in HaCaT keratinocytes and on TPA-induced skin damage in
hairless mice. UVB-induced oxidative damage was signi®cantly decreased by Tocomide
TM
in




and lipid peroxide induced by TPA treatment were
signi®cantly down-regulated by Tocomide
TM
treatment in mouse skin. In addition, reduced SOD
activity by TPA treatment was recovered to normal condition. Topical treatment with
Tocomide
TM
resulted in a substantial decrease in epidermal hyperplasia induced by acetone
treatment in mouse skin. Following topical treatment of Tocomide
TM
, epidermal barrier recovery
and lipid synthesis were increased. Moreover, topically applied Tocomide
TM
increased expression
of involucrin and ®laggrin as differentiation markers of keratinocyte in hyperproliferative
epidermis. These results suggest that Tocomide
TM
improve skin barrier function through
antioxidant effect and barrier recovery effect.
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Co-Operative Action of Vitamin C and Epidermal Keratinocytes in Normal Deposition
of Extracellular Matrix and Basement Membrane Components in Reconstructed Skin
D. Asselineau, C. Vioux, and F. Bernerd
Life Sciences, L Oreal Recherche, Clichy, France
The effect of vitamin C on the synthesis of extracellular matrix (ECM) is well known. Recent
studies using organotypic skin models revealed that vitamin C also improves the epidermal barrier
function. The aim of this study was to analyze the effects of vitamin C added during keratinocyte
differentiation, in reconstructed skin comprising a dermal equivalent with living ®broblasts. After
preparation of dermal equivalents, keratinocytes were seeded and cultures left submerged for
7 days, then lifted at the air±liquid interface for 7 days in the presence of medium supplemented or
not with 2.8 10
±4
M vitamin C. Histological analysis revealed that vitamin C improves the
arrangement of basal keratinocytes and increases the number of dermal ®broblasts. However, major
keratinocyte differentiation markers (loricrin, keratin 10, ®laggrin, involucrin) were not modi®ed.
In the dermal equivalent, in addition to numerous ®broblasts evenly distributed, vitamin C
induced higher deposition of ECM proteins, such as procollagen I, procollagen III, tenascin, and
collagen IV, preferentially located underneath the dermal epidermal junction. Basement membrane
proteins, laminin 5 and collagen VII were also increased by vitamin C, while ®bronectin, BP
antigen and integrins a6 and b1 were not modi®ed. To assess the role of keratinocytes in these
effects, cultures were performed rigorously similarly with or without keratinocytes. Interestingly,
when keratinocytes were missing, some proteins were still increased but not associated with a
speci®c location, as illustrated for procollagens I, III and collagen IV distributed only in and around
®broblasts. In contrast, collagen VII or tenascin were no longer increased by vitamin C in the
absence of keratinocytes. These results revealed that vitamin C in¯uences the interaction between
keratinocytes and ®broblasts in forming well organized basement membrane and subepidermal
zones, both crucial in the cohesion of skin and that in this process keratinocytes play a major role.
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Permeability Barrier Dysfunction in Transgenic Mice Overexpressing Claudin-6
K. Turksen and T. Troy
Divisions of Endocrinology and Dermatology, Department of Medicine, University of Ottawa and Ottawa
Health Research Institute, Ottawa, Ontario, Canada
A defective epidermal permeability barrier (EPB) in premature birth remains a leading cause of
neonatal death due to its associated complications, which include poor temperature stability,
infection by microorganism invasion through the skin, and the out¯ow of water. Despite its
importance in survival, the mechanisms involved in the formation and maintenance of the EPB are
not well understood. To address the possibility that Claudins, a new superfamily of tight junctional
molecules, are involved, we engineered transgenic mice with Claudin-6 overexpressed via the
Involucrin (Inv) promoter. Interestingly, the Inv-Claudin-6 transgenic animals die within two days
of birth, apparently due to lack of an intact EPB as evidenced by increased water loss and the
penetration of X-gal through the skin. Barrier dysfunction was manifested biochemically by the
aberrant expression of late epidermal differentiation markers, including K1, ®laggrin, loricrin,
transglutaminase-3, involucrin, repetin, members of the SPRR family and the transcriptional
regulator Klf4. The overall Claudin pro®le of the epidermis was also modi®ed. Our data suggest
that repetin and SPRR1A & 2 A are down-regulated in response to the down-regulation of Klf4 in
the transgenic animals, which would contribute to decreased protein crossbridging leading to
fragile, defective corni®ed envelopes. These results provide new insights into the role of Claudin-6
in epithelial differentiation and EPB formation. In addition, the epidermal phenotype of these
transgenic mice, which is very reminiscent of that in preterm infant skin, suggest that they will be
an important and novel model for studies on human premature EPB-related morbidity.
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Gingival Tissue Model for Prediction of Irritancy of Oral Care Products
J. Kubilus, B. A. Breyfogle, and M. Klausner
R & D, MatTek Corporation, Ashland, Massachusetts, U.S.A.
The development of human reconstructed tissues of the oral cavity that express in vivo-like
differentiated characteristics would be important to better understand and develop therapies for
gum disease, oral cancer, lesions due to smokeless tobacco, and gingivitis, amongst other diseases of
the oral mucosa. in vitro tissue models would be used to assess the biocompatibility of new dental
materials, dentifrices, and oral care consumer products and would be useful in determining
pharmaceutical delivery through the oral mucosa. To meet these needs, we have recently
developed a tissue culture model of the gingival epithelium. Gingival cells were harvested from
tissue explants, expanded in monolayer culture, and induced to form a three-dimensional tissue
using serum free medium. Histologically, the tissue is 8±12 cells layers thick with cells becoming
increasingly squamous as the apical surface is approached. The tissue is cultured in easily
manipulated cell culture inserts and the tissue extends from wall-to-wall. In terms of ease of use,
these characteristics greatly facilitate testing of oral care products in that direct topical application is
possible. To assess the reproducibility of the tissue, tissues were exposed to the common surfactant,
1% Triton X-100 (TRI), and viability dose±response curves were constructed using the MTT
assay. An Effective Time-50 (ET50), i.e. the time of exposure after which viability is reduced to
50%, was determined. The ET50 for 3 lots of tissue averaged 112 6 12.7 min. In terms of resistance
to surfactant injury by TRI, the gingival tissue is more susceptible to damage compared with the
EpiDerm
TM
skin model (ET50 = 6.74 6 0.99 h) but more robust than the EpiOcular
TM
tissue
model (ET50 = 24.9 6 6.3 mins). Exposure to sensitive and normal strength dentifrices showed
that viability of the tissue was compromised to a greater degree by the normal strength toothpastes.
Based on these initial results, further investigation of the tissue model's ability to predict potential




, a Dermal-Epidermal Skin Model to Study Epithelial±
Mesenchymal Interactions
M. Klausner, S. Ayehunie, P. J. Hayden, K. L. Bellavance, S. D. Lamore, T. J. Last, and J. Kubilus
R & D, MatTek Corporation, Ashland, Massachusetts, U.S.A.
It has long been recognized that signi®cant paracrine signaling occurs between dermal ®broblasts
and epidermal keratinocytes. Further, it is understood that such interactions likely modulate the
response of skin to materials which may lead to contact irritant or allergic responses. Also, dermis
related phenomena such as photoaging and photodamage, wound healing and cancer progression
are ideally studied in a dermis-containing tissue. To address these issues, we have recently
developed a second-generation skin model consisting of a ®broblast-containing dermal/
keratinocyte-containing epidermal, full thickness tissue. In contradistinction to previous dermal/
epidermal models, the new tissue is cultured in an easily manipulated cell culture insert and the
tissue extends from wall-to-wall. In terms of ease of use, these characteristics greatly facilitate
testing of potential allergens or irritants in that direct topical application is possible. Topical
exposure to the common surfactant, 1% Triton X-100, results in MTT tissue viability dose±
response curves which fall within the normal range of the keratinocyte-only tissue, EpiDerm.
Currently, in order to produce a standardized, reproducible organotypic tissue, all lots of EpiDerm
are compared to a reference database of Effective Time-50 (ET50) values, i.e. the time of exposure
after which viability is reduced to 50% following exposure to 100 ml of Triton X-100. The
database average (184 tissue lots) is 6.74 6 0.99 h (6 1 standard deviation); initial lots of the full
thickness tissue, tested in an identical manner, averaged 7.14 6 1.33 h (n = 3). Histological cross-
sections of the full thickness tissue show an epidermal layer which is very similar to EpiDerm and
native epidermis atop a ®broblast-containing collagen matrix dermis-like layer. Based on these
initial results, investigation of the tissue response to stimuli speci®cally affecting the dermis or
epidermal/dermal `crosstalk' may prove rather informative.
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Cultured Keratinocyte from Single Mouse Pups Become Tetraploid
L. M. Milstone,³ V. Bruegel-Sanchez, D. Lacivita,* and J. Zhou²
Dermatology, Yale, New Haven, Connecticut, U.S.A.; *Dermatology, Yale, New Haven, Connecticut,
U.S.A.; ²Dermatology, Yale, New Haven, Connecticut, U.S.A.; ³Dermatology, Yale, New Haven,
Connecticut, U.S.A.
Two recent papers have reported methods for long-term cultivation of newborn mouse
keratinocytes (Hager et al JID 112 : 971±976, 1999; Caldelari et al JID 114 : 1064±1065, 2000). The
desirability of culturing, from a single pup, keratinocytes that maintain their ability to differentiate
is obvious to those working with mutant mice. We used the low calcium, ®broblast conditioned
medium conditions described by Hager et al to con®rm the ease and reproducibility of the method
and to further characterize the resulting cells. Cell lines were established from pups representing
several different mouse strains and de®ned mutants. We were nearly 100% successful in establishing
lines from single, newborn pups. All lines had a polygonal morphology at con¯uence; some have
maintained their epithelial appearance for over 20 passages. All lines tested were nearly tetraploid,
as determined by chromosome counts on at least 10 spread mitotic cells. The ability of these
keratinocyte lines to form epithelia was tested by seeding one million cells on devitalized dermis.
Many formed strati®ed epithelia in vitro and expressed several markers of epidermal differentiation
in high calcium medium. Spontaneous conversion of primary murine cells to polyploid lines is
well-known but was thought to occur less readily with keratinocytes. The culture method of
Hager et al is reproducible and readily establishes polyploid cell lines.
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Spontaneous or Induced Intracellular Reactive Oxygen Species of Normal Human
Keratinocytes are Modulated by Differentiation and Senescent Status
S. Talbourdet, A. Bierry, and M. Dumas
R & D, L.V.M.H. Perfumes and Cosmetics Branch, Saint-Jean de Braye, France
Reactive oxygen species (ROS) are largely suspected to trigger oxidative stress-related disorders
and ageing at the molecular, cellular and tissue levels. We focused on the spontaneous and induced
ROS production of normal human keratinocytes (NHK) as a function of their differentiated and
senescent status. Freshly isolated NHK were plated on human collagen type IV-coated dishes
(6 mg/cm
2
) for 3 h to select basal adherent (BC) and supra basal nonadherent cells (SBC). The
senescent NHK were obtained after successive subcultures of primary NHK (P0) until P7 where
they stopped dividing. The cells were loaded for 45 min with 50 mM of dichlorodihydro¯uorescein
diacetate, emitting a 529-nm-¯uorescence (l & #61548; ex = 504 nm) when oxidized by




. The BC exhibited a strong





A higher sensitivity to oxidative stress was observed with SBC that exhibit a larger ROS increase













-induced ROS production was
observed during the cellular senescence from P0 to P7, but there was a signi®cant increase in
spontaneous ROS. These results point out that the differentiation but not the senescence of NHK




exogenous stress and that only senescence is accompanied by a basal
spontaneous ROS increase.
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Regulation of Adhesion Proteins in Human Keratinocytes by Dapsone
A. Klausegger, A. Huber-Wechselberger, H. Hintner, and J. W. Bauer
Dermatology, General Hospital, Salzburg, Salzburg, Austria
4¥4 Diaminodiphenylsulfone (Dapsone) is considered to be a therapeutic agent in blistering skin
diseases like dermatitis herpetiformis and linear IgA disease (LAD) as well as bullous pemphigoid
(BP). The mechanism of action is thought to include deactivation of the respiratory burst pathway
of neutrophilic leucocytes. However, this cannot fully account for its action in LAD and BP. We
therefore investigated the in¯uence of dapsone on proteins critical for the adhesion of keratinocytes
(hKC). Immuno¯uorescence staining using antibodies directed against the hemidesmosomal
components bullous pemphigoid antigen 1 (BPAG1), bullous pemphigoid antigen 2 (BPAG2) and
plectin we noticed a marked intracellular retention of BPAG2 staining in KC treated with 1 mM
dapsone for 24 h, compared to no difference in hKC stained for BPAG1 and plectin. The steady
state mRNA levels of BPAG2, BPAG1 and plectin were unaffected by this treatment. In contrast,
protein levels in extracts of KC treated with 1 mM dapsone showed markedly reduced levels of
BPAG2 in immunoblotting experiments. To test the pathogenetic relevance of these ®ndings, we
investigated the in¯uence of dapsone on the protein levels of interleukin-8 (Il-8), an important
mediator of in¯ammation in experimental BP. The up-regulation of Il-8 protein expression caused
by incubation of hKC with a serum obtained from a BP patient, was reduced by pretreatment with
dapsone. These data suggest a role for dapsone in the post-translational control of BPAG2
expression.
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Conversion of d-Tocopheryl Glucoside into Free Vitamin E in the Skin
A. Mavon and D. Redoules
Pharmacocinetique Cutane
Á
e, Pierre Fabre Research Institute, Castanet Tolosan, France
Among the enzymes involved in the epidermal barrier function, the b-glucocerebrosidase can serve
to release bioactive compounds. The aim of this study was to assessed the skin hydrolysis of d-
tocopheryl-glucoside (d-T-Glu) to the active antioxidant d-tocopherol (d-TH) through an in vitro
approach and followed by a clinical study. The in vitro study was performed with a reconstructed
human epidermis (RHE), and viable human skin biopsy. Radio-HPLC analysis has been used to
determine the amount of precursors which have penetrate and to quantify the conversion into free
tocopherol at 2, 6 and 18 H. In the clinical study, a cosmetic preparation was applied topically of
the forearm of 12 women every day for two weeks. The analysis was carried out in the upper part
of the stratum corneum (3 tape strippings). In the RHE and in human skin biopsy, about 45, 76
and 89% (n = 4 for each time) and 2, 11 and 18% (n = 4 for each time) d-tocopheryl-glucoside
were converted into free tocopherol at 2, 6 and 18 h. In the clinical study more than 30% of d-T-
Glu absorbed was hydrolysed to free tocopherol. These results shows that the gluco-conjugated
tocopherol is a valuable precursor to deliver into the skin free tocopherol, ®rstly the
glucoconjugation increases the thermal and photochemical stability of d-tocopherol and secondly
the reservoir effect coupled with the enzymatic conversion constitutes an ef®cient controlled
released of free tocopherol in situ.
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Identi®cation of Epidermal-Fatty Acid Binding Protein as a Target of S100A7 Action in
Keratinocytes
M. Ruse and R. L. Eckert*
Physiology & Biophysics, Dermatology, Oncology, Case Western Reserve University, Cleveland, Ohio,
U.S.A.; *Physiology & Biophysics, Case Western Reserve University, Cleveland, Ohio, U.S.A.
S100A7 is small, acidic, EF-hand-containing protein that is a mediator of Ca
2+
-dependent signal
transduction. S100A7 is expressed at low levels in normal skin and in cultured keratinocytes (skin
cells). However, expression is markedly increased in hyperproliferative skin diseases such as
psoriasis and in skin cancer. One of the suggested S100A7 interaction partners is epidermal fatty
acid-binding protein (E-FABP), a protein that is overexpressed in the suprabasal layers of psoriatic
epidermis. Our study focuses on the interaction of S100A7 with E-FABP in normal human
cultured keratinocytes. We developed adenoviral delivery systems that permit controlled
expression of S100A7 or E-FABP in cultured keratinocytes. Co-expression of S100A7 with E-
FABP results in increased levels of each protein, suggesting an interaction that results in mutual
stabilization. Moreover, S100A7 and E-FABP coimmunoprecipitate when keratinocytes are
treated with protein crosslinking agents prior to extract preparation. Immuno¯uorescence studies
of keratinocytes maintained in low Ca
2+
(0.09 mM) reveal a perinuclear localization of S100A7 and
E-FABP, and diffuse staining throughout the nucleus and the cytoplasm. When the extracellular
Ca
2+
concentration is increased to 0.3 mM, both proteins redistribute to domains within the plasma
membrane. This translocation to the plasma membrane is consistent with our ®nding that S100A7
is a substrate for membrane-associated transglutaminase (Ruse et al Biochemistry 40 : 3167, 2001).
Taken together, these results provide evidence that E-FABP is an S100A7 target protein in normal
human keratinocytes, and suggest that S100A7 may regulate cell function by altering E-FABP
action at a plasma membrane location. The mechanism of calcium-dependent redistribution to the
plasma membrane and identi®cation of target structures is presently under investigation.
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A Novel Functional In Vivo Epidermal Stem Cell Assay
C. Barland,* T.E. Schneider,* AM. Alex,* Ml. Mancianti,³ H.J. Lawrence,§ and R. Ghadially*
*Dermatology, University of California, San Francisco, San Francisco, California, U.S.A.; ²Medicine,
University of Miami, Miami, Florida, U.S.A.; ³Pathology, Alta Bates Medical Center, Berkeley,
California, U.S.A.; §Hematology/Oncology, VA Medical Center, San Francisco, California, U.S.A.
Borrowing from well-established functional assays in hematopoietic cells, we designed a
quantitative epidermal stem cell assay that uses the most rigorous test of stem cell function:
ability for long-term tissue repopulation in vivo. Our assay utilizes green ¯uorescent protein
(GFP) + test keratinocytes from a GFP transgenic mouse and GFP- competitor keratinocytes from
inbred GFP- siblings. Test and competitor keratinocytes are isolated, mixed in various ratios, and
seeded in a silicone chamber on the dorsum of a SCID mouse. A ®xed number of competitor GFP
± keratinocytes are seeded along with variable numbers of GFP + test keratinocytes. A complete
epidermis is formed in 2 weeks. At 4 weeks individual GFP + epidermal proliferation units are
detected by microscopy. Thus by this time all seeded transit-amplifying and differentiated cells
have been lost, and remaining green cells are the progeny of GFP + stem cells initially added. To
distinguish GFP + test cells from GFP- competitor cells, epidermis from the chambers is harvested,
dissociated, and studied by ¯ow cytometry. The use of a long-term competitive assay ensures not
only the detection of the most primitive epidermal stem cells but also survival of the transplanted
keratinocytes, even when seeded with very low numbers of GFP + test cells. In conclusion, we
now have an assay that assesses epidermal stem cells by their de®ning function, namely long-term
repopulation. Competition at limiting dilution will allow the quanti®cation of stem cells in a
keratinocyte population. Competition at nonlimiting dilution allows comparison of the
proliferative capacity of two different populations of stem cells.
324
Sequential Utilization of Two Distinct VDR Coactivator Complexes, Mediator/DRIP
and p160/SRC, During Keratinocyte Differentiation
Y. Oda, C. Sihlbom,* L. Huang,* C. Rachez,² C. B. Chang,² A. L. Burlingame,* L. P.
Freedman,² and D. D. Bikle
Medicine and Endocrinology, University of California San Francisco, San Francisco, California, U.S.A.;
*Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, U.S.A.;
²Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, U.S.A.
Cell programs such as proliferation and differentiation involve the sequential activation and
repression of gene expression. Vitamin D, via its active metabolite 1,25(OH)2D3, controls the
proliferation and differentiation of keratinocytes by directly regulating gene transcription. Two
classes of coactivators, Mediator/DRIP (the vitamin D receptor interacting proteins) and the p160
steroid receptor coactivator family (SRC), control the actions the vitamin D receptor (VDR), but
the relationship between these two classes of coactivators is not clear. Using GST-VDR af®nity
beads, VDR binding complexes were puri®ed from keratinocytes and identi®ed by mass
spectrometry (MS) using MALDI MS peptide mass mapping and/or tandem MS peptide
sequencing. The Mediator/DRIP complex was identi®ed as the major VDR binding complex
from proliferating keratinocytes. Following differentiation, members of the p160/SRC family
replaced the major DRIP components. Both DRIP205 and SRC2 and 3 were expressed in
proliferating cells, but DRIP205 expression was down-regulated after the cells differentiated,
whereas SRC levels remained unchanged. Both DRIP and SRC potentiated vitamin D-induced
transcription in proliferating cells, but with differentiation DRIP was no longer effective. These
results indicate that Mediator/DRIP and p160/SRC coactivator complexes are selectively
involved in vitamin D regulation of gene transcription during keratinocyte differentiation,
suggesting that these coactivators are part of the means by which the temporal sequence of gene
expression is regulated during the differentiation process.
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The Unique C-Terminal Peptide of Pro®laggrin is Processed to a 54 Kilodalton Peptide
and is Not Expressed in Flaky Tail Mutant Mice
P. Fleckman, R. Underwood, and R. B. Presland*
Medicine/Dermatology, University of WA, Seattle, Washington, U.S.A.; *Medicine/Dermatology, Oral
Biology, University of WA, Seattle, Washington, U.S.A.
Pro®laggrin, the precursor of ®laggrin, is expressed in the granular layer as a high molecular weight
protein consisting of multiple ®laggrin monomers enclosed within unique N- and C-terminal
peptides. Pro®laggrin is rapidly proteolyzed to ®laggrin in the granular layer. During this process,
the unique N-terminal peptide is found in the nucleus of granular and transition cells. However,
little is known about the unique C-terminal peptide. The purpose of this study was to elucidate
processing of the C-terminal peptide. A monospeci®c peptide antibody raised against the C-
terminal region of mouse pro®laggrin was used for immunomorphologic and immunoblot studies
of newborn mouse epidermis. Immunohistochemistry revealed staining restricted to the granular
layer of normal mice. Immunoelectron microscopy showed reaction limited to keratohyalin
granules. Urea-tris extracts of normal epidermis displayed reaction with high molecular weight
pro®laggrin, however, no reaction was seen with ®laggrin. In addition, a 54-kDa immunoreactive
band was detected. Split blots showed the 54 kDa band did not react with antibodies raised against
pro®laggrin/®laggrin, loricrin, K5 or K14. Possible cross-reaction was seen with the antikeratin
antibody AE1. No immunoreactivity was seen in epidermal extracts from ¯aky tail mice, which
express pro®laggrin protein of reduced Mr but do not process it to ®laggrin. The data suggest that
the unique C-terminal pro®laggrin peptide is processed to a 54-kDa pro®laggrin-derived peptide
that may bind avidly to other epidermal protein(s), and that the C-terminal peptide is not present
in the pro®laggrin expressed in ¯aky tail mice.
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Hyaluronan in the Extracellular Space Modulates Keratinocyte Differentiation in an
Epidermal Lift-Culture Model
E. V. Maytin, A. Passi, L. E. White, H. Kawamura, P. Sadeghi, and V. C. Hascall
Dermatology & Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
Dysregulation of epidermal proliferation and differentiation underlies a variety of skin diseases,
including eczema and psoriasis. Yet, the mechanisms that regulate epidermal differentiation in vivo
have not been fully de®ned. Hyaluronan (hyaluronic acid, HA) is an abundant matrix component
in the intercellular space between keratinocytes of the skin. Our goal was to test the hypothesis that
HA participates in a mechanism to coordinate keratinocyte proliferation, differentiation, and
apoptosis. For these studies, we used `organotypic' cultures in which rat epidermal keratinocytes
(REKs) are grown to con¯uence on a preformed basement membrane, then lifted to the air±
medium interface. By 5 days, the cells stratify into a tissue that resembles normal epidermis, and
expresses differentiation markers such as K10, ®laggrin, keratohyaline granules, and a stratum
corneum. Hyaluronan, detected histologically using biotinylated HA-binding protein (bHABP),
accumulates to high levels between the keratinocytes. To test whether HA has a functional role in
differentiation, Streptomyces hyaluronidase (StrepH, 1 U/ml), shown to digest > 95% of
macromolecular HA in 4 h, was added to the culture medium. This creates, in effect, a functional
HA-knockout. Time-course experiments were designed in which REKs were allowed to
differentiate at the air±medium interface for 5 d in the absence or presence of StrepH. In the
StrepH-treated cultures, keratohyaline granules were increased in number and size, in 3/3
experiments. Expression of other differentiation markers was also accelerated, with more intense
¯uorescence immunostaining observed for K10 (at 2 d) and ®laggrin (at 5 d), as a result of StrepH
treatment. The presence of HA acts as a brake to slow the course of keratinocyte differentiation in
the epidermis. These data indicate that HA is not simply a passive occupant of the extracellular
space, but instead has an active, instructive role in regulating the epidermal differentiation program.
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Demysti®cation of Chester Porphyria: A Nonsense Mutation in the Porphobilinogen
Deaminase Gene
P. Poblete GutieÁrrez, A. Martinez Mir,* H. F. Merk, A. M. Christiano,*² and J. Frank
Department of Dermatology, University Clinic of the RWTH Aachen, Aachen, NRW, Germany;
*Department of Dermatolgy, Columbia University, New York, New York, U.S.A.; ²Department of
Genetics and Development, Columbia University, New York, New York, U.S.A.
The acute porphyrias are inherited disorders of heme biosynthesis. All genes encoding enzymes
involved in heme biosynthesis have been cloned and several disease causing mutations have been
reported. Diagnosis of an acute porphyria is established on the basis of clinical and biochemical
®ndings as well as enzyme essays. In some cases however, these diagnostic tools reveal confusing
data indicating the possibility of so called dual porphyrias with two enzymes of heme biosynthesis
being de®cient. Recently, it was reported that Chester porphyria, one of these dual porphyrias,
shows attributes of both acute intermittent porphyria (AIP) and variegate porphyria (VP). Previous
linkage analyses indicated the involvement of a novel chromosomal locus in this disease. These data
for the ®rst time suggested that a gene might be involved in the pathogenesis of the acute
porphyrias, which does not encode for one of the enzymes of heme biosynthesis. Using PCR based
techniques, we ®rst excluded several candidate genes within the originally published 1 cM linkage
interval on chromosome 11. Since AIP and VP are caused by mutations in the porphobilinogen
deaminase (PBGD) and protoporphyrinogen oxidase (PPO) gene, respectively, we then analzyed
both genes by DNA sequencing although they were not located within the reported linkage
interval. Still, we identi®ed a nonsense mutation in the PBGD gene as the underlying genetic
defect. However, no mutation was detected in the PPO gene. The results of our genetic studies
indicate that Chester porphyria is neither a dual porphyria, nor a separate type of porphyria and
largely exclude the posiibility that a hitherto unknown gene is involved in the pathogenesis of the
porphyrias.
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An Autoimmunity Susceptibility Locus (AIS1) Associated with Vitiligo and
Autoimmune Hypothyroidism Maps to Chromosome Segment 1p31.3-p32.2
R. A. Spritz, A. Alkhateeb, W. Old, G. Stetler, P. Fain, and D. Bennett*
Hum Medical Genet Prog, University Colo Hlth Sci Ctr, Denver, Colorado, U.S.A.; *Department Anat
Devel Biol, St. George's Hosp Medical Sch, London, U.K.
Generalized vitiligo is a common autoimmune disorder in which patchy loss of skin and hair
pigmentation results from loss of pigment-forming melanocytes from the involved regions. Vitiligo
occurs with a frequency of about one percent in most populations, and is highly associated with
other autoimmune disorders, particularly Hashimoto thyroiditis. Most cases of vitiligo are sporadic,
although some cases cluster in families, and the disorder is thought to be oligogenic in origin. We
have studied a large family cluster in which vitiligo and Hashimoto thyroiditis occur in numerous
individuals. A whole-genome scan of 24 family members, including 14 affected with autoimmune
disease, showed signi®cant linkage of an oligogenic autoimmune susceptibility locus, termed AIS1,
to a 14.4-cM interval in 1p31.3-p32.2. This genetic interval corresponds to a completely
sequenced 7.4 Mb physical interval that contains 20 known and 15 predicted genes. Heterogeneity
lod score analysis of 26 additional families with multiple cases of vitiligo suggests that AIS1 may
play a signi®cant role in one-sixth to one-fourth of such families. A two-locus analysis of
Hashimoto thyroiditis in members of the primary study familiy who carry an AIS1 susceptibility
allele showed suggestive linkage to markers in chromosome 6p22.3-q14.1, in a region spanning
both the MHC and AITD1, a susceptibility locus for autoimmune thyroid disease. Our results
indicate that the 1p AIS1 locus is associated with susceptibility to autoimmunity, particularly
vitiligo, in the primary study family, and that a chromosome 6 locus, most likely AITD1, may
mediate the occurrence of Hashimoto's thyroiditis in AIS1-susceptible family members.
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Analysis of the Deletion of a Tandem Repeat Sequence in Human STG Gene in Psoriasis
R. Nair, P. Stuart, N. Chia, J. Epperson, I. Nistor,* T. Henseler,² S. Jenisch,* E. Christophers, J.
Voorhees, and J. Elder
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.; *Dermatology, University of Kiel,
Kiel, Germany; ²Immunology, University of Kiel, Kiel, Germany
The PSORS1 locus maps to the MHC and displays highly signi®cant evidence for linkage to
psoriasis. We identi®ed two adjacent risk haplotypes (RH1 and RH2), located just telomeric to
HLA-C, as the most likely and next most likely locations of PSORS1, respectively (AJHG
66 : 1833±44, 2000). While sequencing RH1 and RH2 in chromosomes known to carry or not to
carry the PSORS1 disease allele, we identi®ed a 33-bp deletion in the STG gene on a Cw6-
positive chromosome known to carry the risk determinant (Cluster 19 of AJHG 66 : 1833±44,
2000). STG is located ~155 kb telomeric of HLA-C. Sequence comparison revealed that the 33 bp
deletion represented loss of a tandem repeat sequence in a coding region of the STG gene. We
investigated whether this deletion was present on all haplotypes known to carry the PSORS1 risk
allele. The segment of genomic DNA containing the tandem repeats was ampli®ed in 32 unrelated
individuals carrying ®ve examples of each of the seven most common risk haplotypes together with
®ve each of common nonrisk haplotypes. Electrophoretic analysis of the PCR products showed
that only the Cluster 19 haplotype carried two tandem repeats; all other risk and nonrisk haplotypes
carried 3 tandem repeats. The rhesus monkey homologue of STG was recently reported to contain
only two units of this 33-bp tandem repeat (Mamm Genome 12 : 60±66, 2001). Thus, addition of
the third repeat may have occurred early in the evolution of modern humans. Although STG was
®rst identi®ed as a transcript expressed in human keratinocytes, rhesus monkey STG is
preferentially expressed in taste buds. Thus, its pattern of expression is also not consistent with
involvement in psoriasis. Based on these ®ndings, we conclude that the 33 bp STG deletion is not
associated with psoriasis.
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Effect of 1,25(OH)2vitamin D3 on the Expression of Cell Cycle-Regulating Genes in
Keratinocytes
X. Dai, K. Yamasaki, Y. Shirakata, K. Sayama, and K. Hashimoto
Dermatology, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
1,25(OH)2vitamin D3 has an antiproliferating effect on keratinocyte growth, and its derivatives are
used to treat hyperproliferating skin diseases, such as psoriasis. The vitamin D receptor is a nuclear
receptor, and acts as a transcription factor after vitamin D binding. Although the effect of vitamin
D3 on keratinocyte growth is well known, it is not fully understood which molecules are involved
in the mechanism of vitamin D3-induced keratinocyte cell cycle arrest. Therefore, we analyzed the
change in cell cycle-regulating gene expression with vitamin D3 using a multiprobe ribonuclease
protection assay system. After adding 10
±6
M 1,25(OH)2vitamin D3 or vehicle, total RNA was
extracted. The expression of cell cycle-regulating genes, including cyclins, cyclin-dependent
kinases (CDK), and CDK inhibitors, was examined. Cyclins A, D1, and D2 were decreased by
vitamin D3 stimulation, while cyclins B, C, E, F, G1, G2, I, and H, were unchanged by vitamin
D3. The decreases in cyclins A, D1 and D2 started 12 h postvitamin D3. Furthermore, the
decreases in cyclin A, D1, and D2 mRNA continued until 48 h in keratinocytes. Interestingly,
cdk1, cdk2, and cdk4 were increased by vitamin D3 beginning at 6 h, and up-regulation continued
until 48 h postvitamin D3.
Of the CDK inhibitors, only p14/15INK4B mRNA was up-regulated by vitamin D3. The level
of expression of other CDK inhibitors (p21CIP1/WAF1, p27Kip1, p57Kip2, p16INK4A,
p18INK4C, p19ARF, p53, p107, and p130) was unchanged by vitamin D3. In contrast, TGF-b, a
potent antiproliferating agent of primary keratinocytes, increased the mRNA of various CDK
inhibitors, such as p21CIP1/WAF1, p27Kip1, p57Kip2, and p14/15INK4B. However, TGF-b
did not change cyclin mRNA levels. Therefore, vitamin D3 has an effect on the expression of cell
cycle-relating genes that is distinct from that of TGF-b. In conclusion, regulation of cyclins is the
main mechanism of the cell cycle arrest of human keratinocytes induced by vitamin D3.
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Pro-Differentiating and Anti-In¯ammatory Effects of Peroxisome Proliferator
Activated Receptor (PPAR)-Delta Activation
M. Schmuth, W. J. Cairns,* C. M. Haqq, M. Mao-Qiang, Y. Uchida, L. Rhein,* K. Schoonjans,²
J. Auwerx,² T. M. Willson,* P. M. Elias, and K. R. Feingold
Medicine & Dermatology, University of California, San Francisco, San Francisco, California, U.S.A.;
*Nuclear Receptor Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina,
U.S.A.; ²IGBMC, CNRS/INSERM, Illkirch, France
The peroxisome proliferator-activated receptors (PPARs) comprise a group of transcription factors
that regulate lipid metabolism and cellular differentiation. The purpose of this study was to
determine the effects of PPAR-d activation on skin. in vitro, using Western, Northern and
microarray technology, we observed an increase in a variety of differentiation markers in cultured
keratinocytes treated with a selective PPAR-d agonist, including involucrin, transglutaminase I,
small proline rich proteins, desmoplakin, envoplakin, and annexin A1. In addition to keratinocyte
speci®c differentiation markers, we observed a robust increase in adipose differentiation related
protein and fasting inhibitory adipose factor, both of which have been implied in adipogenesis. in
vivo, topical PPAR-d activation increased loricrin and ®laggrin expression as assessed by
immunohistochemistry and improved permeability barrier homeostasis in mice. The pro-
differentiating effects were also observed in PPAR-a±/± mice, indicating receptor speci®city.
Furthermore, in a mouse model of epidermal hyperproliferation, PPAR-d activation also showed
pro-differentiating effects. Lastly, PPAR-d mRNA levels were increased in human psoriatic skin as
assessed by quantitative PCR and topical PPAR-d activation reduced ear swelling in a mouse
model of TPA induced irritant contact dermatitis, suggesting a role of PPAR-d in skin
in¯ammation. Thus, we demonstrate that PPAR-d activation has pro-differentiating and anti-
in¯ammatory activity suggesting bene®cial effects in a variety of cutaneous diseases.
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Interleukin-12 p40 Gene Polymorphism is Associated with Atopic Dermatitis and
Psoriasis Vulgaris
Y. Tsunemi, H. Saeki, K. Nakamura, T. Kakinuma, H. Fujita, N. Asano, M. Kishimoto, Y.
Tanida, H. Mitsui, Y. Tada, M. Wakugawa, H. Torii, M. Komine, A. Asahina, and K. Tamaki
Department of Dermatology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan
Interleukin-12 (IL-12) has the ability to switch Th0 cells to a Th1 phenotype and induce Th1
cytokine pro®les. Atopic dermatitis, in which a high expression of Th2-type cytokines is observed,
is viewed as a Th2-type skin disease. In psoriasis, on the other hand, Th1-type cytokines are
critically involved in the pathogenesis. Recently a single nucleotide polymorphism (SNP)
(A1188C) of IL-12 p40 subunit gene has been identi®ed. To learn whether IL-12 p40 gene SNP is
associated with susceptibility to atopic dermatitis (AD) or psoriasis vulgaris (PsV), we investigated
the frequency of genotypes at the polymorphic site of the gene in patients with AD, in patients
with PsV and in controls. We examined 153 Japanese patients with AD, 57 Japanese patients with
PsV and 61 healthy Japanese individuals. Genotyping of the polymorphic site of IL-12 p40 gene
was performed using the polymerase chain reaction- restriction fragment length polymorphism
method (PCR-RFLP). The A/A genotype is decreased in AD (15.7%) and increased in PsV
(43.9%) compared with control (27.9%), with borderline signi®cance (p = 0.041 and p = 0.052,
respectively). The frequency difference of the A/A genotype between AD and PsV is highly
signi®cant (p < 10±4). SNP of IL-12 p40 gene is assumed to play a part in the pathogenesis of AD
and PsV. This SNP may in¯uence the balance between Th1-type and Th2-type cytokine pro®les.
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Prevention of Immune Response Against Transgene Product by the Blockade of CD40±
CD40L Interaction in a Model of Recessive Genodermatosis
M. Ohyama,*² T. Ota,² M. Aoki,² K. Tsunoda,² R. Harada,* S. Koyasu,³ T. Nishikawa,² and
M. Amagai²
*Division of Dermatology, Tokyo Electric Power Company Hospital, Tokyo, Japan; ²Department of
Dermatology, Keio University School of Medicine, Tokyo, Japan; ³Department of Microbiology and
Immunology, Keio University School of Medicine, Tokyo, Japan
Introduction of corrected gene in recessive genodermatoses may provoke unwanted immune
response against the introduced gene product because such patients have not acquired tolerance
against the defected protein. In this study, using desmoglein 3 knockout (Dsg3±/±) mice as a
disease model for genetic defect of DSG3, we investigated whether immune response against Dsg3
is actually provoked by gene therapy and whether such immune reaction could be prevented.
When mouse Dsg3 cDNA under the control of CMV promoter was introduced in the skin of
Dsg3±/± mice by naked DNA injection, Dsg3±/± mice developed circulating anti-Dsg3 IgG
which bound to Dsg3 expressed by the therapy in vivo. To overcome this problem, we used anti-
CD40L monoclonal antibody (MR1) to block co±stimulatory interaction between CD40-CD40L,
which is important in the triggering and maintenance of both humoral and cellular immune
responses. For this assay, we employed the Dsg3+/+ skin graft on Dsg3±/± mice, which should
represent stable gene transfer of Dsg3. After skin grafting, all recipient Dsg3±/± mice were treated
either with MR1 or with hamster IgG on day 0, 2, 4, 7, 14, 21 and 28. All of hamster IgG treated
mice developed circulating anti-Dsg3 IgG 2 weeks after the skin graft. This IgG production lasted
more than 4 weeks and IgG deposition was observed on the surfaces of the keratinocytes in grafts.
However, this unwanted anti-Dsg3 IgG production was effectively suppressed when the recipient
mice were treated with MR1. These ®ndings indicate that the introduction of defected gene does
elicit the immune response against introduced gene product and that ef®cient prevention of such
undesirable immune response can be achieved by the blockade of CD40±CD40L interaction,
which may be required for a successful gene therapy for recessive genodermatoses.
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Skin Blanching Response to Betamethasione Dipropionate Products Containing
Alcohols are Associated with Alcohol Dehydrogenase 1B Alleles
M. R. Hobbs, A. N. Tkachuk, H. L. Rausch,* and L. K. Pershing*
Internal Medicine, University of Utah, Salt Lake City, Utah, U.S.A.; *Internal Medicine, University of
Utah, Salt Lake City, Utah, U.S.A.; ²Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.;
³Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.
We previously demonstrated that an arginine to histidine polymorphism in amino acid 47 of the ¯
subunit of alcohol dehydrogenase 1B (ADH1B) was associated with altered skin blanching
responses (SBR) to 0.05% betamethasone dipropionate (BD) containing alcohol(s) in Asians.
ADH1B encodes the ¯ subunit (present as a dimer) of the enzyme that metabolizes alcohol(s).
Sequencing ADH1B from extracted peripheral blood DNA in a larger subject population revealed
at least three genotypes: 86% of Caucasians were homozygous (ADH1B 1/1) for arginine at amino
acid 47, 71% of Asians were homozygous (ADH1B 2/2) for histidine at amino acid 47, and the
remainder of Asians and Caucasians were heterozygous (ADH1B 1/2) for arginine and histidine at
amino acid 47. ADH1B 1/2 and ADH1B 2/2 variants encode for proteins that metabolize alcohol
at much faster rates than ADH1B 1/1. Representative numbers of each genotype were analyzed for
SBR to six commercial BD products (ointments, creams and lotions) with and without alcohol(s).
SBR were measured in these subjects as a function of dose (application duration) and ®tted by an
Emax pharmacokinetic/dynamic model. In the absence of alcohol(s), or in the presence of
isopropyl alcohol, all genotypes produced similar dose±response pro®les to the same BD product.
In the presence of propylene glycol, or isopropyl alcohol + propylene glycol however, ADH1B 1/
2 subjects produced greater maximal SBR but required larger doses than ADH1B 2/2 or ADH1B
1/1. SBR differences among the ADH1B genotypes were independent of BD uptake into skin.
These data suggest that the SBR can be altered by speci®c alcohol(s) in the vehicle as a function of
subject ADH1B genotype and alcohol metabolism independent of drug delivery into the skin.
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Analysis of Gene Mutations in Two Cases of Dermato®brosarcoma Protuberans
H. Saeki, T. Hoashi, Y. Tada, H. Ohmatsu, R. Ashida, H. Torii, Y. Kawabata, A. Asahina, and K.
Tamaki
Dermatology, Tokyo University, Tokyo, Japan
Dermato®brosarcoma protuberans (DFSP) is an uncommon cutaneous neoplasm of intermediate
malignancy. Recently, the fusion of the collagen type 1a1(COL1A1) gene with the platelet-
derived growth factor B-chain (PDGFB) gene has been descrived in DFSP. Various exons (exon 7,
8, 10, 11, 22, 24, 25, 29, 32, 33/34, 37, 38, 39, 40, 43, 45, 46, 47) of COL1A1 gene have been
shown to be involved in the fusion with exon 2 of PDGFB gene. In this study, we examined the
breakpoints of the COL1A1 gene using the tumor specimens from two patients with DFSP. Case 1
is a 41-year-old Japanese man with a multinodular red-brown plaque measuring 58 3 38 mm on
the lower back. Case 2 is a 18-year-old Japanese man with a red-brown, dome shaped nodule
mesuring 47 3 35 mm on the right thigh. Reverse transcription (RT) ± polymerase chain reaction
(PCR) was performed using cultured DFSP tumor cells. To amplify the COL1A1-PDGFB fusion
transcript, PCR was carried out using 16 COL1A1 forward primers and a speci®c PDGFB reverse
primer. Sequence analysis was performed using the PCR products to clarify the breakpoints. The
COL1A1-PDGFB fusion transcripts could be detected from the tumor specimens. Nucleotide
sequence analysis of the PCR products revealed that exon 18 and exon 29 of the COL1A1 gene
were fused with exon 2 of the PDGFB gene in case 1 and 2, respectively. Exon 29 of the COLA1A
gene has already been shown to be involved in the fusion with exon 2 of the PDGFB gene.
However, there has been no report of DFSP with COL1A1 (exon 18) ± PDGFB (exon 2) fusion
transcript. In conclusion, the present study identi®ed a novel COL1A1 breakpoint, namely, exon
18 of the COL1A1 gene.
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Keratitis±Ichthyosis±Deafness Syndrome is Caused by Dominant Missense Mutations in
GJB2 Encoding Connexin-26
G. Richard, F. Rouan, C. Willoughby,* N. Brown, S. Amin, P. Chung, M. Ryynanen,² E. Jabs,³
S. Bale,§ J. DiGiovanna,§ J. Uitto, and L. Russell§
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.;
*Experimental Ophthalmology, University of Liverpool, Liverpool, U.K.; ²Obstetrics and Gynecology,
University Hospital Oulu, Oulu, Finland; ³Institute of Genetic Medicine, Johns Hopkins Hospital,
Baltimore, Maryland, U.S.A.; §Genetic Studies Section, NIAMS, NIH, Bethesda, Maryland, U.S.A.
Keratitis±Ichthyosis±Deafness Syndrome (KID) is a rare ectodermal dysplasia characterized by
vascularizing keratitis, profound sensorineural hearing loss (SNHL), and progressive erythroker-
atoderma, a clinical triad that points to a failure in development and differentiation of multiple
stratifying epithelia. We provide compelling evidence that KID is caused by mutations in the
connexin-26 gene, GJB2. In each of 10 KID patients, we identi®ed a point mutation leading to
substitution of conserved residues in the cytoplasmic N-terminus or ®rst extracellular domain of
Cx26. One of these mutations was detected in 6 unrelated sporadic cases and also segregated in one
family with vertical transmission of KID. These results indicate the presence of a common,
recurrent mutation and establish its autosomal dominant nature. Cx26 and the closely related Cx30
showed differential expression in epidermal, adnexal and corneal epithelia but were not
signi®cantly altered in lesional skin. However, mutant Cx26 was functionally impaired and
incapable of inducing intercellular coupling in vitro. Our data reveal striking genotype-phenotype
correlations and demonstrate that dominant GJB2 mutations can disturb the gap junction system of
one or several ectodermal epithelia, thereby producing multiple phenotypes: syndromic and
nonsyndromic SNHL, palmoplantar keratoderma, and KID. Decreased host defense and increased
carcinogenic potential in KID illustrate that gap junctional communication plays not only a crucial
role in epithelial homeostasis and differentiation but also in immune response and epidermal
carcinogenesis.
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Essential Fatty Acids (EFAs) Regulate Adult Human Keratinocyte Function Via
Activation of PPARg
C. Marcelo, S. Hirano, T. H. Dunham, C. Corpron, A. Reddy, and R. R. Gilmont
Surgery, University of Michigan, Ann Arbor, Michigan, U.S.A.
The nuclear peroxisome proliferator-activated receptors (PPARs) respond to lipid ligands and can
control epidermal function. Adult human keratinocytes in primary culture grow vigorously in lipid
free medium and are EFA de®cient (EFAD). Supplementation with EFAs corrects the de®ciency
and eliminates the rapid growth rate. The expression of all three PPARs: PPARa, b/d, g, was
investigated in EFA de®cient (EFAD) and supplemented (EFAS) keratinocytes. Basal cells from
human skin were grown in Epi-Life de®ned medium. The keratinocytes were fed EFAS medium
at the P1 to P2 passage. The 4 EFAS media were: (1) 10 mM 18:2 (n-6), plus 5 mM 16:0 and 20:4
(n-6); (2) 15 mM 20:4 (n-6); (3) 15 mM 18:2 (n-6); and (4) 15 mM 16:0, using EFA-free BSA as
carrier. Six, 16 and 24 h after adding the EFAs, RNA was extracted using Trizol. Speci®c PPAR
and GAPDH primers were used for RT-PCR. For Western blot analysis, EFAS and EFAD cells
were harvested after 8, 16 and 24 h. Lysates were analyzed by discontinuous SDS-PAGE,
transferred to PVDF membranes and reacted with primary antibody, followed by peroxidase-
conjugated antibody, and chemiluminescence. EFAD cells were grown in 0.1±10 mM Ciglitizone,
a speci®c PPARg agonist, and for 4 h in 0.5±10 mM bisphenol A diglycidyl ether (BADGE), a
speci®c competitive antagonist to PPARg, prior to adding EFAs to the medium. [3H]-Tdr uptake
into DNA measured cell proliferation. Western blot and RT-PCR analysis showed that all PPARs
are expressed in human keratinocytes and that PPARg is increased by the EFAs ligands. RT-PCR
showed that PPARa may also be elevated by EFAs, although PPARb is not. Ciglitizone decreased
DNA synthesis in EFAD cells and BADGE reversed the inhibition by EFAs of proliferation.
Western Blot and RT-PCR analysis showed that both EFAs and Ciglitizone increased PPARg
expression while BADGE decreased expression in EFAS cells. The results suggest that EFAs or
their derivatives are endogenous ligands for PPARs in epidermal keratinocytes and that they act via
PPARg.
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Dominant and Recessive Compound Heterozygous Mutations in Epidermolysis Bullosa
Simplex Demonstrate the Role of the Stutter Region in Keratin Intermediate Filament
Assembly
K. Yasukawa, D. Sawamura, J. McMillan, H. Nakamura, and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Keratin intermediate ®laments are important cytoskeletal structural proteins involved in
maintaining cell shape and function. Mutations in the epidermal keratin genes, keratin 5 or
keratin 14 lead to the disruption of keratin ®lament assembly, resulting in an autosomal dominant
inherited blistering skin disease, epidermolysis bullosa simplex (EBS). We have investigated a large
EBS kindred whose members exhibited a markedly heterogeneous clinical severity and detected
two distinct keratin 5 mutations in the proband, the most severely affected. One missense mutation
(E170K) in the highly conserved helix initiation peptide sequence of the 1A rod domain was found
in all the affected family members. In contrast, the other missense mutation (E418K) was found
only in the proband. The E418K mutation was located in the stutter region, an interruption in the
heptad repeat regularity, whose function remains as yet unclear. We hypothesized that this stutter
mutated allele was clinically silent when combined with the wild type allele but could aggravate the
clinical severity of EBS caused by the E170K mutation on the other allele. To con®rm this in vitro,
we transfected mutant keratin 5 cDNA into cultured cells. While only 12.7% of the cells
transfected with the E170K mutation alone showed disrupted keratin ®lament aggregations,
signi®cantly more cells (30.0%) cotransfected with both E170K and E418K mutations
demonstrated keratin aggregation (p < 0.05). These transfection assay results corresponded to the
clinical heterogeneity of the EBS phenotype in this kindred. We have found the ®rst case who was
compound heterozygous with a dominant (E170K) and a recessive (E418K) mutations in any
keratin gene, and con®rmed a signi®cant involvement of the stutter region in the assembly and
organization of the keratin intermediate ®lament network in vitro.
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Short Human TERT-Promoter Fragments as Ef®cient Tumor-Speci®c Transcriptional
E1A-Targets for Anticancer Gene Therapy with (VP22)-Ad5/12E1A-Derivatives
H. Kirch, B. Opalka,* and U. R. Hengge²
Institute of Molecular Biology (Cancer Research), University of Essen, Essen, NRW, Germany;
*Department of Medicine (Cancer Research), University of Essen, Essen, NRW, Germany; ²Department of
Dermatology, Venerology and Allergology, University of Essen, Essen, NRW, Germany
We have previously de®ned several adenovirus (Ad) 13S E1A derivatives as good candidates for
anticancer gene therapy, since they were (a) transformation defective and (b) more ef®cient with
respect to their antioncogenic properties than the respective E1A wild type (wt) 13S-encoded
proteins. Here we show that two of these derivatives, Ad12 E1A-Spm2, lacking only six amino
acids in the Ad12 E1A unique Spacer region, and the CR2 deletion mutant Ad5 E1A-delCR2
outrivals Ad5 and Ad12 E1A-wt (wild type) in potently transactivating transcription from small
promoter fragments of the human telomerase reverse transcriptase (hTERT) gene in human
melanoma cells (BLM). Transcription from two of these fragments, one from ±208 to +5 and the
other from ±149 to +5 (kindly provided by I Horikawa and JC Barrett), was up to 50-fold
activated by the E1A derivatives, whereas transcription from the complete hTERT promoter or
from a 408-bp fragment that contains a Wilm's Tumor 1 (WT-1) transrepression motif was less
in¯uenced. Transactivation seems to be independent from activation of c-Myc by E1A, since the
smaller promoter fragment does not contain the Myc-binding E-Box motif, de®ning the remaining
SP-1 motifs as targets for E1A-mediated transactivation. Initial experiments showed that both, basic
and E1A-activated transcription can hardly be detected in human foreskin ®broblasts. Despite the
transactivation potential of E1A-Spm2 for hTERT core promoters the endogenous telomerase
activity was left nearly unaltered. Interestingly both the recruitment of histone acetyl transferase
(HAT) and the suppression of histone deacetylase by E1A-Spm2 were involved in transactivation
from the hTERT-promoter. Our data recommend the use of an E1A/hTER transcription system
for the enhanced tumor-targeted expression of antioncogenic transgenes for cancer gene therapy.
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From Gene Chips to Footprints: Molecular Mechanisms of Corticosteroid Action in
Epidermis
M. Tomic-Canic, B. B. Lee, J. DiClerico, C. Vouthounis, and O. Stojadinovic
Dermatology, NYU School of Medicine, New York, New York, U.S.A.
Corticosteroids (CS) are widely used for their anti-in¯ammatory and antiproliferative potential in
treatments of various skin diseases. However, very little is known about their mechanisms of action
in epidermis. Therefore, we used global transcriptional analysis to determine how CS regulate
epidermal gene expression. We treated normal human skin either by control ointment or topical
CS for 1±5 days. mRNA was extracted from both treated and untreated skin samples on the days 1,
2, 3 and 5. Samples were hybridized to HU95A Affymetrix gene chips. Expression pro®ling was
performed on 12 000 known human genes using Affymetrix Data Mining Software tools. We
found that topical treatment by CS inhibits both activation and differentiation while promotes basal
keratinocyte phenotype. For example: keratins K6, K16 and K17 (activation markers) as well as
involucrin and SPRRs (differentiation markers) were inhibited whereas BPAG and TGFb receptor
were induced. We have shown previously that CS, retinoids (RA) and thyroid hormone (T3R)
suppress K6/K16 and K17. Interestingly, both RA and T3R block the inhibition mediated by CS.
Our chip analysis show that CS induce the expression of RAR and T3R receptors. Furthermore,
we found that CS inhibit expression of c-fos, and c-jun transcription factors of the AP1 complex.
All these molecules, RAR, T3R and AP1 are known to cross talk with CS during wound healing.
Therefore differential regulation of these factors by CS selects for a particular negative regulatory
feedback. Taken together, our results show very speci®c regulatory pattern of major transcription
regulators by CS leading to particular keratinocyte phenotype during wound healing.
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Hairless is a Nuclear Matrix Associated Protein with a Putative Chromatin Remodeling
Function
K. Djabali and A. M. Christiano
Dermatology, Columbia University, New York, New York, U.S.A.
Hair follicle cycling is a highly regulated and dynamic cellular process consisting of phases of
growth, regression and quiescence. The transitions between the phases are governed by a growing
number of regulatory proteins, including transcription factors. The hairless (hr) gene encodes a
putative transcription factor that is highly expressed in the skin, where it appears to be an essential
regulator during the regression in the catagen hair follicle. In hairless mice, as well as humans with
congenital atrichia, the absence of hr protein initiates a premature and abnormal catagen due to a
dysregulation of apoptosis and cell adhesion, and defects in the signaling required for hair follicle
remodeling. Here, we report structure-function studies of hr, in which we identify a novel bipartite
nuclear localization signal (NLS) of the form KRA (313) PKR. Deletion analysis of the mouse hr
gene mapped the NLS to amino acid residues 409±427. Indirect immuno¯uorescence microscopy
of cells transiently transfected with hairless-green ¯uorescent fusion proteins demonstrated that
these amino acid residues are both necessary and suf®cient for nuclear localization. Furthermore,
nuclear fractionation analysis revealed that hr is associated with components of the nuclear matrix.
Using similar deletion analysis following a nuclear matrix extraction assay, we identi®ed the nuclear
matrix targeting signal (NMTS) within amino acid residues 111 and 200 of the mouse hr sequence.
Together, our data demonstrate that the amino-terminal region of hr contains the signals not only
to translocate hr protein to the nucleus, but also to a subnuclear compartment where it appears to
associate with the chromatin. This hypothesis is supported by recent evidence that hr belongs to a
family of proteins containing a JmjC domain (jumonji C), which are predicted metalloenzymes and
are involved in chromatin remodeling.
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Co-Expression of von Willebrand Factor with Factor VIII in Epidermis Augments
Circulating Factor VIII in Hemophilia a Mice
A. L. Goldbeck, S. Kobayashi, H. Lu, R. Sankar, and S. S. Fakharzadeh
Dermatology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, U.S.A.
We previously generated a transgenic mouse model for skin-targeted gene therapy for hemophilia
A that expresses factor VIII in the suprabasal epidermis under control of the involucrin promoter.
We bred these mice into a factor VIII knockout background to generate mice that express factor
VIII in the skin, but not at normal sites of factor VIII expression. These mice had functional
circulating factor VIII and displayed phenotypic correction. This demonstrated proof of principle
that targeting factor VIII expression to epidermis can correct hemophilia A. We are now
examining approaches for improving access of factor VIII expressed in the epidermis to the
circulation. One approach is to coexpress factor VIII with von Willebrand factor (vWF), which
binds and stabilizes factor VIII heterodimer. We have generated additional transgenic mice that
produce vWF under control of the involucrin promoter. Three independent lines have been
obtained that express vWF in the skin as shown by RT-PCR analysis. We have been breeding
lines from both sets of transgenic mice to generate mice that coexpress factor VIII and vWF in the
epidermis in a background de®cient for endogenous factor VIII. Average factor VIII activity for
factor VIII/vWF double transgenic mice derived from one vWF line was 16% of normal (n = 6)
whereas factor VIII single transgenic littermates had average factor VIII activity of 9% of normal
(n = 8). This represents a relative increase in average factor VIII activity of 78% (p < 0.0008) for
double transgenic mice. Mice from additional breedings with the other vWF lines will be available
for analysis shortly. Nonetheless, these results suggest that coexpression of vWF with factor VIII
yields signi®cantly higher levels of circulating factor VIII compared to expression of factor VIII
alone. This ®nding may bene®t efforts to target factor VIII gene therapy to not only skin but
potentially other tissues as well.
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Tissue-Speci®c Expression and Transcriptional Modulation of Human ABCC6, the
Gene Mutated in Pseudoxanthoma Elasticum
Y. Matsuzaki, K. Li, A. Nakano, S. Aho, L. Pulkkinen, and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.
Pseudoxanthoma elasticum (PXE), a heritable disorder characterized by calci®cation of elastic
structures in the skin, eyes, and the cardiovascular system, is caused by mutations in the ABCC6
gene. Previous observations have suggested that this gene is expressed primarily in the liver and the
kidneys. In this study, we have examined the tissue-speci®c expression and transcriptional
modulation of the human ABCC6 by mRNA analysis and transient transfections of promoter-
reporter gene (luciferase) constructs. First, the expression of ABCC6 was examined by RT-PCR
of human Multiple Tissue cDNA panels. High level of expression was noted in the liver with
lower levels in kidney and lung, the remaining tissues (12) being negative. Consistent with this,
high level of expression was noted in HepG2 hepatoma cells while expression in dermal ®broblasts,
HaCaT, smooth muscle and kidney 293 cells was relatively low or undetectable. Secondly, a 2.7-
kb ABCC6 promoter-luciferase reporter gene construct was developed and used in transient
transfections of HepG2 cells. The 2.7-kb ¯anking region was devoid of canonical TATA-box, and
there were no AP1 or AP2 consensus sites, while 6 Sp1 ci-elements were noted within the region ±
700 to ±100. A series of 5¢-deletion constructs revealed evidence of an up-regulatory, enhancer-
like element within the region ±286 to ±202. Attempts to modulate the promoter activity by a
number of cytokine and hormonal factors revealed that TGF-b up-regulated and TNF-a down-
regulated promoter activity in dose-dependent manner. Similarly, interferon-g (100 U/ml) reduced
the activity by about 50%. In contrast, retinol, dexamethasone and b-estradiol (10 mM each),
vitamin D3 (100 nM), as well as CaCl
2
(5 mM) and ZnSO
4
(100 mM) had no effect. These results
con®rm the predominant expression of ABCC6 in the liver and indicate that the transcription of
ABCC6 can be modulated by cytokine factors.
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The ATM Protein Kinase Mediates DNA Damage Responses Induced by Telomere-
Speci®c DNA
M. S. Eller, G. Li, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Experimental disruption of the normal telomere loop structure leads to exposure and degradation
of the telomere 3¢ overhang and induction of apoptosis in human lymphocytes and embryonic
mouse ®broblasts. This apoptosis is dependent in these cell types on the ATM kinase, a major
mediator of DNA damage responses also linked to telomere maintenance. We previously reported
that treatment of human cells with DNA oligonucleotides homologous to the telomere 3¢
overhang (T-oligos) activates p53 by multiple criteria including phosphorylation of serine 15. The
oligos also induce E2F1, apoptosis, and an S-phase arrest mediated by phosphorylation of p95/
Nbs1. Many of these responses, particularly phosphorylation of p95/Nbs1 and p53 and E2F1
induction are known to be mediated by ATM after DNA damage from ionizing radiation (IR).
We therefore investigated the role of ATM in mediating these T-oligo effects. In wild type
nontransformed human ®broblasts (fb), T-oligo induced a 10±15 fold increase in the level of p53
phosphorylated on serine-15, compared to diluent alone. In contrast, T-oligo treatment of AT fb,
known to lack functional ATM protein, resulted in a less than 50% increase. As expected, the AT
fb also showed only minimal phosphorylation of p53 in response to IR. The T-oligo also induced
E2F1 levels and p95/Nbs1 phosphorylation in wild type SV40-transformed control fb, but not in
SV40-transformed AT fb. FACS analysis of normal (control) fb showed a 32 and 63% increase in S-
phase cells after 24 and 48 h treatment, respectively, compared to a 0 and 35% increase in S-phase
AT fb, consistent with decreased p95/Nbs1 phosphorylation in cells lacking ATM. Mean telomere
length and integrity of the 3¢ overhang were not decreased in T-oligo-treated cells, excluding
telomere disruption as a mechanism of action. These data demonstrate that ATM mediates many of
the molecular and cellular responses to the T-oligos, presumably mimicking exposure of the
telomere 3¢ overhang DNA that may occur at the time of DNA damage, and suggest a novel
mechanism by which ATM mediates telomere signaling and maintenance.
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Exclusion of Candidate Genes and Loci for Multiple Lentigines Syndrome and Mapping
of Susceptibility Locus to Chromosome 6
T. Pacheco,* N. Oreskovich,*² G. Bellus,* J. Talbert,² W. Old,² and P. Fain²
*Dermatology, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.; ²Human
Medical Genetics, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.
Multiple Lentigines syndrome (MLS) is a rare autosomal dominant disorder, characterized by
diffuse cutaneous lentigines which may occur with noncutaneous manifestations. To identify
molecular defects responsible for this disease, we tested candidate loci for similarly described
lentiginosis disorders ± Peutz±Jeghers syndrome (PJS) (MIM175200), Carney complex (CC)
(MIM160980), Cowden disease (CD) (MIM158350), and Bannayan±Riley±Ruvalcaba syndrome
(BZS) (MIM153480) and two candidate loci for which MLS has been cognated ±
Neuro®bromatosis, Type 1 (NF-1) (MIM162200) and Noonan syndrome (MIM 163950). We
performed linkage analysis using genotyping with microsatellites in a large family with MLS.
Linkage analysis indicated that neither the CC, PJS and CD/BZS loci on chromosomes 2 (2p16),
17 (17q23-q24), 19 (19p13.3, 19q13.4), and 10 (10q23.3) nor the NF1 and Noonan syndrome loci
on chromosomes 17 (17q11.2) and 12 (12q24) harbor the gene defect(s) responsible for the
phenotype in this family. Subsequent genetic linkage analyses studies in this large family with
several MLS affected individuals have mapped a MLS susceptibility locus to the long arm of
chromosome 6.
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G2028R Mutation in COL7A1 Leads to Marked Heterogeneous Clinical Phenotypes of
Dominant Dystrophic Epidermolysis Bullosa
H. Nakamura, D. Sawamura, J. LaDuca,* J. Lee,² T. Masunaga,³ and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; *Dermatology, University
of Rochester, Rochester, New York, U.S.A.; ²Dermatology, National Cheng-Kung University, Tainan,
Taiwan; ³Dermatology, Keio University School of Medicine, Tokyo, Japan
A range of COL7A1 mutations in patients with dystrophic epidermolysis bullosa (DEB) have been
reported so far. Dominant DEB is caused by glycine substitution mutation within the collagenous
domain of the type VII collagen. In this study we examined a large American family in which
many patients in three generations present toe-nail dystrophy without skin fragility in autosomal
dominant manner. Mutation analysis of COL7A1 detected a heterozygous G-to-A transition at
nucleotide position 6082 leading to G2028R in all the affected members. Surprisingly, mutation
database analysis showed that this G2028R mutation was found to be previously reported in two
distinct patients with DDEB who have apparent skin fragility and blister formation. One case was a
27-year-old Japanese female with clinical features of EB pruriginosa, and the other was a 17-
month-old Chinese female whose clinical phenotype was classical type of DDEB with skin
fragility. To elucidate the reason of this marked clinical heterogeneity among these families in
molecular level, we have obtained genomic DNA from these two patients and have examined the
entire sequences of all the exons and exon-intron borders of COL7A1, and compared them with
that of American family. Sequence results indicated that apart from several polymorphisms that do
not substitute amino acid, there is no other mutation than G2028R in these three families
examined. This study indicates that DDEB patients with the same dominant glycine substitution
can present marked heterogeneous clinical severity, and other molecular mechanisms, such as
mutations in the promotor or intron sequences, or difference of expression levels of two distinct
alleles, could be responsible for the clinical heterogeneity.
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Human Gene Expression Mapping in Alopecia Areata
J. Baumgarten, H. Pan,* J. Xiang,² and A.A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.; *Psychiatry,
Weill Medical College of Cornell University, New York, New York, U.S.A.; ²Microbiology and
Immunology, Weill Medical College of Cornell University, New York, New York, U.S.A.
High density oligonucleotide microarrays, so called `gene chips', represent a technological
intersection between biology and computer science. Microarray technology offers simultaneous
monitoring of vast numbers of known and/or unknown sequences. We have applied genome wide
documentation of gene expression by microarray analysis to the study of the genetic basis of
alopecia areata (AA). Although numerous studies suggest a genetic predisposition to AA and there
is increasing support for autoimmune activation, the exact mechanisms of disease initiation and
progression are not well understood. The expression of a number of genes has been reported as
altered in affected scalp, however, a broad perspective on the gene expression abnormalities in AA
has thus far been unavailable. Total RNA was prepared from lesional and site-matched nonlesional
scalp biopsy samples from 10 patients with AA. The RNA was then reverse transcribed and labeled
using ¯uorescent nucleotides, followed by hybridization to Affymetrix Human Genome U95A
Arrays (> 12 500 sequences). In a preliminary analysis of 3 patients, among the pool of top ranking
differentially expressed genes, we report 9 up-regulated and 21 down-regulated sequences shared
in 2 or more patients. Genes of interest include hair keratin 19, type I keratin, hair hHkb1 protein,
hair keratin acidic 3-II, and hair hHa2.
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Genome-Wide Survey of Gene Expression in Vitiligo
P. Ogbogu, H. Pan,* J. Xiang,² and A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.; *Psychiatry,
Weill Medical College of Cornell University, NY, New York, U.S.A.; ²Microbiology and Immunology,
Weill Medical College of Cornell University, NY, New York, U.S.A.
Functional genomics are the new wave in molecular medicine. High-density DNA microarrays are
an emerging technology which promise to provide new levels of insight into the understanding of
induction, pathogenesis, and progression of many human diseases. We have utilized arrays that
allow for the screening of approximately 12 500 human genetic sequences to study gene expression
changes associated with vitiligo. Vitiligo is a common disorder, thought to be autoimmune in
nature, which results in an acquired hypomelanosis of the skin. The immunologic mediators and
gene±environment interactions that translate at the level of gene expression to coordinate the
initiation and progression of the autoimmune response is unknown. The goal of this study is to
document differential gene expression in vitiligo between lesional and nonlesional skin at a
genome-wide level. Total RNA was prepared using 6 mm punch biopsies from lesional and
nonlesional skin samples from 6 patients with vitiligo. Total RNA was then extracted, and
hybridized to high-density oligonucleotide microarrays (Affymetrix U95A). The quanti®cation
and analysis of the data will be performed using Signi®cance of Microarrays (SAM) and Genespring
analysis software for hierarchical and nonhierarchical clustering. Data analysis is aimed at (a)
de®ning disease associated expression signatures that differentiate vitiligo from nonlesional skin, as
well as other in¯ammatory cutaneous lesions, and (b) identifying speci®c up- and down-regulated
sequences of importance in disease.
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Expression of Human Factor VIII Targeted to Basal Epidermis Corrects Factor VIII
De®ciency in Hemophilia a Mice
R. Ubriani, A. L. Goldbeck, S. Kobayashi, R. Sarkar, H. Lu, and S. S. Fakharzadeh
Dermatology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, U.S.A.
Previously, we characterized a transgenic mouse model for skin-targeted gene therapy for
hemophilia A. We generated transgenic mice that express human B domain-deleted factor VIII in
the suprabasal epidermis under control of the involucrin promoter and bred them into a factor VIII
knockout background. These mice had functional circulating factor VIII and displayed phenotypic
correction. This demonstrated proof of principle that targeting factor VIII expression to epidermis
can correct hemophilia A. We are now exploring strategies for optimizing factor VIII expression in
the epidermis to maximize both delivery to and activity in the circulation. One approach is to
express factor VIII in basal epidermis rather than in suprabasal epidermis. We have generated a
transgene construct that uses the keratin-14 promoter to direct human B domain-deleted factor
VIII expression to basal epidermis. Three transgenic founder mice have been obtained that express
this construct as shown by RT-PCR analysis of total RNA from skin. These founders have been
bred into a factor VIII knockout background to generate three independent lines that express factor
VIII in basal epidermis but not at normal sites of factor VIII expression. Mice from these lines
produce functional factor VIII and show average factor VIII activity of 5% (n = 4), 10% (n = 5), and
10% (n = 4). This demonstrates that factor VIII gene expression targeted to basal epidermis can
supply corrective levels of factor VIII to the circulation. We are comparing factor VIII expression,
activity, and antigen levels of these mice to those of transgenic mice that express factor VIII under
control of the involucrin promoter. In this way, we will assess whether expression of factor VIII in
the basal epidermis is superior to expression in the suprabasal epidermis for a skin-targeted
approach to gene therapy for hemophilia A.
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Mutations within ATP2A2 in Japanese Patients with Darier Disease
T. Onozuka, D. Sawamura, K. Yokota, and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Darier disease (DD, keratosis follicularis; OMIM 124200) is autosomal dominant genodermatosis
characterized by warty papules and plaques on the mid-trunk, ¯exures, scalp and forehead. The
cause of DD was identi®ed to be the result of mutation in the ATP2A2 gene on chromosome
12q23±24.1, which encodes the sarco/endoplasmic reticulum Ca
2+
ATPase type 2 isoform
(SERCA2). In this study, we have examined the ATP2A2 gene in 8 DD Japanese families.
Genomic DNA was extracted from peripheral blood lymphocytes and each of the 21 exons of the
ATP2A2 gene were ampli®ed by polymerase chain reaction (PCR). Direct sequencing of the PCR
products was performed using a QIAquick PCR puri®cation kit (QIAGEN). All the PCR
products were sequenced using an ABI PRISM 310 genetic analyzer. In 5 out of 8 families, we
detected 4 distinct mutations, 3 of which were novel. The spectrum of mutations included 3
missense mutations (M1V substitution in the start codon, G233R substitution in the beta-strand
domain, and G840A substitution in the M7 transmembrane domain), 1 insertion (2170 insertion G
in the hinge domain). G233R substitution was identi®ed in 2 unrelated families. These results
together with previous mutation data of DD indicate that the distribution of mutation is scattered
over the entire ATP2A2 gene without concentration. Our ®ndings provide signi®cant additions to
the DD mutation database and will further contribute to the understanding of DD genotype/
phenotype correlations.
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Cluster Analysis of Gene Array-Based Time Course and Dose±Response of In Vivo
Human Skin to Simulated Solar Radiation
T. S. McCormick, M. Takahara, H. M. Ramirez, L. Liu, B. Jones,² J. Nadeau,* S. Gettings,² M.
Traudt,² S. R. Stevens, and K. D. Cooper
Dermatology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio,
U.S.A.; *Genetics, Case Western Reserve University and University Hospitals of Cleveland, Cleveland,
Ohio, U.S.A.; ²Research Division, Avon Products Inc, Suffern, New York, U.S.A.
We have previously described a pattern of gene expression associated with high dose (4MED)
simulated solar radiation (SSR). We have now determined time- and dose-dependent relationships
among the interacting and independently regulating gene products, using cluster analysis. Five
individuals were exposed to 1MED SSR at varying times prior to biopsy. Keratome samples were
then taken from unexposed skin and SSR- irradiated skin at 5, 20 and 32 h post irradiation. RNA
prepared from skin samples at each timepoint were pooled from the ®ve individuals to minimize
interindividual variation and repeated microarray experiments were performed using the Clontech
plastic human 8K microarray (8300 gene cDNA). Our choice of membrane allowed for maximal
gene examination and totally encompassed the previous gene set we had examined at 0 and 4MED
SSR at 32 h with the Clontech human 1.2 array. Concordance between the 4 MED 32 h gene
response pro®le and 1 MED 32 h response was evident by several gene classi®cations including the
transglutaminase substrate and chemoattractant protein S100 A7 (psoriasin gene) and the
TGFbsignaling pathway gene family MAD. Interestingly psoriasin gene signaling was down-
regulated at 5 h then became induced by 20 h and sustained this induction at 32 h, suggesting that
the gene response may be due to cells in®ltrating the SSR skin. Certain in¯ammation-dampening
genes, such as platelet activating factor acetylhydrolase, up-regulated early then down-regulated by
20 and 32 h while alternative in¯ammation-dampening factors, such as IL-10, did not up-regulate
until 20 and 32 h. These dose±response and time course data, validated by cutaneous genes known
to be UV regulated, contribute novel insights into the understanding of the SSR response of
human skin.
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Gene Expression Pro®ling in Psoriasis by High-Density Oligonucleotide Microarray
Analysis De®nes Lesional vs. Nonlesional signatures
L. H. Pai, H. King, H. Pan,* J. Xiang,² and A. A. Sinha
Dermatology, Weill Medical College of Cornell, New York, New York, U.S.A.; *Psychiatry, Weill Medical
College of Cornell, New York, New York, U.S.A.; ²Microbiology and Immunology, Weill Medical College
of Cornell, New York, New York, U.S.A.
Psoriasis Vulgaris is a chronic, polygenetically determined skin disorder estimated to affect
approximately 2% of the US population. The molecular basis for the initiation and mechanisms of
progression are not well understood. However, increasing experimental evidence suggests a
generalized immune dysregulation that is at least in part genetically based. The expression levels of
many genes have been shown to be increased in lesional psoriatic skin, but in spite of these
advances, broad perspectives on the gene expression abnormalities characterizing this disorder have
been unavailable. Thus, we are utilizing the technology of high density oligonucleotide
microarrays, or gene chips, to document differential gene expression between psoriatic lesional and
nonlesional skin at a genome-wide scale. Affymetrix arrays were used to permit the simultaneous
analysis of expression of over 12 500 sequences. Results from 9 psoriatic patients indicate that 578
sequences exhibit differential expression between lesional and nonlesional samples when analyzed
by statistical analysis of microarrays (SAM). 72 sequences were up-regulated and 506 sequences
were down-regulated in psoriatic skin. Hierarchical clustering methods were used to clearly de®ne
lesional vs. nonlesional expression signatures. Subsequently, we utilized K-means clustering to
identify 8 further de®ned clusters within the group of 578 differentially expressed genes. Within
the set of differentially regulated genes, we identi®ed speci®c sequences that have been previously
implicated in disease. In addition, 4 genes shown to be up-regulated in psoriatic skin mapped to
chromosomal locations previously implicated in disease susceptibility: 1p35±34, 4q, 6p21.3,
19p13-q13.
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Enrichment of Keratinocyte Progenitor Cells Transduced with the Multidrug Resistance
Gene by Topical Selection
W. Pfutzner, C. L. Tock,* A. Terunuma,* E. K. Snead,* T. M. Kolodka,* and J. C. Vogel*
Klinik und Poliklinik fuer Dermatologie und Allergologie, Ludwig-Maximilians-Universitaet, Munich,
Germany; *Dermatology Branch, NCI, National Institutes of Health, Bethesda, Maryland, U.S.A.
In gene therapy, expression of a desired transgene is often lost over time thus hampering successful
clinical applications. Possible reasons could be low transduction ef®ciency among stem cells or
transcription silencing of the transgene. In skin, one approach to ensure long-term expression
would be topical selection of keratinocytes (KC) expressing both a desired gene and a linked
selectable gene, such as the multidrug resistance (MDR) gene. Primary human KC transduced with
the MDR retroviral vector pHaMDR1/A (transduction ef®ciency 51% by ¯ow cytometry) were
grafted onto nude mice and subsequently treated by topically applying colchicine. At time points of
up to 5 epidermal turn-over cycles, grafts were harvested and assessed for MDR transgene
expression (by immunohistochemistry and ¯ow cytometry) and MDR provirus integration (by
quantitative polymerase chain reaction (PCR)). While grafts treated with vehicle control cream
showed a continuous loss of MDR-transgene expressing KC (MDR + KC 13 6 5% and 7 6 4% at
9 and 15 weeks after grafting, respectively), topical colchicine signi®cantly increased the percentage
of MDR + KC (50 6 26% and 44 6 15%, respectively). When colchicine treatment was initiated at
a later time point (12 weeks after grafting, 7%MDR + KC present), the percentage of MDR + KC
could still be signi®cantly increased (37%MDR + KC) with 12 weeks of treatment. Furthermore,
colchicine treatment signi®cantly enhanced the amount of MDR-protein in MDR + KC, as
measured by mean ¯uorescence intensity. Interestingly, quantitative real-time PCR analysis
demonstrated signi®cantly elevated MDR transgene copy numbers in colchicine treated grafts
(1.14 6 0.41 vs. 0.34 6 0.16 in control grafts, p = 0.008) These results indicate that topical selection
can enrich MDR + KC progenitor cells leading to increased, persistent transgene expression levels
in skin, thus holding great promise for skin gene therapy applications.
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Biochemical Causes of Ehlers Danlos Syndrome Type VI in Skin Fibroblasts from a
Group of Affected Patients that Appear Unrelated to Decreased Collagen Lysyl
Hydroxylation
H. N. Yeowell, L. C. Walker, J. C. Marini,* W. A. Cabral,* M. Willing,² G. Pals,³ E. Kitamura,§
and M. Yamauchi§
Dermatology, Duke University Medical Ctr, Durham, North Carolina, U.S.A.; *Heritable Disorders
Branch, NICHD, Bethesda, Maryland, U.S.A.; ²Pediatrics, University of Iowa, Iowa City, Iowa,
U.S.A.; ³Human Genetics, VU Medical Ctr, Amsterdam, Netherlands; §Dental Research Ctr, University
of N. Carolina, Chapel Hill, North Carolina, U.S.A.
Patients with the autosomal recessive connective tissue disorder Ehlers Danlos syndrome type VI
(EDS VI) have a clinical phenotype of soft, stretchable skin, hypermobile joints, and
kyphoscoliosis. At the biochemical level, skin ®broblasts from these patients have signi®cantly
decreased levels of lysyl hydroxylase (LH) (25% of normal). LH hydroxylates speci®c lysine residues
in the collagen molecule that are precursors for the formation of crosslinks which provide collagen
with its tensile strength. We have examined skin ®broblasts from a group of 12 patients who,
although they have the clinical phenotype of EDS VI, have normal levels of LH activity (between
80 and 140% of control). Analysis of their mRNAs for the originally described form, LH1, and two
isoforms LH2 and LH3, their crosslinking patterns, and electrophoretic mobility on collagen gels
has shown considerable variability between patients. In contrast to the patients with the classical
form of EDS VI (EDS VIA), who have no detectable mRNA for LH1, this subset of patients has
normal or increased levels of LH1 mRNA. LH2 mRNA was decreased in 4 patients (by 50%) and
up-regulated in 2 patients. Decreases in LH3 mRNA were observed in 2 patients, one of whom
had decreased LH2 mRNA. The collagen-reducible crosslinks in long-term ®broblast cultures
were also variable and did not correlate with changes in the individual LH mRNAs. Based on the
electrophoretic mobility of their type I collagen, the patients could be divided into 3 groups: (a)
structurally abnormal collagen (3 patients); (b) fast migration (characteristic of EDS VIA) in 3
patients and (c) normal migration. This study suggests that, although no single pathway is affected
in this group of patients, it may be possible to identify the individual causes of their clinical
phenotype of EDS VI at the molecular and biochemical level.
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Gene Expression Pro®ling in Cutaneous Lupus Erythematosus
A. Sinha, P. Ogbogu, H. Pan,² and J. Xiang*
Dermatology, Weill Medical College of Cornell University, NY, New York, U.S.A.; *Microbiology and
Immunology, Weill Medical College of Cornell University, NY, New York, U.S.A.; ²Psychiatry, Weill
Medical College of Cornell University, NY, New York, U.S.A.
Lupus erythematosus (LE) is a chronic autoimmune disease that is known to have devastating
effects on many organ systems. Cutaneous ®ndings are quite common in lupus and are thought to
occur in up to 80% of patients with systemic disease at some point in their lives. Although much is
known about the clinical manifestations of this chronic, systemic disease, the molecular basis of
disease induction and pathogenesis are not clearly understood. There is evidence that suggests that
there is generalized immune dysfunction that is, at least in part, genetically based. The pathogenesis
of LE is likely polygenic, with a number of loci contributing to variable phenotypic effects. The
immunologic mediators and gene±environment interactions that translate at the level of gene
expression to coordinate the initiation and progression of the autoimmune response in cutaneous
LE are unknown. The goal of this study is to document differential gene expression in LE between
lesional and nonlesional skin at a genome-wide level. Total RNA was prepared using 6 mm punch
biopsies from lesional and nonlesional skin samples from 6 patients with cutaneous lupus
erythematosus. Total RNA was then extracted, and hybridized to high-density oligonucleotide
microarrays (Affymetrix U95A). These arrays screen for the expression of approximately 12 500
human genetic sequences and can differentiate two-fold or higher changes in expression levels
between experimental samples with high ®delity. Preliminary results involving 3 patients have
identi®ed an overlap of 9 sequences (noted in > 2/3 patients) that rank in the top 20 up-regulated
genes in each of 3 patients. Interestingly, a number of immune-associated targets are illuminated
within this group including, T cell a chemoattractant precursors, T cell speci®c tyrosine kinase, and
Ig lambda light and heavy chain regions. We are further de®ning disease associated expression
patterns using hierarchical and nonhierarchical clustering methods.
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Activation of Dual Cell Cycle Checkpoints in Response to Cisplatin
R. Firoozabadi, M. Eller, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Cisplatin is a widely used anticancer agent known to principally form intrastrand GpG adducts in
DNA. However, the pathways activated by this DNA damage, which then lead to cell cycle arrest
or apoptosis, are incompletely understood. Two of the best-studied mediators of DNA damage-
induced cell cycle arrest are p53 (G0/G1 and G2/M checkpoints) and p95/Nbs1 (S-phase
checkpoint). In order to examine the role of these two mediators in cell cycle responses to
cisplatin-induced DNA damage, normal neonatal human ®broblasts were treated with 1±10 mM
cisplatin for various times, then collected for cell cycle pro®le analysis by FACS and for protein
analysis by Western blot. Twenty-four hours after treatment with 1 mM cisplatin, cultures exhibit a
10% increase in G2/M cells, with a concomitant increase in p53 levels and phosphorylation of p53
serine 15, indicative of p53 activation. Higher cisplatin doses of 5±10 mM result in a strong increase
in the percentage of S-phase cells (42% at 10 mM), with a concomitant increase in phosphorylation
of p95/Nbs1, a modi®cation known to mediate this checkpoint in response to ionizing radiation.
In p53-null Saos-2 cells, the G2/M increase at low doses of cisplatin is absent but the S-phase arrest
remains intact. Introduction of p53 into these cells by adenoviral transfection increases the
percentage of cells in G2/M from 17% (control adenovirus) to 34% (p53 adenovirus) and restores
the 1 mM cisplatin-induced G2/M arrest. Unexpectedly, the p53 transfected Saos-2 cells have
reduced levels of p95/Nbs1, as shown by Western blot, and show a less effective S-phase arrest
than p53 null cells in that more cells progress to mid to late S-phase and fewer arrest in early S-
phase. These data demonstrate that cisplatin induces both a p53-mediated G2/M arrest and an S-
phase arrest mediated by phosphorylation of the p95/Nbs1 protein, with the net effect on cell cycle
pro®le dependent on dose. The data also suggest complex interplay between these two regulators
of different phases of the cell cycle.
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Linkage of Psoriasis to the MHC and Evidence For Additional Loci in a Large Cohort
(International Psoriasis Genetics Consortium)
J.T. Elder, JN. Barker,* D. Burden,² N. Chia, E. Christophers,³ M. Daly,¶ C. Helms,²² T.
Henseler,³ S. Jenisch,§ A. Menter,** R. Mistry,³³ R.P. Nair, P.E. Stuart, D. Tillman,² C.
Veal,³³ JJ. Voorhees, R. Trembath,³³ and A.M. Bowcock²²
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.; *Dermatology, St. John's Institute
Derm, London, U.K.; ²Dermatology, Western In®rmary, Glasgow, U.K.; ³Dermatology, University of
Kiel, Kiel, Germany; §Immunology, University of Kiel, Kiel, Germany; ¶Human Genetics, Whitehead
Institute, Cambridge, Massachusetts, U.S.A.; **Dermatology, Baylor University Medical Ctr, Dallas,
Texas, U.S.A.; ²²Human Genetics, Washington University, St. Louis, Missouri, U.S.A.; ³³Genetics,
University of Leicester, Leicester, U.K.
The genetic basis of psoriasis is complex and several genome-wide scans have identi®ed a number
of potential susceptibility loci. In order to con®rm these linkages we analyzed over 800 affected
sibling pairs (ASPs) from 717 pedigrees for 53 polymorphic microsatellites spanning 14 psoriasis
candidate regions at an intermarker spacing of approximately 5 cM. Allele sharing in ASPs was
tested using Risch's maximum lod score (AJHG 46 : 242±53), as implemented in a modi®cation of
Genehunter 2. This analysis revealed strong evidence for a locus within the major
histocompatibility complex (MHC, p = 2 3 10
-14
). ASP displayed allele sharing of 60%, yielding
a gene-speci®c lambda-s of 1.6. Strong linkage disequilibrium was also observed in the MHC using
the pedigree disequilibrium test (p = 1.3 3 10
-8
). Two psoriasis-associated MHC marker haplotypes
were identi®ed by means of the haplotype-based TDT. Comparison with a previous analysis
(AJHG 66 : 1833±44) revealed that both of these haplotypes carry the same ancestral risk allele.
Across the remainder of the genome, the strongest evidence of allele sharing was obtained on
chromosomes 1q (p = 0.043), 10 (p = 0.012), 16q (p = 0.007) and 17q (p = 0.037). The existence of
non-MHC genetic loci remains the best explanation for the low penetrance of the MHC locus
(approximately 10%, based on the use of HLA-Cw6 as a marker for the disease allele). These results
provide a rationale for more detailed examination of candidate regions on chromosomes 1, 10, 16,
and 17, and for detailed examination of the interactions between these loci and the MHC.
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Generation of Transgenic Skin with Regulated NF-kB Function and Epidermis
De®cient in the RelA/p65 Indicate that NF-kB Subunits Regulate Epidermal Growth
But Not Differentiation
Y. Zhang, R. Kimmel, S. Tao, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
The IKK/NF-kB axis has recently been appreciated as a dominant epidermal regulator, with IKK
dysfunction established as central in incontinentia pigmenti and ectodermal dysplasia. NF-kB-
independent IKK effects on differentiation, however, have recently been established and the
relative role of NF-kB subunits in epidermis is unknown. To de®ne the effects of temporally
regulated NF-kB induction, we have generated inducible forms of all 5 NF-kB subunits [RelA/
p65, p50, p52, c-rel, RelB] via C-terminal fusion to an hydroxytamoxifen (OHT) responsive
mutant estrogen receptor (ER). NF-kB:ER fusions translocate from cytoplasm to nucleus upon
OHT treatment in primary keratinocytes and exhibit inducible transcriptional activity in a pattern
compatible to the wild type subunits. This induction was speci®c in that it did not alter
transcription directed by other promoter elements, including those driven by AP1. Upon
induction, all 5 NF-kB subunits caused rapid human keratinocyte growth inhibition in vitro. These
growth inhibitory effects were blocked by an IkB mutant that sequesters NF-kB subunits and
accelerates proliferation. To extend these studies in vivo, transgenic mice targeting all 5 inducible
subunits to epidermis with the K14 promoter were generated along with an inducible p50-
dominant negative DSP. In initial vivo studies, p50 activation by topical OHT caused epidermal
hypoplasia over 3 days while inducible NF-kB blockade via DSP rapidly induced epidermal
hyperplasia, consistent with a role for NF-kB in negative epidermal growth regulation. Analysis of
mature RelA±/± epidermis generated by grafting E15 skin from RelA±/± mice demonstrated
epidermal hyperplasia with normal granular and corni®ed layers. Further studies examining the
phenotypic response to induction of other NF-kB subunits are underway, however, taken together
these data indicate that classical NF-kB subunits p50/RelA inhibit epidermal growth without
impacting differentiation.
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Evidence that Senescence is Due to Exposure of Telomere 3¢ Overhang Speci®c DNA
Following Critical Telomere Shortening
G. Li, M. Eller, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Telomeres shorten with each cell division and their critical shortening causes cells to become
proliferatively senescent, a suspected cancer prevention strategy. We previously reported that
treatment of human ®broblasts (fb) with oligonucleotides homologous to the telomere 3¢ overhang
(T-oligos) can induce both DNA damage responses and markers of replicative senescence, such as
growth arrest, increased senescence-associated b-galactosidase activity, a large spread morphology,
inability to phosphorylate pRb in response to serum stimulation, and increased expression of p53
and p21 (SDI-1). Recently, others have linked p27Kip1 and p33ING1 to cellular senescence by
demonstrating that p27Kip1 is critical for pRb-mediated senescence and that inhibition of
p33ING1 expression extends cellular replicative life span. To further investigate the possibility that
exposure of the telomere 3¢ overhang due to loop disruption of critically short telomeres, we
examined whether p27Kip1 and p33ING1 are induced by T-oligos and whether these proteins are
also induced by telomere disruption. Normal neonatal human fb were treated with T-oligos or
oligos complementary to the telomere 3¢ overhang as a control. The T-oligo-treated cells, but not
the controls, displayed phenotypic features of senescent fb including a spread morphology,
increased expression of type 1 collagenase, and higher levels of p27Kip1 and p33ING1, as did cells
in paired cultures serially passed to replicative senescence. Fb were then transfected with a
dominant-negative telomere binding factor TRF2DN, known to expose the telomere 3¢ end by
disruption of the telomere loop structure. Cells expressing TRF2DN, but not control transfected
cells, more than doubled protein levels of p21, p27Kipl and p33ING1. These data strongly support
our hypothesis that exposure of the 3¢ overhang sequence by opening of the loop structure of
critically shortened telomeres is a physiologic signal for induction of replicative senescence.
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Regulation of Androgen Activity by Receptor Gene Inhibition Through Speci®c
Antisense Oligonucleotides in Human Sebocytes
S. Fimmel, A. Saborowski, C. Beutler, and C. C. Zouboulis
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
Berlin, Germany
Target cell responsiveness to hormonal signals are product of both cellular concentrations of the
ligand and the corresponding receptor. The effects of androgens in the skin are in¯uenced by the
number of nuclear androgen receptor (AR) molecules available in skin cells. Androgens are the
best-known stimulators of sebaceous gland activity, enhancing lipogenesis, proliferation, and
terminal differentiation of human sebocytes in vitro and in vivo. In this study we applied antisense
technology, which has already proven to be useful both as an experimental tool in functional
genomics and as source of novel therapeutics. Here we describe an approach to inactivate the AR
mRNA in SZ95 sebocytes by thioat- and ribosyl-antisense oligonucleotides. To transfer
oligonucleotides into human SZ95 sebocytes we developed a cationic liposome- mediated
transfection system with DOTAP. The transfection ef®ciency, proved by detection of the cellular
uptake of ¯uorescein-labelled random oligonucleotides with ¯uorescence microscopy, increased
within the nucleus of the sebocytes. The expression of AR on mRNA and protein levels was
investigated by quantitative PCR (TaqMan) and Western blotting. The biological effect of
androgens (5a-DHT and testosterone) was evaluated by a proliferation assay. The most successful
transient control of AR expression was detected with 1.0 mM ribosyl-antisense and revealed a 87%
inhibition of AR expression compared to native cells. After a recovery time longer than 24 h the
AR protein content reached again the level of untreated cells. The functional interaction between
the diminished number of AR molecules and its ligands was demonstrated by an inhibition of
proliferation of AR antisense-transfected SZ95 sebocytes after stimulation with androgens
(1 nmol). The biological gene regulation of the AR with antisense oligonucleotides in vitro is the
®rst step to in¯uence the AR expression in the skin by topical antisense application.
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Differential Inhibition of Lysyl Hydroxylase Isoforms in Human Skin Fibroblasts by
Minoxidil
L. C. Walker, M. A. Overstreet, and H. N. Yeowell
Dermatology, Duke University Medical Ctr, Durham, North Carolina, U.S.A.
Lysyl hydroxylase (LH), an important post-translational modifying enzyme in collagen
biosynthesis, hydroxylates speci®c lysine residues in the collagen molecule to form hydroxylysines
which have two important functions. The residues serve as attachment sites for galactose and
glucosylgalactose and they also act as precursors for the intermolecular crosslinking process that
gives collagen its tensile strength. Minoxidil (MNX), an antihypertensive piperidinopyrimidine
derivative that also stimulates hair growth, has been shown to suppress LH activity and the mRNA
for LH1, the originally described form of LH. This effect appears to be speci®c as the level of prolyl
4-hydroxylase activity, also required in collagen biosynthesis, is not decreased. In this study, we
have compared levels of the mRNAs for LH1 and two isoforms, LH2 and LH3, isolated from
human skin ®broblasts at 0, 3, 6, 12, 24 and 48 h after treatment with MNX (500 mM). Whereas
MNX virtually eliminated the mRNAs for both LH1 and LH2 within 3 h, in contrast the mRNA
for LH3 slowly decreased to 50% of control at 48 h. LH activity decreased gradually to 30% of
control by 48 h. In a second time course in which ®broblasts were treated with 50 mM MNX with
the additional early time points of 1 and 2 h, the mRNA for LH1 decreased signi®cantly more
slowly, with a gradual decline to 30% of control at 48 h. Although initially LH2 mRNA was
decreased up to 6 h, it appeared to recover to normal levels by 12 h and this level was maintained
throughout the later time points. The mRNA for LH3 was unaffected. These results indicate that
LH3, which also acts as a collagen glucosyltransferase, is regulated differently from LH1 and LH2.
This has been suggested both by the lack of similarity between the 5¢ ¯anking regions of the LH1
and LH3 genes and a report of the coregulation of LH1 and LH2, but not LH3, in different human
cell lines. Although the mechanism of action of MNX is unknown, the rapidity of the MNX
suppression (at 500 mM) of LH1 and LH2 mRNAs in human ®broblasts suggests that it may
regulate these genes directly at the transcriptional level.
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Inhibition of Poly (ADP-ribose) Polymerase Blocks Multiple DNA Damage Responses
Induced by Telomere 3¢ Overhang Speci®c DNA
G. Li, M. Eller, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Poly(ADP-ribose) polymerases (PARPs), abundant nuclear proteins that are activated after DNA
damage, polyribosylate key proteins involved in transcription, cell cycle progression and DNA
repair. Evidence suggests that DNA damage responses can originate from telomere disruption and
exposure of the 3¢ overhang, normally buried within a large telomere loop structure. We have
shown that exogenously added DNA oligonucleotides homologous to telomere 3¢ overhang (T-
oligos) mimics telomere disruption and evoke DNA damage responses in the absence of DNA
damage. To investigate the role of PARPs, if any, in mediating these T-oligo responses, normal
human ®broblasts were incubated with a PARP-speci®c inhibitor, isoquinoline (IQ), or diluent
(DMSO) alone for one hour prior to treatment with an 11-base T-oligo, then collected and
analyzed after 48 h. Pretreatment of cells with IQ, compared to diluent alone, reduced all T-oligo
DNA damage responses. There was a 16% reduction of cells arrested in the S-phase (p < 0.07), as
determined by FACS; 90% decreased phosphorylation of p95/Nbs1 serine 343 (p < 0.001); 53%
reduction of total p53 protein to basal level (p < 0.01), 69% decreased phosphorylation of p53 on
serine 15 (p < 0.01) and 54% reduction of p53-regulated p21 protein (p < 0.01) as determined by
Western blot and densitometry. Because telomeres are known to bind to a family of PARPs, the
tankyrases, and these proteins have been implicated in telomere maintenance, our data suggest
telomere function in human cells is regulated at least in part, by poly(ADP-ribosyl)ation in response
to the exposed telomere 3¢ overhang DNA following DNA damage.
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Transcriptional Pro®ling in Response to Pro-In¯ammatory Cytokines in Human
Epidermal Keratinocytes
M. Blumenberg, T. Banno,* M. Adachi,² and I. M. Freedberg
Dermatology, NYU School of Medicine, New York, New York, U.S.A.; *Dermatology, Tsukuba
University School of Medicine, Tsukuba, Japan; ²Dermatology, Tokyo University School of Medicine,
Tokyo, Japan
Proin¯ammatory cytokines cause considerable changes in gene expression in epidermis in response
to various environmental stimuli, during wound healing, and in pathological conditions, To de®ne
these changes, we used oligonucleotide microarrays for transcriptional pro®ling in human
epidermal keratinocytes in response to IL-1, TNFa and IFNg. A set of 12 000 human genes was
probed at 4 time points during the 48 h after treatment. We found that each cytokine caused a
characteristic transcriptional response, turning on or off a distinctive set of genes. For example, the
effects of IFNg tend to be quick and transient, while those of TNFa persist. IFNg does not induce
the cell cycle regulating genes, consistent with its antiproliferative effects. In contrast, both IL-1
and TNFa induce such genes, but only TNFa induces the pro-apoptotic response. These results
are consistent with the effects of IL-1 and TNFa on keratinocyte proliferation. Unexpectedly, we
found signi®cant overlap between genes regulated by TNFa and IFNg, much more than between
TNFa and IL-1, even though TNFa and IL-1 share their signaling pathways. From these results,
we conclude that each proin¯ammatory agent regulates a characteristic set of genes, with unique
timing, thus ®ne-tuning the responses of the epidermis to its environment and disease.
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Identi®cation of a Novel Family of Cell Envelope Components that Contribute to Skin
Barrier Function in the Absence of Loricrin
Z. Zhou,* Jarnick,²³ V. V. Speransky,³ A. C. Steven,³ P. J. Koch,*§ and D. R. Roop*§
*Moleculsr & Cellular, Baylor College of Medicine, Houston, Texas, U.S.A.; ²Structural Biology, Fox
Chase Cancer Center, Philadephia, Pennsylvania, U.S.A.; ³Structural Biology, NIAMS, Bethesda,
Maryland, U.S.A.; §Dermatology, Baylor College of Medicine, Houston, Texas, U.S.A.
Loricrin-de®cient mice exhibit a delay in the formation of skin barrier function during embryonic
development. Although newborn mutant mice weighed less than control littermates at birth and
exhibited a congenital erythroderma with a shiny, translucent skin, we were not able to detect
impaired epidermal barrier function, i.e. increased transepidermal water loss. We have previously
demonstrated that one compensatory mechanism preventing a more severe skin phenotype in
loricrin-de®cient neonates was increased expression of other CE components, e.g. certain small
proline-rich proteins (SPRRs) and repetin, which occurred in utero. An analysis of the amino acid
composition of mutant CEs suggested the presence of additional, loricrin-like proteins. Therefore,
several strategies were applied to identify genes encoding additional CE components that
compensate for the loss of loricrin in our mutant mice. The ®rst approach consisted of a
suppressive-subtractive hybridization screening to detect genes that were up-regulated in mutant
epidermis. The second approach consisted of a detailed expression analysis of ESTs from the
epidermal differentiation cluster (EDC) located on mouse chromosome 3. These two approaches
have resulted in the discovery of a new family of CE components which is located in the EDC
between the SPRR cluster and loricrin. To date, we have identi®ed 13 members of this new
family, which share several structural features with the known CE components, SPRRs and
loricirn. Some of these family members are up-regulated in mutant epidermis, suggesting that these
novel CE components might contribute to the compensatory response that maintains normal water
barrier function in loricrin-de®cient mice.
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Apoptosis Index of Nevi in Utah Kindred Members with and without CDKN2A
Mutations
S. R. Florell,* D. Grossman,* L. J. Meyer,*² and S. A. Leachman*
*Department of Dermatology and the Huntsman Cancer Institute, University of Utah, Salt Lake City,
Utah, U.S.A.; ²Geriatrics Research, Education and Clinical Center, Salt Lake City Veterans Affairs
Medical Center, Salt Lake City, Utah, U.S.A.
Approximately 40% of familial melanoma is caused by a mutation in cyclin dependent kinase
inhibitor 2A (CDKN2A, p16), a tumor suppressor that acts by regulating the cell cycle via the
retinoblastoma (Rb) tumor suppressor pathway. One of several melanoma-prone families studied
15 years ago at the University of Utah was instrumental in establishing the melanoma susceptibility
locus on chromosome 9p21 and later con®rming the relevance of the mutation in CDKN2A. This
family carries a coding mutation of CDKN2A, V126D, that cosegregates with disease. The
mutated protein product is temperature sensitive, showing approximately 33% of normal CDK4
binding at 30 degrees and dropping to less than 10% at 42 degrees. Defective binding to CDK4
results in hyperphosphorylation of Rb, and E2F-mediated re-entry into the cell cycle. We
hypothesized that family members carrying the CDKN2A mutation would have nevi containing
nevus cells that would be more resistant to apoptotic regulation resulting in fewer apoptotic cells
than family members that did not harbor the mutation. Eighteen nevi from 18 kindred members
were immunostained for DNA fragmentation using the TUNEL technique. Nine nevi were from
carriers and nine were from noncarriers. For the noncarriers, ®ve of the nevi were compound
dysplastic nevi and four were common compound nevi; for the carriers, six nevi were compound
dysplastic nevi and three were common compound nevi. The slides were evaluated in blinded
fashion by a pathologist who performed apoptosis index counts on each nevus. Results were
evaluated in conjunction with the kindred members' mutation status. Rare positive cells were
identi®ed in equal numbers in nevi from CDKN2A mutation carriers and noncarriers. These
preliminary results suggest that the apoptosis index of nevi as determined by TUNEL
immunostaining cannot be used to predict CDKN2A mutation status. Future studies with a
more sensitive marker of apoptosis are warranted.
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Transgene Expression by Human Fibroblasts In Vivo is Under Hierarchical Regulation
M. Petersen, C. Jorgensen, T. Tandeski, M. Chen,* J. Morgan,² and G. Krueger
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; *Dermatology, University of
Southern California, Pasadena, California, U.S.A.; ²Research Unit, Shriners Burn Institute, Boston,
Massachusetts, U.S.A.
Genetically modi®ed ®broblasts (GMFb) rapidly lose transgene expression (TGE) when
transplanted to nude mice. Factors that may prolong TGE in vivo include the maturity of the
extracellular matrix (ECM) surrounding the cells, the vector used to transduce the cells, and
lifespan of the GMFb. To examine these factors, normal human ®broblasts (NFb) were transduced
with GFP encoded on one of three vectors: a MLV-based retroviral vector (rv), a 3rd generation
lentiviral vector (3lv) and a vector containing deleted methylation sites (dmsv). To prolong the
cells' inherent lifespan, NFb were ®rst transduced with a retroviral vector encoding human
telomerase (hTRT) and next with GFP encoded on a 3lv or dmsv. GMFb were seeded onto an
empty nylon matrix (ENM) or an ECM-coated matrix, generated from ENM transplanted in vivo
for 4 week (IVENM). Seeded matrices were held in vitro for 4 week, transplanted to nude mice,
and harvested at 4 and 8 week. TGE and survival of GMFb were assessed as a function of vector
(rv, 3lv, dmsv), ECM (ENM vs. IVENM) and lifespan of the GMFb (6 hTRT). All GMFb are
cloned for TGE and of a similar age. At 4 and 8 week, no difference in TGE/S was detected in the
3 vector groups: cells transduced with 3lv and dmsv had the same TGE/S as those transduced with
rv. The IVENM prolonged TGE/S relative to the ENM. TGE/S was signi®cantly enhanced in
GMFb transduced with hTRT at both 4 and 8 week compared with controls. We conclude that
the vectors used to transduce GMFb do not differentially affect TGE/S by GMFb in vivo and,
although the surrounding ECM in¯uences TGE/S, the inherent lifespan of GMFb plays a much
more signi®cant role in TGE/S in vivo.
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STRAL3, a Retinoic Acid-Induced Transcription Factor, is Found in Human
Keratinocytes
M. Bartsch, R. Taneja,* Y. Lu, M. G. Lebwohl, H. Wei, and L. M. Austin
Dermatology, Mount Sinai Medical Center, New York, New York, U.S.A.; *Biochemistry, Mount Sinai
Medical Center, New York, New York, U.S.A.
The mouse STRA13 gene was discovered following retinoic acid treatment of mouse cells
(Boudjelal M et al 1997) with subsequent discovery of the human gene homologue (Antonevich
and Taneja, 1999). In normal mouse tissue, Stra13 expression represses cellular hyperproliferation
while promoting differentiation (Sun and Taneja, 2000). We hypothesize that a de®ciency of
Stra13 expression may contribute to the pathophysiology of psoriatic keratinocytes which are
hyperproliferative and incompletely differentiated. Using a rabbit polyclonal antibody that
recognizes mouse Stra13, we found immunohistochemical staining in normal human skin and
normal mouse skin, which was relatively absent from psoriatic human keratinocytes in lesional skin
using acetone-®xed frozen sections. Therefore, the overall goal of this study is to verify that these
antibodies are recognizing the mouse Stra13 homologue in human keratinocytes and that this
human homologue is induced by retinoic acid. SVK-14 cultured human keratinocytes, an SV-40
transformed cell line, were treated within the dose ranges known to induce Stra13 in mouse cells
for time-periods up to 48 h. Western blot results showed the presence of a 45-kDa protein,
matching that of mouse Stra13, in untreated control cells that increased with retinoid treatment in a
dose and time dependent manner. To our knowledge this is the ®rst report of a human protein
homologue of the STRA13 gene in human keratinocytes. We conclude that the Stra13 protein is
expressed in normal human skin tissue and cultured human keratinocytes, is diminished in human
psoriatic plaque and is up-regulated by retinoic acid in cultured human keratinocytes. These
®ndings imply a role for Stra13 regulation in retinoic acid-responsive skin neoplasms.
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Ribozyme Gene Therapy Strategies for Keratin Disorders
I. Mclean and A. Terron
Human Genetics Unit, University of Dundee, Dundee, U.K.
There are now 18 keratin genes that are known to be involved in dominantly inherited epithelial
disorders. Due to the dominant-negative effect of mutant keratins, gene replacement therapy is not
appropriate for these diseases. Ribozymes are small catalytic RNA molecules that can be designed
to cleave mRNA molecules at speci®c sites. Several potential ribozyme sites in the K14 mRNA
were evaluated and constructs were made for the ®ve sites showing best predicted RNA folding
characteristics. Ribozymes were protected from RNAse degradation in vivo by addition of hairpin
sequences derived from the U1 snRNA, a naturally occurring small RNA molecule that escapes
nuclease attack. Ribozymes were constructed as mini-genes driven by the U1 snRNA promoter in
a modi®ed plasmid vector. The ability of these ribozymes to cleave K14 mRNA was investigated
under a wide range of conditions both in vitro and in cultured cells. Three ribozymes were capable
of cleaving K14 mRNA in vitro. Furthermore, two were capable of rapidly cleaving > 90% of K14
mRNA following transfection of ribozyme plasmids into cultured keratinocytes. These
experiments show (a) that ribozymes are capable of speci®cally degrading even high-abundance
mRNA species such as keratins; and (b) pave the way for gene therapy where all endogenous
keratin mRNA might be ablated and replaced by a modi®ed `ribozyme-immune' keratin gene. A
second way in which ribozymes might be used is to speci®cally target the mutant mRNA in cases
where the mutation creates a suitable cleavage site. More than 40% of patients with the severe
Dowling-Meara form of epidermolysis bullosa simplex (EBS) carry the R125C `hotspot' mutation
in the K14 gene. This mutation creates a uracil, which is required for ribozyme cleavage but
unfortunately, the following residue is guanosine which would result in negligible cleavage by
conventional ribozymes. However, by modifying the sequence of the conserved catalytic domain,
we were able to develop a novel ribozyme that speci®cally and ef®ciently cleaves this mutation.
This novel system can be adapted to treat other keratin diseases and dominant disorders in general.
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Transcriptional and Post-Transcriptional Regulation of Interferon Regulatory Factor 1
Expression
A. K. Gira, K. Otto, K. Casper, S. Naik, S. W. Koo, and R. A. Swerlick
Dermatology, Emory University, Atlanta, Georgia, U.S.A.
Interferon regulatory factor 1 (IRF-1) is a transcription factor necessary for optimal expression of
genes important in cutaneous in¯ammation including vascular cell adhesion molecule 1, IL-6, and
inducible nitric oxide synthase (iNOS). We examined the expression of IRF-1 mRNA and protein
in transformed human dermal endothelial cells (5A32) and transformed human keratinocytes
(HaCaT) in vitro. IRF-1 protein was essentially undetectable in unstimulated cells. IRF-1 protein
was rapidly induced in both cell types by TNFa and IFNg in a concentration-dependent fashion.
Near maximal levels of IRF-1 protein was found by 2 h and persisted for at least 24 h. Despite the
lack of IRF-1 protein expression in quiescent cells, substantial amounts of IRF-1 mRNA were
present. Increases in IRF-1 mRNA after TNFa or IFNg treatment were modest and occurred
coincident with increased protein expression, suggesting both transcriptional and translational
control. Induction of IRF-1 by either TNFa or IFNg was inhibited by the iron chelators dipyridyl
(DP) or desferoxamine (DFO) and this effect was effectively reversed by addition of exogenous
iron. Pretreatment of HaCaT cells with DP also inhibited TNFa induced iNOS expression, a gene
whose expression is IRF-1 dependent. In order to analyze the transcriptional control of IRF-1, we
measured expression of heterogeneous nuclear RNA (hnRNA) for IRF-1 after cytokine
stimulation. IRF-1 hnRNA was up-regulated by TNFa or IFNg in both cell types, and this
increase was inhibited by pretreatment with Actinomycin D or DP, thus supporting an iron-
dependent transcriptional regulatory component. In order to assess post-transcriptional regulatory
controls, we fractionated IRF-1 mRNA using sucrose gradients. Treatment with either TNFa or
IFNg resulted in colocalization of IRF-1 mRNA with polyribosomal fractions, thus also
supporting a role of translational control. These data suggest that IRF-1 is regulated in epithelial
and endothelial cells via both transcriptional and translational components, and point to a
fundamental role for iron in these processes.
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PCR-SSCP Analysis: A Powerful Tool for Malassezia Species Population Genetics in
Related In¯ammatory Dermatoses
G. Gaitanis,*² A. Velegraki,* P. Menounos,³ E. Frangoulis,§ NJ, Legakis,¶ and A. Katsambas²
*Mycology Reference Laboratory, Medical School, Athens, Greece; ²Dermatology, Medical School, Athens,
Greece; ³Research Laboratory, Military School of Nursing, Athens, Greece; §Microbiol., `A Syngros'
Hospital, Athens, Greece; ¶Microbiol., Medical School, Athens, Greece
This study aimed to use gene sequences coding for the ®rst major allergenic protein Mal f 1, as
molecular markers, to attest implication of Malassezia species in in¯ammatory dermatoses. The Mal
f 1 primers were designed and evaluated from the published gene sequences (GenBank Acc.
No x96186). Isolates (n = 36) of all seven malassezia species were studied. Predicted 740 bp m.
Sympodialis pcr amplicons, and malassezia species nonpredicted ones, were selectively recovered
from gels, puri®ed and tested by restriction fragment length polymorphism analysis (r¯p) (genbank
blast/fasta functions). R¯ps were subjected to single-strand conformation polymorphism analysis
(sscp). Sscp, con®rmed by sequencing, detected intraspeci®c polymorphism within m. Sympodialis.
Atypical r¯ps indicated polymorphic mal f 1 sequences in m. Obtusa and m. Restricta populations.
M. Sympodialis and m. Restricta, frequent seborrheic dermatitis coisolates, and m. Obtusa, a
frequent atopic dermatitis coisolate, were polymorphic for mal f 1 gene sequences. No. 740 bp mal
f 1 products were obtained from m. Globosa, a pityriasis versicolor alleged agent. Likewise, no mal
f 1 sequences were ampli®ed from the uncommon isolates m. Sloof®ae, m. Furfur and m.
Pachydermatis. In conclusion, mal f 1 gene sequences as molecular markers, paired with the
concurrent detection of expression of the allergenic protein, might give new insight into the m.
Sympodialis population genetics and contribute in revising trends and perceptions regarding
interactions of malassezia species and human skin.
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Species Identi®cation and Strain Differentiation of Dermatophyte Fungi Using PCR
Ampli®cation and Restriction Enzyme Analysis
J. Yang,*² J. Shin,* J. Sung,² S. Park,* J. Kim,³ J. Lee,* D. Lee,*² and E. Lee*
*Department of Dermatology, Sungkyunkwan University School of Medicine Samsung Medical Center,
Seoul, South Korea; ²Clinical Research Center, Samsung Biomedical Research Institute, Seoul, South
Korea; ³Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea
Standard biochemical tests, microscopy, colony characteristics, and mating test have been used for
the identi®cation of dermatophytes species, conventionally, but these methods are costly, time-
consuming and also demand specialist skills. In order to ®nd the method for rapid species
identi®cation and strain differentiation of dermatophytes, we performed the PCR-RFLP of the
internal transcribed spacer (ITS) region of 11 different dermatophytes (T. rubrum, T
mentagrophytes, M. canis, T. raubitschenkii, E. ¯occosum, T. verrucosum, T. violaceum,
M. audouinii, M. gypseum, T. inkin, and T. schoenleinii) using four restriction enzymes such as
BsYil, Dde1, Hinf1, and Mva1. Almost all dermatophytes showed different RFLP patterns after
each restriction enzyme digestion, but T. rubrum and T. raubischenkii showed same RFLP pattern
after all 4 restriction enzyme digestion. T. mentagrophytes were classi®ed into two different RFLP
patterns by Mva1 and Dde1. All the species except T. rubrum and T. raubitschenkii could easily
differentiated using any kind of 2 restriction enzymes.
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Epidermolytic Palmoplantar Keratoderma in Five Korean Families Caused by Mutations
of Keratin 9 Gene
J. Lee,* K. Ahn,² C. Lee,² S. Youn,* D. Lee,*² E. Lee,* P. Steinert,³ and J. Yang*²
*Department of Dermatology, Sungkyunkwan University School of Medicine, Seoul, South Korea; ²Clinical
Research Center, Samsung Biomedical Research Institute, Seoul, South Korea; ³Laboratory of Skin Biology,
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health,
Bethesda, Maryland, U.S.A.
Epidermolytic palmoplantar keratoderma (EPPK) is an autosomal dominantly transmitted disease
characterized by localized palmoplantar thickening clinically and granular degeneration of the
epidermis histopathologically. Recent molecular biological studies revealed that EPPK is caused by
the mutations mainly in the highly conserved 1A rod domain of the keratin 9 gene. Here we
demonstrate a novel mutation of N160H and two other previously reported mutations, R162W
and N160S in ®ve unrelated Korean families with EPPK. The patients in the family EPPK-YJ had
N160H mutation resulting from A to C substitution at 544 bp of exon 1 of the K9 gene (N160H,
CAA to CCA). Polymerase chain reaction and DNA sequence analyses revealed heterozygous
missense mutations in exon 1 of K9 gene corresponding to the highly conserved 1 A rod domain,
further supporting the functional improtance of this region in the structural integrity of the keratin
intermediate ®laments.
367
Mutation of a Novel Gene Causes a Hermansky±Pudlak Syndrome in Central Puerto
Rico
J. R. Toro, Y. Anikster, M. Huizing, J. White, Y. Shevchenko, S. Bale, and W. Gahl
Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, U.S.A.
Hermansky±Pudlak syndrome (HPS) is a rare autosomal recessive disorder characterized by
oculocutaneous albinism and a storage pool de®ciency due to absence of platelet dense bodies.
Lysosomal ceroid lipofuscinosis, pulmonary ®brosis, and granulomatous colitis are manifestations of
the disease. HPS occurs with a frequency of one in 1800 in north-west Puerto Rico, due to a
founder effect involving a 16-bp duplication in exon 15 of HPS1. We performed homozygosity
mapping on pooled DNA from the 6 affected families using polymorphic markers, ®rst
concentrating on human chromosomes containing regions homologous to mouse loci to which the
14 known murine models of HPS had been mapped. We localized a new HPS susceptibility gene
to a 1.6-cM interval on chromosome 3q24. HPS3 has 17 exons, a 3024-bp coding region, and
putative 114.1 kDa product. Sequencing analysis revealed that the mutation responsible for HPS in
central Puerto Rican patients consists of a 3904-bp deletion encompassing all of exon 1, and
approximately 2874 bases upstream. Based on the structure of the HPS3 deletion, we designed a
multiplex PCR ampli®cation assay to detect individual homozygous or heterozygous for this
mutation. This new test will be useful for screening and early diagnosis of HPS in Puerto Rican
individuals. Using various protein database programs, we predicted the protein sequence and
structure of HPS3. Our analysis predicts that the HPS-3 protein consists of 1007 amino acids with a
molecular weight of 114.1 kDa. It appears to be a cytosolic protein with no predicted
transmembrane regions. It is predicted to be 43% alpha-helix, 19% extended strand, 30% random
coil, and 7% beta-turn. The deletion provides the second example of a founder mutation causing
HPS in Puerto Rico. All patients with HPS3 exhibited only mild visual defect and mild pigment
dilution of hair, eyes and skin. These ®ndings differed signi®cantly from HPS individual with the
16-bp duplication in HPS1. Recently, cocoa was identi®ed as the mouse homologue for HPS3.
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Cooperative Effects of Three Different Isoforms of Transcription Factor AP-2 (a, b, and
g) in Human Keratinocytes
N. Oyama,*³ H. Takahashi,² M. Tojo,* H. Iizuka,² K. Nakamura,* and F. Kaneko*
*Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan; ²Dermatology,
Asahikawa Medical College, Asahikawa, Japan; ³Dermatology, St John's Institute of Dermatology, St
Thomas' Hospital, King's College, London, U.K.
Transcription factor AP-2/promoter system is essential for the complex keratinocyte biology.
Three isoforms, AP-2a, b, and g, share a high homologous structure, but their functions are
considered to be different. Serial skin sections from normal and psoriatic skin, and squamous cell
carcinoma (SCC) were immunohistochemically analyzed for AP-2 expression and distribution.
AP-2a was present only in the nuclei of normal basal keratinocytes, but was signi®cantly increased
in the lesional proliferating keratinocytes of both diseased skin. AP-2b was completely absent in all
samples except the nuclei of dermal sweat grands, whereas AP-2g was homogeneously observed
throughout the epidermis in normal and psoriatic skin, and the whole SCC lesion. There was a
strong correlation in the intraepidermal distribution between three AP-2 isoforms and keratinocyte
proliferation/differentiation markers. in vitro DNA binding assay using three recombinant AP-2
isoforms, which generated bacterially as GST fusion proteins, revealed the isoform-speci®c gene
activation; AP-2a strongly bound to the promoter fragments of K14 and epidermal growth factor
receptor genes rather than those of K1/10, type I transglutaminase, and involucrin genes. In
contrast, AP-2g, but not AP-2b, bound to these ®ve promoter fragments with similar af®nities. We
concluded that three AP-2 isoforms perform unique properties in the spatial and temporal
expression of human keratinocyte-related genes, thereby maintaining epidermal homeostasis.
Disruption of the epidermal AP-2 balance may contribute to the hyperproliferative condition, such
as psoriasis and SCC.
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Two Novel Mutations in the Keratin 1 Gene in Epidermolytic Hyperkeratosis
D. Lee,*² K. Ahn,² C. Lee,² N. Rho,* J. Lee,* E. Lee,* P. Steinert,³ and J. Yang*²
*Department of Dermatology, Sungkyunkwan University School of Medicine Samsung Medical Center,
Seoul, South Korea; ²Clinical Research Center, Samsung Biomedical Research Institute, Seoul, South
Korea; ³Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases,
National Institutes of Health, Bethesda, Maryland, U.S.A.
Epidermolytic hyperkeratosis (EHK) is a rare autosomal dominant genodermatosis, characterized
by blistering and erythema at birth, and development of hyperkeratosis with increasing age.
Previous studies have shown that the disease is caused by point mutations in the genes encoding the
keratin 1 (K1) or the keratin 10 (K10) proteins. Clinically, EHK has been divided into two types:
palmoplantar subtypes and nonpalmoplantar subtypes. In this study, we describe two separate cases
of EHK, classi®ed as PS-2, caused by two different novel mutations: Asn187Lys encoded by exon
1, which is the 8th residue of the 1 A rod domain segment; and Leu475Pro encoded by exon 7,
which is the 10th residue from the end of 2B rod domain segment of K1. According to the KIF
disassembly assay, we predict that the resultant aberrant substitutions imposed by the mutations will
severely interfere with normal KIF structure, ultimately leading to the observed pathogenesis.
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c-Neu and Phosphotyrosin Expression in Proliferating Keratinocye: Effect of Retinoic
Acid and Tetradecanoyl Phorbol Acetate
J. Wille and J. Park*
Research Center, Bioderm Technologies, Inc, Trenton, New Jersey, U.S.A.; *Cancer Control & Prevention,
Unioversity of South Florida, College of Medicine, Tampa, Florida, U.S.A.
The proto-oncogene c-neu codes for erbB tyrosine kinase, a receptor for heparin binding EGF. It
is expressed by postmitotic cells of normal human epidermis. The expression of c-neu and
phosphotyrosine (PT) was studied in nomral human keratinocytes by indirect immuno-
¯uorescence microscopy using a commercially available antibodies (Oncogene Science).
Proliferating keratinocytes were cultured in MCDB 153 medium containing EGF and insulin,
and exposed to retinoic acid (RA, 5 3 10
±8
M) or tetradecanoyl phorbol acetate (TPA, 100 mg/ml)
for 24 h. Samples from each condition were also incubated with alkaline phosphatase (AP). The
cytoplasm (CY) of untreated cells was uniformly stained by both anti-PT and antic-neu antibodies.
Anti-PT also stained peg-like cell-cell contacts (CC); both CY and CC staining were sensitive to
AP. CC were not clearly stained by antic-neu antibodies, but both CY and CC were stained after
AP digestion. RA decreased PT staining of CY, but not FA staining. RA up-regulated c-neu
expression in both CY and CC, while AP digestion eliminated both PT and c-neu expression in
CY and CC. Finally, TPA up-regulated both PT and c-neu expressiom in both CY and CC, while
AP digestion eliminated PT staining of CY only. In summary, RA and TPA up-regulate c-neu
expression in CY that is phosphorylated (P) in CY and CC sites. TPA up-regulates a P form of c-
neu in CY and a P form of PT expression in CY but not at CC sites. Therefore, RA and TPA
regulate c-neu through shifts from a non-P state to a P state.
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Cooperative Interactions of POU Domain Factors Oct6/Oct11 with AP-1 and Sp1
Regulate Transcription of the Loricrin Gene in Murine Keratinocytes
Y. Kawachi, H. Fujisawa, S. Imakado, F. Otsuka, and D. R. Roop*
Dermatology, University of Tsukuba, Tsukuba, Ibaraki, Japan; *Molecular and Cellular Biology, Baylor
College of Medicine, Houston, Texas, U.S.A.
We previously reported that a 77-bp proximal promoter fragment of loricrin gene is necessary and
suf®cient for keratinocyte-speci®c and differentiation-speci®c expression of loricrin gene in vitro. In
that study, we have demonstrated that both the Sp1 and the AP-1 elements located between
position ±77 and ±43 mediate both basic transcription and keratinocyte-differntiation-speci®c
transcription. This ®nding strongly suggested that AP-1 factors and Sp1/Sp3 make up
transcriptional core complex which regulates the differentiation-speci®c expression of loricirn in
keratinocyte. In this study, we demonstrate that the epidermal POU domain proteins, Oct6 and
Oct11, suppress the transcription of loricrin gene through the core complex and have shown the in
vitro evidence that Oct6 and Oct11 can associate with both AP-1 factors and Sp1/Sp3. To
speci®cally localize the domains of Sp1 involved in the activation of loricrin gene transcription, we
used the mutant GST-Sp1 fusion protein and showed that the C-terminal region (amino acids
623±788), containing the zinc ®ngers and domain D is suf®cient and responsible for binding to
Oct6 and Oct11.
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A Nonsense Mutation of the XPAC Gene in a Chinese Patient with Xeroderma
Pigmentosum Group A
Y. Yang, D. Bu, K. Wang, P. Tu, and X. Zhu
Dermatology, Peking University Health Science Center First Hospital, Beijing, China
Xeroderma Pigmentosum (XP) is an autosomal recessive genetic disease characterized by
photosensitivity and early onset of skin cancer. This disease has been divided into seven
complementation groups, A through G, all of which have been identi®ed to be associated with a
defect in the function of nucleotide excision repair. Group A XP (XPAC), which is the most
severe form, exhibits progressive neurological degeneration in addition to photosensitivity. The
gene responsible for XPAC encodes a protein that binds to damaged DNA. Herein we report a
nonsense mutation of the XPAC gene found in a 2-year-old female Chinese patient. This patient
had been suffering from photosensitivity manifested as severe sunburn-like erythema and blistering
in the abscence of skin tumors, and with de®cits including impairment of ambulation and
phonation. Her parents are consanguineous. Genomic DNA was extracted and all exons of the
XPAC gene were analyzed by PCR-DNA sequencing in this pedigree. A homozygous nonsense
mutation of C631T in exon 5 of the XPAC gene, resulting in R211X at the amino acid level, was
identi®ed in this patient, while the parents were heterozygous carriers. This mutated gene encoded
a truncated XPAC protein with a de®ciency of 63 amino acids at the C-terminal end. We propose
that the truncated XPAC protein may lead to a dysfunction of the XPAC protein in DNA repair,
and as a consequence, may cause skin aging and carcinogenesis.
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Proteomic and Microarray Investigation to Identify Potential In Vitro Endpoints For
Skin Irritation
S. Fletcher, J. Fentem, D. Basketter, D. Kelsell,* M. Philpott,* and V. Baker
SEAC, Unilever, Sharnbrook, U.K.; Centre for Cutaneous Research, Queen Mary, London, U.K.
To enable development of relevant in vitro test systems for identi®cation of skin irritation, an
understanding of the mechanistic basis of the response is required. Recent progress in development
of proteomic and microarray technologies provides tools required for identi®cation and
investigation of biochemical events that occur within the skin irritation response. This study
was aimed at the identi®cation of proteins (and genes encoding proteins) which may be involved in
this response, following exposure of a human skin model (EpiDerm
TM
(MatTek)) to the irritant
sodium lauryl sulphate (SLS). EpiDerm
TM
cultures were treated in triplicate with noncytotoxic
dose of SLS (0.1 mg/ml, determined by histology and MTT) for 15 min, 1 h, 2 h, 4 h and 24 h 2D-
gel electrophoresis (Multiphor II and DALT system, APB) and mass spectrometry (Bruker) was
performed to investigate the protein expression pro®le and identify proteins of interest. Western
blotting and ELISA were used to con®rm modi®cations for selected proteins of interest. In addition
microarray analysis was performed on EpiDerm
TM
samples (treated as described), using DermArray
(Research Genetics) covering 4000 human genes of relevance to skin biology. From the proteomic
experiments 67 proteins of potential interest were selected and identi®ed from a range of 2D-gels
(1st dimension: pH 4-7, 4±5, 5±6, 6±9 and 6±11). Of the proteins selected, 35 proteins were up-
regulated, 19 down-regulated and the expression of 4 remained unchanged (controls). The data
indicated that post-translational modi®cation occurred at an early time point (15 min) for
calmodulin-like skin protein and involucrin following exposure of EpiDerm
TM
to SLS. The results
demonstrate the differential regulation of a number of proteins in response to the skin irritant SLS
which could provide potential new in vitro markers of skin irritation.
375
Identi®cation of Differentially Expressed Genes During Keratinocyte Differentiation
Using Suppression Subtractive Hybridization
J. Lee and E. Seo
Dermatology, Chungnam National University, School of medicine, Daejon, South Korea
Differentiation processes of keratinocytes display series of morphological and biochemical changes
while expressing a lot of new differentiation-speci®c genes. To further understand the mechanisms
in this process, we carried out suppression subtractive hybridization with keratinocytes cultured
under high calcium condition, known to induce keratinocyte differentiation in vitro. We arbitarily
picked about 300 clones representing 90 different genes. Using reverse nothern analysis, 24 genes
were found out to be overexpressed in keratinocytes cultured in high calcium medium. Nothern
blot analysis con®rmed 12 genes as differentially expressed genes during keratincyte differentiation.
Of those, three genes ± IL-1RA, kallikrein, and heat shock protein 27 ± have previously been
reported to express highly during epidermal differentiation. Six genes ± ferritin-L chain, ribosomal
protein S6, tumor-associated calcium transducer 2, neuroendocrine secretory protein 55,
phosphoserine aminotransferase, and neutrophil gelatinase-associated lipocalin are not known to
be overexpressed in keratinocyte differentiation. We also identi®ed three novel genes; two genes of
these are mapped to chromosome 1q21 close to the epidermal differentiation complex, whose
expression levels were strongly increased in the keratinocytes to be differentiated by elevated
calcium level. These differentially expressed genes may provide signi®cant opportunities for further
understanding of keratinocyte differentiation.
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In Vivo Tetracycline Regulatable Expression of Green Fluorescent Protein in
Immortalized Human Keratinocytes on Composite Grafts
P. S. Gill, G. G. Krueger,* T. R. Tandeski,* C. M. Jorgensen,* and D. E. Kohan
Division of Nephrology & Hypertension, Department of Internal Medicine, University of Utah Health
Sciences Center, Salt Lake City, Utah, U.S.A.; *Department of Dermatology, University of Utah Health
Sciences Center, Salt Lake City, Utah, U.S.A.
Keratinocytes have unique features such as ease of culture, the potential for transplantation, and
reported success of transgene expression, which make them a good candidate for localized or
systemic delivery of therapeutic genes. We have recently described a method wherein
immortalized human keratinocytes (IMKc) can be transduced in vitro with the retroviral vectors
of the RetroTet-Art system, which confers stable doxycycline (Dox) regulatable green ¯uorescent
protein (GFP) expression. This system houses a tetracycline (TCN) transactivator (+) and a
transrepressor (±) that are activated with the tetracyclines, and are hereafter abbreviated in IMKC as
IMKc(+)(±)GFP. We present here the results of in vivo experiments using nude mice transplanted
with composite grafts carrying IMKc(+)(±)GFP. Dually transduced IMKc's were seeded onto a
human acellular dermis (1.5 cm
2
) and held in media for 7 days to achieve an epidermis that was 3±5
cells thick. These composite grafts were grafted to the lateral dorsal surface of nude mice and
secured in place using established techniques. Transplanted mice were divided in two groups:
(group 1, n = 3) IMKc no Dox in drinking water for 28 days of experiment; (group 2, n = 6)
IMKc(+)(±)GFP were on Dox (1 mg/ml) in drinking water for the last 7 days of the 28 day
experiment. Frozen sections of the composite grafts show GFP expression only with IMKc(+)(±
)GFP. As the expression of GFP in the epidermis was not uniform, we probed the histological
sections for mouse keratinocytes with a species speci®c DNA probe. This showed that mouse cells
had migrated into the composite graft. Our observations demonstrate that in vivo, TCN-regulatable
GFP transgene expression is achievable by using transplanted human keratinocytes. This bolsters
the concept of using keratinocytes with TCN-regulatable switch for gene therapy.
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Pyrosequencing Candidate Biomarkers of Melanoma Susceptibility: High-Throughput
Analysis of Single Nucleotide Polymorphisms (SNPs)
C. S. Spittle,* R. H. Edwards,² Ml. Clapper,* and S. R. Lessin*²
*Population Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania, U.S.A.; ²Medical
Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania, U.S.A.
Predisposition to develop cutaneous melanoma results from interactions that involve inherited
genetic susceptibility, endogenous physiology, and environmental exposures, i.e., ultraviolet (UV)
irradiation. Identi®cation of genetic factors that contribute to melanoma susceptibility will improve
individual risk assessment and facilitate the identi®cation of new targets for melanoma prevention
strategies. Germline mutations account for only 1±2% of melanoma cases. Therefore, other sources
of allelic variability (i.e., SNPs) may determine a person's inherent risk of developing melanoma.
Based on our knowledge of the consequences of UV radiation to skin cells and the cellular stress
response mechanisms that function to repair and protect DNA, genes involved in these pathways
represent good candidate biomarkers of susceptibility to sporadic melanoma. Speci®cally, variants
of the xeroderma pigmentosum (XP) genes which code for essential proteins involved in
nucleotide excision repair (NER) may dictate the overall ef®ciency of the NER process. Thus far,
studies seeking to establish a connection between XP polymorphisms and melanoma risk have
been compromised by the evaluation of single genes. Pyrosequencing is a novel, high-throughput
platform for SNP analysis that can facilitate comprehensive identi®cation and evaluation of
multiple biomarkers of melanoma risk. The goal of this project is to examine eight SNPs that have
been identi®ed in ®ve of the XP genes that are involved in NER and analyze their association with
melanoma risk individually and in combination with each other. One hundred melanoma patient
and control DNA samples were identi®ed from our Melanoma Family Risk Assessment Program
and Biosample Repository. To date we have compared pyrosequencing to standard PCR-RFLP
techniques and our data supports the use of pyrosequencing as an accurate and ef®cient high-
throughput platform for SNP analysis.
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Pseudoxanthoma Elasticum: Improved Mutation Detection Strategy with dHPLC
F. Ringpfeil, E. Pfendner, A. Saxena, A. Nakano, and J. Uitto
Dermatology, Jefferson Medical Colllege, Philadelphia, Pennsylvania, U.S.A.
Mutations in the ABC-cassette transporter gene, ABCC6, have recently been identi®ed in
pseudoxanthoma elasticum (PXE), a debilitating multisystem disease involving the skin, eyes and
cardiovascular system. Although the exact pathomechanisms by which the encoded protein MRP6
causes the clinical phenotype are still unknown, we have previously proven that both alleles must
be affected to exert the characteristic, though highly variable clinical features, establishing
autosomal recessive inheritance. Mutation detection has been complicated by the high number of
`private' mutations, duplication of the 5¢ end of the gene with presence of at least 2 pseudogenes as
well as frequent occurence of large deletions. Mutation screening of the coding sequences,
including exon-intron borders, has traditionally consisted of heteroduplex analysis via conforma-
tion sensitive gel electrophoresis (CSGE) or single-stranded conformation polymorphism with a
detection rate of about 45%. In order to compare mutation detection strategies, the same amplicons
of all ABCC6 exons were subjected to both CSGE and denaturing high performance liquid
chromatography (dHPLC). Detection of sequence alterations has increase by nearly 10% using
dHPLC, and included single nucleotide changes and small deletions. Improved detection with
dHPLC in conjunction with speci®c mutation detection strategies for large, recurrent mutations
has greatly enhanced the detection rate, which now exceeds 60%. Collectively, dHPLC provides a
superior means for identi®cation of mutations and polymorphisms in ABCC6, examination of
pathomechanisms in PXE and establishment of diagnosis prior to the onset of clinical
manifestations. Finally, this should allow genotype-phenotype correlation, which will ultimately
result in preventative interventions in this debilitating disorder.
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Comparison of Gene Expression of Cultured Nevi and Melanocytes Using Microarray
Analysis of Ampli®ed and Nonampli®ed mRNA
L. J. Meyer,*² L. A. Schmidt,*² and J. F. Hurdle*
*Geriatric, Research Education and Clinical Center, Veterans Affairs Medical Center, Salt Lake City, Utah,
U.S.A.; ²Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.
Nevi are both markers of melanoma risk and potential direct precursors of melanoma. They are
believed to be clonal, suggesting that activation or inactivation of a genetic pathway(s) triggers a
clonal cell population. To identify such pathways, gene expression in cultured melanocytic cells
was compared using DNA microarrays. Further, several experimental schemes were used to
directly assess the effects of pair-wise comparisons vs. individual comparisons with a standard
reference, and ampli®cation to the direct use of isolated mRNA. This experimental approach is
especially important in the study of primary melanocytes due to their limited growth potential.
These allow the harvest of cells at a low passage number requiring much less total RNA (2 mg vs.
150 mg per comparison). Three replicates of pair-wise comparisons of primary human melanocytes,
a melanoma cell line (HTB66) and an external reference demonstrated excellent concordance in
the replicates of both ampli®ed and nonampli®ed cDNA's. However, the ampli®ed specimens had
both a signi®cantly higher concordances within each experiment (quadruplicate points) and
between separate replicates. Both ampli®ed and non demonstrated the same patterns of gene
expression differences, but the ampli®ed mRNA showed more difference, primarily among genes
with low expression. These patterns were consistent between replicates suggesting these are
biologically valid differences. Pair-wise comparisons of 4 melanocyte cultures with 4
nevomelanocyte cultures established from the same individuals demonstrated clear differences
between the different pairs, with nevi from a DNS patient showing the greatest magnitude and
number of consistent gene expression differences. We conclude that nevi can result from different
genetic triggers in different persons, and that the use of ampli®ed RNA compared to a reference is
a useful and valid experimental method.
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In¯uence of b-Carotene on UVA-Induced Gene Expression in HaCat Keratinocytes
K. Wertz, P. Buchwald, N. Seifert, G. Riss, and R. Goralczyk
Human Nutrition and Health, Roche Vitamins, Basel, Switzerland
UVA was shown to regulate gene expression, mainly by inducing singlet oxygen (1O2). We
analyzed whether the retinoic acid precursor and 1O2 quencher b-carotene (bC) is able to
interfere with UVA-mediated gene regulation. HaCat cells, treated with 1.5 mM bC, were UVA
irradiated, and subjected to Affymetrix GeneChipá hybridization. Among the 6627 genes found
expressed, 193 were regulated by UVA, including several known UV targets. bC reduced the
UVA effect for 44 genes, while for 69 genes the UVA effect was enhanced. For 80 genes, bC had
no in¯uence on the UVA effect. bC reduced UVA-induced MMP10 expression, indicating
alleviated extracellular matrix degradation. Experiments employing D2O-treatment show that
MMP10 was induced by 1O2, and dose-dependently down-regulated by bC. Chromatin assembly
factor I, an indicator of DNA damage, was heavily induced by UVA and decreased by bC. bC
enhanced repression of CENP-E and several cyclins, suggesting mitotic arrest. Dual-speci®city
phosphatases, which preferably inactivate ERKs over SAPK/JNK, were further induced by bC,
indicating a net increase of SAPK/JNK signalling. Also, bC enhanced the UVA-induced induction
of phosphatidylinositol 3 kinase (PI3K). PI3K plays a major role in regulating Ca in¯ux into cells.
As bC increased the transcript levels of Ca channels, the Ca in¯ux into bC/UVA-treated cells
should have been greatly facilitated. Signalling by Ca and SAPK/JNK can induce apoptosis. This is
consistent with the increased abundance of apoptosis-inducing genes, e.g. TR3 and GADD153.
Apoptosis induction was con®rmed in an assay for caspase 3 activity. In conclusion, bC interfered
with gene regulation by UVA, in part by 1O2 quenching. The in¯uence of the retinoid effect of
bC appeared to be marginal. The different expression pro®les of the genes imply that additional
mechanisms must have been involved. The prominent action of bC in UVA-irradiated HaCat cells
was induction of apoptosis, which occurred at physiological bC concentrations and which was
independent of p53, as HaCat cells carry an inactivated p53 gene.
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TRP Proteins Mediate the Store-Operated Ca
2+
In¯ux in Human Epidermal
Keratinocytes
C. Tu*² and D. D. Bikle*²
*Department of Medicine, University of California, San Francisco, California, U.S.A.; ²Endocrine Research
Unit, Veteran Affair Medical Center, San Francisco, California, U.S.A.
Store-operated calcium entry (SOC) or capacitative calcium entry (CCE) refers to Ca
2+
in¯ux into
cells that replenishes intracellular Ca
2+
stores depleted by IP3 and other agents. Recently
mammalian TRP proteins have been implicated to function as ion channel subunits responsible for
the store-operated and agonist-induced Ca
2+
entry. In this study we examined the SOC and
characterized the expression pattern of the endogenous TRP proteins in human epidermal
keratinocytes. Depletion of Ca
2+
stores with thapsigargin (1±2.5 mM) triggers rapid store-operated
Ca
2+
in¯ux in undifferentiated keratinocytes that is completely blocked by lanthanum. However,
only slow and weak Ca
2+
entry in response to store depletion was observed in differentiated
keratinocytes. Human keratinocytes express TRP1, TRP3, TRP4, TRP5 and TRP6 as revealed
by RT-PCR. Western blot analyses show that the expression of TRP1, TRP3, TRP4 and TRP6
reaches the highest level in undifferentiated cells and their levels decrease as cells differentiate. This
fall with differentiation is most marked for TRP1 and TRP4. To determine the role of these TRP
proteins in the SOC mechanism, we knocked out TRP1 and TRP4 expression in keratinocytes
with antisense cDNA constructs. While the expression of antisense TRP1 cDNA completely
suppresses the thapsigargin-induced SOC, tranfection of antisense TRP4 cDNA was only partially
inhibitory. Our results indicate that TRP1 and to a lesser extent TRP4 mediate SOC in human
keratinocytes.
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Automated mRNA In Situ Hybridization Applications for Formalin-Fixed Mouse Skin




Systems on Ventana Discovery
TM
Slide-Processing Instrument: Effects of Cell Conditioning on mRNA Signal
Visualization
H. Nitta,* J. Kishimoto,² K. Abe,³ S. Yamada,³ and T.M. Grogan*§
*Molecular Discovery Systems, Ventana Medical Systems, Inc., Tucson, Arizona, U.S.A.; ²Skin
Biology Research & Development, Shiseido Research Center, Yokohama, Japan; ³Molecular Discovery
Systems, Ventana Japan K.K., Tokyo, Japan; §Department of Pathology, The University of Arizona
College of Medicine, Tucson, Arizona, U.S.A.





reagents and Ventana Discovery
TM
instrument. We applied the technology for
visualizing the gene expression sites in the formalin-®xed mouse skin tissue paraf®n sections that
were acknowledged as one of the most dif®cult tissues due to its fragile and thin structure and
relatively low levels of gene expression. Our focus of this study was to demonstrate the effects of
protease digestion and/or cell conditioning step (heat treatment as a pretreatment step) on
hybridization signals using a digoxigenin-labeled versican antisense riboprobe (20 ng/slide).
Paraf®n sections were deparaf®nized, ®xed, and acid-treated using the RiboMap
TM
system
reagents. Then, the tissue sections were treated with protease digestion alone (3 strengths), cell
conditioning alone, or the combination of cell conditioning and protease digestion. Hybridization
was performed for 6 h and signals were detected using the BlueMap
TM
substrate solution for 3 h on
the instrument. This application was designed so that all necessary steps were completed within one
day. Cell conditioning alone did not produce noticeable signals while the protease digestion group
indicated speci®c weak signals in the hair papilla region. However, when cell conditioning and
protease digestion were combined, the signals were signi®cantly increased. Thus, we have
demonstrated the automated, simple, and reproducible in situ hybridization applications for
formalin-®xed mouse skin paraf®n sections. The cell-conditioning step followed by protease
digestion enhanced the mRNA target staining signi®cantly compared to protease digestion or cell
conditioning alone.
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Microarray Analysis of UVB-Regulated Genes in Keratinocytes: Down-Regulation of
Angiogenesis Inhibitor Thrombospondin-1
B. G. Howell,*² B. Wang,* S. Kawara,² H. Suzuki,² I. Freed,*² A. J. Mamelak,* H. Watanabe,*
and D. N. Sauder*
*Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.; ²Dermatology,
University of Toronto, Toronto, Ontario, Canada
Ultraviolet (UV) light represents a natural carcinogen and has been implicated in a causal
relationship with nonmelanoma skin cancer. In addition to the mutagenic effects of UVB, previous
studies have demonstrated that UVB can induce changes in cutaneous gene expression and disrupt
networks of cytokines and accessory molecules leading to immune suppression. Keratinocytes
(KC), the predominant cell type in the epidermis, are a primary target for UVB. In the present
study, we sought to further delineate UVB-induced gene expression changes in KC. We utilized
cDNA microarray technology to examine gene expression pro®les in UVB-irradiated normal
human KC (NHKC). A 1700 gene microarray containing characterized human genes relevant to
immunity and cancer was used for differential gene expression analysis of UVB- vs. sham-irradiated
NHKC. From this array, 57 genes were up-regulated, and 27 genes were down-regulated, all by at
least 2-fold. The endogenous angiogenesis inhibitor thrombospondin-1 (TSP-1) was one such
down-regulated gene. RT-PCR analysis con®rmed a persistent down-regulation of TSP-1 up to
18 h following UVB exposure. Microarray analysis also revealed up-regulation of platelet-derived
endothelial cell growth factor (PD-ECGF), an angiogenesis activator. These data suggest that UVB
may trigger an angiogenic switch contributing to tumor growth in the skin.
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Mechanisms of Nuclear Localization of POU Transcriptional Factor Skn-1a in
Epidermal Keratinocytes
R. Moritsugu, K. Tamai, N. Umegaki, A. Kon, H. Nakano, I. Hashimoto, and K. Hanada
Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan
POU domain proteins are important regulators of development and terminal differentiation based
on their transcriptional activity in the nucleus. Here, we analyzed the mechanism underlying the
nuclear localization of Skn-1a, a member of POU family that regulates events during epidermal
differentiation. Nuclear localization of Skn-1a was dependent on the POU domain and its transfer
to the carboxy terminus of green ¯uorescent protein (GFP) was suf®cient to prompt nuclear
accumulation of this normally cytosolic protein in cultured normal human kerationcytes. A basic
cluster (GRKRKKR) preceding helix 1 of the homeodomain was shown by deletion mutagenesis
to be involved in the nuclear localization of GFP. This sequence, which is highly conserved among
POU domain proteins, was by itself capable of translocating GFP to the nucleus de®ning it as the
bona ®de nuclear localization signal (NLS) of Skn-1a and presumably other POU domain factors.
By site-directed mutagenesis study, Thr286 and Ser287 adjacent to the NLS were shown to play an
important role in regulating nuclear localization. TPA dose-dependently increased nuclear
localization signal transduction, and mutagenesis of both Thr286 and Ser287 to Ala itself induced
nuclear translocation by TPA-independent manner. These data suggest that dephosphorilation of
Thr286 and Ser287 after TPA stimulation, probably intermediated by activation of phosphatase,
would have crucial role for the NLS function of Skn-1a in the epidermal keratinocytes.
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Transcriptional Regulation of the CTLA-4 Gene in T Lymphocytes
H.K. Wong, B.M. Au®ero, C. Hedgcock, M. Hafner, and G.C. Tsokos*
Dermatology, Henry Ford Health System, Detroit, Michigan, U.S.A.; *Cellular Injury, Walter Reed Army
Institute of Research, Silver Spring, Maryland, U.S.A.
CTLA-4 is a member of the costimulatory molecules for T cells. CTLA-4 plays an important role
in immunoregulation and regulates anergy and tolerance. Loss of CTLA-4 leads to profound
proliferation of lymphocytes. CTLA-4 was identi®ed initially on activated T cells and more
recently on CD4+ CD25+ T cells. Unlike the expression of the CD28 costimulatory molecule,
which is expressed on most T cells, CTLA-4 expression is low and often transient. The expression
of CTLA-4 is highly restricted within cells of the immune system. Through differential analysis of
gene expression between CD45RA+ and CD45RO+, CD4+ T cells, we have found the CTLA-4
gene to be preferentially expressed in CD45RO+, CD4+ T cells in comparison to CD45RA+ T
cells. CTLA-4 expression was also more responsive to induction via the T cell receptor or phorbol
ester stimulation in CD45RO+ T cells. The mechanism that accounts for the differential
regulation of CTLA-4 in CD4+ T cells is unclear. Because of the essential role of CTLA-4 in
regulating the immune response, understanding the precise control of its expression is crucial. To
study the mechanism regulating CTLA-4 expression in T cells, we have focused on the role of
transcription regulation. We have isolated 2 kb of the human CTLA-4 promoter and cloned this
region into a luciferase reporter plasmid. We demonstrate that this promoter is active and contains
regions important for induction by phorbol ester. We have also made progressive 5¢deletions of the
CTLA-4 promoter to de®ne important regulatory sequences that control CTLA-4 expression in
human lymphocytes. The ®ndings from these studies will provide insight into factors that control
CTLA-4 regulation in T cells.
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Inhibition of Hair-Speci®c Keratin Gene Expression by Gadd 153 (CHOP)
P. E. Bowden, D. Y. Chan, and E. G. Pearce
Dermatology, UWCM, Cardiff, U.K.
Hair-speci®c keratin geneexpression is modulated during the hair-growth cycle, being down
regulated in catagen, silent in telogen and up regulated in anagen. Fifteen hair-speci®c keratin
genes have now been characterised and they are localised together with the epithelial keratin genes,
in type-speci®c clusters on chromosomes 12 (type II) and 17 (type I). We have recently
characterised two human genomic clones (Pac 290 and Cos 9±1b) by Southern blotting, long-
range PCR, subcloning and sequencing. The resulting 120kb contig contained four functional type
II hair-speci®c keratin genes (KRT-hHb1, KRT-hHb3, KRT-hHb5 and KRT-hHb6) and one
pseudogene. Sequencing 50 kb of this contig revealed the complete gene structure and relative
order of three genes (KRT-hHb3, KRT-hHb6 and KRT-hHb1). We established that the
direction of transcription reported for KRT-hHb1 was incorrect and should be downstream not
upstream. Regulatory sequences up to 4kb upstream of KRT-hHb1, KRT-hHb3 and KRT-hHb6
were analysed by Transfac software (v5.0) and seven different prospective regulatory elements
identi®ed (AP1, AP2, C/EBPb, CHOP, c-Rel, Lef1 and NFkB). Portions of the upstream region
of KRT-hHb6 (1 kb, 2 kb and 3 kb) were cloned into a luciferase reporter gene vector (pGL3) and
transfected into Cos cells. Reporter assays revealed that AP1 was a functional enhancer while
CHOP was a functional silencer of KRT-hHb6 transcription. AP1 and CHOP sites were also
present in KRT-hHb1. Double immuno¯uorescence and confocal laser scanning microscopy
revealed that Gadd 153, the human protein that binds to the CHOP site, was differentially
expressed in human hair follicles. Gadd 153 was present at high levels in the IRS where no KRT-
hHb1 and KRT-hHb6 expression occurs and absent in cortical cells during anagen where high
levels of KRT-hHb1 and KRT-hHb6 expression occur. Thus, Gadd 153 may be a major factor in
the differential expression of hair-speci®c keratin genes in hair follicles and may act as a silencer of
cortical-speci®c keratin gene expression during catagen and telogen.
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Non-Invasive Recovery of RNA from the Stratum Corneum
N. R. Benson and L. Rheins
Molecular Diagnostics, DermTech International, San Diego, California, U.S.A.
There continues to be signi®cant efforts to better delineate irritant contact from allergic contact
dermatitis. Various invasive methods have been used to better understand these clinical enigmas.
We report here on a noninvasive method to harvest mRNA from the upper layers of the epidermis
using a tape stripping technique. It appears that the method will be extremely useful for pro®ling
gene expression in the epidermis. In this study, occluded patches containing 1% aqueous sodium
lauryl sulfate or vehicle control were applied to the upper backs of 3 subjects. 24- h later the
patches were removed and the sites tape stripped. Each site was stripped with three tapes and 3
uninvolved skin sites were included as controls for each subject. Puri®ed RNA was analyzed by Q-
RT-PCR for: IL-1b; IL-8; TNFa; b-actin; GAPDH. Quantitation was performed using the 5¢-
nuclease assay. The levels of each of the cytokine transcripts were normalized to those of the
housekeeping genes so that relative levels of cytokine mRNA's could be compared between skin
sites. The data show that in SLS-treated skin all messages could be detected with a high degree of
reproducibility for all subjects. For water-treated and uninvolved skin, IL-1b and TNFa were not
detectable, while they were easily detected in SLS treated sites. IL-8 was detected, with abundance
comparable to b-actin, in all sites and did not show appreciable regulation in response to any
treatment when normalized to either b-actin or GAPDH levels. We conclude that the data
supports the notion that the stratum corneum harbors RNA which can be noninvasively retrieved
and analyzed. We successfully detected cytokines speci®c to in¯ammatory processes suggesting that
the technique will be useful for the pro®ling of in¯ammatory events at the skin surface. We believe
this technology has the potential for wide application in general medicine for the diagnosis of
heritable and acquired disease and may become an invaluable tool for the investigator.
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Phenotypic Changes in WM35 Melanoma Cells Adapted for Tetracycline-Inducible
Gene Expression
I. H. Maxwell, Y. Xu, D. A. Norris, Y. Shellman, and J. L. Urquhart
Dermatology, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.
Earlier studies from our laboratory showed that expression of activated ras in the RGP melanoma
cell line, WM35, confers a VGP-like phenotype (Fujita et al Melanoma Res. 9: 279, 1999). We are
applying an inducible transcription system to enable study of phenotypic effects of controlled levels
of expression of ras and other effectors. For this purpose, we have introduced the positive TET
transactivator, rtTA, into WM35 cells. We used a retroviral vector to obtain a population of
WM35rtTA that shows 50-fold induction of a TET controlled reporter in response to
doxycycline. We have now isolated numerous clones from this population and examined their
phenotype. Cloning was achieved by using an excess of parental WM35 cells as `feeders' which
were then selectively killed by exploiting the blasticidin resistance marker that was introduced with
the retrovirus vector. In general, the WM35rtTA clones maintained excellent inducibility (15±
370-fold response of the TET controlled reporter to doxycycline). However, in some clones, we
observed unexpected alterations in phenotype from the parental WM35 cell line including the
frequent presence of giant, multinucleate cells, and the development of melanin pigmentation (in
contrast to the unpigmented, parental WM35 line). We are investigating the mechanisms involved
in this pigmentation, and whether this arose incidentally to the cloning procedure, or as a
consequence of rtTA expression. Clones that retain the morphology of WM35 are also being used
to pursue our goal of analyzing the effects of inducible expression of activated ras and of ras
effectors.
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Autosomal Dominant Spontaneous Pneumothorax Maps to Chromosome 17p11.2, the
Same Region of Birt±Hogg±Dube Syndrome
J. R. Toro, M. Warren, M. Turner, P. Duray, G. Glenn, M. Linehan, B. Zbar, and L. Schmidt*
Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, U.S.A.; *IRSP, SAIC-
Frederick, Inc. and LIB, NCI Frederick, Frederick, Maryland, U.S.A.
Spontaneous pneumothorax predisposition, can be inherited in an autosomal dominant fashion.
Recently, we showed evidence that Birt±Hogg±Dube syndrome confers an increased risk for the
development of lung cysts and spontaneous pneumothrorax. To localize the disease locus for
autosomal dominant pneumothorax (ADP), we recruited a family with multiple members with a
history of spontaneous pneumothorax. Eleven individuals were classi®ed as affected with ADP
since they had a history of spontaneous penumothorax or lung cyst on high resolution CT scan.
None of the affected individuals were smokers. We performed linkage analysis in this large kindred
and localized the locus for spontaneous pneumothorax to the pericentromeric region of
chromosome 17p with a LOD score of 3.64 at D17S1824 (recombination fraction q = 0). Both low
and high penetrance models were used for the calculation of LOD scores in this family and
signi®cant LOD scores were obtained with either model. The most suitable model for BHD
appears to be the high penetrance model since 90% of the individuals over 25 years of age who
carry the affected haplotype were positive for pneumothorax. Subsequent dermatologic
examination of this family revealed that all members with a history of spontaneous pneumothorax
had mutiple histologically con®rmed ®brofolliculomas consistent with the diagnosis of Birt±Hogg±
dube syndrome. Using ®brofolliculoma as the affected status in this family, we also found linkage to
chromosome 17p11.2 with a LOD score of 3.30 at D17S1824 (recombination fraction q = 0).
Recently, we reported that the Birt-Hogg-Dube syndome maps to chromosome 17p11.2. Our
®ndings suggest that Birt±Hogg±Dube syndrome is part of the spectrum of autosomal dominant
pneumothorax. Patients with a history of spontaneous pneumothorax should be examined carefully
for cutaneous manifestations of Birt±Hogg±Dube syndrome.
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Loss of Transgene Expression by Genetically Modi®ed Human Fibroblasts In Vivo is Not
a Function of the Immunode®cient State of the Murine Host: Nude vs. NOD-SCID
G. Krueger, C. Jorgensen, T. Tandeski, J. Morgan,* and M. Petersen
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; *Research Unit, Shriners Burn Institute,
Boston, Massachusetts, U.S.A.
Human genetically modi®ed ®broblasts (GMFb) carrying stably integrated transgenes lose
transgene expression (TGE) in vivo when constructs containing GMFb are transplanted to nude
mice. TGE loss is an organized process in which host cells replace apparently apoptotic GMFb.
TGE loss is rapid, approaching 50% by day 30 and 90% by day 60, and parallels loss of GMFb. It
has been postulated that loss of TGE in vivo may be secondary to natural killer (NK) cell activity in
nude mice, despite absence of an in¯ammatory in®ltrate surrounding the constructs. In contrast to
nudes, NOD-SCID mice do not have signi®cant NK cell activity. To assess the effect of NK
activity on TGE, GMFb were seeded into a biocompatible empty nylon matrix (ENM) and
transplanted to nude or NOD-SCID mice. Constructs contained Fb without transgene, Fb + lacZ
transgene, or Fb + transferrin transgene (hTf). All Fb were cloned by limiting dilution and tested at
passage 12±17. Skin constructs were matured in vitro for 1 month and transplanted toNOD-SCID
or nude mice (4 per group) and harvested at 4 and 8 weeks. Analysis included blood levels of hTf,
histologic assessment of lacZ expression, and Fb survival by assessment of the origin of ®broblasts
remaining in the construct, using mouse and human speci®c DNA probes. No difference in hTf
levels was detected between the two groups: at 4 weeks NOD-SCID = 28.7 ng/ml and
nude = 9.5 ng/ml; at 8 weeks NOD-SCID = 11.6 ng/ml and nude = 11.2 ng/ml. These differences
were not signi®cant. NOD-SCID and nude groups demonstrated similar, time-dependent loss of
lacZ expression and loss of GMFb in the constructs. No in¯ammatory in®ltrate was noted between
the ®bers of the nylon matrix in either strain of mice. We conclude that loss of TGE of GMFb in
vivo is not a result of NK cell activity.
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Long-Term Transgene Expression and Survival by Genetically Modi®ed Fibroblasts
In Vitro
C. Jorgensen, T. Tandeski, J. Morgan,* M. Petersen, and G. Krueger
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; *Research Unit, Shriners Burn Institute,
Boston, Massachusetts, U.S.A.
Genetically modi®ed human ®broblasts (GMFb) lose transgene expression (TGE) after
transplantation in vivo. This loss is an organized process with host cells replacing apparently
apoptotic GMFb. Loss of TGE is rapid, up to 50% in 30 days and 90% by 60 days, and parallels loss
of GMFb. In contrast, loss of TGE is not seen after 60 days in vitro. This study was designed to
further examine transgene expression and survival (TGE/S) of GMFb in vitro over time and under
varying culture conditions. GMFb were cloned and seeded onto an empty nylon matrix (ENM) or
an in vivo generated empty nylon matrix (IVENM) which prolongs TGE/S in vivo. Constructs
were held in vitro and TGE/S assessed monthly for 8 months. No loss of TGE was appreciated out
to 8 months in either construct (ENM or IVENM). Nuclear degeneration such as seen in apoptotic
cells was detected after 5 months in vitro in GMFb transduced with lacZ or human telomerase.
Constructs were transplanted to nude mice after 7 months in vitro and harvested six weeks later.
Despite histologic evidence of apoptosis before transplantation, both telomerase-transduced cells
and NFb survived and persisted in vivo, although ~50% replacement by host cells was noted. These
studies demonstrated that TGE/S in vitro exceeds that in vivo. Serum is a constituent of culture
medium that cells in vivo do not encounter. In order to examine the effect of serum on TGE/S in
vitro, GMFb were cultured to con¯uence and transferred to medium containing 0±10% serum.
TGE was quantitated and correlated to [DNA]. Serum concentrations less than 2.5% led to less
DNA and correlated with less TGE. Thus, TGE was not selectively modulated as a function of
serum in vitro.
391
Calcium-Dependent Involucrin Expression is Inversely Regulated by PKCa and PKCd
A. Deucher,² T. E®mova,* and R. Eckert*²
*Physiology/Biophysics, CWRU, Cleveland, Ohio, U.S.A.; ²Biochemistry, CWRU, Cleveland, Ohio,
U.S.A.
Calcium is an important physiologic regulator of keratinocyte function that may regulate
keratinocyte differentiation via modulation of protein kinase c (PKC) activity. PKCa and PKCd
are two PKC isoforms that are expressed at high levels in keratinocytes. In the present study, we
examine the effect of PKCd and PKCa on calcium-dependent keratinocyte differentiation as
measured by effects on involucrin (hINV) gene expression. Our studies indicate that calcium
increases hINV promoter activity and endogenous hINV gene expression. This response requires
PKCd, as evidenced by the observation that treatment with dominant-negative PKCd, inhibits
calcium-dependent hINV promoter activity, while wild-type PKCd increases activity. PKCa, in
contrast, inhibits calcium-dependent hINV promoter activation, a ®nding that is consistent with
the ability of dominant-negative PKCa, and the PKCa inhibitor, Go6976, to increase hINV gene
expression. The calcium-dependent regulatory response is mediated by an AP1 transcription factor
binding site located within the hINV promoter distal regulatory region (DRR) that is also required
for PKCd-dependent regulation, moreover, both calcium and PKCd produce similar, but not
identical, changes in AP1 factor expression. A key question is whether calcium directly in¯uences
PKC isoform function. Our studies show that calcium does not regulate PKCa or d level, or cause
a marked redistribution to membranes. However, tyrosine phosphorylation of PKCd is markedly
increased following calcium treatment. These ®ndings suggest that PKCa and PKCd are required
for, and modulate, calcium-dependent keratinocyte differentiation, in opposing directions.
393
Differential Gene Expression Analysis of Rhino Mouse Epidermis Using Affymetrix
GeneChip Mouse Arrays
A. A. Panteleyev, R. F. O'Shaughnessy, and A. M. Christiano
Dermatology, Columbia University, New York, New York, U.S.A.
The hairless (hr) gene plays an essential regulatory role in maintaining the epidermis and hair
follicle homeostasis in mammalian skin. Despite the fact that the pathogenesis of the hairless (hr/
hr) phenotype in humans and mouse is well described, the molecular pathways of hr gene activity
are not known. As an initial attempt to search for downstream targets of hr gene regulation, we
compared gene expression pro®les from the epidermis of newborn (hr/ hr) and (+/+) RHJ/
LeJhrrh-J hairless (rhino) mice. Six newborn pups of each genotype were selected by genotyping
using an Alu I site on mutant allele. The epidermis isolated from trypsinized skin was subjected to
total RNA extraction. Double-stranded cDNA synthesized using Superscript choice system (Gibco
BRL) was used as a template for further synthesis of biotin-labeled cRNA. In keratinocytes isolated
from (hr/ hr) epidermis, 87 genes out of 6000 (GeneChipá murine genome U74 set v2;
Affymetrix) were found to be differentially expressed by more than two-fold. Of the 87 genes, 58
corresponded to known sequences, 21 up-regulated and 37 down-regulated, the encoded proteins
involved in immune response/cytoskeleton transformation/cell cycle/steroid hormone pathways.
Several kinases and neurotransmitters were also detected among the most modulated genes. These
results provide a basis for further studies of selected candidate downstream genes and elucidation of
their role in h-dependent regulatory pathway(s).
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Survival of Genetically Modi®ed Fibroblasts In Vivo as a Function of Cloning,
Transduction and Cellular Lifespan
T. Tandeski, C. Jorgensen, M. Chen,* J. Morgan,² M. Petersen, and G. Krueger
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; *Dermatology, University of Southern
California, Pasadena, California, U.S.A.; ²Research Unit, Shriners Burn Institute, Boston, Massachusetts,
U.S.A.
We have shown previously that genetically modi®ed human ®broblasts (GMFb) seeded into a
biocompatible nylon mesh (skin construct) lose transgene expression and are replaced by host
®broblasts when transplanted in vivo. In these studies, GMFb were cloned by limiting dilution
before seeding the matrix. We hypothesize that loss of transgene expression and survival (TGE/S)
in vivo may result from the process of cloning or transduction. To test this hypothesis, cloned and/
or transduced ®broblasts from the same source were used to seed nylon mesh matrices. Fibroblasts
studied included normal human ®broblasts (Fb) passaged 17 times, cloned Fb passaged 17 times,
cloned lacZ-transduced Fb passaged 17 times, cloned Fb transduced with a retroviral vector
encoding human telomerase (hTRT) passaged 17 or 70 times, and cloned Fb transduced with
hTRT and lacZ passaged 70 times. Skin constructs were matured in vitro for 1 month, transplanted
to nude mice and harvested after 4 and 8 weeks in vivo. After harvesting, Fb survival was assessed by
quantifying the number of murine (host) vs. human cells in the skin constructs. These analyses
demonstrated: a) there is no difference in survival between non-cloned and cloned Fb; b) there is
no difference in survival between lacZ-transduced Fb compared with non-transduced or non-
cloned Fb; c) Fb transduced with hTRT survived considerably longer in vivo than those not
expressing hTRT. The survival advantage of hTRT-transduced Fb was most pronounced in cells
passaged 70 times. Differences were seen after at 4 weeks in vivo. We conclude that transduction
and/or cloning of Fb does not adversely affect cell survival in vivo, and that the inherent lifespan of
the cell is most critical to cell survival in this system.
VOL. 119, NO. 1 JULY 2002 ABSTRACTS 273
398
Mutations in the ED1 Gene in Japanese Families with X-Linked Hypohidrotic
Ectodermal Dysplasia
T. Hashiguchi, S. Yotsumoto, and T. Kanzaki
Dermatology, Kagoshima University Faculty of Medicine, Kagoshima, Kagoshima, Japan
X-linked hypohidrotic ectodermal dysplasia (XLHED; OMIM305100) is the most common form
of ectodermal dysplasia that affects ectodermal structure. The affected organs are ectodermal
origins, but nervous system is usually unaffected. The phenotype is sparse hair, absence or
hypoplasia of teeth and sweat glands. Hyperthermia and respiratory infection may occasionally be
life threatening in early infancy. Mutations in the ED1 gene which encodes ectodysplasin-A (EDA)
is responsible for XLHED. EDA, a ligand for the EDA receptor (EDAR), includes a
transmembrane domain, a furin protease recognition domain, a collagen-like domain, and a
tumor necrosis factor (TNF) domain. The protein plays an important role in epidermal
morphogenesis. We identi®ed the mutations in the ED1 by sequencing genomic DNAs from eight
unrelated Japanese XLHED families. We found three novel mutations: two deletion mutations
(31delC, 49delC) in exon 1, which results in a frameshift at codon 11 and termination at codon 56,
a frameshift at codon 17 and termination at codon 56, and a missense mutation (1174T > C) in
exon 9, which abolished the stop codon. Other mutations were in intracytoplasmic domain (Q23X
in a family) and furin subdomain (R155C in two families, R156C in two families). Data from all
reported mutations reveal that codon 156 in the furin subdomain is the most frequent site of
change in EDA.
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Cellular Growth Regulation and Signal Transduction by Mechanical Stretch in Human
Epidermal Keratinocytes
S. Yano, M. Komine, H. Okochi, and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Japan
Mechanical forces affect epidermal keratinocytes that wrap the entire body, protecting it from
outer environment. Mechanical stress could induce proliferation in the skin enlarged by tissue
expander and in the epidermis of palms and soles. The epidermis around in situ skin tumors
stretched by tumor nests shows proliferation. In order to elucidate the mechanism of these
phenomena, we examined the epidermis stretched by in situ skin tumors and investigated signal
transduction provoked by mechanical stretch in normal human keratinocytes (NHK) or HaCaT
cells plated on ¯exible silicone dishes. Examination of stained sections revealed that basal cells of
epidermis elongated by tumor nests of Bowen's and Paget's disease showed higher positive ratio for
proliferating cell nuclear antigen, Ki-67 and keratin K6 expression. Stretching of NHK or HaCaT
caused up-regulation of 5-bromo-2¢-deoxyuridine (BrdU). The activation of extracellular signal-
regulated kinases (ERK1/2) and Akt was demonstrated by Western blotting, reaching maximal at
5±15 min, ceasing at 30±60 min. Inhibition of mitogen and extracellular signal-regulated kinase by
U0126, phosphoinositide 3-OH kinase by wortmannin, EGF receptor (EGFR) kinase by AG1478,
and calcium channel by gadolinium attenuated BrdU incorporation and the activation of ERK1/2
and Akt by mechanical stretch. Stretch signal stimulated reporter activity of activating protein 1
(AP-1), induced protein expression of keratin K6, and suppressed keratin K10, which were
inhibited by U0126. Our results indicate that mechanical stretch induces proliferative and
antiapoptotic signals in human keratinocytes via induction of calcium in¯ux, phosphorylation of
EGFR, and the activation of ERK1/2 and Akt, which resulted in AP-1 activation, BrdU
incorporation, keratin K6 induction, and keratin K10 suppression. These mechanisms may
contribute to the hyperproliferative nature of epidermis by intraepidermal tumors or tissue
expander.
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Expression of Suppressor of Cytokine Signaling-1 in Human Melanoma Cells In Vitro
and In Situ
Z. Li, T. Cauvet,* C. Mu
È
ller,* C. Poremba,² T. A. Luger, and M. Bo
È
hm
Department of Dermatology, Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the Skin,
MuÈnster, Germany; *Department of Medicine, Hematology and Oncology, Department of Medicine,
Hematology and Oncology, MuÈnster, Germany; ²Gerhard Dornagk-Institute for Pathology, Gerhard
Dornagk-Institute for Pathology, MuÈnster, Germany
Cytokine resistance is an important feature of melanoma progression and has been reported for
interleukin-6 (IL-6) and interferon (IFN). We recently demonstrated that IL-6 resistance of
melanoma cells is linked to impaired activation of the signal transducer and activator of
transcription 3 (STAT3), a key component in IL-6 signal transduction. Since suppressor of
cytokine signaling-1 (SOCS-1) can suppress IL-6- and IFN-induced responses by interfering with
activation of STAT members, we examined the role of SOCS-1 in normal and transformed
melanocytes in vitro as well as in human cutaneous melanomas in situ. RT-PCR and real-time PCR
of RNA samples derived from 8 different melanoma cell lines did not reveal any correlation
between the amount of SOCS-1 RNA, IL-6 sensitivity and the tumor stage, respectively. In both
IL-6 sensitive and resistant cell lines, exogenous IL-6 or IFN-a induced rapid but transient
increases in the RNA levels of SOCS-1 in vitro. However, SOCS-1 protein expression was only
detectable in melanoma cells and localized to the cytoplasm while being absent in normal human
melanocytes. In accordance with the latter ®ndings, SOCS-1 expression was undetectable in
normal human skin but its in situ expression in melanoma cells correlated with the level of invasion
and tumor stage as demonstrated by immunohistochemistry. Our ®ndings show for the ®rst time
that melanoma cells express SOCS-1. Although SOCS-1 alone does not appear to be responsible
for IL-6 resistance in vitro, its in situ expression may act as an important inhibitor of endogenously
produced or therapeutically administered cytokines.
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Application of cDNA Microarrays in Cutaneous B Cell Lymphoma
M. N. Storz,* Y. H. Kim,² S. Mraz-Gerhard,² M. van de Rijn,* and S. Kohler*²
*Pathology, Stanford University, Stanford, California, U.S.A.; ²Dermatology, Stanford University,
Stanford, California, U.S.A.; ³Dermatology, Stanford University, Stanford, California, U.S.A.;
§Pathology, Stanford University, Stanford, California, U.S.A.; ¶Pathology, Stanford University,
Stanford, California, U.S.A.
Cutaneous B-cell lymphomas comprise a heterogeneous group of neoplasms, that for the most part
are characterized by an indolent behavior and therefore usually require less aggressive treatment.
Nevertheless some variability in the clinical course of cutaneous diffuse large B-cell lymphoma
(CDLBL) has been observed. Characterization of the global phenotype of this entity might reveal a
distinct molecular signature responsible for a poorer clinical outcome in some patients with
CDLBL. 11 biopsies of cutaneous B-cell lymphoma, including 7 cases of CDLBL and 4 cases of
follicular lymphoma (FL) were analysed using spotted cDNA microarrays containing 42¢000 spots.
Additionally 3 cases of mycosis fungoides were included and a hierarchical cluster algorithm was
applied to group samples most similar in their gene expression. A clear difference between T- and
B-cell malignancies was apparent. CDLBL seemed to consist of two distinct subgroups. The most
prominent differences in gene expression pattern came from genes, which are expressed in
germinal center B-cells. The majority of cases of CDLBL clustered next to FL and shared gene
expression of germinal center B-cells. A second group of 3 cases of CDLBL clustered on a more
distant branch, lacking this germinal center expression signature. They shared a cluster of up-
regulated transcripts related to genes, involved in cell adhesion, tumor biology and remodeling of
the extracellular matrix, which might indicate a more invasive and malignant phenotype. A similar
observation was previously reported for lymph node based diffuse large B-cell lymphoma by
Alizadeh et al who identi®ed prognostically relevant subtypes for that disease. In summary, this
pilot study mirrored the WHO classi®cation system for cutaneous lymphomas on a transcriptional
level by clustering histologically de®ned entities together. Furthermore it seemed to identify two
molecularly distinct subgroups of CDLBL which may show divergent clinical outcome. Further
studies using tissue arrays are currently undertaken to address this issue.
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Epidermal Growth Factor Up-Regulates Transforming Growth Factor-b Receptor Type
II in Human Dermal Fibroblasts Via Phosphoinositide 3 Kinase/Akt Signaling Pathway
K. Yamane, H. Ihn, and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Tokyo, Japan
TGF-b receptor (TbR) are serine/threonine kinase receptors that bind to TGF-b and propagate
intracellular signaling through Smad proteins. In the present study, we demonstrated that EGF up-
regulated the expression of type II TbR (TbRII) mRNA and proteins in human dermal ®broblasts.
Actinomycin D signi®cantly blocked the EGF-induced TbRII mRNA expression, whereas
cycloheximide did not block this up-regulation. In addition, EGF treatment did not signi®cantly
affect the TbRII half-life. EGF-mediated induction of TbRII expression was inhibited by the
treatment of ®broblasts with a speci®c phosphoinositide 3 kinase (PI3K) inhibitor, wortmannin or
LY294002. And speci®c Akt inhibitor inhibited EGF-induced TbRII expression. Additionally,
EGF induced TbRII promoter activity, which was signi®cantly blocked by wortmannin,
LY294002, and Akt inhibitor. Co-transfection with a dominant negative mutant of p85 (regulatory
component of PI3K) or Akt signi®cantly reduced the induction of TbRII promoter activity by
EGF. Moreover, a constitutive active form of p110 (catalytic component of PI3K) induced TbRII
promoter activity. These results indicate that EGF-mediated induction of TbRII expression occurs
at the transcriptional levels, does not require de novo protein synthesis, and involves the PI3K/Akt
signaling pathway.
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Basic Fibroblast Growth Factor Induces Lef/Tcf-Dependent Transcription in Human
Endothelial Cells
W. Holnthoner, M. Pillinger, M. Groeger, K. Wolff, and P. Petzelbauer
Department of General Dermatology, University of Vienna Medical School, Vienna, Austria
Lef/Tcf proteins belong to a family of architectural transcription factors, which control
developmental processes and also play an important role in oncogenesis. Classical activators of
Lef/Tcf-dependent transcription belong to the Wnt family of proteins, which translocate b-catenin
into the nucleus and allow the formation of transactivation-competent Lef/Tcf/b-catenin
complexes. Here we show that in human endothelial cells FGF reduces GSK-3 activity and
augments nuclear levels of b-catenin. We could show the expression of all four known Lef/Tcf
family members (Lef-1, Tcf-1,3,4). Among others, known target genes of Lef/Tcf-dependent
transcription are Cyclin D1 and the urokinase receptor. FGF induced Lef/Tcf-dependent
transcription of a Cyclin D1-luciferase construct, but not of a urokinase receptor promoter.
However, gel shift assays revealed binding of Tcf-4 as the only Lef/Tcf family member as well as b-
catenin on the Lef/Tcf site in the Cyclin D1 promoter. Furthermore, cotransfection with a
dominant-negative Tcf-4 construct diminished the FGF-induced Cyclin D1 promoter activity.
Thus, our results suggest FGF as a novel modulator of Lef/Tcf/b-catenin signalling.
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The Role of a-MSH in Human Sebaceous Lipogenesis
Q. Huang, M. Anthonavage, W. Li, and M. Eisinger
Skin Biology, Johnson & Johnson Skin Research Center, Consumer and Personal Care Group, Skillman,
New Jersey, U.S.A.
Proopiomelanocortin (POMC) peptides, particularly, a-melanocyte stimulating hormone (a-
MSH) and adrenocorticotrophic hormone (ACTH), have been shown to be produced by and
target different cell types in the skin. Bioregulation of pigment cells as well as immunocytes by
POMC peptides has been studied extensively and their functional importance well established.
Although implicated, less information exists about the role of POMC peptides in the sebaceous
gland physiology. To elucidate this question, cultures of human sebocytes isolated from facial skin
of postmenopausal women, were employed. We found that a-MSH is constitutively produced in
sebocyte cultures at levels of 550 pg/106 cells compared to ACTH that is only 95 pg/106 cells.
Addition of NDP-a-MSH at 0.1±10 nM was shown to induce sebaceous cell differentiation
signi®ed by the appearance of prominent lipid granules in the cytoplasm of sebocytes. The lipid
containing granules were further revealed and quanti®ed by Nile Red staining. Quantitation by
high performance thin layer chromatography (HPTLC) revealed a dose dependent increase in
sebaceous speci®c lipid synthesis, reaching maximum at 10 nM. Moreover, treatment with 0.1±
10 nM NDP-a-MSH induced 1.8±5.5 fold increases in c-AMP level, corroborating our ®ndings of
the presence of MC5-R on these cells. Interestingly, cholera toxin and forskolin were also found to
be potent inducers of sebaceous lipogenesis. RT-PCR analysis revealed that both cholera toxin and
forskolin induce expression of POMC mRNA, as well as its processing enzymes, prohormone
convertase 1(PC1) and PC2 in sebocytes. Thus, induction of sebogenesis by cholera toxin and
forskolin may also be mediated by a-MSH. These data provide ®rst direct evidence that a-MSH is
an important stimulator of human sebaceous lipid synthesis.
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Dermatan Sulfate is an Essential Cofactor for Keratinocyte Growth Factor (FGF7)
J. M. Trowbridge, J. Rudisill, K. Taylor, and R. L. Gallo
Medicine/Dermatology, UCSD/VA Medical Center, San Diego, California, U.S.A.
This study evaluated the potential function of dermatan sulfate (DS) to support keratinocyte
growth factor (FGF-7) activation. Heparan sulfate (HS) or its derivative heparin, is a cofactor for
signaling by members of the FGF family. In wounds, DS activates FGF2, suggesting that in skin DS
may substitute for HS in facilitating signaling of other members of the FGF family. To test this, a
cell line (BAF3) transfected with an FGF-7 receptor (FGFR2IIIb), but devoid of endogenous HS
or DS, was treated with FGF-7 and several glycosaminoglycans (GAGs). Proliferation of these cells
was measured to determine which GAGs act as cofactors for FGF-7. Neither FGF-7 alone, nor any
of the GAGs tested, stimulated cell growth. When DS was added with FGF-7 (5 ng/ml) cell
growth occurred at levels comparable to that seen with heparin (2±3 fold for DS vs. 4 fold with
heparin). In contrast, HS and FGF-7 could not support proliferation. Dependence on DS over HS
was not seen with FGF-1. To determine the active sequence in DS, DS was partially digested and
fractions were assayed for activity. Those with high charge to mass ratio due to disaccharide
sulfation were most active. The growth of normal keratinocytes and the wound repair response was
also sensitive to the addition of DS or treatment with DS-degrading enzymes. These results suggest
that proliferation of keratinocytes in response to FGF-7 is regulated by DS synthesis, sulfation and
release. In wounds, FGF-7 is abundant and DS is the predominant GAG made by dermal
®broblasts. Therefore, appropriate balance of DS and growth factor may be a critical factor in
determining normal repair.
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Innate Immune-Related Reactions Intrinsic to Symptomless Psoriatic Skin
J. Curry, J. Qin, R. Carrick, J. Strande, J. Robinson, F. Nestle,* and B. J. Nickoloff
Pathology, Loyola University Chicago, Maywood, Illinois, U.S.A.; *Dermatology, University Hospital of
Zurich, Zurich, Switzerland
Mounting evidence emphasizes a critical in¯uence of innate immunity on adaptive immune
reactions. Yet, the role of innate immunity in psoriasis is unexplored. Since overactive innate
responses to environmental insults by resident skin immunocytes could contribute to onset of
lesions, we sought to de®ne the initial response of prepsoriatic (PN) skin in absence/presence of
either bacterial superantigens (SEB/SEC2), heat shock proteins (HSPs 27, 60, 70), or LPS. Using
short-term organ culture restricts immune responses to immunocytes normally present in skin,
avoiding confounding exogenous circulating cells. Biopsies from either 13 normal (NN) vs. 7 PN
skin samples were immunostained, or minced and cultured in medium containing either: PBS;
SEB/SEC2 (1 mg/ml); recombinant HSPs (10 mg/ml); LPS (1 mg/ml). After 6 days in culture, cells
and supernatants were examined. Even in absence of exogenous stimuli, numerous activated T cells
underwent proliferation in PN skin explants~105 T cells. Quantity of IFN-g produced (ELISA) in
PN cultures was 4 fold higher than in NN cultures. Addition of SEB/SEC2 or LPS enhanced IFN-
g levels equally in both PN and NN skin; although HSPs induced higher KGF levels in PN vs. NN
skin (4-fold) samples. CD91, a receptor for HSPs, was expressed by dermal dendritic cells in PN
skin. Immunophenotypic analysis of organ culture-derived immunocytes in PN skin revealed a
signi®cant shift in CD4+ T cells (> 90%), and presence of increased number of NK-T cells (33%
CD3+ CD161+). PN-derived CD4+ T cells also expressed KGF. Western blot analysis of psoriatic
scale extracts revealed prominent amounts of HSPs 27,60,70. These data, for the ®rst time, establish
an intrinsic innate immune defect in PN skin. HSPs are likely mediators impacting CD91+
dendritic cells, with a pathogenic role played by NK-T cells via production of IFN-g and KGF.
Such early cytokine/growth factor production by innate immune cells could contribute to
secondary events, i.e. adaptive immunity and increased epidermal thickness.
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A Novel Natural Compound ShikoninÐthe Mechanism of its Anticancer Action on
Ultraviolet B-Induced Skin Carcinogenesis
F. Singh, D. Gao, M. Lebwohl, and H. Wei
Dermatology, Mount Sinai School of Medicine, New York City, New York, U.S.A.
An alarming rise in the incidence of skin cancer has been observed over the past 20years in the
United States. As many as 1.2 million new cases of nonmelanoma, skin cancer (NMSC) are
diagnosed each year. In the last 10 years, a great deal of evidence has emerged to support the view
that ultraviolet B (UVB) radiation acts as a complete carcinogen in skin tumorigenesis models. The
phases of skin carcinogenesis include initiation, usually a rapid process, promotion that usually takes
10 years and ®nally, progression, which takes one to two years. Hence, most chemotherapeutic
agents are targeted to prevent the promotion phase of tumorigenesis. The signaling cascade
involved in carcinogenesis is under intense investigation since it will provide many important
lessons in therapeutics. We report on the properties of a novel quinone compound, Shikonin, and
its mechanism of action as an anticarcinogenic natural compound. Shikonin inhibits the
proliferation of cancer cells (A431) in culture with an IC-50 of 3.1 mg/ml, compared to essentially
normal keratinocytes where the IC-50 equals 12.5 mg/ml. Protein studies revealed that shikonin
inhibits ligand dependent and independent phosphorylation of the epidermal growth factor
receptor (EGF-R) in cultured A-431 cells in a dose dependent manner. Likewise, protein tyrosine
kinase (PTK) activity associated with the EGF-R is decreased. In response to altered cell surface
physiology, several intracellular players in the proliferative and apoptotic pathways are affected.
The phosphorylated level of a proliferative protein MAP Kinase (Erk 1/2) is reduced, whereas pro-
apoptotic biomolecules, phosphorylated p38 and JNK are increased. On the whole, Shikonin
treatment switches cellular fate to an antiproliferative and pro-apoptotic one. Shikonin is a natural
compound that warrants further investigation as an anticarcinogenic compound in animal models.
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BRCA-1 Phosphorylation in Keratinocytes
D. B. Yarosh, M. T. Canning, and D. A. Brown
Research, Agi Dermatics, Freeport, New York, U.S.A.
The tumor suppressor protein BRCA-1 reduces breast and ovarian cancer, but nothing is known
about BRCA-1 function in skin. BRCA-1 activity is controlled by its phosphorylation, so we used
antibodies speci®c for phosphorylated BRCA-1 (pBRCA-1) to examine activation in Western
blots of keratinocytes. Basal levels of pBRCA-1 were elevated in proliferating normal human
epidermal keratinocytes (NHEK) and in the p53- HaCat keratinocyte line, but declined when the
cells reach con¯uence. UV-B induced pBRCA-1 in both cell types. The increase was greatest at
about 2 h and declined to baseline by 24 h postirradiation. pBRCA-1 increased with doses of UV-
B from 125 to 500 J/m
2
, but the increase in HaCat cells was much greater than in NHEK. The
UV-mimetic compound AGI-1140, a bicyclic monoterpene diol, also induced BRCA-1
phosphorylation with a time course similar to UV-B, and in a dose dependent manner.
Rapamycin inhibits FRAP/mTOR, which is part of the family of kinases that includes DNA-PK,
ATM and ATR. Rapamycin blocked pBRCA-1 formation in UV-B irradiated cells after either
UV-B or AGI-1140. ODQ (1H-[1,2,4]oxadiazolo[4,3-a]-quinoxalin-1-one) is a guanylate cyclase
inhibitor, but had no effect on pBRCA-1 induction after either UV or AGI-1140. Surprisingly,
DRB (5,6-dichloro-1-bb-D-ribofuranosylbenzimid-azole), which is an inhibitor of a BRCA-1
phosphorylating kinase casein kinase 2, only blocked pBRCA-1 after AGI-1140 treatment, but not
after UV-B. These results suggest that in keratinocytes pBRCA-1 is associated with proliferation,
and is a p53-independent stress response to UV-B that is activated through mTOR/FRAP but not
through casein kinase 2 nor the NO/cGMP/PKG pathway.
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Possible Role of Transcriptional Coactivator p300/CBP Associated Factor and Nuclear
Acetylation in Calcium-Induced Keratinocyte Differentiation
H. Kawabata, K. Kawahara,* T. Kanekura, N. Araya,² H. Daitoku,² M. Hatta,² N. Miura,* A.
Fukamizu,² T. Kanzaki, I. Maruyama,* and T. Nakajima³
Dermatology, Kagoshima University Faculty of Medicine, Kagoshima, Kagoshima, Japan; *Laboratory and
Molecular Medicine, Kagoshima University Faculty of Medicine, Kagoshima, Kagoshima, Japan; ²Tsukuba
Advanced Research Alliance Center, Institute of Applied Biochemistry, University of Tsukuba, Tsukuba,
Ibaragi, Japan; ³Genome Science, Institute of Medical Science, St. Marianna University School of Medicine,
Kawasaki, Kanagawa, Japan
Several nuclear factors, called coactivators, such as CREB-binding protein (CBP) and p300/CBP
associated factor (p/CAF), have intrinsic histone acetyltransferase (HAT) activity. Recent studies
have shown that, in addition to histones, transcriptional regulatory molecules are also targets of
HATs and nuclear acetylation (NA) is thought to be involved in several biological processes.
Calcium regulates muscle differentiation at least in part due to its interaction with histone
deacetylase. These facts prompted us to investigate the association between calcium induced
keratinocyte differentiation and HAT activation. NA in response to calcium stimulation was
examined by immunoblotting and immunostaining. The interactions between protein kinase C
(PKC), HAT and NA were also evaluated by in vitro and cell-transfection experiments. We
observed that a high concentration of calcium induced HAT activity in the keratinocyte cell line,
HaCaT. The steady-state level of speci®c acetylated nuclear proteins changed in a dynamic fashion
in HaCaT cells induced with 1.2 mM calcium. An approximately 97 kDa acetylated protein,
designated ap97 was transiently induced, another (ap78) was induced and then was expressed
continuously, and another (ap70) disappeared with time. Although the up-regulation of ap70 and
ap78 was not in¯uenced by GF109203X, a speci®c inhibitor of PKC, the calcium-induced
accumulation of ap97 and the induction of p/CAF HAT activity were both attenuated by
GF109203X. Notably, a mutant p/CAF lacking HAT activity repressed the expression of ap97 and
involucrin. Our results suggest that both p/CAF HAT activity and the induction of ap97 are
involved in calcium-dependent keratinocyte differentiation.
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Overexpression of Wildtype TGFb1 in the Epidermis Results in a Severe In¯ammatory
Skin Disorder
G. Li,* D. Wang,* X. Feng,²³ and X. Wang*³
*Dermatology, Baylor College of Medicine, Houston, Texas, U.S.A.; ²Surgery, Baylor College of
Medicine, Houston, Texas, U.S.A.; ³Molecular and Cellular Biology, Baylor College of Medicine,
Houston, Texas, U.S.A.
Transforming growth factor-b (TGFb) plays a pivotal role in skin homeostasis, presumably through
regulating functions of both epidermis and dermis. Previous transgenic studies targeted
overexpression of an active mutant of TGFb1 to the epidermis revealed a potent growth
inhibitory effect on keratinocytes. Since wildtype TGFb1 has a much longer half-life time than
active form of TGFb1, we hypothesized that wildtype TGFb1 may be easier to be secreted into the
dermis, thus providing more potent paracrine effects. To test this hypothesis, we have generated
transgenic mice overexpressing wildtype TGFb1 in the epidermis, utilizing a keratin 5 promoter
(K5.TGFb1). Neonatal epidermis showed slight hypotrophy and fewer hair follicles compared
with nontransgenic littermates. Surprisingly, adult K5.TGFb1 mice revealed hyperplastic
epidermis, accompanied by undistinguished basement membrane zone, hyperproliferation in both
keratinocytes and dermal ®broblasts, leukocyte in®ltration and increased angiogenesis.
Macroscopically, transgenic mice developed erythematic skin lesions and ulceration, and hair
loss. Cultured keratinocytes from K5.TGFb1 pups demonstrated a potent growth inhibition,
indicating that epidermal hyperplasia in K5.TGFb1 mice must be a secondary effect resulted from
hyperproliferative ®broblasts and in®ltrated leukocytes. Supporting this notion, elevated expression
of KGF and amphiregulin were found in K5.TGFb1 skin. Matrix metalloproteinases 2 and ± 9
were also elevated in transgenic skin, which may contribute to the enhanced basement membrane
degradation and angiogenesis. Moreover, interleukin 1a and ± 1b, the primary in¯ammatory
cytokines, were signi®cantly induced in transgenic epidermis, resulting in increased nuclear
translocation of NFkB. Taken together, overexpression of wildtype TGFb1 resulted in a potent
paracrine loop between epidermis and dermis, which is suf®cient to induce an in¯ammatory
disorder by deregulating various genes involved.
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Molecular Mechanisms in Acanthosis Nigricans: FGFR3 Mutations Inhibit Keratinocyte
Apoptosis via PI3-K/Akt Signaling
G. A. Bellus, J. P. Janik, N. M. Annest, and D. P. Kelly
Dermatology, University of Colorado School of Medicine, Denver, Colorado, U.S.A.
Acanthosis nigricans (AN) is a nonmalignant hyperproliferative skin disorder that is often associated
hyperinsulinemia or neoplasia. AN also occurs in patients who carry unique, activating FGFR3
mutations associated with the Crouzono-dermato-skeletal (A391E) and SADDAN (K650M)
syndromes. Previously, we reported evidence that keratinocytes from patients with FGFR3 A391E
or K650M mutations express increased amounts of the antiapoptotic protein bcl-2 and are resistant
to apoptosis. Based on this data we hypothesized that AN may result from prolonged survival of
keratinocytes in the epidermis due to activation of signaling pathways that disrupt the normal
process of differentiation and programmed cell death. In patients without FGFR3 mutations, AN is
often associated with inappropriate activation of IGF-1 or EGF receptors by circulating growth
factors. These receptors affect many signaling molecules including activation of PI3-K and Akt.
Phosphorylated Akt activates many different cellular survival signals. Using quantitative Western
blots, we determined that keratinocytes with FGFR3 A391E or K650M mutations have 3±7 times
higher levels of phosphorylated Akt than control keratinocytes. Levels of the PI3-K inhibitor
PTEN were not signi®cantly different among mutant and control keratinocytes but levels of
phosphorylated Bad were elevated 2 fold in K650M mutant keratinocytes indicating that Akt may
be acting to decrease Bad. Furthermore, treatment of FGFR3 A391E and K650M keratinocytes
with the PI3-K inhibitors wortmannin or LY294002 restored levels of apoptosis caused by uv
irradiation, cisplatin or beauvaricin to that of control keratinocytes. This data supports our
hypothesis that AN results from increased survival of keratinocytes in the epidermal compartment
and that activation of PI3-K/Akt by mutant FGFR3 receptors may play an important role in the
pathogenesis of AN in Crouzono±dermato±skeletal syndrome and SADDAN syndrome
414
The In¯uence of Human Fibroblast Growth Factor-10 on the Healing Time of Full-
Thickness Porcine Wounds in a Wet Environment
D. Hoeller,*² J. J. Vranckx,* N. C. Petrie,* H. Augustinova,* F. Yao,* and E. Eriksson*
*Division of Plastic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston,
Massachusetts, U.S.A.; ²University Clinic of the RWTH Aachen, Interdisciplinary Center for Clinical
Research on Biomaterials, Aachen, Germany
Human Fibroblast Growth Factor 10 (hFGF-10) is expressed by ®broblasts. Its main function is the
induction of cell proliferation in adult tissue. Experiments revealed that a formation of hFGF-10 in
the dermal compartment by ®broblasts is induced during the early phases of wound healing and
demonstrated a shortened wound healing with an increase in epidermal thickness of healed
incisional and split skin graft donor sites wounds. We established a pig model for gene delivery of
hFGF-10 to full thickness wounds in a wet wound healing environment. Autologous ®broblasts
were grown in culture for one week. After passing of cells, in vitro gene transfer of hFGF-10 was
performed using the lipofection technique. At 48 h after transfection we created 18 full-thickness
wounds in 4-month-old Yorkshire pigs, covered them with wound chambers and applied the cells
to the wounds. The control groups were treated with untransfected ®broblasts or saline. In the
follow-up wound ¯uid was collected daily and the wet environment created by adding saline to the
wound chambers. After 12 days the experiment was stopped and wound biopsies were taken to
examine the wounds. We found a slightly increased expression of hFGF-10 in the wound ¯uid of
the transfected group by day 6 after the operation. An onset of endogenous FGF-10 expression was
found on day 8 after the operation with a maximum on day 11. Histological examinations of the
wound biopsies indicate an in¯uence of FGF-10 on the formation of granulation tissue and
revascularisation. Our results indicate that FGF-10 might have a positive in¯uence on wound
healing, especially on the formation of granulation tissue and revascularisation. Further experiments
to prove this theory are in process.
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Adiponectin, an Adipose-Speci®c Cytokine, Enhances Keratinocyte Proliferation and
Migration Through the Activation of Extracellular Signal-Regulated Kinase 1/2
Y. Nakatani, Y. Yamaguchi, M. Nishida,* S. Kihara,* I. Shimomura,* H. Nishizawa,* T.
Funahashi,* Y. Matsuzawa,* S. Itami, and K. Yoshikawa
Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; *Internal Medicine and
Molecular Science, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Adipose tissue has recently identi®ed as an organ actively secreting several cytokines in response to
external stimuli. Adipnectin/apM1/adipoQ/Acrp30, one of adipocyte-derived cytokines, is the
most abundant gene product in adipose tissue. To examine the possible involvement of
adiponectin on cutaneous wound healing, we ®rst quanti®ed the local expression of adiponectin in
the adipose tissue around wounds or intact skin, as measured by ELISA. The local concentrations
of adiponectin in acute wounds, chronic wounds, and intact skin were 5.22 6 2.34 microg/ml
(mean 6 SD; n = 8), 3.01 6 0.30 microg/ml (n = 5), and 1.88 6 0.21 microg/ml (n = 12),
respectively. The distribution of adiponectin in acute wounds was most remarkable under the
keratinocyte layer of the epithelial tongue, especially around newly formed vessels. We also
checked whether keratinocytes or ®broblasts express adiponectin mRNA, as measured by RT-
PCR, and have receptors for adiponectin. Neither keratinocytes nor ®broblasts expressed
adiponectin mRNA, but both of them stained positively for adiponectin. Finally, we checked its
effects on the keratinocyte growth, locomotion, and the quantity of extracellular signal-regulated
kinase (ERK) 1/2 phosphorylation, as measured by BrdU uptake, in vitro scratch assay, and
immunoblot analyses, respectively. Adiponectin enhanced the cultured keratinocyte proliferation
and migration in a dose dependent manner up to 30 microg/ml. The phosphorylation of ERK1/2
in keratinocytes was enhanced at 10 min after the addition of adiponectin. These results strongly
suggest that adiponectin plays important roles in normal wound healing by promoting
reepithelialization.
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Differential Regulation of Gli1 Activity by PKC Isoforms
G. W. Neill, J. L. Green, M. P. Philpott, and A. G. Quinn
Centre for Cutaneous Research, Queen Mary University of London, London, U.K.
Up-regulation of the transcription factor Gli1 is associated with the development of basal cell
carcinoma (BCC). Gli1 activity is subject to post-transcriptional regulation and a number of factors
have been identi®ed which regulate Gli1 activity based on genetic studies of Hh signalling in
Drosophila. For example, PKA has been shown to negatively regulate both Ci and Gli1
highlighting conservation of the pathway. Here we present evidence that Gli1 activity is subject to
regulation by PKC signalling. Using a transient reporter-based assay we have shown that
constitutively active PKC isoforms differentially regulate Gli1 activity. Co-expression of PKC in
HEK293 cells reduces the activity of Gli1 by 50%, whereas PKC increases activity over 2-fold.
Western analysis demonstrates that the increase in Gli1 activity induced by PKC is not due to an
increase in the level of Gli1 protein. Surprisingly, despite reducing Gli1 activity, PKC actually
increases the level of Gli1 suggesting that Gli1 is subject to complex regulation by PKC signalling.
The expression pattern of Gli1 is predominantly cytoplasmic in 293 cells, and previous work by us
and others has identi®ed nuclear export sequences indicating that Gli1 is subject to nuclear-
cytoplasmic shuttling. To assess if nuclear-cytoplasmic shuttling is necessary for PKC regulation of
Gli1, we analysed the activity of a mutant Gli1 protein ± Gli1 mNES (mutated nuclear export
sequence) ± that is localised exclusively to the nucleus. Regulation of Gli1mNES activity by both
PKC isoforms is similar to native Gli1 indicating that nuclear-cytoplasmic shuttling is not a
determinant of Gli1 control by PKC. Gli1 contains multiple PKC consensus motifs suggesting that
PKC may regulate Gli1 directly or, alternatively, PKC may in¯uence signalling pathways to
regulate Gli1. In summary, we have identi®ed a novel mechanism regulating the activity of the
oncogenic protein Gli1.
413
Growth Inhibition of Primary Keratinocytes by the Prostanoid Receptor EP3 is
Associated with a Parallel Increase in Diacylglycerol and Ceramide Synthesis
R. L. Konger, S. Partilo, and A. P. Pentland
Dermatology, University of Rochester School of Medicine, Rochester, New York, U.S.A.
We have previously demonstrated that growth of primary adult human keratinocytes (PHKs) is
inhibited by sulprostone, a selective agonist for EP3 and EP1 subtypes of prostaglandin E2
receptors. We sought to determine the speci®c receptor and signaling mechanism involved in
growth inhibition. PHKs express mRNA for both EP1 and EP3 receptors. Growth inhibition by
sulprostone was maximal at 0.1 ng/ml (0.215 nM), suggesting involvement of high af®nity EP3
receptors, Ki = 0.35 nM, rather than lower af®nity EP1 receptors, Ki = 107 nM. Growth inhibitory
concentrations of sulprostone increased expression of the cell cycle regulators, p21Waf1 and
p27Kip1. Since p21Waf1 is known to be induced by both protein kinase C (PKC) and ceramide,
we examined the affects of sulprostone on production of ceramide and the endogenous PKC
activator, diacylglycerol (DAG). Sulprostone induced a parallel increase in both DAG and
ceramide, with a maximal response observed at 0.1 ng/ml. In time-course experiments, maximal
DAG and ceramide production occured at 15 min. Both DAG and ceramide responses were
abolished by cotreatment with the nonspeci®c EP receptor antagonist AH6809, demonstrating that
sulprostone's activity is receptor speci®c. EP3 receptors are coupled to pertussis toxin (PTX)-
sensitive Gai subunit activation, while EP1 receptors are coupled to PTX-insensitive Gaq
subunits. Signi®cantly, PTX blocked the rise in both DAG and ceramide. Mass levels of ceramide
were approximately 10-fold greater than DAG levels. This strongly suggests that the parallel
increase in DAG and ceramide is due to activation of sphingomyelinases or ceramide synthase, with
conversion of ceramide to DAG by sphingomyelin synthase. Since both DAG and ceramide are
known to mediate growth arrest associated with apoptosis, terminal differentiation, and senescence,
the above results suggest that EP3 receptor signaling may be important in epidermal tumorigenesis,
wound healing, and skin aging.
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A Highly Ef®cient Gene Transduction System Using Lentiviral Vectors for Primary
Human Skin Cells
J. Fan, W. Li, N. Kasahara,* C. Mazurek,* D. T. Woodley, and M. Chen
Dermatology, University of Southern California, Los Angeles, California, U.S.A.; *Institute for Genetic
Medicine, University of Southern California, Los Angeles, California, U.S.A.
One of the critical challenges for cellular genetic studies in vitro and gene targeting studies in vivo is
to establish gene delivery systems that offer ef®cient transduction and sustained expression of the
transgenes in target cells. Currently available transfection procedures do not offer satisfactory gene
transduction ef®ciency and sustained transgene expression in primary cells. We carried out a series
of gene delivery experiments with cells in culture and compared the transduction ef®ciencies of
lentivirus-mediated transduction with 5 different DNA-mediated cell transfection methods in
primary human dermal ®broblasts (HDFs) and human keratinocytes (HKs). We found that the
lentivirus-based vectors achieved a much higher transduction ef®ciency (90±95%) than 5 other
transfection methods (3±27%). Further, the expression of transgenes by lentiviral vectors were
sustained. We also compared the effects of a loss-of-function mutant of p38-MAPK (p38) and a
PKC d gene, when they were delivered either by lentiviral infection or LipoFectamine
transfection, on the migration of HDFs and HKs. The dominant negative effect of the kinase-
defective p38 on PDGF-stimulated HDF was clearly detected with lentiviral infection. In contrast,
the dominant negative effect of the same p38 mutant was marginally detectable with
LipoFectamine transfection. Similarly, the inhibition by the kinase-defective PKC d on growth
factor-stimulated HK migration was readily detected when the transgene was expressed by
lentiviral-mediated infection. In contrast, a much smaller effect of the same gene was detected
when Lipofectamine transfection was used. Our study provides evidence that the lentiviral system
enabled clear detection of loss-of-function mutant effects, which were otherwise greatly
compromised when the best transfection technique was used. We conclude that identi®cation
of this gene transduction system for primary human skin cells will greatly bene®t future studies of
human skin diseases in vitro.
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Amphiregulin is an Epidermal Growth Factor Ligand-Associated with Rapidly Growing
Squamous Cell Carcinomas
S. Billings,*² M. D. Southall,* T. Li,* P. Cook,³ A. Hood,*² W. B. Moores,*² D. Spandau,* and
J. B. Travers*
*Dermatology, Indiana University, Indianapolis, Indiana, U.S.A.; ²Pathology, Indiana University,
Indianapolis, Indiana, U.S.A.; ³Dermatology, Cascade Biologicals, Portland, Oregon, U.S.A.
Amphiregulin is a growth factor that is a member of the epidermal growth factor family.
Amphiregulin was ®rst described as an autologous growth factor produced by human keratinocytes
that allow these cells to grow without serum. Though amphiregulin is expressed in primary
cultures of human keratinocytes in vitro, it is not expressed in human epidermis under resting
conditions. However, amphiregulin has been shown to be expressed in conditions associated with
keratinocyte hyperproliferation such as wounded skin or psoriasis. Recent reports have indicated
that amphiregulin is also expressed in squamous cell carcinomas, suggesting that this growth factor
might be involved in autonomous growth seen in epithelial neoplasia. To test this, we used
immunohistochemistry to demonstrate amphiregulin expression in squamous cell carcinomas
(SCC), with the highest levels found in rapidly growing keratoacanthoma type of SCC. To assess
the role of amphiregulin in the proliferation of epithelial cells, we used a retroviral strategy to
overexpress amphiregulin in the keratinocyte-derived cell line HaCaT. Both western- and
northern-blotting con®rmed Amphiregulin overexpression in transduced populations of HaCaT
cells. Overexpression of amphiregulin allowed HaCaT cells (but not HaCaT cells transduced with
a control retrovirus) to grow in serum-free conditions in vitro. Consistent with the ability of
amphiregulin to induce growth in vitro, implantation of HaCaT cells overexpressing amphiregulin
into immunode®cient SCID mice resulted in the rapid growth of large squamous cell carcinomas,
whereas control HaCaT cells formed thin slowly growing tumors. Use of BrdU incorporation
studies con®rmed an increased growth rate of HaCaT cells overexpressing amphiregulin. These
studies suggest that amphiregulin has potential as an important growth factor for epithelial
neoplasia.
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Brain Derived Neurotrophic Factor can Induce Human Hair Growth Regression
(Catagen)
E. M. Peters, M. G. Hansen,* R. W. Overall,* M. Nakamura,* P. Pertile,* B. F. Klapp, P. C.
Arck, and R. Paus*
Charite
Á
Campus Virchow Clinic, Medical School of the Humboldt University, Clinic for Internal Medicine-
Psychosomatics, Berlin, Germany; *Department of Dermatology, University Hospital Eppendorf, Hamburg,
Germany
Neurotrophins such as brain derived neurotrophic factor (BDNF) mediate neuronal cell survival
and sustain neuron development and differentiation. BDNF and its high af®nity receptor tyrosine
kinase B (TrkB) are expressed by peripheral targets such as the hair follicle. In murine hair follicle
cycling, BDNF and TrkB distribution varies hair cycle dependently, and BDNF signalling appears
to play an important role in catagen development However, studies on the role of BDNF/TrkB
signalling in human hair growth control have not been performed date. Here, we present PCR,
immunohistochemical and in situ evidence for BDNF and TrkB expression in human hair follicles.
Human scalp skin anagen VI hair follicles express BDNF and TrkB. BDNF expression was
strongest in the proximal inner root sheath and in the dermal papilla of anagen VI hair follicles.
TrkB-immunoreactivity, in contrast, was strongest in the basal layer of the hair follicle ostium,
positive in the proximal inner and outer root sheath, and negative in the dermal papilla of anagen
VI hair follicles by immunohistochemistry. This distribution suggests mesenchymal-epithelial
cross-talk between the BDNF-excreting dermal papilla and the TrkB + hair matrix. In cultured
human scalp skin anagen hair follicles BDNF signi®cantly decreased hair shaft elongation in a dose
dependent manner over a culture period of 10 days. Histomorphometric analysis showed that hair
follicles treated with BDNF had entered a catagen-like stage, while the majority of control hair
follicles remained in anagen VI. Analysis of TUNEL- (apoptotic cells) and Ki67-immunoreacitivity
(proliferating cells) revealed an increase in apoptosis and decrease in proliferation in hair bulbs
treated with BDNF. These results suggest the existence of complex pilo-neural signalling networks
also within the human hair follicle, where TrkB-mediated-signalling may act as one important
switch between growth and regression.
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Multiple Molecular Pathways Converge on the INK4a Promoter During Keratinocyte
Senescence
M. Cesnjaj, V. Chaturvedi,* J. Qin,* D. Choubey,* B. J. Nickoloff,* and M. Diaz
Medicine, Loyola University, Chicago, Illinois, U.S.A.; *Pathology, Loyola University, Chicago, Illinois,
U.S.A.
Regulation of cellular senescence involving skin-derived cells such as keratinocytes (KCs) is under
investigation because of links to aging and neoplasia. Human KCs undergo senescence, i.e.
irreversible growth arrest, expression of SA-b gal, and enhanced levels of the cyclin dependent
inhibitors (CDKIs) p15, p16 in response to multiple stimuli. To de®ne molecular mechanisms of
senescence, cultured KCs were examined with particular focus on the promoter region of INK4A
regulating the expression of p16, using EMSA and gene reporter assays. In contrast to replicative
senescence, premature senescence can be induced by either: allowing KCs to reach con¯uence; or
exposing noncon¯uent KCs to either TPA or IFN-g. Con¯uence-induced senescence was
characterized by enhanced Ras activity with engagement of MEK/ERK pathway, and increased
binding of Egr1 to DNA sequences in the INK4A promoter. TPA-induced accelerated senescence
also involves MEK activation followed by increased Ets-2 binding to response elements within this
promoter. Gene reporter assays revealed increased p16 promoter activity in KCs overexpressing
Ets-2. IFN-g mediated accelerated senescence had increased Egr protein levels accompanied by
enhanced Egr1 DNA binding at a promoter element. KCs undergoing replicative senescence were
characterized by low Ras and Egr1 levels, but increased Ets-2 DNA binding. These data establish
discrete molecular pathways underlying the KC senescent phenotype. While the different
senescent switches included a shared enhancement in activity of the INK4a locus, the promoter
region activated by speci®c stimuli for premature senescence can involve either Ets-2 or Egr1,
whereas the mechanism mediating replicative senescence involves Ets-2. Since tumor cells bypass
senescence, elucidating mechanisms regulating CDKI expression provides new strategies for
treatment of premature skin aging and cancer.
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B-cellulin is an Autocrine Growth Factor for Human Epidermal Keratinocytes, and its
Auto- and Cross-Induction are Mediated Via the JNK Pathway
Y. Shirakata, S. Tokumaru, K. Yamasaki, K. Sayama, and K. Hashimoto
Dermatology, Ehime University, Ehime, Japan
B-cellulin (BTC) is a member of the EGF family. However, it has not been determined whether
BTC is an autocrine growth factor for human epidermal keratinocytes (NHEK). We investigated
the ability of recombinant BTC to stimulate NHEK proliferation. BTC optimally increased cell
numbers 10-fold at 0.1 ng/ml after a 5-day incubation under subcon¯uent culture conditions. It
also stimulated DNA synthesis under con¯uent conditions. This effect is the same as that of TGF-a
or epiregulin. NHEK expressed BTC mRNA. The addition of BTC (10 ng/ml) up-regulated its
own mRNA at 1 h by 2.5-fold as determined using a multiprobe RNase protection assay (RPA).
The anti-BTC-blocking antibody reduced the DNA synthesis signi®cantly, but only by 10±20%
for a 24- h incubation. These results indicate that BTC is an autocrine growth factor for NHEK.
BTC also up-regulated the levels of HB-EGF mRNA 5.4-fold, TGF-a mRNA 1.6-fold,
amphiregulin mRNA 2.5-fold, and epiregulin mRNA 2.8-fold at 1 h. This indicates that BTC
induces cross-induction of other EGF family growth factors. Next, we investigated the signal
transduction pathways of auto- and cross-induction by BTC. BTC phosphorylated EGFR after
5 min, and induction of BTC was inhibited by the addition of AG1478, an EGFR inhibitor. ERK,
p38, and JNK were phosphorylated by the addition of BTC after 10 min, suggesting the activation
of all three pathways by BTC. NHEK were treated with various signal transduction inhibitors;
then, the induction of EGF family mRNA was examined by RPA. The auto- and cross-induction
of BTC was completely blocked by treatment with curcumin, a natural JNK inhibitor, but not by
p38 or MEK inhibitors. These results demonstrate that the auto- and cross-induction mechanisms
of BTC are mediated by the EGFR and JNK pathways. In conclusion, this is the ®rst report that
BTC is an autocrine growth factor for keratinocytes, and that the auto- and cross-induction
mechanism of the EGF family is mediated by the JNK pathway.
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The p75 Neurotrophin Receptor Mediates Spontaneous and UV-Induced Apoptosis in
Keratinocytes
A. Marconi, M. Pignatti, C. Fila, M. Puviani, A. Giannetti, and C. Pincelli
Dermatology, University of Modena and Reggio Emilia, Modena, Italy
Human keratinocytes express both the high (trkA) and the low-af®nity (p75) nerve growth factor
(NGF) receptors (R). While trkA mediates NGF-induced keratinocyte protection from
spontaneous and ultraviolet (UV)-induced apoptosis, the role of p75 remains to be clari®ed. p75
is a member of the tumor necrosis factor(TNF)-R superfamily and has been shown to be involved
in neuronal cell death. The aim of the present study was to evaluate the role of p75 in keratinocyte
apoptosis. We ®rst transiently transfected human keratinocytes with either wild-type or a mutant
form of p75 cDNA. Both full-length p75 and p75 lacking the `death domain', induced apoptosis in
keratinocytes (19% and 22%, respectively), as compared to either controls (5%) or mock transfected
cells (7%). Addition of trk speci®c inhibitor K252 augmented keratinocyte apoptosis in cells
transfected with both constructs (33% and 40%, respectively), as compared to mock (25%). Brain-
derived neurotrophin factor, which acts through p75 in keratinocytes, increased the rate of
apoptotic cells (9.5% vs. 2.8). In order to support the pro-apoptotic role of p75 and to evaluate the
involvement of p75 in UV-induced apoptosis, keratinocyte derived from p75 knock-out (±/±) and
wild-type (+/+) mice were prepared and both keratinocyte proliferation and apoptosis were
evaluated. Cell yields from keratinocytes derived from p75(±/±) mice were signi®cantly higher
than those from (+/+) animals, as detected by crystal violet staining (O.D. 0.8 6 0.1 vs. 0.3 6 0.07,
p < 0.01). Percentage of keratinocytes undergoing spontaneous apoptosis was signi®cantly higher
in p75(+/+) than in p75(±/±) mice (22% vs. 7%), as detected by TUNEL. Upon UV-B irradiation,
the number of apoptotic cells was higher in p75(+/+) than in p75(±/±) mice (69% vs. 30%).
Moreover, UV-B induced an increased apoptosis in the neuroblastoma cell line SK-N-BE lacking
trk and ectopically expressing p75, as compared to the parental SK-N-BE (59% vs. 19%). Taken
together, these data seem to indicate that p75 mediates keratinocyte apoptosis.
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Survival Effects of Endothelin-1 and a-Melanocyte Stimulating Hormone on UV-
Irradiated Human Melanocytes
Z. A. Abdel-Malek, A. Kadekaro, H. Kanto, E. A. Pereira, R. Kavanagh, and G. A. Scott*
Dermatology, University of Cincinnati, Cincinnati, Ohio, U.S.A.; *Dermatology, University of Rochester,
Rochester, New York, U.S.A.
Survival and maintenance of genetic stability of human melanocytes (MC) is crucial for optimal
cutaneous photoprotection, particularly since those cells have a low proliferation capacity in situ. in
vitro, MC respond to UV-irradiation (75% UVB, 25% UVA) with dose-dependent growth arrest
and apoptosis. Treatment of MC with 0.1 nM endothelin-1 (ET-1) and/or 1 nM a- melanocyte
stimulating hormone (a-MSH) prior to and immediately after UV-irradiation signi®cantly
enhanced their proliferation and survival. ET-1 and a-MSH inhibited the UV-induced reduction
in the levels of Bcl2 and the increase in the levels of Bax. As expected, ET-1 and a-MSH
stimulated melanogenesis, as determined by increased tyrosinase activity. Treatment of MC with
loss of function mutations in the melanocortin 1 receptor with UVR resulted in more extensive
cell death than in MC with comparable melanin content and functional melanocortin 1 receptor.
The cAMP pathway mediates the effects of a-MSH, as they could be mimicked by forskolin. Also,
the survival effects of ET-1 or a-MSH were inhibited by the IP3 kinase inhibitor LY 294002,
suggesting that they be mediated by the IP3 kinase pathway. Our results de®ne a new role for ET-1
and a-MSH as survival factors for MC, in addition to their known mitogenic and melanogenic
effects. Differences in the abilities of MC from different individuals to respond to these two factors
may be an important determinant for susceptibility to UV-induced DNA damage and skin cancer.
Future experiments are aimed at investigating the effects of ET-1 and a-MSH on the extent of
UV-induced DNA damage and the genetic stability of MC.
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Ganglioside GM3 Clustering by Endogenous Accumulation Sequentially Modulates
Tyrosine and Serine Phosphorylation of Caveolin-1 and Prevents EGFR Activation
A. S. Paller, P. Sun, and X. Wang
Dermatology, North-western University Medical School, Chicago, Illinois, U.S.A.
We have shown that GM3, the major ganglioside of keratinocytes, binds directly to the epidermal
growth factor receptor (EGFR), leading to its decreased autophosphorylation and inhibiting
keratinocyte proliferation. We hypothesized that GM3 also inhibits EGFR activity by associating
with caveolin-1 and modulating caevolin-1 tyrosine phosphorylation. We endogenously
accumulated GM3 by treating keratinocyte-derived SCC12 cells with antisense oligodeoxynu-
cleotides of both GD3 synthase (synthesizes GD3 from GM3)and GM2/GD2 synthase (synthesizes
GM2 from GM3). GM3 overexpression was veri®ed by ganglioside ELISA. Confocal microscopy
showed a shift from the baseline homogeneous pericellular distribution to clustering of GM3 with
endogenous overexpression. When EGFR was immunoprecipitated from SCC12 cell membranes
with anti-EGFR antibodies, immunoblots showed both caveolin-1 and GM3. Consistently,
immunoprecipitation with anti-GM3 antibody showed both EGFR and caveolin-1. Tyrosine
phosphorylation of caveolin±1 in association with EGFR was signi®cantly increased in GM3
overexpressors, in comparison with untreated and sense treated SCC12 cells after a 10-min
incubation with 10 nM EGF or 12 nM TGF-a; by 30 min after stimulation tyrosine
phosphorylation was not longer seen. In contrast, serine and not tyrosine phosphorylation was
exclusively seen in caveolin-1 unassociated with the EGFR, and was maximal 30 min after
stimulation. These data show the colocalization of GM3, EGFR and caveolin-1 in SCC12 cells,
particularly with endogenous overexpression of GM3. In addition, the demonstration of increased
early tyrosine phosphorylation of caveolin-1 with overexpression of GM3 suggests a role for
tyrosine phosphorylation of caveolin-1 in GM3-induced suppression of EGFR function.
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Upstream Regulators of Ras Function in Epidermal Cells
T. Cai and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Ras functions downstream of receptor tyrosine kinases (RTKs) important in epidermal growth and
differentiation through adapter proteins such as Shc and Grb2. Recently, additional molecules
involved in RTK signaling have been identi®ed, including Gab1 and Shp2. Gab1 is a docking
protein of the DOS family that binds Grb2 and, upon stimulation by growth factors, associates with
PI3K and the tyrosine phosphatase Shp2. To study factors upstream of Ras in epidermal RTK
signaling, we established that EGF, but not IGF or PDGF, potently activates Ras in primary
keratinocytes, as quantitated biochemically using the active Ras-GTP pull-down assay. EGF-
induced Ras activation was accompanied by tyrosine phosphorylation of Gab1 and blockade of
EGFR kinase activity using the EGFR-speci®c inhibitor PD153035 suppressed both Gab1
phosphorylation and levels of active Ras. A Gab1 mutant de®cient in Shp2 binding inhibited basal
levels of both active Ras and its target MAPK, suggesting that Gab1 functions upstream of Ras in a
Shp2-dependent manner. Consistent with this, Shp2 was found to physically bind to wild-type
tyrosine phosphorylated Gab1 by immunoprecipitation. If Shp2 action downstream of Gab1 is
important for Ras activity then other approaches to inhibit Gab1/Shp2 function should diminish
Ras-GTP levels. In support of this, expression of a dominant-negative Shp2 mutant diminishes
basal levels of active Ras and MAPK in keratinocytes without affecting Gab1 phosphorylation.
Blocking Shp2 function also induces keratinocyte differentiation, similar to effects of Ras
inhibition. To test the function of these two Ras regulators in vivo, we generated human skin from
genetically engineered keratinocytes expressing wild-type and mutant Gab1 and Shp2. Initial
®ndings that disruption of Gab1 and Shp2 function alters epidermal growth and differentiation,
suggesting that Gab1 and Shp2 are important upstream regulators of Ras in epidermis. Our data
thus support a model in which Gab1/Shp2 maintain basal Ras/MAPK activity while the classical
Shc/Grb2 upstream regulators activate Ras during strong RTK stimulation.
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Jun ± N-Terminal Kinases 1 and 2 Mediate the Antagonistic Activity of TNF-a Against
TGF-b-Induced a(2) Type I Collagen Gene (COL1A2) Promoter Transactivation
A. Mauviel, F. Verrecchia, and E. F. Wagner*
INSERM U532, HU
Á
pital Saint-Louis, Paris, France; IMP, University of Vienna, Vienna, Austria
Our aim was to investigate the molecular events underlying the antagonistic activity of TNF-a
against TGF-b-induced a(2) type I collagen gene (COL1A2) promoter transactivation. Transient
transfection experiments using human dermal ®broblasts showed that expression of a dominant
negative mutant form of MAP kinase kinase 4 (MKK4), blocking Jun N-terminal kinase (JNK)
activation, prevented the antagonistic effect of TNF-a against TGF-b, whereas overexpression of a
dominant-negative form of I-kB kinase-a (IKK-a, preventing NF-kB activation by TNF-a, did




®broblasts, in which the
extent of COL1A2 promoter transactivation by TGF-b is comparable to that observed in wild-
type ®broblasts, to examine the speci®c roles played by the Jun N-terminal kinase (JNK)/AP-1 and
NF-kB/Rel pathways in mediating TNF-a inhibitory activity. In a cellular context devoid of JNK
activity (i.e. JNK
±/±
®broblasts), exogenous TNF-a, or ectopically overexpressed c-Jun, did not
inhibit Smad-driven COL1A2 promoter transactivation induced by TGF-b. On the other hand, in
NEMO
±/±
®broblasts, the absence of NF-kB activity did not affect the antagonistic activity of
TNF-a against TGF-b but prevented repression of basal COL1A2 promoter activity by TNF-a.
In the latter cell type, overexpression of an antisense c-jun vector, or that of a dominant-negative
mutant form of MKK4, blocked TNF-a antagonism against TGF-b. Also, overexpression of jnk1
in JNK
±/±
®broblasts restored the ability of TNF-a to block TGF-b effect. In JunAA mouse
embryo ®broblasts, in which c-Jun can no longer be phosphorylated by JNK, JunB substituted for
c-Jun to mediate TNF-a effect, in a JNK-dependent manner. These results provide the ®rst
evidence for a critical role of JNK activation, and resulting phosphorylation of Jun proteins, in
mediating the antagonisitc effect of TNF-a on the up-regulation of type I collagen gene expression
by TGF-b.
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Evidence for Expression of Mu-Opioid Receptors on Human Sebocytes which Mediate
Paracrine and/or Endocrine Actions of b-Endorphin
M. Bo
È
hm, Z. Li, C. Zouboulis,* and T. A. Luger
Department of Dermatology and Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the
Skin, University of MuÈnster, MuÈnster, Germany; *Department of Dermatology, University Medical Center
Benjamin Franklin, Free University of Berlin, Berlin, Germany
There is increasing evidence that the skin is a target for a number of neuropeptides, some of which
also generated by the skin itself. With regard to sebocytes, it is well known from clinical experience
that patients with acne respond to stress with exacerbation. We demonstrate here by RT-PCR and
Western immunoblotting that SZ95 sebocytes, a human immortalized sebaceous gland cell line,
express mu-opioid receptors on the RNA and protein level. The receptor was detected on the
surface of SZ95 sebocytes and was distributed in a punctate staining pattern as shown by
immuno¯uorescence. In contrast to all other cutaneous cell types hitherto examined, SZ95
sebocytes did not express proopiomelanocortin, the precursor for b-endorphin and the latter a
natural ligand for the mu-opioid receptor. However, exogenous treatment of SZ95 sebocytes with
b-endorphin resulted in a dose-dependent rise of intracellular cAMP indicating functionality of the
mu-opioid receptor. In calcium-rich but not in calcium-de®cient medium b-endorphin suppressed
SZ95 sebocyte proliferation induced by epidermal growth factor (EGF). The effect of b-endorphin
on SZ95 sebocyte proliferation was not due to altered phosphorylation of the EGF receptor or the
extracellular signal-regulated kinases 1 and 2, two downstream targets of the EGF receptor and
crucial signal intermediates of proliferative signals. Our data show for the ®rst time that human
sebocytes in vitro express mu-opioid receptors. b-endorphin released from neighbouring cells or
neuroendocrine cells counteracts proliferative signals by EGF and thus may promote a
differentiated state of the sebaceous gland. These ®ndings further form a link between the
cutaneous stress response and the activity of exocrine glands of the skin.
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Srcasm: An Activator of src-Family Tyrosine Kinases Expressed in Differentiating
Keratinocytes
J. T. Seykora, L. Mei, D. Shurman, M. Pulitzer, and P. Stein
J. Seykora, University of Pennsylvania, Philadelphia PA, Pennsylvania, U.S.A.; Department of
Dermatology, University of Pennsylvania, Philadelphia PA, Pennsylvania, U.S.A.
Fyn, a Src-family tyrosine kinase, plays an important role in keratinocyte differentiation. We have
identi®ed Srcasm: Src activating and signaling molecule, as a substrate and activator of Src-family
tyrosine kinases. In this study, we determine how Srcasm activates Fyn and determine that this
activation promotes phosphorylation of exogenous substrates and signaling through Src-family
kinases. By mRNA in situ hybridization, we determine that human Srcasm expression in various
cutaneous disorders correlates with keratinocytes undergoing differentiation. Activated Src-family
kinases are phosphorylated at tyrosine 416. Using in vitro kinase assays coupled with western
blotting to follow phosphorylation at tyrosine 416, we determined that Srcasm contains two motifs
involved in activating Fyn. The Srcasm motif 457pYEEI which engages the Fyn SH2 domain
promotes rapid activation of Fyn, but this activation is dependent on phosphorylation at Y457. The
421PPLP motif which binds to the Fyn SH3 domain weakly activates Fyn, but this activation is not
dependent on phosphorylation. Activation of Fyn by Srcasm promotes phosphorylation of
exogenous substrates. Initial studies demonstrate that Fyn in the presence of Srcasm stimulates
SRE-dependent trancription 15 fold over Fyn alone as measured by luciferase assays. Human
Srcasm is expressed predominantly in the lower stratum spinosum with decreasing amounts near
the stratum granulosum. In psoriatic biopsies and benign keratoses, prominent Srcasm expression
was seen in the stratum spinosum. In squamous cell carcinoma, decreased Srcasm expression was
detected. This study gives support to the hypothesis that Srcasm may play a role in keratinocyte
differentiation by promoting signaling through Src-family kinases.
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A Cyclic Decapeptide that Mimics TNF-a
M. Kosmadaki, D. Goldberg, M. Yaar, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Tumor necrosis factor-a (TNF-a) is a cytokine that modulates multiple biological phenomena
including in¯ammation and apoptosis. In order to determine if TNF-a effects could be mimicked,
cells of keratinocyte origin (SCC 12F) maintained in increasing concentrations of TNF-a (0±
3.5 nM) were subjected to Northern blot analysis. TNF-a induced the expression of IL-1a and
vascular endothelial growth factor (VEGF) in a dose dependent manner to more than 150% and
100% above control levels, respectively. TNF-a exerts its biological effects by binding and
activating two transmembrane receptors: a 55-kDa TNF R1 with Kd 0.02 nM and a 75-kDa TNF
R2 with Kd 0.5 nM. Crystal structure suggests that 15 amino acids mediate TNF±a interaction
with one or both receptors, and that arginine in position 31 is required for binding to both. Hence,
a peptide that expresses one of the TNF-a binding motifs might act as TNF-a receptor agonist.
The peptide QWLNRRAN (TNF-a amino acids 27±34) ¯anked by two cysteines was
synthesized, cyclized and puri®ed by HPLC. Cells were treated with diluent alone or increasing
concentrations of the peptide (2±100 mM) alone, or together with TNF-a (0.57 nM). Northern
blotting showed that TNF-a alone approximately doubled transcript levels for IL-1a, VEGF and
TGF-a, as expected. Interestingly, the peptide mimicked TNF-a, inducing VEGF (62%), IL-1a
(42%) and TGF-a (59%) transcripts above diluent control levels at 10 mM, without further
induction at higher concentrations. Thus, compared to TNF-a, peptide had similar but less
prominent effects, suggesting that for maximal receptor activation interaction at sites other than
amino acids 27±34 on TNF-a is required. Treatment with both TNF-a and the peptide were as
effective as TNF-a alone, as determined by transcript levels. Our data show that a cyclic peptide
expressing amino acids 27±34 of mature TNF-a induces the same genes as native TNF-a and
hence acts as a TNF-a receptor agonist. The data suggest the possibility of designing a small TNF-
a mimetic immunomodulator for application to the skin.
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Fyn Tyrosine Kinase is a Downstream Mediator of Rho/PRK2 Function in Keratinocyte
Cell-Cell Adhesion
E. Calautti, M. Grossi, and G. Dotto
Cutaneous Biology Research Center, Massachusetts General Ho
Ã
pital/Harvard Medical School, Charlestown,
Massachusetts, U.S.A.
The Rho GTPase and Fyn tyrosine kinase have been independently implicated in positive
regulation of keratinocyte cell-cell adhesion. The purpose of this work is to assess whether Rho
and Fyn act independently in this process, or if they are functionally connected. In this study, we
have used primary keratinocytes derived from wild-type and Fyn-de®cient mice for the analysis of
the cell-cell adhesion processes at the cellular and molecular level; we have also used adenoviral
vectors to express in these cells a constitutively active Rho mutant, and the PRK2 serine/threonine
kinase. We show that Rho and Fyn operate along the same signaling pathway. Endogenous Rho
activity increases in differentiating keratinocytes, and is required for Fyn kinase activation and for
increased tyrosine phosphorylation of b-and g-catenin, an event associated with establishment of
keratinocyte cell-cell adhesion. Conversely, expression of constitutive active Rho promotes cell/
cell adhesion through a tyrosine kinase- and Fyn-dependent mechanism, and triggers Fyn kinase
activation, induces tyrosine phosphorylation of b- and g-catenin and p120ctn. The positive effects
of activated Rho on cell/cell adhesion are not induced by an activated Rho mutant with defective
binding to the serine/threonine PRK2/PKN kinases. Endogenous PRK2 kinase activity increases
with keratinocyte differentiation, and increased PRK2 activity, like activated Rho, promotes
keratinocyte cell/cell adhesion and induces tyrosine phosphorylation of b- and g-catenin and Fyn
kinase activation. Thus, these ®ndings reveal a novel role of Fyn as a downstream mediator of Rho
in control of keratinocyte cell/cell adhesion, and implicate the PRK2 kinase, a direct Rho effector,
as a link between Rho and Fyn activation.
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Regulation of CDK4 Expression Levels by TGFb, TNFa, IL-1, NF-kB and Ras
Determines Cellular Proliferative Responses to these Regulators of Epidermal Growth
M. Lazarov, M. Dajee, Y. Kubo, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Precise control of cell cycle progression is necessary for epidermal homeostasis and is most tightly
controlled in G1 phase by regulation of growth-promoting cyclin dependent kinases (CDKs) that
include CDK4. Like other CDKs, CDK4 expression is believed to be stable while the levels of its
cyclin partners oscillate, however, CDK4 protein levels have not been carefully studied in response
to growth regulatory stimuli. In primary human keratinocytes, TGFb, TNFa, IL-1, NF-kB and
oncogenic Ras all led to a rapid decrease in CDK4 protein levels accompanied by growth arrest. In
all cases, CDK4 suppression is both time and dose-dependent. The mechanistic basis for this
observation was explored further with respect to Ras and NF-kB. Northern blotting indicated that
CDK4 protein suppression occurs at the post-transcriptional level and could be blocked by the
proteasome inhibitors lactacystin and PI-I, but not by the caspase inhibitor DEVD-CHO or the
lysosome inhibitor E-64. In primary human keratinocytes, coexpression of CDK4, but not CDK2
or CDK6, bypassed Ras and NF-kB-induced growth arrest in spite of induction of CDK inhibitors
p15INK4B, p16INK4A and p21CIP1, underscoring the functional importance of CDK4
suppression. These ®ndings were also observed in a number of other primary human cell types,
including endothelial cells and melanocytes, indicating that CDK4 degradation may represent a
broadly operative mechanism. Moreover, when expressed with oncogenic Ras in normal human
keratinocytes used to regenerate human skin tissue on immune de®cient mice, CDK4 not only
bypassed Ras-induced growth arrest, but induced invasive neoplasia indistinguishable at the levels
of histology and protein expression from human SCC. Thus, in contrast to the paradigm in which
CDK expression is stable and cyclin levels ¯uctuate, our data indicate that selective CDK4
degradation can determine whether primary human cells will undergo growth arrest or
uncontrolled proliferation in response to signals from dominant growth control pathways.
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Potential Redundancy of MEK Kinase Impacts on Epidermal Growth and
Differentiation
F. Scholl, M. Dajee, J. Charron, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
A number of regulatory cascades exert important effects on epithelial growth and differentiation,
including Ras/Raf/MEK/MAPK. Con®dant assignment of function for elements of this Ras
pathway requires loss of function studies. To address this, we chose to study the two MEK
isoforms, MEK1 and MEK2, which are more than 86% homologous and represent a point in the
pathway with only two potentially redundant isoforms. These proteins are dual speci®city protein
kinases that phosphorylate both regulatory Thr and Tyr residues of the ERK1 and ERK2 MAP
kinases. In an initial effort to examine the effects of MEK blockade on epidermal differentiation,
we incubated normal human keratinocytes in low calcium growth media with MEK inhibitors
U0126 and PD098059. Both inhibitors rapidly led to induction of keratinocyte differentiation
markers, including K1, K10, involucrin and loricrin. This observation suggests that MEK function
is required to suppress induction of epidermal differentiation in cells of the basal layer. Because
concerns about speci®city are a general limitation plaguing pharmacologic loss-of-function studies,
we endeavored to take a genetic approach by analyzing the effects of MEK gene deletion on
epidermal differentiation. MEK2
±/±
mice generated by targeted gene deletion were analyzed for
epidermal differentiation gene expression and epidermal architecture. Of interest, MEK2
±/±
epidermis was indistinguishable from wild-type littermate in terms of epidermal morphology
and expression of differentiation markers. Moreover, MEK2
±/±
skin displayed wound healing
kinetics comparable to MEK2
+/±
and wild-type controls as well as an absence of proliferation
defects in response to stress. These data indicate that MEK genes may be redundant in epidermis.
Because MEK1
±/±
mice are nonviable, dying at E10.5, these ®ndings provide support for efforts to
generate conditional MEK1 disruption in epidermis and MEK1 and MEK2 double knock-outs in
order to surmount potential functional MEK protein redundancy in epidermis.
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Impact of Ras Effectors RalGDS, Akt and Raf on Epidermal Growth and Differentiation
M. Tarutani, M. Dajee, Q. Lin, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Ras proteins exert their pleiotropic effects through 3 major downstream effector cascades that
include the following proteins; (1) Raf/MEK/MAPK (2) RalGDS/Ral (3) PI3K/Akt. Recent
work indicates that Ras contributes to proliferative activity and abnormal differentiation of the
dermis, however, the Ras cascade involved in this effect is unknown. To test the suf®ciency these 3
main Ras effector pathways in mediating Ras effects in epidermis, we expressed key components of
each in transgenic epidermis. Using the K14 promoter, independent lines of mice expressing active
Raf, RalGDS, and Akt were generated. Both Raf and Akt were expressed in inducible form as
hydroxytamoxifen (OHT)-responsive mutant estrogen receptor ligand binding domain C-terminal
fusions. RalGDS was expressed as the constitutively active RalGDS-CAAX mutant. Transgene
expression was con®rmed in multiple independent founder lines for each construct. While K14-
RalGDS-CAAX and K14-Akt:ER mice displayed normal epidermal growth and differentiation as
measured by histologic and immunochemical analysis, K14-Raf:ER mice displayed massive clinical
and histologic hyperplasia in response to OHT. Epidermal hyperplasia was accompanied by
parakeratosis and hyperkeratosis. These data indicate that Ras effects on epidermal growth and
differentiation can be recapitulated by Raf signaling and suggest that the Raf signaling cascade, as
opposed to RalGDS and PI3K/Akt, may serve as the primary downstream cascade mediating Ras
effects in the epidermis.
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Metalloproteinases Stimulate ErbB-Dependent ERK Signaling in Human Skin Organ
Culture
S. Stoll,* S. Kansra,* and J. Elder*²
*Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, U.S.A.; ²Dermatology, Ann
Arbor Veterans Affairs Health System, Ann Arbor, Michigan, U.S.A.
We investigated the mechanism of ERK activation in human skin organ culture, a system that
recapitulates many events of cutaneous wound healing (JCI 100 : 1271±81). Organ cultures were
maintained for 0.5, 2 and 4 h at 37°C in KBM, followed by measurement of ERK phosphorylation
(ERK-p) or mRNA levels. The MEK inhibitor PD98059 (50 mM) produced near-complete
inhibition of ERK-p (97 6 1% at 0.5 h, 98 6 1% at 2 h, and 97 6 1.5% at 4 h, mean 6 SEM, n
> 6). However, inhibition of c-fos, c-jun, HB-EGF and VEGF mRNAs by PD98059 was
incomplete at all time points (range, 41±65% inhibition). After 2 h, the metalloproteinase (MP)
inhibitor BB2516 (20 mM) inhibited ERK-p by 72 6 7%, similar to the inhibition produced by the
pan-ErbB tyrosine kinase inhibitor PD158780 (1 mM) (67 6 9%, n = 6 for each). HB-EGF mRNA
was also inhibited by 56 6 11% in the presence of BB2516 (n = 2) and by 52 6 6% in the presence
of PD158780 (n = 3). At 30 min, PD98059 was signi®cantly more effective than either PD158780
or BB2516 as an inhibitor of c-fos and c-jun mRNA (p < 0.005 by ANOVA). In contrast, these
compounds did not differ signi®cantly as inhibitors of HB-EGF mRNA at 2 and 4 h. Exogenous
EGF (100 ng/ml) abrogated the inhibition of ERK-p caused by BB2516 (n = 4). These data
indicate that MP-mediated proteolytic cleavage of membrane-anchored ErbB ligands plays an
important role in juxtacrine ErbB activation of ERK in wounded skin. They also indicate that
ERK-dependent and independent mechanisms contribute to the induction of gene expression
during skin wounding. Finally, they suggest that ERK is activated by non-ErbB signals at the
earliest times after wounding. As MP-mediated cleavage of the HB-EGF transmembrane precursor
is ERK-dependent (JBC 274 : 28828±35), our data suggest that ERK activation resulting from
initial trauma leads to MP-mediated cleavage of HB-EGF, thereby triggering the ErbB signaling
cascade.
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Human Cutaneous Tissues Express Functional N-Methyl-D-Aspartate Receptors
W. K. Nahm, B. D. Philpot,* E. Badiavas, J. Butmarc, and V. Falanga
Dermatology, Roger Williams Medical Center, Providence, Rhode Island, U.S.A.; *Neuroscience, Brown
University, Providence, Rhode Island, U.S.A.
Glutamate acts as the main mediator of excitatory neurotransmission in the CNS. Recent data
suggest that glutamate also acts as a cell-signaling molecule in the skin. The presence of both
ionotropic and metabotropic glutamate receptors has been observed in cutaneous tissues. One such
ionotropic receptor is the NMDAR, which is strongly expressed in cutaneous tissues. Although
there are high expression levels of NMDARs in normal human skin, the functional and behavioral
activity of this receptor in skin remains unknown. Therefore, we performed immunocytochem-
istry (ICC) using a monoclonal antibody to the NR1 NMDAR subunit in a meshed bioengineered
skin construct (BSC), which is composed of human keratinocytes and ®broblasts, and is able to re-
epithelialize after injury. We also examined the pattern of expression of NR1 with ICC in cultured
keratinocytes grown either to con¯uence or subcon¯uence. Finally, we attempted to determine
whether NMDARs were functional by using whole-cell patch clamp techniques on these cultured
keratinocytes treated with NMDA (NMDAR agonist). Twenty-four hours after injury by
meshing, BSC demonstrated increased NR1 expression in a polarized pattern in migrating
keratinocytes. In cultures, keratinocytes that were sparsely grown expressed no cell surface NR1.
However, con¯uency of cultured keratinocytes promoted NR1 expression on the cell surface.
Bath application of 100 mM NMDA evoked prominent current responses (peak current 150 pA &
duration 1500 ms) in con¯uently grown keratinocytes voltage-clamped at +40 mV. Subcon¯uent
keratinocyte cultures demonstrated no NMDA-evoked current responses. These studies provide
the ®rst direct evidence for the functional activity of NMDARs in human cutaneous tissues and
indicate that the expression of NMDARs can be modulated by use-dependent activity. Our data
also suggest syncytial networks of keratinocytes communicating through paracrine processes may




Epiregulin is More Potent than EGF or TGFa in Promoting In Vitro Wound Closure
Due to Enhanced ERK/MAPK Activation
B. K. Draper,*² T. Komurasaki,§ M. K. Davidson,* and L. B. Nanney²³
*Medicine (Dermatology), Vanderbilt University, Nashville, Tennessee, U.S.A.; ²Cell Biology, Vanderbilt
University, Nashville, Tennessee, U.S.A.; ³Plastic Surgery, Vanderbilt University, Nashville, Tennessee,
U.S.A.; §Molecular Biology Laboratory, Taisho Pharmaceutical Co., Ltd, Saitama, Japan
Epiregulin (EPR) displays 24±50% sequence homology to other EGF family members. EPR has
the broadest speci®city of any EGF-like ligand and activates ErbB1 and ErbB4 homodimers and all
possible heterodimeric ErbB complexes. Our recent experiments indicate that EPR is more potent
and more effective than EGF and TGFa in promoting in vitro wound closure in A431 cells. The
purpose of this study was to determine the signal transduction pathways stimulated by EPR and
compare them to those activated by EGF and TGFa. Growth factor starved, con¯uent A431 cells
were wounded in a standardized manner (scratch assay) and treated for 24 h with either 2 nM EPR,
10 nM EGF or 10 nM TGFa in the presence or absence of mitomycin-c. This mitogenic inhibitor
reduced EPR induced in vitro wound closure by 59%, vs. a nonsigni®cant 9% and 25% decrease in
EGF and TGFa induced closure, respectively. Addition of the ERK/MAPK inhibitor PD-98059
to wounded monolayers treated with EPR led to an 88% decrease in wound closure. By contrast,
the PLC inhibitor U-73122, only reduced the EPR induced response by a nonsigni®cant 21%,
suggesting that the ERK/MAPK pathway plays a greater role in the promotion of EPR induced in
vitro wound closure than the motility-associated PLCg pathway. Immunoblot analysis of A431 cell
lysates for either phosphorylated ERK1/2 or PLCg1 demonstrated that 2 nM EPR stimulated a
greater than 6-fold increase in p-ERK1/2, whereas 10 nM EGF or TGFa stimulated only a
maximal 3- and 2.5-fold increase in pERK1/2, respectively. EPR promoted a 2-fold maximal
increase in p-PLCg1 vs. a 6 fold maximal increase observed with both EGF and TGFa. When
compared with EGF or TGFa, these data demonstrate that EPR is a more potent and more
effective inducer of A431 in vitro wound closure due to its ability to promote signi®cantly greater
ERK/MAPK activation.
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`Dual Signaling' by PDGF-BB and a Collagen Matrix Controls Optimal Human Dermal
Fibroblast Migration
W. Li, J. Fan, M. Chen, N. Kasahara,* and D. T. Woodley
Dermatology and the Norris Cancer Center, University of Southern California, Los Angeles, California,
U.S.A.; *Institute for Genetic Medicine, University of Southern California, Los Angeles, California,
U.S.A.
During wound repair, human dermal ®broblasts (HDFs) proliferate and migrate into the wound
bed in response to newly formed matrix and newly released growth factors, predominantly platelet-
derived growth factor (PDGF). These DUAL signaling processes by extracellular matrix (ECM)
proteins and growth factors regulate optimal migration. The mechanisms, however, are poorly
understood. In this study, we found that PDGF-BB promotes HDF migration on a collagen matrix
as effectively as whole serum. This suggests that the main migration-promoting activity in serum
for HDFs comes from PDGF-BB. More importantly, we provide evidence for the ®rst time that
signaling by a collagen matrix initiates migration while signaling by PDGF-BB further enhances
migration. Furthermore, at the molecular levels, we show that Pak1, ERK, p38-MAPK/SAK, but
not JNK, pathways have distinct functions in PDGF-BB and/or collagen signaling. To block
individual steps of these signaling pathways, we used both speci®c chemical inhibitor and loss-of-
function mutants of the genes. To deliver the mutant genes into HDFs, we used a lentiviral vector
system that produced > 90% gene transduction ef®ciency. Our studies unequivocally showed that
Pak1 and p38-MAPK only participate in the PDGF-BB signaling, whereas ERK is required by
both collagen and PDGF-BB signaling. With regards to the functional relationships of these
kinases, inhibition of Pak1 partially blocked PDGF-BB- and collagen-stimulated ERK activation,
suggesting that ERK acts as one downstream effector of Pak1. However, Pak1 is not an upstream
activator of p38-MAPK. Rather, Pak1 and p38 act as independent pathways in mediating PDGF-
BB and collagen-induced migration. Therefore, this study has uncovered a novel signaling
mechanism, the `dual signaling process', for optimal cell migration, and identi®ed the salient
signaling molecules that participate in either single or both signaling processes.
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Development of a New Chip-Based Technique for Measuring the Lateral Electric Field
Near a Skin Wound
R. Isseroff, E. V. Mukerjee,² S. D. Collins,² R. L. Smith,² and R. Nuccitelli*
Dermatology, University of California, Davis, Davis, California, U.S.A.; *Molecular and Cellular Biology,
University of California, Davis, Davis, California, U.S.A.; ²Electrical and Computer Engineering,
University of California, Davis, Davis, California, U.S.A.
in vivo animal studies have shown that electric ®elds radiate laterally from skin wound sites. In
addition, in vitro testing of keratinocytes has shown that they actively migrate towards the negative
pole in physiological DC electrical ®elds (100±200 mV/mm). Results from human wound studies
are less forthcoming due to the mechanical fragility inherent with standard drawn glass
microelectrodes. A micromachined, chip-based alternative was therefore pursued as a reliable,
repeatable, wound potential measuring device. We fabricated a microneedle array with individually
electrically addressable needle microelectrodes for the measurement of endogenous electric ®elds in
wounded tissue, and have made the ®rst measurements with this device. The microneedles are
150 mm long and 300 mm apart. They are insulated along their length and measure the electrical
potential where the insulation has been removed at platinum-coated tips. Depth of penetration
within the epidermis is monitored by noninvasive in vivo confocal microscopic imaging, and by
electrical impedance measurements. Thus, the needles penetrate the stratum corneum and measure
the voltage within the epidermis. We measure lateral ®elds of 50±250 mV/mm near the edges of
CO 2 laser-induced, volar skin wounds that are 1 mm in diameter. The polarity of these ®elds is
negative at the wound site and positive in all directions leading away from the wound. The
strength of the electric ®eld is reduced as the distance from the wound edge is increased. These
®elds appear immediately upon wounding and persist for more than 10 min after wounding. These
are the ®rst such electric ®eld measurements on human skin wounds and suggest that the lateral
®elds may be important for guiding keratinocytes to migrate toward the wound to effect closure.
435
Adenovirus-Mediated Expression of P450 Epoxygenase Activities Increases In Situ
Transglutaminase Activities in Human Epidermal Keratinocytes
D. S. Keeney*² and P. A. Ladd*²
*Medical Research Service, Department of Veterans Affairs, Nashville, Tennessee, U.S.A.; ²Medicine/
Dermatology & Biochemistry, Vanderbilt University, Nashville, Tennessee, U.S.A.
Epidermal keratinocytes express unique P450 epoxygenases, which generate mainly epoxyeicosa-
trienoic acids from arachidonate. This occurs at the spinous to granular cell transition. The
differentiation-speci®c regulation of this metabolism led us to over-express P450 epoxygenases in
cultured keratinocytes, to identify speci®c roles for their lipid metabolites in the unique cellular
processes occurring in granular cells. We transduced (18 h) normal human epidermal keratinocyte
cultures in growth media containing recombinant adenoviruses encoding P450 BM3v, which
generates 14,15-epoxyeicosatrienoic acid from arachidonate, or b-galactosidase (control virus).
Other cultures were mock transduced (no virus). Cultures were switched to differentiation media
at the time of virus removal (Day 0). Transglutaminase enzyme activities were measured in
keratinocyte lysates, based on incorporation of tritiated putrescine into casein, in vitro. We also
measured in situ transglutaminase activities in living keratinocytes, where regulatory mechanisms
remain intact. A biotinylated pentylamine added to the differentiation medium was taken up by
cultured keratinocytes and cross-linked, via endogenous transglutaminase activities, into cellular
proteins. Cross-linked complexes were visualized by Western blotting using a streptavidin-
peroxidase conjugate. The major biotinylated specie was similar in molecular size to involucrin
immunoreactivity. Increasing transglutaminase enzyme activities were observed with increasing
time in differentiation medium. Keratinocyte cultures expressing P450 BM3v contained more
biotinylated cellular proteins within 96 h, indicative of higher transglutaminase activities in situ,
compared with control virus or mock transduction. These results suggest that P450-derived lipid
epoxides may participate in regulating transglutaminase-mediated cross-linking and corni®ed cell
envelope formation in differentiating keratinocytes.
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Keratinocyte Adherens Junctions Initiate Nuclear Signaling
D. S. Rubenstein, P. Hu, P. Berkowitz, and E. J. O'Keefe
Dermatology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, U.S.A.
Cell-cell adhesion and signaling are thought to be independent functions of b-catenin and
plakoglobin. Because changes in cell-cell adhesion have profound affects on cellular behavior, we
hypothesized a link between the adhesion and signaling functions of b-catenin and plakoglobin. To
investigate the existence of adherens junction mediated signaling, we used peroxovanadate to
tyrosine phosphorylate b-catenin and plakoglobin and to dissociate adherens junctions in
keratinocytes. The distribution of b-catenin and plakoglobin was determined by immun¯uores-
cence and by biochemical subcellular fractionation. 35S pulse chase labeling enabled selective
labeling of junction associated b-catenin and plakoglobin, since nonjunction-associated protein was
rapidly degraded, while junction associated protein persisted. Co-immunoprecipitation studies
from nuclear fractions, gel shift assays, and transient transfections with TCF/LEF optimized
promoter reporter constructs were used to investigate the ability of b-catenin and plakoglobin that
had redistributed from the membrane to nuclear fractions to form functional transcriptional
regulatory complexes with TCF/LEF family member transcription factors. We observed that
tyrosine phosphorylation of b-catenin and plakoglobin results in a rapid translocation of b-catenin
and plakoglobin from the cell membrane to the nucleus. Nuclear fractions showed (i) signi®cant
changes in the ability of b-catenin and plakoglobin to associate with TCF/LEF family member
transcription factors and (ii) down regulation of gene transcription from TCF/LEF reporter
constructs. These results are consistent with a signaling pathway in which plakoglobin released
from the adherens junction translocates to the nucleus where formation of plakoglobin-TCF/LEF
complexes sequesters TCF/LEF proteins from b-catenin. Compared with b-catenin, plakoglobin-
TCF/LEF complexes have low af®nities for DNA; therefore, this sequestration results in decreased
transcription from TCF/LEF optimized promoters. Thus, adherens junction derived plakoglobin
regulates nuclear transcription.
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Insulin-Like Growth Factor 1 Improves Survival of Primary Human Keratinocytes After
UVB-Irradiation by Postponing Apoptosis, Giving the Cell More Time to Repair
Damaged DNA
D. Decraene and M. Garmyn
Dermatology, University of Leuven, Leuven, Belgium
The ability of primary human keratinocytes to survive a genotoxic insult such as UVB-irradiation is
greatly enhanced by the activation of the insulin-like growth factor receptor and subsequently the
AKT kinase pathway. In recent years, this pathway is slowly being unravelled, however, the
underlying mechanism resulting in enhanced survival is largely unknown. The fate of an UVB-
irradiated cell, survival vs. programmed cell death, depends on its capacity to repair UVB-damaged
DNA. We therefore investigated in UVB-irradiated human keratinocytes the effect of insulin-like
growth factor 1 (IGF-1) on survival, repair of cyclobutane thymine dimers and apoptosis. 24 h after
irradiation with 16 mJ/cm
2
UVB, a signi®cant increase (30%) in cell survival was observed in IGF-
1 supplemented cells as opposed to their growth factor deprived counterparts. At this timepoint
IGF-1 supplemented cells had repaired up to 40% of the cyclobutane thymine dimers in contrast to
growth factor deprived cells, which showed no repair of cyclobutane thymine dimers at all. Pre-
treatment of these growth factor deprived cells with a global caspase inhibitor resulted in an equally
pro®cient cyclobutane thymine dimer removal as IGF-1 supplemented cells. A time course for the
induction of apoptosis after UVB-irradiation revealed that apoptosis could be observed as early as
3 h postirradiation in growth factor deprived cells, while IGF-1 supplemented cells displayed a
delay in induction of apoptosis by at least 7 h. These data, together with increased removal of
cyclobutane thymine dimers in growth factor deprived cells when early apoptosis is inhibited,
indicates that IGF-1 supplementation does not inhibit, but merely postpones the induction of
apoptosis. However, this allows for extra time to repair UVB damaged DNA and as a consequence,
survival of human keratinocytes after UVB-irradiation is enhanced.
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Axin Facilitates Smad3 Activation in the Transforming Growth Factor-b Signaling
Pathway
M. Furuhashi,*² M. Kato,² K. Miyazono,² and S. Shimada*
*Dermatology, Yamanashi Medical University, Yamanashi, Japan; ²Biochemistry, The Japanese Foundation
for Cancer Research (JFCR) Cancer Institute, Tokyo, Japan
The Wnt signaling pathway plays important roles in the regulation of cellular proliferation,
differentiation, motility, and morphogenesis in vertebrates and invertebrates. & #65533; @Axin
acts as a negative regulator in Wnt signaling through interacting with various molecules involved in
this pathway, including b-catenin, adenomatous polyposis coli and glycogen synthase kinase-3b.
Transforming growth factor-b (TGF-b) is an also multifunctional protein that regulate various
cellular functions, including proliferation, differentiation, migration, and apoptosis. TGF-b binds
to type II and type I serine/threonine kinase receptors, and transduce intracellular signals by Smad
proteins Smad2 and Smad3 are activated by TGF-b and activin receptors. In order to examine
cross-talk between the signaling pathways of TGF-b and Wnt, we ®rst examined the physical
interaction between Smads and various molecules involved in the Wnt signaling pathway. We
found that Axin directly interacted with Smad3. In the absence of activated TGF-b receptors, Axin
physically interacted with Smad3 through its C-terminal region located between the b-catenin
binding site and Dishevelled homologous domain. An Axin homologue, Axil/conductin, also
interacted with Smad3. In the absence of ligand stimulation, Axin was colocalized with Smad3 in
the cytoplasm in vivo. Upon receptor activation, Smad3 was strongly phosphorylated by TGF-b
type I receptor (TbR-I) in the presence of Axin, and dissociated from TbR-I and Axin. Moreover,
the transcriptional activity of TGF-b was enhanced by Axin, and repressed by an Axin mutant,
which is able to bind to Smad3. Axin may thus function as an adaptor of Smad3, facilitating its
activation by TGF-b receptors for ef®cient TGF-b signaling.
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The b2-Adrenergic Receptor Does Not Transactivate the Epidermal Growth Factor
Receptor in Normal Human Keratinocytes
M. S. Chan, C. E. Pullar, and R. R. Isseroff
Department of Dermatology, School of Medicine, University of California, Davis, Davis, California, U.S.A.
Activation of the epidermal growth factor receptor (EGFR) is required for initiation of growth
stimulatory and pro-migration signals in keratinocytes. Previous investigations have shown that, in
the absence of epidermal growth factor (EGF), the EGFR may be transactivated by activation of
G-protein coupled receptors (GPCRs) such as the b2-adrenergic receptor (b2-AR). However,
these investigations have focused on nonepithelial or immortalized cell lines such as mouse
astrocytes, COS-7 cells, and HaCaTs. Here we have shown that the EGFR in normal human
keratinocytes (NHKs), isolated from human foreskins, is not transactivated upon b2-AR
stimulation with isoproterenol, a b-adrenergic agonist. By immunoblotting with an antiphospho-
tyrosine antibody, we measured the level of EGFR tyrosine phosphorylation in serum-starved
NHKs following 15 minute stimulation with isoproterenol (0.001 pM, 0.1 nM, or 1 mM). Negative
and positive (EGF 10 ng/ml) controls were used for comparison. The tyrosine phosphorylation
level of the EGFR following isoproterenol stimulation was not signi®cantly different from that of
the negative control. A time course experiment was conducted. NHKs were stimulated for 1, 5,
10, 15, or 30 min with 1 mM isoproterenol. The tyrosine phosphorylation level of the EGFR
remained at or below the level of the negative control at all time points. These results suggest that
NHKs are unique in their lack of response to GPCR-mediated transactivation of the EGFR and
warrant further investigation.
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BMP-4 can Induce Keratinocyte Commitment by Inhibition of the Neural
Antiapoptosis Pathway






It has been stated that the differentiation of epidermis requires inductive signals while the
neuralization of the dorsal ectoderm requires only an inhibition of this signaling, interpreted as a
`default' state. BMP4 is a key regulator of this commitment since it can directly induce epidermal
fate and inhibit the formation of neural tissue. Embryonic stem (ES) cell technology is an attractive
model system for studying the initial molecular mechanisms underlying lineage differentiation.
Murine ES cells treated by physiological concentrations of BMP-4 undergo effective keratinocyte
commitment. cDNA microarray technology was used for a search of genes whose steady-state
levels are modulated during the early induction (2 and 10 h) by BMP-4. As con®rmed by Real
Time PCR, 36 genes (0.72%) are substantially variable (2.7±5-fold) in their expression. Among
them, 15 unknown (EST) genes await identi®cation. Interestingly, BMP-4 prominently repress
neural embryonic-speci®c markers, including transmembrane receptors, neural speci®c kinase and
protease, and candidate genes for neural defect diseases. Of particular signi®cance is the ®nding that
genes encoding neural antiapoptotic ligands are rapidly extinguished by BMP-4. BMP-4 activity
has been identi®ed as part of apoptotic mechanisms in many cell types in vitro. Therefore, we
suggest that, as an active inducer of keratinocyte commitment, BMP-4 may interfere with the
survival of neural precursor cells by inhibition of the neural antiapoptosis pathway.
441
Interferon-b Inhibits Cell Cycle Progression of Neuro®broma-Derived Cultured Cells
from Patients with Neuro®bromatosis 1
S. Imakado, T. Maruyama, Y. Kawachi, H. Fujisawa, and F. Otsuka
Dermatology, University of Tsukuba, Tsukuba, Ibaraki, Japan
Neuro®bromatosis 1 (NF1) is an autosomal-dominant inherited disorder, characterized by the
presence of six or more cafe au lait spots, axillary freckles, multiple neuro®bromas and Lisch
nodules. Neuro®broma-derived cultured cells (NF cells) were prepared from surgical specimens of
cutaneous neuro®bromas. Interferon-b (IFNb) signi®cantly inhibited growth of NF cells, when
assayed by the tritium thymidine incorporation method. Immunoblot analyses were performed to
examine effects of IFNb on various cell cycle regulator expressions of those cells. Expression of p21
in NF cells was induced by IFNb earlier than in nontreated cells. Cyclin D1 expression was delayed
by IFNb. IFNb also decreased phosphorylated RB protein. Taken together, IFNb seemed to
inhibit cell cycle progression of NF cells from patients with NF1.
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MAPK and SAPK Phosphorylation of Keratinocytes from Psoriatic Uninvolved Skin
During Accelerated Focal Adhesion Kinase Responses to Fibronectin
G. Chen, K. D. Cooper, S. R. Stevens, and T. S. McCormick
Dermatology, Case Western Reserve University, University Hospitals of Cleveland and the VAMC,
Cleveland, Ohio, U.S.A.
Previously, we have demonstrated that keratinocytes (Kc) isolated from uninvolved psoriatic
epidermis exhibit a rapid (1 h) response to ®bronectin (Fn) characterized by cell spreading and focal
adhesion kinase (FAK) assembly and activation. Because Fn exposure also leads to increased cell
cycle induction in psoriatic Kc, we reasoned that identi®cation of phosphoproteins functioning as
downstream signaling molecules following integrin engagement and FAK formation would be
important to understand mechanisms of psoriatic basal keratinocyte hyperresponsiveness. Baseline
levels of MAPK activity in Kc isolated from psoriatic and normal volunteers, as assessed by
phospho-MAPK Western blotting and densitometry measurement, revealed very similar levels of
phospho-MAPK and phospho-SAPK (relative to total MAPK and SAPK) in psoriatics vs. controls
(n = 6, p > 0.05 for each). Fn stimulation of phospho-MAPK in psoriatic uninvolved Kc was
detectable as early as 10 min postexposure with a mean peak at 60 min and a mean peak increase of
1.45 6 0.2 fold as compared to control. Fn-induced increases in phospho-SAPK showed an
average peak at 30 min and an average peak increase of 2.35 6 1.02 fold as compared to control. Fn
did not induce signi®cant increases in either integrin linked kinase (ILK) nor p38 phosphorylation
in psoriatic uninvolved Kc. Addition of T cell lymphokines enhanced the mean 10 minute MAPK
response in each of three subjects tested. Thus, MAPK and SAPK, but not ILK or P38, appear to
exhibit changes in phosphorylation in psoriatic uninvolved keratinocytes during their accelerated
spreading and FAK responses to Fn, and ultimate cell cycle entry. The involvement of both MAPK
and SAPK is consistent with integrin potentiation of proliferative and stress responses in psoriatic
basal Kc exposed to both Fn and growth factors.
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In Vitro Induction of Apoptosis by a Mixture of Isothiazolinones in Normal Human
Keratinocytes
L. Andreassi, A. Ettorre,* M. Andreassi,² S. Tavanini,* G. Bernini, C. Anselmi,² P. Neri,* and A.
Di Stefano*
Institute of Dermatological Sciences, University of Siena, Siena, Italy; *Department of Molecular Biology,
University of Siena, Siena, Italy; ²Department of Pharmaceutical and Chemical Technology Science,
University of Siena, Siena, Italy
The combination of 5-chloro-2-methyl-4-isothiazolin-3-one (CMI) and 2-methyl-4-isothiazolin-
3-one (MI), in an approximate ratio of 3 : 1, is widely used to preserve cosmetic products. We have
previously shown that CMI/MI induces necrosis and apoptosis in HL60 leukemia cells. The aim of
this study was to investigate whether CMI/MI is able to induce apoptosis or necrosis in human
keratinocytes in vitro. CMI/MI was tested at different concentrations (0.001±0.1%) and at different
times after brief applications (10 min) to human keratinocytes. The effect on cell viability was
monitored by the MTT test and Trypan Blue dye exclusion assay while the induction of apoptosis
was quanti®ed by evaluating both subdiploid DNA content and Annexin-V binding by ¯ow
cytometry. CMI/MI treatment resulted in a dose-dependent decrease of cell viability. The mode
of cell death was dose-dependent: necrosis occurred at high concentrations (0.1%) and apoptosis
occurred at low concentrations (0.05±0.001%). To investigate the role of the Fas/FasL system in
CMI/MI-mediated apoptosis, we evaluated the change in the amount of Fas antigen expression on
the surface of keratinocytes. Our preliminary results show that enhanced Fas expression was
detectable within 3 h of treatment with CMI/MI (0.05%) and within 6 h at a lower concentration
(0.01%). It has been reported that Fas expression on human keratinocytes is dramatically enhanced
in a number of in¯ammatory and infectious skin diseases (such as contact dermatitis and Herpes
virus infection). This new aspect of the in vitro toxicity of CMI/MI will provide important
information about the correlation of in vitro apoptotic activity of chemicals with their in vivo
toxicity: Fas/FasL-mediated apoptosis may play a critical role in the widely described allergic
contact dermatitis reactions to the preservative.
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Enhanced Phosphatidylethanolamine-Binding Protein Expression in Human
Keratinocytes Differentiated by Calcium
T. Yamazaki,*² H. Nakano,* M. Hayakari,² J. Mayama,² and S. Tsuchida²
*Dermatology, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan; ²Second Department of
Biochemistry, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan
Phosphatidylethanolamine-binding protein has been demonstrated to bind to Raf-1 and mitogen-
activated protein kinase kinase (MEK), components of the extracellular signal-regulated protein
kinase (ERK) pathway, and thereby inhibits the pathway, resulting in the suppression of cell
proliferation. In the present study we examined whether PEBP is involved in differentiation
induction of human keratinocytes. PEBP expression was immunohistochemically examined in
normal human skin and skin cancers with different differentiation properties. PEBP is not
expressed in the basal layer of the epidermis but expressed in the spinous and granular layers of
normal skin. The protein is expressed in differentiated carcinoma but not in undifferentiated
carcinoma. By reverse transcription-polymerase chain reaction and immunoblot analyses, PEBP
expression is shown to be enhanced in normal human keratinocytes differentiated by treatment
with a 2.0-mM CaCl2. Transfection of HaCaT keratinocytes with an expression vector and
subsequent immunohistochemical examination have revealed that cells expressing PEBP exhibit
characters of differentiated cells and repressed proliferation. These results suggest that PEBP can
induce differentiation of human keratinocytes and is involved in calcium-induced differentiation of
the cells.
450
The MAPK and JAK3 Signaling Pathways in Mastocytosis
I. Chan, K. Kayashima,* and M. Tharp
Department of Dermatology, Rush-Presbyterian-St. Luke, Chicago, Illinois, U.S.A.; *Department of
Dermatology, Kumamoto University, School of Medicine, Kumamoto, Japan
Stem cell factor (SCF) and its surface receptor Kit are important in the development of human mast
cells, and Kit autoactivation is often associated with mastocytosis. Ras/Raf-1/Mapk (MAPK) and
Jak3/stats (JAK3) are two signaling pathways important in the growth of mastocytosis. Previous
studies from our laboratory have shown that blocking the MAPK signaling pathway with inhibitor
Uo126 (20 mM) and the JAK3 pathway with inhibitor Whi-p131 (20 mM) signi®cantly reduced the
proliferation of the HMC-1 and RMT mast cell lines which express autoactivated KIT. We
investigated further the effect of SCF on these inhibitors and the pathways that they affect. The
addition of SCF (30 ng/ml) to HMC-1 and RMT for 5 days did not increase the proliferation of
these cells, but SCF reversed the Uo126-induced inhibition of the MAPK pathway and restored
the proliferation of HMC-1 and RMT cells to the level of controls. In contrast, SCF did not rescue
the JAK3 inhibitor Whi-p131-induced growth reduction of HMC-1 and RMT cells. No further
decrease of mastocytosis mast cell proliferation was observed when these cells were cultured with
both inhibitors. To examine the effects of these inhibitors on other normal skin cells, Uo126 and
Whi-p131 were added to cultures of human ®broblasts (HF) and human skin mast cells (HSMCs)
for 5 days. Neither Uo126 (20 mM) nor Whi-p131 (20 mM) signi®cantly affected the growth of
these normal cells. These results demonstrate that JAK3 is a predominant signaling pathway for
mastocytosis mast cell growth. Uo126 and Whi-p131 appear to have little effect on normal cells,
since these MAPK and JAK3 pathway inhibitors does not affect their growth. We concluded from
these studies that inhibitors of the JAK3 and MAPK pathways may be useful for treatment of
mastocytosis.
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Identi®cation of a Functional PPAR-g System in Human Epidermal Cells
S. Mezsick,*² Y. Pei,* Q. Yi,* J. B. Travers,*² and M. D. Southall*²
*Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.; ²Pediatrics and HB
Wells Center, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.
Human epidermal cells play an important role in cutaneous in¯ammatory response. Recently the
peroxisome proliferator-activated receptor (PPAR) has been shown to have effects on
in¯ammatory responses in various cell types. We sought to determine whether epidermal cells
express PPARs and whether PPAR agonists could modulate COX-2 expression. Using RT-PCR
and immunoblotting we report that human keratinocytes and various human keratinocyte and
epidermoid cell lines including HaCaT, KB and A431 express PPARg. Using a PPAR-gene
reporter assay, exposure to the PPARg agonist, ciglitazaone, was found to result in a dose-
dependent increase in luciferase activity, indicating that epidermal PPARg is functional. To
determine the effects of PPAR activation, cultures of human epidermal (KB) cells were exposed to
PPARa and PPARg agonists, and COX-2 expression was examined. Ciglitazone, a PPAR g
agonist, did not directly induce COX-2 expression, but instead induced a two to threefold increase
in the platelet-activating factor, PMA and IL-1B stimulated expression of COX-2. Exposure to the
PPARa agonist, WY-14 643 did not effect COX-2 expression. To address whether the effects of
ciglitazone on COX-2 expression were mediated by PPARg, KB cells were transfected with a
dominant negative PPARg. Consistent with our hypothesis on the role of PPARg, the ciglitazone-
induced PPAR luciferase activity and the actions of ciglitazone on COX-2 were abolished in KB
cells with the dominant negative PPARg. These results establish that PPARs are present in human
epidermal cells and play role in the modulation of in¯ammatory responses. Furthermore, these
results suggest that PPAR antagonists could be therapeutically useful agents in treating
in¯ammatory diseases of the skin.
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Flavonoids Inhibit Epidermal Growth Factor-Induced Cell Proliferation and Signal
Transduction Through the MAPK Pathway
S. Shen,*² Y. Chen,³ C. Hsiao,§ C. Hu,*² and W. Lee§¶
*Dermatology, Taipei Medical University, Taipei, Taiwan; ²Dermatology, Taipei Municipal Wan-Fang
Hospital, Taipei, Taiwan; ³Graduate Institute of Pharmacognosy Science, Taipei Medical University,
Taipei, Taiwan; §Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan; ¶Dermatology,
Taipei Medical University Hospital, Taipei, Taiwan
Epidermal growth factor (EGF) is a major mitogen for dermal ®broblasts. EGF mediated receptor
tyrosine phosphorylation is a primary indicator of signal transduction regulating cell growth and
proliferation. In this study, we found EGF induced signi®cant proliferative effects in epidermal
carcinoma cells A431 and EGF receptors (EGFR) was time-dependently phosphorylated in the
presence of EGF (10 ng/ml) in the culture medium. We investigated the inhibitory effects of eight
structure related ¯avanones including 2°¶-OH ¯avanone, 4°¶-OH ¯avanone, 6-OH ¯avanone, 7-
OH ¯avanone, narigenin, naringin, and taxifolin on EGF-induced signaling transduction and
proliferation. PD98059, a MEK inhibitor, attenuated EGF- induced COX-2 protein expression,
but do not affect the EGF- induced EGFR phosphorylated status. These results indicated that the
phosphorylation of EGFR is located upstream of MAPK activation site, and the induction site of
COX-2 protein is located downstream of MAPK activation site in EGF- induced signaling
transduction. We concluded that inhibitory effects of structurally related ¯avonoids on EGF-
induced cellular proliferation is through inhibition of mitogen- activated protein kinases.
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Down-Regulation and Degradation of Protein Kinase C Isoforms a and e Via the
Ubiquitin Proteasome Pathway in Human Keratinocytes
A. T. Sirajuddin and P. J. Sperry
Biological Sciences, California State Polytechnic University, Pomona, California, U.S.A.
Protein kinase C (PKC) regulates cell growth and differentiation in keratinocytes. PKC activated
by phorbol esters and diacylglycerol translocates to the membrane, phosphorylates substrates that
control cell growth and proliferation, and is then down-regulated to terminate its activity. Previous
studies have implicated calpain in the down-regulation of PKC in keratinocytes, but recent studies
in other cell types have shown that PKC is down-regulated and degraded by the ubiquitin
proteasome pathway. In order to examine the mechanism of PKC down-regulation and
degradation, cultured quiescent adult human keratinocytes were treated with varying concentra-
tions (50, 100, 200 nM) of tetradecanoyl phorbol 13-acetate (TPA) with and without proteasome
inhibitors Lactacystin and MG132, for 5 min and 18 h. Cytosolic and membrane proteins were
separated by SDS-PAGE and transferred to PVDF membranes by electroblotting. PKC down-
regulation was detected using antibodies speci®c for PKC isozymes a and e. Ubiquitination of
PKC was detected by immunoprecipitating cytosolic and membrane proteins with PKC
antibodies, separating these proteins by SDS-PAGE, transferring the proteins to PVDF membranes
and using ubiquitin antibodies. Acute treatment (5 min) of keratinocytes with TPA induced
translocation of PKC a and e from the cytosol to the membrane and chronic treatment (18 h)
down regulated PKC a and e. Lactacystin and MG132 prevented the down-regulation of PKC
from the membrane. Ubiquitination of PKC was detected by 5 min in TPA treated keratinocytes,
but was absent in 18 h TPA treated keratinocytes. These results suggest that TPA causes activation
and translocation of PKC a and e to the membrane. Upon activation, these isozymes become
ubiquitinated and are subsequently down regulated and degraded by the proteasome, indicating the
involvement of the ubiquitin proteasome pathway in PKC signaling in keratinocytes.
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Differing Effects of KGF and EGF on UVB-Induced Apoptosis and Signaling Pathways
in Keratinocytes
K. L. Hamacher and M. R. Pittelkow
Dermatology, Mayo Clinic/Foundation, Rochester, Minnesota, U.S.A.
Keratinocyte growth factor (KGF/FGF-7) has been implicated in a variety of epithelial functions,
including proliferation, differentiation and wound healing. KGF has been reported to protect
against chemotherapy-induced alopecia, postradiation therapy mucositis and graft vs. host disease.
The precise mechanisms of activity remain to be elucidated. This laboratory has previously
reported that KGF exerts effects primarily on well-differentiating keratinocyte cultures. We have
also shown its protective effects on keratinocyte proliferation in culture following UVB-radiation.
In these studies, we analyzed effects of KGF and EGF on apoptosis and survival of proliferating and
differentiating keratinocyte cultures following UVB-exposure. Speci®c cell-signaling pathways
mediating EGF and KGF responses were also examined. KGF signi®cantly inhibited UVB-
mediated apoptosis in differentiating keratinocytes compared to EGF. Increasing exposure to UVB
had no additive effect on either apoptosis or survival of proliferating keratinocytes, implicating a
self-protective mechanism. KGF receptor stimulation was minimally detected in well-
differentiated human keratinocytes. KGF induced signi®cantly lower levels of p70S6 kinase
phosphorylation than equimolar EGF in proliferating keratinocytes. Interestingly, con¯uent,
differentiating keratinocytes show no detectable phosphorylation following KGF treatment. KGF
induced MAPK phosphorylation, but less than EGF. This data demonstrates that KGF inhibits
UVB-induced apoptosis in human keratinocytes and mediates its effects differentially from EGF.
These ®ndings are relevant in diseases such as psoriasis, photodermatoses and following acute solar
injury. In psoriasis, the expression of KGF and its receptor is signi®cantly altered. In
photodermatoses and acute solar injury, KGF or pharmacomimetic agents may minimize
keratinocyte injury and death following more severe ultraviolet radiation-induced insults.
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Fli-1 is a Speci®c Negative Regulator of Collagen Biosynthesis in Dermal Fibroblasts
M. Kubo, J. Czuwara-Ladykowska, H. Gardner,* D. K. Watson, and M. Trojanowska
Rheumatology and immunology, Laboratory of Cancer Genomics, Medical Univesity of South Carolina,
Charleston, South Carolina, U.S.A.; *Biogen, Inc., Cambridge, Massachusetts, U.S.A.
Fli-1, a member of the Ets family of transcription factors, has been previously implicated in
collagen gene regulation (JBC 276 : 20839±20848, 2001). The goal of this study was to gain further
insights into Fli-1 function in dermal ®broblasts. For these studies, an adenoviral vector expressing
Fli-1 was generated to allow ef®cient gene delivery into human dermal ®broblasts. To measure
collagenous proteins secreted into conditioned medium from ®broblasts labeled with 3H-proline,
SDS PAGE and autoradiography were used. To measure collagen type I protein in total cell lysates
obtained from cells and deposited extracellular matrix (cell/matrix layer), Western blot was used.
The protein levels of heat shock protein 47 (HSP 47), prolyl-4-hydroxylase a, protein disul®de
isomerase (PDI), and b-actin (loading control) in total cell lysates were determined by Western
blot. Immunohistochemistry was used to investigate in vivo expression of Fli-1. Adenoviral delivery
of Fli-1 in human ®broblasts demonstrated that Fli-1 strongly suppressed basal and TGF-b induced
secretion of collagenous proteins. Fli-1 also signi®cantly inhibited collagen deposition into cell/
matrix layers. Furthermore Fli-1 suppressed synthesis of the other components of the collagen
biosynthetic pathway such as PDI and HSP 47. in vivo expression of Fli-1 has been detected in a
subset of ®broblasts and endothelial cells in healthy human skin. Fli-1 was predominantly localized
to the nuclei in both endothelial cells and ®broblasts. Fibroblasts also stained positively for Fli-1 in
mouse skin, with both nuclear and cytoplasmic staining detected. Together, these studies strongly
suggest that Fli-1 is a speci®c negative regulator of collagen biosynthetic pathway in dermal
®broblasts in vitro and may also be involved in regulation of collagen synthesis in vivo.
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Activation of Heat Shock Protein Expression by Serine Protease Inhibitors
E. Goyarts, D. Gan, M. Matsui, T. Mammone, K. Marenus, and D. Maes
BRD, Estee Lauder Companies, Melville, New York, U.S.A.
Heat shock proteins confer protection against many forms of cellular stress and tissue injury. The
mechanism by which heat shock protein synthesis is regulated is largely unknown. However, serine
protease inhibitors have been shown to up-regulate the heat shock transcription factor 1 in Jurkat T
cells (J. Biol. Chem. 273 : 16446). We investigated the effect of serine protease inhibitors on
modulating the levels of Hsp70 mRNA and Hsp70 protein in keratinocytes. A dose-dependent
increase in Hsp70 mRNA levels was observed when NHEKs were treated for 18 h with the serine
protease inhibitor, 3,4 dichloroisocoumarin (DCIC). A 22-fold increase in Hsp70 mRNA levels
was measured after treating NHEKs with 20 mM DCIC. We observed a dose-dependent increase
in Hsp70 mRNA levels after treating NHEKs for 18±24 h with betulinic acid. A 17-fold increase
in Hsp70 mRNA levels was observed with 25 mg/ml betulinic acid. Keratinocytes treated for 21 h
with ursolic-oleanolic acid did not up-regulate Hsp70 transcripts. Aprotinin, a broad-spectrum
serine protease inhibitor used at 100 nM and leupeptin, a reversible inhibitor of trypsin-like
proteases and cysteine proteases used at 100 mM, did not up-regulate Hsp70 mRNA levels after
22 h. It may be possible that higher concentrations of these inhibitors are necessary for an
observable effect. Protease inhibitors also modulated the level of Hsp70 protein. A dose-dependent
increase in Hsp70 protein levels was observed after treating keratinocytes with betulinic acid for
24 h. A 23-fold increase in Hsp70 protein was observed at 25 mg/ml. NHEKs treated with ursolic-
oleanolic acid increased Hsp70 protein levels in a dose-dependent manner without affecting
mRNA levels. A 4-fold increase in Hsp70 protein levels was observed with 20 mg/ml ursolic-
oleanolic acid. These observations suggest that exogenous addition of serine protease inhibitors
may be used to increase the levels of heat shock proteins and heat shock mRNAs. In addition, the
data indicate that different classes of protease inhibitors exert their effects by different mechanisms.
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Secretory Leukocyte Protease Inhibitor Expression in Cultured Keratinocytes
J. Lai and M. R. Pittelkow
Dermatology, Mayo Clinic, Rochester, Minnesota, U.S.A.
Chronic wounds are a major health care problem, particularly with increasing geriatric population
and prevalence of diabetes. Chronic wounds develop when the orderly wound healing cascade is
disrupted. Many novel factors have been studied for potential roles in chronic wound healing.
Secretory leukocyte protease inhibitor (SLPI) is constitutively expressed in epithelial cells and has
antimicrobial activities. We hypothesized that SLPI expression correlates with mitotic state and
differentiation of keratinocytes. Normal keratinocytes were isolated from neonatal foreskin. When
cultures reached 80% and 100% con¯uency, growth factors including epidermal growth factor
(EGF) were removed. One day later, EGF was added to half of the culture plates and total RNA
was extracted 24 h later. Cells were also seeded at 80% con¯uence and medium was changed every
48 h. At con¯uence, RNA was extracted and served as control. Thereafter, RNA was harvested
every other day for 8 days. A set of primers and a competitor were designed to enumerate the copy
numbers of SLPI mRNA by quantitative competitive RT-PCR. Following RT-PCR, the target
and competitor products were analyzed by capillary electrophoresis, and the amount of SLPI was
calculated by means of a regression equation. Subcon¯uent keratinocytes without EGF contained
152 copies of SLPI mRNA per nanogram (ng) of total RNA, and 937 copies/ng with EGF.
Con¯uent keratinocytes without EGF contained 30 328 copies/ng and 41 865 copies/ng with
EGF. Also, SLPI expression increased until 4 days following con¯uence and then decreased. QC-
RT-PCR has been shown to be a sensitive and accurate assay to quantify gene expression and
demonstrates that EGF enhances SLPI expression. However, SLPI expression continued to
increase in early postcon¯uent cultures, possibly due to autocrine growth factor expression. This
quantitative assay will allow the study of SLPI expression in normal and chronic wounds and
examination of the therapeutic potential of SLPI in chronic wound healing. Further investigation is
underway to characterize the regulatory events in SLPI expression.
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Pathways of Signal Transduction in Anergic CD4+ T Cells Induced by IL-10-Treated
Human Dendritic Cells
S. Kubsch, S. Ludwig,* E. Graulich, J. Knop, and K. Steinbrink
Department of Dermatology, University of Mainz, Mainz, Germany; *Institut fuÈr Medizinische
Strahlenkunde und Zellforschung, University of WuÈrzburg, WuÈrzburg, Germany
Previous results demonstrated that human IL-10-treated dendritic cells (DC) induce a state of
antigen-speci®c anergy in various populations of naive and activated CD4+ T lymphocytes.
Anergic T cells are characterized by reduced production of IL-2 and an G1 cell cycle arrest. In this
study we investigated signal transduction pathways of the anergic T cells. After restimulation with
immobilized anti-CD3Ab lysates of anergic and control T cell (stimulated with mature DC) were
prepared. Subsequently, immunoprecipitation, SDS gel electropherisis, Western blot analysis and in
vitro kinase assays were performed. We observed an inhibited TCR-induced activity of CD3-zeta-
chain and an enhanced expression and phosphorylation of the Src kinase p59fyn in anergic T cells
as compared to control T cells. Furthermore, in vitro kinase assays revealed a markedly reduced
activity of the MAP kinases JNK1/2 and ERK1/2. These results con®rmed data obtained in other
models of anergy induction, e.g. using altered peptides ligands or activation of T cells without
costimulation. Additionally, we performed experiments analysing the Src kinase p56lck, which is
involved in positive and negative regulation of T cells In our model of anergy induction an
increased expression and phosphorylation of the Src kinase p56lck was observed. Furthermore,
Western blot analysis and in-vitro-kinase-assays of the MAP kinase p38 demonstrated a markedly
enhanced and sustained activity after restimulation. Our results demonstrated two new mechanisms
of signal transduction pathways in anergic T cells. Further investigations will be performed
analyzing whether these activation processes directly inhibit the signal transduction or induce the
production of negativ regulating molecules.
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Involvement of the erbB Receptor Family in Ultraviolet-B Radiation-Induced
Apoptosis
D. Lewis* and D. Spandau*²
*Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.; ²Biochemistry &
Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.
Exposure of human keratinocytes to ultraviolet B (UVB) light leads to the activation of a variety of
cell-surface receptors; however, the biologic consequences of these activated receptors are still
unclear. We sought to determine the role of erbB receptor tyrosine kinases in human keratinocytes
following UVB irradiation. Currently, there are four members of the erbB receptor family; erbB1
(commonly called the EGF-R), erbB2 (also called neu), erbB3, and erbB4. Human keratinocytes
express the erbB1, erbB2, and erbB3 receptors. The biologic effect of UVB-dependent activation
of these receptors was examined using speci®c inhibitors of the erbB1 (AG 1478) and erbB2 (AG
825) tyrosine kinases. The role of erbB3 was not examined due to its weak intrinsic tyrosine kinase
activity. An inhibitor of the PDGF-R (AG 1295) was used as a control. Normal primary human
keratinocytes were exposed to apoptotic doses of UVB and immediately treated with various
concentrations of one of the tyrosine kinase inhibitors. Fifteen hours following UVB-irradiation,
the keratinocytes were examined for morphologic signs of apoptosis. Keratinocytes were then
harvested and cell lysates were assayed for the activation of the pro-apoptotic enzyme, caspase 3.
Inhibition of either erbB1 or erbB2 independently did not signi®cantly in¯uence UVB-induced
apoptosis at low concentrations of the inhibitors. However, if keratinocytes were treated with a
combination of both erbB1 and erbB2 inhibitors at low concentrations, UVB-induced apoptosis
was signi®cantly reduced. Inhibition of UVB-induced apoptosis was also observed when an
inhibitor of both erbB1 and erbB2 tyrosine kinases (DAPH) was used. AG 1295 did not in¯uence
UVB-induced apoptosis. These data imply that abrogation of erbB1 and erbB2 signaling results in
the inhibition of UVB-induced apoptosis in human keratinocytes.
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Identi®cation of a Novel Phosphorylation Site in the Cyclin-Dependent Kinase Inhibitor
p27Kip1 that Modulates its Stability in Keratinocytes
B. L. Harvat, P. K. Noldner, J. A. MacDonald, T. Haystead, and A. R. Means
Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, U.S.A.
The cdk inhibitor p27Kip1 promotes withdrawal from the cell cycle and helps maintain growth
arrest in terminally differentiated cells. Conversely, p27 levels must decrease during late G1 in
order for S phase entry to occur. p27 levels increase in normal human epidermal keratinocytes
(NHEK) during the irreversible growth arrest that accompanies squamous differentiation, while
low levels of p27 are independently prognostic for a variety of squamous cell carcinomas. These
®ndings implicate p27 as a critical regulator of keratinocyte proliferation and argue the importance
of understanding the mechanisms by which p27 levels are regulated in keratinocytes. Calcium in
the medium of cultured NHEK has a biphasic effect, with low levels being required for robust
proliferation while higher levels initiate terminal differentiation. p27 levels in NHEK are
modulated by ionomycin treatment, which raises intracellular calcium. This study is investigating
whether calcium signals transmitted by calmodulin, a major calcium-responsive effector in cells,
modulate p27 levels in NHEK. We have discovered that human p27 is phosphorylated in vitro by
calmodulin-dependent kinases (CaMK). Mapping of the phosphorylation sites has identi®ed
Thr157 as one target. Mutation of Thr157 to Ala dramatically stabilizes the protein in vivo and
cooperates synergistically with another known phosphorylation mutant, Ser10Ala, which has been
shown to prevent p27 export to the cytosol during late G1. Most dramatically, slower migrating,
ubiquitinated forms of the double mutant of p27 can be easily detected in the absence of treatment
with proteasome inhibitors. We conclude that phosphorylation of p27 on T157 promotes its
down-regulation. Consistent with this interpretation, treatment of NHEK with KN-93, an
inhibitor of the CaMKs, causes an increase in p27 levels. CaMK-mediated phosphorylation of p27
may be part of the signaling pathway by which low levels of calcium in the medium promote cell
cycle progression in keratinocytes.
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VLA-5 Modulates CD28/CD3-Stimulated T Cell Activation: A View into the
Mechanism of UV-Induced T Cell Tolerance
A. R. Swick, Z. Ouyang, T. S. McCormick, and S. R. Stevens*
Dermatology, Case Western Reserve University, Cleveland, Ohio, U.S.A.; *Dermatology, CWRU, UH
Hosp, VA Hosp, Cleveland, Ohio, U.S.A.
We previously showed, in humans, that the activation of CD4+ T-cell (TC) by tolergenic
macrophages that in®ltrate UV-exposed skin (UV-Mph) differs from activation by Langerhans cells
(LC); including de®cient expression of IL2 receptor a chain (CD25), induction of type 2
cytokines, and distinct costimulatory molecule and growth factor use. Relative to LC, UV-Mph
are de®cient in the expression of B7-1 and 2. However UV Mph stimulate T-cells through a5
integrin (CD49e), whereas LC do not. We now explore whether integrin triggering may
compensate for reduced CD28 signaling and in¯uence TC activation by UV-Mph. TC were
obtained by negative selection from PBMC. For antibody stimulation assays, 10(5) cells were
added in triplicate to 96 wells plates with or without precoating of combinations of anti-CD28 (0±
20 mg/ml) and anti-CD49e (0±20 mg/ml). All wells were coated with 0.25 mg/ml anti-CD3, which
doesn't cause proliferation without costimulus. At all concentrations of anti-CD28 Ab tested, anti-
CD49e at concentrations < 3 mg/ml increased TC proliferation while > 5 mg/ml of anti-CD49e
caused inhibition. For example, low level (3 mg/ml) anti-CD28 and anti-CD3 yields minimal
proliferation (3201 6 126 dpm). Adding 1 mg/ml anti-CD49e AB to the plate coating mix raises
proliferation (146084 6 9351 dpm) (n = 3,p > 0.00001). Because this combination of anti49e, anti-
CD3 and anti-CD28 resulted in a near equivalent proliferation as anti-CD3 and CD28 (20 mg/ml)
(163437 6 46884 dpm), we chose these two triggering conditions to model UV-Mph and LC,
respectively. To examine the state of differentiation of responding TC, we examined the
expression of CD25 by ¯ow cytometry by modelling T-cell activation by either UV-Mph or LC
Ag presentation. CD25 expression was decreased by 30% in the UV-Mph model of T-cell
activation, relative to the LC model. These observations suggest that a 5 integrin signals can
compensate for the de®cient B7 expression and promote CD25 de®cient T-cell activation such as
that induced by tolergenic UV-Mph.
462
Negative Regulation of Cell Growth and Differentiation by TSG101 Through
Association with p21Cip1/WAF1
C. Mammucari, H. Oh, A. Nenci, S. Cabodi, S. N. Cohen,* and G. Dotto
Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School,
Charlestown, Massachusetts, U.S.A.; *Department of Genetics, Stanford University School of Medicine,
Stanford, California, U.S.A.
TSG101was discovered in a screen for tumor susceptibility genes and has since been shown to have
a multiplicity of biological effects. However, the basis for TSG101¢s ability to regulate cell growth
has not been elucidated. We report here that the TSG101 protein binds to the cyclin/CDK
inhibitor (CKI) p21Cip1/Waf1 and increases stability of the p21 protein in HEK293F cells and
differentiating primary keratinocytes, suppressing differentiation in a p21-dependent manner. In
proliferating keratinocytes where the p21 protein is relatively stable, Tsg101 does not affect the
stability or expression of p21, but is recruited to cyclin/CDK complexes, inhibits cyclin/CDK
activity, and causes strong growth suppression in a p21-dependent manner. Conversely,
suppression of endogenous TSG101 expression by an antisense TSG101 cDNA causes doubling
of the fraction of keratinocytes in the S phase of the cell cycle similar to p21 de®ciency. Our results
indicate that TSG101 has a direct role in the control of growth and differentiation in primary
epithelial cells, and that p21 is an important mediator of these TSG101 functions.
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Activation of Erk1/2 by TGFb in the Absence of a Functional TGFb Type I Receptor
A. B. Glick, M. Cooley, and E. Bhogte
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda,
Maryland, U.S.A.
Transforming growth factor b1 (TGFb1) activates gene expression and inhibits cell proliferation by
engaging the intracellular Smad signaling pathway. However, by unknown mechanisms, TGFb1
also activates non-Smad signaling pathways such as MAPK and AKT that regulate gene expression,
growth control and cell phenotype. In primary mouse keratinocytes and neoplastic keratinocyte
cell lines, TGFb1 induced phosphorylation of Erk1/2 and AKT within 10 min. As expected,
TGFb caused rapid phosphorylation of Smad2. To test if the TbRI (type I receptor) was required
for Erk activation, the CCL64 epithelial cell line and its TbR1 defective mutant clone R1B, were
treated with TGFb1. Surprisingly, TGFb1 caused a high level of Erk1/2 phosphorylation in the
R1B line even though phosphorylation of Smad2 was completely blocked. Activation of Erk was
signi®cantly higher in the R1B mutant cell line than the wildtype CCL64 cells, suggesting that the
presence of a functional TbRI partially blocked TGFb1 activation of this signaling pathway. As a
further test for the role of intact TGFb receptor signaling in activation of these pathways we
infected keratinocytes with an adenovirus expressing a truncated TbRII receptor (AdTGFbTR)
which acts as a dominant negative inhibitor of TGFb signaling. Surprisingly, by itself the truncated
TbRII caused sustained phosphorylation of erk1/2 and AKT in a time and dose dependent
manner, even though it acted as expected to block Smad2 phosphorylation by TGFb1.
Pretreatment of keratinocytes with the MEK inhibitor UO126, or the PI3-kinase inhibitor
wortmannin blocked phosphorylation of Erk and AKT, respectively, indicating that these upstream
signaling molecules are activated by the truncated receptor. This suggests that the truncated TbRII
is acting as an antagonist for Smad signaling but as an agonist for non-Smad signaling. Taken
together these data imply that activation of non-Smad signalling pathways by TGFb1 occurs by a
mechanism distinct from the well characterized activation of R-Smads by the heterodimeric TGFb
receptor complex.
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Prolonged Con¯uency of Normal Keratinocytes Triggers Irreversible Growth Arrest
Resembling Senescence
M. F. Denning, V. Chaturvedi, S. Tibudan, P. Bacon, J. Qin, and B. J. Nickoloff
Pathology, Loyola University, Chicago, Illinois, U.S.A.
When keratinocytes (KCs) in normal human skin exit the proliferative compartment in the basal
layer they enter a postmitotic growth arrested state until corni®cation. The molecular basis by
which this growth-arrested state is initiated or sustained is poorly understood. To understand
irreversible growth arrest, ®rst or second passage neonatal foreskin derived KCs were grown in
KGM and allowed to become con¯uent for either 1±3, or 4±7 days. While KCs that were
con¯uent for 1±3 days (early con¯uent) could be re-plated at low cell density and re-initiate a
robust proliferative response, KC cultures con¯uent for 4±7 days (late con¯uent) were unable to
proliferate after re-plating. Many KCs in late con¯uent cultures became enlarged with vacuoles
resembling KCs that have undergone replicative senescence. Addition of protein kinase C (PKC)
inhibitor (GF109203X) enhanced by greater than 10 fold the plating ef®ciency of late con¯uent
KCs. Western blot analysis of KCs from con¯uent and senescent cultures revealed many
similarities. In proliferating KCs there were low levels of p16, p14ARF, p12, TGF-b, and PTEN;
but late con¯uent and/or senescent cultures had increased levels of these cell cycle regulators.
Many of these proteins were not elevated when either mammary epithelial or endothelial cells
became con¯uent, suggesting that KCs possess an intrinsically different genetic program initiated
by con¯uency. Upon con¯uency, KCs displayed increased Ras activity compared to proliferating
KCs. Ectopic expression (via a retroviral vector) of active Ras triggered senescence in KCs. These
results indicate several growth inhibitory molecules are triggered during KC con¯uency state that
may contribute to the mechanism by which epidermal cells are maintained in a predominately
growth arrested state. Such a mechanism may involve PKC and/or Ras signaling to ensure proper
epidermal thickness, and may also serve a tumor suppressive function thereby minimizing the
chances for development of cells with altered mitotic responses.
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Speci®c EGFR Tyrosine Kinase Inhibitors Differentially Modulate Keratinocyte EGFR
Activity, Proliferation and Differentiation
K. A. Squillace, M. R. Pittelkow, and A. Sekulic
Dermatology, Mayo Clinic/Foundation, Rochester, Minnesota, U.S.A.
Epidermal Growth Factor Receptor (EGFR) regulates keratinocyte proliferation and differentia-
tion. Several EGFR inhibitors are in clinical trials for various malignancies and signi®cant
cutaneous toxicities have been reported, especially follicular or acneiform reactions severe enough
to require cessation of therapy. We compared the effects of a reversible EGFR inhibitor,
PD153035 and an irreversible EGFR inhibitor, EKI 785 on keratinocyte function. Treatment of
cultured human keratinocytes with either EGFR inhibitor led to inhibition of EGFR
phosphorylation. Equipotent doses leading to over 90% inhibition of EGFR phosphorylation
were 500 nM for PD153035 and 150 nM for EKI 785. The effects of PD153035 on EGFR
phosphorylation were readily reversible within minutes of drug removal. In contrast, EGFR
phosphorylation blockade persisted more than 24 h after removal of EKI 785. Effects of these drugs
on human keratinocyte proliferation and differentiation paralleled the kinetics of EGFR
phosphorylation. 24- h treatment with either drug reduced proliferative rates by more than
90%. However1- h treatment with PD153035 had no effect on proliferation measured 24 h later,
whereas 1- h treatment with EKI 785 induced sustained growth inhibition measured 24 h later.
Treatment with either drug at equipotent doses for 24 h strongly induced K10 expression, an early
keratinocyte differentiation marker. However, 24 h following the removal of PD153035,
expression of K10 was reduced to undetectable levels comparable to vehicle treated controls,
whereas even 1- h treatment with EKI 785 resulted in signi®cant expression of K10 measured 24 h
later. These ®ndings demonstrate that EGFR inhibitors exert signi®cant effects on epidermal
keratinocytes, dependent on the inhibitor class, dose and duration of treatment. in vitro studies will
be useful to identify potential mechanisms by which anticancer EGFR inhibitors also target the
keratinocyte and disrupt epidermal and follicular functions.
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Role of Protein Kinase C in Proliferation of Human Neonatal Keratinocytes
A. Ali and P. Sperry
Biological Sciences, California State Polytechnic University, Pomona, California, U.S.A.
Protein kinase C (PKC) plays an important role in the regulation of keratinocyte proliferation and
differentiation. The purpose of this study was to test the hypothesis that inhibition of PKC leads to
hyperproliferation in human neonatal keratinocytes. Previous studies used general kinase inhibitors
(e.g.,staurosporine). In the present study, PKC-speci®c inhibitors such as GF 109203X and
chelerythrine were used. The effect of isoenzyme-speci®c inhibitors, including Rottlerin and RO
32±0432, was also investigated. Keratinocytes were cultured in 96-well microtitre plates. After the
cells reached 80% con¯uency they were starved for 48 h in media without growth factors. The cells
were treated for 1 day with PKC inhibitors in the presence or absence of varying concentrations of
EGF. DNA synthesis was measured by a colorometric bromodeoxyuridine (BrdU) immunoassay.
The results showed that keratinocytes displayed a classic bi-phasic DNA synthesis response to EGF,
characterized by an increase in DNA synthesis at lower concentrations of EGF followed by a sharp
decline in DNA synthesis at high EGF concentrations. Inhibition of all the PKC isoenzymes by
PKC speci®c inhibitors caused continued stimulation of DNA synthesis at high concentrations of
EGF. Isoenzyme-speci®c inhibitors did not cause increased DNA synthesis in the presence of high
EGF concentrations. The results support the hypothesis by showing that inhibition of PKC leads to
increased proliferation. Inhibition of all PKC isoenzymes is necessary to see continued stimulation.
This model system can be used to investigate how inhibition of PKC is related to keratinocyte
hyperproliferation.
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Cycling Alopecia in Msx2 Mutants: Defects in Hair Shaft Differentiation and Hair
Cycling
C. Chuong, L. Ma,* J. Liu, T. Wu, T. X. Jiang, Y. H. Liu, S. Muller-Rover,² J. Brissette,² H.
Peters,² R. Maxson, and R. L. Maas²
Pathology, University of Southern California, Los Angeles, California, U.S.A.; *Cell and Molecular
Biology, Tulane University, New Orleans, Louisiana, U.S.A.; ²LA Division of Genetics, Department of
Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, U.S.A.
Alopecia, the balding of the scalp, has complex genetic etiology of which very little is known. Here
we present Msx2
±/±
as the ®rst mouse model for cycling alopecia. The homeobox Msx genes
regulate epithelial±mesenchymal interactions during the development of a variety of organs
including hairs. Msx2 mutant mice develop hair but exhibit progressive hair loss, starting at
postnatal day 14 (P14). Hair regrows but is again lost in subsequent hair cycles. We have analyzed
the hair phenotypes of Msx2 knockout mice and have focused on its roles in hair cycling and
differentiation. During hair cycling, loss of Msx2 leads to shortened anagen, prolonged catagen,
and dif®culty re-entering anagen following hair stripping. Cross with Angora (FGF5-de®cient)
mice partially rescued the hair cycle defect, but not the hair shaft structural defect and loss. During
hair differentiation, Msx2 function is required for the normal expression of Whn, the nude gene.
Consequently, expression of several hair differentiation markers including that of type II acidic hair
keratin mHa3, a known downstream target of Whn, is signi®cantly reduced in the mutant hair
follicle. These results offer a molecular explanation for the curvy and fragile mutant hairs that are
lost in catagen and demonstrate an essential role for Msx2 in both hair shaft differentiation and
transition between hair cycle phases.
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Distinct Wnt Members Regulate the Formation and Size of Feather Tract, Apteric
Region, Individual Primordium and its Spacing
C. H. Chang,*² T. X. Jiang,* R. Chodankar,* C. M. Lin,* L. Burrus,* R. B. Widelitz,* and C.
M. Chuong*
*Pathology, University of Southern California, Los Angeles, California, U.S.A.; ²Dermatology, Kaohsiung
Medical University, Kaohsiung, Taiwan
The arrangement of individual feather primodium (micropatterning) and the arrangement of
feather tracts (macropatterning) are issues fundamental to pattern formation. We recently showed
that periodic patterning of individual primordium can form locally, independent of the global
sequential forming process. in vivo, a morphogenetic zone advances at the edge of the tract ®eld
until each tract reaches a certain size and spaced by an apteric zone. Within the morphogenetic
zone, individual primrodia are laid out with certain size and spacing. Here we analyze the roles of
Wnt family in this process. Wnt3a, 5a, 6, 7a, 11, b-catenin are all expressed in the morphogenetic
zone initially. Wnt3a, 6, 7a and b-catenin then are restricted to the epithelium of primordial
region, but Wnt11 becomes enriched in the mesenchyme of apteric and interbud region. Wnt8c,
14, and Frizzled 1 are absent in the morphogenetic tract ®eld and later expressed in the epithelium
of bud primordia directly. Mis-expression of Wnt3a led to expansion of tract, increased dermal
thickeness and primordia with larger diameters or fusion of primordia. Mis-expression of Wnt11
led to expanded apteric region, reduced feather diameter, and widened interbud spacing. The
results imply that the size of feather tracts and apteric region depend on how long the activity of the
morphogenetic zone lasts, which is regulated by the balance of positive (Wnt 3a) and negative
(Wnt11) Wnt members and manifested as the number of competent mesenchymal cells. Within
the morphogenetic zone, the formation of primordia is a cell rearrangement process and their size is
regulated by the ratio of activators (including Wnt3a, 7a) and inhibitors, which also determines the
width of the lateral inhibitory halo.
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Novel PKC Isoforms Regulate Human Keratinocyte Differentiation by Activating a
p38d MAPK Cascade that Targets C/EBPa
T. E®mova,* A. Deucher,* T. Kuroki,³ M. Ohba,§ and R. L. Eckert*²
*Physiology and Biophysics, CWRU School of Medicine, Cleveland, Ohio, U.S.A.; ²Dermatology,
CWRU School of Medicine, Cleveland, Ohio, U.S.A.; ³Institute of Molecular Oncology, Showa
University, Tokyo, Japan; §School of Pharmaceutical Sciences, Showa University, Tokyo, Japan
The novel PKC (nPKC) isoforms are important regulators of human involucrin (hINV) gene
expression during keratinocyte differentiation (E®mova and Eckert, J. Biol. Chem. 275: 1601±
1607, 2000). Although the regulatory mechanism involves MAPK activation, the role of individual
MAPK isoforms has not been elucidated. We therefore examined the effects of individual nPKCs
on MAPK activation. We observe unique changes whereby nPKC expression simultaneously
increases p38 activity and decreases ERK1 and ERK2 activity. Interestingly, although p38a, b and
d are expressed in keratinocytes, only a single isoform, p38d, accounts for the increased p38
activity. Parallel studies indicate that this isoform is also activated by treatment with the
keratinocyte-differentiating agents, 12±0±tetradecanoyl phorbol±13±acetate (TPA), calcium, and
okadaic acid. These changes in MAPK activity are associated with increased C/EBPa transcription
factor expression and DNA binding to the hINV promoter, and increased hINV gene expression.
Expression of PKCd, e or h causes a 10-fold increase in hINV promoter activity while C/EBPa
expression produces a 25-fold increase. However, simultaneous expression of both proteins causes
a synergistic one hundred-fold increase in promoter activity. The increase in hINV gene
expression is associated with increased C/EBPa binding to the hINV promoter C/EBP DNA
binding site. These responses are eliminated by the dominant-negative C/EBP isoform,
GADD153, and are also inhibited by dominant-negative forms of Ras, MEKK1, MEK3, and
p38. These results suggest that the nPKC isoforms produce a unique shift in MAPK activity, via a
Ras, MEKK1, MEK3 pathway, to increase p38d and inhibit ERK1/2, and ultimately increase C/
EBPa binding to the hINV promoter and hINV gene expression.
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Interleukin-4 Up-Regulates the Expression of Tissue Inhibitor of Metalloproteinase-2 in
Dermal Fibroblasts Via the p38 MAP Kinase-Dependent Pathway
H. Ihn, K. Yamane, and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Japan
Tissue inhibitor of metalloproteinase-2 (TIMP-2) is a potent inhibitor of activated matrix
metalloproteinases such as gelatinase and collagenase, and thus helps to control extracellular matrix
metabolism and deposition by connective tissue cells. We examined the responsiveness of the
expression of TIMP-2 to various cytokines in dermal ®broblasts and studied the regulatory and
signaling mechanisms of the response. TIMP-2 protein and mRNA expression was induced by
interleukin-4 (IL-4) in a dose- and time-dependent manner, but not by transforming growth
factor-b, oncostatin M, or interleukin-6. IL-4 induction of TIMP-2 expression was dependent
upon transcription. The p38 MAP kinase inhibitors SB202190 or SB203580 suppressed IL-4-
induced TIMP-2 expression, suggesting the involvement of p38 MAP kinase in the signaling of IL-
4 leading to TIMP-2 expression. Immunoblotting analysis using a speci®c antibody against
phosphorylated p38 MAP kinase (Thr180/Tyr182) showed that IL-4 induced phosphorylation of
p38 MAP kinase in human dermal ®broblasts. Furthermore, p38 MAP kinase assay showed that IL-
4 induces p38 MAPK activation in human dermal ®broblasts. The expression of the dominant-
negative mutant p38 MAPK represses the IL-4 induced TIMP-2 expression in human dermal
®broblasts. Thus, IL-4 can potentially alter the dermal matrix metabolism by regulating TIMP-2.
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Onset of Alopecia Areata in C3H/HeJ Mice Involves Transient, High Statement of
CD44 Variant Isoforms and Low CD4+/CD25+ Suppressor Cell Activity
K. J. McElwee, M. Zo
È
ller,* P. Engel,* and R. Hoffmann
Dermatology, Philipp University, Marburg, Hessen, Germany; *Tumor Progression and Tumor Defense,
German Cancer Research Center, Heidelberg, Hessen, Germany
Alopecia areata (AA) can be induced in normal haired C3H/HeJ mice by grafting AA affected skin
from littermates. Standard CD44 and isoforms are adhesion molecules required for leukocyte
extravasation. CD4+/CD25+ cells are important for T cell homeostasis. By ¯ow cytometry, we
examined skin and lymph node levels of cytokines, CD44 variant isoforms, CD4, CD25, and other
cell surface molecules, at 2, 6, and 12 weeks post grafting as compared to sham grafted mice, normal
haired mice and chronic AA affected mice. Leukocytes in the skin of mice 2 weeks after
transplanting AA affected skin highly expressed CD44v3, CD44v6, CD44v7 and CD44v10 as
compared to sham grafted mice. By 12 weeks, expression of CD44 isoforms had returned to
normal. With chronic AA, CD44s and CD44v6 were elevated, but CD44v3 was reduced. CD4+/
CD25+ cells were present in signi®cantly reduced numbers in mice grafted with AA-affected skin
both at 2 weeks after grafting and in chronic AA-affected mice. In association, CD40 and CTLA-4
was reduced. Cytokines IL-2, IL-4, IL-6, IL-10 and IL-12 were elevated in mice receiving AA
affected skin at all times whereas sham grafted mice exhibited only transient increases post surgery.
Taken together, expression of CD44 variant isoforms appears most important for the migration of
leukocytes during the initial onset of AA, but is less signi®cant in maintenance of the disease state.
The low level of CD4+/CD25+ cells, CD40 and CTLA-4 in the skin of AA-affected mice are in
support of AA as an autoimmune disease on the basis of an altered regulation of immune cell
homeostasis.
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Increased Levels of Natural Antibiotics Protect Embryonic and Newborn Skin
R. A. Dorschner, K. H. Lin, M. Murakami, and R. L. Gallo
Medicine/Dermatology, UCSD, San Diego, California, U.S.A.
Antimicrobial peptides are an essential part of innate defense against infection. Given their role in
barrier immunity, it would be bene®cial to have increased levels of these peptides in situations such
as the perinatal period where the adaptive immune system is developmentally immature. To
determine if major mammalian antimicrobial peptides of the cathelicidin (cath) and b-defensin
families are relatively overexpressed in embryonic and newborn skin compared to adult,
quantitative real time PCR, in situ hybridization, immunohistochemistry, dot and Western blot
were used to measure levels of these natural antibiotics in mouse and human skin. Cath message
and protein were present at increased levels in neonatal skin, with the mouse cath, CRAMP, being
expressed up to 100 fold more in perinatal than in adult skin. Immunohistochemistry and in situ
hybridization localized CRAMP and the human cathelicidin, LL-37, to the basal layers of the
epidermis. Levels of both CRAMP message and protein increased from E-17 through day 4 after
birth. Mouse b-defensin (mBD)-1 was expressed at a constant level while mBD-4 expression was
up to 10 times greater in embryonic and adult skin than in newborn skin. mBD-4 protein levels
detected by dot blot, correlated closely with the levels of message found in the E-17, day 4 and
adult skin, with E-17 having the greatest expression and day 4 having the least expression. These
results show increased contribution by caths and mBD±4 to cutaneous barrier defense of perinatal
skin. These antimicrobial peptides, which are active against a range of potential pathogens,
including E. coli, S. aureus, p. aeruginosa, and Group A Streptoccocus, bolster the immature
immune system of the neonate, providing increased protection while adaptive immunity develops.
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Involvement of p53 and Fas in Hair Follicle Apoptosis in Human Skin/SCID Model for
Chemotherapy-Induced Hair Loss
V. A. Botchkarev,* A. A. Sharov,* W. Syska,*² M. Maurer,² and B. A. Gilchrest*
*Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; ²Dermatology,
Johannes Gutenberg University, Mainz, Germany
We have recently shown that p53 is essential for chemotherapy-induced hair loss in mice (Cancer
Res 60: 5002). To study the roles of p53 and its target genes in response of human hair follicles
(HF) to chemotherapy, we developed a human model for chemotherapy-induced hair loss.
Samples of human skin were transplanted onto SCID mice and studied 4±5 months after grafting.
The response of actively growing human HF to a single intraperitoneal administration of 150 mg/
kg cyclophosphamide (CYP) was studied 1±30 days after CYP administration. By immunohis-
tochemistry, p53 and Fas proteins were strongly up-regulated in proximal hair matrix, outer and
inner root sheath of human HF 24±72 h after CYP treatment, compared to untreated controls.
CYP caused colocalization of p53, Fas and TUNEL staining in the matrix of human HF, which
were entered into regression phase (catagen II) 48±72 h after treatment. After 7 days, further
progression of human HF to catagen IV was observed, associated with appearance of
TUNEL + cells in the outer and inner root sheaths. Hair loss in human skin transplanted onto
SCID mice was ®rst detected when HF were in mid-late catagen 14±16 days after CYP
administration, as occurs in patients undergoing chemotherapy. All hairs in human skin grafts had
been shed 3±4 weeks after CYP administration, when all HF were in late catagen. These data
suggest that response of human HF to chemotherapy show striking similarity to mouse HF, and
that local pharmacological inhibition of the p53 and Fas signaling pathways might reduce or
prevent chemotherapy-induced hair loss in humans.
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Minoxidil Fails to Promote Hair Growth in Organ Culture of Occipital Human Anagen
VI Hair Follicles





Department of Biomedical Sciences, Uni. of Bradford, Bradford, U.K.; *Surgery, Farjo Medical Center,
Manchester, U.K.; ²Department of Dermatology, Uni. Hospital Eppendorf, Hamburg, Germany
Systemic administration of minoxidil can promote hair growth (i.e. vellus-terminal hair follicle
transformation, and possibly anagen induction/prolongation). However, it is not yet known why
only some individuals respond with dense hair regrowth when minoxidil is applied topically and
currently we are unable to preselect minoxidil responders. Previously published work on hair
growth-promoting effects of minoxidil in vitro is largely contradictory. This is complicated further
by the often uncritically made assumption that minoxidil's systemic hair growth effects may be
reliably assessed in short-term culture of amputated anagen VI hair follicles. Therefore, we have
performed the ®rst large in vitro study employing a total of 2300 occipital scalp hair follicles from 36
healthy adult males (24±70 year) not preselected as minoxidil responders. Microdissected anagen VI




M minoxidil in a
0.1% ethanol vehicle. 65 follicles from each person were assessed with measurements taken on days
0, 3, 5, 7, 9, and 12. Optimization experiments were designed to assess the effect of excluding
phenol red and all antibiotics/mycotics. Hair follicles in vehicle control medium grew at approx.
0.23 mm/day for the ®rst 5 days, decreasing to 0.07 mm/day at day 9. Hair follicles treated with 10
±
6
M minoxidil grew at approx. 0.24 mm/day for the ®rst 5 days, decreasing to 0.07 mm/day at day
9. Mean hair elongation as percentage of vehicle controls was 101% (day 5) and 105% (day 9).
Similar results were obtained with 10
±4
M minoxidil. Thus, we were unable to detect a statistically
signi®cant enhancement of hair shaft elongation rate or of anagen duration by minoxidil in this
assay system. Minoxidil effects may not be appreciated in the hair follicle organ culture system as
currently optimized, especially in hair follicles from donors not preselected for minoxidil
responsiveness.
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Three New Type II Epithelial Keratins, hK6irs2±4, are Speci®cally Expressed in
Different Layers of the Human Hair Follicle Inner Root Sheath
L. Langbein, M. A. Rogers,* S. Praetzel, H. Winter,* and J. Schweizer*
Cell Biology, German Cancer Research Center, Heidelberg, Germany; *Tumor Cell Regulation, German
Cancer Research Center, Heidelberg, Germany
EMBO/Genebank analysis using our recently described human K6irs1 cDNA lead to the discovery
of a BAC clone lying upstream of the hK6irs1 gene and harboring 3 novel type II keratin gene loci,
one of which, hK6irs2 in this report, has been recently described at the cDNA level (Br. J.
Dermatol. 145: 558, 2001). Analysis of a human scalp cDNA library lead to the isolation of full
length cDNAs of the remaining 2 genes, termed hK6irs3 and hK6irs4. Speci®c antisera were
produced for hK6irs2±4 and used for Western blot analysis. Both in situ hybridization and
immunohistochemistry showed an exclusive expression of hK6irs1±4 in the inner root sheath
(IRS) of the hair follicle. As previously described, hK6irs1 was found in all 3 IRS layers (Henle,
Huxley and cuticle). hK6irs2 and 3 were sequentially expressed in the IRS cuticle, with hK6irs3
starting just above the germinative cell pool and hK6irs2 initiating above the apex of the dermal
papillae. Their mRNA expression ceased in the mid-follicular region, while their proteins
terminated precisely with the onset of terminal cuticular differentiation. Both K6irs4 mRNA and
protein were clearly restricted to the Huxley layer. Their synthesis began in the lower bulb region
and could be detected in all living cells. hK6irs4 was also found in `Flu
È
gelzellen', specialized
Huxley cells which form foot processes passing through Henle layer and abutting upon companion
layer cells. These `Flu
È
gelzellen' were regularly scattered throughout the total length of the Huxley
layer, indicating that these cells are part of a larger tissue unit (i.e. companion layer, IRS),
important for optimal molding and guidance of the growing hair shaft. In summary, we provide
evidence that the IRS is built by a series of speci®c and sequentially expressed keratins.
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Molecular Changes Induced by Androgens in Human Skin-SCID Mouse Model
W. Li and M. Eisinger
Skin Biology, Johnson & Johnson Skin Research Center, Consumer and Personal Care Group, Skillman,
New Jersey, U.S.A.; Skin Biology, Johnson & Johnson Skin Research Center, Consumer and Personal Care
Group, Skillman, New Jersey, U.S.A.
Clinical observations indicate that steroid hormones (dihydrotestosterone-DHT) and adrenal
steroid (dehydroepiandosterone-DHEA) play an important role in the initiation of acne. Toward a
better understanding of their mechanism of action we studied the effects of topically applied DHT
or DHEA on human skin transplanted onto SCID mice. Skin of postmenopausal women was used
and transplanted onto four to six weeks old male or female SCID mice. A signi®cant increase in the
sebaceous gland size (~ 4 fold) was observed within 8±12 weeks when transplanted onto male mice.
In contrast, when female skin recipients were used, the sebaceous glands remained small.
Measurement of sebum production by Sebutapeá revealed signi®cant sebum production in
human skin grafts on male, but not on female SCID mice. Consequently, human skin grafts
transplanted onto female mice were treated daily with 1% DHT or 1% and 10% DHEA for 30 days.
Morphometric evaluation of such grafts revealed a 9 fold increase in the gland size in grafts treated
with 1%DHT, 8.7 fold increase in the grafts treated with 1%DHEA and 13 fold increase in grafts
treated with 10% DHEA. Moreover, there was a signi®cant increase in the expression of MSH in
the sebaceous glands of grafts treated with 10% DHEA, and of MC5-R in all treatment groups.
Following treatment, EMA, a sebocyte differentiation marker, was expressed on all, but basal cells
of the sebaceous gland, while vehicle treated controls displayed this marker only in cells
approaching the sebaceous duct. Our results indicate that: (1) androgens increase cell proliferation
and differentiation in the sebaceous glands and (2) MSH and its receptor (MC5-R), previously
implicated in sebogenesis, may be the mediators of increased lipid production in sebaceous glands.
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Smad7 Transgenic Mice Exhibit a Severe Delay in Hair Follicle Development, Aberrant
Follicle Morphogenesis and Differentiation, and Cyclical Balding
W. He, D. Wang, M. Goumans,* P. Dijke,* J. P. Sundberg,² and X. Wang
Dermatology, Baylor College of Medicine, Houston, Texas, U.S.A.; *Cellular Biochemistry, the
Netherlands Cancer Institute, Houston, Netherlands and ²Dermatology, The Jackson Laboratory, Bar
Harbor, Maine, U.S.A.
Biochemical studies have depicted Smad7 as an inhibitor for signaling transduction from the TGFb
super family. To study the functions of Smad7 in the skin, we have generated Smad7 transgenic
mice, using a keratin 5 (K5) promoter. K5.Smad7 mice were born without vibrissae, and exhibited
marked epidermal hyperplasia. They died typically within the ®rst 10 days of life. Hair follicles in
neonatal K5.Smad7 skin were at a developmental stage comparable to wildtype E16 to E17 mouse
embryos. By 10 days, K5.Smad7 hair follicles did not show an obvious structure of the hair shaft,
which is further con®rmed by the absence of hair follicle differentiation markers AE13 and AE15.
Additionally, hair follicles in K5.Smad7 mice became disorientated and disorganized, and melanin
was deposited irregularly. Only mosaic mice, which had low transgene expression levels and
extremely low transgene penetrance, survived till adulthood. These mice developed alopecia at the
®rst telogen phase, and became permanently bald after several hair cycles. The hair shaft of these
mice was thinner and curly in comparison with nontransgenic littermates. Transgenic follicles also
showed a delay in entering the catagen phase with decreased apoptosis, suggesting that TGFb1-
induced apoptosis was blocked. At later stages, hair follicles in these mosaic mice degenerated to
piliary cysts, a typical phenotype seen in patients carrying mutations of the hairless gene.
Interestingly, in addition to a reduction in Smad phosphorylation, the levels of the receptors for
TGFb, activin and bone morphogenetic protein were signi®cantly decreased in K5.Smad7 skin.
Our study provides in vivo evidence that Smad7 is a potent inhibitor for signal transduction of the
TGFb superfamily for hair follicle development, differentiation and cycling.
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Role of Versican in Anagen Hair Induction During Hair Cycle
J. Kishimoto, T. Soma,* and T. Hibino
Hair care laboratories, Shiseido Basic Research Center, Yokohama, Japan; *Hair biology, Shiseido Life
Science Research Center, Yokohama, Japan
Hair mesenchyme (dermal papilla cells: DP) plays essential roles in cyclical hair regeneration
process together with follicle epithelial stem cells. We have focused on mesenchymal speci®c large
chondroitin sulfate proteoglycan molecule, versican, and prove its pivotal role in hair follicle
induction in vivo. Versican expression was examined with hair cycling both in human and mice by
in situ hybridization and immunohistochemistry, and results clearly showed speci®c versican
expression in anagen onset of DP in both species. Moreover, versican-IR was also observed in
bulge region of human hair follicle, implying common role of versican in hair induction. Freshly
isolated murine pelage DP cells from versican-GFP transgenic mice were able to induce hair
growth in a skin reconstitution assay when grafted with undifferentiated epidermal cells on nude
mouse back skin. However, this ability and versican expression were rapidly lost during passages in
culture. In order to examine functional role of versican in hair induction, versican full length
cDNAs were transfected into inactive passaged murine dermal cells which include DP cells. Result
demonstrated that this forced expression of versican molecules partially restored hair inductivity of
DP cells. in vitro experiments indicate that induction of versican expression at least in part depends
on the basic FGF stimulation, and BMP-4 acted as a suppressive molecule, and required epithelial
cells other than DP cells. These results demonstrated pivotal role of versican in hair induction and
may connect missing link between the signal from DP cells and follicular stem cells.
478
D-6 Desaturase and the Human Sebaceous Gland: Expression, Enzyme Activity, and
Alteration in Acne
J. S. Gordon, L. Ge, J. Leyden,* C. Hsuan, K. Stenn, and S. M. Prouty
Skin Biology TRC, Johnson & Johnson CPWW, Skillman, New Jersey, U.S.A.; *Dermatology,
University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
Sapienate, the delta-6 (D-6) monodesaturation metabolite of palmitic acid is the most abundant
fatty acid in human sebum lipids. D-6 monodesaturation has not been found in other human tissues
or in the sebum of other species. A D-6 desaturase is known to be a component of a lipid metabolic
pathway that converts the essential fatty acids, linoleate and a-linolenate, into bioactive long-chain
polyunsaturated fatty acids (PUFA) in tissues such as liver and brain. Isolation of the cDNA for this
D-6 desaturase from human skin predicts an identical protein to that expressed in human brain and
Southern analysis indicates a single locus, together suggestive of a single D-6 desaturase gene in
human. Within human skin, D-6 desaturase mRNA and protein expression is restricted to
differentiating sebocytes located in the suprabasal layer of the sebaceous gland. Enzymatic analysis
using CHO cells overexpressing human D-6 desaturase indicate catalysis of a `PUFA-type' reaction,
but also a novel `sebaceous-type' reaction, that of converting palmitate into the monounsaturated
fatty acid, sapienate, a 16 carbon fatty acid with a single cis double bond at the 6th carbon from the
carboxyl end. D-6 desaturase mRNA and protein are absent in sebaceous glands of advanced acne
lesions. This work identi®es D-6 desaturase as the major fatty acid desaturase in human sebaceous
glands and suggests that the environment of the sebaceous gland permits catalysis of the `sebaceous-
type' reaction and restricts catalysis of the `PUFA-type' reaction. Identi®cation of the enzyme
catalyzing this unusual reaction is expected to provide a speci®c marker for understanding and
assessing human sebaceous gland function.
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Dermal Papilla Speci®c Genes Identi®ed by Microarray Analysis
R. O'Shaughnessy, C. Jahoda,* and A. Christiano
Dermatology and Genetics and Development, Columbia University, New York, New York, U.S.A.;
*Biological Sciences, Durham University, Durham, U.K.
At the base of a cycling vibrissa (whisker) follicle there are two distinct mesenchymal populations,
the dermal papilla (DP), which is thought to provide the signals required to produce hair growth,
and the dermal sheath cells (DS), a closely biologically related, yet distinct tissue whose function is
largely unknown. In rodents, the dermal papilla retains the ability to induce new hair follicle
production, while the dermal sheath does not have this inductive capability. We believe that the
differences in gene expression between these two specialized mesenchymal tissues will shed light
on their functions in morphogenesis and the continued cycling of the hair follicle. We compared
microdissected intact DP and DS from the vibrissae of male brown Norway rats using Affymetrix
genechips of over 8000 genes. Of the 8000 genes on the chips, only 800 were present in both
tissues. Of these 800, only 30 were differentially expressed. Further validations steps by RT-PCR
revealed that of these 30 genes only 8 were speci®cally expressed in the DP and not in the rest of
the hair follicle. Of interest among these 8 genes were 4 secreted genes, 3 of which have been
shown to inhibit extracellular proteases ± including the known dermal papilla marker Nexin 1.
Two of the inhibitor of DNA binding (ID) family of genes were also identi®ed. We show that the
secreted genes show variation of expression during the hair cycle of the vibrissa, and that a novel
gene, a homologue of the gene mutated in bone dysplasia sclerostosis is preferentially expressed in
DP. We conclude that there are indeed genes speci®cally expressed by the DP and that microarray
analysis of freshly dissected tissue is a viable approach to detect such genes.
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Changes in Gap Junction Distribution and Connexin Expression Pattern During Human
Fetal Skin Development
K. Arita, M. Akiyama, Y. Tsuji, J. R. McMillan, R. A. Eady,* and H. Shimizu
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan;
*Department of Cell and Molecular Pathology, St. John's Institute of Dermatology, King's College, London,
U.K.
Gap junctions are intercellular channels composed of connexin subunits that mediate cell±cell
communication. The functions of gap junctions are believed to be associated with cell proliferation
and differentiation and to be important in maintaining tissue homeostasis. We therefore
investigated the expression of connexins 26 and 43, the two major connexins in the human
epidermis, and examined the formation of gap junctions during human fetal epidermal
development. By immuno¯uorescence, connexin 26 expression was observed between 49 and
96 days estimated gestational age (EGA). Particularly at day 49 of gestation, connexin 26 expression
was observed between the periderm and basal cells. By 96 days EGA, the expression was restricted
to the periderm. Connexin 26 expression was absent from 108 days EGA onwards. Conversely,
connexin 43 expression was observed from 88 days EGA onwards. At 88 days EGA, connexin 43
was observed within the periderm and intermediate cells. In the keratinized epidermis, at 163 days
EGA, connexin 43 expression was between all the intermediate cells and was weak only at basal
cell borders. Using electron microscopy, the typical gap junction structures were observed from
120 days EGA. The number of gap junctions increased over time, and they were more frequent in
the upper layers, within the periderm and intermediate keratinocyte layers rather than the basal
layer. Immunoelectron microscopy revealed connexin 43 labeling of the gap junction structures
after 105 days EGA. The formation of gap junctions increased as the skin developed, and these
®ndings suggest that the gap junction may play an important role in fetal skin development.
Furthermore, the changing expression pattern of connexin subtypes suggests that connexin 26 is
important for early fetal epidermal development.
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Topical Application of a PKC Inhibitor Reduces Length and Thickness of Guinea Pig
and Mouse Hair In Vivo
H. Park, S. Gonzalez,* J. Lee, M. Middelkamp-Hup,* S. Kaposi, S. Peterson, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; *Dermatology,
Harvard Medical School, Boston, Massachusetts, U.S.A.
Protein Kinase C (PKC) has been suggested to play an important role during differentiation of
keratinocytes. To determine whether modulation of PKC activity would alter development of
hair, the differentiated product of keratinocytes in hair follicles, a selective PKC inhibitor,
bisindolylmaleimide (Bis), was topically applied to rodent skin. Backs of 9-week-old-mice were
®rst depilated to initiate a synchronized anagen hair cycle. Vehicle alone or 100 mM Bis was
topically applied daily for 7±12 days. After the last application, at least 15 hairs were plucked from
the Bis-treated and vehicle-treated areas, and the length and the diameter of hair shafts were
determined using a dissecting microscope. Hair length in Bis-treated areas was signi®cantly shorter
than in vehicle-treated areas (2.6 6 1.4 vs. 6.2 6 2.0 mm, p < 0.00001). Similarly, hair diameter
from the Bis-treated areas was less than in vehicle-treated area (0.026 6 0.02 vs. 0.038 6 0.02 mm,
p < 0.03). In a second model, the guinea pig, paired sites on the back were depilated and 200 mM
Bis or vehicle alone {25% DMSO/75% propylene glycol (v/v)} was applied twice a day for 14
working days over period of 18 days. At the end of the treatment, at least 30 hairs from each site
were plucked and measured. Bis treatment again shortened hair length compared to vehicle
treatment (2.05 6 0.7 vs. 4.69 6 2.0 mm, p < 0.0001); and the diameter of Bis-treated hair was
similarly less than that of vehicle treated hair (0.039 6 0.027 vs. 0.053 6 0.014 mm, p < 0.013).
Skin biopsies revealed no difference in epidermal morphology in Bis-treated vs. control sites and
the hair follicles were not dystrophic. Taken together, these results suggest that PKC may positively
regulate hair growth and thickness and that topically applied PKC inhibitors may be useful in
decreasing unwanted facial or body hair.
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Risk Factors for Hair Loss Among Untreated Men with Androgenetic Alopecia
K. D. Kaufman and C. P. Daurio*
Department of Clinical Research, Merck Research Laboratories, Rahway, New Jersey, U.S.A.; *Department
of Biostatistics, Merck Research Laboratories, Rahway, New Jersey, U.S.A.
The purpose of this analysis was to explore the relationship between various factors and the
progression of hair loss in men randomized to placebo in a controlled clinical trial. In two replicate
studies designed to test the ef®cacy of ®nasteride in the treatment of men with androgenetic
alopecia (AGA), 68 patients, aged 18±41 years, with mild to moderate vertex scalp baldness were
randomized to placebo for up to 5 years. A mixed model ANOVA was performed to explore the
relationship of several factors and the change in hair count from baseline to 6, 12, 24, 36, 48 and
60 months. The factors explored in the analysis included: baseline hair count (hairs in a 1-inch
diameter circle), age at randomization (years), duration of hair loss at randomization (years),
baseline Norwood-Hamilton stage (II vertex, III vertex, IV or V), family history of hair loss (yes/
no), and time elapsed on study (months). The ANOVA was rerun retaining those factors that were
signi®cant at p < 0.20. The relationship was expressed as a coef®cient (C) that quanti®ed the effect
(magnitude and direction) of the factor on change in hair count. As expected, time (months)
elapsed on study was highly predictive of change in hair count (C = ± 3.9, or 3.9 hairs lost/
month = 47 hairs lost/year; p < 0.001): the longer a patient went without treatment, the greater his
hair loss. Age at randomization (years) was also predictive (C = 2.1, or 2.1 fewer hairs lost over
60 months/increasing year of age; p = 0.007), showing that younger men experienced more hair
loss than older men. Finally, baseline Norwood-Hamilton stage (C = ± 10.4, or 10.4 more hairs lost
over 60 months/increase in stage; p = 0.096) was marginally predictive: men with a more severe
stage at baseline experienced more hair loss than those with less advanced baldness. These ®ndings
shed light on factors that contribute to the progression of hair loss in men with AGA.
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Conditional Double Gene Targeting of APC and bcatenin Gene in Mouse Epidermis
Reveals APC Controls Apoptosis and Differentiation of Keratinocytes Through Wnt
Signaling Pathway
K. Harada,*² S. Shimada,* and T. Noda²
*Dermatology, Yamanashi Medical University, Yamanashi, Japan; ²Cell biology, Cancer Institute,
Yamanashi, Japan
We previously showed that APC protein plays an important role not only in keratinocyte
differentiation/survival but also in hair follicular development. But the mechanism by which APC
controls keratinocyte differentiation remains poorly characterized. To elucidate this mechanism,
®rst we analyzed the expression of hair follicle markers including Bmp2 and Sonic hedgehog. in situ
hybridization analysis revealed the overexpression of these markers in APC de®cient mice. This
observation suggested that de®ciency of hair follicles in APC de®cient mice was due to abnormal
differentiation of keratinocytes in spite of Wnt signaling activation. Second we disrupted not only
APC but also b-catenin, a key molecule in Wnt signaling pathway which is degrade by APC only
in epidermis because germline APC gene or b-catenin ablation led to embryonic lethality.
Epidermis-speci®c APC gene knockout mice exhibited marked abnormalities with fragile skin,
while epidermis-speci®c APC and b-catenin double gene knockout mice showed no abnormality
in interfollicular epidermis without hair follicle de®ciency. This double gene targeting study
revealed that as a result of APC de®ciency overexpression of b-catenin in epidermis causes aberrant
terminal differentiation with apoptotic keratinocytes in epidermis.
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b-Endorphin: Evidence of a Role in the Regulation of Human Hair Pigmentation
S. Kauser, K. U. Schallreuter, A. J. Thody, C. Gummer,* and D. J. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, U.K.; *Technical Center, Procter &
Gamble Ltd, Egham, U.K.
Processing of pro-opiomelanocortin (POMC) yields ACTH, a-MSH, b-endorphin and several
other peptides. All three peptides are synthesised in the skin and participate in several important
cutaneous functions including melanogenesis. b-Endorphin has well-recognised immunomodu-
latory and analgesic effects mediated via opiate receptors. Unlike ACTH and a-MSH, a regulatory
role for b-endorphin in hair pigmentation has not been shown. Thus, this study was designed to
investigate the possible involvement of the b-endorphin/m-opiate receptor system in human hair
follicle pigmentation. The expression of b-endorphin and m-opiate receptor was examined in
gp100 + ve melanocytes in pigmented human scalp anagen hair follicles by double immuno-
¯ourescence and in primary hair follicle melanocyte (HFM) cultures. The expression of POMC
and m-opiate receptor mRNA was tested by RT-PCR. Additionally, a functional role for b-
endorphin was investigated in HFM after stimulation with b-endorphin for 72 h. in situ expression
of b-endorphin was strong in all gp100 + ve melanocytes located predominately in the hair bulb
melanogenic zone. By contrast, expression of the m-opiate receptor was restricted to a
subpopulation of less melanogenic hair bulb melanocytes. in vitro expression of b-endorphin
and m-optiate receptor protein was strongest in proliferating/differentiating melanocytes containing
negligible melanin. HFM expressed both POMC and m-opiate receptor mRNA. Functional
studies indicated that stimulation of HFM with b-endorphin signi®cantly increased melanogenesis,
proliferation and dendricity. To our knowledge, this is the ®rst demonstration of prominent b-
endorphin expression in hair bulb melanocytes demonstrating b-endorphin as a potent
melanogenic, mitogenic and dendritogenic factor for HFM. These effects suggest an important
role for b-endorphin in the maintenance of melanogenesis associated with anagen hair growth.
Alterations in b-endorphin homeostasis within the hair follicle pigmentary unit may contribute to
the onset of hair graying.
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EDA: A Novel Gene Involved in Early Epithelial Differentiation
R. M. Lavker, D. G. Ryan, T. Sun,* and L. Sun
Dermatology, University of Pennsylvania, Philaldelphia, Pennsylvania, U.S.A.; *Dermatology, New York
University, New York, New York, U.S.A.
To better understand the molecular mechanisms regulating the commitment of epithelial cells to
terminal differentiation, we identi®ed cDNA clones that are uniquely expressed in differentiating
corneal epithelial cells but not in the limbal epithelial stem cells. Using suppressive subtractive
hybridization, we have identi®ed a novel gene, which we named EDA (early differentiation-
associated), which is uniquely associated with an early stage of strati®ed epithelial differentiation.
This 12-kDa protein is basic (PI 10.6), and contains a protein kinase C and a casein kinase II-
phosphorylation site. The strongest EDA expression occurred in suprabasal precortical cells of
mouse and human anagen follicles as seen by in situ hybridization and immunohistochemistry. In
epidermis, esophageal epithelium, and lens epithelium, EDA mRNA was also abundant in
suprabasal cells, but was markedly down-regulated in more differentiated cells. Consistent with the
limbal location of corneal epithelial stem cells, EDA was expressed in basal corneal epithelial cells
that are out of the stem cell compartment, as well as the suprabasal cells. Interestingly, EDA
expression is shut off when the epithelia were perturbed by wounding and by cultivation under
both high and low Ca
2+
conditions. Thus the 12-kDa EDA protein, which was readily detectable
in normal mouse epidermis, became barely detectable during the early (12±72 h) stages of re-
epithelialization; EDA re-appeared, however, when wound healing was completed (96±120 h).
Developmental studies showed that the appearance of EDA in embryonic mouse epidermis (E16.5)
coincided with morphological kertinization. Taken together, our results indicate that EDA is
involved in the early stages of normal epithelial differentiation, that EDA needs to be shut off
before the committed cells can further differentiate, and that EDA is important for the `normal'
differentiation pathways (vs. the `hyperproliferative' pathway) in a wide range of strati®ed epithelia.
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Distribution of Deiminated Proteins During Human Epidermal Development
Y. Tsuji, M. Akiyama, K. Arita, T. Senshu,* and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan; *System
Functions, Faculty of Science, Yokohama City University, Yokohama, Kanagawa, Japan
Peptidylarginine deiminases (PADs) are widely distributed enzymes that convert arginine residues
into citrulline residues. The reaction is called `deimination'. In the human interfollicular epidermis,
deiminated proteins can be detected in the corni®ed cell layers. The major PAD substrate is keratin
1 (K1) and its deimination is thought to be important for the terminal differentiation. We
investigated the distribution patterns of deiminated keratins to determine the speci®c expression of
PAD activity in the human developing epidermis using an anticitrulline peptide antibody (ACP),
which preferentially recognizes deiminated K1. In early two-layered fetal epidermis (49d and 57d
estimated gestational age; EGA), no staining for ACP was observed. In strati®ed epidermis (88d,
96d and 108d EGA), ACP staining was bright in the periderm cytoplasm and the intermediate cells.
After the periderm cells regressed and keratinization had begun in the interfollicular epidermis
(163d EGA), ACP staining was restricted to the keratinized cells at the surface of the interfollicular
epidermis. In corni®ed cells, ACP staining colocalized with K1, keratin 10 and ®laggrin.
Immunoelectron microscopy revealed ACP immunogold labeling over the cytoplasmic ®lament
network in intermediate cells and in the periderm at 105d EGA. While K1 was weaks in large,
¯attened cultured keratinocytes in high Ca
2+
concentration medium (1.2 mM), ACP staining was
not observed. These PAD expression results indicate that (1) similar events to that in epidermal
keratinization takes place from 163d EGA; (2) similar to adult epidermis, the major substrate of
PAD in fetal epidermis appears to be K1 in the keratinized cells; (3) deiminated K1 cannot be
detected in the keratinocytes cultured in the conventional culture system despite the presence of
some K1. PAD activity may play an important role in the processes of human epidermal
development, epidermal keratinization and in the formation of an impermeable barrier.
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The Human Hair Follicle Pigmentary Unit is a Target for Pro-Opiomelanocortin
Peptides
A. J. Thody, S. Kauser, K. U. Schallreuter, C. Gummer,* and D. J. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, U.K.; *Technical Center, Procter &
Gamble Ltd, Egham, U.K.
Pro-opiomelanocortin (POMC) is cleaved by pro-hormone convertases (PC) 1 and 2 to yield
ACTH and a-MSH, respectively. These peptides are produced locally in the skin and participate
in several important cutaneous functions including melanogenesis where their functions are
mediated via the MC-1 receptor (MC-1R). While the involvement of these POMC peptides in
the regulation of murine hair pigmentation has been well documented, little is known about the
role of a-MSH and ACTH in human hair pigmentation. This study was designed to assess
immunohisto-cytochemically and by RT-PCR the expression of a-MSH, ACTH as well as PC1
and PC2 and the MC-1R in cultures of normal human scalp hair follicle melanocytes (HFM).
Additionally, a functional role for these peptides was investigated by stimulation of HFM cultures
with a-MSH and ACTH for 72 h. ACTH was expressed by a minor subpopulation of gp100-
positive melanogenic melanocytes located in the anagen hair bulb. By contrast, a-MSH was not
expressed by any gp100-positive HFM. Expression of the POMC processing enzymes, PC1 and
PC2, was con®ned to gp-100 positive melanocytes located in the most proximal and peripheral
matrix of the anagen hair bulb. in vitro, variable expression of a-MSH and ACTH and PC1 and
PC2 was observed in primary HFM cultures, with strongest expression in proliferating/
differentiating melanocytes containing little melanin. mRNA expression in HFM was detected for
POMC, PC1, PC2 and also the MC-1R. In functional studies, both a-MSH and ACTH
signi®cantly increased melanogenesis, proliferation and dendricity. This study showed that both a-
MSH and ACTH exhibit potent melanogenic, mitogenic and dendritogenic effects in cultured
HFM. Their differential expression in the anagen hair follicle in situ suggests that these peptides
may play a role in the regulation of HFM differentiation during anagen and also during hair
cycling.
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Over-Expression of Wnt7a in Transgenic Mouse Skin Alters Hair Pigmentation and Hair
Growth
T. Andl, S. T. Reddy, and S. E. Millar
Dermatology, University of Pennsylvania, Philadlephia, Pennsylvania, U.S.A.
Hair pigmentation is controlled in part by the actions of the Agouti gene, which is expressed in the
dermal papilla during early anagen. Agouti peptide is secreted from dermal papilla cells and
antagonizes the actions of melanocyte-stimulating hormone, causing a switch in the type of
pigment made by hair follicle melanocytes from black (eumelanin) to yellow (phaeomelanin), and
resulting in the appearance of a subapical yellow band in the hair shaft. The factors controlling
Agouti transcription in the dermal papilla are unknown. A candidate for one of these factors is
WNT7a, a member of the WNT family of secreted signaling molecules. Wnt7a is expressed in
mouse epidermis and hair follicles, and is able to maintain the inductive capacity of dermal papilla
cells in a paracrine fashion, indicating that the WNT7a protein can alter gene expression in the
dermal papilla. To ask whether over-expression of Wnt7a in mouse skin and hair follicles affects
hair pigmentation, we placed the cDNA under the control of a keratin 14 promoter that directs
expression to the basal layer of the epidermis and the hair follicle outer root sheath, and generated
transgenic mice. Mice expressing the transgene had short hair and altered hair pigmentation.
Speci®cally, the hair of transgenic mice carrying the A (wild-type) allele of the Agouti gene was
markedly darker than that of nontransgenic controls of the same Agouti genotype. Microscopic
examination of plucked transgenic hair revealed that it lacked the yellow Agouti band. Semi-
quantitative RT-PCR analyses of transgenic and nontransgenic skin demonstrated that expression
of the Agouti gene is suppressed in the transgenics. These data reveal a previously unknown link
between WNT signaling and hair pigmentation and suggest that expression of the Agouti gene
may normally be controlled by regulation of WNT activity in the hair follicle bulb during early
anagen.
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The Shedding Phase of the Hair Growth Cycle, Exogen, is Coupled to Anagen and
Creates a Unique Hair Shaft Base
Y. Milner, J. Sudnik,* M. Kizoulis,* M. Filippi,* M. Kashgarian,² and K. Stenn*
Biological Chemistry, Hebrew University of Jerusalem, Jerusalem, Israel; *Juvenir, Biosciences, Skillman,
New Jersey, U.S.A.; ²Pathology, Yale University School of Medicine, New Heaven, Connecticut, U.S.A.
The normal hair follicle undergoes phases of growth (anagen), regression (catagen) and rest
(telogen). It has long been recognized that at some time during the cycle the hair sheds. This
shedding phase, the `exogen', has been given little attention and is poorly understood. We
undertook to characterize the exogen phase in the mouse. Using the C57Bl6 strain we develop a
method for collecting and quantifying shed hair from newborn and adult mice. This was based on a
speci®c vacuum-comb device and collection of hair on ®berglass ®lters. We found that the base of
shed hair differs from the base of telogen (resting follicle) hair and that this difference is
demonstrable by light and electron microscopies. The base of the exogen hair shows various
degrees of deterioration of the enveloping cells resembling `nibbled' club morphology. The
`nibbled' club morphology may be related to the proteolytic mechanism of exogen hair dislodging.
Indeed, trypsin-like activity was found strongly adhering onto shed hair clubs. During spontaneous
and induced hair cycles, although there is a basal amount of hair shedding in telogen hairs, the
greatest amount of shedding occurs during mid-late anagen. The hair shafts that are shed in any
phase show predominantly (~70%) exogen morphology. As seen by metabolic labeling by
rhodamine injection or by hair dying, the shedding hair shafts are formed in the previous cycle of
hair growth and labeled hair are induced to shed by inducing new anagen in the hair population.
These studies present a method for collecting and quantifying shed hair and show, for the ®rst time,
that exogen occurs predominately during anagen and that the shaft base is unique. Collectively,
these ®ndings underscore the existence and distinctiveness of the exogen phase of the hair cycle,
allowing further studies in humans.
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Mechlorethamine Restores Autoimmune-Arrested Follicular Activity by Targeting
In®ltrated Lymphocytes in Mice with an Alopecia Areata-Like Disease
L. Tang, L. Cao, O. Bernado, Y. Chen,² J. P. Sundberg,* H. Lui, S. Chung,² and J. Shapiro
Medicine, The Univesity of British Columbia, Vancouver, British Columbia, Canada; *Pathology, Jackson
Laboratory, Bar Harbor, Maine, U.S.A.; ²Surgery, The University of British Columbia, Vancouver, British
Columbia, Canada
Alopecia areata (AA) is an autoimmune disease targeted at hair follicles with in®ltrated T
lymphocytes likely playing an important role in the pathogenesis. It was reported in 1985 that
mechlorethamine was effective on AA patients. This has never been con®rmed since. The aims of
the study were to investigate the effects of mechlorethamine on balding C3H/HeJ mice affected
with an AA-like disease and to study the underlying mechanisms. Mice were treated on half of the
dorsal skin with mechlorethamine and the contralateral side was treated with the vehicle ointment.
A full pelage of hair covered the treated side in all the mice and was maintained during the
experiment, while the vehicle-treated sides showed either no change or continued hair loss. RNase
protection assay showed that interleukin 12, tumor necrosis factor a/b were consistently and
signi®cantly inhibited by mechlorethamine upon successful treatment. Immunohistochemistry
analysis revealed that in®ltrated CD4+ and CD8+ lymphocytes were eliminated from the treated
side. Furthermore, in vitro cell viability assay showed that lymphocytes were much more sensitive
to the cytotoxic effects of mechlorethamine than skin and hair follicular cells. Our ®ndings support
that mechlorethamine restores follicular activity by selectively targeting in®ltrated lymphocytes in
vivo in AA-affected mice.
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The Sonic Hedgehog Target Gene, BEG4, is an Actin Binding Protein that Regulates
Epithelial Morphogenesis
L. Horng, C. A. Callahan, H. Zhen, J. Xu, T. Ofstad, and A. E. Oro
Dermatology, Program in Epithelial Biology, Stanford University, School of Medicine, Stanford, California,
U.S.A.
Sonic hedgehog (Shh) signaling is required for both hair follicle morphogenesis and basal cell
carcinoma (BCC) formation. How Shh mediates its dramatic morphogenic effects on epithelia is
unknown. BEG4 is a novel protein we previously identi®ed in a microarray screen for hh target
genes in BCCs. Here we show BEG4 binds F-actin in a sedimentation assay. Transfected BEG4
induces densely branching cytoplasmic extensions in cultured ®broblasts. in vivo, areas of
regenerated human epidermis expressing myc tagged BEG4 correlate with increased epithelial
proliferation and ingrowth. Together these data suggest that BEG4 de®nes a novel mechanism
through which Shh controls cell morphology during development and carcinogenesis.
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Trophic Effects of Estrogens and Androgens on Human Hair Bulb Melanocytes in Hair
Follicle Organ Culture
J. Thornton and D. J. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, West Yorkshire, U.K.
Several studies have suggested a role for estrogens and androgens in regulating mammalian
pigmentation. While some areas become hyperpigmented after puberty when plasma androgens
rise, some become hyperpigmented during pregnancy when estrogen levels rise. Furthermore,
these steroid hormones may also be important in regulating hair and coat color. In order to
establish a role for estrogens and androgens in human hair follicle melanocyte biology, we
examined the effects of these hormones in an organ culture system. Hair follicles isolated from
occipital male scalp were graded morphologically for quality and growth cycle stage. Intact anagen
VI follicles were grown in glucose supplemented William's E serum-free medium containing
vehicle (0.0001% ethanol), or either 10 nM testosterone, 10 nM 5a-dihydrotesterone, 10 nM 17b-
estradiol, or combinations of 17b-estradiol with either testosterone or 5a-dihydrotesterone. After
4 days hair follicles were assessed by high-resolution light microscopy and transmission electron
microscopy. Most pigmented hair bulb melanocytes were lost from control hair follicles (n = 4),
while remaining melanocytes exhibited evidence of apoptosis. By contrast, hair follicles grown in
estradiol contained many hair bulb and outer root sheath melanocytes. The former also exhibited
their characteristic dendritic and pigmented phenotypes and remarkably were occasionally seen to
proliferate. Hair follicles treated with 5a-dihydrotesterone however, contained several pigmentary
abnormalities including cell apoptosis, pigment clumping, and clustering of degenerating pigment
cells transferred to the precortex. Similar, but milder, effects were seen with testosterone. Estradiol
combined with either androgen did not completely reverse these melanocyte defects. For the ®rst
time, this study demonstrates that both estrogens and androgens have a direct role on hair follicle
melanocytes. Although, both steroid hormones positively in¯uence hair follicle melanocyte
homeostasis, estrogens markedly increase cell survival.
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WNT Signals are Required for the Initiation of Hair Follicle Development and for
Postnatal Hair Growth
S. E. Millar, T. Andl, S. T. Reddy, and A. Glick*
Departments of Dermatology and Cell and Developmental Biology, University of Pennsylvania, Philadelphia,
Pennsylvania, U.S.A.; *Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer
Institute, Bethesda, Maryland, U.S.A.
Mutations in downstream effector genes of a conserved WNT signaling pathway cause hair follicle
phenotypes, suggesting that WNT proteins control hair follicle development and postnatal hair
follicle cycling. To begin to test this hypothesis we previously surveyed for Wnt and WNT
receptor (Frizzled) gene expression in developing and postnatal mouse skin. We discovered that
several Wnt and Frizzled genes are expressed in developing hair follicles, in speci®c cell layers of
postnatal anagen follicles, and in the dermal papilla and adjacent epithelial cells of hair follicles at
anagen onset. To investigate the effects of blocking the actions of WNT proteins in the skin and
hair we made use of Dickkopf 1 (DKK1), a potent secreted WNT inhibitor. Transgenic embryos
expressing high levels of Dkk1 in basal epidermal cells under the control of a keratin 14 promoter
displayed a complete absence of hair follicle, tooth and mammary gland development. Molecular
markers of hair follicle placodes, including the very early markers Ectodysplasin receptor and Lef1,
failed to show normal patterned expression in transgenic skin, indicating that WNT signals are
required for the localized expression of placode markers and for initiation of hair follicle
development. To determine whether WNT signals are also necessary for postnatal hair follicle
cycling we developed a bi-transgenic system in which expression of Dkk1 in the epidermis and hair
follicle outer root sheath can be induced by oral doxycycline. Doxycycline treatment of embryos
throughout gestation caused phenotypes identical to those resulting from constitutive expression of
Dkk1. In contrast, single transgenic and untreated bi-transgenic pups were normal. Administration
of doxycycline to previously untreated bi-transgenic postnatal mice prevented hair growth. WNT
signals are therefore necessary for both hair follicle formation and postnatal hair growth.
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Cloning and Initial Characterization of the Human Hairless Promoter
A. Engelhard* and A. M. Christiano*²
*Dermatology, Columbia University, New York, New York, U.S.A.; ²Genetics and Development,
Columbia University, New York, New York, U.S.A.
Mutations in the human hairless gene (hr), which is expressed predominantly in the skin and brain,
are responsible for atrichia with papular lesions. Expression of hr in the skin is regulated in a hair
cycle-dependent manner. During catagen, hr expression is differentially regulated among the
different cellular compartments of the hair follicle (HF) itself, and abrogation of hr leads to the loss
of structural integrity of the HF in humans and mice. Although the exquisite control of h
expression is essential for HF cycling, the elements which regulate it remain unknown. In order to
further understand the control of hr expression, a ®ve-fold replicative human genomic BAC library
was screened with a 5¢ hr cDNA probe. Five positive clones were isolated, and two were used for
chromosome walking upstream of the transcription initiation site. hr has been identi®ed as an early
response gene to thyroid hormone (T3) stimulation in the developing rat brain, and the position of
a thyroid hormone response element (TRE), previously reported at 9 kb upstream in the rat hr
gene, was ®xed at 2.7 kb upstream in the human promoter. Transient transfection of luciferase gene
reporter constructs linked to sequential 5¢ deletions of the promoter demonstrate that the ®rst
1.5 kb of upstream sequence is suf®cient to drive maximal basal expression of the reporter in both
human keratinocyte and human neuroblastoma cell lines in hormone depleted medium. The basal
activity of the full length clone is up-regulated several fold by the addition of T3 to the medium.
Furthermore, basal activity of the promoter is greater in keratinocytes than neuroblastoma cells as
compared to SV40 minimal promoter. Further dissection of cis-acting regulatory regions of the
human hr promoter will provide new insight into the mechanisms of HF cycling.
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Monitoring of Labeled Bone Marrow-Derived Cells in Cutaneous Wounds Made in a
Murine Bone Marrow Transplantation Model
E. V. Badiavas, M. Abedi,* J. Butmarc, P. Quesenberry,* and V. Falanga
Dermatology and Skin Surgery, Roger Williams Medical Center, Boston University School of Medicine,
Providence, Rhode Island, U.S.A.; *Hematology and Oncology, Roger Williams Medical Center, Boston
University School of Medicine, Providence, Rhode Island, U.S.A.
During wound healing a variety of bone marrow derived cells migrate to wounds. Many of these
cells, particularly mature in¯ammatory cells, are well known to participate in the healing process.
The fate of some migrated bone marrow derived cells is however, often dif®cult to determine.
Recent evidence indicating the potential great plasticity of adult bone marrow stem cells raises the
possibility that some of the migrating cells to wounds could become skin structures. We
investigated this possibility in a murine bone marrow transplantation model. We followed the fate
of green ¯uorescent protein (GFP) bone marrow derived cells in wounds made in a non-GFP
expressing mouse that had previously been transplanted with GFP bone marrow. Many more bone
marrow derived cells than predicted were observed in wounded and nonwounded skin. Some
bone marrow derived cells (as evidenced by GFP expression) also were noted within mature skin
structures, including dermal blood vessels. Thus, bone marrow likely represents a greater resource
for cells important in wound healing than was previously expected.
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Replacement of Actinically Damaged p53 Mutant Interfollicular Epidermal Stem Cell




N. Urato, R. Anderson, J. E. Murphy, and T. S. Kupper
Dermatology, BWH/Harvard, Boston, Massachusetts, U.S.A.
Human epidermis contains two populations of keratinocyte stem cells- interfollicular stem cells,
which reside in the basal epidermis, and follicular stem cells, which reside in the follicle bulge.
While follicular stem cells are relatively protected from UVB mediated genetic damage,
interfollicular stem cells are not and may accumulated UVB induced mutations over decades. We
proposed that elimination of the interfollicular epidermis would lead to a repopulation of
interfollicular stem cell niches with the progeny of photoprotected follicular stem cells, and that
this may underlie the observed reduction in the development of actinic keratoses after
dermabrasion, laser resurfacing, or accidental second degree burn. Ten patients with documented
actinically damaged skin had facial shave biopsies taken before or eight weeks after laser resurfacing
of the face. Single cell suspensions were derived from epidermal sheets and enriched for stem cells
by rapid adherence via b1 integrin to collagen I coated plates. Rapidly adherent cells were washed
and were plated at clonal density, and colonies containing > 100 cells (putative stem cell colonies)
were chosen for sequencing. DNA was extracted and exon 7 of the P53 gene was sequenced.
Before laser resurfacing, 8/10 patients had between one and three identi®ed mutations in exon 7,
while 2/10 showed no identi®able mutations. After laser resurfacing, none of the stem cell colonies
derived from shave biopsies from either the 8 previously positive patients or the 2 previously
negative patients showed exon 7 P53 mutations. These data are consistent with the hypothesis that
interfollicular ablation the epidermis removes photodamaged interfollicular stem cells, and that re-
epithelialization from hair follicle stem cells leads to repopulation of interfollicular stem cells niches
with photoprotected, genetically intact stem cells. This suggests a mechanism for the observation
that procedures that ablate interfollicular epidermis may protect against the development of
keratinocyte neoplasia.
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Hair vs. Eccrine Gland: Timing and Competition of Skin Appendage Speci®cation on
the Limb
C. Loomis, C. Tong, and P. Kraus
Dermatology, NYU School of Medicine, New York, New York, U.S.A.
During the phase of rapid limb outgrowth (mouse E9.0±12.5) the ectoderm, not mesenchyme,
directs skin appendage speci®cation. The aim of this study was to determine the precise timing of
this ectodermally mediated event and to clarify the complex interactions of two ectodermally
expressed genes, Wnt7a and En1. As has been previously shown by our lab and others, Wnt7a
signaling from the dorsal limb ectoderm is required for distal hair formation; whereas En1, a
homeobox transcription factor expressed in the ventral/volar ectoderm, is required for pad and
eccrine gland development. Observations in a variety of mouse mutants had suggested to us that
regional speci®cation of distal limb skin occurs earlier than previously thought. To test our
hypothesis, we used a Msx2 enhancer to ectopically drive ventral ectodermal expression of the
dorsalizing gene Wnt7a during a brief period of early limb development. In contrast to the
assumption that mouse ectoderm directs skin appendage speci®cation between E10.5±12.5, our
studies suggest that ectodermal regulation occurs earlier, as the limbs bud from the embryonic ¯ank
(E9.5±10.0). Transient ectopic Wnt7a at this stage is suf®cient to maintain expression of the
transcription factor, Lmx1b, in the underlying volar mesenchyme, which in turn promotes hair
development. Although endogenous volar En1 expression persists in Msx2-Wnt7a transgenic
limbs, its ability to promote eccrine gland development is greatly reduced, and hairs form at the
expense of glands. To further investigate the hierarchical dominance of hair formation over eccrine
gland development we used ultrasound guided microinjection to deliver a replication incompetent
retroviral vector expressing En1 to presumptive epidermis of the mouse embryo. Although we
have successfully used this technique to manipulate expression of other genes, leading to skin
alterations, preliminary results suggest that retroviral-driven En1 is unable to override an
established program of follicle morphogenesis, suggesting that hair formation may be dominant
over eccrine gland development.
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Compound Heterozygous Mutations in the Hairless Gene Underlie Atrichia with
Papular Lesions
A. Zlotogorski, D. Ben-Amitai,* A. Metzker,² A. Martinez-Mir,³ and A. M. Christiano³§
Department of Dermatology, Hadassah University Medical Center, Jerusalem, Israel; *Department of
Dermatology, Rabin Medical Center, Petah-Tikva, Israel; ²Department of Dermatology, Sourasky Medical
Center, Tel.Aviv, Israel; ³Department of Dermatology, Columbia University, New York, New York,
U.S.A.; §Department of Genetics and Development, Columbia University, New York, New York, U.S.A.
Atrichia with papular lesions is a rare, autosomal recessive form of total alopecia, in which
mutations in the hairless (hr) gene have been shown to underlie the phenotype. We suspect that
APL is actually much more common that previously believed. We sought to investigate whether
APL might also be found among patients in small families, particularly those giving a history of
normal hair at birth which was shed and never regrew, and `alopecia universalis' that is
unresponsive to treatment. We identi®ed a small family of Iraqi (paternal)-Moroccan (maternal)
descent in which one of two siblings was affected and gave this clinical history. Sequence analysis of
the hr gene revealed a nonsense mutation in exon 4 (Q478X) on the maternal allele, and a splice
site mutation preceeding exon 5, at the splice acceptor site of intron 4 (1557±1G > T) on the
paternal allele. Interestingly, the mutation Q478X was previously reported in the homozygous
state in an APL patient of Pakistani origin. The recurrence of this mutation in an individual of
Morrocan origin suggests that it may represent a mutational hotspot. These ®ndings con®rm the
hypothesis that APL can exist in small nonconsanguineous families and may be masquerading
clinically as alopecia universalis. We anticipate that an increased recognition of this disorder in
small nonconsanguineous families such as this one will result in accurate discrimination between
APL and alopecia universalis.
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The Role of p63 in Epidermal Development
M. I. Koster* and D. R. Roop*²
*Program in Developmental Biology, Baylor College of Medicine, Houston, Texas, U.S.A.; ²Departments
of Molecular and Cellular Biology and Dermatology, Baylor College of Medicine, Houston, Texas, U.S.A.
Expression of the transcription factor p63 is required for proper development of strati®ed epithelia
and their derivatives. Since p63 is transcribed into six isoforms, we are attempting to determine the
role of each isoform during epidermal development. Transfection studies demonstrate that two p63
isoforms that contain a transactivation domain, TAp63a and TAp63g, are able to induce keratin 14
(K14) expression in cell lines that normally do not express p63 or K14. These cell lines include
Ptk2 cells (kidney epithelial cells), HR9 cells (embryonic endodermal cells) and F9 cells
(embryonic teratocarcinoma cells). Since K14 is one of the ®rst structural proteins expressed during
normal epidermal development, induction of K14 by TAp63a and TAp63g suggests a role for
these p63 isoforms in the commitment to squamous epithelial lineages. To further test this
hypothesis, we are currently studying the role of TAp63a and TAp63g in primary p63
±/±
keratinocytes. Keratinocytes cultured from p63
±/±
embryos proliferate at a lower rate than wild
type keratinocytes and fail to express keratins associated with a squamous differentiation program,
such as K14. Different p63 isoforms are being introduced into p63
±/±
keratinocytes to determine
which of these can rescue the proliferation defect and restore the keratin expression pro®le to that
of wild type keratinocytes. To con®rm these ®ndings in vivo, we are currently generating a
transgenic mouse model in which expression of different p63 isoforms can be induced in a tissue-
speci®c manner. In conclusion, our data demonstrate that TAp63a and TAp63g can induce K14
expression suggesting that these p63 isoforms have an essential role in the commitment to
squamous epithelial lineages, such as the epidermis.
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Difference of Caspase Activation in Hair Follicle and Epidermis
Y. Tsuji and T. Hibino
Basic Research Center, Shiseido, Yokohama, Japan
In hair cycle, regression phase, catagen is characterized with massive apoptosis in epithelial cells.
On the other hand, the terminal differentiation of keratinocytes is suggested to include apoptotic
processes, since TUNEL-positive cells are observed in some of the granular cells. In order to
analyze difference of apoptosis in hair follicle and epidermis, we focused on the three members of
caspase family, caspase-3, 9 and 14. Caspase-3 and 9 are well-known executioner of apoptotic cell
death, while caspase-14 may play a role in keratinizing processes. It is pivotal to identify sites of
caspase activation, since apoptosis is dependent on the activation of caspase network. We used
cleavage-site directed antibodies to these three caspases and analyzed the caspase activation. Active
caspase-3 and 9 immunoreactivities were observed similarly in the regressing epithelial cells during
early to late catagen hair follicles. Anagen hair follicles were mostly negative except few cells in
keratinizing area. Then we tested the effect of TGF-b2 on the caspase activation in hair follicles,
since we have already shown that TGF-b2 functions as a mediator of catagen induction. Using an
organ culture system, we found that TGF-b2 could activate caspase-3 and 9 in two regions, lower
part of germinative matrix cells and outer layer of ORS cells. Interestingly active caspase-14 was
almost undetectable in anagen hair follicles, although corni®ed layer of epidermis was ubiquitously
stained. Even if in the presence of TGF-b2, none of hair follicle cells became positive for this
antibody. Collectively our results suggest that catagen progression is dependent on speci®c caspase
activation and TGF-b2 exerts caspase-3 and 9 active at the speci®c sites in the induction of catagen,
whereas activation of caspase-14 is important for keratinocyte terminal differentiation.
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Laminin 10 is Essential for Hair Development
J. E. Tzu, J. Li,² T. D. Lehman, Y. Chen, N. T. Nguyen, D. R. Keene,* J. H. Miner,³ A. E. Oro,
and M. Marinkovich
Epithelial Biology, Stanford University, Stanford, California, U.S.A.; *Research Unit, Shriners Hosp.,
Portland, Oregon, U.S.A.; ²Dermatology, University Miami, Miami, Florida, U.S.A.; ³Nephrology,
Washington University, St. Louis, Missouri, U.S.A.
Laminins play a key role in epithelial morphogenesis. The ®nding that laminin 10 (a5b1g1) is
prominently expressed in developing hair follicles suggests its key role in hair follicle development.
Mice lacking laminin 10 (Lam a5
±/±
) die at EGA 16, therefore we studied the development of hair
follicles in Lam a5
±/±





skin showed a lack of hair development, showing only occasional rudimentary hair buds
which failed to elongate and displayed decreased sonic hedgehog expression. Lam a5
±/±
skin also
exhibited dermal ®brosis. Triamcinolone injection reversed the ®brosis in Lam a5
±/±
grafts, but had
no effect on hair formation, suggesting that hair and ®brotic defects were not linked. Other defects
of Lam a5
±/±
skin included altered localization of nidogen, perlecan and type VII collagen to
basement membrane and lamina densa disruption, suggesting that laminin 10 s role in basement
membrane assembly may be a critical factor in hair follicle development. Intriguingly, incubation
of Lam a5
±/±
skin with a single application of puri®ed human laminin 10 prior to grafting restored
hair follicle development to levels comparable to Lam a5
+/+
skin for up to 9 days. Exogenous
laminin 10 treatment of Lam a5
±/±
skin also reversed ®brosis, ectopic localization of nidogen/
perlecan/collagen VII, and lamina densa defects. To verify that laminin 10 is important in human
hair development, we grafted human scalp skin to SCID mice, then treated the mice with IP
injections of puri®ed inhibitory antibodies to human laminin 10 (4C7), its receptor b1 integrin
(P5D2), or control mouse IgG. Three weeks of 4C7 or P5D2 treatment induced alopecia and
®brosis in scalp skin grafts, while control IgG had no effect. These studies suggest that laminin 10
plays a key role in human hair development and may effect its function via b1 integrins.
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Large Scale Puri®cation of Murine Dermal Papilla Cells to Study Inductive Signaling in
the Hair Follicle
B. A. Morgan and D. Enshell
CBRC, MGH/Harvard Medical, Charlestown, Massachusetts, U.S.A.
Signaling between the dermal papilla and the epithelial components of the hair follicle is thought to
regulate hair growth. Kishimoto et al ((1999) PNAS USA 96, 7336±7741) reported the use of a
transgenic mouse expressing GFP under the control of a fragment of the versican promoter to
purify a cell population that has the ability to induce hair growth in a skin reconstitution graft assay.
They characterized that population as a highly puri®ed preparation of dermal papilla cells. Our
subsequent collaborative work showed that Wnt signaling can maintain the growth inducing
activity of this population in culture (Kishimoto et al (2000) Genes & Dev. 14 : 1181±1185).
However, our independent analysis of this mouse strain shows that the GFP positive population
puri®ed from P3 newborn skin includes cells from the upper dermis and dermal sheath as well as
dermal papilla cells, and that nondermal papilla cells may comprise more than 60% of the sorted
population. This raises the question of whether dermal papilla cells, cells of the upper dermis, or
both have the ability to induce hair growth in the skin reconstitution assay. We have employed in
situ hybridization to identify a battery of markers that distinguish between these populations and
used these markers to re®ne protocols to purify dermal papilla cells from other GFP positive
populations. We will report an accurate description of GFP expression in these versican-GFP
transgenic mice, methods to separate dermal papilla cells from other contaminating populations,
and our analysis of the ability of different subpopulations of GFP-expressing cells from this
transgenic mouse line to induce hair growth in a skin reconstitution assay.
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Constitutive Activation of the Notch Pathway in the Hair Follicle Inner Root Sheath
Results in Abnormal Differentiation of the Adjacent Outer Root Sheath
H. Uyttendaele,* A. A. Panteleyev,* and A. M. Christiano*²
*Department of Dermatology, Columbia University, New York, New York, U.S.A.; ²Department of
Genetics and Development, Columbia University, New York, New York, U.S.A.
Notch genes encode for transmembrane receptor proteins and control key regulatory processes
during mouse development. Alterations in the Notch signaling pathway have been demonstrated
in human developmental disorders, as well as in benign and malignant tumors. Notch proteins and
their ligands are expressed in mammalian skin and its appendages. The goal of this project is to
study the role of Notch1 in the epidermis and hair follicle using a transgenic mouse model. The
involucrin promoter was used to target over-expression of a constitutive activated Notch1 allele to
the suprabasal keratinocytes in the epidermis and speci®cally to the inner root sheath (IRS) of the
hair follicle. Transgenic animals display skin and hair abnormalities, consistent with the expression
of involucrin in the epidermis and hair follicle. The predominant hair abnormality is a reversible
alopecia that temporarily spares midline hair follicles, which we call `Mohawk alopecia'. The
mechanism of the hair loss appears to be caused by two major defects. The ®rst abnormality is the
failure of formation of the club hair, due to the inability of the hair shaft and outer root sheath
(ORS) to interdigitate and form the normal club in the lower follicle, resulting in the loss of
anchorage. The second defect is the dilation of the hair canal and an abnormal trichilemmal comb
in the upper portion of the hair follcle. Unexpectedly, these abnormalities are hallmarks of a defect
of trichilemmal keratinization, which is a function of the ORS, whereas in our mice, Notch 1 is
targeted to the IRS. These observations suggest that activation of Notch signaling in the IRS
resulted in a disturbance of differentiation in the adjacent ORS, and that these nonautonomous
effects may be the result of homotypic cell±cell interactions between the keratinocytes of the IRS
and ORS. Our ®ndings support the hypothesis that Notch participates in the determination of cell
fate during differentiation of the hair follicle epithelial layers.
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Isolation and Characterization of Epithelial Stem Cells from K15/eGFP Transgenic
Mice
Y. Liu, R. J. Morris,* Z. Yang, C. S. Trempus,² and G. Cotsarelis
Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A.;
*Dermatology, Columbia University, New York, New York, U.S.A.; ²Environmental Carcinogenesis and
Mutagenesis, National Institute of Environmental Health Sciences, RTP, North Carolina, U.S.A.
Kinetic and lineage studies have shown that epithelial stem cells in the hair follicle bulge
differentiate into epidermis, sebaceous gland and hair follicle. Therefore, the isolation and
manipulation of bulge cells could lead to a better understanding of cellular differentiation and
determination in the cutaneous epithelium, and provide a source of stem cells for gene therapy and
reconstitution of skin and its appendages. We previously demonstrated that keratinocytes in the
stem cell rich bulge area of the hair follicle preferentially express cytokeratin 15 (K15) in both
mouse and human skin. We then isolated the K15 promoter and demonstrated its utility for
preferentially targeting putative epithelial stem cells in K15/lacZ transgenic mice. Here we describe
the generation of transgenic mice expressing enhanced green ¯uorescent protein (eGFP) under the
control of the K15 promoter. Using FACS, we isolated the brightest eGFP-positive cells from the
skin of mice from 3 independent K15/eGFP lines. The isolated cells constituted approximately
7.5% of the total live epithelial cell population. We show that these cells have properties of
epithelial stem cells. Firstly, they produce keratinocyte colonies in vitro that are larger and more
numerous when compared to noneGFP expressing basal (a-6 integrin-positive) keratinocytes.
Secondly, they are predominantly in the G0/G1 stage of the cell cycle with only 0.175% of cells in
S-phase, compared to 2.2% of a-6 integrin positive/K15-negative cells (p < 0.01). Lastly, K15/
eGFP-positive cells also express CD34, a marker of hematopoietic progenitor cells that recently
was discovered in hair follicle bulge cells. These data support the concept that cytokeratins are
expressed in a differentiation-speci®c manner, and that K15 is a marker of cutaneous epithelial stem
cells. The K15/eGFP transgenic mouse provides a valuable tool for studying epithelial stem cell
biology both in vitro and in vivo.
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Nestin Expression in Hair Follicle Stem Cells
R. M. Hoffman, L. Li, J. Mignone,* M. Yang, and G. Enikolopov*
N/A, AntiCancer, Inc., San Diego, California, U.S.A.; *N/A, Cold Spring Harbor Laboratory, Cold
Spring Harbor, New York, U.S.A.
Nestin is an intermediate ®lament that is a marker for central nervous system progenitor cells.
Transgenic mice with green ¯uorescent protein (GFP) under the control of the nestin regulatory
sequences have been generated and used for visualization of the self-renewal and multipotency of
CNS stem cells. We found that in early anagen in these nestin-GFP transgenic mice, nestin-
expressing cells are located in the permanent upper hair follicle right below the sebaceous glands in
the follicle bulge where the hair follicle stem cells are located. The nestin-expressing cells in the
bulge area are relatively small, oval shaped and surround the hair shaft with short dendrites
connecting them to each other. We observed that the location of the nestin-expressing cells in the
hair follicle are hair-cycle dependent. During telogen and early anagen, the GFP-positive cells are
mainly in the bulge area. However, in mid and late anagen, the GFP-expressing cells are located in
the upper outer root sheath as well as in the bulge area but not in the hair matrix bulb. These
observations suggest that the nestin-expressing cells form the outer-root sheath consistent with
behavior observed for hair follicle stem cells. Nestin-driven GFP was also found to be highly
expressed in an interfollicullar neural-like network. The common expression of nestin in neural
stem cells, in hair follicle stem cells, and in an interhair-follicle neural-like network suggests their
common origin and gives rise to the possibility of the hair follicle stem cells being able to form
neural cells under appropriate conditions.
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Cessation of Sonic Hedgehog Signaling is Required for Outer Root Sheath Regression
During Postnatal Hair Cycling
H. Sheng, A. Wang, L. Wei, and A. Dlugosz
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Sonic hedgehog (Shh) signaling is required for proliferation of hair follicle keratinocytes during
embryogenesis and has been implicated in regulating the hair cycle, which consists of growth
(anagen), regression (catagen), and resting (telogen) phases. Based on in situ analysis of Shh target
gene expression, this pathway is active in proliferating keratinocytes of the outer root sheath in
anagen but not telogen, when growth of these cells has ceased. To explore the potential
signi®cance of this observation, we analyzed K5 promoter-driven transgenic mouse lines in which
the Shh pathway was stimulated in outer root sheath using an activated mutant of the transcription
factor Gli2, called Gli2DN2. Progression through catagen and telogen (postnatal days 17±20) in
control mice resulted in the typical reduction in hair follicle length due to normal involution of the
lower two-thirds of the follicle. In striking contrast, the length of hair follicles in K5-Gli2DN2
littermates was essentially unchanged at day 17 and 20, and in most cases did not shorten until day
23. Immunostaining for multiple hair follicle markers revealed that this phenotype was due to a
selective defect involving the outer root sheath. While the hair matrix and inner root sheath
regressed at similar times in control and K5-Gli2DN2 mice, outer root sheath cells, surrounding
mature hair shafts, persisted in the transgenics. Double-immunostaining for K5 and BrdU on day
17 revealed continued proliferation in K5-Gli2DN2 outer root sheath keratinocytes at a time when
labeling was not detected in control follicles. Our data support the concept that Shh signaling acts
to stimulate proliferation of hair follicle keratinocytes via Gli transcription factors, and suggest that
programmed cessation of Shh pathway activity is required for hair follicle regression during
catagen.
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Aromatase and Oxidative 3a-Hydroxysteroid Dehydrogenases are Present in Human
Hair Follicles and Regulate Intrafollicular DHT Levels
R. Hoffmann
Dermatology, Philipp University, Marburg, Hessen, Germany
Dihydrotestosterone (DHT) is the most important trigger of androgen-dependent hair growth.
The intrafollicular concentration of DHT is mainly regulated by steroid 5a-reductase. However,
recent data from other tissues revealed that DHT levels can also be modulated via the action of
aromatase or oxidative 3a-hydroxysteroid dehydrogenases (3HSD). We therefore addressed the
questions whether aromatase and 3HSD are present in human hair follicles and whether their
enzymatic activity can be modulated. By the use of immunohistochemistry, quantitative analysis of
steroids with HPLC and direct measurement of enzyme activity, we were able to detect aromatase
mainly in the epithelial parts of the hair follicle, whereas 3HSD was mainly expressed in the dermal
papilla. In addition, were able to show that aromatase activity in isolated intact human hair follicles
is modulated by 17a-estradiol in such way that in comparison to the controls, we noticed a
concentration- and time-dependent increase of aromatase activity in 17a-estradiol-incubated
female hair follicles (e.g. 24 h: 1 nM = + 18%, 100 nM = + 25%, 1 mM = + 57%; 24 h:
1 nM = + 18%, 48 h: 1 nM = + 25%). Moreover, we noticed that the dermal papilla is able to
convert the weak androgen 3a-Androstenediol back to DHT via 3HSD. In summary, our ex vivo
results suggest that aromatase and 3HSD are present in the hair follicle and act antagonistically. In
theory the aromatase pathway may diminish the amount of intrafollicular testosterone available for
conversion to DHT, whereas 3HSD adds additional DHT. Our results suggest that increasing
aromatase or inhibiting 3HSD activity are novel approaches to stop the development or
progression of DHT-mediated processes
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EDA Speci®c Gene Expression Pro®le in Tabby Skin
C. Cui
Nih, Nih/National Institute on Aging, Baltimore, Maryland, U.S.A.
Mutations in the EDA gene cause Anhidrotic Ectodermal Dysplasia (EDA), with lesions in skin
appendage formation. To begin to analyze EDA pathways, we have used expression pro®ling on
15,000-gene mouse cDNA microarrays, comparing adult mouse skin from wild-type, EDA-
defective (tabby) and tabby mice supplemented with a single isoform of the gene, `EDA-A1', that is
suf®cient to rescue multiple phenotypes. 9000 genes (60%) were expressed in skin, including
transcription factors and growth-regulatory genes that had not previouly been identi®ed there; but
only 24 (0.16%), one third of them novel, showed statistically signi®cant differences in RNA levels
between wild type and tabby mice. Differences were con®rmed and extended by quantitative real-
time PCR assays of 9 genes, and by restoration of the expression level of 11 of the 24, including
genes with the most extreme changes, at leads two-fold in EDA-A1 transgenic tabby animals.
Epidermal genes c-fos, c-jun and adrenomedullin were sharply down-regulated, and lesser
reductions were also seen in JNK, NEMO, and NF-kB (p50). Notable up-regulation was observed
for several dermal genes, including COL1A1, COL1A2, COL3A1 and SPARC. The results are
compatible with EDA regulation of a discrete subset of known and novel NF-kB and JNK-
controlled genes involved in dermal and skin-appendage morphogenesis.
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Augmentation of Lipogenesis and the Regulation of Perilipin Expression by
Prostaglandins in Hamster Sebocytes
T. Sato, N. Akimoto, C. Iwata, M. Sumida,* and A. Ito
Department of Biochemistry, Tokyo University of Pharmacy & Life Science, Hachioji, Tokyo, Japan;
*Department of Second Medical Biochemistry, Ehime University School of Medicine, Shigenobu, Ehime,
Japan
Sebaceous glands are important skin appendages and sebum excretion is considered to be associated
with the functional maintenance of the surface of the skin as a biological barrier. Sebaceous gland
cells (sebocytes) differentiate and sequentially form intracellular lipid droplets. We have reported
that growth factors such as EGF, TGF-a and bFGF, and 1a,25-dihydroxyvitamin D3 interfere
with lipid formation in hamster sebocytes in vitro (Sato et al J. Invest. Dermatol. 117, 2001;
Akimoto et al Dermatology 204, in press, 2002). In addition, prostaglandins (PGs) have been
reported to associate with the sebocytic differentiation in vivo. On the other hand, it is also well
known that adipocytes differentiate to accumulate abundant lipids in the cytoplasm. Perilipin, a
protein expressed at the periphery of lipid droplets, may participate in lipid metabolism in
adipocytes. However, it remains unclear whether PGs and perilipin are involved in the formation
of lipid droplets in sebocytes. In the present study, we demonstrated that PGF2a and PGJ2
stimulated hamster sebocytes to form lipid droplets. The augmented lipids consisted mainly of
triglycerides (TGs). In addition, perilipin was constitutively expressed at the periphery of the lipid
droplets in the hamster sebocytes, and its gene expression and production were augmented by
PGJ2. Moreover, in primary hamster adipocytes, PGJ2 similarly augmented the level of TGs and
the production of perilipin whereas PGF2a suppressed the TG levels and did not in¯uence that of
perilipin. These results suggest that PGF2a and PGJ2 may play roles as endogenous regulators for
stimulating lipogenesis in sebaceous glands, and that the regulation of lipogenesis by PGs may differ
between sebocytes and adipocytes. Furthermore, this is novel evidence that in hamster sebocytes
perilipin localizes at the surface of lipid droplets and its expression is augmented by PGJ2.
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T Cells in Extensive Alopecia Areata Scalp are Partially Tolerant
L. Steiner, M. J. Deeths,* M. E. Ericson, and M. K. Hordinsky
Dermatology, University of Minnesota, Minneapolis, Minnesota, U.S.A.; *Dermatology, University of
Colorado, Denver, Colorado, U.S.A.
This study demonstrates the feasibility and ef®cacy of using ¯ow cytometric analysis (FCA)
combined with intracellular cytokine staining for the characterization of T cell phenotype and
function in scalp skin. We compared the data from 12 patients (5M, 7F, ages 30±68, average disease
duration 8 years) with normal control subjects (3M, 3F). All patients had extensive alopecia areata
(> 95% hair loss). A cell suspension was made from two 4-mm punch biopsies taken from the right
parietal scalp of each participant. A 4-ml aliquot was kept at 4C for 4 h while an 8-ml aliquot was
activated and stained for interleukin-2 (IL-2), interferon g (IFN-g), and tumor necrosis factor a
(TNF-a) expression. Both aliquots were subsequently stained with antibodies to CD3, CD4,
CD8, CD69 and/or isotype controls. Becton-Dickenson ¯ow cytometer software was used for
data acquisition and analysis. Using FCA we found the following in EAA scalp biopsies as
compared to normal controls:
* decreased percentage of CD3+ cells
* no difference in CD4/CD8 ratios
* less IL-2 production by CD8-cells
* less IFN-g production by CD8+ cells
* no difference in TNF-a expression
* no IL-4 expression
* expression of CD69 only in EAA scalp biopsies
Our results with CD69 expression suggest T cells from EAA scalp are speci®c for and activated
by an antigen present in the skin. The defects in cytokine production may explain the relative
paucity of in¯ammatory change observed in the clinical setting and suggest that T cell responses in
EAA scalp are tightly, albeit aberrantly, regulated via mechanisms of peripheral T cell tolerance.
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Microarray Analysis of Human, Rat, and Mouse Dermal Papilla and Connective Tissue
Sheath Cells Reveals Multiple Factors with Potential for Hair Follicle Growth
Regulation
M. Christian, K. McElwee,* and R. Hoffmann*
German Resource Center for Genome Research, German Cancer Research Center, Heidelberg, Hessen,
Germany; *Dermatology, Philipp University, Marburg, Hessen, Germany
Previous research has demonstrated the potential of dermal papilla (DP) cells to induce hair follicle
development whereas connective tissue sheath (CTS) cells do not. We compared the pro®les of
hair follicle derived cultured DP cells vs. CTS cells obtained from humans, PVG/OlaHsd rats and
C3H/HeJ mice using cDNA arrays with the capacity to display transcript levels of 33,000, 25,000,
and 27 000 genes or ESTs, respectively. This approach resulted in the identi®cation of 62
differentially expressed known genes (ratio 5 : 1 or greater), encoding products involved in
morphogenic signaling, transcriptional regulation, extra-cellular matrix modeling, cell structure
and motility. Of greatest interest, signi®cant DP cell expression was noted for HGFAC, MMP1,
MMP3, TMSB10, F3, ICAM3, and UDGH. Signi®cant CTS cell expressed genes included
IGFBP2, IGFBP4, ATDC, ANXA6, EXTL1, GLI2, and SOS1. Immunohistochemical analysis
with monoclonal antibodies to selected gene products identi®ed with human micro arrays
con®rmed relevant statement patterns in hair follicles as predicted by array analysis. Gene
expression pro®ling using cDNA arrays is a comprehensive approach to evaluating hair follicle
compartments. By pro®ling hair follicles at different stages during embryological development and
cycling it may be possible to identify the key regulatory products involved. Pro®ling normal vs.
disease affected hair follicle compartments may also reveal regulatory factors behind the disease and
identify candidate genes for targeting with new therapeutic regimes.
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The Heparan Sulfate Proteoglycan, Syndecan-4, is Essential for the Growth Response of
Mouse Whiskers to FGF-2 and FGF-7 Signaling
T. Iwabuchi and P. F. Goetinck
Cutaneous Biol Res Ctr, MGH/Harvard Medical Sch, Charlestown, Massachusetts, U.S.A.
The syndecans make up a family (syndecan-1,2,3,4) of transmembrane heparan sulfate
proteoglycans (HSPGs). HSPGs bind certain growth factors and act as coreceptors with FGF
receptors (FGFRs) by forming a ternary signaling complex of HSPG, FGFR and FGF. We have
generated syndecan-4 de®cient mice in which the b-galactosidase gene was knocked-in for the
syndecan-4 core protein gene (J Clin Invest, 107:R9-R14; 2001). In the present study, we
examined the effects of FGF-2 and FGF-7 on the growth of whiskers from wild-type and
syndecan-4 null mice in an organ culture system. Whiskers in anagen phase were dissected from
16-week-old female mice. Whiskers from wild-type mice displayed a statistically signi®cant and
dose dependent growth response to FGF-2 and FGF-7. In contrast, whiskers from syndecan-4 null
mice did not respond to either growth factor. A statistically signi®cant growth response of whiskers
from both wild-type and syndecan-4 null mice is evident when the culture medium is
supplemented with either 5% FBS or insulin which does not bind to HSPG. The b-galactosidase
expression in mice homozygous for the targeted syndecan-4 gene and immunohistochemical
studies in wild type mice using antisyndecan-4 antibodies indicate that syndecan-4 is expressed in
whisker follicle keratinocytes, especially in those that make up the inner root sheath. These results
indicate that FGF-2 and FGF-7 are growth stimulators for mouse whiskers, and that syndecan-4 is
important in the FGF signaling and dermal-epidermal communication via FGF-FGFR system in
the whisker follicle.
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Differential Cyclin D Expression in the Human Hair Follicle Bulge
X. Xu, S. Lyle, Y. Liu,* B. Solky,² and G. Cotsarelis*
Pathology, Harvard, Boston, Massachusetts, U.S.A.; *Dermatology, University of Pennsylvania,
Philadelphia, Pennsylvania, U.S.A.; ²Dermatology, Harvard, Boston, Massachusetts, U.S.A.
The goal of this study is to identify differentially expressed genes in the bulge region of the hair
follicle. We collected telogen bulges and anagen bulbs from human scalp hair follicles. We then
isolated mRNA and generated cDNA from these tissues. We compared a duplicate set of DNA
macroarrays after probing with p-32 labeled bulge and bulb cDNA. Thirteen out of 588 genes,
including cyclin D1, were expressed in the bulge and not the bulb. Using real time PCR, we
determined that cyclin D1 expression levels were 3.5 fold higher in the bulge compared to the
bulb. Cyclin D1 interacts with cyclin-dependent protein kinases and retinoblastoma protein and
plays a central role in cell proliferation. Using immunohistochemistry, we demonstrated that cyclin
D1 is expressed in suprabasal cells of the bulge outer root sheath of telogen and anagen follicles. We
also noted staining in the immediate proliferating progeny of bulge cells at anagen onset.
Immunohistochemical staining for cyclin D1, D2 and D3 in the bulb matrix cells showed no
distinct nuclear staining, even though these matrix cells were strongly positive for Ki67 and
retinoblastoma. In contrast, pilomatricoma, an adnexal tumor arising from hair matrix cells, stains
for cyclin D1, D2 and D3. We con®rmed the suprabasal expression of cyclin D1 in the bulge outer
root sheath using Laser Capture Microdissection and real-time PCR. Our data suggest that the
normal proliferation of anagen matrix cells is not mediated through cyclin Ds. We hypothesize that
cyclin D1 plays a role in the conversion of stem cells to transit-amplifying cells at anagen onset, and
may facilitate the formation of follicle-derived tumors such as pilomatricomas. Consistent with this,
activating mutations in ?-catenin, a known regulator of cyclin D1 expression, have been identi®ed
in the majority of pilomatricomas. That hair matrix cells are highly proliferative, yet almost never
generate malignant tumors also suggests that noncyclin D mediated proliferation affords a degree of
protection from malignant conversion in rapidly proliferating tissues.
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In Vivo Alteration of the Keratin 17 Gene in Hair Follicles by Oligonucleotide-Directed
Gene Targeting
W. Fan and K. Yoon
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.
Keratin 17 (K17) is an acidic type-I cytokeratin normally not expressed in epidermis but in hair
follicles. Several mutations in K17 were found in Pachonychia Congenita type 2 (PC2) patients
with phenotypes ranging from twisted hair and multiple pilosebaceous cysts. Using intradermal
injection of a chimeric RNA-DNA oligonucleotide (RDO) or a single stranded oligonucleotide
(ssODN) to murine skin, we attempted to make a dominant mutation (R94P) in the conserved a-
helical domain of K17, the same mutation found in PC2. Both K17A-RDO and K17-ssODN
contained a single base mismatch (CGC to CCC) to alter the normal K17 sequence to cause an
amino acid substitution. The complexes consisting of oligonucleotides and cationic liposomes were
injected to C57BL/6 murine skin at 2 and 5 day after birth. Skin biopsies were taken at day 6, 7, 8,
10, 12, 58, 60 and 66 after birth. Histological examination of skin biopsies at day 8 from several
mice (5/7 for K17-RDO and 3/3 for K17-ssODN) showed consistent twisted hair shafts or broken
hair follicles at the sebaceous gland level and an occasional rupture of hair bulb and epidermal cyst-
like changes. In the injected area, the number of full anagen hair follicles decreased 50%. However,
this hair abnormality was transient because twisted hairs were detected on day 8 only. Injection of
the control oligonucleotide, identical to K17A-RDO but containing no mismatch to the normal
sequence, did not result in any detectable abnormality (n = 5). Genomic DNA was isolated by
dissection of hair follicles from slides, PCR ampli®ed and subjected to AciI digestion. The RFLP
analysis indicates that the frequency of gene alteration is lower than 5%. Further studies are
ongoing to determine the precise frequency. Our results indicated that intradermal injection of the
K17A-RDO or K17-ssODN affected the hair growth and morphology. However, these
phenotype changes were transient either due to the compensation of K17 by other keratins or the
replacement of the mutated cells by normal surrounding cells during hair growth.
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Affects with Aging and Hair Loss in Hair Properties of Japanese Women
M. Tajima, C. Hamada, T. Arai, M. Miyazawa,* R. Shibata,* and A. Ishino
Basic Research Center, Shiseido, Yokohama, Kanagawa, Japan; *Department of Mathematics, Keio
University, Yokohama, Kanagawa, Japan
The diagnosis of hair loss in otherwise healthy women is more dif®cult to make than that in men
because of less obvious of hair loss. The racial differences of hair physiology and properties such as
hair color, diameter, shape of cross section, and twist characteristics have also been known. We
characterized the hair properties in Japanese women with or without hair loss. The subjects of
Japanese women between 14 and 68-year-old-with female hair loss (n = 46) or with no or less hair
loss (n = 113) were studied about hair density, hair diameter, anagen ratio and constitution of hair
groups by video-phototrichogram. The patterns of hair loss were likely to resemble female pattern
hair loss described by Olsen, but not Ludwig pattern hair loss or diffused hair loss. The degree of
hair loss was determined by visual comparison of the photograph with the 6 scales of standard
photographs. Anagen hair ratios were practically unalterable in spite of age and degree of hair loss.
Hair densities were decreased on increasing age after fortyish and on progressing the hair loss in the
same decade subjects, owing to reduction of hair number per hair group, but not number of hair
groups. Mean hair diameter were also decreased on increasing age after thirtyish and on progressing
the hair loss in the same decade subjects, owing to reduction of thick hairs, but not vellus-like hairs.
Taken together decrease of hair densities and thick hair ratio mainly cause the female hair loss of
Japanese mid-aged women. The appearance of the female hair loss in at least from 30 s to 50 s ages
results mainly from the hair shedding by the decrease of hair number in hair groups, but not the
miniaturization of hair follicle in androgenetic alopecia. We concluded that female pattern hair loss
of Japanese was classi®ed into neither female androgenetic alopecia nor chronic telogen ef¯uvium,
reported in Caucasian women.
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The Morphology of Quill and Spine Follicles
K. M. Credille, M. Winn-Elliot,* N. A. Andersen,² K. Hudson, and R. W. Dunstan
Comparative Dermatology Laboratory, Texas A & M University, College Station, Texas, U.S.A.;
*NERPRC, Harvard Medical School, Southboro, Massachusetts, U.S.A.; ²Discipline of Anatomy and
Physiology, University of Tasmania, Hobart, Tasmania, Australia
Nowhere is the variability of follicular form and function as pronounced as in the spined and
quilled mammals. We examined samples of skin and/or quills or spines from New World
porcupines (Erethizon dorsatum), hedgehogs (Atelerix albiventris), tenrecs (Setifer setosus) and an
echidna (Tachyglossus aculeatus) using gross examination, DermScope magni®cation, routine
histology, and scanning electron microscopy to de®ne similarities and differences between these
unique follicles and the pelage follicles of humans and mice. Porcupines produced quillsÐmodi®ed
hairs that were easy to break off. Hedgehogs, tenrecs and echidnas produced spinesÐmodi®ed
hairs that remain ®rmly attached to the follicle. In all species, the majority of follicles from adult
animals were in telogen (> 95% in echidnas, tenrecs and hedgehogs, > 70% in porcupines)
indicating that telogen was the predominant stage of the hair cycle. Anagen hairs identi®ed in
hedgehogs and porcupines had no bulge at the insertion of the arrector pili muscles and echidnas
had no arrector pili muscles indicating the dif®culty in de®ning a morphologic bulge at the
insertion of the arrector pili muscles in most mammals. The morphology of the base of telogen
spine/quill follicles was markedly different from the morphology of the bulb of anagen follicles
suggesting that catagen in these species may be more than an involutionary phase of the hair cycle
but rather a phase where there is substantive and purposeful remodeling. Finally, the medulla and
cortex morphology differed markedly from that in humans and mice and served as a further
example of the variability and complexity of the mammalian hair follicle.
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C-kit and Fas are Involved in Migration and Apoptosis of Hair Follicle Melanocytes
During Chemotherapy-Induced Hair Loss
A. A. Sharov, B. A. Gilchrest, and V. A. Botchkarev
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Hair follicles (HF) respond to chemotherapy with dramatic alterations in structure and function of
follicular melanocytes (MC). However, molecular mechanisms that control MC responses during
chemotherapy-induced hair loss remain largely unknown. Here, we showed that cyclopho-
sphamide (CYP) administration into C57BL/6 mice with HF previously synchronized in anagen
alters the expression of melanogenic proteins and distribution of MC in skin. In normal anagen HF
MC actively producing pigment expressed TRP1, TRP2, tyrosinase and were located in hair bulb
above the dermal papilla. CYP administration caused down-regulation of TRP1 and tyrosinase in
hair bulb MC. Only TRP2+ MC were seen in the proximal hair matrix 24±48 h after CYP
administration, and some of them expressed Fas and were TUNEL+. Number of TRP2+/
TUNEL+ hair bulb MC was signi®cantly (p < 0.05) reduced in Fas knockout mice treated with
CYP, compared to wild-type controls suggesting Fas signaling mediates CYP-induced apoptosis in
HF MC. The surviving hair bulb TRP2+ MC showed expression of proliferative marker Ki-67
72 h after CYP administration. Number of TRP2+ MC in regressing HF was markedly increased
4±5 days after CYP treatment, compared to normal catagen HF in untreated nice. 5±7 days after
CYP treatment MC expressing c-kit, TRP2, TRP1, and tyrosinase became visible in the
epidermis, and epidermal keratinocytes showed expression of stem cell factor (SCF). MC migration
from the HF into epidermis was completely abrogated by administration of neutralizing antibody
to c-kit, the SCF receptor, suggesting c-kit regulates MC migration from the HF into epidermis
after CYP treatment. These data suggest that chemotherapy induces a complex response of the HF
MC, which include apoptosis, proliferation and migration, and that pharmacological manipulation
of Fas and c-kit signaling pathways might be useful for the correction of skin hyperpigmentation
and change of hair color as side-effects of chemotherapy.
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Cell Culture Media Stimulate Hair Regrowth in Chemotherapy-Induced Alopecia in
Mice
E. S. Lindenbaum, M. Tendler, A. L. Feitelberg, D. Beach, and A. Gamliel-Lazarovich
Faculty of Medicine, Technion, Haifa, Israel
Cell culture medium MCDB or BGJ gelled in hydroxyethylcellulose and supplemented with three
nonsteroidal anabolic hormones, thyroxine, insulin and growth hormone, was used as a topical
agent to treat chemotherapy-induced alopecia in C57Bl mice. Control animals were treated with
gelled saline or dry massage. The teatment was applied to the depilated skin twice daily. All the
mice were injected with cyclophosphamide 150 mg/kg resulting in severe hair loss in most animals,
reaching maximum after 8 days. The chemotherapy-induced alopecia occurred in about 75% of all
animals except those treated with MCDB-based gel, where chemotherapy-induced alopecia
occurred in only 53% of the animals. Regrowth of normal pigmented hair after the injection was
signi®cantly (p < 0.00001) accelerated by medium treatment when compared to the controls. Both
rate and extent of recovery were effected. In 47% of the MCDB treated mice the return of
regrowth occurred 8 days after the injection compared to 29% or less in all the other mice. Within
14 days after cyclophosphamide injection, 93% of the mice treated with BGL-based gel and 71% of
MCDB treated mice exhibited hair cover while only 38% of the gelled saline treated mice
demonstrated regrowth. Further acceleration of recovery was observed 14 days after cyclopho-
sphamide when the treatment started prior to the injection; in that case 100% of the BGJ and 79%
of the MCDB treated mice were covered with hair, while in the gelled saline and massage treated
only 59% and 42%, respectively, were covered with hair. The ef®cacy of treatment as
demonstrated 14 days after the injection was: BGJ > MCDB > saline > dry massage. These results
point to a protective effect of both gelled media against chemotherapy-induced alopecia. Thus the
enriched cell culture medium decreased the toxic effects of cyclophosphamide and reduced the
time delay between the injection and the regrowth of hair, neither of which were achieved by
using the vehicle control or dry massage.
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The Expression of Insulin-Like Growth Factor-1 in Follicular Dermal Papilla is
Associated with Therapeutic Ef®cacy of Finasteride in Male Androgenetic Alopecia
J. Shapiro, L. Tang, O. Bernardo, C. Bolduc, S. Madani, and H. Lui
Dermatology, University of British Columbia, Vancouver, British Columbia, Canada
The purpose of this study is to identify and quantify changes in expression of speci®c molecular hair
growth regulators in dermal papillae of men with androgenetic alopecia treated with ®nasteride.
Scalp biopsies were collected from nine male patients from both balding and nonbalding areas prior
to and after 4 months of ®nasteride therapy. Dermal papillae were microdissected and total RNA
extracted from equal number of dermal papillae of each biopsy. The expression of various
cytokines including insulin-like growth factor-1 (IGF-1) was determined by RT-PCR. The signals
were detected by autoradiography. Levels of IGF-1 mRNA as determined by RT-PCR were
increased in 4/9 patients treated with ®nasteride for four months. Among the patients with
increased IGF-1 expression, 3 showed signi®cant clinical improvement and another patient
remained the same after 12 months of treatment. In contrast, 3 patients with decreased IGF-1
showed worsening clinically after 12 months. The other two patients without noticeable change in
IGF-1 showed either slight improvement or no change. In a small uncontrolled study of nine male
patients with androgenetic alopecia, an increase of expression of scalp IGF-1 mRNA levels was




Are Murine Nipples an Example of a Regionally Specialized Epidermis?
J. Foley, R. Contreras, G. Cotsarelis,* M. Borjan, and B. Mahler
Medical Sciences, Indiana University, Bloomington, Indiana, U.S.A.; *Department of Dermatology,
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A.
Mesenchyme-derived signals in¯uence the unique keratinization programs and appendage
formation in anatomically specialized skin regions such as foot pads, the oral cavity, tails, ears
and anal/genital tract in part by in¯uencing the cellular fate of epidermal stem cells. Interactions of
epidermal cells with signals produced by the primary mammary mesenchyme result in the
formation of the nipple, but it is unclear as whether this represents a site of regionally specialized
epidermis. We pro®led keratin expression and evaluated epidermal stem cell markers of the murine
nipple and the keratin-14 parathyroid hormone-related protein transgenic mouse in which the
ventral skin models nipple formation. The murine nipple epidermis has expanded spinous and
granular layers and a thickened corni®ed layer as compared to trunk skin and increased levels of
®laggrin, K1 and K10 were observed in extracts from the ventral epidermis of the K14-PTHrP
mouse as compared to that of wild-type littermates. Keratinocytes grown from the ventral
epidermis of the K14-PTHrP mouse or wild type littermates exhibited identical differentiation
pro®les in vitro, suggesting that the modulated differentiation pro®le observed in the nipple or the
ventral K14-PTHrP skin resulted from interactions with the mammary mesenchyme ®broblasts.
The nipple or ventral skin from the K14-PTHrP did not appear to express any keratins that were
not expressed in skin samples from wild-type littermates. These ®ndings suggested that the nipple
represents a region of hairless, thickened epidermis that does not exhibit regionally specialized
keratinocyte differentiation. The absence of hair follicles raised a question as to where the stem cells
for this epidermal structure are located. K15-positive and BrdU-retaining cells were found in the
outer rim of the invaginated epidermis at the base of the nipple. Taken together these ®ndings
suggest that the murine nipple is populated in part by unspecialized trunk keratinocytes that arise
from cells at the base of the structure.
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A Simple and Rapid Method to Isolate and Culture Follicular Papillae from Human
Scalp Hair Follicles
M. Magerl, S. Kauser, R. Paus,* and D. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, U.K.; *Department of Dermatology,
University Hospital Eppendorf, University of Hamburg, Hamburg, Germany
The recent expansion of hair research activity owes much to the elegant microdissection and
implantation experiments of Cohen and Oliver in the 1960s that con®rmed a crucial role for the
follicular/dermal papilla in hair growth. Study of the follicular papilla's involvement in hair growth
regulation was greatly facilitated by the isolation and cultivation of this tiny cluster of ®broblast-like
cells by Jahoda & Oliver in the rat vibrissae and by Messenger in the human hair follicle. While
isolation of the follicular papilla from the former is relatively straight-forward, the current method
to isolate the much smaller human hair follicle HF requires signi®cant skill. Thus, the routine
initiation of primary cultures of human scalp follicular papilla cells requires signi®cant training, time
and commitment. In an attempt to simply our follicular papilla cell culture methodology for new
laboratory personnel, we have made signi®cant re®nements to the current method. Our method
requires only two simple manipulations to isolate follicular papilla from intact isolated hair follicles.
This very rapid and easy method isolates clean and intact follicular papillae. Together with their
attachment via scratching to the growth surface, the isolation and cultivation of this important hair
follicle component can now be achieved easily by the laboratory newcomer. The method relies for
its simplicity on the removal of the follicular papilla from the outside of the intact hair follicle rather
than via internal manipulations within the hair follicle itself.
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Congenital Universal Hypertrichosis with Deafness and Dental Anomalies Inherited as
an X-Linked Trait
M. Tadin,* J. Salas,§ L. Moreno,§ H. Uyttendaele,² D. Warburton,³ and A. M. Christiano*²
*Genetics and Development, Columbia University, New York, New York, U.S.A.; ²Dermatology,
Columbia University, New York, New York, U.S.A.; ³Pediatrics, Columbia University, New York, New
York, U.S.A.; §Dermatology, Servicio Medico Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
Hypertrichosis comprises all forms of excessive hair growth that are inordinate for the body site and
age of an individual and which do not result from androgen stimulation. Some forms of
hypertrichosis are clearly genetic but the underlying mechanisms remain largely unknown. In a
search for a gene whose mutations result in excessive hair growth, we performed haplotype analysis
in large Mexican kindred with congenital universal hypertrichosis. In this family, the only affecteds
are males, suggesting X-linked recessive inheritance, while female carriers can be identi®ed due to
the presence of two symmetric papules near the mouth and slightly more excessive hair than
normal. We found linkage to chromosome Xq between markers GATA198A10 and DXS8106
what corresponds to a region of about 12 cM. This is the same area where linkage was reported in
congenital universal hypertrichosis without deafness and dental anomalies (OMIM 145701)
(Nature Genet 10: 202±207, 1995). We also analyzed karyotypes of the affected individuals and
detected no abnormalities. We are currently saturating the region with additional microsatellite
markers in attempt to narrow the linkage interval further. Since the affected individuals in our
family, in addition to hypertrichosis, exhibit also dental malformations and deafness, and may be
both clinically and genetically distinct, we speculate that the mutated gene is involved in the
regulation of several organ systems.
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Human Scalp Hair Follicle Melanocytes Express the Androgen Receptor and Both
Estrogen Receptors (ERa) & (ERb) In Situ
L. Nelson, M. J. Thornton, A. H. Taylor,* A. G. Messenger,² and D. J. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, U.K.; *Department of Obstetrics &
Gynaecology, Leicester Royal In®rmary, Leicester, U.K.; ²Department of Dermatology, Royal Hallamshire
Hospital, Shef®eld, U.K.
Androgens and estrogens have signi®cant and distinct roles in both hair and skin physiology. Both
steroid hormones can regulate the hair cycle and there is also increasing evidence of a direct role for
these hormones in the regulation of hair pigmentation. The recent identi®cation of a second
estrogen receptor (ERb) in addition to the classical estrogen receptor (ERa) introduces a new level
of complexity to estrogen action. However, to date there is no evidence that hair follicle
melanocytes express either the androgen receptor (AR), or either of the two estrogen receptors
(ERa) or (ERb). Therefore, this study was designed to examine the expression of AR, ERa and
ERb in NKI/beteb (gp 100)-positive hair bulb melanocytes using 6 mm frozen sections of normal
male occipital scalp by double immuno¯ourescence. Strong, though heterogeneous expression of
AR was detected in pigmented melanocytes located in the hair bulb, and in amelanotic
melanocytes located in both the outer root sheath and basal layer of the sebaceous gland. Similar
heterogeneous expression patterns were observed with ERb, although the expression of this
receptor was much higher in the pigmented bulbar melanocyte than in the amelanotic melanocytes
located in the outer root sheath and infundibulum. A similar pattern of expression was detected for
ER a, though some aditional expression was observed in the follicular papilla and proximal
connective tissue sheath. The colocalization of AR, ERaand ERbsuggest a direct role for
androgens and estrogens in the regulation of hair follicle pigmentation. Since their
interdependence is of the utmost importance in some steroid-dependent tissues, further studies
are required to understand how these steroids may interact to modulate hair follicle melanocytes,
and to widen our understanding of melanocyte physiology and pathophysiology.
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Role of the Thyroid Transcription Factor 2 in Skin
C. Missero, A. Brancaccio, R. Parlato,* and M. Corrado
Telethon Institute of Genetcis and Medicine, Napoli, Italy; *Stazione Zoologica `A. Dohrn', Napoli, Italy
The thyroid transcription factor 2 (FoxE1) is a member of the winged-helix family, known to
regulate the expression of some thyroid-speci®c genes. FOXE1 is mutated in the Bamforth±
Lazarus syndrome, characterized by thyroid agenesis, spiky and sparse hair, and cleft palate. We
found that FoxE1 is speci®cally expressed in the outer root sheath of the hair follicle below the
isthmus, while no expression is detected in the epidermis or in the dermis. Mice lacking FoxE1
display severe cleft palate, a sublingual or absent thyroid gland and die perinatally. To explore the
role of FoxE1 in adult skin, we grafted FoxE1-null newborn skin on the back of nude mice in
parallel with wild-type controls. Hair coat derived from null skin appeared abnormally very thin
and wavy, closely resembling human hair of patients affected by the Bamforth±Lazarus syndrome.
Examination of plugged hairs revealed an aberrant presence of straight, single layer hairs, and a
reduced number of thick hairs. At the histological level FoxE1 null hair follicles appeared smaller
than wild-type controls, suggesting a possible defect in cell proliferation and/or in cell migration.
To further explore Fox E1 function in keratinocytes, we generated transgenic mice expressing
FoxE1 under the control of the involucrin promoter, which drives exogenous expression in the
upper layers of the epidermis. Four independent transgenic lines were obtained that displayed an
identical skin phenotype consisting in striped hair coat and ¯aky skin. At the histological level
transgenic epidermis appeared severely altered: focal epidermal hyperplasia, perturbed keratinocyte
differentiation, and skin in¯ammation, were consisting features. Furthermore keratin 6 and 17
were found abnormally expressed in the epidermis of transgenic mice. Taken together these data
suggest that FoxE1 plays a role in keratinocyte proliferation and differentiation, leading to proper
hair follicle formation.
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lnvolvement of the SREBP Pathway in the Mode of Action of Androgens in Sebaceous
Gland In Vivo
C. Rosignoli, J. Nicolas,* A. Jomard, and S. Michel







aires, INSERM, 70 rue de Navacelle, 34090, Montpellier,
France
Androgens have profound effects on the physiology of the sebaceous glands. Using the hamster ear
sebaceous gland model, we performed a detailed kinetic study to clarify the mechanism of
androgen action on sebaceous gland function. We demonstrated that the growth of sebaceous
glands observed after androgen treatment, was due to both an increase in sebocyte proliferation and
a parallel induction of sebocyte terminal differentiation, as evidenced by the induction of the
synthesis of speci®c sebaceous lipids such as cholesterol esters, triglycerides and squalene.
Accordingly, the effect of androgen treatment on the mRNA expression on the mRNA of several
enzymes involved in the synthesis of sebaceous lipids has been studied using semiquantitative RT-
PCR. Up-regulation by androgens of HMG CoA synthase and reductase, glycerol 3-phosphate
acyl transferase, and Far-17c (stearoyl Co A desaturase), was demonstrated. Since sterol-response
elements (SREs) are known to be present in the promoters of these genes, we analyzed the
activation of the trancription factor SREBP-1 by immunoblotting experiments. Our results
showed that SREBP-1 was rapidly activated following androgen treatment. Altogether, these
results demonstrate for the ®rst time that in sebaceous glands, in vivo, androgen regulates the
synthesis of sebaceous lipids through the SREBP pathway.
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Ornithine Decarboxylase Gene Polymorphism and Male Androgenetic Alopecia
R. A. Garton, J. Sugarman, K. Benushkova, A. J. McMichael, and V. Setaluri
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina,
U.S.A.
Androgenetic alopecia (AGA) is the most common form of hair loss in men affecting at least 50% of
adult men over age 50. The mechanisms underlying AGA and its inheritance pattern are largely
unknown. A variety of gene products critical for hair morphogenesis and growth cycles have been
identi®ed. These include transforming growth factor-b, bone morphogenic proteins, steroid 5-a
reductase and ornithine decarboxylase (ODC). We studied the pattern of expression of these genes
in AGA. Biopsies were obtained from affected and unaffected areas of scalp from men with AGA
and the gene expression was analyzed by RT-PCR. We found that in balding scalp the expression
of ODC mRNA was lower compared to nonbalding scalp. Given that inhibition of ODC activity
is currently being used a strategy to treat hirsutism, we investigated the possible mechanisms for the
reduced ODC gene expression in AGA. In human there are two alleles of ODC, which differ by a
single nucleotide polymorphism in intron 1 within the c-myc binding E box. This polymorphism
in the enhancer region results in differences in ODC mRNA expression. More than 50% of
Caucasian individuals are reported to be homozygous for the weak allele. We hypothesized that the
allele associated with increased expression of ODC would be more common in men without
AGA. Blood samples were collected from men ages 18 and older with varying degrees of hair loss,
ranging from no loss to signi®cant balding. Genomic PCR and restriction fragment length
polymorphism assay was used to ascertain their ODC genotype. The distribution of the ODC
alleles in the 44 individuals we analyzed was similar to that reported in general population. We
found that whereas the weak allele is found more commonly in balding men, the allele associated
with increased expression of ODC is signi®cantly more common in men without hair loss. Our
data suggest that polymorphism of the ODC gene is associated with male pattern baldness.
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Preparation and Immunohistochemical Study of a Novel Antibody Against Inner Root
Sheath Cells
M. Takahashi, K. Sugihara, T. Tezuka, Y. Horiuchi,* and M. Manabe²
Dermatology, Kinki University School of Medicine, Osaka-Sayama, Japan; *Life Science, Kinki University,
Osaka-Sayama, Japan; ²Dermatology, Akita University School of Medicine, Akita, Japan
Because our previous ®ndings suggested that a monoclonal antibody, TYHF-1, against hair follicle
cells might be related with secretory carrier membrane protein (SCAMP), we synthesized a peptide
based on an amino acid sequence of SCAMP, produced an antibody against the peptide and
investigated its properties by immunohistochemical technique. When cryostat sections of human
scalp skin ®xed by ethanol were stained with the af®nity puri®ed antibody, the cytoplasm of the
inner root sheath cells were stained positively. Since the speci®c antibodies reacted with only the
inner root sheath cells were not well-known, the cellular localization of this anti-inner root sheath
antibody (anti-IRS Ab) was examined in detail. Paraf®n embedded sections were also stained with
anti-IRS Ab and LSAB method, and the granules in the Huxley layer were stained positively, in
contrast this reaction didn't observed with normal rabbit serum or previous absorbed anti-IRS Ab
by the peptide. The immuno¯uorescent double staining by anti-IRS Ab and antitrichohyalin
monoclonal antibody (AE15) using cryostat sections of human scalp skin ®xed with 4%
paraformaldehyde was performed. Trichohyalin granules (THG) were stained with both antibody
but some THG in the upper bulbar portion were reacted with only AE15. This ®nding was also
con®rmed by the cryoultramicrotomy. Furthermore, anti-IRS Ab reacted with a protein spot at
40 kDa and pI 6.0 but AE15 reacted a high molecular weight protein at pI 5.5. When squamous
cell carcinoma or basal cell carcinoma was immunohistochemically stained with anti-IRS Ab, the
former was reacted positively but the latter was not. These ®ndings suggest that anti-IRS Ab could
be a novel speci®c antibody against inner root sheath cells and useful for classi®cation of some
carcinomas related with hair follicles.
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Combination of Imidazole with Antifungal Agents Effectively Repaired
Hyperkeratinization and Reduced Dandruff Flora
W. Park, W. Cho, K. Shin, C. Lee, B. Lee, and I. Chang
Skin Research Team, Amore Paci®c R & D, Yongin-si, Kyounggi-do, South Korea
Abnormal keratinization is associated principally with dermatological disorders such as pityriasis,
seborrheic dermatitis and dandruff. Hyperkeratinization is usually the result of decreased
desquamation due to increased corneocyte cohesion. The pharmaceutical treatment for dandruff
has been restricted to use antifungal agent such as piroctone olamine, selenium disul®de and zinc
pyrithione to reduce Malassezia spp. We studied that imidazole has activity of antihyperkeratiniza-
tion besides antifungal effects and could be applied to shampoo and hair tonic to repair dandruff.
MIC test and modi®ed skin disk diffusion assay for M. furfur was performed. After inducing
arti®cial scaling with ethyl oleate, the scales degree of hairless mouse was observed using Dsquame
instant tester and the parakeratosis was measured by BrdU-positive outer corneocytes. Clinical
evaluation for 21 volunteer suffering scalp scaling or dandruff was performed, volunteers were
divided into three groups, which contains placebo, and two groups used the only zinc pyrithione
and imidazole & zinc pyrithione. Imidazole showed high MIC value (1000b?/b¢) compared with
common antimicrobial agents. But the hairless mouse group treated imidazole (0.2%) showed
lower both the scales degree (p < 0.008) and the transepidermal water loss (TEWL) value than that
treated vehicle. Furthermore, no BrdU-positve cell was detected in the stratum corneum of
imidazole-treated group, which showed improvement of parakeratosis. In clinical study,
formulation-containing imidazole with zinc pyrithione reduced dandruff in statistically signi®cance
after 4 weeks compared to that containing only zinc pyrithione. This study could suggest that the
use of imidazole together with antifungal agent such as zinc pyrithione or piroctone olamine could
be more ef®cient way to reduce dandruff ¯ora and hyperkeratinization.
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Immuno¯uorescence Analysis of the Basement Membrane Zone Components in
Human Anagen Hair Follicle
S. Joubeh, O. Mori,* K. Owaribe,² and T. Hashimoto*
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.;
*Dermatology, Kurume University, School of Medicine, Kurume, Japan; ²Unit of Biosystems, Graduate
School of Human Informatics, Nagoya University, Nagoya, Japan
The ultrastructure and constituent components of the basement membrane zone (BMZ) of the
interfollicular epidermis has been well characterized, however, little is known about the junctions
between dermal papilla and surrounding epithelial cells in the hair bulb, and between connective
tissues and epithelial cells outside of the hair follicle. In the present study, the expression of various
BMZ components including plectin, BP230, BP180, alfa6b4 integrin, laminin5 and type VII
collagen, in the human anagen hair follicles of the scalp was studied by immuno¯uorescence
method. In the upper portion of the hair follicle, BMZ contained all the BMZ components with
the same labeling intensity as those in the interfollicular epidermis. However, in the lower portion
of the hair follicle, all the BMZ components showed a gradual decrease in staining intensity; in
particular, outside of the hair bulb, the linear staining was diminished and even discontinued in
some areas. In contrast, between dermal papilla and epithelial cells inside the hair bulb, there was a
strong immunoreactivity for all the BMZ components, except for BP230, which was completely
negative. Ultrastructure in the previous and the present studies showed that no apparent
hemidesmosome was seen either in the BMZ of outside of the hair bulb or in the dermal papilla
junctions, instead, peculiar cloudy materials were seen in the lamina densa and adjacent epithelium
outside of the hair bulb. Taken together, the diminished expression of all the BMZ components
outside the hair bulb and complete absence of BP230 at the dermal papilla junction, seem to be
responsible for the incomplete ultrastructure of hemidesmosomes in these regions. The results in
this study led us to speculate that the expression of BMZ components outside and inside of the hair
bulb in the transient regions of the hair follicle is much less than that in the permanent region; i.e.
upper portion of the hair follicle.




The Mediator Secretion Pattern of Dendritic Cells from Atopic Individuals Can be
Reversed to that of Nonatopics
M. W. Grewe, N. Gross, T. Ruzicka, J. Krutmann, and M. Klammer
Dermatology, University Duesseldorf, Duesseldorf, NRW, Germany
The pattern of soluble mediators released by human blood-derived dendritic cells (DC) obtained
from atopic donors has been shown to differ from that observed in nonatopics. Thus far, in 18/19
age- and sex-matched comparitive experiments, atopic DC showed a signi®cant higher secretion of
the chemokine MCP-1 and a tendency to secrete more IL-10 than nonatopics. Further
experiments characterizing atopic and nonatopic DC showed no additional differences for the
expression/secretion of IL-12, TNF & #945; and its type I receptor, IL-1? and IL-1 receptor type
I, IL-6 and its receptors, GM-CSF and its receptor, CD86, CD83, prostaglandin E2, and
thromboxane. Although by far not resembling a complete list of biologically relevant molecules
fully de®ning properties of DC, these molecules are obviously not relevant for differences in atopic
vs. nonatopic DC. On the other hand, these observations are suggestive for the relative importance
of the production of, in particular, MCP-1 in atopic DC. In attempts to analyze enhanced MCP-1
production and to `correct' this atopic feature of DC, atopic and nonatopic DC were kept in
culture in the presence of different biologic response modi®ers putatively related to the atopic
status. In both DC phenotypes, a 24-h pretreatment prior to allergen- or endotoxin-challenge with
IL-10 lead to enhanced MCP-1 production, whereas IFNg decreased MCP-1 production
moderately, IL-12 had no effect. Addition of neutralizing anti-IL-10 antibodies, however, was able
to decrease MCP-1 secretion selectively in atopic DC, resulting in production rates similar to those
in nonatopics. These data indicate that (1) DC from atopics differ from those of nonatopics with
regard to, at least, MCP-1 production (2) IL-10 might be important for the atopic status of DC,
and that (3) atopic DC can be reversed to a nonatopic phenotype, probably suitable for therapeutic
strategies in atopic diseases.
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Mechanism of Action of IVIg in Pemphigus
J. Bystryn and D. Jiao
Dermatology, Nyu School of Medicine, New York, New York, U.S.A.
Intravenous immunoglobulin (IVIg) is now used to treat pemphigus vulgaris (PV) unresponsive to
conventional therapy; but its mechanism of action is not known. To examine this question, 12 pt
with active PV unresponsive to conventional therapy with systemic steroids were treated with IVIg
(400 mg/kg/day for 5 days) and concurrently given cyclophosphamide or azathioprine. Within
1 week of initiating IVIg lesions began to heal in all but 1 pt, within 2 week the extent of skin
lesions was reduced by 75% or more in two-thirds of pts, and within 3 week the average dose of
systemic steroid was reduced by 40% of baseline levels. Serum levels of intercellular (IC) antibodies
declined by an average of 59% of baseline level within 1 week of initiating IVIg and by 70% within
2 week. The decrease was selective, as serum levels of antibody to varicella-zoster in 4 of the pts did
not decrease. The titer of pretreatment IC antibodies was not decreased by incubation with the
IVIg used to treat the pts, indicating that the decline that occurs following treatment was not due to
anti-Id or other blocking factors in the IVIg. The decrease was also too rapid to be due to
suppression of IgG synthesis, as the ? life of circulating IgG is 3 week. A more likely explanation is
that the decrease resulted from increased IgG catabolism, and was selective as the serum level of
normal IgG antibodies was maintained by those present in the IVIg preparation. Thus, IVIg can
rapidly control active PV unresponsive to conventional therapy. The mechanism of this effect is a
profound, rapid and selective decrease in circulating IC antibodies. This appears to be due to
increased catabolism of serum IgG and by replacement of normal but not abnormal antibodies by
those present in the IVIg.
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Lack of Culture Expansion of Donor-Derived Keratinocytes From Skin Biopsies of
Patients with Graft-vs.-Host Disease
M. R. Albert, P. Hematti,* C. L. Yee, E. Sloand,* R. W. Childs,* C. A. Carvallo,* J. A. Barrett,*
C. Dunbar,* and J. C. Vogel
Dermatology Branch, National Cancer Institute/NIH, Bethesda, Maryland, U.S.A.; *Hematology Branch,
National Heart, Lung, and Blood Institute/NIH, Bethesda, Maryland, U.S.A.
The surprisingly multipotent nature of adult stem cells in various organ systems has recently been
demonstrated, suggesting that these cells are capable of differentiating into embryonically unrelated
tissues under certain conditions such as tissue injury. In this study, we investigated whether donor
bone marrow-derived cells could be isolated in keratinocyte cultures obtained from skin biopsies of
patients with cutaneous graft-vs.-host disease (GVHD). We studied 8 female patients with a variety
of hematologic malignancies who had received sex-mismatched allogenic hematopoietic stem cell
transplantation at least 6 months prior to study entry. Patients had either active cutaneous GVHD
or a history of signi®cant cutaneous GVHD. Punch biopsies (4±6 mm) were performed in each
patient at sites of active or past involvement of GVHD. Following enzymatic treatment, cells were
plated on tissue culture dishes using conditions optimized for keratinocyte growth and were
expanded in culture for at least 3 weeks. The purity of the cultured cells was con®rmed by the
absence of CD45+ cells by ¯ow cytometry or CD45 mRNA by RT-PCR of selected samples.
PCR was utilized to evaluate Y-speci®c sequences in the DNA of cultured cells from 6 patients,
with the detection of only a faint Y chromosome speci®c band in one patient. Minisatellite PCR
was performed in 3 patients to evaluate STR polymorphisms, and donor-speci®c sequences were
not observed in each case. While these studies are ongoing, the data to date suggests that
Y + keratinocytes do not contribute signi®cantly to keratinocyte cultures derived from skin
biopsies of patients with cutaneous GVHD.
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Dual Roles for the Nude Gene in Epithelial Self-Renewal
J. L. Brissette, R. M. Baxter, J. Li, L. Weiner, and A. Viel
Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School,
Charlestown, Massachusetts, U.S.A.
Loss-of-function mutations in Foxn1, a winged-helix/forkhead transcription factor, cause the nude
phenotype, which is characterized by defects in epithelial growth and differentiation. In the present
study, Foxn1 function was dissected using primary keratinocytes from wild-type and transgenic
mice. The transgenic animals express foxn1 from the involucrin promoter, which is active in
keratinocytes undergoing terminal differentiation. In wild-type cultures, like the epidermis, Foxn1
was induced during the early stages of terminal differentiation and then declined during later stages.
In transgenic keratinocytes, foxn1 overexpression altered the terminal differentiation program,
stimulating an early differentiation marker (keratin 1) and suppressing later markers (pro®laggrin,
loricrin, and involucrin). These results suggest a role for Foxn1 in the temporal regulation of
differentiation, as Foxn1 can ensure that the differentiation program is carried out in proper
sequence. In addition, medium conditioned by transgenic cultures induced a higher rate of
keratinocyte proliferation than medium conditioned by wild-type cells. Coincident with this effect
on cell division, foxn1 overexpression stimulated the secretion of a low molecular weight
molecule, suggesting a role for Foxn1 in the control of paracrine factors. Thus, Foxn1 possesses the
ability to link proliferation to differentiation, promoting the proper differentiation of a cell while
stimulating the cell's replacement by its neighbors.
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The Growth of Cutaneous T Cell Lymphoma is Driven by Auto-Antigen and Regulated
by CTLA-4
C. Berger, J. Cohen, J. Trinh, D. Hanlon, and R. Edelson
Dermatology, Yale University, New Haven, Connecticut, U.S.A.
We have reported that the long-term growth of cutaneous T cell lymphoma (CTCL) was
supported by autologous dendritic cells (DC) and proposed that CTCL cell growth was driven by
DC class p presentation of autologous tumor peptide. We now demonstrate that when CTCL cells
are stimulated with DC pulsed with autologous apoptotic tumor cells, they proliferate, down-
regulate CD3 and up-regulated expression of CTLA-4, an inhibitory costimulatory molecule.
CTCL cells were CD2-bead puri®ed (> 95% tumor cells) from 1 to 2 month cultures and rendered
apoptotic by incubation with CD3 antibody. As a control, CTCL cells were incubated with an
isotype matched antibody. DC were pulsed overnight with CTCL cells and used to stimulate
freshly isolated autologous CTCL cells. Cultures were analyzed by immunophenotyping,
proliferation was assessed by cell counts and radioisotype incorporation, and IL10 production
monitored by ELISA. When cultured CTCL cells from 3 patients were stimulated overnight with
autologous tumor-loaded DC, CD3 expression decreased 65% 6 11, while CD4 expression was
not altered. Cell numbers increased 49% 6 22 and thymidine uptake increased 57% Cytoplasmic
CTLA-4 expression increased 82% 6 13 and the production of IL10 increased 61%. Continued
culture with IL2 and IL4 led to phenotypic reversion. The results demonstrate that CTCL cells
proliferate in response to autologous tumor-loaded DC. Down-regulation of the T cell receptor
(TCR) and an increase in CTLA-4 expression indicates that TCR engagement in response to class
p peptide presentation may drive CTCL cell proliferation. After the initial burst of proliferation,
CTCL cells develop a transient inhibitory phenotype evidenced by CTLA-4 and IL10 production.
These results suggest that CTCL cell proliferation is stimulated by DC presentation of antigen
intrinsic to the CTCL cells themselves and is constrained by up-regulation of CTLA-4
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Peripheral Blood Monocytes Express Immunoreactive Langerin as an Apparent
Complex with a 20-kDa Protein, and May Constitute Precursors of Epidermal
Langerhans Cells
J. Kieffer, K. Ferenczi, S. King, and T. S. Kupper
Dermatology, Harvard Skin Disease Research Center, Boston, Massachusetts, U.S.A.
Epidermal dendritic, or Langerhans, cells (LC) capture exogenous antigens, which are subsequently
presented to naO
Ã
ve T cells in skin-draining lymph nodes. LC are uniquely characterized by
ultrastuctural Birbeck granules and by the expression of the 40 kDa transmembrane glycoprotein
langerin, recently cloned by Valladeau et al A recent report by Larregina et al suggested that CD14+
cells within the dermis expressed langerin and were precursors of epidermal LC. We asked whether
peripheral blood monocytes, also CD14+, expressed langerin. We de®ned monocytes as CD14+
PBMC. Contrary to recent reports, we have successfully detected langerin in the peripheral blood
monocytes of both normal volunteers and cutaneous T cell lymphoma (CTCL) patients, as well as
one psoriasis patient. All of 8 samples studied by intracellular FACS were positive for langerin or
lag, an intracellular epitope of langerin recognized by a separate antibody. The per cent of langerin
or lag positive cells ranged from 13 to 88% of total CD14 positive cells. Overall, higher values were
observed for patients with skin disease than for normals, but the correlation was incomplete. Of 8
monocyte preparations studied by langerin immunoblot, 7 were positive, with a spectrum of
intensities concordant with the FACS data. In contrast, langerin blots of normal peripheral blood
neutrophils and of dendritic cells cultured from CD34 positive cord blood progenitors were
negative. Surprisingly, the langerin immunoreactivity of monocytes migrated primarily at ~60 kDa,
suggesting a complex of 40 kDa langerin with a 20-kDa cytoplasmic protein. Our ®ndings are
consistent with the hypothesis that peripheral blood monocytes are precursors of LC, and that the
antigen capture molecule langerin may function as a complex with a 20-kDa cytoskeletal protein.
We speculate that linkage with the cytoskeleton may be necessary for the capacity of langerin to
internalize extracellular ligands rapidly.
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Isotypes and Antigenic Pro®les of Pemphigus Foliaceus and Pemphigus Vulgaris
Autoantibodies
M. K. Hacker, M. Janson, J. A. Fairley, and M. Lin
Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
The purpose of this study is to systematically characterize isotype pro®les and antigenic and tissue
speci®city of antidesmoglein (Dsg) autoantibodies from patients with pemphigus foliaceus (PF) and
pemphigus vulgaris (PV) using enzyme-linked immunoabsorbent assays, indirect immuno¯uor-
escence (IIF) staining, and immunoblotting. In PF, we found that IgG1 anti-Dsg1 autoantibodies
react with a linear epitope(s) on the ectodomain of Dsg1, while its IgG4 counterparts recognize a
conformational epitope(s). These two subclasses of anti-Dsg1 are both capable of recognizing
tissues from monkey esophagus, and adult human skin, but the IgG1 is not able to react with
mouse skin, explaining why this isotype of autoantibodies failed to induce PF-like lesions in the
passive transfer animal model. In mucosal PV patients, we found that both IgG1 and IgG4 only
recognize monkey esophagus tissue by IIF, except one patient, indicating that these antibodies
react with a unique conformational epitope(s) that only exits in mucosal tissue. In generalized PV,
IgG1 anti-Dsg3 autoantibodies appear to recognize a linear epitope(s) on Dsg3 ectodomain. In
contrast, IgG4 anti-Dsg3 antibodies recognize both linear and conformational epitope(s) on Dsg3
molecule. Interestingly, the IgG1 anti-Dsg3 antibodies fail to react with human and mouse skin
tissues, suggesting that his subclass of autoantibodies may not play an essential role in the
development of PV lesions. In summary, we conclude that this study further elucidates the
pathological mechanisms of PF and PV autoantibodies by revealing their distinct isotype and
antigenic pro®les. This information may help us to better understand the autoimmune mechanisms
underlying the development of pemphigus.
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Functional Role of Hyaluronan Expressed on Dendritic Cells in Antigen Presentation
M. E. Mummert and A. Takashima
Dermatology, UT South-western, Dallas, Texas, U.S.A.
Hyaluronan (HA) is a high molecular weight glycosaminoglycan present in large quantities in
extracellular matrix. Although HA is known to serve as a substrate for cellular traf®cking, its
immunological functions remain unclear due to unavailability of speci®c inhibitors. We examined
the potential role of HA in antigen (Ag) presentation using two unique inhibitors, a synthetic 12-
mer peptide (Pep-1) (GAHWQFNALTVR, J Exp Medical 192 : 769, 2000) and bovine
proteoglycan (bPG), both of which bind to and block HA function. We observed that: (a)
dendritic cells (DC) express mRNAs for HA synthases 1-3 and hyaluronidases 1-3, (b) DC actively
synthesize HA and incorporate it predominantly into membrane fractions, and (c) DC express HA
polymers on their surfaces. We next examined the function of DC-associated HA using an in vitro
Ag presentation system in which naive CD4+ T cells isolated from DO11.10 transgenic mice were
co-cultured with DC in the presence of Ag, ovalbumin peptide 323-339. Pep-1 oligomer
(synthesized by conjugation with a tetravalent polyethylene glycol derivative) and bPG both
ef®ciently inhibited DC-dependent, Ag-speci®c proliferation as well as IL-2 and INFg production
by DO11.10 T cells, whereas heat-inactivated bPG or oligomeric random peptide (PR) control
showed no signi®cant effect. Oligomeric Pep-1, but not RP, signi®ciantly blocked Ag-speci®c
DC-T cell cluster formation, suggesting that HA is required for physical contact between DC and
T cells during Ag presentation. Moreover, oligomeric Pep-1, but not RP, prevented clonal
expansion of CFSE-labeled DO11.10 T cells triggered by Ag-pulsed DC in mouse peritoneal
cavity, demonstrating in vivo relevance of our ®ndings. These results introduce a new concept that
HA being synthesized and expressed on DC facilitates their interaction with T cells during Ag
presentation, they also form both conceptual and technical frameworks for the development of
novel immunosuppressive reagents designed to interfere with HA-mediated DC-T cell
communication.
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Dual Functions of Langerhans Cell-Associated CD39/NTPDase in Skin In¯ammation
and Immunity
N. Mizumoto, T. Kumamoto, S. C. Robson,* and A. Takashima
Dermatology, UT South-western, Dallas, Texas, U.S.A.; *Medicine, Harvard, Boston, Massachusetts,
U.S.A.
Extracellular ATP and ADP produce in¯ammatory changes by binding to purinergic type-2 (P2)
receptors, and this pathway is regulated by ecto-nucleoside triphosphate diphosphohydrolases
(NTPDase) that hydrolyze ATP and ADP. Although ecto-NTPDase activities are widely used as a
marker of Langerhans cells (LC), identity or function of such enzymatic activities remains
unknown. LC in CD39-de®cient mice express no detectable ecto-NTPDase activities, indicating
that CD39 alone is responsible for LC-associated ecto-NTPDase activities. Keratinocytes rapidly
release ATP and ADP upon exposure to skin irritant chemicals and irritant contact hypersensitivity
responses (CHR) to the same chemicals are signi®cantly exacerbated in CD39
±/±
mice. Thus, LC-
associated CD39 plays a protective role against chemical insults by hydrolyzing otherwise pro-
in¯ammatory nucleotides released by neighboring keratinocytes. Paradoxically, allergic CHR to
haptens are severely attenuated in CD39
±/±
mice. As to mechanisms: (a) T cells elevate pericellular
ATP concentrations upon activation; (b) wild-type dendritic cells (DC) respond to exogenous
ATP, whereas CD39-/- DC show ATP unresponsiveness due to P2 receptor desensitization; (c)
CD39-/- DC exhibit impaired in vitro and in vivo capacities to present haptens to T cells. These
observations imply that T cell-associated ATP delivers DC activation signals during antigen
presentation and that this P2 receptor-mediated signaling is regulated by CD39-dependent
hydrolysis of ATP. Our results document opposing outcomes of CD39 de®ciency in irritant versus
allergic contact dermatitis, illustrating diverse roles of CD39 in regulating extracellular nucleotide-
mediated signaling in in¯ammatory responses to environmental insults and DC-T cell
communication in antigen presentation.
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CD40 Expression of Melanocytes Induced by IFN-g and its Signi®cance
Y. Lu and W. Zhu
Dermatology, The First Af®liated Hospital, Nanjing Medical University, Nanjing, China
Here we demonstrated that human melanocytes (MC) cultured in vitro expressed low but
detectable CD40 surface protein. The surface expressions of CD40 were markedly up-regulated
following stimulation with interferon (IFN)-g of different concentrations for 24 h, 48 h and 72 h,
respectively. We also discovered that the expressions of CD40 correlated with IFN-g levels after
24 hours' incubation. MC underwent a morphologic switch with a full capacity to stimulate
allogenic lymphocytes to proliferate after IFN-g stimulation. Optimal enhancement of stimulation
index was observed at an IFN-g concentration of 300 IU/ml after a treatment period of 72 h.
Meanwhile interleukin-12 but not interleukin-8 or 10 concentration was obviously increased in
the supernants of MC culture. Furthermore, ligation of CD40 via soluble CD40 ligand (CD40L)
enhanced CD80, ICAM-1 and HLA-DR expressions, which could be mostly blocked by speci®c
monoclonal antibody to CD40L. Since CD40-CD40L is a pair of important and special
costimulating signals, it is of great value to elucidate the fact that CD40 is functionally expressed on
MC, thus for a better understanding of MC's role in cellular immune responses in some
pigmentary disorders. MC might activate cytotoxic T lymphocytes directly via a CD40 positive
lymphocytes independent way.
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Role of OX-40R and OX-40L Costimulatory System in the Pathogenesis of Psoriasis
S. Kundu-Raychaudhuri,*² W. Jiang,* A. Weinberg,* E. M. Farber,* and S. P. Raychaudhuri*
*Dermatology, Psoriasis Research Institute, Palo Alto, California, U.S.A.; ²Medicine, Stanford University,
Stanford, California, U.S.A.
OX-40 receptor (OX-40R), a member of the TNF-R family is primarily expressed on activated
CD4+ T lymphocytes. Engagement of OX-40R with its ligand (OX-40 L) provides an alternative,
CD28 independent, costimulatory pathway for T cell activation. Here we studied the role of OX-
40R/OX-40 L system in the pathogenesis of psoriasis. To identify the expression of OX-40R,
immunoperoxidase studies were performed with an anti-OX40R monoclonal antibody (1 : 100)
on cryosections from lesional/nolesional psoriasis skin and normal skin. In psoriatic plaques
lymphomononuclear cells in the papillary dermis showed increased expression of OX-40R and
these cells colacalized with the HLA-DR+ T cells. To investigate the kinetics of the OX-40R
regulatory system in psoriasis we studied the expression of OX-40R in Koebner induced
developing psoriatic lesions. OX-40R+ T cells were identi®ed in the dermo-epidermal junction in
the 2nd week of the developing lesions, which correlated with the clinical appearance of psoriasis.
OX-40R+ T cells were also found in the transplanted plaques in psoriasis SCID mouse model.
These cells were present as long as the psoriatic histology was maintained in the plaque, which is
about six months. All these observations suggest a critical role of the OX-40R and its ligand system
in the pathogenesis of psoriasis. In other systemic in¯ammatory conditions also OX-40R+ T cells
have been reported to be localized only in the diseased organs. Thus, OX-40R provides a unique
target where pharmacological manipulation is not expected to induce generalized immunosup-
pression.
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Antibodies in the Serum of Patients with Melanoma-Associated Retinopathy Recognize
Antigens Expressed from Melanoma Cell Lines
C. Pfo
È
hler, G. Ladewig, C. E. Thirkill,* W. Tilgen, and U. Reinhold
Department of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany;
*Ophthalmology Research, University of California, Davis, California, U.S.A.
Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome in patients with metastatic
melanoma. The pathomechanism is supposed to result from antibody production against not yet
identi®ed melanoma antigens; these antibodies cross-react with epitopes of retinal cells. If a critical
number of retinal cells is destroyed the ophthalmological symptoms appear. Recently, clinical
studies proved that the majority of patients in advanced stages of disease suffer from subclinical
MAR-suspicious symptoms. In this study we screend serum from melanoma patients in the various
stages of disease on several melanoma cell lines and on human ®broblasts using ¯ow cytometry. As
a negative control serum of healthy donors was used. All serum probes were evaluatd in a dilution
of 1 : 5, detection was performed using a FITC-conjugated rabbit antihuman antibody. The
majority of the investigated autologous serum probes reacted with 3 of 5 melanoma cell lines.
Fibroblast were always negative. We could show that serum probes of melanoma patients often
contain antibodies against not yet identi®ed melanoma antigens which seem to expressed from
different melanoma cell lines. Further investigations with these positive cell lines are required to
identify und characterize the antigen(s) able to induce the production of antibodies cross-reactive
with retinal tissue
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Expression of TLR3 and TLR9 on Cutaneous Mast Cells
H. Matsushima, N. Yamada, X. Han, and S. Shimada
Dermatology, Yamanashi Medical University, Yamanashi, Japan
Toll-like receptors (TLR) mediate innate immune responses by their binding to viral and bacterial
products. Recent studies revealed that TLR3 binds to viral double-stranded RNA and that TLR9
binds to CpG motifs, consensus oligodeoxynucleotide sequences speci®c to bacteria and viruses.
This study aimed to determine whether mast cells in skin express TLR3 and TLR9. First we
identi®ed mRNA expression of TLR3 and TLR9 in murine fetal skin-derived cultured mast cells
(FSMC) that closely resemble cutaneous mast cells. The expression levels of both TLR3 and TLR9
in FSMC were several-fold greater than those in bone marrow-derived cultured mast cells
(BMMC) that represent mucosal (or immature) mast cells. Secondary FSMC secreted TNF-a, IL-
6, and RANTES in response to poly (I:C) (synthetic ligand of TLR3) and CpG
oligodeoxynucleotides (but not to randomized oligodeoxynucleotides) to much greater extents
than BMMC did. These data assure expression of functional TLR3 and TLR9 on FSMC, and also
suggest that their expression may be differentially regulated depending on subtypes of mast cells.
Interestingly, unlike stimulation of mast cells through FceRI, stimulation through TLR3 and
TLR9 did not cause degranulation and did not induce production of IL-13. Finally,
immunohistochemical staining of healthy human skin revealed expression of both TLR3 and
TLR9 by cutaneous mast cells in vivo. Thus mast cells in skin express TLR3 and TLR9, recognize
pathogen-speci®c nucleotides, and release proin¯ammatory cytokines. The absence of IL-13 may
be advantageous for the following Th1 responses. Our results suggest novel roles of cutaneous mast
cells in innate immunity distinct from their roles in IgE-mediated allergic responses.
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Cellular Immune Responses Elicited Through Epicutaneous Immunization
R. Kahlon, Y. Hu, K. Orteu,* J. D. Trudeau,² R. Tan,² and J. P. Dutz
Medicine, University of British Columbia, Vancouver, British Columbia, Canada; *Dermatology, London
Free Hospital, London, U.K.; ²Pathology, University of British Columbia, Vancouver, British Columbia,
Canada
In this study we characterize the cellular immune responses generated subsequent to epicutaneous
application of peptide. We have setup an adoptive transfer system to look at the activation and
proliferation of CD4 T cells in response to protein or peptide applied on to the skin. The system
uses a transgenic mouse strain, DO11.10, which has rearranged TCRa and TCRb genes and
expresses a T cell receptor speci®c for ovalbumin 323±339 in complex with I-Ad MHC class II
molecules. For the analysis of CD8 T cell responses to epicutaneous peptide, nontransgenic
C57BL6 mice were immunized with SIINFEKL (OVA254-267), an immunodominant class I
MHC (Kb) restricted peptide and peptide-speci®c CTL were enumerated using multimeric Class I
MHC-peptide complexes. The functionality of these cells was characterized using a cytotoxicity
assay as well as an in vivo tumor-survival assay. Adoptive transfer of CFSE-labeled D011.1 CD4 T
cells revealed that application of cognate peptide to either intact skin, with occlusion, or tape-
stripped skin, with or without the adjuvant cholera toxin (CT) resulted in proliferative responses in
the draining lymph nodes. Application of a class I MHC restricted peptide to tape-stripped skin, in
the presence of CT resulted in the generation of CTL. These CTL could be generated even in the
absence of IL-12 (that is, in IL12p40 knockout mice). The CTL were functional as immunization
was able to induce peptide-speci®c protection against tumor growth. Thus peptides applied onto
the skin are able to elicit peptide speci®c CD4 and CD8 T cells. In addition, CTL responses can be
generated in the absence of IL-12 or CD4 helper epitopes and affect tumor growth. Epicutaneous
immunization is therefore a promising approach for the generation of epitope-speci®c T cell
responses.
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Sezary Syndrome Patients Demonstrate a Defect in Dendritic Cell Numbers and
Function
M. Wysocka,*³ M. H. Zaki,* L. E. French,² J. Chehimi,³ M. Shapiro,* S. E. Everetts,* K. S.
McGinnis,* L. Montaner,³ and A. H. Rook*
*Dematology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; ²Dermatology, Geneva
University Hospital, Geneva, Switzerland; ³Immunology, The Wistar Institute, Philadelphia,
Pennsylvania, U.S.A.
Sezary syndrome (SzS) represents an advanced form of cutaneous T cell lymphoma associated with
involvement of the peripheral blood by malignant T cells. The disease is de®ned by impaired cell-
mediated immunity, production of IFNland IL-2 possibly as a result of de®cient IL-12
production. To understand the mechanism of this impairment, we examined the composition and
function of dendritic cells and monocytes in the blood of SzS patients with different levels of
peripheral blood tumor burden. Consistent with our previous observations, numbers of monocytes
in SzS patients were comparable to numbers observed in normal volunteers. In contrast, decreased
IL-12 production correlated with a decrease in the numbers of CD11c+ dendritic cells, which was
particularly profound among medium (20±50% circulating malignant T cells) and high tumor
burden patients (> 50% circulating malignant T cells). Futhermore, CD123+ dendritic cells, major
producers of IFN a, were signi®cantly diminished in SzS patients, regardless of the level of tumor
burden.GM-CSF treated patients experienced an increase in the numbers of dendritic cells but not
in IFNaor IL-12 production. However, in vitro stimulation of PBMC from SzS patients with
recombinant CD40L (rCD40L) and IFNl signi®cantly increased production of IL-12. Thus, our
results demonstrate a profound defect in circulating dendritic cells in SzS patients that may
contribute to the depressed cellular immunity. Importantly, the ability of rCD40L to induce IL-12
production from monocytes and residual dendritic cells of SzS patients could potentially serve as an
immune restorative therapeutic agent.
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The Effect of an Anti-In¯ammatory Sesquiterpene Lactone Parthenolide on Human
Monocyte-Derived Dendritic Cells
H. Uchi,*² J. Arrighi,² J. Aubry,§ M. Furue,* and C. Hauser²³
*Dermatology, Kyushu University, Fukuoka, Japan; ²Immunology and Allergology, University of Geneva,
Geneva, Switzerland; ³Dermatology, University of Geneva, Geneva, Switzerland; §Immunology, Centre
d'Immunologie Pierre Fabre (CIPF), Saint-Julien-en-Genevois, France
Dendritic cells (DC) represent a critical link between the innate and adaptive immune system and
the control of DC maturation provides a strategy for the treatment of allergic and in¯ammatory
diseases. Human monocyte-derived DC generated by culture with GM-CSF and IL-4 were
pretreated with parthenolide, an anti-in¯ammatory sesquiterpene lactone, and subsequently
stimulated with LPS or TNF-a. Parthenolide inhibited LPS-induced up-regulation of CD86,
CD83, CD80, CD40, and MHC-class II expression on DC. Parthenolide also prevented the
increase of allostimulatory capacity, the down-regulation of endocytic activity, and the production
of TNF and IL-12p40 and p70 from LPS-stimulated DC. On the other hand, the effect of
parthenolide on TNF-a-induced DC maturation was absent. Furthermore, parthenolide inhibited
LPS-induced both p38 MAPK phosphorylation and NFkB nuclear translocation, while only TNF-
a-induced NFkB nuclear translocation, but not p38 MAPK phosphorylation, was inhibited by
parthenolide. These results suggest that PTL may differently affect on LPS- and TNF-a-induced
DC maturation by inhibiting p38 MAPK. Our results may offer PTL not only as a promising
compound for the inhibition of DC maturation, but also as a tool to further dissect the signaling
pathways involved in DC maturation.
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Antimicrobial Peptides are Present in Murine Bone Marrow Derived Mast Cells: a Role
for the Mast Cell in Fighting Skin Infection
A. Di Nardo, A. Vitiello,* and R. L. Gallo
Dermatology Section, VAMC, University of California San Diego, San Diego, California, U.S.A.;
*Infectious Diseases, Johnson & Johnson Pharmaceutical Research & Development, San Diego, California,
U.S.A.
Antimicrobial peptides are now recognized to be a critical ®rst line of defense against bacterial
infection in the skin. The cathelicidin (Cath) antimicrobial family is thought to be increased in the
skin after wounding due (in part) to their release from neutrophil granules and increased synthesis
by keratinocytes. We hypothesized that other cells in the skin belonging to the innate or acquired
immune system may also produce and secrete antimicrobial peptides. To test this, we isolated and
immunolocalized CRAMP from bone marrow derived mast cells (BMD-MC). Murine bone
marrow cells were isolated and cultured with IL-3 and SCF (stem cell factor) for four weeks. Their
phenotype was con®rmed by FACS analysis and the presence of IgE receptor at their surface. Total
RNA and protein was extracted from these cells. The presence of CRAMP mRNA was detected
and con®rmed by standard PCR and real-time PCR, and protein, corresponding to the molecular
weight of CRAMP protein precursor, was seen by Western Blot. In addition, BMD-MCs were
cytospinned, ®xed and permeabilized with methanol, and incubated with anti-CRAMP for direct
observation with a FITC labelled secondary antibody. Mast cells showed a cytoplasmatic granular
¯uorescence. Mast cells are widely distributed in tissues of many species and are important effector
cells in allergic diseases. Recent evidence suggests that they may have an important role in ®ghting
bacterial infection, mostly as adjuvant in activating other effector cells. Until now however, no
antimicrobial peptides have been isolated from mammalian mast cells. Our results indicate that mast
cells are directly involved in the innate defense mechanism through the synthesis and release of
Caths.
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Impaired Contact Hypersensitivity to Trinitrochlorobenzene in Macrophage Migration
Inhibitory Factor De®cient Mice
T. Shimizu, R. Abe, A. Shibaki, H. Watanabe, J. Nishihira,* and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan; *Central
Research Institute, Hokkaido University Graduate School of Medicinete, Sapporo, Hokkaido, Japan
Contact hypersensitivity (CHS) response represents one of the most widely studied in vivo
examples of the cell-mediated immune events. Macrophage migration inhibitory factor (MIF) was
originally identi®ed as a lymphokine concentrating macrophages at in¯ammatory loci, as a potent
activator of macrophages and is thought to play an important role in cell-mediated immunity. To
determine whether MIF is required for optimal contact sensitization, MIF-de®cient (MIF KO) and
wild type (WT) mice were sensitized using 3500E
Â
g trinitrochlorobenzene (TNCB) on their
abdominal skin and challenged on the dorsum skin of one ear 5 days later with 200E
Â
g TNCB.
Signi®cant ear swelling was observed in the WT mice, but this response was inhibited in the MIF
KO mice (p < 0.01, for MIF KO vs. WT mice in 24 h). In addition, lymph node cells from MIF
KO mice sensitized with TNCB were unable to passively transfer CHS to naive recipients. To
examine the effect of MIF on allergen-induced Langerhans cell (LC) migration, the epidermal LC
density was determined following topical application of 100E
Â
g TNCB. TNCB treatment caused a
signi®cant decline in epidermal LC density (20.8%, p < 0.05) 4 h after application in WT mice, but
TNCB treatment failed to provoke a signi®cant epidermal LC migration in MIF KO mice (7.8%).
Taken together these results indicate that MIF is important in the regulation of cutaneous immune
responses and plays a central role in LC migration and CHS.
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Identi®cation of Antigen-Speci®c Lymphocytes, CCR7 Expression and the Role of
Apoptosis During Resolving Cutaneous In¯ammation
J. R. Reed,*² M. Vukmanovic-Stejic,* C. H. Orteu,² M. Bo®ll,* L. W. Poulter,* C. D.
Buckley,³ M. Salmon,³ M. H. Rustin,² and A. N. Akbar*
*Immunology, Royal Free and University College Medical School, London, U.K.; ²Dermatology, Royal
Free Hospital, London, U.K.; ³MRC Centre for Immune Regulation, University of Birmingham,
Birmingham, U.K.
The resolution of an antigen-speci®c immune response relies on the clearance of the in¯ammatory
in®ltrate. This is dependent on the apoptosis and emigration of the largely redundant expanded
population of antigen-speci®c lymphocytes. The Mantoux test (MT) is a resolving antigen-speci®c
immune response to the intradermal injection of tuberculin puri®ed protein derivative. CD4+ T
cells isolated from the peripheral blood (PB) and skin suction blisters raised over MTs have been
analysed in conjunction with the immunohistochemical analysis of biopsies. CCR7 expression, the
degree of apoptosis and the proportion of antigen-speci®c T cells have been determined. We have
de®ned the induction, peak and resolution phases of the MT as days 3, 7 and 14, respectively. Day
7 showed the maximal in®ltrate and proliferation of T cells. This was re¯ected by a marked
increase in antigen-speci®c CD4+ T cells in the skin at day 7 (9.09%) compared to day 3 (0.68%)
and day 5 (1.43%). By day 14 the proportion had increased further to 29.79%. Apoptotic T cells
were increased at day 7 (1.83%) and maximal by day 14 (2.5%) compared to day 3 (0.44%).
Emigration of lymphocytes to peripheral lymphatics may be dependent on the expression of
CCR7. Memory CD4+ T cells from skin blisters raised during MTs expressed low levels of CCR7
compared to PB (MFI 3.14 and 23.92, respectively) consistent with the selective recruitment and
differentiation of CCR7 negative effector memory T cells within the skin. CCR7 expression on
skin memory CD4+ T cells decreased progressively during the course of the MT suggesting
increasing effector differentiation. The residual population of lymphocytes in the skin during
resolution at day 14 is associated with a high level of antigen-speci®city and low CCR7 expression.
The vast majority of these cells are probably destined to undergo apoptosis.
552
Decreased Suppressive Capacity of Psoriatic CD4+CD25+ Regulatory T Cells: A Novel
Mechanism for Sustained Autoreactivity in Psoriasis
H. Sugiyama,*² R. P. Gyulai,* S. Shimada,² K. D. Cooper,* S. R. Stevens,* and T. S.
McCormick*
*Dermatology, University Hospitals of Cleveland and CWRU, Cleveland, Ohio, U.S.A.; ²Dermatology,
Yamanashi Medical University, Yamanashi, Japan
CD4+ CD25+ T cells have been proposed as critical for the regulation of autoimmune responses.
Because an autoimmune response is involved in the pathogenesis of psoriasis, we asked whether
CD4+ CD25+ regulatory T cells (Tr) obtained from psoriasis patients are phenotypically or
functionally aberrant. Phenotypically, both total and skin homing (CLA+) CD4+ CD25high Tr
were present in equal proportions in blood mononuclear cells (MNC) of psoriatic (n = 6) and
normal volunteers (n = 8). In psoriatic lesional skin, CD4+ CD25+ CTLA4 + Tr represented
32.2% and 13.3% of CD4+ cells in epidermis and dermis, respectively (n = 2). For functional
analysis, MNC CD4+ CD25- T cell (Tresp) responses to alloantigen on MNC APC in the
presence or absence of autologous Tr (1 : 1 ratio) were tested. In regard to reactivity of Tresp from
normals and psoriatics (n = 6), the average DPM of [3H] TdR uptake (310±3) was 73.5 6 20.8
and 101.7 6 29.2 (p = 0.166), respectively. Whereas normal Tr profoundly inhibited the
proliferation of autologous Tresp to 9.1 6 9.1, psoriatic Tr only partially inhibited to
32.4 6 14.1 DPM (87.7 6 8.8% vs. 68.2 6 8.8% inhibition, p = 0.003). Reduced Tr function in
psoriasis was also con®rmed by a ¯ow cytometry-based CFSE assay, which allowed identi®cation
of the unregulated proliferating cells. To determine if the lowered inhibitory response was dose
dependent with respect to the number of Tr, we used a 1 : 2 and 2 : 1 ratio of Tr to Tresp (n = 3).
At each ratio, psoriatic inhibition did not reach the level of inhibition exhibited by normal
volunteers. The inhibitory function of skin homing CLA + Tr was also investigated (n = 3), and the
decreased inhibition (63.1 6 19.0%) was again con®rmed, and was comparable to that of the total
(CLA + plus CLA-) Tr in psoriatic patients as above. In conclusion, the decreased immunor-
egulatory capacity of CD4+ CD25+ Tr might represent a novel mechanism for sustaining the
autoimmune in¯ammatory reaction in psoriasis.
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Sweat: An Innate Defense Barrier that Contains Natural Antibiotic Peptides
M. Murakami, T. Ohtake, and R. L. Gallo
Medicine/Dermatology, UCSD/VA Medical Center, San Diego, California, U.S.A.
Cathelicidin (cath) antimicrobial peptides are found in the skin in response to microbial invasion or
injury as a result of production by keratinocytes and neutrophils. We have recently shown their
presence in mice is essential to defend against invasive bacterial infection (Nature, 2001 414 : 454±
456). Recently, sweat was shown to contain dermcidin, a newly discovered class of antimicrobial
peptide (Nat Immunol, 2001 12 : 1133±7). Since antimicrobial peptides can be synergistic, we
asked if caths are also present in sweat. To evaluate expression of the human cath LL37, Western
blots, immuno-blot, immunohistochemistry and in situ hybridization were done on sweat or
axillary skin collected from healthy human volunteers. LL37 was found in sweat in micromolar
concentrations. Skin biopsy showed abundant LL37 protein and mRNA was present in normal
eccrine glands. LL37 and Dermcidin were then evaluated for their combined bacterial killing
activity by radial diffusion assay. Dermcidin was poorly active in this assay and LL37 showed
superior killing against sensitive strains of Staph. aureus. LL37 activity was not augmented by the
presence of dermcidin. These results suggest the production of cath natural antibiotics in sweat is an
important component of the skin's innate defense against infection.
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M-CSF Induces the Differentiation of CD34+ Hematopoietic Progenitor Cells into
Langerhans Cells in a TGF-b1-Dependent Manner
S. Aiba, Z. U. Mollah, S. Nakagawa, H. Manome, Y. Yoshino, and H. Tagami
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
GM-CSF is always considered as an essential factor for developing dendritic cells (DCs) or
Langerhans cells (LCs) from CD34+ hematopoietic progenitor cells (HPCs). Recently, we have
demonstrated that a coculture of HPCs with human cutaneous stromal cells that produce M-CSF,
but noy GM-CSF, induces CD1a+ CD14-DCs without any exogenous cytokines. Therefore, in
this study, we examined whether M-CSF could be used instead of GM-CSF for the in vitro
development of LCs from HPCs. We replaced GM-CSF with M-CSF from a serum-free culture
containing GM-CSF, SCF, Flt3L, TNF-a, and TGF-b1, which were reported to induce LCs.
This serum-free culture medium containing M-CSF, but not GM-CSF (M-CSF medimum),
could induce CD1a+ Birbeck granule + Langerin + E-cadherin + factor XIIIa-LCs. As a control,
the culture of HPCs in the M-CSF medium without M-CSF or without TGF-b1 resulted in far
fewer CD1a+ cells or complete abrogation of CD1a+ cell differentiaion, respectively. M-CSF
increased the number of CD1a+ cells in a dose-dependent fashion. These M-CSF-induced LCs
(M-CSF LCs) were different from GM-CSF-induced LCs (GM-CSF LCs) in their decreased
expression of CD11c and their immature phenotype. The decreased expression of CD11c was
recovered by culturing M-CSF LCs with GM-CSF, while M-CSF LCs were induced to maturate
by GM-CSF, TNF-a, IL-1 b, or LPS. M-CSF LCs were potent antigen presenting cells in
allogeneic T cell stimulation and the pretreatment with GM-CSF or GM-CSF + TNF-a
augmented the potency. M-CSF LCs produced more TNF-a and IL-8, but much less IL-10 than
GM-CSF LCs with some combinations of cytokines. These studies demonstrate that M-CSF can
replace the role of GM-CSF in LC development from HPCs in vitro in a TGF-b1-dependent
manner, which suggests the possibility that M-CSF plays a crucial role in the LC development in
vivo.
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EGF Receptor Transactivation Mediated by the Proteolytic Conversion of Membrane-
Anchored HB-EGF to the Soluble Form is Essential for IL-8-Induced Keratinocyte
Migration
S. Tokumaru, Y. Shirakata, K. Yamasaki, and K. Hashimoto
Dermatology, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
IL-8, a CXC chemokine, is closely associated with the pathogenesis of in¯ammatory skin disorders.
Recently, it has been revealed that keratinocytes produce IL-8. Since keratinocytes express
receptors for IL-8, CXCR1 and CXCR2, IL-8 is expected to affect keratinocyte function in an
auto/paracrine manner. We examined the effect of IL-8 on keratinocyte growth and migration.
IL-8 induced keratinocyte migration in a dose-dependent manner, with a 3-fold optimum at
300 pg/ml, although it had no effect on keratinocyte growth. Several groups have reported that
ligands for the G-protein-coupled receptor (GPCR) can induce EGF receptor (EGFR)
transactivation by HB-EGF shedding (the proteolytic conversion of membrane-anchored HB-
EGF to the soluble form, which binds to EGFR and results in EGFR activation). Since CXCR1
and CXCR2 are GPCR, we hypothesized that IL-8-induced keratinocyte migration is mediated
by an EGFR transactivation mechanism. The addition of IL-8 induced the phosphorylation of
EGFR with a maximum at 15 min. OSU8-1, an HB-EGF converting proteinase inhibitor (JCB
151 : 209±219, 2000), inhibited IL-8-induced keratinocyte migration by 30% at 10 mM. In
addition, anti-HB-EGF neutralizing antibody (10 mg/ml) inhibited IL-8-induced keratinocyte
migration by 30%. To further con®rm the role of converted HB-EGF (soluble form), the effect of
CRM197 was examined. CRM197, a nontoxic mutant of diphtheria toxin, speci®cally binds to
the EGF-like domain of HB-EGF and neutralizes the activity of human HB-EGF, but not other
EGFR ligands. CRM197 inhibited IL-8-induced keratinocyte migration by 30% at 1 mg/ml.
Treatment with anti-EGFR neutralizing antibody (10 mg/ml) and the EGFR kinase-speci®c
inhibitor AG1478 (30 nM) inhibited IL-8-induced keratinocyte migration by 40%. In conclusion,
this is the ®rst report that EGFR transactivation mediated by HB-EGF conversion via the IL-8/
CXC signaling pathway plays an essential role in IL-8 induced keratinocyte migration.
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Lipoteichoic Acid-Induced Keratinocyte Activation is Mediated by Toll-Like Receptor 4
P. I. Song,*² Y. Park,* T. A. Abraham,* B. Harten,* N. G. Neparidze,*² C. A. Armstrong,*²
and J. C. Ansel*²
*Dermatology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.; ²Dermatology, North-
western University, Chicago, Illinois, U.S.A.
CD14 and Toll-like receptors (TLRs) have been known to play an important role in toxin-
mediated innate immune responses in bacterial skin infection. Recently, we have demonstrated
that lipopolysaccharide, a major biologically active component of gram-negative bacteria, can
activate human keratinocytes by CD14 and TLR 4 dependent mechanism. However, the
mechanism of activation of keratinocytes by gram-positive bacteria toxins remains unclear. In this
study we examined the activation of human keratinocytes by lipoteichoic acid (LTA), a
proinfalmmatory component of gram-positive bacteria. TLR4 mRNA expression on keratinocytes
was augmented by exposure to LTA. LTA binding to keratinocytes resulted in a rapid intracellular
calcium response, NF-kB nuclear translocation and the secretion of proin¯ammatory cytokines
(IL-1a and IL-1b) and the chemokine IL-8. These responses by LTA were effectively abrogated by
preincubating cells with anti-TLR4 monoclonal antibodies, but not with anti-CD14 monoclonal
antibodies or anti-TLR2 monoclonal antibodies. Therefore the results of this study indicate that
like LPS, LTA can activate human keratinocytes by a TLR4 mediated mechanism and, in contrast
to LPS, LTA-induced keratinocyte activation is CD14-independent. These results may have
important implications for our understanding of the pathophysiology of cutaneous infections.
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Expression of CC Chemokine Receptor-4 is Critical for the Binding of Antigen-Primed,
but not Naõ
È
ve, T Cells to Dendritic Cells In Vitro
A. R. Cardones, M. Wu, H. Fang, and S. T. Hwang
Dermatology Branch, NCI, National Institutes of Health, Bethesda, Maryland, U.S.A.
The establishment of physical attachment between a T cell and an antigen-laden dendritic cell
(DC) is a critical step of the adaptive immune response. Although DC are known to synthesize a
variety of chemokines, it is unclear which ones are important in stimulating adhesion of T cells to
DC. Herein, we describe a novel system for analyzing rapid T cell±DC binding interactions in real-
time in order to determine whether a DC-produced chemokine can induce the binding of T cells
to DC. First, bone marrow-derived DC (BMDC) were tethered to the bottom of a ¯ow chamber
using antibodies to CD40. Next, naive or antigen-primed T cells were introduced into the
chamber at precise ¯ow rates. Using this system, a T cell line (B 9.1) and antigen-activated T cells
were observed to rapidly bind to immobilized DC at low shear stress (0.1±0.2 dynes/cm
2
) in a
pertussis toxin (PTX)-sensitive manner (p < 0.001). Pretreatment of antigen-primed T cells with a
CCR4 ligand (CCL22) prevented T cells from binding effectively to BMDC (p < 0.001). Antigen-
primed T cell binding was also reduced to background levels when interactions took place in the
presence of neutralizing anti-CCL22 antibodies (p < 0.004). Antigen-primed T cells displayed 3-
to 4-fold enhanced binding to DC compared to unprimed T cells at a shear stress of 0.1 dynes/cm
2
(p < 0.01). At a shear stress of 0.1 dynes/cm
2
, naive T cells showed little binding to BMDC,
although prominent adhesion to DC occurred in a PTX-dependent manner under static
conditions, indicating that longer contact times permitted naive T cell binding to BMDC. While
not inhibited by CCR4 ligands, the binding of naive T cells to DC in the absence of shear was
partially inhibited by pretreatment of these cells with other chemokines. Our results suggest that
DC-derived CCL22 and its receptor, CCR4, may be critical for the binding of antigen-activated T
cells to DC and that antigen-primed and naive T cells fundamentally differ with respect to the
kinetics and chemokine requirements of binding to DC.
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Role for Heat Shock Proteins and Innate Immune Response in Psoriasis
J. Qin, J. L. Curry, J. Robinson, and B. J. Nickoloff
Pathology, Loyola University, Chicago, Illinois, U.S.A.
The role for innate immunity in psoriasis is unclear. Potential cellular contributors to innate
immune responses include resident cells such as keratinocytes (KCs), ®broblasts (Fbs), and dendritic
cells (DCs). Environmental and endogenous derived stimuli include bacterial products or heat
shock proteins (HSPs). Receptors mediating innate immunity include: toll receptors (TLRs),
CD14, and CD91. To explore cutaneous innate immunity, we de®ned the distribution pattern and
functional characteristics of the aforementioned molecules in normal (NN) skin, prepsoriatic (PN)
skin, psoriatic plaques (PP), and blood-derived DCs. Immunostaining revealed KCs expressing
TLR1 and TLR4, but not TLR2, TLR9, or CD14 with no differences between PN and NN skin
(n = 5). However, there was enhanced expression of KC TLR1 and TLR4 in PP skin. Even
though cultured KCs expressed TLRs, no induction of NF-kB activity was observed in response to
LPS. Moving to HSPs, PN and PP skin contained prominent KC immunostaining for HSP 60 and
70. Moreover, a receptor for HSPs, CD91 was found diffusely expressed by upper dermal dendritic
cells (DDCs) in PN skin, and a striking accumulation of CD91+ DDCs was present in PP skin.
Besides DCs, surface CD91 was detected by FACS on Fbs, with low levels on KCs. Addition of
recombinant human HSPs (either individually or in combination) induced ICAM-1 expression on
Fbs, with little effect on KCs. Furthermore, addition of HSPs to immature blood-derived DCs
induced maturation exempli®ed by increased surface levels of costimulatory molecules CD80,
CD83, CD86; as well as increased TNF and IL-12 production (ELISA). Taken together, these data
establish, for the ®rst time, that psoriatic epidermis contains several HSPs, which can in¯uence
CD91+ cells including Fbs to express an important T cell adhesion molecule (ICAM-1), and
induce maturation of DCs into full-¯edged antigen presenting cells. Thus, the multicellular
conspiracy in PP skin that includes an admixture of activated KCs, Fbs, and DCs may in-part be
mediated by various cellular and molecular components of innate immunity.
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Enhanced Tumor Growth in the Antiorthostatic Model of Microgravity
E. H. Lee, W. Ding, A. D. Kulkarni,* and R. D. Granstein
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.; *Surgery, The
University of Texas-Houston Medical School, Houston, Texas, U.S.A.
Space¯ight exposes astronauts to challenging environmental exposures, including microgravity.
Studies on animals and humans show many parameters of innate and adaptive immunity to be
altered by space¯ight. These studies indicate space¯ight may induce a degree of immunosuppres-
sion, suggesting the possibility of adverse health consequences. As some reports have shown aircraft
¯ight crews to have a higher risk for melanoma and nonmelanoma skin cancer, astronauts may be
at risk as well. To investigate the effects of microgravity on immune responses to malignant tumors,
we used the antiorthostatic suspension model of microgravity. In this model rodents are suspended
30°head-down with approximately 50% of body weight held on the front paws. Three groups of
CAF1 (H-2a/d) mice were used: antiorthostatic, orthostatic (i.e. tail suspension without body
suspension) and nonsuspension. Seventy-two hours after suspension, all mice were injected
subcutaneously with S1509a spindle cell tumor cells and tumor growth was assessed every 48 h.
Mice in antiorthostatic suspension had a signi®cantly increased rate of tumor growth compared to
mice in the orthostatic suspension (p = 0.01) and nonsuspension (p = 0.001) groups. We next
examined the delayed-type hypersensitivity (DTH) response to tumor associated antigens (TAA) in
these mice. Mice were challenged in a hind footpad by injection with 0.1 ml of a soluble extract of
S1509a cells as a source of TAA. The DTH response was the difference in footpad thickness
between the injected and noninjected footpad. Tumor-bearing mice in antiorthostatic suspension
had a signi®cantly diminished 24 h. footpad swelling compared to the orthostatic (p = 0.008) and
nonsuspension (p = 0.0006) groups. These results suggest antiorthostatic suspension alters in vivo
immune responses to the S1509a spindle cell tumor. As plans for extended travel (International
Space Station, Mars mission, etc.) develop, it is critical to understand the effects of microgravity on
immune function and its impact on the risk of carcinogenesis.
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Passive Transfer of Mouse Immunoglobulin a Basement Membrane Antibodies
Produces Basement Membrane Zone Blisters
J. J. Zone, T. B. Taylor, and L. J. Meyer
Dermatology, University of Utah, Salt Lake City, Utah, U.S.A.; Dermatology, Veterans Administration
Medical Center, Salt Lake City, Utah, U.S.A.
IgA antibodies have not been shown to be pathogenic in human skin. The purpose of this study
was to assess the pathogenicity of IgA class mouse monoclonal antibodies to a linear IgA disease
antigen in a passive transfer model.
Previously described cells producing IgG class monoclonal antibodies against the 97 kDa linear
IgA disease antigen were used. Cells were grown in culture and cells which spontaneously switched
class to IgA were isolated using the ¯uorescent activated cell sorter. IgA monoclonal antibodies
produced by these cells were designated IgA 97±1 and IgA 97±2. Since the 97 kDa antigen is not
expressed in mouse skin, human foreskin was transplanted to SCID mice as a substrate for passive
transfer. Experimental time course was established in preliminary experiments. Three groups of 5
mice each were studied. Group 1 received 1 mg of each monoclonal IgA antibody on days 1,3, 7
and 10. Group 2 received IgA antibody as in group 1 and 300 ng of intradermal GMCSF on Day
13. Group 3 received GMCSF only on day 13. Biopsies and serum were obtained at baseline and
day 14. Mice receiving IgA alone developed IgA deposition in the human skin graft but no blister
formation or neutrophil in®ltration. Mice receiving GMCSF alone developed minimal in®ltration
with neutrophils but no blister formation or antibody deposition. Mice receiving IgA and GMCSF
developed IgA deposition, neutrophil in®ltration and basement membrane zone separation in 4/5.
We conclude that IgA class mouse monoclonal antibodies directed at the 97 kDa linear IgA disease
antigen can be passively transferred to human skin transplanted to SCID mice. Addition of
GMCSF produced neutrophil in®ltration and basement membrane zone separation.
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Dendritic Cells Treated with TAT Protein Transduction Domain Containing
Recombinant Murine Tyrosinase-Related Protein-2 (Trp-2) Induce B16 Melanoma-
Reactive Cytotoxic Lymphocytes and Antitumor Immunity
N. Shibagaki and M. C. Udey
Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, U.S.A.
Incorporation of short stretches of positively charged amino acids (aa) such as those found in an 11
aa region of the HIV TAT protein (TAT PTD) into bacterial recombinant proteins facilitates rapid
and ef®cient entry into the cytoplasm of cells, including DC. In previous work, we demonstrated
that rTAT PTD-Ovalbumin (Ova)-transduced C57BL/6 bone marrow-derived DC stimulated
antigen (Ag)-speci®c CTL and Th cells. The CTL elicited were suf®cient to prevent engraftment
of Ova-expressing tumor cells and were not expanded in mice immunized with DC transduced
with PTD-de®cient Ova. Thus, TAT PTD-containing recombinant tumor Ag may be rich
sources of MHC class I (and class II) binding peptide epitopes and may promote development of
DC-based vaccines for cancer. To determine if this strategy was ef®cacious in a `more physiologic'
model, we extended our studies to B16 melanoma in C57BL/6 mice using `self' Trp-2 as a
candidate tumor Ag. rTRP-2 6 the PTD was engineered and puri®ed. Immunization of naive
mice with DC that had been treated with rTAT PTD-Trp-2 and Trp-2 (180±188) peptide primed
peptide-speci®c and B16-reactive CTL. DC treated with PTD-de®cient Trp-2 and irrelevant Ag
did not. Vaccination of mice with rTAT PTD-Trp-2-DC prevented growth of melanomas in 11/
20 recipients (day 60). Administration of Trp-2 peptide-DC and irradiated GM-CSF-transfected
B16 cells protected 7/20 and 15/20 mice, respectively. rTAT PTD-Trp-2-DC and Trp-2 peptide-
DC induced a strong memory response to B16 challenge whereas GM-CSF/B16 cells did not.
Treatment of melanoma-bearing mice with rTAT PTD-Trp-2-DC, Trp-2 peptide-DC and
irradiated GM-CSF/B16 cells prevented appearance of palpable tumors in 6/20, 4/20 and 0/20
mice, respectively (day 60). This vaccination strategy has some theoretical and practical advantages
over those that are in current use and may promote development of ef®cacious DC-based
immunotherapies for use in patients.
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Canine Pemphigus Autoantibodies are Pathogenic in Neonatal Mice
T. Olivry,*² S. M. Dunston,* S. J. Warren,² N. Li,² and Z. Liu²
*Department of Clinical Sciences, NC State University College of Veterinary Medicine, Raleigh, North
Carolina, U.S.A.; ²Department of Dermatology, University of NC School of Medicine, Chapel Hill, North
Carolina, U.S.A.
In dogs, pemphigus foliaceus (cPF) is the most common, and pemphigus vulgaris (cPV) represents
one of the rarer forms of spontaneous autoimmune blistering skin diseases. As in man, the major
antigen in canine PF is desmoglein-1 and the main antigen of canine PV is desmoglein-3. The
pathogenic potential of canine PF and PV autoantibodies is unknown. The purpose of this study
was to investigate whether serum IgG autoantibodies cause blistering when passively transferred
into neonatal mouse.
Circulating IgG antibodies were puri®ed from the serum of one dog with PF, from pooled sera
of four dogs with PF, and from one dog with PV. Neonatal BALB/c mice (n = 4 for each group)
were injected intradermally with cPF IgG, cPV IgG and normal canine IgG. Eighteen hours after
IgG injection, skin blistering was observed in all mice injected with cPF and cPV IgG and none of
the mice injected with control canine antibodies. Direct immuno¯uorescence showed binding of
dog IgG to mouse epidermis in the lesional/perilesional skin. H/E staining of blistered skin sections
con®rmed the presence of subgranular clefting in mice injected with cPF IgG and suprabasal
blistering in mice injected with cPV antibodies. Interestingly, neutrophils were rare in induced
mouse PF blisters, a marked contrast with the neutrophil-rich pustules observed in dogs with
spontaneous PF. These results suggest that cPF and cPV IgG autoantibodies are pathogenic. This
investigation con®rms the relevance of spontaneous canine pemphigus as a model to study
autoimmune blistering diseases of human patients.
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CCL27/CCR10 Interactions Regulate T Cell-Mediated Skin In¯ammation
B. Homey,*¶ H. Alenius,** A. Muller,²¶ H. Soto,¶ E. P. Bowman,¶ W. Yuan,¶ L. McEvoy,¶ A.
I. Lauerma,²² T. Assmann,* E. Bunemann,* M. Lehto,** E. Wolff,** D. Yen,¶ H. Marxhausen,§
W. To,¶ J. Sedgwick,¶ T. Ruzicka,* P. Lehmann,* and A. Zlotnik³
*Dermatologgy, Heinrich-Heine-University, Duesseldorf, NRW, Germany, ²Radiation Oncology,
Heinrich-Heine-University, Duesseldorf, NRW, Germany, ³Genomic Medicine, Eos Biotechnology, South
San Francisco, California, U.S.A.; §Research and Development, R & D Systems, Minneapolis, Minnesota,
U.S.A.; ¶Immunology, DNAX Research Inc, Palo Alto, California, U.S.A.; **Industrial Hygiene and
Toxicology, Finish Institute of Occupational Health, Helsinki, Finland and ²²Dermatology, University of
Helsinki, Helsinki, Finland
The skin-associated chemokine CCL27 (CTACK, ALP, ESkine) and its receptor CCR10 (GPR-
2) mediate chemotactic responses of skin-homing T cells in vitro. Here we report that the majority
of skin-in®ltrating lymphocytes in patients suffering from psoriasis, atopic or allergic contact
dermatitis express CCR10. Epidermal basal keratinocytes produce CCL27 protein which binds to
extracellular matrix, is displayed on the surface of dermal endothelial cells and mediates adhesion.
TNF-a/IL-1b induce while the glucocorticosteroid clobsol propionate suppresses CCL27
production. Circulating skin-homing CLA+ T cells, dermal microvascular endothelial cells, and
®broblasts express CCR10 on their cell surface. in vivo, intracutaneous CCL27 injection attracts
lymphocytes and conversely, neutralization of CCL27/CCR10 interactions impairs lymphocyte
recruitment to the skin leading to the suppression of allergen-induced skin in¯ammation. Taken
together, these ®ndings indicate that CCL27/CCR10 interactions play a pivotal role in T cell-
mediated skin in¯ammation and represent a promising new target for the development of selective
therapeutics against in¯ammatory skin diseases.
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CCR6 Receptor Colocalizes with b2 Integrin During Arrest of Model T Cells to
Immobilized ICAM-1 Under Flow Conditions
R. E. Morales, W. Maki, H. Fang, and S. T. Hwang
Dermatology Branch, NCI, Bethesda, Maryland, U.S.A.
Previous studies have indicated that CCR6-expressing T cells are prevalent in psoriatic lesions and
that CCR6 may be critical in inducing arrest of memory T cells on activated endothelial cells.
Although changes in avidity have been noted following exposure of lymphocytes to chemokines,
little is known of the distribution of chemokine receptors with regard to critical adhesion
molecules such as CD18. To follow the distribution of the CCR6 receptor in model T cells during
the process of arrest, we retrovirally transduced a CLA + Jurkat T cell line that was essentially
devoid of most chemokine receptors (except CXCR4) with a fusion receptor consisting of CCR6
fused through its C-terminal end to GFP. The resulting CCR6-GFP-Jurkat cells migrated 6-fold
better to the CCR6 ligand (LARC) in chemotaxis assays, adhered 2.5-fold better to immobilized
LARC in the presence of ICAM-1 under ¯ow conditions (p = 0.04), and arrested 2.3-fold
(p = 0.001) more ef®ciently than mock-transduced Jurkat cells to activated HDMEC (also under
¯ow conditions). As CCR6-GFP-Jurkat cells rolled and arrested on recombinant chemokine
ligand and ICAM-1, CCR6/GFP, which was initially uniform in distribution, segregated to one
end of the cell. By two-color confocal microscopy, CCR6/GFP colocalized with b2 integrin,
suggesting that redistribution of chemokine receptor may play a role in the increase of avidity of b2
integrins. Thus, CCR6 (in the absence of other receptors such as CCR4 or CXCR3) is suf®cient
to induce signi®cant arrest of Jurkat T cells to activated endothelial cells. Moreover, the
redistribution of CCR6 may contribute to the increase in integrin avidity enhances arrest of
lymphocytes to activated endothelium.
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The TNF Ligands, BAFF and APRIL, are Preferentially Expressed in Dendritic Cells:
Differential Regulation Upon LPS Recognition
B. Huard, L. Arlettaz,* P. Schneider,² D. Mauri,³ E. Roosnek,* J. Tschopp,² and L. French
Dermatology, Medical University Center, Geneva, Switzerland; *Immunotransplantation, University
Hospital, Geneva, Switzerland; ²Biochemistry, Lausanne University, Epalinges, Switzerland; ³R & D,
Apotech Corp., Epalinges, Switzerland
BAFF (B cell activating factor from the TNF family) and APRIL (A proliferation-inducing ligand)
are members of the TNF ligand superfamily. These TNF ligands have been shown to provide an
important stimulatory/survival signal to B and T lymphocytes, indicating a role for these two TNF
ligands in T and B cell immunity. Despite the original detection of mRNA in lymphoid tissues and
peripheral blood, the physiological source of these molecules is not well de®ned. Here, we studied
BAFF and APRIL expressions among peripheral blood leukocytes. We found that BAFF and
APRIL are both predominantly expressed in Dendritic Cells (DCs). Interestingly, modulation of
BAFF and APRIL expressions showed some marked differences upon DC exposure to a
maturating agent, such as LPS. An up-regulation of BAFF mRNA was observed, while APRIL
mRNA was found reduced. DC treatment with in¯ammatory molecules such as IL-10, IFNg or
TNFa did not reproduce these effects. Such a different regulation upon DC maturation strongly
suggests a nonredundant role for BAFF and APRIL produced in DCs. BAFF may be an important
stimulatory factor released by DCs that have sensed a pathogen, engaged in a maturation process
and migrating to regional lymph nodes. On the contrary, APRIL may be an important stimulatory
factor released by DCs, resident in lymphoid tissues, and not exposed to maturation signal given by
pathogens.
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Genetic Analysis of Spontaneous Dermatitis in gd T Cell-De®cient (d
±/±
) Mice
J. H. Nam, J. M. Lewis, M. Girardi, and R. E. Tigelaar
Dermatology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.
We previously reported that NOD.d
±/±
, but not B6 or (NODxB6)F1.d
±/±
mice develop an ab T
cell-dependent, localized SpD with several similarities to human atopic dermatitis (AD). To extend
that work, we examined the environmental dependence of SpD; NOD.d
±/±
mice housed in
conventional, nonventilated cages (CNVC) developed SpD, but NOD.d
±/±
mice housed in
individually ventilated cages (IVC) did not. The frequency of SpD (assessed by micrometer





mice and 99/235 (42%) in (F1xNOD).d
±/±
backcross (BC) mice, values
which are consistent with the SpD being controlled by a single recessive allele. As higher IgE levels
have been found in AD patients, we analyzed whether IgE levels correlated with genotype and/or
the SpD phenotype. Total IgE levels (ELISA) were determined in B6 wild-type (w.t.) and B6.d
±/±
mice, NOD w.t. and NOD.d
±/±
mice in CNVC or IVC, and BC.d
±/±
mice in CNVC. Higher IgE
levels were found in NOD w.t. [204 6 59 (SEM) ng/ml] and NOD.d
±/±
mice (282 6 20)
compared to B6 w.t. mice (70 6 42; p < 0.05 for both NOD groups) and B6.d
±/±
mice (51 6 22; p
< 0.001 for both NOD groups). Similar IgE levels were seen in NOD.d
±/±
mice in either CNVC
or IVC. IgE levels in BC.d
±/±
mice with SpD were indistinguishable from those in BC.d
±/±
mice
without SpD. These data suggest that the NOD vs. the B6 genotype is susceptible to higher IgE
production, but that total IgE levels do not correlate with degree of skin in¯ammation. Genome-
wide microsatellite mapping studies in other AD mouse models have identi®ed major susceptibility
intervals to Chr 9 in NC/Nga mice and to Chr 14 in NOA mice. Using primers distinguishing
NOD and B6 polymorphisms in the approximate centers of these previously described intervals,
DNA from BC.d
±/±
mice with SpD was analyzed by PCR. For both intervals, the NOD/NOD vs.
NOD/B6 ratios were 1.0, indicating that the interval(s) controlling susceptibility to SpD in
NOD.d
±/±
mice are distinct from those found in other mouse models of AD.
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Role of Notch Signaling in Dendritic Cell Maturation and Migration
L. Miele, S. Weijzen,* M. Velders,* E. Simel, W. M. Kast,* and B. J. Nickoloff*
Biopharmaceutical Sciences, University of Illinois, Chicago, Illinois, U.S.A.; *Pathology, Loyola University,
Chicago, Illinois, U.S.A.
Epidermal dendritic cells (DCs) ± Langerhans cells (LCs) play a critical role in initiation of many
cutaneous immune responses. Following topical exposure to allergens, LCs are activated and
migrate to draining lymph nodes while maturing. Molecular pathways involved in this response are
poorly understood. The membrane receptor Notch-1 regulates cell fate in many tissues. Mice
de®cient in Notch-1 show a defect in DC maturation. Notch ligands, such as Jagged-1, are
abundantly expressed on the surface of keratinocytes (KCs) in human epidermis as detected by
immunohistochemical staining and ¯ow cytometry. Therefore, we investigated whether activation
of Notch signaling is required for cutaneous DC maturation. Notch-1 is expressed in human DC
and only mature DC expressed the functionally active intracellular cleavage product (NIC).
Blockade of Notch activation (accomplished by exposure to a g secretase inhibitor) prevented LPS-
induced DC maturation as assessed by reduction in expression of costimulatory molecules CD80,
CD83 and CD86; as well as decreased production of IL-12. Direct exposure of immature
monocyte-derived DC to a soluble peptide derived from Jagged 1 induced DC maturation to an
extent similar to LPS. Co-culture of immature DCs with human KCs expressing Jagged-1 induced:
up-regulation of maturation markers, production of IFN-g and IL-12, and stimulation of allogeneic
T-cell proliferation. This maturation and activation of immature DCs via Notch signaling involved
NF-kB activation. Painting of murine skin with the ¯uorescent hapten-FITC revealed delayed
migration of FITC-labeled DCs from the skin into the draining lymph nodes in Notch-1 de®cient
mice compared to control mice (50% decrease in CD11c+/FITC + cells after 24 h). These results
indicate a key role for Notch signaling in the activation, maturation and migratory capacity of DCs.
Thus, epidermal KCs by expressing Jagged-1 can in¯uence the behavior of DCs through Notch
signaling.
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Conversion of Uninvolved to Involved Psoriatic Skin Transplanted onto AGR Mice
Indicates Intrinsic Default Pathway of Psoriasis Disease Pathogenesis
O. Boyman, H. Hefti,* M. Suter,* B. J. Nickoloff,² and F. O. Nestle
Dermatology, University of Zurich Medical School, Zurich, Switzerland; *Veterinary Virology, University of
Zurich Medical School, Zurich, Switzerland; ²Pathology, Loyola University Medical Center, Maywood,
Illinois, U.S.A.
We asked whether disease development in psoriasis is depending on passenger leukocytes or an
intrinsic property of uninvolved (PN) psoriatic skin. This question was addressed in a new psoriasis
mouse model using PN skin transplanted onto AGR 129 mice. AGR 129 mice are de®cient in
type I and type II interferon receptors in addition to lacking functional T- and B-cells (Rag2
±/±
).
We observed spontaneous conversion of PN skin to psoriatic (PP) skin in 28 out of 28 skin grafts
transplanted onto AGR mice after 6 weeks. This is in contrast to previously reported models which
necessitated the injection of immunocytes or superantigen to induce a psoriatic phenotype. PN to
PP skin conversion was shown on the macroscopic as well as microscopic level. Typical clinical
features of converted skin included erythema, in®ltration and scaling. Histology demonstrated
pronounced psoriasiform hyperplasia with thin suprapapillary plates overlying dilated vessels of the
papillary dermis. There was pronounced acanthosis, papillomatosis, loss of the granular layer and
parakeratosis. Premature epidermal differentiation was indicated by an increase of involucrin
positive cell layers as well keratin 16 expression throughout the epidermis. Activated keratinocytes
expressed high levels of ICAM-1 and HLA-DR. Strong suprabasal expression of Ki67 indicated a
hyperproliferative epidermal compartment. Presence of CD3, CD4, CD8 positive T cells in skin
grafts (up to 8 weeks) along with highly increased numbers of HLA-DR positive immunocytes
expressing the heat shock protein receptor CD91 provided a cellular basis for an activated dermal
immune compartment. In addition TNF a and IL-12 was expressed in dermal immunocytes of
converted psoriatic skin. Our model indicates that the conversion of normal appearing skin to a
disease speci®c phenotype is primarily an intrinsic property of uninvolved psoriatic skin and
independent of the recruitment of passenger immunocytes.
568
Development and Maintenance of Peripheral Tolerance to Epidermal Cell-Associated
Proteins Using a Transgenic Approach
A. Sato, A. Shibaki, and S. I. Katz
Dermatology Branch, NCI/NIH, Bethesda, Maryland, U.S.A.
We have previously reported that transgenic (Tg) mice which express membrane-associated
ovalbumin (mOVA) under the control of a K14 promoter develop a graft vs. host-like (GvH)
disease after reconstitution with 1±5 3 10
6
OVA-speci®c TCR Tg T (Va2Vb5 +) cells from OT-I
mice. Transferred OT-I T cells accumulate and expand in the super®cial lymph nodes (LN) and
exhibit activation markers (CD25, CD44 and CD62L). To elucidate mechanisms of peripheral
tolerance to skin-associated proteins, we developed double Tg [K14-mOVA X OT-I TCR] mice
which are phenotypically normal. In contrast to OT-I mice where 95% of T cells are
Va2Vb5 + CD3+ CD8+ CD4-, we found that double Tg mice expressed 3 different
CD3+ (Va2Vb5+) T cell populations in LN-[CD3+ CD8-CD4- (42%), CD3+ CD8+ CD4-
(8%), and CD3+ CD8-CD4+ (50%)]. Remarkably, when OT-I T cells (5 3 10
6
) were infused into
the double Tg mice-GvH did not ensue and OT-I cells remained quiescent. In an attempt to
identify a regulatory subset of T cells in the double Tg mice, we assessed their T cells for CD25
expression. 4.8% of LN T cells in double Tg mice were CD4+ CD25+ before injection of OT-I
cells whereas only 2.2% of T cells were CD4+ CD25+ 5 days after injection. In contrast, less than
1% of T cells in the LN of K-14-mOVA mice were CD4+ CD25+ 5 days after injection of OT-I
cells. In addition less than 1% of T cells in double Tg mice were CD8+ CD25+ before and after
OT-I T cell injection. Taken together, the results suggest that, in double Tg mice, regulatory
mechanisms prevent infused OT-I cells from becoming activated and from inducing GvH disease.
Thus, these double Tg mice provide an excellent model to determine whether peripheral tolerance
is a product of clonal deletion, silencing or active suppression by regulatory factors.
570
Experimental Bullous Pemphigoid Induced by Active Immunization is Dependent on
Both T and B Cells and Medicated by MHC Class II-Restricted Responses
M. Zhao, L. A. Diaz, and Z. Liu
Dermatology, UNC-Chapel Hill, Chapel Hill, North Carolina, U.S.A.
Bullous pemphigoid (BP) is a subepidermal blistering skin disease associated with autoantibodies
against the hemidesmosomal proteins, BP180 and BP230. Experimental BP in mice is induced by
passive transfer of anti-BP180 antibodies and by active immunization with BP180 autoantigen. In
this study, we examined the role of T and B cells and MHC expression in the active model of BP.
Wild-type and knockout mice de®cient in T cells, B cells, both T and B cells, MHC class I, MHC
class II, and MHC class I & II, were immunized with recombinant murine BP180 (mBP180). In
the wild-type group (n = 24), all mice produced pathogenic antimBP180 IgG as determined by an
epitope-speci®c ELISA. The IgG from 21 mice induced blisters by passive transfer experiments.
Six of 24 of these immunized wild-type mice also developed skin lesions. In contrast, none of the
mice (n = 8 for each group) de®cient in T cells, B cells, MHC class I, and MHC class II showed
skin lesions. Pathogenic anti-BP180 epitope-speci®c IgG levels were very low in these knockout
mice, except in MHC class I-de®cient mice that showed approximately 17% of pathogenic IgG
levels as compared to the wild-type mice. Since MHC class I-de®cient mice also exhibit reduced
IgG levels in circulation, splenocytes from immunized mice de®cient in MHC class I, class II, and
class I & II were transferred into wild-type mice. Only recipients of splenocytes from class I-
de®cient mice produced pathogenic anti-BP180 IgG. These results demonstrate that experimental
BP requires T and B cells and MHC class II molecules.
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Proteasome Inhibitor PS-519 Reduces Delayed-Type Hypersensitivity Response Via
Inhibition of Carbohydrate Determinant Synthesis of Cutaneous Lymphocyte-
Associated Antigen and T Cell Rolling
T. M. Zollner,*³ M. Podda,* R. Ludwig,* J. Schultz,* C. Weber,* C. Pien,² W. Boehncke,* P.
J. Elliott,² and R. Kaufmann*
*Department of Dermatology, University of Frankfurt, Frankfurt/Main, Germany; ²Millennium,
Millennium Pharm. Inc., Boston, Massachusetts, U.S.A.; ³RBA Dermatology, Schering AG, Berlin,
Germany
T-cell recruitment to skin, a prerequisite for delayed-type hypersensitivity (DTH) responses, is
mediated through the interaction of cutaneous lymphocyte-associated antigen (CLA) and its ligand
E-selectin. In the set of glycosyltransferases involved in CLA synthesisa1,3-fucosyltransferase VII
(FucT-VII) and b1,4-galactosyltransferase I (b4GalT-I) are mainly responsible for the regulation of
its expression on T-cells. Since FucT-VII has a putative NF-kB binding site we asked if the
proteasome inhibitor PS-519 suppresses CLA expression, T-cell rolling and DTH. Human PBMC
were stimulated with the superantigen TSST-1, a known inducer of CLA expression, in the
presence of PS-519 (0±10 mg/ml). PS-519 blocked the activation of NF-kB as visualized by EMSA
and reduced the expression of FucT-VII as determined by RT-PCR. Determination of the
backbone (PSGL-1) and the set of glycosyltransferases involved in the synthesis of CLA (C2GnT,
b4GalT-I, FucT-IV, FucT-VII) by real-time PCR (ABIPrism7700) revealed a 10-fold decrease of
FucTVII and to a smaller extend of C2GnT and b4GalT-I upon PS-519 treatment (5 mg/ml).
Concomitantly, CLA showed a constant inhibition by PS-519 (38.8 6 13.6 vs. 5.8 6 3.1, n = 5,
mean 6 SD) as did CD15s expression and E-selectin binding. Using intravital microscopy with
labeled T-cells injected retrogradely into the right carotid artery of mice we observed a signi®cantly
decreased rolling of PS-519 treated T-cells in postcapillary venules (16.9 6 5.7 vs. 1.8 6 2.6%,
n = 3/13, paÂ0.001). The functional relevance of these ®ndings was further corroborated in a DTH
model where a signi®cant decrease of ear swelling was observed in 1 mg/KG bw i.v. treated
BALB/c mice (161 6 37 vs. 92 6 46 mm, n = 130, mean 6 SD). We conclude that the inhibition
of NF-kB through PS-519 reduces FucT-VII T-cell FucTVII expression leading to decreased T-
cell rolling and reduced DTH response.
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Pituitary Adenylate Cyclase Activating Polypeptide Suppresses Induction of Contact
Hypersensitivity
I. S. Friedman, W. Ding, S. Kless, J. A. Wagner,* and R. D. Granstein
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.; *Neurology,
Weill Medical College of Cornell University, New York, New York, U.S.A.
It has been hypothesized that the nervous system regulates LC function via release of neuron-
derived factors, resulting in the modulation of cutaneous immune responses. PACAP, an
immunomodulatory neuropeptide, widely distributed in the brain and multiple peripheral organs
acts primarily as an anti-in¯ammatory agent. Recently, PACAP has been localized in dermal
nerves. We sought to determine whether PACAP plays an inhibitory role in the skin's immune
response. We previously demonstrated that the murine epidermis-derived dendritic cell line XS52
and LC enriched to > 98% homogeneity from CAF1 mice express PACAP type II and type III
receptors. We now report PACAP plays an inhibitory role in the skin's immune response utilizing
a contact hypersensitivity (CHS) model. CAF1 (BALB/c 3 A/J) F1 (H-2d/a) mice (female, 6±
8 week.) were injected i.d. with 500 pmol PACAP or diluent alone 15 min prior to sensitization
with 5 mL of 1% DNFB at the same site. Seven days later mice were challenged with application of
5 mL of 0.2% DNFB to each side of each ear and 48 h ear-swelling was assessed. PACAP injection





; negative controls received vehicle without DNFB before injection of
PACAP or diluent: 0.65 and 0.125 mm
±2
, resp.; n = 5). We further determined that PACAP





M) and then pulsed with keyhole limpet hemocyanin (KLH). After multiple washes, EC were
cocultured with the KLH-responsive, T cell clone HDK1. Antigen presentation was inhibited as
measured by a signi®cantly decreased IFN-g production (by ELISA) by HDK1 cells upon




M) compared to EC treated with KLH alone
[n = 6 wells]. In contrast, neuropeptide Y and gastrin releasing peptide had no effect on EC antigen
presentation. Thus, PACAP functions as an endogenous immune modulator.
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The Presence of Degenerate TCR D-d Genes at the 5¢ Ends of J-a Genes May Represent
the Location of the Lost TCR D-a Genes
C. L. Reardon
Dermatology, University of Colorado HSC, Denver, Colorado, U.S.A.
Within the T-cell receptor (TCR) a/d locus, TCR-d genes lie between the TCR-a genes, arising
through a very ancient gene-duplication mechanism. Signi®cant similarities exist between the
TCR-a and TCR-d genes, even to the point of sharing V genes. However, one surprising
difference between TCR-a and TCR-d genes is that while the TCR-d gene cluster contains D
genes, the TCR-a gene cluster does not. The apparent advantage of using all or part of the
multiple D genes during rearrangement of TCR-d genes is to increase the diversity of the TCR
gene product for recognizing a large number of antigens. However, since no D genes appear to
contribute to the diversity of rearranged TCR-a genes, a long asked question is what happened to
the TCR D-a genes? We propose that they never actually disappeared but essentially exist in a
previously unrecognized location. With the assumption that D-a genes would be similar to the D-d
genes, it appears that there may be remnants of D-a genes at the 5¢ ends of the J-a genes. When the
over 60 different human and mouse J-a gene sequences are aligned into similar groups (Koop et al
1994), J-a genes as a whole have variable 5¢ ends whereas the 3¢ portion of the genes show a
constant-like gene component. The 5¢ ends of some human and mouse J-a genes show striking
homologies with the DNA sequences of either the 3 human D-d genes or the 2 mouse D-d genes.
Similar homologies based on the amino acid sequences of J-a genes and D-d genes are seen as well.
At some point, D-a genes joined the 5¢ end of J-a genes which mutated over time during gene
duplications leading to the large number of J-a genes with degenerate D-like 5¢ ends. Thus, while
TCR-d gene rearrangement selects and integrates various D genes or portions of them into the
gene, TCR-a genes increase their TCR diversity by receiving a single but different D-gene
component that is hard-wired through their choice of J-a genes.
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Expression of Skin Homing Receptors in Cutaneous T Cell Lymphoma
K. Ferenczi, R. C. Fuhlbrigge, J. J. Campbell,* J. L. Pinkus,² G. S. Pinkus,² and T. S. Kupper
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.; *Joint Program in
Transfusion Medicine, Children's Hospital, Boston, Massachusetts, U.S.A.; ²Pathology, Brigham and
Women's Hospital, Boston, Massachusetts, U.S.A.
Tissue-speci®c T cell homing depends on the simultaneous expression and sequential function of
certain selectins, chemokine receptors and integrins. It is now known that T cell entry into lymph
nodes requires L-selectin, CCR7 and LFA-1. Skin homing T cells are thought to interact with and
extravasate through skin post capillary venules via CLA, CCR4 and LFA-1. In this study we
analyzed the expression of CLA and CCR4 in the blood and skin of patients with cutaneous T cell
lymphoma (CTCL), a putative malignancy of skin homing T cells. In the blood of CTCL patients
with documented peripheral blood involvement we found increased percentages of
CLA+ CCR4+ T cells. In skin lesions of CTCL lesions we detected large numbers of these T
cells along with abundant expression of CCR4 ligands, suggesting a mechanism for accumulation
of CLA+ CCR4+ T cells in the skin in CTCL. In a subset of CTCL patients with peripheral blood
involvement, we could identify a dominant T cell clone, using a panel of antibodies to the TCR
Vb chain. Malignant T cells identi®ed this way expressed very high CCR4, variable CLA and in
most cases, very high levels of L-selectin and CCR7. In these patients, elevated CLA expression
was associated with diffuse skin involvement, while high L-selectin and CCR7 expression
correlated with clinical lymphadenopathy. This is the ®rst demonstration that acquisition of
different tissue-homing phenotype on malignant T cells in cutaneous T cell lymphoma correlates
with the anatomic distribution of these lymphoma cells.
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a-Melanocyte Stimulating Hormone Inhibits Allergic Airway In¯ammation
U. Raap, T. Brzoska,* S. Sohl,² G. Paeth,² U. Herz,² A. Braun,² T. Luger,* and H. Renz²
Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany; *Ludwig
Boltzmann-Institute for Cell- and Immunbiology of the Skin and Department of Dermatology, University of
Muenster, Muenster, Germany; ²Department of Clinical Chemistry and Molecular Diagnostics, Philipps-
University Marburg, Marburg, Germany
In a murine model, a-melanocyte stimulating hormone (MSH) was found to inhibit both
induction and elicitation phase of contact hyper-sensitivity and induced hapten-speci®c tolerance.
Therefore, the purpose of this study was to assess the role of a-MSH in an animal model of allergic
airway in¯ammation. BALB/c mice were sensitized to and challenged with ovalbumin (OVA).
Production of a-MSH, and several pro-in¯ammatory cytokines were assessed in broncho-alveolar-
lavage ¯uids (BALF). Levels of allergen speci®c immunoglobulins were assessed in serum samples.
a-MSH application (1 mg/kg body weight) was undertaken prior to OVA sensitization and
challenge. IL-10 knock-out mice were employed using the same protocol of allergic sensitization,
challenge and a-MSH administration. Levels of a-MSH were decreased in BALF of acute airway
in¯ammation (p < 0.001). a-MSH treatment reduced eosinophil in®ltration into the airways and
reduced serum concentrations of allergen speci®c IgE, IgG1 and IgG2a signi®cantly. In contrast,
IL-10 levels were increased markedly in BALF of a-MSH treated mice (p < 0.001). Although
treated with a-MSH IL-10 knock-out mice did not show inhibition of airway in¯ammation or
inhibition of serum Ig production. In conclusion, a-MSH inhibits allergic airway in¯ammation in
a murine model of allergy and asthma. Furthermore, the anti-in¯ammatory effects of a-MSH are
mediated via increased IL-10 production. This study provides evidence for a novel function of a-
MSH in allergic airway in¯ammation, linking neuro-immune functions and points to a novel
therapeutic strategy in allergic airway in¯ammation.
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Benzo(a)pyrene Plus UVA Induces Redistribution of DEC-205+ Dendritic Cells within
the Skin of SKH-1 Mice
L. M. Austin, R. N. Saladi, D. Gao, M. G. Lebwohl, and H. Wei
Dermatology, Mt. Sinai School of Medicine, New York, New York, U.S.A.
Laboratory in vivo exposures to the environmental carcinogen Benzo(a)pyrene (BaP) plus
ultraviolet light (UV) produces carcinogenic related changes within the skin of tumor-prone SKH-
1 mice. Our hypothesis is that precancerous cells, identi®ed by increases in immunoreactive p53,
can escape protective immunosurveillance mechanisms guided by skin Dendritic cells (DCs) in
SKH-1 mice. DEC-205 (CD205) antibodies identify mouse DCs including Langerhans cells.
Therefore we examined the distribution of CD205 in relation to the appearance of p53 in acetone-
®xed frozen sections of dorsal SKH-1 skin following exposure to topical BaP plus UVA. We
observed that in untreated mice CD205+ cells are primarily restricted to epidermal basal layers of
interfollicular skin and hair follicle remnants but rarely observed in dermis. Immunoreactivity for
p53 was diffuse and cytoplasmic. BaP plus UVA produced signi®cant time and dose related
redistribution of CD205+ cells. Short-term high dosing induced substantial epidermal thickening
with an increase in keratinocyte layers (biweekly topical exposure with 400 nM BaP irradiated 1 h.
later with UVA). CD205+ cells were primarily restricted to upper keratinocyte layers while absent
in lower follicular regions and dermis. These changes were not found with equal doses of either
BaP or UVA alone. Long-term low dosing did not induce epidermal thickening (biweekly topical
exposure with 20 nM BaP irradiated 1 h. later with UVA). Yet, a redistribution of CD205+ cells
occurred between 2 and 10 weeks of treatment. At 10 weeks CD205+ cells were absent from the
epidermis and instead scattered throughout the dermis with focal areas of p53+ nuclei in basal
keratinocytes. Thus, B(a)p plus UVA not only affects changes in the immunodetection of p53
potentially identifying precancerous cells it also causes redistribution of skin DCs expressing the
antigen-capture/presentation molecule DEC-205. These associated changes have potential
implications for skin DCs to direct antigen-based immunosurveillance mechanisms during
carcinogenesis.
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Identi®cation and Characterization of Novel E-Selectin Ligands on Skin-Homing T
Cells
R. C. Fuhlbrigge, S. L. King, R. Sackstein, and T. S. Kupper
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.
Memory T cell recruitment to skin is a critical feature of both the immune response to pathogen
invasion and immune surveillance of unin¯amed skin. Tethering and rolling on vascular selectins is
the initial, required step for T cell extravasation into target tissues. Human memory T cells in
in¯amed skin express the carbohydrate epitope Cutaneous Lymphocyte-associated Antigen (CLA)
identi®ed by mAb HECA-452. We have shown that p-Selectin Glycoprotein Ligand-1 (PSGL-1),
a constitutively expressed surface glycoprotein, can be differentially decorated with the CLA
epitope to serve as both an E-selectin and a P-selectin ligand on T cells. Although studies in mice
de®cient for PSGL-1 have indicated that PSGL-1 is the major E-selectin ligand on murine T cells,
the role of PSGL-1 on human T cells is less well de®ned. Using a method for real-time, direct
observation of adhesive interactions between selectin-bearing cells in shear ¯ow and lysates of
CLA+ human T cells separated by SDS-PAGE and immobilized on Western blots, we have
identi®ed T cell E-selectin ligands with apparent molecular weights of 240 kDa, 140 kDa, 125
kDa, 110 kDa and 100 kDa. The 240 kDa and 140 kDa bands correspond to the dimer and
monomer forms of PSGL-1, respectively, and support binding via both E-selectin and P-selectin.
The other glycoproteins do not label with mAb to PSGL-1 (PL-1 or PL-2), CD44 (HERMES-1)
or CD62L (DREG56). These ligands support E-selectin mediated tethering and rolling but lack
ligand activity for P-selectin in this assay system. Interestingly, gp125 bears the HECA-452 epitope
by Western blot while gp110 and gp100 do not. These ®ndings represent the ®rst direct evidence
for non-PSGL-1 E-selectin ligands on human T cells and for expression of human E-selectin
ligands that do not react with HECA-452. These ligands may play an important role in the
recruitment of CLA+ human T cells to both normal and in¯amed skin.
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Birbeck Granules are Subdomains of the Endosomal Recycling Compartment in
Human Epidermal Langerhans Cells which Form Where Langerin Accumulates
D. Hanau, R. Mc Dermott,* U. Ziylan, D. Spehner, H. Bausinger, D. Lipsker, J. Cazenave, M.
Mommaas,² B. Goud,* H. de la Salle, and J. Salamero*
EPI 99±08, EFS-Alsace, Strasbourg, France; *UMR 144, Institut Curie, Paris, France; ²Department
Dermatology, LUMC, Leiden, Netherlands
Birbeck granules are unusual rod shaped structures speci®c to epidermal Langerhans cells, whose
origin and function remain undetermined. We investigated the intracellular location and fate of
Langerin, a protein implicated in Birbeck granule biogenesis, in human epidermal Langerhans cells.
In the steady state, Langerin is predominantly found in the endosomal recycling compartment and
in Birbeck granules. Langerin internalises by classical receptor-mediated endocytosis and the ®rst
Birbeck granules accessible to endocytosed Langerin are those connected to recycling endosomes
in the pericentriolar area, where Langerin accumulates. Drug induced inhibition of endocytosis
results in the appearance of abundant open ended Birbeck granule-like structures appended to the
plasma membrane, while inhibition of recycling induces Birbeck granules to merge with a tubular
endosomal network. In mature Langerhans cells, Langerin traf®c is abolished and the loss of
internal Langerin is associated with a concomitant depletion of Birbeck granules. Our results
demonstrate an exchange of Langerin between early endosomal compartments and the plasma
membrane, with dynamic retention in the endosomal recycling compartment. They show that
Birbeck granules are not endocytotic structures, rather they are subdomains of the endosomal
recycling compartment which form where Langerin accumulates.
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Comparison of the Response to g-Interferon of Fibroblasts in Monolayer and Three-
Dimensional Culture
J. N. Mansbridge, A. Kern, and K. Liu
Research, Advanced Tissue Sciences, La Jolla, California, U.S.A.
This study compares the responses to g-interferon (IFN-g) of monolayer (ML) and three-
dimensional, scaffold-based (3D) ®broblast cultures. A proportion of the ®broblasts in a 3D culture
fail to show induction of HLADR and CD40 in response to g-interferon, whereas ML cells
respond uniformly. To de®ne the extent of the difference in responses, we have used gene
expression array hybridization. The data were normalized using the positive control values on
Affymetrix arrays combined with the median of experimental values of 12558 genes. In triplicate
experiments, 98.5% of the values agreed within a factor of 2 of their mean. Experiments included
23, 2, 7 and 3 replicates using ML without or with IFN-g, and 3D cultures without or with IFN-g,
respectively. The results con®rmed the reduced response of 3D culture over a range of genes and
that CIITA shows less induction in 3D culture than in ML. Examining genes showing 5-fold
induction, we have found that 47 genes were induced in common, including HLA class 1-
associated genes, some class II genes, transcription factors, protein degradation system and other
IFN-g-inducible genes. Twenty-six genes were substantially more induced in ML cultures than
3D, including several IFN-g-induced genes and class II HLA genes, but no transcription factors or
protein degradation enzymes. Only one gene, STAT1, was more induced in 3D cultures than in
ML. Nine genes were repressed by IFN-g in ML, but, of these, only elastin was also reduced in
IFN-g-treated 3D culture. The results con®rm that scaffold-based three-dimensional culture
modi®es the ®broblast response to IFN-g by comparison with ML.
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Supressed Contact Hypersensitivity in Mice Lacking PGE2 Receptor EP1-De®cient
Mice: Implication of EP1 as an Enhancer of Th1 Immune Responce
M. Nagamachi,*² K. Kabashima,*² S. Narumiya,² and Y. Miyachi*
*Dermatology, Kyoto University, Kyoto, Japan; ²Pharmacology, Kyoto University, Kyoto, Japan
Prostaglandin (PG) E2 is known to be produced by antigen presenting cells and exerts its
physiological role through its speci®c receptors, EP1, EP2, EP3 and EP4. Among them, EP2 and
EP4 are suggested to induce immunosuppression on T cells. However, the function of EP1 and
EP3 in immune systems remains unknown. To ascertain the function of EP1 and EP3, we have
used contact hypersensitivity (CHS) model using DNFB. The ear swelling of EP3-knockout (KO)
mice was comparable to control mice. On the other hand, EP1KO mice showed a signi®cant
suppression in both ear swelling and total cell counts of cervical lymphocytes compared to control
mice. The number of IFN-g producing CD4 and CD8 cells from regional lym-phocytes after CHS
model was also decreased in EP1KO mice. Moreover, when cells were collected from draining
lymph nodes after sensitization and stimulated with DNBS in vitro, the level of IFN-g was
signi®cantly decreased in EP1KO mice. We initially detected the expression of EP1 receptor on
CD4, CD8, B220, CD11b and CD11c cells using RT-PCR. To clarify the action phase of EP1 in
immune system, we used EP1 selective antagonist in CHS model. The suppression was reproduced
pharmacologically when the EP1 antagonist was administered during the sensitization phase, but
not during the elicitation phase. We expected that EP1 acts physiologically during sensization
period. We assessed whether EP1 acts antigen presenting cells or responder cells using mixed
lymphocyte reaction to alloantigen. The antigen presenting capacity of dendritic cells to naive
CD4 T cells was comparable between EP1KO and control mice. Therefore, we assessed the effects
of EP1 on T cell function. When naive CD4 cells and CD8 cells were stimulated under Th1
driving condition, the number of Th1 cytokine producing CD4 and CD8 cells revealed by the
treatment of an EP1 selective agonist. These results suggest that PGE2-EP1 signaling functions
work during sensitization phase of CHS as an inducer of Th1 response by enhanced clonal
expansion of Th1 and Tc1 cells.
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Genetic Fusion of Cholera Toxin B Subunit to a Tumor Antigen Effectively is Presented
Via MHC Class I Pathways
A. Morita, Y. Yasuda, I. Isomura, A. Uenaka,² Y. Yasuda,* K. Tochikubo,* E. Nakayama,² and
T. Tsuji
Dermatology, Nagoya City University Medical School, Nagoya, Aichi, Japan; *Microbiology, Nagoya City
University Medical School, Nagoya, Aichi, Japan; ²Immunology, Okayama University Medical School,
Okayama, Okayama, Japan
Cholera toxin (CT) is the most commonly used for mucosal adjuvant in experimental animals. CT
is composed of two subunits: a toxigenic A subunit (CTA) and a pentameric 11.6-kDa B subunit
(CTB), which is responsible for CT binding to the cell membrane. To separate adjuvanticity from
the toxic property (CTA), we have constructed recombinant CTB protein (rCTB). Splenic
dendritic cells (DC) or XS line were incubated with different concentration of rCTB. Induction of
MHC class II (Ia) and B7-2 in these cells was observed after 24 h at the concentration of 1 mg/ml.
IL-12 secretion from DC was also up-regulated by 1 mg/ml of rCTB. These effects were almost
similar to those of 300 ng/ml of LPS. The stimulated DC with rCTB exhibited higher capacity to
activate naive allogeneic T cells than unstimulated DC. FITC-labeled rCTB was readily able to
bind to XS line and incorporated to the cells. From these results, we further have constructed
recombinant CTB-fused tumor antigen protein (pRL1a-CTB). Similarly, the incubation of
pRL1a-CTB signi®cantly induced MHC class II and IL-12 production in DC. To investigate
whether CTB can ef®ciently deliver exogenous antigen into the MHC class I presentation
pathway, DC was pulsed with pRL1a-CTB and incubated with B24 CTL lines, which was speci®c
to the tumor antigen, RL1a. After 24 h, the supernatant was harvested and measured with INF-g.
INF-g was signi®cantly induced by pRL1a-CTB, but not by CTB-irrelevant protein. The INF-g
level was similar to that obtained with the pulse of RL1a. This fusion protein was incorporated,
precisely processed, and ef®ciently presented to MHC class I molecule, because CTL line only
could recognize the speci®c peptide plus MHC class I. These observations may lead to the
development of effective and safe vaccines to induce CTL acitivity by using CTB molecule.
582
Resistance to Fas-Mediated Lymphocyte Cell Death in Sezary Syndrome: Partial
Reversal by Interferons
K. E. Kerl-Bullani, R. Shane,* M. Zaki,* A. H. Rook,* and L. E. French
Dermatology, Geneva University Hospital, Geneva, Switzerland; *Dermatology, University of
Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
Membrane bound Fas ligand (FasL, Apo-1 L, CD95L) induces rapid apoptosis of Fas (CD95)±
sensitive cells upon interaction with Fas, and is an important effector molecule of cytolytic T
lymphocytes. Cutaneous lymphomas including Sezary syndrome (SSy) are responsive to therapies
that stimulate cellular immune responses but tend eventually to escape immune destruction. We
investigated Fas expression and function in 2 SSy cell lines (Myla, SeAx), as well as in peripheral
blood mononuclear cells (PBMC) from 11 SSy patients and 4 healthy controls. Fas expression was
found to be virtually absent in SeAx cells, but conserved in Myla cells. Analysis of sensitivity to
recombinant human FasL in vitro revealed that loss of Fas surface expression correlated with
resistance to FasL-mediated cell death, SeAx cells being resistant as opposed to Myla cells. In SSy
patients, when compared to healthy controls, Fas surface expression was reduced on CD4+
lymphocytes in 5/11 cases (45%). The loss of Fas expression was not restricted to the malignant
CD4+/CD7- cell population. When susceptibility to FasL-mediated apoptosis was tested in
PBMC from these patients, 6/11 (55%) were signi®cantly more resistant to FasL as compared to
healthy controls. To determine if susceptibility to FasL-mediated apoptosis can be enhanced, we
tested the effect of interferon a (IFNa) and g (IFNg) on Fas expression and signaling function in
PBMC from 2 healthy controls and 2 SSy patients. IFNa and IFNg induced a signi®cant increase
in Fas expression in both healthy control and SSy CD4+ cells. Under these conditions, an increase
in sensitivity to FasL-mediated apoptosis was also observed. This data shows that resistance to Fas-
mediated apoptosis is common in CD4+ lymphocytes of SSy patients. It also suggests IFNa and
IFNg can sensitize SSy patients CD4+ cells to FasL, and has important implications for the use of
interferon-related therapy of Sezary syndrome.
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The Reciprocal Regulation of TARC (Thymus and Activation-Regulated Chemokine/
CCL17) and IP-10 (Interferon-Induced Protein of 10 kDa) by IL-4 but not IL-13 in
Human Keratinocyte Cell Line, HaCaT Cells
T. Kakinuma, K. Nakamura, M. Wakugawa, S. Yano, H. Saeki, H. Torii, M. Komine, A.
Asahina, and K. Tamaki
Department of Dermatology, University of Tokyo, Tokyo, Japan
It is known that interleukin-4 (IL-4) and IL-13, both of which are produced by Th2-type cells,
share similar biological functions. However, recent accumulated evidences have revealed that IL-4
may be involved in the Th1-type response. Both thymus and activation-regulated chemokine
(TARC), a ligand for CC chemokine receotor 4 that is mainly expressed on Th2-type cells, and
interferon-induced protein of 10 kDa (IP-10), a ligand for CXC chemokine receptor 3 that is
mainly expressed on Th1-type cells, are produced by keratinocytes after the stimulation with the
primary cytokines such as tumor necrotic factor-a (TNF-a) and/or interferon-g (IFN-g). In this
study, we investigated the regulation of TARC or IP-10 production from HaCaT cells after the
stimulation with TNF-a, IFN-g, IL-4 and/or IL-13. Without stimulation, the supernatant TARC
levels were 28.0 6 4.2 pg/ml. When both TNF-a and IFN-g were added, they increased
synergistically to 1225.3 6 102.4 pg/ml (p < 0.003). In addition, the stimulation with IL-4 but not
IL-13 in combination with TNF-a and IFN-g showed that the supernatant TARC levels
decreased signi®cantly to 330.0 6 26.4 pg/ml (p < 0.009). This inhibition was completely
abolished with the addition of neutralizing anti-IL-4 antibody. The supernatant IP-10 levels also
increased synergistically by the stimulation with TNF-a and IFN-g (from 17.6 6 5.0 pg/ml to
1750.0 6 325.8 pg/ml, p < 0.001). When IL-4 was added with these cytokines, they enhanced
more synergistically to 2212.5 6 550.3 pg/ml (p < 0.04). Moreover, the stimulation with IL-4
in¯uenced the production of TARC and IP-10 in a dose-dependent manner. From these data, it is
suggested that IL-4 may be involved in the balance between Th1- and Th2-type cytokine
production from human keratinocytes.
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Visualization and Functional Characterization of T±T±Cell Interactions In Vivo
A. Schipf, O. Egeter, A. Heilmann, and M. Roecken
Department of Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
During stimulation naive CD4+ T lymphocytes proliferate and differentiate into memory T cells
that preferentially produce either IFN-g (Th1 cells) or IL-4 (Th2 cells). The differentiation of naive
T cells into either Th1 or Th2 cells is primarily determined by innate signals, such as dendritic cell
(DC) derived IL-12 or natural killer cell derived IL-4 and a series of unknown signals. It has been
proposed that T cells may in¯uence themselves, but the mechanism and the biological signi®cance
of these putative T±T±cell interactions remain enigmatic. To address this question, we stimulated
naive in¯uenza hemagglutinin-speci®c T cells from TCR-transgenic mice in the presence of CFA,
and asked whether and how Th2 cells, with a TCR speci®c for an ovalbumin (OVA) peptide,
could in¯uence Th1-differentiation of HA cells. Naive HA and OVA-Th2 cells were transferred
into BALB/c mice and subsequently challenged either with one or simultaneously with both
peptides (OVA/HA). Migration and T cell differentiation were followed by immunohistology,
FACS and cytokine assays. When priming with antigen, both naive T cells and Th2 cells migrated
with similar dynamics to draining lymph nodes and both homed in close vicinity inside T cell areas
between day 2 and 6 after the priming. In the absence of OVA, naive HA-speci®c T cells
developed an IL-4 de®cient Th1 phenotype even in mice that harbored large numbers of OVA-
speci®c Th2 cells, showing that resting memory cells of the Th2 phenotype did not interfere with
the T cell differentiation. However, when OVA-Th2 and HA-T cells were activated
simultaneously, HA-speci®c T cells differentiated into an IL-4 producing Th2 phenotype.
Moreover, OVA-speci®c `Th2-cells' from IL-4 knock-out mice unraveled that Th2-derived IL-4
is the force deviating the differentiation of naive T cells toward a Th2 phenotype. Showing that
activated Th2 cells directly promote Th2-differentiation of concomitantly activated T cells may
explain the spreading of Th2 immunity towards multiple protein antigens that characterizes allergic
diseases.
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Simultaneous De®ciency in CD28 and STAT6 Results in Ectoparasite-Induced
In¯ammatory Skin Disease
Q. Liu, C. Callendar, Z. Liu, J. Whitmire, M. J. Grusby,* F. D. Finkelman,² T. N. Darling,³ A.
W. Cheever,§ J. Swearengen,¶ and W. C. Gause
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences,
Bethesda, Maryland, U.S.A.; *Department of Immunology and Infectious Diseases, Harvard School of
Public Health, Boston, Massachusetts, U.S.A.; ²Cincinnati Veterans Administration Medical Center,
University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.; ³Department of Dermatology,
Uniformed Services University of the Health Sciences, Bethesda, Maryland, U.S.A.; §Biomedical Research
Institute, National Institute of Health, Rockville, Maryland, U.S.A.; ¶Laboratory of Animal Medicine,
Uniformed Services University of the Health Sciences, Bethesda, Maryland, U.S.A.
A genetically de®cient STAT6/CD28
±/±
mouse was developed. Unlike the single knockout
siblings which maintained a wild type (WT) phenotype, by 4 months of age, all STAT6/CD28
±/±
mice spontaneously developed pruritis, alopecia and pronounced lymphadenapathy. Histological
examination and immuno¯uorescence staining of skin were done. Activation of peripheral lymph
node cells was detected by proliferation assay, RT-PCR, cytokine ELISA as well as FACS analysis.
Serum Ig levels were determined by ELISA. Our results showed that STAT6/CD28
±/±
mouse skin
displayed chronic dermatitis characterized by acanthosis and CD4 and CD8 T cell in®ltration in
the dermal and subdermal region. The mice showed T cell activation and increased IL-12, IFN-g
and IL-4 mRNA and production associated with increased IgG1 and IgG2a and no IgE. Further
study revealed that the hair follicles of STAT6/CD28
±/±
mice contained large numbers of
ectoparasites (Demodex musculi) and topical treatment with an effective miticide greatly reduced
the severity of dermatitis and eliminated associated lymphoid in®ltrates. Lymph node T cells
showed decreased CD69 expression and markedly reduced cytokine expression in miticide-treated
groups compared to control groups given water. These ®ndings suggest that nonatopic chronic
in¯ammatory skin disease, spontaneously triggered by a ubiquitous and normally commensal
murine ectoparasite, develops in the absence of CD28 and STAT6. Thus parasites that are
generally considered harmless may become pathologic when speci®c molecules required for an
effective Th2 response are blocked.
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Predominant Cell-Mediated Immune Response in Oral Mucosa: Genetic Immunization
Against Infectious Diseases
T. Murakami, J. Wang,* and E. Kobayashi*
Department of Dermatology, Jichi Medical School, Tochigi, Japan; *Center for Molecular Medicine, Jichi
Medical School, Tochigi, Japan
The oral cavity is one of the ®rst host defenses against various infectious diseases. Direct
immunization via mucosal surfaces has been considered for many vaccine approaches including
DNA vaccines. Recent studies showed that the particle-mediated gene transfer is one of the most
ef®cient strategies for local DNA delivery. In this study, we established an animal model in hamster
for gene gun-based vaccination into the oral cavity. The optimum condition for gene gun
bombardment into the oral mucosa was determined using the green ¯uorescent protein and the
luciferase genes. Results showed that relative luciferase activity was 3-fold higher in oral mucosa
than skin at 1 day postbombardment (p < 0.05). Based on the gene gun-based vaccination, DNA
vaccines were then tested against an in¯uenza virus and a malaria parasite, using expression plasmids
of the in¯uenza virus A/WSN/33(H1N1) hemagglutinin (HA), and the Plasmodium berghei
circumsporozoite protein (PbCSP), respectively. These DNA vaccines were administrated 3 times
with 3 weeks intervals into the oral mucosa or the skin. Speci®c antibody production was not
observed in each case (under the sensitivity of ELISA), but interferon-g production and cell-
mediated killing activity were signi®cantly induced in splenic lymphocytes from hamsters with the
oral vaccination, compared with the skin vaccination. In the case of malaria, genetic immunization
into the oral mucosa more effectively protected the host hamster from in vivo infection challenge
with Plasmodium berghei sporozoites. These results suggest that genetic immunization into oral
mucosa vs. skin may induce cell-mediated Th1 immunity more ef®ciently, and that oral mucosa
may be one of the most suitable tissues for DNA vaccination against infectious diseases by using
particle-mediated gene transfer.
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Osteopontin Induces Dendritic Cell Activation and Polarizes their Maturation Towards
a Dendritic Cell 1 Phenotype
A. C. Renkl, J. Wussler, T. Ahrens,* K. Thoma, C. Bernardi, J. C. Simon, and J. M. Weiss
Dermatology, University of Freiburg, Freiburg, Germany; *Biology, University of Basel, Basel, Switzerland
Immature dendritic cells (DC) are located at epithelial borders. After activation and antigen uptake
they mature and migrate into secondary lymphatic organs to initiate T-cell mediated immunity. As
DC1 (high secretion of IL-12) or DC2 they are able to polarise naive T-cells towards either a Th1
or Th2 phenotype, decisively affecting the outcome of an immune response. Recently we
demonstrated that osteopontin (OPN) is important in cutaneous contact hypersensitivity by
guiding DC into lymph nodes. Since OPN has been identi®ed to have Th1 cytokine like
properties, we now explored the effect of OPN on the phenotypic and functional maturation of
DC. Human monocyte derived DC were cultured 6 OPN and supernatants and cells were
analysed after 24 and 48 h by ELISA or FACS. OPN strongly induced DC activation, up-
regulating their expression of HLA-DR, CD40, CD80, CD86, CD44 and CD56 and their TNF-a
secretion. Furthermore, these DC highly secreted IL-12 as an indicator for their DC1 polarisation.
In allogeneic mixed lymphocyte reactions (MLR) OPN was either added directly into MLR with
immature DC or OPN prestimulated DC were used. When OPN was added to MLR with
immature DC, T-cell proliferation was enhanced, while addition of OPN to T-cells alone had no
effect on their proliferation or cytokine secretion. However, when MLR was performed with
OPN activated DC a strongly increased T-cell proliferation was detected compared to control DC.
When analysing MLR supernatants we found that both addition of OPN to MLR or OPN
prestimulation of DC induced an up-regulated secretion of the Th1 cytokine IFN-g and high
amounts of IL-12 (IL-12p40, IL-12p70), while IL-10 was not modulated. Our ®ndings indicate
that OPN induces DC maturation and their polarisation towards a DC1 phenotype, indicating that
the Th1 cytokine like properties of OPN are at least in part mediated through its effect on DC.
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Natural-Killer Cell-Dependent Induction of Memory T Cell Immunity by Cytomegalo-
Virus-Induced Suppression MHC Class I
M. Ro
È
cken, O. Egeter, U. Reusch,² H. Ziegler,² U. Koszinowski,² and R. Mocikat*
Dermatology, Ludwig-Maximilians University, Munich, Germany; *Molekulare Immunologie, GSF-
Institut, Munich, Germany; ²Max-von-Pettenkofer-Institut, Ludwig-Maximilians University, Munich,
Germany
MHC down-regulation is considered as a major escape mechanism for viruses and tumors. Despite
this, viruses such as cytomegalovirus (CMV) induce strong MHC class I-restricted immune
responses. As MHC I-de®cient cells may induce natural killer (NK) cell mediated cytotoxicity we
analyzed the interaction between NK cells and memory T cell responses. In order to avoid
unrelated effects of CMV infection, we inhibited MHC I-expression of the murine A20 lymphoma
by introducing the CMV m6 gene into the tumor cells. In transfectants, H-2D expression was
reduced to about 20% of wild-type cells. MHC I-low A20 cells failed to present peptide antigens to
CD8+ T cells and were poorly lysed by cytotoxic T cells. However, when injected into mice, the
tumor cells failed to grow in normal BALB/c mice. Importantly, MHC I-low A20 cells readily
grew in nude and SCID mice. This excluded an intrinsic growth defect and showed that NK cells
alone did not cope with this tumor cell line. Further analysis with deletion experiments and
secondary challenges showed that (1) rejection of MHC I-low A20 cells critically required a close
interaction between NK and CD8+ T cells and (2) that rejection of MHC I-low A20 cells induced
a T cell dependent memory response against the wild type tumor. Thus, suppression of MHC class
I by the CMV-derived m6 gene led to NK- and T-cell-dependent rejection of the A20 lymphoma.
Rejection of MHC class I-de®cient A20 cells induced stable, T cell-dependent immunity against
also against the wild-type tumor, but not against unrelated tumors. Since suppression of MHC is
considered as an escape mechanism used by viruses and tumors, our data will further our
understanding on how innate and adaptive systems cooperate in the defense against this central
evasion mechanism.
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Cloning and Characterization of Mouse Langerin and an Alternatively Spliced Isoform
E. Riedl, M. Wilson, and M. C. Udey
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.
In order to identify genes that are preferentially expressed by dendritic cells (DC), we constructed
and sequenced a subtractive cDNA library from murine fetal skin-derived DC (FSDDC) and skin
macrophages. Forty-two of 548 informative clones were homologous to human Langerin, a novel
C-type lectin that carries the Lag antigen, is selectively expressed by human Langerhans cells (LC)
and promotes Birbeck granule (BG) formation in ®broblasts. cDNA corresponding to full-length
mouse Langerin (mlangerin) was obtained using rapid ampli®cation of cDNA ends (RACE)-
PCR. mlangerin is a type II membrane protein with a C-terminal extracellular carbohydrate
recognition domain (CRD). mlangerin exhibits 66% sequence identity with its human homologue,
and contains a consensus mannan binding site within the CRD. Quantitation of mlangerin mRNA
levels by real-time RT-PCR showed abundant amounts of mlangerin mRNA in epidermal LC
and in FSDDC. LPS-induced maturation of FSDDC led to down-regulation of mlangerin
mRNA. mlangerin mRNA was also detected in thymus, spleen, lymph node, lung and stomach.
An alternatively spliced transcript that retained the intracellular, transmembrane and carbohydrate
recognition domains of mlangerin was detected in RNA derived from FSDDC and epidermal cells.
Transfection of COS-1 cells with full length mlangerin cDNA led to abundant expression of C-
terminal epitope-tagged protein on cell surfaces of transfected cells and within the cytoplasm in a
granular cytoplasmic staining pattern. Transmission electron microscopy of mlangerin cDNA-
transfectants revealed typical BG and BG-like structures. The mlangerin gene is comprised of 6
exons and is localized to chromosome 6 in close proximity to the gene encoding the highly related
Kupffer cell receptor. mlangerin is one of a growing number of putative endocytic receptors that
are expressed by DC. Elucidation of the function of this novel protein and its alternatively spliced
isoform may provide new insights into LC physiology, especially antigen uptake and processing.
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Pathogenicity of Antidesmoglein-1 Antibodies is Modulated by Epitope Spreading in
Fogo Selvagem
L. A. Diaz, S. J. Warren, and N. Li
Dermatology, University of North Carolina, Chapel Hill, North Carolina, U.S.A.
Fogo Selvagem (FS) is an endemic autoimmune disease mediated by antibodies against desmoglein-
1 (Dsg1). The aim of this study was to determine the epitope pro®les of anti-Dsg1 antibodies in
normal individuals with anti-Dsg1 antibodies and individuals 1±2 years before as well as after the
onset of FS. All sera were obtained from the FS focus of Limao Verde in Brazil. Eight chimeric
molecules were constructed and expressed in the baculovirus system, in which different Dsg1
ectodomains (EC1 to EC5) were substituted with corresponding homologous ectodomains of
Dsg3. The interactions of the chimeric molecules with different sera were tested by
immunoprecipitation. All normal subjects tested (n = 8) revealed antibodies that recognized
predominantly the Dsg1-EC5 domain. In ®ve of these subjects there were hardly any detectable
antibodies against EC1-4, and in three there was a weak reactivity against EC1 or EC2. Of the
three sera obtained from three subjects in preclinical stage, one reacted weakly with all ®ve
ectodomains of Dsg1, one had slightly higher reactivity with EC5, and the other showed a
relatively high anti-Dsg1 reactivity not only with EC5 but also EC1-2. Sera obtained from the
same three subjects, but in clinical stage, showed signi®cantly increased levels of anti-Dsg1 that
reacted predominantly with EC1 and EC2. An additional serum obtained one month before the
onset of FS displayed very high levels of anti-Dsg1 antibodies that reacted with EC1 and EC2.
These results suggest that: (1) transition from the pre-clinical to clinical stage of FS is associated
with a switch in epitope speci®cities of the anti-Dsg1 antibodies; (2) anti-Dsg1EC5 antibodies may
be generated initially but are non-pathogenic whereas anti-Dsg1EC1 or EC2 antibodies are
developed later and pathogenic; (3) detection of anti-Dsg1 EC1 and/or EC2 antibodies might be a
more reliable diagnostic test for FS, and (4) epitope-spreading may be relevant in the pathogenesis
of FS.
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Pemphigus Foliaceus Autoantibodies Recognize Two Dominant Pathogenic Epitopes
Located in EC1 and EC2 Domains of Desmoglein-1
N. Li, Z. Liu, and L. A. Diaz
Dermatology, University of North Carolina, Chapel Hill, North Carolina, U.S.A.
Non-endemic pemphigus foliaceus (PF) and fogo selvagem (FS) are autoimmune blistering diseases
mediated by autoantibodies against desmoglein 1 (Dsg1). The aim of this study was to investigate
the epitope speci®cities of anti-Dsg1 autoantibodies in PF and FS patients during active disease and
undergoing clinical remission. We constructed eight chimeric molecules in which different Dsg1
ectodomains (EC1 to EC5) were substituted with corresponding homologous ectodomains of
Dsg3, and expressed them in the baculovirus system. We tested these chimeric molecules by
immunoprecipitation with different PF/FS sera. All sera from PF/FS patients (n = 10) in active
disease reacted strongly with chimeric proteins that harbored Dsg1 EC1, or EC2, or both. Three of
the 10 PF/FS sera also showed weak reactivity with EC3-5, while the majority (n = 7) had hardly
any activity against EC3-5. In addition, the epitope speci®cities changed dramatically in two FS
patients that underwent remission, from EC1/EC2 reactivity (active phase) to a predominantly
EC5 (inactive phase). Further, the IgG fraction from two PF sera, which contained anti-Dsg1
antibodies speci®c for EC1 and EC2 only, were pathogenic as determined by passive transfer
experiments. Interestingly, one of the two pathogenic IgG tested had predominantly IgG1 anti-
Dsg1 and barely detectable IgG4 anti-Dsg1. Depletion of anti-Dsg1 EC1 antibodies from these
IgG fractions did not block the capability of inducing blisters in mice. These ®ndings suggest that:
(1) Dsg1 harbors at least two distinct pathogenic epitopes, one located in the EC1 and another in
the EC2 domain; (2) the pathogenicity of anti-Dsg1 IgG subclasses (IgG1 or IgG4) depends on
their epitope speci®cities (anti-EC1/EC2), and (3) clinical activity may be modulated by a switch
in epitope speci®cities of the anti-Dsg1 antibodies.
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Low Zone Tolerance to Contact Allergens: The Role of Interleukin-10
K. Steinbrink, W. Seidel-Gouyenot, M. Metz, E. von Stebut, J. Knop, and M. Maurer
Department of Dermatology, University of Mainz, Mainz, Germany
The induction of hapten-speci®c low zone tolerance (LZT) by epicutaneous application of low
doses of contact allergens is mediated by CD8+ suppressor T cells (Tc2) that secrete
immunosuppressive cytokines such as IL-4 and IL-10. Here, we have used IL-10-de®cient (IL-
10
±/±
) mice and normal wild type (
+/+
) animals, to better characterize the role of IL-10 in the
induction of LZT. Tolerizing doses of the contact allergen TNCB (0.45 or 4.5 mg per site, 5 times
per mouse) were applied epicutaneously. Subsequently, for the assessment of tolerance induction
the inhibition of the contact hypersensitivity reaction was measured by ear swelling. Performing
this protocol resulted in robust LZT in
+/+





mice with IL-10 during tolerization completely restored LZT in these
mice, indicating that normal LZT is IL-10-dependent. In addition, lymph node cells (LNC) or
puri®ed T cells of tolerized
+/+
mice and IL-10-reconstituted IL-10
±/±
mice showed markedly
reduced antigen-speci®c proliferative responses, as compared to LNC or T cells derived from
tolerized IL-10
±/±
animals. To better characterize the potential mechanisms of the IL-10-
dependent induction of tolerance, LZT was assessed in
+/+





mice. Interestingly, adoptive transfer of LNC or puri®ed TC
derived from
+/+
mice induced strong LZT in naive mice whereas LNC and puri®ed TC obtained
from tolerized IL-10
±/±
mice failed to do so, indicating that the induction of LZT requires the
presence of IL-10 at sites of antigen presentation and lymphocyte activation. To test whether LZT
in normal mice may be enhanced by IL-10, C57BL/6 mice were treated systemically with IL-10
during tolerization (i.p., 3 3 100 ng/day for 10 days). Notably, such treatment signi®cantly
increased LZT as compared to vehicle treated control animals. Our ®ndings indicate that IL-10 is a
critical player in the induction of tolerance to contact allergens.
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Analysis of CCR6 Expression in Langerhans Cells Using a CCR6 EGFP Knock-In Mouse
Model
R. L. Waikel, T. Kucharzik, A. Luegering, J. T. Hudson III, and I. R. Williams
Pathology, Emory University, Atlanta, Georgia, U.S.A.
The chemokine receptor 6 (CCR6) is the predominant chemokine receptor on bone-marrow
dendritic cell (DC) precursors, suggesting a role for CCR6 in the traf®cking of dermal DC and
epidermal Langerhans cells (LC) to their sites of residence in skin. To study the regulation of
CCR6 expression as well as the consequences of absence of CCR6, we produced mutant mice in
which the Enhanced Green Fluorescent Protein (EGFP) reporter gene was knocked into the
CCR6 locus. Heterozygous knock-in mice were analyzed by ¯ow cytometry for EGFP to identify
cells in which the CCR6 gene was transcriptionally active. CD11b+ myeloid DC from the spleen
and lymph node expressed the CCR6/EGFP knock-in, but CD8a+ lymphoid DC from the same
lymphoid tissues were negative for the EGFP reporter. Among the myeloid DC, the
CD4+ CD11b+ subset was uniformly positive for CCR6 expression and the CD4- CD11b+
subset was ~75% positive. MHC class II positive LC in epidermal cell suspensions also expressed
the EGFP knock-in, but at signi®cantly lower levels than splenic myeloid DC or the B and T
lymphocytes that expressed CCR6. CCR6/EGFP knock-in expression patterns correlate with
surface expression of CCR6 as detected by staining with a monoclonal antibody to mouse CCR6.
These results demonstrate that CCR6 expression can distinguish DC subsets with different
functional properties. Cell culture experiments using bone marrow stem cells from CCR6 EGFP
knock-in mice have yielded preliminary data on the regulation of CCR6 expression in LC. Rare
CD11c+ dendritic cell precursors freshly isolated from bone marrow lack CCR6 expression.
Culturing bone marrow cells for 4 days with GM-CSF generated a subset of CD11+ cells which
were MHC class II positive cells with CCR6 expression. CCR6 expression by these DC declined
with longer periods of culture in GM-CSF. Addition of TGF-b1 to GM-CSF-stimulated cultures
prevented induction of CCR6 expression. The CCR6 EGFP knock-in mouse is an ideal model
system to study the regulation of CCR6 in LC differentiation and maturation.
594
Differential MHC Class I Presentation of Cytosolic and Membrane-Bound Tumor
Antigens by Dendritic Cells
D. Hokey, L. Geskin, and L. D. Falo Jr
Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.
Dendritic cells (DCs) are potent antigen-presenting cells capable of eliciting effective antitumor
CTL-mediated immune responses both in vitro and in vivo. Importantly, DCs have the capacity to
internalize, process, and present exogenous antigens on class I MHC molecules, making them
attractive biological adjuvants for tumor vaccine development. Many current antitumor
immunotherapy strategies rely on the identi®cation and production of tumor-speci®c or tumor-
associated antigens. However, polyvalent vaccine strategies have a greater potential to induce
tumor-speci®c immune responses than those that employ only single epitopes. Our laboratory and
others have investigated the use of whole tumor cells or tumor cell lysates as a source of tumor
antigens for DCs to elicit immunity to multiple tumor-speci®c epitopes, obviating the need for
tumor antigen identi®cation. However little has been done to compare their relative ef®cacy. We
compare the transfer of ¯uorescently labeled tumor antigens to DCs following overnight culture
with whole tumor cells or pulsing overnight with tumor cell lysates. Our results demonstrate that
both methods deliver tumor antigens to DCs. Quantitatively, feeding DCs with tumor cell lysates
results in a signi®cantly greater amount of antigen transfer than coculture with whole tumor cells.
Interestingly, functional analysis demonstrates that DCs differentially present tumor antigens from
whole tumor cells and tumor cell lysates based on the localization of the antigens in the tumor cell.
The data suggest that coculture of DCs with whole tumor cells results in the class I presentation of
cytosolic, but not membrane-bound, tumor antigens. However, pulsing DCs with tumor cell
lysates induces the class I presentation of membrane-bound, but not cytosolic, antigens. These
results indicate that these two methods of antigen delivery to DCs result in a signi®cant difference
in the processing and presentation of tumor antigens. Further, the data suggest there may be two




In¯ux in CD8+ T Cells Induced by Mature Dendritic Cells Correlates
with their Proliferative Potential
C. Termeer, M. Averbeck, T. Braun, B. Kremer, J. Dudda, S. Martin, and J. Simon
Dermatology, University of Freiburg, Freiburg, Germany
Dendritic cells (DC) as potent antigen presenting cells are able to induce MHC class I dependent
CD8+ cytotoxic T-cell responses. Here, we wanted to determine, whether the maturational state
of the DC plays a role during the early cell-cell contacts leading to CD8+ T-cell proliferation.
TCR-transgenic CD8+ T-cells were used from P14 mice and coincubated with autologous bone
marrow derived DC in a time-lapse video microscopy system. We found that DC can interact with
T-cells by both short±lived interactions or long±lasting interactions. Low-peptide concentrations
or addition of immature DC mainly induced short-lived Ca
2+
-in¯ux of 3±5 min in CD8+ T-cells,
even detectable in the absence of peptide or during T-cell/T±cell self interactions. In contrast, the
number of CD8+ T-cells with a persistent Ca
2+
-in¯ux for 30 min or more could be substantially
raised by the use of higher peptide concentrations or matured DC. 3H-Thymidine incorporation
assays directly correlated with the number of T-cells showing persistent Ca
2+
-signals, suggesting
that those are critical events needed to induce T-cell proliferation. Interestingly, DC incubated
only for 7 h with the maturational stimulus showed similar effectiveness to induce long-lasting
Ca
2+
-in¯ux. Therefore, the induction of long-lasting Ca
2+
-in¯ux seems to be independent of the
maturation-induced up-regulation of MHC and costimulatory molecules on the surface of DC,
since these changes occur much later at the earliest after 18 h as determined by FACS-analysis.
Instead, experiments using small RHO-GTPase inhibitors suggest that the reorganization of MHC
and costimulatory molecules on DC by actin-polymerisation were responsible for sustained Ca
2+
-
in¯ux resulting in CD8+ T-cell proliferation.
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Skin Transfection and Activation of Human Dendritic Cells by Intradermal Injection or
Gene Gun Delivery of Naked DNA
A. Larregina, L. Spencer, G. Papworth,* S. Watkins,* and L. Falo Jr
Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.; *Cell Biology and Physiology,
University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.
Skin dendritic cells (DC) play a central role in the process of genetic immunization however, the
mechanisms underlying immune responses to transgenic antigens are not well elucidated. Here we
compare two different methods to deliver plasmid DNA to human skin: intradermal injection
(DNA-ID-inj) or gene gun (GG), to analyze: (i) gene expression by different skin cell populations
(ii) DC viability, activation and migration, and (iv) cytokine production by DC. Ef®ciency of skin
transfection was assessed with the reporter luciferase and transfection of different cell populations
was visualized with pEGFP. Migration of Langerhans cells (LC) was quanti®ed at different time
points after transfection in epidermal sheets. Migration of EGFP + DC throughout the dermis was
visualized in skin blocks using a two-photon confocal microscope. Viability and the activation
phenotype of different skin migratory DC (miDC) was analyzed by ¯ow cytometry 72 h after skin
transfection. Cytokine production by miDC was determined after skin transfection with plasmid
encoding MART-1 with or without terminal differentiation with CD40L. We demonstrate that (i)
the use of the GG resulted in a higher expression of genes in epidermis and in LC than DNA-ID-
inj (ii) both methods triggered similar migration of DC, however, DNA-ID-inj induced a higher
expression of activation molecules (iv) the viability of miDC was not affected under our
experimental conditions and (v) regardless the transfection method employed miDC produced IL-
10 and TGF-b1 but not IL-12 p70, and (vi) ®nal maturation with CD40L did not alter the pattern
of cytokines produced by miDC.
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Role of Transfected and Nontransfected Skin Migratory Dendritic Cells in Cutaneous
Genetic Immunization
L. Spencer, A. Larregina, G. Papworth,* J. Plowey, P. Robbins,² S. Watkins,* and L. Falo Jr
Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.; *Cell Biology and Physiology,
University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.; ²Molecular Genetics and Biochemistry,
University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A.
Resident populations of professional antigen presenting cells (APCs) in the skin are largely
responsible for the success of cutaneous gene delivery. While it is clear that acquisition of
transgenic antigens (Ags) by professional APCs is a key event for immunity, how different gene
delivery methods affect transfection, activation, migration, and Ag uptake by dendritic cells (DCs)
remains to be investigated. Further, it is unclear whether direct transfection of APCs is required for
immunity, since antigenic proteins expressed by transfected keratinocytes may be acquired by DCs
through cross-priming. In the murine system, we compared three routinely used transfection
methods for skin: (i.) gene gun (ii.) intradermal injection of naked DNA, and (iii.) intradermal
injection of recombinant adenovirus (RAd). These methods were compared in their ability to
induce expression of transgenic proteins in skin and skin-resident DCs. Gene gun induced
expression of transgenic reporter proteins primarily in keratinocytes, while RAd exhibited a
remarkable ability to transfect DCs in situ. Using two-photon confocal microscopy and ¯ow
cytometry, we demonstrated that all three gene delivery approaches induced skin DCs, both
transfected and nontransfected, to migrate from skin to the draining lymph node. RAd induced the
greatest number of transfected DCs in the lymph node, while transfected DCs after DNA injection
or gene gun delivery were rare. Despite poor skin transfection, naked DNA induced considerable
migration. RAd and gene gun both induced robust Ag-speci®c proliferation of OT-1 T-cells, and
resulted in equal loading of a transgenic Ag epitope in MHC-I molecules, despite the inability of
the gene gun to ef®ciently transfect DCs. Collectively, these data suggest that the mechanism of
immune induction differs between the methods, with gene gun priming T-cells through cross-
presentation, and RAd priming predominantly through direct transfection of DCs.
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Slit2 Inhibits Hapten Induced Langerhans Cell Migration
H. Xu, G. Zu, H. Guan, Y. Xie, W. Xiong, J. Y. Wu,* Y. Rao,* and C. Elmets
Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.;
*Department of Pediatrics, Washington University, St Louis, Missouri, U.S.A.
Dendritic cells (DC) are potent antigen-presenting cells for the induction of immune responses.
One of essential properties of DC in vivo is their ability to migrate into peripheral tissues and then,
following antigen uptake, home to secondary lymphoid organs. Many cytokines and chemokines
stimulate DC migration while little is known about counter-regulatory factors in the process. Here
we show that Slit2, an inhibitory factor for leukocyte migration, down-regulates the hapten-
induced migration of DC in the skin. Slit2 was expressed in the naive and hapten treated skin. A
receptor for Slits, Robo1, was detected on DC. In the presence of Slit2, the migration of
Langerhans cells out of the skin explants that were treated with hapten was signi®cantly suppressed
in a dose dependent manner. The effect of Slit2 was mediated through the receptor Robo and
could be neutralized by a soluble form of Robo extracellular domain, RoboN. Pretreatment of DC
with Slit2 inhibited DC migration into draining lymph nodes when subcutaneously administered
in animals, indicating that Slit2 directly acted on DC. in vivo application of Slit2 prior to hapten
sensitization reduced contact hypersensitivity responses while treatment with RoboN enhanced
the response. The data have demonstrated that Slit2 plays an important role in the regulation of
cutaneous in¯ammatory reactions by controlling hapten induced DC migration following
sensitization. It implicates potential application of Slit2 and the soluble receptor RoboN as immune
modulators in the treatment of cutaneous in¯ammatory diseases.
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Regulation of Apoptosis, CXCR3 and Cytotoxic Molecule Expressions of CD8+CD56+
Malignant T Cells Derived from a Patient with CD8+ Se
Â
zary Syndrome
H. Yagi, A. Ohshima, Y. Tokura, and M. Takigawa
Dermatol, Hamamatsu University Sch of Medical, Hamamatsu
We have established a malignant T-cell line from blisters arising on erythrodermic skin of a patient
with unusual CD8+ SeÂzary syndrome. The cells showed a CD3+ CD2+ CD4-CD7-
CD8+ CD56+ CLA+ phenotype. The cells expressed a NK cell marker and had a NK1-type
pro®le (IL-10 and IFN-g) despite clonal TCR rearrangement. TGF-b production is another
intriguing feature of this tumor cell. IL-2 induced a marginal enhancement of Bcl-2 expression,
up-regulated the cell surface expression of CD95 and induced tumor cell apoptosis. On the other
hand, IL-7 did not enhance the expression of CD95 and prevented the cells from apoptosis by
retaining a high level of Bcl-2 expression.
CXCR3 is a likely candidate to mediate chemotaxis of lymphocyte into the epidermis and
highly expressed in low-grade mycosis fungoides. The disease progression is accompanied by loss of
CXCR3 expression. The malignant cells freshly isolated from the peripheral blood (PB) were
CXCR3-, while the cells freshly isolated from the blister were CXCR3+. CXCR3 on the
malignant cells in PB was changed from negative to positive when they were cultured in the
medium. CXCR3 expression was down-regulated by the addition of patient's serum in the
culture, suggesting that the existence of unknown factor(s) in the serum that suppress CXCR3
expression. The cells from both blisters and PB constantly expressed CLA and its intensity was
unchangeable by stimulants. In addition, the cells freshly isolated from blisters expressed a high
level of granzyme B, while the expression level of this cytotoxic molecule was lower in those
freshly isolated from PB.
These results demonstrated that although the tumor cells are capable of expressing CXCR3 and
cytotoxic molecules, they are strongly suppressed in the PB. CXCR3 but not CLA may play a
major role for migration of the cells into the skin. The expression of CXCR3 and granzyme B is
closely associated with their skin migration, and released TGF-b, which inhibits tumor
immunosurveillance and augments CXCR3 expression, possibly supports the tumor cell growth.
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Comparison of Genetic and Protein-Based Immunization Strategies to Induce Tumor
Protective Antitumor Immune Responses In Vivo
S. N. Wagner, T. K. Weimann,* M. Bifang,* C. Wagner, P. Luehrs, A. Zemann,* M. Goos,* G.
Stingl, and A. Schneeberger
DIAD, Department of Dermatology, University of Vienna Medical School, Vienna, Austria; *Department of
Dermatology, University of Essen Medical School, Essen, Germany
MAAs represent an attractive target for the development of immunotherapeutic strategies against
malignant melanoma. The recent development of different methods of genetic vaccination with
pDNA now raises the questions (i) what method is best for the induction of protective immunity
and (ii) whether this method is superior to conventional immunization with protein. We therefore
compared different strategies of genetic immunization with pDNA encoding MAA Pmel17/
gp100, i.e. direct ic. injection and the gene gun, with a Baculovirus-generated recombinant full-
length protein vaccine (in CpG ODN or Freund's adjuvant) in the experimental Cloudman M3/
DBA/2 mouse melanoma model. All treatment strategies induced antigen-speci®c IgG responses,
whith genetic vaccines inducing only IgG 1and protein vaccines inducing both IgG1 and IgG2a
isotype responses. Despite the induction of Th1-associated IgG2a responses, mice immunized with
protein vaccines did not show protection against a subsequent challenge with Pmel17 6 M3
melanoma cells as did mice genetically immunized by the gene gun approach. In contrast, mice
genetically immunized by direct injection with mPmel17-encoding pDNA showed signi®cant
protection. As this protective effect was completely abolished by in vivo CD4+/CD8+ T cell
depletion, we analyzed all vaccination strategies for the induction of antigen-speci®c T cell
responses in CTL assays. Interestingly, only splenocytes from mice immunized by direct injection
of pDNA exhibited signi®cant antigen-speci®c CTL activity. These results demonstrate that
genetic immunization by direct injection of pDNA is superior to the gene gun approach as well as
to immunization with the respective recombinant protein for the induction of antigen-speci®c
protective T cell responses in vivo.
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Confocal Analysis of MHC Class II±Autoantigen Interactions in Pemphigus Vulgaris
M. Berry, A. K. Moesta, and A. A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.
The initiation of normal, and presumably autoimmune responses is dependent on intracellular
antigen processing and presentation events that are prerequisites for T cell activation. We have
sought to characterize the intracellular interactions of a putative autoantigenic relevant in
pemphigus vulgaris (PV) with a known Human Leukocyte Antigen (HLA) class II disease
susceptibility allele (DRB1*0402) to further our understanding of early disease mechanisms
relevant in autoimmune pathways. Confocal microscopy was utilized to allow three-dimensional,
real-time imaging of dynamic cell processes related to the HLA class II processing/presentation
pathway. To undertake our studies, we transfected the PV associated MHC class II allele
DRB1*0402, which we had previously coupled to enhanced green ¯uorescent protein (EGFP),
into the human melanoma cell line Mel JuSo. Intracellular and cell surface expression of the B
chain was con®rmed using confocal microscopy. Furthermore, we have demonstrated that these
experimentally manipulated cells are functionally competent and capable of presenting antigen to
PV patient derived T cell lines. To track the cellular uptake and intracellular processing of a
putative disease relevant epitope, we coupled tetramethylrhodamine-isothiocyanate to the amino
terminus of desmoglein 3 (Dsg3) 190±204, a peptide previously shown to elicit T cell proliferation
in PV patients. This manipulation allowed us to visually document the uptake of labeled peptide by
immuno¯uorescent microscopy. By two-color, time-course confocal analysis, we report the ®rst
direct visualization of intracellular colocalization between antigen and class II HLA molecules. We
have furthermore begun to track the precise intracellular route and sites of MHC class II±peptide
interactions by three color analysis using a panel of cyanine 5-conjugated antibodies directed
against markers for speci®c subcellular compartments within the endosomal/lysosomal system.
Confocal microscopy offers an innovative platform to systematically study the earliest cellular
events in autoimmune induction.
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Immunophenotypical Analysis of Langerhans Cell Progenitors in Human Fetal Skin
A. Shibaki, M. Akiyama, K. Arita, and H. Shimizu
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Langerhans cells (LC) are bone marrow derived antigen presenting cells of dendritic cell lineage.
Their physiological roles as immunological sentinels in the skin have been extensively investigated.
In contrast, the cellular ontogeny and developmental pathways of LC have not been fully
elucidated. In this study, we investigated whether LC progenitors are present in human fetal skin
from various estimated gestational ages (EGA). 6 mm thick skin sections were prepared from 57 to
163 d EGA fetuses, and stained with various primary monoclonal antibodies, followed by
¯uorochrome conjugated secondary antibodies. The stained sections were counter stained and
analyzed using a confocal ¯uorescent microscope. CD45+ dendritic shaped cells were observed in
the epidermis as early as 73 d EGA. Double immunostaining demonstrated that epidermal CD45+
cells also expressed CD1a, but not CD11c, CD33, CD34 or CD117. HLA-DR expression was
detected at a slightly later time point (108 d EGA). The numbers of CD1a+ CD45+ LC in the
epidermis increased with gestational age (0.4 6 0.9 cells/®eld at 73 d EGA and 3 6 1.2 cells/®eld at
163 d EGA), but the numbers remained much less than in adult skin (7.2 6 1.5 cells/®eld). The
majority of the CD1a+ CD45+ cells were located in the peri-follicular areas within fetal skin. No
other CD45+ and/or CD34+ cell populations were observed within fetal epidermis at any of the
ages tested, suggesting that LC may acquire most of their immunophenotypical characteristics
before they reach into the epidermis. In the dermis large, round-shaped CD45+ cells accumulated
with advancing gestational age. The majority of these cells expressed HLA-DR, and partially
CD14 or CD123, but not other lineage markers. They did not express CD1a, CD11c, CD33,
CD34 or CD117. These data suggest that dendritic cell progenitors may migrate to the dermis
during fetal development. Our results will aid the further understanding of dendritic cell
differentiation pathways and pave the way for a more detailed examination of the developing
cutaneous immune systems.
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Delayed-Type Hypersensitivity Reactions Requires TNF Receptor 1 Expression by
Endothelial Cells




Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany; *Experimental
Hematology, GSF, Munich, Germany; ²Inhalationbiology, GSF, Munich, Germany; ³Institut for
Medical Microbiology, Technical University, Munich, Germany
TNF is critically involved in the regulation of innate and T cell mediated immune responses and
plays a central role in protective and harmful delayed-type hypersensitivity reactions (DTHR).
However the role of TNF Receptor 1 (TNFR1) in the induction and effector phase of DTHR
remains controversial. To address this question we sensitized and challenged gene-targeted mutant
TNFR1 de®cient mice (TNFR1
±/±
) with TNCB to induce and elicit contact hypersensitivity
reactions (CHSR). These mice developed 60% lower ear swelling responses than wild-type mice,
histology and determination of myeloperoxidase activity revealed that TNFR1
±/±
mice had
strongly reduced neutrophil in®ltrates and tissue destruction. To investigate whether reduced
in¯ammation in TNFR1
±/±
mice is the consequence of a defect in T cell priming we examined
hapten speci®c T cell responses. No differences were found between CD4++ T cells from
TNFR1
±/±
and wild-type mice, analysing T cell proliferation and IFN-g producing T cell
precursor frequency directly ex vivo. We next examined whether reduced ear swelling was
secondary to impaired T cell functions. However hapten speci®c Th1 and Tc1 cells from
TNFR1
±/±
mice were fully capable in transferring CHSR into WT mice. On the contrary hapten
speci®c Th1 and Tc1 cells from WT mice failed to elicit normal CHSR in TNFR1
±/±
mice,
suggesting that the defect residues inside the tissue. Indeed during early phases of CHSR mRNA
expression of I-CAM, V-CAM and P-selectin was strongly suppressed in ears from TNFR1
±/±
mice. Our data show that inef®cient DTHR in TNFR1
±/±
mice was not due to defective T cell
responses but was associated with inappropriate expression of adhesion molecules. These data may
help to elucidate the mode of neutrophil recruitment during T cell dependent immune responses
such as rheumatoid arthritis or psoriasis.
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Epidermal IL-18 Induces Severe Th2 Type Dermatitis Without IgE/stat6 Under Speci®c
Pathogen-Free Conditions
H. Konishi, T. Murakami, K. Yamanaka, K. Tokime, and H. Mizutani
Dermatology, Mie University, Tsu, Japan
As we reported recently, IL-18 directly stimulates T cells and mast cells to release AD-associated
molecules, Th2-related cytokines and histamine, we investigated IL-18 induction of AD-like skin
lesion by analyzing KIL-18Tg and KCASP1Tg, which skin-speci®cally over-express IL-18 and
caspase-1. They spontaneously developed relapsing dermatitis with mastocytosis and Th2 cytokine
accumulation with systemic elevation of IgE and histamine. Stat6 de®cient KCASP1Tg has
undetectable level of lgE but manifests the same cutaneous changes. However, IL-18-de®cient
KCASP1Tg evaded the dermatitis, suggesting that IL-18 causes AD-like changes in the absence of
IgE/stat6. Thus, IL-18 plays important roles in atopic in¯ammation.
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Expression of Caspase-1 Regulatory Proteins in Keratinocytes
J. Mee and R. Groves
Medicine, Imperial College, London, U.K.
Caspase-1 is a cysteine protease initially identi®ed as interleukin-1 b converting enzyme (ICE),
responsible for processing inactive precursor IL-1b into the mature, pro-in¯ammatory cytokine.
Caspase-1 has also been shown to cleave the precursor of IL-18. Caspase-1 knockout mice are
consequently de®cient in active IL-1b and IL-18 and exhibit resistance to endotoxic shock. We
have previously shown that human keratinocytes exclusively produce proIL-18 and were interested
to determine whether the absence of processed IL-18 was the result of a de®ciency in caspase-1
production or more complex inhibition. Total RNA and protein extracts were prepared from
primary human keratinocytes and assessed for caspase-1 production. All samples analysed showed
constitutive caspase-1 transcription by RT-PCR and Northern blot. However, Western blotting
revealed that caspase-1 was present in the inactive 45 kDa form. Functional caspase-1 activity was
con®rmed in lysates from the monocytic cell line THP-1, by the presence of processed IL-18
whereas only precursor was seen in keratinocytes. Caspase-1 is synthesised as a zymogen which
oligomerises and autoprocesses upon receipt of an appropriate signal. Recently, several proteins
which speci®cally bind caspase-1 and facilitate oligomerisation have been described. Like caspase-
1, they all possess a caspase recruitment domain (CARD) through which association occurs. Two
molecules, RICK and IPAF induce cleavage of caspase-1 on binding, whereas the CARD proteins
ICEBERG and COP inhibit caspase-1 processing. RT-PCR analysis of human keratinocytes
revealed strong expression of both the antagonistic CARD proteins and RICK, whereas IPAF was
weakly transcribed. Further, ICEBERG mRNA production was signi®cantly higher in
keratinocytes than any other cell type tested, suggesting a net antiprocessing phenotype in these
cells. These ®ndings indicate a complex regulatory mechanism for caspase-1 activation in
keratinocytes involving at least 4 speci®c CARD proteins which may in¯uence the levels of pro-
in¯ammatory cytokines including IL-1b in cutaneous in¯ammation.
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Interleukin-18 is a Key Mediator of Epidermal Langerhans Cell Migration and Contact
Hypersensitivity in Mice
R. Groves, C. Antonopoulos, M. Cumberbatch,* J. Mee, R. Dearman,* F. Liew,² and I. Kimber*
Dermatology, Imperial College of Science Technology and Medicine, London, U.K.; *Central Toxicology
Laboratory, Syngenta Ltd, Maccles®eld, U.K.; ²Immunology and Bacteriology, University of Glasgow,
Glasgow, U.K.
Langerhans cell (LC) migration from epidermis to lymph node is a tightly regulated process, and
current data suggest that IL-1b and TNFa are involved in this event. In this study we assessed the
role of IL-18, a cytokine structurally similar to IL-1b, in the regulation of LC migration and
contact hypersensitivity (CHS). To determine whether IL-18 is required for optimal CHS, IL-18
KO and wild type (WT) mice were sensitized with 1% oxazolone (OX) and challenged 5 days later
with 0.5% OX. Vigorous ear swelling responses were observed in WT mice, but this was
attenuated by 36% (n = 3; p < 0.05) in IL-18 KO mice. The reduced response was completely
restored in IL-18 KO mice by local intradermal injection of IL-18 (50 ng) prior to sensitization
with OX (n = 3) suggesting that the defect in IL-18 KO mice was in the afferent phase of the CHS
response. Administration of IL-18 to WT mice prior to sensitization did not affect CHS. To
examine the effect of IL-18 on allergen-induced LC migration, epidermal LC density was
determined following topical application of 1% OX. OX treatment caused a signi®cant decline in
MHC class II + ve epidermal LC density 4 h after application in WT mice (26%, n = 3; p < 0.05)
but this was absent in IL-18 KO mice. Intradermal injection of IL-1b, TNF-a or IL-18 (50 ng
each, n = 3) lead to equivalent LC migration in both IL-18 KO and WT mice, indicating that,
given an appropriate signal, IL-18 KO LC are able to migrate normally. Finally, intradermal
injection of IL-18 prior to topical sensitization with 1% OX in caspase-1 de®cient mice (which
have impaired release of both IL-1 and IL-18) failed to restore their attenuated CHS response,
whereas IL-1b pretreatment resulted in complete restoration (n = 3). These results indicate that IL-
18 is a key mediator of LC migration and CHS, acting upstream of IL-1b, and that this cytokine
may play a central role in the regulation of cutaneous immune responses.
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Genomic Deletion of Neutral Endopeptidase in Mice Promotes Hapten Uptake,
Maturation and Function of Bone Marrow-Derived Dendritic Cells
T. E. Scholzen, T. Brzoska, M. Fastrich, S. Grundmann, C. A. Armstrong,* J. C. Ansel,* and T.
A. Luger
Ludwig-Boltzmann Institute & Department of Dermatol., University of MuÈnster, MuÈnster, Germany;
*Department of Dermatol., Emory University, Atlanta, Georgia, U.S.A.
The availability of neuropeptides such as substance P (SP) which is released from sensory nerves or
immune cells during cutaneous neurogenic in¯ammation is effectively controlled by proteolytic
peptidases. We have previously demonstrated that acute inhibition or genomic deletion of neutral
endopeptidase (NEP) results in a SP-dependent augmentation of murine allergic contact dermatitis
(ACD) by affecting sensitization and elicitation phase. In this study we address the hypothesis that
absence of NEP may modulate ACD responses by affecting bone marrow-derived dendritic cell
(BMDC) maturation and function. BMDC were generated from NEP-de®cient mice (C57BL/6 J-
NEP
±/±
) or wild type controls (C57BL/6 J) in the presence of GM-CSF and IL-4. As demonstrated
by FACS analysis, d3, d6 and d7 NEP
±/±
BMDC expressed signi®cantly more DC cell surface
markers such as DEC205, IA and costimulatory molecules (CD40, CD80 and CD86) compared to
NEP
&
mice BMDC, in particular after BMDC maturation with LPS for 48 h. In MLR utilizing d8





mice, BMDC from NEP
±/±
animals promoted proliferation of T-cells with higher ef®cacy
compared to wild type mice BMDC, as determined by 3H-thymidine incorporation. Likewise, T-
cells from NEP
±/±
mice demonstrated a higher proliferative response to Concavalin A stimulation
or CD3/CD28 ligation compared to NEP
&
mice. In addition, acute systemic NEP inhibition in
NEP
&
mice prior to sensitization with ¯uorescein isothiocyanate (FITC) after 24 h signi®cantly
augmented uptake of FITC in the CD11c-positive DC fraction from regional lymph nodes but not
from spleen compared to cells obtained from mice not treated with the NEP inhibitor. These data
indicate that functional absence of NEP may signi®cantly control cutaneous ACD in¯ammatory
responses by promoting hapten uptake, DC maturation and T-cell stimulation.
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Resistance in Experimental Leishmaniasis is Associated with Early Expression of the
Th1-Inducing Cytokine Osteopontin
J. Ehrchen,*² C. Sorg,² and C. Sunderkoetter*²
*Department of Dermatology, University of MuÈnster, MuÈnster, NRW, Germany; ²Institute Exp Derm,
University of MuÈnster, MuÈnster, NRW, Germany
In experimental leishmaniasis, susceptibility in BALB/c mice is associated with a Th2 cell response,
and resistance in C57Bl/6 mice with a Th1 cell response. The elaboration of the Th1 or Th2 cells
depends on the early cytokine milieu. While there are early differences in IL-4 expression, so far
none of the Th1-inducing cytokines has been shown to differ signi®cantly between both strains.
To identify potential factors and cells contributing to Th cell polarization we used Differential
Display-PCR and Northern blot analysis to study gene expression in the early cutaneous in®ltrate.
We found that transcript levels for osteopontin (Opn) were 3±4-fold higher in C57Bl/6 than in
BALB/c mice as early as 1 day after infection with approximately. We then performed in situ
hybridization in order to detect other cells expressing Opn in vivo. We detected Opn expression by
only few in®ltrating cells (likely M¢). However, there was a marked expression of Opn transcripts
by epidermal cells in infected feet. Expression of Opn by keratinocytes was con®rmed by
immunohistochemistry and the strain speci®c differences by immuno-precipitation. The
expression of Opn by keratinocytes would be of eminent relevance in sight of the high number
of epidermal cells at the site of infection. As Opn is known to stimulate the secretion of IL12 it
could directly overcome the IL12 suppression by L.major. Our results thus introduce (i) a Th1-
inducing cytokine which presents with signi®cant differences very early in Leishmaniasis and (ii)
epidermal cells as possible participants in in¯uencing the Th1 response.
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Epidermal Langerhans Cells are the Speci®c Target of Dectin-2 Promoter Activity:
Evidence from Transgenic Mice and Implications for LC-Speci®c Gene Expression
T. Yudate, M. Bonkobara, K. Ariizumi, and P. Cruz Jr
Dermatology, The University of Texas South-western Medical Center, Dallas, Texas, U.S.A.
Despite their preeminent role in 10 immunity, gene-based modulation of LC function is limited by
lack of de®ned transcription regulatory units directing LC-speci®c gene expression. Recently, we
reported on the promoter activity of a 5¢-¯anking region of the dectin-2 gene (Dec2FR) directing
luciferase (Luc) gene expression in Dec2FR-Luc transgenic mice. In these mice, constitutive Luc
activity was remarkably high in skin, with > 80% in epidermis restricted to Ia + LC. By contrast,
Luc activities in other organs were close to background. How speci®cally is Dec2FR activity
targeted to LC? Can Luc activity be induced/up-regulated in non-LC leukocyte subpopulations?
To address these questions, epidermal cells were isolated from transgenic mice and stimulated with
LPS, IFNg, or PMA; Ia + LC were puri®ed using Ab-coated beads and examined for the CD86
activation marker and for relative Luc activity (RLU/cell). Treated LC showed up-regulated
CD86 expression, with no signi®cant change in Luc activity. Ex vivo, skin was painted with a
contact sensitizer (DNFB) and cultured for 2 days. Ia + LC in skin and those that emigrated into
media were puri®ed and examined for Luc activity; both types of LC displayed slight increments in
Luc activity. We then examined CD11c+ dendritic cells and B220+ and CD3+ lymphocytes (B
and T cells, respectively) puri®ed from spleen cells using Ab-coated beads or FACS and Mac-1high
macrophages isolated from thioglycollate-activated peritoneal cells by FACS. Despite activation
with optimal LPS or ConA doses, Luc activities of these leukocytes remained markedly low
compared to epidermal LC. These ®ndings indicate that Dec2FR in Luc transgenic mice is targeted
to epidermal LC, serving as a basis for studies engineering LC-speci®c gene expression to induce/
potentiate 10 immune responses (e.g. vaccines), modulate established immunity (Th1 vs. Th2), or
even delete LC (treatment for LC histiocytosis).
308 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
608
T Cell Populations Restored in IL-7 De®cient Mice by Keratinocyte-Derived Transgenic
IL-7
B. E. Rich, I. R. Williams,* and T. S. Kupper
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.; *Pathology, Emory
University School of Medicine, Atlanta, Georgia, U.S.A.
Interleukin-7 (IL-7) is an essential signaling molecule that regulates the expansion of B and T
lymphocyte populations before and during the rearrangement of their antigen receptor genes and
may have a role in systemic lymphocyte homeostasis. IL-7 is principally a product of epithelial cells
and it appears to also have a role in regulating the action of intraepithelial T cells. The
developmental role of IL-7 is clearly demonstrated in mice de®cient in various components of the
IL-7 pathway. These include mice lacking intact genes for IL-7, IL-7 receptor, or components of
the signal transduction apparatus, the gc chain or the JAK-3 kinase. These mice each have a severe
de®cit in lymphopoiesis that results in populations of T and B cells that are only a few percent of
normal. Previously we have reported the restoration of T cell populations in nude mice (1995, J.
Exp. Medical 191 : 1223±1228) as well as B and T lymphopoeisis in IL-7 de®cient mice (1997,
Immunology 92 : 374±380) by transgenic expression of IL-7 in an autocrine fashion. Autocrine
expression of IL-7 in lymphocytes, however, can also lead to in¯ammatory disorders and
malignancy. The keratin 14 gene is active in strati®ed epithelial tissues including cortical thymic
epithelium. We now report that paracrine expression of IL-7 from a transgene under the control of
the keratin 14 promoter causes signi®cant restoration of circulating populations of T cells and, to a
lesser extent, B cells, in mice lacking the normal IL-7 gene. Studies on this model system may be
particularly pertinent as therapeutic approaches involving IL-7 are being considered for the
treatment of lymphoid de®ciencies.
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Vasoactive Intestinal Peptide and Cytokines Enhance Stem Cell Factor Production from
Epidermal Keratinocytes DJM-1
M. Kakurai, N. Fujita,* T. Kiyosawa, T. Inoue,² S. Ishibashi,* Y. Furukawa,³ T. Demitsu, and H.
Nakagawa
Department of Dermatology, Jichi Medical School, Tochigi, Japan; *Department of Medicine, Jichi Medical
School, Tochigi, Japan; ²Department of Dermatology, Akita University School of Medicine, Akita, Japan;
³Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan
Stem cell factor (SCF) can induce mast cell proliferation. Vasoactive intestinal peptide (VIP) has
been suggested to play some roles in in¯ammatory dermatoses such as atopic dermatitis. The aim of
this study is to investigate the possible role of SCF in atopic dermatitis by analyzing epidermal SCF
production induced by VIP and cytokines. Full-length type SCF transcript was detected in normal
human epidermal keratinocytes (NHEK), and a human epidermal keratinocyte cell line DJM-1
cells, as well as normal human dermal ®broblasts, using RT-PCR. Spliced type SCF transcript was
detected in both DJM-1 cells and NHEK. Western blot analysis of all these cell lysates with SCF
antibody revealed a protein with the known molecular weight of membrane-bound stem cell
factor. SCF immunoreactivity was found in cytoplasm of both DJM-1 cells and NHEK using
confocal laser scanning microscope. We examined the effects of VIP and cytokines on SCF
production of DJM-1 cells using ELISA. SCF contents signi®cantly increased in culture
supernatants of DJM-1 cells treated with 1000 nM VIP and/or cytokines. The combination of VIP
and IL-4 induced a maximum release of SCF approximately 1.7 fold increased compared to
control. Overall, these results suggest that several in¯ammatory cytokines (Th1 and Th2) and VIP
from mast cells and nerve ending are capable of inducing SCF production from epidermal
keratiocytes, possibly leading to mast cell activation in atopic dermatitis.
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Interleukin-10 Knockout Mice are Relatively Resistant to Induction of Alopecia Areata
P. Freyschmidt-Paul, K. J. McElwee, M. Zo
È
ller,* J. P. Sundberg,² R. Happle, and R. Hoffmann
Dermatology, Philipp University, Marburg, Germany; *DKFZ, DKFZ, Heidelberg, Germany;
²Pathology, The Jackson Laboratory, Bar Harbor, Maine, U.S.A.
Alopecia areata (AA) occurs spontaneously in C3H/HeJ mice, but it can be induced in unaffected
C3H/HeJ mice or other histocompatible strains by grafting of AA-affected mouse skin. Because
IL-10 expression is increased in scalp from AA-patients successfully treated with DCP, we wanted
to determine whether the absence of IL-10 results in increased susceptibility to AA development.
For this purpose we tried to induce AA in 20 C3H/HeJBir-Il10
±/±
mice by skin grafting and as
controls we grafted AA-affected skin onto 20 unaffected C3H/HeJ mice. FACS-analysis for
various cytokines and surface markers was performed on skin-in®ltrating leucocytes and cells from
skin draining lymph nodes. 13/20 Il10
±/±
mice did not develop hair loss, 7/20 Il10
±/±
mice
developed limited AA, but no mice developed extensive AA. In contrast, 19/20 controls
developed AA. FACS-analysis revealed elevated levels of dendritic cells and monocytes in the skin




mice had increased levels of IFN-g
and TNF-a in lymph nodes and decreased levels of IL-6 in skin. CD25, CD28, CD40, CD80 and
CD86 were increased in skin of IL-10
±/±
mice and CD44s, CD44v3, CD44v6, CD44v7 and
CD44v10 were increased in both, skin and lymph nodes of IL-10
±/±
mice. In a second part of the
study, skin from Il10
±/±
mice and from control mice was grafted onto C3H/HeJ mice with
extensive AA. AA developed in control skin grafts, but not in skin grafts from Il10
±/±
mice.
Contrary to expectations we have found that IL-10 de®cient mice are relatively resistant to the
induction of AA, despite their elevated levels of proin¯ammatory cytokines and adhesion
molecules. Whether the decreased levels of IL-6 could be responsible for the resistance to AA
induction requires further investigation.
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BP180 Speci®c IgE in Bullous Pemphigoid
J. A. Fairley,*² O. Dimson,* C. L. Fu,* M. Janson,* and G. Giudice*³
*Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.; ²Dermatology,
VAMC, Milwaukee, Wisconsin, U.S.A.; ³Biochemistry, Medical College of Wisconsin, Milwaukee,
Wisconsin, U.S.A.
Bullous pemphigoid (BP) is an autoimmune skin disease characterized by the development of
autoantibodies directed against the hemidesmosomal protein BP180. In addition to IgG
autoantibodies, IgE autoantibodies have been reported in the skin and sera of BP patients. This
study examined the incidence, speci®city and potential relevance of IgE class autoantibodies in BP.
Thirty BP patients participated in these studies. Total IgE was measured in the patients' sera and the
speci®city of the IgE autoantibodies was determined by immunoblotting with the NC16A domain
of BP180 and normal human keratinocyte extract. Double labeling immuno¯uorescence with
antihuman mast cell tryptase and antihuman IgE was used to identify IgE -coated mast cells in the
dermis of BP patients. Double immunolabeling was performed with a monoclonal antibody to
BP180 and antihuman mast cell tryptase. Histamine release after exposure to the recombinant
NC16A domain of BP180 was measured from basophils from untreated BP patients (n = 9), BP
patients undergoing therapy (n = 9) and controls (n = 16). Elevated serum IgE levels were found in
70% of untreated BP patients. IgE class autoantibodies directed against BP180 were found in 86%
of untreated BP patients by immunoblotting. All but one of these patients reacted with the NC16A
domain of BP180. IgE-coated mast cells were detected in perilesional skin of the BP patients.
Moreover, BP180 peptides were also detected on the surface of these mast cells. BP180-stimulated
histamine release was signi®cantly higher in basophils obtained from untreated BP patients when
compared with control basophils (p = 0.006) or those from BP patients undergoing immunosup-
pressive therapy (p = 0.01). Our ®ndings support the hypothesis that IgE autoantibodies play a role
in the pathogenesis of BP. The ability of BP basophils to degranulate in response to exposure to the
antigenic region of BP180 suggests a mechanism by which the IgE autoantibodies may contribute
to lesion development.
609
Negative Correlation Between Eosinophil Cationic Protein Blister Fluid Levels and
Intensity of IgG4 Dermo-Epidermal Junction Deposits in Human Bullous Pemphigoid
M. Dmochowski and M. Bowszyc-Dmochowska
Dermatology, University School of Medicine, Poznan, Poznan, Poland, Poland
The role of eosinophils in pathogenesis of bullous pemphigoid (BP), in the light of data obtained
on murine models of the disease, is unclear. The aim of this study was to investigate whether there
is an association between eosinophils and IgG4-mediated autoimmunity in human BP at the tissue
level. The activity of the disease was assessed using a numerical scale in 19 BP cases. The eosinophils
were counted in Tzanck smears of the content of fresh blisters. The eosinophil cationic protein
(ECP) blister ¯uid levels were examined with ¯uoroenzymeimmunoassay. The intensity of IgG4
deposits along the dermo-epidermal junction (DEJ) was evaluated using single-step direct
immuno¯uorescence on sodium chloride-separated peribullous skin with the titration of
¯uorescein-conjugated antihuman IgG4 antibody. The correlations between the activity of BP
and ECP blister ¯uid levels, the activity of BP and intensity of IgG4 DEJ deposits, and ECP blister
¯uid levels and intensity of IgG4 DEJ deposits were statistically analyzed. The eosinophils, but not
neutrophils as in mouse, were predominating cell type in all but one BP cases. There were no
signi®cant correlations between the activity of BP and either ECP blister ¯uid levels or intensity of
IgG4 DEJ deposits. Nevertheless, in our series of BP cases, a signi®cant negative correlation
between ECP blister ¯uid levels and intensity of IgG4 DEJ deposits was found. Thus, there appears
to be a regulatory relationship between ECP-releasing tissue eosinophils and IgG4 autoantibody
responses in human BP.
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Tissues Affected by Graft-Vs.-Host Disease Vary with MHC Haplotype in MHC-
Matched, MiHA-Incompatable Murine Models
D. H. Kaplan, B. E. Anderson,* W. Shlomchik,² and M. Shlomchik*
Department of Dermatology, Yale University, New Haven, Connecticut, U.S.A.; *Department of
Laboratory Medicine, Yale University, New Haven, Connecticut, U.S.A.; ²Department of Medical
Oncology, Yale University, New Haven, Connecticut, U.S.A.
Chronic graft-vs.-host disease (cGVHD) is a frequent complication in recipients of allogenic stem
cell transplants, yet the immunologic mechanisms underlying this disease are poorly de®ned.
Moreover, the majority of the work with murine models has focused on acute graft-vs.-host
disease and employed transplants from parent into sublethally irratiated F1 recipients (parent F1)
which does not accurately mirror current clinical transplantations. We have revisited the B10.D2
BALB/c, murine model of cGVHD in which bone marrow and spleen cells from B10.D2 (H-2d)
mice are transplanted into lethally irradiated BALB/c (H-2d) mice. These H-2-matched strains
differ only at minor histocompatability loci. Approximately 3±4 weeks after transplantation the
BALB/c mice developed patches of induration and alopecia which was histologically similar to
cGVHD. To determine whether this phenotype was unique to the B10.D2 BALB/c pairing we
examined GVHD in two other MHC-congenic pairs, B10 BALB.b (H-2b) and B10.BR BALB.k
(H-2 k). Both the BALB.b and BALB.k mice developed a more acute form of GVHD. By 2±
3 weeks these mice developed diarrhea and hunched posture but never developed any cutaneous
disease. Like the B10.D2 BALB/c model, the B10 BALB.b model is dependent on CD4+ but not
CD8+ T cells. Since the effector cells are the same in both models, the results suggest that
differences within the MHC locus alone can determine the tissues affected by GVHD.
Furthermore, this argues that MHC-based selection of immunodominant antigens can determine
the location and character of the graft-vs.-host response.
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Interleukin-10 Therapy Decreases the Incidence of Relapse and Prolongs the Relapse-
Free Interval in Psoriasis
M. A. Friedrich,* W. D. Doecke,² A. Klein,* S. Philipp,* H. D. Volk,² W. Sterry,* and K.
Asadullah*³
1 Dermatology, University Hospital Charite, Berlin, Berlin, Germany; ²Immunology, University Hospital
Charite, Berlin, Berlin, Germany; ³RBA Dermatology, Schering AG, Berlin, Berlin, Germany
The ability of interleukin-10 therapy to reduce the severity of exacerbated psoriasis has been
demonstrated recently. Considering the immunobiological properties of this cytokine we
investigated the effects of long-term interleukin-10 application on the immune system and
duration of psoriasis remission. We performed a placebo-controlled, double-blind, phase II trial
using interleukin-10 in patients with chronic plaque psoriasis in remission. Patients received
subcutaneous injections with either interleukin-10 (10 mg/kg body weight; n = 7) or placebo
(n = 10) 3 times per week until relapse or study termination after 4 month. The treatment was well
tolerated. In the placebo group almost all patients (90%) showed a relapse during the observation
period. In contrast to this, only 2 out of 7 patients (28.6%) relapsed in the interleukin-10-treated
group. Kaplan Meier analysis revealed a signi®cantly lower relapse incidence in the interleukin-10
than in the placebo group (p = 0.02). The mean relapse-free interval time was 101.6 6 12.6 days in
the interleukin-10 group in comparison to 66.4 6 10.4 days in the placebo group. Immunological
activity of interleukin-10 application was indicated by an increase in soluble interleukin-2 receptor
plasma levels and higher ex vivo interleukin-4 secretion capacities. Remarkably, a signi®cant
negative correlation was demonstrated between the IL-4 secretion capacity and Psoriasis Area and
Severity Index score (r = 0.36, p < 0.01). Our data suggest that interleukin-10 therapy is
immunological effective, decreases the incidence of relapse and prolongs the disease-free interval in
psoriasis. Its value should be further determined in larger trials and for the prevention of re-
exacerbation of other in¯ammatory disorders with a similar immunological pro®le.
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Comparison of Protease-Activated Receptor-2 and Mast Cell Tryptase on Cytokine
Release and Activation of NFkB in Human Dermal Microvascular Endothelial Cells
M. Steinhoff, V. Shpacovitch, T. Brzoska, J. Buddenkotte, C. Stroh,* C. Sommerhoff,² K.
Shulze-Osthoff,* and T. Luger
Dermatology, University of Muenster, Muenster, Germany; *Immunology and Cell Biology, University of
Muenster, Muenster, Germany; ²Clinical Chemistry, University of Munich, Munich, Germany
Protease-activated receptor 2 (PAR-2) belongs to a new subfamily of G protein-coupled receptors
with 7 transmembrane domains. PAR-2 can be activated by serine proteases such as mast cell
tryptase, extrapancreatic trypsin or bacterial proteases. Because both tryptase and PAR-2 are
discussed to regulate important in¯ammatory and allergic responses in the skin, one important
question is whether tryptase mimics all effects observed for PAR-2 activation. We demonstrate that
human dermal microvascular cells (HDMEC) express functional PAR-2. Activation of PAR-2 by
speci®c activating peptide (AP) or trypsin results in increased levels of IL-6, IL-8 expression and
release with a maximum at 6 h, 9 h and 12 h. PAR-2 stimulation by AP and trypsin also leads to
activation of the NFkB complex (heterodimer p50/p65) in HDMEC with a maximum at 1 h. We
also observed that mast cell tryptase as well as AP stimulate PAR2-induced up-regulation of IL-1b
with a maximum at 3 h and 6h. In contrast, tryptase treatment has negative effect on IL-6
expression and release as compared to AP, and has no signi®cant effect on IL-8 expression and
release in HDMEC. Accordingly, there were no signi®cant changes in NFkB levels after tryptase
stimulation. These effects were not attributable to heparin. Thus, tryptase-induced effects of mast
cells during in¯ammation and immune response are only partially mediated by PAR-2. Cell
stimulation by different PAR-2 agonists may lead to different cell responses. Finally, tryptase also
exerts anti-in¯ammatory effects on HDMEC. Further investigation is needed to fully explore the
role of tryptase±PAR±2 interaction in the skin during in¯ammation and allergic reactions.
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Lymphatic Endothelial Cells Directly Stimulate Transendothelial Migration of
Migratory Skin-Derived Dendritic Cells In Vitro
M. Wu*² and S. T. Hwang*
*Dermatology Branch, National Cancer Institue, Bethesda, Maryland, U.S.A.; ²Department of
Dermatology, China Medical College, Taichung, Taiwan
Activated DC migrate from peripheral tissues such as skin to regional secondary lymphoid organs
(i.e. lymph nodes) via afferent lymphatic vessels, which are known to constitutively secrete the
chemokine CCL21. CCL21 and its receptor, CCR7, have been shown to be critical in this
migratory pathway. To determine whether lymphatic endothelial cells directly stimulate
transendothelial migration of DC, we developed a transendothelial migration assay using murine
skin-derived migratory DC (mDC) and cultured ovine lymphatic endothelial cells (LEC) grown
on Transwell ®lters. In standard chemotaxis assays without LEC, mDC migrated 14-fold better to
conditioned medium (CM) from LEC compared to control medium (p < 0.01). This response
could be blocked by pretreatment of mDC with CCL21 (~98%) or pertussis toxin (PTX) (~96%).
While migration in the absence of LEC was minimal, migration was 32-fold better (p = 0.01) in the
presence of a LEC monolayer covering the Transwell ®lter. While pretreatment of mDC with
PTX resulted in a 96% decrease (p < 0.05) in trans-LEC migration, pretreatment of mDC with
CCL21 resulted in a statistically insigni®cant (p = 0.057) decrease in migration, suggesting that
chemokines other than CCR7 ligand may be responsible for stimulating transendothelial
migration. Interestingly, transendothelial migration was not stimulated by NIH-3T3 cells or
murine transformed vascular endothelial cell lines (MS1 and SVR) using the same Transwell
culture system. Thus, CCL21 is a major factor produced by LEC that stimulates chemotaxis of DC.
Furthermore, LEC, in contrast to vascular endothelial cells, are able to directly stimulate
transmigration of DC in a PTX-sensitive fashion. Therefore, we postulate that while LEC
contribute to both attraction of DC to lymphatic vessels as well as to subsequent transmigration via
chemokine-dependent mechanisms, the chemokine receptors involved are not necessarily
identical.
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Synergy Between TREM-1 and TLR Family Members in the Establishment of Th1
Immune Responses
J. R. Bleharski, A. Bouchon,* Y. W. Ng, A. J. Legaspi, S. Stenger,² M. Colonna,*³ and R. L.
Modlin
Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, California, U.S.A.;
*Department of Immunology, Basel Institute for Immunology, Basel, Switzerland; ²Klinische Mikrobiologie,
Immunologie, und Hygiene, Universitat Erlangen-Nurnberg, Erlangen, Germany; ³Department of Pathology
and Immunology, Washington University School of Medicine, St. Louis, Missouri, U.S.A.
TREM-1 (triggering receptor expressed on myeloid cells) has been implicated in the initiation of
in¯ammatory responses based on its ability to trigger production of Th1 cytokines and chemokines
in monocytes. Here we show that ligands for several TLR (Toll-like receptor) family members,
including TLR2, are able to up-regulate expression of TREM-1 mRNA and protein in cultured
primary human monocytes. Functionally, TREM-1 synergized with several TLR family members
to dramatically augment production of in¯ammatory cytokines, such as TNF-a and GM-CSF,
necessary for the generation of Th1 immune responses while inhibiting TLR-mediated production
of Th2 cytokines. TREM-1 engagement also appeared to in¯uence monocyte cell-surface
phenotype, causing a more rapid down-regulation of monocyte markes such as CD14 while up-
regulating expression of CD1a, CD86, and HLA-DR, expressed at higher levels on immature
dendritic cells. Immunoperoxidase staining of skin lesions from leprosy patients revealed that
TREM-1 positive cells were 5 times more frequent in the relatively more resistant tuberculoid
patients compared to those taken from the relatively susceptible lepromatous patients. Taken
together, our data suggest that TREM-1 is up-regulated in response to TLR ligands during the
innate response, and cooperates with TLR family members in the generation of in¯ammatory
immune responses required for clearance of microbial infections.
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Suppression of PPD Induced Responses by CD4+ CD25+ Regulatory T Cells
M. Vukmanovic-Stejic, L. S. Taams,² J. R. Reed, J. Smith, J. M. Fletcher, P. J. Dunne, M.
Salmon,³ M. H. Rustin,* and A. N. Akbar
Clinical Immunology, Royal Free and University College Medical School, London, U.K.; *Dermatology,
Royal Free and University College Medical School, London, U.K.; ²Rheumatology and Clinical
Immunology, University Medical Center, Utrecht, Netherlands; ³Rheumatology, MRC Centre for Immune
Regulation, University of Birmingham, Birmingham, U.K.
Regulation of T cell responses by anergic/suppressive CD4+ CD25+ T cells has been proposed to
play an important role in the maintenance of peripheral tolerance. The Mantoux Test, which is
induced by the intradermal injection of tuberculin puri®ed protein derivative (PPD), is a classical
example of a resolving cutaneous delayed-type hypersensitivity reaction and has been well
characterized in our department. The role of regulatory T cells in response to PPD is unclear. We
demonstrate that in humans CD4+ CD25+ T cells suppress lymphocyte proliferation to PPD in
vitro (as well as to various other antigens). These regulatory CD4+ CD25+ T cells reside in the
primed/memory CD4+ CD45RO+ population, are CD45RB low and have short telomeres,
indicating the occurence of repeated episodes of stimulation in vivo. This is the ®rst report of the
suppression of speci®c antigen induced responses in humans by CD4+ CD25+ regulatory T cells.
Our results suggest the possibility that these cells may arise as a consequence of repeated stimulation
of antigen-speci®c cells over time in vivo.
617
Intradermal, but Not Intravenous, Application of Bone-Marrow Derived Dendritic Cells
Primes for a Skin Homing CD8+ T Cell Subset
J. C. Simon, J. Dudda, and S. Martin
University of Freiburg, Dermatology, Freiburg, Germany
Skin associated immune responses are driven by a T Cell (TC) subset specialized for skin homing
by expression of chemokine receptors and adhesion molecules like CCR4, CCR10 and E-selectin
ligand. Little is known about the factors which determine the targeting of TC to speci®c tissues.
For example, the site of priming or the speci®c antigen presenting cell (APC) could be crucial.
Based on our observation that, in contrast to intradermal (i.d.) injection, intravenous (i.v.) injection
of in vitro generated bone marrow-derived hapten-modi®ed Dendritic Cells (DC) is inef®cient in
sensitizing mice for hapten-induced contact hypersensitivity we compared the homing properties
of the main effectors, CD8+ TC, depending on the immunization route. We used the adoptive
transfer of TCR transgenic CD8+ P14 TC speci®c for peptide p33 from LCMV glycoprotein to
generate traceable CD8+ effector TC in C57BL/6 recipient mice. After in vivo priming of the
transferred TC with peptide-pulsed DC given i.v. or i.d., skin in¯ammation was induced by
painting the contact sensitizer Tri-Nitro-Phenyl (TNP) on both ears and the TC emigrated in vitro
from earsheets were analysed by FACS. In general we found 2±10 times more CD8+ TC
emigrating from in¯amed ear skin if the DC had been given intradermally compared to
intravenuous application. E-Selectin ligand expression was increased on blood P14 TC only after
intradermal immunization suggesting an important role in the observed homing differences. Other
markers are currently under investigation. We conclude that during TC priming the APC or the
lymphoid tissue microenvironment crucially in¯uences the homing properties of CD8+ TC.
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Propionibacterium Acnes and T Cell Stimulation: A Comparison Between the
Laboratory Strain and Clinical Isolates
R. Boit, E. Ingham,* D. Petzoldt, K. Holland,* and U. Jappe
Dermatology, University Heidelberg, Heidelberg and *Microbiology, University of Leeds, Leeds, U.K.
P acnes is associated with in¯ammatory acne via antigenic and T-cell-mitogenic mechanisms.
Preliminary data suggested that there might be differences between P. acnes strains for T-cell
stimulation. In order to determine whether the stimulative capacities of two clinical isolates, one
from in¯ammatory acne and one from a patient with P. acnes associated endocarditis and the
laboratory strain P37 differ, a lymphocyte transformation assay (LTA) was performed with 11
peripheral blood mononuclear cell (PBMNC) samples from patients with in¯ammatory acne, as
well as with 9 cord blood mononuclear cell (CBMNC) samples. For statistics, the Wilcoxon
matched paires signed rank test was used. 6/11 of the PBMNC samples were reactive with two
peaks of stimulation at day 3 and 7. The endocarditis strain had a signi®cantly higher stimulative
capacity compared to the other clinical isolate or to P. acnes P37. There were no differences for T-
cell stimulation between the clinical isolate from in¯ammatory acne and P. acnes P37. 9/9
CBMNC samples were stimulated by all three bacterial isolates and showed maximal stimulation
between day 5 and 7. In a time course experiment (day 3 to day 7) the stimulation indices (SI) were
signi®cantly higher for the endocarditis strain compared to P. acnes P37. There were no differences
for CBMNC-stimulation between the laboratory strain and the clinical isolate from in¯ammatory
acne. Although mass spectrometry analysis of total cells had revealed only minor differences
between the clinical isolates and the laboratory strain P. acnes P37, our data suggest that there are
statistically signi®cant differences between P. acnes isolates concerning their stimulative capacity
and/or susceptibility in patients with in¯ammatory acne.
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Agonists of Proteinase-Activated Receptor-2 Stimulate Activation of NFkB and Up-
Regulation of ICAM-1 in Human Keratinocytes
J. Buddenkotte, C. Stroh, C. Moormann,* I. H. Engels, K. Schulze-Osthoff, D. Vestweber,² T.
A. Luger,* and M. Steinhoff*
Immunol and cell biology, University of Muenster, Muenster, Germany; *Dermatology, University of
Muenster, Muenster, Germany; ²Center for Molecular Biology of In¯ammation (ZMBE), University of
Muenster, Muenster, Germany
Proteinase-activated receptor-2 (PAR-2) belongs to a new G protein-coupled receptor subfamily
which is activated by various serine proteases. In the skin, it is involved in several biological
processes such as growth, differentiation, melanosome transfer and in¯ammation. PAR-2
expression was detected in large amounts in keratinocytes, for example. However, the underlying
mechanisms of PAR-2-mediated regulation of keratinocyte function are still incomplete.
Therefore we investigated activation of important signaling cascades after PAR2-stimulation
using speci®c agonists and compared PAR-2-immunoreactivity in the epidermis of in¯ammatory
dermatoses. Northern blot analysis revealed PAR2-RNA in primary KTC and endothelial cells.
Moreover, increased RNA levels were detected in lesional skin of patients with atopic dermatitis.
PAR-2 agonists also induced up-regulation of ICAM-1 RNA, as shown by by RT PCR.
Electrophoretic mobility shift assays and morphological transduction studies revealed PAR2-
induced activation and translocation of NFkB in KTC with a maximum after 1 h. Supershift
analysis demonstrated acivation of the p50/p65 heterodimer complex. Use of NFkB inhibitors
prevented up-regulation of the cell adhesion molecule ICAM-1 in KTC indicating a role of NFkB
in PAR-2 mediated up-regulation of ICAM-1. In conclusion, PAR-2 induces NFkB activation
and up-regulation of cell adhesion molecules such as ICAM-1. Thus, NFkB may mediate some of
the effects of PAR-2 on human KTC under physiological and pathophysiological conditions.
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Inhibition of Epidermal Cell Antigen Presentation by Catecholamines
K. Seiffert, J. Hosoi, H. Torii, H. Ozawa, W. Ding, J. A. Wagner,* and R. D. Granstein
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.; *Neurology,
Weill Medical College of Cornell University, New York, New York, U.S.A.
Adrenergic receptors (AR) are present in the skin, and nerve endings can be detected in close
vicinity to epidermal Langerhans cells (LC). We have previously shown that murine LCs express
mRNA for speci®c ARs. Treatment of murine epidermal cells (EC) and puri®ed LCs with
epinephrine (EPI) and norepinephrine (NE) inhibited antigen presentation in vitro. Furthermore,
pretreatment of ECs with EPI or NE in vitro suppressed the ability of these cells to present antigen
for elicitation of delayed-type hypersensitivity in previously immunized mice via the b2-AR.
Intradermal injection of EPI inhibited the induction of contact hypersensitivity to epicutaneously
administered haptens. The mechanisms by which EPI reduces antigen presentation have been
unknown. To determine wether catecholamines affect antigen presenting capability of murine LCs
by reducing expression of MHC class II molecules, we enriched murine EC preparations by anti-
Thy 1.2 antibody- and complement-treatment. The cells were cultured for 16 h with or without
EPI 10
±6
M and subsequently stained with ¯ourochrome-labelled anti I-Ad antibodies for 30 min.
Flow cytometry analysis showed a 27% decrease in I-Ad expression. To determine whether
catecholamines affect MHC class II expression directly or indirectly, LC were seperated from
enriched EC utilizing I-Ad-targeted magnetic beads. This method of puri®cation itself caused a
marked down-regulation of I-A-expression. Nevertheless, treatment with EPI augmented the
down-regulation observed, suggesting a direct effect. No decrease in viability of eEC or puri®ed
LC was seen after treatment with EPI. Additionally, the speci®city of the catecholamines was
investigated by comparing the active and inactive isomers of the adrenergic agonist isoproterenol.
While the active isomer inhibited antigen presentation of EC to a T cell clone in vitro at 10
±7
M, the
inactive isomer had no effect. We conclude that the effects of catecholamines on antigen
presentation are speci®c, not due to decreased viability of APC, and may involve alteration of I-A-
expression.
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The Effects of Bovine Colostrum on Human Skin
K. Yoon, S. Ha, N. Kim,* and K. Kim²
Department of Dermatology, Ajou University, Suwon, South Korea; *Skin Evaluation Center, Ellead,
Seongnam, South Korea; ²Central Research Institute, Boryung Medience, Ansan, South Korea
Bovine colostrum is known to modulate wound healing, in¯ammation, and immunologic
reactions by its components including growth factors, antibodies and immune regulatory elements.
Milk peptide complex (MPC) contains cytokines, lactoalbumin, lactoglobulin, latoferrin, lactose,
and, etc.,-glucans modulate immunologic responses by activating T and B lymphocytes. We have
observed if the components of colostrum, MPC and,-glucans, have effects on the cytokine
production from cultured keratinocytes and human skin. HaCaT cells treated for 48 h with 5oI
È
g/
ml of MPC increased amount of TNF-o´mRNA, while,-glucans did not. None of the tested
material increased mRNA production for IL-1, IL-6, IL-8, or IL-10. Skin biopsy specimens
topically treated with a mixture of MPC and,-glucans for 12 weeks showed increased staining
intensities with anti-TNF-o´, anti-IL-10, and anti-IL-6 antibodies. Staining with anti-IL-1o´, anti-
IL-1o,, or anti-IL-8 antibodies did not show difference between tested and control skin specimens.
Although these results is not enough to demonstrate that some components of bovine colostrum
have immunologic effects on human skin when they are topically applied, bovine colostrum can be
introduced as an available material to affect immunologic events on human skin.
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Pimecrolimus Does Not Affect the Expression of Surface Markers and Functions of
Dendritic Cell, in Contrast to Corticosteroids
F. S. Kalthoff, J. Chung, M. Grassberger, and A. Stuetz
DI, Novartis Research Institute, Vienna, Austria
Pimecrolimus is a cell selective inhibitor of in¯ammatory cytokine synthesis, speci®cally developed
for the treatment of in¯ammatory skin diseases. Corticosteroids (CS) are widely used in the therapy
of in¯ammatory, allergic and autoimmune diseases and potently inhibit the activation of immune
cells. However, due to their pleiotropic mode of action, the prolonged use of CS causes undesired
side-effects. In this study, we evaluated the activity of pimecrolimus and the CS dexamethasone
(Dex) and b-methasone (?MS) on the cytokine-induced differentiation of monocytes to dendritic
cells (DC) in vitro. Dex and ?MS inhibited the granulocyte-macrophage colony-stimulating factor
(GM-CSF) plus interleukin-4 (IL-4) induced differentiation of monocytes into DC as shown by
the impaired expression of several DC speci®c antigens such as CD1a, CD86 and MHC class II.
50% to 80% inhibition was obtained at concentrations between 1 nM and 10 nM for both CS.
Furthermore, the addition of Dex or ?MS during the ®nal maturation of DC impaired the ability of
the DC to activate primary CD4+ T cell proliferation. In contrast, maturation of DC in the
presence of 10 nM to 100 nM pimecrolimus did not affect their T cell stimulatory function. In
addition, surface antigen expression of pimecrolimus-treated mature DC was comparable to
control DC. Taken together, these data suggest that ± in contrast to CS ± pimecrolimus does not
interfere with the function of DC in priming of naive T lymphocytes, which is key for the
maintenance of speci®c immunocompetence.
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Differential Regulation of Thymus- and Activation-Regulated Chemokine Induced by
IL-4, IL-13, TNF-a and IFN-g in Human Keratinocytes and Fibroblasts
Y. Bin, T Koga, K Urabe, Y Moroi, S Maeda,* Y. Yanagihara,* and M Furue
Dermatology, Kyushu University, Fukuoka, Fukuoka, Japan; *Clinical Research Center for Allergy,
National Sagamihara Hospital, Sagamihara, Kanagawa, Japan
The CC chemokine thymus- and activation-regulated chemokine (TARC) acts on CC
chemokine receptor 4, which is known to be selectively expressed in Th2 cells. In order to
compare the regulatory pro®les of TARC production by TNF-a IFN-g IL-4 and IL-13 in
keratinocytes and ®broblasts, HaCaT cells, a human keratinocyte cell line, and NG1RGB cells, a
human skin ®broblast cell line, were used. The expression of TARC protein was measured using
enzyme-linked immunosorbent assay (ELISA), and the mRNA level was detected by reverse
transcriptase polymerase chain reaction (RT-PCR). The spontaneous expression of TARC protein
and mRNA levels were augmented by TNF-a and IFN-g and were inhibited by IL-4 and IL-13 in
the keratinocytes. The ®broblasts expressed the TARC protein and mRNA only in the presence of
IL-4 + TNF-a or IL-13 + TNF-a stimulation. IFN-g further enhanced the IL-4 + TNF-a{ or IL-
13 + TNF-a-induced TARC production in the ®broblasts. Thus, TNF-a and IFN-g -induced
TARC production was differentially regulated by IL-4 and IL-13 in human keratinocytes and
®broblasts.




Independent T Cell Adherence to In¯amed Gingival Epithelium Detected by a
Shear-Dependent Lymphocyte Adherence Assay
O. Leshem,* T. Kawai,² M. Milinkovic,* M. Taubman,² and R. Sackstein*³
*Dermatology, BWH, Boston, Massachusetts, U.S.A.; ²Immunology, The Forsyth Institute, Boston,
Massachusetts, U.S.A.; ³Medicine, BWH, Boston, Massachusetts, U.S.A.
Epithelial lymphocytic in®ltrates are characteristic of oral lesions, including Oral Lichen Planus,
Erythema Multiformae, Graft Versus Host Disease and Periodontal Disease. To analyze the
mechanism mediating lymphocyte in®ltrates in gingival epithelium (GE), we induced gingival
in¯ammation in rats (Rowett, female 2±4 months old, 3±6 animals/group) via injection of LPS
(E. coli or Actinobacillus actinomycetemocomitans) 500 ng/ml (5 mL/region) or PBS (control) for
8±72 h and tested for lymphocyte adhesion to frozen sections of gingival tissue (6±8 mm) in a shear-
based adherence assay (Stamper Woodruff assay). In this assay, rat thoracic duct lymphocytes (TDL)
were overlaid onto gingival tissues under rotational shear (80 r.p.m.) for 30 min at 4o C, after
which unbound cells were washed off and adherent cells were ®xed in glutaraldehyde and
visualized by light microscopy. TDL bound to GE injected with LPS (15.2 cells/mm
2
6 3.9 SD,
n = 6) signi®cantly more than the control PBS injected groups (3.0 cells/mm
2
6 1.8 SD, n = 4)
(Student t, p < 0.05). Binding of TDL was observed prominently in the basal epithelial layer, with
maximum binding at 48 h after LPS challenge. TDL binding to the LPS-treated GE was not
inhibited by EDTA (10 mM), by treatment of TDL with anti-L-selectin antibody (HRL-1,10 mg/
ml), nor by neuraminidase (0.1 U/ml) or hyaluronidase (9 U/ml) treatment of sectioned GE. In
addition, treatment of TDL with phorbol 12-myristate 13-acetate (PMA, 50 ng/ml) did not
increase binding. Taken together, these data indicate that the binding of TDL to epithelium of
LPS-treated gingiva under shear conditions is not mediated by integrins, selectins, CD44 or LEEP-
CAM receptor±ligand interactions, and appears to involve a novel adhesive receptor±ligand
interaction.
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Decreased Murine Graft-vs.-Host Disease Caused by T Cells from Aged Donors is Not
Related to E-Selectin Binding Activity
D. Hurwitz, J. Friedman, A. Boyd, S. King, R. Moreno, B. Rich, and T. Kupper
Harvard Skin Disease Research Center, Brigham & Women's Hospital, DFCI, Boston, Massachusetts,
U.S.A.
GVHD is a major complication of bone marrow transplant (BMT). Age of donors may play a role
in moderating disease. T cells from older mice do not cause severe GVHD. One possible reason
might be impaired tissue homing. In this study we used in vitro analyses to compare E-selectin
binding ability of pre- and post-transplant T cells from young vs. old mice. We used an allo-BMT
model system in which parental T cells are infused into irradiated F1 hosts. Donor lymph node and
spleen T cells came from young (4 month old) or old (23 month old) mice. Cells were harvested
11 days post-transplant. We found that pretransplant E-selectin rolling was signi®cantly greater in T
cells from older mice vs. younger mice. E-selectin ligand activity correlates with expression of
core-2 b1,6-glucosaminyltransferase (C2GNT). Staining with the 1B11 antibody is used as a
marker for C2GNT. Pre-transplant 1B11 staining was also higher in T cells from older mice. Pre-
transplant aged donors also had a much higher proportion of CD44+ memory-phenotype cells
than did young donors, consistent with prior data. Post-transplant E-selectin rolling was increased
in T cells from younger mice to the levels seen in older mice. Rolling was not signi®cantly
changed in T cells from older mice. Post-transplant T cells from both older and younger mice
showed substantial increases in 1B11 staining. We conclude that decreased GVHD caused by T
cells from aged donors is unlikely to be related to E-selectin binding activity. It is possible that
changes in phenotype of young cells indicated skin homing activity of newly activated GVHD-
causing T cells; lack of change in phenotype of old cells showed retention of skin-homing-
associated phenotype for pre-existing memory cells but no signi®cant induction of newly activated
GVHD-causing T cells. Alternatively, T cells from older mice may roll effectively but be unable to
exit vessels ef®ciently, or they may home normally but be incapable of causing GVHD once they
arrive in tissues.
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Enhancement of Acquired as Well as Innate Immunity In Vivo by Overexpression of IL-
15 in Murine Keratinocytes
K. Loser, A. Mehling, B. Eing,* G. Varga, P. Andres,² H. Reinecker,² T. Schwarz, S. Grabbe,
and S. Beissert
Dermatology, University of MuÈnster, MuÈnster, Germany; *Virology, University of MuÈnster, MuÈnster,
Germany; ²GI Unit, Medicine, MGH-Harvard, Boston, Massachusetts, U.S.A.
IL-15 plays an important role in T- and NK cell homeostasis. IL-15 is present in various cell types,
including keratinocytes although it is poorly translated and secreted in these cells. To study the
effects of IL-15 on cutaneous acquired and innate immunity, we generated transgenic (tg) mice
using the K14 promoter which overexpress IL-15 in basal keratinocytes. IL-15tg mice show a
uniform transgene expression in their basal keratinocytes. IL-15tg mice have normal numbers of
Langerhans cells, but reduced numbers of Thy-1+ dendritic epidermal T cells (DETC). However,
wild-type (WT) and IL-15tg mice displayed equal numbers of CD3+ DETC, suggesting that
either Thy-1 expression was lost on DETC or a different subset of intraepithelial T cells may have
developed in tg mice. To investigate acquired immunity in IL-15tg mice contact hypersensitivity
(CHS) was performed. IL-15tg mice have signi®cantly enhanced CHS responses compared to
controls. Since IL-15 has been shown to regulate memory phenotype T cells, immunized/
challenged mice were re-challenged on the ears after six weeks. Interestingly, IL-15tg mice
demonstrated signi®cantly increased and prolonged ear swelling response which was accompanied
by strongly enhanced numbers of activation/memory phenotype (CD44, CD122/IL-2Rb) and
effector (CD43) phenotype CD8 T cells compared to WT mice indicating augmented T cell
activation by IL-15. Since IL-15 is involved in NK cell function, IL-15tg mice were
epicutaneously infected with Herpes simplex Virus type 1 (HSV) to investigate innate
antimicrobial immunity. Notably, IL-15tg mice developed signi®cantly smaller HSV lesions,
which additionally healed much faster compared to WT mice suggesting induction of antiviral
immunity by IL-15. Also, IL-15tg mice showed strongly enhanced numbers of NK- as well as
activated CD4 T cells after infection. These data demonstrate that extracellular IL-15 plays an
important role in (cutaneous) acquired and innate immunity.
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Skin-Targeted Noninvasive Vaccination as a Potent Modality Against the Malignant
Growth of Mammary Tumor Cells In Vivo
Z. Shi,* C. Huang,² G. Yang,* C. Elmets,* and D. C. Tang*²
*Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.; ²Research Program,
Vaxin, Inc, Birmingham, Alabama, U.S.A.
Our aim is to develop an antitumor vaccination modality by topical application of a noninvasive
patch. In these studies, we have immunized mice by topical application as well as intranasal
inoculation of an adenovirus vector (AdCMV-hcea) encoding the human carcinoembryonic
antigen (CEA) prior to implanting a monolayer of JC mammary tumor cells expressing human
CEA into female Balb/c mice. in vivo growth of JC cells was analyzed by in vivo cytotoxicity assay.
Host responses induced by vaccination and/or tumor challenges were determined by RT-PCR
analysis and proteomic pro®ling of the tumor bed. ELISA using puri®ed CEA as the capture
antigen and histological analysis of the tumor bed 5 days postimplantation of JC cells showed that
intranasal inoculation of AdCMV-hcea elicited an anti-CEA antibody response of higher titer than
topical application of the same vector, whereas topical application of AdCMV-hcea was more
effective in eradicating JC cells in vivo; both vaccination modalities could induce the expression of
perforin and granzyme A at the tumor bed as shown by RT-PCR; proteomic pro®ling using two-
dimensional electrophoresis in conjunction with mass spectrometry revealed that the array of host
proteins induced by topical application of AdCMV-hcea in conjunction with tumor challenge was
distinct from their counterparts evoked by intranasal instillation of AdCMV-hcea. We conclude
that topical application of a vaccine patch is not only simple, but also effective and potentially safe
in mobilizing the immune repertoire toward a bene®cial protection against the malignant
proliferation of tumor cells in vivo. Moreover, inoculation of vectored vaccines via different routes
may elicit different immune pro®les capable of determining the degree of potency of an antitumor
vaccine.
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Murine Epidermal Langerhans Cells Express B7-DC, a New B7 Family Member, After
Maturation
B. Wang, H. Watanabe, T. Shin,* B. G. Howell, I. Freed, A. J. Mamelak, D. M. Pardoll,* and D.
N. Sauder
Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.; *Oncology,
Johns Hopkins University SChool of Medicine, Baltimore, Maryland, U.S.A.
Antigen presentation and T-cell activation require at least two signals. Interaction of the MHC-
peptide complex on dendritic cells (DC) with the T cell receptor (TCR) delivers signal 1.
Interaction between the costimulatory molecules B7-1/B7-2 on DC and the coreceptor CD28/
CTLA-4 on T cells delivers signal 2. Epidermal Langerhans cells (LC), a member of the DC family,
represent the major antigen presenting cells in the skin. Resting LC do not express detectable levels
of B7-1 or B7-2. However, after maturation, LC up-regulate the expression of these molecules.
B7-DC is a new member of the B7 family. Unlike B7-1/B7-2, B7-DC does not bind CD28/
CTLA-4, but binds PD
±1
, a receptor for B7-H1 (another new member of the B7 family). It has
been demonstrated that B7-DC is expressed in bone marrow-derived DC and spleen DC. As well,
B7-DC possesses potent costimulatory properties for T cells. In the present study, we examined
whether epidermal LC express B7-DC using two speci®c anti-B7-DC monoclonal antibodies. in
situ immunolabeling of epidermal sheets from BALB/c mice showed that resting LC did not
express detectable levels of B7-DC. However, when epidermal sheets were cultured ex vivo in the
presence of rmTNF-a (10 ng/ml) for 48 h, the remaining LC in epidermal sheets became B7-DC
(+). Moreover, the emigrated LC in the medium showed anti-B7-DC reactivity. Collectively, our
observations demonstrate that epidermal LC up-regulate B7-DC expression after maturation,
suggesting that this new B7 family member may play a role in LC-dependent cutaneous
in¯ammatory and immune responses such as contact hypersensitivity.
629
Inhibition of Caspase Activation in Langerhans Cells Confers Resistance to T Cell-
Mediated Apoptosis
L. Timares, K. Felix,* D. T. Warren,* and X. Wu²
Dermatology, Cell Biology, Pathology, University of Alabama at Birmingham, Birmingham, Alabama,
U.S.A.; *Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.;
²Medicine, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
The regulation of initiator caspase activation may play an important role in regulating Langerhans
cell (LC) longevity or resistance to various apoptotic stimuli. We examined the response of murine
Langerhans cells and a LC line, XS106, to stimuli of apoptosis pathways of either activation
induced cell death (AICD) or passive cell death (PCD). We determined that normal primary LCs as
well as XS106 cells are highly susceptible to AICD by Fas cross-linking with Jo2 mAb or by
antigen±speci®c interaction with T cells. XS106 cells were similarly susceptible to Staurosporine-
induced PCD. Fas expression levels correlated with susceptibility to apoptosis by crosslinking with
Jo2 mAb, resulting in 80% cell death of LC and LPS-treated XS106 in 20- h cultures, as indicated
by Annexin V and 7AAD staining. To monitor the speci®c death of LCs during culture with 3A9
T cells, we generated stable XS106 transfectant clones expressing green ¯uorescent protein (GFP)
using an HIV-based vector system. When the XS106-GFP clones were cultured for 20 h in the
presence of the model antigen hen egg lysozyme (HEL) and HEL-speci®c 3A9 T cells, cell death
occurred in 30%±50% of the XS106 cells. To test the role of caspase activation in regulating LC
death during T cell interactions, caspase-speci®c peptide inhibitors were utilized. XS106-GFP
clones exhibited resistance to antigen-speci®c T cell-mediated apoptosis in the presence of
inhibitor peptides for caspases involved in either AICD or PCD. Speci®cally, inhibitors for caspase-
3, caspase-8 or caspase-9 resulted in 60%-80% inhibition of T cell-mediated LC apoptosis. We are
currently examining what impact apoptosis-resistant LCs have on T cell activation. These results
support the feasibility of generating apoptosis-resistant LCs, which may be useful for enhanced
therapeutic applications.
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Regulation of Skin Mast Cells by Stress and Odorant Inhalation
J. Hosoi, M. Tanida, and T. Tsuchiya
Life Science Research Center, Shiseido Research Center, Yokohama, Kanagawa, Japan
Stress is known to exacerbate skin diseases, especially pruritic ones. We have reported several
effects of odorant inhalation, i.e. prevention of stress-induced impairment of skin functions
including barrier recovery and immune reactions. Interaction of skin and stress/odorant inhalation
was further studied in terms of mast cell activation. Healthy volunteers with cotton pad under their
noses which were absorbed with odorants or diluent alone were subjected to the interview stress.
Balb/c mice were immobilized for the last 1 h of 24- h exposure to the odorants. Substance P or
saline was injected into tail vein. Paraf®n sections of the skin tissue were stained with toluidine
blue. Plasma substance P level was assayed by ELISA after C18 column puri®cation. The plasma
substance P level in human did not change by blood sampling alone but increased (about 50%) after
taking interview. The increase was blocked almost completely by inhalation of odorant materials
containing 2% 1,3-dimethoxy-5-methylbenzene (DMMB). Immobilization of mice increased
plasma substance P level (by 125%) and the increase was prevented by exposure to DMMB (31%)
or methyl-2-pentyl-3-oxocyclopent-1-yl acetate (hedione) (18%), but not by exposure to other
odorants. The administration of substance P into the mouse vein induced time-dependent and
dose-dependent increase in activation of skin mast cells. Furthermore, inhalation of DMMB (23%
increase) or hedione (27%) blocked the induction of mast cell activation by stress (69%). These
results suggest that stress increases substance P level resulting mast cell degranulation which
probably lowers the threshold of in¯ammation. Additionally, certain odorants may block the stress-
induced increase in substance P and mast cell degranulation.
634
Granulysin Level, a Determining Factor to Prevent Secondary Infection in
In¯ammatory Diseases
S. P. Raychaudhuri, W. Jiang, A. M. Krensky, E. M. Farber, and S. Kundu Raychaudhuri
Dermatology, Psoriasis Research Institute, Palo Alto, California, U.S.A.
In¯ammatory diseases, e.g.rheumatoid arthritis, atopic dermatitis and asthma are frequently
associated with septic arthritis, pyoderma and pneumonia. In contrast, secondary infection is
uncommon in psoriasis and pemphigus despite open wounds and cracks. It is likely that in vivo
factors, including antimicrobial peptides, are responsible for this relative susceptibility or resistance
to infection. Granulysin is a novel antimicrobial protein produced by activated T cells and NK
cells. We determined granulysin levels in speci®c cutaneous in¯ammatory diseases and correlated
expression with the relative risks of secondary infections in these conditions. A monoclonal
antigranulysin antibody was used at 1 : 150 dilutions. Immunoperoxidase studies were performed
on cryosections of skin biopsies obtained from psoriasis, lichen planus, nummular eczema, and
atopic dermatitis patients as well as healthy individuals. Strong expression of granulysin was
observed in lymphomononuclear in®ltrates in psoriasis. We also con®rmed that the granulysin
positive cells colocalized with HLA-DR+ positive T cells in the papillary dermis of the psoriatic
plaques. Relative distributions of granulysin positive T cells in per sq.mm in the dermis were:
psoriasis (70 6 25), lichen planus (30 6 10), nummular eczema (12 6 4), atopic dermatitis (8 6 4),
normal skin (10 6 6). Granulysin has broad antimicrobial activities, which includes Gram positive
and Gram negative bacteria, fungi and parasites. It is important to note that increased numbers of
granulysin positive T cells (p < 0.01) were observed in psoriasis, where secondary bacterial
infection is extremely rare. Very few granulysin positive T cells were observed in atopic dermatitis
and nummular eczema, two conditions frequently associated with Gram positive bacterial
infections. These observations suggest that lesional granulysin levels may modulate the relative risks
of secondary infection in certain in¯ammatory conditions.
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Staphylococcus Aureus Induces Interleukin-8 Expression in Primary Human
Keratinocytes
M. Guo, N. Meduri,* D. Yao, and G. Murakawa
Dermatology, Wayne State University, Detroit, Michigan, U.S.A.; *Pathology, Albany Medical College,
Albany, New York, U.S.A.
The skin protects the host from infection by pathogens, yet little is known regarding the role of
skin cells in the immune response to invading bacteria. Toward this regard, we studied the role of
human keratinocytes in the host immune response to infection with S. aureus, the most common
cause of cutaneous infections. Particularly, we focused on determining the involvement of
proin¯ammatory cytokines in S. aureus infections. Skin infections caused by S. aureus are clinically
recognized through in¯ammation of the skin, suggesting a pro-in¯ammatory immune-mediated
response. However, not all bacterial infections trigger identical host immune responses.
Speci®cally, the response of IL-8, a pro-in¯ammatory cytokine, was studied. Both mRNA
synthesis and protein expression were studied using RT-PCR and ELISA. Initial studies revealed
that S. aureus adheres quickly and ef®ciently (~40%) to primary human keratinocytes, and followed
by minimal invasion (~4% in 4 h). Moreover, S. aureus is capable of replicating after entering
keratinocytes. RT-PCR revealed that IL-8 mRNA expression was induced 3±5 fold at 6 h and
24 h post bacterial infection compared to uninfected controls. Similarly, IL-8 protein levels were
increased 3-fold 24 h after S. aureus infection. In conclusion, our studies showed that S. aureus
ef®ciently and rapidly adheres to, invades into, and grows in keratinocytes, and induces both the
gene and protein expression of IL-8 in keratinocytes. Since IL-8 is an early expressed pro-
in¯ammatory cytokines in the course of S. aureus infections, its induction/up-regulation may lead
to the activation of a cascade of host regulatory events in response to S. aureus infection. Thus, we





SCID Mouse Model of Psoriasis: A Unique Tool to Develop Novel Anti-In¯ammatory
Drugs
A. D. Chatterjee, S. P. Raychaudhuri, S. K. Raychaudhuri, and E. M. Farber
Dermatology, Psoriasis Research Institute, Palo Alto, California, U.S.A.
The in¯ammatory reaction in psoriasis is uniquely characterized by up-regulations of adhesion
molecules, angiogenesis, in®ltrates of activated T cells and increased levels of chemokines along
with their receptors. As medicine can be delivered directly at the disease sites and a visible
therapeutic response can be determined, psoriasis is often selected for evaluating newly discovered
anti-in¯ammatory drugs. Recent development of the SCID mouse xenograft model for psoriasis
has provided a valuable tool to study this common disease. Our extensive experiments on several
hundreds of transplanted psoriasis plaques on SCID mice has generated signi®cant insights. With
the use of cyanoacrylate tissue glue we have noticed much higher rate of graft acceptance (70%-
80%) compared to conventionally suturing the grafts (40%-50%). In the transplanted plaques all key
histopathological features can be maintained as long as 6 months. Following molecules are
identi®ed and found to be maintained for the life time of the transplanted plaques:
ICAM,CXCR3, Fractalkine, IL-8,CD3, CD4, CD8, HLA-DR,CD40,OX-
40R,CD80,CD86,K16, Ki67, substance p, NGF, NGF-R. This indicates that proliferative and
in¯ammatory cascades of psoriasis remain intact in the transplanted plaques. The SCID mouse
model is of immense help to target these molecules and develop novel drugs for psoriasis and other
in¯ammatory diseases. Grafts respond well to the therapeutic agents such as topical steroids and
cyclosporin. We have also noticed that manipulation of the CD28-B7 costimulatory system by
novel agents induces signi®cant histological improvement. Compared to transplants of normal skin
we observed marked proliferation of nerves in the transplanted psoriasis plaques. These nerves are
strongly positive for NGF-R. This substantiates the in vivo effect of NGF from psoriatic
keratinocytes. Thus this model also provides to study neurogenic in¯ammation and develop drugs
targeting neuropeptides and NGF/NGF-R system.
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In Vitro Study of UVB-Induced Nitric Oxide Production in Human Telomerase
Immortalized Keratinocyte Cell Line (hTERT)
V. Goldburt, Y. E, S. Bradu, W. S. Lee, and A. R. Shalita
Dermatology, SUNY-Downstate Medical Center, Brooklyn, New York, U.S.A.
Nitric oxide (NO) modulates complex physiologic and pathophysiologic processes involving
vasodilation, erythema formation, cell±cell interactions, immune/in¯ammatory responses. The
objective of this study is to examine in vitro expression of inducible NO synthase (iNOS) and NO
activity in human keratinocytes (primary vs. telomerase immortalized cells, hTERT) in the
presence and absence of UVB and cytokines. Keratinocyte cultures were exposed to UVB (310 nm
at 10±150 mj/cm
2
) and cytokines such as IL-1, TNF-a, and g INF for 6, 32, 48 and 72 h. The
expression of iNOS was assessed by FACS analyses, while the NO production was measured by the
modi®ed Griess assay and/or Siever NO analyzer. Our data showed that UVB treatment of the
primary or hTERT cells increased iNOS activity in time- and dose-related manner when
compared to that in sham control. The cytokine failed to signi®cantly affect iNOS/NO activity in
keratinocytes. These data re¯ect NO production pathways in tissue cultures are not responsive to
cytokine, which may relate to an altered state of differentiation of the cells. Human telomerase
reverse transcriptase (hTERT) which extends the life span of human keratinocytes provides an
inexpensive, stable and reliable system that is ideal for the study of NO modulators. In conclusion,
our results provide the ®rst reported evidence supporting the involvement of iNOS up-regulation
during UVB induced in¯ammatory responses in human skin. This work will facilitate the
development and testing of agents of interest which may speci®cally modulate NO related events
in skin.
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De®ciency of Antibiotic Peptides in Atopic Dermatitis Explains Susceptibility to
Infection
T. Ohtake, P. Ong,* C. Brandt, I. Strickland,* D. Leung,* and R. L. Gallo
Medicine/Dermatology, UCSD/VA Medical Center, San Diego, California, U.S.A.; *Immunology,
National Jewish Medical Center, Denver, Colorado, U.S.A.
The innate immune system of human skin contains antimicrobial peptides known as cathelicidins
and b-defensins (LL37 and HBD2, respectively). These peptides are not expressed in signi®cant
amounts in normal skin but are after injury or in in¯ammatory skin disease such as psoriasis (PS). In
this study we compared expression of LL37 and HBD2 in the affected skin of patients with atopic
dermatitis (AD) and PS to determine if the increased susceptibility to infection in AD is due to a
relative de®ciency in antimicrobial peptide production. By immunohistochemistry, we con®rmed
that there is abundant LL-37 and HBD2 in the super®cial epidermis (granular layer and stratum
corneum) of all patients studied with PS. In contrast, there was much less expression of
antimicrobials in AD, with most in the basal cell layer. To further quantify expression, skin biopsies
were acid-extracted from patients with PS or AD (n = 12) and measured by immuno-dot blot with
antibody speci®c to LL-37. All PS had abundant LL-37 (ave. = 0.7 mM, range 0.2±1.6 mM) while
only a single biopsy from a chronic lesion of AD had detectable amounts. Finally, to evaluate the
signi®cance of a relative de®ciency of LL37 and HBD2, the antimicrobial activity of both were
tested against Staph. aureus by radial diffusion assay. There was synergistic activity between LL37
and HBD2, each becoming effective at 4 mM against the most sensitive strain of S. aureus. These
data suggest that a de®ciency in antimicrobial peptide expression could account for the ability of
bacteria to easily colonize and infect skin from patients with AD.
640
Genetically Engineered Antimicrobial Peptides as a Novel Therapeutic Approach
Against Emerging Resistant Infectious Microbes
M. Zaiou and R. L. Gallo
Medicine/Dermatology, UCSD/VA Medical Center, San Diego, California, U.S.A.
Cathelicidins (caths) are mammalian cationic antimicrobial peptides (AMP) characterized by a
putative N-terminal signal peptide, a highly conserved prosequence, and a structurally variable
mature C-terminal peptide. Caths have potent antimicrobial activity against a broad-range of
microorganisms. Whereas the c-terminal region possesses microbicidal activity, the function of the
prosequence (cathelin) is unknown. Production of large amounts of cath is necessary to study
cathelin and to provide material for therapeutic trial. Attempts to engineer AMP for recombinant
expression have encountered dif®culties such as low yield and toxicity. To overcome this, we
developed a novel bacterial expression system to produce human cath in e.coli. Human full-length
cath (prosequence = cathelin, peptide = LL-37) or cathelin alone were cloned in pET-28 designed
with a signal for insolubility and with an N-terminus histidine tag to facilitate further puri®cation.
Cathelin or full length recombinant proteins were puri®ed and released by designed enterokinase
cleavage. Western blot using antibodies speci®c to the cathelin region or LL-37 con®rmed identity.
Mass spectrometry on MALDI TOF further established mass (11 165 Da) and purity. The
effectiveness of this approach was seen by the ®nal high yield of pure recombinant proteins (10±
20 mg/L). Therefore, we have established a successful strategy to produce caths. This approach may
enable the production of a variety of cationic antimicrobial peptides, provides recombinant
antimicrobial proteins for development of effective therapeutic agents, and enables study of the
function of the cathelin domain.
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Direct Injection of Plasmid DNA into the Human Skin Induces Dermatitis Mediated by
Monocyte Activation
D. Sawamura, R. Abe, K. Yokota, H. Hemmi,* S. Akira,* and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; *Host Defence, Research
Institute for microbial Diseases, Osaka University, Osaka, Japan
Injection of naked DNA can transfer genes ef®ciently into keratinocytes and myocytes.
Intramuscular injection of the plasmid DNA expressing the cytokine genes to patients with
critical limb ischemia provides favorable results in the area of angiogenesis. Toward clinical use of
this method for keratinocyte gene therapy, this study examined whether injection of plasmid DNA
induced any adverse effects on the human skin. First, we injected plasmid into the skins of several
normal individuals and found in¯ammatory reaction in the treated sites. Immunohistochemical
analysis showed that in®ltrating cells were predominantly monocytes and neutrophils. in vitro
experiments demonstrated that plasmid DNA directly activated only monocyte motility, not
transendothelial neutrophils migration. These indicated that plasmid-induced dermatitis was
initiated by monocytes. Furthermore, plasmid increased IL-6 and NO production by monocytes,
suggesting activation of NF-kB via NO production in the cells. Since it was recently shown that
cellular response to CpG motif in bacterial DNA was mediated by toll-like receptor (TLR) 9, we
injected plasmid into the skin of TLR9- knockout mice. A decrease of the in¯ammatory cell
in®ltration in the TLR9 knockout mice suggested that plasmid DNA-induced dermatitis was also
mediated by TLR9. This study demonstrates that injection of plasmid DNA induces in¯ammation
in human skin and suggests that this was initiated by monocyte activation through TRL9 and NO
production. We should ®nd the way to prevent it before clinical use of the naked DNA method for
the skin.
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IL-4 Induces m-CSF by Conjunctival Fibroblasts: Possible Role in the Recruitment of
Macrophages in Cicatricial Pemphigoid
M. S. Razzaque, C. Foster,* and A. Ahmed
Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts, U.S.A.; *Immunology and
Uveitis Service, Massachusetts Eye and Ear In®rmary, Harvard Medical School, Boston, Massachusetts,
U.S.A.
Macrophage accumulation in the conjunctiva is an important histologic feature in ocular cicatricial
pemphigoid (OCP). We examined the role of macrophage colony-stimulating factor (m-CSF) in
the pathogenesis of OCP. Biopsies obtained from the conjunctiva of 10 untreated patients with
OCP and 5normal subjects were examined for the expression of m-CSF, and CD-68. The
expression level of m-CSF was determined in the ®broblasts isolated from conjunctiva of normal
individuals and OCP patients. ELISA and real time PCR were used to study the role of IL-4 on the
induction of m-CSF by conjunctival ®broblasts. Compared to the weak expression of m-CSF in
the normal conjunctiva, a signi®cant increase (p < 0.0001) in the expression of m-CSF was noted
in biopsies obtained from conjunctiva of OCP patients. Increased expression m-CSF signi®cantly
correlated (p < 0.0004) with an increased stromal accumulation of macrophages in conjunctival
biopsies of OCP patients. Compared with normal conjunctival ®broblasts, an increased (1.7-fold)
expression of m-CSF was detected in ®broblasts isolated from conjunctiva of OCP patients. When
normal conjunctival ®broblasts were treated with IL-4 (0.1, 1, 10, and 100 ng/ml for 24 h), an
increased level of m-CSF was detected both in mRNA (as high as 3.2 fold) and protein level. In
summary, a correlation between m-CSF expression and macrophage accumulation was seen in
conjunctival sections of patients with OCP. Increased expression of m-CSF, by conjunctival
®broblasts, may play an important role in the regulation of local accumulation of macrophages in
the conjunctiva of OCP patients. IL-4 may play an important role to enhance the local
in¯ammatory responses and tissue injuries in the conjunctiva of OCP patients by inducing the
expression of m-CSF.
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A Genetic Study of Group A Streptococcal Susceptibility to Cath Antimicrobial
Peptides
X. Lauth,* T. Ohtake,* M. Zaiou,* V. Nizet,² and R. L. Gallo*²
*Medicine/Dermatology, UCSD, San Diego, California, U.S.A.; ²Pediatrics, UCSD, San Diego,
California, U.S.A.
Group A Strep. (GAS) are an important cause of skin infections. Infection with GAS strongly
induces local production of cathelicidin antimicrobial peptides (caths) from keratinocytes and
in®ltrating neutrophils. To assess the role caths play in innate defense against GAS, we generated a
GAS transposon mutant library and identi®ed a mutant that was resistant to caths in vitro. When
compared to the wild-type parent GAS, the cath-resistant mutant was found to (a) produce larger
and more persistent necrotic skin lesions in mice and (b) demonstrated increased survival in a
whole blood killing assay. These data reinforce our observations that cath-knockout mice are more
susceptible to GAS (Nature 2001 414 : 454±456) and help prove the crucial role of caths in innate
skin immunity. The mutation in the cath-resistant GAS was mapped to a putative transcriptional
regulator (crgR) and con®rmed by targeted mutagenesis. Phenotypic changes in the crgR mutant
include a slower growth rate, increased bouyancy, and decreased af®nity for the hydrophobic n-
hexadecane. These changes suggested a change in the structure and/or surface charge
characteristics of the cath-resistant mutant. However, testing of allelic exchange mutants such as
the hasA gene (unencapsulated phenotype) and csrR gene (mucoid phenotype) did not identify an
association of the GAS hyaluronic acid capsule with cath-resistance. Companion studies indicate
that cath-mediated bacterial killing requires protein synthesis or division, as it was inhibited by
growth at 4o C or cotreatment with bacteriostatic antibiotics. Further analysis of cath-resistant
mutants are being carried out by comparison of global gene expression pro®les and, at the
phenotypic level, by EM, measurement of cell-wall permeability, and patterns of cationic/anionic
protein binding. Understanding the mechanism of GAS killing by caths will reveal the microbial
target(s) selected by natural antibiotics.
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Evaluation of the Ef®cacy of Antihistamines Using Human Monocyte-Derived
Dendritic Cells Stimulated with Histamine
S. Aiba, T. Ohtani, and H. Tagami
Department of Dermatology, Tohoku University School of Medicine, Sendai
H1-type antihistamines are the mainstays in the management of urticaria. However, it is quite
often that one therapeutic group of H1-type antihistamine proves ineffective, while an agent from
another groups is effective. So far, there is no scienti®c way to predict the ef®cacy of each
antihistamine on urticaria of different patients. The major reason is that there is no in vitro assay to
evaluate the ef®cacy of antihistamines using the responding cells from each patient. Recently, it has
been demonstrated that histamine induces CD86 expression and chemokine production by human
immature dendritic cells via H1 and H2 receptor. In this study, we examined the suppressive effects
of 5 different H1-type antihistamines, e.g. cetirizine, diphenhiramine, ketotifen, orpatadine, and
emedastine, on the induction of CD86 and IL-8 production by human monocyte-derived
dendritic cells (MoDCs) stimulated with histamine. When we examined MoDCs from 20 healthy
controls, these 5 antihistamines signi®cantly suppressed these two responses in therapeutic
concentrations. Unexpectedly, however, the suppressive effects of these antihistamines are highly
variable among MoDCs from different subjects, indicating that the ef®cacy of antihistamines on
different subjects is unpredictable even in the evaluation using MoDCs. Interestingly, in 6 cases of
chronic urticaria, the ef®cacy of these 5 antihistamines on the suppression of CD86 induction by
histamine-treated MoDCs correlated with the clinical ef®cacy evaluated by patients' and
physician's assessment. This study suggests that the evaluation of antihistamines using MoDCs
stimulated with histamine can be a useful method for the screening of antihistamines, for the
comparison of the ef®cacy of antihistamines, and for predicting the ef®cacy of antihistamines on
each individual.
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ti, B. Merkl,* M. Paulsson,* and N. Smyth*
Department of Dermato-Venerology, Semmelweis University, Budapest, Hungary; *Institute for Biochemistry
II, University of Cologne, KoÈln, Germany
While tissue transglutaminase has been implicated as the major autoantigen of gluten sensitive
disease, there has been no explanation as to why this condition appears in two distinct forms, celiac
disease and dermatitis herpetiformis. We performed ELISA and immunohistochemical studies to
®nd the difference between the two conditions. Here we show that while sera from patients with
either form of gluten sensitive disease react both with tissue transglutaminase and the related
enzyme epidermal (type 3) transglutaminase, antibodies in patients having dermatitis herpetiformis
show a markedly higher avidity for epidermal transglutaminase. Further, these patients have an
antibody population speci®c for this enzyme. We also show that the IgA precipitates in the
papillary dermis of patients with dermatitis herpetiformis, the de®ning signs of the disease, contain
epidermal transglutaminase, but not tissue transglutaminase or keratinocyte transglutaminase. These
®ndings demonstrate that epidermal transglutaminase, rather than tissue transglutaminase, is the
dominant autoantigen in dermatitis herpetiformis and explain why skin symptoms appear in a
proportion of patients having gluten sensitive disease.
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Brain-Derived Neurotrophic Factor Signaling Through p75 kDa Neurotrophin
Receptor Stimulates CD8 Cell Apoptosis in Autoimmune Alopecia
T. N. Palkina,*² A. A. Sharov,* M. Yaar,* P. Freyschmidt-Paul,³ W. Syska,*§ A. Y.
Baryshnikov,² R. Hoffmann,³ M. Maurer,§ J. P. Sundberg,¶ B. A. Gilchrest,* and V. A.
Botchkarev*
*Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; ²Institute of
Experimental Diagnostics and Therapy of Cancer, Cancer Research Center, Moscow, Russian Federation;
³Dermatology, Philipp University, Marburg, Germany; §Dermatology, Johannes Gutenberg University,
Mainz, Germany; ¶Research Facility, Jackson Laboratory, Bar-Harbor, Maine, U.S.A.
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family that ful®lls a
variety of non-neurotrophic functions in postnatal skin. It was shown previously that BDNF
promotes murine hair follicle (HF) regression (catagen) and keratinocyte apoptosis via stimulation
of the p75 kDa neurotrophin receptor (p75NTR). Here, we investigated a possible role of BDNF
in autoimmune hair loss (alopecia areata, AA). In the C3H/HeJ mouse model for AA, we showed
by ELISA that BDNF protein is up-regulated (p < 0.05) in affected skin, compared to unaffected
control. BDNF immunoreactivity was found in MOMA-2 positive macrophages of perifollicular
in¯ammatory in®ltrates, while p75NTR expression was seen on CD8 lymphocytes. By FACS
analysis, 45±75% of CD8 cells isolated from the affected skin expressed p75NTR, while no
p75NTR was seen on CD4 cells and macrophages. BDNF administration into AA-affected skin
was associated with reduction (p < 0.01) in number of CD8 cells, which coexpressed p75NTR and
TUNEL. Conversely, treatment of AA-affected mice with cyclic peptide that blocks signaling
through p75NTR prominently increased a number of CD8 cells in skin. These data suggest a
previously unrecognized role for BDNF in stimulating CD8 cell apoptosis in skin affected by AA.
Stimulation of neurotrophin signaling through p75NTR may prove effective treatment of
autoimmune hair loss.
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Identi®cation of a Functional Vanilloid Receptor (VR1) in Human Keratinocytes
G. D. Nicol,* T. Li,² L. S. Gharibova,* Y. Pei,² J. B. Travers,*² and M. D. Southall²
*Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.; ²Dermatology,
Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.
During dermal injury and the associated trauma a number of compounds are released which can
mediate the in¯ammatory response. Determining the cellular mechanisms which initiate the
in¯ammatory responses to acute keratinocyte damage is important for understanding the regulation
of epidermal in¯ammation. The recently cloned vanilloid receptor (VR1) is a polymodal receptor,
responding to thermal, pH, or vanilloids such as capsaicin stimulation. Although VR1 has been
localized only on sensory neurons and within the central nervous system, recent evidence suggests
VR1 is expressed in human skin. Using RT-PCR and immunoblotting we report that human
keratinocytes and the human keratinocye cell line (HaCaT) express VR1. Consistent with
neuronal VR1, activation of epidermal VR1 by capsaicin induced a calcium in¯ux. Treating
HaCaT cells with capsaicin resulted in a dose-dependent expression of COX-2 whereas
pretreatment with the VR1 receptor antagonist, capsazepine, abolished the capsaicin stimulated
increase in COX-2 expression. Futhermore, the capsaicin-induced expression of COX-2 was
dependent on extracellular calcium. Activation of the epidermal VR1 also resulted in an increased
release of IL-8 and PGE2, and the stimulated release was attenuated by capsazepine. The ®nding
that VR1 is expressed not only by sensory neurons is of great importance since it expands the
putative role of VR1 beyond that of pain perception. VR1 expression in keratinocytes may be
involved in the induction and regulation of in¯ammatory responses that occur secondary to
epidermal damage or insult.
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Contact Hypersensitivity is Mediated by Early Recruitment of Cytotoxic CD8+ T Cells
Inducing Keratinocyte Apoptosis
H. Akiba,*² J. Kehren,² M. Ducluzeau,² M. Krasteva,² F. Horand,² D. Kaiserlian,³ K.
Nakamura,* F. Kaneko,* and J. Nicolas²
*Department of dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan;
²INSERM U.503, UCBL-ENS de LYON, Lyon, France; and ³INSERM U.404, IFR 74-CERVI,
Lyon, France
Contact hypersensitivity (CHS) is a T cell-mediated, antigen-speci®c skin in¯ammation induced
by skin exposure to haptens in sensitized individuals. Th1/Tc1 cells are effector cells of CHS
whereas Th2/Treg CD4+ T cells have down-regulating properties. We have previously shown
that CHS to DNFB is mediated by speci®c CD8+ effector cells, whose cytolytic activity is
mandatory for induction of skin in¯ammation. The purpose of this study is to analyze the kinetics
of recruitment of effector CD8+, regulatory CD4+ T cells, and that of skin changes during CHS
response, using immunohistochemistry and RT-PCR analysis. We show that CD8+ T cells are
rapidly recruited into the skin at the site of hapten challenge, before the onset of clinical and
histological signs of skin in¯ammation. This early CD8+ T cell recruitment is concomitant with:
(i) transient IFN-g mRNA expression; (ii) induction of keratinocyte apoptosis which gradually
increased to a maximum at the peak of the CHS response. In contrast, skin in®ltration of CD4+ T
cells occurred later and coincided with the peak of the CHS reaction and the beginning of the
resolution of skin in¯ammation. Mice de®cient in CD8+ T cells did not develop CHS, whereas
mice de®cient in CD4+ T cells developed an enhanced in¯ammatory response with increased
numbers of CD8+ T cells recruited in the skin associated with massive keratinocyte apoptosis.
These data show that CHS is due to the early and selective recruitment in the skin of CD8+ Tc1
effector cells responsible for keratinocyte apoptosis.
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A Novel Mouse Model of Occupational Asthma: The Role of Skin Exposure in
Diisocyanate Sensitization
C. A. Herrick, L. Xu,* A. Wisnewski,² C. Redlich,² and K. Bottomly*
Dermatology, Yale School of Medicine, New Haven, Connecticut, U.S.A.; *Immunobiology, Yale School of
Medicine, New Haven, Connecticut, U.S.A.; ²Internal Medicine, Yale School of Medicine, New Haven,
Connecticut, U.S.A.
Exposure to diisocyanates, a group of highly reactive, low molecular weight compounds used in
the manufacture of polyurethanes, is a major cause of occupational asthma. While inhalation is the
presumed mode of sensitization, the possibility has recently been raised that workers may become
sensitized from skin exposure. To date, mouse models of diisocyanate asthma have failed to show
lung in¯ammation similar to that seen in humans. We exposed BALB/c mice epicutaneously to
hexamethylene diisocyanate (HDI) in acetone/olive oil (A/OO), or to A/OO alone, on days 0 and
7. Mice exposed to either 0.1 or 1.0% HDI had signi®cant ear swelling responses following
challenge on day 12, although these responses were greater in mice exposed to 0.1% HDI
(p = 0.001). In contrast, HDI-speci®c antibodies were only detected in mice sensitized with 1.0%
HDI, including both IgG1 and IgG2a. Total serum IgE was signi®cantly elevated in mice sensitized
with either HDI dose. Inhalational challenge of 0.1% HDI-sensitized mice with an HDI-protein
conjugate via intranasal droplet resulted in: (1) higher numbers of cells in bronchoalveolar lavage
(BAL) ¯uid compared to A/OO exposed mice (p = 0.004), including both lymphocytes
(p = 0.002) and eosinophils (p = 0.02); (2) mucus hypersecretion as demonstrated by
PAS + staining of lung tissue; and (3) production of Th1 (IFN-g) and Th2 (IL-4, ±5, ±13) type
cytokines by lung in¯ammatory cells. In contrast, mice sensitized with 1.0% HDI had no increases
in BAL cell numbers or lung in¯ammation. Thus, although HDI-speci®c antibodies were only
detected in mice sensitized with the higher dose of HDI (1.0%), the lower HDI dose (0.1%) was
optimal for induction of both contact hypersensitivity and lung in¯ammatory responses.
Interestingly, antibody levels in diisocyanate exposed workers do not correlate with development
of airway disease. The data support the notion that skin exposure to diisocyanates may contribute
to sensitization of workers.
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Latency Associated Peptid as an Inhibitor of Skin Fibrosis in Sclerodermatous Graft-vs.-
Host Disease (Scl GVHD), a Model for Human Scleroderma
Y. Zhang, L. L. McCormick, S. R. Desai, and A. C. Gilliam
Dermatology, Case Western Reserve University, Cleveland, Ohio, U.S.A.
Murine Scl GVHD models human scleroderma with up-regulation of cutaneous TGF-b1 and type
I collagen mRNAs, mononuclear cell in®ltration, and skin and lung ®brosis, occurring by day 21
post bone marrow transplantation (BMT). Scl GVHD is produced by transplanting lethally
irradiated BALB/c mice with B10.D2 bone marrow and spleen cells. Syngeneic transplanted
BALB/c mice served as controls. Elevated TGF-b1 is critical in Scl GVHD, which can be
prevented with antibodies to TGF-b given early in disease. We tested the ability of LAP, a
naturally occurring antagonist of TGF-b1 to inhibit Scl GVHD. Two mg of human recombinant
LAP were administered to mice by intravenous injection on days 1 and 6post-BMT. By day 21
post-BMT, skin thickness of LAP-treated Scl GVHD animals is comparable to that of syngeneic
controls, while the skin of untreated animals with Scl GVHD is more than 40% thicker by image
analysis. LAP treatment also prevents the up-regulation of cutaneous TGF-b1 mRNA and type I
collagen synthesis in Scl GVHD by RT/PCR analysis and immunostaining. In contrast to anti-
TGF-b Ab treatment, which reduces cutaneous immune cell in¯ux and prevents up-regulation of
activation markers on those cells, LAP at 4 mg total/mouse has no signi®cant suppressive effect on
immune cell in¯ux (mainly T cells and monocytes) to skin or activation as demonstrated by FACS
and immunostaining analysis. To assay activation, we measured expression of I-A, a MHC class II
alloantigen that is up-regulated during antigen presentation. In Scl GVHD animals by day 21 post-
BMT, I-A expression on cutaneous in®ltrating CD45+, CD11b+ and CD3+ cells is markedly up-
regulated. I-A expression on these cells in Scl GVHD mice receiving LAP treatment remains as
high as that in untreated Scl GVHD mice. Thus, LAP may target TGF-b more speci®cally,
without affecting other critical functions of TGF-b, and may be a new potential therapy for
scleroderma and other TGF-b-driven ®brosing diseases.
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Direct Contact of S. aureus with Keratinocytes Triggers the Production of b-Defensins
and CAP18 ± An Innate Defense Against Bacterial Infection of the Skin
K. Midorikawa, H. Komatsuzawa,* K. Sayama, K. Yamasaki, M. Sugai,* and K. Hashimoto
Dermatology, Ehime University School of Medicine, Shigenobucho, Ehime, Japan; *Microbiology, Hiroshima
University Faculty of Dentistry, Hiroshima-Shi, Hiroshima, Japan
The human antimicrobial peptides b-defensin-1 (hBD1), hBD2, hBD3, and CAP18 are implicated
in innate defense against bacterial infection of the skin. However, the mechanism of their
production by keratinocytes is not fully understood. We hypothesized that keratinocytes produce
hBDs and CAP18 as a result of direct contact with bacteria. Heat-inactivated S. aureus was added
to the medium of normal human keratinocyte cultures. Expression of defensins and CAP18
mRNA was analyzed using quantitative real-time PCR. Contact with S. aureus induced signi®cant
expression of hBD2 mRNA, while hBD3 and CAP18 were induced slightly. On the contrary,
hBD1 was constitutively expressed and was not elevated by contact with S. aureus. Next, the
effects of hBDs and CAP18 on S. aureus were examined in turn. S. aureus was treated with various
concentrations of hBDs and CAP18 for 2 h, and then plated on trypticase soy agar plates. After
24 h, the number of colonies was counted. The antimicrobial activity of hBD3 and CAP18 against
S. aureus was stronger than that of hBD1 and hBD2. Of 44 S aureus clinical isolates, including 22
MRSA strains, the numbers of strains with more than 20% survival in the presence of hBD3 (1 mg/
ml) and CAP18 (0.5 mg/ml) were 12 and 13 for MRSA (55 and 59%), and 3and 6for methicillin-
sensitive S. aureus (MSSA) (13 and 27%) strains, respectively. All hBDs and CAP18 had
antibacterial activity against S. aureus, but some S. aureus strains, especially MRSA strains, had low
susceptibility, suggesting that MRSA are more likely to cause skin infection due to their resistance
to antimicrobial peptides. In conclusion, on direct contact with S. aureus, epidermal keratinocytes
produce hBD2, hBD3, and CAP18, to prevent infection.
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Over-Expression of Interferon-Inducible Protein IFI 16 in the Immunopathogenesis of
Psoriasis
B. J. Nickoloff, J. Curry, V. Chaturvedi, J. Panella, P. Bacon, D. Choubey, and J. Qin
Pathology, Loyola, Chicago, Illinois, U.S.A.
Psoriasis, as a chronic in¯ammatory disease like Crohn's disease (CD) involves the interplay of both
environmental and genetic factors. Recently, the Nod2 gene (16q) was implicated in an altered
innate immune response to bacteria thereby contributing to development of CD. While our initial
search for mutations in Nod2 in psoriasis was unremarkable, 3 independent lines of inquiry
suggested a role for IFI 16 in psoriasis. First, IFI 16 belongs to a family of proteins that impact
in¯ammation and interferon responses similar to Nod2. Second, we recently identi®ed murine
I®202 as a susceptibility locus for another autoimmune disease- systemic lupus erythematosus
(SLE). Third, IFI 16 ± human homologue of mouse p202 is located on 1q22, a psoriasis
susceptibility locus. Immunostaining to detect IFI 16 revealed not only diffuse nuclear staining of
KCs in psoriatic plaques, but in®ltrating dendritic cells (DCs) and T cells also contained enhanced
nuclear staining. Examination of several other in¯amed tissues including kidney, prostate and GI
tract (CD), revealed only rare scattered DCs or epithelial cell staining. Other T-cell mediated
dermatoses were characterized by relatively few IFI 16 positive DCs. Moreover, DCs obtained
from blood-derived monocytes in psoriatic patients when compared to healthy individuals (n = 9)
revealed signi®cantly greater constitutive intranuclear levels of IFI 16 in psoriatic DCs as assessed by
immunostaining of cytospin preparations or Western blots. The promoter region of IFI 16 was
explored, and a putative transcription initiation site identi®ed using 5¢-Race procedure.
Sequencing studies of the promoter region revealed several different mutations when comparing
psoriatic to nonpsoriatics; including the same mutation in several affected family members. Based
on these data, IFI 16 is overexpressed by DCs in psoriatic individuals. Since plaques are
characterized by presence of activated immunocytes including DCs, we propose that IFI 16 is a
potential candidate for a disease susceptibility gene in psoriasis.
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Overexpression of Protein Kinase C a in Mouse Epidermis Causes In¯ammation and
AP-1-Mediated Apoptosis In Vitro
C. Cataisson, A. Wang, J. Subleski,* E. Joseloff, C. Vinson, R. Wiltrout,* and S. Yuspa
Laboratory of cellular carcinogenesis and tumor promotion, NCI, Bethesda, Maryland, U.S.A.; *LE, NCI,
Frederick, Maryland, U.S.A.
It is increasingly evident that skin keratinocytes are major mediators of host immune responses, and
conversely, the skin is a target for immunologically based in¯ammation in a variety of pathological
states. During the course of analysis of PKCa in cutaneous biology, we generated transgenic mice
that overexpress PKCa in basal keratinocytes and the outer root sheath of hair follicles under the
regulation of the keratin 5 promoter. Transgenic mice display a severe cutaneous in¯ammation
12 h after a single application of 12-O-tetradecanoylphorbol-13-acetate (TPA) to activate the
transgene. In¯ammatory cells migrate rapidly out of dermal vessels, in®ltrate hair follicles, and
produce massive intraepidermal abscesses with destruction of the epidermis.The in¯ammatory
in®ltrate is largely neutrophilic. in vitro, TPA alters the transcription of numerous cytokine and
chemokine genes expressed by transgenic keratinocytes.Transcripts for pro-in¯ammatory cytokines
such as IL-1a and TNFa and chemokines MIP-1a and MIP-2 are increased while IL-18 is
decreased. Changes are also detected in expression of transcripts for chemokine receptors in treated
transgenic keratinocytes.Furthermore PKCa overexpressing keratinocytes are extremely sensitive
to apoptosis when treated by TPA in vitro. Since PKCa has been linked to the AP-1 transcription
factor family, we prevented the DNA binding activity of AP-1 proteins by infecting cells with an
adenovirus encoding a dominant-negative Fos mutant (A-FOS). In conditions that abolished AP-1
binding activity, A-FOS rescued the cells from TPA-induced apoptosis but further increased the
expression of IL-1a and MIP-2. These results suggest that PKCa is an important mediator of skin
in¯ammation and cytokine release and could be a novel target for therapy of cutaneous
in¯ammatory diseases.
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Serologic Follow-Up of Patients with Erythema Migrans After Antibiotic Therapy
R. R. Mu
È
llegger, M. Glatz, and H. Kerl
Department of Dermatology, University of Graz, Graz, Austria
To examine the kinetics of B. burgdorferi (Bb) antibody (AB) titers in EM patients after standard
antibiotic therapy (TH). In 394/1014 patients, seen from 1993 to 99, serum Bb ELISA IgG (G) and
IgM (M) AB titers were available from at least 3 consecutive time points (before TH and during 4±
320w (median 28) thereafter). The serologic outcome was retrospectively evaluated and statistically
correlated to clinical parameters (c
2
or Kruskal±Wallis test). Five pro®les of G and M AB
development were identi®ed. (i) persistent positive (pp) (G, 49/394 patients, 13%; M, 52, 13%) (ii)
persistent negative (pn) (G, 239, 61%; M, 195, 50%) (iii) decrease from positive to negative (p-n)
(G, 55, 14%; M, 76, 19%) (iv) increase from negative to positive with consecutive decrease to
negative (n-p-n) (G, 39, 9%; M, 43, 11%) (v) increase from negative to positive with no decrease
(n-p) (G, 12, 3%; M, 28, 7%). The time after TH over which the AB levels persisted (pp, pn) or
changed (p-n, n-p-n, n-p) was as follows: G/pp, 3±166w (median 16w), M/pp, 3±101 (19); G/pn,
3±341 (21), M/pn, 3±341 (19); G/p-n, 0±70 (13), M/p-n, 0±98 (11); G/n-p-n, increase 0±17 (1),
decrease 2±132 (13), M/n-p-n, increase 0±5 (0), decrease 4±78 (10); G/n-p, 0±130 (11), M/n-p,
0±55 (1). Signi®cant correlations of the AB pro®les were found with the following clinical
parameters: Patients with a G/pn, M/pp, or M/n-p pro®le were younger than those with a G/n-p,
M/pn, or M/n-p-n pro®le. Patients with a G/p-n or G/n-p-n pro®le had most often disseminated
disease (extracutaneous features a/o 2nd EM lesions). Patients with a G/pn, M/n-p-n, or M/n-p
pro®le had the shortest, those with a M/pn or M/p-n pro®le the longest disease duration before
TH. The Bb G and M AB response in EM after antibiotic TH develops in 5 different pro®les. A
longstanding positive M titer develops especially in young patients or after a short disease duration
before TH, whereas those patients usually don't show G seroconversion. Disseminated disease is
not re¯ected by a particular M AB pro®le. Disease duration after TH does not in¯uence the AB
pro®le.
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Histone Deacetylase Inhibitors Reactivate Kaposi's Sarcoma-Associated Herpesvirus
N. Y. Talanin, E. Chung,* J. M. Orenstein,² J. Trepel,* and A. Blauvelt
Dermatology Branch, National Cancer Institute, Bethesda, Maryland, U.S.A.; *Medical Oncology Clinical
Research Unit, National Cancer Institute, Bethesda, Maryland, U.S.A.; ²Department of Pathology, George
Washington University, Washington, District of Columbia, U.S.A.
Kaposi's sarcoma-associated herpesvirus (KSHV) infects all tumor spindle cells in KS lesions,
although infection is predominantly latent (nonreplicating). The purpose of this study was to
determine whether KSHV could be reactivated from a latent to a lytic (replicating) state using
histone deacetylase inhibitors (HDAI), thereby rendering infected cells susceptible to apoptosis
and/or antiherpesviral drugs. HDAI were chosen for this purpose because they induce transcription
of cellular genes involved in tumor suppression, apoptosis, and maturation (a particular subset of
genes that is often `silenced' in cancers and virally transformed cells). Four different HDAI
(suberoylanilide hydroxamic acid, MS-275, depsipeptide, and trichostatin A) were assessed for their
ability to induce viral reactivation in two B cell lines latently infected with KSHV (BCBL-1 and
BC-3); reactivation was quanti®ed by real time PCR for lytic viral gene expression (RTA, PF-8,
and gpK8.1), ¯ow cytometry for lytic viral protein expression (PF-8 and gpK8.1), and electron
microscopy for virion production. As con®rmed by each of these assays, each HDAI induced
KSHV reactivation in a time (1±3 days)- and dose (5±500 nM)-dependent manner. On average, the
number of cells entering lytic cycle was enhanced 10±100 fold over cells not exposed to HDAI.
Cell death, as revealed by DeadRedá staining and WST-8 reduction assay, also occurred in a
parallel time- and dose-dependent fashion. Lastly, we documented concomitant hyperacetylation
of B cells treated with HDAI using mAb staining of acetylated histones and direct
immuno¯uorescence. In summary, all four HDAI tested were able to induce KSHV reactivation
and cell death. These results suggest that HDAI may be a therapeutic option for patients with KS
by `¯ushing out' virus from latently infected KS tumor spindle cells, thus making these cells
susceptible to apoptosis and adjunct antiherpesviral therapy.
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The Classical Pathway of the Complement Cascade Plays a Major Role in Subepidermal
Blistering in Experimental Bullous PemphigoidÐSoluble Complement Receptor 1
Inhibits the Development of the Disease
K. E. Carter, P. A. Rose, L. A. Diaz, and Z. Liu
Dermatology, UNC School of Medicine, Chapel Hill, North Carolina, U.S.A.
Bullous pemphigoid (BP) is a subepidermal blistering skin disease associated with complement-
activating autoantibodies directed against the hemidesmosomal proteins, BP180 and BP230. Using
a passive transfer mouse model, we have previously shown that rabbit antimurine BP180 IgG can
trigger an in¯ammatory blistering skin disease that closely resembles BP. Lesion formation in this
animal model is dependent upon complement activation, mast cell degranulation and neutrophil
in®ltration. In the present study, we have studied the roles of the classical and alternative
complement activation pathways and the membrane-attack complex (MAC) in this animal model
system. Mice de®cient in classical pathway component C4 were resistant to experimental BP. A
57% reduction of neutrophil in®ltration and a 64% reduction of mast cell degranulation were seen
in the IgG-injected C4-de®cient mice. Disease susceptibility in C4-de®cient mice was fully
reconstituted by treatment of the animals with the neutrophil chemoattractant IL-8 in the absence
of membrane attacking complex formation. In addition, complement inhibition using soluble
complement receptor 1 (sCR1), a potent inhibitor of the classical and alternative pathways,
blocked blister formation in experimental BP. These results indicate that complement activation
via the classical pathway is crucial in subepidermal blister formation in experimental BP. These data
suggest that speci®c complement inhibiting agents may be an effective approach to the treatment of
BP.
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A Passive Transfer Model of Epidermolysis Bullosa Acquisita Using Antibodies
Generated Against the Noncollagenous (NC1) Domain of Human Type VII Collagen
C. Chang, M. Chen, G. Pai, F. K. Costa, and D. T. Woodley
Dermatology, University of Southern California, Los Angeles, California, U.S.A.
Epidermolysis bullosa acquisita (EBA) is an antibody-mediated autoimmune blistering disease in
which patients develop subepidermal blisters and antibodies directed against the type VII
(anchoring ®bril) collagen. EBA autoantibodies recognize four major immunodominant epitopes
localized within the amino-terminal noncollagenous (NC1) domain of type VII collagen. The
dysfunction of anchoring ®brils caused by the binding of these autoantibodies to type VII collagen
may play an important role in the pathogenesis of EBA. However, direct evidence of a pathogenic
role for EBA autoantibodies has not been demonstrated. To develop an animal model of EBA, we
used a recombinant human NC1 domain as an antigen to generate a high titer rabbit polyclonal
antibody. This antibody bound to the basement membrane zone (BMZ) of mouse skin. IgG
puri®ed from the rabbit immunized with NC1 was administered subcutaneously (0.5±1 mg/g of
body weight) to wounded or unwounded SKH 1 hairless mice every 48 h for two weeks.
Wounded mice (100%) and unwounded mice (75%) injected with anti-NC1 IgG developed
widespread erosions and crusted lesions on their back, feet, ears and face. By clinical, histologic,
and immunologic criteria, their lesions were reminiscent of human EBA. Tissue sections from
lesion sites demonstrated epidermal-dermal separation in the sublamina densa zone. Injected
antibodies bound to the BMZ of murine skin in vivo. Serum samples from mice receiving anti-
NC1 IgG antibodies had high titers of circulating antibodies that labeled the BMZ of human skin
even two months after the termination of injections. Similarly concentrations of control IgG
puri®ed from normal rabbits did not induce disease when injected into mice. We conclude that
antibodies to the NC1 domain of type VII collagen may play an important role in the pathogenesis
of EBA. This experimental mouse model may provide a useful tool for dissecting the molecular and
immunological mechanisms of subepidermal blister formation in EBA.
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Prostaglandin E2-EP4 Signaling is Essential in the Initiation of Contact Hypersensitivity
by Modulating Langerhans Cell Migration and Costimulatory Molecule Expression
K. Kabashima,*² M. Nagamachi,*² K. Inaba,³ S. Narumiya,² and Y. Miyachi*
*Dermatology, Kyoto University, Kyoto, Japan; ²Pharmacology, Kyoto University, Kyoto, Japan;
³Immunobiology, Kyoto University, Kyoto, Japan
Prostaglandin (PG) E2 is one of the arachidonic acid metabolites and produced abundantly from
keratinocytes and antigen presenting cells upon various kinds of stimulation as hapten application.
PGE2 exerts its actions through its speci®c receptors EP1, 2, 3, and 4. However, the physiological
role of PGE2 has been unknown so far in cutaneous immune responses. We initially detected the
expression of EP4 abundantly in CD11c positive cells by RT-PCR. We sought to ®gure out the
role of EP4 on Langerhans cells (LCs) by using the EP4 selective compounds and EP4 de®cient
mice. We then assessed the migration of LCs from skin to draining lymph nodes using FITC
application assay and ®gured out that the migration of LCs from EP4-de®cine mice and C57BL/6
mice treated with the EP4 antagonist was reduced compared to that from control mice. The
number of LCs from ear skin explants in culture medium was also reduced by the EP4 antagonist
treatment and increased by the EP4 agonist treatment. Moreover, the expression of costimulatory
molecule (CD80 and CD86) of emigrated LCs was up regulated with the EP4 agonist treatment.
Furthermore, EP4-de®cient mice have a signi®cantly reduced CHS response induced by DNFB as
hapten. Reduced CHS response was con®rmed by the treatment with the EP4 speci®c antagonist
to C57BL/6 mice if administered during sensitization period but not during elicitation period.
When the regional lymphocytes from EP4-de®cient mice after sensitization were stimulated with
DNBS in vitro, the proliferation and Th1 cytokine production were down-regulated compared to
control mice. These results correlate with an impaired ability of EP4 de®cient mice to migrate LCs
to draining lymph nodes and to present antigen to T cells during sensitization period. In
conclusion, PGE2-EP4 signaling is an essential factor for the initiation of CHS by inducing LCs
from skin into lymphatic organs and up-regulated costimulatory molecule expression to naive T
cells.
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High Responses of Peripheral Blood Lymphocytes to Mosquito Salivary Gland Extracts
in Hypersensitivity to Mosquito Bites-Epstein Barr Virus Infection-NK Cell Leukemia
Disease
Y. Tokura, H. Matsuoka,* N. Seo, S. Ishihara,§ A. Adachi,² M. Ibe,³ H. Yagi, and M. Takigawa
Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan;
*Department of Medical Zoology, Jichi Medical School, Minami-kawachi, Tochigi, Japan; ²Department of
Dermatology, Hyogo Prefectural Kakogawa Hospital, Kakogawa, Hyogo, Japan; ³Department of Pediatrics,
National Yokohama Hospital, Yokohama, Kanagawa, Japan; §Pediatrics, Ishida Clinic, Osaka, Osaka,
Japan
We have proposed a unique clinical entity that is de®ned as the triad of hypersensitivity to
mosquito bites (HMB), chronic Epstein-Barr virus (EBV) infection, and natural killer (NK) cell
leukemia/lymphoma, and named it HMB-EBV-NK (HEN) disease (JAAD 45: 569±78, 2001). To
address the mechanisms of HMB in this EBV-infected NK cell lymphoproliferative disorder, we
investigated peripheral blood T and NK cell responses to mosquito salivary gland (MSG) extracts.
Peripheral blood mononuclear cells (PBMC) were taken from (1) 3 de®ned cases of HEN disease
(2) 3 borderline cases (3) 5 individuals with simple exaggerated skin reactions to mosquito bites
(simple ER), and (4) 8 normal healthy subjects. MSG extracts were prepared from each of ®ve
mosquito species by homogenizing 10 MSGs into 10 micro L of PBS. PBMC were cultured with
each of the extracts at a ®nal dilution of 1 : 1000 and pulsed with 3H-thymidine. High stimulation
indeces (SI, 6.5±68.9) were found in the patients with HEN disease variously in responses to the
extracts from Aedes albopictus, Aedes aegypti, Anopheles sinensis, Culex pipiens pallens, but not
Anopheles stephensi. Some borderline or simple ER cases exhibited moderate responses, while
normal subjects' SI were typically 1.3±1.5. CD4+ T cells, but not CD8+ T cells or CD56+ NK
cells, proliferated well in response to MSG extracts. However, this CD4+ T cell response and their
IL-4 production were strongly enhanced in the presence of CD56+ cells. These ®ndings suggest
that CD4+ T cells speci®c to MSG substances and NK cells serving as an enhancer are pathogenic
in the development of HMB.
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Inhibition of Allergic Contact Dermatitis by a Topically Applied SP Receptor
Antagonist
L. T. Jaiani,*² M. Sachdeva,³ B. R. Jaychandra,³ N. Kanikkannan,³ F. J. Legat,* N. G.
Neparidze,*² L. Kikwai,³ C. A. Armstrong,*² and J. C. Ansel*²
*Dermatology, Emory University, Atlanta, Georgia, U.S.A.; ²Dermatology, North-western University,
Chicago, Illinois, U.S.A.; ³Pharmacology, College of Pharmacy Division of Basic Pharmaceutical Sciences,
Tallahassee, Florida, U.S.A.
There is increasing evidence that the neurological systems play an important role in modulating
cutaneous in¯ammatory skin diseases by the release of neuropeptides such as substance p (SP). To
further de®ne the role of the cutaneous neurosensory system in in¯ammatory responses in the skin
we examined the anti-in¯ammatory effects of the SP receptor antagonist spantide II in the
elicitation phase of allergic contact dermatitis (ACD). Normal C57BL/6 mice or neutral
endopeptidase (NEP) de®cient mice (NEP
±/±
) that have augmented neuroin¯ammatory responses
were sensitized with 0.5% DNFB on an abdomen on day 0 and challenged with 0.2% DNFB on a
right ear on day 5. Right ears were treated with the topically applied SP antagonist, spantide II, or
dexamethasone 30 min after antigen challenge and three times a day thereafter for 4 days. The
ACD response was determined by measuring the ear swelling of the test drug-treated ears
compared to that of vehicle-treated contralateral ears before DNFB challenge and at 12, 24, 48,
and 72 h after challenge. Our results indicate that, like dexamethasone, spantide II was capable of
reducing ear swelling response to antigen in a dose dependent fashion in NEP (+/+) C57BL/6
mice at all time points after challenge. Similarly, spantide II treatment of NEP (±/±) mice, which
have exaggerated ACD responses compared to NEP (+/+) mice also signi®cantly inhibited the
ACD response at all time points after challenge. Tissue studies indicated that spantide II treatment
visibly decreased histological changes of in¯ammation in both NEP (+/+) mice and neuro-
impaired NEP (±/±) mice. These results demonstrate the anti-in¯ammatory activity of a topically
applied speci®c SP receptor (NK-1R) antagonist in ACD and support the role of the neurosensory
system in cutaneous in¯ammation.
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Characterization of a Potential Autoantigen in Psoriasis
K. Suh, N. Yawalkar, S. Sadat, T. Kupper, and D. Jones
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.
A previously uncharacterized protein fragment was identi®ed as a potential autoantigen in psoriasis
using an expression cloning approach similar to the SEREX (SErological identi®cation of
Recombinant EXpressed antigens) method of identifying tumor antigens. This approach is based
on the fact that antigens for T cells can also have B cell responses allowing for identi®cation by
screening serum samples for humoral responses. Using this method, our protein, which we refer to
as PAAg-1 (Psoriasis AutoAntigen-1), was found to have antibody responses in a subset of psoriatic
subjects but not normal controls. The purpose of this study is to further investigate this protein
fragment as a candidate autoantigen in the pathogenesis of psoriasis. Sequence analysis demonstrates
that this protein has signi®cant homology to phosphoprotein 75, which associates with Ro and is
itself a known autoantigen in neonatal lupus erythematosus. Database searches showed that the
partial PAAg-1 sequence maps to chromosome 8p11. RACE experiments of the fragment further
con®rmed the match to the chromosome, and were used to generate a more complete cDNA
sequence for PAAg-1. This was subcloned into a vector system that expressed our gene of interest
as a maltose-binding protein (MBP) fusion protein, allowing for puri®cation by binding to maltose
resin. To con®rm the role of this 37-kDa protein as an autoantigen in psoriasis, further experiments
using an ELISA as a more sensitive test of psoriatic serum and an ELISPOT assay for T cell
responses are underway. Preliminary results show that subsets of both psoriasis patients and controls
have both humoral and cellular immune responses to this protein, verifying that it can serve as an
autoantigen for both B and T cells. We conclude that PAAg-1 is a viable candidate autoantigen in
psoriasis based on humoral autoimmune responses, its homology to a known autoantigen, and T
cell autoimmune responses.
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Blockade of CD40/CD40L Interaction has Therapeutic Bene®ts in the Pemphigus
Vulgaris Mouse Model
M. Aoki,*³ K. Tsunoda,* T. Ota,*² T. Iwasaki,³ S. Tanaka,§ S. Koyasu,² M. Amagai,* and T.
Nishikawa*
*Dermatology, Keio University of School of Medicine, Tokyo, Japan; ²Microbiology & Immunology, Keio
University of School of Medicine, Tokyo, Japan; ³Veterinary Internal Medicine, Tokyo University of
Agriculture & Technology, Tokyo, Japan; §Clinical Research Center, Eisai Co., Ltd, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease against desmoglein 3 (Dsg3). We have





mice. The interaction between antigen-speci®c B cells and T cells via CD40/CD40L
pathway is considered to play an important role in the production of anti-Dsg3 IgG. In this study
we examined the effects of blockade of CD40/CD40L interaction by MR1 hamster anti-CD40L
monoclonal antibody both in prevention and treatment using our experimental PV. For assay in
prevention, we injected 500 mg of MR1 or control hamster IgG to Rag2
±/±
mice at day ± 2, 0, 2, 4,
7 of the transfer of Dsg3
±/±
splenocytes (n = 5). Mice injected with control IgG started to develop
anti-Dsg3 IgG at day 14 and showed weight loss due to oral erosions with suprabasilar acantholysis
in histology as well as telogen hair loss. In contrast, none of the mice injected with MR1 showed
any detectable anti-Dsg3 IgG and developed any phenotype of PV as long as observed until day 66.
For assay in treatment, we injected 1 mg of MR1 or control IgG to PV model mice that were
stably producing anti-Dsg3 IgG twice a week for 6 weeks (n = 10). To monitor natural course of
the disease, PV model mice without treatment were also observed (n = 5). MR1 treated mice
showed signi®cant decline of anti-Dsg3 IgG titers in general and some of the mice demonstrated
improvement of PV phenotype. The average titers of anti-Dsg3 IgG in MR1 treated mice were
lower than those of control IgG or nontreated mice throughout the course of the study. The ratios
of average titers at day 56 against day 0 (initiation of treatment) were 0.29 in MR1 injected mice,
0.54 in control IgG injected mice, and 0.79 in nontreated mice. These results indicate that the
blockade of CD40/CD40L interaction may have potential therapeutic bene®ts in human PV.
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Development of Pemphigus Vulgaris Mouse Model by Adoptive Transfer of Naive
Lymphocytes from Dsg3 Knockout Mouse
H. Anzai,* M. Aoki,* K. Tsunoda,* T. Ota,*² Y. Fujii,* S. Koyasu,² M. Amagai,* and T.
Nishikawa*
*Dermatology, Keio University School of Medicine, Tokyo, Japan; ²Immunology and Microbiology, Keio
University School of Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is a blistering disease caused by autoantibodies against desmoglein 3
(Dsg3). Recently we showed that adoptive transfer of splenocytes from Dsg3
±/±
mice immunized
with recombinant mouse Dsg3 (rDsg3) to Rag2
±/±
immunode®cient mice that express Dsg3
resulted in the development of PV phenotype. The purpose of this study was to determine whether
recipient mice transferred with naive splenocytes from nonimmunized Dsg3
±/±
mice develop PV
phenotype, and to compare Dsg3 epitopes in PV mice with immunized and naive splenocyte.
When 5 3 10
7
splenocytes from nonimmunized Dsg3
±/±
mice were transferred, 16 out of 20
recipient mice produced anti-Dsg3 IgG antibodies by day 14, and 15 of them developed PV
phenotype, including in vivo IgG deposition on keratinocyte cell surfaces and suprabasilar
acantholysis in oral mucous membranes. The appearance of the PV phenotype showed dose
dependency of the number of splenocytes transferred. Then we characterized epitopes on Dsg3 in
these PV model mice by competition ELISA using four mouse Dsg3/Dsg1 domain-swapped
molecules produced by baculovirus expression system. Amino-terminal residues 1±162 of Dsg3,
which contain adhesive region of cadherins, are more frequently recognized in PV model mice
with naive splenocytes (15.6%, 5/32) than in those with immunized splenocytes (0.0%, 0/28).
These results indicate that recipient mice transferred with naive lymphocytes from Dsg3
±/±
mice
produced the pathogenic anti-Dsg3 speci®c IgG with resultant PV phenotype. This new model
without active immunization will provide a valuable tool to investigate in vivo cellular and
molecular mechanisms for the production of pathogenic anti-Dsg3 IgG.
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Therapeutic Targeting of the Endothelial Regulation of T Cell Migration with Low
Molecular Weight Heparin
M. Southall, K. Christopherson,* J. Campbell,* H. Ramsey,* J. B. Travers, A. Hood, and R.
Hromas*
Dermatology, Indiana University, Indianapolis, Indiana, U.S.A.; *Medicine, Indiana University,
Indianapolis, Indiana, U.S.A.
The chemokine CCL21, also known as Exodus-2/6-Ckine/SLC/TCA4, regulates T cell adhesion
and migration. The objective of this study was to examine whether CCL21 was involved in T-cell-
mediated skin diseases. First, the presence of this T-cell speci®c chemokine was tested in normal
skin and in a variety of skin diseases by immunohistochemistry. No expression of CCL21 was seen
in normal skin. However, signi®cant expression of this chemokine was found in a variety of
in¯ammatory skin diseases including allergic contact dermatitis, atopic dermatitis, lichen planus,
cutaneous T cell lymphoma and graft-vs. host disease in a restricted pattern involving vascular
endothelium. Endothelial heparin-like glycosaminoglycans (GAGs) are known to present
chemokines at sites of in¯ammation, maintaining a local concentration gradient to which
leukocytes can respond. We have found that GAGs inhibit the ability of CCL21 to stimulate T cell
adhesion and chemotaxis in vitro, in contrast to other chemokines. Enzymes such as heparinase that
can degrade GAGs blocked these inhibitory effects on CCL21 functions, implying a local
regulation of this inhibition. We also found that low molecular weight heparins inhibit CCL21-
mediated T cell adhesion and chemotaxis in vitro, and could inhibit in¯ammation in vivo when
systemically administered to mice in an experimental model of allergic contact dermatitis. These
studies indicate that CCL21 is a potentially important T cell-speci®c chemokine involved in
human in¯ammatory skin diseases, and suggest that low molecular weight heparins could be
effective therapeutic agents through targeting the CCL21-mediated endothelial regulation of T cell
interactions.
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Involvement of Leukotriene B4 in the Exaggerated Cutaneous In¯ammation Induced by
Sterile Fungal Hyphae in a Murine Model of Chronic Granulomatous Disease
J. B. Travers,*² W. S. Goebel,² C. Johnson,³ R. C. Murphy,³ and M. C. Dinauer²
*Dermatology, Indiana University, Indianapolis, Indiana, U.S.A.; ²Pediatrics, Indiana University,
Indianapolis, Indiana, U.S.A.; ³Pediatrics, National Jewish Medical and Research Center, Denver,
Colorado, U.S.A.
As a result of the inability of their phagocytes to undergo a respiratory burst, patients with the
genetic condition chronic granulomatous disease (CGD) develop recurrent infections with
catalase-positive bacterial and fungal pathogens, and are predisposed to chronic in¯ammatory
granulomatous lesions in many organs including the skin. CGD can result from mutations in any
one of four genes encoding different subunits of the leukocyte NADPH-oxidase. Previously, our
laboratory has generated a murine model of X-linked CGD by homologous recombinant deletion
of the gp91phox component of the NADPH oxidase. Functional studies with these X-CGD mice
demonstrated exaggerated in¯ammatory responses consisting of neutrophils which later form
granulomas in response to intratracheal, intraperitoneal, or intradermal administration of sterile
Aspergillus fumigatus (AF) hyphae, in comparison to wild-type mice. We present three separate
lines of evidence suggesting that leukotrienes, especially the potent neutrophil chemoattractant
LTB4, are critically involved in the early in¯ammatory reaction to AF in X-CGD mice. First,
signi®cant levels of LTB4 were measured by mass spectrometry in skin biopsies taken from the
neutrophil-rich early in¯ammatory skin reactions to AF in X-CGD, but not wild-type mice.
Second, topical application of a LTB4 receptor antagonist inhibited subsequent in¯ammation
induced by intradermal AF. Finally, activation of the NADPH-oxidase by phorbol ester treatment
inhibited ionophore-stimulated increase in leukotriene levels in a neutrophilic cell line expressing
the NADPH-oxidase, yet had no effect on ionophore-stimulated leukotriene levels in cells in
which the NADPH-oxidase was disrupted by gene targeting. These studies suggest that a
component of the aberrant in¯ammatory response to sterile fungal products in CGD can be
explained by unregulated levels of leukotrienes.
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Immunological Analysis of Severe Hypersensitivity to Mosquito Bites Associated with
Epstein-Barr Virus Infected NK Cell Lymphocytosis
H. Asada, H. Fujii, Y. Ando, M. Isonokami, S. Itami, S. Suguri,* Y. Tokura,² K. Iwatsuki,³ and
K. Yoshikawa
Department of Dermatology, Osaka University Grad. School of Medical, Suita, Osaka, Japan; *Department
of Medical Zoology, Kagawa Medical University, Kida, Kagawa, Japan; ²Department of Dermatology,
Hamamatsu University School of Medical, Hamamatsu, Shizuoka, Japan; ³Department of Dermatology,
Okayama University Grad. School of Medical, Shikata, Okayama, Japan
Recent studies suggest that NK cell lymphocytosis associated with Epstein-Barr virus (EBV)
infection often shows severe hypersensitivity to mosquito bites (HMB) characterized by intense
local skin reactions and general symptoms such as high fever, lymphadenopathy, and
hepatosplenomegaly. Here we examined immune mechanism of these clinical symptoms. The
biopsy specimens were taken from the lesional skin of the patients with HMB associated with
EBV-positive NK cell lymphocytosis after scratch-patch test with mosquito antigens. in situ
hybridization with EBER probe demonstrated that 3±10% of in®ltrated cells were infected with
EBV and immunohistochemistry showed that CD4+ T lymphocytes dominantly in®ltrated in the
skin lesions. CD4+ T, CD8+ T, and NK cells were separated from peripheral blood mononuclear
cells of 5 patients, and were stimulated with various mosquito antigens (4 mg/ml). After four-day
stimulation, triplicate cultures were measured on [3H]-thymidine incorporation. In all patients,
CD4+ T cells, but not EBV infected NK cells, reacted to mosquito antigens, and they especially
responded intensely to the extract from salivary glands of Aedes albopictus. Furthermore, EBV was
reactivated from latent state in NK cells of the patients when the NK cells were cocultured with
CD4+ T cells activated by mosquito antigens. These results suggested that CD4+ T cells had a role
of the local primary reaction to mosquito antigens, and EBV reactivation from NK cells was
involved in the general symptoms in the patients with HMB associated with EBV-positive NK cell
lymphocytosis.
663
Lentiviruses and Dendritic Cells: Friends or Foes?
V. Piguet, F. Leuba, S. Zarei,* J. Arrighi, S. Abraham, A. Engering,² C. Hauser,* and Y. van
Kooyk²
Department of Dermatology, University Hospital of Geneva, Geneva, Switzerland; *Division of Allergy and
Immunology, University Hospital of Geneva, Geneva, Switzerland; ²Department of Molecular Cell Biology,
VUMC, Amsterdam, Netherlands
In the past 20years, we have witnessed the acquired immunode®ciency syndrome (AIDS) evolve
from a rare medical curiosity to a major health crisis. Since new infections occur primarily through
sexual transmission, small amounts of virus have to cross the mucosal barrier and reach replication-
competent sites. Evidence has accumulated that a speci®c subtype of cells, called Langerhans/
dendritic (DC) cells, plays a crucial role in the early events of entry of the virus in the host. HIV
can avoid digestion by the DC and uses their migratory properties in order to gain access to the
lymph nodes, where maximal viral replication occurs. We provide evidence of how HIV escapes
degradation and processing in DC and replicates actively in DC-T cell clusters, which contributes
to HIV pathogenesis. However, HIV not only prevails as a dangerous parasite, but can be
transformed into a useful tool for gene therapy. Attenuated variants of HIV/SIV are promising
tools to genetically modify DC, usually resistant to physical transfection methods. Lentiviral vectors
ef®ciently transduce human CD34+ stem cell derived DC, monocyte derived DC, as well as
murine bone marrow derived DC. We will demonstrate that targeting of dendritic cells by
antigen-encoding lentiviral vectors permits antigen processing and MHC class I dependant
presentation. Together, these studies illustrate the complex interactions between dendritic cells and
HIV and their potential implications for immunotherapy strategies.
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Virus-Like Particles of Epidermodysplasia Verruciformis Human Papillomavirus Type 5
Stimulate Production of Interferon-g by T Cells From Patients with Psoriasis
S. Majewski, M. Malejczyk, M. Favre,* G. Orth,* and S. Jablonska
Department of Dermatology and Venereology, Warsaw School of Medicine, Warsaw, Poland; *Unite des
Papillomavirus, Institut Pasteur, Paris, France
Our recent studies suggest that EV HPV5 could be involved in the pathogenesis of psoriasis both
by direct stimulation of keratinocyte proliferation and serving as a target for humoral and cellular
immune reactions (Favre et al JID 111 : 333±6,1998; Majewski et al JID 111 : 541±2,1998 and
Immunol Today 20 : 475±6,1999). The aim of the present study was to examine cell-mediated
immune responses to HPV5 VLPs in patients with psoriasis (n = 7), EV (n = 4), chronic wounds
(n = 4) and healthy controls (n = 7). T lymphocytes were cultured for 14 days in the presence of
HPV5a VLPs (generated in a baculovirus system) and IL-2, and then studied for their proliferative
responses to these VLPs presented by freshly isolated, X-ray irradiated peripheral blood
mononuclear cells (PBMC). We also studied concentration of Th1 cytokine ± interferon-g
(IFNg) in supernatants from 5-day cultures of T lymphocytes stimulated or not by HPV5 VLPs.
The results showed that T lymphocytes from EV patients did not respond to HPV5a VLPs, as
measured by the proliferative assay and IFNg production. In the samples from two patients with
EV, addition of HPV5a VLPs to the cultures even led to a decrease in both spontaneous and IL-2-
stimulated T cell proliferation. HPV5a VLPs only slightly stimulated T cell proliferation in patients
with psoriasis and chronic wounds, however, these differences were statistically not signi®cant. In
contrast, only patients with psoriasis showed a signi®cant (p < 0.05) increase in production of IFNg
by T lymphocytes stimulated by HPV5a VLPs as compared to cultures without VLPs. Our results
support a speci®c cell-mediated defect towards HPV5 in EV patients, and show that EV HPV5a
proteins are capable of stimulating psoriatic T cells to produce IFNg, a cytokine crucially involved
in the immunopathogene- sis of psoriasis.
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Differential Modulation of Toll-Like Receptor 2 and 4 Expression in Human Sebocytes
M. K. Oeff, H. Seltmann, N. H. Hakiy, B. Bogdanoff, A. Nastos,* R. J. Walters,* S. Fimmel, S.
R. Bornstein,* and C. C. Zouboulis
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University of Berlin,
Berlin, Germany; *Department of Endocrinology, University Medical Center, Heinrich Heine University,
Duesseldorf, Germany
Human sebocytes are able to regulate in¯ammatory and immune functions, involved in the
development of acne lesions, by intrinsic mechanisms. A bacterial role in the potentation of
in¯ammatory acne has been widely accepted. Toll-like receptors (TLRs) are involved in innate
immunity are able to recognize microbial components. We address here a potential mechanism of
gram-negative and gram-positive bacterial component action on human sebocytes through a
possible modulation of TLR2 and TLR4 expression. We tested the actions of the bacterial cell wall
components lipopolysaccharide (LPS) and lipoteichoic acid (LTA) upon TLR2 and TLR4 mRNA
expression in SZ95 sebocytes after prolonged (+ 24 h) exposure. Changes in TLR expression by
these agents were compared to the action of hydrocortisone. The mRNA and protein levels were
detected by rt-PCR and immunocytochemistry. The regulation of TLR mRNA levels was
investigated by using the TaqMan quantitative PCR method. We have shown that SZ95 sebocytes
express TLR2 and TLR4 on mRNA and protein levels. LPS and hydrocortisone increased TLR2
expression (n = 4, p < 0.05), while LTA suppressed it. Preliminary data suggests that LTA
suppresses TLR4, whereas LPS was without signi®cant effect. Hydrocortisone had an suppressive
effect on TLR4 (n = 3, p < 0.05). This is a ®rst evidence that bacterial cell wall components may
directly in¯uence human sebocytes via a speci®c receptor-dependent mechanism in the absence of
in¯ammatory cells. Future research will concentrate upon the role of Toll-like receptors in the
immune-in¯ammatory response of human sebocytes.
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Identi®cation of Autoantigens in Psoriasis Using an Expression Cloning Method
D. Jones, N. Yawalkar, S. Sadat, B. Rich, and T. Kupper
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.
Current evidence suggests that psoriasis is mediated predominantly by T cells, and an autoimmune
etiology is strongly suspected. However, no autoantigens have yet been identi®ed. To do this, we
have developed an expression cloning approach in which cDNA libraries of psoriatic plaque
epidermis are screened with psoriatic serum samples. This approach is analogous to the SEREX
method, which identi®es tumor antigens recognized by T cells by screening for antibody responses.
Several potential candidate autoantigens have been identi®ed and here we present our studies of
two promising candidates, keratin 13 (K13, which is present in regenerating but not normal
epidermis) and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1, which has homology to
keratin). Initial screening of these using phage plaque blots showed antibody reactivity only in a
subset of psoriatics. For further characterization, we cloned, expressed and puri®ed these proteins
using a histidine tag and nickel column system. Immune responses to the proteins were then
measured using additional patient samples in an ELISA, a dot blot, and an ELISPOT assay. Results
using the more sensitive ELISA and dot blot assays con®rmed humoral responses in a subset of
psoriatics, but also showed reactivity in controls. This difference between the screening plaque
blots and the ELISA may be due to the use of antigens as protein fragment fusions in the plaque
assay and as longer pure proteins in the ELISA. Measurement of peripheral blood T cell responses
using an IFN-g ELISPOT assay demonstrated that K13 and hnRNPA1 can also serve as
autoantigens for T cells: subsets of both psoriatics and controls were found to have T cell responses.
Interestingly, very similar results have been demonstrated for known autoantigens in multiple
sclerosis, with comparable autoreactivity in the peripheral blood of both patients and controls. We
conclude that K13 and hnRNPA1 can serve as autoantigens for both B cells and T cells and that
abnormal responses directed against these proteins may be involved in the pathogenesis of psoriasis.
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Identi®cation of Intracellular T Cell Epitopes in Pemphigus Vulgaris
A. K. Moesta, S. Stevanovic,* H. G. Rammensee,* M. S. Lin,*² and A. A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York, U.S.A.; *Immunology,
UniversitaÈt TuÈbingen, TuÈbingen, Germany; ²Dermatology, Medical College of Wisconsin, Milwaukee,
Wisconsin, U.S.A.
A major focus of autoimmune research is the identi®cation of functionally relevant T-cell epitopes.
Computer based algorithms that incorporate Human Leukocyte Antigen (HLA) allele speci®c
motifs, de®ned by preferences in size, structure and charge for that antigen binding pocket, have
been used to de®ne T-cell epitopes in several systems. Susceptibility to pemphigus vulgaris (PV) is
strongly correlated with the HLA alleles DRB1*0402 and DQB1*0503. While the disease is
ultimately mediated by antidesmoglein 3 (Dsg3) antibodies, an initial T cell response, restricted to
HLA DRB1*0402 or HLA DQB1*0503, is presumably required for autoimmune initiation. A
previous study utilized an earlier de®ned HLA DRB1*0402 motif to predict 4 peptides (Dsg3190±
206, Dsg3206±220, Dsg3251±265, and Dsg3762±786) that elicited T cell reactivity in PV patients.
We recently developed an updated and more precisely de®ned motif for DRB1*0402 deduced
from DRB1*0402 peptide elution studies and X-ray cyrstallography data of the closely related
DRB1*0401. Seven top scoring peptides were synthesized and screened for functional activity by
proliferation assays with patient derived PBMC. We detected T cell reactivity to four Dsg3-
derived predicted peptides: Dsg3190±204, Dsg3342±356, Dsg3810±824, and Dsg3963±974.
Interestingly, two epitopes, Dsg3810±824 and Dsg3963±974 are contained within the cytoplasmic
region of Dsg3; while Dsg3190±204 and Dsg3342±356 map to the extracellular domain. We also
demonstrate a response within one patient to two predicted peptides (Dsg3963±974 and Dsg3190±
204). Our data suggest that the intracellular portion of Dsg3 may harbor disease relevant T cell
epitopes and that multiple epitopes may be operative in the autoimmune response in an individual
patient. These ®ndings may be of clinical relevance regarding disease initiation and subsequent
epitope spreading.
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Role of IgE in Subepidermal Blistering in Experimental Bullous Pemphigoid
Z. Liu, M. Zhao, K. E. Carter, and L. A. Diaz
Dermatology, University of North Carolina, Chapel Hill, North Carolina, U.S.A.
Bullous pemphigoid (BP) is a human autoimmune in¯ammatory skin disease characterized by
subepidermal blistering and deposition of complement-®xing autoantibodies at basement
membrane. BP autoantibodies react with the hemidesmosomal proteins, BP180 and BP230.
These BP autoantibodies belong to IgG and IgE isotypes. Anti-BP180 antibodies appear to be
pathogenically relevant as suggested by passive transfer and active immunization protocols. In this
study, we examined the role of IgE in the disease development in experimental BP. C57BL/6 J
mice were actively immunized with recombinant murine BP180 (mBP180). As previously shown,
4 weeks after boosting immunization, these mice produced pathogenic antimBP180 antibodies and
in some of the mice skin lesions were observed. Signi®cantly, high levels of BP180-speci®c IgE
antibodies were detected in the sera of these mice by a mBP180-speci®c ELISA. In vitro, these
antimBP180 IgE-containing sera stimulated cultured murine mast cells to release histamine and
TNF-a in a dose-dependent fashion. This effect was mediated through the high-af®nity IgE
receptor (FceRI). In vivo, these sera depleted of IgG degranulated dermal mast cells when injected
into wild-type neonatal mice, but not FceRI-de®cient mice. Further, FceRI-de®cient mice
injected with murine pathogenic antimBP180 antibodies and wild-type mice injected with murine
pathogenic antimBP180 IgG depleted of IgE activity failed to develop subepidermal blisters. These
animals also showed signi®cant reduction in mast cell degranulation and neutrophil in®ltration.
These results suggest that BP180-reactive IgE antibodies plays a direct role in the pathogenesis of
BP.
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Therapeutic Immune Deviation Abrogates Pathogenicity of Autoreactive T Cells




Dermatology, Ludwig-Maximilians University, Munich, Germany; *Neurology, University of Texas-South-
western Medical Center, Dallas, Texas, U.S.A.
Psoriasis is an in¯ammatory T cell mediated autoimmune disease dominated by interferon g (IFN-
g) producing CD4+ T cells (Th1). Therapy with fumaric acid esters (FAE) is highly effective in the
treatment of psoriasis. The mechanisms underlying the therapeutic effects of FAE remain unclear.
We investigated the effects of FAE on T cells of patients with psoriasis and on autoreactive T cells
in mice with experimental autoimmune encephalomyelitis (EAE), an organ speci®c Th1-mediated
autoimmune disease. 18 patients were treated with FAE and PBMC were analyzed at regular
intervals. In humans, intracellular cytokine analysis of freshly isolated T cells showed a signi®cant
suppression of the IFN-g/Interleukin 4 (IL-4) ratio only within the CD4+ population, but not
CD8+ T-cells, which was closely associated with a marked decrease of the PASI (> 70%). To
determine whether this deviation of Th1 into Th2 responses is causally related to the
improvement, we investigated the effect of FAE on the capacity of autoreactive Th cells to
transfer autoimmune diseases in experimental mice. Feeding mice FAE during the development of
EAE strongly delayed the onset and signi®cantly decreased the severity of EAE, even in mice with
a T cell receptor transgenic for the autoantigen in the brain, myelin basic protein (MBP). In
parallel, FAE induced IL-4-producing MBP-speci®c CD4+ T-cells (Th2) in these mice.
Importantly, transfer of MBP-speci®c T cells from untreated mice induced severe EAE and
mortality in naive mice. In sharp contrast, T cells derived from FAE-treated mice had lost the
capacity to transfer EAE into naive mice. None of the mice died and 55% were completely
protected from EAE. Thus FAE induced a Th2 phenotype in autoreactive T cells and directly
abolished their pathogenicity in vivo. This ®nding may provide a rationale to develop therapeutic
vaccines against psoriasis and, if successful, also other in¯ammatory autoimmune diseases.
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The Ascomycin Derivatives ASM 981 (Pimecrolimus) and ASD 732 Inhibit
Neuroin¯ammation in Cutaneous Hypersensitivity
J. C. Ansel, H. Kalden, L. T. Jaiani, W. S. Caughman, C. A. Armstrong, and A. Stuetz*
Dermatology, Emory University, Atlanta, Georgia, U.S.A.; *Pharmacology, Novartis Research Institute,
Vienna, Austria
There is increasing evidence that the neurological systems play an important role in modulating
cutaneous in¯ammatory skin diseases by the release of neuropeptides such as substance p (SP). The
cell surface metalloprotease neutral endopeptidase (NEP) is the principal proteolytic enzyme that
degrades SP. Absence of NEP results in dysregulated in¯ammatory skin responses as can be shown
by comparing contact hypersensitivity (CHS) responses in normal C57BL/6 mice or NEP
de®cient mice (NEP
±/±
). We investigated the anti-in¯ammatory effects of the ascomycins ASM
981 (pimecrolimus) and ASD 732 on CHS in these animals in comparison with dexamethasone, in
order to further pro®le these two anti-in¯ammatory nonsteroids. Pimecrolimus is an inhibitor of
in¯ammatory cytokine production in T cells and highly effective in patients with atopic dermatitis.
ASD 732 is an experimental compound that does not affect T cells but has anti-in¯ammatory
activity with a so far unknown mode of action. Our results indicated that both ascomycins
signi®cantly and dose dependently reduced ear swelling response after a single topical application
(0.1 mM and 1mM) in NEP (+/+) mice at all time points after challenge with allergen (12 h, 24 h,
48 h, 72 h). Similarly, ASM 981 and ASD 732 treatment of NEP (±/±) mice, which show
exaggerated CHS response compared to NEP (+/+) mice, signi®cantly inhibited the CHS
response in a dose dependent fashion at all time points. Treatment of these NEP (±/±) mice with
topical dexamethasone 1 mM inhibited the CHS swelling response similar to its effect in normal
mice at 12, 24, and 48 h, but ear swelling began to increase again at 72 h in these knockout mice.
These results con®rm the anti-in¯ammatory activity of ASD 732 and demonstrate that both
ascomycins can inhibit the neuroin¯ammatory components of CHS. In conclusion, our data
suggest that ascomycins might have a broader anti-in¯ammatory activity with a so far unknown
mechanism beyond their effect on T cells.
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Potential Targets for Antiscarring Therapy: Cyclo-Oxygenase-2 and Thrombospondin
T. Wilgus, N. Flavahan,* S. Mitra,* and T. Oberyszyn
Pathology, The Ohio State University, Columbus, Ohio, U.S.A.; *Heart Lung Research Institute, The
Ohio State University, Columbus, Ohio, U.S.A.
The process of wound repair begins with in¯ammation and ends with scar formation. Fetal wound
healing studies have provided evidence for the importance of early in¯ammatory events
in¯uencing the outcome of the later events such as scar formation. Cyclooxygenase-2 (COX-2) is
an in¯ammatory enzyme responsible for the formation of prostaglandins, such as PGE2, which has
been shown to promote the growth of keratinocytes and ®broblasts as well as increasing collagen
production by ®broblasts. We have demonstrated COX-2 expression in keratinocytes at the
leading edge of the wound during the in¯ammatory phase of wound healing. In addition,
wounded skin contained elevated levels of PGE2 compared to unwounded skin. The goal of this
study was to examine the effect of inhibiting COX-2 activity on the scarring process in adult skin
following incisional wounds. Daily topical treatment of wounds with 1 mg of the COX-2
inhibitor, Celecoxib, resulted in the inhibition of PGE2 levels in the skin and in decreased
neutrophil in®ltration and activation compared to vehicle treated wounds. This early decrease in
in¯ammation correlated with both a decrease in hydroxyproline levels as well as a 50% reduction in
scar tissue formed in Celecoxib treated wounds 14 days postwounding. Examination of the
mechanism by which Celecoxib could be acting to decrease scar formation demonstrated
signi®cant increases in Thrombospondin-2 (Tsp-2) message levels compared to vehicle treated
wounds. This matrix protein has been shown to inhibit angiogenesis and bind to TGF-b protein,
inhibiting its activation. Both a lack of angiogenesis and a lack of TGF-b have been noted in
scarless fetal healing. The present study makes a novel link between decreased COX-2 activity,
increased Tsp-2 levels and the reduction of scarring. These studies not only provide a possible
mechanism for the decreased scarring seen with Celecoxib treatment, but also suggests that
modulating Tsp-2 via COX-2 may be useful as a therapeutic target to limit scar formation in the
skin.
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Association of a Promoter Polymorphism of Tumor Necrosis Factora with Adult
Dermatomyositis
G. C. Ang,* J. P. Callen,² K. E. Sullivan,³ and V. P. Werth*§
*Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; ²Dermatology, University
of Louisville, Louisville, Kentucky, U.S.A.; ³Immunologic and Infectious Diseases, Children's Hospital of
Philadelphia, Philadelphia, Pennsylvania, U.S.A.; §Dermatology, Philadelphia V.A. Hospital,
Philadelphia, Pennsylvania, U.S.A.
We recently reported that the ± 308 A TNF promoter polymorphism is associated with subacute
cutaneous lupus erythematosus (SCLE) and mediates an exaggerated response to ultraviolet B
(Werth et al J Invest Dermatol 115 : 726±730, 2000). We now hypothesized that this
polymorphism may also be important in adult dermatomyositis (DM), a photosensitive disorder
with some features in common with SCLE. 50 patients with DM and 239 race-matched controls
were examined for the ±308 A TNF polymorphism and the more common 308G allele. The
frequency of the ±308 A allele was 0.27 in the entire DM group, vs. 0.14 for all controls (p < 0.003,
c2 2 3 2 table). Caucasians were the only racial/ethnic group in our study large enough to allow
separate statistical analysis (47 DM, 223 controls). The frequency of the ± 308 A allele was 0.26 for
DM and 0.15 for the controls (p < 0.01). Caucasians are known to exhibit a linkage dysequilibrium
between ±308 A and HLA-DR3. We previously reported that 53% of controls but 100% of SCLE
patients with at least one ±308 A allele also carry the DR3 allele. In contrast, we found no increase
in the association of 3 308 A and HLA-DR3 in DM over control (p = 0.8 by Fisher's exact test),
and the association of these two genes in DM was signi®cantly less than we reported for SCLE
(p = 0.009). The three homozygous ±308 A patients with DM had exceptionally severe skin disease
in a photodistribution that continued after resolution of myositis, requiring continued combination
antimalarials and immunosuppressive therapy. The mean age of the AA homozygous group
(34 6 3 years) was trending to younger than the mean ages of the GG (48 6 3; years) and GA
(52 6 4 years) group. We conclude that the TNF-308 A polymorphism is associated with DM,
which suggests a pathophysiologic contribution from UV-induced TNFa. The difference in HLA-
DR3 linkage and several divergent clinical features suggest a speci®c mechanistic difference
between DM and SCLE.
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De®ciency of a (1,3) Fucosyltransferase VII has Distinct Effects in Th1 and Th2 Models
of Skin In¯ammation
A. J. Schottelius, J. B. Lowe,* and K. Asadullah
Research Business Area Dermatology, Research Laboratories of Schering AG, Berlin, Germany;
*Department of Pathology, Howard Hughes Medical Institute, The University of Michigan Medical
School, Ann Arbor, Michigan, U.S.A.
Synthesis of cutaneous lymphocyte-associated antigen (CLA), which plays a pivotal part in skin
homing of memory T cells via CLA/E- and p-selectin binding, is strongly dependent on a (1,3)
fucosyltransferase VII (FucTVII) activity. Although de®ciency of leukocyte adhesion and
leukocyte recruitment in acute cutaneous in¯ammation has been demonstrated in FucTVII
±/±
mice, the effects on Th1 and Th2 models of skin in¯ammation have not been completely
characterized. Sensitization and challenge with DNFB and irritation with mezerein in ears of
wildtype mice induced a signi®cant induction of edema and granulocyte in®ltration as assessed by
ear weight, peroxidase/elastase activity and skin histology. In contrast, mice de®cient of FucTVII
developed no edema in response to DNFB challenge and irritation with mezerein. Moreover, no
cutaneous in®ltration of granulocytes/neutrophils was observed in FucTVII
±/±
mice post challenge
or irritation. Interestingly, differential effects on in¯ammatory parameters were seen in the model
of ovalbumin-induced late phase reaction (LPR). A signi®cant post challenge increase in
neutrophil in®ltration seen in wildtype was decreased in FucTVII
±/±
mice. However, de®ciency of
FucTVII did not in¯uence the induction of total granulocyte in®ltration and IL-4 secretion in this
Th2-type skin in¯ammation model. The data point toward a more pronounced inhibition of
neutrophils within the granulocyte population with no impact on eosinophils, which play a strong
pathogenic role in this model. These observations demonstrate a central role of FucTVII activity/
CLA-positive T cells and neutrophils in the Th1-dominant delayed type hypersensitivity/contact
hypersensitivity reaction and a minor role in the Th2-dominant ovalbumin-induced LPR.
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Identi®cation and Characterization in Skin of Interferon-Inducible Protein16, a Human
Homologue of a Mouse Systemic Lupus Erythematosus Susceptibility Gene
D. Choubey, V. Chaturvedi, J. Qin, J. Curry, H. Xin, and B. J. Nickoloff
Radiation Oncology, Loyola University, Chicago, Illinois, U.S.A.; *Pathology, Loyola University,
Chicago, Illinois, U.S.A.
Recently, we provided evidence linking the mouse I®202 gene to susceptibility of several murine
models of human systemic lupus erythematosus (SLE; Immunity 15 : 435, 2001). The human gene
I® 16 is a homologue of the mouse I®202 gene, and hence may represent a candidate gene for
susceptibility to SLE in human patients. To investigate a role for IFI 16 in human skin, we
explored its pattern of expression in-vivo, and functional activity in-vitro. Immunostaining of
normal human skin revealed intranuclear IFI 16 staining in basal and suprabasal epidermal layers,
with less to absent keratinocyte (KC) positivity in upper layers. Examination of discoid and
systemic LE skin lesions (n = 5) revealed diffuse intranuclear KC staining in basal and mid
epidermal layers. Cultured neonatal foreskin derived KCs revealed prominent intranuclear IFI 16
by immunostaining (n = 3) which was con®rmed by Western blots that demonstrated the presence
of all three isoforms. Normal skin ± derived ®broblasts, expressed low constitutive levels for all
three isoforms of IFI 16, but exposure (24 h) to either IFN-a (103 U/ml) and/or IFN-g (103 U/
ml) induced IFI 16 levels. Since skin lesions of lupus feature premature KC apoptosis, we next
asked if IFI 16 regulated the survival of KCs. KCs were infected with a retrovirus containing an IFI
16 antisense construct, and compared to KCs infected with an empty retrovirus. After con®rming
reduced IFI 16 levels, antisense containing retroviral infected KCs were found to have greater
susceptibility (2 fold) to UV-induced apoptosis compared to control infected KCs.
Immunoprecipitation/Western blot analysis revealed IFI 16 could bind to wild type, but not
mutated p53-a mediator of apoptosis. These results indicate that IFI 16 is constitutively expressed
by KCs in-vivo and in-vitro. The presence of IFI 16 regulates susceptibility to UV-light mediated
apoptosis in KCs, and may thereby contribute to the cutaneous phenotype of SLE patients.
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Activated T Cells and Their Soluble Products From Vitiligo Patients In¯uence
Melanocyte Destruction by Apoptosis In Vitro
R. Tackey, C. S. Walters,* and R. M. Halder²
Medicine and Dermatology, Howard University Hospital, Washington, District of Columbia, U.S.A.;
*Medicine and Dermatology, Howard University Hospital, Washington, District of Columbia, U.S.A.;
²Dermatology, Howard University Hospital, Washington, District of Columbia, U.S.A.
Patients with vitiligo have been found with lymphocytic in®ltrate at the marginal of de-pigmented
areas of the skin. However, the mechanisms by which melanocyte destruction occurs in vitiligo
remain elusive. Flow cytometry, ELISA and cytotoxicity assays were used to examine the in¯uence
of activated skin homing cytotoxic T cells or their released products in melanocyte destruction in
vitro. Expression of cutaneous leukocyte antigens (CLA), FasL, CD69 and CD28 were up-
regulated on T cells from vitiligo patients. In addition, 5- h cytotoxicity assay by ¯ow cytometry
showed increase in melanocyte destruction after exposure to activated T cells. Furthermore,
supernatants from vitiligo T cells activated with crude melanocyte antigens or melanoma peptide
resulted in over two-fold increase in apoptosis compared to control. Serum from 12 of 16 vitiligo
showed higher amount of interferon g compared to nonvitiligo patients. Taken together, our data
suggest that the presence of activated skin homing cytotoxic T cells, their soluble products, and the
increased interferon g provide an ideal microenvironment necessary for apoptotic mediated
destruction of melanocytes in susceptible subjects. Supported in part by National Vitiligo
Foundation, American Skin Association and HU-RCMI
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Adult Dermatomyositis and Subacute Cutaneous Lupus Erythematosus are Oligogenic
Disorders Associated with Speci®c Polymorphisms of Mannose-Binding Lectin and
Tumor Necrosis Factora
V. P. Werth,*² G. Ang,* and K. E. Sullivan³
*Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; ²Dermatology,
Philadelphia V.A. Hospital, Philadelphia, Pennsylvania, U.S.A.; ³Immunologic and Infectious Diseases,
Children, Philadelphia, Pennsylvania, U.S.A.
Exposure of apoptotic keratinocytes to the immune system is a likely trigger of photosensitive
cutaneous autoimmune diseases. We previously reported that subacute cutaneous LE (SCLE) is
associated with an elevated frequency of the TNFa-308 A promoter polymorphism, which
increases TNFa production and presumably apoptosis compared to wild-type ±308G (Werth et al
JID 115 : 726,2000). Several proteins, such as mannose binding lectin (MBL) and C1q, are
involved in the clearance of apoptotic cells. We now report the frequency of three MBL
polymorphisms associated with decreased MBL protein production, MBL54A, MBL57A, and the
MBL-LX promoter polymorphism, in 37 patients with SCLE, 35 with dermatomyositis (DM), 36
with discoid lupus (DLE), and 167 normal controls. The frequency of the MBP54A allele was
signi®cantly increased in DM (0.37, p < 0.001), showed a trend towards an increase in SCLE
(0.23), but no increase in DLE (0.14; control value was 0.18). MBP57A was signi®cantly increased
in DM (0.14, p < 0.006) and DLE (0.14, p < 0.005), but not in SCLE (0.03; control value was
0.05). All groups showed statistically indistinguishable frequencies of MBP-LX. To examine
interactions between TNFa and MBL, we re-examined MBL polymorphisms in subjects strati®ed
by TNFa genotype. In DM patients homozygous for the TNFa-308G allele (GG), i.e. without
elevated TNFa production, 69% had at least two of the MBL polymorphisms, vs. 20% of healthy
GG controls (p < 0.0002). In DM patients with one ±308 A allele (GA), 46% had at least two MBL
polymorphisms, vs. 9% of GA controls (p < 0.03). In GA SCLE patients, 40% showed two or more
MBL polymorphisms, vs. 9% of GA controls (p < 0.02). We conclude that overproduction of
apoptotic keratinocytes resulting from the TNFa-308 A polymorphism and impaired clearance of
these cells from the MBL 54 A, 57 A, and LX polymorphisms contribute separately and in
combination to the pathogenesis of photo-induced autoimmune diseases.
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Host Defense Against Leishmania Major is Impaired in the Absence of Mast Cells
M. Maurer, M. Metz, J. Knop, and E. von Stebut
Dermatology, University Hospital Mainz, Mainz, Germany
We and others have shown that murine mast cells (MC) are essential for initiating protective innate
immune responses against bacterial pathogens such as E. coli and p. aeruginosa. Here, we asked
whether MC are also involved in controlling skin infections by the intracellular protozoan parasite
Leishmania major (LM). Genetically MC-de®cient KitW/KitW-v-mice and normal+/+ litter
mates (Kit+/+) were subjected to low dose infections with LM, a model for natural parasite
transmission (~103 metacyclic promastigotes/ear). Developing skin lesions were markedly larger
(~3-fold as assessed by planimetric analysis) in KitW/KitW-v-mice than in Kit+/+ mice at all time
points studied (every week, for 12 weeks). Kit+/+ skin lesion size reached a maximum 7 weeks
after infection (Kit+/+: 4.0 6 0.1 vs. 11.4 6 1.7 mm
3
in KitW/KitW-v), while lesions in KitW/
KitW-v-mice continued to increase for 9 weeks following infection (Kit+/+: 3.9 6 1.1 vs.
12.6 6 2.6 mm
3
in KitW/KitW-v at 9 week). In addition, the parasite burden of later skin lesions
was signi®cantly increased in KitW/KitW-v-mice as compared to Kit+/+ mice (Kit+/+: 3.2 vs.
27.3 3 103 LM/ear in KitW/KitW-v, 5 week after infection). Interestingly, early LM-lesions in
Kit+/+ mice contained nÄ3-fold more PMN than KitW/KitW-v-mice (Kit+/+: 14 vs. 4.2 3 10
3
PMN/ear in KitW/KitW-v, 18 h after infection), suggesting that MC may control skin infection
with LM by inducing early PMN in¯ux to LM lesions. To test whether the PMN-recruting
cytokine TNFa, of which large amounts are produced and stored by skin MC, is involved in the
initiation and development of anti-LM host defense, we assessed LM-infections in TNFa
±/±
mice.
As compared to +/+ litter mates, LM-induced skin lesions in TNFa
±/±
mice exhibited markedly
reduced numbers of PMNs and were signi®cantly larger. Thus, TNFa
±/±
mice showed a
phenotype similar to KitW/KitW-v-mice upon infection with LM, suggesting that MC may
contribute to immune responses against cutaneous LM-infection by release of TNFa. These
®ndings extend the view of MC as salient sentinels to innate host defense reactions against
intracellular pathogens.
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Proin¯ammatory IL-1a Induces Th1 Differentiation and Protective Immunity in
Leishmania-Susceptible BALB/c Mice Via Induction of IL-12
E. von Stebut, Y. Belkaid,² S. Lopez Kostka, E. Schmitt,* J. Knop, D. Sacks,² and M. C. Udey³
Department of Dermatology, University of Mainz, Mainz, Germany; *Institute of Immunology, University
of Mainz, Mainz, Germany; ²Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, Maryland,
U.S.A.; ³Dermatology Branch, NCI, NIH, Bethesda, Maryland, U.S.A.
Induction of protective immune responses against intracellular pathogens such as Leishmania is
strongly dependent on the induction of IL-12-dependent Th1 immune responses. Because skin-
dendritic cells (DC) from both resistant C57BL/6 and susceptible BALB/c mice release
comparable amounts of IL-12 when infected with L. major amastigotes and vaccinate against
leishmaniasis, we surveyed DC from both strains for production of other cytokines that might
in¯uence the outcome of infection. L. major-infected skin APC (including DC) produced
signi®cantly less IL-1a and b when isolated from BALB/c rather than C57BL/6 mice. Injection of
IL-1a into sites of parasite challenge during the ®rst 3 days after infection with standard high dose
inocula also dramatically reduced skin lesion sizes in both susceptible BALB/c as well as resistant
C57BL/6 mice when followed over the course of 3 months. In BALB/c mice, IL-1 administration
resulted in increased Leishmania-speci®c IFNg production and reduced IL-4 levels in draining
lymph node cells, and led to lesional parasite burdens that were decreased by several logs.
Surprisingly, IL-1 treatment (50 ng/mouse) was as ef®cient as administration of similar amounts of
recombinant IL-12. In IL-12p40-de®cient BALB/c mice, IL-1a did not improve disease outcome,
suggesting that IL-1a acts via modulation of IL-12-dependent Th1 differentiation. Taken together,
our data suggest that transient local administration of IL-1a acts via IL-12 to in¯uence Th1
development in cutaneous leishmaniasis and attenuates disease progression in susceptible BALB/c
mice. Therefore, differential production of IL-1 by APC in lesional tissues of C57BL/6 and
BALB/c mice may in¯uence the outcome of infection in these mouse strains.
684
Sphingosine 1-Phosphate Induces Chemotaxis of Immature and Modulates Cytokine-
Release in Mature Human Dendritic Cells for Emergence of Th2 Immune Responses
S. Dichmann,² M. Idzko,² P. Elisabeth,² S. Corinti,* A. Morelli, D. Ferrari, Y. Herouy,² M.
Mockenhaupt,² P. Gebicke-Haerter,² F. Di Virgilio, G. Girolomoni,* and J. Norgauer²
Experimental and Diagnostic Medicine, General Pathology, Ferrara, Italy; *Laboratory of Immunology,
Istituto Dermopatico dell Immacolata, Roma, Italy; ²Experimental Dermatology, University of Freiburg,
Freiburg, Germany
Sphingosine 1-phosphate (S1P) is a potent extracellular lysolipid phosphoric acid mediator that is
released after IgE-stimulation of mast cells. Here we investigated the biological activity and
intracellular signaling of S1P on human dendritic cells (DC), which are specialized antigen
presenting cells with the ability to migrate into peripheral tissues and lymph nodes, as well as
control the activation of naive T cells. We show that immature and mature DC express the mRNA
for different S1P receptors such as EDG-1, EDG-3, EDG-5 and EDG-6. In immature DC, S1P
stimulated pertussis toxin-sensitive Ca
2+
increase, actin-polymerization and chemotaxis. These
responses were lost by DC matured with lipopolysaccharide. In maturing DC, however, S1P
inhibited the secretion of tumor necrosis factor a and interleukin-12 whereas enhanced secretion of
interleukin-10. As a consequence, mature DC exposed to S1P showed a reduced and increased
capacity to generate allogeneic Th1 and Th2 responses, respectively. In summary, our study
implicates that S1P might regulate the traf®cking of DC and ultimately favor Th2 lymphocyte-
dominated immunity.
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Compound CCR5 Polymorphisms In¯uence R5 HIV Infection Levels in Langerhans
Cells: Implications for Sexual Transmission of HIV
T. Kawamura, F. Gulden,* D. McNamara,* M. Lederman,* P. Zimmerman,* and A. Blauvelt
Dermatology Br, NCI/NIH, Bethesda, Maryland, U.S.A.; *Department of Medicine, Case Western
Reserve University, Cleveland, Ohio, U.S.A.
Initial biologic events underlying sexual transmission of HIV are poorly understood, although it is
believed that epithelial Langerhans cells (LC) are initial targets for virus. It is also known that the
majority of transmitted viruses utilize CCR5 as a coreceptor for cell entry (termed R5 viruses). To
determine whether LC susceptibility to HIV is in¯uenced by CCR5 genotype, we performed a
prospective blinded study using 62 randomly selected healthy volunteers. As previously reported
(Kawamura et al J Exp Medical, 2000), LC within epidermal sheets were obtained from individuals
by suction blister technique and infected with HIVBaL (a prototypic R5 isolate); infection levels in
single LC were determined by ¯ow cytometry 3 days later. In addition, genomic DNA was isolated
from peripheral leukocytes, and post-PCR RFLP and ligase chain reaction analyses were used to
genotype two CCR5 loci (base pair ± 2459 in the CCR5 promoter region that contains either A/
A, A/G, or G/G and sequences in the CCR5 ORF that may contain a 32 nucleotide deletion
[D32]); polymorphisms in these regions have been previously shown to in¯uence HIV disease. We
found that LC from D32/wt individuals were signi®cantly less susceptible to HIV when compared
to LC from wt/wt individuals (p = 0.013). As well, LC from G/G individuals were slightly less
susceptible to HIV than LC from A/A individuals. Strikingly, further analysis of compound CCR5
genotypes revealed that LC from A/G + D32/wt individuals were very dif®cult to infect, showing
nearly 4-fold less susceptibility to HIV than LC from A/A + D32/wt individuals (p = 0.002). In
summary, we have shown that CCR5 genotype in¯uences R5 HIV infection of LC ex vivo. These
results suggest that compound CCR5 genotypes may determine host susceptibility to initial HIV
infection.
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Macrophage Recruitment to Sites of Cutaneous Granuloma Formation Results from
Chemokines Released by Neutrophils Recruited by Mast Cell-Derived TNFa
M. Metz, M. Maurer, G. Milon,* J. Knop, and E. von Stebut
Dermatology, University Hospital Mainz, Mainz, Rh.-Pf., Germany; *Unite d'Immunophysiologie et
Parasitisme Intracellulaire, Institut Pasteur, Paris, France
The early induction of cutaneous granuloma (CG) formation, e.g. in foreign body granulomas or
cutaneous lesions of leishmaniasis, is essential for the host's initiation of protective immune
responses. We have previously shown that the recruitment of neutrophils (PMN) as well as
macrophages (Mj) to sites of CG is largely dependent on mast cell (MC)-derived TNFa. Using
the murine model of polyacrylamide gel (PAG)-induced CG formation, we have now analysed the
mechanism of MC-TNFa-dependent Mj recruitment in more detail. C57BL/6 mice were
injected subcutaneously with PAG (Biogel p-100, 1 ml, back skin) and in®ltrating cells were
recovered from the granulomas for FACS analysis. Interestingly, onset and progression of TNFa-
induced PMN in¯ux correlated directly with the time course and extent of subsequent Mj
migration to developing CG, suggesting that TNFa may regulate Mj in¯ux via recruitment of
PMN, rather than attracting Mj directly. Depletion of PMN by mAb injection (clones NIMP-
R14 or 7/4, 100 or 200 mg i.v.) 1±3 h before induction of CG completely inhibited Mj in¯ux to
developing CG. Mj recruitment was restored to ~60% in PMN-depleted mice when CG were
reconstituted with PMN-supernatant twice daily as compared to vehicle-treated CG (5.5 6 0.4 vs.
1.6 6 0.8 3 106 Mj per granuloma, p < 0.001). RNAse protection assays revealed RNA for Mj-
recruiting MIP-1a, MIP-1b and MIP-2 in PMN isolated from 6 h and 12-h-old-granuloma.
Taken together, we show that MC-TNFa is responsible for recruiting PMN, which control the
in¯ux of CG-forming Mj by releasing chemokines. Therefore, our data suggest that MC are not
only critically involved in the induction of acute in¯ammatory processes (i.e. immediate
hypersensitivity reactions), but can also initiate and control long-term immune responses such as
Mj recruitment and granuloma formation.
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Development of an Active Mouse Model of Pemphigus Vulgaris by DNA Immunization
M. Barria, J. Uitto, and R. F. Ghohestani
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, U.S.A.
Development of an animal model of PV is crucial for creating novel approaches in immunotherapy
of the disease. A mouse model of PV has been recently established by adoptive transfer of
autoreactive splenocytes from desmoglein 3 (Dsg3) knockout mice into Rag2
±/±
immunode®cient
mice. However, handling of these mice is technically dif®cult. Dsg3 knockout mice develop
multiple oral lesions and ultimately dehydration and severe weight loss. Therefore, we determined
to develop an active model of PV by DNA immunization. cDNA coding for the full length (Dsg3)
was conjugated with Flag sequence and subcloned into a mammalian expression vector. The
resulting construct, using the in vitro transfection studies, was shown to express the full length Dsg3
as determined by Western blot using anti-Flag and anti-Dsg3 monoclonal antibodies. The
endotoxin free cDNA was then delivered into mouse skin using a ballistic particle-mediated
delivery system. The immunized mice developed anti-Dsg3 autoantibodies as determined by
immuno¯uorescence microscopy of lesional mucosal epithelium. Circulating antibodies to Dsg3
were detected by ELISA. T cells obtained from the immunized mice proliferated signi®cantly in
vitro in presence of Dsg3 as compared to the controls. Clinically, the immunized mice developed
hair loss and mucocutaneous lesions. These features were quite similar to those found in patients
with PV. This is the ®rst demonstration of development of an active model of PV in mice by DNA
immunization.
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The Autoantibody Response to Human Calreticulin Displays Features of a Nonclassical
Heat Shock Protein Autoimmune Response
D. Racila and R. D. Sontheimer
Dermatology, University of Iowa College of Medicine, Iowa City, Iowa, U.S.A.
Our laboratory has previously identi®ed CR as a polypeptide constituent of a subpopulation of
human Ro/SS-A (Ro) autoantigenic ribonucleoprotein particles. In addition, CR AAB have been
identi®ed in patients with Ro AAB-associated diseases such as subacute cutaneous lupus
erythematosus (SCLE), Sjo
È
gren's syndrome (SSj), and systemic LE (SLE). However, CR AAB
have also been associated and other disorders not associated with Ro AAB production such as
celiac disease, halothane hepatitis, and certain parasitic & viral diseases. To better understand the
clinical signi®cance of the CR AAB response, we have carried out a systematic analysis of CR
AAB levels in 408 individuals having various autoimmune disorders and normal pregnancy (SLE-
85, SCLE-12, discoid LE-31, newborns from mothers with SLE-83, dermatomyositis-13, SSj-68,
dermatitis herpetiformis-26, celiac disease-70, normal pregnant women-20). A puri®ed, full-length
recombinant form of human CR expressed in E. coli was employed in a direct ELISA technique.
Surprisingly, elevated levels of CR AAB were identi®ed in 20±40% of each of the disorders/
conditions examined. Since CR is a heat shock protein (HSP) and HSP autoantibodies are found in
approximately one third of patients having various autoimmune disorders, we examined the
relationship between the CR AAB response and classical HSP AAB responses in a subgroup of 76
autoimmune disease patients. We were unable to identify signi®cant correlations between CR
AAB and HSP70 AAB or HSP90 AAB levels in this subset of autoimmune disease patients. We
conclude that AAB reactive with the prokaryotically expressed form of human CR employed in
this study is a nonspeci®c feature of a substantial percentage of different autoimmune disorders and
that the CR AAB response is not merely re¯ective of a classical HSP AAB response.
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Inhibition of IL-12 Production by Human Blood Monocytes: Role of Soluble Factors
Secreted by Candida albicans
L. Liu,* K. Kang,* M. Takahara,* K. D. Cooper,*² and M. A. Ghannoum*³
*Dermatology, The Research Institute of University Hospitals of Cleveland, Cleveland, Ohio, U.S.A.;
²Dermatology, VA Medical Center, Cleveland, Ohio, U.S.A.; ³Center for Medical Mycology, University
Hospital of Cleveland, Cleveland, Ohio, U.S.A.
We explored the mechanisms of Interleukin-12 (IL-12) inhibition in monocytes (Mo) by soluble
factors secreted by C. albicans (CA). Yeast supernatants obtained from 20 h cultured wildtype and
mutant CA as well as S.cerevisiae (SC). Two hours post incubation of Mo with heat-killed CA
(HKCA,2 : 1), concentrated yeast supernatants were added and continued to incubate for 20 h.
Supernatants then were harvested and assayed for IL-12 with ELISA. Our data showed that the
supernatants of wild-type CA strongly inhibited the induced IL-12 by Mo while the supernatant of
SC did not (75 6 29 pg/ml and 211 6 61 pg/ml, respectively). Interestingly, even the supernatants
from germination-de®cient CA, HLC54 as well as its reconstructed strain, HLC84 suppressed IL-
12 induced by HKCA. In an effort to identify the components present in the supernatants that are
responsible for IL-12 suppression, preliminary study showed that the molecular weight of IL-12
inhibitors is greater than 30 Kda. Moreover, heating the supernatants did not abrogate the ability to
suppress IL-12, indicating that these components are heat-resistant and likely nonproteinaceous in
nature. Flow cytometry analysis of FITC-labeled CA and PE-labeled Mo showed that in contrast
to Cytochalasin D, the supernatant inhibitory factors did not affect the phagocytosis of heat-killed
CA spores by Mo. This suggests that the IL-12 inhibition effect is not due to failure of
phagocytosis. Our data indicate that CA inhibition of induced-IL-12 production by Mo can be
mediated by soluble factors released from CA but not the nonpathogenic SC. Further
characterization of these soluble factors is under investigation.
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The Effect of Dermatophytosis on Cytokine Production by Human Keratinocytes
M. Adachi, K. Tani, Y. Nakamura,* R. Kano,² A. Hasegawa,² N. Kanda, and S. Watanabe
Dermatology, Teikyo University, Tokyo, Japan; *Veterinary Internal Medicine, Nihon University,
Kanagawa, Japan; ²Pathobiology, Nihon University, Kanagawa, Japan
Super®cial mycoses such as cutaneous candidiasis and dermatophytosis (tinea) are common diseases
and are generally con®ned to the stratum corneum in the epidermis and cutaneous appendages. We
have previously reported that Candida albicans induce interleukin (IL)-8 production by human
keratinocyte (KC). The purpose of this study was to evaluate the effect of Trichophyton
mentagrophytes, T. rubrum and Microsporum canis on cytokine production by human
keratinocyte. After 3±24 h of coculture of KC with T. mentagrophytes, T. rubrum and M. canis,
the IL-1a, IL-8 and tumor necrosis factor (TNF)-a in the supernatant were measured by ELISA.
In the supernatants cocultured with T. mentagrophytes, the IL-8 was increased following
coculture, whereas the IL-1a and TNF-a was slightly increased but may not be associated with the
time course. There were no signi®cant differences of cytokine levels among KCs cocultured with
T. rubrum and M. canis and control KC. T. mentagrophytes did not induce IL-8 production from
KC through a ®lter (pore size: 0.1 micrometer), nor did heat-killed fungi. Taken together, these
results indicated that causative fungi of dermatophytosis could induce IL-8 production as well as
Candida albicans and that there were differences in their ability to induce cytokine production by
human keratinocytes between T. mentagrophytes and the others. Also, we concluded that the cell





Homozygous Variant of the Complement C1qA Gene Associated with Subacute
Cutaneous Lupus Erythematosus
R. D. Sontheimer, C. J. Sontheimer, A. Shef®eld, E. Racila, and D. Racila
Dermatology, University of Iowa College of Medicine, Iowa City, Iowa, U.S.A.
Our lab has had a long interest in better characterizing the etio-pathogenesis of photosensitive
forms of lupus erythematosus (LE)-speci®c disease such as subacute cutaneous LE (SCLE). Recent
work has indicated that C1q±calreticulin interaction may be involved in the physiological clearance
of UVB-induced apoptotic keratinocytes. We have therefore been probing for possible disease-
related polymorphisms within gene sequences that confer direct binding between the C1q
component of complement and the SCLE-related autoantigen, calreticulin. Using PCR
ampli®cation, direct DNA sequencing, single-stranded conformational polymorphism, and
restriction enzyme mapping of peripheral blood-derived genomic DNA we have identi®ed a
single nucleotide polymorphism (SNP) in the C1qA gene that is strongly associated with SCLE.
This SNP consists of adenine replacing the third guanine in the codon for amino acid residue
Gly70 that is located in the second exon of the C1qA gene. A survey of 19 SCLE patients showed
that 11 (58%) carried this SNP (which we have designated as C1qA-Gly70G > A) on both alleles
while 7 (37%) were found to be heterozygous. Only 1 patient (5%) did not exhibit this SNP on
either allele. C1qA-Gly70G > A was found on both alleles in only 1 of 24 (4%) healthy individuals
while 17 (71%) were heterozygous and 6(25%) showed an unchanged C1qA biallelic sequence.
Thus, the C1qA-Gly70G > A SNP is highly associated with SCLE (p < 0.0005). Although this
SNP does not encode a different amino acid, it does appear to be functionally signi®cant by virtue
of the fact that its presence correlates inversely with serum levels of C1q protein as determined by a
sandwich ELISA in the SCLE patients examined. The biological and clinical implicatons of these
®ndings will be discussed.
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The Sensitivity and Speci®city of `Caterpillar Bodies' in the Differential Diagnosis of
Subepidermal Blistering Disorders
M. A. Fung, D. Hoss, A. Berke, M. Murphy, and J. Grant-Kels
Dermatology, University of Connecticut, Farmington, Connecticut, U.S.A.
Caterpillar bodies (CB) are eosinophilic, elongated, segmented bodies located within the roofs of
blisters and are considered to represent a speci®c histopathologic feature of porphyric bullous
eruptions, including porphyria cutanea tarda (PCT) and erythropoietic protoporphyria (EPP). The
possibility that similar or identical bodies may be present in other disorders prompted further study
exploring the speci®city of CB in the differential diagnosis of subepidermal vesiculobullous
disorders. Seventy-®ve cases exhibiting subepidermal clefting at least 1.0 mm in diameter were
reviewed by all investigators using light microscopy during a 1-month period in 2001. Cases were
signed out from 1998 to 2001 and identi®ed by computerized database search. `Classic' CB were
present in PCT (6/14) and 1case of either venous stasis-associated bulla or bullosis diabeticorum.
CB-like rosettes or clusters containing eosinophilic globules and necrotic keratinocytes were
present in PCT (4/14), EPP (1/3) bullous pemphigoid (BP) (6/23), and junctional or dystrophic
epidermolysis bullosa (EB) (3/5). In some cases, classic CB and CB-like rosettes coexisted in a
blister roof. CB or CB-like areas were not identi®ed in any cases of dermatitis herpetiformis, linear
IgA bullous dermatosis, bullous erythema multiforme, epidermolysis bullosa acquisita, or wound
healing reactions. In conclusion, CB appear to represent a speci®c feature of PCT but were present
in less than half of those cases in this study. Clusters of CB-like segments are not speci®c and may
be present in PCT, EPP, pseudoporphyria, BP, EB, and EBA.
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Cellular Skin Model for In¯ammation
J. Franchi, C. Marteau, C. Crola,* M. Mitterrand,* P. Andre, and C. Kieda*
Laboratoires de Recherche et developpement, LVMH Branche Parfums et Cosmetiques, Saint Jean de Braye,
France; *Centre de Biophysique Moleculaire, UPR CNRS, Orleans, France
Upon exposure to physical or chemical stimuli, human skin elicits an in¯ammatory process that
profoundly in¯uences the biological functions of a variety of epidermal and dermal cells. This
creates, in association with skin in®ltrating cells, the production of pro-in¯ammatory soluble or
membrane-associated mediators which might be involved in intercellular communication. To
reproduce a key feature of this in¯ammation response following the insult (i.e. the movement of
leukocytes from blood vessels to a speci®c tissue: the skin), we established an in vitro model to
investigate human leukocyte adhesion to human endothelial cells from capillaries, stimulated by a
UV or neuropeptides-stressed human keratinocyte culture medium. Because vascular endothelial
cells act as a barrier and are decision makers which allow blood borne cells and molecules to enter
the tissues in a speci®c manner, they take an active part in the in¯ammatory reaction.
Consequently, they have to be taken into account as tools to evaluate the anti-in¯ammatory
properties of potentially active molecules. Furthermore, their highly speci®c reactions point out
that the signi®cance of such an in vitro model requires the choice of the proper cells from skin
origin. This is illustrated here by the identi®cation of stress-induced intercellular secreted mediators
(ELISA) and the observation of their direct in¯uence towards endothelial cells adhesion and
leukocyte recruitment capacity (¯ow cytometry).
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Immunohistochemical Evidence of Type I and Type II 5-a Reductase Isozymes in
Sebaceous Glands of Acne Lesions
J. T. Nguyen, S. Kim, R. Lavker, and J. J. Leyden
Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
The differential localization of the two isozymes of 5-a reductase has been extensively investigated
in various human tissues, including normal skin. However, the distribution of the isozymes in acne
lesions has not been clearly elucidated, though the type I isozyme has been presumed to the
predominant form since it is the type found in normal adult skin. Our goal was to determine the
isozyme pattern of 5-a reductase in the sebaceous glands of acne follicles compared to normal skin,
in hopes of gaining a better understanding of the hormonal mechanism underlying acne. We
performed immunohistochemical analysis with monoclonal antibodies speci®c for the two forms of
5-a reductase on specimens of normal skin and in¯ammatory acne lesions from 14 acne patients
and 7age-matched controls in order to detect which isozymes were present in various cutaneous
components, speci®cally the pilosebaceous units. Consistent with previous reports, our results
revealed the type I isozyme to be the predominant form in the sebaceous glands of normal skin
from both acne patients and controls. However, unlike prior studies, we identi®ed both type I and
type II 5-a reductase isozymes within the sebaceous glands of acne follicles. This apparent up-
regulation of the type II isozyme may be responsible for increased dihydrotestosterone production,
leading to increased sebum secretion with resultant formation of an acne lesion. Furthermore, type
II was the only isozyme reactive in the epithelium of hair follicles in both normal and acne skin.
Thus, we conclude that the type II 5-a reductase isozyme may be involved in the pathogenesis of
acne. These ®ndings have important implications for the therapy of acne with inhibitors of 5-a
reductase.
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Anti-In¯ammatory Properties of Narrow Band Blue Light
E. Shnitkind, Y. E, S. Geen, W. Lee, and A. R. Shalita
Dermatology, Sunydownstate Medical Center, Brooklyn, New York, U.S.A.
It has been shown that the release of cytokines from cutaneous cells is of major importance in the
initiation and development of many in¯ammatory skin disorders. High intensity narrow band blue
light (420 nm) has been shown to be safe and effective in the treatment of acne vulgaris by
exhibiting the phototoxic effect on the heme metabolism of Propionibacterium acnes. This study
was conducted to investigate the effect of narrow band blue light on the in¯ammatory process in
the presence and absence of cytokines and UVB using IL-1a and ICAM-1 as in¯ammatory
markers. Two immortalized keratinocyte cell lines were compared: HaCaT (produced by
spontaneous immortalization of genetically altered cell line) and hTERT (obtained by stable
transfection of primary cell culture with human telomerase reverse transcriptase). Cells were treated
with INF-g and TNF-a and exposed to UVB (310 nm at 50 mJ/cm
2
) and/or blue light (420 nm at
50 J/cm
2
). The expression of IL-1a and ICAM-1 was measured by quantitative ELISA at 48 h. The
experiments showed that blue light and low dose UVB treatment of HaCaT and hTERT cells
resulted in the inhibition of cytokine-induced production of IL-1a. The level of IL-1a decreased
by 60% in HaCaT and by 50% in hTERT cells when exposed to blue light. It decreased by 80% in
HaCaT and by 70% in hTERT cells when blue light was used in combination with UVB. ICAM-
1 expression was similarly reduced in HaCaT, but not in hTERT cells. This study showed that
high intensity narrow band blue light has anti-in¯ammatory effect on keratinocytes by decreasing
the cytokine-induced production of IL-1a and ICAM-1. In addition, blue light has been shown to
have synergistic effect with low dose UVB light. These results expand the properties of narrow
band blue light in modulating the in¯ammatory process and will facilitate testing of its photo-
therapeutic applications in the in¯ammatory skin conditions such as acne, atopic dermatitis and
psoriasis.
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Nobiletin, a Polymethoxy Flavonoid, Prevents Ultraviolet B-Induced Prostaglandin E2
Production by Inhibiting the Expression of Cyclooxygenase 2 and the Activity of
Cytosolic Phospholipase A2 in Human Keratinocytes
A. Ito, S. Tanaka, M. Yano,* and T. Sato
Department of Biochemistry, Tokyo University of Pharmacy & Life Science, Hachioji, Tokyo, Japan;
*Department of Citriculture, National Institute of Fruit Tree Science, Shimizu, Shizuoka, Japan
Exposure to ultraviolet B (UVB) irradiation induces acute in¯ammation of skin and prominent
visible signs are erythema (sunburn) and edema. Prostaglandin (PG)E2 is an in¯ammatory mediator
and its production is augmented primarily in epidermis by UVB irradiation. Cyclooxygenase 2
(COX-2) is a crucial enzyme to synthesize PGE2 under in¯ammatory conditions. Thus, the
inhibition of COX-2 activity may be effective in preventing in¯ammatory responses such as
erythema. On the other hand, ¯avonoids possess various pharmacological effects such as
antioxidant activity and antitumor-promoting activity. Recently, we have reported that nobiletin,
a polymethoxy ¯avonoid from Citrus depressa, inhibits the production of PGE2 in rabbit articular
chondrocytes and synovial ®broblasts (Ishiwa et al J. Rheumatol. 27, 2000). In the present study,
we investigated the effect of nobiletin on the production of PGE2 in UVB-irradiated human
keratinocytes. When the keratinocytes were irradiated with 60 mJ/cm
2
UVB, the production and
gene expression of COX-2, but not COX-1, was augmented along with an increase in PGE2
level. The augmented COX-2 production was transcriptionally abolished by nobiletin. In addition,
either the release of arachidonic acids (AAs) from membrane phospholipids or the gene expression
of cytosolic phospholipase A2 (cPLA2) was not altered in UVB-irradiated human keratinocytes.
However, nobiletin inhibited the release of AAs by which it might inhibit the activity of cPLA2.
Therefore, these results suggest that nobiletin inhibits the production of PGE2 by suppressing the
expression of COX-2 and decreasing the activity of cPLA2 in UVB-irradiated human
keratinocytes. Furthermore, nobiletin may become a therapeutic drug for preventing UVB-
mediated acute in¯ammation of skin.
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Induction of Generalized Skin Disease by Antigen-Speci®c Cytotoxic T Lymphocytes
That Develop Extrathymically
H. Azukizawa, H. Kosaka, S. Sano, S. Itami, and K. Yoshikawa
Department of Dermatology, Course of Molecular Medicine, Osaka University, Graduate School of Medicine,
Suita, Osaka, Japan
It has been widely accepted that attack by cytotoxic T lymphocytes (CTL) of the epidermis results
in development of generalized skin disease including drug eruption, viral exanthema, and GVHD,
although the underlying mechanism is still unknown. To examine whether CTL are involved in
damage of the epidermis under a given condition, we generated double transgenic mice carrying
both ovalbumin (OVA) which was expressed selectively in the keratinocytes under the keratin 5
(K5) promoter, and the Kb-restricted OVA-speci®c TCR transgene. In C57/BL6 background,
however, OVA-speci®c T lymphocytes were scarcely found in the periphery presumably because
of clonal deletion of the cells by OVA-expressing thymic epithelia, in which the K5 promoter was
active. Strikingly, in C57/BL6 nm/nm background, OVA-speci®c, Kb-restricted CTL propagated
in the regional lymph nodes, resulting in development of skin in®ltration, and ®nally, targeted to
the epidermis in eight weeks of age. They died of generalized epidermal damage, which was
mimicking toxic epidermal necrolysis. By contrast, no CTL propagation nor skin damage occurred
in nu/nm single transgenic mice in which keratinocytes did not express OVA. These results suggest
that effector CTL developed and underwent maturation extrathymically in response to speci®c
antigen of keratinocytes, and ®nally killed antigen-expressing keratinocytes. This animal model not
only provide a cue to investigate the mechanism by which CTL cause generalized skin lesion but
also imply the importance of extrathymical differentiation and maturation of effector T
lymphocytes reactive with skin-associated antigens.
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Propionibacterium Acnes Induces IL-8 Production Inhuman Monocytes via NF-kB
Activation
Q. Chen, T. Koga, H. Uchi, H. Hara, H. Terao, Y. Moroi, K. Urabe, and M. Furue
Dermatology, Kyushu university, Fukuoka, Fukuokaken, Japan
Propionibacterium acnes (P. acnes) causes an in¯ammatory acne that is characterized by massive
neutrophilic in®ltration. IL-8 is thought to play an important role in the pathophysiology of p.
acnes, but the mechanisms by which P. acnes up-regulates the release of IL-8 from target cells is
not well understood. This study investigated the mechanisms through which heat-killed P. acnes
induces IL-8 production in THP-1 cells (a human monocytic cell line). We found that P. acnes is
able to directly induce IL-8 production in a dose- and time-dependent manner and able to induce
the expression of IL-8 mRNA at 4 h±20 h and reached its peak at 8 h in human monocytic cells.
NF-kB luciferase activity was up-regulated in p. acnes stimulated THP-1 cells by NF-kB luciferase
reporter gene assay. Additionally, P. acnes-induced IL-8 secretion was inhibited by roxithromycin,
a macrolide antibiotic, and its inhibitory effect seemed to be partially associated with the inhibition
of P. acnes-induced NF-kB activation. This is the ®rst study to show that NF-kB activation is
involved in the IL-8 production of monocytic cells stimulated by P. acnes.
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Correlation Between the Level of Toll-Like Receptor 4 Expression and Cytokine
Production in Response to Lipopolysaccharide by Human and Mouse Keratinocyte Cell
Lines
H. Jang and C. L. Reardon
Dermatology, University of Colorado HSC, Denver, Colorado, U.S.A.
As an important constituent of the outer membrane of Gram-negative bacteria, lipopolysaccharide
(LPS) is a potent initiator of the innate antimicrobial in¯ammatory response. Toll-like receptor 4
(TLR-4) is well known to be a primary signal-transducing receptor for LPS in macrophages. From
our previous studies of LPS responses in keratinocytes, we asked the question if there was a
relationship between the baseline levels of cell-surface expression of TLR4, determined by ¯ow
cytometry, and degrees of stimulation by LPS, determined by the production of IL-8, for human
and mouse keratinocytes. By using the human macrophage cell line, U937, as a positive control, a
comparison was made between the levels of cytokine production following 24 h stimulation by
LPS and baseline TLR-4 expression for the human keratinocyte cell lines, A431, HaCaT, CL-22,
and mouse keratinocyte cell lines, Balb/MK, PAM 212. The cells fell into two functional
categories with the macrophage and mouse keratinocyte lines representing a high-expresser/
responder group, showing higher levels of TLR-4 expression and cytokine responses than the
human keratinocytes, a low-expresser/responder group. Moreover, when we examined up-
regulation of the level of TLR-4 expression following LPS stimulation, the macrophage and mouse
keratinocyte cell lines continued to be high-expresser cells, revealing higher levels of up-regulated
TLR-4 expression than the human keratinocyte lines which remained in the low TLR-4-expresser
group. In support, the cells fell into the similar groups following TLR-4 up-regulation by
paclitaxel which also binds TLR-4. In contrast, stimulation of the keratinocyte and macrophage
lines with IL-1b, although producing increases in cytokine production, did not up-regulate TLR-
4-expession in any of the cells, suggesting that cytokines are not the source for the increases in
TLR-4 expression. Our results suggest that differences in LPS responsiveness are re¯ected by the
levels of TLR-4 expression.
700
Production of Lipopolysaccharide-Binding Protein by Human and Mouse Keratinocyte
Cell Lines
P. Matheis, H. Jang, and C. L. Reardon
Dermatology, University of Colorado HSC, Denver, Colorado, U.S.A.
Lipopolysaccharide (LPS), a component of Gram-negative bacteria, is an initiator of the innate
immune response. As a means for detecting this bacterial product at very low levels, macrophages
produce lipopolysaccharide-binding protein (LBP), an acute-phase protein. It functions to bind
circulating LPS, creating a complex that binds to CD14 receptors on macrophages that transmit
signals through TLR-4 receptors. Our previous studies of LPS receptors on and responses by
keratinocytes led us to question if serum-derived LBP could reach the upper levels of the epidermis
or enter hair follicles at suf®cient quantities to help initiate in¯ammatory responses by the
keratinocytes. Because it seemed more ef®cient to produce LBP at the site in which it was
required, we evaluated whether or not keratinocytes could produce and secrete LBP. We assessed
production of LBP by the human keratinocyte lines, A431 and HaCaT, the murine keratinocyte
lines, PAM212 and Balb/MK, and the macrophage lines, U937 and THP-1, as positive controls.
By ¯ow cytometry, we evaluated the intracellular production of LBP in these cells. The cells were
®xed with paraformaldehyde, permeablized with saponin and incubated with anti-LBP
monoclonal and ¯uorescent secondary antibodies. The macrophage and human and mouse
keratinocyte lines were found to be producing intracellular LBP under standard culture conditions.
To determine that the LBP actually was secreted by the cells, we assessed culture supernatants for
the presence of LBP by using LBP-speci®c ELISAs. This method showed that the macrophage and
human and mouse keratinocyte lines all secreted LBP as well. We next determined if the secreted
LBP was functional. Anti-LBP monoclonal antibodies that block LBP interactions with CD14
were shown to block LPS stimulation of keratinocytes, as assessed by ELISA measurements of IL-8
production. Therefore, the data further emphasize the role that keratinocytes have in initiating
innate in¯ammatory responses by possessing the ability to recognize and respond to low levels of
bacterial products, such as LPS.
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Neutral Endopeptidase Expression and Activity are Differentially Regulated in Human
Dermal Microvascular Endothelial Cells Upon Stimulation with Neuropeptides,
Cytokines and Ultraviolet Light
S. Grundmann, M. Fastrich, T. Brzoska, T. A. Luger, and T. E. Scholzen
Department of Dermatology & Ludwig-Boltzmann Institute, University of MuÈnster, MuÈnster, Germany
Cutaneous neurogenic in¯ammation is modulated by the release of neuropeptides such as substance
(SP) or a-melanocyte stimulating hormone from sensory nerves or skin cells. The effect of SP to
trigger cellular responses is controlled by the presence and activity of SP-speci®c proteolytic
peptidases. We have previously demonstrated that functional inactivation of neutral endopeptidase
(NEP, EC 3.4.24.11) augments murine allergic contact dermatitis (ACD) via SP. In this study we
address the hypothesis that human dermal microvascular endothelial cell (HDMEC) NEP
expression and activity is regulated in response to cytokines, neuropeptides and ultraviolet (UV)
irradiation. HDMEC or the cell line HMEC-1 were stimulated with SP, CGRP, a-MSH, IL-1,
phorbol 13-myristate 12-acetate (PMA), or irradiated with UVB. Subsequently, semiquantitative
RT-PCR was performed using primers speci®c for NEP or b-actin. After 3 h, CGRP (10 nM), SP
(100 nM), a-MSH (10, 100 nM), IL-1 or PMA signi®cantly decreased constitutive NEP mRNA
levels compared to unstimulated controls. Conversely, the same mediators increased HDMEC and
HMEC-1 NEP mRNA levels after 6 h. UVB treatment (10 mJ/cm
2
) resulted in a sustained
reduction of HDMEC mRNA levels at 1, 3 and 6h. In accordance, on protein level HDMEC and
HMEC-1 NEP cell surface expression is down-regulated after 6 h in response to CGRP, IL-1 or
PMA. However, at 24 and 48 h in particular, IL-1 and PMA up-regulated NEP expression and
activity as determined by FACS analysis and NEP activity using the arti®cial substrate Glutaryl-
Ala-Ala-Phe-4-methoxy-b-naphtylamide. These data indicate that important in¯ammatory
mediators and UV light are capable of down-regulating NEP expression in HDMEC which
may temporally increase the susceptibility of these cells to SP and neuropeptides. Subsequently, up-
regulation of NEP expression and activity may have a signi®cant role in terminating cutaneous
in¯ammatory responses in vivo.
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Modulation of Protease-Activated Receptor-2 Expression in Skin Tissue and Cell Lines
N. Castex-Rizzi, N. Decanis, M. Charve
Á
ron, and Y. Gall
Cell Biology Laboratory, Institut de Recherche Pierre Fabre/CERPER, Toulouse, France
Protease-activated receptor-2 (PAR-2) is activated by cleavage of the N terminus of the receptor
by a serine protease such as trypsin or tryptase. PAR-2 is up-regulated in in¯ammatory skin of
patients with atopic dermatitis or psoriasis suggesting a role of PAR-2 in cutaneous in¯ammation.
Moreover, vascular component participates to the in¯ammatory process through leukocyte
in®ltration. Therefore, we were interested in assessing PAR-2 expression and its modulation in
endothelial (EA.hy926) and keratinocyte (HaCaT) cell lines, human skin, hair follicles and
keratinocytes freshly isolated from normal skin. PAR-2 activation was performed with speci®c
stimuli (agonist SLIGKV and trypsin) and in¯ammatory stimuli (TNFa and LPS). Inhibition of
PAR-2 activation was evaluated with soybean trypsin inhibitor (STI) and compared with a natural
soybean extract. Expression of PAR-2 was detected by RT-PCR (mRNA) and immunohis-
tochemistry (protein). Our results showed that PAR-2 mRNA was identi®ed in EA.hy926 and
HaCaT cell lines, and in keratinocytes and hair follicles originating from plastic surgery.
Immunolabelling corroborated these results. PAR-2 like immunoreactivity was present
throughout the skin with stronger labelling in the epidermis and skin appendages (sebaceous
and sweat glands, and hair follicles). PAR-2 mRNA was up-regulated at 4 h and protein was
increased at 24 h after treatments with the different speci®c and in¯ammatory stimuli. Finally,
speci®c PAR-2 inhibitors (STI and soybean extract) tested on cell lines and skin isolated elements
were able to reduce PAR-2 activation at transcriptional and traductional levels. In conclusion, we
have shown that PAR-2 is over-expressed in the human skin and cell lines during in¯ammatory
conditions. Moreover, serine protease inhibitors blocked PAR-2 expression suggesting that the
inhibition of the PAR-2 pathway by soybean extract may be an effective way for reducing skin
in¯ammatory responses.
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Major Histocompatibility Complex Related Gene (MICA) and HLA Class II are
Associated with Alopecia Areata in Multiplex Families
N. Barahmani, M. Duvic, J. Slusser,* and M. de Andrade*
Dermatology, MD Anderson Cancer Center, Houston, Texas, U.S.A.; *Health Sciences Research, Mayo
Clinic, Rochester, Minnesota, U.S.A.
Alopecia areata (AA) is an organ-speci®c autoimmune disease in which T-cells are directed against
the hair follicle causing patches of baldness (AA) or total hair loss (Alopecia Totalis, Alopecia
Universalis). The major histocompatibility locus (HLA) on human chromosome 6p encodes
polymorphic surface proteins of immune recognition and is also a major genetic susceptibility locus
for most autoimmune diseases. While both HLA class I and II associations have previously been
reported in unrelated AA patients, we found HLA class II antigens (DQB*302 and DRB4) are
strongly associated with AA in multiplex families. To further explore this association, polymorphic
alleles of 5 microsatelite markers (TNF-B, MICA, M6S166, M6S101, M6S151) spanning the HLA
class I region were genotyped using the polymerase chain reaction on genomic DNA samples from
members of 10 large multiplex AA families and the transmission disequilibrium test (TDT) was
applied. The major histocompatibility complex class I related gene-A or MICA, located 46 kb
away from HLA-B in the HLA class I region, was signi®cantly associated with AA (p = 0.012) and
the MICA*3 allele was also associated (p = 0.035). To determine whether class I and II HLA alleles
are independently associated with AA or are in disequilibrium, conditional TDT analyses was also
performed. Of interest, a signi®cant joint association between AA and DQ*302 and MICA*3
(p = 0.025) as well as between HLA-DRB4 and MICA*3 (p = 0.035) was found. This suggests an
extended HLA haplotype may contribute to genetic susceptibility to AA in families. Although this
is the ®rst report of an association between MICA and alopecia areata, MICA has also been
associated with a number of other autoimmune diseases such as psoriasis, diabetes, rheumatoid
arthritis, and Behcet's syndrome.
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Assessing the Role of the Platelet-Activating-Factor Receptor in Epidermal Cytokine
Production Using Tet-On Regulated PAF Receptor Antisense Gene Expression System
Y. Pei, T. Li, M. D. Southall, Q. Yi, and J. B. Travers
Dermatology, Indiana University, Indianapolis, Indiana, U.S.A.
Increasing evidence suggests that the lipid mediator platelet-activating factor (1-alkyl-2-acetyl
gycerophosphocholine; PAF) is involved in skin in¯ammation. Our group has previously shown
that not only do keratinocytes express functional PAF receptors, activation of the PAF receptor
resulted in cytokine biosynthesis in epidermal cells. The objective of these studies was to use an
inducible retroviral-based system to ablate endogenous PAF receptor expression with an antisense
construct. The Tet-on regulated gene expression system was used to express the antisense PAF
receptor cDNA in the PAF receptor positive human epidermal cell line HaCaT. Doxycycline
treatment of transduced HaCaT cells resulted in ablation of the epidermal PAF receptor as shown
by loss of PAF-induced intracellular calcium mobilization responses. Ablation of the endogenous
PAF receptor with this inducible antisense strategy blocked PAF-induced interleukin(IL)-8
production. In addition, IL-8 production induced by ultraviolet B radiation (a powerful inducer of
PAF production) was also signi®cantly diminished, which suggests a potential role of the PAF
system in UVB-induced cytokine production. However, IL-8 production in response to a phorbol
ester was not affected by ablation of the epidermal PAF receptor. These studies characterize a novel
model system to assess the role of the PAF system in epidermal function.
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Signaling Through Rho GTPases Mediates Spongiotic Change In Vitro
S. Yashar, D. C. Carranza, and M. S. Kolodney
Dermatology, UCLA, Los Angeles, California, U.S.A.
Spongiosis is the characteristic histologic manifestation of a broad class of in¯ammatory skin
diseases. Using a tissue culture model, we investigated the role of Rho GTPases in mediating
spongiotic change by functioning as intracellular signals controlling cell adhesion and contractility.
In this model, keratinocytes were cocultured with activated T lymphocytes for 24 h. The
keratinocytes developed intercellular gaps along with stretched bridges resembling in vivo
spongiosis. Gap formation was associated with disassembly of adherens junctions as evidenced by
disappearance of b-catenin at cell margins. Co-culture with activated T lymphocytes also decreased
the level of Rho activation (GTP Rho) in keratinocytes. To determine if Rho inactivation was
suf®cient to cause spongiotic change, we speci®cally inactivated keratinocyte Rho with C3
transferase. Rho inactivation caused loss of b-catenin at intercellular junctions as well as
morphological changes resembling spongiosis. To determine if Rho caused spongiosis through
inhibition of myosin based contractility, we directly inhibited myosin with 2,3-butanedione-2-
monoxime. Myosin inhibition was suf®cient to cause cell separation. Our results suggest that
inactivation of Rho may contribute to spongiotic change through inhibition of myosin function.
This work was supported by the Dermatology Foundation and the UCLA Short-term Training
Program.
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Pathogenicity Test of Pemphigus Vulgaris Autoantibodies: Use of Enzymatic Activity of
the Apoptotic Caspase 3
M. Frusic-Zlotkin, D. Goldshmit, X. Wang, M. David,* L. Maron,* B. Michel,² and Y. Milner
Biological Chemistry, Hebrew University of Jerusalem, Jerusalem, Israel; *Pathology, Rabin Medical Center,
Petach Tiqwa, Israel; ²Michel Skin Care Enterprises, Inc., Beachwood, Ohio, U.S.A.
In this work we undertook to set up a rapid assay for gauging pemphigus vulgaris autoantibodies
(PV-IgG) pathogenicity. The classical bioassay for PV-IgG activity is the induction of acantholysis,
either in organ culture of skin or in a nude mouse model, which are laborious and relatively
prolonged tests. Previously we have shown that in cell (normal human keratinocytes, HaCaT and
A431) and skin organ cultures, PV-IgG induced acantholytic lesions via apoptotic pathway
activation, similar to anti-FasR antibodies (Milner et al 1999., In The Decade of Autoimmunity,
Schoenfeld Y, ed. Elsevier Science. 197±207; Wang et al submitted to J. Clin. Invest.).
Accordingly, we established an assay using HaCaT cells grown on 96-well-plates and measured
caspase 3 activity (`executioner' caspase). Both rabbit polyclonal anti-PVA antibodies [directed
towards the whole desmoglein 3 molecule (Memar et al 1999., J Immun.157 : 3171±3177)] or
commercial anti-Dsg3 [directed towards residues 988±999 of Dsg 3 (Serotec Ltd, UK)] were active
in caspase 3 induction. Caspase activity in PV-IgG-treated keratinocytes (coincubated with either
10 ng/ml interferon-g or 2 mg/ml cycloheximide for 30±40 h) was proportional to the amount of
PV-IgG in cases of sera with titer 1:360±1:640 or higher. PV serum depleted of IgG did not
activate caspase 3. Both PV-IgG1 and PV-IgG4 from one sample caused strong caspase 3
activation. The caspase 3 assay was well correlated to the appearance of apoptotic/acantholytic
lesions in the culture and apoptotic cells elicitation (annexin V/propidium iodide test). Further
work is under way to ®nd conditions for determination of caspase 8 activation (initiating caspase) in
the same system, that will allow even shorter assays. We conclude that caspase 3 activity in cell
cultures is a fast and simple procedure for measurement of the pathogenicity of PV sera.
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Commensal and Pathogenic Bacteria Exhibit Differences in Induction and Susceptibility
to b-Defensins in Keratinocytes
L. P. Fredericks,* G. Darmstadt,§ J. Dinulos,¶ M. C. Roberts,² and B. A. Dale*³
*Oral Biology, University of Washington, Seattle, Washington, U.S.A.; ²Pathobiology, University of
Washington, Seattle, Washington, U.S.A.; ³Medicine/Dermatology, University of Washington, Seattle,
Washington, U.S.A.; §Dermatology, Save the Children, Washington, District of Columbia, U.S.A.;
¶Dermatology, Dartmouth, Hanover, New Hampshire, U.S.A.
As part of the innate immune system of the skin and oral mucosa, human b-defensins 1 and 2
(hBD1 and hBD2) help to protect these tissues from invading microorganisms. Skin and oral
keratinocytes constitutively express hBD1, while hBD2 is expressed upon stimulation by bacterial
cell wall components and proin¯ammatory mediators. Commensal bacteria are thought to out-
compete pathogens within their microenvironment, and do not infect the host except when they
escape their normal environment, and when patients are immunocompromised. Previous work
showed that keratinocytes respond differently to commensal and pathogenic bacterial exposure. An
oral commensal bacteria (Fusobacterium nucleatum), but not a pathogen (Porphyromonas
gingivalis), up-regulates the inducible hBD2 expression in oral keratinocytes (Krisanaprakornkit
et al 2000). F. nucleatum signals hBD2 up-regulation via stress signaling pathways (JNK and p38)
and not by the NF-kB pathway associated with in¯ammation and infection (Krisanaprakornkit et al
2002). Our objective in this study was to examine the relationship between commensal and
pathogenic bacteria andb-defensin expression and function in skin keratinocytes. As in oral
keratinocytes, we found that the commensal bacteria, Staphylococcus epidermidis, but not the
pathogen, Streptococcus pyogenes, up-regulates hBD2 expression. We also show that
S. epidermidis is more susceptible to hBD1 than hBD2. In contrast, S. pyogenes, is more
susceptible to hBD2. The constitutively expressed hBD1 may keep commensal bacteria from
becoming opportunistic pathogens. The commensal bacterial up-regulation of hBD2 may aid in
protecting the tissue against pathogens. We suggest that this re¯ects an intricate mutualism between
the host and its commensal bacteria. This pattern is consistent with the bene®cial coexistence of
commensal bacteria and the host tissue.
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MyD88 Over-Expression in Basal Layer Keratinocytes Enhances the Cutaneous
In¯ammatory Response
J. Murphy,* J. M. Jensen,*² and T. S. Kupper*
*Dermatology, Brigham & Women's Hospital, Boston, Massachusetts, U.S.A.; ²Dermatology, University
of Kiel, Kiel, Germany
Resting epidermal keratinocytes contain large stores of biologically active Interleukin-1a (IL-1a)
which can stimulate a rapid proin¯ammatory immune response. Upon release, IL-1a binding to
the Type I IL-1 receptor (IL-1RI) induces a signaling cascade that results in NFkB-translocation.
The consequent up-regulation of secondary cytokines, endothelial cell adhesion molecules, and
chemokines stimulates leukocyte recruitment to the site. MyD88 is a component of the highly
conserved IL-1 RI signaling complex but its precise role in skin homeostasis has not been de®ned.
To test the biological relevance of this important signaling molecule in skin, we have targeted
expression of murine MyD88 to the basal layer keratinocytes in FVB mice using the human keratin
14 promoter. Consistent with its role as a component of the IL-1 signaling cascade, over-
expression of MyD88 did not induce spontaneous in¯ammatory skin disease. Contact sensitizers
were applied epicutaneously to investigate the primary immune response of the K14/MyD strain.
Relative to their FVB littermates, naive MyD transgenic mice exhibited an enhanced ear swelling
response to the hapten Oxazalone which peaked 1 day after challenge. Despite the stronger ear
swelling response of the MyD Tg's, resolution of the induced-in¯ammation proceeded at a similar
rate for the Tg and control animals. Chronic application of PMA, a well-characterized stimulus of
IL-1 release, also induced an exaggerated ear swelling response in the Tg mice and it resolved at a
comparable rate to the FVB control littermates. These results suggest that the skin's cell-mediated
immune response to hapten involves MyD88, and that the in¯ammatory response is intact in the
skin of the K14/MyD Tg mice. Further characterization of this new model of in¯ammatory skin
disease will help to de®ne the biological role of MyD88 in the skin.
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Cytokine Pro®les in Animal Models of Alopecia Areata
L. Cao, L. Tang, J. P. Sundberg,* H. Lui, and J. Shapiro
Dermatology, The University of British Columbia, Vancouver, British Columbia, Canada; *Pathology, The
Jackson Laboratory, Bar Harbor, Maine, U.S.A.
An imbalance between pro-in¯ammatory cytokines and cytokine antagonists or inhibitors has been
one of the factors predisposing to initiation or perpetuation of various in¯ammatory and
autoimmune disorders. Alopecia areata (AA) is a common in¯ammatory disease targeting anagen
hair follicles. The cytokine pro®le of AA has not been extensively investigated. There are two well
known AA animal models: C3H/HeJ mice and Dundee experimental bald rat (DEBR). Using
real-time PCR and RNase protection assay, we have compared the cytokine expression pro®le
between normal C3H/HeJ mice and AA-affected mice, between normal Wistar rats and AA-
affected DEBR rats. Proin¯ammatory cytokines interferon-g (IFN-g), tumor necrosis factor-a
(TNF-a), and interleukin-12 (IL-12) are dramatically increased in the diseased mice. No
signi®cant changes were observed in the expression of IL-1b and IL-10. Interestingly, the
expression of TNF-a/b, IL-12 and IFN-g were consistently and signi®cantly decreased upon
successful treatment in AA-affected C3H/HeJ mice. The decreased expression of TNF-a and
IFN-g were also observed in DEBR rats after therapeutic hair restoration. In addition, IL-10 and
IL-1 receptor antagonist (IL-1ra) were consistently up-regulated upon successful treatment in
DEBR rats. Our data illustrates that various cytokines are involved in the in¯ammatory and
destructive changes during the development of AA as well as in reversing hair follicle activity




as an In¯ammatory Model for Preclinical Screening
T. J. Last, P. J. Hayden, B. Burnham, and M. Klausner
R & D, MatTek Corporation, Ashland, Massachusetts, U.S.A.
Organotypic skin models are becoming widely used by the pharmaceutical industry as an
alternative to animal testing for screening potential therapeutics for safety and ef®cacy. The purpose
of this study is to test if MatTek's EpiDerm skin model can be induced at the molecular level to
initiate an in¯ammatory response. EpiDerm is a highly differentiated, three-dimensional epidermal
tissues composed solely of keratinocytes. Skin keratinocytes are known to be involved with the
progression of numerous in¯ammatory skin diseases such as psoriasis and contact dermatitis.
Molecular markers of these skin diseases include intercellular adhesion molecule-1 (ICAM-1),
inducible nitric oxide synthase (iNOS) and interleukin 20 (IL-20). In the present work, EpiDerm
tissues were treated with a panel of cytokines including IFN-g, IL-1a, IL-1b, TNF-a, and various
combinations thereof. IL-20, iNOS and ICAM-1 message levels of the tissues were examined by
RT-PCR. IL-20 message levels are signi®cantly up-regulated by treatment with some of these
cytokines. Inducible nitric oxide synthase was also up-regulated. However, there were temporal
differences in response between the two genes. ICAM-1 levels were also enhanced following
cytokine treatment and detectable soluble ICAM levels were present in the supernatant, as analyzed
by ELISA. In conclusion, this study shows that genes important in in¯ammatory skin response can
be regulated in EpiDerm tissues by the various cytokines studied. Furthermore, these results suggest
that EpiDerm can be used as in vitro skin model for testing therapeutics that target suppression or
inhibition of in¯ammatory responses in epidermis.
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Efalizumab (Anti-CD11a) Inhibits Transendothelial Migration of T Cells
J. Lowe, E. Stefanich, L. Rangell, and S. Pippig
Developmental Sciences, Genentech, Inc., So. San Francisco, California, U.S.A.
This mechanism of action study investigated the effect of efalizumab on rhuSDF-1a/PBSF-
induced transendothelial migration of T-cells. Transendothelial migration of T-cells is used as an in
vitro assay to model in vivo migration of T-cells from blood vessels into tissues, such as in¯amed skin
of psoriasis patients. Previously, in vitro data demonstrated that efalizumab, a humanized
monoclonal IgG1 antibody binding to CD11a, the a chain of lymphocyte function-associated
antigen-1 (LFA-1), inhibits 2 processes considered to be important in psoriasis pathogenesis: T-cell
binding to endothelial cells and T-cell activation. To demonstrate that efalizumab can also inhibit
transendothelial migration of T-cells, the following experiments were performed. Human
peripheral blood mononuclear cells were isolated by Ficoll gradient centrifugation of buffy coats,
and after puri®cation processes, a yield of 4±20 3 10
7
of 97% pure T-cells was obtained from 1
buffy coat. Puri®ed T-cells were activated overnight on tissue culture ¯asks coated with anti-CD3
and anti-CD28 antibodies. T-cells were then ¯uorescently labeled and incubated with efalizumab
concentrations ranging from 0.001 to 100 000 ng/ml. Transendothelial migration assays were
conducted in transwell plates. Labeled T-cells were transferred to insert wells coated with a
monolayer of human umbilical vein endothelial cells (HUVECs). The T-cell chemoattractant,
rhuSDF-1a/PBSF, was added to the lower chamber and T-cells allowed to transmigrate in
response to this chemokine. The insert wells were then discarded and remaining transmigrated T-
cells quanti®ed by ¯uorescence. Efalizumab resulted in dose-dependent inhibition of rhuSDF-1a/
PBSF-induced T-cell transendothelial migration with an IC50 of 0.01 mg/ml. Maximal inhibition
of T-cell migration was achieved at 10 mg/ml efalizumab. The results suggest that efalizumab is
capable of inhibiting T-cell migration from blood vessels into the skin, thus targeting a crucial
mechanism involved in the pathogenesis of psoriasis.
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Toll-Like Receptor-2 is Expressed on Neutrophils in Skin Lesions of Erythema
Nodosum Leprosum
M. T. Ochoa, T. H. Rea,* and R. L. Modlin
Dermatology, University of California, Los Angeles, Los Angeles, California, U.S.A.; *Dermatology,
University of Southern California, Los Angeles, California, U.S.A.
ENL, a major cause of morbidity in patients with lepromatous leprosy, is characterized by the
in®ltration of neutrophils into the skin lesions of these patients. Given the role of TLR2 in
mediating innate immunity to mycobacterial lipoproteins, we sought to investigate the role of
TLR2 in the pathogenesis of ENL. Using immuno¯uorescence staining and confocal microscopy
analysis, we found expression of TLR2 in the skin lesions of patients with ENL. By confocal laser
microscopy, we determined that TLR2 was expressed on Cathepsin G+ neutrophils and on
CD68+ monocytes/macrophages within ENL cutaneous lesions. Expression of HNP 1, known to
be released by activated neutrophils, was greater in the lesions of the ENL patients compared with
the nonreactional lepromatous lesions from the same patients. Our data indicate that TLR2 is
expressed on PMNs and the antimicrobial peptide HNP-1 is produced at the site of disease in
ENL. This suggests a role for a TLR2 dependant mechanism that contributes to an antimicrobial
function and/or to the tissue damage observed in ENL.
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Chamomile Constituent (±)-a-Bisabolol Inhibits Lipopolysacharide Induced
Interleukin-12 and Monocyte Chemotactic Protein-1, But Not Interleukin-8, in the
Human Monocytic Cell Line THP-1
D. R. Smith and B. B. Fuller
Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City,
Oklahoma, U.S.A.
In¯ammatory skin disorders are characterized by marked increases in the presence of dermal and
epidermal monocytes and T-cells. These immune cells produce cytokines, such as monocyte
chemotactic protein-1 (MCP-1), interleukin-8 (IL-8), and interleukin-12 (IL-12), which are
required for the propagation of an in¯ammatory response. Inhibition of the production of these
cytokines would aid in the treatment of in¯ammatory skin disorders. The anti-in¯ammatory action
of chamomile has been recognized for many years. Topical formulations have proven to be useful
in skin conditions such as eczema, and may provide an effective alternative to cortisone creams for
many in¯ammatory skin diseases. Chamomile contains 0.24%-1.9% volatile oil, and up to 50% of
this volatile oil is composed of (±)-a-bisabolol. Experiments conducted in rat paw edema models
have shown that (±)-a-bisabolol has prominent anti-in¯ammatory effects. The means by which (±
)-a-bisabolol is able to reduce in¯ammation is unknown, but is most likely due to the ability to
inhibit in¯ammatory cytokine production. Lipopolysacharide (LPS) induces cytokine production
in many cell types, including the human monocytic cell line THP-1. The present studies were
carried out to determine the effects of (±)-a-bisabolol on LPS-induced production of MCP-1, IL-
12, and IL-8 in THP-1 cells. Using ELISA analysis, we determined that (±)-a-bisabolol inhibits
LPS induced MCP-1 and IL-12 production, but failed to inhibit IL-8 production. Similar results
were obtained at the mRNA level using a ribonuclease protection assay. Reporter assays with an
AP-1 or NF-kB consensus element were used to determine which promoter regions are inhibited
by (±)-a-bisabolol. These results suggest that the anti-in¯ammatory properties of (±)-a-bisabolol
are due to the ability to inhibit cytokine production.
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Limitations in ELISA Assays for Antibodies Dsg1 and Dsg3 in Patients with Pemphigus
A. Akman, D. Jiao,* and J. Bystryn*
Dermatology, Cukurova University, Adana, Turkey, Turkey; *Dermatology, New York University, New
York, New York, U.S.A.
The aim of this study was to re-evaluate indirect immuno¯ourescence (IIF) autoantibodies titers
comparing Dsg 1 and Dsg 3 ELISA results for disease monitoring. Recently a commercially
available enzyme-linked immunosorbent assays (ELISA) have become available to measure the
antibodies against desmoglein (Dsg) 1 and Dsg 3 which are associated with pemphigus vulgaris
(PV) and pemphigus foliaceus (PF). Samples were analysed from 47 subjects with PV and 26 with
PF by IIF and ELISA. The ®rst limitation that became evident is that the results of ELISA are no
longer quantitative at high IIF antibody titer. There isn't a linear relation between IIF titers and
ELISA results after IIF titers increase above 640. The probable explanation for the plateau in index
values reading at high IIF antibody titer is that the limited amount of antigen present on the ELISA
is saturated in the presence of excess antibodies againts Dsg 1 and Dsg3. A second limitation is that
there is a wide variation in the results of ELISA among sera that have identical level of antibodies
by IIF. There were differences of 1,7±2,7 fold in index valeus among sera with identical IIF
antibody titers. ELISA assays provide a powerful new tool to evaluate antibodies Dsg 1 and Dsg3 in
patients with pemphigus, but the results of the assay as currently conducted are not quantitative in
patients with high levels of these antibodies. There are discrampancies between the results of IIF





Propionibacterium Acnes Induction of Pro-In¯ammatory Cytokines in
Polymorphonuclear Cells Occurs Through Toll-Like Receptor 2: The Role of Innate
Immune Response in Acne Vulgaris
J. K. Lee, B. Duong, M. Ochoa, A. Legaspi, R. L. Modlin, and J. Kim
Division of Dermatology, UCLA School of Medicine, Los Angeles, California, U.S.A.
One of the factors that contributes to the pathogenesis of acne is Propionibacterium acnes, a gram-
positive anaerobic pleomorphic diptheroid which is a part of normal skin ¯ora, but can be
signi®cantly increased in pilosebaceous units of patients with acne. One way in which p. acnes
contributes to the in¯ammatory nature of acne is by inducing neutrophils to secrete
proin¯ammatory cytokines including TNF-a, IL-1b and IL-8. In this way, polymorphonuclear
cells, part of the innate immune system, are thought to play an important role in the development
and maintenance of in¯ammatory responses in acne. The exact mechanism of how P. acnes induces
cytokine production in human neutrophils is not known. Recent studies have demonstrated that
innate cells express Toll-like receptors (TLRs) and mediate antimicrobial response upon activation
by pathogens. We investigated whether Toll-like receptor 2 mediates P. acnes induced cytokine
production in acne. We found that in acne lesions TLR2 was expressed on the cell surface of
polymorphonuclear cells surrounding the pilosebaceous units. In addition, we found that
proin¯ammatory cytokine, TNF-a, was released by PMNs upon activation with P. acnes. This
cytokine production was inhibited by addition of TLR2 blocking antibody but not by addition of
control antibody. These data suggest that TLR2 is the direct mediator of signaling by P. acnes in
neutrophils and may initiate the innate immune response in the pathophysiology of in¯ammatory
acne. As such, TLR2 may provide a novel target for treatment of this common skin disease.
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The In¯uence of Lysophosphatidic Acid on Migration, Intracellular Signaling, Cytokine
Release and Priming Properties in Human Dendritic Cells
J. Norgauer, S. Dichmann, E. Panther, M. Idzko, P. Gebicke-Haerter, S. Cortini,* and G.
Girolomoni*
Experimental Dermatology, University of Freiburg, Freiburg, Germany, Germany; *Laboratory of
Immunology, Istituto Dermopatico dell Immacolata, Rome, Italy
Lysophosphatidic acid (LPA), is a bioactive lipid mediator, which is generated by secretory
phospholipase A2 (PLA2). Here we studied the biological activity and intracellular signaling of
LPA on human dendritic cells (DC), which are specialized antigen presenting cells characterized by
their ability to migrate into target sites and secondary lymphoid organs in order to process antigens
and activate naive T cells. We show that immature and mature DC express the mRNA for
different LPA receptors such as EDG-2, EDG-4 and EDG-7. In immature DC LPA stimulated
pertussis toxin-sensitive Ca
2+
increase, actin-polymerization and chemotaxis. During the
maturation process DC lost their ability to respond towards LPA with Ca
2+
-transients, actin
polymerization and chemotaxis. However, in LPS-differentiated DC LPA inhibited the secretion
of tumor necrosis factor a and interleukin-12 as well as enhanced secretion of interleukin-10. As a
consequence LPA impaired the ability of mature DC to generate allogeneic Th1 response. In
summary, our study implicate that LPA might regulate the traf®cking of DC and ultimately favor
Th2 lymphocyte-dominated immunity.
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Resveratrol Inhibits Ultraviolet B Radiation-Mediated Activation of Nuclear Factor kB
in Normal Keratinocytes
V. M. Adhami, F. Afaq, and N. Ahmad*
Dermatology, Case Western Reserve University, Cleveland, Ohio, U.S.A.; *Dermatology, University of
Wisconsin, Madison, Wisconsin, U.S.A.
Excessive solar ultraviolet (UV) exposure, particularly its UVB component (290±320 nm), results
in a variety of cutaneous disorders including skin cancers, photoaging and immune suppression.
The exogenous supplementation of the skin with antioxidant agents could ameliorate the adverse
effect of UV exposure. Resveratrol (3, 4¢, 5-trihydroxystilbene), a polyphenolic antioxidant
chemopreventive agent found in grapes and red wine, has been shown to afford protection against
many cancers including skin cancer and UV-mediated damages. The mechanism of its action is not
well-de®ned. In this study, we investigated the involvement of nuclear factor kB (NF-kB), a redox
sensitive transcriptional factor that plays a critical role in many physiological processes, as a
mechanism of prevention of UV-mediated damage by resveratrol employing normal human
epidermal keratinocytes (NHEK). NHEK were treated with resveratrol (5, 10 and 25 mM) for 24 h
(for dose- dependent studies) or with 5 mM resveratrol for 12, 24 and 48 h (for time- dependent
studies) followed by exposure to UVB (40 mJ/cm
2
). Six hours following UVB exposure, the cells
were washed and further studies were performed. Immunoblot analysis demonstrated that
resveratrol treatment of NHEK inhibited UVB-mediated (i) phosphorylation and degradation of
IkBa, and (ii) activation of IKKa, in dose- as well as time- dependent fashion. Employing
immunoblot analysis, enzyme linked immunosorbent assay and gel shift assays, we found that
resveratrol treatment to the cells resulted in signi®cant dose- and time- dependent inhibition of the
UVB-mediated activation and nuclear translocation of NF-kB/p65. This study suggested the
involvement of NF-kB pathway, as the mechanism of chemoprevetion of UV responses by
resveratrol.
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Macrophage Migration Inhibitory Factor Mediates UVA-Induced Matrix-
Metalloproteinase-1 (MMP-1) Synthesis by Human Dermal Fibroblasts
H. Watanabe, T. Shimizu, R. Abe, J. Nishihira,* and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan; *Central
Research Institute, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Matrix metalloproteinases (MMPs) are believed to be responsible for human skin dermal
photoaging. MMP-1 is a member of MMPs and degrades types 1 and 3 collagens that are major
components of the dermis. Ultraviolet (UV) irradiation up-regulates the production of various
in¯ammatory cytokines. In this study, we evaluated the involvement of macrophage migration
inhibitory factor (MIF) on MMP-1 expression by UVA stimulation in cultured human dermal
®broblasts. UVA (10 J/cm
2
) up-regulated MIF expression at the protein level. MIF (100 ng/ml)
induced the elevation of MMP-1 mRNA and MMP-1 protein in human dermal ®broblasts. UVA-
induced MMP-1 mRNA production was inhibited by anti-MIF neutralizing antibodies when
added to ®broblast cultures. We also investigated the signal transduction pathway involved in MIF
synthesis. The up-regulation of MMP-1 mRNA by UVA stimulation was inhibited by the PKC
inhibitor (GF109203X), src-family tyrosine kinase inhibitor (herbimycin A), tyrosine kinase
inhibitor (genistein), PKA inhibitor (H89), and MEK inhibitor (PD98089) but the p38 inhibitor
(SB203580) had no effect on the expression of MMP-1 mRNA. Phosphorylation of PKC (pan),
Raf, and MAPK were recognized by Western blot analysis. The DNA binding activities of AP-1
were up-regulated 1 h after MIF stimulation. Taken together, these results suggested that MIF is
involved in the up-regulation of UVA-induced MMP-1 in human dermal ®broblasts through
PKC, PKA, src-family tyrosine kinase, MAPK and AP-1 dependent pathways.
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Granulysin has Antimicrobial Activity Against Propionibacterium Acnes
B. T. Duong, D. Khandabi, R. L. Modlin, and J. Kim
Dermatology, University of California, Los Angeles, Los Angeles, California, U.S.A.
Propionibacterium acnes is a gram-positive anaerobic bacteria associated with acne vulgaris.
Cytolytic T cells contribute to host defense against microbial pathogens through release of the
antimicrobial peptide granulysin. Since T cells are prevalent in acne lesions, we sought to
determine if granulysin or granulysin peptides exhibited antimicrobial activity against P. acnes.
Puri®ed granulysin or peptides derived from the amino acid sequence of granulysin were incubated
with P. acnes for 3 h and colony forming units were determined. Granulysin killed P. acnes in a
dose-dependent manner, with 98% of bacteria killed at 10 mM granulysin. A peptide corresponding
to amino acids 31±50 of granulysin also killed P. acnes, although 5-fold higher concentrations were
needed to achieve the same level of killing. Peptides corresponding to amino acids 1±35 and 36±70
showed evidence of lower antimicrobial activity. Neither granulysin nor peptide 31±50 was
cytotoxic against a keratinocyte cell line, as assessed by a colorimetric MTT (tetrazolium) assay.
Our data indicate that granulysin kills P. acnes and may control growth of this bacterium in acne
lesions. Thus, granulysin may have therapeutic applications for the treatment of acne.
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Narrow Band Ultraviolet B Treatment of Vitiligo and In¯ammatory Dermatoses
S. S. Yashar, R. Gielczk, and H. W. Lim
MD Dermatology, Henry Ford Health System, Detroit, Michigan, U.S.A.
Narrow band ultraviolet B (NB-UVB) therapy has been used for the treatment of in¯ammatory
and pigmentary skin disorders. Here we report a retrospective analysis of our experience during the
past four years, using NB-UVB to treat 77 patients with vitiligo, and 40 patients with various
inlfammatory disorders including atopic dermatitis (7), polymorphous light eruption (7), lichen
planus (6), lichen simplex chronica (3), granuloma annulare (2), pytiriasis lichenoides chronica (2),
and pruritus (6). Patients with psoriasis and mycosis fungoides were not included in this report.
Medical records were reviewed and patients were interviewed. Vitiligo patients were treated with a
starting dose of 280 mJ/cm
2
, with 10±15% dose increments at each subsequent treatment. Non-
vitiligo patients were started at a dose of 70% of the minimal erythema dose to NB-UVB. Ef®cacy
was evaluated by improvement in lesions and symptoms. Safety was evaluated by review of adverse
effects immediately following phototherapy and during follow-up interviews and examinations.
Repigmentation was noted in the the majority of vitiligo patients, with the face and trunk having a
better response than the extremities. Thirty patients experienced signi®cant improvement, 17
moderate, 16 mild, 8 no improevement; 6 were lost to follow-up. Associated laboratory
abnormalities in vitiligo patients included hypothyroidism in 6.4% of patients (4/67), and anemia in
5.9% (4/68). NB-UVB was also ef®cacious in a large proportion of patients with in¯ammatory
dermatoses. Follow-up was available for 37 patients with in¯ammatory disordrs. Sixteen patients
experienced signi®cant improvement (43%), 7 moderate improvement (19%), 7 mild (19%), and
7showed no improvement (19%). NB-UVB was generally well tolerated. The most common
adverse effects were mild to moderate transient erythema and pruritus. Our experience has shown
that NB-UVB is a safe and ef®cacious therapy for vitiligo and in¯ammatory dermatoses.
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Differing Effects of Bicyclic Monoterpene Diols and UV Irradiation
E. Kraus, S. Boumakis, J. Galvin, E. Boamah, D. Yarosh, and D. A. Brown
Research, AGI Dermatics, Freeport, New York, U.S.A.
Previous studies have demonstrated that Bicyclic Monoterpene (BMT) diols induce melanogenesis
using the same molecular pathways as UV-B in both S91 mouse melanoma cells as well as in
normal epidermal melanocytes. The purpose of this study was to compare the effects of BMT Diols
and UV irradiation on signaling molecules, cell cycle arrest and p53 induction. We investigated
whether BMT diols, like UV irradiation, would increase the secretion of Tumor Necrosis Factor-
a (TNF-a) and Prostaglandin E2 (PGE2). These primary cytokines are responsible for
in¯ammatory and immunosuppressive responses in skin after UV-B irradiation and their over-
expression may contribute to carcinogenesis. BMT diols did not induce TNF-a or PGE2 secretion
in the absence or presence of hydrocortisone (which favors the expression of TNF-a) while UV-B
induced a 3.6-fold increase in TNF-a and 2-fold increase in PGE2. Moreover, pretreating the
cultures with BMT diols did not affect the induction and secretion of either cytokine following
UV-B irradiation. UV-B irradiation causes DNA damage and induces a cell cycle arrest through
the activation of the tumor suppressor protein p53. Cell cycle progression studies using FACS
analysis demonstrated that the BMT diols cause a dose dependent decrease in the number of cells
entering into S and G2 phase of the cell cycle and an increase the number of cell remaining in G1.
FACS analysis also demonstrated that the decrease in cell number was not due to apoptosis but
rather a slower growth rate. Western blot analysis demonstrated that BMT diols did not induce p53
expression. This would suggest that while the BMT diols decrease cell growth, the arrest observed
is not due to a p53 induced cell cycle arrest after DNA damage. In summary, while UV irradiation
and bicyclic monoterpene diols both induce melanogenesis, the BMT diols do not induce signaling
events associated with carcinogenesis.
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Exposure of Fibroblasts to Telomere 3¥ Overhang Speci®c DNA Enhances Repair of




nger, G. Z. Li, D. Luo, M. Eller, and B. A. Gilchrest
Dermatology, Boston University, Boston, Massachusetts, U.S.A.
Previous work from our group demonstrated that 11-base oligonucleotides homologous to the
TTAGGG repeats of telomeres (11mer-1), but not oligonucleotides with complementary (11mer-
2) or unrelated sequences (11mer-3), induce DNA damage responses in a variety of different cell
types, with up-regulation and activation of p53, S-phase arrest, senescence, apoptosis, and
pigmentation. In order to further characterize this sequence-speci®c DNA damage response and to
clarify whether it provides protection against UVB-induced mutagenesis, we investigated DNA
repair of UVB-induced DNA damage with the reporter gene plasmid plucCMV and UVB-
induced mutation formation with the HPRT-assay following 2 day incubation of human neonatal
®broblasts with either diluent, 11mer-1, ±2, or ±3 (40 mM). Only 11mer-1, but not 11mer-2 or ±3,
induced a transient S-phase arrest (seen by FACS-analysis and cell counts) and p53 up-regulation
and phosphorylation (shown by Western blot). Reactivation of plasmids irradiated with 0.05 and
0.1 J/cm
2
UVB was 80±100% higher in cells pretreated with 11mer-1 than in diluent pretreated
controls. This effect, which demonstrates enhanced DNA repair by transfected host cells, was not
seen with the 11mer-2 or ±3. In the HPRT-mutagenesis assay, the frequency of HPRT-mutations
was 17.7 mutants per 106 colony forming cells (CFC) after irradiation with 20 mJ/cm
2
UVB,
which was 59-fold higher than the spontaneous mutation frequency in the unirradiated control.
Pretreatment with 11mer-1, but not with 11mer-2, reduced the frequency of UVB-induced
mutations to background levels (0.3 mutants per 106 CFC). These data show that treating cells
with the telomere 3¥ overhang DNA sequence speci®cally prevents mutation formation after
UVB-exposure, at least in part by enhancing DNA repair. This further supports the hypothesis that
exposure of such sequences by telomere disruption is a physiologic signal for an SOS-like DNA
damage response in human cells, and that this response is highly protective against UV-
mutagenesis.
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CD11b-Dependent iC3b Transient Arrest of Dermal and Blood Monocytic Dendritic
Cell Precursor Differentiation
M. Takahara,*² K. Kang,* L. Liu,* Y. Yoshida,² T. S. McCormick,* and K. D. Cooper*
*Dermatology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio,
U.S.A.; ²Dermatology, Kyushu University, Fukuoka, Japan
We have shown that iC3b is critically involved in UV-induced immunosuppression. One
mechanism may be that iC3b inhibits up-regulation of CD1c and CD40 expression on monocytes
(Mo) induced by GM-CSF, indicating that iC3b may be involved in the delayed reappearance of
CD1c + DC after UV. In this study, we further identi®ed the effect of iC3b on Mo differentiation.
(1) To determine if Mo exposed to iC3b terminally differentiate away from a DC lineage, Mo
were re-stimulated with IL-4 + GM-CSF for 3 days after removal of iC3b. Almost the entire
population of CD1c- cells after initial iC3b exposure were differentiated into CD1c + CD14- cells,
indicating that these cells still retain a capacity to differentiate into DC and are only temporarily
arrested. (2) To verify this effect is iC3b-CR3 ligation speci®c, we utilized an anti-CR3 Ab in
which the binding site overlaps the I region that binds iC3b. Pre-incubation with this Ab reversed
inhibition of CD1c expression by iC3b. (3) To determine if iC3b-modi®ed DC precursors are also
functionally altered, iC3b-treated Mo cultured with GM-CSF for 3 days were stimulated with
LPS + IFN-g. ELISA analysis showed that the iC3b-regulated cells produced a reduced amount of
IL-12, but not IL-10. (4) To determine if cells in dermis also could be modi®ed by iC3b, dermal
cells from keratomes harvested 6 h after UV (when newly immigrating monocytic cells are present)
were incubated with iC3b. HLA-DR + cells were analyzed by ¯ow cytometry and the number of
CD1c + cells was reduced by 38.2 6 22.2%, indicating that at least a subset of Mo entering or in
the dermis are still in a suf®ciently precursor state to undergo iC3b-induced arrest of DC
differentiation. Taken together, the criticality of iC3b and CD11b for UV-induced immune
suppression may be due to the ability of iC3b to transiently arrest monocytic DC precursor
differentiation.
726
Photodynamic Therapy-Induced Suppression of Cell-Mediated Immune Responses is
Mediated by CD4+ T Lymphocytes
N. Yusuf, C. A. Elmets, and S. K. Katiyar
Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
Photodynamic therapy (PDT)is a new modality with known ef®cacy for actinic keratoses and
nonmelanoma skin cancers. However, previous studies in mice have shown that this modality is
immunosuppressive and can inhibit the induction of contact hypersensitivity responses. The
purpose of this study was to determine the T-cell responsible for suppression of this response. Non-
tumor bearing CD4 knockout (CD4KO) mice and their wild type (WT) C3H/HeN counterparts
were subjected to phthalocyanine 4 (Pc4)-PDT in an identical manner as used for tumor regression
(1 cm spot size, 0.5 mg/kg Pc4110 J/cm
2
672 nm light from a diode laser). Three days after that,
attempts were made to sensitize the mice to dinitro¯uorobenzene (DNFB) on the unirradiated
abdomen. The magnitude of the cell-mediated immune response was assessed by applying DNFB
to the ear ®ve days after sensitization. As expected, WT C3H/HeN mice treated with Pc4 PDT
had a markedly suppressed response (89% 24 h after ear challenge). CD4KO mice developed
signi®cantly less immunosuppression (45%). The same trend was observed at 48 h, although there
was less immunosuppression among all groups at that timepoint (30% in CD4KO and 52% in WT).
These studies indicate that Pc4 PDT-induced suppression of cell-mediated immune responses is
mediated at least in part by CD4+ cells. Efforts to reduce the immunosuppressive effects of Pc4
PDT through manipulation of T-cell subpopulations that are activated may prove bene®cial in
enhancing the therapeutic ef®cacy of this new modality. Procedures that limit PDT induced
immunosuppression but do not affect PDT induced regression of tumors may prove superior to
PDT alone in promoting long-term antitumor responses.
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Three Independent Pathways Mediate Mitochondrial Cytochrome C Release During
UV-Induced Apoptosis
D. Kulms, B. Po
È
ppelmann, E. Zeise, and T. Schwarz
Dermatology, Cell Biology, Muenster, Germany
During UV-induced apoptosis nuclear DNA damage as well as direct activation of death receptors
play a major role, both pathways contributing independently to the UV response. Enhancement of
DNA repair via photoreactivation and inhibition of cell death receptor clustering by irradiating
cells at low temperature resulted in a strong reduction but was never able to completely inhibit
UV-induced apoptosis. Another important event during UV-induced apoptosis is the release of
cytochrome c (cyto c) from mitochondria into the cytoplasm. We tried to ®nd out whether UV-
induced cyto c release is functionally connected to DNA damage, to death receptor activation or
represents a third independent pathway. Activation of the cell death receptor CD95 results in
activation of upstream caspase 8 which at the same time mediates activation of the effector caspase
3 and cleavage of the proapoptotic bid protein. Activated bid then interacts with the antiapoptotic
bcl-2 protein leading to cyto c release from mitochondria. Furthermore, proapoptotic bax protein,
which also interacts with bcl-2, is known to be up-regulated by damaged DNA following UV
irradiation. Utilization of the free radical scavenger pyrolidene-dithiocarbamate (PDTC) indicated
that formation of reactive oxygen species (ROS) following UV irradiation directly triggers cyto c
release independent from UV-induced DNA damage or death receptor activation. Time course
experiments revealed that ROS formation occurs prior to cyto c release and can only be avoided by
early application of PDTC. Finally, inhibition of DNA damage via photoreactivation plus blockade
of death receptor signalling via inhibition of upstream caspase-8 by zIETD plus free radical
scavenging by PDTC reduced the UV-induced apoptosis rate to zero and maximally inhibited cyto
c release.
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Inhibition of Base Excision Repair Alters Mutation Formation by UVA1, But Not by
UVB
D. Luo and T. M. Ru
È
nger
Dermatology, Boston University, Boston, Massachusetts, U.S.A.
Oxidative DNA damage has been suggested to be responsible for the carcinogenic properties of
UVA. It is primarily processed by base excision repair (BER), in which a DNA-glycosylase
removes the damaged DNA base and leaves an apyrimidinic/apurinic AP-site for further
processing. By demonstrating that sensitivity to UVA1 can be altered by modifying BER, we
recently reported evidence that oxidative DNA damage in¯uences cellular sensitivity to UVA1.
Since mutation formation is a more relevant end-point for carcinogenesis, we were interested,
whether modulation of BER also alters UVA-mutagenesis. Toward that goal, we pretreated
primary human ®broblasts with 5 mM methoxyamine (MX), which binds to AP-sites and blocks




UVB, or sham. Subsequently, the HPRT-mutagenesis assay was used to
measure the frequency of spontaneous or UV-induced hprt-mutations by selection for 6-
thioguanine-resistance. In two independent experiments, UVA1-irradiation increased the
mutation frequency 235- and 410-fold over the background to 41 and 70.4 mutants per 106
colony forming cells (CFC). Pretreatment with MX was not mutagenic by itself, and reduced the
UVA1-induced mutation frequency 5.5- to 5.9-fold to 7 and 12.8 mutants/106 CFC. UVB-
induced mutation frequencies were 59- and 110-fold higher than background, but were not
signi®cantly altered by pretreatment with MX. There are several explanations why blocking BER
with MX did not increase, but decrease UVA1-mutagenesis: If processing of AP-sites after removal
of the damaged base is error-prone, blocking it by MX would reduce mutagenesis. A less error-
prone backup repair pathway could have the same effect. The MX-adduct at the AP-site might also
be genotoxic and result in reduced survival of damaged cells. Nevertheless, our results indicate that
BER of presumably oxidative DNA damage contributes signi®cantly only to UVA1-mutagenesis,
but not to UVB-mutagenesis. The latter is most likely determined by nucleotide excision repair of
pyrimidine dimers, which is not inhibited by MX.
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A Critical Role of Dectin-2 in the Induction of Regulatory-Like T Cells in Ultraviolet-
Induced Tolerance
Y. Aragane, A. Maeda, K. Ariizumi,* T. Schwarz,² and T. Tezuka
Dermatology, Kinki University School of Medicine, Osakasayama, Japan; *Dermatology, South-western
Medical Center, University of Texas, Dallas, Texas, U.S.A.; ²Dermatology, University of Muenster,
Muenster, Germany
We currently showed that the induction of tolerance is mediated by Dectin-2 (Dec-2), a novel
costimulatory molecule selectively expressed on dendritic cells. Because T suppressor cells (Ts) are
believed to play a pivotal role in ultraviolet radiation (UV)-induced tolerance, we were interested
whether Dec-2-mediated signals are required for the immune regulatory properties of Ts. C3H/
HeN mice, which were exposed to low doses of UV and sensitized with dinitro¯uorobenzene
through the UV-irradiated skin areas, exhibited profound suppression of contact hypersensitivity
(CHS). When soluble Dec-2 (sol-Dec2), a competitive inhibitor of Dec-2, was injected into the
UV-tolerized mice before resensitization, mice responded with a pronounced speci®c ear swelling
response upon rechallenge, indicating that sol-Dec2 breaks UV-induced tolerance. Transfer of T
cells obtained from UV-tolerized mice into naive animals inhibited the induction of CHS in the
recipients. Suppression, however, was not observed when T cells were depleted of the fraction
binding to sol-Dec2. Three channel FACS analysis revealed that sol-Dec2-bound T cells are
CD4+ CD8-CD25+ CTLA-4+ , thus being phenotypically similar to the recently identi®ed
regulatory T cells (Tr). Co-incubation of hapten-pulsed epidermal cells with T cells that were
isolated from UV-tolerized mice resulted in enhanced expression of the death receptor Fas on Ia+
Langerhans cells (LC) and in augmented apoptosis rate. Apoptosis of LC was signi®cantly reduced
by sol-Dec2. Together, these data demonstrate that UV-tolerized Ts belong to the family of Tr
cells and are able to induce apoptosis of LC mediated via Dec-2. This indicates that Dec-2 may be a
critical molecule, which induces death dignals in LC and thereby causes UV-induced tolerance.
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Cytokine Productions of a Model for Fluorouracil-Induced Discoid Lupus
Erythematosus in TCR a-Chain Knockout Mouse
T. Yoshimasu, A. Hiroi, N. Seo,* T. Ohtani, and F. Furukawa
Dermatology, Wakayama Medical University, Wakayama, Japan; *Dermatology, Hamamatsu University
School of Medicine, Hamamatsu, Japan
Fluorouracil (FU) is well known to induce discoid lupus-like eruption in Japan. It is still obscure
which cytokines are involved in the development of DLE. In this study, we established the murine
model of FU-induced discoid lupus and studied the immunological characteristics of models of
C57BL/6 J (B6) mice, TCRaKO mice, and TCRdKO mice treated with FU and UVB. FU was
dissolved with PBS and intraperitoneal injection (0.2 mg or 2 mg) was performed every two day.
UVB (200 mJ/cm
2
) was irradiated to relative mice 5 times a week. Experimental group were as
follows; PBS injection group, FU injection group, UVB irradiation group and the group of FU
injection + UVB irradiation. TCRaKO mice treated with 0.2 mg FU + UVB showed rapidly and
frequently marked erythema at the neck and back with positive subepidermal IgG deposits. In
contrast, B6 mice treated with PBS or FU alone had no changes. B6 mice treated with UVB and
TCRaKO mice treated with FU showed high frequency of hyperkeratosis and perivascular CD4
positive cell in®ltration. B6 mice treated with 2 mg FU and UVB developed a slight erythema
around the neck. In TCRaKO mice treated with 0.2 mg FU + UVB, Th1 type cytokine
production were predominant by RT-PCR methods. Especially, IFN-gand TNF-a were
signi®cantly produced. However, antinuclear antibody of this group was low as well as other
groups without eruption. We established drug-induced DLE model with using FU and UVB
irradiation. It was suggested that Th 1 type cytokine production was associated with the
mechanism of drug induced DLE.
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Role of Melanin and Polyunsaturated Fatty Acid in Epidermal Homeostasis
C. Muriel, S. Briganti,* G. Farout, V. Maresca,* O. Nikaido,² M. Picardo,* and A. Taieb
PMTG, University Bordeaux 2, Bordeaux, France; *San Gallicano Dermatological Institute, IRCCS,
Rome, Italy; ²Division of radiation Biology, Kanawaza University, Kanawaza, Japan
Epidermal reconstructs are useful models to assess the in¯uence of melanocytes and additive factors
on epidermal homeostasis with or without UV irradiation. Our previous work has suggested that
melanocytes from fair-skinned individuals can be compared to a mixture of melanin and PUFA.
In this study, we used around 1 MED UVA and/or 4±5 MED UVB to irradiate epidermal
reconstructs (REK: without melanocytes; REM: with melanocytes). To evaluate the in¯uence of
culture conditions, we measured vitamin E and PUFA content, catalase and SOD activities as well
as endogenous protein oxidation. In addition, cyclobutane pyrimidine dimers (CPD) and 8-
oxoguanine (8 oxodG) positive cells as well as sunburn cells (SBC) were counted after irradiation.
Overall, UVA plus B was less deleterious than UVA or UVB alone, as assessed with the majority
of the markers. For catalase or SOD activities, UV induced opposite effects (1) in REK and REM
for similar phototypes, and (2) in high and low phototypes REM.
Low phototype melanocytes may amplify oxidative damage but still protect against cell death.
On the other hand, tocopherol and ascorbic acid may protect against cell death but not against
direct DNA damage. PUFA have no effect on CPD production but boost oxidative damage
(8oxodG) leading to increased cell death. Taken together, our data suggest that melanin, even in
low phototype individuals, has a protective effect against
UV irradiation, but seems to have no in¯uence on the basal epidermal redox status.
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Differential Gene Expression Pro®ling in Individuals with De®cient and Pro®cient DNA
Repair as a Predictive Tool for Individual Skin Cancer Risk
T. Gremmel, S. Wild, V. Ku
È
rten, T. Ruzicka, J. Krutmann,* and M. Berneburg
Department of Dermatology, Heinrich-Heine-University, Clinical & Experimental Photodermatology,
Duesseldorf, Germany; *Institut fuer Umweltmedizinische Forschung, Heinrich-Heine-University,
Duesseldorf, Germany
Xeroderma pigmentosum (XP) is a disorder characterized by defective repair of UV-induced DNA
damage comprising 8 complementation groups (A to G, and variant). Patients with XP have a
highly increased skin cancer risk clinically varying according to the speci®c group. The highest risk
is found in group A, intermediate in group D and a lower risk in group F. Available test systems
assessing skin cancer risk thus far only detected gross differences between single parameters. In
order to increase sensitivity and predictive power of a test system, employing DNA-array
technology, we compared differential mRNA expression in ®broblasts from XP patients of the
above complementation groups with a high, intermediate and low skin cancer risk after UVB
irradiation. A dose dependent tendency from mild to severe was detected in 17 genes with 11
genes involved in functionally relevant pathways (DNA repair, cell-cycle, apoptosis, transcription,
matrix-degradation). Thus it is possible to use DNA array technology to identify distinct patterns of
UV-induced gene expression correlating with the skin cancer risk in XP patients. Therefore we
next investigated if this approach could also be applied in DNA repair pro®cient individuals which
nevertheless exhibit an increased skin cancer risk. The gene patterns previously identi®ed in XP
patients could also be observed in patients with > 2 skin tumours and age < 35 years. Expression
levels of genes were lower than in XP cells but higher than in age matched normals. Thus it is
possible to correlate the skin cancer risk with the complementation groups in XP patients, thereby
identifying a limited number of genes with possible functional relevance for photocarcinogenesis.
Furthermore this data could be transferred into the DNA repair pro®cient background and may
provide a predictive test system to determine the skin cancer risk of clinically normal individuals.
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Prevention of Cutaneous Photoaging in Mice by Polyphenols From Green Tea
S. K. Katiyar, P. K. Vayalil, C. A. Elmets, and Y. Hara
Dermatology, The University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
Exposure of solar ultraviolet (UV) radiation to skin induces oxidative stress and phosphorylation of
matrix metalloproteinases (MMPs), which play a crucial role in cutaneous photoaging. In this
study, we investigated the prevention of UV light-induced oxidative stress and phosphorylation of
MMPs in SKH-1 hairless mice skin by polyphenone E (a mixture of polyphenols) from green tea
or its most chemopreventive constituent (±)-epigallocatechin-3-gallate (EGCG) using immuno-
histochemistry, Western blot analysis and analytical assays. Topical treatment of polyphenone E or
EGCG (10%) in hydrophilic cream to skin before both single and multiple exposure to UV (90mJ/
cm2) for one month markedly decreased oxidative stress when measured in terms of hydrogen
peroxide (56±73%) and nitric oxide (30±68%) production, epidermal lipid peroxidation (41±64%)
and protein oxidation (56±90%). Polyphenone E and EGCG treatment also resulted in a signi®cant
inhibition of UV-induced in®ltration of CD11b+ cells, which are the major producers of reactive
oxygen species in UV irradiated skin. In other experiments, mice were exposed to UV (90 mJ/
cm
2
) for one month on alternate days with or without polyphenone E in the drinking water (0.2%,
w/v). This protocol also inhibited UV-induced markers of oxidative stress but to a lesser extent
than topical treatment. Additionally, topical treatment of polyphenone E or EGCG resulted in
inhibition of UV-induced phosphorylation of aging-related MMPs-2,7, and 9 (41±66%). The
chemopreventive ef®cacy of EGCG was superior to polyphenone E. Further, skin appearance in
polyphenone E or EGCG plus UV exposed mice was relatively better and smooth in comparison
to UV alone exposed skin sites. Together, our data indicate that prevention of cutaneous
photoaging by green tea is associated with the prevention of oxidative stress and phosphorylation of
MMPs, which in turn may reduce age-dependent dysfunction including increased ease of
wounding, poor wound healing, and infectious disease susceptibility to skin and drugs.
729
UVA, But Not UVB, Irradiation Induces Hepatocyte Growth Factor/Scatter Factor
Production in Human Dermal Fibroblasts
M. Mildner,* C. Ballaun,* A. Uthman,* and E. Tschachler*²
*Department of Dermatology, Vienna Medical School, Vienna, Austria; ²CE.R.I.E.S., Neuilly, France
We have recently reported that hepatocyte growth factor/scatter factor (HGF/SF) is able to inhibit
UVB induced apoptosis in primary human keratinocytes (KC). Since dermal ®broblasts (FB) are
the major source for HGF/SF in the skin we proposed that ®broblast derived HGF/SF might
provide a survival signal to KC in a paracrine manner. In the present study we investigated whether
irradiation of FB with UVA (340±390 nm) and UVB (290±330 nm) using a Mutzhas Supersun
5000-type solar simulator leads to a direct activation of HGF/SF in these cells. The exposure of FB
to UVB (8±32 mJ/cm
2
) showed no effect on the production of HGF/SF. In contrast we observed a
strong induction of HGF/SF after UVA-irradiation (10±40 J/cm
2
). The induction of HGF/SF
mRNA analyzed by semiquantitative RT-PCR was detected as early as 12 h after UVA-irradiation
and was present up to 24 h. The secretion of HGF/SF protein into the culture supernatant
measured by ELISA was detected as early as 24 h with a maximum secretion after 48 h. The
induction of HGF/SF by UVA irradiation does not seem to be mediated via the induction of other
soluble factors, since conditioned supernatants of UVA irradiated FB did not lead to an induction
of HGF/SF production. The fact that FB also express the HGF/SF receptor c-met, could explain
the very late time points of secreted HGF/SF detected in the supernatants, since secreted HGF/SF
would be immediately bound to its own receptor and thereby removed from the culture medium.
Our ®ndings that exposure of FB to UVA induces HGF/SF-production in these cells and that
HGF/SF inhibits UVB-induced apoptosis of KC might represent an important paracrine loop
supporting epidermal homeostasis after UV-injury.
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Apoptotic and Proliferative Responses to UV Irradiation in Humans are Heterogeneous
A. Pentland, M. Mercurio, D. Carey,* F. Yang,* R. Han, S. Niwas,² W. Bell,* C. Elmets,* W.
Grizzle,* and C. Rodriguez-Burford*
Dermatology, University of Rochester, Rochester, New York, U.S.A.; *Dermatology, University of
Alabama, Birmingham, Alabama, U.S.A.; ²Dermatology, GD Searle, Skokie, Illinois, U.S.A.
An acute study examining the effect of celecoxib on ultraviolet (UV) erythema and markers likely
to be informative in UV injury and photocarcinogenesis was performed. Forty-®ve subjects with
skin types I, II or III were UV-irradiated with 12 doses of light using a solar simulator. Paired
punch biopsies were taken from nonexposed and from 2 to 3 MED UV-irradiated skin 24 and 96 h
after UV. The same subjects were then treated with placebo or celecoxib (100 mg bid, 200 mg qd,
200 mg bid, or 400 mg qd) for 10 days, and UV and biopsy were repeated on the opposite buttock.
The effect of drug treatment on erythema was measured using a Minolta chromameter. COX-1
and COX-2 and other biomarkers (proliferating cell nuclear antigen [PCNA], Ki-67, p53, and
TUNEL were measured by immunohistochemical staining on paraf®n embedded tissue. Tissue
staining scores were quanti®ed by blinded observers. UV produced an intense erythema and
induction of COX-2, PCNA, Ki-67, TUNEL and p53 in UV-irradiated skin. Following
treatment with celecoxib, two distinct populations of individuals was observed: one whose
erythema was suppressed approximately 50% by celecoxib and a second group in which a
reduction in erythema was not observed. Erythema reduction was not correlated with the trough
level of celecoxib measured in participant's blood at the time of biopsy. In these two groups, there
was a strong correlation between the effect of celecoxib on the erythema response and the degree
of PCNA (p = 0.003) and TUNEL staining (p = 0.015). The work presented here suggests that: (1)
COX-2 is involved in the erythema response in humans; (2) in humans, there is genetic
heterogeneity celecoxib-induced suppression of the erythema response; and (3) Cox-2 mediated
effects on erythema are related to UV-induced apoptosis and proliferation. These ®ndings could
have implications for the design of chemoprevention studies using celecoxib in UV-induced
cutaneous carcinomas.
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UVB Induces IL-12 by Nodal Dendritic CellsÐHowever, in Combination with DNFB,
Inhibits IL-12
E. Toichi, T. S. McCormick, and K. D. Cooper
Dermatology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio,
U.S.A.
Although the ability of UVB to inhibit DNFB contact hypersensitivity and induce tolerance is well
appreciated, the nature and timing of cellular and cross±immunoregulatory interactions of skin and
draining lymph nodes (DLN) after each signal alone, vs. in combination, remain unclear. To study
the interacting effects of sensitization and UVB irradiation, IL-12 p40 and IL-10 mRNA
expression in C3H/HeN murine DLN, where effector T cells are induced, were examined in
detailed time course analyses using highly sensitive, quantitative real-time PCR. In contrast to
prior reports using semiquantitative PCR, IL-12 p40 mRNA expression was 2.5-fold up-regulated
48 h after sensitization of normal skin with 0.5% DNFB (paÂ0.01), dropping toward baseline at 72 h.
Like DNFB alone, UVB irradiation (72 mJ/cm
2
tolerogenic dose) alone up-regulated IL-12 p40,
but between 48 and 120 h. Despite that both signals alone induced IL-12, combined exposure
(DNFB applied 48 h after UVB), resulted in a progressive decrease between 3 and 15 h, and
baseline levels thereafter. Although IL-10 mRNA rose slightly 3 h after sensitization alone, no up-
regulation of IL-10 was observed after UVB alone; prior UVB, however, resulted in a potentiated
3±6 h spike of IL-10 after sensitization (paÂ0.05), rapidly returning to baseline by 15 h. The cellular
source of IL-12 p40 in DLN was CD11c + dendritic cells (DC) after either DNFB or UVB. By
contrast, the spike of IL-10 induced by the combination of DNFB and UVB was produced by cells
expressing the macrophage marker F4/80 as well as CD11c. We conclude that IL-12 p40 mRNA
is produced by CD11c + DC that migrate to DLN from skin after sensitization, with up-regulation
between 48 and 72 h. Interestingly, UVB alone also up-regulates IL-12 mRNA by DC, with
minimal IL-10 induction. By contrast, application of a sensitizer on UVB exposed skin under
conditions that result in tolerance rapidly induces a spike of IL-10 up-regulation by F4/80+
macrophages and CD11c+ cells in DLN which is followed by quick extinction of IL-12 p40 up-
regulation.
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Single-Stranded DNA Homologous to the 3¢ Overhang Telomere Sequence Mimics UV
Effects on Mitochondrial Gene Expression
M. Kinouchi,* D. Luo, M. Yaar, M. Eller, H. Iizuka,* and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; *Dermatology,
Asahikawa Medical College, Asahikawa, U.S.A.
Exposure of keratinocytes (Kc) to UVB irradiation affects the expression of genes involved in cell
cycle arrest, DNA repair and cytokine production. We have shown that single-stranded
oligonucleotides sharing sequence homology with the telomere 3¢ overhang, when introduced into
cells, mimic these UV effects. To identify other genes that may be similarly modulated, cells of Kc
origin (SCC12F) were exposed to solar simulated irradiation (SSR) (20 mJ/cm
2
, measured at
285 6 5 nm), to an 11-base oligonucleotide homologous to the telomere overhang (T-oligo), or to
a complementary sequence as control (control oligo). Similar to SSR, T-oligo substantially
inhibited cellular proliferation and arrested > 43% of cells in the S-phase of the cell cycle, compared
to < 23% of control cells. Using DNA microarray chips containing > 700 genes known to be
modulated by aging and stress conditions, we identi®ed 8 genes that were down-regulated
by > 50% with SSR and T-oligo treatment, but not with sham irradiation or control oligo
treatment. Speci®cally, the modulated genes encode subunits of the mitochondrial enzymes
ATPase, cytochrome c oxidase, known to be transcriptionally down-regulated by UV, and NADH
dehydrogenase. These are mitochondrial-transcribed genes whose encoded proteins participate in
cellular respiration. Semi-quantitative RT-PCR and Northern blot analysis con®rmed the above
data and showed that the genes were comparably down-regulated by SSR and T-oligo treatment as
early as 24 h and 48 h, respectively. Using microarray chips that provide a rapid means for analyzing
expression of many genes simultaneously, we demonstrate that mitochondrial-encoded gene
products involved in respiration are similarly modulated by UV irradiation and DNA homologous
to the telomere 3¢ overhang. The data suggest that DNA damage responses mimicked by telomere
homolog DNA include temporary reduction of energy consumption by cells.
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Senescent and Psoriatic Plaque-Derived Keratinocytes Resistance to UV-Induced
Apoptosis is Linked to p53 Inactivation
V. Chaturvedi, J. Qin, M. F. Denning, D. Choubey,* and B. J. Nickoloff
Pathology, Loyola University Chicago, Maywood, Illinois, U.S.A.; *Radiation Oncology, Loyola
University Chicago, Maywood, Illinois, U.S.A.
A growing body of evidence in-vitro and in-vivo has implicated p53 in the aging process.
However, while senescence in ®broblasts is p53 dependent, a role for p53 in keratinocyte (KC)
senescence has not been established. In skin, p53 may impact aging and cancer predisposition. Both
cultured KCs undergoing replicative senescence, and KCs derived from psoriatic plaques (PP skin),
share features including elevated p16 levels and resistance to apoptosis. To determine a mechanism
underlying this apoptotic resistant phenotype, we studied p53 ± an important regulator of
apoptosis. Using normal human skin organ cultures and living epidermal equivalents (n = 9),
exposure to UV-light (25±100 mJ/cm
2
) produced a dose dependent increase in thymine dimers
and triggered rapid (2 h) onset of apoptosis in KCs. This apoptotic response involved induction of
Apaf-1, activation of caspase 3, and was dependent on p53 as addition of a speci®c inhibitor
(pi®thrin) blocked p53 activity and KC death. Steady state levels of p53 increased in normal
irradiated KCs, accompanied by phosphorylation of serine 9 and 15, but not serine 6 residues
veri®ed by immunostaining and Western blots. UV greatly enhanced p53 activity as assessed by
DNA binding and luciferase-based reporter assays. By contrast, senescent KCs contained low p53
levels without increased phosphorylation of p53 residues after UV-exposure. Low DNA binding
by p53 pre/post irradiation was seen in senescent KCs. Treatment of senescent KCs with DNA
damaging agent-adriamycin did not produce p53 activation or apoptosis. KCs within PP skin also
contained p53, which was not phosphorylated either before or after UV-exposure. These data
establish a key role for p53 activation in UV-induced apoptosis of normal KCs, and support the
hypothesis that p53 is not activated in senescent KCs. Furthermore, we propose that failure to
induce post-transcriptional modi®cation of speci®c residues on p53 renders senescent and psoriatic
KCs resistant to UV-mediated apoptosis.
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DNA Oligonucleotides Protect Murine Skin From Photodamage
D. Goukassian, E. Helms, S. Arad, N. Kobayashi,* T. Mori,* and B. A. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; *Dermatology, Nara
Medical University, Nara, Japan
Patients with a mutated xeroderma pigmentosum group A (XPA) gene have a greater than 1000
fold increased risk of UV-induced skin cancer. XPA
±/±
mice mimic the human syndrome. We
have previously shown that oligonucleotides (oligos), particularly thymidine dinucleotide (pTT)
and pGAGTATGAG (p9mer) that are partial homologs of the telomere overhang tandem repeat
(TTAGGG), increase levels of proteins involved in nucleotide excision repair and enhance DNA




mice were treated with pTT
(100 mM), p9mer (40 mM), or diluent alone daily for 4 days then UV irradiated on day 5 with a
previously determined erythemogenic UVB dose, weekly for 4 weeks. 72 h after the last dose,
mouse skin was processed histologically to assess general morphology, proliferation (Ki67),
cyclobutane pyrimidine dimers (CPDs) determined by speci®c antibody binding, and on-going




skin showed spongiosis, blistering, and
dyskeratosis, whereas oligo-treated samples lacked these features. After 72 h, only XPA
±/±
diluent-
treated samples contained CPDs: 15 6 5 (+) cells per 400x microscopic ®eld vs. none in pTT and
p9mer samples (p < 0.0001). No XPA
+/+
samples contained CPDs. Ki67 (+) cells were more
numerous in diluent-treated than in oligo-treated XPA
±/±
skin, consistent with a hyperproliferative
`rebound' after UVB damage: 14 6 4 vs. 5 6 2 (p < 0.005). However, PCNA (+) cells were more




oligo-treated skin: 38 6 2 vs. 52 6 6 (p < 0.01) and 125 6 8 vs.
89 6 11 (p < 0.001), consistent with the role of PCNA in on-going DNA repair, and with
previously reported up-regulation of PCNA by oligos in vitro. These data demonstrate that topical
application of telomere homolog oligos enhances the skin's ability to repair repeated UVB damage,
in large part through increased DNA repair capacity. The photoprotective effects are observed in
both repair-pro®cient and severely repair-de®cient animals, suggesting a therapeutic role in cancer
prevention.
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Intracellular Binding of 8-Methoxypsoralen to Cytosolic Smac/DIABLO Leads to
Alteration in Caspase 3-Induced Apoptosis
D. J. Hanlon, J. Trihn, C. Berger, R. Edelson, X. Jiang,* and X. Wang*
Dermatology, Yale University, New Haven, Connecticut, U.S.A.; *Biochemistry, University of Texas,
Dallas, Texas, U.S.A.
The photoactivatable compound 8-methoxypsoralen (8-MOP) is utilized in the treatment of a
broad range of dermatologic disorders of differing etiologies. 8-MOP's ef®cacy against such a
varied group of seemingly dissimilar conditions points to the existence of multiple intracellular
targets of the drug, but presently, the only de®ned interaction is with nuclear DNA. Here we
describe an alternative, cytosolic target of 8-MOP whose binding leads to alteration in caspase 3-
mediated apoptosis induction. Utilizing a tritium-labeled 8-MOP molecule and two-dimensional
gel electrophoresis, a single predominant cytoplasmic 8-MOP binding protein was directly excised
from the gel matrix, digested and sequenced by Q-Tof mass spectroscopy. The protein was
identi®ed as Smac/DIABLO, a mitochondrial protein released to the cytosol with cytochrome c
following apoptotic stimuli. Smac/DIABLO performs a critical function in apoptosis by
eliminating the inhibitory effects of IAP's (inhibitor of apoptosis proteins) on caspases. The
binding of 8-MOP to Smac/DIABLO was veri®ed by in vitro binding assays to a recombinant
Smac protein and by immunopreciptation of 8-MOP/Smac conjugates from treated cells. The
ability of 8-MOP to alter the functional status of Smac was also veri®ed utilizing a procaspase 3
reconstitution assay, with increasing concentrations of 8-MOP able to progressively inactivate
Smac's ability to bind IAP proteins and activate caspase 3. These observations represent the ®rst
identi®cation of a cytosolic target of 8-MOP and suggest a mode of action of the drug beyond
antimitotic effects within the nucleus. It appears 8-MOP binding may fundamentally alter the
induction of apoptosis in treated cells, suggesting that psoralen moieties may represent a new tool
in the control and study of programmed cell death.
737
Effects of Experimental Ultraviolet B-Phototherapy on The Cutaneous Neurosensory
System in Hairless Mice
F. J. Legat,*² L. T. Jaiani,*³ P. Wolf,² R. Lang,* T. Abraham,* C. A. Armstrong,*³ and J. C.
Ansel*³
*Dermatology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.; ²Dermatology, Karl-
Franzens University, Graz, Austria and ³Dermatology, North-western University, Chicago, Illinois,
U.S.A.
Ultraviolet B (UVB) is an effective treatment for various skin diseases, e.g. psoriasis, atopic
dermatitis, and pruritus. In these skin disorders the cutaneous neurosensory system is suggested to
play a pathophysiological role. Thus, we investigated the effects of UVB treatment on the
cutaneous neurosensory system in hairless mice. Female hairless SKH-1 mice were repeatedly
exposed to suberythemogenic UVB thrice weekly for 4 weeks. Broadband UVB was delivered by a
bank of 8 Kodacel-®ltered FS-20 sunlamps. Three days after the last UVB exposure mice were
killed and the cutaneous expression of the neuropeptides substance p (SP) and calcitonin gene-
related peptide (CGRP) as well as the content of nerve growth factor (NGF) was determined by
ELISA. Immuno¯uorescent staining of tissue sections was performed using speci®c antibodies
against SP, CGRP, the common neuronal marker PGP 9.5, and the neurokinin-1 (NK-1)
receptor. Our results indicated that repeated suberythemogenic UVB did not induce visibly
observable or microscopic signs of skin in¯ammation, however, the skin of UVB-exposed mice
demonstrated a signi®cant increase in SP, CGRP, and NGF compared to nonirradiated control
animals. Histologically there was an increase in the SP and CGRP content of individual cutaneous
nerve ®bers in the chronically UV irradiated animals whereas the number of nerve ®bers appear to
be similar in the skin of UV and non UV exposed mice. The immunoreactivity for the NK-1
receptor was also found to be markedly increased in dermal vessels of UVB-irradiated mice.
Therefore the results of these studies indicated that repeated exposure of hairless mice to
suberythemogenic UVB induced distinct changes of the cutaneous neurosensory system. The
potential of UVB to alter the expression of neurosensory mediators and receptors in the skin might
contribute to both detrimental and therapeutic effects of UV on a wide range of cutaneous
biological processes and diseases of the skin.
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Ef®cient Repair of DNA Damage in Terminally Differentiated Keratinocytes
D. H. Oh*² and K. Yeh*²
*Department of Dermatology, University of California, San Francisco, San Francisco, California, U.S.A.;
²Dermatology Service, VA Medical Center, San Francisco, California, U.S.A.
Terminally differentiated cells do not generally repair their bulk DNA as ef®ciently as their
undifferentiated precursors, presumably because mutagenic replication of damaged DNA is no
longer an issue. However, little is known about DNA repair activity as keratinocytes terminally
differentiate, although such cells are the predominant epidermal cell type and the most likely to be
damaged by external genotoxic agents such as ultraviolet radiation (UVR). Using an immunoblot
assay, we have measured genomic repair of the major UVR-induced DNA photoproductsoÂ
cyclobutane pyrimidine dimers (CPD) and pyrimidine-pyrimidone (6±4) photoproducts (6±4
PP)oÂin undifferentiated and differentiated cultured, normal human keratinocytes. Undifferentiated
proliferating cells were grown in media with < 0.07 mM Ca
2+
, while terminal differentiation was
induced by several methods, including placing cells in media containing 1.2 mM Ca
2+
with or
without phorbol ester. Terminal differentiation was con®rmed by the lack of genomic
incorporation of [3H]-labeled thymidine, characteristic morphologic changes, and expression of
differentiation markers such as involucrin. Following damage by 10 J/m
2
of 254 nm UVR,
undifferentiated cells repaired both 6±4 PP and CPD in their global genomes over 24 h as quickly
and completely as normal human ®broblasts. However, in contrast to other terminally
differentiated cell types, differentiated keratinocytes also repaired both 6±4 PP and CPD as
ef®ciently as their undifferentiated precursors. p53, a key regulator of global nucleotide excision
repair of CPD, was induced at 6 and 24 h following UVR similarly in both undifferentiated and
differentiated cell types. These results demonstrate that terminally differentiated keratinocytes,
unlike other differentiating cell types that have been described, actively maintain mechanisms to
repair DNA damage in their global genome. The results suggest that global repair of genomic




S. Grether-Beck, A. Timmer, H. Brenden, I. Felsner, and J. Krutmann
Cell Biology, Institute for Environmental Health Research at the Heinrich-Heine-University, Duesseldorf,
Germany
Ultraviolet A (UVA) radiation-induced signal transduction in human keratinocytes (KC) was
previously shown to result from the formation of ceramide (cer) from cell membrane
sphingomyelin (sm). Cer then served as a second messenger and induced the release of
cytochrome C from mitochondria, which by redox regulation activated transcription factor AP-2
and caused an increased expression of UVA-inducible, proin¯ammatory genes such as ICAM-1. It
is now believed that signal transducing cell membrane lipids are organized in `rafts' or
microdomains, which, in addition to sm/cer also contain cholesterol (chol). We have therefore
analyzed the role of chol in UVA radiation-induced ICAM-1 expression in normal human KC.
Exposure of KC to sublethal doses of UVA (30 J/cm
2
) radiation increased ICAM-1 mRNA and
protein expression in a biphasic manner with a ®rst maximum (4-fold) between 0.5 and 4h, and a
second more sustained peak (5-fold) at 24±48 h. This biphasic increase in ICAM-1 expression
could be mimicked in unirradiated cells, in which chol synthesis was inhibited upon treatment with
lovastatin, a speci®c hydroxymethyl-glutaryl-CoA reductase inhibitor. Also, extraction of chol
from the cell membrane of unirradiated KC through treatment of cells with cyclodextrin (cd)
strongly (14-fold) induced ICAM-1 expression in a monophasic manner. Lowering of cell
membrane chol levels thus led to increased expression of a UVA-inducible gene indicating a
regulator function for chol. Accordingly, cd treatment of UVA-irradiated KC resulted in a 2-fold
enhancement of UVA radiation-induced ICAM-1 up-regulation at 24±48, but not at 1±4 h. This
effect was speci®c because cd did not increase IFN-g or TNF a-induced ICAM-1 expression.
Even more important, incubation of KC with chol prior to UVA irradiation completely abolished
their capacity to mount a UVA response by releasing cer and up-regulating ICAM-1 expression.
The capacity of chol to prevent UVA radiation-induced gene expression indicates its previously
unrecognized potential as a photoprotective molecule.
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Caspase-3 Mediates Degradation, But Not Dephosphorylation, of Epidermal Growth
Factor Receptor During Singlet Oxygen-Induced Apoptosis in Human Keratinocytes
I. E. Kochevar and S. Zhuang
Dermatology, Harvard Medical School, Boston, Massachusetts, U.S.A.
Apoptosis initiated by reactive oxygen species (ROS) may involve both enhancement of pro-
apoptotic processes and inhibition of pro-survival processes. We have examined whether pro-
survival signaling from the epidermal growth factor receptor (EGFR) is altered during singlet
oxygen-induced apoptosis in human keratinocytes. Singlet oxygen was produced by Rose Bengal
(RB) photosensitization using 514 nm argon ion laser radiation in normal human keratinocytes
immortalized by expression of the telomerase catalytic subunit, hTERT (Mol. Cell Biol. 20, 1436,
2000). Singlet oxygen produced using 3 mM RB and 300 mJ/cm
2
radiation initiated apoptosis that
was detected within 4 h by chromatin condensation and annexin V staining. The same conditions
caused time-dependent loss of EGFR as detected by Western blotting, which was ®rst observable
at 5 min. EGFR degradation was not blocked by either inhibition of receptor internalization, using
monodansylcadaverine or ba®lomycin, or by agents interrupting the major proteolytic pathways
(i.e. proteasome, lysosome, or calpain). However, pretreatment with a caspase-3 inhibitor, DEVD-
FMK, inhibited EGFR degradation and singlet oxygen-induced cleavage of caspase-3 was detected
within 5 min. In addition, recombinant active caspase-3 completely cleaved EGFR in a membrane
fraction prepared from keratinocytes. The singlet oxygen-induced loss of EGFR was accompanied
by dephosphorylation of EGFR as well as of Akt and ERK1/2, downstream effectors of EGFR
that promote cell survival and proliferation. However, DEVD-FMK did not affect depho-
sphorylation of these proteins by singlet oxygen. These results indicate that caspase-3 activity is
required for singlet oxygen-induced degradation of EGFR but not for dephosphorylation of
EGFR, Akt and ERK1/2 and suggest that inhibition of pro-survival pathways may contribute to
ROS-induced apoptosis in human keratinocytes.
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Protein-Bound Chromophores of the Extracellular Matrix are Sensitizers of Photo-
Oxidative Stress in Human Skin Cells
G. T. Wondrak, M. J. Roberts, M. K. Jacobson, and E. L. Jacobson
Pharmacology and Toxicology, College of Pharmacy, Arizona Cancer Center, University of Arizona and
Niadyne, Inc., Tucson, Arizona, U.S.A.
Skin cell photodamage by solar irradiation is widely believed to originate from direct irradiation of
cellular components. Here we demonstrate that solar simulated irradiation of skin extracellular
matrix (ECM) proteins indirectly induces photooxidative stress in cultured human skin cells. Type
I collagen sensitized HaCaT keratinocytes and CF3 ®broblasts towards the antiproliferative effects





collagen or elastin added to unirradiated cells inhibited proliferation of skin cells. The
antiproliferative effect was fully suppressed, when the irradiation was performed in the presence
of catalase or the antioxidant D-penicillamine suggesting a photooxidative mechanism of
sensitization. Indeed, collagen and elastin sensitized the photo-generation of the reactive oxygen
species (ROS) superoxide and hydrogen peroxide. The ¯uorescent collagen-crosslink pyridinoline
(PYD) was examined as a candidate sensitizer, since signi®cant amounts of PYD occur in skin and
accumulate on skin collagen in hypertrophic scar tissue and sclerotic skin lesions. Isolated PYD
sensitized SSL-induced inhibition of cell proliferation and generation of ROS. The 3-
hydroxypyridine (3-HP) portion of PYD was identi®ed as the minimum sensitizing chromophore.
The elastin-derived pyridinium crosslink desmosine, lacking the 3-hydroxy substituent, was not a
sensitizer. SSL-irradiation of the model chromophore 3-HP generated an unidenti®ed organic free
radical as indicated by electron spin resonance (ESR) measurements. In a plasmid cleavage assay,
PYD and 3-HP sensitized DNA strand cleavage by SSL, suggesting the sensitized photo-generation
of ROS and organic free radicals as effectors of DNA strand breakage. Our data demonstrate that
ECM-protein chromophores can act as sensitizers of photooxidative stress and may therefore be
important mediators of skin cell phototoxicity leading to skin deterioration including skin cancer.
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Ultraviolet A is Not Always Immunosuppressive: Low-Dose Ultraviolet A Irradiation
Enhances Immune System on Mice
N. M. Khaskhely, M. Maruno, M. A. K. Khan, H. Uezato, Y. Tanaka, Y. Hashiguchi, S. Nonaka
Dermatology, University of the Ryukyus, Nishihara, Okinawa, Japan; *Immunology and Infectios Disease,
Asia-Paci®c research institute, University of the Ryukyus, Nishihara, Okinawa, Japan; ²Parasitology, Kochi
Medical School, Kochi, Kochi, Japan
It is well known that ultraviolet light, by its immunosuppressive effects, causes skin cancers and
viral infection. Our previous studies have demonstrated that pre-exposure of low-dose ultraviolet
A and B irradiation to Leishmania infected mice suppressed the lesion development through Th1
induction. Those contradictory ®ndings on the effect of ultraviolet lights raise the question
whether ultraviolet light is harmful or bene®cial to immune system. To elucidate the ultraviolet-A
action to mice immunity, we examined cytokine expression after different doses of ultraviolet-A
exposure. Shaved back skin of BALB/c and C57/BL6 mice was irradiated with 25, 50, 100, 200
and 400 J/cm
2
for four consecutive days. After 6 h of last exposure serum levels for interferon-g and
tumor necrosis factor-a, interleukin-4 and interleukin-10 cytokines were measured by ELISA.
Those cytokines expression was also studied by immunohistochemistry. Serum interferon-g and
tumor necrosis factor-a levels were up-regulated until 25 J/cm
2
of ultraviolet-A irradiation, but
down-regulated by higher doses. In contrast, serum interleukin-4 and interleukin-10 cytokines
levels were down-regulated by 25 J/cm
2
of ultraviolet-A and up-regulated by higher doses. Present
results suggest that ultraviolet-A effects as an immunostimulant until the dose of 25 J/cm
2
and
immunosuppressive over the dose of 50 J/cm
2
. Serum cytokines levels after ultraviolet irradiation
might be used as an index of immunity. Low-dose or high-dose of ultraviolet should be
determined by cytokines induction.
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In Vivo Evidence for a Link Between Photoaging and Oxidative Stress in Human Skin
C. S. Sander, A. Hansel,* S. H. Heinemann,* P. Elsner, and J. J. Thiele
Department of Dermatology, Friedrich Schiller University, Jena, Germany; *Department of Molecular and
Cellular Biophysics, Friedrich Schiller University, Jena, Germany
Chronic sun exposure causes photoaging of human skin. However, the underlying molecular
mechanisms are not yet fully understood. Oxidative stress is discussed as one of the major
contributors, but convincing in vivo evidence is still lacking. We hypothesized, that photoaging is
associated with oxidative stress mediated protein oxidation and an increase of repair enzymes of
oxidative protein damage. To investigate the consequences of chronic UV-exposure, biopsies were
taken from patients with histologically con®rmed solar elastosis, from non-UV-exposed sites of
age-matched controls, and young healthy subjects. As a marker of ROS-mediated protein
oxidation, carbonyl groups were visualized in frozen sections by the dinitrophenylhydrazine
(DNPH) method. Methionine sulfoxide reductase (MsrA) which can reverse oxidative damage of
methionine residues in proteins was detected by a newly developed antihuman MsrA antibody in
human skin sections. Protein oxidation was investigated in tissue lysates of photoaged skin as well
as in cell lysates of UVA/UVB-irradiated or hydrogen peroxide treated ®broblasts and
keratinocytes by immunoblotting. In photoaged skin, an accumulation of oxidatively modi®ed
proteins was found speci®cally within the upper dermis, whereas both, age-matched and young
controls, displayed signi®cantly lower protein oxidation. Exposure of keratinocytes and ®broblasts
to UVB/UVA irradiation as well as hydrogen peroxide treatment led to a dose-dependent increase
of protein oxidation, thus con®rming in vivo results. Intriguingly, MsrA-expression which was
analyzed for the ®rst time in human skin, was found within the epidermis and displayed a
signi®cantly higher expression in intrinsically and photoaged skin. In conclusion, the correlation
between photoaging and protein oxidation was demonstrated in vivo. The presented results indicate
that repair enzymes of oxidative protein damage may play an important role in maintaining the
cellular redox status.
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Caspase-9 is Required for UV and Trail/UV-Induced Apoptosis of Human
Keratinocytes
L. A. Sitailo, J. Qin, S. S. Tibudan, B. J. Nickoloff, and M. F. Denning
Pathology, Loyola University Chicago, Maywood, Illinois, U.S.A.
UV radiation from the sun activates both the membrane death receptor and intrinsic or
mitochondrial apoptotic signaling pathways in epidermal keratinocytes (KCs), triggering apoptosis,
and affording protection against skin cancer formation. We have investigated the involvement of
caspase-9 in the UV death effector pathway in human KCs. Caspase-9 is the initiating caspase in
the mitochondrial pathway required for UV-induced apoptosis in some, but not all, cell types. UV
irradiation of foreskin-derived KCs triggered activation of caspase-3, caspase-9, and caspase-8 with
similar kinetics, although the rank order of activation was caspase-3 > caspase-9 > caspase-8.
Inhibition of caspase-9 with either the peptide inhibitor z-LEHD-FMK, or expression of a
catalytically inactive caspase-9 by retroviral transduction, inhibited UV-induced apoptosis of
normal KCs 66% and 84%, respectively. HaCaT cells harboring mutant p53 alleles were also
protected to a similar extent from UV-induced apoptosis by the dominant/negative (D/N)
caspase-9. D/N caspase-9 blocked UV-induced activation of caspase-3, caspase-9, and caspase-8,
and protected from the loss of mitochondrial membrane potential (77% inhibition). In contrast, D/
N caspase-9 did not protect from anti-Fas-induced apoptosis, or caspase activation. The role of
caspase-9 in cross-talk between the mitochondrial and death receptor pathways was also explored
by combining low dose UV (10 mJ/cm
2
) with TRAIL/Apo2L (100 ng/ml). Neither of these
treatments induced extensive apoptosis in normal KCs as single agents, however, together they
induced massive (~70%) apoptosis. The D/N caspase-9 signi®cantly protected from this combined
apoptotic effect (~50% inhibition), suggesting that caspase-9 is also involved in the synergy
between death receptor and intrinsic death effector pathways. These results identify caspase-9 as the
critical upstream caspase initiating apoptosis by UV radiation in human KCs, the relevant cell type
for this important environmental carcinogen.
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UV Induction of Vascular Endothelial Growth Factor Independent of TNF-a
M. Kosmadaki, M. Yaar, B. Arble, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Vascular endothelial growth factor (VEGF) is a potent keratinocyte-derived angiogenic factor. One
report suggested that ultraviolet (UV) induces VEGF in normal human keratinocytes primarily by
inducing secretion of tumor necrosis factor a (TNF-a) into the medium. To further explore the
relationship between UV, TNF-a and VEGF in human epidermis, studies were performed with a
well differentiated human squamous cell line (SCC 12F). Northern blot analysis of SCC 12F cells
exposed to a physiologic dose of solar simulated irradiation (30 mJ/cm
2
, metered at 285 6 5 nm)
showed induction of VEGF mRNA as early as 6 h, with maximal induction of 218 6 69% above
sham at 24 h (p < 0.005). Increased VEGF protein was detected by ELISA in medium conditioned
by UV irradiated-cells but not by sham-irradiated cells as early as 16 h after irradiation. Maximal
VEGF induction was observed at 48 h: 14.5 6 1.8 pg/ml/10000 UV irradiated cells vs.
7.4 6 1.2 pg/ml/10000 sham irradiated cells. Increasing concentrations of TNF-a (0±100 ng/ml)
also induced VEGF expression, with maximal induction (> 100% above control) observed with the
highest TNF-a dose. To determine if autocrine TNF-a is required for VEGF induction, we
synthesized a hexapeptide KWIIVW that blocks TNF-a binding to its 55 kDa receptor and is not
toxic to the cells as determined by cell yields 72 h after peptide supplementation. Addition of
hexapeptide (3 mM) abrogated the effect of 10 ng/ml TNF-a on VEGF induction through 24 h.
This TNF-a dose is much higher than the reported TNF-a level secreted by UV-irradiated SCC
12F cells suggesting that a peptide concentration of 3 mM is suf®cient to block all UV-induced
TNF-a.
However, addition of the peptide (3 mM or 9 mM) to cells immediately after UV irradiation did
not affect VEGF mRNA induction or protein secretion into the medium. Our results suggest that
after UV irradiation VEGF induction in keratinocytes is mediated by multiple mechanisms and that
blocking a single pathway may not affect the response.
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Decreased Gene Expression Responsible for Post-UV DNA Repair Synthesis in Aging: A
Possible Mechanism of Age-Related Reduction in DNA Repair Capacity
Y. Takahashi,*² S. Moriwaki,²³ Y. Sugiyama,* T. Mori,§ M. Takigawa,² and S. Inoue*
*Basic Research Laboratory, Kanebo, Ltd, Odawara, Japan; ²Department of Dermatology, Hamamatsu
University School of Medicine, Hamamatsu, Japan; ³Photon Medical Research Center, Hamamatsu
University School of Medicine, Hamamatsu, Japan; §Radioisotope Research Center, Nara Medical
University, Kashihara, Japan
A reduction in the post-UV DNA repair capacity (DRC) is known to be associated with aging, but
the mechanism of this process remains unknown. We have demonstrated that post-UV DRC is
impaired during aging in human skin ®broblasts derived from normal donors of different ages. This
®nding is obtained by a host cell reactivation method to evaluate the functional recovery of
transfected reporter genes damaged by UV light. In this study, we directly examined DNA damage
by ELISA using speci®c monoclonal antibodies for cyclobutane pyrimidine dimers and (6±4)
photoproducts to show reduced DRC. Between young (0±7 years old) and elderly (68±95 years
old) subjects, there was no difference in the rates of photodamage removal in UV-irradiated
®broblasts. Therefore, we speculated that cells of the elderly subjects had an impaired ability of
repair synthesis, but no impairment of recognition or excision in nucleotide excision repair (NER).
To investigate the relevance of the expression of genes responsible for NER, we compared
constitutive expression levels of about 20 NER-related genes in ®broblasts from 3 years-old boy
(N-3) and 95 years-old man (N-95), using adaptor-tagged competitive PCR. This method is
quantitative and highly sensitive for the simultaneous analysis of changes in the relative expression
of many genes. In N-95 cells, while most of the genes examined were down-regulated, markedly
decreased expression was observed in several genes related to repair synthesis in NER such as DNA
polymerase d, e, and replication factor C. These ®ndings suggest that the declined post-UV DRC
in aging results from a delay in the latter step of NER by decreased expression of factors in DNA
repair synthesis.
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UVA and UVB Induce Depletion of Vitamin E and Generation of a Highly Sensitive
Lipid Photooxidation Product in Human Sebum
S. Ekanayake Mudiyanselage, P. Elsner, and J. J. Thiele
Department of Dermatology, Friedrich Schiller Unversity, Jena, Germany
At the outermost surface of the stratum corneum, skin surface lipids (SSL) are ®rst-line-targets of
natural UV radiation. Recently, we have reported that SSL contain high amounts of the lipophilic
antioxidant vitamin E. Here, we hypothesized that UVA- and UVB-irradiation deplete vitamin E
and induce photooxidation of SSL. Samples of sebum were collected from facial skin of 15 healthy
volunteers using sebutapes, then weighed and immediately irradiated with increasing doses of UVB
or UVA. Lipids were extracted from the tapes and analyzed by HPLC using electrochemical
detection for screening of photooxidation products and in-line UV detection for measuring
vitamin E and squalene content. To test possible protective or phototoxic effects, standard
sunscreens, antioxidants, and photosensitizers were topically applied prior to irradiation. Upon
UVB- and UVA-exposure, a dose dependent depletion of human SSL-vitamin E was observed.
Accordingly, a dose dependent generation of an unidenti®ed sebum lipid photooxidation product
(USLPP) was found. USLPP was readily generated even after small, suberythemogenic doses of
UVA (5 J/cm
2
) and UVB (30 mJ/cm
2
). Intriguingly, USLPP formation was ef®ciently suppressed
by sunscreens and antioxidants and enhanced by photosensitizers, strongly pointing to an reactive
oxygen species (ROS) mediated mechanism. Accordingly, squalene is several-fold stronger
depleted by UVA than by UVB, pointing to ROS mediated squalene depletion and to the
generation of squalene oxidation products. Current investigations focus on the identi®cation of
USLPP using LC-MS and NMR analysis and the biological relevance of USLPP. Both, vitamin E
depletion and USLPP formation in human sebum were demonstrated to be very sensitive new
markers for UVB- and UVA-induced oxidative stress in skin.
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Epidermal Growth Factor Receptor Activation is a Critical Mediator of Multiple UV
Reponses in Human Keratinocytes
Y. Xu, J. J. Voorhees, and G. J. Fisher
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Epidermal growth factor receptor (EGFR) is a prototypic cell surface receptor protein tyrosine
kinase, whose activation by EGF and other EGF-like ligands triggers downstream signal
transduction resulting in cell-type speci®c responses. EGFR tyrosine kinase is activated directly by
cognate ligands and indirectly by other cell surface growth factor, cytokine, and G-protein
receptor-associated signaling pathways. EGFR tyrosine kinase is also activated by ultraviolet (UV)
irradiation in a ligand-independent manner. We have utilized two approaches to investigate the
function of EGFR in cellular UV responses. Pretreatment of human keratinocyte HaCat cells with
PD169540, a highly speci®c, potent, irreversible EGFR tyrosine kinase inhibitor, differentially
inhibited UV activation of JNK, p38, and Erk MAP kinases. p54/46 JNK was inhibited 47%
(n = 5, p < 0.05), p38 was inhibited 39% (n = 5, p < 0.05), and p42/44 Erk was inhibited 84%
(n = 5, p < 0.05). Furthermore, PD169540 blocked UV induction of both c-Fos and c-Jun mRNA
by 67% (n = 3, p < 0.05) and 79% (n = 3, p < 0.05), respectively. Inhibition of EGFR tyrosine
kinase by PD169540 also markedly suppressed UV-induced phosphorylation of multiple substrates
for Akt, PKA, and PKC serine/threonine protein kinases. Secondly, we utilized B82 mouse L cells
that lack EGFR and the derived B82K + EGFR expressing cells. UV irradiation induced dose-
dependent activation of Erk in EGFR-expressing B82K + cells. In contrast, UV failed to induce
any signi®cant activation of Erk in EGFR(±) B82 cells. Activation of p54/46 JNK by UV was
reduced 61% (n = 7, p < 0.05) in EGFR(±) B82- vs. EGFR(+) B82K + cells. In addition, both c-
Fos and c-Jun protein, which were induced 5-fold and 6-fold, respectively, by UV in EGFR(+)
B82K + cells, were not induced in EGFR(±) B82 cells. Taken together, these data provide direct
evidence that EGFR tyrosine kinase activation is necessary for divergent UV-induced cellular
responses.
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Topical Imiquimod Prevents UVB-Induced Cutaneous Immunosuppression
T. T. Thatcher, M. Tomai,* R. L. Miller,* and A. A. Gaspari²
Pulmonary Medicine, University of Rochester, Rochester, New York, U.S.A.; *Drug Development, 3M
Pharmaceuticals, St. Paul, Minnesota, U.S.A.; ²Dermatology, University of Maryland, Baltimore,
Maryland, U.S.A.
Acute exposure to ultraviolet radiation (UVB, 290±320 nm) can suppress contact hypersensitivity
(CHS), a form of cutaneous delayed type hypersensitivity (DTH). This UVB immunosuppression
may play a role in skin cancer development. Imiquimod (R-837, S-26308) is a topical immune
response modi®er with antiviral and antitumor activity. Imiquimod induces Langerhans cell (LC)
migration, functional maturation, and IL-12 production. To test our hypothesis that Imiquimod
may be effective in preventing or reversing UVB-induced suppression of cutaneous DTH
responses, this agent was studied in a mouse model of UVB-suppression of CHS. The hapten 2,4-
dinitro¯uorobenzene (DNFB) was used to sensitize mice, and ear swelling was measured after local
challenge. Irradiation of the skin with UVB (70 mJ/cm
2
UVB for four consecutive days) prior to
sensitization with DNFB suppressed the ear swelling response (CHS) by 55% (p < 0.001). When
Imiquimod was applied for two days prior to UVB irradiation, CHS was suppressed only 10%
relative to nonirradiated mice, indicating this agent prevented UVB immunosuppression.
Histologic examination of ear skin con®rmed the ear swelling data. However, application of
Imiquimod after UVB exposure did not reverse UVB-induced immunosuppression. Since
Imiquimod stimulates LC to migrate to lymph nodes, IL-12 production was measured in cells from
the lymph nodes draining the irradiated area. While UVB-irradiation completely suppressed
secretion of IL-12 by LPS-stimulated lymph node cells, pretreatment with Imiquimod induced IL-
12 production 3-fold over nonirradiated controls. In contrast, treatment with Imiquimod
following UV irradiation did not result in increased production of IL-12 from the draining lymph
node cells. These results are consistent with the hypothesis that application of Imiquimod to the
skin prior to, but not following, UVB exposure prevents immunosuppression by stimulating LC to
produce IL-12. These data suggest that topical imiquimod may play a role in preventing UVB
cutaneous immunosuppression in humans.
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A Serial Analysis of Gene Expression in Sun-Damaged Human Skin
J. Urschitz, S. Iobst,* Z. Urban, C. Granda, K. A. Souza, C. Lupp, K. Schilling,* I. Scott,* K.
Csiszar, and C. D. Boyd
Paci®c Biomedical Research Center, University of Hawaii, Honolulu, Hawaii, U.S.A.; *Skin Biosciences,
Unilever Research U.S., Inc., Edgewater, New Jersey, U.S.A.
Aging of the skin consists of two simultaneous processes: intrinsic, chronologic aging and
photoaging, an environmentally induced remodeling of the dermis that arises as a result of repeated
exposure of skin to sunlight. Although both intrinsic aging and photoaging share some common
characteristics such as decreased procollagen expression and increased expression of several matrix
metalloproteinases, photoaging is considered to be the predominant contributing factor to the
prematurely aged appearance of sun-exposed skin. To study the phenotypic changes in human skin
associated with repeated sun exposure at the transcription level, we have undertaken a comparative
Serial Analysis of Gene Expression (SAGE) of sun-damaged skin and sun-protected skin as well as
sun-protected epidermis. SAGE libraries were made to mRNA isolated from human preauricular
(sun-damaged) skin and postauricular (sun-protected) skin, as well as epidermal nick biopsy
samples. 5330 cDNA tags from the postauricular SAGE library were sequenced and compared with
cDNA sequences identi®ed from 5105 tags analyzed from a preauricular SAGE library. Of the total
of 4742 different tags represented in both libraries we found 34 tags with at least a 4-fold difference
of tag abundance between the libraries. Among the mRNAs with altered steady-state levels in sun-
damaged skin, we detected those encoding keratin 1, macrophage inhibitory factor and
calmodulin-like skin protein. In addition, a comparison of cDNA sequences identi®ed in the
SAGE libraries obtained from the epidermal biopsy samples (5257 cDNA tags) and from both full-
thickness skin samples indicated that many genes with altered steady-state transcript levels upon
sun-exposure were expressed in epidermal keratinocytes. These results suggest a critical role for the
epidermis in the pathomechanism of largely dermal changes in chronically sun-exposed skin.
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Anti-Keratinocyte IgG Antibodies in Vitiligo Stimulate Nerve Growth Factor Release
From UVB-Treated Cultured Keratinocytes and Reveal a Photoprotective Effect
H. Yu, C. Wu, and Y. Li
Department of Dermatology, Kaohsiung Medical University, Kaohsiung, Taiwan, Taiwan
Functional melanocytes in patients with vitiligo vulgaris disappear from involved skin. The
depigmented skin has lost some of the protection against the damaging effects of sunlight.
However, reports of the long-term risk of skin cancers and actinic damage in vitiligo are rare.
These clinical and pathological studies strongly suggest that an effective protective mechanism
exists in keratinocytes (KC) of vitiligo. Besides antimelanocyte IgG antibodies, noncytotoxic
antikeratinocyte IgG antibodies (V-KC-IgG) exist in vitiligo. The purpose of this study is to clarify
the role of V-KC-IgG in the protection against UVB damage in KC. Our results revealed: (1) both
V-KC-IgG and IgG from normal controls (N-KC-IgG) induce nerve growth factor (NGF) release
from KC, however, the stimulatory effect of N-KC-IgG is higher than that of V-KC-IgG; (2) V-
KC-IgG, but not N-KC-IgG, stimulates a signi®cant increase in NGF release from UVB-treated
KC, this stimulatory effect is UVB dose-dependent; (3) both V-KC-IgG and N-KC-IgG inhibit
apoptosis in UVB-treated KC, the protective effect of V-KC-IgG is higher than that of N-KC-
IgG; (4) V-KC-IgG reveals a signi®cant stimulatory effect on BCL-2 expression in UVB-treated
KC. NGF protects both keratinocytes and melanocytes from UV-induced apoptosis by up
regulating BCL-2 levels in the cells. The stimulatory effect of NGF release by V-KC-IgG in UVB
irradiated KC in this study provides an explanation for the UVB protective mechanism in vitiligo.
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Effects of Hydrophobic Wound Healing Enhancers on UVB Light-Induced Production
of Reactive Oxygen Species in Keratinocytes
D. Heck, N. Rozanova, F. Rezai, and V. S. Goldman*
Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey, U.S.A.; *Consumer Health
Care, P®zer, Inc., Parsippany, New Jersey, U.S.A.
Wound healing is regulated by a complex array of physiological processes involving the actions of
growth stimulatory factors and in¯ammatory mediators including reactive oxygen and lipid species
that modulate tissue regeneration. In the present studies we examined the effects of three
hydrophobic moieties that facilitate wound healing on UVB light-induced formation of reactive
oxygen species (ROS) in PAM 212 murine keratinocytes. In these studies, the hydroperoxide-
sensitive dye, dichloro¯uorescin diacetate (DCFH-DA, 5 micromolar) was used in conjunction
with ¯ow cytometry to evaluate intracellular levels of ROS. We found that exposure of mouse
keratinocytes to UVB light (0±30 mJ/cm
2
) resulted in dose-related increases in ROS. This was
associated with an inhibition of cellular proliferation. Treatment with cottonseed oil, olive oil and
a-tocopherol, both alone, and in combination, dramatically altered UVB light-mediated ROS
production resulting in 1±7 fold decreases in hydrogen peroxide production. The effects of a-
tocopherol < olive oil < cottonseed oil. Inhibition of hydrogen peroxide production was associated
with increases in cell growth. Regenerating skin is populated with both proliferating and
differentiating keratinocytes, therefore both of these cell types were tested for responses to the
hydrophobic agents. Proliferating keratinocytes were 3±5 fold more sensitive than growth arrested
con¯uent cells to inhibition of ROS production. These data suggest that the production of reactive
oxygen species is important in the control of cellular proliferation. We speculate that regulation of
ROS production by these moieties may be important in the regeneration of skin following injury.
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The Role of Intracellular pH in UV-Induced Apoptosis of Neutrophils
N. A. Konstantinova, N. F. Khomyakova, D. Gaevski,* and N. V. Konstantinova²
Physics, Russian Medica University, Moscow, *Finance, Georgia Institute of Technology, Atlanta, Georgia,
U.S.A.; ²Research, Nioxin Research lab, Atlanta, Georgia, U.S.A.
In this study we investigated the in¯uence of UV-irradiation (334 nm) on the vitality and
intracellular pH of neutrophils of healthy donors' blood. Neutrophils were separated in double
gradient density on phicol-verographin by the standard method. To determine the vitality,
apoptosis, and the magnitude of the intracellular pH in the particular cell we used
micro¯uorimetric methods with ¯uorescent probes: ethidium bromide, propidium iodide,
¯uoresceindiacetat correspondingly. It was shown that the behavior of inner nuclear pH change
depends not only on the dose of radiation (0.04±9.0 J/cm
2
) but also on the time of the consecutive
incubation (5±180 min). Method of approximation revealed that the experimental data can be
described the best by employing the functions of fading oscillations. It was shown also that the
value of the beginning amplitude and eigen frequency depend on the dose of radiation. At the same
time the damping factor does not depend on radiation parameters. The percentage of apoptosis
cells observed after 3 h of radiation increases sharply starting from the 0.6 J/sm
2
dose of radiation.
The presence of the alkali in the medium increases doses of UV-irradiation leading to apoptosis of
neutrophils due to the increase of intracellular pH. Change of Intracellular pH plays a leading role
in transferring neutrophils into apoptosis stage.
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A Long-Term Evaluation of Erythema and Pigmentation Induced by Different Wave-
Lengths of Ultraviolet Radiation
M. Jang, T. Choi, K. Suh, and S. Kim
dermatology, Kosin Medical College, Pusan, Pusan, South Korea
Though multiple studies have been reported about the biological effects of ultraviolet radiations,
the comparative and long-term reactions of human skin by several different UV-wavebands were
not reported. We evaluated a time course of skin color changes induced by UVA-1, broad band
UVA (BBUVA), narrow band UVB (NBUVB), and broad band UVB (BBUVB) for 6 months.
Four skin areas, from the back of each subject, were irradiated with 2MED of four different UV
wavelengths corresponding to: (1) UVA-1, (2) BBUVA, (3) NBUVB, (4) BBUVB. Skin color
changes were evaluated by visual scoring and values converted into L*a*b color system. The resuls
were as follows: (1) For both UVA-1 and BBUVA, erythema and pigmentation were most
pronounced immediately and 1h after exposure. Thereafter, erythema rapidly diminished but
pigmentation persisted throughout the study. (2) For UVB, test areas reacted with erythema of
maximum intensity at day 1 for NBUVB and at day 2 for BBUVB. A maximum tanning was
reached at day 3±6 for NBUVB and day 4±7 for BBUVB, and the return towards the original color
point was at 1 month and 3 months, respectively. No signi®cant difference was found in visual and
colorimetric evaluation for time course of skin color changes. As a conclusion, 2MED of UVA
produced far prolonged erythema and pigmentation than UVB. For UVA, UVA-1 and BBUVA
showed similar intensity and time course of skin reaction. For UVB, erythema and pigmentation
prdoduced by NBUVB were milder in intensity and shorter in time course than thoes by BBUVB.
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Protection Effects of an Algae Extract on Proteasome Activities of UV-Irradiated
Normal Epidermal Human Keratinocytes
C. Nizard, A. Bulteau,* M. Moreau, A. Saunois, and B. Friguet*
Laoratoire Recherche et Developpement R & D, LVMH Branche Parfums et Cosmetiques, Saint Jean de




The proteasome is a multicatalytic proteinase in charge of intracellular protein turnover and of
oxidized proteins degradation. Consequently, proteasome function is very important in controlling
the level of altered proteins in eukaryotic cells. Evidence for a decline in proteasome activity during
aging and upon oxidative stress has been provided previously. However, no data are available on
the status of skin cells proteasome exposed to ultraviolet radiations which are known to induce
damages of cellular components such as DNA, proteins, and lipids. We have reported (Bulteau et al




UVB-irradiation induced a decrease of proteasome
activities and an increase of modi®ed proteins (e.g. oxidized, ubiquitinated and modi®ed by the
lipid peroxydation product 4-hydroxy-2-nonenal). We describe here the ability of an apolar algae
extract (Phaeodactylum Tricornutum) to stimulate 20S proteasome peptidase activities. Moreover,





) irradiation of keratinocytes is abolished when the algae extract is added to the culture
medium. Furthermore, keratinocytes treated with Phaeodactylum Tricornutum extract and then
irradiated, exhibited a sustained level of proteasome peptidase activities comparable to the one of
non irradiated cells. Finally, in the presence of this algae extract the level of oxidized proteins is
reduced as assessed by the Oxyblot technique. Altogether, these results argue for the presence of a
compound in this algae extract that have a stimulating and protective effect on proteasome activity
and whose characterization is under progress.
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The Cytotoxicity of UVA Depends on the Mode of Exposure
H. Merwald, G. Klosner, R. Knobler, H. Ho
È
nigsmann, and F. Trautinger
Division of Special and Environmental Dermatology, Department of Dermatology, University of Vienna,
Vienna, Austria
The reciprocity rule (Bunsen-Roscoe law) states that a photochemical reaction is directly
proportional to the total energy dose, irrespective of the dose distribution. The dose is the product
of intensity and duration of exposure. In photomedicine the validity of this rule is generally taken
for granted, although the in¯uence of radiation intensity and dose fractionation are largely
unknown. We have examined the effects of fractionation at a constant total dose on viability,
apoptosis, and proliferation in the human squamous carcinoma cell line A431. For these
experiments UV-A and UV-B from a metal halide source were delivered either as a single dose or
as three equal fractions separated by intervals of 10, 30, 60, 120, and 240 min 12 h after initiation of
exposure cells were investigated for Annexin V binding, viability (MTT assay), and BrdU
incorporation. With UV-A fractionation with intervals of 10, 30, and 60 min led to a decrease in
viability of up to 40%, compared to an identical single dose. In contrast, intervals of 120 and
240 min increased the viability up to 30%. Corresponding results were obtained for Annexin V
binding and BrdU incorporation. With UV-B we observed no in¯uence of dose fractionation on
the rate of cell death. These results indicate that in a simple experimental model the Bunsen-
Roscoe law is not valid with regard to biologically relevant endpoints. Our observations might be
explained by cumulative oxidative stress caused by fractionated UV-A radiation with short
intervals. On the other hand, the protective effects of repetitive low irradiation with long intervals
may be attributed to an up-regulation of antioxidative defense mechanisms.
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Enhancement of UV-Induced Apoptosis by p53-Stabilizing Compound CP-3139
Y. Luu and G. Li
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Melanoma is a highly chemoresistant disease and its incidence has been steadily increasing over the
last decades. The primary factor contributing to the development of melanoma is ultraviolet (UV)
radiation. Exposure of skin cells to UV light leads to the accumulation of the p53 tumor suppressor
protein, which subsequently initiates cell cycle arrest, DNA repair, and/or apoptosis. Proper
functioning of the p53 protein is required for the prevention of skin cancer development after UV
exposure. In a recent study by Foster and colleagues, the pharmacological compound CP-31398
was found to stabilize wild-type (wt) p53, enabling it to enhance its transcriptional activity and
slow tumor growth in mice. We hypothesize that CP-31398 enhances UV-induced apoptosis by
stabilizing the p53 protein and activating caspases. Using the wild-type p53 melanoma cell line,
MMRU, we demonstrated that a nontoxic dose of CP-31398 elevated p53 protein levels and
enhanced UV-induced apoptosis. Moreover, we also found that treatment with UVB and CP-
31398 altered mitochondrial membrane potential and increased the cleavage of caspase-9, ±8 and &
#8211; 3, suggesting that the mitochondrial- and/or death receptor-mediated apoptotic pathway(s)
may be activated. Elucidating the mechanism by which CP-31398 induces apoptosis after UV
irradiation may establish it as a preventative cancer agent.
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UV-Induced T Suppressor Cells Cause Apoptosis of Dendritic Cells by Modulating the
Expression of Antiapoptotic Molecules
A. Schwarz, K. Grosse-Heitmeyer, S. Beissert, and T. Schwarz
Department Dermatol., University Muenster, Muenster, Germany
Immune tolerance caused by ultraviolet radiation (UV) is due to the induction of hapten-speci®c
regulatory T cells, previously called T suppressor cells. Recently we observed that these T cells
express the surface marker CTLA-4 which in contrast to its cognate member CD28 acts as a
negative regulatory molecule. CTLA-4 appears to be functionally relevant since blocking of
CTLA-4 is associated with a loss of suppression. Activation of CTLA-4 induces the release of a
cytokine pattern, similar to that of type 1 regulatory T cells. The present study was performed to
further elucidate the mechanism by which CTLA-4+ T cells cause suppression. Therefore lymph
node cells were obtained from mice which were tolerized against dinitro¯uorobenzene by UV and
enriched for CTLA-4+ cells. Cells were cocultured with bone marrow-derived dendritic cells
(DC) in the presence or absence of the water soluble analogue of the speci®c hapten. After 48 h
apoptosis of DC was analyzed by annexin V staining. While CTLA-4 negative cells did not affect
DC in their survival rate, pronounced apoptosis of DC was observed upon coincubation with
CTLA-4+ cells. However, CTLA-4+ cells exerted their apoptotic activity only in the presence of
the speci®c hapten. To identify the pathway by which CTLA-4+ cells induce apoptosis, DC were
subjected to FACS analysis to determine the expression of the death receptor CD95/Fas. CD95,
however, was only slightly induced by CTLA-4+ T cells. Therefore, the expression of the
antiapoptotic proteins Flip and Bcl-xL was determined in DC by intracellular FACS analysis. Both
proteins were constitutively expressed, but signi®cantly down-regulated in the presence of CTLA-
4+ T cells and the speci®c hapten. Taken together, these data suggest that UV-induced T
suppressor cells seem to exert their inhibitory capacity on antigen presentation via induction of
apoptotsis of DC and that down-regulation of the antiapoptotic proteins Flip and Bcl-xL is
involved in this process.
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The Effect of Amniotic Membrane Extract on the Expression of iNOS mRNA and
Generation of NO in HaCaT Cells by Ultraviolet B Irradiation
S. J. Seo, D. S. Chang, Y. J. Kim, and C. K. Hong
Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, South Korea
Amniotic membrane (AM) is innermost fetal membrane which contains several proteinase
inhibitors and expresses several growth factors. Nitric oxide (NO) has been implicated in the
pathogenesis of various in¯ammatory diseases including sunburn and ultraviolet induced erythema.
The expression of inducible nitric oxide synthase (iNOS) is up-regulated by UVB irradiation and
inhibited by TGF-b and EGF-b. We evaluated the effect of AM extract on the expression of iNOS
mRNA by UV irradiation in HaCaT cell (immortalized human keratinocyte cell line). HaCaT
cells were irradiated UVB 30 mJ/cm
2
and added AM extract. The iNOS mRNA was isolated by
RT-PCR and NO production was assessed by spectrophotometric method based on Griess
reaction. The expression of iNOS mRNA was induced by UVB irradiation in HaCaT cell and the
expression of iNOS mRNA was higher at 48 h than that at 24 h. AM extract down regulated the
induction of iNOS mRNA in HaCaT cell by UVB irradiation. NO generation was increased by
UVB irradiation, but down regulated by AM extract treatment in HaCaT cells. These results
assured that the expression of iNOS mRNA and generation of NO are up-regulated by UVB
irradiation and showed that AM extract down regulated the induction of iNOS mRNA and
decreased generation of NO by UVB irradiation.
759
UV Photoprotection by Topical Vitamins C & E
S. R. Pinnell, J. Lin, J. Grichnik, M. Selim, and C. Shea
2
Dermatology, Duke University, Durham, North Carolina, U.S.A.; 2Dermatology, University of Chicago,
Chicago, Illinois, U.S.A.
New photoprotection methods are necessary to halt the epidemic of skin cancer and to prevent
photoaging. Sunscreens often fail because they are incorrectly applied, removed by rubbing or
sweating, and don't achieve full spectral protection. Virtually all plants and animals protect
themselves from the sun using vitamins C & E. The purpose of this study was to see if a topical
formulation of vitamins C & E could provide additional UV protection to skin. We developed a
stable aqueous formulation of 15% L-ascorbic acid (vitamin C) and 1% a-tocopherol (vitamin E)
optimized for percutaneous absorption. We applied 0.5 ml to a 10 3 7.5 cm area of shaved pig skin
daily for four days. We irradiated (1±5x MED) control and antioxidant-treated skin using a solar
simulator with a 295-nm band-pass ®lter. After 24 h, we determined an antioxidant protection
factor (APF) fourfold in treated skin. We measured sunburn cells in 4x MED-treated skin. Control
skin had 35 6 2.9 SD sunburn cells/mm, whereas vitamin C & E-treated skin had only 6 6 5.4 SD
sunburn cells/mm (n = 3, p = 0.004). UV-induced thymine dimer formation also appears to be
reduced. The formulation has no UV absorption above 295 nm; this is not a sunscreen effect. We
demonstrate that appreciable photoprotection can be obtained from topical C & E and suggest that
it is a useful supplement to sunscreens for protection against skin cancer and photoaging. Having
protection in the skin, rather than on the skin, is an attractive advantage.
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Antioxidant Activity of Topically Applied Lycopene
M. Andreassi, E. Stanghellini,* A. Ettorre,² A. Di Stefano,² and L. Andreassi*
Department of Pharmaceutical and Chemical Technology Science, University of Siena, Siena, Italy; *Institute
of Dermatological Sciences, University of Siena, Siena, Italy; ²Department of Molecular Biology, University
of Siena, Siena, Italy
The cutaneous antioxidant capacity can be strengthened with suitable substances applied on the
skin. This property has been demonstrated for vitamin E, vitamin C, and melatonin specially when
applied in combination. On these bases we evaluated the protective capacity of three emulsions,
respectively, containing: (a) lycopene 0.03% (Lycopersicon Esculentum extract); (b) a-tocopherol
acetate (0.5%) and ascorbic acid (1%); (c) a mixture of the 3 substances at the above concentrations.
Twenty healthy volunteers with phototype II or III were irradiated with solar simulator (Multiport
Solar UV Simulator, Model 601) on the ¯exural surface of forearm with doses ranging from 20 to
80 mJ/cm
2
. The products containing antioxidants were applied on areas with similar characteristics
which were irradiated after 30 min with the same UV doses. Skin damage was evaluated measuring
erythema and trans epidermal water loss before UV exposure and after 24 and 48 h. Erythema was
measured with tristimulus colorimeter (Chroma Meter CR-200, Minolta) according to our
previous experience. The barrier function was evaluated with evaporimeter (Tewameter TM 210,
Courage-Khazaka). The product containing lycopene alone revealed a protective capacity against
UV exposure similar to the one of the product containing a-tocopherol acetate and ascorbic acid.
When the three antioxidants were applied in combination the protective capacity resulted more
marked, as demonstrated by statistical evaluation performed on a*-values of the L*a*b* system.
The above results demonstrate that lycopene exhibits an antioxidant activity which is strengthened
when applied in combination with other substances according to their biochemical characteristics.
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UVB Radiation Suppresses Endocytosis, Subsequent Maturation, and Migration
Activity of Langerhans Cells
K. Mizuno, H. Okamoto, and T. Horio
Dermatology, Kansai Medical University, Moriguchi, Osaka, Japan
Langerhans cells (LC) capture exogeneous antigens (Ag) and migrate to lymph nodes, where they
present processed Ag to T cells. UVB radiation is known to impair an Ag-presenting function of
LC, resulting in Ag-speci®c immunosuppression of contact hypersensitivity (CHS). We tested the
possibility that UVB radiation inhibits an endocytic activity of LC, leading to an impairment of
both migration and maturation of LC. Fluid phase pinocytosis and receptor-mediated endocytosis
were estimated by measuring the uptake of lucifer yellow (LY) and FITC-dextran (Fd),
respectively. Human monocyte-derived LC had the abilities to take up LY and Fd. Exposure of
20±40 mJ/cm
2
of UVB radiation to LC reduced their uptake activities in both endocytosis.
Membrane ruf¯ing required for ¯uid phase pinocytosis and CD32 expression for receptor-
mediated endocytosis were also suppressed by UVB radiation. Migration activity of LC to 6Ckine
was enhanced after taking up LY or Fd, but the enhancement was inhibited by UVB radiation. The
level of TNF-a, a well-described inducer of LC migration, was higher in cultured medium of LC
taking up LY (LY-LC) or Fd (Fd-LC) than that of untreated LC. Prior UVB radiation to
endocytosis inhibited such an increment of TNF-a level. LY-LC and Fd-LC showed the
properties of mature DC, including an increase in CD54 and CD86 expression and potent
stimulators in allogenic mixed leukocyte reaction. However, UVB-irradiated LY-LC and Fd-LC
exhibited the lower phenotypic and stimulatory activation. These data suggested that impaired
endocytosis of LC by UVB radiation inhibits their capacity to migrate and mature, leading to
immunosuppression of CHS.
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Replacement of Langerhans Cells in UVB-Irradiated Murine Epidermis
H. Okamoto, K. Mizuno, F. Yamazaki, M. Hamakawa, A. Sugihara, and T. Horio
Dermatology, Kansai Medical University, Moriguchi, Osaka, Japan
Low dose of UVB radiation decreases the number of Langerhans cells (LC) at the peak of 1±2 days
after irradiation. LC are replaced by precursors in bone marrow (BM) and their number returned
to the original at 2 weeks later. To further understand the manner of LC replacement after UVB
radiation, we transferred LC precursors from green ¯uorescent protein (GFP)-transgenic mice
(green mice) into UVB-irradiated C57BL/6 mice. When C57BL/6 mice reconstituted with BM
cells of green mice were exposed to 50mJ/cm2 of UVB radiation, a small number of GFP+, Ia+
dendritic cells appeared in irradiated epidermis 7 days after irradiation. Two weeks later, GFP+,
Ia+ dendritic cells were distributed in a patchy pattern. On the other hand, when BM cells from
unirradiated or UVB-irradiated green mice were injected 7±12 days after irradiation, no GFP+
cells were seen in irradiated skin 2 weeks after irradiation. This indicated that injected BM cells did
not directly enter into irradiated skin. Injection of dendritic cells generated from BM cells of green
mice in culture with GM-CSF/IL-4 or freshly isolated LC from normal green mouse skin did not
induce the appearance of GFP+ cells in irradiated skin. By contrast, when peripheral blood cells
from unirradiated or UVB-irradiated green mice were injected, a small number of GFP+, Ia+ cells
with the same extent appeared in the epidermis of irradiated recipients. These ®ndings suggested
that constitutively circulating precursors of LC can entry into UVB-irradiated epidermis.
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Visual Discrimination Testing of Ultraviolet Transmitting and Ultraviolet Blocking
Acrylic Thermoplastics
M. J. Kucenic, M. Patel, S. Feldman, A. Liguori,* and A. Fleischer
1 Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North
Carolina, U.S.A.; *Department of Physiology and Pharmacology, Wake Forest University School of
Medicine, Winston-Salem, North Carolina, U.S.A.
Visual perception has hindered the development of blinded, placebo-controlled ultraviolet light
exposure conditions in humans. New acrylic thermoplastics that block or transmit ultraviolet light
have visual properties that may provide a solution.
Methods: In a series of triangle taste tests, 60 subjects were tested for the ability to visually
perceive ultraviolet light transmission by two of four types of acrylic thermoplastics.
Results: Forty six of sixty (67%) subjects were unable to visually detect ultraviolet light
transmitting acrylics among ultraviolet blocking acrylics in both an ambient light background
condition and an ambient light background condition with ultraviolet A light supplementation.
Conclusion: Acrylic thermoplastics allow for the production of blinded, placebo-controlled
ultraviolet light exposure conditions by eliminating visual discrimination differences between
active and control groups.
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Enhanced Expression of Inducible Cyclo-Oxygenase with Aging in Human Skin In Vivo
J. Seo, J. Chung, E. Kim, M. Lee, J. Han, H. Eun, and K. Kim
Dermatology, Seoul National University College of Medicine, Seoul, South Korea
Chronic sun exposure is a well-recognized etiologic agent for skin cancer and skin aging. UV light
is a carcinogen acting as both a tumor initiator and promoter. One possible mechanism for the
promotional activity of UV light involves its ability to induce prostaglandin formation. The aging
process of the skin can be divided into intrinsic aging and photoaging. UV irradiation induces the
synthesis of matrix metalloproteinases (MMP) in human skin in vivo. MMP-mediated collagen
destruction accounts, in large part, for the connective tissue damage (wrinkle) that occurs in
photoaging. PGE2 plays roles in the regulation of matrix metabolism. Human epidermis is a tissue
which undergoes active metabolism of arachidonic acid to prostaglandins which is regulated by the
action of cyclooxygenase (COX). The production of prostaglandin in human skin is increased by
UV irradiation, however, the age-related changes in the susceptibility of human skin in response to
UV remain unclear. The purpose of this study was to examine the in¯uence of aging on the
cyclooxygenase (COX) expression in human skin in vivo. Aged human skin produced a higher
amount of PGE2, as compared with young skin, when the skins were exposed to UV. The
induction of COX-2 mRNA and protein levels by UV in aged skin was higher than that in young
skin, whereas COX-1 mRNA remained unchanged. Our data suggest that skin aging may affect
the severity of in¯ammation, photocarcinogenesis and photoaging through the production of a
large amount of PGE2 in response to UV in human skin.
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Reduction of UV-Induced Oxidative Damage by Fructose 1,6 Diphosphate in HaCaT
Keratinocytes and Hairless Mouse Skin
S. Ahn, J. Kim, J. Lee, B. Lee, S. Lee,* and I. Chang
Skin Research Team, Amore Paci®c R & D Center, Yongin-si, South Korea; *Physiology, Ajou University,
Suwon-si, South Korea
Fructose 1,6 diphosphate (F1,6DP), a glycolytic metabolite, is reported to have cytoprotective
effects against hypoxia or ischemia/reperfusion injury in brain and heart. It is also reported that
F1,6DP inhibits the nitric oxide production in murine macrophages stimulated with endotoxin.
These data implicate that F1,6DP may have regulatory roles in the controlling cellular responses,
although the mechanism is not completely understood. In this study, we examined the effects of
F1,6DP on UVB-induced oxidative stress in HaCaT keratinocytes and hairless mouse. UVB (280±
320 nm) irradiation (30 mJ/cm
2
) increased prostaglandin E2 (PGE2) production, which was
signi®cantly decreased by F1,6DP in a dose dependent manner. UVB irradiation increased the
COX-2 mRNA and total COX activity in HaCaT keratinocytes, which were signi®cantly
blocked by F1,6DP in a dose dependent manner. F1,6DP reduced UVB-induced increase in
cellular reactive oxygen species (ROS) level although it did not show direct antioxidant activity. It
increased the cellular antioxidant capacity including catalase activity and GSH content. It also have
protective effect on UV-induced antioxidant enzyme depression in hairless mouse skin.
Considering that UVB induces a potent oxidative stress by which the in¯ammatory responses
are enhanced, data obtained hitherto suggest that F1,6DP may have a protective role in UVB-
injured skin by decreasing UVB-induced in¯ammatory reaction and increasing cellular antioxidant
system, which are possibly through blocking intracellular ROS generation.
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Dietary Lutein and Zeaxanthin Partially Prevent UVB-Induced Skin Carcinogenesis in
Skh-1 Hairless Mouse Model
J. Chen, A. Wu, M. A. Pathak, F. Rius-Diaz, C. M. Mihm,* D. A. Goukassian,² and S. Gonzalez
Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.;
*Dermatopathology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts,
U.S.A.; ²Department of Dermatology, Boston University Medical School, Boston, Massachusetts, U.S.A.
The xanthophylls, lutein and zeaxanthin, are nonprovitamin A carotenoids with potent antioxidant
properties. The present study, preliminary in nature, was carried out to investigate whether dietary
supplementation with lutein and zeaxanthin prevents UVB-induced skin cancer in chronically
irradiated Skh-1 hairless mice. Female Skh-1 hairless mice were fed daily either with 0.4% lutein
plus zeaxanthin supplemented diet or with a standard nonsupplemented diet. Skin tumors were
induced by exposing dorsal skin of mice to UVB irradiation (100±300 mJ/cm
2
) ®ve days a week
for 22 weeks (cumulative dose 30 200 J/cm
2
). The irradiation protocol was stopped when all
control animals developed skin tumors. Tumor observation and clinical analysis was performed
weekly in each one of the mice during the time course of the irradiation protocol. All animals were
sacri®ced 24-h after last UVB exposure dose and all tumors larger than 2 mm in diameter were
bisected for routine histology and immunohistochemical analysis. Supplementation of lutein and
zeaxanthin to mice diet increased signi®cantly tumor free survival time (p = 0.04, Kaplan-Meier).
Compared to control, lutein treated mice revealed signi®cant reduction in tumor multiplicity
(p < 0.001, Mann±Whitney) and in addition to decreasing the total tumor volume per mouse
(p < 007, MANOVA). Additionally, oral administration of lutein and zeaxanthin signi®cantly
reduced the volume of individual tumors and inhibited their proliferation index (p < 0.05,
Student's t test). No change in body weight was found in lutein-fed mice compared to control
mice. These data demonstrate that lutein and zeaxanthin supplementation to diet may have the
potential to act as chemopreventive agents against UVB-induced skin cancer, at least murine
carcinogenesis model, suggesting a therapeutic role in cancer prevention.
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The In¯uence of Topically Applied Melatonin, Vitamin C and E on UVA-Irradiated
skh-1 Hairless Mouse Skin
T. W. Fischer, I. Kelm, and P. Elsner
Dermatology, FSU-Jena, Jena, Germany
UVA-light induces reactive oxygen species in skin leading to skin aging. Photoaging may be
prevented by antioxidants such as vitamin C and E. Melatonin is a relatively new substance in skin
aging research. We have investigated the skin aging process histologically in skh-1 hairless mice.
Skh-1 hairless mice were treated on the back with 0,1 ml of a cream containing 2% vitamin E, C
and melatonin or placebo-cream trice a week. UVA irradiation was performed at a cumulative dose
of approximately 3000 J/cm
2
over a time period of 10 weeks. Four groups were treated with the 3
antioxidants or the placebo cream, one group was treated only with the vehicle cream and was not
irradiated, and another group was irradiated but not treated with any cream. Biopsies were taken
before and after 10 weeks of irradiation. Staining of the samples was conducted with HE, van
Giesson stain, Resorcin-Fuchsin and Tropoelastin. The thickness of the epidermis and dermis had
increased signi®cantly in all groups after 10 weeks irradiation. Epidermis and dermis were
signi®cantly thicker in melatonin and vitamin E treated groups compared to vitamin C groups.
Elastika staining revealed only a slight increase of elastic ®bers in the irradiated groups and no
increase in the placebo treated and unirradiated group. The ¯uorescence intensity of tropoelastin
increased more in placebo treated mouse skin than in melatonin, vitamin E and C treated mouse
skin after UVA irradiation. Vitamin C treated mice showed a slightly reduced intensity of
¯uorescence compared to melatonin and vitamin E treated mice. The in¯uence of different
antioxidants on skh-1 mice under the in¯uence of UVA irradiation was investigated for the ®rst
time. We found qualitative and quantitative changes in histological slices, whereby vitamin C
reduced the thickening process signi®cantly compared to melatonin and vitamin E. The elastosis
was not seen in van Giesson stain. A longer irradiation period of 6 or 12 months may be suitable to
induce and investigate changes in elastic ®bers.
772
UVA Induced Oxidative Stress in Human Skin may be Evaluated by In Vivo
Chemiluminescence
H. Ouyang, G. N. Stamatas, and N. Kollias
Methods and Models Development, Johnson & Johnson Consumer Products Worldwide, Skillman, New
Jersey, U.S.A.
Chemiluminescence has been used to study oxidative stress in biological systems. in vivo
chemiluminescence has been proposed as a noninvasive approach to assess oxidative stress in skin.
Chemiluminescence signal induced by UVA is very weak (~~500 cp) and it undergoes a fast
exponential decay immediately following the UVA exposure. The decrease of chemiluminescence
signal from its initial burst is indicative of the recombination of free radials formed during UVA
exposure. The purpose of this investigation was to study kinetics of the decay of the UVA induced
chemiluminescence and its dependence on UVA dose and irradiance. The chemiluminescence
signals were measured from the lower inner arms of 10 healthy human volunteers following UVA






. In a second experiment,
UVA was delivered at 2 J/cm
2





chemiluminescence signals induced by UVA exposure were subsequently measured with a red-
sensitive, Peltier-cooled photomultiplier (Electron Tubes Inc, Rockway, NJ). The decays of the
chemiluminescence signals with time were monitored for 300 s and were ®tted to exponential
functions. We observed that the chemiluminescence signal reached maximum immediately after
UVA exposure. It then decays exponentially to baseline in ~~300 s. The time needed to go back to
baseline increases with increasing dose. Chemiluminescence caused by high UVA doses (> 5 J/cm
2
)
remains to be above baseline even after 300 s. The intensity of the initial burst increases
monotonically with the increasing irradiance while the shape of the decay curve remains constant.
UVA induced chemiluminescence is probably related to free oxidative species generated during
UVA exposure and we found positive correlations with chemiluminescence signals for both UVA
dose and irradiance. We thus conclude that in vivo chemiluminescence may serve as an objective
marker for UVA induced oxidative stress.
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The Use of Noninvasive Biophysical Methods to Assess the Degree of Structural Damage
to Human Skin from Chronic Exposures to Sunlight
I. Sadiq, T. Stoudemayer, and A. M. Kligman
Research, S.K.I.N., Incorporated, Conshohocken, Pennsylvania, U.S.A.
Exposure of human skin to sunlight has bene®cial as well as harmful effects. While the
photosynthesis of previtamin D is good, cumulative sun-exposure results in the gradual structural
degradation and the appearance of an assortment of unwelcome signs of photodamage, viz.
dyspigmentation, wrinkles, roughness, dull, yellowish, leathery and lax skin. We have studied these
ravages with an array of biophysical methods. We used videomicroscopy, digital photography and
¯uorescence photography to compare the severely damaged to relatively less photodamaged skin.
Surface topographic features were studied with a phase-shift fringe projection device. Optical
coherence tomography and ultrasonography techniques were used to visualize subsurface, cross-
sectional structures. Some typical effects of photoaging like the ¯attening of the dermal-epidermal
junction and the appearance of hypo-ecogenic areas in the dermal matrix, were observed.
Viscoelastic properties were measured using a suction device which revealed loss of elasticity and
extensibility in relation to the degree of photodamage. The use of biophysical methods has
enhanced our ability to assess photodamage. These methods will be useful for developing protocols
to assess the ef®cacy of surgical and pharmaceutical treatments for reversing the signs of
photoaging.
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Oral Administration of Lutein Modulates Cell Proliferation Induced by Acute UVB
Radiation in the SHK-1 Hairless Mouse Animal Model
A. Wu, M. A. Pathak, M. Sifakis, D. A. Goukassian,* and S. Gonzalez
Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.;
*Department of Dermatology, Boston University Medical School, Boston, Massachusetts, U.S.A.
Naturally occurring carotenoids lutein and zeaxanthin are found in green leafy vegetables and
reported to exhibit antioxidant properties. Because UV irradiation is known to induce oxidative
DNA damage that, if not properly removed, could lead to the development of skin cancer; we
hypothesized that orally administered lutein and zeaxanthin may alter the cutaneous responses to
ultraviolet B (290±320 nm) irradiation. Female hairless Skh-1 mice were fed with 0.4% and 0.04%
lutein plus zeaxanthin enriched diets for a period of 2 weeks and then were irradiated with different
single doses of UVB (40, 80 and 160 mJ/cm
2
). Skin biopsies were taken at 24 and 48 h after
irradiation and processed histologically to assess general morphology, apoptosis (TUNEL) and
proliferation (BrdU and PCNA). PCNA expression was also quanti®ed by Western blot analysis
using tissue lysates. Our results show a clear dose dependent DNA-damage response to single
exposures of UVB. Orally administered 0.4% lutein and zeaxanthin reduced signi®cantly the
edematous cutaneous response (p < 0.01) as determined by suppression of the increase of ear bifold
thickness in response to single doses of UVB irradiation. In addition, these carotenoids were also
ef®cient in reducing the UVB-induced increases in the percentage of PCNA (p < 0.05), BrdU
(p < 0.05), and TUNEL positive cells (p < 0.01) at all doses of ultraviolet radiation given, and this
reduction was found to be UVB dose dependent. A lutein dose-dependent down-regulation of
PCNA expression was con®rmed by Western blot analysis. These data demonstrate that oral
supplementation of lutein and zeaxanthin protects the mouse skin against UVB-induced
photodamage by inhibiting the DNA damage and diminishing its in¯ammatory effects.
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Uptake of the Silicon Phthalocyanine Pc 4 and Photodynamic Dose±Response
Relationships in A-431 vs. Jurkat Cells
M. S. Ke,* L. Y. Xue,² D. K. Feyes,* K. Azizuddin,² T. S. McCormick,* H. Mukhtar,* N. L.
Oleinick,² and S. R. Stevens*³
*Dermatology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio,
U.S.A.; ²Radiation Oncology, University Hospitals of Cleveland and Case Western Reserve University,
Cleveland, Ohio, U.S.A.; ³Dermatology, Louis Stokes Department of Veterans Affairs Medical Center,
Cleveland, Ohio, U.S.A.
The silicon phthalocyanine Pc 4 is a second generation photosensitizer which has shown excellent
treatment response in mouse skin tumors and is currently used in a Phase I photodynamic therapy
(PDT) clinical trial for the treatment of cutaneous tumors. This pure compound can be activated at
longer wavelengths than ®rst-generation photosensitizers like Photofrin, hence providing deeper
tissue penetration. in vitro uptake of Pc 4 was evaluated in human epidermoid carcinoma cells (A-
431) compared with human acute T cell leukemic cells (Jurkat) using both ethyl acetate extraction
with absorption spectrophotometry and ¯ow cytometry. in vitro PDT was performed by
administration of Pc 4 to the extracellular medium for two hours followed by irradiation with an
EFOS light-emitting diode array delivering red light (lmax = 675 nm) at varying ¯uences. Cell
viability was measured by MTT assay. Uptake by A-431 and Jurkat cells was similar at low-to-
moderate doses (0.1±100 nM) but signi®cantly increased in Jurkat cells at higher doses (200±
500 nM). At still higher doses (500±2000 nM), uptake is greater in A431 cells relative to Jurkat
cells. Additionally, ¯uorescence was signi®cantly reduced in Jurkat cells by Pc 4 aggregation.
Viability data after PDT reveal a greater killing effect in Jurkat cells compared with A-431 cells.
This differential sensitivity to in vitro PDT may offer therapeutic advantages in targeting
in¯ammatory cells over normal keratinocytes in the treatment of in¯ammatory skin diseases like
psoriasis.
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All-trans-Retinoic-Acid Sensitizes Primary Keratinocytes to UVB-Induced p53-
Dependent Apoptosis
P. E. Mrass,* M. Rendl,* M. Mildner,* and T. Erwin*²
*Dermatology, AKH, Vienna, Austria; ²Dermatology, CE.R.I.E.S., Neuilly, France
We have previously demonstrated that all-trans-retinoic-acid (ATRA) up-regulates caspase-3
protein expression in keratinocytes (KC). Here we show that ATRA also induces other effector
caspases, i.e. caspases-6, ±7, and the mitochondrial initiator caspase-9. The up-regulation of caspase
expression by itself was not accompanied by increased apoptosis of KC. However, when con¯uent
KC were irradiated with UVB (20 mJ/cm
2
) after 3 days of ATRA treatment, the majority (> 70%)
of cells detached and showed morphologic signs of apoptotic cell death. That KC indeed died of
apoptosis was con®rmed by demonstration of caspase-3 activation and DNA-laddering. In contrast
to ATRA treated KC, only little (< 20%) apoptosis was observed in con¯uent KC irradiated before
ATRA treatment, and con¯uent KC cultured for additional 3 days became altogether resistant to
apoptosis. The UVB-induced apoptosis in ATRA-treated KC could be completely blocked when
the p53-inhibitor a-pi®thrin was added to the KC after UVB-irradiation, whereas blockade of
death-receptor activation by incubating the cells on ice prior to, and during irradiation, did not
have any protective effect. Our results demonstrate that ATRA treatment sensitizes KC to UVB-
induced, p53-dependent apoptosis probably due to the up-regulation of pro-apoptotic caspases.
Sensitization of KC to UV-induced apoptosis, might be involved in the synergistic effect of
combined UVB and retinoid treatment in psoriasis.
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Role for Heat Shock Proteins in the Immunopathogenesis of Vitiligo
I. Le Poole, J. Curry, J. Qin, L. Stennett, and B. Nickoloff
Department of Pathology, Loyola University Chicago, Maywood, Illinois, U.S.A.
Vitiligo is a mysterious disease in which melanocytes (MCs) are lost from the epidermis. Several
precipitating factors trigger this putative autoimmune process. However, the molecular basis
underlying activation of immunocytes responsible for selective loss of melanocytes is unknown.
Recently, heat shock proteins (HSPs) have been recognized as possessing both antigenic
chaperone, as well as cytokine-like functions capable of activating immunocytes via speci®c
receptors such as CD91. To determine if HSPs play a role in vitiligo, we analyzed differential
expression of HSPs and CD91 in symptomless (VN), perilesional (PM) and depigmented (VL) skin
of patients with vitiligo in comparison to normal skin (NN) from healthy volunteers (n = 5). We
also determined a functional role for HSPs as inducers of ICAM-1 expression on MC, and inducers
of dendritic cell (DC) expression of TRAIL. Immunostaining to detect HSP27, HSP60 and HSP70
revealed enhanced expression in VN compared to NN skin, and loss of HSP27 in VL skin. Focal
loss of HSP70 was apparent in VL skin. CD91 was strongly expressed by dermal DC, with
dendritic processes frequently extending into the lower epidermis. In VP skin, marked
accumulation of CD91+ DCs was admixed with HSP27 bearing MCs and ICAM-1 expressing
epidermal cells. In culture, exposure of MCs to depigmenting agent 4TBP enhanced HSP levels.
Addition of HSP27 induced ICAM-1 expression on CD91+ MCs. A cocktail of recombinant
human HSPs induced expression of death ligand TRAIL on blood-derived DCs. Addition of
TRAIL (300 ng/ml) to PIG1 immortalized human melanocytes induced rapid and prominent
apoptosis. Given that various stressful stimuli enhance HSP levels and trigger vitiligo, we propose
that HSP27 initially produced by MCs mediates ICAM-1 expression and retention of CD91
positive DCs. TRAIL mediated apoptosis of MCs may be a previously overlooked contributor to
the etiopathogenesis of vitiligo.
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Co-Expression of Wild Type Tyrosinase Enhances Maturation of Temperature-Sensitive
Tyrosinase Mutants
R. Halaban, E. Cheng,* and D. N. Hebert²
Dermatology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.; *Dermatology, Yale
University School of Medicine, New Haven, Connecticut, U.S.A.; ²Biochemistry and Molecular Biology,
University of Massachusetts, Amherst, Massachusetts, U.S.A.
Tyrosinase is a type I membrane glycoprotein whose activity is essential for melanin synthesis. Loss
of function mutations in tyrosinase is the cause of oculocutaneous albinism 1 (OCA1). In the
milder OCA1B form in which mutant proteins retain residual activity, the severity of albinism
depends on the type of mutations expressed in the melanocyte. In the present study, we show that
coexpression of temperature-sensitive tyrosinase mutants with wild type protein corrects the
mutant conformation defect in an activity dependent manner. Exit from the endoplasmic
reticulum and complex carbohydrate processing in the Golgi was promoted when temperature-
sensitive tyrosinase mutants were ectopically expressed in host melanocytes carrying wild type
protein even at the nonpermissive temperature. Incubation of transfected melanocytes with DOPA
(the cofactor and substrate for tyrosinase), or tyrosine (the substrate), further enhanced processing
of ectopic mutant proteins. The analysis of glycosylation-de®cient mutants revealed regions in
tyrosinase with high, low and intermediate dependency on glycans for maturation. We concluded
that the presence of active tyrosinase enhances the maturation of temperature-sensitive and
glycosylation-de®cient forms of tyrosinase. The results may explain the variation in pigmentation
and the development of pigment later in life in OCA1B patients carrying different mutant alleles.
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Bone Morphogenetic Protein 4 Modulates Melanocyte Proliferation and Melanogenesis
M. Yaar, H. Y. Park, V. Botchkarev, K. Stewart, I. Panova, and B. A. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.
Bone morphogenetic proteins (BMP), originally characterized by their role in development of
cartilage and bone, signal in many cells including neural precursors. To determine the BMP effect
on neural crest-derived normal human melanocytes (Mc), Mc were stimulated with BMP4 (0±
25 ng/ml). Within 72 h, BMP4 increased Mc yield by ~300% (p < 0.03) and decreased melanin/
cell by 75 6 1% (p < 0.005). BMP4 does not affect Mc yield by inhibition of apoptosis, as there was
no increase in cytoplasmic DNA-histone levels at 48 h or 72 h. BMP4 signaling involves two
receptors: BMP R1and BMP R2. BMP R1 binds BMP, while BMP R2 transduces the signal.
BMP R1 has two distinct forms: A and B. BMP R1A promotes neural precursor proliferation and
BMP R1B promotes their mitotic arrest and differentiation. RT-PCR using primers
complementary to these human receptor transcripts, con®rmed by product sequencing, clearly
demonstrated strong constitutive expression of the proliferation-associated BMP R1A in Mc. Mc
also expressed BMP R1B and BMP R2, demonstrating that Mc express all transmembrane
receptors required to respond to BMP stimulation. BMP signals are transduced through
phosphorylation of cytoplasmic Smad proteins that translocate to the nucleus to affect gene
transcription. The DNA consensus sequence recognized by Smad, cagaca, is present in the
promoter region of human tyrosinase (nucleotides ±2051 to ±2045). Indeed, northern and Western
blot analyses of BMP4-treated Mc show substantially down-regulated tyrosinase mRNA and
protein, respectively, within15 h through 72 h. Interestingly, BMP4 also substantially down-
regulates the two PKC-b transcripts as well as PKC-b protein, the enzyme that activates tyrosinase.
Intriguingly, by RT-PCR and sequencing we found that keratinocytes weakly express BMP4, but
Mc strongly express BMP4, suggesting an autocrine effect of BMP4 on Mc. These data provide
evidence of a novel signaling pathway that in¯uences Mc function in human skin.
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Restoration of Energy Metabolism Protects from Induction of Photoaging-Associated
Mitochondrial (mt) DNA Deletion
M. Berneburg, S. Wild, V. Kuerten, L. Declercq,² M. Matsui,² T. Ruzicka, and J. Krutmann*
Department of Dermatology, Clin. & Exp. Photodermatology, U. of Duesseldorf, Duesseldorf, Germany;
*Heinrich-Heine-University, Institut fuer Umweltmedizinische Forschung, Duesseldorf, Germany; ²Research
Laboratories, Estee Lauder, Melville New York, New York, U.S.A.
Deletions of mitochondrial (mt) DNA are involved in UV-induced photoaging. MtDNA only
encodes for genes of the respiratory chain (RC) for energy generation. It has been hypothesized
that the so called common deletion, induced by reactive oxygen species (ROS), leads to a
decreased energy pool. The cell is then believed to increase RC activity leading to the generation
of more ROS. Evidence for the vicious cycle: ROS ± mtDNA deletions ± energy reduction ± RC
up-regulation ± ROS ± mtDNA deletions, has been elusive, however. We have thus assessed if
restoration of energy levels in cells undergoing chronic UVA exposure could prevent induction of
the common deletion. While cellular ATP levels are volatile, phosphocreatine is more stable.
Employing a nested-PCR assay we investigated if induction of the common deletion by UVA and
subsequent functional changes (O2 consumption, MMP-1 induction) could be inhibited by
coincubation of human ®broblasts with the energy precursor creatine. Lipid peroxidation assays
and absorbance spectrometry showed no antioxidative or UV absorbing capacities for creatine.
However, creatine led to a dose dependent decrease of the common deletion. Most interestingly,
creatine not only reduced mtDNA mutagenesis but also normalized functional parameters (oxygen
consumption and MMP-1 induction). These results provide direct evidence for the existence of a
vicious cycle in which mtDNA mutations lead to reduced energy levels, an increase of ROS and
thereby to new mtDNA mutations. Furthermore, application of energy equivalents may represent
a new and innovative way to protect the skin from UV-induced photoaging.
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Topical Application of a PKC Inhibitor Reduces Skin Pigmentation
H. Park, S. Gonzalez,* J. Lee, M. Middelkamp-Hup,* S. Kaposi, S. Peterson, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts, U.S.A.; *Dermatology,
Harvard Medical School, Boston, Massachusetts, U.S.A.
The b isoform of protein kinase C- (PKC-b) activates tyrosinase, the rate-limiting enzyme in
melanogenesis, by phosphorylating serines at amino acid (aa) positions 505 and 509. To determine
whether PKC-b inhibition decreases pigmentation, paired cultures of primary human melanocytes
were ®rst pretreated with 50 mM bisindolylmaleimide (Bis), a selective PKC inhibitor, or vehicle
alone for 30 min. Then the cells were treated with 2 mM phorbol dibutyrate for an additional
90min to activate PKC in the presence of Bis. Bis blocked the expected induction of tyrosinase
activity by activation of PKC (1000 6 50 cpm/mg in Bis vs. 2500 6 235 cpm/mg in vehicle treated
cultures); where the basal tyrosinase activity was 1100 6 155 cpm/mg. Addition of a peptide
pseudosubstrate for PKC corresponding to aa 501±511 of tyrosinase and not expected to bind other
PKC-b isoforms gave similar results, suggesting that inhibition of PKC-b activity alone will reduce
pigmentation. To determine whether topical application of Bis reduces pigmentation in vivo, six
pigmented guinea pigs were ®rst shaved and depilated. Three animals were UV irradiated daily
with a solar simulator for 10 days using a protocol that gives tanning by day 10 and three were
nonirradiated. Then 200 mM Bis or vehicle alone was applied twice daily for three weeks,
excluding weekends, to all animals. After the last application, 4-mm punch biopsies were processed
for H&E and Fontana Masson staining to address overall morphology and quantify total epidermal
melanin. In both UV-irradiated and nonirradiated animals, Bis decreased pigmentation. Visual
analysis was con®rmed by image analysis where total epidermal melanin was decreased by 50%
(p < 0.03) in Bis-treated areas when compared to that of the vehicle-treated areas. Cross-sections
revealed no cytologic damage, atrophy, irritation or in¯ammation after topical application of Bis.
These results suggest that inhibiting PKC-b activity in vivo selectively blocks tanning and reduces
baseline epidermal pigmentation.
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Simultaneous Targeted Alteration of the Tyrosinase and C-Kit Genes by Single-
Stranded Oligonucleotides
V. Alexeev, O. Igoucheva, and K. Yoon
Dermatology and Cutaneous Biology, Thomas Jefferson University, Jefferson Medical College, Philadelphia,
Pennsylvania, U.S.A.
Previously we have shown the ability of the short single-stranded oligonucleotides (ODNs) to
correct episomal and chromasomal DNA using the mutant LacZ reporter system that has been
developed in our laboratory. Extending the application of such oligonucleotides we attempted to
alter two endogenous genes, tyrosinase and c-kit, simultaneously in albino mouse melanocytes.
The products of these genes are exeptionally important for the melanin synthesis and for the
development of the pigmentation system. In order to alter two genes simultaneously we designed
two oligonucleotides to correct a single point mutation (S85C, TGTCË TCT) in the tyrosinase gene
and to introduce an activating point mutation (D814Y, GACCË TAC) into the c-kit gene. Upon
transfection of the albino melanocytes with both oligonucleotides, relying on a pigmentation
change caused by the tyrosinase gene correction, we were able to achieve targeted gene alteration
with the frequencies ranging from 2 3 10
±4
to 1 3 10
±3
. The presence of the desired modi®cations
in tyrosinase and c-kit genes were analyzed in several clones isolated from single pigmented cells.
Two out of eight individual clones revealed the simultaneous targeted alteration in these genes.
Conversion of both genes was con®rmed by DNA analysis and enzymatic activities of two
proteins. For the ®rst time we demonstrate the feasibility of simultaneous targeting of two genes
that may enhance the oligonucleotide-based stratagies.
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Topical Application of Dimethylbenz(a)anthracene to the Skin of C3H/HeN Mice
Results in the Generation of Multiple Melanocytic Pigmented Nevi with Increased H-ras
Expression
C. A. Elmets,* N. Iranikhah,* E. Sanders,* H. Skelton,*² A. Volk,² and K. Smith*²
*Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.;
²Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
Melanocytic nevi are a common dermatological problem for which there are few in vivo models.
Some nevi are known to contain ras oncogene mutations and the polyaromatic hydrocarbon
dimethylbenz(a)anthracene (DMBA) produces ras mutations. Therefore, experiments were
conducted to determine whether application of DMBA to the skin of mice would result in the
development of melanocytic nevi. One hundred mL of a 0.1% solution of DMBA was applied to
the dorsal skin of C3H/HeN mice. The animals did not receive further treatment (unless otherwise
speci®ed) and were observed for the appearance of pigmented lesions. By week 17 postapplication,
several 1±3 mm pigmented macules could be identi®ed on the treated skin. Pigmented lesions did
not occur in animals treated with vehicle alone. Both greater numbers of nevi and larger diameters
of lesions were observed as the dose of DMBA was increased. Topical application of DMBA
followed by repeated application of TPA increased the mean size of the pigmented lesions.
Histological examination revealed perifollicular accumulations of pigmented cells, some showing a
nested morphologic pattern. The cells were S-100 protein and HMB-45 positive, con®rming their
melanocytic origin. During the 40 week observation period, no invasive melanomas were
observed. Immunohistochemical stains for H-ras showed moderate cytoplasmic staining. Lesions
were also examined for p16, p21, and p53, all of which are up-regulated by H-ras. p16 showed
moderate nuclear staining, p21 showed moderate to dark nuclear staining, and p53 showed weak to
moderate nuclear staining within the same cell population. Further examination of this model may
facilitate identi®cation of the molecular and biochemical mechanisms that lead to the development
of pigmented nevi and the factors that promote their evolution into invasive melanomas.
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Differential Effect of Solar Simulated Irradiation on Cytoplasmic Dynein Intermediate
Chain Expression in Cultured Human Keratinocytes vs. Melanocytes
H. R. Byers and S. G. Dykstra
Dermatology, Boston Univerisity School of Medicine, Boston, Massachusetts, U.S.A.
The intermediate chain of cytoplasmic dynein links the heavy chain retrograde microtubular motor
to the dynactin complex associated with membrane-bound organelles. We have demonstrated that
cytoplasmic dynein intermediate chain in human keratinocytes and melanocytes is involved in the
perinuclear directed aggregation of melanophagolysosomes and melanosomes, respectively. We
hypothesize that solar irradiation promotes the release of melanosomes from the melanocyte
perinuclear region and maintains perinuclear aggregation in keratinocytes by differential expression
of the keratinocyte and melanocyte cytoplasmic dynein intermediate chain. Time-lapse video
microscopy and western immunoblots of cultured keratinocytes and melanocytes were performed
24 or 48 h after sham, 10, 20 and 30 mJ/cm
2
solar simulated irradiation. In response to solar
simulated irradiation, melanocytes by 24 h increased intermediate chain expression at 10±20mJ/
cm
2
, then markedly decreased expression at 20 or 30 mJ/cm
2
. In contrast, keratinocytes maintained
a remarkable steady state of the intermediate chain at 24±48 h postirradiation, despite increasing
exposure to solar irradiation. Keratinocytes treated with increasing dosages of cyclohexamide for
48 h did not exhibit a change in expression after solar irradiation indicating that the maintenance
levels were not due to increased synthesis coupled with enhanced degradation. In conclusion, solar
irradiation in melanocytes at low dosages promotes intermediate chain mediated maintenance of
melanosomes in the perinuclear region, whereas at higher dosages the decrease in the intermediate
chain permits release of melanosomes for transport into the dendrites by centrifugal microtubule
and actin-based motors. In contrast, keratinocytes are resistant to this modulation, maintaining the




, an Epidermal Model Containing Functional
Melanocytes, Demonstrate Ef®cacy of Novel Skin Lightening Formulations
G. de Paoli Ambrosi,* M. Klausner, J. Kubilus, and P. J. Hayden
R & D, MatTek Corporation, Ashland, Massachusetts, U.S.A.; *R & D, General Topics, s r l, San Felice
del Benaco, Italy
To minimize the cost of human clinical studies and shorten the time to market, we have used the
MelanoDerm skin model (MatTek Corporation) to screen novel skin lightening formulations that
we have recently developed. The formulations were applied topically to MelanoDerm tissues 5
times over an 8-day period. Tissue samples were ®xed for histological analysis on Days 4, 7, 11, and
14; others were frozen on Days 11 and 14 to measure melanin content. Visual observation of the
tissues showed that the tissues progressively darken over the 14-day culture period and that the 4
formulations tested resulted in signi®cantly decreased pigmentation vs. the negative control
(untreated) tissues. This was borne out by melanin assay results that showed decreases of 64±77% in
melanin content vs. the controls. Histological analysis showed that the tissues maintained normal
epidermal morphology over the experimental period and that the reduction in pigmentation was
not due to cytotoxicity. Using en face microscopic observation, the melanocytes were dif®cult to
visualize in the treated tissues up through Day 11. However, 6 days after the ®nal lightener
application (Day 14), the melanocytes in tissues treated with 3 of the 4 formulations were highly
pigmented and dendritic, similar to the melanocytes contained within the control tissues. Based on
these results, we conclude that 3 of the 4 formulations dramatically inhibit melanogenesis without
cytotoxicity. These and initial, positive clinical results lead us to believe that the formulations will
be commercially useful in skin lightening products.
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b-Endorphin: Evidence of a Role in the Regulation of Human Skin Pigmentation
K. U. Schallreuter, S. Kauser, A. A. Thody, C. Gummer,* and D. J. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, U.K.; *Technical Center, Procter &
Gamble (UK), Egham, U.K.
b-Endorphin, a-MSH and ACTH are enzymatically cleaved from the precursor protein pro-
opiomelanocortin (POMC). These peptides are synthesized locally in the skin where they are
involved in multiple regulatory functions including immuno-modulation, neurotransmission and
melanogenesis. a-MSH and ACTH stimulate melanogenesis in human epidermal melanocytes via
the activation of the MC-1 receptor. b-Endorphin acts predominately via m-opiate receptors. To
date a functional role for b-endorphin in the regulation of human epidermal melanocytes has not
been demonstrated. Thus, this study was designed to examine the involvement of b-endorphin/m-
opiate receptor system in epidermal melanocyte biology. The expression of m-opiate receptor and
b-endorphin was assessed in gp100-positive melanocytes in situ and in vitro using double
immuno¯ourescence. Additionally, POMC and m-opiate receptor mRNA expression was
examined by RT-PCR. The potential melanogenic, dendritogenic and mitogenic effects of b-
endorphin were investigated in epidermal melanocyte cultures after stimulation for 72 h. This study
showed that both b-endorphin and m-opiate receptor were strongly expressed in situ in gp100-
positive melanocytes. Variable expression for both b-endorphin and m-opiate receptor was evident
in gp100-positive melanocytes in vitro. POMC and m-opiate receptor mRNA expression was
demonstrated in epidermal melanocyte cultures. Functional studies indicated that b-endorphin
signi®cantly increased melanogenesis and proliferation. b-endorphin stimulation also increased
melanocyte dendricity to variable degrees in different cell lines. This study reports for the ®rst time,
a role for b-endorphin in regulating human skin pigmentation and suggests that altered b-
endorphin homeostasis may be involved in pathology of the epidermal melanin unit.
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A Multidomain Adaptor Protein Links Intracellular Sorting of Tyrosinase-Related
Protein-1 with Phosphatidylinositol 3-Kinase Signaling Pathway
T. Liu,* G. Kandala,* N. D. Sangha,* Y. Q. Chen,² and V. Setaluri*²
*Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.;
²Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, U.S.A.
The tyrosinase related protein-1 (TRP-1/gp75) is thought to in¯uence biogenesis of melanosomes.
We have recently identi®ed a multipurpose PDZ domain protein GIPC that interacts with gp75 in
the Golgi. PDZ domain proteins are known to facilitate the assembly of signaling complexes by
virtue of their interaction with multiple target proteins through multiple PDZ domains. However,
GIPC contains only one PDZ domain. We hypothesized that actions of GIPC are mediated by
additional protein±protein interactions. Using GST-GIPC af®nity chromatography, we identi®ed
a GIPC-interacting signaling adpator protein APPL (adaptor protein containing pleckstrin
homology, phosphotyrosine binding domain and leucine zipper motif). APPL was originally
identi®ed based on its interaction with the inactive form of the serine/threonine kinase, Akt2,
which is the principal downstream target for phosphatidylinositol 3-kinase (PI3K). Although GIPC
and APPL are present in all normal skin-derived and melanoma cells, coimmunoprecipitation
analysis showed that GIPC interacts with APPL only in melanocytic cells. Akt2, however, forms a
ternary complex with GIPC-APPL only in melanoma cells but not in normal melanocytes. A role
for PI3K signaling, Akt2 phosphorylation and GIPC±APPL interaction in gp75 sorting was
suggested by the following observations. First, treatment of melanoma cells with wortmannin, a
speci®c inhibitor of PI3K, results in accumulation of newly synthesized gp75 in the juxtanuclear
region. Second, synchronized new synthesis of gp75 coincides with increased phosphorylation of
Akt2 and its dissociation from the GIPC-APPL complex. Our data suggest GIPC-APPL complex
provides a link between external stimuli that activate PI3K signaling pathway and melanosome
biogenesis.
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Topical Tacrolimus: An Assessment of Pre- and Post-Treatment Cytokines in Lesional
and Adjacent Skin of Patients with Vitiligo
P. Grimes,*² R. Morris,² E. Avaniss-Aghajani,* M. Meraz,* and A. Metzger*
*N/A, Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, U.S.A.;
²Department of Dermatology, University of California ± Los Angeles, Los Angeles, California, U.S.A.
Numerous studies have documented immunologic defects in patients with vitiligo. However,
there is a dearth of data regarding lesional cytokine expression. The purpose of this investigation
was to assess pre- and post-treatment expression of proin¯ammatory cytokines in the depigmented
and normal skin of patients with vitiligo. Nineteen patients with generalized disease were included
in this investigation. At baseline, 3 mm punch biopsies were taken from the inner border of
depigmented nonsun exposed and adjacent normal skin. Twelve age, race and sex matched
controls were also biopsied. Patients were treated with tacrolimus ointment 0.1% twice daily for
24 weeks. Biopsies were repeated from lesional and adjacent normal skin at 24 weeks. Total RNA
was extracted by using Qiagen's RNEASY Kit. Cellular mRNA expression for IL2, IL4, IL10,
TNF a and interferon-g were determined by real time quantitative PCR (Taqman). At baseline,
compared to healthy controls, vitiligo patients demonstrated a statistically signi®cant increased
expression of interferon g in the involved and normal skin compared to healthy controls (p = 0.05
and 0.02, respectively). TNF a expression was increased in involved and uninvolved skin
compared to controls (p = 0.01 and 0.02, respectively). In addition, there was signi®cant expression
of IL-10 in the involved and normal skin compared to controls (p = 0.01 and 0.04). Post-treatment,
TNF a expression decreased in the depigmented and adjacent uninvolved skin (p < 0.001).
Varying levels of repigmentation were observed in 79% of the patients. Sixty-two percent achieved
greater than 75% repigmentation of face and neck lesions. The results of this investigation suggest
that supression of TNF a expression induced by tacrolimus ointment may bene®cially impact
repigmentation of vitiliginous skin lesions.
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Synergistic Activation of the Murine Dopachrome Tautomerase Gene by the
Transcription Factors Sox10 and Mitf
T. J. Hornyak, Z. Jiao, and J. L. Lanning
Department of Dermatology, Henry Ford Health System, Detroit, Michigan, U.S.A.
The purpose of this study was to de®ne the transcriptional requirements for expression of the
dopachrome tautomerase (Dct) gene, a melanogenic gene expressed early in melanocyte
development during embryogenesis that encodes tyrosinase-related protein-2 (TRP-2), a
eumelanogenic enzyme. Deletion mutagenesis of the Dct promoter region, transfection studies,
and electrophoretic mobility shift assay (EMSA) procedures were used to de®ne the transcriptional
determinants of Dct expression. Initial deletion mutagenesis studies of a 3.2-kb region of Dct
regulatory sequence showed that promoter sequences responsible for transcriptional activity in cell
lines of melanocytic origin were located within the proximal 634 nucleotides relative to the
transcriptional start site. Additional reporter gene assays showed that sequences within the proximal
461 nucleotides were critical to high levels of expression in B16 melanoma cells. This region of the
promoter contained candidate binding sites for the transcription factors Sox10 and Mitf.
Transfections into heterologous 293T cells showed that Sox10 and Mitf independently activated
both the 3.2 kb Dct promoter and the ±634 base pair deletion mutant modestly (up to 4-fold
induction), but that Sox10 and Mitf, when cotransfected, synergistically activated expression from
these promoter sequences (greater than 10-fold induction). Direct interaction of both in vitro-
generated Sox10 and Sox10 from B16 cell nuclear extracts was demonstrated using EMSA analysis
to oligonucleotide probes derived from promoter sequences within the region required for both
Sox10-dependent activation and Sox10-induced potentiation of Mitf-dependent activation. These
results suggest that a combinatorial transcription factor interaction is important for the initial
expression of Dct in neural crest-derived melanocytes, and support a model for sequential gene
activation in melanocyte development whereby Mitf, a Sox10-dependent transcription factor,
must be expressed initially before the ®rst melanogenic gene, Dct, can be highly expressed.
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Rede®ning the Skin's Pigmentary System with a Novel Tyrosinase Assay
R. Han,*² H. P. Baden,*² J. L. Brissette,*² and L. Weiner*²
*Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts,
U.S.A.; ²Dermatology, Harvard Medical School, Boston, Massachusetts, U.S.A.
Tyrosinase is an enzyme speci®c to pigment cells and essential for the production of melanin. Here,
we describe a novel method for the detection of tyrosinase activity, named tyramide-based
tyrosinase assay (TTA). In this assay, histological sections are incubated with biotinyl tyramide, a
compound that mimics the natural substrates of tyrosinase. The tyramide reacts with tyrosinase and
deposits onto the section in close proximity to the enzyme. Since the tyramide is biotinylated, its
deposition is visualized with streptavidin conjugated to a ¯uorescent dye. In the skin and eyes,
TTA produced intense staining at sites known to exhibit melanogenesis. This staining was
abolished by kojic acid (a tyrosinase inhibitor) or a null mutation in the tyrosinase gene (the murine
albino mutation). In human epidermis, all TTA-positive cells possessed c-Kit, a melanocyte
marker; moreover, the assay detected pigment cell defects, such as melanocytic nevi and vitiligo,
providing con®rmation of medical diagnoses. Thus, TTA is highly speci®c for tyrosinase and serves
as a sensitive indicator of pigment cell distribution and status within a tissue. Using the assay, we
identi®ed a new tyrosinase-positive cell type- the differentiating epithelial cells of the hair medulla.
To our knowledge, this is the ®rst demonstration of tyrosinase activity in epithelial cells of the skin.
Since tyrosinase by itself can generate pigment from tyrosine, it is likely that medullary cells
contribute to hair coloration and constitute a new class of pigment-forming cells.
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Modulation of Microphthalmia-Associated Transcription Factor Expression Alters Skin
Pigmentation
C. B. Lin, L. Babiarz, F. Liebel, R. E. Price,* D. E. Fisher,* G. J. Gendimenico, and M. Seiberg
Skin Research Center, Johnson & Johnson, Skillman, New Jersey, U.S.A.; *Peadiatric Hematology/
Oncology, Dana Farber Caner Research Institute, Boston, Massachusetts, U.S.A.
The microphthalmia-associated transcription factor (MITF) is implicated in melanocyte
development and in the regulation of melanogenesis. MITF binds to the M-box of tyrosinase,
TRP-1 and TRP-2 and transactivates these genes, resulting in increased pigmentation. Using a
luciferase reporter construct driven by the MITF promoter, we show that UVB irradiation induces
MITF promoter activity in a time and dose dependent manner. The natural extract TCM-1
induces the melanocyte-speci®c MITF promoter, while dihydrolipoic acid (DHLA), lipoic acid
(LA) and resveratrol (RES) reduce MITF expression. DHLA, LA and RES induce skin lightening
in vivo, inhibit UVB-induced tanning of light skin swine. Over-expression of MITF rescued the
repressive effects of DHLA, indicating that the depigmenting effect of DHLA is largely dependent
on the inhibition of endogenous MITF expression. Modulation of the MITF promoter by TCM-1
and DHLA has no effect on cAMP concentration. However, MITF promoter containing the
mutated CRE did not respond to either forskolin or TCM-1. Taken together, these data suggest
that TCM-1 and DHLA might target transcription factors that cooperate with CRE binding
protein(s) to transactivate MITF promoter. Alternatively, these agents could affect the localization
of cAMP within the melanocytes. Modulation of MITF expression therefore could alter skin
pigmentation. The precise mechanism by which these agents modulate MITF promoter activity
needs to be further investigated.
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Oncogenic Ras and Telomerase Induce Invasive Human Melanocytic Neoplasia
P. Robbins, S. Sheu, J. Chudnovsky, T. Cai, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Generation of a human tissue model of melanoma may surmount limitations of purely murine
models, including major differences in melanocyte distribution and the greater ease of
transformation of murine tissue. Creation of human melanoma cells from de®ned genetic
elements, however, has yet to be achieved. Towards this goal, genes of potential importance in
melanoma were expressed within a mixed population of normal human melanocytes and
keratinocytes and used to regenerate human skin on SCID mice. Co-expression of hTERT and
oncogenic Ras expression produced black plaques in the regenerated skin grafts at a frequency of
100% (n = 4). Ras-hTERT expressing skin displayed histologic features of invasive melanoma,
including melanocytic hyperplasia with cellular atypia, abundant mitoses and upward pagetoid
spread into suprabasal layers as well as invasion of melanocytes through the basement membrane
and dermis down to the subcutaneous fat. The melanocytic origin of the neoplasms was con®rmed
by staining for S100 and Melan A. Control samples (n = 25) were clinically and histologically
normal.We then injected 1±10 3 10
6
transduced primary human melanocytes subcutaneously into
nude mice. In parallel, GFP, Ras, hTert and Ras-hTert transduced primary human ®broblasts were
injected. Within 3 weeks, we observed tumor formation with coexpression of Ras and hTert in
melanocytes. Neither melanocyte controls nor any of the transduced ®broblasts induced
tumorigenesis. Initial histological and immunohistochemical analysis suggests that the tumors are
of melanocytic origin. Intravascular injection of Ras-hTert transduced primary melanocytes
produced tumor nodules in the lungs of nude mice by 4 weeks, with characterization of viscerally
disseminated tumors in progress. Therefore, interplay between oncogenic Ras and telomerase
function in primary human melanocytes induces features of invasive melanocytic neoplasia and
establishes a human tissue model which may provide insight into melanoma pathogenesis as well as
potential molecular targets for therapeutic intervention.
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LPHA-Positive Vesicles and Coarse Melanin in Primary and Metastatic Melanomas
J. M. Pawelek and T. Handerson
Dermatology, Yale School of Medicine, New Haven, Connecticut
We investigated the extent and distribution of b1±6 branched N-glycans in primary and metastatic
melanomas. b1±6 branched N-glycans are produced by the enzyme GnT-V, whose activity is a
predictor of poor prognosis in human breast and colon carcinomas. b1±6 branched N-glycans can
be detected by histochemical staining with the lectin LPHA (leucocyte phytohemagglutinin).
Clark (1977) observed coarse melanin granules `commonly seen in vertical phase melanomas'. We
show for the ®rst time that coarse melanin consists of melanosomes packaged into LPHA-positive
phagolysosomal vesicles. In an initial survey, large LPHA-positive coarse melanin vesicles were
detected in melanoma cells from 22 of 26 nonselected primary vertical phase tumors. The vesicles
also stained with anti-CD63 (phagolysosomal membrane component), and HMB45 (antimelano-
somal protein gp100). Surprisingly, similar vesicles were detected in some nonmelanized regions of
vertical phase melanomas, staining positively for LPHA, HMB45, and CD63, yet lacking melanin.
Melanoma cells expressing LPHA-positive phagolysosomal vesicles (with or without melanin)
were generally but not always in the minority of the primary tumor cell population. Since b1±6
branched N-glycans are associated with metastasis, the possibility is raised that these LPHA-positive
melanoma cells may have high metastatic potential. Consistent with this, an initial survey of
melanoma metastases showed that cells with LPHA, HMB45, and CD63-positive phagolysomal
vesicles, with or without melanin, comprised a majority of the tumor cell population in 6 of 6
metastases analyzed to date. In summary, the preliminary results indicate for the ®rst time that
coarse melanin in human melanoma cells is contained in phagolysosomal vesicles rich in b1±6
branched N-glycans. Melanoma cells containing such vesicles can be found in the majority of at
least some metastases, suggesting the possibility that LPHA-positive melanoma cells in primary
tumors may be prone to metastatic progression.
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Imaging of Tyrosinase Maturation in Nonpigmented Cells
A. Kamada, H. Nagaya,* H. Jin, T. Yamashita, K. Jimbow, H. Kanoh,* and I. Wada*
Departments of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan; *Departments
of Biochemistry, Sapporo Medical University School of Medicine, Sapporo, 131, Japan
To elucidate molecular mechanisms for maturation of endomembrane proteins, imaging of
immature protein dynamics in living cells has been proven to be a powerful method. For this
purpose, a temperature-sensitive folding mutant (ts045) of a plasmalemmal glycoprotein of
vesicular stomatitus virus (VSVG) has been used. However, no such model protein targetted to the
endocytic organella has been known. We report here that dynamics of a lysosomal membrane
protein from the site of synthesis to lysosomes upon maturation can be visualized in vliving cells by
utilizing the unstable properties of tyrosinase folding in nonpigmented cells. This protein formed
large aggregates when synthesized at 40 & #65533; aÄC in nonpigmented cells. When transferred to
37 & #65533; aÄC, though the aggregation was not resolved, tyrosinase acquired dopa oxidase
activity upon increased lateral mobility and the protein tagged with ¯uorescent protein was moved
to COPII coated endoplasmic reticulum (ER) exit sites from the ER network. The folding
competence at 40 & #65533; aÄC was maintained by calnexin cycles coupled with glucose turnover
on tyrosinase oligosacharides. Tyrosinase was segregated from VSVG within the Golgi apparatus,
and formed tubulovesicular structures, which later incorporated mannose-6-phosphate receptor
and ®nally fused to mature lysosomes labeld with ¯uorescent pepstatin. We suggest that this system
may become a novel tool to study biogenesis of lysosomes.
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Mechanism of Action of the Skin-Lightening Effect of OPC-10407, a New Skin-
Bleaching Active Ingredient
N. Oizumi, K. Kuwahara, Y. Oshiro, K. Fujita, and S. Fujisawa
Ako Research Institute, Otsuka Pharmaceutical Co., Ltd, Ako, Hyogo, Japan
It was previously shown that OPC-10407, currently under development as a new active ingredient
for skin bleaching, elicits a marked skin-lightening effect in both a natural dark-colored swine skin
model and an ultraviolet-radiation-induced pigmentation swine skin model without causing
damage to epidermal pigment cells. As part of the investigation of the mechanism of action of this
skin-lightening effect, the present study was conducted to examine whether OPC-10407 has an
inhibitory action on the melanin synthesizing ability of pigment cells or on tyrosinase. In tests using
normal human epidermal pigment cells and B16 mouse melanoma cells, OPC-10407 was found to
inhibit melanin synthesis at concentrations that did not affect cell proliferation. Upon further
investigation, OPC-10407 was also found to strongly inhibit the synthesis of the dark-colored
melanin known as eumelanin. On the other hand, no inhibitive action against either the activity or
expression of the tyrosinase originating from either type of cell was observed. These ®ndings
indicate that the skin-lightening effect of OPC-10407 results from the agent's inhibition of the
synthesis of eumelanin, a substance responsible for the darkening of the skin, and that, unlike
currently available active ingredients, OPC-10407¢s eumelanin synthesis inhibitory action may be
due to a totally new mechanism that does not involve tyrosinase.
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Differential Expression of PAR-2 and its Activator Trypsin in Different Skin Types
L. Babiarz, C. B. Lin, and M. Seiberg
Skin Biology, Johnson & Johnson, Skillman, New Jersey, U.S.A.
The protease-activated receptor-2 (PAR-2) is a seven transmembrane G-protein coupled receptor
that is activated by proteolytic cleavage of its N-terminus. PAR-2, which is expressed in
keratinocytes but not in melanocytes, affects skin pigmentation by regulating keratinocyte
phagocytosis of melanosomes. Activation of PAR-2 by serine proteases or by the peptide agonist
SLIGRL increases melanosome transfer, resulting in increased skin pigmentation, whereas
inhibition of PAR-2 activation by soybean trypsin inhibition (STI) results in depigmentation.
Recently, keratinocytes were shown to regulate melanosome distribution patterns in vitro regardless
of the origin of the donor melanocytes. We hypothesize that PAR-2 may play a role in the
modulation of pigmentation in a skin-type dependent manner. Therefore, we examined the
expression of PAR-2 and its activator, trypsin, in hyper-pigmented and lightly pigmented human
skins. Using Western blotting and immuno-histochemistry analyses, we show that hyper-
pigmented skin expresses higher levels of PAR-2 and trypsin than lighter pigmented skin.
Furthermore, hyper-pigmented skin exhibits higher PAR-2-speci®c protease activation levels than
that of lightly pigmented skin, although they have no signi®cant differences in total protease
activities. Our results demonstrate that PAR-2 expression and activation correlate with skin color,
suggesting the possible role of PAR-2 in the modulation of pigmentation in different skin types.
798
Non-Invasive Assessment of Cutaneous Pigmentary Changes In Vivo by Re¯ectance
Confocal Microscopy
M. A. Middelkamp-Hup, H. Y. Park,* J. Lee,* L. T. Wang, B. A. Gilchrest,* and S. Gonz´lez
Dermatology, Harvard Medical School, Boston, Massachusetts, U.S.A.; *Dermatology, Boston University
School of Medicine, Boston, Massachusetts, U.S.A.
Re¯ectance confocal microscopy (RCM) offers a noninvasive window into the living skin,
allowing repeated high resolution visualization of the same area during dynamic events. In the
present study, RCM was used for studying cutaneous pigmentation in vivo in guinea pigs known to
have epidermal melanocytes (Mc), before and at intervals following ultraviolet exposure. Optical
en face images were obtained, digitalized and videotaped from the ear and the back skin. Brightly
refractile melanin throughout the Mc cytoplasm allowed easy quanti®cation of the distinct
dendritic Mc in the basal layer of nonexposed epidermis, in the same irregular distribution
previously described in en face histologic sections. The skin was then irradiated daily (150 mJ/cm
2
)
for 10 days using a solar simulator, producing dark tanning by the end of week 2. in vivo RCM was
repeated weekly for 4 weeks on both exposed and unexposed skin of each animal in a 30 minute
procedure. During the procedure, images at multiple depths up to 150 mm were monitored
continuously, allowing interesting or instructive areas to be documented in detail. The digitalized
live images were compared to other images from the same animal over time and to biopsy cross-
sections obtained after 4 weeks from the same sites and stained with DOPA or Fontana-Masson.
RCM could readily distinguish irradiated (tanned) skin from unexposed skin by increased image
brightness that was progressive over 2 weeks. Increased epidermal thickness could be detected.
Digitalized RCM images also allowed quanti®cation of the changes. Pigmented keratinocytes
became visible in the upper epidermis during the ®rst week and a markedly increased volume and
density of Mc was apparent concomitantly, preceding clinical tanning. We conclude that RCM is a
powerful tool for evaluating epidermal changes in vivo, and this technique is particularly useful to
study Mc and overall pigmentation during manipulations intended to modulate melanogenesis.
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OPC-10407, a New Skin-Bleaching Active Ingredient Without Injury to the Skin
K. Kuwahara, N. Oizumi, Y. Oshiro, K. Fujita, and S. Fujisawa
Ako Resaerch Institute, Otsuka Pharmaceutical Co.,Ltd, Ako, Hyogo, Japan
External preparations containing hydroquinone or one of its derivatives as an active ingredient are
commonly used in the treatment of such epidermal hyperpigmentary disorders as melasma and solar
lentigines. However, as prolonged administration of these medications causes such side-effects as
skin irritation and leukoderma, we began research to develop an active ingredient possessing both
an effective skin-bleaching action and a high level of safety, and eventually we arrived at OPC-
10407. In the present study, we repeatedly applied OPC-10407 topical solutions to 2 skin
pigmentation models (a natural dark-colored swine skin model and an ultraviolet-radiation-
induced pigmentation swine skin model) twice daily for 10 weeks in order to examine the skin-
lightening effects of the solutions and also to see whether they caused any damage to the skin (skin
irritation or damage to pigment cells). OPC-10407 topical solutions showed a signi®cant
concentration-dependent skin-lightening action in both skin models, with this action being
equivalent to or better than those of the marketed medications that were used as controls. In
addition, no evidence of damage to the skin such as skin irritation or changes in the number of
epidermal pigment cells at the application sites was observed. These ®ndings indicate that OPC-
10407 would be an effective and safe skin-bleaching active ingredient, and that it has great promise
as an ideal treatment for skin pigmentation and as a replacement for existing skin-bleaching agents.
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Cyclic AMP Inhibits Activation of Cdc42, Rac1 and Rho in Melanocytic Cells:
Implications for Dendrite Formation and Melanogenesis
G. Scott and S. Leopardi
Dermatology, University of Rochester, Rochester, New York, U.S.A.
Rac, Rho and Cdc42 have been implicated in dendrite formation in melanocytes. We wish to
de®ne the role of second messenger systems important in dendrite formation in modulating the
activity of Rho-GTP binding proteins in melanocytic cells. In this report we show that activation
of cAMP leads to a rapid decrease in levels of activated Rac, Rho and Cdc42 in B16F10 cells. Rac,
Rho and Cdc42 show a cell-type speci®c hierarchy of cross-activation and/or inhibition, which
coordinate distinct cytoskeletal changes. To determine the hierarchy of activation of these proteins
we overexpressed constitutively active Rac, Cdc42 or Rho in B16F10 cells using adenovirus
vectors. Three days following infection activated Rac and Cdc42 were isolated from cell lysates
using GST-conjugated PAK binding protein (PBP); activated RhoA was isolated using GST-
conjugated rhotekin (C21). Rac1 activated both Cdc42 and Rho approximately three-fold. Rac-
induced Rho activation was also documented in situ using an overlay assay in cells overexpressing
activated Rac. Melanocyte stimulating hormone (MSH) induces dendrite extension and possibly
melanosome transport, as well as melanin synthesis; cAMP is the primary second messenger in
MSH-mediated signaling from the MC1 receptor. Cells were treated with forskolin and activated
Rac, Cdc42 and Rho were measured. Forskolin induced a rapid decrease in activated Rac, Cdc42
and Rho. Overlay assays on ®xed cells con®rmed that forskolin resulted in a decrease in activated
Rac/Cdc42 and Rho.Others have shown that inhibition of Rho leads to outgrowth of melanocyte
dendrites and that expression of activated Rho can block the effects of cAMP on dendrite
formation (Busca et al 1998, J Cell Biol). We now demonstrate that this effect is through inhibition
of Rho activation and suggest that this may occur through inhibition of Rac with subsequent
inhibition of Rho activity. Because Rho has also been implicated in regulation of tyrosinase gene
expression, Rho may be involved in cAMP-induced melanin synthesis.
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Antisense Oligonucleotide-Mediated Inhibition of Tyrosinase mRNA and Protein in
Human and Mouse Melanoma Cells
T. P. Condon and J. G. Karras
Antisense Drug Discovery, Isis Pharmaceuticals, Carlsbad, California, U.S.A.
Tyrosinase is one of approximately 80 known genes involved in the biosynthesis of melanin
pigments in mammals. Melanin both absorbs and scatters ultra-violet (UV) light and thus provides
an effective photoprotective barrier against the damaging and mutagenic effects of UV radiation. In
order to better understand the role of tyrosinase in melanocyte function and disorders such as
vitiligo universalis and oculocutaneous albinism, we have developed a 20 base antisense
oligonucleotide that potently and speci®cally inhibits tyrosinase gene expression. We designed
and screened 30 different antisense oligonucleotides in human M14 melanoma cells and selected
the most potent compounds for dose±responses. The most potent inhibitors of human tyrosinase
mRNA were Isis 149486 and Isis 149488 which had IC50 values of less than 1 mM for RNA
reduction. In addition, Western blot analysis was performed on Isis 149486 and Isis 149488 treated
cells and an almost complete reduction of protein was observed. Isis 149486 and Isis 149488 have
100% homology to mouse tyrosinase and were potent inhibitors of mouse tyrosinase as well in the
murine melanoma cell line M-3. These results identify stable nucleic acid inhibitors of tyrosinase
gene expression that are amenable to topical delivery strategies and may be useful in preclinical and
clinical studies.
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Ultrastructural Characteristics of Hair Bulb in Segmented Heterochromia of Scalp Hairs
K. Yoon, S. Sohn,* E. Lee, and W. Kang
Department of Dermatology, Ajou University, Suwon, South Korea; *Laboratory of Cell Biology, Ajou
University, Suwon, South Korea
Segmented heterochromia is a pigmentary disorder of scalp hairs characterized by alternating dark
and light segments on each hair shaft. It is known to be associated with iron de®ciency anemia.
Only four cases of the disease have been reported in Korea and Japan. Here we observed
ultrastructure of affected hair shaft and hair bulb. The amount of melanosomes was reduced in the
hair cortex of light segments, which suggests that there may be temporary retardation of
melanogenesis or melanosome transport to hair cortex. Fontana Masson and GP-100 stains showed
few melanocytes in the hair follicles including hair bulbs. Transmission electron microscopy
showed that the amount of cortical melanosomes decreased along the hair shaft from the dark
segment to the light segment. In dark segments, dense and homogenous ellipsoidal melanosomes
were noted while small, round melanosomes were found in the light segments. There were two
groups of melanosomes lined up along the hair shaft on the upper portion of hair matrix. One
group was composed of compact homogenous ellipsoidal melanosomes and the other was
composed of small round melanosomes with irregular densities. Both kinds of the melanosomes
were found in keratinocytes. Melanocytes were rare and most of them were found near the basal
lamina between hair matrix and dermal papilla. They were seemed to be under apoptosis because
they had dense nuclei and few melanosomes, most of which were collected near nuclei. Langerhans
cells were found in the outer root sheath of the hair bulb area. They were only a few in their
number and possessed no melanosome but Birbeck granules and lysosomes. Bacteria were present
in the dermis just by the hair bulb. It is not clear whether the organisms are related to the
pathogenesis of the disease or incidentally present.
802
The Inhibitory Effect of an Extract of Clove (Syzygium aromaticum (L.) Merr. et Perry)
on Ultraviolet B-Induced Pigmentation Via Inhibition of Stem Cell Factor/c-kit
Signaling
A. Hachiya, A. Kobayashi, A. Ohuchi, T. Kitahara, and Y. Takema
Biological Science Laboratories, Kao Corporation, Haga, Tochigi, Japan
We have previously reported that the expression of membrane-bound Stem Cell Factor (SCF)
increases in human epidermis after ultraviolet B (UVB) irradiation and that SCF/c-kit signaling
plays a pivotal role in UVB-induced pigmentation. Our results further suggested that SCF
expression increases followed by the expression of another melanogenic cytokine, endothelin-1
(ET-1), in the course of UVB-induced pigmentation of human skin and that SCF signaling
enhances the ET-1/endothelin B receptor (ETBR) system by increasing the expression of ETBR
in human melanocytes. Based on these ®ndings, we have searched for factors that inhibit SCF/c-kit
signaling in human melanocytes and found that an extract of clove (Syzygium aromaticum (L.)
Merr. et Perry) speci®cally suppresses SCF/c-kit binding. This clove extract (at 0.03%, w/v)
inhibited the binding of 125I-labelled SCF to c-kit on human melanocytes by 60%. In order to
clarify the potential use of this botanical extract as a whitening agent, we examined whether this
extract inhibits UVB-induced pigmentation. When this clove extract (at 0.001%, w/v) was applied
to human melanocytes with 10 nM recombinant human SCF, the SCF-induced stimulation of
[3H]thymidine incorporation and ETBR expression (by Western blotting) were reduced. In the
course of UVB-induced pigmentation of brownish guinea pig skin, repeated topical application of
this extract (0.15%, w/v) signi®cantly diminished pigmentation of UVB-exposed areas, compared
with vehicle-treated controls. These ®ndings suggest that an extract of clove, which inhibits SCF/
c-kit binding on human melanocytes, is a potent ingredient for a whitening agent.
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Methyl Aminolevulinate and Photodynamic Therapy in the Treatment of Actinic
Keratosis
P. S. Yamauchi,² N. J. Lowe,*² G. P. Lask,*² R. Patnaik,² D. Moore,² and P. Foley³
*Medicine, UCLA School of Medicine, Los Angeles, California, U.S.A.; ²Dermatology, Clinical Research
Specialists, Santa Monica, California, U.S.A.; ³Dermatology, St. Vincent's Hospital, Melbourne,
Australian Capital Territory, Australia
Metvixá (methyl aminolevulinate; Photocure, ASA, Oslo) photodynamic therapy (PDT) is a
promising new treatment option for premalignant and malignant skin diseases. Results of clinical
studies using Metvixá PDT in the management of actinic keratosis (AK) compared to vehicle
cream and cryotherapy is presented. A total of 280 patients were enrolled in 2 randomized
controlled trials, at 9 centers in Australia (Study 1) and 5centers in the USA (Study 2), where 130
patients were treated with Metvixá PDT. Metvixá PDT was compared to vehicle in Study 1 & 2
and also to cryotherapy in Study 1. The Metvixá PDT procedure was standardized and similar in
the two studies, with light surface preparation of the lesions, Metvixá cream application for 3 h,
and illumination by red light using a dose of 75 J/cm
2
. The treatment was repeated after one week.
Cryotherapy was performed with a single freeze-thaw cycle. At the completion of the trials, 1240
AK lesions of the face and scalp were evaluated for ef®cacy, of these 531 lesions received Metvixá
PDT. The complete lesion response rate (CR) for Metvixá PDT was 91% (267/295) in Study 1
and 89% (209/236) in Study 2.For vehicle cream, CR was 30% (18/61) in Study 1 and 38% (92/
241) ins Study 2, and for cryotherapy CR was 68% (278/407) in Study 1. The cosmetic outcome
was rated as excellent by the investigator in 84% of the patients with complete lesion response in
Study 1 and 91% in Study 2, while cryotherapy was rated excellent in 51%. Metvixá PDT is an
excellent treatment option in the management of AK, and is a robust method shown in these two
studies being performed on two different continents and at 14 different centers. It has been shown
that Metvixá PDT gives a better complete response rate and cosmetic outcome for AK lesions
than cryotherapy and vehicle cream.
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Electron Microscopic Analysis of Epidermal Melanosomes in a Panel of Mouse Models
of the Hermansky±Pudlack Syndrome
M. L. Wei, T. Nguyen, E. K. Novak,* and R. T. Swank*
Dermatology, Veterans Affairs Medical Center, University of California, San Francisco, California, U.S.A.;
*Molecular Biology, Roswell Park Cancer Institute, Buffalo, New York, U.S.A.
The Hermansky±Pudlack Syndrome (HPS) is an autosomal recessive disease which exhibits genetic
heterogeneity; in humans, 3 genes have thus far been cloned that when defective in isolation give
rise to a clinical syndrome classi®ed as HPS. The defective genes have been shown to affect the
functioning of melanosomes, platelet dense granules and lysosomes, suggesting a common pathway
of biogenesis or maturation for these seemingly disparate organelles. Murine models of HPS have
been identi®ed, and also show genetic heterogeneity; a panel of 15 mutant mice strains have been
classi®ed as mouse models of HPS. Some of the murine genes have been cloned and are implicated
in vesicle traf®cking: budding, targeting, and secretion. Many of the murine HPS genes remain
uncloned and their functions are unknown. Potential clues to the function of these genes can be
found by analyzing the resulting clinical and cellular phenotypes. As a ®rst step in studying the
function of these HPS genes, we have a systematically examined the morphology and distribution
of the epidermal melanosomes in the murine HPS strains by using electron microscopy (EM). Here
we present our initial ®ndings in a subset of the panel of murine HPS strains. We ®nd that the
mutant melanosomes can be characterized by (1) pattern of pigmentation (normal vs.
hypopigmented) (2) degree of morphological maturation (elliptical vs. spherical) (3) size and (4)
organization within cells. We classify the mutations on the basis of melanosome morphology and
clinical phenotype found in the mice. Based on this data, a suggested placement of the known HPS
gene products along a proposed pathway of melanosome biogenesis is possible, and the resulting
model of melanosome biogenesis, incorporating the genetic and morphologic data, is presented.
801
Human Epidermal Melanocytes Express the Androgen Receptor and Both Estrogen
Receptors (ERa) & (ERb) In Situ
A. H. Taylor,* M. J. Thornton, A. G. Messenger,² and D. J. Tobin
Department of Biomedical Sciences, University of Bradford, Bradford, U.K., *Department of Obstetrics &
Gynaecology, University of Leicester, Leicester, U.K.; ²Department of Dermatology, Royal Hallamshire
Hospital, Shef®eld, U.K.
A number of studies have suggested that melanocytes are estrogen-sensitive, while epidemiological
studies suggest a female survival advantage in melanoma. However, the role of estrogens in the
development of skin cancer has been controversial since, to date the presence of an estrogen
receptor (ER) has not been demonstrated. Recently, a second ER (ERb) has been identi®ed
which is distinct from the classical ER (now termed ERa) which introduces a new level of
complexity to estrogen action. Since there is also some evidence that melanocytes are androgen-
sensitive, we have compared the expression of both ERa and ERb and the androgen receptor
(AR) in NKI/beteb (gp 100)-positive epidermal melanocytes using 6 mm frozen sections of normal
male occipital scalp by double immuno¯ourescence. Strong cytoplasmic and weak nuclear
expression of AR was detected in pigmented and dendritic melanocytes located in the basal layer of
the epidermis. Similar heterogeneous expression patterns were observed for ERa, where punctate
staining was present throughout the cell's dendrites. Expression of ER bwas mainly cytoplasmic
and correlated positively with melanocyte differentiation status, i.e. greatest ER bexpression was
apparent in more pigmented and dendritic cells. This study demonstrates for the ®rst time the
presence of androgen and estrogen receptors in human melanocytes in vivo, suggesting a direct role
for estrogens and androgens in the regulation of epidermal pigmentation. Since it is now emerging
that the interaction of androgens and estrogens and their receptors is of the utmost importance in
other steroid-dependent tissues, the colocalization of ERa, ERb and AR in human melanocytes is
signi®cant. To understand the effects of reproductive hormones on skin ageing and skin cancer, we
need to understand how steroid hormones and their receptors interact in human skin.
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A Phenotype-Driven Genetic Screen for Dark Skin
K. McGowan, K. Fitch, C. Van Raamsdonk, H. Fuchs,* M. Hrabe de Angelis,* and G. Barsh
Genetics, Stanford University, Stanford, California, U.S.A.; *Institute of Experimental Genetics, GSF,
Neuherberg, Germany
Previously existing mouse mutations that affect hair color have provided a wealth of information
about neural crest migration, intracellular sorting, and paracrine signaling. By contrast, changes in
mouse skin color are not readily apparent to the casual observer, and little is known about how
pigment cells choose to reside within, or between, hair follicles, giving rise to hair, or skin color,
respectively. Using the dysmorphology component of a large scale ENU-mutagenesis screen, we
have speci®cally searched for dominant mutations that cause increased skin pigmentation of the
ears, tail, or feet. We will present a genetic, histologic, and molecular characterization of nine dark
skin (Dsk) mutations, among which we have identi®ed two general classes. Mutants in the ®rst class
(Dsk2, Dsk3, Dsk4, Dsk5, Dsk6 and Dsk8) have increased epidermal pigment in nonhairy skin;
some are caused by an increased number of epidermal melanocytes (Dsk2, Dsk3, Dsk6, and Dsk8).
A second class of mutants (Dsk1, Dsk7 and Dsk9) exhibits increased melanin deposition in the
dermis of glabrous and nonglabrous skin. Molecular candidates have been identi®ed for Dsk2 and
Dsk5, and, together with additional mutations arising from the screen, mouse models have been
identi®ed for Ichthyosis Bullosa of Siemens and Pachyonychia Congenita. We anticipate that
further study of dark skin and coat color mutants will provide insight into the pathophysiology of
hyperpigmentation and the relationship between melanocyte and keratinocyte biology.
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A Double-Blind Randomized Trial of 0.1% Tacrolimus vs. 0.05% Clobsol for the
Treatment of Childhood Vitiligo
V. Lepe, B. Moncada, and J. P. Castanedo
Dermatology, University of San Luis Potosi, San Luis Potosi, SLP, Mexico
Vitiligo is a common idiopathic acquired depigmentation disorder of the skin, affecting 4% of the
world population. Pathogenesis is controversial but the main idea is that vitiligo is an autoimmune
disease since there is evidence that there are humoral and cellular abnomal immune responses
against melanocytic cells and one useful way of treating these patients is with the application of
topical steroids.Tacrolimus is an immunosuppresive agent and.it has been used topically in atopic
dermatitis and psoriasis. We devised a randomized double blind clinical study in 20 children with
vitiligo aged 4±17-year-old-with symmetrical lesions, without previous therapy for the two
months prior. Patients with segmental vitiligo and vitiligo associated with autoimmune diseases
were excluded. All of them had a vitiligo disease activity (VIDA) scale of three.or more.The mean
duration of disease was 2.2 years. Two macules with the same size and evolution time.were selected
for twice a day application of either 0.1 tacrolimus ointment (Protopic) or clobsol propionate
0.05% to each lesion for a two month period; blind observers evaluated the degree of new
pigmentation, but also a morphometric study was performed with digital prints to assess the
percentage of improvement. New pigmentation was observed with these two agents. Three
patients in the clobsol group had mild atrophy but none in those treated with tacrolimus. Two
patients using this later drug complained of mild burning sensations that did not required
discontinuation of therapy. There was 48.28% of repigmetation in the clobsol group and. 41.28%
with tacrolimus.The clobsol & tacrolimus correlation was 0.6. The con®dence interval of the
difference was 95%, and t = 1.410. We concluded that tacrolimus is less effective than clobson for
pigmenting vitiligo lesion in children,however, tacrolimus still produces an acceptable degree of
good clinical results and appears to be a good option to avoid the side efects of topical steriods,
particularly in this age group
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Wax Epilation Prior to Laser Hair Removal Improves Treatment Outcomes: A Pilot
Study
M. S. Lehrer, G. H. Crawford, J. M. Gelfand, J. J. Leyden, and C. C. Vittorio
Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania,
U.S.A.
Recent reports indicate that laser hair removal is most effective on anagen hairs. To date, however,
no published trials have examined laser epilation following synchronization of the hair cycle. We
identi®ed four 2.5 cm squares with subjectively equivalent hair length and density on the backs of
13 dark-haired white men. In order to induce typically telogen hairs into anagen, two squares on
each patient were epilated using hot wax and muslin stripping. Two weeks later, the remaining
two squares were shaved. Immediately thereafter, one waxed square and one shaved square were
treated with 9 nonoverlapping pulses of a long-pulsed alexandrite laser with a spot size of 12 mm.
Depending on patient skin type and hair color, ¯uences varied from 15 to 19 J/cm
2
and pulse
durations from 10 to 27 ms as selected by the laser software. Both waxing and laser epilation were
well tolerated by all patients. One month after laser treatment, standardized high-resolution digital
photographs were taken of each square. Enlarged images were then compared subjectively based
upon hair density, length, and thickness. Inter-rater agreement among three blinded examiners was
100%. In 12 of 13 patients, lasered areas that had been pretreated with wax epilation were clearer of
hair as compared to areas that had been pretreated by shaving (p = 0.0034, sign test, two sided). No
signi®cant difference was noted between waxed and shaved areas that had not been laser treated
(p = 1.0). We conclude that wax epilation prior to laser hair removal improves cosmetic outcome
at one month. While we hypothesize that this effect is secondary to the heightened sensitivity of
early anagen hairs, histologic analysis will be necessary to con®rm this conclusion.
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Increased Nuclear Localisation of NFAT1 in Psoriatic Epidermis and Inhibition of
Calcineurin/NFAT Activation in Human Keratinocytes by Cyclosporin A
N. J. Reynolds, K. R. Grant, S. K. Sikkink, and W. I. Aldaraji
Dermatology, University of Newcastle, Newcastle upon Tyne, U.K.
Systemic cyclosporin A (CsA) is an effective treatment for psoriasis but there are concerns about
toxicity. CsA blocks T cell activation by inhibiting the phosphatase calcineurin and preventing
nuclear translocation of the transcription factor nuclear factor of activated T cells (NFAT). We
studied the expression patterns of calcineurin and NFAT in normal and psoriatic skin by
immunohistochemistry. We assessed calcineurin/NFAT activation in cultured keratinocytes by
measuring nuclear localisation of endogenous calcineurin and NFAT1 using immuno¯uorescence/
confocal microscopy and by monitoring the cellular location of HA-NFAT1-GFP in real time.
Reverse transcriptase/PCR and Western analysis demonstrated the presence of calcineurin A & B,
NFAT1, NFAT2, NFAT3 and NFAT4 in keratinocytes and ®broblasts. Immunohistochemistry of
normal skin biopsies showed prominent expression of calcineurin B and NFAT1 in epidermal
keratinocytes; NFAT1 was predominantly nuclear in the basal layer. Increased nuclear localisation
of NFAT1 was observed in suprabasal keratinocytes within lesional and nonlesional psoriatic
epidermis (n = 12) compared to normal skin (n = 8, p = 0.001 and p = 0.03, respectively).
Treatment of keratinocytes with 12±0-tetradecanoyl-phorbol-13-acetate (TPA) plus ionomycin,
TPA and raised extracellular calcium induced translocation of calcineurin B, NFAT1 and HA-
NFAT1-GFP from the cytoplasm to the nucleus. Nuclear translocation of calcineurin B and
NFAT1 was inhibited by pretreatment with CsA (1 mM, n = 3, p < 0.0001). In contrast in human
dermal ®broblasts, TPA plus ionomycin or TPA did not signi®cantly alter the proportion of
nuclear-associated NFAT1. These results show functionally activity of calcineurin in human
keratinocytes, increased nuclear NFAT1 in suprabasal psoriatic epidermis and indicate cell-type
speci®c regulation of NFAT1 in human skin. Inhibition of this pathway in epidermal keratinocytes
may account, in part, for the therapeutic effect of CsA in psoriasis.
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Functional Modulation of Cutaneous Lymphocyte-Associated Antigen on Skin-Homing
Lymphocytes and Prevention of Allergic Contact Dermatitis with a Fluorinated Analog
of N-Acetylglucosamine
C. J. Dimitroff, B. Rich, and R. Sackstein
Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.
Expression of E- and P-selectin on postcapillary venules in in¯amed skin plays a critical role in
mediating dermal-speci®c migration of human skin-homing memory T-cells. The principal ligand
for E- and P-selectin on human skin-homing T-cells is cutaneous lymphocyte-associated antigen
(CLA), which is a specialized carbohydrate epitope on P-selectin glycoprotein ligand-1 (PSGL-1)
recognized by monoclonal antibody HECA-452. Therapeutic modulation of CLA expression
could dampen lymphocytic tropism associated with skin pathologies. In this study, we examined
the ef®cacy of a novel carbohydrate modi®er, 2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-¯uoro-
D-glucopyranose (4-F-GlcNAc), to metabolically inhibit the expression of CLA natively expressed
on human CLA+ T-cells and prevent rolling adhesions of CLA+ T-cells on E- and P-selectin
under hydrodynamic shear stress. In comparison to the effects of other glycosylation inhibitors
(swainsonine, benzyl-O-GalNAc and tunicamycin) at nongrowth inhibitory concentrations, 4-F-
GlcNAc (50 mM) caused a more profound inhibitory effect on HECA-452 epitopes expressed on
PSGL-1 without attenuating PSGL-1 expression itself as determined by both ¯ow cytometry and
Western blotting. Metabolic inhibition of CLA expression with 4-F-GlcNAc resulted in signi®cant
reductions in E and P-selectin-mediated T-cell tethering and rolling in the parallel plate ¯ow
chamber. Using a mouse model of contact hypersensitivity, 4-F-GlcNAc (50 mg/kg, q.d.x 6)
prevented the elicitation of an antigen (dinitro¯uorobenzene)-dependent in¯ammatory response.
Results from these studies indicate that 4-F-GlcNAc is a strong metabolic inhibitor of selectin-
binding determinants on PSGL-1 expressed by human CLA+ T-cells, while not affecting cell
growth or protein synthesis. The profound effect of 4-F-GlcNAc on dermal lymphocytic tropism
suggests that this agent could be bene®cial in the long term treatment of chronic leukocyte-
associated skin disorders.
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Liver X Receptor Activators Display Anti-In¯ammatory Activity in Irritant and Allergic
Contact Dermatitis Models
A. Fowler,² M. Y. Sheu,² J. Kao,² J. W. Fluhr,² M. Schmuth,² L. Rhein, T. M. Willson, D. J.
Mangelsdorf,* P. M. Elias,² and K. R. Feingold²
Nuclear Receptor Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A.;
*Howard Hughes Medical Institute, University of Texas South-western Medical Center, Houston, Texas,
U.S.A.; ²Departments of Medicine and Dermatology, University of California, San Francisco, San
Francisco, California, U.S.A.
Recently we have shown that oxysterols stimulate epidermal differentiation and development and
inhibit keratinocyte proliferation by activating LXR in keratinocytes. In the present study, the
anti-in¯ammatory effect of two oxysterols, 22(R)-hydroxycholesterol (22ROH) and 25
hydroxycholesterol (25OH), and a nonsterol activator of LXR, GW3965, were examined
utilizing models of irritant and allergic contact dermatitis. Irritant dermatitis was induced by
applying TPA to the ears of CD1 mice followed by topical vehicle, 22ROH, 25OH, or GW3965.
TPA alone induced approximately a 2-fold increase in ear weight and thickness, whereas 22ROH,
25OH, or GW3965 markedly suppressed the TPA induced increase (greater than 50% decrease in
thickness and weight). This inhibition was comparable to that observed with topical glucocorticoid
treatment. Histology revealed a marked decrease in cutaneous in¯ammation in oxysterol treated





indicating that LXRb is required for this anti-in¯ammatory effect. However, 22ROH only caused
a partial reduction in ear thickness in LXRa
±/±
animals (~ 50% of that observed in wild type mice)
suggesting that activation of this receptor also plays a role in the anti-in¯ammatory effects of
oxysterols. Ear thickness and weight were increased approximately 1.5 fold in the oxazolone-
induced allergic dermatitis model and 22ROH, 25OH, and GW3965 reduced in¯ammation by
approximately 50% in this model. Immunohistochemistry of the oxysterol treated animals
demonstrated an inhibition in the production of the proin¯ammatory cytokines, IL-1a and TNFa,
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Interferon a Antitumor Activity and DNA Microarray Analysis in Malignant Melanoma
Xenotransplants
C. Krepler, U. Certa,² B. Jansen,* K. Wolff, V. Wacheck,* and H. Pehamberger
Department of Dermatology, University of Vienna, Vienna, Austria; *Department of Clinical Pharmacology,
University of Vienna, Vienna, Austria; ²Roche Genetics, Hoffmann- La Roche Ltd, Basel, Switzerland
Interferon a 2a (Roferon, Roche) is widely used in the treatment of malignant melanoma and has
been shown to prolong disease free survival. However the relatively high rate of side-effects and
administration thrice weekly are compromising patient compliance. Recently it has been reported
that pegylated interferon a (Pegasys, Roche) administered once weekly has the potential for
increased ef®cacy and less toxicity as compared to Roferon and is a promising novel approach for
interferon a therapy of malignant melanoma. In the present study we investigated whether
interferon a (Roferon or Pegasys) inhibits growth of human melanoma in a SCID mouse
xenotransplantation model. After s.c. tumor inoculation mice were treated either with Roferon
100 mg thrice weekly or Pegasys 900 mg (300 mg Roferon equivalent) once weekly (6 mice per
group). Tumor growth was compared to an untreated control group. We found that Pegasys as
well as Roferon inhibited melanoma growth by 86.5% (Pegasys, week 3) or 88% (Roferon, week
3), respectively, as compared to saline control. After four weeks of treatment mice were sacri®ced.
Tumors were then subjected to DNA microarray analysis and we were able identify a subset of
about 90 differentially expressed genes. In conclusion, we demonstrated for the ®rst time, that
treatments with Pegasys once weekly or Roferon thrice weekly have a comparable impressive
antitumoral effect in a human melanoma SCID mouse xenotransplantation model. Gene chip
analysis may provide insights in the gene regulating effects of interferon a in vivo with the potential
to identify targets for novel nucleotide based therapeutics.
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Long-Term Treatment with Topical Tretinoin Improves Cellular Atypia in Photoaged
Skin
S. Cho, L. Lowe, T. Hamilton, J. Voorhees, and S. Kang
Dermatology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Topical tretinoin is established as an effective therapy for photoaging. With its chronic use,
however, concerns have been raised as to potential worsening epidermal cellular atypia. Our
purpose was to investigate possible alterations in cellular atypia following long-term (> 6 months)
use of tretinoin in photoaging. Patients with moderate to severe photoaging were treated daily
with 0.05% tretinoin (Renovaá). Mean age of the 34 participants was 62, and the mean duration
of therapy was 2.3 years (0.5±4.3). Two investigators examined histologic sections independently.
Each patient's specimens (pre- and post-treatment) were randomized and blinded. Cellular atypia
of keratinocytes and melanocytes were graded using a semiquantitative 5-point scale (0 = normal
and 4= in-situ malignancy). For each pair of slides, evaluators selected the one with greater overall
cellular atypia. Solar elastosis and in¯ammatory cell in®ltrate were also assessed semiquantitatively.
Severity of epidermal cellular atypia in all biopsied specimens was low (< 2). Compared to
pretreatment, cellular atypia in melanocytes and keratinocytes after tretinoin therapy was reduced
by 47% (0.95±0.5; p < 0.002) and 45% (0.55±0.3; p < 0.03), respectively. Pretreatment biopsies
were rated as having greater atypia than post-treatment biopsies in 73% of cases by one evaluator
and in 85% by the other. Overall, the two investigators were in total agreement in 28 of 34 (82%)
subjects. Solar elastosis and in¯ammatory cell in®ltrate were unaffected by tretinoin. Long-term use
of topical tretinoin is not associated with worsening of cellular atypia. On the contrary, the
treatment improved epidermal cellular atypia, which is consistent with tretinoin's ability to act as a
chemopreventive agent in epithelial carcinomas.
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Regulated Lentivectors for Controlled and Reversible Cutaneous Gene Delivery
Z. Siprashvili and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Current approaches lack capacity for direct, regulated and reversible gene delivery to intact skin
tissue. In an effort to develop such capabilities, we have generated regulated lentiviral vectors.
Lentiviruses are attractive because they infect both dividing and nondividing cells within skin after
direct administration. In these vectors, we have incorporated 2 mechanisms that allow topical
regulation: (1) at the promoter level by replacing the constitutive viral promoter with a synthetic
promoter composed of 5 high-af®nity glucocorticoid responsive elements placed upstream of the
adenovirus 2 major late promoter TATA sequence (2) at the viral maintenance level by
engineering the capacity for complete cessation of gene delivery via inducible `snap out' excision of
proviral sequences from the host genome using the Cre recombinase acting at loxP sites inserted in
the U3 region of the LTR. The latter is mediated by inclusion of a C-terminal fusion of Cre to a
hydroxytamoxifen (OHT)-responsive mutant estrogen receptor ligand binding domain (Cre:ER)
in vector coding sequences. For regulated gene delivery, we used erythropoietin (EPO) as a
prototype because of the need for regulation of hematopoiesis. Furthermore, we have recently
demonstrated that a single intracutaneous EPO lentivector injection to human skin on immune
de®cient mice effectively delivers EPO protein to the bloodstream and can boost hematocrit
dramatically. In series of ELISA assays with cells in vitro, lentivector-delivered EPO levels were
induced in corticosteroid dose-dependent manner to levels up to 150 fold by 250 nM
dexamethasone within 4 days, with induction ®rst detectable at 6 h. Furthermore, activation of
Cre:ER using OHT led to dose and time-dependent decrease in induced gene delivery levels,
consistent with excision of viral sequences from the host genome in response to this exogenously
induced Cre recombinase activity. While further studies are underway to de®ne the ef®ciency and
pharmacokinetics of this system in vivo, these data provide a platform for regulated and reversible
direct cutaneous gene delivery.
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Restoration of Full-Length Type VII Collagen Expression in RDEB via Nonviral Gene
Integration Using the phiC31 Integrase
S. Ortiz-Urda, B. Thyagarajan, M. Calos, and P. Khavari
Dermatology, VA Palo Alto and Stanford University, Stanford, California, U.S.A.
Genetic correction of recessive dystrophic epidermolysis bullosa (RDEB) has been hindered by the
large 8823 bp size of the COL7A1 cDNA. Large capacity viral vectors suffer from drawbacks,
including transience and biosafety concerns. Non-viral approaches, while less constrained in insert
size, have suffered from a poor ef®ciency of stable gene transfer. To circumvent these barriers, we
used the site-speci®c recombinase, phiC31 bacteriophage integrase, which stably integrates large
DNA sequences containing a speci®c 34 bp attB sequence into genomic pseudo attP sites. Unlike
the other major integrating nonviral approach, transposases, which are limited to inserts < 6.5kb,
this approach readily integrate > 10kb inserts. An attB containing gene delivery plasmid was
constructed in which wild-type human COL7A1 cDNA and an IRES-linked blastocidin resistance
gene is driven by the CMV IE promoter. This plasmid was transfected along with a plasmid
encoding phiC31 integrase at > 40% ef®ciency using modi®ed polybrene shock into genetically
characterized Type VII collagen-de®cient primary RDEB keratinocytes. Gene delivery plasmid
without an attB site as well as attB-containing plasmid transfected without integrase were used as
controls. 3 days later cells underwent 10 days of blastocidin selection. Controls failed to normalize
cell morphology or display Type VII collagen protein. Transfection of the attB containing
COL7A1 expression plasmid along with functional integrase, however, normalized morphology
and restored expression of full length Type VII collagen in the entire bulk cell population by
14 days post-transfection. Genomic PCR con®rmed that the COL7A1 expression sequence
integrated at chromosome 8 at a known endogenous human genomic pseudo attP site. This new
nonviral integrating gene delivery approach is thus capable of rapidly correcting populations of
primary cells for ex vivo gene therapy and provides an opportunity for corrective gene delivery of
large cDNAs in RDEB and other genodermatoses.
811
Pimecrolimus Inhibits Allergic Contact Dermatitis in Rodents Without Affecting
Draining Lymph Nodes, Different to Tacrolimus
J. G. Meingassner, H. Fahrngruber, A. Schweitzer,* J. Figueiredo,* H. Zehender,* and A. Stuetz
ISD, Novartis Research Institute, Vienna, Austria; *DMPK, Novartis Pharma, Basle, Switzerland
Allergic contact dermatitis (ACD) in laboratory animals has been used to pro®le pimecrolimus for
therapeutical use in patients with in¯ammatory skin diseases. In this study, pimecrolimus was
compared with tacrolimus after oral administration in mice and rats in inhibiting ACD and in
inhibition of hyperplasia of regional lymph nodes. Drug levels were determined in cutis and axillar
lymph nodes in rats: Mice sensitized with oxazolone on day (d) 1 were treated at time of challenge
(d7) and evaluated for ACD (in¯ammatory ear swelling) on d8 or treated on d1±3 during
sensitization phase and evaluated for inhibition of hyperplasia of draining lymph nodes (weight and
cellularity) on d5. Inhibition of ACD (skin fold thickness) and weight of lymph nodes were
examined in DNFB-sensitized rats on d8, 1d after challenge and treatment. Drug levels were
determined in satellite groups by a LC-MS method. Treatment with pimecrolimus or tacrolimus
equaled in doses and schedules. Pimecrolimus and tacrolimus inhibited murine ACD similarly by
40% at a minimal effective dose (MED) of 30 mg/kg. However, pimecrolimus had no effect on
sensitization-induced lymph node hyperplasia, which was signi®cantly decreased by 44% (weight)
or 40% (cell counts) in mice treated with tacrolimus at this dose. The MED dose in rats inhibiting
ACD signi®cantly was 12.5 mg/kg pimecrolimus (by 35%) and 25 mg/kg tacrolimus (by 25%). In
contrast, tacrolimus inhibited lymph node hyperplasia signi®cantly by 26% at 12.5 mg/kg (MED),
whereas pimecrolimus, even at 25 mg/kg, had no effect on lymph node weight but inhibited ACD
simultaneously by 50%. The concentration of pimecrolimus was 6.7 fold higher in the cutis and 77
fold lower in the axillar lymph node than that of tacrolimus. These results indicate a tissue selective
distribution of pimecrolimus which results in an inhibition of the in¯ammation in the skin without
affecting the draining lymph nodes whereas tacrolimus targets secondary lymphoid organs ®rst and
skin second.
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Sanguinarine Induces Apoptosis in Human Carcinoma Keratinocytes (HaCaT cells) via
an Increase in bax/bcl-2 Ratio and Induction in WAF1/p21
N. Ahmad,*² D. K. Feyes,² H. Mukhtar,² and V. M. Adhami²
*Dermatology, University of Wisconsin, Madison, Wisconsin, U.S.A.; ²Dermatology, Case Western
Reserve University, Cleveland, Ohio, U.S.A.
The incidence of nonmelanoma skin cancers is increasing at a steady rate, which warrants
mechanism-based efforts for their treatment. Sanguinarine, derived from the root of Sanguinaria
canadensis and other poppy fumaria species, has been shown to possess strong antimicrobial, anti-
in¯ammatory and antioxidant properties. We have earlier shown that sanguinarine kills human
epidermoid carcinoma A431 cells via an induction of apoptosis. In this study, employing human
carcinoma keratinocytes (HaCaT cells), we studied the antiproliferative effects of sanguinarine and
the mechanism of its action. Sanguinarine (0.1 mM±2 mM) treatment to HaCaT cells was found to
inhibit in a dose-dependent manner, the cell proliferation and induction of apoptosis, as measured
by MTT assay and ELISA, respectively. Sanguinarine treatment was also found to result in the
cleavage of poly (ADP-ribose) polymerase in HaCaT cells. Because members of bcl-2 family of
proteins, especially bcl-2 and bax, are critical regulators of the apoptotic pathway, we studied the
involvement of bcl-2 and bax during sanguinarine-mediated apoptosis of HaCaT cells. The
immunoblot analysis clearly demonstrated a dose-dependent (i) increase in bax level (ii) decrease in
bcl-2 levels, and (iii) an overall increase in bax/bcl-2 ratio, as a result of sanguinarine treatment to
the cells. Sanguinarine treatment to HaCaT cells was also found to cause a dose-dependent increase
in the cyclin kinase inhibitor WAF1/p21, which is known to be closely associated with apoptotic
pathway. Taken together our data, for the ®rst time, showed the involvement of bcl-2 family
proteins and cyclin kinase inhibitor WAF1/p21during sanguinarine-mediated apoptosis of
keratinocytic carcinoma cells. Since HaCaT cells carry mutant p53, the modulations in WAF1,
bax and bcl-2 leading to apoptotic cell death appears to be independent of p53. Based on our data,
we suggest that sanguinarine could be developed as a drug for the treatment of skin cancer.
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Azathioprine in Severe Adult Atopic Dermatitis: A Double-Blind, Placebo-Controlled,
Crossover Trial
R. A. Graham-Brown, A. Takwale,* E. Tan,* G. Barclay,* S. Agarwal,* I. Ahmed,* K.
Hotchkiss,* and J. Berth-Jones*
Dermatology, Leicester Royal In®rmary, Leicester, U.K.; *Dermatology, George Eliot Hospital, Nuneaton,
U.K.
There is a limited range of treatments for atopic dermatitis (AD). Azathioprine has often been used
but there has not been subject to randomized controlled trial. To establish or refute its ef®cacy and
to investigate safety and tolerability in severe AD, we performed a double-blind, randomized,
placebo-controlled, crossover trial of azathioprine. All patients were adults with severe AD,
resistant to ®rst-line treatment modalities.Each treatment period was of three months duration.
Treatments given were azathioprine 2.5 mg/kg/day and matched placebo. Disease activity was
monitored using the objective SASSAD sign score. In addition, severity of pruritus, sleep
disturbance and disruption of work or daytime activity were assessed using visual analogue scales.
Adverse events were recorded and haematological and biochemical monitoring was performed. 37
subjects were enrolled: mean age 38 years (range 17±73). 16 patients were withdrawn: 12 during
azathioprine treatment and 4during placebo treatment. The SASSAD score fell by 26% during
treatment with azathioprine vs. 3% on placebo (p = 0.02). Pruritus, sleep disturbance and
disruption of work/daytime activity all improved signi®cantly (p < 0.02) on active treatment but
not on placebo. The difference in mean improvement between azathioprine and placebo was
signi®cant for disruption of work/daytime activity (p = 0.001) but not for pruritus or sleep
disturbance. Gastrointestinal disturbances were reported by 14 patients during azathioprine
treatment, and 4were withdrawn because of severe nausea and vomiting. Leukopenia was observed
in 2 patients, and deranged liver enzymes in 8 during treatment with azathioprine. Azathioprine is
effective in severe AD altough it is not always well-tolerated.
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Anti-In¯ammatory Effects of Thymosin-b4 Splice Variants in the Skin
M. A. Sherling, E. Theodoridis,* R. Filler, A. Hayday,* R. Tigelaar, and M. Girardi
Dermatology, Yale University School of Medical, New Haven, Connecticut, U.S.A.; *Immunobiology,
Guy's Hospital, London, U.K.
Pro-thymosin-b4 (pTb4) was recently identi®ed as a major transcript in a SAGE library of gut
intraepithelial lymphocytes (IELs). To determine whether gd dendritic epidermal T cells (DETCs),
the IELs of the skin, produce pTb4, quantitative RT-PCR was performed on freshly isolated
DETCs. DETCs produce both splice variants of pTb4, lymphoid-Tb4 (L-Tb4) and ubiquitous-
Tb4 (U-Tb4), and L-Tb4 is selectively up-regulated with activation. To study the relative anti-
in¯ammatory properties of L-Tb4 and U-Tb4, the peptides were synthesized by FMOC, and
tested in BALB/c 8±10 week-old mice. Three different models of cutaneous in¯ammation were
utilized: neutrophil in®ltration by foot-pad carageenan injection, irritant contact dermatitis (ICD)
to TPA, and allergic contact dermatitis (ACD) to DNFB. In all cases, mice received intradermal
and intraperitoneal (IP) injections of 20 mg of L-Tb4 or U-Tb4, or saline vehicle prior to
elicitation, and 20 mg peptide IP 6 h later. Footpad or ear thickness was measured at 0, 6, 24, and
72 h. In the carageenen model, L-Tb4 suppressed footpad swelling more than U-Tb4 at 6 h
(0.36 6 0.06 vs 0.51 6 0.05 mm, p < 0.03), and at 24 h (0.28 6 0.04 vs 0.38 6 0.01, p < 0.02), and
much more than saline at 6 h (0.36 6 0.06 vs 0.72 6 0.06, p < 0.001) and 24 h (0.28 6 0.04 vs
0.69 6 0.03, p < 0.0001). In the ICD model, L-TB4 decreased ear swelling more than U-Tb4 at
6 h (0.18 6 0.02 vs.24 6 0.02, p < 0.01) and more than saline at 6 h (0.18 6 0.02 vs 0.31 6 0.01, p
< 0.0001), and 24 h (0.17 6 0.02 vs 0.22 6 0.02, p < 0.02). In the ACD model, L-Tb4 suppressed
ear swelling more than U-Tb4 at 24 h (0.17 6 0.00, vs 0.20 6 0.02, p < 0.03), and 72 h
(0.15 6 0.00 vs 0.20 6 0.02, p < 0.01), and more than saline at 24 h (0.17 6 0.00 vs 0.23 6 0.01, p
< 0.0001), and 72 h (0.15 6 0.00 vs 0.26 6 0.01, p < 0.0001). These studies indicate that L-Tb4 is
an effective anti-in¯ammatory factor in the skin in vivo and is more potent than U-Tb4; in
addition, they suggest that one of the mechanisms of DETC down-regulation of cutaneous
in¯ammation is the production and secretion of L-Tb4.
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Ef®cacy and Safety of Multiple Courses of Intramuscular Alefacept in Patients with
Chronic Plaque Psoriasis
R. D. Langley, E. Christophers,* and M. Lebwohl²
Department of Dermatology, Dalhousie University Medical Sch., Halifax, Nova Scotia, Canada; *Abt.
Dermatol.,Venereol. und Allergol., Klinikum an der University Kiel, Kiel, Germany; ²Department of
Dermatology, Mt. Sinai Medical Sch., New York, New York, U.S.A.
Current systemic immunotherapies for psoriasis do not provide lasting remissions and/or have
safety issues. Safe and effective therapies that provide patients with prolonged remissions after
cessation of treatment are clearly needed. AMEVIVEq (alefacept, a human LFA-3/IgG1 fusion
protein) is a novel and selective biologic agent that reduces memory-effector (CD45RO+) T cells
in the circulation. These cells are present in the in¯ammatory in®ltrate in psoriatic lesions. By
speci®cally reducing this subset of T cells, the physiopathological substrate of psoriasis is directly
targeted to induce long-term remission. This was con®rmed by data collected in phase II and III
trials of IV alefacept in which durable clinical responses were observed. For patients who achieved
either > 75% PASI reduction from baseline or `clear' or `almost clear' on PGA with a single 12-
week course of alefacept, the median duration of response (> 50% PASI reduction from baseline)
was > 7 months. A second course of alefacept provided additional bene®t. To determine the time
to retreatment and duration of response following IM alefacept, a double-blind, dose-comparison,
retreatment study was conducted as a follow-up to the IM phase III study. In the initial study, 507
patients were randomized to receive either 10 mg or 15 mg of alefacept or placebo IM once weekly
for 12 weeks, followed by a 12-week observation period. At the end of this period, patients could
enter the retreatment study and receive a second treatment course when they had a rating of `mild'
or `worse' by PGA given that they had CD4+ lymphocyte counts at or above the lower limit of
normal and had not initiated other systemic or phototherapy. Patients who had received alefacept
in the initial study continued on the same dose for 12 weeks, whereas placebo patients received
alefacept 10 mg IM weekly for 12 weeks. Each group was followed for an additional 12 weeks after
treatment cessation.
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The Effect of Intramuscular Alefacept on the Individual Components of the Psoriasis
Area and Severity Index
W. Gulliver, J. C. Prinz,* and J. Ortonne²
Dermatol., NewLab Clin.Res., Inc., St. Johns, Newfoundland, Canada; *Dermatol., University of
Munich, Munich, Germany; ²Dermatol., Ho
Ã
pital L'Archet II, Nice, France
An international, multicenter, double-blind, dose-comparison, phase III study evaluated the
ef®cacy of intramuscular AMEVIVEq (alefacept), a novel and selective biologic agent, in patients
with chronic plaque psoriasis. A total of 507 subjects were randomized to receive 10 or 15 mg of
alefacept or placebo administered weekly for 12 weeks, with an additional 12-week follow-up after
treatment completion. Ef®cacy was assessed by the Psoriasis Area and Severity Index (PASI), which
combines assessments of erythema, desquamation, and induration to produce a score ranging from
0 (no psoriasis) to 72 (most severe psoriasis). Two weeks after the last dose, 21% and 5% of subjects
in the 15-mg and placebo groups, respectively, achieved > 75% reduction in PASI from baseline
(primary endpoint; p < 0.001). PASI reduction of > 50% was achieved by 42% and 18% of subjects
in the 15-mg and placebo groups, respectively (p < 0.001). In the 10-mg group, 12% and 36% of
subjects achieved these levels of improvement, respectively, at the same time point (p = NS
and < 0.001, respectively). Overall PASI improvement within each treatment group was the result
of consistent improvements in the individual PASI components. Mean percentage reductions from
baseline for PASI, erythema, induration, and desquamation for the 15-mg group, 2 weeks after the
last dose, were 44.2, 40.4, 45.7, and 44.7, respectively, while placebo mean percentage decreases
were 21.6, 19.1, 20.4, and 21.8, respectively. In the 10-mg group, corresponding mean percentage
reductions in PASI and its components at 2 weeks after the last dose were 34.0, 28.7, 33.9, and
34.1, respectively. The greatest mean PASI percentage decrease from baseline (46.5) was observed
in the 15-mg group 6 weeks after the last dose, with erythema, induration, and desquamation
percentage reductions of 43.6, 48.6, and 47.3, respectively. These data demonstrate that mean
PASI improvements in response to alefacept were associated with consistent reductions in all
components of the PASI composite during dosing and follow-up.
817
The Ef®cacy and Safety of Topical Tacrolimus in Patients with Vitiligo
T. Soriano,² P. E. Grimes,*² M. Meraz,* and R. Morris*
*N/A, Vitiligo & Pigmentation Insitute of Southern California, Los Angeles, California, U.S.A.;
²Department of Dermatology, University of California ± Los Angeles, Los Angeles, California, U.S.A.
Immunomodulatory agents have been investigated as repigmenting agents for vitiligo. Tacrolimus
ointment is a macrolide lactone which inhibits the transcription of proin¯ammatory cytokines.
Early preliminary data from our institute documented repigmentation of vitiliginous lesions with
tacrolimus ointment (J Am Acad Dermatol, in press). The purpose of the present investigation was
to further assess the ef®cacy and safety of tacrolimus ointment in patients with vitiligo. Twenty-
three patients with generalized disease were enrolled in this 24 week open-label study. Their mean
age was 39 years 6 10 SD and the mean duration of vitiligo was 6 years 6 2 SD. The severity of
disease ranged from 10% to 50%. Eight were male and 11 were female. Detailed clinical assessments
were performed at baseline. Laboratory studies including a complete blood count, BUN,
creatinine, liver enzymes, thyroid panel, thyroid peroxidase antibodies, ANA, and lymphocyte
immunophenotypes (CD3, CD4, CD8, CD19, CD4/8 ratio, CD56/16) were performed at
baseline, 12 and 24 weeks. Patients were treated with tacrolimus ointment 0.1% twice daily. They
were evaluated monthly for ef®cacy and signs and symptoms of irritation. Photographs were taken
at baseline, 12 and 24 weeks. Nineteen patients completed the study. At 24 weeks, 79% achieved
varying levels of repigmentation. Forty-two percent achieved an overall repigmentation of greater
than 25%, and 26% had greater than 50% repigmentation. Sixty-®ve percent had greater than 75%
repigmentation of face and/or neck lesions. Maximal repigmentation occurred on sun exposed
areas of skin. Signs and symptoms of irritation were minimal throughout the study. Laboratory
parameters showed no statistically signi®cant alterations compared to baseline throughout the
study. These data suggest that tacrolimus ointment is an ef®cacious and safe therapy for patients
with vitiligo. It further substantiates the ef®cacy of immunomodulatory therapy for patients with
this therapeutically challenging disease.
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Ef®cacy of Two Courses of Intravenous Alefacept in Patients with Chronic Plaque
Psoriasis
G. G. Krueger
Department of Dermatology, University of Utah, Health Sciences Ctr., Salt Lake City, Utah, U.S.A.
A multicenter, double-blind study evaluated the ef®cacy of 2 courses of AMEVIVEq (alefacept), a
novel and selective biologic agent under investigation for psoriasis. Patients with chronic plaque
psoriasis received 2 treatment courses, each with a 12-week treatment period and a 12-week
treatment-free follow-up period. Patients were randomized to 1 of 3 cohorts: Cohort 1 received 2
courses of alefacept (n = 183), Cohort 2 received an alefacept course followed by a placebo course
(n = 184), and Cohort 3 received a placebo course followed by an alefacept course (n = 186).
Alefacept 7.5 mg and placebo were administered once weekly by 30-second IV bolus. A single
course of alefacept provided statistically and clinically signi®cant reductions in the symptoms and
severity of psoriasis. Two courses of alefacept provided greater bene®t. Patients who received 2
courses of alefacept had a maximum reduction from baseline Psoriasis Area Severity Index (PASI)
of 54% at 6 weeks after the last dose of the second course. Ef®cacy was maintained throughout the
study; mean PASI scores had not yet returned to baseline values at the ®nal follow-up visit after
either alefacept course. The percentage of Cohort 1 patients (alefacept/alefacept) who
achieved > 75% or > 50% reduction in PASI was 40% and 71%, respectively, during the entire
study period. Among patients who received 2 courses of alefacept and who achieved > 75%
reduction in PASI during either the treatment or follow-up periods, the estimated median duration
of a > 50% reduction in PASI could not be estimated because the study ended before 50% of the
patients reached this threshold. No rebound of disease or ¯ares were observed following treatment
cessation. In summary, 2 courses of IV alefacept produce signi®cant clinical improvements in
psoriasis. The incremental effectiveness of a second course of alefacept provides strong support for
its use as an intermittent therapy. The duration of response indicates that alefacept is a remittive
therapy, which may allow for more disease-free and treatment-free living.
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Safety of Two Courses of Intravenous Alefacept in Patients with Chronic Plaque
Psoriasis
K. B. Gordon and A. Menter*
Department of Dermatology, North-western University, Chicago, Illinois, U.S.A.; *Department of
Dermatology, Baylor Medical Ctr., Dallas, Texas, U.S.A.
AMEVIVEq (alefacept), a novel and selective biologic agent, selectively reduces memory-effector
T cells, the source of the pathogenic mediators of psoriasis. The safety of 2 courses of alefacept was
evaluated in a multicenter, double-blind study. Men and women with chronic plaque psoriasis
received 2 treatment courses, each with a 12-week treatment period and a 12-week treatment-free
follow-up period. Patients were randomized to 1 of 3 cohorts: Cohort 1 received 2 courses of
alefacept (n = 183), Cohort 2 received an alefacept course followed by a placebo course (n = 184),
and Cohort 3 received a placebo course followed by an alefacept course (n = 186). Alefacept
7.5 mg and placebo were administered once weekly by 30-second IV bolus. Adverse events (AEs)
occurring in > 10% of Cohort 1 patients were headache (19% vs. 10%), accidental injury (18% vs.
20%), pharyngitis (14% vs. 16%), chills (13% vs. < 1%), rhinitis (13% vs. 5%), pruritus (12% vs. 3%),
and infection (8% vs. 11%) in the ®rst vs. second alefacept course, respectively. These rates were
generally similar to those reported in placebo-treated patients. The incidence of headache, chills,
rhinitis, and pruritus was noticeably lower during the second vs. ®rst alefacept course. There was
no evidence that a single course or 2 courses of alefacept therapy increased the risk of infection.
Most infections were common colds; no opportunistic infections occurred. No patient
discontinued because of AEs during the second alefacept course, and the incidence of serious
AEs was similar after both alefacept courses (~5%). Alefacept had a low potential for
immunogenicity; thus, among Cohort 1 patients (alefacept/alefacept), antialefacept antibodies
were detected in 3 patients, 1 during Course 1 and 2during Course 2. Titers were low in each case
and they were not associated with any ef®cacy issues or hypersensitivity reactions. In conclusion,
alefacept was similarly well tolerated over 1 or 2 treatment courses with no evidence for cumulative
increase in adverse reactions, infections, or immunogenicity.
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Selective Reductions in Memory-Effector (CD45RO+) T Cells by Alefacept are Related
to Clinical Improvement in Psoriasis
N. Lowe, C. Grif®ths,* and A. B. Gottlieb²
Clin. Res., Clinical Research Specialists, Santa Monica, California, U.S.A.; *Dermatol. Ctr., Hope
Hosp., Salford, U.K.; ²Clin. Res. Ctr., R W Johnson Medical Sch., New Brunswick, New Jersey, U.S.A.
AMEVIVEq (alefacept) binds CD2 on T cells and FcgRI/RIII receptors on accessory cells, and
has been shown to selectively reduce the number of circulating memory-effector (CD45RO+) T
cells. Because this T-cell subset is implicated in psoriasis pathology, the relationship between
reduction of memory-effector T cells and clinical improvement was assessed in 2 phase 3 trials of
alefacept. In one trial, 507 patients were randomized to alefacept 10 or 15 mg or placebo,
administered weekly by IM injection for 12 weeks, followed by 12 weeks of observation. The
other study (n = 553) consisted of 2 double-blind, 12-week treatment courses (alefacept 7.5 mg or
placebo by 30- s IV), each with 12 weeks of observation. Patients were randomized to 1 of 3
cohorts: alefacept/alefacept, alefacept/placebo, or placebo/alefacept. In both studies, the
magnitude of reduction in circulating CD4+ and CD8+ memory-effector T cells was measured
by area under the effect curve (EAUC). EAUC values were divided into quartiles (Q1-Q4), with
Q4 having the greatest reduction. Clinical response was measured by PASI. In both studies,
alefacept reduced CD45RO+ T cells, with little effect on naO
Ã
ve (CD45RA+) T cells. In the IM
study, the percentage of alefacept-treated patients (10 or 15 mg) who had > 75% PASI reduction
from baseline at any time increased with increasing EAUC for CD4+ CD45RO+ T cells (21%,
28%, 33%, and 38% for EAUC Q1-Q4, respectively). Similar results were found in the IV study.
The percentage of alefacept-treated patients with > 75% PASI reduction from baseline at any time
in Course 1 increased with increasing EAUC (16%, 20%, 32%, and 44%, respectively). Of those
receiving 2 courses of alefacept, corresponding response rates at any time in Course 2 were 19%,
9%, 30%, and 62%. Clinical response was also related to the EAUC of CD8+ CD45RO+ T cells in
both studies. Alefacept produced selective reductions in circulating memory-effector (CD45RO+)
T cells that were related to improvements in psoriasis during 1 and 2courses of treatment.
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The Effect of Laser on the Skin to Enhance and Control the Transdermal Delivery of 5-
FU
K. Wang,*² W. Lee,²³ S. Shen,*³ C. Hu,²³ and J. Fang§
*Dermatology, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan; ²Dermatology, Taipei Medical
University Hospital, Taipei, Taiwan; ³Graduate institue of Medical sciences, Taipei Medical University,
Taipei, Taiwan; §Pharmaceutics laboratory, Graduate institute of Natural Products, Chang Gung
University, Taoyuan, Taiwan
The abilities of three lasers, i.e. Q-switched ruby, erbium-YAG, and CO
2
lasers, to enhance and
control the penetration of 5-Fluorouracil (5-FU) were studied in vitro. Both histopathological and
ultrastructural changes of the skin after laser treatments were also investigated. The permeation
pro®les of the lasers and their effects on the skin differed since they produced different physical and
physiological effects on the treated skin. For Q-switched ruby laser, the permeation of 5-FU
through the skin could be moderately promoted at 4.0 and 7.0 J/cm
2
with minimal histological
changes. The enhancement effect of 5-FU with erbium-YAG laser-treated skin was the greatest,
with a ¯ux of 53±133-fold higher than that across intact skin. While, While lower energy of CO2
laser apparently did not have an effect on 5-FU permeation, a 36±41-fold of 5-FU ¯ux was
observed after exposure to higher ¯uences (4.0 and 7.0 J/cm
2
) of the CO2 laser. The erbium-YAG
and ruby laser showed synergistic effects when they were combined. Scanning electron
microscopic ®ndings in the erbium-YAG/ruby combined group may explain the synergistic
effect of the two modes of lasers. Ouanti®ed histological changes of the skin treated by erbium-
YAG and CO2 lasers retured to normal within four to seven days. Laser is an effective modality to
enhance 5-FU delivery across the skin. A suitable laser can be selected to enhance 5-FU
administration according to different therapeutic needs.
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In¯uence of IVIg on Serum Autoantibody Titers in Pemphigus Vulgaris
K. Bhol, N. Sami, N. Aziz, and A. Ahmed
Oral Medicine, Harvard Sch Dental Medical, Boston, Massachusetts, U.S.A.
Pemphigus vulgaris (PV) is an autoimmune blistering disease, which affects skin and mucous
membrane. PV is characterized by the presence of pathogenic autoantibodies to desmoglein 3.
Intravenous immunoglobulin (IVIg) has been successfully used to treat many autoimmune diseases
including PV. It has been reported that, intravenous immunoglobulin (IVIg) is a safe therapy in
treating PV. The actual mechanisms of action of IVIg are not clearly known. Antibody titers can be
used to measure response to therapy in patients with autoimmune mucocutaneous blistering
disease. The purpose of this study is to investigate the serological response to IVIg therapy, in
patients with PV. This study consisted of 12 patients with active PV. Twenty normal healthy
individuals were used as controls. Sera samples from 12 patients treated with IVIg were collected in
a monthly interval for 18 months. ELISA was used to measure antidesmoglein 1 and
antidesmoglein 3 antibody levels during the course of the study. Sera of all 12 patients had high
antibody titers prior to initiating IVIg therapy. All 20 normal health individuals had negative
antibody titers to both desmoglein 1 and 3. A reduction in antibody titers to desmoglein 1 and 3in
patients with PV was observed. The difference in the reduction of antibody titers became
signi®cant (p < 0.05) after four months of therapy in PV patients. Patients with PV had
nondetectable titers after a mean period of 9 months. Patients with severe PV, receiving IVIg
therapy, demonstrate a positive serological response during the course of therapy. IVIg may have
the potential to reduce antibody production in PV patients.
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Psoriasis-Related Subpopulations of Memory CD4+and CD8+ T Cells are Selectively
Reduced by Alefacept
J. Krueger, P. Gilleaudeau, T. Kikuchi, and E. Lee
Laboratory for Investigative Dermatology, Rockefeller University, New York, New York, U.S.A.
Psoriasis is a T-cell mediated in¯ammatory disease. Alefacept (human LFA-3/IgG1 fusion protein)
has been shown to reduce circulating levels of CD4+ and CD8+ memory-effector (CD45RO+) T
cells. The effect of alefacept on T-cell subsets more directly related to psoriasis pathogenesis was
investigated in an open-label study of patients with chronic plaque psoriasis. Alefacept 7.5 mg was
administered once weekly by IV bolus for 12 weeks. T-cell populations in skin lesions and
peripheral blood were studied by a combination of immunohistology and ¯ow cytometry. Data are
available for 9 patients. At week 13, 7 patients were judged complete responders on the basis of
reversal of K16 staining in the epidermis; 1 patient was a partial responder and 1did not respond. In
all patients, mean epidermal thickness was reduced from 296 microns at baseline to 99 microns at
week 13 (p = 0.03). In complete responders, mean T-cell counts were reduced from baseline to
week 13 in both the epidermis (141±13) and dermis (315±43). At week 13, epidermal thickness
was highly correlated with the residual number of T cells in the epidermis (r = 0.98) or dermis
(r = 0.96) of treated lesions. In responders, the reduction in epidermal T cells (averaging 10.8-fold)
far exceeded the reduction of circulating memory T cells (averaging 1.8-fold for CD3+ CD45RA-
cells). Reductions were selective for skin-homing subsets: CLA + CD8+ CD3+ (56%),
CD3+ CD8+ CD103+ (69%), and CD3+ CD8+ CD45RA-CD27+ (73%). The reduction in
IFNg-producing T cells in the circulation (60%) exceeded that of the overall memory T-cell
population (44%), supporting the selectivity of alefacept for Type 1 T cells. These results establish
selective effects of alefacept on disease-related T cells with at least 5:1 therapeutic selectivity.
Overall data are most consistent with selective depletion as the relevant therapeutic mechanism,
though relative immune deviation also occurs.
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Macrolides Inhibit TARC, IL-8, Groa, and GM-CSF Production from Keratinocytes
and NFkB Activation but not IkB a Degradation
M. Komine, T. Kakinuma, S. Yano, and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Japan
The newly synthesized 14-membered ring macrolides, have recently been revealed to have various
anti-in¯ammatory effects, which was shown to be effective in treating psoriasis, prurigo
pigmentosa, and eosinophilic pustular folliculitis. We evaluated the anti-in¯ammatory effects of
roxithromycin (RXM), one of such macrolides, on HaCaT ketratinocytes in vitro. ELISA
experiments revealed that it inhibited thymus and activation-regulated chemokine (TARC), IL-8,
Groa, and GM-CSF production stimulated by IFNg and/or TNFa. TARC production stimulated
by IFNg and TNFa was reduced by the addition of antisense oligo for NFkB, but not by the
addition of sense oligo. NFkB consensus sequence controlled luciferase construct cotransfected
with CMV renulla luciferase vector showed reduced reporter activity with RXM. In order to
elucidate the mechanism of action, we performed Western blotting to see if IkB a degradation is
affected by RXM. It revealed that incubation with RXM of HaCaT keratinocytes stimulated by
TNFa did not alter the protein expression of IkB a. These results indicate that RXM exibits anti-
in¯ammatory effects on keratinocytes at least in part by affecting NFkB activation, but by the
mechanism other than inhibiting degradation of IkB a. Patients with psoriasis have elevated levels
of IL-8 and Groa, which may be the target of macrolide action. We have recently shown that
serum TARC level is elevated in patients of atopic dermatitis, bullous pemphigoid and mycosis
fungoides, which led us to speculate the possible therapeutic effects of macrolides on these
disorders.
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Peroxisome Proliferator Activator Receptor-g and Retinoid X Receptor Agonists Exert
Synergistic Proapoptotic Effects on Cutaneous T Cell Lymphoma Cells
C. Zhang, X. Ni, M. Konopleva, M. Milella, P. Hazarika, M. Andreeff, and M. Duvic
Dermatology and Blood & Marrow Transplatation, The University of Texas M.D. Anderson Cancer Center,
Houston, Texas, U.S.A.
Mycosis fungoides (MF) is the most common and indolent cutaneous T cell lymphoma (CTCL)
characterized by accumulation of epidermotropic CD4+ CD45RO+ helper/memory T cells in
skin, caused by defects in apoptosis regulation rather than cell proliferation. Pharmacological
modulation of T-cell apoptosis may provide novel therapeutic approaches for this disease. The
peroxisome proliferator activator receptor-g(PPAR-g) and its heterodimer partner, the retinoid X
receptor (RXR), belong to the nuclear hormone receptor superfamily of transcription factors that
regulate cellular differentiation, proliferation and apoptosis. A novel synthetic oleanane triterpenoid
2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO) is a ligand for PPAR-g. We have
shown that the RXR-selective retinoid, bexarotene, induces apoptosis in CTCL cell lines,
however, little is known about PPAR-g activity in CTCL. Using Western blotting, we show that
PPAR-g protein was expressed in three CTCL cell lines (MJ, Hut78, and HH) and was decreased
by 50% in MJ, 40% in Hut78, and 30% in HH cell lines following CDDO treatment at 2 mM for
48 h. CDDO at 0.5±5 mM for 48 h caused apoptosis by 13%-68% in MJ, 4%-57% in Hut78, 3%-
55% in HH, and 10%-71% in freshly isolated SeÂzary cells from one CTCL patient over vehicle
control (DMSO) determined by ¯ow cytometry analysis of sub-G1 hypodiploid nuclei and
annexin V binding populations. In the HH cell line, the induction of apoptosis was 10% with
bexarotene (20 mM), 19% with CDDO (2 mM), and 48% when the two ligands were combined.
These data suggest that PPAR-g agonists may be active for treatment of CTCL, and may have
synergistic effects combined with an RXR-selective rexinoid.
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The Effect of Ultrasound on Aged Skin
E. Choi, S. Lee, S. Ahn, and S. Lee
2
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, South Korea;
*Department of Dermatology, Yonsei University College of Medicine, Seoul, South Korea
As human skin ages, the most remarkable histological changes are a decrease of skin thickness and
connective tissue, and an alteration in elastic ®bers. Recently, many dermatologists are using
ultrasound for transdermal delivery of cosmetic agents. However, systematic investigation
con®rming the effect of ultrasound on the skin has not been done. It has been reported that the
effects of ultrasound include increased protein synthesis in the ®broblasts, but the exact mechanism
is unknown. The hypothesis was, when skin is treated by ultrasound, TGF-b expression is
increased so that ®broblasts are activated and an increases in collagen synthesis and skin thickness
follow. A treatment of 1 MHz ultrasound was given to old and young mice. Changes in skin
thickness, collagen, elastic ®bers and ground substances were investigated along with TGF-b
expression. H&E stain and Massons trichrome stain were used in order to measure skin thickness
and dermal density including collagen. Immunohistochemical stain for TGF-b expression was
quanti®ed by the image analyzer. Electron microscopic study was performed to determine dermal
ultrastructural changes. RT-PCR for TGF-b mRNA was performed. In the aged mice, ultrasound
increased the epidermal thickness and dermal density, but it did not increase dermal thickness,
elastic ®ber or ground substance. In young mice, changes in epidermal thickness and dermal
density as in aged mice were not observed. In aged mice, an increase of TGF-b expression on
immunohistochemical stain and compact arrangement of collagen ®ber on electron microscope
were observed after ultrasound. But, these changes were not found in young mice. The expression
of TGF-b mRNA was increased in the ultrasound treated aged and young mice, but the difference
was not statistically signi®cant.
In conclusion, ultrasound is thought to increase the epidermal thickness and dermal collagen
®bers, and these effects may be resulted from the increase of TGF-b activated ®broblasts.
832
Evaluation of the Safety and of the Anti-In¯ammatory Effect of a Water Paste for Diaper
Rashes
P. Nathalie, C. Jean-Christophe, d. Bart,* C. Marina,* C. Alain,² and M. Philippe
R & D, Laboratoires Pharmascience, Epernon, *R & D, SkinEthic Laboratories, Nice, 81, France; ²R
& D, SGS Biopharma, Wavre
We have developed a water paste for the prevention of diaper rash, containing green tea (1%)
which act as proteases inhibitor, zinc oxide (20%) with antifungic and protective activities, and zinc
salts (0.02%) which act as lipase inhibitor. Due to the physiological particularities of baby skin, baby
care products must ful®l the criteria of safety and ef®cacy. We present here the results of 2 distinct
in vitro experiments in order to evaluate the safety and the ef®cacy of this product. in vitro human
reconstructed epidermis tissues (RHE, SkinEthic,) were dosed topically with 10 mg/cm
2
of each
tested product for 24 h and 72 h. Untreated negative control as well as positive control (SDS 0.4%)
treated tissues were run in parallel. The tissues were assessed for viability (MTT and LDH assays),
protein content, and histology. The release of in¯ammatory mediators (IL-1, IL-8 and PGE2) was
quanti®ed using an ELISA method. We also used RHE in order to evaluate the potency of the
formulation to inhibit epidermal in¯ammation. RHE were exposed to SLS during 2 h, rinsed and
then treated the tested product for 20 h. The formulation was also applied before SLS. The release
of IL-1 and PGE2 was evaluated. MTT assay as well as morphological examination were also
performed. Topically applied on normal RHE, the formulation is devoided of pro-in¯ammatory
and cytotoxic effect. When applied on SLS-treated RHE, the product doesn't ampli®ed the
in¯ammatory response. Moreover, the formulation seems to inhibit epidermal synthesis and/or
release of IL-1 when used as therapy, and to prevent the release of PGE2 when applied before SLS.
These results were con®rmed by the evaluation of cell viability and by histological examination.
With regard to these in vitro results, we can conclude that this product should be very well tolerated
when applied on baby skin, both normal and irritated area, and may be effective in reducing and/or
preventing the in¯ammation linked to diaper rashes.
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Target Tissue Regulation of Retinoic Acid Isomers and their 4-Oxo Derivatives in
Cultured Normal Human Keratinocytes
H. F. Merk, F. K. Jugert, B. Jens, D. R. Bickers,* M. Athar,* R. Schiffer, and U. Wiegand²
Derm & Allergy, RWTH Aachen, Aachen, NRW, Germany; *Dermatology, Columbia University, New
York, New York, U.S.A.; ²Roche, Hoffmann La, Basel, Basel, Switzerland
The mechanism of action of retinoids is complex and targhet tissue responses in the skin are of
particular interest because of the unique effectiveness of these compounds in cutaneous tissue.Both
therapeutic and toxic effects of retinoids may be mediated by nuclear receptors. Metabolic
transformation of retinoids in the skin itself likely in¯uence ef®cacy and safety. RA exists as three
isomers including all-trans-RA, 13-cis RA, and 9-cis RA, which bind variably to retinoid receptors.
The factors in¯uencing cellular concentrations of these isomers are incompletely understood. RA
isomers are capable of transformation into 4-oxo metabolites, a reaction catalyzed by cytochrome
P450 26 (CYP26). In this study RA isomers and their 4-oxo metabolites were incubated with
NHK and metabolism evaluated by reverse phase HPLC after 0, 24, 48, 72, and 96 h. All-trans-RA
was stable whereas 13-cis RA and 9-cis RA were converted into all-trans RA. In contrast 4-oxo-9-
cis RA was the most stable RA isomer among the oxo metabolites and both 4-oxo-all-trans RA and
4-oxo-13-cis RA were converted to 4-oxo-9-cis RA. Our results indicate that all-trans RA is the
most stable retinoid in NHK whereas 4-oxo-9-cis RA is the most stable 4-oxo metabolite.
Retinoid action in NHK may be dependent on both all-trans RA and 4-oxo-9-cis RA.
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Clinical Evaluation of Topical Sodium L-Ascorbyl-2-Phosphate Lotion (5% W/V) in
Patients with Acne
N. Takeshi, T. Ohba,* H. Ikeno,² T. Tsuzuki,³ E. Isogai,§ T. Yamashita,¶ T. Okayasu, and
S. Arashima
Medice and Nursing, Hokkaido University of Education, Sapporo, Hokkaido, Japan; *Medicine, Nothbio
Laboratories, Sapporo, Hokkaido, Japan, ²Dermatology and Plastic Surgery, Ikeno Clinic, Tokyo, Japan;
³Central Research Laboratory, Showa Denko K.K., Kawasaki, Kanagawa, Japan; §Preventive Dentistry,
Health Sciences University of Hokkaido, Toubetu, Hokkaido, Japan; ¶Medicine, Sapporo Medical
University, Sapporo, Hokkaido, Japan
Sixteen subjects with acne (15 women and 1man), 18±22 years of age were enrolled in this study.
This was an open comparison study. These patients were instructed to apply the study 5% (W/V)
sodium L-ascorbyl-2-phosphate lotion (APSL) topically to the acne lesions on one side of the face
only, once a day, after washing the face in the evening. Treatment was continued for 7 weeks. At
the beginning, after 3 weeks and after 7 weeks of treatment, patients were observed for clinical
response. Clinical response of each patient was evaluated by an observation of both sides of the face
and rated on a 5-point scale. Clinical improvement of in¯ammation, and papules-pustules were
obtained in 87% and 73.3% of the APSL treated side, but only 26.7% and 20.0% in the untreated
side of the face, respectively. This is the ®rst time the evaluation of topical APSL in patients with
acne has been repoted.
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Pimecrolimus Permeates Less Through Skin than Corticosteroids and Tacrolimus
A. Billich, H. Aschauer, and A. Stuetz
ISD, Novartis Research Institute, Vienna, Austria
Pimecrolimus (Elidelá, SDZ ASM 981) is an in¯ammatory cytokine inhibitor speci®cally
developed for treatment of in¯ammatory skin diseases. For topical application it is important to
know the extent to which the active principle remains con®ned to the skin after application or to
which degree it passes through the skin. We compared the skin penetration properties of
pimecrolimus (i) to those of tacrolimus, and (ii) to topical corticosteroids used in standard treatment
of in¯ammatory skin diseases. We used an in vitro model system, where drug solutions are applied
epicutaneously to skin (human, porcine or rat) mounted in static Franz-type diffusion cells. Topical
steroids (bmethasone valerate, clobsol propionate, di¯ucortolon valerate) and pimecrolimus
showed concentrations of the same order of magnitude in human skin at the end of 48- h
experiments. However, pimecrolimus showed only marginal permeation through the skin: in the
absence of a penetration enhancer skin permeation of pimecrolimus was not detectable; in the
presence of an enhancer, permeation rates of steroids were 70- to 120-fold higher than for
pimecrolimus. The comparison of pimecrolimus and tacrolimus revealed similar skin concentra-
tions at the end of the 48- h exposure period for both compounds. In contrast, pimecrolimus
featured reduced permeation through the skin, by factors of 9±10 in the case of human, porcine
and rat skin. These observations might be explained by different physico-chemical properties of the
two compounds. Indeed, a higher lipophilicity of pimecrolimus was deduced from logP values and
from retention times in RP chromatography. In conclusion, it appears that pimecrolimus shows
signi®cantly lower permeation through skin in the in vitro model, as compared to topical
corticosteroids and to tacrolimus. Based on these observations and the fact that pimecrolimus has
highly reduced intrinsic capability to affect systemic immune response as compared to tacrolimus, it
can be expected that pimecrolimus offers a larger safety margin with respect to potential systemic
side-effects as compared to existing therapies.
833
Increased Hair Growth Inhibition by the Active Enantiomer of E¯ornithine
G. Ahluwalia, P. Styczynski, and D. Shander
Dermatologics, Gillette Company, Needham, Massachusetts, U.S.A.
E¯ornithine (a-di¯uoromethylornithine), the active component in VaniqaTM, a topical
preparation for the control of unwanted facial hair in women, is present as a racemic mixture
(50 : 50, D and L-enantiomers). A series of studies to measure the magnitude of the response and
onset of action were conducted to compare the ef®cacy pro®le of the active L-e¯ornithine
enantiomer. Using the hamster hair mass model L-e¯ornithine was shown to result in about a 2-
fold increase in hair mass reduction ef®cacy when compared to the racemate. In addition, the
number of animals showing maximal ef®cacy after topical treatment with the L-e¯ornithine isomer
was more than double after two and three weeks of dosing when compared with the racemate.
Examination of ¯ank organ hair follicle bulbs showed a 4-fold increase in ef®cacy with L-
e¯ornithine as determined by hair follicle spatial mass analysis. Furthermore, an earlier onset of
action was shown for the L-e¯ornithine. When the enantiomers and racemate of DFMO were
evaluated in a human hair follicle culture assay, L-e¯ornithine alone produced statistically
signi®cant hair growth inhibition. IC50 values for e¯ornithine isomers were determined using the
highly proliferative, mouse leukemia L1210 cell line, which has a high level of activity of the target
enzyme ornithine decarboxylase. Consistent with the hair growth reduction data, L-e¯ornithine
had an apparent IC50 of about 5 micromolar, whereas the racemate had an IC50 value of about 10
micromolar. Skin penetration rates for L-e¯ornithine and the racemate were found to be similar.
Taken together, these data suggest that an increase in hair growth inhibitory activity and an
increase in the response rate (i.e. number of subjects demonstrating ef®cacy) as well as an earlier
onset of action can be achieved by replacing the racemic e¯ornithine with the pure L-enantiomeric
form in the current VaniqaTM product ± the only FDA approved drug for the topical treatment of
unwanted facial hair in women.
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Reduction of Mcl-1 Expression by Antisense Oligonucleotides Chemosensitizes Human
Melanoma
C. Thallinger,*² M. Wolschek,* P. Gu
È
nsberg,* H. Maierhofer,* V. Wacheck,* K. Wolff,² H.
Pehamberger,² E. Selzer,³ and B. Jansen*²
*Clinical Pharmacology, University of Vienna, Vienna, Austria; ²Dermatology, University of Vienna,
Vienna, Austria; ³Radiotherapy and Radiobiology, University of Vienna, Vienna, Austria
There exists strong evidence that high level expression of antiapoptotic Bcl-2 family proteins, such
as Bcl-2, Bcl-xl and Mcl-1 confer a clinically important chemoresitant phenotype on cancer cells.
Given the expression of the antiapoptotic Bcl-2 family member Mcl-1 in human melanoma we
hypothesise that Mcl-1 is one key factor in¯uencing the chemosensitivity of this malignancy. In the
present study we were interested whether the reduction of Mcl-1 expression by antisense
oligonucleotides improves the chemosensitivity of human melanoma grown in severe combined
immunodeciciency (SCID) mice.
Six groups of SCID mice (group A-F; A: antisense, B: antisense + DTIC, C: mismatch
oligonucleotides, D: mismatch oligonucleotides + DTIC E: saline, F: saline + DTIC) were injected
subcutaneously with 518A2 human melanoma cells (n = 6 per group). When the mice had
developed palpable tumours oligonucleotide or saline treatment was initiated (oligonucleotide
dosage was 20 mg/kg per day over 14 days). Five days after initiation of the oligonucleotide
treatment, animals were injected intraperitoneally with darcabazine for 5 days (DTIC, 80 mg/kg
per day).
Dacarbazine exerted an antineoplastic response in our 518A2 melanoma SCID mouse system as
compared to the untreated control group. The combination of Mcl-1 antisense oligonucleotides
and dacarbazine, however, reduced the mean tumour growth by about two thirds compared to the
dacarbazine treated control group (t test; p < 0.01). Combination treatment with dacarbazine and
mismatch control resulted in no signi®cant tumour growth reduction compared to the dacarbazine
treated control group.
These data clearly show that Mcl-1 signi®cantly contributes to the chemoresistance of human
melanoma cells and that the chemoresistance can be reduced by antisense oligonucleotides. We
speculate that the reduction of more than one antiapoptotic factor could provide a promising
approach that may help to overcome chemoresistance in this malignancy.
838
CD25+ Expression in Mycosis Fungoides by Stage, Histology, and Response to Ontak
Therapy
R. Talpur, A. Alencar, N. Apisarnthanarax, D. Jones, and M. Duvic
Dermatology & Hematopathology, MD Anderson Cancer Center, Houston, Texas, U.S.A.
Diphtheria fusion toxin denileukin di®tox (Ontaká) targets the a subunit of interleukin 2 receptor
(IL2R/CD25)that is variably expressed on malignant lymphocytes in mycosis fungoides. To
evaluate the degree of CD25+ expression in MF, we performed immunohistochemistry on
formalin-®xed paraf®n-embedded involved skin biopsies using the CD25 mouse monoclonal
antibody 4C9 (Novocastra, Newcastle Upon Tyne, England). Skin lesions from 121 MF patients,
including 25 patients who received Ontak therapy, were graded at baseline as having either < 20%
or > 20% CD25+ lymphoma cells. Overall, 30 of 121 patients or 25% had > 20% of lesional
lymphocytes staining positive for CD25. The percentage of patients with > 20% CD25+ tumor
cells increased with higher clinical stage as follows: stage IA-IIA-10/64 (16%); stage IB-8/25
(32%); and stage III-IVB-12/32 (38%). Of the 30 patients with the high level of CD25+
expression, 9 had large cell transformation (signifying > 25% large tumor cells) including 2 stage I-
IIA, 3 stage IIB, and 4stage III-IV patients. Fifteen of 25 (60%) of patients treated with Ontak
showed > 20% CD25 + expression in their baseline skin biopsies. Eleven of 15 (75%) had partial
responses after 2±16 courses, and 4/15 (27%) had stable disease after 1±2 courses. Ten patients
with < 20% CD25+ expression also received Ontak. Three of 10 (30%) achiev ed partial response
after 2±3 courses, 5/10 (50%) had stable disease after 2±3 courses, 1/10 (10%) had progressive
disease and 1was lost to follow up. In conclusion, by immunohistochemistry, only 25% of all MF
patients' biopsies showed high CD25+ expression. Increased CD25 expression was seen in all
patients with large cell transformation, with increased expression seen in advanced stage disease.
Degree of CD25 expression correlated with a clinical response to Ontak therapy, although patients
with < 20% CD25+ do respond to Ontak. In order to better understand the relationship between
CD25+ expression and clinical response to Ontaká, a blinded two-armed study is currently being
conducted at several centers.
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A Topical Niacin Prodrug Enhances Wound Healing by Stimulation of Leptin Secretion
H. Kim,*² M. Jacobson,* M. Kim,*² E. Jacobson,* and J. Qasem²
*Pharmacology/Toxicology, University of Arizona, Tucson, Arizona, U.S.A.; ²R & D, Niadyne, Inc,
Tucson, Arizona, U.S.A.
Leptin, the ob gene product, has been characterized as a satiety-regulating cytokine that is
predominantly expressed by adipocytes. Recent studies indicate that leptin exerts numerous
protective effects including the enhancement of skin re-epithelialization following wounding. The
purpose of this study was to test the hypothesis that niacin and prodrugs of niacin designed for
topical delivery could stimulate leptin release and thereby accelerate wound healing. A prodrug of
niacin was designed and synthesized with physical properties that allow transdermal delivery to the
skin at an optimal rate to release niacin while avoiding the vasodilation observed following oral or
topical delivery of niacin. The ef®cacy of delivery was demonstrated by increases in the active form
of niacin, NAD, in skin samples taken from the site of application. Safety testing of this compound
on human volunteers showed that it did not cause irritation or any other adverse effects following
topical application. The niacin prodrug stimulated leptin release when applied to the skin of mice.
That niacin also stimulates leptin release in humans was demonstrated by the observation that
niacin increased leptin secretion from cultured human adipocytes. In contrast, the same levels of
niacinamide did not have any effect on leptin secretion. Studies on wound healing in mice showed
that the topical niacin prodrug decreased wound diameter by greater than 60% relative to vehicle
control at 8 days following wounding (p = 0.014). Assessment of the niacin prodrug in human
volunteers revealed that it enhanced resistance of the epidermal barrier to environmental stresses
and resulted in signi®cant improvement in skin texture. These data support the hypothesis that
niacin derivatives designed for topical delivery will provide therapeutic bene®t for wound healing.
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Inhibitory Activity of Pimecrolimus and Tacrolimus on Induced Cytokine mRNA and
Protein Expression in a Human T Cell Line (Jurkat) Measured via RT-PCR and ELISA
A. Winiski, S. Wang, B. Schwendinger, and A. Stuetz
In¯ammatory Skin Diseases, Novartis Research Institute, Vienna, Austria
Pimecrolimus (Elidelá, SDZ ASM 981) is an ascomycin macrolactam derivative speci®cally
designed and developed to treat in¯ammatory skin diseases. It has been shown to be highly
effective and safe in atopic dermatitis after topical administration and in chronic plaque psoriasis
after oral application. Previous in vitro studies demonstrated that pimecrolimus acts as a speci®c
inhibitor of the release of in¯ammatory cytokines from T cells and mast cells. In this study, we
pro®led the inhibitory effect of pimecrolimus, in comparison to tacrolimus (FK 506), on the
expression of several cytokines in the human T cell line Jurkat stimulated by PMA + PHA, by the
use of real-time PCR and ELISA for quantitation of mRNA and protein, respectively. In this
respect, this is the ®rst reported in vitro study of either compound employing quantitative real-time
PCR. We ®rst studied the kinetics of cytokine gene expression in PMA + PHA-stimulated Jurkat
cells. TNFa mRNA was induced relatively early upon stimulation at 2 h. The IL-2, IL-3, IL-8 and
GM-CSF mRNAs were up-regulated at 6 h. Regarding protein secretion, maximum levels were
obtained after 24 h (TNFa, IL-8) or 48 h (IL-2, IL-3, GM-CSF). Based on these kinetics,
compounds were evaluated for their effect on the expression of cytokine mRNAs at 2 h or 6 h and
cytokine secretion at 24 h or 48 h after activation. Our results showed that pimecrolimus inhibited
TNFa, GM-CSF, IL-2, IL-3 and IL-8 production at both mRNA and protein levels, with IC50s
in the subnM range. Pimecrolimus was nearly as effective as tacrolimus at both the mRNA level
(IC50s: 0.03±0.83 nM vs. 0.04±0.6 nM) and at the protein level (IC50s: 0.02±0.22 nM vs. 0.01±
0.1 nM). Thus the intrinsic activity of pimecrolimus and tacrolimus in inhibiting the expression
and release of T cell cytokines is in the same range.
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Pimecrolimus Does Not Affect Langerhans Cells in Murine Epidermis, in Contrast to
Corticosteroids
A. Stuetz, E. Kowalsky, K. Schwendinger, and J. Meingassner
ISD, Novartis Research Institute, Vienna, Austria
Langerhans' cells (LC) function as specialized antigen-presenting cells in the epidermis and
therefore play a critical role in cutaneous immunological reactions. Epicutaneous treatment with
corticosteroids is associated with a decrease in epidermal LC number and antigen presenting
capacity in laboratory animals and patients. We examined whether pimecrolimus, an ascomycin
macrolactam derivative speci®cally designed for the treatment of in¯ammatory skin diseases, differs
from corticosteroids in reducing LC density in murine skin after topical treatment. Corticosteroids
of various potencies were used as comparators. Groups of Balb/c mice were treated twice daily on
1±5 consecutive days on the inner surface of the right ear with 10 mL of ethanolic solutions of the
test compounds at their clinically used concentrations: pimecrolimus at 1%, clobsol propionate at
0.05%, bmethasone 17-valerate at 0.1% and hydrocortisone at 1.0%. Three, 11, 27 or 45 days after
the last application 4 mice were sacri®ced, epidermal sheets prepared and immunostained with a
FITC labeled anti-Ia antibody. The number of Ia-bearing LC per square millimeter was
determined with a ¯uorescence microscope and a calibrated ocular grid. Treatment with all
corticosteroids resulted in a dramatic reduction or elimination of Ia-positive LC by 96±100% in the
treated skin. In contrast, neither morphological nor numerical changes in LC were observed in test
sites exposed to topical pimecrolimus, not even after 10 applications. Almost complete depletion of
Ia-positive cells by corticosteroids was already observed after 2 applications. A tendency towards
recovery was seen earliest in hydrocortisone-treated mice on day 32 (40% of controls) and on day
45 in clobsole-treated mice (67% of controls). Therefore it is unlikely, that topically applied
pimecrolimus interferes with immunologic functions of epidermal cells dependent on Langerhans
cells.
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Enhancement of E¯ornithine Skin Penetration Leads to Increased Hair Growth
Inhibition
P. Styczynski, G. Ahluwalia, and D. Shander
Department of Dermatologics, The Gillette Company, Needham, Massachusetts, U.S.A.
The stratum corneum provides an excellent barrier against the entry of foreign substances,
including drugs, into the body. The skin penetration of a molecule is dependent on its physical and
chemical properties as well as on the properties of the carrier vehicle. To enhance the hair growth
inhibitory ef®cacy of e¯ornithine (a-di¯uoromethylornithine; Vaniqa
TM
), formulation improve-
ments were investigated that would facilitate greater delivery through the skin to its site of action in
hair follicles. Previous topical pharmacokinetics studies have demonstrated that the skin penetration
of e¯ornithine is extremely low (c. < 1%), and this likely represents a limiting factor in achieving
the maximal ef®cacy potential of this drug molecule. Polyoxyethylene ethers including brij-30, ±
35, ±68 and ±78, individually and in combination with urea, demonstrated about a 2-fold
enhancement in the skin penetration of e¯ornithine when directly added to a cream-based
formulation as determined by an in vitro skin diffusion assay. In addition, a 1.5±2-fold ef®cacy
enhancement was observed in an animal model system using two endpoints ± hamster hair mass
and hair follicle spatial mass. A decrease in hair follicle spatial mass also suggests an earlier onset of
action when brij and urea are included in the formulation. Other penetration enhancers were also
evaluated, including fatty acids and several terpenes. Pretreatment of the skin with selected cis-fatty
acids resulted in a marked enhancement in e¯ornithine skin penetration, whereas pretreatement
with its trans-fatty acids produced no increase in skin penetration. Terpenes, such as 1,8-cineole,
nerolidol and menthone, produced a 2±3-fold increase in e¯ornithine skin penetration. The results
suggest that a moderate enhancement in ef®cacy can be achieved by a relatively minor
modi®cation to the current VaniqaTM formulation ± the only FDA approved drug for the topical
treatment of unwanted facial hair in women.
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The Effect of a Zinc/Iron Solution as Compared to a Topical Growth Factor on
Epithelization of Partial Thickness Wounds
A. L. Cazzaniga, S. C. Davis, A. Drosou, and P. M. Mertz
Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami,
Florida, U.S.A.
Zinc has been shown to be bene®cial to the wound healing process. The purpose of this study was
to compare the effect of a new zinc/iron solution (ZIS) to a topical growth factor on the healing of
partial thickness wounds. Ten pigs received multiple partial thickness wounds and received one of
the following treatments: (1) 0.003% ZIS (2) topical Platelet Derived Growth Factor [PDGF], or
(3) untreated air exposed. Wounds were treated by sterile 4-ply gauze saturated with each agent
and then covered with a polyurethane dressing. The topical PDGF was applied then covered with
saline moistened gauze. Wounds were treated daily. Five wounds were excised on days 3±8 and
evaluated for complete epithelization using a well-described salt-split technique. A total of ®ve
hundred and forty wounds were evaluated. All wounds that received any treatment stimulated
epithelization sooner than untreated air exposed. The 0.003% ZIS enhanced complete
epithelization as compared to wounds treated with topical PDGF. This data demonstrates that a
new zinc/iron agent is effective at stimulating healing which may have important clinical
implications.
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Update of the Phase I Clinical Trial of O6Benzylguanine (BG) and Carmustine (BCNU)
in the Treatment of Cutaneous T Cell Lymphoma
M. S. Ke,* S. K. Szabo,* L. Liu,² A. C. Gilliam,* S. L. Gerson,² G. S. Wood,§ and S. R.
Stevens*³
*Dermatology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio,
U.S.A.; ²Medicine, University Hospitals of Cleveland and Case Western Reserve University, Cleveland,
Ohio, U.S.A.; ³Dermatology, Louis Stokes Department of Veterans Affairs Medical Center, Cleveland,
Ohio, U.S.A.; §Dermatology, University of Wisconsin, Madison, Wisconsin, U.S.A.
BCNU alone has proven ef®cacy in CTCL. It works by forming DNA alkyl adducts at the 06
position of guanine which then rearrange to ultimately induce cytotoxic crosslinks in target cells.
AGT (alkylguanine DNA alkyltransferase) removes these adducts and is the main mechanism of
tumor cell resistance. AGT activity is readily detectable in CTCL, but not in normal skin. BG
competitively binds and inactivates AGT in tumor tissue. This provided a biochemical rationale to
a phase I dose escalation clinical trial with BG/BCNU, to assess the toxicity of biweekly
administered low dose topical BCNU following 120 mg/m
2
intravenous BG, and to determine the
kinetics of AGT depletion in CTCL skin lesions. Besides a transient SGOT increase in one patient
associated with alcohol intake, there have not been any signi®cant adverse events noted. Severity
weighted assessment tool (SWAT) measurements showed that of the 10 patients treated to date, 6
achieved a partial response, 3 a marginal response, and 1had progressive disease at BCNU dose
levels from 10 to 30 mg administered every other week. Baseline AGT activity, determined from
CTCL lesional biopsies, was diminished by 86.8% at 6 h following the ®rst BG administration. This
depletion was maintained at 24 h (87.3% depletion), but resolved by 8 days (76.3% of original AGT
activity), indicating that the depletion of AGT is reversible. In conclusion, 120 mg/m
2
BG is
suf®cient to deplete AGT in the skin lesions of CTCL, which is central to enhancing the antitumor
effect of BCNU in CTCL. Combination BG/BCNU is well tolerated at these dose levels and
warrants further development for the treatment of CTCL.
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Pimecrolimus (SDZ ASM 981) Cream 1% Provides Signi®cant and Rapid Relief of
Pruritus in Pediatric Patients with Moderate to Severe Atopic Dermatitis
M. Boguniewicz, L. Eichen®eld,* M. Ling,² and R. Cherill³
Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado, U.S.A.;
*Childrens Hospital and Health Center, San Diego School of Medicine, San Diego, California, U.S.A.;
²Dermatology, Emory University School of Medicine, Atlanta, Georgia, U.S.A.; ³Clinical Research,
Novartis Pharmaceuticals Corp, East Hanover, New Jersey, U.S.A.
Pimecrolimus is a skin-selective in¯ammatory cytokine inhibitor. One of the primary symptoms of
atopic dermatitis (AD), causing considerable discomfort to patients and their families, is pruritus.
This analysis compared the effect on pruritus of pimecrolimus cream 1% with that of vehicle.
Pooled analyses of three short-term (6 week) double-blind, vehicle-controlled studies in subjects
ranging in age from 3 months to 18 years with mild-to-moderate AD were performed. The
constituent studies were identical in design, except for the age range of the subjects enrolled. In the
pooled study populations, the total number of subjects in the pimecrolimus treatment groups was
390, and 199 in the vehicle groups. The severity score of pruritus (ranging from 0 = none to
3 = severe) was used as a secondary ef®cacy evaluation. There was no meaningful difference
between the treatment groups in the severity of pruritus at baseline (p = 0.419), with the majority
of subjects in each treatment group with pruritus rated moderate to severe. Signi®cantly more
subjects achieved a pruritus severity assessment of absent or mild within the ®rst week of treatment
with pimecrolimus than with vehicle (52.3% vs. 29.1% p < 0.001) and this effect was maintained
during the remainder of the treatment period. At study endpoint, 61.5% of the pimecrolimus
subjects had absent or mild pruritus compared to 33.7% on vehicle (p < 0.001). The results of the
pooled analyses show that pimecrolimus cream 1% provides rapid and sustained relief from pruritus
in pediatric subjects with moderate to severe AD.
841
In Vitro Evaluation of the Bactericidal Activity of Three Wound Antiseptics Against
Common Wound Pathogens
A. Drosou, A. L. Cazzaniga, S. C. Davis, J. Silver, and P. M. Mertz
Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami,
Florida, U.S.A.
Bio®lms, associations of adherent bacteria living in a polysacharide matrix, have been found in
wounds and are protected from antimicrobials. The purpose of this evaluation was to examine the
effect of antiseptics on cells living in bio®lms. Pseudomonas aeruginosa and Staphylococcus aureus
bio®lms or planctonic cells were treated with Povidone-Iodine, Hydrogen Peroxide,
Chlorhexidine, and PBS. After 10 min, 1 h or 24 h, bacteria were quantitated, following removal
and neutralization of antiseptics. p.aeruginosa: Planctonic cells were susceptible to antiseptics at all
time periods whereas the cell in bio®lms were reduced by three logs from the control value at
10 min and 1h. The values were still at approximately log 5 CFU/ml as compared to 8 CFU/ml.
At 24 h Povidone-Iodine and Chlorhexidine had reduced the cells in bio®lm to < 2.3 vs. 2.9 CFU/
ml as compared to control of 5.8 CFU/ml. S.aureus: Both planctonic and bio®lm cells were
susceptible to Povidone-Iodine and Chlorhexidine but not to Hydrogen Peroxide at 10 min and
1h. We concluded that antiseptics appear to be effective against S.aureus bio®lms but are unable to
penetrate the thick pseudomonas bio®lm in a short time. Treatment longer than 10 minutes may
offer some therapeutic advantages.
843
Use of Proteomics to Probe Retinoid Action in Cultured Normal Human Keratinocytes
W. S. Blaner, S. Vogel, M. Athar,* H. F. Merk,² F. K. Jugert,² J. Baron,² U. Wiegand,³ and D.
R. Bickers*
Medicine, Columbia University, New York, New York, U.S.A.; *Dermatology, Columbia University,
New York, New York, U.S.A.; ²Dermatology, RWTH Aachen, Aachen, Germany and ³Clinical Unit,
Hoffmann-LaRoche, Basel, Switzerland
The uniquely effective therapeutic retinoid, isotretinoin, interacts poorly with the known retinoid
nuclear receptors leading to the hypothesis that the clinical ef®cacy of the drug is explainable by its
more favorable pharmacokinetics and its conversion within tissues to the more transcriptionally
active tretinoin. We have explored this hypothesis using cultures of NHK and proteomics to
investigate the patterns of protein expression in cells treated with isotretinoin (2 mM), tretinoin
(2 mM) or the vehicle ethanol. These agents were added to NHK in complete medium for 26 h and
the cells harvested for analysis of total cellular proteins by 2-dimensional (2D) electrophoresis. The
results obtained from replicate silver stained 2D gels, which provided separation of keratinocyte
proteins based on their isoelectric points and molecular weights, indicated that the proteins
expressed in NHK were similar but not identical for the 3 retinoids. Some proteins were expressed
highly only in isotretinoin-treated cells; whereas others were expressed highly only in tretinoin-
treated cells. Treatment with either isotretinoin or tretinoin resulted in expression of proteins not
seen in vehicle-treated cells. In addition, treatment with isotretinoin in¯uenced the electrophoretic
mobilities of some proteins in a manner distinct from that seen in tretinoin- or vehicle-treated cells.
The altered electrophoretic mobilities indicate possible post-translational modi®cations, including
proteolytic processing and other covalent modi®cations such as phosphorylation or binding of lipid
moieties to proteins. Our results indicate that isotretinoin and tretinoin have unique effects on
protein expression in NHK in a pattern suggesting that isotretinoin action is not totally dependent
on its conversion to tretinoin. The molecular mechanism of isotretinoin action in NHK appears to
require its transformation to multiple metabolites capable of altering protein expression.
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Ef®cacy and Local Tolerability of Pimecrolimus Cream 1% in the Treatment of Atopic
Dermatitis in the Face/Neck Region of Pediatric Subjects
D. Pariser, A. Paller,* R. Langley,² and C. Paul³
Dermatology, E. Virginia Medical School, Norfolk, Virginia, U.S.A.; *Dermatology, Children's Memorial
Hospital, Chicago, Illinois, U.S.A.; ²Center for Clinical Research, QE II Health Sciences Center, Halifax,
Nova Scotia, Canada; ³Clinical Research, Novartis Pharma AG, Basel, Switzerland
Early treatment of atopic dermatitis (AD) signs/symptoms with pimecrolimus cream 1% has been
shown to be more effective than conventional treatment (emollients plus topical corticosteroids) at
preventing AD ¯ares. Especially in children, AD occurs frequently on the face. This analysis
addresses ef®cacy and local application tolerability in the face and neck areas with pimecrolimus
cream 1%. Pooled analyses of three 6-week double-blind, vehicle-controlled studies in subjects
aged 3 months to 18 years were performed. The Eczema Area Severity Index (EASI) was used for
evaluation of ef®cacy. EASI analysis showed pimecrolimus cream was signi®cantly more effective
than conventional treatment at controlling the signs of AD (p < 0.001). The mean percentage
improvement (decrease) in overall EASI score from baseline in the pimecrolimus group was 50%,
compared with a deterioration (increase) for vehicle of 1.84%. Speci®cally for the face/neck
component of EASI, the mean percentage improvement in score was 64% in the pimecrolimus
group compared with a deterioration (increase) of 11.6% for vehicle. The incidence of application
site reactions was low. In the pimecrolimus group, application site burning was reported in 7.4% of
subjects, and application site irritation in 2.1% (9.5% and 5.0% for vehicle, respectively). Evaluation
of application site reactions by body region showed application site burning was less common on
the face/neck (1.8%) and intertriginous regions (0.3%) than in the other body areas (6.9%). There
were no reports of irritation with pimecrolimus treatment on the face/neck. Pimecrolimus cream
1% is highly ef®cacious in the treatment of pediatric subjects, especially in the face/neck region.
The overall local tolerability of pimecrolimus was very good, with a lower incidence of application
site reactions in the face/neck and intertriginous regions than in the rest of the body.
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Altered Gene Expression in Normal Human Epidermal Keratinocytes by Retinoic Acid
Isomers and their 4-Oxo-Metabolites
R. Schiffer,* G. Zwadlo-Klarwasser,* H. F. Merk,² U. Wiegand,§ F. Jugert,*² D. R. Bickers,³
and J. M. Baron²
*Interdisciplinary Center for Clinical Research BIOMAT, RWTH Aachen, Aachen, Germany;
²Department of Dermatology, RWTH Aachen, Aachen, Germany; ³Department of Dermatology,
Presbytarian Hospital, Columbia University New York, New York, New York, U.S.A.; §Roche, Roche,
Basel, Switzerland
Vitamin A and its natural and synthetic derivatives (retinoids) exert profound effects on
fundamental processes such as vision, embryonic development and cell proliferation and
differentiation. Retinoids are effective in the treatment of numerous dermatologic disorders.
There is increasing evidence that target tissue metabolic transformation is crucial for regulation of
their biological and pharmacological activity. In this experiment RA isomers and their 4-oxo
metabolites were incubated with cultured NHEK for 24 h and analysis of differentially expressed
genes was performed using DNA-Chip-technology. We examined 4400 sequence-validated
cDNAs and ESTs arrayed on DermArray GeneFilters microarray and analyzed suitably exposed
autoradiograms with Pathway analysis software. Incubation of cells with all-trans-RA for 24 h
revealed up-regulation of the human metallothionein (MT)I-F gene, corticotropin releasing
hormone-binding protein, glutathione S-transferase M5, epidermal growth factor, keratins 8 and
13 and interleukin 18 receptor. Genes encoding for keratin 10, human interleukin enhancer
binding factor 3, steroid-5-a-reductase and CYP2C8 were down-regulated simultaneously.
Incubation with 4-oxo-all-trans-RA showed a different gene expression pro®le with up-regulation
of keratin 15, thiosulfate sulfurtransferase, ®broblast growth factor receptor 2, d-aminolevulinate-
synthase 1, CYP3A3 and TIMP3. In contrast 9-cis- and 4-oxo-9-cis RA as well as 13-cis-RA and
4-oxo-13-cis RA revealed different expression pro®les. Genearray analysis is a powerful tool for
exploring retinoid effects in the skin.
850
The Pharmacokinetic Properties of Alefacept are Similar Among Caucasian and
Japanese Healthy Volunteers
R. D. Wasnich, C. N. TenHoor,* D. Freedman,* L. Li, X. Lin, and J. Ruckle
Clinical Research, Radiant Research, Honolulu, Hawaii, U.S.A.; *Medical Research, Biogen, Inc.,
Cambridge, Massachusetts, U.S.A.
AMEVIVEq (alefacept, a human LFA-3/IgG1 fusion protein) is a novel and selective biologic
agent currently being evaluated in chronic plaque psoriasis. Alefacept reduces memory-effector
(CD45RO+) T cells, which have been implicated in the pathogenesis of psoriasis. Studies have
been conducted in > 1500 subjects, primarily from North America and Western Europe. To
initiate development of alefacept in Japanese subjects, a randomized, double-blind study compared
the pharmacokinetic and biologic properties of three doses of alefacept administered as an IV bolus
injection in healthy Caucasian and Japanese volunteers. Eligible patients included males aged
between 20 and 45 years with a body mass index between 18.5 and 30. Subjects were admitted to
the clinic within 24 h prior to study drug administration. They were randomized to receive a single
dose of either placebo or alefacept 0.04 mg/kg, 0.075 mg/kg, or 0.15 mg/kg. Subjects remained at
the clinic for 48 h postdosing and returned periodically for 29 days for follow-up tests and
evaluations. A total of 48 subjects were enrolled, 24 of each ethnicity. Six subjects from each ethnic
group were randomized to the 4 treatment groups. Concentration-vs.- time curves for the
Caucasian and Japanese subjects were superimposable within each dose group. Mean Cmax and
AUClast increased with increasing dose, and Tmax occurred at approximately 1 h in both ethnic
groups within each dose group. There was no difference between ethnic groups in mean half-life
or clearance at any dose level. Alefacept was well tolerated by all subjects; the most common
adverse events were headache, asthenia, and pharyngitis. The majority of adverse events were mild
and judged by the investigator not to be related to study medication. These data show that the
pharmacokinetics and tolerability of a single IV dose of alefacept are comparable in Caucasian and
Japanese subjects. In addition, these data are consistent with those from previous studies of healthy
Caucasian subjects from North America and Europe.
852
Intralesional Interferon alfa-2b in the Treatment of Basal Cell Carcinoma and Squamous
Cell Carcinoma: Revisited
K. H. Kim, R. Yavel, V. L. Gross, and N. Brody
Dermatology, SUNY-Downstate Medical Center, Brooklyn, New York, U.S.A.
Intralesional interferon alfa-2b has been shown to be a safe and effective mode of treatment for
basal cell carcinoma and squamous cell carcinoma. Multiple studies published in the 1980s through
the early 1990s have demonstrated the ef®cacy of intralesional interferon in the treatment of these
malignancies. Unfortunately, this modality appears to be underutilized. We wish to remind
dermatologists that in addition to cryotherapy, curettage and electrodesiccation, and surgical
excision, intralesional interferon alfa-2b is an important part of the armamentarium in the
treatment of nonmelanoma skin cancers. In addition to a review of the literature, we present eight
cases in seven patients successfully treated with intralesional interferon for basal cell carcinoma and
squamous cell carcinoma. Given its nonsurgical approach and excellent cosmetic results, interferon
alfa-2b is an attractive option for patients and an important alternative when other treatment
modalities are impractical or contraindicated.
847
A Zinc/Iron Solution Stimulates Epithelization of Second-Degree Burn Wounds
S. C. Davis, A. L. Cazzaniga, A. Drosou, and P. M. Mertz
Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami,
Florida, U.S.A.
Zinc has been shown to be bene®cial to the wound healing process in various studies. The purpose
of this study was to evaluate a new zinc/iron solution (ZIS) on the healing of second-degree burn
wounds. Eight pigs received multiple second-degree burns and received one of the following
treatments: (1) 0.001% ZIS (2) 0.003% ZIS (3) 0.01% ZIS (4) saline control, or (5) untreated air
exposed. Wounds were treated by sterile 4-ply gauze saturated with each agent and then covered
with a polyurethane dressing. The wounds were then covered with polyurethane dressing.
Wounds were treated daily for the ®rst ®ve days postburn. Five burns were excised on days 7±13
and evaluated for complete epithelization using a well-described salt-split technique. Over eight
hundred wounds were evaluated. All burn wounds that received treatment-stimulated
epithelization sooner than untreated air exposed. The 0.003% ZIS enhanced complete
epithelization sooner when compared to wounds from vehicle, 0.001% and air exposed treatment
groups. This data demonstrates that a new zinc/iron agent is effective in stimulating healing which
may have important clinical implications.
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Stress-Induced Inhibition of Hair Growth in Mice is Reduced by Topical Minoxidil
P. C. Arck,* B. Handjiski,* E. M. Peters,*² E. Hagen,* B. F. Klapp,* and R. Paus²
*Department of Internal Medicine, CharitE
Á
, Humboldt University, Berlin, Germany; ²Department of
Dermatology, University of Hamburg, Hamburg, Germany
Stress has long been suspected as a possible cause of hair loss in various species, even though
convincing experimental evidence has not been available. Recently, we have shown that sonic
stress in fact alters hair growth in vivo in a murine model, and have postulated the existence of a
`brain-hair follicle axis' (FASEB J, 13 : 2536±2538; 2001). In order to study whether a clinically
available and widely used, topically active hair growth stimulator mitigates stress-triggered hair
growth inhibition in a murine stress model, we have applied topical minoxidil in 5% solution.
Female CBA/J mice were depilated and randomized in 2 groups, control (n = 20) and stress
(n = 20). These groups were further divided into two subgroups and either treated daily with 5%
minoxidil solution or vehicle alone. The stress group was exposed to sonic stress for 24 h starting
14 days after anagen induction by depilation. All mice were sacri®ced 16 days after depilation and
assessed by standardized quantitative histomorphometry. Compared to nonstressed controls, all
stressed mice showed an advanced progression towards catagen. This stress-triggered effect could
be reduced by topical minoxidil treatment (p < 0.001). Further, sonic stress signi®cantly increased
the number of hair follicles with apoptotic cells in the bulge and bulb region and inhibited
intrafollicular keratinocyte proliferation (as measured by TUNEL/Ki67 immunostain). In addition,
the number of clusters of perifollicular MHC class II + cells (largely representing activated
macrophages) and the number of degranulated perifollicular mast cells was signi®cantly enhanced
in the stressed mice. All of these stress-induced changes along the `brain-hair follicle axis' (apoptosis
induction and inhibition of proliferation in the hair follicle, perifollicular in¯ammatory events)
were down-regulated by topical minoxidil application. We conclude that stress-induced hair
growth-inhibition in mice can be effectively counteracted by topical minoxidil treatment.
851
Resveratrol-Induced Apoptosis of B16-F10 Murine Melanoma Cells
S. N. Mandrea, A. J. Chang, and R. Kumar
Dermatology, University of Illinois-Chicago, Chicago, Illinois, U.S.A.
The growth inhibitory effect of the phytoalexin Resveratrol (RES) on murine melanoma cells has
prompted us to study RES-induced apoptosis (AP). Concentration and time- dependence of RES-
induced AP were studied. Chromatin condensation, an early marker of AP, was determined
following treatment with a radioactive dye and subsequent visualization by ¯uorescence
microscopy and measurement of pixel intensity. Treatment of cells for 2 h with RES(150 mM)
showed 45% (6 15) AP vs. control 15% (6 9); at 4 h 10% (6 8) vs. control 5% (6 5). RES
(300 mM): at 1 h, RES-treated 48% (6 23) vs. control 16% (6 15); at 2 h, RES-treated 84% (6 4)
vs. control 23% (6 16); at 4 h, RES-treated 93% (6 4) vs. control 82% (6 11). RES (600 mM): at
1 h, RES-treated 78% (6 10) vs. control 23% (6 28); at 2 h, RES-treated 80% (6 5) vs. control
32% (6 20). Flow cytometry using an AnnexinV-FITC probe was done to identify the
translocation of phosphatidylserine (PS) from the inner to outer plasma membrane, another early
marker of AP. Treatment with RES (300 mM) for 24 h showed 8% AP vs. control 3%; at 36 h, 15%
vs. control 4%; at 42 h, 30% vs. control 4%; at 48 h, 47% vs. control 6%. TUNEL assay was used to
measure DNA fragementation, a later phase of AP. Data for RES(300 mM) at 2 h was 21% (6 36)
vs. control 9% (6 14); 24 h, 45% (6 29) vs. control 0.12% (6 0.21). Flow cytometric analysis was
performed to distinguish populations of cells at different phases of the cell cycle and apoptotic cells
that contain sub-G1 DNA. Cells were treated for speci®c timepoints, ®xed, and stained with
propidium iodide and RNAse to identify cells in the sub-G1 phase of the cell cycle. Cells treated
with RES (300 mM) at 24 h vs. control showed different patterns of DNA content (e.g. marked
increase in S phase and sub-G1 quantity). RES showed a time-dependent increase in AP with 12%
at 24 h vs. control 2% and 16% at 48 h vs. control 6%. Resveratrol induces AP in B16-F10 murine
melanoma cells in vitro as demonstrated by chromatin condensation, externalization of plasma
membrane PS residues, DNA fragmentation and DNA content.
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Pimecrolimus Cream 1% Provides Long-Term Disease Management in Children with
Severe Atopic Dermatitis
R. Kaufmann, M. Good®eld,* A. Kapp,² and N. Gourmala³
Center for Dermatology, Goethe University, Frankfurt, Germany; *Dermatology, Leeds General In®rmary,
Leeds, U.K.; ²Dermatology and Allergology, Hannover Medical University, Hannover, Germany; ³Clinical
Research, Novartis Pharma AG, Basel, Switzerland
Use of pimecrolimus cream 1% at the ®rst signs/symptoms of atopic dermatitis (AD) has been
demonstrated to be superior to conventional treatment in reducing the number of AD ¯ares in
children with mild-to-very severe AD (p < 0.001). This paper focuses on ef®cacy in severe/very
severe AD patients (Investigators Global Assessment [IGA] = 4 or 5). Pooled 6-month analyses of
two randomized, double-blind studies are presented; one in infants (i.e. 3±23 months), and one in
children & adolescents (2±17 years). Subjects were randomized either 2 : 1 (children & adolescents)
or 4 : 1 (infants) to either a pimecrolimus-based (n = 678) or conventional (n = 283) treatment. To
prevent progression to ¯ares, study medication (pimecrolimus cream 1% or, to maintain study
blind, vehicle) was applied bid at the ®rst signs or symptoms, and until they resolved. In addition to
study medication, emollients were used for dry skin, and moderately potent topical CS were used
to treat ¯ares not controlled by study medication. The primary ef®cacy endpoint was the ranked
¯ares of AD. The severe/very severe disease group (IGA = 4 or 5) constituted 16% of the
randomized population. For the primary ef®cacy analysis (ranked ¯ares) in these subjects, there was
a signi®cant difference in favor of the pimecrolimus group (p = 0.016). The incidence of ¯ares was
higher in the conventional treatment group. The proportion of subjects in this group remaining
¯are free for 6 months was more than twice as high in the pimecrolimus group compared with the
control group (43% vs. 16%). The proportion of severe/very severe patients who needed no
corticosteroid in this period was 39% and 21% in the pimecrolimus and control groups,
respectively. The pooled analyses of two large long-term studies has demonstrated that treatment
with pimecrolimus 1% cream is superior to a conventional treatment regimen in preventing disease
¯ares in children with severe/very severe AD.
856
Contrasting Impacts of Immunosuppressive Drugs on Bi-Directional Dendritic Cell±T
Cell Interaction During Antigen Presentation
H. Matsue, K. Matsue, C. Yang, D. Edelbaum, and A. Takashima
Dermatology, UT South-western, Dallas, Texas, U.S.A.
During antigen (Ag) presentation, dendritic cells (DC) deliver various activation signals to naive T
cells, leading to T cell priming, clonal expansion, and differentiation. However, whether reverse
signaling occurs in Ag presentation remains relatively unknown. When CD4+ T cells isolated from
DO11.10 transgenic mice were cocultured with bone marrow-derived DC and relevant antigen
(ovalbumin peptide), DC induced proliferation, secretion of IL-2 and interferon-g, and CD69
expression by T cells. Conversely, T cells delivered maturation signals back to DC, leading to IL-6
and IL-12 production and CD40 up-regulation. None of these changes occurred in the absence of
DC, T cells, or Ag, establishing speci®city. Our results document bi-directionality (DCCË T cell and
T cell CË DC) of the intercellular signaling in Ag presentation. Using this Ag presentation system,
we systematically compared in¯uences of rapamycin (RAP), tacrolimus (FK506), and cyclosporin








M) each blocked ef®ciently and uniformly all
the above changes resulting from bi-directional intercellular signaling in Ag presentation, although





M) was as ef®cient as FK506 in blocking DC-dependent T cell proliferation and even more
potent than FK506 in preventing T cell-induced CD40 up-regulation by DC. By marked contract,
RAP even at higher doses (up to 10
±7
M) caused minimal, if any, inhibition of CD69 expression by
T cells or cytokine production by T cells or DC. Our results demonstrate quantitative and
qualitative differences between RAP vs. calcineurin inhibitors in their impacts on Ag presentation,
thus forming a conceptual framework for rationale-based selection and combination of these agents
for clinical application.
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Treatment with Pimecrolimus Cream 1% is Corticosteroid Sparing in Infants with
Atopic Dermatitis
A. Kapp, K. Papp,* W. Gulliver,² and H. P. Goertz³
Dermatology and Allergology, Hannover Medical University, Hannover, Germany; *Dermatology, Probity
Medical Research, Waterloo, Ontario, Canada; ²NewLab, Clinical Research, St John's, Newfoundland,
Canada; ³Clinical Research, Novartis Pharma AG, Basel, Switzerland
Conventional treatment for atopic dermatitis (AD) is based on the use of topical corticosteroids
(CS), which can cause local and systemic side-effects. Pimecrolimus, a novel nonsteroid inhibitor
of in¯ammatory cytokines, has been developed as a 1% cream for the treatment of AD. This study
compared the long-term ef®cacy and safety of early intervention with pimecrolimus cream 1% in
infants with AD with that of a conventional treatment control (emollients and reactive use of CS).
Patients (n = 251) aged 3±23 months were randomized 4 : 1 to a pimecrolimus-based treatment
or a control treatment in a long-term (12 months) double-blind, multicenter, parallel-group study.
To prevent ¯ares study medication (pimecrolimus cream or, to maintain study blind,
corresponding vehicle) was to be applied bid at ®rst signs or symptoms of ad and until they
resolved. In addition, emollients were used for dry skin, and moderately potent topical cs were
used to treat ¯ares not controlled by study medication. After each cycle of second-line medication,
study medication was to be applied for 7 days to treat residual disease. The primary ef®cacy
endpoint was the ranked ¯ares of ad. Pimecrolimus was signi®cantly more effective than the
conventional treatment control in the primary ef®cacy analysis, ranked ¯ares of ad. The proportion
of subjects remaining ¯are free for 12 months was more than twice as high in the pimecrolimus
group compared with the control group (57% vs. 28%, p < 0.001). The proportion of subjects
requiring treatment with corticosteroids was markedly lower in the pimecrolimus group compared
with the control group at 12 months (36.3% vs. 65.2%), despite a much higher discontinuation rate
in the control group (25% vs. 39%). Compared to a conventional treatment, early intervention
with pimecrolimus cream 1% leads to better long-term control of ad in infants with a much-
reduced reliance on topical corticosteroids.
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Pimecrolimus Cream 1% Provides Signi®cant and Rapid Relief of Pruritus and
Improves Disease Control and Quality of Life in Atopic Dermatitis in Adults
M. Meurer, R. Fo
È
lster-Holst,* G. Wozel, G. Weidinger,² M. Ju
È
nger,³ and M. Bra
È
utigam²
Dermatology, Dresden University of Technology, Dresden, Germany; *Dermatology, UniversitaÈtshautklinik,
Kiel, Germany; ²Clinical Research, Novartis Pharma Gmbh, Nuremberg, Germany; ³Dermatology, Klinik
und Poliklinik fur Hautkrankheiten, Greifswald, Germany
This study compared early intervention with pimecrolimus cream 1% to prevent progression to
disease ¯ares in adults with moderate-to-severe atopic dermatitis (AD), with a conventional
treatment (i.e. emollients and topical corticosteroid [CS]).
Patients (n = 192) were randomized (1 : 1) to either the pimecrolimus-based treatment or to a
conventional treatment in a 24-week parallel-group, double-blind study. First signs/symptoms of
ad were treated bid with either pimecrolimus cream 1% or, to maintain the study blind,
corresponding vehicle to prevent progression to ¯ares. In the event of ¯ares (i.e. Disease
exacerbation unacceptable to the patient), cs (prednicarbate 0.25% cream) bid for 7 days followed
by od for 7 days was prescribed. Cs use was signi®cantly less frequent in the pimecrolimus group
than in the conventional treatment group (mean 14.2% vs. 37.2% of days, p < 0.001). Median time
to ®rst ¯are was 144 days (95% ci: 105 to > 168) in the pimecrolimus group and 26 days (95% ci:
21±47) in the conventional treatment group (p < 0.001). Pruritus relief in the pimecrolimus group
was achieved within the ®rst 2-to-3 days (decrease in mean pruritus on a 0 [none] to 3 [severe] scale
from 2.5 at baseline to 1.8 at day 3). The mean improvement in quality of life (qol) was 25.6%
(qoliad) and 22.0% (dlqi) in the pimecrolimus group; the bene®t with the conventional therapy
was only 7.4% and 6.7% (p < 0.002 for group differences in qoliad and p = 0.01 for group
differences in dlqi). There were no clinically relevant differences between treatment groups in any
safety assessments. Pimecrolimus cream signi®cantly reduced the time to ®rst ¯are, rapidly
controlled pruritus, and improved patients' qol, offering signi®cant advantages over a conventional
treatment in the long term management of ad in adults.
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